Citrus Sinensis ID: 008828
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 552 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RY65 | 635 | Protein NSP-INTERACTING K | yes | no | 0.985 | 0.856 | 0.801 | 0.0 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.987 | 0.854 | 0.759 | 0.0 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.974 | 0.848 | 0.640 | 0.0 | |
| Q8VYT3 | 648 | Probable LRR receptor-lik | no | no | 0.909 | 0.774 | 0.673 | 0.0 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.978 | 0.854 | 0.642 | 0.0 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.969 | 0.856 | 0.586 | 1e-164 | |
| C0LGU5 | 614 | Probable LRR receptor-lik | no | no | 0.947 | 0.851 | 0.556 | 1e-163 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.931 | 0.829 | 0.543 | 1e-151 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.907 | 0.814 | 0.508 | 1e-145 | |
| C0LGT1 | 613 | Probable LRR receptor-lik | no | no | 0.947 | 0.853 | 0.525 | 1e-144 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 897 bits (2319), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/548 (80%), Positives = 484/548 (88%), Gaps = 4/548 (0%)
Query: 9 APSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS 68
APSQNLSGTLSSSIGNLTNLQ VLLQNN I+G+IP EIGKL KL TLDLS N FTG IP
Sbjct: 88 APSQNLSGTLSSSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPF 147
Query: 69 TVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNS 128
T+S+ + LQYLR+NNNSLTG IP SL+NM+QL FLDLSYNNLSGPVP AKTFN+ GNS
Sbjct: 148 TLSYSKNLQYLRVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKTFNVMGNS 207
Query: 129 LICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGF 188
IC TG E+DC GT P P+S LN+S N G K +KIA+ G SL C+ LLI+GFGF
Sbjct: 208 QICPTGTEKDCNGTQPKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGF 267
Query: 189 LLWWRQRHNQQI-FFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVY 247
LLWWR+RHN+Q+ FFD+NEQ +EE+CLGNL+RF+FKELQSATSNFSSKNLVGKGGFGNVY
Sbjct: 268 LLWWRRRHNKQVLFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVY 327
Query: 248 KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307
KG L DG+++AVKRLKD N GGE+QFQTE+EMISLAVHRNLLRL GFC T++ERLLVYP
Sbjct: 328 KGCLHDGSIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYP 387
Query: 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 367
YMSNGSVASRLKAKP LDW TRKRIALGA RGLLYLHEQCDPKIIHRDVKAANILLD+Y+
Sbjct: 388 YMSNGSVASRLKAKPVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYF 447
Query: 368 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
EAVVGDFGLAKLLDH +SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+G
Sbjct: 448 EAVVGDFGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 507
Query: 428 LRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYL 487
LRALEFGK ANQ+GA+LDWVKK+ QEKKLE +VDKDLK+NYDRIE+EEMVQVALLCTQYL
Sbjct: 508 LRALEFGKAANQRGAILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYL 567
Query: 488 PSLRPKMSEVVRMLEGDGLAEKW-AASQKAEATR--SRANEFSSSERYSDLTDDSSLLVQ 544
P RPKMSEVVRMLEGDGL EKW A+SQ+AE R S+ NEFSSSERYSDLTDDSS+LVQ
Sbjct: 568 PIHRPKMSEVVRMLEGDGLVEKWEASSQRAETNRSYSKPNEFSSSERYSDLTDDSSVLVQ 627
Query: 545 AMELSGPR 552
AMELSGPR
Sbjct: 628 AMELSGPR 635
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 848 bits (2191), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/552 (75%), Positives = 471/552 (85%), Gaps = 7/552 (1%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
G PSQNLSGTLS SI NLTNL++VLLQNNNI G IP EIG+L++L TLDLS+NFF G IP
Sbjct: 87 GTPSQNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIP 146
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
+V +L++LQYLRLNNNSL+G P SLSNM+QLAFLDLSYNNLSGPVP F AKTF+I GN
Sbjct: 147 FSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVPRFAAKTFSIVGN 206
Query: 128 SLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFG 187
LIC TG E DC GT +P+S LN + +G + K+A+A+GSS+G +SL+ + G
Sbjct: 207 PLICPTGTEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVG 266
Query: 188 FLLWWRQRHNQQIFFDVNE-QRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNV 246
LWWRQRHNQ FFDV + EEV LGNL+RF F+ELQ AT+NFSSKNL+GKGG+GNV
Sbjct: 267 LFLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNV 326
Query: 247 YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306
YKG L D TVVAVKRLKDG A+GGEIQFQTEVEMISLAVHRNLLRL GFC+T TE+LLVY
Sbjct: 327 YKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVY 386
Query: 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 366
PYMSNGSVASR+KAKP LDW+ RKRIA+GAARGL+YLHEQCDPKIIHRDVKAANILLD+Y
Sbjct: 387 PYMSNGSVASRMKAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDY 446
Query: 367 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL++
Sbjct: 447 CEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVT 506
Query: 427 GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL--KNNYDRIELEEMVQVALLCT 484
G RA EFGK ANQKG MLDWVKKIHQEKKLE+LVDK+L K +YD IEL+EMV+VALLCT
Sbjct: 507 GQRAFEFGKAANQKGVMLDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCT 566
Query: 485 QYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEAT---RSRANEF-SSSERYSDLTDDSS 540
QYLP RPKMSEVVRMLEGDGLAEKW ASQ++++ +R NE SSS+RYSDLTDDSS
Sbjct: 567 QYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTDDSS 626
Query: 541 LLVQAMELSGPR 552
LLVQAMELSGPR
Sbjct: 627 LLVQAMELSGPR 638
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 705 bits (1820), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/562 (64%), Positives = 430/562 (76%), Gaps = 24/562 (4%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
GAPSQ+LSGTLS SIGNLTNL+ V LQNNNISG IP EI L KL TLDLSNN F+G IP
Sbjct: 80 GAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDLSNNRFSGEIP 139
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
+V+ L LQYLRLNNNSL+G P SLS + L+FLDLSYNNL GPVP F A+TFN+ GN
Sbjct: 140 GSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVPKFPARTFNVAGN 199
Query: 128 SLICATGAEEDCFGT-APMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGF 186
LIC E C G+ + PLS +L +S + + +A+ALG SLG +IL
Sbjct: 200 PLICKNSLPEICSGSISASPLSVSLRSSSGRRTN------ILAVALGVSLGFAVSVILSL 253
Query: 187 GFLLWWRQRHNQQIFFDVNEQRREEVC-LGNLKRFHFKELQSATSNFSSKNLVGKGGFGN 245
GF+ W+R++ + +++++ E + LGNL+ F F+EL AT FSSK+++G GGFGN
Sbjct: 254 GFI-WYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGN 312
Query: 246 VYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305
VY+G DGTVVAVKRLKD N G QF+TE+EMISLAVHRNLLRLIG+C +++ERLLV
Sbjct: 313 VYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERLLV 372
Query: 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE 365
YPYMSNGSVASRLKAKP+LDW TRK+IA+GAARGL YLHEQCDPKIIHRDVKAANILLDE
Sbjct: 373 YPYMSNGSVASRLKAKPALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDE 432
Query: 366 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 425
Y+EAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI
Sbjct: 433 YFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 492
Query: 426 SGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQ 485
+G+RALEFGK+ +QKGAML+WV+K+H+E K+E LVD++L YDRIE+ EM+QVALLCTQ
Sbjct: 493 TGMRALEFGKSVSQKGAMLEWVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQ 552
Query: 486 YLPSLRPKMSEVVRMLEGDGLAEKWAASQK---------------AEATRSRANEFSSSE 530
+LP+ RPKMSEVV+MLEGDGLAE+WAAS + ++ S
Sbjct: 553 FLPAHRPKMSEVVQMLEGDGLAERWAASHDHSHFYHANMSYRTITSTDGNNQTKHLFGSS 612
Query: 531 RYSDLTDDSSLLVQAMELSGPR 552
+ D D+ +L AMELSGPR
Sbjct: 613 GFEDEDDNQALDSFAMELSGPR 634
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 684 bits (1765), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/508 (67%), Positives = 408/508 (80%), Gaps = 6/508 (1%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
GAPSQ+LSG LS SIGNLTNL+ V LQNNNISG IP E+G L KL TLDLSNN F+G IP
Sbjct: 83 GAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNNRFSGDIP 142
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
++ L +LQYLRLNNNSL+G P SLS + L+FLDLSYNNLSGPVP F A+TFN+ GN
Sbjct: 143 VSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPKFPARTFNVAGN 202
Query: 128 SLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFG 187
LIC + E C G+ A S + S + ++A+AL SLG + +L+L G
Sbjct: 203 PLICRSNPPEICSGSIN-----ASPLSVSLSSSSGRRSNRLAIALSVSLGSVVILVLALG 257
Query: 188 FLLWWRQRHNQQIFFDVNEQRREEV-CLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNV 246
W+R++ + + ++N+++ E + LGNL+ F F+EL T FSSKN++G GGFGNV
Sbjct: 258 SFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNV 317
Query: 247 YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306
Y+G L DGT+VAVKRLKD N G+ QF+ E+EMISLAVH+NLLRLIG+C T+ ERLLVY
Sbjct: 318 YRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGERLLVY 377
Query: 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 366
PYM NGSVAS+LK+KP+LDW RKRIA+GAARGLLYLHEQCDPKIIHRDVKAANILLDE
Sbjct: 378 PYMPNGSVASKLKSKPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDEC 437
Query: 367 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
+EAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+
Sbjct: 438 FEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 497
Query: 427 GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQY 486
GLRALEFGKT +QKGAML+WV+K+H+E K+E L+D++L NYD+IE+ EM+QVALLCTQY
Sbjct: 498 GLRALEFGKTVSQKGAMLEWVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQY 557
Query: 487 LPSLRPKMSEVVRMLEGDGLAEKWAASQ 514
LP+ RPKMSEVV MLEGDGLAE+WAAS
Sbjct: 558 LPAHRPKMSEVVLMLEGDGLAERWAASH 585
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 670 bits (1728), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/554 (64%), Positives = 424/554 (76%), Gaps = 14/554 (2%)
Query: 10 PSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 69
PSQ+LSGTLS IGNLT LQ V+LQNN I+G IP IG+L KL +LDLSNN FTG IP++
Sbjct: 82 PSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNNSFTGEIPAS 141
Query: 70 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSL 129
+ L+ L YLRLNNNSL G P SLS + L +D+SYNNLSG +P A+TF + GN+L
Sbjct: 142 LGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPKVSARTFKVIGNAL 201
Query: 130 ICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFL 189
IC A +C P PL+ + S G +ALA +S + G
Sbjct: 202 ICGPKAVSNC-SAVPEPLTLPQDGPDES--GTRTNGHHVALAFAASFSAAFFVFFTSGMF 258
Query: 190 LWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKG 249
LWWR R N+QIFFDVNEQ EV LG+LKR+ FKEL+SAT++F+SKN++G+GG+G VYKG
Sbjct: 259 LWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKG 318
Query: 250 YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309
+L DGT+VAVKRLKD N GGE+QFQTEVE ISLA+HRNLLRL GFC + ER+LVYPYM
Sbjct: 319 HLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYM 378
Query: 310 SNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE 365
NGSVASRLK +P+LDW+ RK+IA+G ARGL+YLHEQCDPKIIHRDVKAANILLDE
Sbjct: 379 PNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDE 438
Query: 366 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 425
+EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI
Sbjct: 439 DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 498
Query: 426 SGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQ 485
+G +AL+FG++A+QKG MLDWVKK+HQE KL+ L+DKDL + +DR+ELEE+VQVALLCTQ
Sbjct: 499 TGQKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQ 558
Query: 486 YLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRS----RANEFSSSER---YSDLTDD 538
+ PS RPKMSEV++MLEGDGLAE+W A+Q SSS R YSD +
Sbjct: 559 FNPSHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQE 618
Query: 539 SSLLVQAMELSGPR 552
SSL+V+A+ELSGPR
Sbjct: 619 SSLVVEAIELSGPR 632
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 579 bits (1492), Expect = e-164, Method: Compositional matrix adjust.
Identities = 322/549 (58%), Positives = 386/549 (70%), Gaps = 14/549 (2%)
Query: 14 LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 73
LSG L +G L NLQ + L +NNI+G IP+ +G L+ L++LDL N F+GPIP ++ L
Sbjct: 81 LSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIPESLGKL 140
Query: 74 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP---SFHAKT-FNITGNSL 129
L++LRLNNNSLTG+IP SL+N++ L LDLS N LSG VP SF T + N
Sbjct: 141 SKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLD 200
Query: 130 ICA-TGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGF 188
+C + P + P S PSG G A+A G + G L
Sbjct: 201 LCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGY--GITGAIAGGVAAGAALLFAAPAIA 258
Query: 189 LLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYK 248
WWR+R IFFDV + EV LG LKRF +ELQ A+ FS+KN++G+GGFG VYK
Sbjct: 259 FAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYK 318
Query: 249 GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308
G L DGT+VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPY
Sbjct: 319 GRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 378
Query: 309 MSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 364
M+NGSVAS L+ ++P LDW TRKRIALG+ARGL YLH+ CDPKIIHRDVKAANILLD
Sbjct: 379 MANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 438
Query: 365 EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 424
E +EAVVGDFGLAKL+D+ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLEL
Sbjct: 439 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLEL 498
Query: 425 ISGLRALEFGKTANQKGAM-LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLC 483
I+G RA + + AN M LDWVK + +EKKLEMLVD DL+ NY+ ELE+++QVALLC
Sbjct: 499 ITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLC 558
Query: 484 TQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLV 543
TQ P RPKMSEVVRMLEGDGLAEKW QK E R + S SD DS+ +
Sbjct: 559 TQGSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILREEID--LSPNPNSDWILDSTYNL 616
Query: 544 QAMELSGPR 552
A+ELSGPR
Sbjct: 617 HAVELSGPR 625
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 575 bits (1481), Expect = e-163, Method: Compositional matrix adjust.
Identities = 304/546 (55%), Positives = 396/546 (72%), Gaps = 23/546 (4%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
S+ LSG LS+SIG LT+L +LLQNN ++G IP+E+G+LS+L TLDLS N F+G IP+++
Sbjct: 88 SKGLSGILSTSIGELTHLHTLLLQNNQLTGPIPSELGQLSELETLDLSGNRFSGEIPASL 147
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLI 130
L L YLRL+ N L+G +P ++ +S L+FLDLS+NNLSGP P+ AK + I GN+ +
Sbjct: 148 GFLTHLNYLRLSRNLLSGQVPHLVAGLSGLSFLDLSFNNLSGPTPNISAKDYRIVGNAFL 207
Query: 131 CATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLL 190
C ++E C P+ + L+ NSK + ++ A G + I L+ F ++L
Sbjct: 208 CGPASQELCSDATPVRNATGLSEKDNSKHHSL----VLSFAFGIVVAFIISLMFLFFWVL 263
Query: 191 WWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY 250
W R R ++ + Q+ E +G+LKRF F+E+Q+ATSNFS KN++G+GGFG VYKGY
Sbjct: 264 WHRSRLSRS-----HVQQDYEFEIGHLKRFSFREIQTATSNFSPKNILGQGGFGMVYKGY 318
Query: 251 LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 310
L +GTVVAVKRLKD GE+QFQTEVEMI LAVHRNLLRL GFCMT ER+LVYPYM
Sbjct: 319 LPNGTVVAVKRLKD-PIYTGEVQFQTEVEMIGLAVHRNLLRLFGFCMTPEERMLVYPYMP 377
Query: 311 NGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 366
NGSVA RL+ KPSLDW R IALGAARGL+YLHEQC+PKIIHRDVKAANILLDE
Sbjct: 378 NGSVADRLRDNYGEKPSLDWNRRISIALGAARGLVYLHEQCNPKIIHRDVKAANILLDES 437
Query: 367 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
+EA+VGDFGLAKLLD DSHVTTAVRGT+GHIAPEYLSTGQSSEKTDVFGFG+L+LELI+
Sbjct: 438 FEAIVGDFGLAKLLDQRDSHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELIT 497
Query: 427 GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQY 486
G + ++ G +KG +L WV+ + EK+ +VD+DLK +D + LEE+V++ALLCTQ
Sbjct: 498 GHKMIDQGNGQVRKGMILSWVRTLKAEKRFAEMVDRDLKGEFDDLVLEEVVELALLCTQP 557
Query: 487 LPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAM 546
P+LRP+MS+V+++LE GL E+ +A A S S YS+ ++ S +++A+
Sbjct: 558 HPNLRPRMSQVLKVLE--GLVEQCEGGYEARAP-------SVSRNYSNGHEEQSFIIEAI 608
Query: 547 ELSGPR 552
ELSGPR
Sbjct: 609 ELSGPR 614
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 534 bits (1376), Expect = e-151, Method: Compositional matrix adjust.
Identities = 304/559 (54%), Positives = 375/559 (67%), Gaps = 45/559 (8%)
Query: 14 LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 73
LSG L +G L NLQ + L +NNI+G IP E+G L +L++LDL N +GPIPS++ L
Sbjct: 87 LSGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKL 146
Query: 74 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN-SLICA 132
L++LRLNNNSL+G IP +L+++ QL LD+S N LSG +P + G+ SL
Sbjct: 147 GKLRFLRLNNNSLSGEIPMTLTSV-QLQVLDISNNRLSGDIP--------VNGSFSLFT- 196
Query: 133 TGAEEDCFGTAPMPLSFALNNSPNSKPSGMPK-----------GQKIALALGSSLGCISL 181
P+SFA NNS P P GQ A G +L
Sbjct: 197 -------------PISFA-NNSLTDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAAL 242
Query: 182 L--ILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVG 239
L + F WW +R Q FFDV + EV LG LKRF +EL AT NFS+KN++G
Sbjct: 243 LFAVPAIAFA-WWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLG 301
Query: 240 KGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT 299
+GGFG VYKG L DG +VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMT
Sbjct: 302 RGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 361
Query: 300 TERLLVYPYMSNGSVASRLKAKP----SLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 355
TERLLVYPYM+NGSVAS L+ +P +LDW RK IALG+ARGL YLH+ CD KIIHRD
Sbjct: 362 TERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRD 421
Query: 356 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 415
VKAANILLDE +EAVVGDFGLAKL+++ DSHVTTAVRGT+GHIAPEYLSTG+SSEKTDVF
Sbjct: 422 VKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVF 481
Query: 416 GFGILLLELISGLRALEFGKTANQKGAM-LDWVKKIHQEKKLEMLVDKDLKNNYDRIELE 474
G+G++LLELI+G +A + + AN M LDWVK++ +EKKLE LVD +L+ Y E+E
Sbjct: 482 GYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVE 541
Query: 475 EMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSD 534
+++Q+ALLCTQ RPKMSEVVRMLEGDGLAE+W QK E N + +D
Sbjct: 542 QLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPIHDFNYQAYPHAGTD 601
Query: 535 -LTDDSSLLVQAMELSGPR 552
L S+ L++ SGPR
Sbjct: 602 WLIPYSNSLIENDYPSGPR 620
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 517 bits (1331), Expect = e-145, Method: Compositional matrix adjust.
Identities = 293/576 (50%), Positives = 369/576 (64%), Gaps = 75/576 (13%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
NLSG L +G L NLQ + L +NNI+G IP ++G L++L++LDL N +GPIPS
Sbjct: 79 NLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNNLSGPIPS---- 134
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS-----FHAKTFNITGN 127
+L + +L FL L+ N+LSG +P + +++ N
Sbjct: 135 --------------------TLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNN 174
Query: 128 SLICATGAEEDCFGTAPM--------PLSFALNNSPNSKPSGMPK--------------- 164
L G P+ P+SFA N+K + +P
Sbjct: 175 PLT----------GDIPVNGSFSLFTPISFA-----NTKLTPLPASPPPPISPTPPSPAG 219
Query: 165 GQKIALALGSSLGCISLLILGFGF--LLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHF 222
+I A+ + + L+ L WWR++ Q FFDV + EV LG LKRF
Sbjct: 220 SNRITGAIAGGVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSL 279
Query: 223 KELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS 282
+ELQ A+ NFS+KN++G+GGFG VYKG L DGT+VAVKRLK+ GGE+QFQTEVEMIS
Sbjct: 280 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMIS 339
Query: 283 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS----RLKAKPSLDWATRKRIALGAAR 338
+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS R +++P LDW R+RIALG+AR
Sbjct: 340 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR 399
Query: 339 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 398
GL YLH+ CDPKIIHRDVKAANILLDE +EAVVGDFGLAKL+D+ D+HVTTAVRGT+GHI
Sbjct: 400 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 459
Query: 399 APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM-LDWVKKIHQEKKLE 457
APEYLSTG+SSEKTDVFG+G++LLELI+G RA + + AN M LDWVK + +EKKLE
Sbjct: 460 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 519
Query: 458 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAE 517
LVD DL+ NY E+E+++QVALLCTQ P RPKMSEVVRMLEGDGLAE+W QK E
Sbjct: 520 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEE 579
Query: 518 ATRSRANEFSSSERYSD-LTDDSSLLVQAMELSGPR 552
R N + S + DS+ ++ SGPR
Sbjct: 580 MFRQDFNYPTHHPAVSGWIIGDSTSQIENEYPSGPR 615
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 512 bits (1318), Expect = e-144, Method: Compositional matrix adjust.
Identities = 289/550 (52%), Positives = 367/550 (66%), Gaps = 27/550 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
N SGTLSS +G L NL+ + L+ N I+G IP + G L+ L +LDL +N TG IPST+ +
Sbjct: 81 NFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPSTIGN 140
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS--FHAKTFNITGNSLI 130
L+ LQ+L L+ N L G IP SL+ + L L L N+LSG +P F +N T N+L
Sbjct: 141 LKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTSNNL- 199
Query: 131 CATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLL 190
+C G P P A+ +S +S PK IA + ++++ G L
Sbjct: 200 -------NCGGRQPHPCVSAVAHSGDSSK---PKTGIIAGVVAGV----TVVLFGILLFL 245
Query: 191 WWRQRHN---QQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVY 247
+ + RH + +F DV + + G LKRF ++ELQ AT NFS KN++G+GGFG VY
Sbjct: 246 FCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVY 305
Query: 248 KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307
KG L D T VAVKRL D + GG+ FQ EVEMIS+AVHRNLLRLIGFC T TERLLVYP
Sbjct: 306 KGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYP 365
Query: 308 YMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363
+M N S+A RL+ P LDW TRKRIALGAARG YLHE C+PKIIHRDVKAAN+LL
Sbjct: 366 FMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLL 425
Query: 364 DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 423
DE +EAVVGDFGLAKL+D ++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLE
Sbjct: 426 DEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE 485
Query: 424 LISGLRALEFGKTANQKGA-MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALL 482
L++G RA++F + + +LD VKK+ +EK+L +VDK+L Y + E+E M+QVALL
Sbjct: 486 LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALL 545
Query: 483 CTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLL 542
CTQ P RP MSEVVRMLEG+GLAE+W Q E TR +EF +R D +DS
Sbjct: 546 CTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRR--HEFERLQRRFDWGEDSMHN 603
Query: 543 VQAMELSGPR 552
A+ELSG R
Sbjct: 604 QDAIELSGGR 613
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 552 | ||||||
| 224099221 | 622 | predicted protein [Populus trichocarpa] | 0.983 | 0.872 | 0.860 | 0.0 | |
| 147815751 | 609 | hypothetical protein VITISV_025883 [Viti | 0.987 | 0.894 | 0.862 | 0.0 | |
| 225425033 | 625 | PREDICTED: protein NSP-INTERACTING KINAS | 0.987 | 0.872 | 0.862 | 0.0 | |
| 110432095 | 622 | leucine-rich repeat receptor-like kinase | 0.983 | 0.872 | 0.849 | 0.0 | |
| 449434692 | 623 | PREDICTED: protein NSP-INTERACTING KINAS | 0.985 | 0.873 | 0.829 | 0.0 | |
| 224108601 | 627 | predicted protein [Populus trichocarpa] | 0.983 | 0.866 | 0.834 | 0.0 | |
| 255546957 | 576 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.983 | 0.942 | 0.849 | 0.0 | |
| 356502688 | 770 | PREDICTED: protein NSP-INTERACTING KINAS | 0.983 | 0.705 | 0.831 | 0.0 | |
| 356498122 | 621 | PREDICTED: protein NSP-INTERACTING KINAS | 0.983 | 0.874 | 0.827 | 0.0 | |
| 298204417 | 622 | unnamed protein product [Vitis vinifera] | 0.987 | 0.876 | 0.816 | 0.0 |
| >gi|224099221|ref|XP_002311408.1| predicted protein [Populus trichocarpa] gi|222851228|gb|EEE88775.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 958 bits (2477), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/545 (86%), Positives = 499/545 (91%), Gaps = 2/545 (0%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
GAPSQ LSGTLS SIGNLTNLQ +LLQ+NNISGHIP+E+G+LSKL T+DLS+N F+G IP
Sbjct: 80 GAPSQRLSGTLSPSIGNLTNLQSLLLQDNNISGHIPSELGRLSKLKTIDLSSNNFSGQIP 139
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
S +S+L +LQYLRLNNNSL GAIP SL NM+QL FLDLSYN+LS PVP HAKTFNI GN
Sbjct: 140 SALSNLNSLQYLRLNNNSLDGAIPASLVNMTQLTFLDLSYNDLSTPVPPVHAKTFNIVGN 199
Query: 128 SLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFG 187
LIC G E+ C GT P+P S ALNNS NS+PSG K KIALA GSSLGCI LL+LGFG
Sbjct: 200 PLIC--GTEQGCAGTTPVPQSVALNNSQNSQPSGNNKSHKIALAFGSSLGCICLLVLGFG 257
Query: 188 FLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVY 247
F+LWWRQRHNQQIFFDVNEQ EE+ LGNL+ F FKELQ AT+NFSSKNL+GKGGFGNVY
Sbjct: 258 FILWWRQRHNQQIFFDVNEQHNEELNLGNLRSFQFKELQVATNNFSSKNLIGKGGFGNVY 317
Query: 248 KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307
KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL GFCMTTTERLLVYP
Sbjct: 318 KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTTTERLLVYP 377
Query: 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 367
YMSNGSVA+RLKAKP+LDW TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD+Y
Sbjct: 378 YMSNGSVATRLKAKPALDWGTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDYC 437
Query: 368 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG
Sbjct: 438 EAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 497
Query: 428 LRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYL 487
LRALEFGK+ NQKGA+LDWVKKIHQEKKLE+LVDKDLKNNYDRIELEE+VQVALLCTQYL
Sbjct: 498 LRALEFGKSTNQKGALLDWVKKIHQEKKLELLVDKDLKNNYDRIELEEIVQVALLCTQYL 557
Query: 488 PSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAME 547
PS RPKMSEVVRMLEGDGLAEKW ASQ+AE TRSRANEFSSSERYSDLTDDSSLLVQAME
Sbjct: 558 PSHRPKMSEVVRMLEGDGLAEKWEASQRAEETRSRANEFSSSERYSDLTDDSSLLVQAME 617
Query: 548 LSGPR 552
LSGPR
Sbjct: 618 LSGPR 622
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815751|emb|CAN63733.1| hypothetical protein VITISV_025883 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 950 bits (2455), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/546 (86%), Positives = 505/546 (92%), Gaps = 1/546 (0%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
G PSQNLSGTLS SIGNLTNLQ VLLQ+N+ISG IP+E+GKLSKL LDLSNNFF G IP
Sbjct: 64 GTPSQNLSGTLSPSIGNLTNLQTVLLQDNSISGPIPSELGKLSKLHLLDLSNNFFNGEIP 123
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
+++SHL++LQYLRLNNNSL+GAIP SL+NM+ LAFLD+SYNNLSGPVP F A+TFNI GN
Sbjct: 124 TSLSHLKSLQYLRLNNNSLSGAIPSSLANMTHLAFLDMSYNNLSGPVPGFAARTFNIVGN 183
Query: 128 SLICATGAEEDCFG-TAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGF 186
LIC TG E+DCFG P+P+S ++NNS +S+PS PK K+ALA GSSLGCI LLILGF
Sbjct: 184 PLICPTGTEKDCFGRPTPLPVSISMNNSQSSQPSARPKSHKVALAFGSSLGCICLLILGF 243
Query: 187 GFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNV 246
GFLLWWRQRHNQQIFFDVNEQ REEVCLGNL+RF FKELQ AT+NFSSKN++GKGGFGNV
Sbjct: 244 GFLLWWRQRHNQQIFFDVNEQYREEVCLGNLRRFPFKELQIATNNFSSKNILGKGGFGNV 303
Query: 247 YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306
YKGYLQDGTVVAVKRLKDGNAIGG IQFQTEVEMISLAVHRNLLRL GFCMTTTERLLVY
Sbjct: 304 YKGYLQDGTVVAVKRLKDGNAIGGVIQFQTEVEMISLAVHRNLLRLYGFCMTTTERLLVY 363
Query: 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 366
PYMSNGSVA RLKAKP+LDW+TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD+Y
Sbjct: 364 PYMSNGSVAYRLKAKPALDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDY 423
Query: 367 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+
Sbjct: 424 CEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 483
Query: 427 GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQY 486
G RALEFGK ANQKGAMLDWVKKIHQEKKL+MLVDKDLK NYDRIELEEMVQVALLCTQY
Sbjct: 484 GQRALEFGKAANQKGAMLDWVKKIHQEKKLDMLVDKDLKANYDRIELEEMVQVALLCTQY 543
Query: 487 LPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAM 546
LPS RPKMSEVVRMLEGDGLAEKW A+Q+AEATR +ANEFSSSERYSDLTDDSSLLVQAM
Sbjct: 544 LPSHRPKMSEVVRMLEGDGLAEKWEATQRAEATRCKANEFSSSERYSDLTDDSSLLVQAM 603
Query: 547 ELSGPR 552
ELSGPR
Sbjct: 604 ELSGPR 609
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425033|ref|XP_002269902.1| PREDICTED: protein NSP-INTERACTING KINASE 1 [Vitis vinifera] gi|297738231|emb|CBI27432.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2454), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/546 (86%), Positives = 505/546 (92%), Gaps = 1/546 (0%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
G PSQNLSGTLS SIGNLTNLQ VLLQ+N+ISG IP+E+GKLSKL LDLSNNFF G IP
Sbjct: 80 GTPSQNLSGTLSPSIGNLTNLQTVLLQDNSISGPIPSELGKLSKLHLLDLSNNFFNGEIP 139
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
+++SHL++LQYLRLNNNSL+GAIP SL+NM+ LAFLD+SYNNLSGPVP F A+TFNI GN
Sbjct: 140 TSLSHLKSLQYLRLNNNSLSGAIPSSLANMTHLAFLDMSYNNLSGPVPGFAARTFNIVGN 199
Query: 128 SLICATGAEEDCFG-TAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGF 186
LIC TG E+DCFG P+P+S ++NNS +S+PS PK K+ALA GSSLGCI LLILGF
Sbjct: 200 PLICPTGTEKDCFGRPTPLPVSISMNNSQSSQPSARPKSHKVALAFGSSLGCICLLILGF 259
Query: 187 GFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNV 246
GFLLWWRQRHNQQIFFDVNEQ REEVCLGNL+RF FKELQ AT+NFSSKN++GKGGFGNV
Sbjct: 260 GFLLWWRQRHNQQIFFDVNEQYREEVCLGNLRRFPFKELQIATNNFSSKNILGKGGFGNV 319
Query: 247 YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306
YKGYLQDGTVVAVKRLKDGNAIGG IQFQTEVEMISLAVHRNLLRL GFCMTTTERLLVY
Sbjct: 320 YKGYLQDGTVVAVKRLKDGNAIGGVIQFQTEVEMISLAVHRNLLRLYGFCMTTTERLLVY 379
Query: 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 366
PYMSNGSVA RLKAKP+LDW+TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD+Y
Sbjct: 380 PYMSNGSVAYRLKAKPALDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDY 439
Query: 367 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+
Sbjct: 440 CEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 499
Query: 427 GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQY 486
G RALEFGK ANQKGAMLDWVKKIHQEKKL+MLVDKDLK NYDRIELEEMVQVALLCTQY
Sbjct: 500 GQRALEFGKAANQKGAMLDWVKKIHQEKKLDMLVDKDLKANYDRIELEEMVQVALLCTQY 559
Query: 487 LPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAM 546
LPS RPKMSEVVRMLEGDGLAEKW A+Q+AEATR +ANEFSSSERYSDLTDDSSLLVQAM
Sbjct: 560 LPSHRPKMSEVVRMLEGDGLAEKWEATQRAEATRCKANEFSSSERYSDLTDDSSLLVQAM 619
Query: 547 ELSGPR 552
ELSGPR
Sbjct: 620 ELSGPR 625
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|110432095|gb|ABG73621.1| leucine-rich repeat receptor-like kinase [Populus tomentosa] | Back alignment and taxonomy information |
|---|
Score = 941 bits (2433), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/545 (84%), Positives = 493/545 (90%), Gaps = 2/545 (0%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
GAPSQ LSGTLS IGNLTNLQ +LLQ+NNISGHIP+E+G+L KL T+DLS+N F+G IP
Sbjct: 80 GAPSQRLSGTLSPYIGNLTNLQSLLLQDNNISGHIPSELGRLPKLKTIDLSSNNFSGQIP 139
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
S +S+L LQYLRLNNNSL GAIP SL NM+QL FLDLSYN+LS PVP HAKTFNI GN
Sbjct: 140 SALSNLNNLQYLRLNNNSLDGAIPASLVNMTQLTFLDLSYNDLSTPVPPVHAKTFNIVGN 199
Query: 128 SLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFG 187
IC G E+ C GT P+P S ALNNS NS+PSG K KIALA GSSLGCI LL+LGFG
Sbjct: 200 PQIC--GTEQGCAGTTPVPQSVALNNSQNSQPSGNNKSHKIALAFGSSLGCICLLVLGFG 257
Query: 188 FLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVY 247
F+LWWRQRHNQQIFFDVNEQ EE+ LGNL+ F FKELQ AT+NFSSKNL+GKGGFGNVY
Sbjct: 258 FILWWRQRHNQQIFFDVNEQHNEELSLGNLRSFQFKELQVATNNFSSKNLIGKGGFGNVY 317
Query: 248 KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307
KGYLQDGTVVAVKRLKDGNAIGG IQFQTEVEMISLAVHRNLLRL GFCMTTTERLLVYP
Sbjct: 318 KGYLQDGTVVAVKRLKDGNAIGGVIQFQTEVEMISLAVHRNLLRLHGFCMTTTERLLVYP 377
Query: 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 367
YMSNGSVA+RLKAKP+LDW TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD+Y
Sbjct: 378 YMSNGSVATRLKAKPALDWGTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDYC 437
Query: 368 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG
Sbjct: 438 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 497
Query: 428 LRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYL 487
LRALEFGK+ NQKGA+LDWVKKIH EKKLE+LVDKDLKNNYDRIELEE+VQVALLCTQYL
Sbjct: 498 LRALEFGKSTNQKGALLDWVKKIHLEKKLELLVDKDLKNNYDRIELEEIVQVALLCTQYL 557
Query: 488 PSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAME 547
PS RPKMSEVVRMLEGDGLAEKW ASQ+AE +RSRANEFSSSERYSDLTDDSSLLVQAME
Sbjct: 558 PSHRPKMSEVVRMLEGDGLAEKWEASQRAEESRSRANEFSSSERYSDLTDDSSLLVQAME 617
Query: 548 LSGPR 552
LSGPR
Sbjct: 618 LSGPR 622
|
Source: Populus tomentosa Species: Populus tomentosa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434692|ref|XP_004135130.1| PREDICTED: protein NSP-INTERACTING KINASE 1-like [Cucumis sativus] gi|449478323|ref|XP_004155284.1| PREDICTED: protein NSP-INTERACTING KINASE 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 935 bits (2416), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/546 (82%), Positives = 497/546 (91%), Gaps = 2/546 (0%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
GAPSQNLSG+LS SIGNLTNLQ VLLQ+NNISG IP E+G + L TLDLS+N F G IP
Sbjct: 79 GAPSQNLSGSLSPSIGNLTNLQSVLLQDNNISGTIPMELGNIPSLDTLDLSSNGFHGEIP 138
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
+++SHL++LQYLRLNNNSL+GAIP SL+NM+QLA LDLS+NNLSGP+P AKT+N+ GN
Sbjct: 139 TSLSHLKSLQYLRLNNNSLSGAIPSSLANMTQLALLDLSFNNLSGPLPRLLAKTYNLAGN 198
Query: 128 SLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFG 187
SLIC+ G+E C GTAP PL FA+N S NS+PSG KG K+ALA GSSLGC+ LL +GFG
Sbjct: 199 SLICSPGSEHSCNGTAP-PLLFAVNTSQNSQPSGRSKGHKLALAFGSSLGCVFLLTIGFG 257
Query: 188 FLLWWRQRHNQQIFFDVN-EQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNV 246
F +WWRQRHNQQIFFDVN +QR EEVCLGNL+ F F+ELQ+AT+NFSSKNLVGKGGFGNV
Sbjct: 258 FFIWWRQRHNQQIFFDVNNDQRFEEVCLGNLRIFQFRELQAATNNFSSKNLVGKGGFGNV 317
Query: 247 YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306
YKGYLQDGT++AVKRLKDGNA+ GEIQFQTEVEMISLAVHRNLLRL GFCMTTTERLLVY
Sbjct: 318 YKGYLQDGTIIAVKRLKDGNAMRGEIQFQTEVEMISLAVHRNLLRLYGFCMTTTERLLVY 377
Query: 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 366
PYMSNGSVASRLKAKP+LDW+TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD+Y
Sbjct: 378 PYMSNGSVASRLKAKPALDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDY 437
Query: 367 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG+GILLLELI+
Sbjct: 438 CEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGYGILLLELIT 497
Query: 427 GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQY 486
G RALEFGK NQKGAMLDWVKKIHQEKKLE+LVDKDL++NYDRIELEEMVQVALLCTQY
Sbjct: 498 GQRALEFGKAVNQKGAMLDWVKKIHQEKKLEILVDKDLRSNYDRIELEEMVQVALLCTQY 557
Query: 487 LPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAM 546
LP+ RPKMSEVVRMLEGDGLAEKW ASQ+A+A R R NEFSSSERYSDLTDDSSLL QAM
Sbjct: 558 LPTTRPKMSEVVRMLEGDGLAEKWEASQRADANRYRVNEFSSSERYSDLTDDSSLLAQAM 617
Query: 547 ELSGPR 552
ELSGPR
Sbjct: 618 ELSGPR 623
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108601|ref|XP_002314905.1| predicted protein [Populus trichocarpa] gi|222863945|gb|EEF01076.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2413), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/550 (83%), Positives = 494/550 (89%), Gaps = 7/550 (1%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
GAPSQ+LSGTLS SIGNLTNLQ +LLQ+NNISGHIP E+GKL KL T+DLS+N F+G IP
Sbjct: 80 GAPSQSLSGTLSPSIGNLTNLQSLLLQDNNISGHIPAELGKLPKLKTIDLSSNNFSGQIP 139
Query: 68 STVSHLETLQYL-----RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 122
ST+S+L +L YL RLNNNSL GAIP SL+NM+QL FLDLSYNNL+ PVP HAKTF
Sbjct: 140 STLSNLNSLHYLGIWIRRLNNNSLNGAIPASLANMTQLTFLDLSYNNLNTPVPPVHAKTF 199
Query: 123 NITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLL 182
NI GN+LIC G E+ C GT P+P S A++NS NS+PSG K KIALA GSSLGCI LL
Sbjct: 200 NIVGNTLIC--GTEQGCAGTTPVPQSLAVHNSQNSQPSGNSKSHKIALAFGSSLGCICLL 257
Query: 183 ILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGG 242
+LGFGF+LWWRQRHNQQIFFD+NEQ EE+ LGNL+RF FKELQ ATSNFSSKNL+GKGG
Sbjct: 258 VLGFGFILWWRQRHNQQIFFDINEQHHEELNLGNLRRFQFKELQIATSNFSSKNLIGKGG 317
Query: 243 FGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 302
FGNVYKG+LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL G CMTTTER
Sbjct: 318 FGNVYKGHLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGLCMTTTER 377
Query: 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 362
LLVYPYMSNGSVA+RLKAKP LDW TRKR+ALGA RGLLYLHEQCDPKIIHRDVKAANIL
Sbjct: 378 LLVYPYMSNGSVATRLKAKPVLDWGTRKRVALGAGRGLLYLHEQCDPKIIHRDVKAANIL 437
Query: 363 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLL 422
LD+Y EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLL
Sbjct: 438 LDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLL 497
Query: 423 ELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALL 482
ELISGLRALEFGK+ NQKGA+LDWVKKIHQEKKLE+LVDKDLKNNYD IEL+E VQVALL
Sbjct: 498 ELISGLRALEFGKSTNQKGALLDWVKKIHQEKKLELLVDKDLKNNYDPIELDETVQVALL 557
Query: 483 CTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLL 542
CTQ LPS RPKMSEVVRMLEGDGLAEKW ASQ+AEATR+R EFSSSERYSDLTDDSSLL
Sbjct: 558 CTQNLPSHRPKMSEVVRMLEGDGLAEKWEASQRAEATRTRTIEFSSSERYSDLTDDSSLL 617
Query: 543 VQAMELSGPR 552
VQAMELSGPR
Sbjct: 618 VQAMELSGPR 627
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255546957|ref|XP_002514536.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223546140|gb|EEF47642.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 926 bits (2393), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/546 (84%), Positives = 499/546 (91%), Gaps = 3/546 (0%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
GAPSQ+LSGTLS SIGNL+NLQLVLLQNNN SG IP+EIGKLSKL TLDLSNNFF IP
Sbjct: 33 GAPSQSLSGTLSPSIGNLSNLQLVLLQNNNFSGQIPSEIGKLSKLKTLDLSNNFFNSQIP 92
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
+T S L+ LQYLRLNNNSL+G IPPSL+NMSQL F+DLS+NNL+ P+P+FHAKTFNI GN
Sbjct: 93 TTFSTLKNLQYLRLNNNSLSGVIPPSLANMSQLTFVDLSFNNLTAPLPAFHAKTFNIVGN 152
Query: 128 SLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFG 187
LIC T +E C G PLS LNNS NS+PSG KG KIALA GSSLGCI LLILGFG
Sbjct: 153 PLICRT--QEQCSGAIQSPLSMNLNNSQNSQPSGSGKGHKIALAFGSSLGCICLLILGFG 210
Query: 188 FLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVY 247
FLLWWRQRHNQQIFFDVNEQR+EE+ LGNLKRF FKELQ AT NFSSKNL+G+GGFGNVY
Sbjct: 211 FLLWWRQRHNQQIFFDVNEQRQEELNLGNLKRFQFKELQVATKNFSSKNLIGQGGFGNVY 270
Query: 248 KGYLQDGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306
KG+LQDG+VVAVKRLKDGN +IGGE QFQTEVEMISLAVHRNLLRL GFCMT+TERLLVY
Sbjct: 271 KGHLQDGSVVAVKRLKDGNGSIGGETQFQTEVEMISLAVHRNLLRLYGFCMTSTERLLVY 330
Query: 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 366
PYMSNGSVASRLKAKP+LDW+TRKRIALG ARGLLYLHEQCDPKIIHRDVKAANILLDEY
Sbjct: 331 PYMSNGSVASRLKAKPALDWSTRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEY 390
Query: 367 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL+
Sbjct: 391 CEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVH 450
Query: 427 GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQY 486
GLRALEFGK+ANQKGAMLDW+KKIHQ+KKLE+LVDK+LKNNYD IELEE+V+VALLCTQ+
Sbjct: 451 GLRALEFGKSANQKGAMLDWIKKIHQDKKLELLVDKNLKNNYDPIELEEIVRVALLCTQF 510
Query: 487 LPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAM 546
+P RPKMSEVVRMLEGDGLAEKW ASQ+AEATRSRANEFSSSERYSDLTDDSSLLVQAM
Sbjct: 511 IPGHRPKMSEVVRMLEGDGLAEKWEASQRAEATRSRANEFSSSERYSDLTDDSSLLVQAM 570
Query: 547 ELSGPR 552
ELSGPR
Sbjct: 571 ELSGPR 576
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356502688|ref|XP_003520149.1| PREDICTED: protein NSP-INTERACTING KINASE 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2357), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/545 (83%), Positives = 491/545 (90%), Gaps = 2/545 (0%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
G PSQ++SGTLS SIGNLTNLQ VLLQ+NNI+G IP EIG+L KL TLDLS+NFFTG +P
Sbjct: 228 GIPSQSISGTLSPSIGNLTNLQTVLLQDNNITGPIPFEIGRLQKLQTLDLSDNFFTGQLP 287
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
T+S+++ L YLRLNNNSLTG IP SL+NM+QLAFLD+SYNNLS PVP +AKTFNI GN
Sbjct: 288 DTLSYMKGLHYLRLNNNSLTGPIPSSLANMTQLAFLDISYNNLSEPVPRINAKTFNIIGN 347
Query: 128 SLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFG 187
ICATG E++CF T +P A NNS +S+ + PK K ALA SSL CI LLILG G
Sbjct: 348 PQICATGVEKNCFRTTSIP--SAPNNSQDSQSTKRPKSHKFALAFASSLSCICLLILGLG 405
Query: 188 FLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVY 247
FL+WWRQR+N+QIFFDVNEQ REEVCLGNLK+FHF+ELQ AT+NFSSKNL+GKGGFGNVY
Sbjct: 406 FLIWWRQRYNKQIFFDVNEQHREEVCLGNLKKFHFRELQLATNNFSSKNLIGKGGFGNVY 465
Query: 248 KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307
KGY+QDGTV+AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL GFCMT TERLLVYP
Sbjct: 466 KGYVQDGTVIAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTATERLLVYP 525
Query: 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 367
YMSNGSVASRLKAKP+LDWATRKRIALGA RGLLYLHEQCDPKIIHRDVKAANILLD+Y
Sbjct: 526 YMSNGSVASRLKAKPALDWATRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYC 585
Query: 368 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG
Sbjct: 586 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 645
Query: 428 LRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYL 487
RALEFGK ANQKGAMLDWVKKIHQEKK+++LVDKDLKNNYDRIEL+E+VQVALLCTQYL
Sbjct: 646 QRALEFGKAANQKGAMLDWVKKIHQEKKIDLLVDKDLKNNYDRIELDEIVQVALLCTQYL 705
Query: 488 PSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAME 547
PS RPKMSEVVRMLEGDGLAEKW ASQ AE+TRSR NE SSSERYSDLTDDSSLL QAME
Sbjct: 706 PSHRPKMSEVVRMLEGDGLAEKWEASQSAESTRSRGNELSSSERYSDLTDDSSLLAQAME 765
Query: 548 LSGPR 552
LSGPR
Sbjct: 766 LSGPR 770
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498122|ref|XP_003517902.1| PREDICTED: protein NSP-INTERACTING KINASE 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 911 bits (2354), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/545 (82%), Positives = 490/545 (89%), Gaps = 2/545 (0%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
G PSQN+SGTLS SIGNLTNLQ VLLQ+NNI+G IP+EIG+L KL TLDLS+NFFTG +P
Sbjct: 79 GIPSQNISGTLSPSIGNLTNLQTVLLQDNNITGPIPSEIGRLQKLQTLDLSDNFFTGQLP 138
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
++SH++ L YLRLNNNSLTG IP SL+NM+QLAFLD+SYNNLS PVP +AKTFNI GN
Sbjct: 139 DSLSHMKGLHYLRLNNNSLTGPIPSSLANMTQLAFLDISYNNLSEPVPRINAKTFNIVGN 198
Query: 128 SLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFG 187
IC TG E++C T +P A NNS +S+ + PK K+ALA SSL CI LLILG G
Sbjct: 199 PQICVTGVEKNCSRTTSIP--SAPNNSQDSQSTKRPKSHKVALAFASSLSCICLLILGLG 256
Query: 188 FLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVY 247
FL+WWRQR+N+QIFF VNEQ REEVCLGNLK+FHF+ELQ AT+NFSSKNL+GKGGFGNVY
Sbjct: 257 FLIWWRQRYNKQIFFVVNEQHREEVCLGNLKKFHFRELQLATNNFSSKNLIGKGGFGNVY 316
Query: 248 KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307
KGYLQDGTV+AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL GFCMT TERLLVYP
Sbjct: 317 KGYLQDGTVIAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGFCMTATERLLVYP 376
Query: 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 367
YMSNGSVASRLKAKP+LDW TRKRIALGA RGLLYLHEQCDPKIIHRDVKAANILLD+Y
Sbjct: 377 YMSNGSVASRLKAKPALDWPTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYC 436
Query: 368 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG
Sbjct: 437 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
Query: 428 LRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYL 487
RALEFGK ANQKGAMLDWVKKIHQEKK+++LVDKDLKNNYDRIEL+E+VQVALLCTQYL
Sbjct: 497 QRALEFGKAANQKGAMLDWVKKIHQEKKIDLLVDKDLKNNYDRIELDEIVQVALLCTQYL 556
Query: 488 PSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAME 547
PS RPKMSEVVRMLEGDGLAEKW ASQ+AE+TRSR NE SSSERYSDLTDDSSLL QAME
Sbjct: 557 PSYRPKMSEVVRMLEGDGLAEKWEASQRAESTRSRGNELSSSERYSDLTDDSSLLAQAME 616
Query: 548 LSGPR 552
LSGPR
Sbjct: 617 LSGPR 621
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204417|emb|CBI16897.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 908 bits (2347), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/545 (81%), Positives = 489/545 (89%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
G PSQNLSGTLS SIGNLTNLQ+VLLQNNNI+G IP E+G+LSKL TLDLSNNFFT +P
Sbjct: 78 GTPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPQELGRLSKLHTLDLSNNFFTDEVP 137
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
S++ HL +LQYLRLNNNSL+G P SL+NM+QLAFLDLS+NNLSGPVP F AKTFNI GN
Sbjct: 138 SSLGHLTSLQYLRLNNNSLSGPFPVSLANMTQLAFLDLSFNNLSGPVPRFPAKTFNIVGN 197
Query: 128 SLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFG 187
LICATG+E++C+GT MP+S LN+S + P+ K K+ALA G+SLGCI LLI G G
Sbjct: 198 PLICATGSEQECYGTTLMPMSMTLNSSQTALPTRRSKNHKLALAFGTSLGCICLLIFGGG 257
Query: 188 FLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVY 247
LLWWRQRHNQQ+FFDVN++ EEV LGNLKRF F+ELQ AT NFSSKN++GKGGFGNVY
Sbjct: 258 LLLWWRQRHNQQMFFDVNDRHHEEVSLGNLKRFQFRELQIATDNFSSKNILGKGGFGNVY 317
Query: 248 KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307
KGYLQDGT+VAVKRLKDGNA+GGEIQFQTEVEMISLAVHRNLLRL GFC+TT+ERLLVYP
Sbjct: 318 KGYLQDGTIVAVKRLKDGNAVGGEIQFQTEVEMISLAVHRNLLRLYGFCITTSERLLVYP 377
Query: 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 367
YMSNGSVASRLK KP LDW TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD+Y
Sbjct: 378 YMSNGSVASRLKGKPVLDWGTRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDYC 437
Query: 368 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+G
Sbjct: 438 EAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 497
Query: 428 LRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYL 487
RALEFGK ANQKGAMLDWVKKIHQEK+LE+LVDKDLK+ YDR+ELEEMVQVALLCTQYL
Sbjct: 498 QRALEFGKAANQKGAMLDWVKKIHQEKRLEILVDKDLKHFYDRVELEEMVQVALLCTQYL 557
Query: 488 PSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAME 547
P RPKMSEVV+MLEGDGLAE+W ASQ+ E T+ + +E SSSERYSDLTDDSSLLVQAME
Sbjct: 558 PGHRPKMSEVVQMLEGDGLAERWEASQRGEVTKCKPHELSSSERYSDLTDDSSLLVQAME 617
Query: 548 LSGPR 552
LSGPR
Sbjct: 618 LSGPR 622
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 552 | ||||||
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.987 | 0.854 | 0.719 | 2.3e-204 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.978 | 0.854 | 0.613 | 9.9e-174 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.905 | 0.771 | 0.641 | 6.1e-170 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.972 | 0.847 | 0.612 | 9.4e-169 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.967 | 0.854 | 0.570 | 2.3e-149 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.965 | 0.848 | 0.560 | 1e-146 | |
| TAIR|locus:2171973 | 614 | AT5G45780 [Arabidopsis thalian | 0.947 | 0.851 | 0.531 | 4.3e-141 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.947 | 0.843 | 0.536 | 2.6e-134 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.943 | 0.849 | 0.509 | 2.8e-128 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.922 | 0.846 | 0.511 | 4e-122 |
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1977 (701.0 bits), Expect = 2.3e-204, P = 2.3e-204
Identities = 397/552 (71%), Positives = 441/552 (79%)
Query: 8 GAPSQNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
G PSQNLSGTLS SI I G IP EIG+L++L TLDLS+NFF G IP
Sbjct: 87 GTPSQNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIP 146
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
+V +L++LQYLRLNNNSL+G P SLSNM+QLAFLDLSYNNLSGPVP F AKTF+I GN
Sbjct: 147 FSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVPRFAAKTFSIVGN 206
Query: 128 SLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXXX 187
LIC TG E DC GT +P+S LN + +G + K+
Sbjct: 207 PLICPTGTEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVG 266
Query: 188 XXXWWRQRHNQQIFFDVNE-QRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNV 246
WWRQRHNQ FFDV + EEV LGNL+RF F+ELQ AT+NFSSKNL+GKGG+GNV
Sbjct: 267 LFLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNV 326
Query: 247 YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306
YKG L D TVVAVKRLKDG A+GGEIQFQTEVEMISLAVHRNLLRL GFC+T TE+LLVY
Sbjct: 327 YKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVY 386
Query: 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 366
PYMSNGSVASR+KAKP LDW+ RKRIA+GAARGL+YLHEQCDPKIIHRDVKAANILLD+Y
Sbjct: 387 PYMSNGSVASRMKAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDY 446
Query: 367 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL++
Sbjct: 447 CEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVT 506
Query: 427 GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL--KNNYDRIELEEMVQVALLCT 484
G RA EFGK ANQKG MLDWVKKIHQEKKLE+LVDK+L K +YD IEL+EMV+VALLCT
Sbjct: 507 GQRAFEFGKAANQKGVMLDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCT 566
Query: 485 QYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATR---SRANEF-SSSERYSDLTDDSS 540
QYLP RPKMSEVVRMLEGDGLAEKW ASQ++++ +R NE SSS+RYSDLTDDSS
Sbjct: 567 QYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTDDSS 626
Query: 541 LLVQAMELSGPR 552
LLVQAMELSGPR
Sbjct: 627 LLVQAMELSGPR 638
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1688 (599.3 bits), Expect = 9.9e-174, P = 9.9e-174
Identities = 340/554 (61%), Positives = 407/554 (73%)
Query: 10 PSQNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 69
PSQ+LSGTLS IG I+G IP IG+L KL +LDLSNN FTG IP++
Sbjct: 82 PSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNNSFTGEIPAS 141
Query: 70 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSL 129
+ L+ L YLRLNNNSL G P SLS + L +D+SYNNLSG +P A+TF + GN+L
Sbjct: 142 LGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPKVSARTFKVIGNAL 201
Query: 130 ICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXXXXX 189
IC A +C P PL+ + P+ + G +
Sbjct: 202 ICGPKAVSNC-SAVPEPLTLP-QDGPDESGT-RTNGHHVALAFAASFSAAFFVFFTSGMF 258
Query: 190 XWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKG 249
WWR R N+QIFFDVNEQ EV LG+LKR+ FKEL+SAT++F+SKN++G+GG+G VYKG
Sbjct: 259 LWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKG 318
Query: 250 YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309
+L DGT+VAVKRLKD N GGE+QFQTEVE ISLA+HRNLLRL GFC + ER+LVYPYM
Sbjct: 319 HLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYM 378
Query: 310 SNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE 365
NGSVASRLK +P+LDW+ RK+IA+G ARGL+YLHEQCDPKIIHRDVKAANILLDE
Sbjct: 379 PNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDE 438
Query: 366 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 425
+EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI
Sbjct: 439 DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 498
Query: 426 SGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQ 485
+G +AL+FG++A+QKG MLDWVKK+HQE KL+ L+DKDL + +DR+ELEE+VQVALLCTQ
Sbjct: 499 TGQKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQ 558
Query: 486 YLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRA----NEFSSSER---YSDLTDD 538
+ PS RPKMSEV++MLEGDGLAE+W A+Q SSS R YSD +
Sbjct: 559 FNPSHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQE 618
Query: 539 SSLLVQAMELSGPR 552
SSL+V+A+ELSGPR
Sbjct: 619 SSLVVEAIELSGPR 632
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1627 (577.8 bits), Expect = 6.1e-170, Sum P(2) = 6.1e-170
Identities = 326/508 (64%), Positives = 389/508 (76%)
Query: 8 GAPSQNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
GAPSQ+LSG LS SIG ISG IP E+G L KL TLDLSNN F+G IP
Sbjct: 83 GAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNNRFSGDIP 142
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
++ L +LQYLRLNNNSL+G P SLS + L+FLDLSYNNLSGPVP F A+TFN+ GN
Sbjct: 143 VSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPKFPARTFNVAGN 202
Query: 128 SLICATGAEEDCFGTA-PMPLSFALNNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXX 186
LIC + E C G+ PLS +L++S SG + ++
Sbjct: 203 PLICRSNPPEICSGSINASPLSVSLSSS-----SGR-RSNRLAIALSVSLGSVVILVLAL 256
Query: 187 XXXXWWRQRHNQQIFFDVNEQRREEVC-LGNLKRFHFKELQSATSNFSSKNLVGKGGFGN 245
W+R++ + + ++N+++ E + LGNL+ F F+EL T FSSKN++G GGFGN
Sbjct: 257 GSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGGFGN 316
Query: 246 VYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305
VY+G L DGT+VAVKRLKD N G+ QF+ E+EMISLAVH+NLLRLIG+C T+ ERLLV
Sbjct: 317 VYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGERLLV 376
Query: 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE 365
YPYM NGSVAS+LK+KP+LDW RKRIA+GAARGLLYLHEQCDPKIIHRDVKAANILLDE
Sbjct: 377 YPYMPNGSVASKLKSKPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDE 436
Query: 366 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 425
+EAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI
Sbjct: 437 CFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 496
Query: 426 SGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQ 485
+GLRALEFGKT +QKGAML+WV+K+H+E K+E L+D++L NYD+IE+ EM+QVALLCTQ
Sbjct: 497 TGLRALEFGKTVSQKGAMLEWVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQ 556
Query: 486 YLPSLRPKMSEVVRMLEGDGLAEKWAAS 513
YLP+ RPKMSEVV MLEGDGLAE+WAAS
Sbjct: 557 YLPAHRPKMSEVVLMLEGDGLAERWAAS 584
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1641 (582.7 bits), Expect = 9.4e-169, P = 9.4e-169
Identities = 345/563 (61%), Positives = 407/563 (72%)
Query: 8 GAPSQNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
GAPSQ+LSGTLS SIG ISG IP EI L KL TLDLSNN F+G IP
Sbjct: 80 GAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDLSNNRFSGEIP 139
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
+V+ L LQYLRLNNNSL+G P SLS + L+FLDLSYNNL GPVP F A+TFN+ GN
Sbjct: 140 GSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVPKFPARTFNVAGN 199
Query: 128 SLICATGAEEDCFGT-APMPLSFALNNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXX 186
LIC E C G+ + PLS +L +S SG + I
Sbjct: 200 PLICKNSLPEICSGSISASPLSVSLRSS-----SG--RRTNILAVALGVSLGFAVSVILS 252
Query: 187 XXXXWWRQRHNQQIFFDVNEQRREEVC-LGNLKRFHFKELQSATSNFSSKNLVGKGGFGN 245
W+R++ + +++++ E + LGNL+ F F+EL AT FSSK+++G GGFGN
Sbjct: 253 LGFIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGN 312
Query: 246 VYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305
VY+G DGTVVAVKRLKD N G QF+TE+EMISLAVHRNLLRLIG+C +++ERLLV
Sbjct: 313 VYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERLLV 372
Query: 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE 365
YPYMSNGSVASRLKAKP+LDW TRK+IA+GAARGL YLHEQCDPKIIHRDVKAANILLDE
Sbjct: 373 YPYMSNGSVASRLKAKPALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDE 432
Query: 366 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 425
Y+EAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI
Sbjct: 433 YFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 492
Query: 426 SGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQ 485
+G+RALEFGK+ +QKGAML+WV+K+H+E K+E LVD++L YDRIE+ EM+QVALLCTQ
Sbjct: 493 TGMRALEFGKSVSQKGAMLEWVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQ 552
Query: 486 YLPSLRPKMSEVVRMLEGDGLAEKWAASQKAE-----------ATRSRANE-----FSSS 529
+LP+ RPKMSEVV+MLEGDGLAE+WAAS T + N F SS
Sbjct: 553 FLPAHRPKMSEVVQMLEGDGLAERWAASHDHSHFYHANMSYRTITSTDGNNQTKHLFGSS 612
Query: 530 ERYSDLTDDSSLLVQAMELSGPR 552
+ D D+ +L AMELSGPR
Sbjct: 613 G-FEDEDDNQALDSFAMELSGPR 634
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1458 (518.3 bits), Expect = 2.3e-149, P = 2.3e-149
Identities = 314/550 (57%), Positives = 374/550 (68%)
Query: 14 LSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 73
LSG L +G I+G IP+ +G L+ L++LDL N F+GPIP ++ L
Sbjct: 81 LSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIPESLGKL 140
Query: 74 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP---SFHAKT-FNITGNSL 129
L++LRLNNNSLTG+IP SL+N++ L LDLS N LSG VP SF T + N
Sbjct: 141 SKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLD 200
Query: 130 ICATGAEEDCFGTAPM--PLSFALNNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXXX 187
+C C G+ P P F + P S PSG G
Sbjct: 201 LCGPVTSHPCPGSPPFSPPPPF-IQPPPVSTPSGY--GITGAIAGGVAAGAALLFAAPAI 257
Query: 188 XXXWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVY 247
WWR+R IFFDV + EV LG LKRF +ELQ A+ FS+KN++G+GGFG VY
Sbjct: 258 AFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVY 317
Query: 248 KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307
KG L DGT+VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYP
Sbjct: 318 KGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 377
Query: 308 YMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363
YM+NGSVAS L+ ++P LDW TRKRIALG+ARGL YLH+ CDPKIIHRDVKAANILL
Sbjct: 378 YMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL 437
Query: 364 DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 423
DE +EAVVGDFGLAKL+D+ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLE
Sbjct: 438 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLE 497
Query: 424 LISGLRALEFGKTANQKGAML-DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALL 482
LI+G RA + + AN ML DWVK + +EKKLEMLVD DL+ NY+ ELE+++QVALL
Sbjct: 498 LITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALL 557
Query: 483 CTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLL 542
CTQ P RPKMSEVVRMLEGDGLAEKW QK E R + S SD DS+
Sbjct: 558 CTQGSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILREEID--LSPNPNSDWILDSTYN 615
Query: 543 VQAMELSGPR 552
+ A+ELSGPR
Sbjct: 616 LHAVELSGPR 625
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1433 (509.5 bits), Expect = 1.0e-146, P = 1.0e-146
Identities = 310/553 (56%), Positives = 373/553 (67%)
Query: 13 NLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
+LSG L +G I+G +P+++G L+ L++LDL N FTGPIP ++
Sbjct: 83 DLSGQLVPQLGQLKNLQYLELYSNNITGPVPSDLGNLTNLVSLDLYLNSFTGPIPDSLGK 142
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP---SFHAKT-FNITGNS 128
L L++LRLNNNSLTG IP SL+N+ L LDLS N LSG VP SF T + N
Sbjct: 143 LFKLRFLRLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNL 202
Query: 129 LICATGAEEDCFGTAPM--PLSFALNNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXX 186
+C C G+ P P F P P+ P G
Sbjct: 203 DLCGPVTSRPCPGSPPFSPPPPFI---PPPIVPT--PGGYSATGAIAGGVAAGAALLFAA 257
Query: 187 --XXXXWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFG 244
WWR+R Q+ FFDV + EV LG LKRF +ELQ AT +FS+KN++G+GGFG
Sbjct: 258 PALAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFG 317
Query: 245 NVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304
VYKG L DGT+VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLL
Sbjct: 318 KVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 377
Query: 305 VYPYMSNGSVASRLKAKPS----LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 360
VYPYM+NGSVAS L+ +P L W+ R++IALG+ARGL YLH+ CDPKIIHRDVKAAN
Sbjct: 378 VYPYMANGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAAN 437
Query: 361 ILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGIL 420
ILLDE +EAVVGDFGLA+L+D+ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+
Sbjct: 438 ILLDEEFEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIM 497
Query: 421 LLELISGLRALEFGKTANQKGAML-DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQV 479
LLELI+G RA + + AN ML DWVK + +EKKLEMLVD DL++NY E+E+++QV
Sbjct: 498 LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQV 557
Query: 480 ALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDS 539
ALLCTQ P RPKMSEVVRMLEGDGLAEKW QK E R E SS SD DS
Sbjct: 558 ALLCTQSSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEVLRQEV-ELSSHPT-SDWILDS 615
Query: 540 SLLVQAMELSGPR 552
+ + AMELSGPR
Sbjct: 616 TDNLHAMELSGPR 628
|
|
| TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1380 (490.8 bits), Expect = 4.3e-141, P = 4.3e-141
Identities = 290/546 (53%), Positives = 375/546 (68%)
Query: 11 SQNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
S+ LSG LS+SIG ++G IP+E+G+LS+L TLDLS N F+G IP+++
Sbjct: 88 SKGLSGILSTSIGELTHLHTLLLQNNQLTGPIPSELGQLSELETLDLSGNRFSGEIPASL 147
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLI 130
L L YLRL+ N L+G +P ++ +S L+FLDLS+NNLSGP P+ AK + I GN+ +
Sbjct: 148 GFLTHLNYLRLSRNLLSGQVPHLVAGLSGLSFLDLSFNNLSGPTPNISAKDYRIVGNAFL 207
Query: 131 CATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXXXXXX 190
C ++E C P+ + L+ NSK + +
Sbjct: 208 CGPASQELCSDATPVRNATGLSEKDNSKHHSLV----LSFAFGIVVAFIISLMFLFFWVL 263
Query: 191 WWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY 250
W R R ++ + Q+ E +G+LKRF F+E+Q+ATSNFS KN++G+GGFG VYKGY
Sbjct: 264 WHRSRLSRS-----HVQQDYEFEIGHLKRFSFREIQTATSNFSPKNILGQGGFGMVYKGY 318
Query: 251 LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 310
L +GTVVAVKRLKD GE+QFQTEVEMI LAVHRNLLRL GFCMT ER+LVYPYM
Sbjct: 319 LPNGTVVAVKRLKDP-IYTGEVQFQTEVEMIGLAVHRNLLRLFGFCMTPEERMLVYPYMP 377
Query: 311 NGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 366
NGSVA RL+ KPSLDW R IALGAARGL+YLHEQC+PKIIHRDVKAANILLDE
Sbjct: 378 NGSVADRLRDNYGEKPSLDWNRRISIALGAARGLVYLHEQCNPKIIHRDVKAANILLDES 437
Query: 367 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
+EA+VGDFGLAKLLD DSHVTTAVRGT+GHIAPEYLSTGQSSEKTDVFGFG+L+LELI+
Sbjct: 438 FEAIVGDFGLAKLLDQRDSHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELIT 497
Query: 427 GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQY 486
G + ++ G +KG +L WV+ + EK+ +VD+DLK +D + LEE+V++ALLCTQ
Sbjct: 498 GHKMIDQGNGQVRKGMILSWVRTLKAEKRFAEMVDRDLKGEFDDLVLEEVVELALLCTQP 557
Query: 487 LPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAM 546
P+LRP+MS+V+++LEG L E+ +A A S S YS+ ++ S +++A+
Sbjct: 558 HPNLRPRMSQVLKVLEG--LVEQCEGGYEARAP-------SVSRNYSNGHEEQSFIIEAI 608
Query: 547 ELSGPR 552
ELSGPR
Sbjct: 609 ELSGPR 614
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1316 (468.3 bits), Expect = 2.6e-134, P = 2.6e-134
Identities = 295/550 (53%), Positives = 361/550 (65%)
Query: 14 LSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 73
LSG L +G I+G IP E+G L +L++LDL N +GPIPS++ L
Sbjct: 87 LSGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKL 146
Query: 74 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP---SFHAKT-FNITGNSL 129
L++LRLNNNSL+G IP +L+++ QL LD+S N LSG +P SF T + NSL
Sbjct: 147 GKLRFLRLNNNSLSGEIPMTLTSV-QLQVLDISNNRLSGDIPVNGSFSLFTPISFANNSL 205
Query: 130 ICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXX-XXX 188
T E P P S + P PSG GQ
Sbjct: 206 ---TDLPE------PPPTSTSPTPPP---PSG---GQMTAAIAGGVAAGAALLFAVPAIA 250
Query: 189 XXWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYK 248
WW +R Q FFDV + EV LG LKRF +EL AT NFS+KN++G+GGFG VYK
Sbjct: 251 FAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYK 310
Query: 249 GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308
G L DG +VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPY
Sbjct: 311 GRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 370
Query: 309 MSNGSVASRLKAKP----SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 364
M+NGSVAS L+ +P +LDW RK IALG+ARGL YLH+ CD KIIHRDVKAANILLD
Sbjct: 371 MANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLD 430
Query: 365 EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 424
E +EAVVGDFGLAKL+++ DSHVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLEL
Sbjct: 431 EEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 490
Query: 425 ISGLRALEFGKTANQKGAML-DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLC 483
I+G +A + + AN ML DWVK++ +EKKLE LVD +L+ Y E+E+++Q+ALLC
Sbjct: 491 ITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLC 550
Query: 484 TQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSD-LTDDSSLL 542
TQ RPKMSEVVRMLEGDGLAE+W QK E N + +D L S+ L
Sbjct: 551 TQSSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSL 610
Query: 543 VQAMELSGPR 552
++ SGPR
Sbjct: 611 IENDYPSGPR 620
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1259 (448.2 bits), Expect = 2.8e-128, P = 2.8e-128
Identities = 281/552 (50%), Positives = 354/552 (64%)
Query: 13 NLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
N SGTLSS +G I+G IP + G L+ L +LDL +N TG IPST+ +
Sbjct: 81 NFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPSTIGN 140
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS--FHAKTFNITGNSLI 130
L+ LQ+L L+ N L G IP SL+ + L L L N+LSG +P F +N T N+L
Sbjct: 141 LKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTSNNL- 199
Query: 131 CATGAEEDCFGTAPMP-LSFALNNSPNSKP-SGMPKGQKIXXXXXXXXXXXXXXXXXXXX 188
+C G P P +S ++ +SKP +G+ G
Sbjct: 200 -------NCGGRQPHPCVSAVAHSGDSSKPKTGIIAG---------VVAGVTVVLFGILL 243
Query: 189 XXWWRQRHN---QQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGN 245
+ + RH + +F DV + + G LKRF ++ELQ AT NFS KN++G+GGFG
Sbjct: 244 FLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGK 303
Query: 246 VYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305
VYKG L D T VAVKRL D + GG+ FQ EVEMIS+AVHRNLLRLIGFC T TERLLV
Sbjct: 304 VYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLV 363
Query: 306 YPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 361
YP+M N S+A RL+ P LDW TRKRIALGAARG YLHE C+PKIIHRDVKAAN+
Sbjct: 364 YPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANV 423
Query: 362 LLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 421
LLDE +EAVVGDFGLAKL+D ++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+L
Sbjct: 424 LLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 483
Query: 422 LELISGLRALEFGKTANQKGAML-DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVA 480
LEL++G RA++F + + +L D VKK+ +EK+L +VDK+L Y + E+E M+QVA
Sbjct: 484 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVA 543
Query: 481 LLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSS 540
LLCTQ P RP MSEVVRMLEG+GLAE+W Q E TR +EF +R D +DS
Sbjct: 544 LLCTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRR--HEFERLQRRFDWGEDSM 601
Query: 541 LLVQAMELSGPR 552
A+ELSG R
Sbjct: 602 HNQDAIELSGGR 613
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1201 (427.8 bits), Expect = 4.0e-122, P = 4.0e-122
Identities = 269/526 (51%), Positives = 335/526 (63%)
Query: 38 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM 97
+SG + ++ +L L L+L NN TG IP + L L L L N+++G IP SL +
Sbjct: 82 LSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFANNISGPIPSSLGKL 141
Query: 98 SQLAFLDLSYNNLSGPVP-SFHAKTFNIT--GNSLICATGAEEDCFGTAPMPLSFALNN- 153
+L FL L N+LSG +P S A ++ N+ + F +SFA N
Sbjct: 142 GKLRFLRLYNNSLSGEIPRSLTALPLDVLDISNNRLSGDIPVNGSFSQFTS-MSFANNKL 200
Query: 154 SPN-SKPSGMPKGQKIXXXXXXXXXXXXXXXXXXXXXXWWRQRHNQQIFFDVNEQRREEV 212
P + PS P G WW +R Q F DV + EV
Sbjct: 201 RPRPASPSPSPSG-----TSAAIVVGVAAGAALLFALAWWLRRKLQGHFLDVPAEEDPEV 255
Query: 213 CLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI 272
LG KRF +EL AT FS +N++GKG FG +YKG L D T+VAVKRL + GGE+
Sbjct: 256 YLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGEL 315
Query: 273 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP----SLDWAT 328
QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS L+ +P +LDW
Sbjct: 316 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPK 375
Query: 329 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388
RK IALG+ARGL YLH+ CD KIIH DVKAANILLDE +EAVVGDFGLAKL+++ DSHVT
Sbjct: 376 RKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVT 435
Query: 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML-DWV 447
TAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELI+G +A + + AN ML DWV
Sbjct: 436 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWV 495
Query: 448 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLA 507
K++ +EKKLE LVD +L+ Y E+E+++Q+ALLCTQ RPKMSEVVRMLEGDGLA
Sbjct: 496 KEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLA 555
Query: 508 EKWAASQKAEATRSRANEFSSSERYSD-LTDDSSLLVQAMELSGPR 552
E+W QK E N + +D L S+ L++ SGPR
Sbjct: 556 ERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSGPR 601
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q8RY65 | NIK2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8010 | 0.9855 | 0.8566 | yes | no |
| Q9LFS4 | NIK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7590 | 0.9873 | 0.8542 | no | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| estExt_fgenesh4_pg.C_LG_VIII0972 | hypothetical protein (622 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 552 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-47 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-29 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-25 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-21 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-15 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.001 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.002 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.003 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.003 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 6e-47
Identities = 67/191 (35%), Positives = 95/191 (49%), Gaps = 8/191 (4%)
Query: 238 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 296
+G+GGFG VY + G VA+K +K ++ + E+E++ H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 297 MTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRD 355
LV Y GS+ LK L RI L GL YLH IIHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117
Query: 356 VKAANILLDE-YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTD 413
+K NILLD + + DFGL+KLL D + + GT ++APE L SEK+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTS-DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 414 VFGFGILLLEL 424
++ G++L EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-46
Identities = 147/515 (28%), Positives = 256/515 (49%), Gaps = 53/515 (10%)
Query: 13 NLSGTLSSSIG--NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
G L S G L NL L N SG +P ++G LS+L+ L LS N +G IP +
Sbjct: 463 KFFGGLPDSFGSKRLENLDL---SRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL 519
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITG-NSL 129
S + L L L++N L+G IP S S M L+ LDLS N LSG +P N+ SL
Sbjct: 520 SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK------NLGNVESL 573
Query: 130 ICATGAEEDCFGTAPMPLSF-ALNNSP---------NSKPSGMPKGQKIA------LALG 173
+ + G+ P +F A+N S SG+P +++ +
Sbjct: 574 VQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYIT 633
Query: 174 SSLGC-ISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNF 232
+LG + L ++ FGF ++ R R+N ++ NE E+ + K + S+
Sbjct: 634 CTLGAFLVLALVAFGF-VFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSL 692
Query: 233 SSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
+N++ +G G YKG +++G VK + D N+I +E+ + H N+++
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVK 747
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
LIG C + L++ Y+ +++ L+ +L W R++IA+G A+ L +LH +C P +
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 411
+ ++ I++D E + L LL C T + ++APE T +EK
Sbjct: 805 VVGNLSPEKIIIDGKDEPHL-RLSLPGLL--C---TDTKCFISSAYVAPETRETKDITEK 858
Query: 412 TDVFGFGILLLELISGLRA--LEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN-- 467
+D++GFG++L+EL++G EFG G++++W + + + L+M +D ++ +
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFG----VHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914
Query: 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
++ E+ E++ +AL CT P+ RP ++V++ LE
Sbjct: 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 87/294 (29%), Positives = 127/294 (43%), Gaps = 59/294 (20%)
Query: 236 NLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 290
+G+G FG VYKG L+ T VAVK LK+ + F E M L H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVV 59
Query: 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKA---------KPSLDWATRKRIALGAARGLL 341
RL+G C LV YM G + L+ K +L A+ A+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI--- 398
YL + K +HRD+ A N L+ E + DFGL++ + D + G I
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWM 174
Query: 399 APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQE 453
APE L G + K+DV+ FG+LL E+ + G T +N+
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFT------LGATPYPGLSNE-------------- 214
Query: 454 KKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
E+L + L+ Y R+ +E+ ++ L C Q P RP SE+V LE
Sbjct: 215 ---EVL--EYLRKGY-RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 4e-46
Identities = 77/269 (28%), Positives = 124/269 (46%), Gaps = 25/269 (9%)
Query: 239 GKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
G+G FG VYKG L+ VAVK LK+ + +F E ++ H N+++L+
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL 67
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
G C +V YM G + S L+ +P L + AL ARG+ YL + I
Sbjct: 68 GVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFI 124
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 412
HRD+ A N L+ E + DFGL++ L D + + + +APE L G+ + K+
Sbjct: 125 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKS 184
Query: 413 DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 472
DV+ FG+LL E+ + G + + +L+++K ++ +
Sbjct: 185 DVWSFGVLLWEIFTLGEQPYPGMSNEE---VLEYLKNGYRLPQPPNCPP----------- 230
Query: 473 LEEMVQVALLCTQYLPSLRPKMSEVVRML 501
E+ + L C P RP SE+V +L
Sbjct: 231 --ELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 6e-45
Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 26/270 (9%)
Query: 239 GKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
G+G FG VYKG L+ VAVK LK+ + +F E ++ H N+++L+
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL 67
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKI 351
G C ++V YM G + L+ L + AL ARG+ YL +
Sbjct: 68 GVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NF 124
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 411
IHRD+ A N L+ E + DFGL++ L D + + + +APE L G+ + K
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSK 184
Query: 412 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471
+DV+ FG+LL E+ + G + + +L+++KK ++ K
Sbjct: 185 SDVWSFGVLLWEIFTLGEEPYPGMSNAE---VLEYLKKGYRLPKPPNCPP---------- 231
Query: 472 ELEEMVQVALLCTQYLPSLRPKMSEVVRML 501
E+ ++ L C P RP SE+V +L
Sbjct: 232 ---ELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 9e-44
Identities = 76/277 (27%), Positives = 123/277 (44%), Gaps = 40/277 (14%)
Query: 239 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
G+G FG VYKG L T VAVK LK+G + +F E ++ H N++RL+
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLL 67
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
G C +V YM G + L+ L ++AL A+G+ YL + +
Sbjct: 68 GVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK---NFV 124
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 407
HRD+ A N L+ E + DFGL++ + D + ++ APE L G+
Sbjct: 125 HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM----APESLKDGK 180
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKT--ANQKGA-MLDWVKKIHQEKKLEMLVDKDL 464
+ K+DV+ FG+LL E+ + G+ +L+ ++ ++ L +
Sbjct: 181 FTSKSDVWSFGVLLWEIFT------LGEQPYPGMSNEEVLELLEDGYR---LPRPENCP- 230
Query: 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501
+E+ ++ L C Y P RP SE+V L
Sbjct: 231 ---------DELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 6/197 (3%)
Query: 232 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 290
+ +G+G FG VY + G +VA+K +K + E++++ H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
RL + LV Y G + LK + L + L YLH +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK---G 117
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 410
I+HRD+K NILLDE + DFGLA+ LD +TT V GT ++APE L +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDP-GEKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 411 KTDVFGFGILLLELISG 427
D++ G++L EL++G
Sbjct: 176 AVDIWSLGVILYELLTG 192
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 4e-43
Identities = 72/193 (37%), Positives = 93/193 (48%), Gaps = 7/193 (3%)
Query: 238 VGKGGFGNVYKGYLQ-DGTVVAVKRL-KDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295
+G G FG VYK + G +VAVK L K + + E+ ++ H N++RLI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 296 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 355
LV Y G + L L K+IAL RGL YLH IIHRD
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---GIIHRD 123
Query: 356 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 414
+K NILLDE + DFGLAK L S T GT ++APE L G K DV
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDV 182
Query: 415 FGFGILLLELISG 427
+ G++L EL++G
Sbjct: 183 WSLGVILYELLTG 195
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 5e-35
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 8/197 (4%)
Query: 236 NLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLRLI 293
L+G+G FG+VY +D G ++AVK ++ E+ + E+ ++S H N++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 294 GFCMTTTER-LLVY-PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
G + L ++ Y+S GS++S LK L ++ GL YLH I
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GI 122
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 410
+HRD+K ANIL+D + DFG AK L D T +VRGT +APE + +
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR 182
Query: 411 KTDVFGFGILLLELISG 427
D++ G ++E+ +G
Sbjct: 183 AADIWSLGCTVIEMATG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 68/199 (34%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 235 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKD-GNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
+GKG FG+V G + G VAVK LKD A F E +++ H NL++L+
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLL 66
Query: 294 GFCMTTTERLLVYPYMSNGSVAS--RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
G + +V YM+ GS+ R + + + A + AL G+ YL E+
Sbjct: 67 GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 411
+HRD+ A N+L+ E A V DFGLAK + + + V APE L + S K
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQ--DSGKLPVKWTAPEALREKKFSTK 179
Query: 412 TDVFGFGILLLELISGLRA 430
+DV+ FGILL E+ S R
Sbjct: 180 SDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 66/204 (32%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 232 FSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISLAV 285
F +GKGGFG VYK + + G VA+K +K I EIQ + +
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK------ 55
Query: 286 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLH 344
H N+++ G + E +V + S GS+ LK+ +L + + +GL YLH
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPEYL 403
IIHRD+KAANILL E + DFGL+ L D + GT +APE +
Sbjct: 116 SN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVI 169
Query: 404 STGQSSEKTDVFGFGILLLELISG 427
+ K D++ GI +EL G
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRN 288
N+ +L+G+G FG VYKG L+ G VA+K++ ++ E++++ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 348
+++ IG T+ ++ Y NGS+ +K + +GL YLHEQ
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ-- 118
Query: 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 408
+IHRD+KAANIL + + DFG+A L+ S +V GT +APE + +
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 409 SEKTDVFGFGILLLELISG 427
S +D++ G ++EL++G
Sbjct: 177 STASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 85/269 (31%), Positives = 127/269 (47%), Gaps = 26/269 (9%)
Query: 237 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 296
L+GKG FG V+KG L+D T VAVK K+ +I+F +E ++ H N+++LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 297 MTTTERLLVYPYM---SNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
T+R +Y M G S L K K L + AL AA G+ YL + I
Sbjct: 62 ---TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 412
HRD+ A N L+ E + DFG+++ D + + + APE L+ G+ S ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 413 DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 472
DV+ +GILL E S L + NQ+ + EK M +
Sbjct: 176 DVWSYGILLWETFS-LGVCPYPGMTNQQA-------REQVEKGYRMSCPQKCP------- 220
Query: 473 LEEMVQVALLCTQYLPSLRPKMSEVVRML 501
+++ +V C Y P RPK SE+ + L
Sbjct: 221 -DDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 7/199 (3%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
F+ + +G G FG V++G ++ VA+K LK + + + FQ EV+ + H++L
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHL 64
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQC 347
+ L C ++ M GS+ + L++ L A+ +A A G+ YL EQ
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ- 123
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
IHRD+ A NIL+ E V DFGLA+L+ D ++++ + APE S G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAASHGT 180
Query: 408 SSEKTDVFGFGILLLELIS 426
S K+DV+ FGILL E+ +
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 27/271 (9%)
Query: 237 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 296
+GKG FG+VYKG L+ T VAVK + + +F E E++ H N+++LIG C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 297 MTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 355
+ +V + GS+ + L K K L +++L AA G+ YL + IHRD
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 356 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT----VGHIAPEYLSTGQSSEK 411
+ A N L+ E + DFG+++ + + T G + APE L+ G+ + +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 412 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471
+DV+ +GILL E S G + Q ++ + ++
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRER----------------IESGYRMPAPQL 219
Query: 472 ELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
EE+ ++ L C Y P RP SE+ L+
Sbjct: 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 236 NLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
++GKG FG VY G L D AVK L + QF E ++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 292 LIGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCD 348
L+G C+ + L+V PYM +G + + ++ + + + I G A+G+ YL +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIR-SETHNPTVKDLIGFGLQVAKGMEYLASK-- 117
Query: 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLD--HCDSHVTTAVRGTVGHIAPEYLST 405
K +HRD+ A N +LDE + V DFGLA+ + D + H T + V +A E L T
Sbjct: 118 -KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 406 GQSSEKTDVFGFGILLLELIS 426
+ + K+DV+ FG+LL EL++
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 105 bits (261), Expect = 2e-24
Identities = 75/283 (26%), Positives = 114/283 (40%), Gaps = 25/283 (8%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI--QFQTEVE-MISLAVHR 287
++ +G+G FG VY D +VA+K L + +F E++ + SL
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLH 344
N+++L F LV Y+ GS+ LK L + I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 345 EQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCDSHV-----TTAVRGTVGHI 398
+ IIHRD+K NILLD + DFGLAKLL S + GT G++
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 399 APEYL---STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455
APE L S +S +D++ GI L EL++GL E K ++ L + ++
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 456 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 498
L + + + + P R S +
Sbjct: 236 A-----SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 35/278 (12%)
Query: 236 NLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
++G G FG V +G L+ VA+K LK G++ + F TE ++ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPK 350
L G + +++ YM NGS+ L+ + G A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLST 405
+HRD+ A NIL++ V DFGL++ L+ ++ TT +R T APE ++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182
Query: 406 GQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464
+ + +DV+ FGI++ E++S G R + +NQ D +K + +L +D
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERP--YWDMSNQ-----DVIKAVEDGYRLPPPMDCP- 234
Query: 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ Q+ L C Q + RP S++V L+
Sbjct: 235 ---------SALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 31/285 (10%)
Query: 236 NLVGKGGFGNVYKGY---LQDGT--VVAVKRLKDGNAIGGEIQ---FQTEVEMISLAVHR 287
+G+G FG V L D T VAVK L N G E F+ E+E++ H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL---NHSGEEQHRSDFEREIEILRTLDHE 66
Query: 288 NLLRLIGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLH 344
N+++ G C R L+ Y+ +GS+ L + + ++ + +G+ YL
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEY 402
Q + IHRD+ A NIL++ + DFGLAK+L + G + APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 403 LSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462
L T + S +DV+ FG+ L EL + + + L + + + L++
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGD-----PSQSPPAEFLRMIGIAQGQMIVTRLLEL 238
Query: 463 DLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
LK +R+ +E+ + LC + P RP ++++ +++
Sbjct: 239 -LKEG-ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 77/275 (28%), Positives = 125/275 (45%), Gaps = 30/275 (10%)
Query: 238 VGKGGFGNVYKGYLQ--DGTV--VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
+G G FG+V KG G VAVK LK + G+ +F E +++ H ++RLI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
G C +LV G + LK + + + K +A A G+ YL + +H
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVH 118
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--VTTAVRGTVGHIAPEYLSTGQSSEK 411
RD+ A N+LL ++A + DFG+++ L + TTA R + APE ++ G+ S K
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK 178
Query: 412 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471
+DV+ +G+ L E S A +G+ + + + ++L R
Sbjct: 179 SDVWSYGVTLWEAFS-YGAKPYGEMKGA-----EVIAMLESGERLP------------RP 220
Query: 472 EL--EEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504
E +E+ + L C +Y P RP SE+ D
Sbjct: 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 1e-23
Identities = 63/192 (32%), Positives = 100/192 (52%), Gaps = 10/192 (5%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
+G G FG V+ GY T VA+K LK G+ F E ++ H L+RL + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRL--YAV 69
Query: 298 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 354
T E + ++ YM NGS+ LK + K I + A A G+ ++ + IHR
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHR 126
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 414
D++AANIL+ E + DFGLA+L++ + + + APE ++ G + K+DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 415 FGFGILLLELIS 426
+ FGILL E+++
Sbjct: 187 WSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 65/193 (33%), Positives = 94/193 (48%), Gaps = 13/193 (6%)
Query: 239 GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 298
G G FG V+ G T VAVK LK G F E +++ H L++L C
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 299 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHRDV 356
+V YMS GS+ LK+ + + + A A G+ YL + IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDL 129
Query: 357 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT---VGHIAPEYLSTGQSSEKTD 413
A NIL+ E + DFGLA+L++ D TA G + APE + G+ + K+D
Sbjct: 130 AARNILVGENLVCKIADFGLARLIE--DDEY-TAREGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 414 VFGFGILLLELIS 426
V+ FGILL E+++
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 3e-23
Identities = 56/190 (29%), Positives = 93/190 (48%), Gaps = 6/190 (3%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
+G G FG V+ GY + VA+K +++G E F E +++ H L++L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 298 TTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356
+ LV+ +M +G ++ L+A+ T + L G+ YL +IHRD+
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 357 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 416
A N L+ E V DFG+ + + +T + V +PE S + S K+DV+
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 417 FGILLLELIS 426
FG+L+ E+ S
Sbjct: 187 FGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 5e-23
Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 53/285 (18%)
Query: 235 KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLRL 292
+GKG FG VY DG + +K + N E + EV+++ H N+++
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPS----------LDWATRKRIALGAARGLLY 342
+ +V Y G ++ ++K + LDW + + L L Y
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA----LKY 118
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 402
LH + KI+HRD+K NI L +GDFG++K+L T V GT +++PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE- 173
Query: 403 LSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461
L + + K+D++ G +L EL + F + + L L
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHP--F------------------EGENLLELAL 213
Query: 462 KDLKNNYDRI------ELEEMVQVALLCTQYLPSLRPKMSEVVRM 500
K LK Y I EL +V +LL P RP ++++++
Sbjct: 214 KILKGQYPPIPSQYSSELRNLVS-SLLQKD--PEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 50/113 (44%), Positives = 70/113 (61%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
NL+G + SS+GNL NLQ + L N +SG IP I L KL++LDLS+N +G IP V
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNIT 125
L+ L+ L L +N+ TG IP +L+++ +L L L N SG +P K N+T
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT 359
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 51/114 (44%), Positives = 72/114 (63%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
S L G + +G + +L+ + L NN+SG IP EIG L+ L LDL N TGPIPS++
Sbjct: 197 SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNI 124
+L+ LQYL L N L+G IPPS+ ++ +L LDLS N+LSG +P + N+
Sbjct: 257 GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNL 310
|
Length = 968 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 3e-22
Identities = 63/198 (31%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 238 VGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLR 291
+GKG FG V K G + A+K LK I TE ++S H +++
Sbjct: 1 LGKGSFGKVLLVRKK---DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 292 LIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
L + T E+L LV Y G + S L + + A L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---G 113
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 410
II+RD+K NILLD + DFGLAK L S T GT ++APE L +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGK 172
Query: 411 KTDVFGFGILLLELISGL 428
D + G+LL E+++G
Sbjct: 173 AVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 6e-22
Identities = 61/192 (31%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 296
+G G FG V+ GY + T VAVK LK G +Q F E ++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 297 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 354
++ YM+ GS+ LK+ K I A A G+ Y+ + IHR
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 127
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 414
D++AAN+L+ E + DFGLA++++ + + + APE ++ G + K+DV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 415 FGFGILLLELIS 426
+ FGILL E+++
Sbjct: 188 WSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 8e-22
Identities = 67/201 (33%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 232 FSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR--LKDGNAIGGEIQF-QTEVEMISLAVHR 287
F+ +GKG FG VYK + VVA+K L++ EI+ Q E++ +S
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED---EIEDIQQEIQFLSQCRSP 59
Query: 288 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 346
+ + G +L ++ Y GS LK LD I GL YLHE+
Sbjct: 60 YITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEE 117
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 406
IHRD+KAANILL E + + DFG++ L S T V GT +APE +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQS 173
Query: 407 QSSEKTDVFGFGILLLELISG 427
EK D++ GI +EL G
Sbjct: 174 GYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 9e-22
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 236 NLVGKGGFGNVYKGY-LQDGTVVAVK--RLKDGN-AIGGEIQFQTEVEMISLAVHRNLLR 291
N +G G FG VY L G ++AVK R++D + EI E++++ L H NL++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA--DEMKVLELLKHPNLVK 63
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
G + + + Y S G++ L+ LD + L GL YLH I
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR------GTVGHIAPEYLST 405
+HRD+K ANI LD +GDFG A L ++ TT GT ++APE ++
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 406 GQSSEK---TDVFGFGILLLELISGLR 429
G+ D++ G ++LE+ +G R
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 9e-22
Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 36/282 (12%)
Query: 238 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
+G+G FG VY+G + T VA+K + + ++ I+F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKAK-------PSLDWATRKRI---ALGAARGLL 341
L+G T L+V M+ G + S L+++ P L T ++ A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAP 400
YL + K +HRD+ A N ++ E +GDFG+ + + D + V +AP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 401 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460
E L G + K+DV+ FG++L E ++ L + +N E+ L+ ++
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWE-MATLAEQPYQGLSN--------------EEVLKFVI 235
Query: 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
D + + ++++++ +C QY P +RP E+V L+
Sbjct: 236 DGGHLDLPENCP-DKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 81/296 (27%), Positives = 132/296 (44%), Gaps = 55/296 (18%)
Query: 237 LVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGE-IQFQTEVEMI-SLAVHRN 288
+G+G FG V K + VAVK LKD +A + +E+EM+ + H+N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--------KPSLDWATRKRI-------- 332
++ L+G C +V Y ++G++ L+A P + +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 333 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 391
A ARG+ +L + K IHRD+ A N+L+ E + + DFGLA+ + H D + TT
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 451
R V +APE L + ++DV+ FG+LL E+ + G + +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT------LGGSP-------------Y 235
Query: 452 QEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+E L K LK Y R+E +E+ + C +PS RP ++V L+
Sbjct: 236 PGIPVEELF-KLLKEGY-RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 239 GKGGFGNVYKGY-LQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
G G FG VYKG + +G VA+K L++ + + E +++ H +++RL+
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 294 GFCMTTTERLLVYPYMSNGSV-------ASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 346
G C+++ L+ M G + + ++ L+W + A+G+ YL E+
Sbjct: 76 GICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEEK 128
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 405
+++HRD+ A N+L+ + DFGLAKLLD + + + +A E +
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 406 GQSSEKTDVFGFGILLLELISGLRALEFGK 435
+ K+DV+ +G+ + EL + FG
Sbjct: 186 RIYTHKSDVWSYGVTVWEL------MTFGA 209
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-21
Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 28/171 (16%)
Query: 33 LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 92
L N + G IP +I KL L +++LS N G IP ++ + +L+ L L+ NS G+IP
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 93 SLSNMSQLAFLDLSYNNLSGPVPS------FHAKTFNITGNSLICATGAEEDCFGTAPMP 146
SL ++ L L+L+ N+LSG VP+ H +FN T N+ +C C
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC------- 537
Query: 147 LSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHN 197
+ G KI +A G S+ + L+I + WW++R N
Sbjct: 538 ------------GPHLSVGAKIGIAFGVSVAFLFLVICA---MCWWKRRQN 573
|
Length = 623 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 72/281 (25%), Positives = 137/281 (48%), Gaps = 28/281 (9%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
S+ + + ++G G FG V++G L+ VA+K LK G F +E ++
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 286 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYL 343
H N++RL G +++ YM NG++ L+ ++++ + + + G A G+ YL
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYL 123
Query: 344 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPE 401
D +HRD+ A NIL++ E V DFGL+++L D ++ T+ + + APE
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 402 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461
++ + + +DV+ FGI++ E++S FG+ + + +K I+ +L +D
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMS------FGERPYWDMSNHEVMKAINDGFRLPAPMD 234
Query: 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ Q+ L C Q + RP+ ++V +L+
Sbjct: 235 CP----------SAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 5e-21
Identities = 73/267 (27%), Positives = 123/267 (46%), Gaps = 22/267 (8%)
Query: 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 296
+G+G FG V+ G L+ D T VAVK ++ + +F E ++ H N++RLIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 297 MTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 355
+V + G + L+ + P L ++ AA G+ YL + IHRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 356 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT-VGHIAPEYLSTGQSSEKTDV 414
+ A N L+ E + DFG+++ + T ++ V APE L+ G+ S ++DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 415 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE 474
+ FGILL E S L A+ + +NQ+ + E+ + + + +
Sbjct: 180 WSFGILLWEAFS-LGAVPYANLSNQQ-------TREAIEQGVRLPCPELCP--------D 223
Query: 475 EMVQVALLCTQYLPSLRPKMSEVVRML 501
+ ++ C +Y P RP S V + L
Sbjct: 224 AVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 6e-21
Identities = 59/191 (30%), Positives = 89/191 (46%), Gaps = 7/191 (3%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
+G G FG V++G + T VAVK LK G + F E +++ H L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 298 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHRD 355
+V M GS+ L+ + I + A A G+ YL Q IHRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRD 128
Query: 356 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 415
+ A N+L+ E V DFGLA+++ + + APE + S K+DV+
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 416 GFGILLLELIS 426
FGILL E+++
Sbjct: 189 SFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 14/195 (7%)
Query: 239 GKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG-FC 296
G+G G VYK + G + A+K++ Q E++ + +++ G F
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 297 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356
+ V YM GS+A LK + IA +GL YLH IIHRD+
Sbjct: 70 KEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDI 126
Query: 357 KAANILLDEYYEAVVGDFGLAKLL----DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 412
K +N+L++ E + DFG++K+L D C++ V GTV +++PE + S
Sbjct: 127 KPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPERIQGESYSYAA 181
Query: 413 DVFGFGILLLELISG 427
D++ G+ LLE G
Sbjct: 182 DIWSLGLTLLECALG 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 8e-21
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 232 FSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL 289
F +G+G +G+VYK + + G VVA+K + + ++Q E+ ++ +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPYI 60
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 348
++ G T+ +V Y GSV+ +K +L I +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN-- 118
Query: 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV-G---HIAPEYLS 404
K IHRD+KA NILL+E +A + DFG++ L T A R TV G +APE +
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPFWMAPEVIQ 172
Query: 405 TGQSSEKTDVFGFGILLLELISG 427
+ K D++ GI +E+ G
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 288
++ + K+ +G G +G VY+G + VAVK LK+ E F E ++ H N
Sbjct: 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 63
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQ 346
L++L+G C ++ +M+ G++ L+ + ++ +A + + YL ++
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTVGHIAPEYLST 405
IHRD+ A N L+ E + V DFGL++L+ D++ A + + APE L+
Sbjct: 124 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAY 179
Query: 406 GQSSEKTDVFGFGILLLEL 424
+ S K+DV+ FG+LL E+
Sbjct: 180 NKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRL--------KDGNAIGGEIQ-FQTEVEMISLAVH 286
L+GKG +G VY + G ++AVK++ + + ++ ++E+E + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 287 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 346
N+++ +GF T + Y+ GS+ S L+ + + GL YLH +
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC-DSHVTTAVRGTVGHIAPEYLST 405
I+HRD+KA N+L+D + DFG++K D D+ +++G+V +APE + +
Sbjct: 128 ---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 406 GQS--SEKTDVFGFGILLLELISGLR 429
S K D++ G ++LE+ +G R
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 82/283 (28%), Positives = 128/283 (45%), Gaps = 55/283 (19%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKR--LKDGNAIGGEI--QFQTEVEMISLAVHRNLLR 291
L+G G FG+VY+G L DG AVK L D G E Q + E+ ++S H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 292 LIGFCMTTTERLLVY-PYMSNGSVASRLKAKPSLDWA-----TRKRIALGAARGLLYLHE 345
+G + L ++ + GS+A LK S TR+ + GL YLH+
Sbjct: 67 YLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHD 120
Query: 346 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-----AVRGTVGHIAP 400
+ +HRD+K ANIL+D + DFG+AK V + +G+ +AP
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYWMAP 170
Query: 401 EYL-STGQSSEKTDVFGFGILLLELISG---LRALEFGKTANQKGAMLDWVKKIHQEKKL 456
E + G D++ G +LE+ +G LE A+ KI + K+L
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE------GVAAVF----KIGRSKEL 220
Query: 457 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499
+ D L + E ++ + L C Q PSLRP +E++
Sbjct: 221 PPIPD-HLSD-----EAKDFI---LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 62/199 (31%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 238 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLRLIGF 295
+G G VY L + VA+KR+ D + + EV+ +S H N+++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 296 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQCDPKII 352
+ E LV PY+S GS+ +K+ IA +GL YLH I
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQI 124
Query: 353 HRDVKAANILLDEYYEAVVGDFGL-AKLLDH--CDSHVTTAVRGTVGHIAPEYLSTGQS- 408
HRD+KA NILL E + DFG+ A L D V GT +APE +
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 409 SEKTDVFGFGILLLELISG 427
K D++ FGI +EL +G
Sbjct: 185 DFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRL---KDGNAIGGEI-QFQTEVEMISLAV 285
N+ L+G+G FG VY Y D G +AVK++ D E+ + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 286 HRNLLRLIGFCMTTTERLLVY-PYMSNGSVASRLKAKPSL-DWATRK--RIALGAARGLL 341
H +++ G C+ E L ++ YM GSV +LKA +L + TRK R L G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL---EGVE 118
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIA 399
YLH I+HRD+K ANIL D +GDFG +K L S T +V GT ++
Sbjct: 119 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 400 PEYLSTGQSSEKTDVFGFGILLLELIS 426
PE +S K DV+ G ++E+++
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 70/272 (25%), Positives = 116/272 (42%), Gaps = 36/272 (13%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
+G G FG V+ G + VA+K +++G E F E +++ H NL++L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 298 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA----RGLLYLHEQCDPKIIH 353
+V YM+NG + + L+ + L + YL IH
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGK---LGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 354 RDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGT---VGHIAPEYLSTGQSS 409
RD+ A N L+ E V DFGLA+ +LD D + T+ +GT V PE + S
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLD--DQY--TSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 410 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469
K+DV+ FG+L+ E+ S GK ++ + + V+ + +L
Sbjct: 180 SKSDVWSFGVLMWEVFSE------GKMPYERFSNSEVVESVSAGYRLYR----------P 223
Query: 470 RIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501
++ E+ + C P RP +++ L
Sbjct: 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 238 VGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
+G+G FG V+ G D +VAVK LK+ + F+ E E+++ H N+++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKR-------------IALGAA 337
G C ++V+ YM +G + L++ P + IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--- 394
G++YL Q +HRD+ N L+ +GDFG+++ + D + V G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGHTML 186
Query: 395 -VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 435
+ + PE + + + ++DV+ FG++L E+ + +GK
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT------YGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 236 NLVGKGGFGNVYKGYLQDGTVVAVKR--LKDGNAIGGEIQF---QTEVEMISLAVHRNLL 290
++GKG +G VY G G ++AVK+ L N + E ++ Q EV+++ H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
+ +G C+ + ++ GS++S L L + G+ YLH C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--- 122
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-----TAVRGTVGHIAPEYLST 405
++HRD+K N++L + DFG A+ L H T ++ GT +APE ++
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 406 GQSSEKTDVFGFGILLLELISG 427
K+D++ G + E+ +G
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATG 204
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 84/286 (29%), Positives = 134/286 (46%), Gaps = 35/286 (12%)
Query: 237 LVGKGGFGNVYK-GY--LQDGT--VVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLL 290
+GKG FG+V Y LQD T VVAVK+L+ A ++ F+ E+E++ H N++
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIV 68
Query: 291 RLIGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQC 347
+ G C + R LV Y+ GS+ L K + LD A +G+ YL +
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK- 127
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH---VTTAVRGTVGHIAPEYLS 404
+ +HRD+ NIL++ +GDFGL K+L D V + APE L+
Sbjct: 128 --RYVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPIFWYAPESLT 184
Query: 405 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV---D 461
+ S +DV+ FG++L EL F + ++++ + +K+ +M+V
Sbjct: 185 ESKFSVASDVWSFGVVLYEL--------FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236
Query: 462 KDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ LKNN R+ E+ + C PS RP SE+ +E
Sbjct: 237 ELLKNNG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 237 LVGKGGFGNVYKGYL-QDGTV---VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLR 291
++G+G FG+V +G L QD VAVK +K EI+ F +E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 292 LIGFCMTTTER------LLVYPYMSNGSV-----ASRLKAKP-SLDWATRKRIALGAARG 339
LIG C + +++ P+M +G + SRL P L T + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-AVRGTVGHI 398
+ YL + IHRD+ A N +L E V DFGL+K + D + + V I
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 399 APEYLSTGQSSEKTDVFGFGILLLELIS 426
A E L+ + K+DV+ FG+ + E+ +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-19
Identities = 45/112 (40%), Positives = 67/112 (59%), Gaps = 2/112 (1%)
Query: 4 LCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT 63
L Y + N +G++ G++ NL+ + L NN +SG IP +IG S L LDL N
Sbjct: 120 LRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177
Query: 64 GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115
G IP+++++L +L++L L +N L G IP L M L ++ L YNNLSG +P
Sbjct: 178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP 229
|
Length = 968 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 29/214 (13%)
Query: 236 NLVGKGGFGNVYKGYLQD----GT---VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 288
N +G G FG VY+G D G+ VAVK L+ G + +F E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-------PSLDWATRKRIALGAARGLL 341
+++L+G C+ + ++ M G + S L+ P L I L A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 342 YLHEQCDPKIIHRDVKAANILLDEY-YEA----VVGDFGLAKLLDHCDSHVTTAVRG--- 393
YL IHRD+ A N L+ E Y+A +GDFGLA+ + D + G
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGL 174
Query: 394 -TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
V +APE L G+ + ++DV+ FG+L+ E+++
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 7e-19
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLK------DGNAIGGEIQFQTEVEMISLAVHRNL 289
L+G+G +G VY+G + G VVA+K + D + I E+ ++ + + N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQ---LRQSQPPNI 64
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL----YLHE 345
+ G + ++ Y GSV + +KA P K I++ R +L Y+H+
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP----IAEKYISV-IIREVLVALKYIHK 119
Query: 346 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405
+IHRD+KAANIL+ + DFG+A LL+ S +T V GT +APE ++
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITE 175
Query: 406 GQSSE-KTDVFGFGILLLELISG 427
G+ + K D++ GI + E+ +G
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 67/229 (29%), Positives = 106/229 (46%), Gaps = 25/229 (10%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHR 287
+F N +GKG FG V+K + D V A+K+ L N E E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP------SLDWATRKRIALGAARGLL 341
++R + + +V Y NG + LK + W R + GL
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLA 115
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 401
+LH + KI+HRD+K+ N+ LD Y +GD G+AKLL + T V GT +++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPE 171
Query: 402 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 450
+EK+DV+ G++L E +G + AN +GA+ + KI
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGAL---ILKI 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 20/197 (10%)
Query: 238 VGKGGFGNVYKG-YLQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
+G G +G+VYK + G +VA+K +L+ G+ Q E+ M+ H N++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE---IIQQEISMLKECRHPNIVAYFG 67
Query: 295 FCMTTTERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
+ + +V Y GS+ + L A R L +GL YLHE
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHET---G 121
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL---STGQ 407
IHRD+K ANILL E + + DFG++ L + + + GT +APE G
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGG 180
Query: 408 SSEKTDVFGFGILLLEL 424
K D++ GI +EL
Sbjct: 181 YDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 82/281 (29%), Positives = 117/281 (41%), Gaps = 43/281 (15%)
Query: 237 LVGKGGFGNVYKGYLQD--GTV--VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 291
+G G FG V +G G V VAVK LK F E M SL H NL+R
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIR 60
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGLLYLHEQCDP 349
L G +T ++V GS+ RL+ A +T A+ A G+ YL +
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV--GHIAPEYLSTGQ 407
+ IHRD+ A NILL + +GDFGL + L + H V APE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 408 SSEKTDVFGFGILLLELIS-------GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460
S +DV+ FG+ L E+ + GL + +KKI +K+ E L
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI-------------LKKI--DKEGERLE 221
Query: 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501
+ +++ V L C + P+ RP + + L
Sbjct: 222 RPEACP-------QDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 73/289 (25%), Positives = 135/289 (46%), Gaps = 46/289 (15%)
Query: 238 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
+G+G FG VY+G +D T VAVK + + ++ I+F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKA------------KPSLDWATRKRIALGA--A 337
L+G L+V M++G + S L++ P+L ++ I + A A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL----QEMIQMAAEIA 129
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TV 395
G+ YL+ + K +HRD+ A N ++ + +GDFG+ + + D + +G V
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPV 185
Query: 396 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455
+APE L G + +D++ FG++L E I+ L + +N E+
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSN--------------EQV 230
Query: 456 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504
L+ ++D + D E + + +C Q+ P +RP E+V +L+ D
Sbjct: 231 LKFVMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 79/277 (28%), Positives = 121/277 (43%), Gaps = 39/277 (14%)
Query: 232 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLL 290
F+ +GKG FG V+KG V ++ D EI+ Q E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
+ G + T+ ++ Y+ GS L+ P LD I +GL YLH + K
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE---K 121
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVRGTVGHIAPEYLSTGQSS 409
IHRD+KAAN+LL E+ E + DFG+A L D+ + GT +APE +
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 410 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE---KKLEMLVDKD--- 463
K D++ GI +EL G + H E K+ L+ K+
Sbjct: 180 SKADIWSLGITAIELAKG--------------------EPPHSELHPMKVLFLIPKNNPP 219
Query: 464 -LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499
L+ NY + L+E V+ C PS RP E+++
Sbjct: 220 TLEGNYSK-PLKEFVEA---CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-18
Identities = 43/107 (40%), Positives = 61/107 (57%), Gaps = 3/107 (2%)
Query: 11 SQNLSGTLSSSIGNLT-NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 69
+ LSG + I + +L+ + L NNN +G IP G + L TLDLSNN +G IP+
Sbjct: 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPND 159
Query: 70 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
+ +L+ L L N L G IP SL+N++ L FL L+ N L G +P
Sbjct: 160 IGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-18
Identities = 48/108 (44%), Positives = 65/108 (60%), Gaps = 5/108 (4%)
Query: 10 PSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS-KLLTLDLSNNFFTGPIPS 68
+N+SG +SS+I L +Q + L NN +SG IP +I S L L+LSNN FTG IP
Sbjct: 77 SGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR 136
Query: 69 -TVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115
++ +LETL L+NN L+G IP + + S L LDL N L G +P
Sbjct: 137 GSIPNLETLD---LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
|
Length = 968 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 74/277 (26%), Positives = 130/277 (46%), Gaps = 32/277 (11%)
Query: 237 LVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
++G G FG V +G L+ VA+K LK G F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCDPK 350
G + +++ +M NG++ S L+ + + + + G A G+ YL E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEM---N 126
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGT--VGHIAPEYLSTG 406
+HRD+ A NIL++ V DFGL++ L D D T+++ G + APE ++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 407 QSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465
+ + +DV+ +GI++ E++S G R + +NQ D + I Q+ +L +D
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQ-----DVINAIEQDYRLPPPMDCP-- 237
Query: 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ Q+ L C Q + RPK ++V L+
Sbjct: 238 --------TALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 66/197 (33%), Positives = 101/197 (51%), Gaps = 18/197 (9%)
Query: 238 VGKGGFGNVYKG-YLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295
+G+G FG V +G Y G VAVK +K D A F E +++ H+NL+RL+G
Sbjct: 14 IGEGEFGAVLQGEYT--GQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLGV 67
Query: 296 CMTTTERLLVYPYMSNGSVAS--RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
+ +V MS G++ + R + + + + +L A G+ YL + K++H
Sbjct: 68 ILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 413
RD+ A NIL+ E A V DFGLA++ S + V APE L + S K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSD 179
Query: 414 VFGFGILLLELISGLRA 430
V+ +G+LL E+ S RA
Sbjct: 180 VWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 63/197 (31%), Positives = 91/197 (46%), Gaps = 6/197 (3%)
Query: 232 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLL 290
F+ +GKG FG VYKG V ++ D EI+ Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
R G + T+ ++ Y+ GS LK P L+ I +GL YLH + +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSE---R 121
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 410
IHRD+KAAN+LL E + + DFG+A L T V GT +APE +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDF 180
Query: 411 KTDVFGFGILLLELISG 427
K D++ GI +EL G
Sbjct: 181 KADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 69
Query: 298 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 354
+ E + +V YMS GS+ LK + + + + A A G+ Y+ +HR
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 126
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 414
D++AANIL+ E V DFGLA+L++ + + + APE G+ + K+DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 415 FGFGILLLELISGLR 429
+ FGILL EL + R
Sbjct: 187 WSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 17/205 (8%)
Query: 237 LVGKGGFGNVYKG-YLQDGTVVAVKRLK-DGNAIGGEIQ-------FQTEVEMISLAVHR 287
L+G G FG+VY G G ++AVK+++ + + + E+ ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 347
N+++ +G + + Y+ GSVA+ L + + + +GL YLH +
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR- 125
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-----AVRGTVGHIAPEY 402
IIHRD+K ANIL+D + DFG++K L+ T +++G+V +APE
Sbjct: 126 --GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
Query: 403 LSTGQSSEKTDVFGFGILLLELISG 427
+ + K D++ G L++E+++G
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 69/224 (30%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 296
+GKG FG+V G + G VAVK +K D A F E +++ H NL++L+G
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGVI 68
Query: 297 MTTTERL-LVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
+ L +V YM+ GS+ L+++ L + +L + YL +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 413
RD+ A N+L+ E A V DFGL K V+ T APE L + S K+D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSD 181
Query: 414 VFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457
V+ FGILL E+ S FG+ + + D V ++ + K++
Sbjct: 182 VWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMD 219
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 238 VGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295
+G+G +G VYK + G +VA+K+++ + G I E++++ H N++RL
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK-- 64
Query: 296 CMTTTERL----LVYPYMSN--GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 349
+ T++ +V+ YM + + + K + K GL YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES--QIKCYMKQLLEGLQYLHSN--- 119
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL--STGQ 407
I+HRD+K +NIL++ + DFGLA+ +S T T+ + PE L +T +
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT-R 178
Query: 408 SSEKTDVFGFGILLLELISG 427
+ D++ G +L EL G
Sbjct: 179 YGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLK---DGNAIGGEIQ-FQTEVEMISLA 284
+N+ L+G+G FG VY Y D G +AVK+++ + E+ + E++++
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 285 VHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 342
+H +++ G ER L +M GS+ +LK+ +L ++ G+ Y
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH-CDSHV-TTAVRGTVGHIAP 400
LH I+HRD+K ANIL D +GDFG +K L C S +V GT ++P
Sbjct: 122 LHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 401 EYLSTGQSSEKTDVFGFGILLLELIS 426
E +S K D++ G ++E+++
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-17
Identities = 38/103 (36%), Positives = 65/103 (63%)
Query: 14 LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 73
LSG + + IG+ ++L+++ L N + G IP + L+ L L L++N G IP + +
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211
Query: 74 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
++L+++ L N+L+G IP + ++ L LDL YNNL+GP+PS
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-17
Identities = 42/102 (41%), Positives = 62/102 (60%)
Query: 14 LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 73
L G + +S+ NLT+L+ + L +N + G IP E+G++ L + L N +G IP + L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
Query: 74 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115
+L +L L N+LTG IP SL N+ L +L L N LSGP+P
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP 277
|
Length = 968 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 72/297 (24%), Positives = 132/297 (44%), Gaps = 54/297 (18%)
Query: 238 VGKGGFGNVYK----GYL--QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
+G+G FG V++ G L + T+VAVK LK+ + + FQ E +++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKA----------------------KPSLDWATR 329
L+G C L++ YM+ G + L+ L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 330 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK---LLDHCDSH 386
IA A G+ YL E+ K +HRD+ N L+ E + DFGL++ D+ +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLD 445
A+ + + PE + + + ++DV+ +G++L E+ S G++ +G
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY-YGMA--------- 237
Query: 446 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
E+ + + D ++ + D L E+ + LC LPS RP + + R+L+
Sbjct: 238 ------HEEVIYYVRDGNVLSCPDNCPL-ELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 66/200 (33%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 232 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL 289
F+ +GKG FG V+KG + VVA+K + D EI+ Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQC 347
+ G + T+ ++ Y+ GS L+A P AT + L +GL YLH +
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE- 120
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
K IHRD+KAAN+LL E + + DFG+A L T V GT +APE +
Sbjct: 121 --KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSA 177
Query: 408 SSEKTDVFGFGILLLELISG 427
K D++ GI +EL G
Sbjct: 178 YDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 11/193 (5%)
Query: 239 GKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQ--TEVEMISLAVHRNLLRLIGF 295
G G G V K + G ++AVK ++ I IQ Q E++++ ++ G
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 296 CMTTTERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
+ + YM GS+ LK + + +IA+ +GL YLHE+ KIIHR
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHR 125
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 414
DVK +NIL++ + + DFG++ L +S T V GT ++APE + S K+D+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182
Query: 415 FGFGILLLELISG 427
+ G+ L+EL +G
Sbjct: 183 WSLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 238 VGKGGFGNVYKGYL-QDGTV--VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLI 293
+G+G FG+V +G L QD ++ VAVK +K E++ F +E + H N++RLI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 294 GFCMTTTER------LLVYPYMSNGSVAS-----RLKAKPS-LDWATRKRIALGAARGLL 341
G C+ T E +++ P+M +G + S RL P L + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV-RGTVGHIAP 400
YL + IHRD+ A N +L+E V DFGL+K + + D + + + V IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 401 EYLSTGQSSEKTDVFGFGILLLEL 424
E L+ + K+DV+ FG+ + E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 34/216 (15%)
Query: 238 VGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
+G+G FG VYKG L T VA+K LK+ + +F+ E E++S H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRL----------------KAKPSLDWATRKRIALG 335
L+G C +++ Y+++G + L K SLD + IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 336 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-----SHVTTA 390
A G+ YL +HRD+ A N L+ E + DFGL++ + D S
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
VR + PE + G+ + ++D++ FG++L E+ S
Sbjct: 190 VR----WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 76/282 (26%), Positives = 133/282 (47%), Gaps = 30/282 (10%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
S + ++G G FG V G L+ VA+K LK G F +E ++
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 286 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYL 343
H N++ L G + ++V YM NGS+ + L+ K + + + + G A G+ YL
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR-KHDGQFTVIQLVGMLRGIASGMKYL 122
Query: 344 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPE 401
D +HRD+ A NIL++ V DFGL+++L D ++ T + + APE
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 402 YLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460
++ + + +DV+ +GI++ E++S G R + + +NQ D +K I + +L +
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERP--YWEMSNQ-----DVIKAIEEGYRLPAPM 232
Query: 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
D + Q+ L C Q + RPK ++V +L+
Sbjct: 233 DCPAA----------LHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 6e-17
Identities = 66/270 (24%), Positives = 124/270 (45%), Gaps = 30/270 (11%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
+G G FG V+ T VAVK +K G+ F E ++ H L++L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKL--HAV 69
Query: 298 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 354
T E + ++ +M+ GS+ LK+ K I A A G+ ++ ++ IHR
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 126
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 414
D++AANIL+ + DFGLA++++ + + + APE ++ G + K+DV
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 415 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL- 473
+ FGILL+E+++ +G+ + + ++ + + ++ R E
Sbjct: 187 WSFGILLMEIVT------YGRIPYPGMSNPEVIRALERGYRMP------------RPENC 228
Query: 474 -EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
EE+ + + C + P RP + +L+
Sbjct: 229 PEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 238 VGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGE-IQFQTEVEMISLAVHRNLLRLIG- 294
+GKG FG V K DG ++ K + GN E Q +EV ++ H N++R
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 295 FCMTTTERL-LVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARGLLYLH--EQC 347
+ + L +V Y G +A + K + ++ RI L H
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
++HRD+K ANI LD +GDFGLAK+L H S T V GT +++PE L+
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHMS 186
Query: 408 SSEKTDVFGFGILLLELISG 427
EK+D++ G L+ EL +
Sbjct: 187 YDEKSDIWSLGCLIYELCAL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 30/223 (13%)
Query: 226 QSATSNFSSKNLVGKGGFGNVYKG---YLQDGTV---VAVKRLKDGNAIGGEIQFQTEVE 279
+ + + +G G FG VY+G V VAVK L + + E F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 280 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK-AKPSLDWATRKR------I 332
++S H+N++RLIG R ++ M+ G + S L+ +P + +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 333 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGLAKLLDHCDSHVTT 389
A A+G YL E IHRD+ A N LL A + DFG+A+ D + +
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRAS 173
Query: 390 AVRG------TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
R + + PE G + KTDV+ FG+LL E+ S
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 61/195 (31%), Positives = 96/195 (49%), Gaps = 10/195 (5%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
+G G FG V+ G T VAVK LK G F E +++ H L++L + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQL--YAV 69
Query: 298 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 354
+ E + +V YMS GS+ LK + + A A G+ Y+ IHR
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHR 126
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 414
D+++ANIL+ + + DFGLA+L++ + + + APE G+ + K+DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 415 FGFGILLLELISGLR 429
+ FGILL EL++ R
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 45/105 (42%), Positives = 63/105 (60%), Gaps = 1/105 (0%)
Query: 12 QN-LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
QN LSG + SI +L L + L +N++SG IP + +L L L L +N FTG IP +
Sbjct: 269 QNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115
+ L LQ L+L +N +G IP +L + L LDLS NNL+G +P
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 28/222 (12%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMIS-LAV 285
+F ++G+G F V + A+K L I + E E+++ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 286 HRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 344
H +++L + E L V Y NG + ++ SLD + A L YLH
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR------------ 392
+ IIHRD+K NILLD+ + DFG AK+LD S +
Sbjct: 120 SK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 393 -------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
GT +++PE L+ + + +D++ G ++ ++++G
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLK--DGNAIGGEIQFQT---EVEMISLAVHRNLL 290
+G G F + Y+ ++ GT++AVK++ + E + E+ +++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
R++G + L +M+ GSV+ L + A RGL YLHE +
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---Q 123
Query: 351 IIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTA------VRGTVGHIAPEYL 403
IIHRDVK AN+L+D + + + DFG A L + T A + GT+ +APE L
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 404 STGQSSEKTDVFGFGILLLELISG 427
Q DV+ G +++E+ +
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 238 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 288
+G+G FG V K VAVK LKD +E+EM+ + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRI--- 332
++ L+G C ++ Y S G++ L+A+ P +D++ T K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 333 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 391
A ARG+ YL Q K IHRD+ A N+L+ E + DFGLA+ + + D + TT
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
R V +APE L + ++DV+ FG+LL E+ +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLK---DGNAIGGEIQ-FQTEVEMISLAV 285
N+ L+G+G FG VY Y D G +AVK++ D E+ + E++++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 286 HRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 343
H +++ G E+ L YM GS+ +LKA +L +R +G+ YL
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 344 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH-CDSHV-TTAVRGTVGHIAPE 401
H I+HRD+K ANIL D +GDFG +K + C S +V GT ++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 402 YLSTGQSSEKTDVFGFGILLLELIS 426
+S K DV+ ++E+++
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 79/302 (26%), Positives = 140/302 (46%), Gaps = 55/302 (18%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAV 285
++ ++++G+G FG V K + +DG + A+KR+K+ + F E+E++ L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 286 HRNLLRLIGFCMTTTERLLVYPYMSNGSV-----ASR-LKAKPSLDWATRKRIALGA--- 336
H N++ L+G C L Y +G++ SR L+ P+ A L +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 337 -------ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389
ARG+ YL ++ + IHRD+ A NIL+ E Y A + DFGL++ +
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------V 176
Query: 390 AVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML 444
V+ T+G + A E L+ + +DV+ +G+LL E++S G T
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCA 230
Query: 445 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV----RM 500
+ +K+ Q +LE ++ D +E+ + C + P RP ++++ RM
Sbjct: 231 ELYEKLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
Query: 501 LE 502
LE
Sbjct: 281 LE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 51/300 (17%)
Query: 235 KNLVGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 288
K +G+G FG V+ +D +VAVK LKD + FQ E E+++ H +
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEH 68
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKA----------------KPSLDWATRKRI 332
+++ G C ++V+ YM +G + L+A K L + I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 333 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-----SHV 387
A A G++YL Q +HRD+ N L+ +GDFG+++ + D H
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 447
+R + PE + + + ++DV+ FG++L E+ + +GK + + + +
Sbjct: 186 MLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSNTEVI 235
Query: 448 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLA 507
+ I Q + LE R+ +E+ + L C Q P R + E+ ++L G A
Sbjct: 236 ECITQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 237 LVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQT---EVEMISLAVHRNLLRL 292
+VG+G +G V K + G +VA+K+ K+ + E +T EV+++ H N++ L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKE--SEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKI 351
LV+ Y+ ++ L+A P L + + + Y H I
Sbjct: 66 KEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NI 121
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--DSHVTTAVRGTVGHIAPEYL-STGQS 408
IHRD+K NIL+ E + DFG A+ L S +T V T + APE L
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARAL-RARPASPLTDYV-ATRWYRAPELLVGDTNY 179
Query: 409 SEKTDVFGFGILLLELISG 427
+ DV+ G ++ EL+ G
Sbjct: 180 GKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 238 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 288
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRI--- 332
++ L+G C ++ Y S G++ L+A+ P ++++ T K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 333 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 391
ARG+ YL Q K IHRD+ A N+L+ E + DFGLA+ +++ D + TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
R V +APE L + ++DV+ FG+L+ E+ +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-16
Identities = 42/103 (40%), Positives = 60/103 (58%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
NLSG + IG LT+L + L NN++G IP+ +G L L L L N +GPIP ++
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115
L+ L L L++NSL+G IP + + L L L NN +G +P
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
|
Length = 968 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLK---DGNAIGGEIQ-FQTEVEMISLAV 285
N+ L+G+G FG VY Y D G +A K+++ + E+ + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 286 HRNLLRLIGFCMTTTERLLV--YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 343
H +++ G E+ L YM GSV +LKA +L + ++ G+ YL
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 344 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH-CDSHV-TTAVRGTVGHIAPE 401
H I+HRD+K ANIL D +GDFG +K L C S +V GT ++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 402 YLSTGQSSEKTDVFGFGILLLELIS 426
+S K DV+ G ++E+++
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 10/195 (5%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
+G+G FG V+ G T VA+K LK G + F E +++ H L+ L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE--AFLQEAQIMKKLRHDKLVPL--YAV 69
Query: 298 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 354
+ E + +V +M GS+ LK + + + A A G+ Y+ IHR
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHR 126
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 414
D++AANIL+ + + DFGLA+L++ + + + APE G+ + K+DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 415 FGFGILLLELISGLR 429
+ FGILL EL++ R
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 237 LVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHRNLLRL 292
++GKG FG V L + G + AVK LK + I + + TE ++SLA + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 293 IGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
+ C T +RL V +++ G + ++ D A + A L++LH++ I
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GI 117
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 411
I+RD+K N+LLD + DFG+ K + T+ GT +IAPE L
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQEMLYGPS 176
Query: 412 TDVFGFGILLLELISG 427
D + G+LL E++ G
Sbjct: 177 VDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 58/300 (19%)
Query: 238 VGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
+G+G FG V K T VAVK LK+ + +E ++ H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLK----------------AKPSLDWATRKRIALG 335
L G C LL+ Y GS+ S L+ LD + + +G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 336 --------AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387
+RG+ YL E K++HRD+ A N+L+ E + + DFGL++ + DS+V
Sbjct: 128 DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 388 TTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW 446
+ R V +A E L + ++DV+ FG+LL E+++ L + A ++ L
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-LGGNPYPGIAPERLFNL-- 241
Query: 447 VKKIHQEKKLEMLVDKDLKNNY--DRIE--LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
LK Y +R E EEM + L C + P RP +++ + LE
Sbjct: 242 -----------------LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 64/201 (31%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 238 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
+G+G FG V Y D G +VAVK LK ++ E+ ++ H N+++
Sbjct: 12 LGEGHFGKVSL-YCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 292 LIGFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 349
G C + L+ Y+ GS+ L K L+ A A G+ YLH Q
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQ--- 126
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAPEYLST 405
IHRD+ A N+LLD +GDFGLAK + + H VR V A E L
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP--EGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 406 GQSSEKTDVFGFGILLLELIS 426
+ S +DV+ FG+ L EL++
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 66/196 (33%), Positives = 87/196 (44%), Gaps = 20/196 (10%)
Query: 238 VGKGGFGNVYKGY-LQDGTVVAVKRL----KDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
+G G FG VY ++ VVA+K++ K N +I EV + H N +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII--KEVRFLQQLRHPNTIEY 80
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
G + LV Y GS + L+ K L I GA +GL YLH
Sbjct: 81 KGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---R 136
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY---LSTGQS 408
IHRD+KA NILL E + DFG A L+ +S V GT +APE + GQ
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQY 191
Query: 409 SEKTDVFGFGILLLEL 424
K DV+ GI +EL
Sbjct: 192 DGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 34/226 (15%)
Query: 232 FSSKNLV-----GKGGFGNVYK--GY-----LQDGTV-VAVKRLKDGNAIGGEIQFQTEV 278
F LV G+G FG V + Y D TV VAVK LKD +E+
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 279 EMISL-AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA---TRK-- 330
E++ L H+N++ L+G C ++ Y + G++ L+A+ P D+ T+
Sbjct: 69 ELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 331 ---------RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381
A ARG+ YL + + IHRD+ A N+L+ E + DFGLA+ +
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185
Query: 382 HCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
D + T+ R V +APE L + ++DV+ FGIL+ E+ +
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 25/218 (11%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN----AIGGEIQFQTEVEMISL 283
+ + +G+G G VYK G VA+K+++ I EI M
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILI-----MKDC 72
Query: 284 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLY 342
H N++ + E +V YM GS+ + ++ + +GL Y
Sbjct: 73 -KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEY 131
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 402
LH Q +IHRD+K+ NILL + + DFG A L S + V GT +APE
Sbjct: 132 LHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEV 187
Query: 403 LSTGQSSEKTDVFGFGILLLELISG---------LRAL 431
+ K D++ GI+ +E+ G LRAL
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-15
Identities = 42/106 (39%), Positives = 57/106 (53%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
S N +G + ++ +L LQ++ L +N SG IP +GK + L LDLS N TG IP +
Sbjct: 317 SNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
L L L +NSL G IP SL L + L N+ SG +PS
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
|
Length = 968 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 69/279 (24%), Positives = 130/279 (46%), Gaps = 38/279 (13%)
Query: 238 VGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
+G+G FG VY KG ++D T VA+K + + ++ I+F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKA-------KPSLDWATRKRIALGA---ARGLL 341
L+G L++ M+ G + S L++ P + K++ A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIA 399
YL+ K +HRD+ A N ++ E + +GDFG+ + + D + +G V ++
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMS 189
Query: 400 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459
PE L G + +DV+ FG++L E I+ L + +N E+ L +
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWE-IATLAEQPYQGMSN--------------EQVLRFV 234
Query: 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 498
++ L + D + + ++ +C QY P +RP E++
Sbjct: 235 MEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 57/207 (27%), Positives = 107/207 (51%), Gaps = 31/207 (14%)
Query: 237 LVGKGGFGNVYKG-YLQDGTVV----AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
++G G FG VYKG ++ +G V A+K L + ++F E +++ H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 292 LIGFCMTTTERL----------LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 341
L+G C++ T +L L Y + ++ S+L L+W + A+G++
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLL----LNWCVQ------IAKGMM 123
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIA 399
YL E+ +++HRD+ A N+L+ + DFGLA+LL+ D A G + +A
Sbjct: 124 YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG-DEKEYNADGGKMPIKWMA 179
Query: 400 PEYLSTGQSSEKTDVFGFGILLLELIS 426
E + + + ++DV+ +G+ + EL++
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 68/218 (31%), Positives = 94/218 (43%), Gaps = 28/218 (12%)
Query: 253 DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG-------FCMTTTE-RLL 304
V VK + G G EI ++ IS HR ++ LI CM + +
Sbjct: 118 QRKKVIVKAVTGGKTPGREIDI---LKTIS---HRAIINLIHAYRWKSTVCMVMPKYKCD 171
Query: 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 364
++ Y+ R P T +R L A L YLH + IIHRDVK NI LD
Sbjct: 172 LFTYVD------RSGPLPLEQAITIQRRLLEA---LAYLHGR---GIIHRDVKTENIFLD 219
Query: 365 EYYEAVVGDFGLA-KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 423
E AV+GDFG A KL H D+ GT+ +PE L+ KTD++ G++L E
Sbjct: 220 EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
Query: 424 LISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461
+ L FGK + L + + Q LE +
Sbjct: 280 MSVKNVTL-FGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316
|
Length = 392 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 238 VGKGGFGNVYKGYLQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
+GKGGFG V ++ G + A K+L K GE E +++ V + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEK-VSSRFIVSLA 59
Query: 295 FCMTTTERL-LVYPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
+ T + L LV M+ G + + +P A A GL +LH++ +I
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RI 116
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 411
++RD+K N+LLD++ + D GLA ++ GT G++APE L
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 412 TDVFGFGILLLELISG 427
D F G L E+I+G
Sbjct: 175 VDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 56/212 (26%), Positives = 80/212 (37%), Gaps = 28/212 (13%)
Query: 231 NFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+F ++GKG FG V + A+K + Q VE S+ N
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMK----------YMNKQKCVEKGSVRNVLNE 50
Query: 290 LR---------LIGFCMTTTER---LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA 337
R L+ + + LV + G + L K K
Sbjct: 51 RRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIV 110
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 397
L YLH + IIHRD+K NILLDE + DF +A + +TT+ GT G+
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTSTSGTPGY 165
Query: 398 IAPEYLSTGQSSEKTDVFGFGILLLELISGLR 429
+APE L S D + G+ E + G R
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 29/215 (13%)
Query: 238 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 288
+G+G FG V K T VAVK LK +E+EM+ + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRK--------------RI 332
++ L+G C ++ Y S G++ L+A+ P +++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 333 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 391
A ARG+ YL + K IHRD+ A N+L+ E + DFGLA+ + H D + TT
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
R V +APE L + ++DV+ FG+LL E+ +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 70/276 (25%), Positives = 118/276 (42%), Gaps = 35/276 (12%)
Query: 231 NFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQ-TEVEMISLAVHRN 288
+F +GKG +G+VYK L D A+K + G+ E + E+ +++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVA----SRLKAKPSLDWATRKRIALGAARGLLYLH 344
++ + + +V Y G ++ R K + + RI + RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 404
EQ KI+HRD+K+ANILL +GD G++K+L ++ GT ++APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWK 174
Query: 405 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464
S K+D++ G LL E+ + A F + + ++ L K
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATF--APPF------------------EARSMQDLRYKVQ 214
Query: 465 KNNYDRIEL---EEMVQVALLCTQYLPSLRPKMSEV 497
+ Y I +++ Q P LRP ++
Sbjct: 215 RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 52/217 (23%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 224 ELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMI 281
E + + ++GKG +G VY L +A+K + + ++ +Q E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALH 59
Query: 282 SLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--------PSLDWATRKRIA 333
S HRN+++ +G + + GS+++ L++K ++ + T++ +
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL- 118
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVR 392
GL YLH+ +I+HRD+K N+L++ Y V + DFG +K L + T
Sbjct: 119 ----EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFT 170
Query: 393 GTVGHIAPEYLSTGQS--SEKTDVFGFGILLLELISG 427
GT+ ++APE + G D++ G ++E+ +G
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 238 VGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
+G+ FG +YKG+L +VA+K LKD N +FQ E +++ H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRL-----------------KAKPSLDWATRKRIALG 335
+G +++ Y++ G + L K SLD IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 336 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGT 394
A G+ YL +H+D+ A NIL+ E + D GL++ + D + V
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 395 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
+ + PE + G+ S +D++ FG++L E+ S
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 225 LQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMI- 281
L T F ++G+G +G VYK + + G +VA+K + + I E + + E ++
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILR 57
Query: 282 SLAVHRNLLRLIGFCMTTTERL------LVYPYMSNGSVASRLKAKPSLDWATRKR---- 331
+ H N+ G + LV GSV + L K R +
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-TDL-VKGLRKKGKRLKEEWI 115
Query: 332 --IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389
I RGL YLHE K+IHRD+K NILL + E + DFG++ LD T
Sbjct: 116 AYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 390 AVRGTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELISG 427
+ GT +APE ++ + + + DV+ GI +EL G
Sbjct: 173 FI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 56/179 (31%), Positives = 81/179 (45%), Gaps = 37/179 (20%)
Query: 227 SATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRL-----KDGNAIGGEIQFQTEVEM 280
S ++ +G+G FG VYK ++ G VVA+K++ KDG I E+++
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA----LREIKI 60
Query: 281 ISLAVHRNLLRLIGFCM-----TTTERLLVY---PYM--------SNGSVASRLKAKPSL 324
+ H N++ LI + + +R VY PYM N SV L
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV--------KL 112
Query: 325 DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383
+ K L G+ YLHE I+HRD+KAANIL+D + DFGLA+ D
Sbjct: 113 TESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 69/288 (23%), Positives = 126/288 (43%), Gaps = 33/288 (11%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 283
SN +G+G FG V+ + T+V VK L+ + +F+ E++M
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 284 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW-------ATRKRIALGA 336
H+N++RL+G C ++ Y G + L+A S D +T++++AL
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 337 --ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 394
A G+ +L + +HRD+ A N L+ E V L+K + + + +
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 395 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 454
+ +APE + S K+DV+ FG+L+ E+ + L F +++ + + ++ Q
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDE-----EVLNRL-QAG 234
Query: 455 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
KLE+ V + + ++ C P RP SE+V L
Sbjct: 235 KLELPVPEGCPSRLYKLMTR--------CWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 10/192 (5%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
+G G FG V G + VA+K +K+G+ E +F E +++ H L++L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 298 TTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356
+V YMSNG + + L+ + + G+ YL + + IHRD+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDL 126
Query: 357 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV--RGTVGHIAPEYLSTGQSSEKTDV 414
A N L+D+ V DFGL++ + D T++V + V PE L + S K+DV
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 415 FGFGILLLELIS 426
+ FG+L+ E+ S
Sbjct: 185 WAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 232 FSSKNLVGKGGFGNVYKGYL--QDGTV--VAVKRLK-DGNAIGGEIQFQTEVEMISLAVH 286
F+ ++GKG FG+V + L +DG+ VAVK LK D + +F E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 287 RNLLRLIGFCMTTTER------LLVYPYMSNGSV-----ASRLKAKP-SLDWATRKRIAL 334
N+++LIG + + + +++ P+M +G + SR+ +P +L T R +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 335 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVRG 393
A G+ YL + IHRD+ A N +L+E V DFGL+K + D + A +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 394 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
V +A E L+ + +DV+ FG+ + E+++
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 70/296 (23%), Positives = 128/296 (43%), Gaps = 48/296 (16%)
Query: 231 NFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 284
N K +G+G FG V+ QD +VAVK LKD + F E E+++
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNL 64
Query: 285 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-------------PSLDWATRKR 331
H ++++ G C+ ++V+ YM +G + L+A L +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-----SH 386
IA A G++YL Q +HRD+ N L+ E +GDFG+++ + D H
Sbjct: 125 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW 446
+R + PE + + + ++DV+ G++L E+ + +GK + + +
Sbjct: 182 TMLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFT------YGKQPWYQLSNNEV 231
Query: 447 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
++ I Q + L+ R +E+ + L C Q P +R + E+ +L+
Sbjct: 232 IECITQGRVLQR----------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 17/200 (8%)
Query: 237 LVGKGGFGNVYKG-YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAV--HRN 288
L+G G FG V+KG ++ +G VA+K ++D + G FQ + M+++ H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAY 70
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQC 347
++RL+G C + +L V GS+ + + + SLD + A+G+ YL E
Sbjct: 71 IVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTG 406
++HR++ A NILL + DFG+A LL D + + + + +A E + G
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 407 QSSEKTDVFGFGILLLELIS 426
+ + ++DV+ +G+ + E++S
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 58/242 (23%), Positives = 109/242 (45%), Gaps = 32/242 (13%)
Query: 238 VGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
+G+G FG V+ QD +VAVK LK+ + FQ E E++++ H++++R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTVLQHQHIVR 71
Query: 292 LIGFCMTTTERLLVYPYMSNGSV---------------ASRLKAKPSLDWATRKRIALGA 336
G C L+V+ YM +G + A L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTV 395
A G++YL +HRD+ N L+ + +GDFG+++ + D + V +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 396 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455
+ PE + + + ++D++ FG++L E+ + +GK + + + ++ I Q ++
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT------YGKQPWYQLSNTEAIECITQGRE 242
Query: 456 LE 457
LE
Sbjct: 243 LE 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 35/278 (12%)
Query: 235 KNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 290
+G+G FG+VY+G VAVK K+ + +F E ++ H +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 349
+LIG T +V G + S L+ K SLD A+ + + L YL +
Sbjct: 71 KLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK--- 126
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 409
+ +HRD+ A N+L+ +GDFGL++ L+ + + + + +APE ++ + +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 410 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469
+DV+ FG+ + E++ G Q VK ++E N +
Sbjct: 187 SASDVWMFGVCMWEILM------LGVKPFQ------GVKNNDVIGRIE---------NGE 225
Query: 470 RIELEEMVQVAL-----LCTQYLPSLRPKMSEVVRMLE 502
R+ + L C Y PS RP+ +E+ L
Sbjct: 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 8e-14
Identities = 76/296 (25%), Positives = 137/296 (46%), Gaps = 55/296 (18%)
Query: 236 NLVGKGGFGNVYKGYLQ-DGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLLR 291
+++G+G FG V K ++ DG + A+KR+K+ + F E+E++ L H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLD--------------WATRK--RIALG 335
L+G C L Y +G++ L+ L+ ++++ A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 336 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 395
ARG+ YL ++ + IHRD+ A NIL+ E Y A + DFGL++ + V+ T+
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 170
Query: 396 GHI-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 450
G + A E L+ + +DV+ +G+LL E++S G T + +K+
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCAELYEKL 224
Query: 451 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV----RMLE 502
Q +LE ++ D +E+ + C + P RP ++++ RMLE
Sbjct: 225 PQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-14
Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
+G G FG V+ G + VA+K + +G E F E +++ H L++L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 298 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR----GLLYLHEQCDPKIIH 353
+V +M NG + + L+ + K + L + G+ YL IH
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIH 123
Query: 354 RDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTA-VRGTVGHIAPEYLSTGQSSEK 411
RD+ A N L+ V DFG+ + +LD D + +++ + V PE + + S K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLD--DEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 412 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471
+DV+ FG+L+ E+ + GK +K + + V+ I + +L R
Sbjct: 182 SDVWSFGVLMWEVFTE------GKMPFEKKSNYEVVEMISRGFRLY------------RP 223
Query: 472 ELEEMV--QVALLCTQYLPSLRPKMSEVVRML 501
+L M +V C P RP +E++R +
Sbjct: 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 66/303 (21%), Positives = 121/303 (39%), Gaps = 40/303 (13%)
Query: 215 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQ 273
G H E ++ K N D V VAVK L+ +
Sbjct: 16 GQFGEVHLCE------ADGLQDFSEKAFAENDNA----DAPVLVAVKVLRPDASDNARED 65
Query: 274 FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-----------KP 322
F EV+++S N+ RL+G C ++ YM NG + L+
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 323 SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382
SL ++T +A A G+ YL +HRD+ N L+ + Y + DFG+++ L
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 383 CDSHVTTAVRG-TVGHI---APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN 438
D + V+G I A E + G+ + K+DV+ FG+ L E+++ R + +
Sbjct: 183 SDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239
Query: 439 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 498
Q+ +++ ++ ++ + + +++ ++ L C + RP E+
Sbjct: 240 QQ--VIENAGHFFRDDGRQIYLPR------PPNCPKDIYELMLECWRRDEEDRPTFREIH 291
Query: 499 RML 501
L
Sbjct: 292 LFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 239 GKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
G+G G+V K L G + A+K + + Q E+E+ +++ G +
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 298 --TTTERLLVYPYMSNGSVASRLKAKPSLDWATRK----RIALGAARGLLYLHEQCDPKI 351
+++ + Y GS+ S K + +IA +GL YLH + KI
Sbjct: 70 DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KI 126
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLA-KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 410
IHRD+K +NILL + + DFG++ +L++ T GT ++APE + S
Sbjct: 127 IHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPERIQGKPYSI 182
Query: 411 KTDVFGFGILLLELISG 427
+DV+ G+ LLE+
Sbjct: 183 TSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 232 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHR 287
FS +G G FG VY +++ VVA+K++ E ++Q EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQ 346
N ++ G + LV Y GS + L+ K L + GA +GL YLH
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY---L 403
+IHRDVKA NILL E +GDFG A ++ + V GT +APE +
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAM 186
Query: 404 STGQSSEKTDVFGFGILLLEL 424
GQ K DV+ GI +EL
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 21/204 (10%)
Query: 238 VGKGGFGNVYKGYLQDGTVVA---VKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
+G G FG V G G A VK L+ ++ F EV+ H N+L+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKAKPSL-----DWATRKRIALGAARGLLYLHEQCDP 349
C+ + LLV + G + + L++ + +R+A A GLL+LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG--HIAPEYLSTGQ 407
IH D+ N L +GD+GLA L + + + T V +APE +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 408 S-------SEKTDVFGFGILLLEL 424
++K++++ G+ + EL
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 75/296 (25%), Positives = 122/296 (41%), Gaps = 56/296 (18%)
Query: 232 FSSKNL-----VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
F++++L +G+G FG V K + GT++AVKR++ + + +++++ +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 286 H-RNLLRLIG---------FCM----TTTERLLVYPYMS-NGSVASRLKAKPSLDWATRK 330
+++ G CM + ++ Y Y + + K
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK--------- 111
Query: 331 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 390
IA+ + L YL E + KIIHRDVK +NILLD + DFG++ L DS T
Sbjct: 112 -IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTR 166
Query: 391 VRGTVGHIAPEYLSTGQSSE---KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 447
G ++APE + ++DV+ GI L E+ +G K K W
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG-------KFPYPK-----WN 214
Query: 448 KKIHQEKKLEMLVDKD---LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500
Q L +V D L N+ +R V LC S RPK E++
Sbjct: 215 SVFDQ---LTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 72/298 (24%), Positives = 134/298 (44%), Gaps = 55/298 (18%)
Query: 235 KNLVGKGGFGNVYKGYLQ-DGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLL 290
++++G+G FG V + ++ DG + A+K LK+ + F E+E++ L H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLD--------------WATRK--RIAL 334
L+G C + Y G++ L+ L+ +++ + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 335 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 394
A G+ YL E+ + IHRD+ A N+L+ E + + DFGL++ + V+ T
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKKT 176
Query: 395 VGHI-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 449
+G + A E L+ + K+DV+ FG+LL E++S G T + +K
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS------LGGTPYCGMTCAELYEK 230
Query: 450 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV----RMLEG 503
+ Q ++E + D +E+ ++ C + P RP +++ RMLE
Sbjct: 231 LPQGYRMEKPRNCD----------DEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 238 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVHRNLLRLIG 294
+G+G G V+K + G VA+K++ GG I Q E++ + H +++L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGG-IPNQALREIKALQACQHPYVVKLLD 66
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
+ +LV YM ++ L+ + L A K +G+ Y+H I+H
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMH 122
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKT 412
RD+K AN+L+ + DFGLA+L + + + T + APE L +
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV 182
Query: 413 DVFGFGILLLELISG 427
D++ G + EL++G
Sbjct: 183 DLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 20/228 (8%)
Query: 238 VGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
+G G FG V KG + VA+K LK+ N + E E++ + ++R+IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQCDPKI 351
C +LV S G + L K D T + + G+ YL +
Sbjct: 63 VCEAEA-LMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NF 116
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIAPEYLSTGQSS 409
+HRD+ A N+LL + A + DFGL+K L DS+ +A + + APE ++ + S
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 410 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457
++DV+ +GI + E A +G+ +K + + I Q K+L+
Sbjct: 177 SRSDVWSYGITMWE------AFSYGQKPYKKMKGPEVMSFIEQGKRLD 218
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 230 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 284
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 285 VHRNLLRLIGFCMTTTERLLVYPYMSNGSV-------ASRLKAKPSLDWATRKRIALGAA 337
+ ++ RL+G C+T+T +L + M G + + ++ L+W + A
Sbjct: 67 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 119
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV-- 395
+G+ YL E+ +++HRD+ A N+L+ + DFGLAKLL D A G V
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-ADEKEYHAEGGKVPI 175
Query: 396 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
+A E + + ++DV+ +G+ + EL++
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 4e-13
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 23/219 (10%)
Query: 225 LQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 282
L+ F LVG G +G VYKG +++ G + A+K + + G E + + E+ M+
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLK 57
Query: 283 -LAVHRNLLRLIGFCMTTT------ERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIA 333
+ HRN+ G + + LV + GSV +K +L I
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 393
RGL +LH+ K+IHRD+K N+LL E E + DFG++ LD T + G
Sbjct: 118 REILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-G 173
Query: 394 TVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELISG 427
T +APE ++ ++ + K+D++ GI +E+ G
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 237 LVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
++G G FG VYKG ++ DG VA+K L++ + + E +++ + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 292 LIGFCMTTTERLLVYPYMSNGSV-------ASRLKAKPSLDWATRKRIALGAARGLLYLH 344
L+G C+T+T +L V M G + R+ ++ L+W + A+G+ YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV--GHIAPEY 402
E +++HRD+ A N+L+ + DFGLA+LLD D A G V +A E
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD-IDETEYHADGGKVPIKWMALES 182
Query: 403 LSTGQSSEKTDVFGFGILLLELIS 426
+ + + ++DV+ +G+ + EL++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 68/221 (30%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 222 FKELQSATSNFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEM 280
+ L T + +GKG +G VYK +DG++ AVK L + + EI+ + + +
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-L 72
Query: 281 ISLAVHRNLLRLIGFCMTTTERL-----LVYPYMSNGSVASR----LKAKPSLDWATRKR 331
SL H N+++ G + + LV + GSV L LD A
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391
I GA GL +LH +IIHRDVK NILL + DFG++ L T+V
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 392 RGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELISG 427
GT +APE ++ Q + + DV+ GI +EL G
Sbjct: 190 -GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (171), Expect = 5e-13
Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 232 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL---AVHR 287
+ +G+G +G VYK + G +VA+K+++ N G I T + ISL H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG-IP-STALREISLLKELKHP 58
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQ 346
N+++L+ T + LV+ Y + L +P L K I RGL Y H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSH--VTTAVRGTVGHIAPE 401
+I+HRD+K NIL++ + DFGLA+ +H VT R APE
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR------APE 168
Query: 402 YL--STGQSSEKTDVFGFGILLLELISG 427
L S S+ D++ G + E+I+G
Sbjct: 169 ILLGSKHYSTA-VDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 232 FSSKNLV-----GKGGFGNVYK----GYLQDGTV--VAVKRLKDGNAIGGEIQ-FQTEVE 279
F NL G G FG V + G + V VAVK LK A E + +E++
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP-TAHSSEREALMSELK 90
Query: 280 MIS-LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS--RLKAKPSLDWATRKRIALGA 336
++S L H N++ L+G C L++ Y G + + R K + L +
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150
Query: 337 ARGLLYL-HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT- 394
A+G+ +L + C IHRD+ A N+LL + DFGLA+ + + ++V V+G
Sbjct: 151 AKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNA 203
Query: 395 ---VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
V +APE + + ++DV+ +GILL E+ S
Sbjct: 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 60/198 (30%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 237 LVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
++GKG FG V KG + AVK LK + + T E LA+ L
Sbjct: 2 VLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 293 IGF--CMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 349
C T +RL V Y++ G + ++ D + A GL +LHE+
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER--- 115
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 409
II+RD+K N+LLD + DFG+ K T+ GT +IAPE LS
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKE-GILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 410 EKTDVFGFGILLLELISG 427
D + G+LL E+++G
Sbjct: 175 PAVDWWALGVLLYEMLAG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 9e-13
Identities = 65/201 (32%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 232 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHR 287
F+ +G G FG VY ++ VVA+K++ E ++Q EV+ + H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-KWQDIIKEVKFLQRIKHP 85
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQ 346
N + G + LV Y GS + L+ K L I GA +GL YLH
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY---L 403
+IHRD+KA NILL E + + DFG A + +S V GT +APE +
Sbjct: 145 ---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAM 196
Query: 404 STGQSSEKTDVFGFGILLLEL 424
GQ K DV+ GI +EL
Sbjct: 197 DEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 65/194 (33%), Positives = 85/194 (43%), Gaps = 16/194 (8%)
Query: 238 VGKGGFGNVY-KGYLQDGTVVAVKRLK-DGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIG 294
+G G FG VY VVAVK++ G + Q EV+ + H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
+ LV Y GS + L+ K L I GA +GL YLH +IH
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIH 144
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY---LSTGQSSE 410
RD+KA NILL E + + DFG A +S V GT +APE + GQ
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYDG 199
Query: 411 KTDVFGFGILLLEL 424
K DV+ GI +EL
Sbjct: 200 KVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 238 VGKGGFGNVY---KGYLQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHRNLLR 291
+ KG +G V+ K G + A+K +K + I + Q TE +++S A +++
Sbjct: 1 ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIR-KNQVDQVLTERDILSQAQSPYVVK 57
Query: 292 LIGFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 349
L + ++ LV Y+ G +AS L+ SLD + L YLH
Sbjct: 58 L--YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN--- 112
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKL---LDHCDSHVTTA----VRGTVGHIAPEY 402
IIHRD+K NIL+D + DFGL+K+ + + + GT +IAPE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 403 LSTGQSSEKT-DVFGFGILLLELISG 427
+ GQ KT D + G +L E + G
Sbjct: 173 I-LGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 67/265 (25%), Positives = 116/265 (43%), Gaps = 20/265 (7%)
Query: 235 KNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
+ ++G G G VYK Y L ++AVK + + + Q +E+E++ ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
G + +M GS L + RIA+ +GL YL KI+H
Sbjct: 66 GAFFVENRISICTEFMDGGS----LDVYRKIPEHVLGRIAVAVVKGLTYLWSL---KILH 118
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 413
RDVK +N+L++ + + DFG++ L +S T V GT ++APE +S Q +D
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISGEQYGIHSD 175
Query: 414 VFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 473
V+ GI +EL G + + +G+++ + L+ +VD+D
Sbjct: 176 VWSLGISFMELALG--RFPYPQIQKNQGSLMPL-------QLLQCIVDEDPPVLPVGQFS 226
Query: 474 EEMVQVALLCTQYLPSLRPKMSEVV 498
E+ V C + P RP ++
Sbjct: 227 EKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 10/195 (5%)
Query: 238 VGKGGFGNVYKGYLQ---DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
+G G FG V KG + VAVK LK D N + + E ++ + ++R+I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
G C +LV G + L+ + + + G+ YL E +H
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVH 118
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSSEK 411
RD+ A N+LL + A + DFGL+K L +++ G V APE ++ + S K
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178
Query: 412 TDVFGFGILLLELIS 426
+DV+ FG+L+ E S
Sbjct: 179 SDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 231 NFSSKNLVGKGGFGNVY--KGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 287
+ +VG+G FG V+ + D +V +K++ + + Q E +++ L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 347
N++ + ++V Y G++A K I + LL LH
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLA-EYIQKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 348 DPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 406
I+HRD+K NILLD++ V +GDFG++K+L S T V GT +I+PE
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV-GTPCYISPELCEGK 176
Query: 407 QSSEKTDVFGFGILLLELISGLRALE 432
++K+D++ G +L EL S RA E
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 16/195 (8%)
Query: 239 GKGGFGNVYKG-YLQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295
G G FG VYK + + G A K ++ + F E++++S H N++ L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE---DFMVEIDILSECKHPNIVGLYEA 70
Query: 296 CMTTTERLLVYPYMSNGSVAS-RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
+ ++ + G++ S L+ + L + + L +LH K+IHR
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHR 127
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE---- 410
D+KA NILL + + DFG++ T + GT +APE ++ +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYD 186
Query: 411 -KTDVFGFGILLLEL 424
K D++ GI L+EL
Sbjct: 187 YKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 232 FSSKNLVGKGGFGNVYKGYLQDGTV-----VAVKRLKDGNAIGGEIQ---FQTEVEMISL 283
+ +L+ +G FG ++ G L D V VK +KD + EIQ E ++
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS---EIQVTLLLQESCLLYG 64
Query: 284 AVHRNLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKR---------IA 333
H+N+L ++ C+ E V YPYM+ G++ L+ + L A + +A
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQ-QCRLGEANNPQALSTQQLVHMA 123
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVR 392
+ A G+ YLH++ +IH+D+ A N ++DE + + D L++ L D H +
Sbjct: 124 IQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
V +A E L + S +DV+ FG+LL EL++
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 232 FSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNL 289
F +VG G +G VYKG +++ G + A+K + EI+ E+ M+ + HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL--EINMLKKYSHHRNI 75
Query: 290 LRLIGFCMTTT------ERLLVYPYMSNGSVASRLKAKP----SLDWATRKRIALGAARG 339
G + + + LV + GSV +K DW I RG
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRG 133
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 399
L +LH K+IHRD+K N+LL E E + DFG++ LD T + GT +A
Sbjct: 134 LAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMA 189
Query: 400 PEYLSTGQSSEKT-----DVFGFGILLLELISG 427
PE ++ ++ + T D++ GI +E+ G
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 68/222 (30%), Positives = 107/222 (48%), Gaps = 30/222 (13%)
Query: 236 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISLAVHR 287
+G+G +G VYK L G VA+K+++ + G EI ++E H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE---HP 61
Query: 288 NLLRLIGFCMT-TTER----LLVYPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGL 340
N++RL+ C T+R LV+ ++ +A+ L KP L T K + RG+
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 341 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 400
+LH I+HRD+K NIL+ + + DFGLA++ + +T+ V T+ + AP
Sbjct: 121 DFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EMALTSVVV-TLWYRAP 175
Query: 401 EYLSTGQSSEKT--DVFGFGILLLELISGLRALEFGKT-ANQ 439
E L QSS T D++ G + EL R L G + A+Q
Sbjct: 176 EVLL--QSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQ 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 72/283 (25%), Positives = 125/283 (44%), Gaps = 39/283 (13%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMIS 282
NF + +GKG F VYK L DG VVA+K+++ D A ++ E++++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLK 57
Query: 283 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL-----KAKPSLDWATRKRIALGAA 337
H N+++ + + E +V G + SR+ K K + T + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG- 396
L ++H + +I+HRD+K AN+ + +GD GL + S TTA VG
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGT 169
Query: 397 --HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 454
+++PE + + K+D++ G LL E+ + L++ +G N + KKI +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM-AALQSPFYGDKMN----LYSLCKKIEKCD 224
Query: 455 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEV 497
L ++ EL ++V C P RP +S V
Sbjct: 225 Y------PPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 69/284 (24%), Positives = 125/284 (44%), Gaps = 37/284 (13%)
Query: 230 SNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR-----LKDGNAIGGEIQFQTEVEMISL 283
+NF + +G+G F VY+ L DG VA+K+ L D A I+ E++++
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQ 58
Query: 284 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARG 339
H N+++ + E +V G ++ + K K + T + +
Sbjct: 59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG--- 396
L ++H + +++HRD+K AN+ + +GD GL + S TTA VG
Sbjct: 119 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPY 171
Query: 397 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456
+++PE + + K+D++ G LL E+ + L++ +G N + KKI Q
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM-AALQSPFYGDKMN----LYSLCKKIEQCDYP 226
Query: 457 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500
+ D +Y EE+ Q+ +C P RP ++ V +
Sbjct: 227 PLPSD-----HYS----EELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 13/196 (6%)
Query: 238 VGKGGFGNVYKGYLQD-GTVVAVKRL---KDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
+G+G +G V+K ++ G +VA+K+ +D I +I + E+ M+ H NL+ LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIALR-EIRMLKQLKHPNLVNLI 66
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKII 352
+ LV+ Y + +V + L+ P + K+I + + + H+ I
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCI 122
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL-STGQSSEK 411
HRDVK NIL+ + + + DFG A++L T V T + APE L Q
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYGPP 181
Query: 412 TDVFGFGILLLELISG 427
DV+ G + EL++G
Sbjct: 182 VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 4e-12
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 30/159 (18%)
Query: 236 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG----------EIQFQTEVEMISLA 284
+G+G + VYK + G +VA+K++K G EI+ E++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK----- 60
Query: 285 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-----KPSLDWATRKRIALGAARG 339
H N++ L+ + LV+ +M + L+ L A K L RG
Sbjct: 61 -HPNIIGLLDVFGHKSNINLVFEFME-----TDLEKVIKDKSIVLTPADIKSYMLMTLRG 114
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378
L YLH I+HRD+K N+L+ + DFGLA+
Sbjct: 115 LEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 51/217 (23%)
Query: 239 GKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
G+G +G V K ++ GT++AVKR++ ++ + LL + M
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIR---------------ATVNSQEQKRLLMDLDISM 54
Query: 298 TTTERLLVYPYM--------SNGSVASRLKA-KPSLDWATRK--------------RIAL 334
+ + PY G V ++ SLD +K +IA+
Sbjct: 55 RSVD----CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV 110
Query: 335 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 394
+ L YLH + +IHRDVK +N+L++ + + DFG++ L DS T G
Sbjct: 111 SIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGC 166
Query: 395 VGHIAPEYLSTGQSSE----KTDVFGFGILLLELISG 427
++APE ++ + + K+DV+ GI ++EL +G
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 69/247 (27%), Positives = 110/247 (44%), Gaps = 45/247 (18%)
Query: 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-----KDGNAIGG--EIQFQTEVEMI 281
+ F N +G+G +G VY+ G +VA+K++ +DG I EI +
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-- 64
Query: 282 SLAVHRNLLRLIGFCMTTTERL----LVYPYMSNGSVASRLKAKPS-LDWATRKRIALGA 336
H N++ L + + L LV Y +AS L P+ + K + L
Sbjct: 65 ----HPNIVELKE--VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQL 117
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 396
RGL YLHE IIHRD+K +N+LL + + DFGLA+ +T V T+
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLW 173
Query: 397 HIAPEYL--STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 454
+ APE L T + D++ G +L EL++ + L GK+ +I Q
Sbjct: 174 YRAPELLLGCTTY-TTAIDMWAVGCILAELLAH-KPLLPGKS------------EIEQ-- 217
Query: 455 KLEMLVD 461
L++++
Sbjct: 218 -LDLIIQ 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 237 LVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI---GGEIQFQTEVEMISLAVHRNLLRL 292
++G+GGFG VY D G + A+K L D I GE E M+SL + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 293 IGFCMT----TTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 347
+ CM+ T ++L + M+ G + L A + A GL ++H +
Sbjct: 60 V--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF 117
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
+++RD+K ANILLDE+ + D GLA H + GT G++APE L G
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 171
Query: 408 SSEKT-DVFGFGILLLELISG 427
+ + + D F G +L +L+ G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 37/208 (17%)
Query: 239 GKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI----------SLA 284
G+G FG V YK G + A+K LK G+ I + EVE + +
Sbjct: 8 GRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARD-----EVESLMCEKRIFETANSE 59
Query: 285 VHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR---GL 340
H L+ L C T + + V Y + G + + D + R AA GL
Sbjct: 60 RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGL 114
Query: 341 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVRGTVGHIA 399
YLHE KI++RD+K N+LLD + DFGL K + D T+ GT +A
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLA 169
Query: 400 PEYLSTGQSSEKTDVFGFGILLLELISG 427
PE L+ + D +G G+L+ E++ G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 238 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR----- 291
+GKG FG V + DG AVK L+ I + E + I RN+L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKA-----ILKKKEQKHI--MAERNVLLKNVKH 55
Query: 292 --LIG--FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 346
L+G + T ++L V Y++ G + L+ + S + A A L YLH
Sbjct: 56 PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVRGTVGHIAPEYLST 405
II+RD+K NILLD V+ DFGL K ++H + T+ GT ++APE L
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRK 170
Query: 406 GQSSEKTDVFGFGILLLELISGL 428
D + G +L E++ GL
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-12
Identities = 64/270 (23%), Positives = 113/270 (41%), Gaps = 29/270 (10%)
Query: 238 VGKGGFGN--VYKGYLQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
+GKG FG +Y+ +D ++V K L + E+ ++SL H N++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDA-LNEIVILSLLQHPNIIAYY 65
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCDPKI 351
M L+ Y + G++ ++ + + + + Y+H+ I
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GI 122
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 411
+HRD+K NI L + +GDFG++K+L S T V GT +++PE + + K
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNFK 181
Query: 412 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471
+D++ G +L EL++ R + N L+ V KI Q +V Y
Sbjct: 182 SDIWALGCVLYELLTLKRTFD---ATNP----LNLVVKIVQ-GNYTPVVSV-----YS-- 226
Query: 472 ELEEMVQVALLCTQYLPSLRPKMSEVVRML 501
E++ + Q P RP EV+
Sbjct: 227 --SELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 397
GL YLH Q +IIHRDVK NI +++ + +GD G A+ + + GTV
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVET 222
Query: 398 IAPEYLSTGQSSEKTDVFGFGILLLELIS 426
APE L+ + + K D++ GI+L E+++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 237 LVGKGGFGNVYKGYLQDGT--VVAVKRLKDGNAIGGEIQFQ--------TEVEMISLAVH 286
++GKG FG V L+ GT V A+K LK ++ Q TE +++LA
Sbjct: 2 VLGKGSFGKVMLAELK-GTDEVYAIKVLKK------DVILQDDDVDCTMTEKRILALAAK 54
Query: 287 RNLLRLIGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 345
L + C T +RL V Y++ G + +++ D + A L++LH
Sbjct: 55 HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 346 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405
+I+RD+K NILLD + DFG+ K + TT GT +IAPE L
Sbjct: 115 H---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 406 GQSSEKTDVFGFGILLLELISG 427
+ D + G+L+ E+++G
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 237 LVGKGGFGNVYKGYLQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
++G+GGFG VY D G + A+K L K GE E M+SL + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 294 GFCMT----TTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 348
CMT T ++L + M+ G + L + A GL ++H +
Sbjct: 61 --CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF- 117
Query: 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 408
+++RD+K ANILLDE+ + D GLA H + GT G++APE L G +
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTA 172
Query: 409 SEKT-DVFGFGILLLELISGLRALEFGKTANQ 439
+ + D F G +L +L+ G KT ++
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 238 VGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
+G G FG V G + G V VK L+ ++ +++F E + H NLL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKAKP-----SLDWATRKRIALGAARGLLYLHEQCDP 349
C T LLV + G + L++ + D T +R+A A GLL+LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT-VGHIAPEYLSTGQS 408
IH D+ N LL +GD+GL+ D +VT + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 409 -------SEKTDVFGFGILLLEL 424
+++++V+ G+ + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 47/178 (26%), Positives = 88/178 (49%), Gaps = 8/178 (4%)
Query: 254 GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER--LLVYPYMSN 311
G VAVK LK + + E+E++ H N+++ G C L+ ++ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 312 GSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 370
GS+ L + K ++ + + A+ +G+ YL + + +HRD+ A N+L++ ++
Sbjct: 93 GSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK 149
Query: 371 VGDFGLAKLLDHCDSHVTTA--VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
+GDFGL K ++ + T + V APE L + +DV+ FG+ L EL++
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 367
+M GS+ K + +IA+ GL YL+ +I+HRD+K +NIL++
Sbjct: 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRG 141
Query: 368 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
+ + DFG++ L +S T V GT +++PE + G+ + K+DV+ GI ++EL G
Sbjct: 142 QIKLCDFGVSGEL--INSIADTFV-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198
Query: 428 LRALEFGKTANQKGA----MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLC 483
F + +LD +++I QE + + +L + V LL
Sbjct: 199 KFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE------DLRDFVDACLLK 252
Query: 484 TQYLPSLRPKMSEVVRM 500
P+ RP ++ M
Sbjct: 253 D---PTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 237 LVGKGGFGNVYKGYLQD-GTVVAVKRLKDG--NAIGGEIQFQTEVEMISLAVHRNLLRLI 293
LVG+G +G V K ++ G +VA+K+ + + + +I + E+ M+ H NL+ LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKII 352
LV+ ++ + +V L+ P+ LD + ++ RG+ + H II
Sbjct: 67 EVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NII 122
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK- 411
HRD+K NIL+ + + DFG A+ L T V T + APE L +
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKYGRA 181
Query: 412 TDVFGFGILLLELISG 427
D++ G L+ E+++G
Sbjct: 182 VDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQDGT--VVAVKRLKDGNAIGGEIQFQTEVE--MISLAVH 286
+F+ ++GKG FG V + GT + A+K LK I + T VE +++L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59
Query: 287 RNLLRLIGFCMTTTERL-LVYPYMSNGSV------ASRLKAKPSLDWATRKRIALGAARG 339
L + C T +RL V Y++ G + R K ++ +A I G
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------G 113
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 399
L +LH + II+RD+K N++LD + DFG+ K + D T GT +IA
Sbjct: 114 LFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFCGTPDYIA 169
Query: 400 PEYLSTGQSSEKTDVFGFGILLLELISG 427
PE ++ + D + FG+LL E+++G
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN- 288
+F+ ++GKG FG V + + A+K LK I + T VE LA+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 289 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 346
L + C T +RL V Y++ G + ++ A + GL +LH +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLST 405
II+RD+K N++LD + DFG+ K +H VTT GT +IAPE ++
Sbjct: 121 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAY 175
Query: 406 GQSSEKTDVFGFGILLLELISG 427
+ D + +G+LL E+++G
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 27/224 (12%)
Query: 226 QSATSNFSS---KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 281
SA + S N +G G G VYK + G + A+K + + Q E+E++
Sbjct: 67 PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126
Query: 282 SLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV-ASRLKAKPSLDWATRKRIALGAARGL 340
H N+++ E ++ +M GS+ + + + L R+ ++ G+
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-----GI 181
Query: 341 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG----LAKLLDHCDSHVTTAVRGTVG 396
YLH + I+HRD+K +N+L++ + DFG LA+ +D C+S V GT+
Sbjct: 182 AYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIA 233
Query: 397 HIAPEYLSTGQSSEK-----TDVFGFGILLLELISGLRALEFGK 435
+++PE ++T + D++ G+ +LE G G+
Sbjct: 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 18/197 (9%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
+G G FG VYK ++ V+A ++ D + + E+++++ H N+++L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 298 TTTERLLVYPYMSNGSV-ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356
++ + + G+V A L+ + L + + L YLHE KIIHRD+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDL 129
Query: 357 KAANILLDEYYEAVVGDFGLA----KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 410
KA NIL + + DFG++ + + DS + GT +APE + S +
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSKDRP 184
Query: 411 ---KTDVFGFGILLLEL 424
K DV+ GI L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 237 LVGKGGFGNVYKG-YLQDGTVVAVKRL-KDGNAIGGE-IQFQTEVEMISLAVHR--NLLR 291
+G G G VYK + + G V+AVK++ + GN + I +V + S H +++
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIVK 78
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKAK-----PSLDWATRKRIALGAARGLLYLHEQ 346
G+ +T ++ + MS + +L + P ++ + + L YL E+
Sbjct: 79 CYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPE---DILGKMTVAIVKALHYLKEK 133
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 406
+IHRDVK +NILLD + DFG++ L DS T G ++APE +
Sbjct: 134 --HGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSAGCAAYMAPERIDPP 189
Query: 407 QSSEK----TDVFGFGILLLELISGL 428
+ K DV+ GI L+EL +G
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 42/113 (37%), Positives = 64/113 (56%), Gaps = 8/113 (7%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL-ETLQYLRLN 82
N + + + L NISG I + I +L + T++LSNN +GPIP + +L+YL L+
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS-----FHAKTFNITGNSLI 130
NN+ TG+IP ++ L LDLS N LSG +P+ K ++ GN L+
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177
|
Length = 968 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 237 LVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQ-FQTEVEMISLAVHRNLLRLI 293
++GKG FG V L+ G AVK LK D I +++ E +++LA L +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 294 GFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
T E L V +++ G + ++ K D A GL +LH + II
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GII 118
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 412
+RD+K N++LD + DFG+ K D+ +T GT +IAPE L + +
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFSV 177
Query: 413 DVFGFGILLLELISG 427
D + FG+LL E++ G
Sbjct: 178 DWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRN 288
F ++GKGGFG V ++ G + A KRL K GE E +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRL--KAKPSLDWATRKRIALGAAR---GLLYL 343
++ L T LV M+ G + + P + +R AA GL L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE---EERALFYAAEILCGLEDL 118
Query: 344 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 403
H + ++RD+K NILLD+Y + D GLA + +S GTVG++APE L
Sbjct: 119 HRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVL 173
Query: 404 STGQSSEKTDVFGFGILLLELISG 427
+ + + D +G G L+ E+I G
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 8/195 (4%)
Query: 237 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVE--MISLAVHRNLLRLI 293
++GKG FG V+ L+ A+K LK + + T VE ++SLA L +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 294 GFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
T E L V Y++ G + +++ D A GL +LH + I+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIV 118
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 412
+RD+K NILLD + DFG+ K D+ T GT +IAPE L + +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNTSV 177
Query: 413 DVFGFGILLLELISG 427
D + FG+LL E++ G
Sbjct: 178 DWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 38/102 (37%), Positives = 55/102 (53%)
Query: 14 LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 73
LSG + + L NL+++ L +NN +G IP + L +L L L +N F+G IP +
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355
Query: 74 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115
L L L+ N+LTG IP L + L L L N+L G +P
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 63/268 (23%), Positives = 113/268 (42%), Gaps = 28/268 (10%)
Query: 237 LVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
++G G FG + +G L+ VA+ L+ G + F E + H N++RL
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
G ++V YMSNG++ S L K + L + G A G+ YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GY 128
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIAPEYLSTGQSS 409
+H+ + A +L++ + F +L + + T + G V APE + S
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 410 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469
+DV+ FGI++ E++S +G+ + D +K + E + ++ N
Sbjct: 187 SASDVWSFGIVMWEVMS------YGERPYWDMSGQDVIKAV--EDGFRLPAPRNCPNLLH 238
Query: 470 RIELEEMVQVALLCTQYLPSLRPKMSEV 497
++ L+ C Q RP+ S++
Sbjct: 239 QLMLD--------CWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 28/225 (12%)
Query: 238 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISLAVHRNL 289
+G+G +G VYK G +VA+K++K G EI+ E+ H N+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN------HPNI 60
Query: 290 LRLIGFCMTTTERLLVYPYM-SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 348
++L+ + LV+ +M ++ + + + L + K +GL + H
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQ 407
I+HRD+K N+L++ + DFGLA+ T T + APE L
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452
S D++ G + EL+S R L GK+ +D + KI +
Sbjct: 176 YSTPVDIWSVGCIFAELLSR-RPLFPGKSE------IDQLFKIFR 213
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 32/107 (29%), Positives = 56/107 (52%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
+ NL+G + + + NL ++L +N++ G IP +G L + L +N F+G +PS
Sbjct: 365 TNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 117
+ L + +L ++NN+L G I +M L L L+ N G +P
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS 471
|
Length = 968 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 43/135 (31%), Positives = 69/135 (51%), Gaps = 14/135 (10%)
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
I CM +M GS+ LK + +I++ RGL YL E+ KI+
Sbjct: 74 ISICME---------HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIM 122
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 412
HRDVK +NIL++ E + DFG++ L DS + V GT +++PE L + ++
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYTVQS 179
Query: 413 DVFGFGILLLELISG 427
D++ G+ L+E+ G
Sbjct: 180 DIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 37/223 (16%)
Query: 235 KNLVGKGGFGNVY-------KGYLQDGT--------VVAVKRLKDGNAIGGEIQFQTEVE 279
K +G+G FG V+ +L +G +VAVK L+ F E++
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 280 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK------------PSLDWA 327
++S + N++RL+G C++ ++ YM NG + L + PS+ A
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 328 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387
+A+ A G+ YL +HRD+ N L+ +Y + DFG+++ L D +
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY- 185
Query: 388 TTAVRG----TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
++G + +A E + G+ + +DV+ FG+ L E+ +
Sbjct: 186 --RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQT---------EV 278
T+ + VG G FG V Q G VA+K++ F T E+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK--------PFSTPVLAKRTYREL 60
Query: 279 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR 338
+++ H N++ L ++ E + + + L ++P L+ + R
Sbjct: 61 KLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQILR 119
Query: 339 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 398
GL Y+H ++HRD+K +NIL++E + + DFGLA++ D +T V T +
Sbjct: 120 GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP---QMTGYV-STRYYR 172
Query: 399 APEYLSTGQS-SEKTDVFGFGILLLELISG 427
APE + T Q + D++ G + E++ G
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 7/194 (3%)
Query: 238 VGKGGFGNVYKGYLQDGT-VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGF 295
+GKG FG V + +D + A+K ++ + + T E LA V+ + + F
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 296 CMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
+ E+L LV +++ G + L+ + D +R R A L L +I+R
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFD-LSRARFY--TAELLCALENLHKFNVIYR 117
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 414
D+K NILLD + DFGL K L+ D T GT ++APE L ++ D
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176
Query: 415 FGFGILLLELISGL 428
+ G+LL E+++GL
Sbjct: 177 WTLGVLLYEMLTGL 190
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 37/232 (15%)
Query: 238 VGKGGFGNVYKG--YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---------- 285
+G+G +G V+K G VA+KR ++ QT E + L+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKR----------VRVQTGEEGMPLSTIREVAVLRHL 58
Query: 286 ----HRNLLRLIGFCMTT-----TERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALG 335
H N++RL C + T+ LV+ ++ K +P + T K +
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 336 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 395
RGL +LH +++HRD+K NIL+ + + DFGLA++ T+V T+
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTL 173
Query: 396 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 447
+ APE L + D++ G + E+ +Q G +LD +
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 8/196 (4%)
Query: 237 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRLI 293
++GKG FG V + DG AVK L+ + + Q E ++ V L +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 294 GFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
+ TTE+L V +++ G + L+ + S + A A L YLH I+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIV 118
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 412
+RD+K NILLD V+ DFGL K S TT GT ++APE +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 413 DVFGFGILLLELISGL 428
D + G +L E++ GL
Sbjct: 178 DWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 40/120 (33%), Positives = 66/120 (55%), Gaps = 5/120 (4%)
Query: 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 367
+M GS+ LK + ++++ RGL YL E+ +I+HRDVK +NIL++
Sbjct: 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRG 141
Query: 368 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
E + DFG++ L DS + V GT +++PE L S ++D++ G+ L+EL G
Sbjct: 142 EIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 231 NFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISL-A 284
NF ++G G +G V+ G G + A+K LK + + T E L A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 285 VHRN--LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA-ARGLL 341
V R L+ L T T+ L+ Y++ G + + L + + R+ + L
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIAEIVLALD 119
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 401
+LH+ II+RD+K NILLD V+ DFGL+K + + GT+ ++APE
Sbjct: 120 HLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 402 YLSTGQS--SEKTDVFGFGILLLELISG 427
+ G + D + G+L EL++G
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 12/203 (5%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQDGT--VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 288
+F+ ++GKG FG V + GT + A+K LK I + T VE LA+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 289 --LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 345
L + C T +RL V Y++ G + ++ A A GL +LH
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 346 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLS 404
+ II+RD+K N++LD + DFG+ K ++ TT GT +IAPE ++
Sbjct: 120 K---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIA 174
Query: 405 TGQSSEKTDVFGFGILLLELISG 427
+ D + FG+LL E+++G
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 66/287 (22%)
Query: 238 VGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLR---- 291
VGKG +G V + DG +K+L NA E + + E +++S H N++
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 292 ----------LIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--------LDWATRKRIA 333
++GFC G + +LK + ++W +
Sbjct: 68 WEGEDGLLYIVMGFC-------------EGGDLYHKLKEQKGKLLPENQVVEWFVQ---- 110
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVR 392
A L YLHE+ I+HRD+K N+ L VGD G+A++L+ CD + + +
Sbjct: 111 --IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLI 163
Query: 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452
GT +++PE S + K+DV+ G + E+ + A N K M V +I +
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF------NAKD-MNSLVYRIIE 216
Query: 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499
K M D Y EL E++ +L + P RP + ++R
Sbjct: 217 GKLPPMPKD------YSP-ELGELIA-TMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 21/197 (10%)
Query: 238 VGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
VG G +G+VYK L G + AVK +L+ G+ Q E+ M+ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS---LIQQEIFMVKECKHCNIVAYFG 73
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
++ + + Y GS+ L + +GL YLH + +HR
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHR 130
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAPEYLS---TGQ 407
D+K ANILL + + + DFG+A + T A R GT +APE + G
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKIT-----ATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 408 SSEKTDVFGFGILLLEL 424
++ D++ GI +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 62/227 (27%), Positives = 110/227 (48%), Gaps = 46/227 (20%)
Query: 237 LVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVHRNLL 290
L+GKGG G VY Y D VA+K++++ + + +F E ++ + +H ++
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIRE-DLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 291 RLIGFCMTTTERLLVY---PYMSNGSVASRLKA---KPSLDWATRKRIALGA-------- 336
+ C ++ VY PY+ ++ S LK+ K SL ++ ++GA
Sbjct: 66 PVYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK--------LLD------- 381
+ Y+H + ++HRD+K NILL + E V+ D+G A LLD
Sbjct: 123 CATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 382 HCDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
C S +T + GT ++APE L +SE TD++ G++L ++++
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 238 VGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV---HRNLLRL 292
+G G +G VYK G VA+K ++ N G + EV ++ H N++RL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 293 IGFCMTT-----TERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQ 346
+ C T+ T+ LV+ ++ K P L T K + RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 406
C I+HRD+K NIL+ + + DFGLA++ C +T V T+ + APE L
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMALTPVVV-TLWYRAPEVLLQS 182
Query: 407 QSSEKTDVFGFGILLLEL 424
+ D++ G + E+
Sbjct: 183 TYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 3e-10
Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 48/220 (21%)
Query: 235 KNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EVEMISLA 284
+G G +G V + G VA+K++ N F E++++
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNV------FDDLIDAKRILREIKLLRHL 56
Query: 285 VHRNLLRLIGFCMTTTERL------LVYPYMSN--GSVASRLKAKPSLDWATRKRIALGA 336
H N++ L+ + +V M V +K+ L +
Sbjct: 57 RHENIIGLLDI-LRPPSPEDFNDVYIVTELMETDLHKV---IKSPQPLTDDHIQYFLYQI 112
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--------VT 388
RGL YLH +IHRD+K +NIL++ + + DFGLA+ +D + VT
Sbjct: 113 LRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169
Query: 389 TAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 427
R APE LS+ + ++ D++ G + EL++
Sbjct: 170 RWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 237 LVGKGGFGNVYKGYLQDGT-VVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRL 292
++GKG FG V L+ A+K LK + + T VE LA+ H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 293 IGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
FC T+ L V Y++ G + +++ D A + A GL +LH++
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---G 116
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 410
II+RD+K N+LLD+ + DFG+ K + + +T GT +IAPE L + +E
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYNE 175
Query: 411 KTDVFGFGILLLELISG 427
D + FG+LL E++ G
Sbjct: 176 SVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 6/196 (3%)
Query: 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 296
+G+G + VYKG + +G +VA+K ++ G E ++ H N++ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 297 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356
T LV+ Y+ K L K RGL Y+H++ I+HRD+
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDL 129
Query: 357 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDVF 415
K N+L+ + E + DFGLA+ SH + T+ + P+ L + + S D++
Sbjct: 130 KPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMW 188
Query: 416 GFGILLLELISGLRAL 431
G G + +E+I G+ A
Sbjct: 189 GVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 14/229 (6%)
Query: 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRN 288
F ++GKGGFG V ++ G + A K+L K GE E +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR---GLLYLHE 345
++ L T LV M+ G + + + R AA GL LH+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDLHQ 120
Query: 346 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLS 404
+ +I++RD+K NILLD++ + D GLA H T R GTVG++APE +
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVK 174
Query: 405 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 453
+ + D + G LL E+I+G + K ++ + VK++ +E
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRL-------KDGNAIG-GEIQFQTEVE--- 279
F ++GKGGFG V ++ G + A K+L + G A+ E Q +V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 280 MISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLK--AKPSLDWATRKRIALGA 336
++SLA + T + L LV M+ G + + P D +R A
Sbjct: 62 VVSLA----------YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYA 108
Query: 337 AR---GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 393
A GL LH + +I++RD+K NILLD+Y + D GLA + + G
Sbjct: 109 AEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP--EGETIRGRVG 163
Query: 394 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
TVG++APE + + + D +G G L+ E+I G
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 238 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF- 295
+GKG +G V+K ++G+ AVK L + I EI+ + + + +L+ H N+++ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDHPNVVKFYGMY 84
Query: 296 ----CMTTTERLLVYPYMSNGSVASR----LKAKPSLDWATRKRIALGAARGLLYLHEQC 347
+ LV + GSV LK ++ I A GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
K IHRDVK NILL + DFG++ L T+V GT +APE ++ Q
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 200
Query: 408 S-----SEKTDVFGFGILLLELISG 427
+ DV+ GI +EL G
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 10/195 (5%)
Query: 238 VGKGGFGNVYKGYLQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
+GKGGFG V +++ G + A K+L K GE E E++ ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKII 352
+ T LV M+ G + + + I A G+L+LH I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIV 117
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 412
+RD+K N+LLD+ + D GLA L D T GT G++APE L S
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 413 DVFGFGILLLELISG 427
D F G + E+++G
Sbjct: 176 DWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 237 LVGKGGFGNVY---KGYLQD-GTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLR 291
++G+G FG V+ K D G + A+K LK + ++ + E ++++ H +++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
L T + L+ ++ G + +RL + K A L +LH I
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GI 119
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 410
I+RD+K NILLDE + DFGL+K +DH + GTV ++APE ++ ++
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQ 177
Query: 411 KTDVFGFGILLLELISGLRALEF-GKTANQKGAML 444
D + FG+L+ E+++G +L F GK + M+
Sbjct: 178 SADWWSFGVLMFEMLTG--SLPFQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 18/197 (9%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
+G G FG VYK ++ +A ++ + + + E+E+++ H +++L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 298 TTTERLLVYPYMSNGSV-ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356
+ ++ + G+V A L+ L + I L YLH KIIHRD+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDL 136
Query: 357 KAANILLDEYYEAVVGDFGLA----KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 410
KA N+LL + + DFG++ K L DS + GT +APE + +
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMKDTP 191
Query: 411 ---KTDVFGFGILLLEL 424
K D++ GI L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 17/199 (8%)
Query: 252 QDGTVVAVKRLKDGNAIGGEIQ---FQTEVEMISLAVHRNLLRLIGFCMTTTERLL-VYP 307
G VA+K L+ +A E Q F+ E + + H N++ L+ L V+
Sbjct: 1 MTGHEVAIKLLRT-DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFE 59
Query: 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---D 364
Y+ ++ L A +L R+ L L H Q I+HRD+K NI++
Sbjct: 60 YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116
Query: 365 EYYEAVVGDFGLAKLL-DHCDSHVTTAVR-----GTVGHIAPEYLSTGQSSEKTDVFGFG 418
A V DFG+ LL D+ V T R GT + APE L + +D++ +G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 419 ILLLELISGLRALEFGKTA 437
++ LE ++G R ++ A
Sbjct: 177 LIFLECLTGQRVVQGASVA 195
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 9e-10
Identities = 70/278 (25%), Positives = 113/278 (40%), Gaps = 37/278 (13%)
Query: 238 VGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+G+G F ++KG ++ T V +K L + E F M+S H++L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSE-SFFEAASMMSQLSHKHL 61
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY-LHEQCD 348
+ G C+ E ++V Y+ GS+ + LK +L + K L A+ L + LH D
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK---LEVAKQLAWALHFLED 118
Query: 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLST 405
+ H +V A N+LL + G+ KL D S + I PE +
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIEN 178
Query: 406 GQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH-QEKKLEMLVDKD 463
Q+ S D + FG L E+ SG ++ + LD KK+ E + ++ K
Sbjct: 179 PQNLSLAADKWSFGTTLWEIFSG---------GDKPLSALDSQKKLQFYEDRHQLPAPK- 228
Query: 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501
EL ++ C Y P RP ++R L
Sbjct: 229 ------WTELANLINQ---CMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 36/214 (16%)
Query: 232 FSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQT---------EVEMI 281
+ + + VG G +G V + G VA+K+L FQ+ E+ ++
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR--------PFQSAIHAKRTYRELRLL 68
Query: 282 SLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKRIAL 334
H N++ L+ T L LV M G+ + + L + +
Sbjct: 69 KHMDHENVIGLLD-VFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVY 125
Query: 335 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 394
RGL Y+H IIHRD+K +NI ++E E + DFGLA+ H D +T V T
Sbjct: 126 QILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYV-AT 178
Query: 395 VGHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 427
+ APE L+ ++ D++ G ++ EL++G
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 17/175 (9%)
Query: 260 KRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL--------IGFCMTTTERLLVYPYMSN 311
KR+K G+ IQ + E+ + H N+L++ + +T +Y +M +
Sbjct: 198 KRVKAGSRAA--IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255
Query: 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV 371
A K +P L TR I + Y+H D K+IHRD+K NI L+ + V+
Sbjct: 256 E--AFDWKDRPLL-KQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVL 308
Query: 372 GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
GDFG A + GTV +PE L+ E TD++ G++LL+++S
Sbjct: 309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 59/198 (29%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 237 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVE---MISLAVHRNLLRL 292
++GKG FG V + DG+ AVK L+ + + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 293 IGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
+ T E+L V Y++ G + L+ + + A A + YLH I
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NI 117
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLSTGQSSE 410
I+RD+K NILLD V+ DFGL K + + TT+ GT ++APE L
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 411 KTDVFGFGILLLELISGL 428
D + G +L E++ GL
Sbjct: 176 TVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 237 LVGKGGFGNVYKGYLQDG--TVVAVKRLKDGNAIGGEIQFQ---------TEVEMISLAV 285
+G G FG VYK ++ ++A+K + N G+ + + +EV +I +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 286 -HRNLLRLIGFCMTTTERLLVYPYM------SNGSVASRLKAK-----PSLDWATRKRIA 333
H N++R + T E +Y M G + LK K W ++
Sbjct: 67 RHPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 393
L L YLH++ +I+HRD+ NI+L E + + DFGLAK +S +T+ V G
Sbjct: 124 LA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-ESKLTSVV-G 175
Query: 394 TVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 424
T+ + PE + EK DV+ FG +L ++
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 39/120 (32%), Positives = 66/120 (55%), Gaps = 5/120 (4%)
Query: 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 367
+M GS+ LK + ++++ +GL YL E+ KI+HRDVK +NIL++
Sbjct: 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRG 141
Query: 368 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
E + DFG++ L DS + V GT +++PE L S ++D++ G+ L+E+ G
Sbjct: 142 EIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 37/105 (35%), Positives = 57/105 (54%), Gaps = 12/105 (11%)
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL-----DHCDSHVTTAVR 392
RGL Y+H +IHRD+K +N+L++E E +GDFG+A+ L +H +T V
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK-YFMTEYV- 172
Query: 393 GTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 436
T + APE LS + + D++ G + E++ G R L GK
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKN 216
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 39/214 (18%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQF-----------QTEVE 279
+ +G+G FG +Y +A + + + EI + EV
Sbjct: 1 RYEIIKKIGEGSFGKIY---------LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVI 51
Query: 280 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--------LDWATRKR 331
+++ H N++ +V Y G + R+ + L W +
Sbjct: 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ-- 109
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLDHCDSHVTTA 390
I+LG L ++H D KI+HRD+K+ NI L + A +GDFG+A+ L+ T
Sbjct: 110 ISLG----LKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC 162
Query: 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 424
V GT +++PE + KTD++ G +L EL
Sbjct: 163 V-GTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 30/168 (17%)
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHI 398
LL +H +IHRD+K+ANILL +GDFG +K+ S V GT ++
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 399 APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458
APE S+K D+F G+LL EL++ +K+ + +E
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLT--------------------LKRPFDGENMEE 252
Query: 459 LVDKDLKNNYDRI------ELEEMVQVALLCTQYLPSLRPKMSEVVRM 500
++ K L YD + E++E+V ALL + P RP S+++ M
Sbjct: 253 VMHKTLAGRYDPLPPSISPEMQEIVT-ALLSSD--PKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 40/115 (34%), Positives = 60/115 (52%), Gaps = 4/115 (3%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
S N +L S + NL NL+ + L N++S +P + LS L LDLS N + +P +
Sbjct: 148 SDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEI 205
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNIT 125
L L+ L L+NNS+ + SLSN+ L+ L+LS NN +P N+
Sbjct: 206 ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS-NNKLEDLPESIGNLSNLE 258
|
Length = 394 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 42/277 (15%)
Query: 238 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-------HRNL 289
+G+G G VY + G VA+K++ +Q Q + E+I + H N+
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMN--------LQQQPKKELIINEILVMRENKHPNI 78
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 349
+ + + E +V Y++ GS+ + + + +D + + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 134
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 409
++IHRD+K+ NILL + DFG + S +T V GT +APE ++
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 410 EKTDVFGFGILLLELISG---------LRALEF----GKTANQKGAMLDWVKKIHQEKKL 456
K D++ GI+ +E++ G LRAL G Q L + + + L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 253
Query: 457 EMLVDKDLKNNYDRIELEEMVQVALL-CTQYLPSLRP 492
EM V+K R +E++Q L + L SL P
Sbjct: 254 EMDVEK-------RGSAKELLQHPFLKIAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRN 288
F ++GKGGFG V ++ G + A K+L K GE E ++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 289 LLRLIGFCMTTTERL-LVYPYMSNGSVASRL--KAKPSLDWATRKRIALGAAR---GLLY 342
++ L + T + L LV M+ G + + P D +R AA GL
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD---EQRAIFYAAELCCGLED 117
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 402
L + +I++RD+K NILLD+ + D GLA + + GTVG++APE
Sbjct: 118 LQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETVRGRVGTVGYMAPEV 172
Query: 403 LSTGQSSEKTDVFGFGILLLELISG 427
++ + + D +G G L+ E+I G
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 245 NVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304
NV KG +VAVK L+ F EV+++S N++RL+G C+ +
Sbjct: 40 NVRKGR---PLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCM 96
Query: 305 VYPYMSNGSVASRLKAK-------------------PSLDWATRKRIALGAARGLLYLHE 345
+ YM NG + L + P++ +++ +AL A G+ YL
Sbjct: 97 ITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156
Query: 346 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG----TVGHIAPE 401
+HRD+ N L+ E + DFG+++ L D + ++G + +A E
Sbjct: 157 L---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWE 210
Query: 402 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK 440
+ G+ + +DV+ FG+ L E++ + +G+ +++
Sbjct: 211 CILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 32/209 (15%)
Query: 238 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQT--------EVE-MISLAVHR 287
+G G FG+VY + G +VA+K++K +F + EV+ + L H
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKK--------KFYSWEECMNLREVKSLRKLNEHP 58
Query: 288 NLLRLIGFCMTTTERLLVYPYMSN---GSVASRLKAKPSLDWATRKRIALGAARGLLYLH 344
N+++L E V+ YM + R K KP + + I +GL ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDR-KGKP-FSESVIRSIIYQILQGLAHIH 116
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL- 403
+ HRD+K N+L+ + DFGLA+ + + T V T + APE L
Sbjct: 117 KH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILL 171
Query: 404 -STGQSSEKTDVFGFGILLLELISGLRAL 431
ST SS D++ G ++ EL + LR L
Sbjct: 172 RSTSYSS-PVDIWALGCIMAELYT-LRPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 64/204 (31%), Positives = 88/204 (43%), Gaps = 27/204 (13%)
Query: 238 VGKGGFGNVY------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VH-RNL 289
+GKGGFG V G L + KRLK G + VE LA VH R +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAM-----VEKRILAKVHSRFI 55
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAAR---GLLY 342
+ L T T+ LV M+ G + + + P R A+ GL +
Sbjct: 56 VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP---EPRACFYTAQIISGLEH 112
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 402
LH++ +II+RD+K N+LLD + D GLA L S T GT G +APE
Sbjct: 113 LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPEL 168
Query: 403 LSTGQSSEKTDVFGFGILLLELIS 426
L + D F G+ L E+I+
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIA 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 27/158 (17%)
Query: 238 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGF 295
+G+G FG V+K + + +VA+K++ N G I E++++ L H N++ LI
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 296 CMTTTERLLVYPYMSNGSVAS-------------RLKAKPSLDW--ATRKRIALGAARGL 340
C T N S L + ++ + + K++ GL
Sbjct: 80 CRTK-------ATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGL 132
Query: 341 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378
Y+H KI+HRD+KAANIL+ + + DFGLA+
Sbjct: 133 YYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 6e-09
Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 14/139 (10%)
Query: 339 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 398
L ++H D KI+HRD+K+ NI L + +GDFG+A++L+ T + GT ++
Sbjct: 113 ALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYL 168
Query: 399 APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK------KIHQ 452
+PE + K+D++ G +L E+ + A E G N K +L ++ H
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKIIRGSYPPVSSHY 225
Query: 453 EKKLEMLVDKDLKNNY-DR 470
L LV + K N DR
Sbjct: 226 SYDLRNLVSQLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 237 LVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLI 293
++GKG FG V + + AVK L+ + E +E ++ V L +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 294 GFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
F T ++L V Y++ G + L+ + + A A L YLH I+
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIV 118
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLSTGQSSEK 411
+RD+K NILLD V+ DFGL K ++ + + TT+ GT ++APE L
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 412 TDVFGFGILLLELISGL 428
D + G +L E++ GL
Sbjct: 177 VDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 9/206 (4%)
Query: 238 VGKGGFGNVYKGY--LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295
+G+G + VYKG L D +VA+K ++ + G EV ++ H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 296 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 355
T LV+ Y+ S++ K RGL Y H + K++HRD
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRD 129
Query: 356 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDV 414
+K N+L++E E + DFGLA+ + V T+ + P+ L + S + D+
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDM 188
Query: 415 FGFGILLLELISGLRALEFGKTANQK 440
+G G + E+ +G R L G T ++
Sbjct: 189 WGVGCIFYEMSTG-RPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 20/164 (12%)
Query: 276 TEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL- 334
TE ++ H ++++L G L+ P R K A ++ IA+
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILP---------RYKTDLYCYLAAKRNIAIC 182
Query: 335 -------GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387
R + YLHE +IIHRD+KA NI ++ + +GDFG A +++
Sbjct: 183 DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239
Query: 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRAL 431
GT+ APE L+ D++ GI+L E+ + +L
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 54/229 (23%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 224 ELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTE 277
E+ +T F + +G+ FG VYKG+L + VA+K LKD +F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 278 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN----------------GSVASRLKAK 321
M S H N++ L+G +++ Y S+ GS K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 322 PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381
+L+ A I A G+ +L ++H+D+ N+L+ + + D GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 382 HCDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
D + + G + ++PE + G+ S +D++ +G++L E+ S
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 231 NFSSKNLVGKGGFGNVY-----KGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMIS 282
NF ++G G +G V+ G+ G + A+K LK + +TE +++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 283 LAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 341
L + + T +L L+ Y++ G + + L + + + + + +L
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF---KEQEVQIYSGEIVL 116
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 401
L II+RD+K NILLD V+ DFGL+K + + GT+ ++AP+
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176
Query: 402 YLSTGQS--SEKTDVFGFGILLLELISG 427
+ G + D + G+L+ EL++G
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 288
+ N + +G +G VY+ + G +VA+K+LK + G I E+ ++ H N
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65
Query: 289 LLRLIGFCMTTTER--LLVYPYMSNGSVASRLKA-----KPSLDWATRKRIALGAARGLL 341
++ + + + +V Y+ + LK+ K + K + L G+
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVEH-----DLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 401
+LH+ I+HRD+K +N+LL+ + DFGLA+ T V T+ + APE
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPE 176
Query: 402 -YLSTGQSSEKTDVFGFGILLLELISG 427
L + S D++ G + EL++
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 50/187 (26%), Positives = 87/187 (46%), Gaps = 8/187 (4%)
Query: 275 QTEVEMISLAVHRNLLRLIGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIA 333
QTE + A + L + C T RL V Y++ G + ++ + L + +
Sbjct: 43 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 102
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVR 392
+ L YLHE+ II+RD+K N+LLD + D+G+ K L D+ T+
Sbjct: 103 AEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFC 157
Query: 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF-GKTANQKGAMLDWVKKIH 451
GT +IAPE L D + G+L+ E+++G + G + N D++ ++
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217
Query: 452 QEKKLEM 458
EK++ +
Sbjct: 218 LEKQIRI 224
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
NF +G+G + VYKG + G +VA+K + G E+ ++ H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLK-------AKPSLDWATRKRIALGAARGLLY 342
+RL T + +LV+ YM LK + +LD T K +G+ +
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-----LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 402
HE +++HRD+K N+L+++ E + DFGLA+ + + V T+ + AP+
Sbjct: 116 CHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171
Query: 403 LSTGQS-SEKTDVFGFGILLLELISGL 428
L ++ S D++ G ++ E+I+G
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 32/166 (19%)
Query: 238 VGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA---VHRNLLR 291
+G+G +G VYK + DG A+K+ K I Q+ I+L H N++
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS-QSACREIALLRELKHENVVS 66
Query: 292 LIGFCMTTTERL--LVYPYMSNGSVAS----------RLKAKPSLDWATRKRIALGAARG 339
L+ + ++ L++ Y A R + S+ + K + G
Sbjct: 67 LVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 340 LLYLHEQCDPKIIHRDVKAANILL--DEYYEAVV--GDFGLAKLLD 381
+ YLH ++HRD+K ANIL+ + VV GD GLA+L +
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 1e-08
Identities = 72/277 (25%), Positives = 120/277 (43%), Gaps = 42/277 (15%)
Query: 238 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI--SLAVHR-----NL 289
+G+G G VY + G VA+K++ +Q Q + E+I + V R N+
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMN--------LQQQPKKELIINEILVMRENKNPNI 78
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 349
+ + + E +V Y++ GS+ + + + +D + + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALDFLHSN--- 134
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 409
++IHRD+K+ NILL + DFG + S +T V GT +APE ++
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 410 EKTDVFGFGILLLELISG---------LRALEF----GKTANQKGAMLDWVKKIHQEKKL 456
K D++ GI+ +E++ G LRAL G Q L V + + L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253
Query: 457 EMLVDKDLKNNYDRIELEEMVQVALL-CTQYLPSLRP 492
EM VD+ R +E++Q L + L SL P
Sbjct: 254 EMDVDR-------RGSAKELLQHPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIG--GEIQFQTEVEMISLA 284
+ VG G FG V+ ++D A+K + I E E ++
Sbjct: 1 DDLERIKTVGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV 58
Query: 285 VHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 342
H ++RL F +R L + Y+ G + S L+ +T A L Y
Sbjct: 59 SHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEY 116
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPE 401
LH + +I++RD+K NILLD+ + DFG AK L D T + GT ++APE
Sbjct: 117 LHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPE 168
Query: 402 YLSTGQSSEKTDVFGFGILLLELISG 427
+ + ++ D + GIL+ E++ G
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR---NLLRLI 293
+ KG FG+VY + G A+K LK + I + E + + + +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 294 GFCMTTTERL-LVYPYMSNGSVASRLKAKPSL--DWATRKRIALGAARGLLYLHEQCDPK 350
+ + + L LV Y++ G AS +K L DWA K+ G+ LH++
Sbjct: 64 -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWA--KQYIAEVVLGVEDLHQR---G 117
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 410
IIHRD+K N+L+D+ + DFGL++ GT ++APE + +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDK 172
Query: 411 KTDVFGFGILLLELISGLRALE 432
+D + G ++ E + G
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 54/236 (22%), Positives = 108/236 (45%), Gaps = 28/236 (11%)
Query: 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISL 283
+NF + +G+G F VY+ L D VA+K+++ D A ++ E++++
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQ 58
Query: 284 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARG 339
H N+++ + + E +V G ++ + K K + T + +
Sbjct: 59 LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG--- 396
+ ++H + +++HRD+K AN+ + +GD GL + S TTA VG
Sbjct: 119 VEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPY 171
Query: 397 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452
+++PE + + K+D++ G LL E+ + L++ +G N + +KI Q
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM-AALQSPFYGDKMN----LFSLCQKIEQ 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 32/212 (15%)
Query: 230 SNFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISL 283
+F +G G FG V +K G A+K L + E ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 284 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLL 341
H L+ L G + LV Y+ G + S L+ + A AA+ +L
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR-----FYAAQVVL 112
Query: 342 ---YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 398
YLH I++RD+K N+LLD + DFG AK + T + GT ++
Sbjct: 113 ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK----GRTYTLCGTPEYL 165
Query: 399 APEYLST---GQSSEKTDVFGFGILLLELISG 427
APE + + G++ D + GIL+ E+++G
Sbjct: 166 APEIILSKGYGKAV---DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 34/221 (15%)
Query: 236 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGE------------IQFQT--EVEM 280
+G+G +G V K Y G +VA+K++K I + I F T E+++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKI-IEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 281 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 340
++ H N++ L+ + LV M+ + + K L + K I L GL
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 341 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK------LLDHCDSHVTTAVRG- 393
LH+ +HRD+ ANI ++ + DFGLA+ D T R
Sbjct: 133 NVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 394 ------TVGHIAPEYL-STGQSSEKTDVFGFGILLLELISG 427
T+ + APE L + D++ G + EL++G
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 231 NFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMISL 283
NF ++G G +G V+ G + A+K L+ + +TE ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 284 AVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 342
L + + T +L L+ Y+S G + + L + D + + + +L
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILA 117
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 402
L I++RD+K NILLD V+ DFGL+K + T + GT+ ++APE
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 403 L-STGQSSEKTDVFGFGILLLELISG 427
+ G + D + GIL+ EL++G
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 223 KELQSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAI--GGEIQFQTEVE 279
++LQ ++ ++G+G FG V + V A+K L I F E +
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 280 MISLAVHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLD-WATRKRIALGA 336
+++ A +++L FC ++ L V YM G + + + + WA
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK-----FYT 148
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-----HCDSHVTTAV 391
A +L L +IHRDVK N+LLD++ + DFG +D CD+ V
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV---- 204
Query: 392 RGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELISG 427
GT +I+PE L + G + D + G+ L E++ G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 7/155 (4%)
Query: 275 QTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIA 333
QTE + A L + C TT RL LV Y++ G + ++ + L + A
Sbjct: 43 QTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYA 102
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVR 392
L +LHE+ II+RD+K N+LLD + D+G+ K L D+ T+
Sbjct: 103 AEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFC 157
Query: 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
GT +IAPE L + D + G+L+ E+++G
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 296
+G+G + V+KG + +VA+K ++ + G EV ++ H N++ L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 297 MTTTERLLVYPYMSN---------GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 347
T LV+ Y+ G++ S K L RGL Y H +
Sbjct: 74 HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL---------YQILRGLAYCHRR- 123
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTG 406
K++HRD+K N+L++E E + DFGLA+ + V T+ + P+ L +
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180
Query: 407 QSSEKTDVFGFGILLLELISGLRALEFGKT 436
+ S + D++G G + E+ SG R L G T
Sbjct: 181 EYSTQIDMWGVGCIFFEMASG-RPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 32/205 (15%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GE------IQFQTEVEMIS-------L 283
+GKG FG VY ++D VA +RLK I GE +Q E +++S +
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 284 AVHRNLLRLIGFCMTTT---ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 340
H + L FC+ T R L L +W + + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GV 119
Query: 341 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTAVRGTVGHIA 399
Y+H++ +I+HRD+KA NI L +GDFG+++LL CD + T GT +++
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD--LATTFTGTPYYMS 173
Query: 400 PEYLSTGQSSEKTDVFGFGILLLEL 424
PE L K+D++ G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 25/204 (12%)
Query: 238 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR----- 291
+GKG FG VY+ +D + A+K L EI + EV RN+L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK-----KEIVAKKEVA--HTIGERNILVRTLLD 53
Query: 292 ----LIGF---CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 344
++G T ++ LV YMS G + L+ + R A +L L
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALE 110
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 404
I++RD+K NILLD + DFGL+K + D+ T GT ++APE L
Sbjct: 111 HLHKYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 405 TGQSSEK-TDVFGFGILLLELISG 427
+ K D + G+L+ E+ G
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 14/196 (7%)
Query: 238 VGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRLIG 294
+G GGFG V A+K +K + + Q +E E++ H +++L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 295 FCMTTTERLLVY---PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
T ++ +Y Y G + + L+ + D T + YLH + I
Sbjct: 60 --RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GI 114
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 411
I+RD+K N+LLD + DFG AK L T GT ++APE +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLK--SGQKTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 412 TDVFGFGILLLELISG 427
D + GILL EL++G
Sbjct: 173 VDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 52/226 (23%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 203 DVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKR 261
++ E+ R V +G+ K+ ++ +G+G G V+ + G VA+K+
Sbjct: 3 EIMEKLRTIVSIGDPKK-----------KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQ 51
Query: 262 LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK 321
+ E+ + M L + N++ + + E +V Y++ GS+ + + +
Sbjct: 52 INLQKQPKKELIINEILVMKELK-NPNIVNFLDSFLVGDELFVVMEYLAGGSL-TDVVTE 109
Query: 322 PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381
+D A + + L +LH ++IHRD+K+ N+LL + DFG +
Sbjct: 110 TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166
Query: 382 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
S +T V GT +APE ++ K D++ GI+ +E++ G
Sbjct: 167 PEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 4/86 (4%)
Query: 339 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 398
G+ ++HE+ +++HRD+K+ NI L + + +GDFG A+LL ++ T V GT ++
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 399 APEYLSTGQSSEKTDVFGFGILLLEL 424
PE + K+D++ G +L EL
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 7/205 (3%)
Query: 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 296
+G+G + V+KG + +VA+K ++ + G EV ++ H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 297 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356
T LV+ Y+ + + K RGL Y H++ KI+HRD+
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDL 129
Query: 357 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDVF 415
K N+L++E E + DFGLA+ + V T+ + P+ L + + S D++
Sbjct: 130 KPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMW 188
Query: 416 GFGILLLELISGLRALEFGKTANQK 440
G G +L E+ +G R + G T ++
Sbjct: 189 GVGCILYEMATG-RPMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 45/186 (24%), Positives = 91/186 (48%), Gaps = 21/186 (11%)
Query: 256 VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV- 314
+VAVK L++ F E++++S N++RL+ C+T+ ++ YM NG +
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 315 --ASRLKAK--------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 364
SR + + ++ ++T +A A G+ YL +HRD+ N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVG 164
Query: 365 EYYEAVVGDFGLAKLLDHCDSHVTTAVRG----TVGHIAPEYLSTGQSSEKTDVFGFGIL 420
+ Y + DFG+++ L D + ++G + ++ E + G+ + +DV+ FG+
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 421 LLELIS 426
L E+++
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 4/106 (3%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
S N L I L+ L+ + L NN+I + + + L L L+LSNN +P ++
Sbjct: 194 SGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESI 251
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
+L L+ L L+NN ++ SL +++ L LDLS N+LS +P
Sbjct: 252 GNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPL 295
|
Length = 394 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 227 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
+ATS + + L G+G + VYKG + +G +VA+K + G E ++
Sbjct: 3 AATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61
Query: 286 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLH 344
H N++ L T V+ YM +A + P L + RGL Y+H
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH 120
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAPEYL 403
Q I+HRD+K N+L+ E + DFGLA+ ++ + V T+ + P+ L
Sbjct: 121 GQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVL 175
Query: 404 --STGQSSEKTDVFGFGILLLELISG 427
+T SS D++G G + +E++ G
Sbjct: 176 LGATDYSSA-LDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 7/194 (3%)
Query: 237 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIG 294
L+GKG FG V + G A+K LK I + T E L R+ L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 295 FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
+ T +RL V Y++ G + L + + L YLH KI++
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVY 118
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 413
RD+K N++LD+ + DFGL K D+ GT ++APE L D
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 414 VFGFGILLLELISG 427
+G G+++ E++ G
Sbjct: 178 WWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 26/235 (11%)
Query: 232 FSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNL 289
F +G+G +G VYK +D G +VA+K+++ D G I E++++ HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 290 LRL----------IGFCMTTTERLLVYPYMSN---GSVASRLKAKPSLDWATRKRIALGA 336
+ L + F LV+ YM + G + S L + + L
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL-- 126
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 396
GL Y H++ +HRD+K +NILL+ + + DFGLA+L + +S T T+
Sbjct: 127 -EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 397 HIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 450
+ PE L + DV+ G +L EL + + F ANQ+ A L+ + ++
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFT--KKPIF--QANQELAQLELISRL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 59/232 (25%), Positives = 89/232 (38%), Gaps = 46/232 (19%)
Query: 239 GKGGFGNVYKG-YLQDGTVVAVKRLKDG-------NAIGGEIQFQTEVEMISLAVHRNLL 290
G+G F V K + G A+K +K N + EIQ + L+ H N+L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQ-----ALRRLSPHPNIL 61
Query: 291 RLIGF-------CMTTTERLL---VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 340
RLI + L+ +Y + K L K + L
Sbjct: 62 RLIEVLFDRKTGRLALVFELMDMNLYELIKG--------RKRPLPEKRVKSYMYQLLKSL 113
Query: 341 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 400
++H I HRD+K NIL+ + + DFG + + T T + AP
Sbjct: 114 DHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGI--YSKPPYTEYISTRWYRAP 167
Query: 401 E-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 451
E L+ G K D++ G + E++S L L G N+ LD + KIH
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGT--NE----LDQIAKIH 212
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 21/197 (10%)
Query: 238 VGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
+G G +G+VYK + G + A+K +L+ G Q E+ M+ H N++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA---VVQQEIIMMKDCKHSNIVAYFG 73
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
+ + + + GS+ L + ++ +GL YLH + +HR
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHR 130
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAPEYLST---GQ 407
D+K ANILL + + DFG++ + T A R GT +APE + G
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQIT-----ATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 408 SSEKTDVFGFGILLLEL 424
++ D++ GI +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLK---DGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
+GKG +G+VYK + G +A+K ++ D + I E++++ AV ++
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM---ELDILHKAVSPYIVDFY 65
Query: 294 GFCMTTTERLLVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
G + YM GS+ A + +RI +GL +L E+ +
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-- 123
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG---HIAPEYLSTGQ 407
IIHRDVK N+L++ + + DFG++ L V + + +G ++APE + +G
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPERIKSGG 177
Query: 408 SSE------KTDVFGFGILLLELISG 427
++ ++DV+ G+ +LE+ G
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 238 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI--SLAVHR-----NL 289
+G+G G VY + G VA++++ +Q Q + E+I + V R N+
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN--------LQQQPKKELIINEILVMRENKNPNI 79
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 349
+ + + E +V Y++ GS+ + + + +D + + L +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 409
++IHRD+K+ NILL + DFG + S +T V GT +APE ++
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 410 EKTDVFGFGILLLELISG 427
K D++ GI+ +E+I G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 36/208 (17%)
Query: 238 VGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQFQT---------EVEMISLAVHR 287
VG G +G V + G VA+K+L FQ+ E+ ++ H
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYR--------PFQSELFAKRAYRELRLLKHMKHE 74
Query: 288 NLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 340
N++ L+ T L LV P+M G+ +L L + + +GL
Sbjct: 75 NVIGLLD-VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131
Query: 341 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 400
Y+H IIHRD+K N+ ++E E + DFGLA+ DS +T V T + AP
Sbjct: 132 KYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-TRWYRAP 184
Query: 401 EY-LSTGQSSEKTDVFGFGILLLELISG 427
E L+ ++ D++ G ++ E+++G
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 4/88 (4%)
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 399
L YLH +++RD+K N++LD+ + DFGL K D GT ++A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 400 PEYLSTGQSSEKTDVFGFGILLLELISG 427
PE L D +G G+++ E++ G
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 235 KNLVGKGGFGNVYKGYLQDGT----VVAVKRLKDGNAIGGE---IQFQTEVEMISLAVHR 287
++GKGG+G V++ G + A+K LK + + + E ++ H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 347
++ LI T + L+ Y+S G + L+ + T + L +LH+Q
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ- 119
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
II+RD+K NILLD + DFGL K H + VT GT+ ++APE L
Sbjct: 120 --GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILMRSG 176
Query: 408 SSEKTDVFGFGILLLELISG 427
+ D + G L+ ++++G
Sbjct: 177 HGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTV 395
ARG+ +L + K IHRD+ A NILL E + DFGLA+ + +V R +
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 396 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
+APE + + ++DV+ FG+LL E+ S
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 288
NF +G+G +G VYK G VVA+K+++ D G E+ ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GL 340
+++L+ T + LV+ ++ K +D + I L + GL
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-------DLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113
Query: 341 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 400
+ H +++HRD+K N+L++ + DFGLA+ T V T+ + AP
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 169
Query: 401 E-YLSTGQSSEKTDVFGFGILLLELISGLRAL 431
E L S D++ G + E+++ RAL
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 36/143 (25%), Positives = 68/143 (47%), Gaps = 5/143 (3%)
Query: 238 VGKGGFGNVYKGYLQD-GTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295
+G+G +G V+K ++ +VA+KR++ D + G E+ ++ H+N++RL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 296 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 355
+ + LV+ Y +D K +GL + H ++HRD
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRD 124
Query: 356 VKAANILLDEYYEAVVGDFGLAK 378
+K N+L+++ E + DFGLA+
Sbjct: 125 LKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 238 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLI 293
+G+G +G VYKG + G +VA+K+++ + G T + ISL H N++ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPS--TAIREISLLKELQHPNIVCLQ 65
Query: 294 GFCMTTTERLLVYPYMSNG--SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
M + L++ ++S L +D K +G+L+ H + ++
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RV 122
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SE 410
+HRD+K N+L+D + DFGLA+ V T T+ + APE L S
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFG-IPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 411 KTDVFGFGILLLELIS 426
D++ G + E+ +
Sbjct: 182 PVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 32/86 (37%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 401
YLH D II+RD+K N+LLD V DFG AK + T + GT ++APE
Sbjct: 133 YLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPE 185
Query: 402 YLSTGQSSEKTDVFGFGILLLELISG 427
+ + + D + G+LL E I+G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 288
S + +G+G G V G VAVK++ E+ F EV ++ H N
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPN 77
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRKRIALGAARGLLYL 343
++ + + E +V ++ G++ +R+ + + AT L A L +L
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMN-EEQI--ATVCLAVLKA---LSFL 131
Query: 344 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV---RGTVGH--- 397
H Q +IHRD+K+ +ILL + DFG C + V+ V + VG
Sbjct: 132 HAQ---GVIHRDIKSDSILLTSDGRVKLSDFGF------C-AQVSKEVPRRKSLVGTPYW 181
Query: 398 IAPEYLSTGQSSEKTDVFGFGILLLELISG 427
+APE +S + D++ GI+++E++ G
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 21/221 (9%)
Query: 231 NFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLA 284
+F K+LVG+G FG V K G + A+K +K + E F+ E +++S++
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREK---ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 285 VHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLY 342
+ +L + + L LV Y G + S L + + D A +L
Sbjct: 59 NSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD---EDMAQFYLAELVLA 114
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 402
+H +HRD+K N+L+D + DFG A L + GT +IAPE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 403 LSTGQSSEKT------DVFGFGILLLELISGLRALEFGKTA 437
L+T K D + G++ E+I G G +A
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 38/127 (29%), Positives = 66/127 (51%), Gaps = 9/127 (7%)
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 396
RGL Y+H ++HRD+K AN+ ++ E +GDFGLA+++D SH G V
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 397 --HIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTA-NQKGAMLDWVKKIHQ 452
+ +P LS ++ D++ G + E+++G + L G Q +L+ V + +
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHELEQMQLILESVPVVRE 240
Query: 453 EKKLEML 459
E + E+L
Sbjct: 241 EDRNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 57/240 (23%), Positives = 91/240 (37%), Gaps = 45/240 (18%)
Query: 239 GKGGFGNVYKGYL-QDGTVVAVKRLKD--------GNAIGGEIQFQTEVEMISLAVHRNL 289
G+G F N+YKG L + V ++ G+ + F ++S H++L
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL-GAARGLLYLHEQCD 348
++L G C+ E ++V Y+ G + L + + K A L YL ++
Sbjct: 64 VKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK-- 120
Query: 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH----------I 398
K++H +V NIL+ Y G KL D + TV I
Sbjct: 121 -KLVHGNVCGKNILVAR-YGLNEGYVPFIKLSD-------PGIPITVLSREERVERIPWI 171
Query: 399 APEYLSTGQSS--EKTDVFGFGILLLELISG----------LRALEFGKTANQKGAMLDW 446
APE + GQ+S D + FG LLE+ S F + ++ M D
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRL-PMPDC 230
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 42/145 (28%), Positives = 66/145 (45%), Gaps = 6/145 (4%)
Query: 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIG 294
+ +G FG VY G + + + AVK +K + I + Q + E +LA+ ++ ++ L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
+ LV Y+ G V S L D + A L YLH IIHR
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHR 128
Query: 355 DVKAANILLDEYYEAVVGDFGLAKL 379
D+K N+L+ + DFGL+K+
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 51/175 (29%), Positives = 83/175 (47%), Gaps = 22/175 (12%)
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-AVRGTV 395
ARG+ +L + K IHRD+ A NILL E + DFGLA+ + +V + R +
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 396 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF-GKTANQKGAMLDWVKKIHQEK 454
+APE + + ++DV+ FG+LL E+ S L A + G N+ ++ +++
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-LGASPYPGVQINE-----EFCQRLKDGT 294
Query: 455 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEK 509
++ E+ ++ L C Q P RP S +V +L GD L E
Sbjct: 295 RMRA----------PENATPEIYRIMLACWQGDPKERPTFSALVEIL-GDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 45/191 (23%), Positives = 89/191 (46%), Gaps = 7/191 (3%)
Query: 238 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 296
+G+G G V ++ G +VAVK++ E+ F EV ++ H N++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86
Query: 297 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356
+ E +V ++ G++ + + ++ + L + L LH Q +IHRD+
Sbjct: 87 LVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDI 142
Query: 357 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 416
K+ +ILL + DFG + + ++ GT +APE +S + D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWS 201
Query: 417 FGILLLELISG 427
GI+++E++ G
Sbjct: 202 LGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 44/173 (25%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 331 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTT 389
R + A+G+ +L + IHRDV A N+LL + A + DFGLA+ +++ + V
Sbjct: 216 RFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 390 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 449
R V +APE + + ++DV+ +GILL E+ S GK+ G +++
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGKSP-YPGILVN---- 321
Query: 450 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
K +V + + + E+ + +C P+ RP S++ ++++
Sbjct: 322 ----SKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 40/127 (31%), Positives = 67/127 (52%), Gaps = 4/127 (3%)
Query: 303 LLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 360
LL+ Y S G + ++K K L + + + L + +L L E K++HRD+K+AN
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYE-VGLLFYQIVLALDEVHSRKMMHRDLKSAN 199
Query: 361 ILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGI 419
I L +GDFG +K D V ++ GT ++APE + S+K D++ G+
Sbjct: 200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259
Query: 420 LLLELIS 426
+L EL++
Sbjct: 260 ILYELLT 266
|
Length = 478 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 6/174 (3%)
Query: 254 GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 313
G VAVK++ E+ F EV ++ H N++ + + E +V ++ G+
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 314 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 373
+ + + ++ + L R L YLH Q +IHRD+K+ +ILL + D
Sbjct: 106 L-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSD 161
Query: 374 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
FG + + ++ GT +APE +S + D++ GI+++E+I G
Sbjct: 162 FGFCAQVSK-EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 397
RGL YLH I+HRD+K N+L++ + DFGLA++ + +S T T +
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 398 IAPEYLSTGQS-SEKTDVFGFGILLLELISG 427
APE L + + D++ G + EL+
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 5/154 (3%)
Query: 275 QTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIA 333
QTE + A + L + C T RL V ++S G + ++ + L + +
Sbjct: 43 QTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYS 102
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 393
+ L +LHE+ II+RD+K N+LLD + D+G+ K T+ G
Sbjct: 103 AEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCG 158
Query: 394 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
T +IAPE L D + G+L+ E+++G
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 2e-06
Identities = 24/57 (42%), Positives = 30/57 (52%)
Query: 54 TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 110
+LDLSNN T L L+ L L+ N+LT P + S + L LDLS NNL
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 34/210 (16%)
Query: 238 VGKGGFGNVYKGYLQDGTVVA---VKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
+G G FG V + T VA VK LK + + +F + + + H N+L+ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATR-------KRIALGAARGLLYLHEQC 347
C+ LLV+ Y G + S L + W R +R+A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQE---QWHRRNSQLLLLQRMACEIAAGVTHMHKH- 118
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT------AVRGTVGHIAPE 401
+H D+ N L VGD+G+ + + ++ T +R APE
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWL----APE 171
Query: 402 YLSTGQ----SSEKT---DVFGFGILLLEL 424
+ ++E+T +V+ G+ L EL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 9/143 (6%)
Query: 286 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 345
+ N ++L T +L+ Y+ +G + LK + L A K+I L LH+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 346 QCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 404
IIH D+K N+L D + + + D+GL K++ + GT+ + +PE +
Sbjct: 128 H---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPEKIK 179
Query: 405 TGQSSEKTDVFGFGILLLELISG 427
D + G+L EL++G
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 62/239 (25%), Positives = 97/239 (40%), Gaps = 54/239 (22%)
Query: 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI-GGEIQ-FQTEVEMISLAVH 286
+F ++G+G FG V+ G V A+K L+ + I +I + E ++++ A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 287 RNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLD--WATRKRIA-LGAARGLLY 342
+++L + E L LV YM G + + L K A R IA L A L
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIAELVLA--LDS 116
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD--------------------- 381
+H+ IHRD+K NIL+D + DFGL K ++
Sbjct: 117 VHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 382 ------------HCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISG 427
+S V GT +IAPE L G + D + G++L E++ G
Sbjct: 174 LVRRRDHKQRRVRANSTV-----GTPDYIAPEVL-RGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 397
RGL Y+H IIHRD+K +N+ ++E E + DFGLA+ H D +T V T +
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 183
Query: 398 IAPE-YLSTGQSSEKTDVFGFGILLLELISG 427
APE L+ ++ D++ G ++ EL++G
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 19/166 (11%)
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTV 395
A+G+ +L + K IHRD+ A NILL E + DFGLA+ + +V R +
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 396 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455
+APE + + ++DV+ FG+LL E+ S L A + + +++
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPY--------------PGVKIDEE 290
Query: 456 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501
+ + + EM Q L C PS RP SE+V L
Sbjct: 291 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 232 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEV-------EMISL 283
++S VG G +G+V + G VA+K+L FQ+E+ E+ L
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR--------PFQSEIFAKRAYRELTLL 68
Query: 284 A--VHRNLLRLIGFCMTTT------ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 335
H N++ L+ + + LV PYM ++ P L + +
Sbjct: 69 KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHP-LSEDKVQYLVYQ 125
Query: 336 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 395
GL Y+H IIHRD+K N+ ++E E + DFGLA+ H D+ +T V T
Sbjct: 126 MLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TR 178
Query: 396 GHIAPEY-LSTGQSSEKTDVFGFGILLLELISG 427
+ APE L+ ++ D++ G ++ E+++G
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 20/199 (10%)
Query: 239 GKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
G+G + VYKG + G +VA+K ++ + G E ++ H N++ L
Sbjct: 14 GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH 73
Query: 298 TTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356
T LV+ Y+ + + L + RGL Y H++ +++HRD+
Sbjct: 74 TKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDL 129
Query: 357 KAANILLDEYYEAVVGDFGLAK---LLDHCDSH--VTTAVRGTVGHIAPEYL--STGQSS 409
K N+L+ E E + DFGLA+ + S+ VT R P+ L ST S+
Sbjct: 130 KPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR------PPDVLLGSTEYST 183
Query: 410 EKTDVFGFGILLLELISGL 428
D++G G + E+ +G
Sbjct: 184 S-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 38/160 (23%)
Query: 238 VGKGGFGNVYKG-YLQDGTVVAVKRLK-----DG---NAIGGEIQFQTEVEMISLAVHRN 288
+G+G +G VYK G +VA+K+++ +G AI EI E+ H N
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELN------HPN 59
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA----------R 338
++RL+ + + LV+ ++ L K +D + L +
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLD-------LDLKKYMD--SSPLTGLDPPLIKSYLYQLLQ 110
Query: 339 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378
G+ Y H +++HRD+K N+L+D + DFGLA+
Sbjct: 111 GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
VG+G +G+VYK +DG LK G + E+ ++ H N++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 298 TTTER--LLVYPYMSNG-------SVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQC 347
+ ++R L++ Y + AS+ KP L + K + G+ YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 348 DPKIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIAPE 401
++HRD+K ANIL+ E + D G A+L + + V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 402 YLSTGQSSEKT-DVFGFGILLLELIS 426
L + K D++ G + EL++
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 14/85 (16%)
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLD-----HCDSHVTTAVRGTVGHIAPEYLST- 405
IHRDVK N+LLD+ + DFG +D CD TAV GT +I+PE L +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD----TAV-GTPDYISPEVLKSQ 218
Query: 406 ---GQSSEKTDVFGFGILLLELISG 427
G + D + G+ L E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 30/207 (14%)
Query: 242 GFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 296
GF N+ YL GT+V V+ N ++ Q EV + H N++
Sbjct: 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF 68
Query: 297 MTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
T + ++ P+M+ GS S LK + A I GA RGL YLH+ IHR
Sbjct: 69 TTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHR 125
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ---SSE- 410
++KA++IL+ + +V GL+ H S V + V + P++ ++ S E
Sbjct: 126 NIKASHILISG--DGLVSLSGLS----HLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179
Query: 411 ----------KTDVFGFGILLLELISG 427
K+D++ GI EL +G
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 52/267 (19%), Positives = 106/267 (39%), Gaps = 35/267 (13%)
Query: 246 VYKGYLQDGTVVAVKRLK-DGNAIGGEI-QFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303
+YKG + V ++ K I + E++ + N+L++ GF + + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 304 ----LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAA 359
L+ Y + G + L + L + T+ +A+ +GL L++ ++++ +
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSV 152
Query: 360 NILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAV---RGTVGHIAPEYLSTGQSSEKTDVF 415
+ L+ E Y+ + GL K+L +V V + I EY K D++
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYT------IKDDIY 206
Query: 416 GFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEE 475
G++L E+ +G + F + K + K + KL + ++K +
Sbjct: 207 SLGVVLWEIFTG--KIPF-ENLTTKEIYDLIINKNNSL-KLPLDCPLEIKCIVEA----- 257
Query: 476 MVQVALLCTQYLPSLRPKMSEVVRMLE 502
CT + RP + E++ L
Sbjct: 258 -------CTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 51/194 (26%), Positives = 81/194 (41%), Gaps = 7/194 (3%)
Query: 237 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIG 294
L+GKG FG V + G A+K L+ I + T E L R+ L +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 295 FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
+ T +RL V Y + G + L + + L YLH + +++
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVY 118
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 413
RD+K N++LD+ + DFGL K D GT ++APE L D
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 414 VFGFGILLLELISG 427
+G G+++ E++ G
Sbjct: 178 WWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 38/207 (18%)
Query: 238 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQ--------TEVEMISLAVHRN 288
VG+GG+G V+ +D G +VA+KR+K + F+ TE ++++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKK------SLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 289 LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLD------WATRKRIALGAARGLL 341
L++L+ + E L L Y+ G + L L + A+ A
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA----- 116
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAP 400
LHE IHRD+K N L+D + DFGL+K ++ + +S V G+ ++AP
Sbjct: 117 -LHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAP 167
Query: 401 EYLSTGQSSEKTDVFGFGILLLELISG 427
E L D + G +L E + G
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 9e-06
Identities = 30/93 (32%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD--HCDSHVTTAVRGTV 395
RGL Y+H ++HRD+K +N+LL+ + + DFGLA++ D H + T T
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 396 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 427
+ APE L++ ++ D++ G +L E++S
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 9e-06
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
VG+G +G+VYK +DG LK G + E+ ++ H N++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 298 TTTER--LLVYPYMSNG-------SVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQC 347
+ +R L++ Y + AS+ KP L K + G+ YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 348 DPKIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIAPE 401
++HRD+K ANIL+ E + D G A+L + + V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 402 YLSTGQSSEKT-DVFGFGILLLELIS 426
L + K D++ G + EL++
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 53/210 (25%), Positives = 82/210 (39%), Gaps = 39/210 (18%)
Query: 241 GGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLRLIGFCMTT 299
++ K + T+VAVK++ + +++ Q E+ H N+L
Sbjct: 13 LMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP-YVTSFIV 70
Query: 300 TERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQCDPKIIHRD 355
L +V P M+ GS L + IA L Y+H + IHR
Sbjct: 71 DSELYVVSPLMAYGS-CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRS 126
Query: 356 VKAANILLDEYYEAVVGDFGLAKL--LDHCDSHVTTAVRGTVGH------------IAPE 401
VKA++ILL GD G L L + S + R V H ++PE
Sbjct: 127 VKASHILLS-------GD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 402 YLSTGQS----SEKTDVFGFGILLLELISG 427
L Q+ +EK+D++ GI EL +G
Sbjct: 179 VLQ--QNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 42/174 (24%), Positives = 82/174 (47%), Gaps = 6/174 (3%)
Query: 254 GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 313
G VAVK + E+ F EV ++ H+N++ + + E ++ ++ G+
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 314 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 373
+ + + ++ L+ + + L YLH Q +IHRD+K+ +ILL + D
Sbjct: 105 L-TDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSD 160
Query: 374 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
FG + D ++ GT +APE +S + D++ GI+++E++ G
Sbjct: 161 FGFCAQISK-DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 337 ARGLL----YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC-DSHVTTAV 391
AR LL Y+H + IIHRD+K N+L++ + +GDFG A + +
Sbjct: 266 ARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322
Query: 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 423
GTV APE L+ + D++ G+++ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 51/194 (26%), Positives = 80/194 (41%), Gaps = 6/194 (3%)
Query: 237 LVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIG 294
L+GKG FG V G A+K LK + + T E L R+ L +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 295 FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
+ T +RL V Y + G + L + + L YLH + +++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVY 119
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 413
RD+K N++LD+ + DFGL K D GT ++APE L D
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178
Query: 414 VFGFGILLLELISG 427
+G G+++ E++ G
Sbjct: 179 WWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTV 395
A+G+ +L + IHRD+ A NILL + DFGLA+ + + ++V R V
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 396 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
+APE + + ++DV+ +GILL E+ S
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT-- 394
ARG+ +L + +HRD+ A N+LL + + DFGLA+ + H ++V+ +G+
Sbjct: 247 ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300
Query: 395 --VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426
V +APE + + +DV+ +GILL E+ S
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 8/91 (8%)
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 397
RGL Y+H IIHRD+K +N+ ++E E + DFGLA+ D +T V T +
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYV-ATRWY 181
Query: 398 IAPE-YLSTGQSSEKTDVFGFGILLLELISG 427
APE L+ ++ D++ G ++ EL+ G
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 4/103 (3%)
Query: 10 PSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 69
PS S S ++ NL L + L N + +I +E+ +L+ L +LDL NN T IP
Sbjct: 77 PSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPL 134
Query: 70 VSHL-ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ L L+ L L++N + ++P L N+ L LDLS+N+LS
Sbjct: 135 IGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS 176
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-05
Identities = 23/61 (37%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 27 NLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85
NL+ + L NN ++ IP L L LDLS N T P S L +L+ L L+ N+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 86 L 86
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 9/91 (9%)
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 397
RGL Y+H ++HRD+K +N+LL+ + + DFGLA+ +T V T +
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 398 IAPEYLSTGQSSEKT---DVFGFGILLLELI 425
APE L SE T DV+ G + EL+
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 25/202 (12%)
Query: 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLK--------DGNAIGGEIQFQTEVEMISLAVHRN 288
+G+G +G VYK + +A+K+++ AI EI E++ H N
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQ------HGN 62
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATR--KRIALGAARGLLYLHEQ 346
++RL + LV+ Y+ + + + + P R K RG+ Y H
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 347 CDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLS 404
+++HRD+K N+L+D A+ + DFGLA+ T V T+ + APE L
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLG 177
Query: 405 TGQSSEKTDVFGFGILLLELIS 426
+ S D++ G + E+++
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 18 LSSSIGNLT-NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 76
+ IG L NL+ + L +N I +P+ + L L LDLS N + +P +S+L L
Sbjct: 131 IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNL 188
Query: 77 QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 110
L L+ N ++ +PP + +S L LDLS N++
Sbjct: 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI 221
|
Length = 394 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 29/228 (12%)
Query: 230 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA 284
+F + L+ G +G VY K Q A+K++ N I +IQ Q VE L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQR---FAMKKINKQNLILRNQIQ-QVFVERDILT 56
Query: 285 VHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 342
N + FC T+R L V Y+ G A+ LK +L + L Y
Sbjct: 57 FAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEY 116
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL------LDHCDSHVTTAVR---- 392
LH I+HRD+K N+L+ + DFGL+K+ + + H+ R
Sbjct: 117 LHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 393 ----GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 436
GT +IAPE + + D + GI+L E + G FG T
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF-FGDT 220
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 6e-05
Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 35/222 (15%)
Query: 238 VGKGGFGNVYKGY-LQDGTVVAVKRLKD--GNAIGG-----EIQFQTEVEMISLAVHRNL 289
+GKG +G V+K + VVA+K++ D NA EI F E L H N+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE-----LGDHPNI 69
Query: 290 LRLIGFCMTTTER--LLVYPYMSNGSVASRLKA---KPSLDWATRKRIALGAARGLLYLH 344
++L+ ++ LV+ YM + L A L+ ++ I + L Y+H
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYME-----TDLHAVIRANILEDVHKRYIMYQLLKALKYIH 124
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAP 400
+IHRD+K +NILL+ + DFGLA+ L + + V T + AP
Sbjct: 125 SG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 401 EYL--STGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 439
E L ST + ++ D++ G +L E++ G + L G T NQ
Sbjct: 182 EILLGST-RYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQ 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 27/77 (35%), Positives = 42/77 (54%), Gaps = 4/77 (5%)
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 410
I++RD+K N+LLD+ + DFG AK++D T + GT +IAPE L +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLNVGHGK 207
Query: 411 KTDVFGFGILLLELISG 427
D + GI + E++ G
Sbjct: 208 AADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 64/231 (27%), Positives = 92/231 (39%), Gaps = 50/231 (21%)
Query: 237 LVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGE---IQFQTEVEMISLAVHRNLLRL 292
L+GKG G V+ L+ G + A+K L D + + TE E+++ H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVL-DKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLH 344
T T LV Y G + L+ +P K ++ AR L YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQP------GKCLSEEVARFYAAEVLLALEYLH 120
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR------------ 392
I++RD+K NILL E ++ DF L+K D V+ A+R
Sbjct: 121 LL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 393 ----------------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
GT +IAPE +S D + GILL E++ G
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 14/85 (16%)
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLD-----HCDSHVTTAVRGTVGHIAPEYLST- 405
IHRDVK N+LLD+ + DFG ++ CD+ V GT +I+PE L +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQ 218
Query: 406 ---GQSSEKTDVFGFGILLLELISG 427
G + D + G+ L E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 8/150 (5%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+F S ++G+G FG V +D G V A+K L+ + + E E + V +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAER-DILVEADS 60
Query: 290 LRLIGFCMTTTERL---LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 346
L ++ + ++L L+ ++ G + + L K +L T + A +L +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTL---TEEETQFYIAETVLAIDSI 117
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGL 376
IHRD+K N+LLD + DFGL
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 339 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 398
G+ +LH IIHRD+K +NI++ + DFGLA+ C + + T T +
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYR 189
Query: 399 APEYLSTGQSSEKTDVFGFGILLLELISG 427
APE + E D++ G ++ EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 9/95 (9%)
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD----HCDSHVTTAVRG 393
GL Y+H ++HRD+K N+L++ E + DFGLA+ +T V
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 394 TVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 427
T + APE + + QS K DV+ G +L EL+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 29/126 (23%), Positives = 59/126 (46%), Gaps = 10/126 (7%)
Query: 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 364
+ + + P+L + + A G+ +L + +HRD+ A N+L+
Sbjct: 217 LPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC 273
Query: 365 EYYEAVVGDFGLAKLLDHCDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGIL 420
E + DFGLA+ + ++++ +G+ + +APE + + +DV+ FGIL
Sbjct: 274 EGKLVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGIL 330
Query: 421 LLELIS 426
L E+ +
Sbjct: 331 LWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 48/202 (23%), Positives = 90/202 (44%), Gaps = 9/202 (4%)
Query: 230 SNFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVH 286
+ F +VG+G +G V K + + +VA+K+ KD E++ T E++M+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQ 59
Query: 287 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL-GAARGLLYLHE 345
N++ L + LV+ Y+ ++ L+ P+ + R + + + + H+
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 346 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405
I+HRD+K N+L+ + DFG A+ L + T T + +PE L
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175
Query: 406 GQSSEKTDVFGFGILLLELISG 427
+ D++ G +L EL G
Sbjct: 176 APYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 14/102 (13%)
Query: 352 IHRDVKAANILLDEYYEAVVGDFG-LAKLLDHCDSHVTTAVRGTVGHIAPEYLST----- 405
+HRD+K NIL+D + DFG KL++ + AV GT +I+PE L
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEDGK 182
Query: 406 GQSSEKTDVFGFGILLLELISGLRAL-------EFGKTANQK 440
G+ + D + G+ + E++ G +GK N K
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 7/97 (7%)
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG-LAKLLDHCDSHVTTAVRGTV 395
A +L +H +HRD+K N+LLD + DFG K+ + AV GT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTP 167
Query: 396 GHIAPEYLST-----GQSSEKTDVFGFGILLLELISG 427
+I+PE L G+ + D + G+ + E++ G
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.2 bits (82), Expect = 0.003
Identities = 17/36 (47%), Positives = 24/36 (66%), Gaps = 2/36 (5%)
Query: 76 LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L+ L L+NN +T +PP LSN+ L LDLS N ++
Sbjct: 3 LETLDLSNNQITD-LPP-LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 9/83 (10%)
Query: 352 IHRDVKAANILLDEYYEAVVGDFG-LAKLLDHCDSHVTTAVR-GTVGHIAPEYL-----S 404
+HRD+K N+LLD+ + DFG +LL D V + V GT +I+PE L
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLA--DGTVQSNVAVGTPDYISPEILQAMEDG 181
Query: 405 TGQSSEKTDVFGFGILLLELISG 427
G+ + D + G+ + E++ G
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 552 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.66 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.58 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.55 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.44 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.33 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.3 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.29 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.24 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.23 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.19 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.13 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.01 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.99 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.98 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.97 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.96 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.96 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.95 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.93 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.93 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.9 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.88 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.82 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.8 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.77 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.77 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.77 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.7 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.69 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.68 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.67 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.62 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.6 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.56 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.53 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.52 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.4 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.37 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.33 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.29 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.28 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.23 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-61 Score=553.51 Aligned_cols=481 Identities=28% Similarity=0.448 Sum_probs=311.0
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|+.|+|++|++.+.+|..+ .+++|+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|..+.++++|+.|+|
T Consensus 452 ~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 530 (968)
T PLN00113 452 PSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDL 530 (968)
T ss_pred CCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEEC
Confidence 456666666666665555444 3456666666666666666666666666666666666666566666666666666666
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCCCCCCCCCCCCCCCccccCCCCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPN 156 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~~~~~c~~~~~~p~s~~~~~~~~ 156 (552)
++|.+++.+|..+..+++|+.|+|++|++++.+|..+. +.+++++|++.+..+....-. . ....++.++...+
T Consensus 531 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~-~-~~~~~~~~n~~lc 608 (968)
T PLN00113 531 SHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFL-A-INASAVAGNIDLC 608 (968)
T ss_pred CCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhc-c-cChhhhcCCcccc
Confidence 66666666666666666666666666666655554332 455566665554222110000 0 0000001110000
Q ss_pred C------CC-CCC-CCcceeeeeehhhhHHHHHHHHHHHHhhhhhcccccccccccchhhhhhhh-c--CCccccCHHHH
Q 008828 157 S------KP-SGM-PKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVC-L--GNLKRFHFKEL 225 (552)
Q Consensus 157 ~------~~-~~~-~~~~~~~i~v~~~~~~v~l~il~~~~~~~~r~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~e~ 225 (552)
. .+ ... ......++++++++++++++++++++++++|+++..+...........+.. . .....++++++
T Consensus 609 ~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (968)
T PLN00113 609 GGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI 688 (968)
T ss_pred CCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH
Confidence 0 00 000 011122333444444444433333344444443322111000000000000 0 00112333333
Q ss_pred HHHhcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 226 QSATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 226 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
...|...+.||+|+||.||+|+. .++..||||.++..... ...|++.+++++||||++++|+|......++
T Consensus 689 ---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 689 ---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred ---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 34577888999999999999997 47899999998643321 1246888999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
||||+++|+|.++++ .++|..+.+|+.|+|+||+|||..+.++|+||||||+||+++.++.+++. ||........
T Consensus 761 v~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 761 IHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred EEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 999999999999996 38999999999999999999997767799999999999999999988875 6655432211
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
....+|..|+|||++.+..++.++|||||||++|||+||+.|++.... ....+..|++............|+.+
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHHHHhcCccchhheeCccc
Confidence 123578999999999999999999999999999999999999854322 23446677776655555666667665
Q ss_pred cCc--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 465 KNN--YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 465 ~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
... .+..+..++.+++.+||+.||++||||+||++.|+..
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 432 3456677899999999999999999999999999863
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-57 Score=454.35 Aligned_cols=287 Identities=51% Similarity=0.866 Sum_probs=253.9
Q ss_pred CccccCHHHHHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeE
Q 008828 216 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295 (552)
Q Consensus 216 ~~~~~~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~ 295 (552)
..+.|+++++..||++|...++||+|+||.||+|.+.+|+.||||++....... ..+|..|+.++++++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567899999999999999999999999999999999999999999887655433 5569999999999999999999999
Q ss_pred eecCC-ceeEEEeeccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEc
Q 008828 296 CMTTT-ERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG 372 (552)
Q Consensus 296 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 372 (552)
|.+.+ +.+||||||++|+|.++++... +++|..|.+||.++|+||+|||+.+.++||||||||+|||+|+++++||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99998 5999999999999999998654 89999999999999999999999999999999999999999999999999
Q ss_pred ccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh
Q 008828 373 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 373 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
|||+|+..............||.+|+|||++..+..|.|+|||||||+++||+||+.+.+... +.....+.+|+.....
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHHH
Confidence 999997654311111111169999999999999999999999999999999999998887644 2233347899998888
Q ss_pred hcchhhhcccccc-CcCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 453 EKKLEMLVDKDLK-NNYDR-IELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 453 ~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
...+.+++|+.+. ..+.. .+...+..++.+|++.+|++||+|.||+++|+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 8899999999987 66664 6788899999999999999999999999999653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=382.53 Aligned_cols=252 Identities=26% Similarity=0.354 Sum_probs=214.0
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCC-ceeEEEeec
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-ERLLVYPYM 309 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-~~~lv~e~~ 309 (552)
++..+.||+|..|+|||++++ +++.+|+|++..........++.+|++++...+||+||.++|+|.... +..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344578999999999999987 688999999966555556678999999999999999999999999988 599999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 310 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 310 ~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
++|+|..++...+.+++...-+|+.++++||.|||+ . +||||||||+|||++..|++||||||.++.+... ..
T Consensus 161 DgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a 234 (364)
T KOG0581|consen 161 DGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA 234 (364)
T ss_pred CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence 999999999988889999999999999999999996 5 9999999999999999999999999999877543 55
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
.++.||..|||||.+.+..|+.++||||||+.++|+++|+.|+..... ....+.+.+ ..+++... +..
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~--~~~~~~~Ll---------~~Iv~~pp-P~l 302 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP--PYLDIFELL---------CAIVDEPP-PRL 302 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC--CCCCHHHHH---------HHHhcCCC-CCC
Confidence 667899999999999999999999999999999999999999976411 111222222 22333211 222
Q ss_pred CH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 469 DR-IELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 469 ~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
+. ..++++.+++..||++||.+||+++|+++|-
T Consensus 303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 33 3678999999999999999999999998753
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-50 Score=397.94 Aligned_cols=251 Identities=34% Similarity=0.482 Sum_probs=210.8
Q ss_pred CCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCC-ceeEEEeeccC
Q 008828 234 SKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-ERLLVYPYMSN 311 (552)
Q Consensus 234 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-~~~lv~e~~~~ 311 (552)
..+.||+|+||+||+|.++....||||++....... ....|.+|+.+|.+++|||||+++|+|.... ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345699999999999999855559999997543222 2558999999999999999999999999988 79999999999
Q ss_pred CChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCc-eEEcCCCCCceeeCCCC-ceEEcccccceecCCCCCce
Q 008828 312 GSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPK-IIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 312 g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~ 387 (552)
|+|.++++. ...+++..+..++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~ 200 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TS 200 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-cc
Confidence 999999987 67899999999999999999999999 7 99999999999999997 99999999998765432 22
Q ss_pred eecccccccccCchhhc--cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 388 TTAVRGTVGHIAPEYLS--TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~--~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... .. ....++....+
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~---------~~~~v~~~~~R 264 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQ---------VASAVVVGGLR 264 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HH---------HHHHHHhcCCC
Confidence 33367999999999999 66999999999999999999999999985332 01 11112222333
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
...+..++..+..++.+||+.||..||++.+++..|+..
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 444555678899999999999999999999999999854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=391.00 Aligned_cols=249 Identities=26% Similarity=0.374 Sum_probs=214.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.+|...++||+|||+.||.++. ..|+.||+|++.+... ......+.+||++.+.++|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688999999999999999997 7899999999965322 234556889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
|+|.+|+|.++++..+++++++++.++.||+.||.|||+. +|+|||||..|++++++.++||+|||+|..+... ..
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-GE 173 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc-cc
Confidence 9999999999999889999999999999999999999999 9999999999999999999999999999988753 33
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
...+.+||+.|+|||++.....+..+||||+||++|.|++|++||+.....+. ... +.....
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-------y~~---------Ik~~~Y-- 235 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-------YNK---------IKLNEY-- 235 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-------HHH---------HHhcCc--
Confidence 45567899999999999999999999999999999999999999985322111 001 110000
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+|...+.+..+||.++|+.+|.+|||+++|+.+
T Consensus 236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1233455788999999999999999999999964
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-49 Score=388.36 Aligned_cols=253 Identities=28% Similarity=0.419 Sum_probs=214.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
+.+...+.||+|.||.||.|.++....||+|.++.... ...+|.+|+++|.+++|+|||+++|+|...+..+||||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 33455678999999999999999888999999987532 3457889999999999999999999999989999999999
Q ss_pred cCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 310 SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 310 ~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+.|+|.++|+. +..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+...+.....
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 99999999986 56899999999999999999999999 99999999999999999999999999999665544444
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....-...|.|||.+..+.++.|||||||||+||||+| |+.|+... ...+.+..+. ...+-
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-------sn~ev~~~le----------~GyRl 423 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-------SNEEVLELLE----------RGYRL 423 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-------CHHHHHHHHh----------ccCcC
Confidence 444445678999999999999999999999999999999 55555432 2223333333 33333
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
+.|..++.+++++|..||+.+|++|||++.+...|++.
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 44666889999999999999999999999998888764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=369.01 Aligned_cols=200 Identities=27% Similarity=0.436 Sum_probs=181.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc-cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.+|...+.||+|+||+||+|+++ ++..||||.+.... .....+.+..|+.+|+.++|||||++++++..++..++|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 56888888999999999999976 58999999996653 23334557899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC------CceEEcccccceecC
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY------YEAVVGDFGLAKLLD 381 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfg~~~~~~ 381 (552)
||.+|+|.++++..+.+++...+.++.|+|.||++||++ +||||||||+|||++.. -.+||+|||+|+.+.
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 999999999999999999999999999999999999999 99999999999999864 568999999999887
Q ss_pred CCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccC
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 434 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~ 434 (552)
......+.+|++-|||||+++..+|+.|+|+||+|+|+|++++|+.||...
T Consensus 167 --~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 167 --PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred --chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 334556778999999999999999999999999999999999999999853
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=369.54 Aligned_cols=255 Identities=25% Similarity=0.346 Sum_probs=211.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCc------hHHHHHHHHHHHhhccccccceeeeEeecCCce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 302 (552)
+.|.+.+.||+|+||.|-+|+. ++|+.||||++++..... ....+++|+++|.+++|||||++++++...+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 4567889999999999999995 479999999997543322 233467999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC---CceEEccccccee
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY---YEAVVGDFGLAKL 379 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~~ 379 (552)
|+||||++||+|.+.+-.++.+.+..-+.+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999888999999999999999999999999 99999999999999866 7899999999998
Q ss_pred cCCCCCceeecccccccccCchhhccCC---CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcch
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (552)
.+ ......+.+||+.|.|||++.+.. +..++||||+||+||-+++|.+||....... .+.+. +. .+..
T Consensus 329 ~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---sl~eQ---I~-~G~y 399 (475)
T KOG0615|consen 329 SG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---SLKEQ---IL-KGRY 399 (475)
T ss_pred cc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc---cHHHH---Hh-cCcc
Confidence 76 445667789999999999998764 3448899999999999999999998543321 01111 11 0110
Q ss_pred hhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 457 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
. ..+......+++..++|.+||..||++|||+.|++++-.
T Consensus 400 ~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 400 A------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred c------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 0 112234556789999999999999999999999987543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=394.64 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=216.1
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
...+....+.||+|.||+||+|... +...||||.+++........+|++|+++++.++|||||+++|+|..++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3455666789999999999999843 3568999999987766667789999999999999999999999999999
Q ss_pred eeEEEeeccCCChhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC
Q 008828 302 RLLVYPYMSNGSVASRLKA--------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 367 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 367 (552)
.++|+|||..|||.++|.. ..+++..+.+.||.|||.|+.||-++ .+|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence 9999999999999999951 22388999999999999999999999 999999999999999999
Q ss_pred ceEEcccccceecCCCCCceee-cccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHH
Q 008828 368 EAVVGDFGLAKLLDHCDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLD 445 (552)
Q Consensus 368 ~~kl~Dfg~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 445 (552)
.|||+|||+++.+-..+.+... ...-.++|||||.++.+++|.+||||||||+|||++| |+.|+.....
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--------- 711 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--------- 711 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---------
Confidence 9999999999866544433222 3335689999999999999999999999999999998 7777653221
Q ss_pred HHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 446 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
++-++.+....+ -..++.++.+++.||..||+..|++||+++||-..|+..
T Consensus 712 -------~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 712 -------QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred -------HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 222333333333 335677889999999999999999999999999999863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=357.35 Aligned_cols=244 Identities=27% Similarity=0.310 Sum_probs=208.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCch--HHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
.++|++.++||+|+||+||.++.+ +++.+|+|++++...... ......|..+|..++||.||+++-.|.+.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999965 589999999987654433 45688999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
+||+.||.|..+|++.+.+++..+..++..|+.||.|||++ +||||||||+|||+|.+|+++|+|||+++..-. .+
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-~~ 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-DG 179 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc-CC
Confidence 99999999999999999999999999999999999999999 999999999999999999999999999985432 33
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
..+.+++||+.|||||++....|+..+|.||+|+++|||++|.+||...... .+...+.... .
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-------~~~~~I~~~k----------~ 242 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-------KMYDKILKGK----------L 242 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-------HHHHHHhcCc----------C
Confidence 4455689999999999999999999999999999999999999999854321 2222222221 1
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCC
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPK 493 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs 493 (552)
...+.....+..+++.+.+..||++|..
T Consensus 243 ~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 243 PLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 1223334578899999999999999974
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=348.15 Aligned_cols=267 Identities=19% Similarity=0.234 Sum_probs=209.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCch-HHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
+.|+...++|+|+||+||+++++ +|+.||||++........ .+-.++|+.+|++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 34677789999999999999987 599999999976554332 3346799999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
||+..-|.++-+....++.+.+.+++.|++.|+.|+|++ ++|||||||+||||+.++.+||||||+|+.+.. .+..
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~ 157 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDN 157 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccch
Confidence 998844444444455799999999999999999999999 999999999999999999999999999998875 4455
Q ss_pred eecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHH--------Hhhhcchhh
Q 008828 388 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK--------IHQEKKLEM 458 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 458 (552)
.+.++.|.+|.|||++.+ .+|...+||||+||++.||++|.+.|......++-..+...+.. +.....+..
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 667789999999999988 68999999999999999999999888765543332222211111 111111222
Q ss_pred hccccccC--cC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 LVDKDLKN--NY---DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ~~~~~~~~--~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+.-+.... .. .+....-+.++++.|++.||++|++-+|++.+
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 22221111 11 12234578999999999999999999999854
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=348.05 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=206.1
Q ss_pred cCCCCCCeeeeeCceEEEEEE-ECCCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeee-EeecCCc-eeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIG-FCMTTTE-RLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~-~~~~~~~-~~lv 305 (552)
.+|.+.+.||+|.||+||++. ..+|..||.|.++-+.... ...+...|+.+|++++|||||++++ .+....+ ..+|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 346777899999999999998 4589999999997433222 2345789999999999999999999 4444444 7899
Q ss_pred EeeccCCChhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 306 YPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDP-KIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 306 ~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
||||..|+|...++ ++..+++..+++++.|+++||.++|++.++ -|+||||||.||+++.+|.+||+|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999986 456799999999999999999999995332 2889999999999999999999999999988
Q ss_pred CCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 381 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 381 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
..... .....+||+.||+||.+...+|+.|+||||+||++|||+.-.+||... .+....+.+.+.
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~L~~KI~qg------- 243 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLSLCKKIEQG------- 243 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHHHHHHHHcC-------
Confidence 75443 345577999999999999999999999999999999999999999753 222322222221
Q ss_pred cccccCcCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 461 DKDLKNNYD-RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 461 ~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.. +..+ ..++.++..||..|+.+||+.||+.-.+++.+.
T Consensus 244 --d~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 244 --DY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --CC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 11 1123 567789999999999999999999555554444
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=360.33 Aligned_cols=267 Identities=22% Similarity=0.257 Sum_probs=209.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecCC-ceeEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTT-ERLLV 305 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~-~~~lv 305 (552)
.++|.+.+.||.|+||.||+|+. .+|..||||+++.....-++.-=.+|+..|++++ ||||+++.+++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 35788889999999999999995 4689999999986543322333468999999998 999999999999888 89999
Q ss_pred EeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
||||+. +|+++++. ...+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.+...+
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCC
Confidence 999976 99999975 45799999999999999999999999 99999999999999999999999999999876443
Q ss_pred CceeecccccccccCchhh-ccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh-----cchhh
Q 008828 385 SHVTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE-----KKLEM 458 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 458 (552)
..+.++.|..|+|||++ +.+.|+.+.||||+|||++|+.+-++.|.+....++-..+.+.++.-... ..+..
T Consensus 165 --PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 165 --PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred --CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 34567789999999987 55789999999999999999999998887654433322222211110000 01111
Q ss_pred hc--------cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 459 LV--------DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 459 ~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.+ ...+..-. +.++.+..+++.+|+.+||.+|||+.|++++--
T Consensus 243 ~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred HhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 11 11111111 226688999999999999999999999997543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=356.45 Aligned_cols=265 Identities=23% Similarity=0.315 Sum_probs=210.5
Q ss_pred CCCCCCeeeeeCceEEEEEE-ECCCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecC--CceeEEE
Q 008828 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLVY 306 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv~ 306 (552)
.|+..+.||+|+||.||+|+ ..+|+.||+|+++-... .+...-..+||.+|++++||||+++.+...+. ...|+|+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 35556789999999999999 56799999999975543 33344577999999999999999999998876 6899999
Q ss_pred eeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|||++ +|.-++.. .-.+++.++..+++|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||+|+++.....
T Consensus 198 eYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred ecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99987 88888875 44799999999999999999999999 999999999999999999999999999999887777
Q ss_pred ceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcch-hhhccc-
Q 008828 386 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL-EMLVDK- 462 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~- 462 (552)
...+..+.|..|.|||++.+. .|+.++|+||.|||+.||++|++.|.......+...+......-..+.+- ..+...
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 667778899999999999875 69999999999999999999999988655443333332222211111111 011100
Q ss_pred --cccCcCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 463 --DLKNNYDR-------IELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 463 --~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
.....|.+ ..+...++|+..+|..||.+|.|+.++++
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00111211 12456789999999999999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=351.81 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=208.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC-CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCC--ceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~--~~~lv~ 306 (552)
.++...+.||+|+||+||++...+ |+..|||.+....... ...+.+|+.+|.+++|||||+++|...... ..++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 456778999999999999999764 8999999986543222 456889999999999999999999855554 588999
Q ss_pred eeccCCChhhhhccCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC-CCceEEcccccceecCC--
Q 008828 307 PYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDH-- 382 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~-- 382 (552)
||+++|+|.+++...+ .+++..+..++.||++||+|||++ +||||||||+|||++. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998765 799999999999999999999999 9999999999999999 79999999999987663
Q ss_pred CCCceeecccccccccCchhhccCC-CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
..........||+.|||||++..+. ...++|||||||++.||+||++||..- .....++-.....
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~-------- 238 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGRE-------- 238 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhcc--------
Confidence 1222334567999999999999643 345999999999999999999999742 0111111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
...+.++...+.+..+++.+|+..+|+.|||+.+++++..-..
T Consensus 239 -~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 239 -DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred -CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 1222455556788999999999999999999999998877543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=372.92 Aligned_cols=253 Identities=28% Similarity=0.410 Sum_probs=217.0
Q ss_pred CCCCCeeeeeCceEEEEEEECC----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
..+.++||.|.||.||+|+++- ...||||.+|......+..+|+.|..+|.++.||||+++-|+.......++|+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3567899999999999999762 457999999988877777889999999999999999999999999999999999
Q ss_pred eccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 308 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 308 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||++|+|..+|+. .+.+.+.+...++++||.|+.||-+. ++|||||.++||||+.+..+|++|||+++.+.++...
T Consensus 711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 9999999999974 45799999999999999999999999 9999999999999999999999999999988765544
Q ss_pred eeecccc--cccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 387 VTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 387 ~~~~~~g--t~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
..+...| ..+|.|||.+..+++|.++||||||++|||.++ |.+|+.. ..-.+.++.+.++.
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd-------mSNQdVIkaIe~gy--------- 851 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-------MSNQDVIKAIEQGY--------- 851 (996)
T ss_pred cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc-------cchHHHHHHHHhcc---------
Confidence 4444433 468999999999999999999999999999887 6666653 22234444444333
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
+-+.+..++..|++||+.||++|-.+||++.||+.+|...
T Consensus 852 -RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 852 -RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred -CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 3333556778999999999999999999999999999874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=361.00 Aligned_cols=241 Identities=25% Similarity=0.393 Sum_probs=207.4
Q ss_pred CCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCC
Q 008828 234 SKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 313 (552)
Q Consensus 234 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 313 (552)
..+-||+|+.|.||.|+++ ++.||||+++.-+ ..+|+-|++++||||+.+.|+|....-+|||||||..|-
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3578999999999999997 7899999886432 256788999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecccc
Q 008828 314 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 393 (552)
Q Consensus 314 L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g 393 (552)
|+++|+...++.......|.++||.|+.|||.+ .|||||||+-||||..+..+||+|||.++.+... .....++|
T Consensus 199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaG 273 (904)
T KOG4721|consen 199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAG 273 (904)
T ss_pred HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhh
Confidence 999999999999999999999999999999999 9999999999999999999999999999876543 33446789
Q ss_pred cccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHH
Q 008828 394 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 473 (552)
Q Consensus 394 t~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 473 (552)
|..|||||++...+.++|+||||||||||||+||..|+..-... ..+-.+-...+.-..+..++
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----------------AIIwGVGsNsL~LpvPstcP 337 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----------------AIIWGVGSNSLHLPVPSTCP 337 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----------------eeEEeccCCcccccCcccCc
Confidence 99999999999999999999999999999999999998632210 00111112223334566778
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 474 EEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 474 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
+.+.-|+++||+..|..||++++++.+|+-.
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 8999999999999999999999999999853
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=356.54 Aligned_cols=256 Identities=22% Similarity=0.289 Sum_probs=213.6
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCch--HHHHHHHHHHHhhc-cccccceeeeEeecCCcee
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~ 303 (552)
...+|..++.||+|+|++|++|+.+ .++.+|||++.+.....+ ...+..|-.+|.++ .||.|++|+--|.+....|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3467888999999999999999954 689999999965433222 23467888899988 8999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
+|+||+++|+|.++++..+.+++...+.++.+|+.||+|||+. |||||||||+|||+|+|+++||+|||.|+.+...
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999999999999999999999999999999999 9999999999999999999999999999987532
Q ss_pred CCc------------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHh
Q 008828 384 DSH------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 451 (552)
Q Consensus 384 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 451 (552)
... ....++||..|.+||++.....+..+|+|+|||++|+|+.|.+||.....- .
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------l------- 294 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------L------- 294 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH------H-------
Confidence 211 114578999999999999999999999999999999999999999754321 0
Q ss_pred hhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 452 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.++.+++-. =.+++..++.+.+|+.+.|..||.+|+|..||-+|.--.
T Consensus 295 ---iFqkI~~l~--y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~ 342 (604)
T KOG0592|consen 295 ---IFQKIQALD--YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE 342 (604)
T ss_pred ---HHHHHHHhc--ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence 011111111 123334447899999999999999999999998876543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=340.08 Aligned_cols=261 Identities=26% Similarity=0.349 Sum_probs=209.6
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.+.|++.+.||.|..++||+|+. ..++.||||++.-+........+.+|+..++.++||||++++..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 35788899999999999999995 46899999999877776667789999999999999999999999999999999999
Q ss_pred eccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 308 YMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||.+|++.+++... ..+++..+..|++++++||.|||++ |.||||||+.||||+.+|.|||+|||.+..+...+.
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999742 3599999999999999999999999 999999999999999999999999998876644332
Q ss_pred ce--e-ecccccccccCchhhcc--CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 386 HV--T-TAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 386 ~~--~-~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
.. . ..+.||+.|||||+++. ..|+.|+||||||++..||.+|..||..-.+.. -.+..+..... ...
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLqn~pp--~~~ 253 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQNDPP--TLL 253 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhcCCCC--Ccc
Confidence 21 1 45679999999999654 469999999999999999999999997432210 01111111100 000
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+..+-.......+.+++..|++.||++|||+.+++.+
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0011111122234688999999999999999999999853
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=360.47 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=203.3
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEE------CCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCC
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTT 300 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~ 300 (552)
..++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|+.++..+ +||||+++++++....
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456788999999999999999974 235689999997554434455789999999999 8999999999887654
Q ss_pred -ceeEEEeeccCCChhhhhccC----------------------------------------------------------
Q 008828 301 -ERLLVYPYMSNGSVASRLKAK---------------------------------------------------------- 321 (552)
Q Consensus 301 -~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------------- 321 (552)
..++||||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 578999999999999888632
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce-eeccccccc
Q 008828 322 ----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVG 396 (552)
Q Consensus 322 ----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~ 396 (552)
..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......... .....++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 2478889999999999999999998 99999999999999999999999999998654322211 122346678
Q ss_pred ccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHH
Q 008828 397 HIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEE 475 (552)
Q Consensus 397 y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 475 (552)
|+|||++.+..++.++|||||||++|||++ |..||...... ........... ....+...+..
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~----------~~~~~~~~~~~ 305 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFCQRLKDGT----------RMRAPENATPE 305 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHhcCC----------CCCCCCCCCHH
Confidence 999999999999999999999999999997 99998643211 01111111110 01112234467
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 476 MVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 476 l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
+.+++.+||+.||++|||+.|+++.|+.
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 8999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=322.58 Aligned_cols=266 Identities=24% Similarity=0.324 Sum_probs=207.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCch-HHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.+|...+.+|+|.||.||+|+. ++|+.||||.++.....++ .....+|++.|+.++|+||+.++++|...+..-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999994 5799999999987655444 3457899999999999999999999999999999999
Q ss_pred eccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 308 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 308 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+. +|...++.. ..++..++..++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+++.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9986 999999854 5799999999999999999999999 9999999999999999999999999999988654433
Q ss_pred eeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHH-----------Hhhhc
Q 008828 387 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK-----------IHQEK 454 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~ 454 (552)
.. ..+.|..|.|||++.+. .|+..+||||.|||+.||+-|.+-|.....-++-..+..-+.. +....
T Consensus 158 ~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 QT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred cc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 22 23579999999999875 6999999999999999999987666544332221111111110 00001
Q ss_pred chhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 455 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
.+.....+... ..-..+..++.+++..++..+|.+|+|+.|++++=
T Consensus 237 ~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 237 KIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred HHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 11111111111 12233456779999999999999999999998653
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=348.49 Aligned_cols=250 Identities=28% Similarity=0.381 Sum_probs=217.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
..|+..++||+|.||.||+|.. +.++.||+|++.-+...+....+++|+.++++++++||.+++|.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4567778999999999999995 468999999998777777777899999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
|.+|++.+.++....+++..+..|+.++..|+.|||.+ +.+|||||+.|||+..+|.+|++|||.+..+...... .
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-r 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-R 168 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc-c
Confidence 99999999999888889999999999999999999999 9999999999999999999999999999877654333 3
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
..++||+.|||||++....|+.|+||||||++.+||++|.+|+....+. ...-++.+...+..
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----------------rvlflIpk~~PP~L 231 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----------------RVLFLIPKSAPPRL 231 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----------------eEEEeccCCCCCcc
Confidence 6778999999999999889999999999999999999999999754432 11122222223333
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.......+.+++..|+..+|+.||++.+++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 34455779999999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=324.28 Aligned_cols=237 Identities=22% Similarity=0.311 Sum_probs=205.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|+..+.||.|+||.|.+++.+ +|..+|+|++.+..... +.+...+|..+|+.+.||.++++.+.+.+....++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46788899999999999999975 68899999997654322 3445788999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||++||.|.++++..+.++++.++.++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999999987632
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
+.+.+||+.|+|||++.+..|+.++|.|||||++|||+.|.+||....... ..+.++...+
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~----------------iY~KI~~~~v-- 258 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ----------------IYEKILEGKV-- 258 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH----------------HHHHHHhCcc--
Confidence 556789999999999999999999999999999999999999998544311 1112222222
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCC
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLR 491 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~R 491 (552)
.+|+....++.+|+...++.|-.+|
T Consensus 259 ~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2455556789999999999999999
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=353.01 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=208.6
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC----chHHHHHHHHHHHhhcc-ccccceeeeEeecCCc
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTE 301 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~ 301 (552)
...+|.+.+.||+|+||+|+.|... +++.||+|++...... .....+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3567899999999999999999854 6899999977653111 23445778999999999 9999999999999999
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC-CceEEcccccceec
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLL 380 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~ 380 (552)
.++||||+.+|+|++++...+.+.+..+..++.|++.|++|||+. +|+||||||+|||++.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999999988999999999999999999999999 99999999999999999 99999999999977
Q ss_pred CCCCCceeecccccccccCchhhccCC-CC-CccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhh
Q 008828 381 DHCDSHVTTAVRGTVGHIAPEYLSTGQ-SS-EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458 (552)
Q Consensus 381 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (552)
. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..... .....+.
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-------~l~~ki~------- 236 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-------NLYRKIR------- 236 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-------HHHHHHh-------
Confidence 4 2333455678999999999999977 75 7899999999999999999999853221 1111111
Q ss_pred hccccccCcCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 459 LVDKDLKNNYDRIE-LEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 459 ~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
.... .++... +.++..++.+|+..+|..|+|+.+++.
T Consensus 237 --~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 237 --KGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred --cCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1111 112222 588999999999999999999999984
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=340.75 Aligned_cols=263 Identities=17% Similarity=0.244 Sum_probs=208.8
Q ss_pred hcCCccccCHHHHHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCch--HHHHHHHHHHHhhccccccc
Q 008828 213 CLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLL 290 (552)
Q Consensus 213 ~~~~~~~~~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv 290 (552)
+..+++.++.++++ ......||+|++|.||+|.+ +|+.||||.++....... ...+.+|+.++.+++||||+
T Consensus 8 ~~~~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv 81 (283)
T PHA02988 8 YINDIKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNIL 81 (283)
T ss_pred hcCcceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEE
Confidence 34455666666652 23336899999999999998 589999999975432221 34678999999999999999
Q ss_pred eeeeEeec----CCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC
Q 008828 291 RLIGFCMT----TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 366 (552)
Q Consensus 291 ~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 366 (552)
+++|++.+ ....++||||+++|+|.+++.....+++.....++.|++.||.|||+.. +++||||||+||+++++
T Consensus 82 ~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 82 KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTEN 159 (283)
T ss_pred EEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCC
Confidence 99999876 3467899999999999999988888999999999999999999999732 78899999999999999
Q ss_pred CceEEcccccceecCCCCCceeecccccccccCchhhcc--CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchH
Q 008828 367 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML 444 (552)
Q Consensus 367 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~ 444 (552)
+.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||+||+.||..... .
T Consensus 160 ~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-------~ 228 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-------K 228 (283)
T ss_pred CcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-------H
Confidence 999999999998654321 22347899999999976 6899999999999999999999999974321 1
Q ss_pred HHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 445 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
+........ ......+...+..+.+++.+||+.||++|||++|+++.|+.
T Consensus 229 ~~~~~i~~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 229 EIYDLIINK---------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHHHHhc---------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111111111 11111222345789999999999999999999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=348.40 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=214.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+....+ ....+.+|+++++.++||||+.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999965 58899999996544333 44568999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
|+.+ +|..++...+.++++.+..++.|++.||.|||+. +|+|||+||+|||++..+++|+||||+|+.... ....
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSV 156 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Ccee
Confidence 9976 9999999999999999999999999999999999 999999999999999999999999999997765 3445
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
.+.+.||+-|||||++.+..|+..+|+||+|||+||+++|++||.. ..+...++.+..+. . .
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------~si~~Lv~~I~~d~---------v--~ 218 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------RSITQLVKSILKDP---------V--K 218 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------HHHHHHHHHHhcCC---------C--C
Confidence 6677899999999999999999999999999999999999999973 22334444443221 1 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 468 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
++......+.+++...+.+||..|.|-.+++.+
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 233566889999999999999999999998754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=352.76 Aligned_cols=266 Identities=26% Similarity=0.405 Sum_probs=211.4
Q ss_pred HHHHHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCC
Q 008828 222 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTT 300 (552)
Q Consensus 222 ~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 300 (552)
.+++++..+.+.+.+.||+|.||+||+|.|. ..||||+++...... ..+.|++|+.++++-+|.||+-+.|||..+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3566666777888999999999999999986 469999997654333 4567999999999999999999999999888
Q ss_pred ceeEEEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 301 ERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
. .+|+.+|+|-+|+.+++. ...++..+...|+.|||+|+.|||.+ +|||||||..||++.+++.|||+|||++..
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence 7 999999999999999984 35799999999999999999999999 999999999999999999999999999865
Q ss_pred cCC-CCCceeecccccccccCchhhccC---CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcc
Q 008828 380 LDH-CDSHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455 (552)
Q Consensus 380 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 455 (552)
... ..........|...|||||+++.. +|++.+||||||+++|||+||..|+..... ++ .++ ...++.-
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dq--Iif----mVGrG~l 610 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQ--IIF----MVGRGYL 610 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hh--eEE----Eeccccc
Confidence 321 111222233478899999999754 689999999999999999999999973211 10 010 0000100
Q ss_pred hhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 008828 456 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL 506 (552)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 506 (552)
..+.. .....++.++.+|+..||.+++++||.+.+|+..|+....
T Consensus 611 ~pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 611 MPDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred Cccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 00100 1123456789999999999999999999999998887543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=335.91 Aligned_cols=269 Identities=28% Similarity=0.386 Sum_probs=206.4
Q ss_pred CCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhh--ccccccceeeeEeecCC----ceeE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLIGFCMTTT----ERLL 304 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~h~niv~l~~~~~~~~----~~~l 304 (552)
..+..++||+|.||.||||.+. ++.||||++... ..+.|+.|-++.+. ++|+||++++++-.... +++|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3455678999999999999997 599999999643 35578888888774 58999999999977655 8999
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC------DPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
|++|.+.|+|.++|..+ .++|....+|+..+++||+|||+.. +|+|+|||||++||||.+|+++.|+|||+|.
T Consensus 286 Vt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred EeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999999876 5999999999999999999999753 5789999999999999999999999999998
Q ss_pred ecCCCCCc-eeecccccccccCchhhccCC-CC-----CccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHh
Q 008828 379 LLDHCDSH-VTTAVRGTVGHIAPEYLSTGQ-SS-----EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 451 (552)
Q Consensus 379 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 451 (552)
.+...... .....+||.+|||||++.+.- .. .+.||||+|.|||||++....+..+..++....+..-+....
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 87644332 233467999999999997752 22 367999999999999998777654333333222222222222
Q ss_pred hhcchhh-hccccccCcCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 452 QEKKLEM-LVDKDLKNNYDR-----IELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 452 ~~~~~~~-~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
.-+.+.+ ++.+..++.++. ..+..+.+.+..||..||+.|.|+.=|.+++....
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 2222222 222223333322 23567899999999999999999998888777643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=343.86 Aligned_cols=248 Identities=21% Similarity=0.271 Sum_probs=208.0
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
..++|++...||+|+||.||+|+-+ +|..+|+|++++..- .++...+..|-++|....+|.||+++..|.+.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4678999999999999999999955 699999999986532 2344568889999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC--
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH-- 382 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-- 382 (552)
||||++||++..+|...+.|++..+..++.+++.|+..||+. |+|||||||+|+|||..|++||+|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999999999999999999999999999999999999 999999999999999999999999999853210
Q ss_pred ------------------C--CCc------------------------eeecccccccccCchhhccCCCCCccchhHHH
Q 008828 383 ------------------C--DSH------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG 418 (552)
Q Consensus 383 ------------------~--~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G 418 (552)
. +.. .....+||+.|||||++.+..|+..+|.||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 000 00124699999999999999999999999999
Q ss_pred HHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCC
Q 008828 419 ILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK 493 (552)
Q Consensus 419 v~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 493 (552)
||+|||+.|.+||....+......+..|-..+... -......+..+||.+|+. ||++|..
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP--------------~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP--------------EEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC--------------CcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999998766654444455554333211 111223788999999999 9999987
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=377.08 Aligned_cols=256 Identities=30% Similarity=0.444 Sum_probs=211.7
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECC--Cc----EEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCce
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQD--GT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 302 (552)
..+.+....||+|.||.||.|...+ |. .||||.+++........+|.+|..+|+.++|||||+++|+|......
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4456677899999999999999653 33 49999998887777788999999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhccC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccc
Q 008828 303 LLVYPYMSNGSVASRLKAK-------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 375 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~-------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 375 (552)
++++|||++|+|..+|++. ..++..+.+.++.|||+|+.||+++ ++|||||.++|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999854 4689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeecc-cccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhh
Q 008828 376 LAKLLDHCDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQE 453 (552)
Q Consensus 376 ~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 453 (552)
+|+.+...+....... .-...|||||.+..+.+|.|+|||||||++||++| |..|+..... .+.+.....+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-------~~v~~~~~~g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-------FEVLLDVLEG 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-------HHHHHHHHhC
Confidence 9995443332222222 23468999999999999999999999999999999 6666653221 1111112222
Q ss_pred cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 454 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
+ +-+.+..+++.++++|..||+.+|++||++..+++.+...
T Consensus 921 g----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 921 G----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred C----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 2 2234666789999999999999999999999999977754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=355.24 Aligned_cols=261 Identities=30% Similarity=0.402 Sum_probs=211.2
Q ss_pred HHHHHhcCCCCCCeeeeeCceEEEEEEECC--C---cEEEEEEeccC--ccCchHHHHHHHHHHHhhccccccceeeeEe
Q 008828 224 ELQSATSNFSSKNLVGKGGFGNVYKGYLQD--G---TVVAVKRLKDG--NAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 296 (552)
Q Consensus 224 e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--~---~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~ 296 (552)
.++...++....+.||+|+||.||+|.++. + ..||||..+.. .......+|++|.+++++++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344455667777999999999999999653 2 23899999852 3344566899999999999999999999999
Q ss_pred ecCCceeEEEeeccCCChhhhhccCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccc
Q 008828 297 MTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 375 (552)
Q Consensus 297 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 375 (552)
......++|||+|.||+|.++|+..+ .++..++..++.+.|+||+|||++ +++||||.++|+|++.++.+||+|||
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999999999776 599999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceee-cccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhh
Q 008828 376 LAKLLDHCDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQE 453 (552)
Q Consensus 376 ~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 453 (552)
+++.-.. ..... ...-...|+|||.+..+.|+.++|||||||++||+++ |..|+...... +...
T Consensus 308 Ls~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------~v~~----- 373 (474)
T KOG0194|consen 308 LSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------EVKA----- 373 (474)
T ss_pred cccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------HHHH-----
Confidence 9875431 11111 1235679999999999999999999999999999999 77777643221 1111
Q ss_pred cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 454 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
.+.....+...+...+.++..++.+||..+|++||+|.++.+.++...
T Consensus 374 ----kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 374 ----KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred ----HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 111112222334455688999999999999999999999999988743
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=353.08 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=203.6
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE------CCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCc
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~ 301 (552)
.++|.+.+.||+|+||.||+|.+ +++..||||+++..........+.+|+.++..+ +||||++++++|.....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999973 235689999997554444455788999999999 89999999999999999
Q ss_pred eeEEEeeccCCChhhhhccC------------------------------------------------------------
Q 008828 302 RLLVYPYMSNGSVASRLKAK------------------------------------------------------------ 321 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~------------------------------------------------------------ 321 (552)
.++||||+++|+|.+++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999888532
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 322 ---------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 322 ---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
..+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1478899999999999999999998 9999999999999999999999999999866432221
Q ss_pred e-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 387 V-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 387 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
. .....++..|+|||.+.+..++.++|||||||++|||+| |..||...... .....+ .... .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~---~~~~----------~ 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKM---IKEG----------Y 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHH---HHhC----------c
Confidence 1 112335678999999999999999999999999999998 78887532211 111111 1111 0
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....+...+.++.+++.+||+.||++||++.||++.|+.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 111112234678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=344.40 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=209.0
Q ss_pred cCCCCCCeeeeeCceEEEEEE-ECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
..|..-..||+|+.|.||.|+ ..+++.||||++.... ....+-+.+|+.+|+..+|+|||++++.|...++.|+||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 446667899999999999998 4568899999996443 22334578999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
|++|+|.+.+.... +++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..... ..
T Consensus 352 m~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred cCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 99999999987654 99999999999999999999999 999999999999999999999999999987765433 55
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
...+||+.|||||++....|++|+||||||++++||+-|.+||..+..- .-+..+... -.+.+ ..
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-------rAlyLIa~n------g~P~l--k~ 491 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIATN------GTPKL--KN 491 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH-------HHHHHHhhc------CCCCc--CC
Confidence 6677999999999999999999999999999999999999999743221 001111111 11111 12
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
+...+..+.+++.+||+.||++||++.|++++-
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 344568899999999999999999999999753
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=335.42 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=205.6
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC----CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
.++|++.+.||+|+||.||+|.++ .+..||+|.++..........+.+|+.++.+++||||++++|++......++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999853 3568999999865444445578899999999999999999999999999999
Q ss_pred EEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999875 35789999999999999999999998 9999999999999999999999999987653322
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.........++..|+|||.+.+..++.++|||||||++||+++ |..||..... .+........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-------~~~~~~~~~~--------- 224 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QDVIKAVEDG--------- 224 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHCC---------
Confidence 1111122235678999999999999999999999999999875 9999864321 1111111111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.....+...+..+.+++.+||+.+|++||+++++.+.|..
T Consensus 225 -~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 225 -FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 0111223345779999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=349.23 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=213.7
Q ss_pred CCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 231 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
-|..++.||.|+.|.|..|++ .+|+.+|||++.+... ......+.+|+-+|+.+.|||++++++++....+.|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 467889999999999999996 5799999999976522 2233458899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
|+++|.|++++..++++++.++.+++.||+.|+.|+|.. +|+||||||+|+|+|..+++||+|||+|..... ...
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--gkl 167 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP--GKL 167 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC--Ccc
Confidence 999999999999999999999999999999999999999 999999999999999999999999999986542 334
Q ss_pred eecccccccccCchhhccCCC-CCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 388 TTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
-.+.+|++.|.|||++++.+| ..++||||.|||||.|+||+.||+.+. +...+..+. .+.+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LLlKV~-~G~f---------- 229 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLLLKVQ-RGVF---------- 229 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHHHHHH-cCcc----------
Confidence 456789999999999999988 679999999999999999999998322 111111111 1111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCc
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLA 507 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 507 (552)
+.+...+.++.+|+.+|+..||++|.|++||++|.--....
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 12344567899999999999999999999999876544333
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=348.38 Aligned_cols=286 Identities=23% Similarity=0.321 Sum_probs=223.5
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhc-cccccceeeeEeecCCce
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 302 (552)
..-++|...++||+|.||+|+++..+ +++.+|||++++..... ..+..+.|..++... +||.+++++.+|...++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34567899999999999999999976 58899999999875443 345678888888877 499999999999999999
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||||+.||++ .+++....+++..+..++..|+.||.|||++ +|||||||.+|||+|.+|++||+|||+++..-.
T Consensus 445 ~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 445 FFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence 999999999994 4444556799999999999999999999999 999999999999999999999999999985432
Q ss_pred CCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
....+.+++||+.|||||++.+..|+..+|.|||||+||||+.|..||...+..+ -.+.++..
T Consensus 521 -~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee----------------~FdsI~~d 583 (694)
T KOG0694|consen 521 -QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE----------------VFDSIVND 583 (694)
T ss_pred -CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHHhcC
Confidence 2336678999999999999999999999999999999999999999998543211 11111111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHhcCCCchhhhHhhhhhhhhcccccccccccCCCCCC
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKM-----SEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTD 537 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (552)
. ..||...+.+..+++.+++..+|++|..+ .+|.++---.. -.|...........-.....+.+.+|.+++
T Consensus 584 ~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~--i~w~~L~~r~i~PPf~P~i~~~~D~snFd~ 659 (694)
T KOG0694|consen 584 E--VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS--IDWDDLLNRRIKPPFVPTIKGPEDVSNFDE 659 (694)
T ss_pred C--CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc--CCHHHHhhccCCCCCCcccCChhhhcccch
Confidence 1 23667778999999999999999999977 33433222111 125544444444333344444555555543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=339.77 Aligned_cols=268 Identities=19% Similarity=0.224 Sum_probs=205.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|++.+.||+|+||+||+|+.+ +++.||+|+++..... .....+.+|+.++..++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999976 5889999999754322 234467899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
|++++.+..+......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 999887776655556799999999999999999999998 99999999999999999999999999998764333323
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchH--------HHHHHHhhhcchhhh
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKKIHQEKKLEML 459 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 459 (552)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...........+. .+.............
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 334568999999999999899999999999999999999999997533211100000 011111000000000
Q ss_pred cccccc------CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 460 VDKDLK------NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 460 ~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+... ..+....+..+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 01112235679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=339.21 Aligned_cols=261 Identities=22% Similarity=0.345 Sum_probs=202.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC-----------------CcEEEEEEeccCccCchHHHHHHHHHHHhhcccccccee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD-----------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l 292 (552)
.+|.+.+.||+|+||.||+|.+++ +..||+|.++..........|.+|+.++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468888999999999999998532 336999999765443445578999999999999999999
Q ss_pred eeEeecCCceeEEEeeccCCChhhhhccC-------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEE
Q 008828 293 IGFCMTTTERLLVYPYMSNGSVASRLKAK-------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353 (552)
Q Consensus 293 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 353 (552)
++++...+..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 99999999999999999999999988532 2468889999999999999999998 9999
Q ss_pred cCCCCCceeeCCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhC--CCc
Q 008828 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG--LRA 430 (552)
Q Consensus 354 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg--~~p 430 (552)
|||||+|||++.++.+||+|||+++........ ......++..|+|||++..+.++.++|||||||++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865433221 12233457889999999988999999999999999999975 445
Q ss_pred cccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 431 LEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
|..... ......+.......... .....+..++..+.+++.+||+.||++|||+.||.+.|++
T Consensus 242 ~~~~~~----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTD----EQVIENAGEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCH----HHHHHHHHHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 542211 11112222111111000 0001122344779999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=321.91 Aligned_cols=267 Identities=22% Similarity=0.287 Sum_probs=206.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCch-HHHHHHHHHHHhhccccccceeeeEeecC--CceeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~l 304 (552)
.++|+..+.|++|+||.||+|+.+ +++.||+|+++-+....+ -....+||.+|.+++|||||.+..+.... +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 345778899999999999999965 689999999985543332 23467999999999999999999987644 57999
Q ss_pred EEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
|||||+. +|..++.. ..++...++..++.|+++|++|||.. .|+|||||++|+|++..|.+||+|||+|+.++..
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999987 89888874 34899999999999999999999999 9999999999999999999999999999988754
Q ss_pred CCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHH----hhhcc-hh
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI----HQEKK-LE 457 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~-~~ 457 (552)
. ...+..+.|..|.|||++.+. .|+..+||||+|||+.||+++++.|......++-..+...+..- ..... +.
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3 334556789999999999875 59999999999999999999999887655433322222211110 00000 00
Q ss_pred --------hhccccccCcCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 --------MLVDKDLKNNYDRI-ELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 --------~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......++..+... ..+.-++|+...+..||.+|.|+.|.+++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00001111112211 34677899999999999999999999864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=350.20 Aligned_cols=256 Identities=26% Similarity=0.386 Sum_probs=203.4
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCc
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~ 301 (552)
.++|++.+.||+|+||.||+|+.. ++..||+|+++..........+.+|+.+++.+ +|+||++++++|.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457888999999999999999842 24579999997654444455688999999999 89999999999999999
Q ss_pred eeEEEeeccCCChhhhhccC------------------------------------------------------------
Q 008828 302 RLLVYPYMSNGSVASRLKAK------------------------------------------------------------ 321 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~------------------------------------------------------------ 321 (552)
.++||||+++|+|.+++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999887431
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc-eeec
Q 008828 322 ----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTA 390 (552)
Q Consensus 322 ----------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 390 (552)
..+++..+.+++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 2478889999999999999999998 9999999999999999999999999999865432221 1122
Q ss_pred ccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCC
Q 008828 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469 (552)
Q Consensus 391 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (552)
..++..|+|||++.+..++.++|||||||++|||++ |+.||....... ....... . ......+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~-~---------~~~~~~~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVK-R---------GYQMSRP 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHH-c---------ccCccCC
Confidence 335678999999999999999999999999999998 999986422110 0011110 0 0011111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 470 RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 470 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
...+.++.+++.+||+.||++|||+.++++.|+.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1224779999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=339.21 Aligned_cols=247 Identities=22% Similarity=0.235 Sum_probs=204.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999975 689999999864321 223446889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 9999999999998888899999999999999999999999 9999999999999999999999999999865432
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....||+.|+|||.+.+..++.++|||||||++|||+||+.||..... .......... . .
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~---------~--~ 215 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-------FGIYEKILAG---------K--L 215 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhC---------C--c
Confidence 1234589999999999999999999999999999999999999974321 1111111111 0 1
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRML 501 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L 501 (552)
.++......+.+++.+||+.||.+||+ +.|++++-
T Consensus 216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 122223467899999999999999995 88877653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=308.89 Aligned_cols=249 Identities=26% Similarity=0.366 Sum_probs=211.3
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
-++|++++.||+|.||.||.|+.+ ++-.||+|++.+.... ....++.+|+++.+.++||||++++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357899999999999999999965 6789999999654322 2345789999999999999999999999999999999
Q ss_pred EeeccCCChhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 306 YPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 306 ~e~~~~g~L~~~l~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
+||..+|+++..|+ ....+++.....++.|+|.||.|+|.+ +|+||||||+|+|++..+..||+|||.+..-+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999998 556799999999999999999999999 99999999999999999999999999987543
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
.......+||..|.|||...+...+..+|+|++|++.||++.|.+||+.....+ ....+...+
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e----------------tYkrI~k~~ 238 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE----------------TYKRIRKVD 238 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH----------------HHHHHHHcc
Confidence 445667889999999999999999999999999999999999999998533111 111111111
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
+ .++...+.+..++|.+|+..+|.+|.+..|++++-
T Consensus 239 ~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 239 L--KFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred c--cCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 1 12334457889999999999999999999998753
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=332.58 Aligned_cols=259 Identities=23% Similarity=0.294 Sum_probs=206.7
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-------------CchHHHHHHHHHHHhhccccccceee
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-------------IGGEIQFQTEVEMISLAVHRNLLRLI 293 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~~e~~~l~~~~h~niv~l~ 293 (552)
.-++|++.+.||+|.||.|-+|+.. +++.||||++.+... ....+...+||.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3468999999999999999999954 799999999954321 11234688999999999999999999
Q ss_pred eEeecC--CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEE
Q 008828 294 GFCMTT--TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV 371 (552)
Q Consensus 294 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 371 (552)
++..+. +..|||+|||..|.+...=.....+++.++++|+.++..||+|||.+ +||||||||+|+|++++|++||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEe
Confidence 998765 57899999999888765444444499999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCc----eeecccccccccCchhhccCC----CCCccchhHHHHHHHHHHhCCCccccCcccccccch
Q 008828 372 GDFGLAKLLDHCDSH----VTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 443 (552)
Q Consensus 372 ~Dfg~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~ 443 (552)
+|||.+......... ......||+.|+|||...++. .+.+.||||+||+||-|+.|+.||.....
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~------- 324 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE------- 324 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-------
Confidence 999999866322111 122356999999999997743 36788999999999999999999974321
Q ss_pred HHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 444 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
.. -...++...+.-...++..+.+.+||+++|.+||+.|.+..+|..+..-..
T Consensus 325 ~~---------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 325 LE---------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HH---------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 11 122233334433333455688999999999999999999999988776543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=334.62 Aligned_cols=247 Identities=29% Similarity=0.481 Sum_probs=195.4
Q ss_pred CCeeeeeCceEEEEEEEC-----CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 235 KNLVGKGGFGNVYKGYLQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
.+.||.|.||.||+|.+. .+..|+||.++..........|.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999976 357899999966444444678999999999999999999999999888899999999
Q ss_pred cCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc-
Q 008828 310 SNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH- 386 (552)
Q Consensus 310 ~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 386 (552)
++|+|.+++... ..+++..+..|+.|||+||.|||+. +++|+||+++||++++++.+||+|||++.........
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999875 6899999999999999999999999 9999999999999999999999999999876332222
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
..........|+|||.+....++.++||||||+++|||+| |+.|+.... ...+...+.....
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-------~~~~~~~~~~~~~---------- 223 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-------NEEIIEKLKQGQR---------- 223 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-------HHHHHHHHHTTEE----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccccc----------
Confidence 2233347789999999999999999999999999999999 677765321 1122222221111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
...+..++..+.+++.+||+.+|++|||+.++++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112223447799999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=329.67 Aligned_cols=249 Identities=20% Similarity=0.342 Sum_probs=212.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCch--HHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.+|++.+.||+|.||.|-+|+. ..|+.||||.+++....+. ...+.+||++|+.++||||+.++++|.+.+..++||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3577778999999999999994 6799999999987655443 336889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||..+|.|++++...+.+++.+.+.++.||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+.. ..
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~--~k 207 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--KK 207 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc--cc
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999987753 34
Q ss_pred eeecccccccccCchhhccCCC-CCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
...+++|++-|.+||++.+.+| .+.+|-||+||+||.|+.|.-||+..+. -..++++.... .
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------k~lvrQIs~Ga---------Y- 270 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------KRLVRQISRGA---------Y- 270 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------HHHHHHhhccc---------c-
Confidence 4567899999999999999988 6899999999999999999999974221 12222222211 1
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.++..+....-||.+||..+|++|-|+.+|..+-.
T Consensus 271 --rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 271 --REPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred --cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 12223356778999999999999999999987643
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=341.35 Aligned_cols=264 Identities=21% Similarity=0.272 Sum_probs=207.4
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|++.+.||+|+||.||++... ++..+|+|.++..........+.+|++++.+++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367889999999999999999976 6889999999754333334578999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
|+++|+|.+++.....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++...... .
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 158 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---c
Confidence 9999999999988778999999999999999999999852 6999999999999999999999999998765322 2
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh---------------
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ--------------- 452 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------------- 452 (552)
.....|+..|+|||.+.+..++.++|||||||++|||+||+.||....... +...+.....
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhcccccccccCCccccCcccc
Confidence 233458999999999999999999999999999999999999996432110 0000000000
Q ss_pred -------------------hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 453 -------------------EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 453 -------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
......+.............+.++.+++.+||+.||++|||++|++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000000000112457799999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=333.57 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=200.9
Q ss_pred CCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 232 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
|...+.||+|+||+||+|.. .+++.||+|.+..... ......+.+|+.++..++|+||+++++++...+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999996 4789999999864322 22334578899999999999999999999999999999999
Q ss_pred ccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 999999888753 34689999999999999999999999 99999999999999999999999999998754322
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......||..|+|||++.+..++.++|||||||++|||++|+.||.......... ...... .. ...
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~---------~~--~~~ 222 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRV---------KE--DQE 222 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHh---------hc--ccc
Confidence 2234468999999999999999999999999999999999999997533211100 000000 00 011
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 500 (552)
.++...+..+.+|+.+||+.||++||+ +++++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 122334577899999999999999997 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.84 Aligned_cols=243 Identities=22% Similarity=0.241 Sum_probs=199.6
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 312 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 312 (552)
+.||+|+||.||+|..+ +|+.||+|+++.... ......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 689999999975432 223346788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeeccc
Q 008828 313 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 392 (552)
Q Consensus 313 ~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 392 (552)
+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 156 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccccee
Confidence 9999998888899999999999999999999999 99999999999999999999999999987532211 2233456
Q ss_pred ccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHH
Q 008828 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 472 (552)
Q Consensus 393 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 472 (552)
||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ........ .. ..++...
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~~~~---------~~--~~~p~~~ 218 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILM---------EE--IRFPRTL 218 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-------HHHHHHHc---------CC--CCCCCCC
Confidence 999999999999999999999999999999999999999642210 11111110 00 1122334
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008828 473 LEEMVQVALLCTQYLPSLRP-----KMSEVVRM 500 (552)
Q Consensus 473 ~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 500 (552)
..++.+++.+||+.||++|| ++.+++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 57789999999999999999 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=332.52 Aligned_cols=254 Identities=27% Similarity=0.436 Sum_probs=206.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC------CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
++|++.+.||+|+||.||+|.... ...||+|.++..........|.+|+..+..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 367788999999999999998643 25799999975544444557899999999999999999999999989999
Q ss_pred EEEeeccCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC
Q 008828 304 LVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 367 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 367 (552)
++|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999998643 4588899999999999999999999 999999999999999999
Q ss_pred ceEEcccccceecCCCCC-ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHH
Q 008828 368 EAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLD 445 (552)
Q Consensus 368 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 445 (552)
.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||+| |..||..... .+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-------~~ 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-------QE 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence 999999999986533221 12223346788999999998999999999999999999998 9988864221 11
Q ss_pred HHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 446 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....+. .......+...+.++.+++.+||+.+|.+||++.||+++|+.
T Consensus 235 ~~~~i~----------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIR----------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHH----------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111 111112234456889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=343.02 Aligned_cols=247 Identities=21% Similarity=0.267 Sum_probs=204.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.+|.+.+.||+|+||.||+|..+ +++.||+|+++.... ......+.+|+.++..++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888899999999999999975 588999999965321 223446889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 9999999999998888899999999999999999999999 99999999999999999999999999998664322
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
....||+.|+|||.+.+..++.++|||||||++|||+||+.||..... ......... ...
T Consensus 173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~---------~~~-- 232 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKILA---------GRL-- 232 (329)
T ss_pred --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHhc---------CCc--
Confidence 234689999999999999999999999999999999999999964221 111111111 100
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRML 501 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L 501 (552)
.++......+.+++.+||+.||++||+ +++++.+-
T Consensus 233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 233 KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 112223467889999999999999997 57776553
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=335.07 Aligned_cols=266 Identities=20% Similarity=0.280 Sum_probs=200.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|.+.+.||+|+||+||+|..+ ++..||+|.++..........+.+|+.+++.++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999965 68899999997544333345678999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+++ +|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 975 898888643 4579999999999999999999999 999999999999999999999999999976543222 2
Q ss_pred eecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHH--------HHHhhhcchhh
Q 008828 388 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV--------KKIHQEKKLEM 458 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 458 (552)
.....++..|+|||.+.+ ..++.++||||+||++|||+||+.||...........+.... ...........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 233458899999999865 568999999999999999999999997533211100000000 00000000000
Q ss_pred hccccccCc----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 LVDKDLKNN----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+..... .......+..+++.+|++.||.+|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 010100000 011124678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=343.70 Aligned_cols=255 Identities=20% Similarity=0.253 Sum_probs=206.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||.||+|+.. +++.||+|+++.... ......+..|+.++..++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999976 588999999975422 223446888999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 9999999999998888899999999999999999999999 999999999999999999999999999976543
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........ .........
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~---~~~~~~~~~ 223 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------WENLKYWK---ETLQRPVYD 223 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------HHHHHhcc---ccccCCCCC
Confidence 22345689999999999999999999999999999999999999974322111 11111000 000000000
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
......+.++.+++.+||..+|++||++.+++++-
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 00112357789999999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=338.46 Aligned_cols=264 Identities=22% Similarity=0.346 Sum_probs=216.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.+...+.+.||+|-||.|..+....+..||||.++.........+|.+|+++|.+++||||++++|+|..++..++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34567789999999999999999888999999999887777778999999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
|++|+|.+++... +.++......|+.|||.|++||.+. ++|||||.++|+|+|.++++||+|||+++-+-.++.+
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999999755 3456677788999999999999998 9999999999999999999999999999966544443
Q ss_pred e-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh--CCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 387 V-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS--GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 387 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
. .....-..+|||||.+..+++|.++|||+|||++||+++ ...|+..... +...+-...+........
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~~~~~~~----- 764 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFRDQGRQV----- 764 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcCCCCcce-----
Confidence 2 334446789999999999999999999999999999876 4455543221 111121222222111111
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
....++.++..+++++.+||+.|.++||+++++...|++++
T Consensus 765 -~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 765 -VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred -eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 12235667789999999999999999999999999998754
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=325.80 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=203.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
++|++.+.||+|+||.||+|.++++..+|+|.++.... ....+.+|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 35777889999999999999998888999998864322 2456889999999999999999999999999999999999
Q ss_pred cCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 310 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 310 ~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||.++..........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 99999999874 34689999999999999999999998 999999999999999999999999999876543222222
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+.+........ ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~~~~~i~~~~~----------~~ 221 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVVEMISRGFR----------LY 221 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCC----------CC
Confidence 22335678999999998889999999999999999999 8888864321 111122211111 00
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 468 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11122367899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=323.46 Aligned_cols=269 Identities=21% Similarity=0.291 Sum_probs=206.4
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccC-ccCchHHHHHHHHHHHhhccccccceeeeEeec-----CC
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-----TT 300 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-----~~ 300 (552)
....|...+.||+|+||.|+.|..+ +|+.||||.+... ......++..+|+.+|+.++|+||+.+++++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999964 7899999999632 222345567899999999999999999998865 35
Q ss_pred ceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 301 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
..|+|+|+|+ .+|...++.+..++......++.|+++||.|+|+. +|+||||||+|+|++.+..+||+|||+|+..
T Consensus 100 DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeec
Confidence 6899999995 49999999988899999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCC-CceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhh
Q 008828 381 DHCD-SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458 (552)
Q Consensus 381 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (552)
.... ....+....|..|.|||++.. ..||.+.||||.|||+.||++|++.|.+.+...+-..+...+... .+..+..
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP-~~e~l~~ 254 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP-SEEDLQK 254 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC-CHHHHHH
Confidence 5421 122355668999999998855 679999999999999999999999998655433222221111100 0001111
Q ss_pred hc--------c---ccccCcC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 459 LV--------D---KDLKNNY---DRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 459 ~~--------~---~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
+- . .....++ -+...+...+|+.+||..||.+|+|++|++++-
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 11 0 0000011 113346789999999999999999999998653
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=325.81 Aligned_cols=254 Identities=28% Similarity=0.396 Sum_probs=206.6
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
..++|++.+.||+|+||.||+|...+++.||+|.++.... ....+.+|+.++++++||||+++++++...+..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3456888899999999999999987788999999875432 24568899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 308 YMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999997543 689999999999999999999998 999999999999999999999999999987653222
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
........+..|+|||++.+..++.++||||||+++|||+| |+.||...... ... ...... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~---~~~~~~----------~ 221 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVL---QQVDQG----------Y 221 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHH---HHHHcC----------C
Confidence 21222223458999999999999999999999999999999 88888632210 011 111110 0
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....+...+..+.+++.+|++.+|++||++.++++.|++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111222345789999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=338.39 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=216.4
Q ss_pred HHHHHHhcCCCCCCeeeeeCceEEEEEEECC-CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 223 KELQSATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 223 ~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
++++-...+....++||-|.||.||.|+|+. .-.||||.++.+.. ...+|..|..+|+.++|||+|+++|+|.....
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 4455555677888999999999999999975 56899999976542 34579999999999999999999999999999
Q ss_pred eeEEEeeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 302 RLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
+|||+|||.+|+|.++|++ +..++.-..+.++.||+.|++||..+ ++|||||.++|+||.++..+|++|||++++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999984 33566777889999999999999999 999999999999999999999999999999
Q ss_pred cCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhh
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (552)
+..+.........-.+.|.|||.+....++.|+|||+|||+|||+.| |..|+..-+ ...+. +
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------lSqVY---------~ 477 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVY---------G 477 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------HHHHH---------H
Confidence 87655444444445678999999999999999999999999999998 666665321 11122 2
Q ss_pred hccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 459 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 459 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
++....+-.-+..|++.+++||+.||++.|.+||++.|+-+.++.
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 223334444567788999999999999999999999999887775
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=337.24 Aligned_cols=243 Identities=22% Similarity=0.247 Sum_probs=198.6
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 312 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 312 (552)
+.||+|+||.||++... +|..||+|+++.... ......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 689999999975422 223345778999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeeccc
Q 008828 313 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 392 (552)
Q Consensus 313 ~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 392 (552)
+|..++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... ........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 156 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcccccc
Confidence 9999998877899999999999999999999999 9999999999999999999999999998753221 12223456
Q ss_pred ccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHH
Q 008828 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 472 (552)
Q Consensus 393 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 472 (552)
||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ....... ... ..++...
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~~~---------~~~--~~~p~~~ 218 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELIL---------MEE--IRFPRTL 218 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHh---------cCC--CCCCCCC
Confidence 999999999999999999999999999999999999999643211 1011111 000 0122234
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008828 473 LEEMVQVALLCTQYLPSLRP-----KMSEVVRM 500 (552)
Q Consensus 473 ~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 500 (552)
+.++.+++.+||+.||++|| ++.+++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 57789999999999999998 78888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=335.62 Aligned_cols=246 Identities=22% Similarity=0.247 Sum_probs=198.6
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCCh
Q 008828 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 314 (552)
Q Consensus 238 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 314 (552)
||+|+||.||+|... +++.||+|+++... .......+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 58899999996432 122344678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeeccccc
Q 008828 315 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 394 (552)
Q Consensus 315 ~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt 394 (552)
.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence 99998878899999999999999999999999 99999999999999999999999999997543222 223345699
Q ss_pred ccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHH
Q 008828 395 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE 474 (552)
Q Consensus 395 ~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 474 (552)
+.|+|||.+.+..++.++|||||||++|||+||+.||..... ......... .. ..++...+.
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~~~~~~---------~~--~~~~~~~~~ 218 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NEMYRKILQ---------EP--LRFPDGFDR 218 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-------HHHHHHHHc---------CC--CCCCCcCCH
Confidence 999999999999999999999999999999999999974321 111111111 00 112233447
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 475 EMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 475 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
.+.+++.+||+.||++||++..+.+.|....
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 7899999999999999987544444444433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=324.02 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=199.5
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCc-----eeE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE-----RLL 304 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~-----~~l 304 (552)
.|...+++|.|+||.||+|+.. +++.||||+........ .+|.++|+.+.|||||+++-+|..... ..+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 3556789999999999999965 57999999986554322 368999999999999999988865432 348
Q ss_pred EEeeccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC-CceEEccccccee
Q 008828 305 VYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKL 379 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~ 379 (552)
|||||+. +|++.++. +..++.-.++-+..||.+||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999987 99998874 56789999999999999999999998 99999999999999965 9999999999998
Q ss_pred cCCCCCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh-----
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE----- 453 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 453 (552)
+..+... .....|..|+|||++.+. .||.+.||||.||++.||+-|++-|......++-..+...++.-..+
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 8765544 344578899999999875 69999999999999999999999998654433322222221110000
Q ss_pred -cchhhhccccccC-----cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 454 -KKLEMLVDKDLKN-----NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 454 -~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+...+.+.. -+....+.++.+++.++++++|.+|.++.|++.+
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0000111122211 1234456889999999999999999999999864
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=338.22 Aligned_cols=253 Identities=23% Similarity=0.291 Sum_probs=201.7
Q ss_pred CCCCCCeeeeeCceEEEEEEE----CCCcEEEEEEeccCcc---CchHHHHHHHHHHHhhc-cccccceeeeEeecCCce
Q 008828 231 NFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 302 (552)
+|++.+.||+|+||+||+++. .+++.||+|+++.... ......+..|+.++..+ +||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999885 3578999999964321 12234577899999999 599999999999999999
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999999998878899999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
..........||..|+|||.+.+. .++.++|||||||++|||+||+.||......... ......... .+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~-------~~ 227 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILK-------CD 227 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhc-------CC
Confidence 333333445699999999999865 4789999999999999999999999643221111 111111110 01
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM 500 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 500 (552)
..++...+..+.+++.+||+.||++|| ++++++++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 ----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 112223346789999999999999999 66677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=325.46 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=206.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.++|++.+.||+|+||.||+|...++..||+|.+..... ....+.+|+.+++.++|+||+++++++......+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 356888899999999999999988888999999864322 345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999999864 35689999999999999999999998 9999999999999999999999999999876543222
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......++..|+|||.+....++.++|||||||++|+|+| |+.||...... .... ...... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~---~~~~~~------~---- 222 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DVMS---ALQRGY------R---- 222 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HHHH---HHHcCC------C----
Confidence 2223346678999999998899999999999999999999 88888642211 1111 111110 0
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.......+.++.+++.+|++.+|++||+++++.+.|++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01111234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=340.20 Aligned_cols=247 Identities=21% Similarity=0.217 Sum_probs=203.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC--CcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD--GTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
++|.+.+.||+|+||.||+|..++ +..||+|++..... ......+.+|+.++..++||||+++++++......++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998643 36899999864321 22344678899999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 99999999999998888899999999999999999999999 9999999999999999999999999999876432
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ....... ...
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~---------~~~-- 244 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKIL---------EGI-- 244 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHh---------cCC--
Confidence 22346999999999999988999999999999999999999999743211 0011111 110
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRML 501 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 501 (552)
..++...+..+.+++.+|++.||++|+ ++++++++-
T Consensus 245 ~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 245 IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 011222346688999999999999995 888887653
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=324.23 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=206.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
++|++.+.||+|+||+||+|.++. ...||+|.++..........|.+|+.+++.++||||+++++++......+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999999742 4589999987654444455788999999999999999999999999999999
Q ss_pred EeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999865 34789999999999999999999998 99999999999999999999999999998765222
Q ss_pred Cc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 385 SH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 385 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..........
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~-------- 225 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------DVIKAVEDGY-------- 225 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcCC--------
Confidence 22 2222335678999999999999999999999999999998 98888532211 1111111110
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....+...+..+.+++.+||+.+|++||++.|++++|+.
T Consensus 226 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 226 --RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 001122345778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=334.33 Aligned_cols=255 Identities=22% Similarity=0.382 Sum_probs=203.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCc----EEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
.+|+..+.||+|+||.||+|++. ++. .||+|.++.........++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999864 333 48999997544434455788999999999999999999998764 5779
Q ss_pred EEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
++||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999764 4689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcee-ecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 384 DSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 384 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
..... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||...... .+.......
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------~~~~~~~~~-------- 227 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILEKG-------- 227 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHhCC--------
Confidence 32211 22234678999999999999999999999999999998 99888642211 111111100
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
.....+..+...+.+++.+||+.+|.+||++.+++..+....
T Consensus 228 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 228 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011112223467899999999999999999999999888653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=343.11 Aligned_cols=255 Identities=23% Similarity=0.269 Sum_probs=207.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||+||+|... +++.||+|+++.... ......+..|+.++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999975 689999999975422 233456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC--
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-- 384 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-- 384 (552)
||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999999999998878899999999999999999999998 99999999999999999999999999998654332
Q ss_pred --------------------------CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccc
Q 008828 385 --------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN 438 (552)
Q Consensus 385 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~ 438 (552)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~- 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ- 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH-
Confidence 11223345899999999999999999999999999999999999999753321
Q ss_pred cccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHh
Q 008828 439 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK-MSEVVRMLE 502 (552)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~ 502 (552)
.....+... . ..+........+..+.+++.+|++ ||.+||+ ++|++++.-
T Consensus 237 ------~~~~~i~~~--~-----~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 237 ------ETYNKIINW--K-----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred ------HHHHHHhcc--C-----CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 111111100 0 000000011135778999999998 9999999 999998644
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=323.14 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=203.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
++|.+.+.||+|+||+||+|.++++..+|+|.++.... ....+.+|+.++.+++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 35777889999999999999988777899999875432 2456889999999999999999999999888899999999
Q ss_pred cCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 310 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 310 ~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
.+|+|.+++... ..+++..++.++.||+.||.|||+. +++|+||||+||++++++.+||+|||.++..........
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999998753 4689999999999999999999999 999999999999999999999999999886543322222
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
....++..|+|||.+.+..++.++|||||||++|||+| |..||...... .......... ...
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~----------~~~ 221 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-------ETVEKVSQGL----------RLY 221 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHhcCC----------CCC
Confidence 22335678999999998899999999999999999999 98888632211 1111111110 001
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 468 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11123478899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.01 Aligned_cols=257 Identities=23% Similarity=0.340 Sum_probs=204.7
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecCC
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTT 300 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~ 300 (552)
..++|.+.++||+|+||.||+|... .+..||||+++..........+.+|++++..+. ||||+++++++....
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3567889999999999999999853 134699999976544444557899999999996 999999999999999
Q ss_pred ceeEEEeeccCCChhhhhccC-----------------------------------------------------------
Q 008828 301 ERLLVYPYMSNGSVASRLKAK----------------------------------------------------------- 321 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------------- 321 (552)
..++||||+++|+|.+++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999887531
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC
Q 008828 322 -------------------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 364 (552)
Q Consensus 322 -------------------------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 364 (552)
..+++..+..++.|++.||.|||+. +|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 2478888999999999999999998 999999999999999
Q ss_pred CCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccc
Q 008828 365 EYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGA 442 (552)
Q Consensus 365 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~ 442 (552)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~---~~ 348 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD---ST 348 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh---HH
Confidence 9999999999999865432221 1222346788999999999999999999999999999997 88888642210 00
Q ss_pred hHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 443 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.. ..... ......+...+..+.+++.+||+.+|++||++.+|.++|+.
T Consensus 349 ~~---~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 349 FY---NKIKS----------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HH---HHHhc----------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 00 01110 01111223345789999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=330.23 Aligned_cols=264 Identities=22% Similarity=0.313 Sum_probs=199.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|.+.+.||+|+||+||+|... +++.||+|+++..........+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367899999999999999999975 6889999999754433334467789999999999999999999999999999999
Q ss_pred eccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 308 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 308 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
|+. ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 996 577777754 45689999999999999999999999 99999999999999999999999999987543222 2
Q ss_pred eeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcc---------h
Q 008828 387 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK---------L 456 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 456 (552)
......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||........ ....+........ .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD---QLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhCCCChhhccchhhc
Confidence 2233458899999999865 4588999999999999999999999974321100 0010100000000 0
Q ss_pred hhhccccccCcCC---H------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 457 EMLVDKDLKNNYD---R------IELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 457 ~~~~~~~~~~~~~---~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
............+ . .....+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000000000000 0 012567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.65 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=205.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC------CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
.+|.+.+.||+|+||.||+|...+ +..||+|.++..........+.+|++++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778999999999999998643 47899999976554444567999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCce
Q 008828 304 LVYPYMSNGSVASRLKAK--------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 369 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~--------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 369 (552)
+||||+++|+|.+++... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 999999999999998643 3478999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHH
Q 008828 370 VVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWV 447 (552)
Q Consensus 370 kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 447 (552)
||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||...... +..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------~~~ 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------EVI 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHH
Confidence 99999999765322211 1122335788999999999999999999999999999999 99998643221 111
Q ss_pred HHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 448 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.... .+. ....+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus 235 ~~~~-~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 ECIT-QGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHH-cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111 110 111122344779999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.74 Aligned_cols=243 Identities=24% Similarity=0.256 Sum_probs=199.5
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 312 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 312 (552)
+.||+|+||.||++... +++.||+|+++.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999965 689999999975432 223446788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeeccc
Q 008828 313 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 392 (552)
Q Consensus 313 ~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 392 (552)
+|..++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 156 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFC 156 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccccc
Confidence 9999998777899999999999999999999999 99999999999999999999999999987533211 2223456
Q ss_pred ccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHH
Q 008828 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 472 (552)
Q Consensus 393 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 472 (552)
||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .......... + ..++...
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-------~~~~~~~~~~-------~----~~~p~~~ 218 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILME-------D----IKFPRTL 218 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-------HHHHHHhccC-------C----ccCCCCC
Confidence 99999999999999999999999999999999999999964221 1111111100 0 0122233
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008828 473 LEEMVQVALLCTQYLPSLRP-----KMSEVVRM 500 (552)
Q Consensus 473 ~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 500 (552)
+.++.+++.+||+.||++|| ++.|++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 46789999999999999997 88998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=328.16 Aligned_cols=257 Identities=23% Similarity=0.391 Sum_probs=203.4
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCC
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT 300 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 300 (552)
...++|++.+.||+|+||.||+|... .+..||+|.++.........++.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35677999999999999999999753 256799999865443334456889999999999999999999999999
Q ss_pred ceeEEEeeccCCChhhhhccC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceE
Q 008828 301 ERLLVYPYMSNGSVASRLKAK----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 370 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 370 (552)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998642 2367888999999999999999998 999999999999999999999
Q ss_pred EcccccceecCCCCCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHH
Q 008828 371 VGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK 448 (552)
Q Consensus 371 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 448 (552)
|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... .....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------~~~~~ 232 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVLR 232 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH
Confidence 99999987654322211 112235778999999999899999999999999999999 6777753221 11111
Q ss_pred HHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 449 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.... ... ...+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 233 ~~~~-~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVME-GGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHc-CCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111 100 01122234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=337.48 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=201.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecC-C
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT-T 300 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~-~ 300 (552)
.++|++.+.||+|+||.||+|... +++.||+|+++..........+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457889999999999999999732 25789999997544333445678899999999 799999999988754 5
Q ss_pred ceeEEEeeccCCChhhhhccC-----------------------------------------------------------
Q 008828 301 ERLLVYPYMSNGSVASRLKAK----------------------------------------------------------- 321 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------------- 321 (552)
..+++|||+++|+|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999887531
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce-eeccccccccc
Q 008828 322 --PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHI 398 (552)
Q Consensus 322 --~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~ 398 (552)
..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.++|+|||+++.+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 2589999999999999999999998 99999999999999999999999999998764332222 12234567899
Q ss_pred CchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHH
Q 008828 399 APEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMV 477 (552)
Q Consensus 399 aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 477 (552)
|||++.+..++.++|||||||++|||++ |..||...... . ....... .. .....+.....++.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~---~~~~~~~-~~---------~~~~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---E---EFCRRLK-EG---------TRMRAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---H---HHHHHHh-cc---------CCCCCCccCCHHHH
Confidence 9999999999999999999999999998 98888632110 0 1111111 11 01111223346799
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 478 QVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 478 ~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
+++.+||+.+|++||++.|++++|+.
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHH
Confidence 99999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=323.17 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=204.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.+|.+.+.||+|+||.||+|..+ .++.||+|.++... .....+.+|++++..++||||+++++++......+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 45777889999999999999965 58899999986432 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999998643 4689999999999999999999998 9999999999999999999999999999876543222
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......++..|+|||.+.+..++.++|||||||++|||+| |..|+..... .++....... ..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~----------~~ 223 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEKG----------YR 223 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCC----------CC
Confidence 2222234668999999999999999999999999999998 8888863221 1111111111 11
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
...+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 12223345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=340.54 Aligned_cols=261 Identities=21% Similarity=0.241 Sum_probs=200.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.+|.+.+.||+|+||.||++... +++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 57999999999999999999964 688999996532 2467899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+. ++|..++.....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 95 68999888777899999999999999999999999 999999999999999999999999999975433222233
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh-------h------cc
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ-------E------KK 455 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~------~~ 455 (552)
....||+.|+|||++.+..++.++|||||||++|||+||+.|+...............+..+.. + ..
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 3456999999999999999999999999999999999999887643221111000000000000 0 00
Q ss_pred hhhhc---------cccccCcC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 456 LEMLV---------DKDLKNNY--DRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 456 ~~~~~---------~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
..... .+...... ....+.++.+++.+||+.||++|||++|++++-
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 00000 00000000 012356789999999999999999999998643
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=333.03 Aligned_cols=200 Identities=25% Similarity=0.348 Sum_probs=176.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|++.+.||+|+||.||+|..+ ++..+|+|.++..........+.+|++++..++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467999999999999999999976 5889999988754333344578899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
|+++|+|.+++.....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++...... .
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 158 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---c
Confidence 9999999999988778999999999999999999999742 6999999999999999999999999998755322 1
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCcccc
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 433 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~ 433 (552)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2234589999999999988999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=302.67 Aligned_cols=260 Identities=26% Similarity=0.308 Sum_probs=208.5
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEE-ECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC-----C
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----T 300 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~ 300 (552)
...++|.+.+.+|+|||+-||.+. ..++..+|+|++.... .++.+..++|++..++++|||+++++++.... .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 456789999999999999999998 5678999999997655 44566788999999999999999999987543 3
Q ss_pred ceeEEEeeccCCChhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccc
Q 008828 301 ERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 376 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 376 (552)
..|++++|...|+|.+.+. ++..+++.+.+.|+.+|++||.+||+. .++++||||||.|||+.+++.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 5899999999999999886 344799999999999999999999997 44699999999999999999999999999
Q ss_pred ceecCCCCCc--------eeecccccccccCchhhc---cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHH
Q 008828 377 AKLLDHCDSH--------VTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 445 (552)
Q Consensus 377 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~ 445 (552)
++...-.-.. .......|..|.|||++. +...++++|||||||++|+|+.|..||+....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------- 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------- 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------
Confidence 8754311110 111233688999999985 44679999999999999999999999984322
Q ss_pred HHHHHhhhcchh-hhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 446 WVKKIHQEKKLE-MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 446 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
+++.+. .+....+.-+-....++.+.+++..|++.||.+||++.+++..+.+
T Consensus 247 ------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 247 ------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 112221 1222222222223367899999999999999999999999998875
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=321.54 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=202.0
Q ss_pred CCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeecc
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 310 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 310 (552)
+|++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|+.+++.++||||+++++++......++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4777899999999999999988778999999864332 23468889999999999999999999999999999999999
Q ss_pred CCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceee
Q 008828 311 NGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389 (552)
Q Consensus 311 ~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 389 (552)
+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 9999999864 34689999999999999999999999 9999999999999999999999999999865432222122
Q ss_pred cccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 390 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 390 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
...++..|+|||.+.+..++.++||||||+++|||+| |+.||...... ......... .....
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~----------~~~~~ 222 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------EVVESVSAG----------YRLYR 222 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------HHHHHHHcC----------CcCCC
Confidence 2224568999999999999999999999999999999 78888642211 111111110 01111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 2234578999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=340.34 Aligned_cols=254 Identities=19% Similarity=0.225 Sum_probs=199.5
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.|...+.||+|+||+||+|+.. +++.||+|+++.... ......+..|+.++..++||||+++++++...+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999864 688999999965432 2234468899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC--
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-- 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 385 (552)
|+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999998888899999999999999999999998 999999999999999999999999999754311000
Q ss_pred --------------------------------------------ceeecccccccccCchhhccCCCCCccchhHHHHHH
Q 008828 386 --------------------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 421 (552)
Q Consensus 386 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l 421 (552)
.......||..|+|||.+.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001234699999999999998999999999999999
Q ss_pred HHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHH--ccCCCCCCCCCHHHHHH
Q 008828 422 LELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALL--CTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 422 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~evl~ 499 (552)
|||+||+.||......... ....... ..+........+.++.+++.+ |+..+|..||++.|++.
T Consensus 239 ~elltG~~Pf~~~~~~~~~-------~~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQ-------LKVINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHhCCCCCcCCCHHHHH-------HHHHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999753321100 0000000 000000011134667888877 55666777999999987
Q ss_pred HH
Q 008828 500 ML 501 (552)
Q Consensus 500 ~L 501 (552)
+-
T Consensus 305 hp 306 (381)
T cd05626 305 HP 306 (381)
T ss_pred Cc
Confidence 63
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.78 Aligned_cols=256 Identities=20% Similarity=0.217 Sum_probs=203.7
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
..++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++||||+++++++......++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567899999999999999999975 688999999964321 1223457789999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
||||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999999988754 588999999999999999999999 99999999999999999999999999998765333
Q ss_pred CceeecccccccccCchhhccC----CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.....
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~----- 264 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMDHKN----- 264 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcCCC-----
Confidence 2223345699999999998653 478999999999999999999999974322 111111111000
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSL--RPKMSEVVRML 501 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 501 (552)
.+.-......+.++.+++.+|++.+|++ ||++.|++.+-
T Consensus 265 --~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 265 --SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred --cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 0000001123478899999999999998 99999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.34 Aligned_cols=248 Identities=22% Similarity=0.353 Sum_probs=195.2
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
+|+..+.||+|+||+||+|+.. +++.||||++...........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3556688999999999999965 689999999965543334557889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceee
Q 008828 310 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389 (552)
Q Consensus 310 ~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 389 (552)
++|+|... ...++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 155 ~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 226 (353)
T PLN00034 155 DGGSLEGT----HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCN 226 (353)
T ss_pred CCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cccc
Confidence 99998653 2456778889999999999999999 99999999999999999999999999998664321 1223
Q ss_pred cccccccccCchhhcc-----CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 390 AVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 390 ~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
...||..|+|||.+.. ...+.++|||||||++|||++|+.||...... +|....... . ...
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-------~~~~~~~~~------~-~~~ 292 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-------DWASLMCAI------C-MSQ 292 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-------cHHHHHHHH------h-ccC
Confidence 3468999999998743 23456899999999999999999999732211 111111000 0 000
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+.....++.+++.+||+.||++|||+.|++++
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111222345779999999999999999999999975
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=328.32 Aligned_cols=265 Identities=23% Similarity=0.332 Sum_probs=195.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC--CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhc---cccccceeeeEeec-----
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ--DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLA---VHRNLLRLIGFCMT----- 298 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~~~~~~----- 298 (552)
++|++.+.||+|+||+||+|... +++.||+|.++...... ....+.+|+.++..+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46889999986543222 233466777776655 69999999998853
Q ss_pred CCceeEEEeeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccc
Q 008828 299 TTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 376 (552)
Q Consensus 299 ~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 376 (552)
....++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 345789999996 589888864 34589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcch
Q 008828 377 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456 (552)
Q Consensus 377 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (552)
++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...........+.+...........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9866432 22334558999999999998899999999999999999999999997543221111111100000000000
Q ss_pred h------hhccccccC---cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 457 E------MLVDKDLKN---NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 457 ~------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ......... ...+..+..+.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 000000000 0111234677899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=333.74 Aligned_cols=243 Identities=26% Similarity=0.311 Sum_probs=198.3
Q ss_pred CeeeeeCceEEEEEEE----CCCcEEEEEEeccCcc---CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 236 NLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+.||+|+||.||+++. .+++.||+|+++.... ......+..|+.++..++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 3578999999975321 12234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++|+|.+++...+.+.+..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence 99999999998888899999999999999999999999 99999999999999999999999999987543222 222
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......... .. ...
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-------~~~~~~~~~---------~~--~~~ 219 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-------KKTIDKILK---------GK--LNL 219 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-------HHHHHHHHc---------CC--CCC
Confidence 335699999999999998899999999999999999999999974321 111111111 11 111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM 500 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 500 (552)
+...+..+.+++.+||+.+|++|| ++.+++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 222346789999999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=332.42 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=198.2
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||.||+|... +++.||+|+++..... .....+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 5789999999754322 2234577888888766 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|+|..++.....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccccc
Confidence 99999998778899999999999999999999999 99999999999999999999999999987532211 122345
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCccccc-ccchHHHHHHHhhhcchhhhccccccCcCCH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ-KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 470 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (552)
.||..|+|||++.+..++.++|||||||++|||+||+.||........ ......++........ ..++.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~p~ 226 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRIPR 226 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CCCCC
Confidence 689999999999999999999999999999999999999964222111 1111222222111111 11233
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 008828 471 IELEEMVQVALLCTQYLPSLRPK------MSEVVRM 500 (552)
Q Consensus 471 ~~~~~l~~li~~cl~~dP~~RPs------~~evl~~ 500 (552)
..+..+.+++.+||+.||++||+ +.+++++
T Consensus 227 ~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 227 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 34467889999999999999998 4566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=325.70 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=202.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-----CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
.+|++.+.||+|+||+||+|.. .++..||+|.++..........+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3577789999999999999984 24678999999754443344578899999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC
Q 008828 305 VYPYMSNGSVASRLKAK-----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 367 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~-----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 367 (552)
||||+++|+|.+++... ..+++.....++.|++.||.|||++ +|+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 99999999999988421 2478899999999999999999998 999999999999999999
Q ss_pred ceEEcccccceecCCCCC-ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHH
Q 008828 368 EAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLD 445 (552)
Q Consensus 368 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 445 (552)
.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------QE 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence 999999999986543221 12223345678999999988889999999999999999999 8888753211 01
Q ss_pred HHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 446 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
......... ....+...+..+.+++.+||+.+|++||++.++.++|..
T Consensus 235 ~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQ----------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111110 011122334678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=325.45 Aligned_cols=267 Identities=25% Similarity=0.347 Sum_probs=203.8
Q ss_pred CCCCCeeeeeCceEEEEEEE-----CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC--CceeE
Q 008828 232 FSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLL 304 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~l 304 (552)
|...+.||+|+||+||++.. .++..||+|.++..........+.+|+++++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 357899999997654333455788999999999999999999988654 35789
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
+|||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 86 v~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 99999999999998764 599999999999999999999999 99999999999999999999999999998665322
Q ss_pred Cce--eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 385 SHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 385 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
... .....++..|+|||.+....++.++||||||+++|||+||+.|+........ ....+..............+.
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE--EMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh--hhhcccccccchhhhhhhhhc
Confidence 211 1222356679999999988999999999999999999999999764321100 000000000000111111222
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
......+...+..+.+++.+||+.+|++|||++++++.|+..
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 222222334457899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=337.77 Aligned_cols=258 Identities=20% Similarity=0.234 Sum_probs=203.5
Q ss_pred HHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 225 LQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 225 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
+....++|++.+.||+|+||.||++... +++.||+|++..... ......+.+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344578999999999999999999976 588999999864321 1223457889999999999999999999999999
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.++||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999999999754 589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeecccccccccCchhhccC----CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (552)
...........||+.|+|||++... .++.++|||||||++|||+||+.||..... ......
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-------~~~~~~-------- 258 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-------VGTYSK-------- 258 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-------HHHHHH--------
Confidence 3332223355699999999999764 378899999999999999999999974321 111111
Q ss_pred hhccccccCcCC--HHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHh
Q 008828 458 MLVDKDLKNNYD--RIELEEMVQVALLCTQYLPSL--RPKMSEVVRMLE 502 (552)
Q Consensus 458 ~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~ 502 (552)
+.+......++ ...+..+.+++.+|+..++.+ ||++.|++++-.
T Consensus 259 -i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 259 -IMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred -HHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 11111000111 123467888999999866554 889999988633
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=325.51 Aligned_cols=255 Identities=26% Similarity=0.370 Sum_probs=203.0
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEECC------CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
.+++|.+.+.||+|+||.||+|.+.+ +..||+|.+...........|..|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678889999999999999999753 568999988654433345568899999999999999999999999999
Q ss_pred eeEEEeeccCCChhhhhccCC-------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC---ceEE
Q 008828 302 RLLVYPYMSNGSVASRLKAKP-------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVV 371 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl 371 (552)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 999999999999999986432 589999999999999999999999 999999999999998654 6999
Q ss_pred cccccceecCCCCCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHH
Q 008828 372 GDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKK 449 (552)
Q Consensus 372 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 449 (552)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------~~~~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------EVMEF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH
Confidence 9999998663222111 111223568999999999999999999999999999997 88888643211 11111
Q ss_pred HhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 450 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.... .....+...+..+.+++.+|++.+|++||++.+|+++|+
T Consensus 234 ~~~~----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGG----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111 111122334577899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=343.03 Aligned_cols=254 Identities=20% Similarity=0.265 Sum_probs=202.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||+||+|... +++.||||+++.... ......+.+|+.++..++||||+++++++......++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999975 689999999975321 223345788999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999998888899999999999999999999999 9999999999999999999999999998754321100
Q ss_pred -------------------------------------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCC
Q 008828 387 -------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR 429 (552)
Q Consensus 387 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~ 429 (552)
......||+.|+|||++....++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112358999999999999999999999999999999999999
Q ss_pred ccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHH
Q 008828 430 ALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK---MSEVVRML 501 (552)
Q Consensus 430 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L 501 (552)
||...... .......... ..+........++.+.+++.+|+. +|.+|++ +.|++++-
T Consensus 238 Pf~~~~~~-------~~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 238 PFCSDNPQ-------ETYRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCHH-------HHHHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 99743221 1111111000 000000011224678899999996 9999998 88887653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=320.28 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=204.0
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.++|++.+.||+|+||.||+|..+++..+|+|.++.... ....+.+|+.++++++|+|++++++++. ....+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 356888899999999999999988888999999975432 2456889999999999999999999875 4568899999
Q ss_pred ccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999999874 34589999999999999999999999 9999999999999999999999999999876543322
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .+........ ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~----------~~ 221 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-------REVLEQVERG----------YR 221 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcC----------CC
Confidence 2222335678999999988899999999999999999999 8888863221 1111111111 11
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
...+...+..+.+++.+|+..+|++|||+.++.+.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11223345779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=317.20 Aligned_cols=247 Identities=31% Similarity=0.457 Sum_probs=200.0
Q ss_pred CeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCChh
Q 008828 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVA 315 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 315 (552)
++||+|+||.||+|...++..+|+|.++..........+.+|+++++.++||||+++++++......++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999876543333456889999999999999999999999999999999999999999
Q ss_pred hhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeeccccc
Q 008828 316 SRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 394 (552)
Q Consensus 316 ~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt 394 (552)
+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 99864 34689999999999999999999998 999999999999999999999999999875443222111222346
Q ss_pred ccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHH
Q 008828 395 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 473 (552)
Q Consensus 395 ~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 473 (552)
..|+|||++.+..++.++||||||+++|++++ |..||...... ......... .....+...+
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~----------~~~~~~~~~~ 220 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKG----------YRMSCPQKCP 220 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcC----------CCCCCCCCCC
Confidence 78999999999999999999999999999998 88888643211 000111100 0111122345
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 474 EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 474 ~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 78999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=335.01 Aligned_cols=253 Identities=22% Similarity=0.252 Sum_probs=203.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||+||+|... +++.||+|+++.... ......+.+|+.++..++||||+++++++......++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999965 689999999975432 223446888999999999999999999999999999999
Q ss_pred eeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999765 6799999999999999999999999 999999999999999999999999999987654433
Q ss_pred ceeecccccccccCchhhc------cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 386 HVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....+.........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~ 230 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------KTYNNIMNFQRFLKF 230 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------HHHHHHHcCCCccCC
Confidence 3334456899999999987 456789999999999999999999999743221 111111111100000
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......+..+.+++..|++ +|++||++.+++.+
T Consensus 231 -------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 -------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0011234678899999998 99999999998864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=331.16 Aligned_cols=243 Identities=26% Similarity=0.316 Sum_probs=196.9
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||.||+|+.. +++.||+|+++.... ......+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999975 578999999975422 22334567788888765 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|+|...+.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTF 156 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccccc
Confidence 99999998888899999999999999999999999 99999999999999999999999999987543222 223345
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.||..|+|||++.+..++.++|||||||++|||+||+.||..... ........... . .++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-------~~~~~~i~~~~---------~--~~p~~ 218 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-------DDLFESILHDD---------V--LYPVW 218 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC---------C--CCCCC
Confidence 689999999999999999999999999999999999999974321 11111111110 0 11222
Q ss_pred HHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 008828 472 ELEEMVQVALLCTQYLPSLRP-------KMSEVVRM 500 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 500 (552)
.+.++.+++.+||+.||++|| ++.+++++
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 346789999999999999999 77777755
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=331.26 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=199.4
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||.||+|... +++.||+|+++..... .....+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999975 6889999999754322 2234577899999888 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|+|..++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccccc
Confidence 99999998778899999999999999999999999 9999999999999999999999999998743211 1223345
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCccccc-ccchHHHHHHHhhhcchhhhccccccCcCCH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ-KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 470 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (552)
.||..|+|||++.+..++.++|||||||++|||+||+.||........ .....++......... . ..+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~--~~p~ 226 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I--RIPR 226 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C--CCCC
Confidence 699999999999999999999999999999999999999974322111 1111222222211111 0 1222
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 008828 471 IELEEMVQVALLCTQYLPSLRPK------MSEVVRM 500 (552)
Q Consensus 471 ~~~~~l~~li~~cl~~dP~~RPs------~~evl~~ 500 (552)
..+..+.+++.+||+.||.+||+ +.+++++
T Consensus 227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 33467899999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=318.54 Aligned_cols=247 Identities=28% Similarity=0.425 Sum_probs=198.0
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCCh
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 314 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 314 (552)
+.||+|+||.||+|... +++.||+|.+......+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999975 68999999886544444456789999999999999999999999999999999999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce-eeccc
Q 008828 315 ASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVR 392 (552)
Q Consensus 315 ~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~ 392 (552)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9998653 4689999999999999999999998 99999999999999999999999999987543211111 01112
Q ss_pred ccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 393 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.+..|+|||.+.++.++.++|||||||++|||++ |..|+...... ...... ........+..
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~----------~~~~~~~~~~~ 220 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAI----------EQGVRLPCPEL 220 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHH----------HcCCCCCCccc
Confidence 3457999999999999999999999999999998 87777532210 000001 01111122233
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.+..+.+++.+|++.+|++|||+.++.+.|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 4578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=331.98 Aligned_cols=265 Identities=20% Similarity=0.303 Sum_probs=198.4
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc-cCchHHHHHHHHHHHhhccccccceeeeEeecCC-----cee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-----ERL 303 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-----~~~ 303 (552)
+|++.+.||+|+||.||+|+.. ++..||||+++... ......++.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999965 68999999986432 2223446889999999999999999999886432 478
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
+||||+. ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 68999998877899999999999999999999999 9999999999999999999999999999754322
Q ss_pred CC--ceeecccccccccCchhhcc--CCCCCccchhHHHHHHHHHHhCCCccccCcccccccc--------hHHHHHHHh
Q 008828 384 DS--HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA--------MLDWVKKIH 451 (552)
Q Consensus 384 ~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~ 451 (552)
.. .......||..|+|||++.+ ..++.++|||||||++|||+||+.||........... ...+.....
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 11 12234568999999999876 6789999999999999999999999965332110000 000000000
Q ss_pred hhc---chhhhccccccCcCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 452 QEK---KLEMLVDKDLKNNYD---RIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 452 ~~~---~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
... ....+. ........ +..+..+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMR-KKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhc-ccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 000000 00000000 1123568899999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=337.07 Aligned_cols=201 Identities=22% Similarity=0.330 Sum_probs=175.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|+..+.||+|+||+||+|... +++.||+|+++.... ......+..|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 588999999965322 122346788999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC-
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS- 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 385 (552)
||+++|+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999999998888899999999999999999999999 999999999999999999999999999875432110
Q ss_pred ---------------------------------ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccc
Q 008828 386 ---------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 432 (552)
Q Consensus 386 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~ 432 (552)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123469999999999999999999999999999999999999997
Q ss_pred c
Q 008828 433 F 433 (552)
Q Consensus 433 ~ 433 (552)
.
T Consensus 238 ~ 238 (363)
T cd05628 238 S 238 (363)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=318.96 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=203.6
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
..+|.+.+.||+|+||.||+|..+++..||+|.++.... ....+.+|+++++.++||||+++++++. ....++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 356888999999999999999987777899999975332 2356889999999999999999999874 4567999999
Q ss_pred ccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999753 4589999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......++..|+|||...+..++.++|||||||++|||+| |..||...... ......... ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~----------~~ 221 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERG----------YR 221 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHHHhcC----------CC
Confidence 2223346778999999998999999999999999999999 77777532210 101111100 01
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.......+..+.+++.+|++.+|++||++.++++.|++
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 11223445788999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=322.45 Aligned_cols=254 Identities=29% Similarity=0.415 Sum_probs=208.5
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
...+|++.+.||+|+||.||+|...++..+|+|.++.... .....+..|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 3456888899999999999999988899999999875432 234568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 308 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||.+.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~- 158 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV- 158 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence 9999999999975 34689999999999999999999998 99999999999999999999999999997654322
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
.......++..|+|||.+....++.++||||||+++|+|++ |+.||..... ........ ...
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~----------~~~ 221 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-------HEVYDQIT----------AGY 221 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHH----------hCC
Confidence 11223346778999999998899999999999999999998 8888864321 01111111 111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 112233445789999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=334.58 Aligned_cols=244 Identities=22% Similarity=0.243 Sum_probs=198.5
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 312 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 312 (552)
+.||+|+||.||++... +++.||+|+++.... ......+..|+.++..++||||+++.+++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 689999999975422 122345778999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 313 SVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 313 ~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
+|..++.....+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTF 156 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccccc
Confidence 999999887789999999999999999999997 6 99999999999999999999999999987533221 122345
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.||..|+|||++.+..++.++|||||||++|||+||+.||...... ........ .. ..++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~~~~~i~~---------~~--~~~p~~ 218 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILM---------EE--IRFPRT 218 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-------HHHHHHhc---------CC--CCCCCC
Confidence 6999999999999999999999999999999999999999643211 11111110 00 012223
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 008828 472 ELEEMVQVALLCTQYLPSLRP-----KMSEVVRML 501 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 501 (552)
.+.++.+++.+||+.||++|+ ++.+++++-
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 346789999999999999997 899998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=329.27 Aligned_cols=242 Identities=25% Similarity=0.330 Sum_probs=193.8
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhh-ccccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISL-AVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||.||+|... +++.||+|+++.... ......+..|..++.. .+||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 578999999975421 1223345566666654 4899999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|+|..++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence 99999998877899999999999999999999998 99999999999999999999999999997643322 223345
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.||..|+|||.+.+..++.++|||||||++|||++|+.||..... .......... ...++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~-----------~~~~~~~ 218 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-------DELFDSILND-----------RPHFPRW 218 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcC-----------CCCCCCC
Confidence 699999999999999999999999999999999999999974321 1111111100 1112233
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKMS-EVVR 499 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~~-evl~ 499 (552)
.+.++.+++.+||+.+|++||++. ++++
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 446788999999999999999975 4544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=327.72 Aligned_cols=258 Identities=28% Similarity=0.412 Sum_probs=205.7
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEECC------CcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecC
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 299 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~ 299 (552)
...++|+..+.||+|+||.||+|...+ ...+|+|.++..........+.+|+.++.++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345678888999999999999998642 3689999997654333445688999999999 799999999999999
Q ss_pred CceeEEEeeccCCChhhhhcc----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee
Q 008828 300 TERLLVYPYMSNGSVASRLKA----------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 363 (552)
...+++|||+++|+|..+++. ...+++..+..++.|++.||.|||+. +|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 999999999999999999853 34689999999999999999999998 99999999999999
Q ss_pred CCCCceEEcccccceecCCCCCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCccccccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG 441 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~ 441 (552)
++++.+||+|||+++.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---- 241 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---- 241 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH----
Confidence 999999999999998665332211 122235678999999999999999999999999999998 88887532211
Q ss_pred chHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 442 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
....... .......+......+.+++.+||+.+|++|||+.|+++.|++.
T Consensus 242 ---~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 242 ---ELFKLLK----------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHHHH----------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1011111 1111112223457799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=330.79 Aligned_cols=237 Identities=27% Similarity=0.348 Sum_probs=193.1
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||+||+|+.+ +++.||+|+++... .......+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 58899999997532 122344567788888766 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|+|..++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTF 156 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccccc
Confidence 99999998878899999999999999999999999 99999999999999999999999999987543222 223345
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ........... ..++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~-----------~~~~~~ 218 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILNDE-----------VVYPTW 218 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCC-----------CCCCCC
Confidence 699999999999999999999999999999999999999974321 11111111110 011222
Q ss_pred HHHHHHHHHHHccCCCCCCCCCH
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKM 494 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~ 494 (552)
.+.++.+++.+|++.||++||++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCC
Confidence 34678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=329.59 Aligned_cols=246 Identities=25% Similarity=0.346 Sum_probs=195.2
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHH---hhccccccceeeeEeecCCceeEE
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMI---SLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l---~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
|.+.+.||+|+||.||+|... +++.||||+++.... ......+..|+.++ ..++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999965 689999999975421 12234566666654 466799999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|||+++|+|...+.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG- 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence 999999999988865 4699999999999999999999999 99999999999999999999999999987533221
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .......... .
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~---------~-- 217 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-------EEVFDSIVND---------E-- 217 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhC---------C--
Confidence 223345699999999999999999999999999999999999999974321 1111111111 0
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 500 (552)
..++...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 218 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 112223347789999999999999999 46666554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=331.77 Aligned_cols=265 Identities=25% Similarity=0.381 Sum_probs=219.9
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEECC---C--cEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQD---G--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
...+.....++||+|-||.||+|.+.+ | -.||||.-+.....+..+.|..|..+++.++||||++++|+|.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 334445667899999999999999532 3 36899998887777778889999999999999999999999975 56
Q ss_pred eeEEEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 302 RLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
.++|||.++.|.|..+++.+ ..++......++.||+.||+|||+. .+|||||..+|||+.....+||+|||+++.+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 89999999999999999854 4799999999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 381 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 381 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
........+...-...|||||.+.-+++|.++|||.|||-+||++. |..||..-...+.- ..
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-----------------~~ 604 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-----------------GH 604 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-----------------EE
Confidence 8766555444445678999999999999999999999999999876 99999754332111 11
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCchhhhH
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAA 512 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 512 (552)
+...-+.+.++.+++.++.|+.+||.+||.+||+++|+...|.+.-..++-.+
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~ 657 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINS 657 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhh
Confidence 11122334567788999999999999999999999999999987655444333
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.00 Aligned_cols=246 Identities=27% Similarity=0.359 Sum_probs=198.2
Q ss_pred eeeeeCceEEEEEEEC---CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCC
Q 008828 237 LVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 312 (552)
Q Consensus 237 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 312 (552)
.||+|+||.||+|.++ ++..+|+|+++..... .....+..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 5789999998644322 23456889999999999999999999875 45678999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee--ec
Q 008828 313 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TA 390 (552)
Q Consensus 313 ~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~~ 390 (552)
+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||+++.......... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999998777899999999999999999999998 999999999999999999999999999987654332211 12
Q ss_pred ccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCC
Q 008828 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469 (552)
Q Consensus 391 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (552)
..++..|+|||.+....++.++|||||||++|||+| |..||..... ..+....... .....+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~i~~~----------~~~~~~ 220 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-------NEVTQMIESG----------ERMECP 220 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCC----------CCCCCC
Confidence 224578999999988889999999999999999998 8889864221 1112221111 111122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 470 RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 470 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
...+.++.+++.+||+.||++||++.+|.+.|++
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 2345778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=321.56 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=198.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCc----EEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
.+|.+.+.||+|+||+||+|.+. +++ .+++|.+..........++..|+..++.+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35777899999999999999964 344 4788887543322333467788888999999999999998754 45778
Q ss_pred EEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
++||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 9999999999999975 45799999999999999999999998 9999999999999999999999999999866433
Q ss_pred CCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 384 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 384 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
... ......++..|+|||.+.++.++.++|||||||++|||+| |..||...... ...+++ .... ...
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~----~~~~--~~~- 231 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDLL----EKGE--RLA- 231 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH----HCCC--cCC-
Confidence 221 2233447788999999999999999999999999999998 98888643211 011111 1110 000
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.+..+...+.+++.+||..+|++|||+.|+++.|..
T Consensus 232 ------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 232 ------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 111123567889999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.19 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=205.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC----chHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
++|...+.||+|++|.||+|... ++..||+|.++..... .....+.+|++++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 6899999998643221 123468889999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|+||+++++|.+.+.....+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999998877899999999999999999999998 99999999999999999999999999997654322
Q ss_pred Ccee--ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 385 SHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 385 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .. ..... ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~-~~~~~---------~~ 222 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AA-IFKIA---------TQ 222 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HH-HHHHh---------cc
Confidence 1111 2345788999999999999999999999999999999999998642211 00 00110 11
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......+......+.+++.+||..+|++|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11112233345778999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=314.77 Aligned_cols=265 Identities=22% Similarity=0.289 Sum_probs=201.4
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccc-cceeeeEeecCC------c
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRN-LLRLIGFCMTTT------E 301 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~n-iv~l~~~~~~~~------~ 301 (552)
.|...+.||+|+||+||+|+.+ +|+.||+|.++-.... ..-....+|+.++..++|+| |+++++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3555577999999999999954 6899999999755432 22234578999999999999 999999998877 6
Q ss_pred eeEEEeeccCCChhhhhccCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccc
Q 008828 302 RLLVYPYMSNGSVASRLKAKP----SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 377 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 377 (552)
.++|+||++. +|..++.... .++...+..++.||++||+|||++ +|+||||||+||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 7899999976 8999987543 577789999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcch
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (552)
+..... ....+...+|..|.|||++.+. .|+...||||+|||++||++++.-|......++...+...+..-....+-
T Consensus 168 ra~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 168 RAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 965532 2234555689999999999886 69999999999999999999988887654422222121111111111111
Q ss_pred hhhccccccCcC---------CHH---HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 457 EMLVDKDLKNNY---------DRI---ELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 457 ~~~~~~~~~~~~---------~~~---~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....-+.....+ ... ......+++.+|++.+|.+|.|++.++++
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111111111011 011 11478999999999999999999999987
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=346.09 Aligned_cols=257 Identities=21% Similarity=0.245 Sum_probs=206.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCC-cEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeE-eec------CC
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDG-TVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGF-CMT------TT 300 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~-~~~------~~ 300 (552)
.++++.+.|.+|||+.||.|....+ ..||+|++-.. .......+.+||++|+++. |+|||.+++. ... .-
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 3456778999999999999997765 99999999655 3445667899999999997 9999999993 221 23
Q ss_pred ceeEEEeeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 301 ERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
+.+|.||||.+|.|.+++.. ...|++.++++|+.|+++|+++||.. .++|||||||.+||||+.++..||||||.+.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 67899999999999999973 34599999999999999999999986 7789999999999999999999999999986
Q ss_pred ecCCCC-Ccee-------ecccccccccCchhh---ccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHH
Q 008828 379 LLDHCD-SHVT-------TAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 447 (552)
Q Consensus 379 ~~~~~~-~~~~-------~~~~gt~~y~aPE~~---~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 447 (552)
-.-... .... .....|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 432222 1110 122378999999987 466899999999999999999999999985321
Q ss_pred HHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCch
Q 008828 448 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAE 508 (552)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 508 (552)
..|++....-.-.+.+...+.+||..||+.+|++||++-||+..+....-.+
T Consensus 264 ---------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 ---------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1233333332223567799999999999999999999999998887654443
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=318.01 Aligned_cols=252 Identities=28% Similarity=0.441 Sum_probs=204.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.++|++.+.||+|+||.||+|..++++.||+|.+..... ....+.+|+.+++.++|+||+++++++. ....+++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 457888999999999999999988899999999875432 2457889999999999999999999864 4578999999
Q ss_pred ccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+.+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999998864 34689999999999999999999998 9999999999999999999999999999876533222
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......++..|+|||.+....++.++||||||+++|||++ |+.||...... +........ ..
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~----------~~ 221 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------EVIQNLERG----------YR 221 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------HHHHHHHcC----------CC
Confidence 2223346678999999998999999999999999999999 99998643211 111111111 01
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
...+...+.++.+++.+|++.+|++||+++++...|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11122234679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=331.13 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=196.1
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhcccc-ccceeeeEeecCCceeEEE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHR-NLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~-niv~l~~~~~~~~~~~lv~ 306 (552)
+|++.+.||+|+||.||+|..+ +++.||+|+++.... ......+..|..++..+.|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999965 578999999975322 22344677889999888765 5888999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-K 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-C
Confidence 9999999999998888899999999999999999999998 99999999999999999999999999987532222 2
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......||..|+|||++.+..++.++|||||||++|||+||+.||...... ....... .. ..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~---------~~--~~ 218 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQSIM---------EH--NV 218 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHH---------cC--CC
Confidence 233456999999999999999999999999999999999999999743211 1111111 00 01
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKM 494 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 494 (552)
.++...+.++.+++.+||+.||.+|++.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1222344678999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=324.83 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=200.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC-C--cEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD-G--TVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 305 (552)
++|++.+.||+|+||.||+|..++ + ..+++|.++..........+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998753 3 347888887543333455788999999998 799999999999999999999
Q ss_pred EeeccCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCce
Q 008828 306 YPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 369 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 369 (552)
+||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 9999999999998643 2488899999999999999999998 99999999999999999999
Q ss_pred EEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHH
Q 008828 370 VVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK 448 (552)
Q Consensus 370 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 448 (552)
||+|||++...... ........+..|+|||.+.+..++.++|||||||++|||+| |..||..... .....
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-------~~~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-------AELYE 229 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH
Confidence 99999998643211 11111123567999999998899999999999999999998 9899864321 11111
Q ss_pred HHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 449 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.... ......+...+..+.+++.+||+.+|.+||++.++++.|+..
T Consensus 230 ~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 230 KLPQ----------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HHhc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 111112223447789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=323.46 Aligned_cols=254 Identities=28% Similarity=0.386 Sum_probs=202.3
Q ss_pred CCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
+|.+.+.||+|+||.||+|... ....+++|.++.........++.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999853 2357999988755443344578899999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccC------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCc
Q 008828 305 VYPYMSNGSVASRLKAK------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 360 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 360 (552)
++||+.+|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 99999999999987531 2478999999999999999999998 99999999999
Q ss_pred eeeCCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccc
Q 008828 361 ILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTAN 438 (552)
Q Consensus 361 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~ 438 (552)
|++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||+| |..||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999765332221 1122335678999999988899999999999999999999 9888853221
Q ss_pred cccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 439 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
..+..++ . .......+...+.++.+++.+||+.+|++||++.|+++.|++.
T Consensus 236 --~~~~~~~---~----------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 236 --ERLFNLL---K----------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred --HHHHHHH---h----------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 0111111 1 1111111223346799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.78 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=204.6
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCc
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~ 301 (552)
.++|...+.||+|+||.||+|... .+..||+|.++..........+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 456888999999999999999742 34579999987654333445688999999999 79999999999999999
Q ss_pred eeEEEeeccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 302 RLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
.++||||+++|+|.++++... .+++.++..++.|++.||.|||++ +|+|+||||+||+++.++.++++|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999997533 389999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchh
Q 008828 380 LDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457 (552)
Q Consensus 380 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (552)
....... ......++..|+|||.+.+..++.++|||||||++|||+| |..||....... ......
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~------- 257 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLI------- 257 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHH-------
Confidence 5432221 1222345678999999999999999999999999999998 888886422110 000001
Q ss_pred hhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 458 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
........+...+..+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 258 ---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 258 ---KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---HcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0011111112234679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=329.35 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=211.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchH-HHHHHHHHHHhhccccccceeeeEeecCCc-eeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGE-IQFQTEVEMISLAVHRNLLRLIGFCMTTTE-RLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~~~h~niv~l~~~~~~~~~-~~lv~ 306 (552)
++|...+.+|+|+||.++..+++ ++..+++|.+.-....+.. ....+|+.++++++|||||.+.+.+..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46888899999999999999865 5789999999754433333 357889999999999999999999998888 89999
Q ss_pred eeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 307 PYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 307 e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
+|++||++.+.+... ..++++.+..++.|++.|+.|||++ +|+|||||+.||+++.+..|||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999743 4789999999999999999999988 99999999999999999999999999999887544
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
. ......||+.|+.||++.+.+|..|+|||||||++|||++-+++|...... ..+-.+. . ..
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-------~Li~ki~---------~-~~ 222 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-------ELILKIN---------R-GL 222 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-------HHHHHHh---------h-cc
Confidence 2 345567999999999999999999999999999999999999999753321 1111111 1 11
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+..+..++..++..|++.+|+.||++.+++.+
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 233456667889999999999999999999999875
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=334.36 Aligned_cols=263 Identities=21% Similarity=0.225 Sum_probs=205.4
Q ss_pred HHHHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecC
Q 008828 223 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT 299 (552)
Q Consensus 223 ~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 299 (552)
.++....++|++.+.||+|+||.||++..+ +++.||+|++..... ......+.+|+.++..++||||+++++++...
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344556689999999999999999999976 588999999864221 12234577899999999999999999999999
Q ss_pred CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 300 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
...++||||+++|+|.+++... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 9999999999999999998754 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeecccccccccCchhhccC----CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcc
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 455 (552)
.............||+.|+|||++... .++.++|||||||++|||++|+.||..... ......+.....
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~ 264 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMNHKN 264 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCC
Confidence 654333233445699999999998754 378999999999999999999999974321 111111111100
Q ss_pred hhhhccccccCcCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHhc
Q 008828 456 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSL--RPKMSEVVRMLEG 503 (552)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~~ 503 (552)
. +........+..+.+++.+|+..++.+ ||++.|++++..-
T Consensus 265 ~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 265 S-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred c-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 0 000011123467889999999844443 7899999887643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=317.07 Aligned_cols=257 Identities=20% Similarity=0.314 Sum_probs=207.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||.||+|+.. +++.||||.++.... ......+.+|+.+++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999965 689999998864322 223446889999999999999999999999999999999
Q ss_pred eeccCCChhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 307 PYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 307 e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
||+++|+|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875 234589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+........
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~~~~~~-------- 224 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQKIEQCD-------- 224 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHHHhcCC--------
Confidence 221 12234588899999999988899999999999999999999999864221 1112222211100
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
..+......+..+.+++.+||+.+|++||++.+|++.++..
T Consensus 225 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 -YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11111223457799999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.81 Aligned_cols=247 Identities=27% Similarity=0.348 Sum_probs=197.4
Q ss_pred eeeeeCceEEEEEEEC---CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCC
Q 008828 237 LVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 313 (552)
Q Consensus 237 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 313 (552)
.||+|+||.||+|.+. ++..||+|+++..........+.+|+.++++++||||+++++++. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 355799999976544334456899999999999999999999875 457899999999999
Q ss_pred hhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceee--c
Q 008828 314 VASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT--A 390 (552)
Q Consensus 314 L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~--~ 390 (552)
|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++............ .
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999874 45799999999999999999999998 9999999999999999999999999999865433322111 1
Q ss_pred ccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCC
Q 008828 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469 (552)
Q Consensus 391 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (552)
..++..|+|||.+....++.++|||||||++||+++ |..||..... .++....... .....+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~----------~~~~~~ 220 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-------PEVMSFIEQG----------KRLDCP 220 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHCC----------CCCCCC
Confidence 223578999999988889999999999999999996 9998864321 1111111111 111222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 470 RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 470 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
..++.++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 33457899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=335.97 Aligned_cols=265 Identities=22% Similarity=0.275 Sum_probs=201.5
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc-cCchHHHHHHHHHHHhhccccccceeeeEeecCC-----cee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-----ERL 303 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-----~~~ 303 (552)
+|++.+.||+|+||+||+|... +++.||+|.+.... .......+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999964 68999999986432 2223456889999999999999999999998776 789
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
+|+||+. ++|.+.+.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999996 58888887777899999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHH--------HHHHhhhc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW--------VKKIHQEK 454 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 454 (552)
.........++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+.+. +.... ..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~ 235 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EG 235 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh-HH
Confidence 33333334578999999998774 4799999999999999999999999754322111100000 00000 00
Q ss_pred chhhhccccccC-------cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 455 KLEMLVDKDLKN-------NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 455 ~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+....... .......+++.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000 0111224678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=301.68 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=206.5
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC---c----hHHHHHHHHHHHhhc-cccccceeeeEee
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI---G----GEIQFQTEVEMISLA-VHRNLLRLIGFCM 297 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~----~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 297 (552)
.....|...+.+|+|..++|.++.++ +|..+|+|++...... + -.+.-.+|+.+|+++ .||+|+.+.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34456778889999999999998865 6888999988532211 1 122456799999988 5999999999999
Q ss_pred cCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccc
Q 008828 298 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 377 (552)
Q Consensus 298 ~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 377 (552)
.+...++|+|.|+.|.|++++.+.-.++++...+|+.|+..|++|||.. .||||||||+|||+|++.++||+|||++
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecccee
Confidence 9999999999999999999999999999999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeecccccccccCchhhcc------CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHh
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 451 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 451 (552)
..+..+ ..-...+||++|+|||.+.- ..|+..+|+||.|||+|.|+.|.+||..... +. +-...
T Consensus 171 ~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------ml--MLR~I 240 (411)
T KOG0599|consen 171 CQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------ML--MLRMI 240 (411)
T ss_pred eccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------HH--HHHHH
Confidence 987643 34566789999999998853 3588899999999999999999999963211 00 00111
Q ss_pred hhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 452 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
.++.. ...++-....+....+||.+|++.||++|.|++|++++-
T Consensus 241 meGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 241 MEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred Hhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 11111 111222234457789999999999999999999998653
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=322.22 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=206.9
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEECC-----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeec-CCc
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTE 301 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~ 301 (552)
..++|.+.+.||+|+||.||+|.+.+ +..|++|+++..........+.+|+.++..++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45678889999999999999999765 688999998755444445668899999999999999999998776 467
Q ss_pred eeEEEeeccCCChhhhhccC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcc
Q 008828 302 RLLVYPYMSNGSVASRLKAK--------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 373 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~--------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 373 (552)
.++++||+++|+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998642 4589999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHh
Q 008828 374 FGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIH 451 (552)
Q Consensus 374 fg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 451 (552)
||+++.+....... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||..... .++.....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-------FEMAAYLK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-------HHHHHHHH
Confidence 99998654332221 122346778999999998899999999999999999999 9998864221 11111111
Q ss_pred hhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 452 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
..... ......++++.+++.+||+.+|++|||+.++++.|++.
T Consensus 234 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 234 DGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred cCCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11110 11122346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=337.25 Aligned_cols=259 Identities=22% Similarity=0.331 Sum_probs=204.4
Q ss_pred HHHhcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeec
Q 008828 226 QSATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMT 298 (552)
Q Consensus 226 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~ 298 (552)
....++|.+.+.||+|+||.||+|++. .+..||+|+++..........+.+|+.++.++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344456788899999999999999864 246899999976543333456889999999997 9999999999999
Q ss_pred CCceeEEEeeccCCChhhhhccC---------------------------------------------------------
Q 008828 299 TTERLLVYPYMSNGSVASRLKAK--------------------------------------------------------- 321 (552)
Q Consensus 299 ~~~~~lv~e~~~~g~L~~~l~~~--------------------------------------------------------- 321 (552)
....++||||+++|+|.++++..
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 99999999999999999988532
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCc
Q 008828 322 -----------------------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 360 (552)
Q Consensus 322 -----------------------------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 360 (552)
..+++..+..++.|++.||.|||+. +|+||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 1367778899999999999999998 99999999999
Q ss_pred eeeCCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccc
Q 008828 361 ILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTAN 438 (552)
Q Consensus 361 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~ 438 (552)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~- 348 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN- 348 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-
Confidence 99999999999999999865322211 1122346788999999998889999999999999999998 88887532210
Q ss_pred cccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 439 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....... ........+...+.++.+++.+||+.+|.+||+++|+++.|+.
T Consensus 349 ------~~~~~~~---------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 349 ------EQFYNAI---------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred ------HHHHHHH---------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0000100 0111111222335789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=338.65 Aligned_cols=254 Identities=19% Similarity=0.225 Sum_probs=199.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||+||++... +++.||||++..... ......+.+|++++..++||||+++++++......++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999864 689999999864321 223446888999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999999998888899999999999999999999999 9999999999999999999999999998633210000
Q ss_pred ----------------------------------------------eeecccccccccCchhhccCCCCCccchhHHHHH
Q 008828 387 ----------------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGIL 420 (552)
Q Consensus 387 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~ 420 (552)
......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012458999999999999999999999999999
Q ss_pred HHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCC---CCHHHH
Q 008828 421 LLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLR---PKMSEV 497 (552)
Q Consensus 421 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ev 497 (552)
+|||+||+.||...... .......... ..+.-+ . ....+.++.+++.+|+. +|.+| +++.|+
T Consensus 238 l~elltG~~Pf~~~~~~-------~~~~~i~~~~--~~~~~p---~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 238 MFECLIGWPPFCSENSH-------ETYRKIINWR--ETLYFP---D--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhcCCCCCCCCCHH-------HHHHHHHccC--CccCCC---C--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 99999999999643221 1111111000 000000 0 01124678899999998 66665 599998
Q ss_pred HHHH
Q 008828 498 VRML 501 (552)
Q Consensus 498 l~~L 501 (552)
+.+-
T Consensus 303 l~hp 306 (377)
T cd05629 303 KSHP 306 (377)
T ss_pred hcCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=329.64 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=196.0
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 306 (552)
+|.+.+.||+|+||.||+|... +++.||+|+++.... ......+..|..++... +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999976 578999999975432 12233466777777766 5899999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+.+.....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-V 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-C
Confidence 9999999999998877899999999999999999999998 99999999999999999999999999997543222 1
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ........ .. .
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------~~~~~i~~---------~~--~ 218 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIME---------HN--V 218 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-------HHHHHHHh---------CC--C
Confidence 233456899999999999999999999999999999999999999743211 11111111 00 1
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKM 494 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 494 (552)
.++...+.++.+++.+|++.+|++|++.
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1223345778999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=328.24 Aligned_cols=243 Identities=27% Similarity=0.323 Sum_probs=197.4
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||+||+|... +++.||+|+++.... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 578999999975421 22334567888888877 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|+|..++.....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTF 156 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccce
Confidence 99999998887899999999999999999999999 99999999999999999999999999987532211 122334
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.|+..|+|||++.+..++.++|||||||++|+|+||+.||..... .......... . ..++..
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-------~~~~~~i~~~---------~--~~~~~~ 218 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-------DELFQSILED---------E--VRYPRW 218 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHcC---------C--CCCCCc
Confidence 689999999999999999999999999999999999999964321 1111111110 0 112223
Q ss_pred HHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKM-----SEVVRM 500 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 500 (552)
.+..+.+++.+||+.||++||++ .+++++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 45778999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=322.89 Aligned_cols=251 Identities=26% Similarity=0.345 Sum_probs=201.2
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
+|+..+.||+|+||+||++... +++.||+|.+...... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777889999999999999964 6899999998643221 223457789999999999999999999999999999999
Q ss_pred eccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 308 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 9999999988753 34689999999999999999999999 99999999999999999999999999998754322
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....+... + .. ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~--------~-~~-~~ 221 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERR--------V-KE-DQ 221 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHH--------h-hh-cc
Confidence 1223458999999999999899999999999999999999999997432110 00001000 0 00 01
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 500 (552)
..++...+..+.+++.+||+.||++|| ++++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 122334557789999999999999999 77787655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.79 Aligned_cols=256 Identities=18% Similarity=0.214 Sum_probs=199.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||+||+++.. +++.||+|++..... ......+.+|+.++...+|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999975 578999999864321 122345788999999999999999999999999999999
Q ss_pred eeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999976 46789999999999999999999998 999999999999999999999999999987654333
Q ss_pred ceeecccccccccCchhhcc-----CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 386 HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
.......||+.|+|||++.+ +.++.++|||||||++|||++|+.||..... ............. .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~--~- 227 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHEER--F- 227 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-------HHHHHHHHcCCCc--c-
Confidence 23334569999999999875 4678899999999999999999999964321 1111111111000 0
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSL--RPKMSEVVRML 501 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 501 (552)
.+ +......++++.+++.+|+..++++ |+++++++++-
T Consensus 228 --~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 228 --QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred --cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 00 0111123467889999999876554 46788777653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.40 Aligned_cols=242 Identities=26% Similarity=0.329 Sum_probs=194.4
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhh-ccccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISL-AVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||+||+|... +++.||+|+++.... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 578999999975421 2223446667777775 4899999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeee
Confidence 99999998877899999999999999999999999 99999999999999999999999999987532222 122345
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.||..|+|||++.+..++.++|||||||++|||++|+.||..... .......... . ..++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~-------~----~~~~~~ 218 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-------EELFQSIRMD-------N----PCYPRW 218 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhC-------C----CCCCcc
Confidence 689999999999999999999999999999999999999964321 1111111100 0 112222
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKMS-EVVR 499 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~~-evl~ 499 (552)
...++.+++.+||+.||++||++. ++.+
T Consensus 219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 346789999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=339.05 Aligned_cols=253 Identities=20% Similarity=0.224 Sum_probs=199.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++..++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999965 589999999864321 122345788999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC--
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-- 384 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-- 384 (552)
||+++|+|.+++...+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999998888899999999999999999999999 99999999999999999999999999975321000
Q ss_pred ----------------------------------------CceeecccccccccCchhhccCCCCCccchhHHHHHHHHH
Q 008828 385 ----------------------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 424 (552)
Q Consensus 385 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el 424 (552)
........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001134699999999999999999999999999999999
Q ss_pred HhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 008828 425 ISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRP---KMSEVVRM 500 (552)
Q Consensus 425 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~ 500 (552)
++|+.||...... .+......... ..........+..+.+++.+|+ .+|.+|+ ++.|++.+
T Consensus 238 l~G~~Pf~~~~~~-------~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPA-------ETQLKVINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHH-------HHHHHHhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999753321 11111110000 0000001122356778888876 5999999 88888866
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=327.17 Aligned_cols=242 Identities=25% Similarity=0.314 Sum_probs=194.3
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhh-ccccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISL-AVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||.||+|..+ +|+.||+|.++.... ......+..|..++.. .+||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 588999999975421 1223446667777765 4899999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|+|..++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceecc
Confidence 99999998877899999999999999999999999 99999999999999999999999999987432211 223345
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.||..|+|||++.+..++.++|||||||++|||++|+.||...... ......... . ..++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~~~-------~----~~~~~~ 218 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIRVD-------T----PHYPRW 218 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC-------C----CCCCCC
Confidence 6999999999999999999999999999999999999999643211 111111100 0 112222
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKMS-EVVR 499 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~~-evl~ 499 (552)
...++.+++.+||+.||++||++. ++.+
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 346789999999999999999985 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=338.33 Aligned_cols=252 Identities=20% Similarity=0.217 Sum_probs=196.9
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
+|+..+.||+|+||+||+|+.. +++.||+|++..... ......+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999964 688999999965321 2234468899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC---
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD--- 384 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--- 384 (552)
|+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999998777899999999999999999999999 99999999999999999999999999975321000
Q ss_pred -------------------------------------------CceeecccccccccCchhhccCCCCCccchhHHHHHH
Q 008828 385 -------------------------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 421 (552)
Q Consensus 385 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l 421 (552)
........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001224689999999999999999999999999999
Q ss_pred HHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHH
Q 008828 422 LELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK---MSEVV 498 (552)
Q Consensus 422 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 498 (552)
|||++|+.||........ ....... ............+.++.+++.+++ .+|++|++ +.|++
T Consensus 239 ~elltG~~Pf~~~~~~~~-------~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 239 YEMLVGQPPFLAQTPLET-------QMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHhCCCCCCCCCHHHH-------HHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 999999999974322110 0011000 000000011122356778787765 49999997 77776
Q ss_pred HH
Q 008828 499 RM 500 (552)
Q Consensus 499 ~~ 500 (552)
++
T Consensus 304 ~h 305 (382)
T cd05625 304 AH 305 (382)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=321.62 Aligned_cols=262 Identities=23% Similarity=0.349 Sum_probs=205.7
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECC-----------------CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccce
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQD-----------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~ 291 (552)
..+|.+.+.||+|+||.||+|...+ +..||+|.+...........+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999998542 24689999876554445567889999999999999999
Q ss_pred eeeEeecCCceeEEEeeccCCChhhhhccCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCc
Q 008828 292 LIGFCMTTTERLLVYPYMSNGSVASRLKAKP-----------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 360 (552)
Q Consensus 292 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 360 (552)
+++++......+++|||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999987544 689999999999999999999998 99999999999
Q ss_pred eeeCCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh--CCCccccCccc
Q 008828 361 ILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS--GLRALEFGKTA 437 (552)
Q Consensus 361 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt--g~~p~~~~~~~ 437 (552)
|++++++.++|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 99999999999999999765432221 2223446778999999998899999999999999999998 5566643211
Q ss_pred ccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 438 NQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
................ ......+...+.++.+++.+||+.||++|||+.|+++.|+.
T Consensus 240 ---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 ---QQVIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---HHHHHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111111111111000 00011122334789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=319.71 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=202.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCc----EEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
++|+..+.||+|+||+||+|.+. ++. .||+|.++..........+.+|+.++..+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56788899999999999999853 444 4899999765444445678899999999999999999999875 45779
Q ss_pred EEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
++||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 9999999999999976 45689999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 384 DSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 384 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
.... .....++..|+|||.+.+..++.++|||||||++|||+| |..||..... .....++..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~------------ 226 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLLEK------------ 226 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHC------------
Confidence 2221 112235678999999999999999999999999999998 8888763221 111111110
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
......+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 227 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 227 -GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred -CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 001111223446789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=314.73 Aligned_cols=248 Identities=28% Similarity=0.435 Sum_probs=199.8
Q ss_pred CeeeeeCceEEEEEEECC----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||.||+|++.. +..+|+|.++.........++.+|+++++.+.||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 36899999976554445567899999999999999999999876 4567999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeec-
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA- 390 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~- 390 (552)
|+|.+++.....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++............
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999998877899999999999999999999998 99999999999999999999999999998664433222111
Q ss_pred -ccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 391 -VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 391 -~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
..++..|+|||.+.+..++.++|||||||++|||++ |..||..... .....+ ...... ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~---~~~~~~----------~~~ 219 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAM---LESGER----------LPR 219 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHH---HHcCCc----------CCC
Confidence 123568999999999999999999999999999998 8998864321 111111 111110 011
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 222346789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=322.69 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=204.1
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCC
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT 300 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 300 (552)
...++|++.+.||+|+||.||+|..+ .+..||+|.++..........+.+|+..++.++||||+++++++....
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34678999999999999999999754 245899999875543334456888999999999999999999999999
Q ss_pred ceeEEEeeccCCChhhhhccC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceE
Q 008828 301 ERLLVYPYMSNGSVASRLKAK----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 370 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 370 (552)
..++||||+++|+|.+++... ...++..+..++.|++.||.|||++ +|+||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999632 3456778899999999999999998 999999999999999999999
Q ss_pred EcccccceecCCCCCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHH
Q 008828 371 VGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK 448 (552)
Q Consensus 371 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 448 (552)
|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... .++..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-------~~~~~ 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVLK 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH
Confidence 99999988654322111 112235678999999999999999999999999999999 6777753211 11111
Q ss_pred HHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 449 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
....... ...+...+..+.+++.+|++.+|++|||+.++++.|++.
T Consensus 233 ~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 FVMDGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111100 011222347899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=314.02 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=202.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
++|.+.+.||+|+||.||+|..+++..+|+|.+..... ....+.+|+.+++.++|||++++++++. ....+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 45788899999999999999988777899998865432 2456889999999999999999999875 45688999999
Q ss_pred cCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 310 SNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 310 ~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
.+|+|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999753 3589999999999999999999998 99999999999999999999999999998764332222
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....++..|+|||...+..++.++|||||||++|||+| |..||...... .... ..... ...
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~---~~~~~----------~~~ 222 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLE---QVERG----------YRM 222 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH---HHHcC----------CCC
Confidence 223346778999999998999999999999999999999 88888642211 1111 11110 011
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
..+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1222345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.15 Aligned_cols=255 Identities=25% Similarity=0.429 Sum_probs=204.3
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECC------CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCce
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 302 (552)
.++|.+.+.||+|+||.||+|...+ +..||+|.+...........+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578888999999999999998642 4689999987554434455788999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhccC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEc
Q 008828 303 LLVYPYMSNGSVASRLKAK----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG 372 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 372 (552)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 9999999999999998632 2478889999999999999999998 99999999999999999999999
Q ss_pred ccccceecCCCCC-ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHH
Q 008828 373 DFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKI 450 (552)
Q Consensus 373 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 450 (552)
|||+++....... .......++..|+|||.+.+..++.++|||||||++|||+| |..||...... ....+ .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~~---~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE----EVLKF---V 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH----HHHHH---H
Confidence 9999876543221 11223346789999999998899999999999999999998 88887532211 11111 1
Q ss_pred hhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 451 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
. ... ....+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 235 ~-~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 I-DGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred h-cCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1 110 011122235789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=321.66 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=203.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
.+|.+.+.||+|+||.||+|... ++..+++|.++... ......+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45777899999999999999742 35578999886433 223456889999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC
Q 008828 304 LVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 367 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 367 (552)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 999999999999998643 2489999999999999999999999 999999999999999999
Q ss_pred ceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHH
Q 008828 368 EAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLD 445 (552)
Q Consensus 368 ~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 445 (552)
.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||...... .
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~ 233 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------E 233 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------H
Confidence 9999999999755432211 1223346788999999999999999999999999999999 99988643221 1
Q ss_pred HHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 446 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
...... ... ....+...+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 234 ~~~~~~-~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 234 VIECIT-QGR---------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHHh-CCC---------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111 110 0111222356789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=324.29 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=200.4
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCc--EEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGT--VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~l 304 (552)
.++|++.+.||+|+||.||+|.++ ++. .+|+|.++..........+.+|+.++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 356888899999999999999965 344 46888776544334455788999999999 89999999999999999999
Q ss_pred EEeeccCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc
Q 008828 305 VYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 368 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 368 (552)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 99999999999998633 2578999999999999999999998 9999999999999999999
Q ss_pred eEEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHH
Q 008828 369 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWV 447 (552)
Q Consensus 369 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 447 (552)
+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|||+| |..||..... .+..
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~ 233 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELY 233 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-------HHHH
Confidence 9999999986432111 1111224668999999988889999999999999999998 9998863221 1111
Q ss_pred HHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 448 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
...... .....+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 234 ~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 234 EKLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHhcC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 01111122346789999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=322.53 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=200.9
Q ss_pred CCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
+|.+.+.||+|+||.||+|... ++..||+|+++..........+.+|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556688999999999999853 2578999999754433334568899999999999999999999999999999
Q ss_pred EEeeccCCChhhhhcc----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc
Q 008828 305 VYPYMSNGSVASRLKA----------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 368 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 368 (552)
++||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 9999999999998742 23478889999999999999999998 9999999999999999999
Q ss_pred eEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHH
Q 008828 369 AVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDW 446 (552)
Q Consensus 369 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 446 (552)
+||+|||+++........ ......+++.|+|||.+.++.++.++|||||||++|||+| |..||..... .++
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~ 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDV 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------HHH
Confidence 999999998765432211 1223345778999999998899999999999999999998 7777753211 122
Q ss_pred HHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 447 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
........ ....+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 236 ~~~i~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQ----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCC----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22211111 011223345778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=321.31 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=202.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
.+|.+.+.||+|+||+||++... ++..+|+|.+.... ......+.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 56888899999999999999842 34578999886533 223456889999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCC-------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceE
Q 008828 304 LVYPYMSNGSVASRLKAKP-------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 370 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~-------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 370 (552)
+||||+++++|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 489999999999999999999998 999999999999999999999
Q ss_pred EcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHH
Q 008828 371 VGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK 448 (552)
Q Consensus 371 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 448 (552)
|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||+| |..||...... ....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------~~~~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EVIE 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH
Confidence 9999999765332211 1122335778999999998899999999999999999999 88887533211 1111
Q ss_pred HHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 449 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
..... ... ..+...+..+.+++.+||+.+|.+|||+.|+.+.|++.
T Consensus 234 ~i~~~-~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 234 CITQG-RVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HHHcC-CcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11111 000 01112346799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.74 Aligned_cols=245 Identities=24% Similarity=0.295 Sum_probs=195.0
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCCh
Q 008828 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 314 (552)
Q Consensus 238 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 314 (552)
||+|+||+||++... +++.||+|.+...... .....+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 6889999998643221 1234577899999999999999999999999999999999999999
Q ss_pred hhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeec
Q 008828 315 ASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 390 (552)
Q Consensus 315 ~~~l~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 390 (552)
...+. ....+++..+..++.||+.||.|||+. +|+||||||+||++++++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 88763 345699999999999999999999999 999999999999999999999999999986644322 2233
Q ss_pred ccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCH
Q 008828 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 470 (552)
Q Consensus 391 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (552)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ...... +.... ..++.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~---------~~~~~--~~~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQR---------ILNDS--VTYPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHh---------hcccC--CCCcc
Confidence 46899999999999999999999999999999999999999743221100 000000 11110 11223
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008828 471 IELEEMVQVALLCTQYLPSLRP-----KMSEVVRM 500 (552)
Q Consensus 471 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 500 (552)
..+..+.+++.+||+.||++|| ++++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 3457789999999999999999 66666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=321.54 Aligned_cols=260 Identities=22% Similarity=0.365 Sum_probs=200.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC---------------CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD---------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~ 294 (552)
++|.+.+.||+|+||.||++...+ ...||+|.++..........|.+|++++.+++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987542 23589999975543334457899999999999999999999
Q ss_pred EeecCCceeEEEeeccCCChhhhhccC------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCcee
Q 008828 295 FCMTTTERLLVYPYMSNGSVASRLKAK------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 362 (552)
Q Consensus 295 ~~~~~~~~~lv~e~~~~g~L~~~l~~~------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 362 (552)
++......++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 999999999999999999999988532 2478899999999999999999999 9999999999999
Q ss_pred eCCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh--CCCccccCccccc
Q 008828 363 LDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS--GLRALEFGKTANQ 439 (552)
Q Consensus 363 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt--g~~p~~~~~~~~~ 439 (552)
+++++.+||+|||++......... ......++..|+|||.+..+.++.++|||||||++|+|++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 999999999999999765432211 1122335678999999999999999999999999999998 4455543211
Q ss_pred ccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 440 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
............... .......+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 239 -~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 -EQVIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111111000 00001111223468999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=329.45 Aligned_cols=239 Identities=23% Similarity=0.289 Sum_probs=195.8
Q ss_pred CeeeeeCceEEEEEEE----CCCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeecc
Q 008828 236 NLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 310 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 310 (552)
+.||+|+||.||++.. .+|+.||+|+++..... .....+..|++++.+++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 35789999999753321 223457789999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeec
Q 008828 311 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 390 (552)
Q Consensus 311 ~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 390 (552)
+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++...... .....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 999999998777899999999999999999999999 99999999999999999999999999997654322 22334
Q ss_pred ccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCH
Q 008828 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 470 (552)
Q Consensus 391 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (552)
..|+..|+|||.+.+..++.++|||||||++|||+||+.||..... .......... . ...+.
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-------~~~~~~i~~~---------~--~~~p~ 219 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-------KETMTMILKA---------K--LGMPQ 219 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-------HHHHHHHHcC---------C--CCCCC
Confidence 5689999999999988899999999999999999999999974321 1111111110 0 01222
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHH
Q 008828 471 IELEEMVQVALLCTQYLPSLRPKMSE 496 (552)
Q Consensus 471 ~~~~~l~~li~~cl~~dP~~RPs~~e 496 (552)
..+..+.+++.+||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 33467899999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.75 Aligned_cols=239 Identities=27% Similarity=0.286 Sum_probs=191.4
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHH-HHhhccccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||+||+|... +|+.||+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 689999999964321 112234455554 45778999999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|+|..++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 156 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTF 156 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccccc
Confidence 99999998888899999999999999999999999 9999999999999999999999999998753221 1223345
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......... ... .....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~---------~~~--~~~~~ 218 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYDNILN---------KPL--RLKPN 218 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHHHHHc---------CCC--CCCCC
Confidence 689999999999999999999999999999999999999974321 111111111 100 11122
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHH
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKMSE 496 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~~e 496 (552)
.+..+.+++.+|++.||++||++.+
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 3477899999999999999999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=316.00 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=205.4
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CC---cEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
.++|+..+.||+|+||.||+|... ++ ..+|+|.++..........+..|+.++..++|||++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346778899999999999999975 23 37999998754433345578899999999999999999999999999999
Q ss_pred EEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
||||+++++|.+++.. ...+++..+..++.|++.|+.|||+. +++||||||+||++++++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999999875 35789999999999999999999998 9999999999999999999999999999866433
Q ss_pred CCceee--cccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 384 DSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 384 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
...... ....+..|+|||++....++.++|||||||++|||+| |+.||..... ..+...+....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~~~~~i~~~~------ 227 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HEVMKAINDGF------ 227 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHHHHHhcCC------
Confidence 222111 1123457999999998899999999999999999998 9999864321 11222221110
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
........+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111222347789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=315.90 Aligned_cols=254 Identities=27% Similarity=0.398 Sum_probs=204.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC----CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
.+|.+.+.||+|+||.||+|... .+..+|+|.++..........+..|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999863 23479999987544333455789999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|||+++++|.+++... ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999754 4689999999999999999999998 99999999999999999999999999998765433
Q ss_pred Cceeec--ccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 385 SHVTTA--VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 385 ~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
...... ..++..|+|||.+.+..++.++|||||||++||+++ |..||...... +.........
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~~~~------- 226 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-------DVIKAIEEGY------- 226 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-------HHHHHHhCCC-------
Confidence 222211 123568999999998899999999999999999887 99988643211 1111111110
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 227 ---RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 011122234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=322.91 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=204.0
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC--------CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeec
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMT 298 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 298 (552)
...+|.+.+.||+|+||.||+|... ++..||+|.++..........+.+|+.++..+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3456888899999999999999741 24579999987544334455788999999999 89999999999999
Q ss_pred CCceeEEEeeccCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCcee
Q 008828 299 TTERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 362 (552)
Q Consensus 299 ~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 362 (552)
....++||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 99999999999999999998642 2478889999999999999999999 9999999999999
Q ss_pred eCCCCceEEcccccceecCCCCCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccc
Q 008828 363 LDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQK 440 (552)
Q Consensus 363 l~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~ 440 (552)
+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||+| |..|+....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----- 244 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 244 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----
Confidence 9999999999999998764332221 122335678999999999899999999999999999998 677764321
Q ss_pred cchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 441 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
...+........ ....+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 245 --~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 245 --VEELFKLLKEGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred --HHHHHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 112222221111 011122345779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=315.12 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=206.3
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
..++|.+.+.||+|+||.||+|..+++..||+|.+..... ....+.+|+.+++.++|+||+++++++......++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3467889999999999999999988888999999875432 34568899999999999999999999998889999999
Q ss_pred eccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 308 YMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|+++++|.+++... ..+++..+..++.|++.|+.|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999999754 3689999999999999999999999 999999999999999999999999999986653222
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
.......++..|+|||.+.+..++.++|||||||++|||+| |+.||..... .......... .
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------~~~~~~~~~~----------~ 221 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-------REVLEQVERG----------Y 221 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcC----------C
Confidence 21222234568999999998899999999999999999999 8888853221 1111111110 0
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011111224679999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=324.16 Aligned_cols=255 Identities=29% Similarity=0.400 Sum_probs=202.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC--------CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecC
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 299 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~ 299 (552)
.++|.+.+.||+|+||.||+|... +...+|+|.++..........+..|+.++..+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357889999999999999999852 23579999997654333445688899999999 799999999999999
Q ss_pred CceeEEEeeccCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee
Q 008828 300 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 363 (552)
...++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 9999999999999999999643 2488999999999999999999998 99999999999999
Q ss_pred CCCCceEEcccccceecCCCCCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCccccccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG 441 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~ 441 (552)
+.++.+||+|||.++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 999999999999987654322111 111224568999999999899999999999999999998 7777753211
Q ss_pred chHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 442 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.+........ .....+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 249 --~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 249 --EELFKLLKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred --HHHHHHHHcC----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 1111111111 1111222345788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=312.43 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=208.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||.||+|... +|+.||+|.++.... ......+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 789999999864322 223457889999999999999999999999999999999
Q ss_pred eeccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 307 PYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 307 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998853 34689999999999999999999998 999999999999999999999999999886543
Q ss_pred CCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+........
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--------- 223 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEKC--------- 223 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHHHHhhhhcC---------
Confidence 3222 2234588899999999988899999999999999999999999864321 111111111110
Q ss_pred cccCcCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 463 DLKNNYD-RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 463 ~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.....+ ...+..+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 224 -~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 224 -DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 011111 23456889999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.22 Aligned_cols=255 Identities=22% Similarity=0.271 Sum_probs=204.1
Q ss_pred HHHhcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCC---
Q 008828 226 QSATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--- 300 (552)
Q Consensus 226 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~--- 300 (552)
....++|.+.+.||+|+||+||+|.. .+++.||||++..... ......+.+|+..+..++|+|++++.+.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457899999999999999999985 4689999999965432 223446888999999999999999988765432
Q ss_pred -----ceeEEEeeccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEE
Q 008828 301 -----ERLLVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV 371 (552)
Q Consensus 301 -----~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 371 (552)
..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 25799999999999998863 34689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCC-CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHH
Q 008828 372 GDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 450 (552)
Q Consensus 372 ~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 450 (552)
+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+...
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~ 257 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKT 257 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHH
Confidence 9999998654322 1223345699999999999999999999999999999999999999964221 1222211
Q ss_pred hhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 451 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.... ....+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 258 ~~~~----------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGR----------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1110 011223345779999999999999999999999864
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=315.21 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=202.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.+|++.+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|+.++.+++||||+++++++......++||||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 5788999999999999999996 4688999999864432 2334678899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++........ ..
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KR 163 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-cc
Confidence 99999999998777899999999999999999999998 999999999999999999999999999986542211 12
Q ss_pred ecccccccccCchhhc---cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 389 TAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
....|+..|+|||.+. ...++.++|||||||++|||++|+.|+.......... . ... .....+...
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---~----~~~----~~~~~~~~~ 232 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---L----MSK----SNFQPPKLK 232 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---e----eec----CCCCCCCCc
Confidence 3345888999999884 3457889999999999999999999985322110000 0 000 000000000
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
.....+..+.+++.+||+.+|++|||+++++++|
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 --DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0112346789999999999999999999999765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=324.54 Aligned_cols=244 Identities=23% Similarity=0.260 Sum_probs=194.6
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||+||+|... +++.||+|+++..... .....+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 5789999999754322 2234577899988887 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|+|..++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTF 156 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceecc
Confidence 99999998777899999999999999999999999 99999999999999999999999999987532211 223345
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.||+.|+|||++.+..++.++|||||||++|||+||+.||........ .....+........ . ...+..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~--------~--~~~p~~ 225 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILEK--------P--IRIPRF 225 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHhC--------C--CCCCCC
Confidence 699999999999999999999999999999999999999964322111 11112221111111 0 112223
Q ss_pred HHHHHHHHHHHccCCCCCCCCCH
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKM 494 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~ 494 (552)
.+..+.+++.+||+.||++||++
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCC
Confidence 34678899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=304.01 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=207.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc-cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++.|++.+.||+|.|+.||+..+. +|+.+|+|++.... ...+.+.+.+|+.+.+.++||||+++...+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 356777889999999999999864 68899999885322 2235667889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC---CCCceEEcccccceecCCC
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~~ 383 (552)
|+|.||+|..-+-....+++..+-.++.||+.+|.|+|.+ +|||||+||+|+++. ...-+||+|||++..+.
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 9999999987776666789999999999999999999999 999999999999995 34568999999999887
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
+........||++|||||++...+|+..+|||+.|||||-|+.|++||....... +. ..+... -+ .
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r----ly---e~I~~g-----~y--d 230 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LY---EQIKAG-----AY--D 230 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH----HH---HHHhcc-----cc--C
Confidence 4556667789999999999999999999999999999999999999998533211 11 111110 01 1
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+.+.....++..+|+.+|+..||.+|.|+.|++.+
T Consensus 231 ~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 231 YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1222233345788999999999999999999999854
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=315.28 Aligned_cols=252 Identities=27% Similarity=0.375 Sum_probs=195.9
Q ss_pred CCCCCeeeeeCceEEEEEEECC-Cc--EEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecC------Cc
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQD-GT--VVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TE 301 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~ 301 (552)
|.+.+.||+|+||.||+|...+ +. .||+|.++.... ......+..|+.++..++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467899999999999999754 33 689998865432 22345688999999999999999999987532 24
Q ss_pred eeEEEeeccCCChhhhhc------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccc
Q 008828 302 RLLVYPYMSNGSVASRLK------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 375 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 375 (552)
.+++|||+++|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999988773 223589999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhh
Q 008828 376 LAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQE 453 (552)
Q Consensus 376 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 453 (552)
+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcC
Confidence 998764322211 122235678999999999999999999999999999999 7888753211 1111111111
Q ss_pred cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 454 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.. ...+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 231 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NR----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 10 01112234678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=312.25 Aligned_cols=248 Identities=31% Similarity=0.437 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.++|++.+.||+|+||.||+|... |+.||+|.++.... ...++.+|+.+++.++|+||+++++++......++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 357888899999999999999876 78999999975543 456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999997654 799999999999999999999999 999999999999999999999999999986532211
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
....+..|+|||.+.++.++.++||||||+++|||++ |..||...... +........ ..
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~----------~~ 217 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPHVEKG----------YR 217 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhcC----------CC
Confidence 2235678999999998899999999999999999998 98888532110 111111100 01
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
...+...+..+.+++.+||..+|++||++.|++++|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11122235789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=330.59 Aligned_cols=243 Identities=23% Similarity=0.345 Sum_probs=203.4
Q ss_pred eeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCChh
Q 008828 237 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVA 315 (552)
Q Consensus 237 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 315 (552)
+||+|.||+||.|+.. +...+|||-+...... ..+-+.+||.+.++++|.|||+++|.+...+..-+.||.++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 7999999999999965 4678999998654332 2334789999999999999999999999999999999999999999
Q ss_pred hhhc-cCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC-CCCceEEcccccceecCCCCCceeecc
Q 008828 316 SRLK-AKPSL--DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 316 ~~l~-~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
++++ .++++ .+.++-.+.+||++||.|||++ .|||||||-.||||+ -.|.+||+|||.++.+..- ...+.++
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccccc
Confidence 9998 45777 7888999999999999999999 999999999999997 6799999999999877543 2355667
Q ss_pred cccccccCchhhccC--CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCC
Q 008828 392 RGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (552)
.||..|||||++..+ .|..++|||||||++.||.||++||.....+.... .+-+. -...++.+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---------FkVGm------yKvHP~iP 801 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---------FKVGM------YKVHPPIP 801 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---------hhhcc------eecCCCCc
Confidence 799999999999876 48999999999999999999999997544322110 00000 11235567
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 470 RIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 470 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
.+.+.+...+|++|+.+||.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 888899999999999999999999999985
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=312.00 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=204.4
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc-cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|...+.||+|++|.||+|..+ +++.|++|.+.... .......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999975 68999999986432 223345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999998753 5789999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......|+..|+|||+..+..++.++|||||||++|||+||+.||...... ........ ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~----------~~~~ 219 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILKIIR----------GVFP 219 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHc----------CCCC
Confidence 223345888999999999999999999999999999999999999643210 11111110 0111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+...+..+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1222445789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=314.39 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=199.2
Q ss_pred CCCCCeeeeeCceEEEEEEECC----CcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCc-----
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE----- 301 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~----- 301 (552)
|.+.+.||+|+||.||+|.... +..||+|+++..... .....+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4677899999999999998642 367999999754322 234578899999999999999999998876554
Q ss_pred -eeEEEeeccCCChhhhhcc------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccc
Q 008828 302 -RLLVYPYMSNGSVASRLKA------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 374 (552)
Q Consensus 302 -~~lv~e~~~~g~L~~~l~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 374 (552)
.++++||+++|+|..++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 7899999999999988842 23689999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhh
Q 008828 375 GLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 375 g~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... .........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-------~~~~~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-------HEIYDYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHc
Confidence 9998664332221 112235678999999988899999999999999999999 8888753221 111111111
Q ss_pred hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.. ....+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 231 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 GN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 10 111223345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=322.60 Aligned_cols=262 Identities=22% Similarity=0.301 Sum_probs=204.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|++.+.||+|+||.||++... ++..+|+|.++.........++.+|++++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999965 57889999987543333345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++++|.+++.....+++..+..++.|++.||.|||+.+ +++||||||+||++++++.+||+|||++...... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~ 155 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 155 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc---cc
Confidence 999999999988788999999999999999999999732 8999999999999999999999999998755322 12
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh---------------
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE--------------- 453 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------------- 453 (552)
....++..|+|||.+.+..++.++|||||||++|+|+||+.||....... ...+.......
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE----LEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh----HHHhhcCccccccccCCcccccCCCC
Confidence 33458899999999988889999999999999999999999986432110 00000000000
Q ss_pred ---------cchhhhccccccCcC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 454 ---------KKLEMLVDKDLKNNY-DRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 454 ---------~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
.....+.... .+.. ....+.++.+++.+||+.+|++|||+.|++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000000 0000 011346789999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=313.02 Aligned_cols=252 Identities=23% Similarity=0.395 Sum_probs=204.1
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.++|.+.+.||+|+||.||+|...++..+|+|.++... .....+.+|+.+++.++|+||+++.+++.. ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 46788899999999999999998778889999886532 224568899999999999999999999887 778999999
Q ss_pred ccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999999975 34688999999999999999999998 9999999999999999999999999999866433322
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......++..|+|||++....++.++|||||||++|+++| |+.||...... ....+ .... ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~---~~~~----------~~ 221 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRA---LERG----------YR 221 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHHH---HhCC----------CC
Confidence 2223345678999999998899999999999999999999 88888642211 01111 1111 00
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.......+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122334679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=312.16 Aligned_cols=251 Identities=27% Similarity=0.454 Sum_probs=203.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
.+|++.+.||+|+||.||+|.+.+++.+|+|.++.... ....+.+|++++++++|||++++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 35777899999999999999987788999999864332 2456889999999999999999999999999999999999
Q ss_pred cCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 310 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 310 ~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
++++|.+++... ..++++.+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++..........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999998753 4689999999999999999999998 999999999999999999999999999886543222222
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
....++.+|+|||.+.++.++.++||||||+++|||++ |+.||..... ........... ...
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~---~~~------- 221 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-------SEVVETINAGF---RLY------- 221 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHhCCC---CCC-------
Confidence 22335678999999998899999999999999999998 8888863221 11111111110 001
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 468 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.+...+..+.+++.+||+.+|++|||+.|++++|.
T Consensus 222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11123477999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=323.87 Aligned_cols=252 Identities=22% Similarity=0.277 Sum_probs=212.4
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECC-CcEEEEEEeccCccCch--HHHHHHHHHHHhhcc-ccccceeeeEeecCCceeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~l 304 (552)
...|++.+.||+|.||.||+++.+. |+.+|+|.+.+...... ...+.+|+++|+++. |||||.+.+++......++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3568888999999999999999764 99999999976554332 357889999999998 9999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC----CceEEcccccceec
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY----YEAVVGDFGLAKLL 380 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~~ 380 (552)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+. ||+||||||+|+|+... +.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999766 499999999999999999999998 99999999999999733 57999999999988
Q ss_pred CCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 381 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 381 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
.. .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... .+....
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~------ 254 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGD------ 254 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCC------
Confidence 75 445566789999999999999999999999999999999999999998644211110 111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..............+.+++..|+..||.+|+|+.+++++
T Consensus 255 -~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 -FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 022233334456889999999999999999999999996
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=327.32 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=199.3
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE------CCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecC-C
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT-T 300 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~-~ 300 (552)
.++|.+.+.||+|+||.||+|.. .+++.||||+++..........+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999973 347899999997654333445688999999999 689999999988654 4
Q ss_pred ceeEEEeeccCCChhhhhccC-----------------------------------------------------------
Q 008828 301 ERLLVYPYMSNGSVASRLKAK----------------------------------------------------------- 321 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------------- 321 (552)
..+++|||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 578999999999999887532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc-eeeccc
Q 008828 322 --------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVR 392 (552)
Q Consensus 322 --------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~ 392 (552)
..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 2367888899999999999999998 9999999999999999999999999999765322211 112233
Q ss_pred ccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 393 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ........... ....+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~----------~~~~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGT----------RMRAPDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhccC----------CCCCCCC
Confidence 5678999999999899999999999999999997 88887542211 01111111110 0011111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.+.++.+++.+||+.+|++|||+.|++++|+.
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 23578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=322.82 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=202.1
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC--------CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecC
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 299 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~ 299 (552)
..+|.+.+.||+|+||.||+|... ....+|+|.++..........+..|+.++.++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457888999999999999999742 24579999987554444455688999999998 699999999999998
Q ss_pred CceeEEEeeccCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee
Q 008828 300 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 363 (552)
...+++|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 9999999999999999998642 3488999999999999999999998 99999999999999
Q ss_pred CCCCceEEcccccceecCCCCCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCccccccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG 441 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~ 441 (552)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----- 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----- 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 999999999999998654322211 111224467999999999899999999999999999999 8888753211
Q ss_pred chHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 442 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
......... .. ....+...+.++.+++.+||+.+|++|||+.|+++.|+.
T Consensus 243 --~~~~~~~~~-~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 243 --EELFKLLRE-GH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred --HHHHHHHHc-CC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 111111111 10 011122334678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=339.88 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=192.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC--------
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-------- 299 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-------- 299 (552)
..+|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 467999999999999999999975 68899999885432 1245799999999999999999876432
Q ss_pred CceeEEEeeccCCChhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC-ceEEccc
Q 008828 300 TERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDF 374 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Df 374 (552)
...++||||+++ +|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999975 6766654 456799999999999999999999999 999999999999999654 7999999
Q ss_pred ccceecCCCCCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHH------
Q 008828 375 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV------ 447 (552)
Q Consensus 375 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~------ 447 (552)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||+||.+||...........+....
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99986643222 2234589999999998764 68999999999999999999999997543221111010000
Q ss_pred --HHHhh---hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 448 --KKIHQ---EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 448 --~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..... ......+....+...++...+.++.+++.+||+.||.+|||+.|++++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000 000000011111111222345789999999999999999999999864
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=314.54 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=200.9
Q ss_pred CCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 231 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
+|+..+.||+|+||.||+|.. .++..||+|.+...........+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577889999999999999986 4688999999865433334457889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceee
Q 008828 310 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389 (552)
Q Consensus 310 ~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 389 (552)
++++|..+ ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++...... ...
T Consensus 82 ~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~ 151 (279)
T cd06619 82 DGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAK 151 (279)
T ss_pred CCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---ccc
Confidence 99998654 3478899999999999999999999 9999999999999999999999999999765422 123
Q ss_pred cccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCC
Q 008828 390 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469 (552)
Q Consensus 390 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (552)
...|+..|+|||.+.+..++.++|||||||++|+|++|+.||..............+........ .+.+ ..
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~---~~ 222 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVL---PV 222 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCC---CC
Confidence 34689999999999998999999999999999999999999974322111111111111111000 0000 01
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 470 RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 470 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
...+.++.+++.+|++.+|++||+++|++++..
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 123467899999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=326.66 Aligned_cols=246 Identities=24% Similarity=0.263 Sum_probs=194.2
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHH-HHhhccccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||+||+|+.. +++.||+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 578899999964321 112233444443 46778999999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 156 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccc
Confidence 99999998877899999999999999999999999 99999999999999999999999999987543211 123345
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... ... .....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~---------~~~--~~~~~ 218 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILN---------KPL--QLKPN 218 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-------HHHHHHHHh---------CCc--CCCCC
Confidence 699999999999999999999999999999999999999974321 111111111 000 11122
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.+..+.+++.+|++.+|.+||++.+.+..+.+
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 34678999999999999999998865544444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=323.08 Aligned_cols=256 Identities=20% Similarity=0.215 Sum_probs=198.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||+||+++.. +++.||+|++.... .......+.+|+.++..++|+||+++++++......++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999965 58999999996422 1223345888999999999999999999999999999999
Q ss_pred eeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999999975 45799999999999999999999999 999999999999999999999999999876543333
Q ss_pred ceeecccccccccCchhhcc-----CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 386 HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+.............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~-- 228 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKEHFQ-- 228 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCccc--
Confidence 22233458999999999863 4578899999999999999999999964321 111111111110000
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCC--CCCCHHHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPS--LRPKMSEVVRML 501 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~L 501 (552)
+. ......+..+.+++.+|+..+++ .||++.+++.+-
T Consensus 229 ---~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 229 ---FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred ---CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 00 01112346788888887765443 378999888763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=340.75 Aligned_cols=248 Identities=20% Similarity=0.256 Sum_probs=200.8
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-C-CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-D-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.|.+.+.||+|+||.||+|... + +..||+|.+.... ......+..|+.+++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3788899999999999999854 3 6788888774332 22334577899999999999999999999999999999999
Q ss_pred ccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 309 MSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 309 ~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
+++|+|.+++.. ..++++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999987753 45689999999999999999999998 99999999999999999999999999998765332
Q ss_pred C-ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 385 S-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 385 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ...+...... .
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~~~~~---------~ 287 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQVLYG---------K 287 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhC---------C
Confidence 2 123445699999999999999999999999999999999999999964221 1111111110 0
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
. ...+...+..+.+++.+||+.+|++||++.+++.
T Consensus 288 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 Y-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred C-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0 1122234467999999999999999999999875
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=314.30 Aligned_cols=247 Identities=27% Similarity=0.399 Sum_probs=194.9
Q ss_pred CeeeeeCceEEEEEEECC-Cc--EEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQD-GT--VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||.||+|..++ +. .+++|.++..........+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999753 43 57888887544344455788999999999 799999999999999999999999999
Q ss_pred CChhhhhccCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccc
Q 008828 312 GSVASRLKAKP----------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 375 (552)
Q Consensus 312 g~L~~~l~~~~----------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 375 (552)
|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 478999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhc
Q 008828 376 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEK 454 (552)
Q Consensus 376 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 454 (552)
++....... .......+..|+|||++....++.++|||||||++|||+| |..||..... .+........
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~~~~~~~~~~- 227 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYEKLPQG- 227 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-------HHHHHHHhCC-
Confidence 986322111 1111224567999999988899999999999999999997 9998853221 1111111111
Q ss_pred chhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 455 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.....+...+.++.+++.+||+.+|.+|||+.+++..|+..
T Consensus 228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 ---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 01111222346789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=324.53 Aligned_cols=242 Identities=23% Similarity=0.290 Sum_probs=195.4
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhcc-ccccceeeeEeecCCceeEEE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~ 306 (552)
+|+..+.||+|+||+||+|... +++.||+|+++.... ......+..|..++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999965 688999999975321 223345777888888775 577888999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-V 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC-c
Confidence 9999999999998878899999999999999999999998 99999999999999999999999999987543221 2
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......||..|+|||++.+..++.++|||||||++|||+||+.||..... ......... .. .
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~~---------~~--~ 218 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-------DELFQSIME---------HN--V 218 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh---------CC--C
Confidence 23345689999999999999999999999999999999999999974321 111111111 00 1
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKM 494 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 494 (552)
.++...+.++.+++.+|++.+|.+|++.
T Consensus 219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1223344678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=324.21 Aligned_cols=266 Identities=21% Similarity=0.287 Sum_probs=200.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|.+.+.||+|+||+||+|+.+ +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999965 57899999997554444445677899999999999999999999999999999999
Q ss_pred ccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+++ +|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 975 78887764 34589999999999999999999998 999999999999999999999999999976433221 2
Q ss_pred eecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHH--------HHHHHhhhcchhh
Q 008828 388 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--------WVKKIHQEKKLEM 458 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 458 (552)
.....++..|+|||.+.+ ..++.++|||||||++|||+||+.||......+....+.. +............
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 223457899999998865 4689999999999999999999999975432111100000 0000000000000
Q ss_pred hccccccC----cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 LVDKDLKN----NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+.... ......+.++.+++.+|++.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000 0011234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=317.33 Aligned_cols=261 Identities=21% Similarity=0.352 Sum_probs=201.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-----------------CCcEEEEEEeccCccCchHHHHHHHHHHHhhcccccccee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-----------------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l 292 (552)
++|++.+.||+|+||.||++... ++..||+|.++..........+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998643 2346999999755444445678999999999999999999
Q ss_pred eeEeecCCceeEEEeeccCCChhhhhccC-----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCce
Q 008828 293 IGFCMTTTERLLVYPYMSNGSVASRLKAK-----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 361 (552)
Q Consensus 293 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni 361 (552)
++++...+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 99999999999999999999999998643 2477889999999999999999999 999999999999
Q ss_pred eeCCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh--CCCccccCcccc
Q 008828 362 LLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS--GLRALEFGKTAN 438 (552)
Q Consensus 362 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt--g~~p~~~~~~~~ 438 (552)
+++.++.++|+|||+++.+...... ......++..|+|||....+.++.++|||||||++|||+| |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 9999999999999999765332211 1122234678999999988899999999999999999998 66666532211
Q ss_pred cccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 439 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
................. ....+..++..+.+++.+||+.||++||++.||++.|+.
T Consensus 241 ---~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 ---QVIENTGEFFRDQGRQV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHHhhccccc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111100000 001112234788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=317.98 Aligned_cols=255 Identities=25% Similarity=0.418 Sum_probs=203.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCce
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 302 (552)
.++|+..+.||+|+||.||+|... ++..||+|.++..........+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888999999999999999863 46789999997554433445688999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhccC----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCc
Q 008828 303 LLVYPYMSNGSVASRLKAK----------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 360 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~----------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 360 (552)
+++|||+++|+|.+++... ..+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 9999999999999998632 2478889999999999999999998 99999999999
Q ss_pred eeeCCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccc
Q 008828 361 ILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTAN 438 (552)
Q Consensus 361 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~ 438 (552)
|++++++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999998755332211 1112234667999999998899999999999999999998 7777753211
Q ss_pred cccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 439 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.++....... ... ..+...+.++.+++.+||+.+|++|||+.|+++.|+.
T Consensus 239 -----~~~~~~~~~~---------~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 -----EEVIYYVRDG---------NVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHHHHhcC---------CCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1112111111 110 1122234779999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=316.89 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=201.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
++|...+.||+|+||.||++... ++..+|+|.++... ......+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 46777899999999999999732 35689999886433 233457899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc
Q 008828 304 LVYPYMSNGSVASRLKAK---------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 368 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 368 (552)
++|||+++|+|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 999999999999998643 2488999999999999999999998 9999999999999999999
Q ss_pred eEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHH
Q 008828 369 AVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDW 446 (552)
Q Consensus 369 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 446 (552)
+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... +.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~ 233 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------EA 233 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------HH
Confidence 999999999765432211 1122235678999999999999999999999999999998 88888532211 11
Q ss_pred HHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 447 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
........ ....+...+..+.+++.+||+.||.+||++.||++.|+.
T Consensus 234 ~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 IECITQGR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHcCc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111000 011122334678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=310.80 Aligned_cols=247 Identities=31% Similarity=0.472 Sum_probs=204.1
Q ss_pred CeeeeeCceEEEEEEECC----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||.||+|.... +..|++|.++..........+.+|++.+..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999753 7899999997655444456789999999999999999999999999999999999999
Q ss_pred CChhhhhccC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 312 GSVASRLKAK---------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 312 g~L~~~l~~~---------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++|.+++... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999864 7899999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC-ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 383 CDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 383 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
... .......++..|+|||.+....++.++||||+||++|||++ |..||..... ..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EEVLEYLRKG------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcC-------
Confidence 321 12233447889999999998899999999999999999999 5888864311 1111111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.....+...+.++.+++.+||+.+|++|||+.|++++|+
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ---YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122333578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=314.58 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=202.2
Q ss_pred CCCCCCeeeeeCceEEEEEEECC-C---cEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQD-G---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
+|.+.+.||+|+||.||+|.... + ..||+|.++..........|..|+.+++.++||||+++++++......++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999999653 3 3699999975543334557999999999999999999999999999999999
Q ss_pred eeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 99999999999875 45689999999999999999999998 999999999999999999999999999876543222
Q ss_pred cee--eccc--ccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 386 HVT--TAVR--GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 386 ~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
... .... .+..|+|||.+....++.++|||||||++|||++ |..||...... ....++ ...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----~~~~~i---~~~------- 227 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVINAI---EQD------- 227 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----HHHHHH---HcC-------
Confidence 111 1111 2457999999999999999999999999999887 99888642211 111111 110
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.....+...+..+.+++.+||+.+|.+||++.+++..|+.
T Consensus 228 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 228 ---YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ---CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0011122334678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=311.45 Aligned_cols=249 Identities=19% Similarity=0.264 Sum_probs=203.3
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
+|++.+.||+|+||.||++... ++..+|+|.++..........+..|+.+++.++||||+++++++......+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4777899999999999999965 688999999865443344557888999999999999999999999999999999999
Q ss_pred cCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 310 SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 310 ~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++++|||.++...... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 99999998864 34689999999999999999999998 99999999999999999999999999998664322 22
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ......... .. ...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~~~~~-~~---------~~~ 219 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNLILKVCQ-GS---------YKP 219 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-------HHHHHHHhc-CC---------CCC
Confidence 2335588999999999998999999999999999999999999964221 111111110 00 011
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 468 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+...+..+.+++.+||+.||++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 222344678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=314.99 Aligned_cols=249 Identities=24% Similarity=0.282 Sum_probs=196.0
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCCh
Q 008828 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 314 (552)
Q Consensus 238 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 314 (552)
||+|+||+||++..+ +|+.||+|.+..... ......+..|++++..++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999965 589999999864321 11233456799999999999999999999999999999999999999
Q ss_pred hhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeeccc
Q 008828 315 ASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 392 (552)
Q Consensus 315 ~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 392 (552)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9887533 3589999999999999999999998 99999999999999999999999999998664322 223345
Q ss_pred ccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHH
Q 008828 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 472 (552)
Q Consensus 393 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 472 (552)
|+..|+|||++.+..++.++|||||||++|||++|+.||........ ......... ...... .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~---~~~~~~~~~---------~~~~~~-~~~~~ 222 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA---KEELKRRTL---------EDEVKF-EHQNF 222 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh---HHHHHHHhh---------cccccc-ccccC
Confidence 89999999999998999999999999999999999999864221100 011111111 000000 01123
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 473 LEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 473 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
+.++.+++.+||+.||++||+++|+++.+..+
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h 254 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPRKH 254 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhhcC
Confidence 46789999999999999999998877655543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=330.76 Aligned_cols=253 Identities=20% Similarity=0.284 Sum_probs=198.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|+..+.||+|+||+||++..+ +++.||+|+++... .......+..|+.++..++||||+++++++......++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999975 58999999996432 1223446788999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC-
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS- 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 385 (552)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999999998888899999999999999999999999 999999999999999999999999999875432110
Q ss_pred ---------------------------------ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccc
Q 008828 386 ---------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 432 (552)
Q Consensus 386 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~ 432 (552)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123469999999999999999999999999999999999999997
Q ss_pred cCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 008828 433 FGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK---MSEVVRM 500 (552)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 500 (552)
..... ........... .+. .... ...+.++.+++.+|+. +|.+|++ +.|++++
T Consensus 238 ~~~~~-------~~~~~i~~~~~--~~~---~p~~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQ-------ETYRKVMNWKE--TLV---FPPE--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHH-------HHHHHHHcCCC--cee---cCCC--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 43221 11111110000 000 0000 1123667888888764 9999996 4555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=323.66 Aligned_cols=238 Identities=24% Similarity=0.265 Sum_probs=190.5
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHH-HHhhccccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||.||+|... +++.||+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 588999999964321 112234555554 57788999999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|+|...+.....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTF 156 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccccc
Confidence 99999998777899999999999999999999998 99999999999999999999999999987532211 223345
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ........ ... ...+..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~---------~~~--~~~~~~ 218 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQMYDNIL---------HKP--LQLPGG 218 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHHHHHHh---------cCC--CCCCCC
Confidence 689999999999999999999999999999999999999964321 11111111 111 112223
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHH
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKMS 495 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~~ 495 (552)
....+.+++.+|++.||.+||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 346789999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=314.27 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=203.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
++|.....||+|+||+||+|+.+ +...|++|.+...........+.+|+.++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999964 246799998865433223457899999999999999999999999989999
Q ss_pred EEEeeccCCChhhhhccCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccc
Q 008828 304 LVYPYMSNGSVASRLKAKP---------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 374 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~---------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 374 (552)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997544 689999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhh
Q 008828 375 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQE 453 (552)
Q Consensus 375 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 453 (552)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...+.... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~-~ 233 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQ-A 233 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHH-c
Confidence 9987543322222233346778999999988889999999999999999999 7777753211 11111111 0
Q ss_pred cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 454 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.. .....+...+..+.+++.+||+.+|++||++.|++..|.
T Consensus 234 ~~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GK--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CC--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 001111223467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=317.80 Aligned_cols=260 Identities=23% Similarity=0.355 Sum_probs=203.4
Q ss_pred CCCCCCeeeeeCceEEEEEEE-----CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC--Ccee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERL 303 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~ 303 (552)
.|++.+.||+|+||.||++.. .++..||+|.++..........+.+|+.+++.++|||++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999984 247889999997554344455789999999999999999999998775 5678
Q ss_pred EEEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 304 LVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++.+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999998654 4689999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCc--eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccc--------cccchHHHHHHHhh
Q 008828 383 CDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN--------QKGAMLDWVKKIHQ 452 (552)
Q Consensus 383 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~ 452 (552)
.... ......++..|+|||.+.+..++.++|||||||++|||+|++.|........ .......++.....
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 3221 1223446778999999988899999999999999999999876653211100 00001111111111
Q ss_pred hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
. .....+...+..+.+++.+||+.+|++|||++++++.+++
T Consensus 242 ~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 242 G----------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred C----------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 0 0111122245789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.22 Aligned_cols=251 Identities=26% Similarity=0.421 Sum_probs=208.4
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CC----cEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
....++||+|+||+||+|.|- +| -+||+|++.........+++.+|+-.|..++|||+++++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 345689999999999999962 33 4799999977666666778999999999999999999999998776 88999
Q ss_pred eeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
+||+.|+|.++++. +..+.....+.|..|||+||.|||.+ ++|||||..+||||..-..+||.|||+++.+.....
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999999984 45799999999999999999999999 999999999999999999999999999998876554
Q ss_pred ceee-cccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 386 HVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 386 ~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
.... ...-.+.|||=|.+....|+.++|||||||++||++| |..|++.... ..+.+++...
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----------------~eI~dlle~g 916 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----------------EEIPDLLEKG 916 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----------------HHhhHHHhcc
Confidence 4332 2224568999999999999999999999999999999 7777653221 1122222222
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
-+-.-++.+..+++.++.+||..|+..||+++++...+.+
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 2233466778899999999999999999999999876664
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=314.38 Aligned_cols=263 Identities=26% Similarity=0.375 Sum_probs=201.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-----CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC--Cce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 302 (552)
.+|.+.+.||+|+||.||+|..+ ++..||+|.++... ......+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46788899999999999999743 57899999986543 23345788999999999999999999987543 467
Q ss_pred eEEEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 303 LLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 8999999999999999753 4689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcee--ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh------
Q 008828 382 HCDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE------ 453 (552)
Q Consensus 382 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 453 (552)
....... ....++..|+|||.+.+..++.++|||||||++|||++|..++...... +.......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 231 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--------FMRMMGNDKQGQMI 231 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--------hhhhcccccccccc
Confidence 3322211 1122345699999999889999999999999999999987765422110 00000000
Q ss_pred -cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 454 -KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 454 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
..+.+..........+...+..+.+++.+||+.+|++|||+.||++.|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000011111111111223346799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=324.00 Aligned_cols=245 Identities=25% Similarity=0.264 Sum_probs=194.0
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHH-HHhhccccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||+||+|... +|+.||+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999965 689999999964321 122334555554 46778999999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|+|..++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTF 156 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccc
Confidence 99999998888899999999999999999999999 99999999999999999999999999987532211 122345
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.||..|+|||.+.+..++.++|||||||++|||++|+.||...... ........ ..+ ...+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~~~~---------~~~--~~~~~ 218 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------EMYDNILH---------KPL--VLRPG 218 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-------HHHHHHHc---------CCc--cCCCC
Confidence 6999999999999999999999999999999999999999743211 11111111 000 01112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.+..+.+++.+|++.+|++||++.+.++.+.
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 3467889999999999999999875444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=310.50 Aligned_cols=247 Identities=30% Similarity=0.410 Sum_probs=199.2
Q ss_pred CeeeeeCceEEEEEEECC--C--cEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQD--G--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|++|.||+|.+.+ + ..||+|.+...........+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 36999999765443445678999999999999999999999988 888999999999
Q ss_pred CChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc--e
Q 008828 312 GSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--V 387 (552)
Q Consensus 312 g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~ 387 (552)
|+|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999764 3689999999999999999999999 9999999999999999999999999999876543222 1
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....++..|+|||.+.+..++.++|||||||++|||+| |..||...... +......... ...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~---------~~~ 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------QILKKIDKEG---------ERL 220 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhcC---------CcC
Confidence 122346789999999999999999999999999999999 99998632211 1111111100 001
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
..+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112233578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=310.99 Aligned_cols=268 Identities=25% Similarity=0.357 Sum_probs=200.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHh--hccccccceeeeEeecCC----cee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS--LAVHRNLLRLIGFCMTTT----ERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~--~~~h~niv~l~~~~~~~~----~~~ 303 (552)
++..+.+.||+|.||.||+|.|+ |+.||||++... ++..+.+|.++.+ .++|+||+.+++....+. +.+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 56677899999999999999998 899999999643 2456777777776 569999999999876543 578
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ-----CDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
||++|.+.|+|+++|.. ..++.+...+++..+|.||+|||.. .+|.|.|||||+.||||..++.+.|+|+|+|.
T Consensus 286 LvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred EeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 99999999999999987 4699999999999999999999964 47889999999999999999999999999998
Q ss_pred ecCCCCCce---eecccccccccCchhhccC------CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHH
Q 008828 379 LLDHCDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 449 (552)
Q Consensus 379 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 449 (552)
......... ....+||.+|||||++... +.-..+||||||.|+||++-...--. ...+..-...+|+..
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg--i~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG--IVEEYQLPYYDVVPS 442 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC--EehhhcCCcccCCCC
Confidence 765443222 2345699999999999653 22347899999999999976321100 000000111112111
Q ss_pred Hhhhcch-hhhccccccCcC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 450 IHQEKKL-EMLVDKDLKNNY-----DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 450 ~~~~~~~-~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
-+..+.+ .-+....+++.. .......+.++|+.||..+|..|-|+=.+-+.|....
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 1111111 122233344333 3456788999999999999999999988888777643
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.62 Aligned_cols=256 Identities=22% Similarity=0.335 Sum_probs=206.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.+|++.+.||+|+||.||+|.. .+++.+|||.+...... .....+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3677889999999999999996 47899999988643222 23346889999999999999999999999999999999
Q ss_pred eeccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 307 PYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 307 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998862 45689999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ...+.+... ....+
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~------~~~~~ 226 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKIE------QCDYP 226 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-----HHHHhhhhh------cCCCC
Confidence 222 122345889999999999989999999999999999999999998642211 111111111 11111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.. .....+..+.+++.+||+.+|++|||+.+|++.++.
T Consensus 227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 11 112345789999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=313.12 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=203.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
.+|.+.+.||+|+||.||+|...+ ...||+|.............+.+|+.+++.++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998643 347999988655433445578999999999999999999998875 557899
Q ss_pred EeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999754 3689999999999999999999998 99999999999999999999999999998765432
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
........++..|+|||.+....++.++|||||||++|||++ |..||...... .... .......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~---~~~~~~~-------- 226 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIG---RIENGER-------- 226 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHH---HHHcCCc--------
Confidence 222222334568999999988889999999999999999986 99998643221 1111 1111110
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
...+...+..+.+++.+|+..+|++|||+.++++.|++.
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 227 --LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011223456899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=312.47 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=202.8
Q ss_pred CCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccC-----chHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
+|...+.||+|+||+||+|...+++.+|+|.++..... .....+.+|+++++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999999888999999998643211 1224588999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC-
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD- 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 384 (552)
+||+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999998777899999999999999999999998 99999999999999999999999999987543211
Q ss_pred ----CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 385 ----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 385 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
........|+..|+|||.+.+..++.++|||||||++|+|++|+.||....... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~------ 225 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------AMFYIGAHRG------ 225 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH------HHHHhhhccC------
Confidence 111223458899999999999889999999999999999999999996422110 0000000000
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
.....+...+..+.+++.+||+.+|.+||++.|++.
T Consensus 226 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 ---LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011122234577899999999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=313.09 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=201.0
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHH-HHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
|++.+.||+|+||+||++... +++.||+|++.......... ...+|+.++..++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456689999999999999976 46789999997654332222 3356999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceee
Q 008828 310 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389 (552)
Q Consensus 310 ~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 389 (552)
++++|.+++.....+++..+..++.|+++||.+||+. +|+|+||||+||++++++.++|+|||.+..... ......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENFN 156 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cccccc
Confidence 9999999998777899999999999999999999999 999999999999999999999999999976421 223344
Q ss_pred cccccccccCchhhc-cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 390 AVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 390 ~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
...++..|+|||.+. +..++.++||||+|+++|+|++|..|+......... .......... . ..... .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~----~~~~~~~~~~-~----~~~~~--~ 225 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL----EIIEKILKRP-L----PSSSQ--Q 225 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH----HHHHHHHHTH-H----HHHTT--S
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhh----hhhhhccccc-c----ccccc--c
Confidence 556899999999998 788999999999999999999999999754111110 1111100000 0 00000 0
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.......+.+++.+||+.||++||++.+++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00012789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=308.82 Aligned_cols=246 Identities=28% Similarity=0.397 Sum_probs=199.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEee-cCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM-TTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~-~~~~~~lv~e~ 308 (552)
.+|.+.+.||+|+||.||+|... |..||+|.++... ....+.+|+.++++++|+|++++++++. .....+++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46888899999999999999875 7889999986432 2456889999999999999999999765 44678999999
Q ss_pred ccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++|+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999987533 489999999999999999999998 99999999999999999999999999987543221
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
....++..|+|||++.+..++.++|||||||++|||++ |+.|+.... ........... ..
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-------~~~~~~~~~~~----------~~ 217 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKG----------YK 217 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHhcC----------CC
Confidence 22335678999999998899999999999999999998 888875321 11111111111 11
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
...+...+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11223345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=317.87 Aligned_cols=264 Identities=24% Similarity=0.294 Sum_probs=193.9
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhc---cccccceeeeEeecC-----C
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLA---VHRNLLRLIGFCMTT-----T 300 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~~~~~~~-----~ 300 (552)
+|++.+.||+|+||+||+|... +++.||+|.++...... ....+.+|+.++..+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999975 68899999987533222 223456677776655 699999999987642 3
Q ss_pred ceeEEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 301 ERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
..+++|||+.+ +|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999974 888888643 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhh
Q 008828 379 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458 (552)
Q Consensus 379 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (552)
...... ......||..|+|||++.+..++.++|||||||++|||++|++||...........+..+............
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 664322 223345889999999999999999999999999999999999998643221111111111100000000000
Q ss_pred ------hcccccc---CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 ------LVDKDLK---NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ------~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+... ....+.....+.+++.+|++.||++|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 00112234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=323.73 Aligned_cols=255 Identities=19% Similarity=0.218 Sum_probs=198.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||+||++..+ +++.+|+|++.+... ......+..|+.++..++|+||+++++++......++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888899999999999999976 478899999864221 122335788999999999999999999999999999999
Q ss_pred eeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999999976 45789999999999999999999998 999999999999999999999999999976543333
Q ss_pred ceeecccccccccCchhhc-----cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 386 HVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ............. .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~--~- 227 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKER--F- 227 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCcc--c-
Confidence 3333456999999999986 34678999999999999999999999974321 1111111111000 0
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSL--RPKMSEVVRM 500 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 500 (552)
.. +......+.++.+++.+|+..++.+ |+++.|++++
T Consensus 228 --~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 --QF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --cC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 0111223467888999988655444 7899998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=315.84 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=208.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|++.+.||+|+||+||++... +++.||+|++...........+.+|++++..++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777889999999999999965 58899999987554444456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++++|.+++...+.+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++...... ..
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---~~ 159 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IA 159 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh---cc
Confidence 999999999988778999999999999999999999732 8999999999999999999999999998654321 12
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCccccc----ccchHHHHHHHhhhcchhhhccccc
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ----KGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
....|+..|+|||.+.+..++.++|||||||++|+|+||+.||........ ...+.++........ .+.+
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 233 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPRL 233 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCCC
Confidence 234589999999999888999999999999999999999999975432211 111112222221110 0000
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.....+..+.+++.+|++.||++|||+.|++++..
T Consensus 234 ---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 234 ---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred ---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 01124467899999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.14 Aligned_cols=248 Identities=28% Similarity=0.356 Sum_probs=204.7
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
+|+..+.||.|+||.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++......++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5778889999999999999965 688999999975544444557889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceee
Q 008828 310 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389 (552)
Q Consensus 310 ~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 389 (552)
++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||+++....... ...
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (274)
T cd06609 82 GGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRN 156 (274)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccc
Confidence 999999999865 799999999999999999999998 999999999999999999999999999987654321 223
Q ss_pred cccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCC
Q 008828 390 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469 (552)
Q Consensus 390 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (552)
...++..|+|||.+.+..++.++|||||||++|+|+||+.||...... ........ . ......
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~-~---------~~~~~~ 219 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVLFLIPK-N---------NPPSLE 219 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHHHHhhh-c---------CCCCCc
Confidence 345788999999999988999999999999999999999999643210 11111110 0 011111
Q ss_pred HH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 470 RI-ELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 470 ~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.. .+..+.+++.+||..+|++|||+++++++
T Consensus 220 ~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11 44678999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=323.64 Aligned_cols=256 Identities=29% Similarity=0.401 Sum_probs=203.1
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC--------CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecC
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 299 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~ 299 (552)
..+|.+.+.||+|+||.||+|... .+..||+|.++..........+.+|++++.++ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 356888999999999999999742 12368999887544333456788999999999 799999999999999
Q ss_pred CceeEEEeeccCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee
Q 008828 300 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 363 (552)
...++++||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence 9999999999999999998642 2478899999999999999999998 99999999999999
Q ss_pred CCCCceEEcccccceecCCCCCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCccccccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG 441 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~ 441 (552)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------ 241 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------ 241 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------
Confidence 999999999999998654322111 122224567999999999999999999999999999999 777775321
Q ss_pred chHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 442 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
..++....... .....+...+..+.+++.+||+.+|++||++.|+++.|+..
T Consensus 242 -~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 242 -VEELFKLLKEG----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred -HHHHHHHHHcC----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11222221111 01111223346789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=313.87 Aligned_cols=251 Identities=26% Similarity=0.356 Sum_probs=198.0
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecC------
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT------ 299 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~------ 299 (552)
++..|+..+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 5667888899999999999999965 58899999986433 2345678899999988 699999999998753
Q ss_pred CceeEEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccc
Q 008828 300 TERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 377 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 377 (552)
...+++|||+.+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4578999999999999998753 4689999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCceeecccccccccCchhhc-----cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||...... ..+.. ...
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------~~~~~-~~~ 230 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFL-IPR 230 (272)
T ss_pred eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------HHHHH-Hhc
Confidence 86543222 223355889999999986 335788999999999999999999998632211 01100 000
Q ss_pred hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. .... ......+..+.+++.+||+.+|.+|||+.|++++
T Consensus 231 -~-----~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 -N-----PAPR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -C-----CCCC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 0011 1111234678999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=309.93 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=191.8
Q ss_pred CeeeeeCceEEEEEEECC---CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCC
Q 008828 236 NLVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 312 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 312 (552)
+.||+|+||.||+|...+ +..+|+|.++..........+.+|+.++++++||||+++++++......++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 45799998876544444457889999999999999999999999999999999999999
Q ss_pred ChhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 313 SVASRLKAK-----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 313 ~L~~~l~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+|.+++... ...++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999998642 2467788889999999999999998 99999999999999999999999999987543222111
Q ss_pred -eecccccccccCchhhccC-------CCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhh
Q 008828 388 -TTAVRGTVGHIAPEYLSTG-------QSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458 (552)
Q Consensus 388 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (552)
.....++..|+|||++... .++.++|||||||++|||++ |+.||....... .... .. ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----~~~~--~~--~~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ----VLTY--TV--REQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH----HHHH--Hh--hcccCC
Confidence 1233467889999998642 35789999999999999996 999986432211 0000 00 011111
Q ss_pred hccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 459 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 459 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
..++.+. ......+.+++.+|+ .+|++|||++||.+.|+
T Consensus 230 ~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111 123356888999999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=306.94 Aligned_cols=248 Identities=30% Similarity=0.436 Sum_probs=199.7
Q ss_pred CeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCChh
Q 008828 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVA 315 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 315 (552)
++||+|+||.||+|...+++.||+|.++..........+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999987799999999876543334567899999999999999999999999999999999999999999
Q ss_pred hhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee-ecccc
Q 008828 316 SRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVRG 393 (552)
Q Consensus 316 ~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~g 393 (552)
+++.. ...+++..+..++.+++.||.|||++ +++||||||+||+++.++.++|+|||++........... ....+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99864 34689999999999999999999999 999999999999999999999999999976542211111 11224
Q ss_pred cccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHH
Q 008828 394 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 472 (552)
Q Consensus 394 t~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 472 (552)
+..|+|||.+.++.++.++|||||||++|||+| |..||...... ........ ......+...
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------~~~~~~~~----------~~~~~~~~~~ 220 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------QTRERIES----------GYRMPAPQLC 220 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------HHHHHHhc----------CCCCCCCccC
Confidence 567999999998899999999999999999999 77777532211 11111110 0011122234
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 473 LEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 473 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 5689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=308.09 Aligned_cols=250 Identities=24% Similarity=0.260 Sum_probs=205.7
Q ss_pred CCCCCCeeeeeCceEEEEEEECC-CcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.|+..+.||.|.-|+||++..++ +..+|+|++.+.... ....+.+.|.++|+.++||.+..+++.+..+...|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45566899999999999999874 589999999654332 233467889999999999999999999999999999999
Q ss_pred eccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC---
Q 008828 308 YMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH--- 382 (552)
Q Consensus 308 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~--- 382 (552)
||+||+|...++.+ +.+++..++.++..++.||+|||.. |||+|||||+||||.++|++.|+||.++.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999999998754 5799999999999999999999999 999999999999999999999999998743211
Q ss_pred ------------------------------CCC----------------------ceeecccccccccCchhhccCCCCC
Q 008828 383 ------------------------------CDS----------------------HVTTAVRGTVGHIAPEYLSTGQSSE 410 (552)
Q Consensus 383 ------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 410 (552)
... .....++||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 0112356899999999999999999
Q ss_pred ccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCC
Q 008828 411 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSL 490 (552)
Q Consensus 411 ~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 490 (552)
++|.|+|||++|||+.|..||..... ...+..++.+.+.-...+..+..+.+||.+.|.+||++
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 99999999999999999999986543 22344445554443333355678999999999999999
Q ss_pred CCC----HHHHHH
Q 008828 491 RPK----MSEVVR 499 (552)
Q Consensus 491 RPs----~~evl~ 499 (552)
|.. +.||-+
T Consensus 379 Rlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 379 RLGSKRGAAEIKR 391 (459)
T ss_pred hhccccchHHhhc
Confidence 998 556554
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=309.63 Aligned_cols=249 Identities=30% Similarity=0.434 Sum_probs=192.5
Q ss_pred CeeeeeCceEEEEEEEC----CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEee-cCCceeEEEeecc
Q 008828 236 NLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM-TTTERLLVYPYMS 310 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~-~~~~~~lv~e~~~ 310 (552)
+.||+|+||.||+|.+. ++..||+|.+...........+.+|+.+++.++||||+++++++. .....++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 245799999864433334557889999999999999999999876 4556789999999
Q ss_pred CCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc---
Q 008828 311 NGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--- 386 (552)
Q Consensus 311 ~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 386 (552)
+|+|.+++... ...++..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999998753 4567888899999999999999998 9999999999999999999999999999755322111
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCC-ccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR-ALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......++..|+|||.+.+..++.++|||||||++|||++|.. |+.... ............ .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-------~~~~~~~~~~~~----------~ 220 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-------SFDITVYLLQGR----------R 220 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHhcCC----------C
Confidence 1112335678999999998899999999999999999999654 443211 111111111110 0
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
...+...+..+.+++.+||+.+|++||++.|+++.|+..
T Consensus 221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011122346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=308.75 Aligned_cols=249 Identities=25% Similarity=0.348 Sum_probs=204.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC-CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|+..+.||+|+||.||+|+..+ +..+++|.+..... ..++.+|+++++.++||||+++++++......++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 578888999999999999999864 78999999865432 56789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++........ .
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 999999999874 45789999999999999999999998 999999999999999999999999999986653321 2
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.|+........ .. ... ..... ...
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---~~----~~~------~~~~~--~~~ 220 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---IF----MIP------NKPPP--TLS 220 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---hh----hhc------cCCCC--CCC
Confidence 2334478899999999999999999999999999999999999874322100 00 000 00000 011
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 468 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+......+.+++.+||+.+|++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 122344678999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.32 Aligned_cols=250 Identities=19% Similarity=0.278 Sum_probs=202.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.+|+..+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.+++.+.||||+++++.+......++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 57888899999999999999964 688999999865433 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++++|.+++... .+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~ 173 (296)
T cd06654 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (296)
T ss_pred cCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-cc
Confidence 9999999998654 589999999999999999999999 999999999999999999999999999876543221 12
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .+........ ......
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-------~~~~~~~~~~--------~~~~~~ 238 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNG--------TPELQN 238 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-------HhHHHHhcCC--------CCCCCC
Confidence 2345889999999999888999999999999999999999999643210 1111110000 000111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+......+.+++.+||..+|++||++.+++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 22344678999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=314.41 Aligned_cols=250 Identities=25% Similarity=0.332 Sum_probs=199.1
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
|+..+.||+|+||+||++... +++.||+|.+....... ....+..|+.++.+++|+|++.+++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566789999999999999965 68899999986543222 234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999988532 3589999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....|+..|+|||.+.+..++.++|||||||++|+|++|+.||......... .-....... ...
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~----~~~~~~~~~----------~~~ 222 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEVERLVKE----------VQE 222 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH----HHHHhhhhh----------hhh
Confidence 12345899999999999999999999999999999999999999743221100 000000000 001
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 500 (552)
.++......+.+++.+||+.||++||| ++|++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 112223467899999999999999999 7788754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=309.28 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=202.7
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--------hHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
+|.+...||+|+||.||+|... +++.+|+|.+....... ....+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999864 58899999886443221 12357889999999999999999999999999
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.+++|||+++++|.+++.....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999999999999999998878899999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCc-----eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcch
Q 008828 382 HCDSH-----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456 (552)
Q Consensus 382 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (552)
..... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...... .-+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~----- 225 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QAIFKIG----- 225 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HHHHHHh-----
Confidence 22111 112234788999999999889999999999999999999999999743210 0000000
Q ss_pred hhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 457 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.. .....+...+..+.+++.+||+.||++||++.|++++
T Consensus 226 -~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 226 -EN----ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -cc----CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00 1112223345788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=311.03 Aligned_cols=249 Identities=27% Similarity=0.365 Sum_probs=205.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
..|+..+.||+|+||.||+|... ++..||+|.++..........+.+|+.+++.+.||||+++++++......++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34667789999999999999975 58899999987544334455788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++|+|.+++... .+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 84 ~~~~~L~~~i~~~-~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06640 84 LGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence 9999999998754 689999999999999999999998 999999999999999999999999999976643322 22
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
....++..|+|||.+.+..++.++|||||||++|||+||..|+....... ... ..........
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~----------~~~~~~~~~~ 221 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-------VLF----------LIPKNNPPTL 221 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-------Hhh----------hhhcCCCCCC
Confidence 33457889999999998889999999999999999999999986432110 000 0111111233
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+..+.+++.+||+.+|++||++.+++.+
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 44567889999999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.76 Aligned_cols=192 Identities=25% Similarity=0.357 Sum_probs=165.5
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
...+|.+.+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++......++|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 3467999999999999999999975 5778999975432 2346899999999999999999999999999999
Q ss_pred eeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+. ++|.+++.. ...+++..+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 9995 588888754 45799999999999999999999999 9999999999999999999999999999754321
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 432 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~ 432 (552)
.......||..|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 12233558999999999999999999999999999999999766654
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=313.62 Aligned_cols=270 Identities=23% Similarity=0.327 Sum_probs=205.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-----CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeec--CCce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~ 302 (552)
+.|...+.||+|+||.||+|.+. ++..||||.++..........|.+|+++++.+.||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999864 3679999999755433245679999999999999999999999877 5578
Q ss_pred eEEEeeccCCChhhhhccCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 303 LLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
+++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999997544 699999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCce--eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 382 HCDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 382 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
...... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+.............. ............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 238 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA--QGQMIVTRLLEL 238 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc--cccccHHHHHHH
Confidence 322211 1122355679999999988999999999999999999999988764321110000000 000000000111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
+........+..++.++.+++.+||+.+|++|||+.||+++|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111112233447899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=314.41 Aligned_cols=247 Identities=28% Similarity=0.371 Sum_probs=201.2
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeecc
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 310 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 310 (552)
|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.++||||+++++++......++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 445578999999999999865 5789999998754433445578899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeec
Q 008828 311 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 390 (552)
Q Consensus 311 ~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 390 (552)
+++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++..+..... ....
T Consensus 86 ~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~ 160 (277)
T cd06642 86 GGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNT 160 (277)
T ss_pred CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhc
Confidence 9999998865 4689999999999999999999998 999999999999999999999999999976543221 1223
Q ss_pred ccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCH
Q 008828 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 470 (552)
Q Consensus 391 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (552)
..++..|+|||.+.+..++.++|||||||++|||+||+.|+...... .+.... ..........
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~----------~~~~~~~~~~ 223 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-------RVLFLI----------PKNSPPTLEG 223 (277)
T ss_pred ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-------hHHhhh----------hcCCCCCCCc
Confidence 45788999999999989999999999999999999999998632211 000000 0011111222
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 471 IELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 471 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+..+.+++.+||+.+|++||++.+++++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 345778999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=310.59 Aligned_cols=248 Identities=28% Similarity=0.461 Sum_probs=197.7
Q ss_pred CeeeeeCceEEEEEEECC-------CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 236 NLVGKGGFGNVYKGYLQD-------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+.||+|+||.||+|...+ +..+|+|.+...........+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2579999886554334456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcc-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC-----ceEEccccc
Q 008828 309 MSNGSVASRLKA-------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-----EAVVGDFGL 376 (552)
Q Consensus 309 ~~~g~L~~~l~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfg~ 376 (552)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999863 23478999999999999999999998 999999999999999877 899999999
Q ss_pred ceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhc
Q 008828 377 AKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEK 454 (552)
Q Consensus 377 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 454 (552)
++........ ......++..|+|||.+.++.++.++|||||||++|||+| |..||...... +........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-------EVLQHVTAG- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-------HHHHHHhcC-
Confidence 8755332211 1122235678999999999999999999999999999998 99888632211 111111110
Q ss_pred chhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 455 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.....+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 230 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 ---------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0111223345788999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=306.43 Aligned_cols=250 Identities=29% Similarity=0.448 Sum_probs=202.6
Q ss_pred CCCCCeeeeeCceEEEEEEECC-----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
+++.+.||+|+||.||++...+ +..||+|.++..........+..|+.++..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999753 48899999976544435667899999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCC--CCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 307 PYMSNGSVASRLKAKPS--LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~--l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
||+++++|.+++..... +++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999976544 99999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
........++..|+|||.+.+..++.++||||+|+++|+|++ |..||..... ...........
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~~~--------- 221 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVLEYLKKGY--------- 221 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcCC---------
Confidence 222212236789999999988889999999999999999999 7777753211 11111111111
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
....+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111222457899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=307.87 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=198.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC----chHHHHHHHHHHHhhccccccceeeeEeecC--Cce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 302 (552)
.+|...+.||+|+||.||+|... ++..||+|.+...... .....+.+|+.+++.++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 5889999988643211 1234588899999999999999999988653 567
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++++||+++++|.+++.....+++.....++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 89999999999999998777899999999999999999999998 999999999999999999999999999876532
Q ss_pred CCC--ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 383 CDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 383 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
... .......++..|+|||.+.+..++.++|||||||++|||++|+.||..... ....... .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~~~~~---------~ 222 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAAIFKI---------A 222 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------HHHHHHH---------h
Confidence 111 111234588899999999988899999999999999999999999863211 0111111 1
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
........+....+.+.+++ +||..+|++||+++||+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 223 TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 11111223333446667777 7888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=309.47 Aligned_cols=255 Identities=21% Similarity=0.310 Sum_probs=201.4
Q ss_pred HHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 226 QSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 226 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
+.+++++.....||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 345666667789999999999999965 57889999886543 2234578899999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccC-CCC--CHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC-CCceEEcccccceec
Q 008828 305 VYPYMSNGSVASRLKAK-PSL--DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLL 380 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~-~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~ 380 (552)
|+||+++++|.+++... ..+ ++..+..++.||+.||.|||+. +|+||||||+||+++. ++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999999998753 445 8888999999999999999998 9999999999999986 679999999998765
Q ss_pred CCCCCceeecccccccccCchhhccCC--CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhh
Q 008828 381 DHCDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458 (552)
Q Consensus 381 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (552)
..... ......|+..|+|||++.... ++.++||||||+++|+|++|+.|+........ ..+.....
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~----~~~~~~~~------- 227 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA----AMFKVGMF------- 227 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh----hHhhhhhh-------
Confidence 43222 122335789999999986643 78999999999999999999999864221100 00000000
Q ss_pred hccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......+....+++.+++.+||+.+|++|||+.|++++
T Consensus 228 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 01112233445778999999999999999999999865
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=313.46 Aligned_cols=267 Identities=22% Similarity=0.247 Sum_probs=203.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|+..+.||+|+||.||+|..+ +++.||+|++...... .....+.+|+.++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999976 5899999998654322 233457899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
|+++++|..+......+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 999998888887767799999999999999999999998 999999999999999999999999999987654322 2
Q ss_pred eecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHH-------Hh-hhcchhh
Q 008828 388 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK-------IH-QEKKLEM 458 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~-~~~~~~~ 458 (552)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+...... .. .......
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 223457889999999876 45789999999999999999999999743321110000000000 00 0000000
Q ss_pred hccccccCcC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 LVDKDLKNNY-----DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+...... ....+..+.+++.+||+.+|++||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0001000000 01224678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.44 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=199.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.+|++.+.||+|+||.||+|... +++.||+|+++..... ....++.+|+.+++.++||||+++++++...+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999965 5899999999754322 22446899999999999999999999999999999999
Q ss_pred eeccCCChhhhhcc-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccc
Q 008828 307 PYMSNGSVASRLKA-----------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 375 (552)
Q Consensus 307 e~~~~g~L~~~l~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 375 (552)
||+++|+|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998853 12456778899999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCC-----------------ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccc
Q 008828 376 LAKLLDHCDS-----------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN 438 (552)
Q Consensus 376 ~~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~ 438 (552)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 01112458999999999999999999999999999999999999996422110
Q ss_pred cccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 008828 439 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRP-KMSEVVRMLEG 503 (552)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~ 503 (552)
.. + . ..+.++.... .....+..+.+++.+|++.||++|| +++++.+.|+.
T Consensus 239 ----i~-~------~---~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 ----IS-Y------R---DVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred ----hh-h------h---hhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 0 0 0000000000 0122346788999999999999996 55666666654
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.79 Aligned_cols=262 Identities=23% Similarity=0.286 Sum_probs=201.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC---CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
..+|.+.+.||+|+||.||++... .+..||+|.+.... ...+|+.++++++||||+++++++......++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 356889999999999999999753 35789999885432 345899999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||++. ++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.++|+|||++........
T Consensus 165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99996 68888887777899999999999999999999999 999999999999999999999999999976543322
Q ss_pred c-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh-------
Q 008828 386 H-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE------- 457 (552)
Q Consensus 386 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 457 (552)
. ......||..|+|||++....++.++|||||||++|||++|+.||...........+...++... .....
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~-~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ-VHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhc-cCccccCCccch
Confidence 2 22345699999999999999999999999999999999999999975433221111111111100 00000
Q ss_pred ---h---hccccccCcCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 458 ---M---LVDKDLKNNYD-------RIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 458 ---~---~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
. .........+. .....++.+++.+||+.||++|||+.|++.+-
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0 00000001010 11235688999999999999999999999763
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=327.40 Aligned_cols=261 Identities=20% Similarity=0.253 Sum_probs=197.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
..+|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+||+++++++......++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 446889999999999999999976 478899996421 235689999999999999999999999999999999
Q ss_pred eccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 308 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 308 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
++. ++|..++.. ...+++..+..|+.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 995 688888764 34699999999999999999999999 9999999999999999999999999999876433221
Q ss_pred -eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcch--hhhc---
Q 008828 387 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL--EMLV--- 460 (552)
Q Consensus 387 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--- 460 (552)
......||..|+|||++.+..++.++|||||||++|||++|..++...............+......... ....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2234569999999999999999999999999999999999987665332211111111111111000000 0000
Q ss_pred c------------ccccCcCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 461 D------------KDLKNNYD-------RIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 461 ~------------~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ......+. ......+.+|+.+||+.||++|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 00000000 0122468899999999999999999999976
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=316.04 Aligned_cols=267 Identities=21% Similarity=0.272 Sum_probs=205.3
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|++.+.||+|+||.||+|..+ +++.||+|.++.... ......+.+|+++++.++|+||+++++++...+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6788899999999999999976 588999999865432 22345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
++++.+..+......+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++...........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99877777776666799999999999999999999999 999999999999999999999999999987654433233
Q ss_pred ecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHH--------HHhhhcchh--
Q 008828 389 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK--------KIHQEKKLE-- 457 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~-- 457 (552)
....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.......... .........
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 345678899999999888 889999999999999999999998864322110000000000 000000000
Q ss_pred ---hhccc-cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 ---MLVDK-DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 ---~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+. .....++...+.++.+++.+||..+|++||++++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 00011222346889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=321.89 Aligned_cols=265 Identities=20% Similarity=0.251 Sum_probs=197.4
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCC------
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ 300 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 300 (552)
.++|.+.+.||+|+||.||++... +|..||+|.++.... ......+.+|+.++..++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 468999999999999999999864 589999999965422 223456789999999999999999999986543
Q ss_pred ceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 301 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
..++||||+++ +|...+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 46899999975 56666543 488999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCccccccc--------chHHHHH----
Q 008828 381 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG--------AMLDWVK---- 448 (552)
Q Consensus 381 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~--------~~~~~~~---- 448 (552)
... .......||..|+|||.+.+..++.++|||||||++|+|+||+.||.......... ....+..
T Consensus 174 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 174 CTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 321 22233468999999999999999999999999999999999999997532211000 0000000
Q ss_pred ---HHhhhc------chhhhcccccc---CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 449 ---KIHQEK------KLEMLVDKDLK---NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 449 ---~~~~~~------~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
...... ...+....... ..........+.+++.+||+.||++|||+.|++++-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000000 00000000000 001112346789999999999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=316.15 Aligned_cols=254 Identities=24% Similarity=0.421 Sum_probs=199.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCc----EEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
++|+..+.||+|+||.||+|.+. ++. .||+|.+...........+.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45777889999999999999864 343 57899886544333344688999999999999999999998754 4679
Q ss_pred EEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
++||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999998754 3689999999999999999999998 9999999999999999999999999999866432
Q ss_pred CCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 384 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 384 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .....++. ....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~~~~~~~---~~~~------ 229 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----REIPDLLE---KGER------ 229 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHH---CCCC------
Confidence 221 1122335678999999999999999999999999999998 8888853211 01111111 1000
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
...+..++..+.+++.+||..+|++||++.++++.|+..
T Consensus 230 ----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 ----LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011122346789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=310.31 Aligned_cols=254 Identities=23% Similarity=0.395 Sum_probs=203.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC-Cc----EEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD-GT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
.+|.+.+.||+|+||.||+|.+++ |. .+|+|.+...........+.+|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467788999999999999998642 33 6899988765443445578899999999999999999999987 78899
Q ss_pred EEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 9999999999999875 34699999999999999999999998 9999999999999999999999999999876533
Q ss_pred CCcee-ecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 384 DSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 384 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
..... ....++..|+|||.+....++.++||||||+++||++| |+.||..... .++........
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~------- 228 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-------VEIPDLLEKGE------- 228 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhCCC-------
Confidence 22211 11224568999999988899999999999999999999 9999864321 11111111110
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
....+..+...+.+++.+||..+|.+||++.++++.|+..
T Consensus 229 ---~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 229 ---RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111222346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=316.82 Aligned_cols=273 Identities=21% Similarity=0.269 Sum_probs=203.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|...+.||+|+||.||+|..+ +++.||+|.++..........+.+|+.+++.++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999875 58899999987544333344677899999999999999999999999999999999
Q ss_pred ccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
++ ++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++........ .
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence 97 588888764 45689999999999999999999998 999999999999999999999999999975432221 1
Q ss_pred eecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHH--------HHHhhhcchhh
Q 008828 388 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV--------KKIHQEKKLEM 458 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 458 (552)
.....++..|+|||.+.+. .++.++|||||||++|||+||+.||...........+.... ...........
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 2233478899999998654 57889999999999999999999997543211100000000 00000000000
Q ss_pred hccccccCc----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCc
Q 008828 459 LVDKDLKNN----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLA 507 (552)
Q Consensus 459 ~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 507 (552)
...+..... .....+..+.+++.+|++.||.+|||++|++++---....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000000000 0112345788999999999999999999999754443333
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=305.40 Aligned_cols=249 Identities=27% Similarity=0.391 Sum_probs=203.4
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc----CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA----IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
+|...+.||+|+||.||+|... +++.|++|.+..... ......+.+|+++++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999976 789999999864321 12345688999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
+||+++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999999998777899999999999999999999998 99999999999999999999999999988654322
Q ss_pred ceeecccccccccCchhhccCC-CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
......++..|+|||.+.... ++.++|+|||||++|+|++|+.||..... ............
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~--------- 219 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKE--------- 219 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhccc---------
Confidence 223455889999999987766 89999999999999999999999864321 111111111000
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+......+.+++.+||+.+|.+||++.+++.+
T Consensus 220 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111222344778999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=307.39 Aligned_cols=239 Identities=21% Similarity=0.322 Sum_probs=187.2
Q ss_pred CeeeeeCceEEEEEEECC-------------CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCce
Q 008828 236 NLVGKGGFGNVYKGYLQD-------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 302 (552)
+.||+|+||.||+|++.+ ...|++|.+.... ......+.+|+.++..++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 368999999999998532 2358899875432 22344688899999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc-------eEEccc
Q 008828 303 LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE-------AVVGDF 374 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~kl~Df 374 (552)
++||||+++|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++. ++++||
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999988864 45699999999999999999999998 9999999999999987664 899999
Q ss_pred ccceecCCCCCceeecccccccccCchhhc-cCCCCCccchhHHHHHHHHHH-hCCCccccCcccccccchHHHHHHHhh
Q 008828 375 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELI-SGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 375 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
|++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+...... .. .....
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~-~~~~~ 223 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-------EK-ERFYE 223 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------HH-HHHHh
Confidence 998754321 2234788999999886 466899999999999999998 577776532110 00 00000
Q ss_pred hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
. ... .......++.+++.+||+.||++||++.++++.++
T Consensus 224 -~--------~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 -G--------QCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -c--------Ccc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 000 01112367899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=312.23 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=194.9
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
|+..+.||+|+||+||+|... +++.||+|.+...... .....+.+|++++..++|+|++.+.+++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 556688999999999999965 6889999998653322 1234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 999999988854 34699999999999999999999998 99999999999999999999999999997654322
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......|+..|+|||.+.+..++.++|||||||++|||++|..||........ ...+..... .. ..
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~---------~~--~~ 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVL---------ET--EE 222 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhh---------cc--cc
Confidence 12334689999999999999999999999999999999999999974321100 001100000 00 01
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMS 495 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 495 (552)
.+....+..+.+++.+|++.||++||++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 12223346789999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=307.33 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=200.4
Q ss_pred CCCCCCeeeeeCceEEEEEEECC--CcEEEEEEeccCc---------cCchHHHHHHHHHHHhh-ccccccceeeeEeec
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQD--GTVVAVKRLKDGN---------AIGGEIQFQTEVEMISL-AVHRNLLRLIGFCMT 298 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~ 298 (552)
+|++.+.||+|+||.||+|..+. ++.+|+|.+.... ......++..|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999764 6889999885321 11123356778887764 789999999999999
Q ss_pred CCceeEEEeeccCCChhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEEcCCCCCceeeCCCCceEEcc
Q 008828 299 TTERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGD 373 (552)
Q Consensus 299 ~~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~D 373 (552)
.+..+++|||+++++|.+++. ....+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999998874 34568999999999999999999996 4 899999999999999999999999
Q ss_pred cccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh
Q 008828 374 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 453 (552)
Q Consensus 374 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 453 (552)
||.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ........
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------~~~~~~~~-- 226 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------LSLATKIV-- 226 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-------HHHHHHHh--
Confidence 99998755432 23345588999999999998899999999999999999999999863221 11111111
Q ss_pred cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 454 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.....+......+..+.+++.+||+.||++||++.|+.+++++
T Consensus 227 -------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 227 -------EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred -------hccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1111111111234678999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=307.36 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=188.7
Q ss_pred eeeeeCceEEEEEEECC---CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCC
Q 008828 237 LVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 313 (552)
Q Consensus 237 ~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 313 (552)
.||+|+||+||+|...+ ...+|+|.+...........+.+|+..++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 357888887654433344568899999999999999999999999999999999999999
Q ss_pred hhhhhccCC-----CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce-
Q 008828 314 VASRLKAKP-----SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV- 387 (552)
Q Consensus 314 L~~~l~~~~-----~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 387 (552)
|.+++.... ..++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999986432 346788899999999999999999 99999999999999999999999999986543222111
Q ss_pred eecccccccccCchhhcc-------CCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 388 TTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... +......... ...+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~-~~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVREQ-DIKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhhcc-CccC
Confidence 122335678999999753 356889999999999999999 67777532211 1111111111 1111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.++. .....+..+.+++..|| .||++|||++||++.|.
T Consensus 231 ~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 22234466778899998 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=304.79 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=204.6
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc-cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|+..+.||+|+||.||.+... ++..+++|.+.... .......+.+|++++++++|+||+++++++......+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999999854 68899999886432 223445688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999754 4689999999999999999999998 999999999999999999999999999987644332
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......++..|+|||.+.+..++.++||||||+++|||++|..||..... .......... .. .
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~---------~~-~ 219 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVKIVQG---------NY-T 219 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcC---------CC-C
Confidence 22344589999999999888899999999999999999999999864221 1111111111 00 1
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
......+.++.+++.+||+.+|.+||+++++++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123357789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=324.14 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=204.1
Q ss_pred CCCCCeeeeeCceEEEEEEECC--C--cEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQD--G--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
....++||+|.||.|++|.|.. | ..||||.++..........|.+|+.+|.+++|||+++++|+..+ ....+|||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3445789999999999999863 3 36899999876655456789999999999999999999999887 77889999
Q ss_pred eccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 308 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
.++.|+|.+.|+. ...+-......++.|||.|+.||.++ ++|||||..+|+|+-....+||+|||+.+-+...+.
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999985 44688888999999999999999999 999999999999999999999999999998876554
Q ss_pred cee--ecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 386 HVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 386 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
... ....-.+.|+|||.+....++.++|||+|||++|||+| |..||..-.. ..+.+.+|.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qIL~~iD~ 330 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQILKNIDA 330 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHHHHhccc
Confidence 432 22235578999999999999999999999999999999 5566653221 112222332
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
.-+-.-+..++++++++++.||...|.+|||+..+.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 2222335667899999999999999999999999964
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=309.57 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=200.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|.+.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++..++||||+++++++...+..++||||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 45677789999999999999864 688999999865432 2334578899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++++|.+++...+.+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... ...
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR 163 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence 99999999998888899999999999999999999999 99999999999999999999999999987654321 122
Q ss_pred ecccccccccCchhhc---cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 389 TAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
....|+..|+|||.+. ...++.++|||||||++|+|++|..|+........ +....... ...+...
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-------~~~~~~~~----~~~~~~~ 232 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LFLMTKSN----FQPPKLK 232 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-------HHhhhccC----CCCCccc
Confidence 3345899999999974 45688999999999999999999999864321100 00000000 0000000
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ....+..+.+++.+|++.+|++||++++++++
T Consensus 233 ~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 233 D--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred c--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 01123568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=336.83 Aligned_cols=267 Identities=18% Similarity=0.253 Sum_probs=194.5
Q ss_pred HHHHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccc------cccceeeeE
Q 008828 223 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH------RNLLRLIGF 295 (552)
Q Consensus 223 ~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h------~niv~l~~~ 295 (552)
+++...+.+|.+.+.||+|+||+||+|... .++.||||+++.... ....+..|+.++..++| .++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 334455688999999999999999999964 578999999964321 12234566666666654 458889888
Q ss_pred eecC-CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEEcCCCCCceeeCCCC------
Q 008828 296 CMTT-TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYY------ 367 (552)
Q Consensus 296 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~------ 367 (552)
+... .+.++|||++ +++|.+++.....+++..+..|+.||+.||.|||+ . +|+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccc
Confidence 8764 4678999988 67899988877789999999999999999999997 5 899999999999998765
Q ss_pred ----------ceEEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCccc
Q 008828 368 ----------EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTA 437 (552)
Q Consensus 368 ----------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~ 437 (552)
.+||+|||.+..... ......||..|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998764321 223456999999999999999999999999999999999999999753321
Q ss_pred ccccch--------HHHHHHHhhhcchhhhccc--cccCcC---------------CHHHHHHHHHHHHHccCCCCCCCC
Q 008828 438 NQKGAM--------LDWVKKIHQEKKLEMLVDK--DLKNNY---------------DRIELEEMVQVALLCTQYLPSLRP 492 (552)
Q Consensus 438 ~~~~~~--------~~~~~~~~~~~~~~~~~~~--~~~~~~---------------~~~~~~~l~~li~~cl~~dP~~RP 492 (552)
.....+ ..|....... ....+.+. .+.... .......+.+|+.+||+.||++||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTE-EARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccch-hHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 110000 0111100000 00000000 000000 011235678999999999999999
Q ss_pred CHHHHHHH
Q 008828 493 KMSEVVRM 500 (552)
Q Consensus 493 s~~evl~~ 500 (552)
|++|+++|
T Consensus 431 ta~e~L~H 438 (467)
T PTZ00284 431 NARQMTTH 438 (467)
T ss_pred CHHHHhcC
Confidence 99999964
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=314.82 Aligned_cols=267 Identities=23% Similarity=0.313 Sum_probs=202.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|+..+.||+|+||.||+|..+ +++.||+|++....... ....+.+|+++++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999976 58999999986543222 34468899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
|+++++|..+......+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence 999999988877666799999999999999999999998 99999999999999999999999999998654332 22
Q ss_pred eecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHH-------hhhc-chhh
Q 008828 388 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI-------HQEK-KLEM 458 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~-~~~~ 458 (552)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+..+.... .... ....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 233457889999999875 447889999999999999999998886432211100000100000 0000 0000
Q ss_pred hccccccCc-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 LVDKDLKNN-----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+..... ..+..+..+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000 011235779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=304.94 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=204.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|+..+.||+|+||.||+|... +++.+++|.+...... ....+.+|+.+++.++||||+++++++......+++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 56888899999999999999975 5788999999754332 455788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||.+....... ..
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 9999999998765 6899999999999999999999998 99999999999999999999999999987654321 12
Q ss_pred eecccccccccCchhhccC---CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 388 TTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
.....++..|+|||.+... .++.++|||||||++|||+||+.|+........ ....... ......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-------~~~~~~~----~~~~~~- 225 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-------LFLISKS----NFPPPK- 225 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhc----cCCCcc-
Confidence 2334578899999999877 889999999999999999999999864321100 0000000 000000
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.......+.++.+++.+||+.+|.+|||+.+++.+
T Consensus 226 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 -LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred -ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11223445789999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=316.03 Aligned_cols=255 Identities=22% Similarity=0.278 Sum_probs=205.3
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCcc-CchHHHHHHHHHHHhhcc-ccccceeeeEeecCCceeE
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~l 304 (552)
+....|++.+.||+||.+.||++...+.+.+|+|++..... ......|.+|+..|.+++ |.+||++++|-..++..|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34567889999999999999999998888999988764333 333456999999999995 9999999999999999999
Q ss_pred EEeeccCCChhhhhccCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
||||-+ .+|..+|+++.. ...-.++.+..|++.|+.++|++ ||||.||||.|+|+-. |.+||+|||+|..+...
T Consensus 438 vmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred Eeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 999975 499999986543 22238889999999999999999 9999999999999975 89999999999987665
Q ss_pred CCc-eeecccccccccCchhhccCC-----------CCCccchhHHHHHHHHHHhCCCccccCcccccccchH-HHHHHH
Q 008828 384 DSH-VTTAVRGTVGHIAPEYLSTGQ-----------SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML-DWVKKI 450 (552)
Q Consensus 384 ~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~-~~~~~~ 450 (552)
... .....+||+.||+||.+.... .+.++||||+|||||+|+.|+.||.. +. .|
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~---------~~n~~---- 579 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ---------IINQI---- 579 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH---------HHHHH----
Confidence 544 345567999999999986432 46799999999999999999999962 11 12
Q ss_pred hhhcchhhhccccccCcCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 451 HQEKKLEMLVDKDLKNNYDRIE-LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.++..+.|+...-+|+..- ..++.++++.||..||++|||..|++++--
T Consensus 580 ---aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpF 629 (677)
T KOG0596|consen 580 ---AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPF 629 (677)
T ss_pred ---HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence 2345556664433333211 123999999999999999999999997543
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=313.68 Aligned_cols=193 Identities=24% Similarity=0.359 Sum_probs=159.1
Q ss_pred CCeeeeeCceEEEEEEEC---CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeec--CCceeEEEeec
Q 008828 235 KNLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLLVYPYM 309 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~~lv~e~~ 309 (552)
.+.||+|+||+||+|... +++.||+|.++.... ...+.+|+.+++.++||||+++++++.. ....+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999864 467899999864322 2356789999999999999999998864 35678999998
Q ss_pred cCCChhhhhcc---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee----CCCCceEEccccc
Q 008828 310 SNGSVASRLKA---------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVVGDFGL 376 (552)
Q Consensus 310 ~~g~L~~~l~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~ 376 (552)
.+ +|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 64 78777642 12589999999999999999999999 99999999999999 4567899999999
Q ss_pred ceecCCCCCc--eeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccC
Q 008828 377 AKLLDHCDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFG 434 (552)
Q Consensus 377 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~ 434 (552)
++........ ......||+.|+|||++.+. .++.++||||+||++|||+||++||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9876432211 22345689999999999774 5899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=304.37 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=200.8
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecC-CceeEEEe
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-TERLLVYP 307 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-~~~~lv~e 307 (552)
+|++.+.||+|++|.||++..+ +++.||+|.+...... .....+.+|+.++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999965 5789999998653322 2344688899999999999999999987644 45789999
Q ss_pred eccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 308 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|+++++|.+++.. ...+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 9999999999875 34689999999999999999999999 999999999999999999999999999987643222
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..+...... ...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~~-~~~--------- 219 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYRIIE-GKL--------- 219 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHh-cCC---------
Confidence 22334588999999999999999999999999999999999999863221 111111111 111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+...+..+.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11223345789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=304.91 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=199.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc----CchHHHHHHHHHHHhhccccccceeeeEeecC--Cce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA----IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 302 (552)
++|.+.+.||+|+||.||+|... ++..||+|.+..... ......+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999965 589999998853221 11234678899999999999999999988764 457
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
+++|||+++++|.+++.....+++.....++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 79999999999999998777789999999999999999999999 999999999999999999999999999876532
Q ss_pred CCC--ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 383 CDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 383 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .. .. ...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~-~~---------~~~ 222 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AA-IF---------KIA 222 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HH-HH---------HHh
Confidence 111 1122345888999999998888999999999999999999999998632110 00 00 011
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
........+......+.+++.+|+. +|++||+++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1111122344556778899999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=304.90 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=203.5
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|+..+.||+|+||.||+|... +++.|++|.++..... .....+..|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999965 6899999999754332 2456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99999999998877799999999999999999999998 999999999999999999999999999987654332221
Q ss_pred ---ecccccccccCchhhccCC---CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 389 ---TAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 389 ---~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
....++..|+|||.+.... ++.++||||||+++|++++|+.||...... ......... . ..+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~------~~~~~~~~~-~-----~~~ 225 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE------FQIMFHVGA-G-----HKP 225 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch------HHHHHHHhc-C-----CCC
Confidence 1345788999999998766 899999999999999999999999643210 010000000 0 000
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
.+. ........+.+++.+||+.+|++||++.+++.
T Consensus 226 ~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 110 01112467889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=310.62 Aligned_cols=265 Identities=21% Similarity=0.279 Sum_probs=197.2
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|++.+.||+|++|.||+|+.. ++..||+|.++..... .....+.+|+.++..++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777899999999999999975 6899999998643322 2234678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 309 MSNGSVASRLKA---KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 309 ~~~g~L~~~l~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
++ ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 588888753 24689999999999999999999998 99999999999999999999999999997654321
Q ss_pred ceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHH--------HHHhhhcch
Q 008828 386 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV--------KKIHQEKKL 456 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 456 (552)
.......++..|+|||.+.+. .++.++|||||||++|+|+||+.||................ .........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 122233468899999988654 57899999999999999999999997432211100000000 000000000
Q ss_pred hhhcccccc---CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 457 EMLVDKDLK---NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 457 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......... .......+.++.+++.+||+.||++|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000 00011234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=321.45 Aligned_cols=265 Identities=19% Similarity=0.228 Sum_probs=197.9
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecC------
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------ 299 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------ 299 (552)
..++|.+.+.||+|+||.||++... .++.||||.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3468999999999999999999864 5889999999754322 2344677899999999999999999988643
Q ss_pred CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 300 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
...++||||+++ ++.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 346899999975 66666643 488999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccch--------HHHH----
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM--------LDWV---- 447 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~--------~~~~---- 447 (552)
.... .......||..|+|||++.+..++.++|||||||++|||++|+.||............ ..+.
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred CCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 5422 2223456899999999999999999999999999999999999999743221110000 0000
Q ss_pred ---HHHhh-hcchhhhcccc-----cc---CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 448 ---KKIHQ-EKKLEMLVDKD-----LK---NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 448 ---~~~~~-~~~~~~~~~~~-----~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..... ......+..+. .. ..........+.+++.+|++.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 00000000000 00 00111224678999999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=311.20 Aligned_cols=250 Identities=19% Similarity=0.286 Sum_probs=203.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++......++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 6788899999999999999996 4789999999965432 2345688899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++++|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......... .
T Consensus 98 ~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~ 172 (297)
T cd06656 98 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 172 (297)
T ss_pred cCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-c
Confidence 9999999998654 589999999999999999999998 9999999999999999999999999998765433221 2
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||......... . .. ..........
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~---~----~~--------~~~~~~~~~~ 237 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---Y----LI--------ATNGTPELQN 237 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe---e----ee--------ccCCCCCCCC
Confidence 2345888999999999988999999999999999999999999643221100 0 00 0000000111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+...+..+.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22344678899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=310.86 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=201.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|++.+.||+|+||.||++... ++..||+|.++..........+.+|+.++.+++||||+++++++......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35788899999999999999976 68999999987543333345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 309 MSNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 309 ~~~g~L~~~l~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
+++++|..++... ..+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999888753 37999999999999999999999632 8999999999999999999999999998765322
Q ss_pred ceeecccccccccCchhhccCC------CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...... .....+. .+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~---------~~ 222 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA----NIFAQLS---------AI 222 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh----hHHHHHH---------HH
Confidence 122334788999999986543 588999999999999999999999642211 0111111 11
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+.. ....+...+.++.+++.+||+.+|++||++.+++.+
T Consensus 223 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 223 VDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1110 112233456789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=309.87 Aligned_cols=247 Identities=21% Similarity=0.285 Sum_probs=211.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.-|.+.+.||+|.|+.|-+|++- +|..||||++.+..-.. ....+.+|+.-|+.++|||||++|++.......|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 34777889999999999999854 79999999996554322 23457889999999999999999999999999999999
Q ss_pred eccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC-CCCceEEcccccceecCCCCC
Q 008828 308 YMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 308 ~~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
.-++|+|++++. ....+.+....+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+||.|||++..+..+
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-- 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-- 172 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence 999999999985 445799999999999999999999999 999999999998875 5689999999999866543
Q ss_pred ceeecccccccccCchhhccCCCC-CccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
......+|+..|-|||++.+..|+ +++||||+|||||.|++|+.||..... .+.+.+++|...
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----------------SETLTmImDCKY 236 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----------------SETLTMIMDCKY 236 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----------------hhhhhhhhcccc
Confidence 344567899999999999999885 688999999999999999999985443 234566677654
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
. .+.....+..+||..||..||++|-+.+||..
T Consensus 237 t--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 T--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred c--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 3 46677889999999999999999999999974
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=306.90 Aligned_cols=255 Identities=24% Similarity=0.380 Sum_probs=200.6
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc---------hHHHHHHHHHHHhhccccccceeeeEeecCC
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG---------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTT 300 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 300 (552)
+|...+.||+|+||.||+|... +++.||+|.++...... ..+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999864 68899999885321110 1235778999999999999999999999999
Q ss_pred ceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 301 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
..++||||+++|+|.+++.....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 9999999999999999998877899999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCc-eeecccccccccCchhhccCC--CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh
Q 008828 381 DHCDSH-VTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457 (552)
Q Consensus 381 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (552)
...... ......|+..|+|||.+.... ++.++||||||+++||+++|..|+..... .... ...... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~-~~~~~~-~~~ 230 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAM-FKLGNK-RSA 230 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHH-HHhhcc-ccC
Confidence 422111 123345889999999987754 78999999999999999999999853211 0011 111000 000
Q ss_pred hhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...........+..+.+++.+||+.+|++||++.+|+++
T Consensus 231 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 ----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 011111222345789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=323.62 Aligned_cols=264 Identities=20% Similarity=0.259 Sum_probs=197.4
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecC------C
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------T 300 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~ 300 (552)
.++|.+.+.||+|+||.||+|... .++.||||++..... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467999999999999999999964 588999999975432 22345678899999999999999999987543 3
Q ss_pred ceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 301 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
..++||||+++ +|...+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 56899999975 67776653 488999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccch--------HHHHHHHh-
Q 008828 381 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM--------LDWVKKIH- 451 (552)
Q Consensus 381 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~- 451 (552)
... .......||..|+|||++.+..++.++|||||||++|||++|+.||...........+ ..+.....
T Consensus 177 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 177 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 432 2223446899999999999999999999999999999999999999754321110000 00000000
Q ss_pred ------hh-cc-----hhhhccccc---cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 452 ------QE-KK-----LEMLVDKDL---KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 452 ------~~-~~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.. .. ......... ...........+.+++.+|++.||.+|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00 000000000 000111123578899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=308.27 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=199.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+.|++.+.||+|+||.||+|... ++..|++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 56888899999999999999975 48899999986532 22345688899999999999999999999999999999999
Q ss_pred ccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+++++|..++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....... ..
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 999999887753 45789999999999999999999998 99999999999999999999999999987543221 11
Q ss_pred eecccccccccCchhhc-----cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 388 TTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.....++..|+|||++. ...++.++|||||||++|||++|..||..... ........... .+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~------~~ 233 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSE------PP 233 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHHhcCC------Cc
Confidence 23345788999999984 34578899999999999999999999864221 01111111100 00
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.. ..+...+.++.+++.+||+.+|++||++.+++++
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 1122334678999999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=303.78 Aligned_cols=237 Identities=24% Similarity=0.395 Sum_probs=189.4
Q ss_pred CeeeeeCceEEEEEEECCCc-----------EEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 236 NLVGKGGFGNVYKGYLQDGT-----------VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
+.||+|+||.||+|...+.. .+++|.++..... ...+.+|+.+++.++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999976432 5788877644322 5678899999999999999999999988 78899
Q ss_pred EEeeccCCChhhhhccCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC-------ceEEccccc
Q 008828 305 VYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-------EAVVGDFGL 376 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~Dfg~ 376 (552)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999998655 799999999999999999999998 999999999999999887 799999999
Q ss_pred ceecCCCCCceeecccccccccCchhhccC--CCCCccchhHHHHHHHHHHhC-CCccccCcccccccchHHHHHHHhhh
Q 008828 377 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISG-LRALEFGKTANQKGAMLDWVKKIHQE 453 (552)
Q Consensus 377 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 453 (552)
+..... .....++..|+|||++... .++.++|||||||++|||++| ..|+...... .+.......
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-------~~~~~~~~~ 222 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-------EKERFYQDQ 222 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-------hHHHHHhcC
Confidence 986543 1223467789999999876 789999999999999999994 6666432211 111111100
Q ss_pred cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 454 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.. .+......+.+++.+||..+|++|||+.++++.|+
T Consensus 223 ---------~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 ---------HR---LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---------CC---CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00001167899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=307.68 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=205.7
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
+|+..+.||+|+||.||++..+ +++.+|+|.+..........++.+|+++++.++||||+++++++......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999976 689999999976544445567889999999999999999999999999999999999
Q ss_pred cCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 310 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 310 ~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
++++|.+++... ..+++..+..++.|++.||.|||+ . +++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 999999999765 789999999999999999999999 7 999999999999999999999999999875532211
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+.+....... ...
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~----------~~~ 223 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEP----------PPR 223 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCC----------CCC
Confidence 1155888999999999999999999999999999999999998753221 111222222221110 011
Q ss_pred CCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 468 YDRI-ELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 468 ~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+.. .+..+.+++.+||..+|++|||+.+++.+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111 45779999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=310.43 Aligned_cols=261 Identities=25% Similarity=0.312 Sum_probs=202.4
Q ss_pred cCHHHHHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEee
Q 008828 220 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCM 297 (552)
Q Consensus 220 ~~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 297 (552)
+.++.+..+.++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.++..+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 334556667889999999999999999999865 57899999885432 2234577899999998 6999999999874
Q ss_pred -----cCCceeEEEeeccCCChhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc
Q 008828 298 -----TTTERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 368 (552)
Q Consensus 298 -----~~~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 368 (552)
.....++||||+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence 3456899999999999998764 335689999999999999999999998 9999999999999999999
Q ss_pred eEEcccccceecCCCCCceeecccccccccCchhhcc-----CCCCCccchhHHHHHHHHHHhCCCccccCcccccccch
Q 008828 369 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 443 (552)
Q Consensus 369 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~ 443 (552)
++|+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+.......
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----- 236 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----- 236 (286)
T ss_pred EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----
Confidence 99999999986643221 2223458999999999853 457889999999999999999999986432110
Q ss_pred HHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 444 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
.. ...... ......+ +......+.+++.+||+.+|++|||+.|++++.
T Consensus 237 -~~-~~~~~~-~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 -AL-FKIPRN-PPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -HH-hhcccc-CCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 000000 0000001 111235789999999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=322.15 Aligned_cols=241 Identities=24% Similarity=0.261 Sum_probs=187.8
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhc---cccccceeeeEeecCCceeEEEeeccC
Q 008828 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA---VHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 238 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~---~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
||+|+||+||+|... +++.||+|++...... .....+..|..++... .||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 5899999998643211 1222345566666554 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|+|..++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCc
Confidence 99999998888899999999999999999999999 99999999999999999999999999987543222 122345
Q ss_pred cccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCH
Q 008828 392 RGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 470 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (552)
.||..|+|||.+.+. .++.++|||||||++|||+||+.||..... ........... ..+. ..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~-------~~~~---~~ 219 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIAFGK-------VRFP---KN 219 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HHHHHHHHcCC-------CCCC---Cc
Confidence 699999999998764 489999999999999999999999964321 11111111100 0000 01
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 008828 471 IELEEMVQVALLCTQYLPSLRPK----MSEVVR 499 (552)
Q Consensus 471 ~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 499 (552)
..+..+.+++.+||+.||++||+ +.++++
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 13467889999999999999995 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=304.66 Aligned_cols=255 Identities=27% Similarity=0.371 Sum_probs=205.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|++.+.||.|+||+||+|... ++..+|+|++...........+.+|+..++.++|+|++++++.+......++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999964 67899999997554444556789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 309 MSNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 309 ~~~g~L~~~l~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999753 4589999999999999999999998 999999999999999999999999999876654322
Q ss_pred c---eeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 386 H---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 386 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
. ......|+..|+|||.+... .++.++|||||||++|+|++|+.||...... .....+.. . ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~----~------~~ 224 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQ----N------DP 224 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhc----C------CC
Confidence 2 22334588999999999877 7899999999999999999999998643221 01111110 0 00
Q ss_pred ccccCcC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 462 KDLKNNY-DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 462 ~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+.+.... ....+..+.+++.+||+.+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111110 12345778999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=311.54 Aligned_cols=262 Identities=21% Similarity=0.265 Sum_probs=197.3
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|+..+.||+|+||.||+|... +|+.||+|.++..... .....+.+|+++++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999975 6899999999643222 2234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
++ ++|.+++.. ...+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence 97 478777753 56799999999999999999999999 999999999999999999999999999976543221 1
Q ss_pred eecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhc------chhhhc
Q 008828 388 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK------KLEMLV 460 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 460 (552)
.....++..|+|||.+.+. .++.++|||||||++|||+||+.|+..+..... ............ ......
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH---HHHHHHHHhCCCChHHhHHhhhcc
Confidence 2233478899999998765 478999999999999999999998754332111 000000000000 000000
Q ss_pred ccccc---------CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 461 DKDLK---------NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 461 ~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+.... .......+.++.+++.+||+.||.+|||++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 01112234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=308.92 Aligned_cols=238 Identities=24% Similarity=0.342 Sum_probs=186.0
Q ss_pred eeeeeCceEEEEEEECC-------------------------CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccce
Q 008828 237 LVGKGGFGNVYKGYLQD-------------------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291 (552)
Q Consensus 237 ~iG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~ 291 (552)
.||+|+||.||+|.+.. ...|++|++..... .....+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 68999999999997521 13588998864322 23346888999999999999999
Q ss_pred eeeEeecCCceeEEEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC---
Q 008828 292 LIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY--- 367 (552)
Q Consensus 292 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~--- 367 (552)
+++++......++||||+++|+|..++.. ...+++..+..++.||++||+|||++ +|+||||||+|||++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999998864 55789999999999999999999998 999999999999997643
Q ss_pred ----ceEEcccccceecCCCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHH-hCCCccccCccccccc
Q 008828 368 ----EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELI-SGLRALEFGKTANQKG 441 (552)
Q Consensus 368 ----~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~ell-tg~~p~~~~~~~~~~~ 441 (552)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--- 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--- 229 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence 4799999988643221 12247788999998865 56899999999999999995 6888886432211
Q ss_pred chHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 442 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
...+.. . .. ..+......+.+++.+||+.+|++|||+.++++.|.
T Consensus 230 -~~~~~~----~---------~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 -KERFYE----K---------KH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHHHH----h---------cc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 001100 0 00 011112256899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=311.07 Aligned_cols=249 Identities=19% Similarity=0.296 Sum_probs=202.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.+|+..+.||.|+||.||+|+. .+++.||+|.+.... ......+.+|+.+++.++|||++++++++......++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 4588889999999999999985 468999999986433 23345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++++|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 98 LAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred cCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 9999999988654 589999999999999999999999 999999999999999999999999999876543322 12
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .......... . +.+ ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-------~~~~~~~~~~-~-----~~~--~~ 237 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIATNG-T-----PEL--QN 237 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcC-C-----ccc--CC
Confidence 2345888999999999888999999999999999999999999643221 1111111000 0 000 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
+...+..+.+++.+||..||++||++.+++.
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 2223467889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=306.02 Aligned_cols=249 Identities=25% Similarity=0.352 Sum_probs=201.2
Q ss_pred CCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc---ccccceeeeEeecCCceeEEE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~~~~~~lv~ 306 (552)
.|+..+.||+|+||.||+|.. .+++.||+|.++.........++.+|+.+++.++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778999999999999996 4689999999875544444557889999999886 999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++++|.+++... .+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS- 156 (277)
T ss_pred ecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence 999999999998764 799999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||...... .+..... ....+.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~~~~~~------~~~~~~~~ 223 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------RAMMLIP------KSKPPRLE 223 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-------hhhhccc------cCCCCCCC
Confidence 22334588999999998754 4689999999999999999999999643211 1110000 00111111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ...+.++.+++.+||+.||++||++.|++.+
T Consensus 224 ~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 224 D---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred c---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1 1134678999999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.22 Aligned_cols=262 Identities=23% Similarity=0.311 Sum_probs=200.7
Q ss_pred CCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-c-----cccceeeeEeecCCcee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-H-----RNLLRLIGFCMTTTERL 303 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h-----~niv~l~~~~~~~~~~~ 303 (552)
+|.+.++||+|+||.|-+|.. ++++.||||+++..... ..+-+.|+.+|..++ | -|+|+++++|...++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f--~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF--LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH--HHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 788999999999999999995 46999999999865432 345667999999886 3 57999999999999999
Q ss_pred EEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC--CCceEEccccccee
Q 008828 304 LVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--YYEAVVGDFGLAKL 379 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~ 379 (552)
||+|.+.. +|+++++.+ ..++...++.|+.||+.||.+||+. +|||+||||+|||+.+ ...+||+|||.+.+
T Consensus 265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999965 999999854 4799999999999999999999999 9999999999999974 34799999999986
Q ss_pred cCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHH-------HHHHH--
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD-------WVKKI-- 450 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~-------~~~~~-- 450 (552)
.... .. ....+..|+|||++.+.+|+.+.||||||||++||+||.+.|......++-..+.+ |+-..
T Consensus 341 ~~q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 341 ESQR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cCCc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5432 22 45577889999999999999999999999999999999777765443222111111 11100
Q ss_pred -----hhh-cch------hh----------------hccccccC--------cCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 008828 451 -----HQE-KKL------EM----------------LVDKDLKN--------NYDRIELEEMVQVALLCTQYLPSLRPKM 494 (552)
Q Consensus 451 -----~~~-~~~------~~----------------~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~ 494 (552)
... ... .. ..+....+ .........+.+++++|+.+||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 000 000 00 00000000 0112334678999999999999999999
Q ss_pred HHHHHHHh
Q 008828 495 SEVVRMLE 502 (552)
Q Consensus 495 ~evl~~L~ 502 (552)
.|+++|-.
T Consensus 497 ~qal~Hpf 504 (586)
T KOG0667|consen 497 AQALNHPF 504 (586)
T ss_pred HHHhcCcc
Confidence 99997544
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.01 Aligned_cols=262 Identities=19% Similarity=0.244 Sum_probs=194.3
Q ss_pred CCCeeeee--CceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 234 SKNLVGKG--GFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 234 ~~~~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
+.++||+| +|++||++..+ +|+.||+|++....... ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 78999999864 68999999997543322 2345778999999999999999999999999999999999
Q ss_pred cCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc-
Q 008828 310 SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH- 386 (552)
Q Consensus 310 ~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 386 (552)
++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999864 34589999999999999999999998 9999999999999999999999999865433211110
Q ss_pred -----eeecccccccccCchhhcc--CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHH-H--------
Q 008828 387 -----VTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK-I-------- 450 (552)
Q Consensus 387 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~-------- 450 (552)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ....... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLLDTTT 235 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCccccccccc
Confidence 0112246778999999976 4589999999999999999999999964221100 0000000 0
Q ss_pred -hhh------------cchhhh---------ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 451 -HQE------------KKLEML---------VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 451 -~~~------------~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
..+ ...... ........+.......+.+++.+||+.||++|||++|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 000 000000 000000112223456889999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=313.00 Aligned_cols=251 Identities=26% Similarity=0.286 Sum_probs=200.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|+..+.||+|+||+||+|... +++.||+|.+....... ....+..|++++..++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999976 48999999997543332 3456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 307 PYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 307 e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
||+.+++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998743 5689999999999999999999998 99999999999999999999999999987543221
Q ss_pred Cc----------------------------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcc
Q 008828 385 SH----------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 436 (552)
Q Consensus 385 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~ 436 (552)
.. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 11 01123578899999999998999999999999999999999999864321
Q ss_pred cccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 008828 437 ANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK----MSEVVR 499 (552)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 499 (552)
.. . ...+.............+..+.+++.+||+.+|++||| ++|++.
T Consensus 238 ~~------~----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DE------T----------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH------H----------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 10 0 01111111111111124578999999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=302.71 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=208.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|++.+.||+|++|.||+|... +++.|++|++...........+..|+..+..++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999976 48999999987654334456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+++++|.+++.....+++..+..++.|+++|+.|||+ . +++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 9999999999877889999999999999999999999 8 9999999999999999999999999999876533322
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
.....++..|+|||.+.+..++.++||||||+++|+|+||..|+...... .......... ... ...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~---------~~~-~~~ 222 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP----SFFELMQAIC---------DGP-PPS 222 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc----CHHHHHHHHh---------cCC-CCC
Confidence 22345788999999999999999999999999999999999998754320 1111111111 111 111
Q ss_pred CCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 468 YDRI-ELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 468 ~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+.. .+..+.+++.+||+.+|++||++.|++++
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1222 45789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=302.48 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=197.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
++|++.+.||+|+||.||+|.. +++.||+|.++... ....+.+|+.++..++|||++++++++... ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4578889999999999999975 57889999986432 235688999999999999999999998654 579999999
Q ss_pred cCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 310 SNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 310 ~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999998753 3589999999999999999999998 9999999999999999999999999998754321
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......+..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+....... ...
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~----------~~~ 216 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KEVKECVEKG----------YRM 216 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HHHHHHHhCC----------CCC
Confidence 112234568999999998899999999999999999998 8888864321 1111111111 111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1122334778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=303.55 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=204.2
Q ss_pred CCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccC-----chHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
+|+..+.||+|+||.||+|.. .+++.||+|.++..... .....+.+|+.+++.++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 56899999998643211 123468899999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC-ceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~ 383 (552)
|+||+++++|.+++....++++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 999999999999998877899999999999999999999999 999999999999998775 5999999998766432
Q ss_pred CC---ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 384 DS---HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 384 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
.. .......++..|+|||.+.+..++.++||||+|+++|+|++|..||........ ....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~---------~ 224 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKI---------A 224 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHHHHH---------h
Confidence 11 112234578899999999888899999999999999999999999864322111 1111111 0
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
........+......+.+++.+|++.+|.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1111123344456789999999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=305.13 Aligned_cols=248 Identities=27% Similarity=0.379 Sum_probs=202.5
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
-|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+..+..++||||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667789999999999999864 688999999865443344557889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceee
Q 008828 310 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389 (552)
Q Consensus 310 ~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 389 (552)
++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 85 ~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06641 85 GGGSALDLLEPG-PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhc
Confidence 999999988654 689999999999999999999998 999999999999999999999999999876643221 122
Q ss_pred cccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCC
Q 008828 390 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469 (552)
Q Consensus 390 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (552)
...++..|+|||.+.+..++.++|||||||++|+|++|..|+..... ..+...... .......
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~----------~~~~~~~ 222 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-------MKVLFLIPK----------NNPPTLE 222 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-------HHHHHHHhc----------CCCCCCC
Confidence 34578899999999988899999999999999999999999863221 011111110 0011122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 470 RIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 470 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+..+.+++.+||+.+|.+||++.+++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 3345778999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=301.08 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=188.3
Q ss_pred eeeeeCceEEEEEEECCC---cEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCC
Q 008828 237 LVGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 313 (552)
Q Consensus 237 ~iG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 313 (552)
.||+|+||.||+|...++ ..+++|.++..........+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999985433 34667766544433345678999999999999999999999999999999999999999
Q ss_pred hhhhhccC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC-Ccee
Q 008828 314 VASRLKAK----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVT 388 (552)
Q Consensus 314 L~~~l~~~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 388 (552)
|.+++... ...++..+..++.||+.||.|||+. +++||||||+|||++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99998743 3467778889999999999999998 99999999999999999999999999986432111 1112
Q ss_pred ecccccccccCchhhcc-------CCCCCccchhHHHHHHHHHHhC-CCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 389 TAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELISG-LRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
....++..|+|||++.. ..++.++|||||||++|||+++ ..||..... .......... ....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~-~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVIKD-QQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhh-cccccC
Confidence 23457889999998753 2457899999999999999975 556643211 1122222111 112223
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
++.+... ..+.+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333222 3366888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=302.95 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=201.7
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeec--CCceeEEE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLLVY 306 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~~lv~ 306 (552)
+|++.+.||.|+||.||++... ++..||+|.++..... ....++..|+++++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999864 6889999998654322 234468889999999999999999998764 34578999
Q ss_pred eeccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCceEEcCCCCCceeeCCCCceEEcccccc
Q 008828 307 PYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLH-----EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 377 (552)
Q Consensus 307 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH-----~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 377 (552)
||+++++|.+++.. ...+++..++.++.|++.||.||| +. +++|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 99999999999864 457999999999999999999999 65 9999999999999999999999999999
Q ss_pred eecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (552)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ........
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~------ 223 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQLASKIK------ 223 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HHHHHHHh------
Confidence 876543321 2334589999999999998999999999999999999999999874321 11111111
Q ss_pred hhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.......+...+..+.+++.+|++.+|++||++.+|+++
T Consensus 224 ----~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 ----EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111112333455789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=306.78 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=193.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHH-HhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEM-ISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|++.+.||+|+||.||+|..+ +|+.||+|+++.........++..|+.. ++..+||||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999975 6899999999765433334456666665 556689999999999999999999999
Q ss_pred eccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 308 YMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 308 ~~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
|++ |+|.+++.. ...+++..+..++.|++.||.|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 578776642 346899999999999999999999853 8999999999999999999999999999765322
Q ss_pred CCceeecccccccccCchhhcc----CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 384 DSHVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..........
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~------ 223 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------FQQLKQVVEE------ 223 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------HHHHHHHHhc------
Confidence 1 1222457889999998865 45688999999999999999999998632111 1111111100
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+.+. ....+.++.+++.+||..+|++||++.+++++
T Consensus 224 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000110 11234678999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=302.75 Aligned_cols=249 Identities=20% Similarity=0.292 Sum_probs=202.7
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|+..+.||+|+||.||++... +++.||+|.+..... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999864 688999999864322 22344688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999988753 3588999999999999999999998 999999999999999999999999999986543221
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......|+..|+|||.+.+..++.++|||||||++|+|+||+.|+..... .+.+....... ..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~~----------~~ 219 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKIIRGS----------YP 219 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHhcCC----------CC
Confidence 12234478899999999998999999999999999999999999864321 11111111110 01
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+.....++.+++.+||+.+|++||++.+|+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1222345779999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=299.97 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=208.8
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeecc
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 310 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 310 (552)
|.+.++||+|+||.||+|.++ .|..+|||.+.... ...++.+|+.++.+++.|++|+++|.+......++|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 556789999999999999976 69999999886543 35678899999999999999999999999999999999999
Q ss_pred CCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceee
Q 008828 311 NGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389 (552)
Q Consensus 311 ~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 389 (552)
-|++.++++ .++++++.++..++...++||+|||.. .-+|||||+.|||++-+|.+||+|||.+-.+.. .-....
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKRN 187 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKRN 187 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh-hHHhhC
Confidence 999999997 456899999999999999999999998 889999999999999999999999999976643 222345
Q ss_pred cccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc-ccCcC
Q 008828 390 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD-LKNNY 468 (552)
Q Consensus 390 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 468 (552)
.+.||+.|||||++..-.|+.++||||+|++..||..|++|+..-.+. ..+..+.... ..-.-
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------------RAIFMIPT~PPPTF~K 251 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------------RAIFMIPTKPPPTFKK 251 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------------ceeEeccCCCCCCCCC
Confidence 677999999999999999999999999999999999999998743221 1111111111 11112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
+...+.++.+++++|+-..|++|-|+.+++++-.
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTF 285 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence 4556788999999999999999999999998654
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.01 Aligned_cols=254 Identities=20% Similarity=0.303 Sum_probs=198.0
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecC--Cce
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER 302 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 302 (552)
....+|.+.+.||+|+||+||+|... ++..||+|.+...... .....+..|+.++.+++||||+++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999975 5778999998644322 2345688999999999999999999988643 468
Q ss_pred eEEEeeccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCC----CceEEcCCCCCceeeCC---------
Q 008828 303 LLVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCD----PKIIHRDVKAANILLDE--------- 365 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivH~dlk~~Nill~~--------- 365 (552)
++||||+++|+|.+++.. ...+++..++.|+.||+.||.|||+... .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 899999999999998864 3579999999999999999999998521 25999999999999964
Q ss_pred --------CCceEEcccccceecCCCCCceeecccccccccCchhhcc--CCCCCccchhHHHHHHHHHHhCCCccccCc
Q 008828 366 --------YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGK 435 (552)
Q Consensus 366 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~elltg~~p~~~~~ 435 (552)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3458999999998654321 2234468999999999864 458899999999999999999999996422
Q ss_pred ccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 436 TANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
. ....+..+.... .+. ....+.++.+||..||+.+|.+||++.|++.
T Consensus 248 ~------~~qli~~lk~~p--------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 N------FSQLISELKRGP--------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred c------HHHHHHHHhcCC--------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1 111111111110 000 0112467899999999999999999999984
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=306.30 Aligned_cols=251 Identities=21% Similarity=0.272 Sum_probs=197.8
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeecc
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 310 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 310 (552)
|++.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+++++.++|||++++++++......++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 456788999999999999976 47788999885432 2234568889999999999999999999999999999999999
Q ss_pred CCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceee
Q 008828 311 NGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389 (552)
Q Consensus 311 ~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 389 (552)
+|+|..++.. ..++++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... ....
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 9999888754 45799999999999999999999998 99999999999999999999999999987543221 1223
Q ss_pred cccccccccCchhhc-----cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 390 AVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 390 ~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
...++..|+|||++. ...++.++|||||||++|||++|+.||..... ...+........ +.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~------~~- 227 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEP------PT- 227 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-------HHHHHHHhhcCC------CC-
Confidence 345889999999984 34578899999999999999999999864221 011111111100 00
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
...+...+..+.+++.+||+.+|.+||++.+++++--
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 228 -LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 0112223467899999999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=308.55 Aligned_cols=246 Identities=22% Similarity=0.287 Sum_probs=203.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||.||++... +++.||+|.++.... ......+.+|++++++++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999975 589999999865332 223456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 9999999999998888899999999999999999999998 9999999999999999999999999999876433
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... ........ ... .
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~---------~~~--~ 215 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKIL---------EGK--V 215 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHh---------cCC--c
Confidence 2234588999999999888899999999999999999999999864321 00000111 000 1
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 500 (552)
.++......+.+++.+||+.+|.+|| +++|++.+
T Consensus 216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 12222357889999999999999999 67777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=306.77 Aligned_cols=239 Identities=23% Similarity=0.368 Sum_probs=187.5
Q ss_pred CeeeeeCceEEEEEEECC--------CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 236 NLVGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
+.||+|+||.||+|..+. ...||+|.+.... ......+.+|+.++..+.||||+++++++......++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 368999999999998642 2348888875432 2234468889999999999999999999999899999999
Q ss_pred eccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc--------eEEcccccce
Q 008828 308 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--------AVVGDFGLAK 378 (552)
Q Consensus 308 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfg~~~ 378 (552)
|+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++. ++++|||++.
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999754 4689999999999999999999999 9999999999999987765 5899999886
Q ss_pred ecCCCCCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCC-CccccCcccccccchHHHHHHHhhhcch
Q 008828 379 LLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGL-RALEFGKTANQKGAMLDWVKKIHQEKKL 456 (552)
Q Consensus 379 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (552)
.... .....++..|+|||.+.+. .++.++|||||||++|||++|. .|+...... ....... .
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-------~~~~~~~-~--- 220 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-------KKLQFYE-D--- 220 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-------HHHHHHH-c---
Confidence 5432 1224578899999999874 5799999999999999999995 444321110 0000000 0
Q ss_pred hhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 457 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 --------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01122223367899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.18 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=201.3
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|++.+.||+|+||.||+|... ++..+|+|.++... ......+..|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 356888899999999999999975 68899999986432 2234568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 308 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 308 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 9999999999875 35799999999999999999999999 999999999999999999999999999875533221
Q ss_pred eeecccccccccCchhhc-----cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 387 VTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
......++..|+|||.+. ...++.++|||||||++|||++|+.||..... ........... .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~------~ 225 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-------MRVLLKILKSE------P 225 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-------HHHHHHHhcCC------C
Confidence 223345889999999985 34567899999999999999999999864321 11111111100 0
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+.+ ..+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 1122334678999999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=306.88 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=201.6
Q ss_pred cCHHHHHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEee
Q 008828 220 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCM 297 (552)
Q Consensus 220 ~~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 297 (552)
.++.++..+...|++.+.||+|+||.||+|... +++.+|+|++.... .....+..|+.++.++ +|+||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 345566667788999999999999999999974 68899999885432 2234677889988888 6999999999985
Q ss_pred c------CCceeEEEeeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCce
Q 008828 298 T------TTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 369 (552)
Q Consensus 298 ~------~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 369 (552)
. ....+++|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 3 3567899999999999998864 34588899999999999999999998 99999999999999999999
Q ss_pred EEcccccceecCCCCCceeecccccccccCchhhc-----cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchH
Q 008828 370 VVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML 444 (552)
Q Consensus 370 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~ 444 (552)
+|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||+||+.||........ .
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---~- 235 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA---L- 235 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh---h-
Confidence 9999999875532211 122345889999999886 34678899999999999999999999864221100 0
Q ss_pred HHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 445 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.. +.............+..+.+++.+||+.||.+||++.|++++
T Consensus 236 ---~~---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 ---FL---------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ---hh---------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00 000000111112344679999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=314.69 Aligned_cols=264 Identities=24% Similarity=0.288 Sum_probs=195.8
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecC-----
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT----- 299 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~----- 299 (552)
...++|.+.+.||+|+||+||+|... +++.||||.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999864 6889999998653221 2234577899999999999999999987543
Q ss_pred -CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 300 -TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 300 -~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
...+++++++ +++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccce
Confidence 3468999988 6788887764 4699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchH--------HHHHH
Q 008828 379 LLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKK 449 (552)
Q Consensus 379 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~--------~~~~~ 449 (552)
..... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+. .....
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 65432 223458999999999877 568999999999999999999999996432211000000 00000
Q ss_pred Hhhhc---c---hhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 450 IHQEK---K---LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 450 ~~~~~---~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..... . +.......+.. ......+.+.+++.+|++.||.+|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0 00000000000 000122457899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=306.01 Aligned_cols=259 Identities=20% Similarity=0.236 Sum_probs=205.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+.++..++||||+++++.+......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999975 578999999865432 223346788999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC--
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-- 384 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-- 384 (552)
||+++++|.+++.....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999999998878899999999999999999999998 99999999999999999999999999986421100
Q ss_pred ------------CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh
Q 008828 385 ------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 385 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
........++..|+|||.+....++.++|||||||++|||++|..||..... ..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-------~~~~~~~~~ 230 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELFGQVIS 230 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh
Confidence 0011123478899999999888899999999999999999999999863221 111111111
Q ss_pred hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 008828 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL 506 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 506 (552)
. ....+. .....+..+.+++.+||+.+|++||++.++.+.|+...+
T Consensus 231 ~----~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 231 D----DIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred c----ccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 1 001111 011234678999999999999999998777777776543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.60 Aligned_cols=260 Identities=27% Similarity=0.334 Sum_probs=202.2
Q ss_pred cCHHHHHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEee
Q 008828 220 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCM 297 (552)
Q Consensus 220 ~~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 297 (552)
+++.++..++++|.+.+.||+|+||.||+|... +++.+|+|++..... ....+.+|+.++..+ +|||++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 344555667889999999999999999999974 688999999864322 234577899999888 7999999999987
Q ss_pred cC-----CceeEEEeeccCCChhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc
Q 008828 298 TT-----TERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 368 (552)
Q Consensus 298 ~~-----~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 368 (552)
.. ...++||||+++|+|.++++ ....+++..++.++.|++.||.|||+. +++||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 54 35789999999999998875 345789999999999999999999998 9999999999999999999
Q ss_pred eEEcccccceecCCCCCceeecccccccccCchhhccC-----CCCCccchhHHHHHHHHHHhCCCccccCcccccccch
Q 008828 369 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 443 (552)
Q Consensus 369 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~ 443 (552)
+||+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||....... ..
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~---~~ 242 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK---TL 242 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH---HH
Confidence 99999999876543221 12234588899999998654 36899999999999999999999986432110 00
Q ss_pred HHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 444 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..... .....+. .+......+.+++.+||+.+|++||++.|++++
T Consensus 243 ----~~~~~-~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 ----FKIPR-NPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ----HHHhc-CCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 01100 0000010 112234578999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=305.97 Aligned_cols=266 Identities=21% Similarity=0.331 Sum_probs=196.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|+..+.||+|++|.||+|..+ +++.||+|.+...........+.+|++++++++|+||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999975 68999999987543333334567899999999999999999999999999999999
Q ss_pred ccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+.+ +|.+++.. ...+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 985 89888864 34689999999999999999999998 999999999999999999999999999875432111 1
Q ss_pred eecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccc-hH---------HHHHHHhhhcch
Q 008828 388 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA-ML---------DWVKKIHQEKKL 456 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~-~~---------~~~~~~~~~~~~ 456 (552)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........... +. .|..........
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 122346788999999875 4588999999999999999999999864331100000 00 000000000000
Q ss_pred h----hhccccccCcCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 457 E----MLVDKDLKNNYD-RIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 457 ~----~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ......+....+ ......+.+++.+|++.+|++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 000000000000 0012677899999999999999999998853
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=308.46 Aligned_cols=265 Identities=23% Similarity=0.279 Sum_probs=199.8
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC----chHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
+|+..+.||+|+||.||+|... +++.||+|.++..... .....+..|+++++.++|+||+++++++......++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999965 6899999999754322 1234567899999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|||+ +|+|.+++.... .+++..+..++.||++||.|||++ +|+|+||+|+||+++.++.++|+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 899999998765 799999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHH-----Hhhhcchhh
Q 008828 385 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK-----IHQEKKLEM 458 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 458 (552)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|.++|.................. .........
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 2 1222346788999998865 46789999999999999999997777532221100000000000 000000000
Q ss_pred hccccccCc-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 LVDKDLKNN-----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......... ........+.+++.+||+.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000 112235788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=300.03 Aligned_cols=248 Identities=26% Similarity=0.368 Sum_probs=200.7
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|+..+.||+|+||.||++... ++..+|+|.+..... ......+.+|+.+++.++|||++++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 688999999865432 22345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC-CceEEcccccceecCCCCC
Q 008828 309 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 309 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~~~~ 385 (552)
+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++++ +.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 9999999999753 4589999999999999999999998 99999999999999854 468999999998765322
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...+....... .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~~~~~~~----------~ 218 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVLKIMSGT----------F 218 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHHHHHhcC----------C
Confidence 12234588899999999988899999999999999999999999864321 11111111110 0
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+...+..+.+++.+||+.+|++|||+.|++++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11122234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=302.64 Aligned_cols=258 Identities=24% Similarity=0.279 Sum_probs=201.6
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC--CceeEEEe
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLVYP 307 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv~e 307 (552)
+|...+.||.|++|.||++... +++.+|+|.+..........++.+|+++++.++||||+++++++... ...++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5777889999999999999975 58899999997554444456789999999999999999999988654 46789999
Q ss_pred eccCCChhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 308 YMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 308 ~~~~g~L~~~l~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
|+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 999999988764 244689999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+........ ....+.+..
T Consensus 159 ~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~ 232 (287)
T cd06621 159 L---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELLSYIVNM-PNPELKDEP 232 (287)
T ss_pred c---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHHHHHhcC-CchhhccCC
Confidence 1 12344788999999999999999999999999999999999999754321 11111211111110 001111000
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......++.+.+++.+||+.+|.+|||+.|++++
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 233 ---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0011235778999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=307.74 Aligned_cols=192 Identities=24% Similarity=0.363 Sum_probs=158.2
Q ss_pred CeeeeeCceEEEEEEEC---CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeec--CCceeEEEeecc
Q 008828 236 NLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLLVYPYMS 310 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~~lv~e~~~ 310 (552)
..||+|+||+||+|..+ ++..||+|.++.... ...+.+|+.+++.++||||+++++++.. ....++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 58999999999999965 357899999865322 2357789999999999999999998854 456789999987
Q ss_pred CCChhhhhcc---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee----CCCCceEEcccccc
Q 008828 311 NGSVASRLKA---------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVVGDFGLA 377 (552)
Q Consensus 311 ~g~L~~~l~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~~ 377 (552)
+ +|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 77776631 23588999999999999999999999 99999999999999 56679999999999
Q ss_pred eecCCCCCc--eeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccC
Q 008828 378 KLLDHCDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFG 434 (552)
Q Consensus 378 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~ 434 (552)
+........ ......||..|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876433221 12334589999999998764 5899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=314.98 Aligned_cols=244 Identities=30% Similarity=0.392 Sum_probs=199.2
Q ss_pred CCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 232 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
|.-.+.||.|+||.||-|+. .+.++||||.+.-..... ...++.+|+..|.+++|||++.+.|+|......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 33446799999999999995 478999999996443333 345789999999999999999999999999999999999
Q ss_pred ccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
|- |+-.+++. .++++.+-.+..|+.+.+.||+|||+. +.||||||+.|||+++.|.|||+|||.+.+....
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---- 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---- 179 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence 95 57778775 456799999999999999999999999 9999999999999999999999999999876543
Q ss_pred eecccccccccCchhhc---cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 388 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
..++||+.|||||++. .+.|+-|+||||+|++..||...++|........ . +..+... -.+.+
T Consensus 180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS------A-LYHIAQN------esPtL 245 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------A-LYHIAQN------ESPTL 245 (948)
T ss_pred -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH------H-HHHHHhc------CCCCC
Confidence 3467999999999985 4689999999999999999999999886432211 0 1111111 11111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. .+..+..+.+++..||++-|.+|||..+++++
T Consensus 246 q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1 34567889999999999999999999988754
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=305.00 Aligned_cols=266 Identities=20% Similarity=0.257 Sum_probs=197.6
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++++|.+.+.||+|+||.||+|... ++..||+|++...........+.+|+.+++.++|+||+++.+++......++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3567889999999999999999864 688999999975543333446778999999999999999999999999999999
Q ss_pred eeccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+. +++.+.+. ....+.+..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 9996 67766664 345688899999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHH-----------HHhh-
Q 008828 386 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK-----------KIHQ- 452 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~- 452 (552)
.......++..|+|||.+.+. .++.++|||||||++|||+||+.||........ .+..... ....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhhhhc
Confidence 112233478899999998764 578899999999999999999999974332100 0000000 0000
Q ss_pred hcchhhhccccccCcCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 453 EKKLEMLVDKDLKNNYD-----RIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
................. ......+.+++.+|++.||++|||+.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000000000 0113578899999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=307.39 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=201.1
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|++.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999965 689999999975443 22345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+ +++|.+++.. ...+++..+..++.||++||.|||+. +++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 9999999864 45799999999999999999999998 99999999999999999999999999998765433222
Q ss_pred eecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhc------------
Q 008828 388 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK------------ 454 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------ 454 (552)
.....++..|+|||.+.+. .++.++||||+||++|||+||.++|....... ...++.......
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE----QLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH----HHHHHHHHcCCCChHHHhhccCcc
Confidence 3334588999999998654 46899999999999999999977775322111 111111000000
Q ss_pred chhhhcccccc----CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 455 KLEMLVDKDLK----NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 455 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+..+... ..........+.+++.+|++.+|++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00111234788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=302.12 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=196.0
Q ss_pred CCCCCeeeeeCceEEEEEEEC----CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCC------
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ 300 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 300 (552)
|.+.+.||+|+||.||+|.+. ++..||||+++.... .....++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999853 368899999965432 223456889999999999999999999886542
Q ss_pred ceeEEEeeccCCChhhhhcc------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccc
Q 008828 301 ERLLVYPYMSNGSVASRLKA------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 374 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 374 (552)
..++++||+.+|+|..++.. ...+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 24688999999999887642 12578999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhh
Q 008828 375 GLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 375 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
|+++........ ......++..|++||.+....++.++|||||||++|||++ |+.||...... ....+ ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~----~~~~~---~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS----EIYNY---LIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH----HHHHH---HHc
Confidence 999865432211 1122335678999999999899999999999999999999 77887532210 11111 111
Q ss_pred hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.... ..+...+..+.+++.+||+.+|++||++.|+++.|++.
T Consensus 231 ~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1000 01122346899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=302.48 Aligned_cols=252 Identities=27% Similarity=0.347 Sum_probs=199.5
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCC-----
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTT----- 300 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~----- 300 (552)
++++|++.+.||+|+||.||+|..+ +++.+++|++..... ...++.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4678999999999999999999975 578999999865432 345688999999998 6999999999997644
Q ss_pred -ceeEEEeeccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccc
Q 008828 301 -ERLLVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 375 (552)
Q Consensus 301 -~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 375 (552)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 47999999999999998864 35789999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCceeecccccccccCchhhcc-----CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHH
Q 008828 376 LAKLLDHCDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 450 (552)
Q Consensus 376 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 450 (552)
++....... .......|+..|+|||.+.. ..++.++|||||||++|+|+||+.||...... .-....
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~ 230 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-------RALFKI 230 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-------HHHHHh
Confidence 987654322 12233458899999998854 34678999999999999999999999632110 000011
Q ss_pred hhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 451 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
... ..+.+ ..+...+..+.+++.+||..||++|||+.+++++
T Consensus 231 ~~~------~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRN------PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hcc------CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 100 00011 1122245788999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=304.61 Aligned_cols=247 Identities=29% Similarity=0.360 Sum_probs=197.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
..|...+.||+|+||+||+|+.. +++.||+|.+...... .....+.+|+.+++.++||||+++.+++......++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999975 6899999998643322 22346889999999999999999999999999999999
Q ss_pred eeccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+. |++.+.+. ....+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9997 57766664 345799999999999999999999998 9999999999999999999999999998765422
Q ss_pred ceeecccccccccCchhhc---cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 386 HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
....++..|+|||.+. ...++.++||||||+++|||+||+.||...... .........
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-------~~~~~~~~~--------- 229 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQN--------- 229 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-------HHHHHHhcC---------
Confidence 2235788999999874 356889999999999999999999998643211 111111100
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
..........+..+.+++.+||+.+|++||++.+++.+.
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 230 DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000111223457799999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=307.18 Aligned_cols=266 Identities=20% Similarity=0.288 Sum_probs=200.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecC--CceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv 305 (552)
++|+..+.||+|+||.||+|..+ +++.+|+|.++...... ....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999976 58899999997443222 233567899999999999999999998877 889999
Q ss_pred EeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99997 4898888653 4599999999999999999999998 99999999999999999999999999998665432
Q ss_pred CceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHH---------HHH--HHhh
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD---------WVK--KIHQ 452 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~---------~~~--~~~~ 452 (552)
. ......++..|+|||.+.+. .++.++||||||+++|||++|..||...........+.. |.. ....
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1 12233478899999998764 468999999999999999999999875432111111100 000 0000
Q ss_pred h--cchhhhccccccCcCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 453 E--KKLEMLVDKDLKNNYDRI-ELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 453 ~--~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ..........+...++.. ....+.+++.+||+.+|++|||+.|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000011111111222222 35778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=302.85 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=205.2
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.++.|+..+.||+|+||.||+|..+ ++..|++|++..... ....+..|+++++.++|+|++++++++......++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4567888899999999999999976 688999999975433 4557889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999998766 899999999999999999999998 999999999999999999999999999875543221
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......++..|+|||.+.+..++.++|||||||++|+|++|+.|+...... ........ .....
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~~~------- 235 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RALFLITT-KGIPP------- 235 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh-cCCCC-------
Confidence 122334788999999998888999999999999999999999998632211 10111100 00000
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.......+..+.+++.+||+.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00112245778999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.75 Aligned_cols=245 Identities=27% Similarity=0.413 Sum_probs=196.7
Q ss_pred CCCeeeeeCceEEEEEEEC-CCcEEEEEEec---cCccCchHHHHHHHHHHHhhccccccceeeeEeecCCc--eeEEEe
Q 008828 234 SKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK---DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE--RLLVYP 307 (552)
Q Consensus 234 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~---~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~--~~lv~e 307 (552)
...+||+|+|-+||+|... +|..||--.++ .........+|..|+.+|+.++||||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4578999999999999964 47677643332 22233344689999999999999999999999987765 678999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC-CCceEEcccccceecCCCCCc
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
.|..|+|..|++..+.++...++.|++||++||.|||++ +|+|+|||||-+||+|+. .|.|||+|+|+|+..... +
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--H 200 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc--c
Confidence 999999999999999999999999999999999999997 789999999999999985 589999999999987632 2
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
. ..+.||+.|||||... ..|++.+||||||+-++||+|+..|+..-.. .....+....+.+..
T Consensus 201 a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~--------- 263 (632)
T KOG0584|consen 201 A-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPA--------- 263 (632)
T ss_pred c-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHH---------
Confidence 2 2367999999999987 7899999999999999999999999874222 112222222211111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
.+.....+++.++|.+|+.. .++|||+.|++.
T Consensus 264 sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 ALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 11122236789999999999 999999999986
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=299.35 Aligned_cols=243 Identities=22% Similarity=0.285 Sum_probs=199.0
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCCh
Q 008828 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 314 (552)
Q Consensus 238 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 314 (552)
||.|+||.||+|+.. +++.||+|++...... .....+.+|+.+++.++||||+++++++......++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 4899999999654322 3345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeeccccc
Q 008828 315 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 394 (552)
Q Consensus 315 ~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt 394 (552)
.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 99998877899999999999999999999998 99999999999999999999999999998765432 22234578
Q ss_pred ccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHH
Q 008828 395 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE 474 (552)
Q Consensus 395 ~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 474 (552)
..|+|||.+....++.++|+||||+++|+|++|..||..... ........ +.+......++...+.
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~---------~~~~~~~~~~~~~~~~ 221 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYND---------ILKGNGKLEFPNYIDK 221 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHH---------HhccCCCCCCCcccCH
Confidence 899999999888899999999999999999999999975331 01111111 1111111223333357
Q ss_pred HHHHHHHHccCCCCCCCCC-----HHHHHH
Q 008828 475 EMVQVALLCTQYLPSLRPK-----MSEVVR 499 (552)
Q Consensus 475 ~l~~li~~cl~~dP~~RPs-----~~evl~ 499 (552)
.+.+++.+||+.+|++||+ ++|+++
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 8999999999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=306.70 Aligned_cols=261 Identities=20% Similarity=0.302 Sum_probs=197.3
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|+..+.||+|++|.||+|+.. ++..||||.++..... .....+.+|++++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999975 6899999998643322 2334688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+. ++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 588888764 35689999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeecccccccccCchhhccCC-CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh------------
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE------------ 453 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 453 (552)
......++..|+|||.+.+.. ++.++|||||||++|||+||+.||........ ...........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCChhhhhhhhHHH
Confidence 122234688999999887654 68899999999999999999999864332111 11111100000
Q ss_pred ---cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 454 ---KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 454 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
............ ........++.+++.+||+.||++|||+++++.+
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000 0011223567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=303.68 Aligned_cols=265 Identities=22% Similarity=0.307 Sum_probs=199.6
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
+|+..+.||+|++|.||+|+.. +|..||+|.++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 688999999976544444456778999999999999999999999999999999999
Q ss_pred cCCChhhhhccC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 310 SNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 310 ~~g~L~~~l~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
++ +|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 888877643 4689999999999999999999998 999999999999999999999999999975543211
Q ss_pred eeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHH--------HHHhhhcchh
Q 008828 387 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV--------KKIHQEKKLE 457 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 457 (552)
......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+.... ..........
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 12233478899999988664 57889999999999999999999987543221111110000 0000000000
Q ss_pred hhcccc---ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 MLVDKD---LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 ~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...... ......+..+..+.+++.+|++.||.+||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 0001112235678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=301.30 Aligned_cols=248 Identities=24% Similarity=0.276 Sum_probs=204.1
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
+|++.+.||.|+||.||+|... ++..||+|.+...... .....+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999975 5899999999754322 234578899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
|+.+++|.+++....++++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+....... .
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 999999999998777899999999999999999999998 99999999999999999999999999987654322 2
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..|+...... ...+....... ....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~----------~~~~ 220 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET----------ADVL 220 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc----------cccc
Confidence 23345888999999999888999999999999999999999998754321 11111111110 1112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 008828 468 YDRIELEEMVQVALLCTQYLPSLRPKM--SEVV 498 (552)
Q Consensus 468 ~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 498 (552)
.+...+..+.+++.+||+.||.+||++ +|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 233345789999999999999999999 6655
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=301.34 Aligned_cols=245 Identities=25% Similarity=0.282 Sum_probs=191.2
Q ss_pred eeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhh---ccccccceeeeEeecCCceeEEEeecc
Q 008828 237 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISL---AVHRNLLRLIGFCMTTTERLLVYPYMS 310 (552)
Q Consensus 237 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~---~~h~niv~l~~~~~~~~~~~lv~e~~~ 310 (552)
+||+|+||.||++... +++.+|+|.+...... .....+.+|..++.. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 5899999998654322 112234445444433 469999999999999999999999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeec
Q 008828 311 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 390 (552)
Q Consensus 311 ~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 390 (552)
+|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++....... ...
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 154 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA 154 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccC
Confidence 999999998777899999999999999999999999 99999999999999999999999999987554322 123
Q ss_pred ccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCC
Q 008828 391 VRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469 (552)
Q Consensus 391 ~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (552)
..|+..|+|||.+.+ ..++.++|||||||++|||++|..||........ ........ ......+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~----------~~~~~~~ 219 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTL----------TVNVELP 219 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HHHHHHhh----------cCCcCCc
Confidence 458999999999864 5689999999999999999999999974322110 01111100 0111223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 008828 470 RIELEEMVQVALLCTQYLPSLRP-----KMSEVVRMLE 502 (552)
Q Consensus 470 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 502 (552)
...+.++.+++.+||+.||++|| +++|++++.-
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 33457889999999999999999 5998887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.47 Aligned_cols=249 Identities=29% Similarity=0.398 Sum_probs=204.2
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
+|...+.||+|++|.||++... ++..+++|++..... .....+.+|+.+++.++|+|++++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4677889999999999999976 688999999976443 34557889999999999999999999999999999999999
Q ss_pred cCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 310 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 310 ~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999998765 6799999999999999999999998 999999999999999999999999999987654332 2
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ......... ........
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~~~~~~------- 219 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-------MKALFKIAT-NGPPGLRN------- 219 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-------HHHHHHHHh-cCCCCcCc-------
Confidence 344588999999999988899999999999999999999999864321 111111110 00111100
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+..+.+++.+||+.||++|||+.|++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124679999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=306.38 Aligned_cols=247 Identities=22% Similarity=0.290 Sum_probs=197.6
Q ss_pred CCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccC
Q 008828 233 SSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 233 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
.....||+|+||.||++... ++..||||.+.... ......+.+|+..+..++|+||+++++.+...+..++||||+++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 33467999999999999864 58899999985433 23345688999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
++|.+++... .+++..+..++.||+.||.|||+. +|+||||||+||++++++.++|+|||++........ .....
T Consensus 104 ~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 178 (292)
T cd06658 104 GALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSL 178 (292)
T ss_pred CcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCcee
Confidence 9999988544 589999999999999999999999 999999999999999999999999999875533221 12234
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+.... ......... ...
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~------~~~~~~~~~--~~~ 243 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-------QAMRRIR------DNLPPRVKD--SHK 243 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHH------hcCCCcccc--ccc
Confidence 5889999999998889999999999999999999999998643211 1011110 011111111 112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+.+++.+|+..||.+|||++|++++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 34678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=296.37 Aligned_cols=251 Identities=23% Similarity=0.307 Sum_probs=200.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc----cCchHHHHHHHHHHHhhccccccceeeeEeecC--Cce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 302 (552)
.+|.+.+.||+|+||.||+|... ++..||+|.+.... .......+.+|++++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999964 58999999875321 122334688999999999999999999998764 457
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++++||+++++|.+++.....+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999998777799999999999999999999998 999999999999999999999999999976532
Q ss_pred CC--CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 383 CD--SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 383 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
.. ........++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .. + ....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~-~---------~~~~ 222 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AA-I---------FKIA 222 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HH-H---------HHHH
Confidence 11 11112345889999999999888999999999999999999999998632110 00 0 1111
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
........+....+.+.+++.+|++ +|.+||++.+++.+
T Consensus 223 ~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 223 TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1111122344455789999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=304.71 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=197.4
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
|++.+.||+|++|.||+|... +|..||+|++...... .....+.+|+++++.++|||++++++++......+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999964 7999999998644322 22346788999999999999999999999999999999999
Q ss_pred cCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 310 SNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 310 ~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+ ++|.+++.... .+++..+..++.|+++||.|||+. +++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 68999887654 799999999999999999999998 9999999999999999999999999999765432211
Q ss_pred eecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh-----------cc
Q 008828 388 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE-----------KK 455 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~ 455 (552)
.....++..|+|||++.+. .++.++||||||+++|+|+||+.||........ ........... ..
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ---LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhhhhhchh
Confidence 1223468899999988664 578899999999999999999999864332111 01111100000 00
Q ss_pred hhhhccc---cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 456 LEMLVDK---DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 456 ~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....... ..........+..+.+++.+|++.+|++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 00001112233678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=330.18 Aligned_cols=262 Identities=26% Similarity=0.362 Sum_probs=212.4
Q ss_pred HHHHHhcCCCCCCeeeeeCceEEEEEEEC----C----CcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeee
Q 008828 224 ELQSATSNFSSKNLVGKGGFGNVYKGYLQ----D----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIG 294 (552)
Q Consensus 224 e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~ 294 (552)
.++...++..+.+.+|+|.||.|++|... . ...||||.++......+...+..|++++..+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34555566677789999999999999843 1 4579999998877666677899999999988 5999999999
Q ss_pred EeecCCceeEEEeeccCCChhhhhccCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCC
Q 008828 295 FCMTTTERLLVYPYMSNGSVASRLKAKP----------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKA 358 (552)
Q Consensus 295 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~ 358 (552)
+|......++|+||+..|+|.++++..+ .++..+...++.|||.|++||++. ++|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999997554 488999999999999999999999 999999999
Q ss_pred CceeeCCCCceEEcccccceecCCCCCceeecccc--cccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCc
Q 008828 359 ANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 435 (552)
Q Consensus 359 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~ 435 (552)
+|||+.++..+||+|||+++.....+........+ ...|||||.+....|+.|+|||||||+||||+| |..|+..-.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999765544443232223 456999999999999999999999999999999 555554200
Q ss_pred ccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 436 TANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
. ..+.+.. +.+..+...|..+..+++++|+.||+.+|++||++.|+.+.++..
T Consensus 527 ~------~~~l~~~----------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 P------TEELLEF----------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred c------HHHHHHH----------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 0 0111111 112222233555678899999999999999999999999999983
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=303.13 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=194.8
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|...+.||+|+||.||++... +++.||+|.+...........+.+|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445678999999999999965 589999999875443344557889999999986 99999999999999999999999
Q ss_pred ccCCChhhhh---c--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 309 MSNGSVASRL---K--AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 309 ~~~g~L~~~l---~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
+.. ++.++. . ....+++..+..++.|++.||+|||+.. +++||||||+||+++.++.++|+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 554432 2 2357999999999999999999999742 8999999999999999999999999998755422
Q ss_pred CCceeecccccccccCchhhccC---CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
. ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||.... .....+...... .
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~------~ 227 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKG------D 227 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCC------C
Confidence 2 12233588899999999776 68999999999999999999999986422 111111111100 0
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+.+........+.++.+++.+||+.+|++|||+++|+++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111112222345789999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=301.79 Aligned_cols=261 Identities=22% Similarity=0.240 Sum_probs=194.1
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecC--CceeEEEe
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTT--TERLLVYP 307 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~--~~~~lv~e 307 (552)
|.+.+.||+|+||.||+|... +++.||+|.++............+|+.++.++. |+|++++++++... +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556788999999999999964 688999999875433333334557888888885 99999999999887 88999999
Q ss_pred eccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 308 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 308 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
|++ |++.+.+.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 997 588877765 45789999999999999999999999 9999999999999999 9999999999986643222
Q ss_pred eeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccc--------hHHHHHHHhhhcchh
Q 008828 387 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA--------MLDWVKKIHQEKKLE 457 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 457 (552)
.....++..|+|||.+.. ..++.++|||||||++|||++|..||........... ...|......... .
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 232 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH-M 232 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc-c
Confidence 122447889999997654 5578999999999999999999999965332110000 0011111100000 0
Q ss_pred hhccccccC----cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 MLVDKDLKN----NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 ~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+.... ......+..+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 0012346889999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=312.55 Aligned_cols=263 Identities=19% Similarity=0.285 Sum_probs=197.3
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC-----Cce
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TER 302 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~ 302 (552)
+++|.+.+.||+|+||.||+|... +|+.||+|.++..........+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467999999999999999999864 68999999986533333445678899999999999999999987644 357
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++|+||+.+ +|...+.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 899999974 88877754 4699999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCc--eeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh---cch
Q 008828 383 CDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE---KKL 456 (552)
Q Consensus 383 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 456 (552)
.... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ...+...... ...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~----~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ----LNLILGVLGTPSQEDL 234 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHcCCCCHHHH
Confidence 2211 1123458899999998755 5689999999999999999999999964322110 0000000000 000
Q ss_pred hhhccccc---------cCc-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 457 EMLVDKDL---------KNN-----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 457 ~~~~~~~~---------~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+.+... ... ..+.....+.+++.+||+.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 000 001224678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.79 Aligned_cols=259 Identities=27% Similarity=0.366 Sum_probs=212.2
Q ss_pred HhcCCCCCCeeeeeCceEEEEEE-ECCCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
.+-++.....||.|.||.||.|. .++|+..|+|-++-... ......+.+|+.++..++|||+|+++|+-...+..++.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 35567778899999999999999 45799999998864322 22234578999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||||++|+|.+.+..++..++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+.....
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999999999999888889999999999999999999999 999999999999999999999999999987754321
Q ss_pred c---eeecccccccccCchhhccCC---CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 386 H---VTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 386 ~---~~~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
. .-....||+.|||||++.+.. -.-++||||+|||+.||+||+.||..-+. .|.-.+.
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--------e~aIMy~-------- 1453 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--------EWAIMYH-------- 1453 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--------hhHHHhH--------
Confidence 1 123456999999999997643 46689999999999999999999974221 2222111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
+...-.+.+|...+.+-.+++.+|++.||++|+++.|++++--...
T Consensus 1454 V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1454 VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 1111234456667788899999999999999999999988766543
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=311.34 Aligned_cols=265 Identities=20% Similarity=0.275 Sum_probs=199.5
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc-cCchHHHHHHHHHHHhhccccccceeeeEeecC------
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------ 299 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------ 299 (552)
..++|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++.+++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467999999999999999999965 68999999986432 222344677899999999999999999988643
Q ss_pred CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 300 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 34689999996 4888877644 89999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccch--------HHHHHHHh
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM--------LDWVKKIH 451 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~ 451 (552)
..... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+ ..+.....
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 168 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 54322 122345788999999999999999999999999999999999999754321100000 01110000
Q ss_pred -------hh------cchhhhcccccc----CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 452 -------QE------KKLEMLVDKDLK----NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 452 -------~~------~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.. .....+...... ...+...+..+.+++.+||+.||++|||+.|++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000011111100 01122345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=301.64 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=199.1
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc-cCchHHHHHHHHHHHhhccccccceeeeEeecC--CceeEEEe
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLVYP 307 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv~e 307 (552)
|++.+.||+|+||.||+|... +++.+|+|.++... .......+.+|+++++.++|||++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999976 48899999997653 222334678899999999999999999999888 88999999
Q ss_pred eccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 308 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 308 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
|+++ +|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 888888654 5799999999999999999999998 9999999999999999999999999999876544322
Q ss_pred eeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhc--chhh-----
Q 008828 387 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK--KLEM----- 458 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----- 458 (552)
......++..|+|||.+.+ ..++.++||||||+++|||+||+.||...........+........... ....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2233446788999998765 4578999999999999999999999874332111100000000000000 0000
Q ss_pred ------hccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 ------LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.....+...+...++..+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000001111125788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=300.89 Aligned_cols=250 Identities=20% Similarity=0.287 Sum_probs=202.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.+|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++|||++++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 57888899999999999999864 67899999985432 22345688899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++++|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~ 172 (293)
T cd06647 98 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (293)
T ss_pred CCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence 9999999998754 488999999999999999999999 999999999999999999999999999876543222 22
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
....++..|+|||.+....++.++|||||||++|++++|+.||......... . .... ........
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~---~----~~~~--------~~~~~~~~ 237 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---Y----LIAT--------NGTPELQN 237 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe---e----ehhc--------CCCCCCCC
Confidence 3345888999999998888999999999999999999999999643221100 0 0000 00000011
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22234678899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=296.63 Aligned_cols=248 Identities=21% Similarity=0.280 Sum_probs=199.5
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeecc
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 310 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 310 (552)
|...+.||+|++|.||+|... +++.+++|.++... ......+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 444579999999999999964 68899999886432 2234568899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeec
Q 008828 311 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 390 (552)
Q Consensus 311 ~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 390 (552)
+++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.++|+|||.+........ ....
T Consensus 100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 174 (285)
T cd06648 100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS 174 (285)
T ss_pred CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence 9999999877 5689999999999999999999999 999999999999999999999999998875543221 2233
Q ss_pred ccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCH
Q 008828 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 470 (552)
Q Consensus 391 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (552)
..|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ........... .+... ...
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~~~~~~------~~~~~--~~~ 239 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRIRDNL------PPKLK--NLH 239 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHHhcC------CCCCc--ccc
Confidence 4588999999999888899999999999999999999999864221 11111111110 00110 111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 471 IELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 471 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+..+.+++.+||+.+|++||++.+++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 234679999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=292.50 Aligned_cols=252 Identities=26% Similarity=0.363 Sum_probs=207.1
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecC--CceeEEE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLVY 306 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv~ 306 (552)
+|...+.||+|++|.||+|... +++.|++|++..... ......+.+|+..+++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999976 689999999865432 23355788999999999999999999999988 8899999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999998777899999999999999999999998 9999999999999999999999999999876543321
Q ss_pred -eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......++..|+|||.+....++.++||||||+++|+|++|..||..... ....... +......
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~---------~~~~~~~ 222 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALYK---------IGSSGEP 222 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHh---------ccccCCC
Confidence 12334588899999999888899999999999999999999999975331 0111111 1111111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+...+..+.+++.+|++.+|++||++.+++.+
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 22333346889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=301.43 Aligned_cols=245 Identities=20% Similarity=0.268 Sum_probs=196.9
Q ss_pred CCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCC
Q 008828 235 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 313 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 313 (552)
...||+|+||.||+|... +++.||+|.+..... .....+.+|+.++..++||||+++++++...+..++|+||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 357999999999999864 689999999864332 334568899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecccc
Q 008828 314 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 393 (552)
Q Consensus 314 L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g 393 (552)
|..++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... .......|
T Consensus 105 L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~ 179 (297)
T cd06659 105 LTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVG 179 (297)
T ss_pred HHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceec
Confidence 9987755 4589999999999999999999999 99999999999999999999999999987543322 12233458
Q ss_pred cccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHH
Q 008828 394 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 473 (552)
Q Consensus 394 t~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 473 (552)
+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+....... .... .......
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~------~~~~--~~~~~~~ 244 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-------QAMKRLRDSP------PPKL--KNAHKIS 244 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhccC------CCCc--cccCCCC
Confidence 89999999999889999999999999999999999998643211 1111111000 0000 0111223
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 474 EEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 474 ~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+.+++.+||+.+|++||++.+++++
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 678899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=299.61 Aligned_cols=243 Identities=26% Similarity=0.307 Sum_probs=192.8
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCCh
Q 008828 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 314 (552)
Q Consensus 238 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 314 (552)
||+|+||+||++... +|+.||+|.+..... ......+..|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 689999999864321 22344567899999999999999999999999999999999999999
Q ss_pred hhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeeccc
Q 008828 315 ASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 392 (552)
Q Consensus 315 ~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 392 (552)
.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 99987544 799999999999999999999998 9999999999999999999999999998765431 1222345
Q ss_pred ccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHH
Q 008828 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 472 (552)
Q Consensus 393 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 472 (552)
++..|+|||.+.+..++.++|||||||++|+|++|+.||......... ..+... ... ....++...
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~--------~~~--~~~~~~~~~ 221 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK----EELKRR--------TLE--MAVEYPDKF 221 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH----HHHHhc--------ccc--ccccCCccC
Confidence 788999999998888999999999999999999999999643321110 000000 000 011122334
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 008828 473 LEEMVQVALLCTQYLPSLRP-----KMSEVVR 499 (552)
Q Consensus 473 ~~~l~~li~~cl~~dP~~RP-----s~~evl~ 499 (552)
+..+.+++.+||+.+|++|| ++.+++.
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 57889999999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=302.38 Aligned_cols=247 Identities=28% Similarity=0.357 Sum_probs=196.1
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
|...+.||+|+||.||+|+.. ++..||+|.+...... .....+..|+++++.++|||++++++++......++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566788999999999999964 6889999998643222 2234688899999999999999999999999999999999
Q ss_pred ccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+.+ ++.+.+. ....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 974 7777664 355799999999999999999999998 9999999999999999999999999998754321
Q ss_pred eecccccccccCchhhc---cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 388 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
....|+..|+|||.+. .+.++.++|||||||++|||++|+.||..... ........... .
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~---------~ 241 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNE---------S 241 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhcc---------C
Confidence 2335888999999974 45689999999999999999999999864211 01111111110 0
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
........+..+.+++.+||+.+|.+||++.++++++..
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 011112334678999999999999999999999986553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=295.79 Aligned_cols=249 Identities=21% Similarity=0.322 Sum_probs=200.4
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|...+.||+|+||.||+|..+ +|..+|+|.+..... ......+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999975 588999999865322 12345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC-ceEEcccccceecCCCCC
Q 008828 309 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 309 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~ 385 (552)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999998643 3579999999999999999999998 999999999999999875 469999999876643221
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......|+..|+|||...+..++.++||||||+++|||++|..|+..... ..++....... .
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~-----~----- 219 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQGY-----F----- 219 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhccc-----C-----
Confidence 22234588999999999888899999999999999999999999863221 12222111110 0
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.......+..+.+++.+|++.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122234679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=300.17 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=199.8
Q ss_pred CCCCCCeeeeeCceEEEEEEE----CCCcEEEEEEeccCcc---CchHHHHHHHHHHHhhc-cccccceeeeEeecCCce
Q 008828 231 NFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 302 (552)
+|++.+.||+|+||.||++.. .+|..||+|+++.... ......+.+|+.++.++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477789999999999999985 3689999999965322 22334678899999999 599999999999988899
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||||+++++|.+++.....+++..+..++.|++.||.|||+. +++||||+|+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999999998877899999999999999999999998 999999999999999999999999999986644
Q ss_pred CCCceeecccccccccCchhhccC--CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
..........|+..|+|||.+... .++.++||||||+++|+|+||..||...... .....+.......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~------- 227 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK---NSQAEISRRILKS------- 227 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc---ccHHHHHHHhhcc-------
Confidence 332223345588999999998753 4688999999999999999999998642211 1111111111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM 500 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 500 (552)
...++......+.+++.+||+.+|++|| ++++++.+
T Consensus 228 ----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 ----EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0112223446789999999999999997 66666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=294.48 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=203.4
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|++.+.||+|+||.||++... ++..+|+|.+...... .....+.+|+.+++.++|+||+++.+++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 6889999998754322 2344678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 309 MSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 309 ~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999998865 45789999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||...... ...... ....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~----------~~~~ 217 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------DLRYKV----------QRGK 217 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHH----------hcCC
Confidence 222344788999999999999999999999999999999999998643211 000010 0111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+.....++.+++.+|++.+|++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 122233456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=296.56 Aligned_cols=248 Identities=24% Similarity=0.305 Sum_probs=200.0
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCCh
Q 008828 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 314 (552)
Q Consensus 238 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 314 (552)
||+|+||.||++... +|+.+++|.+...... .....+.+|++++..++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 4899999999654321 3345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC-------ce
Q 008828 315 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-------HV 387 (552)
Q Consensus 315 ~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-------~~ 387 (552)
.+++.....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99998777899999999999999999999998 999999999999999999999999999875433211 12
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
.....++..|+|||.......+.++||||||+++|+|++|..||..... ......... ... .
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~---------~~~--~ 219 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-------EEIFQNILN---------GKI--E 219 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhc---------CCc--C
Confidence 2334578899999999888899999999999999999999999864321 111111111 000 0
Q ss_pred CCHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 008828 468 YDRI--ELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL 506 (552)
Q Consensus 468 ~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 506 (552)
.+.. .+..+.+++.+||+.+|++|||+.++.+.|+...+
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence 1111 25788999999999999999999777776665443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=287.81 Aligned_cols=250 Identities=24% Similarity=0.295 Sum_probs=208.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCch--HHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
.++|+..++||+|.||.|-.++-+ .++.+|+|+++++..+.. ...-..|-.+|...+||.+..+.-.|...+..|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888899999999999999865 689999999987755432 22356788899999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|||..||.|+-++.....++++..+.+-..|+.||.|||++ +||+||||.+|.|+|.+|++||+|||+++.-- ...
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g 322 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYG 322 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-ccc
Confidence 99999999999999888999999999999999999999999 99999999999999999999999999997421 233
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.....++||+.|+|||++....|...+|.|.+||++|||++|+.||...+. +.+ .+-+.-..+
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh----~kL------------FeLIl~ed~- 385 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH----EKL------------FELILMEDL- 385 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch----hHH------------HHHHHhhhc-
Confidence 456778999999999999999999999999999999999999999974321 111 111111222
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 500 (552)
.+++...++...|+...+..||.+|. .++||.++
T Consensus 386 -kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 386 -KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 24555667889999999999999997 45566543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=280.35 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=199.3
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecCCceeEEEeec
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
.+....||+|+-|+|++++.+ .|..+|||.+......+..+++...++++.+.+ .|.||+.+|||......++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344568999999999999976 589999999987766666677888888877665 899999999999999999999998
Q ss_pred cCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 310 SNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 310 ~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
.. .+..++. -.+++++..+-++...++.||.||.+++ +|+|||+||+|||+|+.|++|+||||++-.+-. +...
T Consensus 174 s~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--SkAh 248 (391)
T KOG0983|consen 174 ST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKAH 248 (391)
T ss_pred HH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec--cccc
Confidence 64 3444443 4567999999999999999999999875 999999999999999999999999999977653 3334
Q ss_pred ecccccccccCchhhcc---CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 389 TAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
+...|-+.|||||.+.- ..|+..+||||||+.++||+||..|+..-... .+.+..+..+. .+.+.
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td------Fe~ltkvln~e------PP~L~ 316 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD------FEVLTKVLNEE------PPLLP 316 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc------HHHHHHHHhcC------CCCCC
Confidence 45569999999999864 46899999999999999999999999853321 11111111111 12222
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
. ....+..+.+++..||+.|+.+||...+++++-.
T Consensus 317 ~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 317 G--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred c--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 1 1124578999999999999999999999987543
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=291.85 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=205.0
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|.+.+.||+|+||.||++... ++..+++|++...... .....+.+|+++++.++|||++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999975 6889999999754322 3445688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 309 MSNGSVASRLKAK----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 309 ~~~g~L~~~l~~~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
+++++|.+++... ..+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998753 6799999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
.......|+..|+|||...+..++.++||||+|+++|+|++|+.|+..... .......... .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~-~--------- 219 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LELALKILKG-Q--------- 219 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HHHHHHHhcC-C---------
Confidence 223334688899999999988999999999999999999999999864321 1111111110 0
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+...+..+.+++.+||..+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111222344778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=301.75 Aligned_cols=268 Identities=23% Similarity=0.289 Sum_probs=198.5
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCC----
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT---- 300 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~---- 300 (552)
...++|++.+.||+|+||.||+|..+ +++.||+|.++.... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578899999999999999999975 588999999975432 223346778999999999999999999987654
Q ss_pred ------ceeEEEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcc
Q 008828 301 ------ERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 373 (552)
Q Consensus 301 ------~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 373 (552)
..++|+||+++ ++...+.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999986 66666654 34699999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh
Q 008828 374 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 374 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
||++...............++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 238 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC- 238 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-
Confidence 999987654332222233467789999988654 578999999999999999999999874322111000000000000
Q ss_pred hcchhhhc--------cc------cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 453 EKKLEMLV--------DK------DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 453 ~~~~~~~~--------~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......+. +. ..... ....+..+.+++.+||+.+|.+||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000 00 00000 01124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=291.34 Aligned_cols=247 Identities=22% Similarity=0.271 Sum_probs=193.0
Q ss_pred HHHHhcCCCCCCee--eeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCC
Q 008828 225 LQSATSNFSSKNLV--GKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTT 300 (552)
Q Consensus 225 ~~~~~~~~~~~~~i--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~ 300 (552)
.....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+....... .|+.....+ +||||+++++++...+
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 33344566766666 99999999999964 68899999986432211 122222222 6999999999999999
Q ss_pred ceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC-ceEEccccccee
Q 008828 301 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKL 379 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~ 379 (552)
..++||||+++|+|.+++.....+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 9999999999999999998777899999999999999999999999 999999999999999988 999999999876
Q ss_pred cCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
..... ...++..|+|||++.+..++.++|||||||++|||++|+.||....... .....+....
T Consensus 160 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~--------- 223 (267)
T PHA03390 160 IGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ--------- 223 (267)
T ss_pred cCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh---------
Confidence 54321 2358899999999999999999999999999999999999997332111 0111111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK-MSEVVR 499 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 499 (552)
.. ........+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 224 -~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 -QK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -cc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 01112235578999999999999999996 688875
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.68 Aligned_cols=263 Identities=19% Similarity=0.219 Sum_probs=194.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhcc-ccccceeeeEeecCCc-----
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTE----- 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~----- 301 (552)
++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999965 6899999998654322 22346788999999995 6999999999877665
Q ss_pred eeEEEeeccCCChhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC-CCceEEcccc
Q 008828 302 RLLVYPYMSNGSVASRLKA-----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFG 375 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg 375 (552)
.++||||+++ +|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78887753 23589999999999999999999999 9999999999999998 8999999999
Q ss_pred cceecCCCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh-
Q 008828 376 LAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE- 453 (552)
Q Consensus 376 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 453 (552)
+++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.......... .........
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL---HIFKLLGTPT 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHhCCCC
Confidence 9976533221 1122346788999998865 457999999999999999999999987533211110 000000000
Q ss_pred -cchhhh---cc----cccc----CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 454 -KKLEML---VD----KDLK----NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 454 -~~~~~~---~~----~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...... .+ +... ....+..+.++.+++.+||+.+|.+||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 00 0000 00012235778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=298.40 Aligned_cols=259 Identities=22% Similarity=0.282 Sum_probs=205.0
Q ss_pred CCCCCCeeeeeCceEEEEEEE----CCCcEEEEEEeccCcc---CchHHHHHHHHHHHhhc-cccccceeeeEeecCCce
Q 008828 231 NFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 302 (552)
+|++.+.||+|+||.||++.. .+++.||||.++.... ......+..|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999984 3578899999864322 12234678899999999 599999999999988999
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||||+++|+|.+++.....+++..+..++.|+++||.|||+. +++||||+|+||+++.++.++|+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999999998777899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCceeecccccccccCchhhccCC--CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
..........|+..|+|||.+.+.. .+.++||||||+++|||+||..||....... ......+....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~-------- 226 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRILK-------- 226 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHHHHHHHHc--------
Confidence 3322233345889999999987665 7889999999999999999999986422110 01111111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL 506 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 506 (552)
. ....+......+.+++.+||+.+|++|||+.++.+.|+...+
T Consensus 227 -~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 227 -S--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred -c--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 0 011222344678999999999999999999999888887544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=306.61 Aligned_cols=248 Identities=22% Similarity=0.304 Sum_probs=210.7
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
....|.+...||+|.|++|..|++. ++..||+|.+.+..-.. ....+.+|++++..++|||||+++.+.......++|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3457889999999999999999965 69999999997653322 234578999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|||+.+|.+++++...+...+..+..++.|+.+|++|||++ .|+|||||++|||++.+.++||+|||++.++. ..
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~ 208 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--YG 208 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--cc
Confidence 99999999999999888888899999999999999999999 99999999999999999999999999999887 33
Q ss_pred ceeecccccccccCchhhccCCC-CCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
......+|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||+..... ++-+..+
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------------------~Lr~rvl 268 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------------------ELRPRVL 268 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--------------------cccchhe
Confidence 45567789999999999999876 68999999999999999999999853321 1111222
Q ss_pred cCc--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNN--YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
... .+.....+..+++.+++-.+|.+|++++++.++
T Consensus 269 ~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 269 RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111 122334677899999999999999999999764
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.29 Aligned_cols=268 Identities=19% Similarity=0.283 Sum_probs=200.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeec----CCce
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTER 302 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~ 302 (552)
.++|++.+.||+|+||.||+|... ++..||+|++..... ......+.+|+.++.+++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367889999999999999999965 689999999875432 2234567789999999999999999998753 3467
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||||+. |+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 89999996 68999998777899999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCc---eeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchH--------HHHHHH
Q 008828 383 CDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKKI 450 (552)
Q Consensus 383 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~--------~~~~~~ 450 (552)
.... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+. ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 2211 1123458889999999866 468999999999999999999999996432211000000 000000
Q ss_pred hhhcchhhhccc-cccCc-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 451 HQEKKLEMLVDK-DLKNN-----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 451 ~~~~~~~~~~~~-~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
. ........+. ..... ..+..+..+.+++.+||+.+|++||++.+++.+-
T Consensus 240 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 240 G-SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred c-hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0 0000000000 00000 1122357899999999999999999999988753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=299.76 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=195.2
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECC-CcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~ 306 (552)
.++|++.+.||+|+||.||+|..++ ++.||||.++..........+..|+.++.+.. ||||+++++++......+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567888999999999999999874 89999999976543334445667777666664 999999999999999999999
Q ss_pred eeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+. +++.+.+.. ...+++..+..++.|++.||.|||+.. +|+||||+|+||++++++.+||+|||++........
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 9985 467666653 457899999999999999999999732 899999999999999999999999999876543221
Q ss_pred ceeecccccccccCchhhccCC----CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+......... .
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~-~----- 236 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEE-P----- 236 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHHHhcCC-C-----
Confidence 12234788999999987654 789999999999999999999998642110 11111111110 0
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
+... .....+.++.+++.+||+.||++||++.+++++-
T Consensus 237 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 237 PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0000 0112346789999999999999999999998664
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=297.03 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=198.2
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecCCceeEEEeec
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
|.+.+.||+|+||+||+|... +++.|++|++.............+|+..+..++ |||++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999975 478999999865433223334567899999998 999999999999999999999999
Q ss_pred cCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 310 SNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 310 ~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+|+|.+.+.... .+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 789999887653 789999999999999999999998 999999999999999999999999999986543222
Q ss_pred eecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchH---------HHHHHHhhhcchh
Q 008828 388 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML---------DWVKKIHQEKKLE 457 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 457 (552)
.....++..|+|||.+.. ..++.++||||||+++|||++|+.||............. .|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 223457889999998754 457999999999999999999999986543211110000 1111111111111
Q ss_pred hhcccccc---CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 MLVDKDLK---NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 ~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+..... ..........+.+++.+||+.+|++|||++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 00011124679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=311.90 Aligned_cols=252 Identities=21% Similarity=0.270 Sum_probs=200.0
Q ss_pred CCCCCeeeeeCceEEEEEEECCC-cEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeecc
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQDG-TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 310 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 310 (552)
|.++..||.|+||.||+|..++. -..|.|++.. ........|.-||++|+.+.||+||++++.|...+..+++.|||.
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 44567899999999999998753 3455666632 223345679999999999999999999999999999999999999
Q ss_pred CCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceee
Q 008828 311 NGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389 (552)
Q Consensus 311 ~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 389 (552)
||-+..++-. ...+.+.++.-+++|++.||.|||++ .|||||||+.|||++-+|.++|+|||.+.... .......
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qkRD 188 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQKRD 188 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hHHhhhc
Confidence 9999887753 55799999999999999999999999 99999999999999999999999999986432 1233456
Q ss_pred cccccccccCchhhc-----cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 390 AVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 390 ~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
.+.||+.|||||+.+ ..+|+.++||||||++|.||..+.+|...... ...+-.+.... .+.+
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVllKiaKSe------PPTL 255 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSE------PPTL 255 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHHHHhhcC------CCcc
Confidence 678999999999875 45799999999999999999999888753221 11111111111 0111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
. .+......+.+++.+||..+|..||++.+++++-.-
T Consensus 256 l--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv 292 (1187)
T KOG0579|consen 256 L--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFV 292 (1187)
T ss_pred c--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccc
Confidence 1 134456789999999999999999999999976543
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=300.16 Aligned_cols=266 Identities=19% Similarity=0.259 Sum_probs=195.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|++.+.||+|++|+||+|... +++.||+|.++..... .....+.+|+++++.++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999975 6889999998654322 223467889999999999999999999999999999999
Q ss_pred eccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC-CCceEEcccccceecCCCC
Q 008828 308 YMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~ 384 (552)
|++ ++|.+.+.... .+++..+..++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 57887775433 357888899999999999999998 9999999999999985 5679999999997654321
Q ss_pred CceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh-----cchhh
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE-----KKLEM 458 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 458 (552)
.......++..|+|||.+.+. .++.++|||||||++|+|+||+.||..............+....... ..+..
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 112233478899999998664 57899999999999999999999997432211100000000000000 00000
Q ss_pred hcc--ccccC----cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 LVD--KDLKN----NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ~~~--~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
... +.... ......+..+.+++.+|++.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00000 0011234668999999999999999999999863
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=297.51 Aligned_cols=258 Identities=18% Similarity=0.187 Sum_probs=185.7
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECC----CcEEEEEEeccCccCc-hHH---------HHHHHHHHHhhccccccceeee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIG-GEI---------QFQTEVEMISLAVHRNLLRLIG 294 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~---------~~~~e~~~l~~~~h~niv~l~~ 294 (552)
.++|.+.++||+|+||+||+|...+ +..+|+|+........ .+. ....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4678999999999999999999754 3466666543222111 010 1122333455668999999999
Q ss_pred EeecCC----ceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceE
Q 008828 295 FCMTTT----ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 370 (552)
Q Consensus 295 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 370 (552)
++.... ..++++|++.. ++.+.+......++..+..++.|++.||.|||+. +|+||||||+|||++.++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEE
Confidence 765543 34677777643 6666665555578889999999999999999998 999999999999999999999
Q ss_pred EcccccceecCCCCCc------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCccccccc--c
Q 008828 371 VGDFGLAKLLDHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG--A 442 (552)
Q Consensus 371 l~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~--~ 442 (552)
|+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... .
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 9999999866432211 1123459999999999999999999999999999999999999997532211100 0
Q ss_pred hHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 443 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
..++...... .... ....+..+.+++..|++.+|++||++.++.+.++
T Consensus 247 ~~~~~~~~~~---------~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 KCDFIKRLHE---------GKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHHhhh---------hhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0112221111 1111 1122477999999999999999999999998763
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=302.45 Aligned_cols=267 Identities=25% Similarity=0.306 Sum_probs=196.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecC--CceeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~l 304 (552)
.++|++.+.||+|+||.||+|... +|+.||+|.++...... ....+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999975 58999999986443222 223466899999999999999999998755 46799
Q ss_pred EEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999974 78887764 45799999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHH--------Hhhhc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK--------IHQEK 454 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~ 454 (552)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..+... .....
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 211 222335788999999865 45789999999999999999999999743321111000000000 00000
Q ss_pred chhhh-ccccccCcC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 455 KLEML-VDKDLKNNY---DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 455 ~~~~~-~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..... ......... .....+.+.+++.+|++.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 000000000 01125678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=289.89 Aligned_cols=248 Identities=28% Similarity=0.417 Sum_probs=204.3
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+|++.+.||+|++|.||+|... +++.|++|.+...... .....+.+|++++++++|||++++++++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 5789999999755322 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||.+......... .
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~ 156 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-D 156 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-c
Confidence 99999999998778899999999999999999999998 9999999999999999999999999999876543332 2
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
....++..|+|||...+..++.++||||+|+++|+|++|+.|+..... ..... .... . .....
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~-~~~~-~---------~~~~~ 219 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALF-RIVQ-D---------DHPPL 219 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHH-HHhc-c---------CCCCC
Confidence 334588899999999888899999999999999999999999863221 00000 0000 0 01112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
+...+..+.+++.+||..+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 2233578899999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=297.00 Aligned_cols=243 Identities=27% Similarity=0.332 Sum_probs=200.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
+.|..-++||+|+||.||.+..+ +|+.+|.|.+.+.. ....+.-...|-.+|.+++.+.||.+--+|...+..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 55777789999999999999865 69999999884321 1223444678999999999999999999999999999999
Q ss_pred eeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 307 PYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 307 e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
..|.||+|.-++.+- +.+++..+..++.+|+.||++||+. +||+|||||+|||+|++|+++|+|+|+|..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 999999999988643 4899999999999999999999999 99999999999999999999999999998776443
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
.....+||.+|||||++.+..|+...|.||+||++|||+.|+.||.......... -+|...
T Consensus 342 --~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e-----------------Evdrr~ 402 (591)
T KOG0986|consen 342 --PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE-----------------EVDRRT 402 (591)
T ss_pred --ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH-----------------HHHHHH
Confidence 3334479999999999999999999999999999999999999997422111100 111111
Q ss_pred ---cCcCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 008828 465 ---KNNYDRIELEEMVQVALLCTQYLPSLRPKM 494 (552)
Q Consensus 465 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 494 (552)
...|+...+++..++....|+.||++|...
T Consensus 403 ~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 403 LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 123455566888999999999999999744
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.12 Aligned_cols=266 Identities=18% Similarity=0.254 Sum_probs=199.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc-cCchHHHHHHHHHHHhhccccccceeeeEeecC-----Cc
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TE 301 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~ 301 (552)
.++|.+.+.||+|+||+||+|... +++.||||.++... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888999999999999999964 68999999986532 222344677899999999999999999987644 34
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.++|+||+. ++|.+++.....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 799999996 68999988778899999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHH-------Hhhh
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK-------IHQE 453 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~ 453 (552)
... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...........+...... ....
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 322 22233457889999998865 46889999999999999999999998643211100000000000 0000
Q ss_pred cchhhh-------ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 454 KKLEML-------VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 454 ~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...... .+.... ......+..+.+++.+||+.+|++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000 000000 0112245778999999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.20 Aligned_cols=269 Identities=20% Similarity=0.256 Sum_probs=189.1
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEECC--CcEEEEEEe--------------cc--CccCchHHHHHHHHHHHhhcccccc
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQD--GTVVAVKRL--------------KD--GNAIGGEIQFQTEVEMISLAVHRNL 289 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~--------------~~--~~~~~~~~~~~~e~~~l~~~~h~ni 289 (552)
...+|.+.+.||+|+||+||++..+. +..++.|.+ .+ .........+.+|+.++..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34689999999999999999987542 222222211 00 0111123458899999999999999
Q ss_pred ceeeeEeecCCceeEEEeeccCCChhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC
Q 008828 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 364 (552)
Q Consensus 290 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 364 (552)
+++++++...+..++|+|++. ++|.+++... ..........|+.|++.||.|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 4777766432 2234566788999999999999999 999999999999999
Q ss_pred CCCceEEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchH
Q 008828 365 EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML 444 (552)
Q Consensus 365 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~ 444 (552)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++...........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999998765433333334569999999999999999999999999999999999876543322111111111
Q ss_pred HHHHHHh--hhc------chhhhcccc-c---cCcCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 445 DWVKKIH--QEK------KLEMLVDKD-L---KNNYDR-----IELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 445 ~~~~~~~--~~~------~~~~~~~~~-~---~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+.... ... .+...++.. + ....+. ..+..+.+++.+|++.||++|||+.|++++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111100 000 000000000 0 000000 123467788999999999999999999875
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=299.64 Aligned_cols=266 Identities=21% Similarity=0.304 Sum_probs=196.0
Q ss_pred CCCCCCeeeeeCceEEEEEEEC---CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecC--Ccee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERL 303 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~ 303 (552)
+|.+.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.++..++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999975 47899999997632 112234577899999999999999999999988 7899
Q ss_pred EEEeeccCCChhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC----CCceEEccc
Q 008828 304 LVYPYMSNGSVASRLKA-----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE----YYEAVVGDF 374 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Df 374 (552)
+||||+++ ++.+.+.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66666532 23689999999999999999999999 9999999999999999 999999999
Q ss_pred ccceecCCCCC--ceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCccccccc------chHH
Q 008828 375 GLAKLLDHCDS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKG------AMLD 445 (552)
Q Consensus 375 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~------~~~~ 445 (552)
|++........ .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.......... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543222 112234578899999988764 57899999999999999999999997543322100 0001
Q ss_pred HHHHHhh-----------hcchhhhccccccCcCC---------H--HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 446 WVKKIHQ-----------EKKLEMLVDKDLKNNYD---------R--IELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 446 ~~~~~~~-----------~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+..+.. ........+......++ . ....++.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1110000 00000000000000011 1 234578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=305.26 Aligned_cols=267 Identities=23% Similarity=0.336 Sum_probs=198.3
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc-cCchHHHHHHHHHHHhhc-cccccceeeeEeecC--Ccee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT--TERL 303 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~--~~~~ 303 (552)
.++|++.+.||+|+||.||+|... +++.+|+|++.... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 457888899999999999999975 58899999885432 122334577899999999 999999999998654 3679
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
+||||+. ++|..++... .+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999997 5999888766 789999999999999999999998 9999999999999999999999999999865433
Q ss_pred CC----ceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHH--------HHH
Q 008828 384 DS----HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV--------KKI 450 (552)
Q Consensus 384 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~ 450 (552)
.. .......|+..|+|||.+.+ ..++.++||||||+++|+|+||+.||...........+.... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 22 12233458899999998765 457899999999999999999999986433221111100000 000
Q ss_pred ---hhhcchhhhcccccc--CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 451 ---HQEKKLEMLVDKDLK--NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 451 ---~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.....+..+...... .......+.++.+++.+||+.+|++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000000 00111135788999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=294.09 Aligned_cols=243 Identities=25% Similarity=0.296 Sum_probs=189.4
Q ss_pred eeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHH---HhhccccccceeeeEeecCCceeEEEeecc
Q 008828 237 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEM---ISLAVHRNLLRLIGFCMTTTERLLVYPYMS 310 (552)
Q Consensus 237 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~---l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 310 (552)
+||+|+||.||+|... +++.||+|.+...... .....+..|..+ +....||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 5889999998653221 112223344433 344579999999999999999999999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeec
Q 008828 311 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 390 (552)
Q Consensus 311 ~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 390 (552)
+|+|..++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~ 154 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA 154 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcC
Confidence 999999998777899999999999999999999998 99999999999999999999999999987553222 223
Q ss_pred ccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCC
Q 008828 391 VRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469 (552)
Q Consensus 391 ~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (552)
..|+..|+|||.+.++ .++.++||||+||++|||++|+.||......... . ...... ... ...+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~----~-~~~~~~------~~~----~~~~ 219 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----E-IDRMTL------TMA----VELP 219 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH----H-HHHHhh------ccC----CCCC
Confidence 4589999999999754 6899999999999999999999999753221110 0 000000 001 1122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008828 470 RIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM 500 (552)
Q Consensus 470 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 500 (552)
...+..+.+++.+|+..+|.+|| ++.+++++
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 22357899999999999999999 99999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.12 Aligned_cols=266 Identities=20% Similarity=0.270 Sum_probs=202.4
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCC-----cee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-----ERL 303 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-----~~~ 303 (552)
+|.+.+.||+|+||.||+|+.. ++..||+|.+..... ......+.+|+.+++.++||||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 489999999875432 333456889999999999999999999988765 789
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
++|||+. ++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999998 48999988777899999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC--ceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHh-------hh
Q 008828 384 DS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH-------QE 453 (552)
Q Consensus 384 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 453 (552)
.. .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 21 112334578899999999887 789999999999999999999999975432111000000000000 00
Q ss_pred cchhhhcc---ccc---cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 454 KKLEMLVD---KDL---KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 454 ~~~~~~~~---~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......+. ... .....+..+..+.+++.+||+.+|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000 000 000112235778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=291.71 Aligned_cols=246 Identities=22% Similarity=0.275 Sum_probs=192.1
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHH-HhhccccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEM-ISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||.||+|... +++.||+|.++..... .....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 5889999998653321 112234445444 3455899999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
++|.+++.....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++.... ....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence 99999998877899999999999999999999998 999999999999999999999999999875432 2233
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
.++..|+|||.+.+..++.++||||||+++|||+||..||...... ........ ... .........
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~------~~~~~~~~~ 219 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILS-RRI------NWPEEVKEF 219 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHh-ccc------CCCCccccc
Confidence 5788999999998888999999999999999999999999643211 11111110 000 001111223
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.+..+.+++.+||+.+|++||++.++.+.|..
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 45789999999999999999988766655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=302.07 Aligned_cols=260 Identities=23% Similarity=0.294 Sum_probs=192.9
Q ss_pred Ceeeee--CceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKG--GFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
..||+| +||+||++... +|+.||+|++....... ..+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999964 79999999987543222 335688999999999999999999999999999999999999
Q ss_pred CChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce--
Q 008828 312 GSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-- 387 (552)
Q Consensus 312 g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-- 387 (552)
|++.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999988753 3589999999999999999999998 99999999999999999999999998654322111100
Q ss_pred ----eecccccccccCchhhccC--CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHH------------
Q 008828 388 ----TTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK------------ 449 (552)
Q Consensus 388 ----~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~------------ 449 (552)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||........ .......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH---HHHHhcCCCCCCccccccc
Confidence 0112245679999999764 478999999999999999999999964321100 0000000
Q ss_pred --------------------HhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 450 --------------------IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 450 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
...........+..+...........+.+++.+||+.||++|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0000000011111122222344567899999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=296.40 Aligned_cols=264 Identities=21% Similarity=0.239 Sum_probs=200.7
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
|...+.||+|++|.||+|... +++.+++|.++..... .....+.+|+.+++.++|+||+++++++......++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999965 6899999998754332 23456888999999999999999999999999999999999
Q ss_pred cCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 310 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 310 ~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
++ ++.+.+.. ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 75 88887765 45799999999999999999999999 99999999999999999999999999998765433 122
Q ss_pred ecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHH--------HHHHhh--hcchh
Q 008828 389 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW--------VKKIHQ--EKKLE 457 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~--~~~~~ 457 (552)
....++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+........ ...... .....
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 234578899999999876 7899999999999999999999998654321110000000 000000 00000
Q ss_pred hhccccc--cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 MLVDKDL--KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+... ........+.++.+++.+||+.||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000 011123346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=281.85 Aligned_cols=268 Identities=21% Similarity=0.290 Sum_probs=200.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC---C--CcEEEEEEeccCccCchH-HHHHHHHHHHhhccccccceeeeEeec-CCce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ---D--GTVVAVKRLKDGNAIGGE-IQFQTEVEMISLAVHRNLLRLIGFCMT-TTER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~ 302 (552)
..|+....||+|+||.||+|+-+ + ...+|+|.++.+....+. ....+|+.+++.++|||++.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46888899999999999999743 2 237999999876544332 357799999999999999999999887 7788
Q ss_pred eEEEeeccCCChhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC----CceEEcc
Q 008828 303 LLVYPYMSNGSVASRLK-----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY----YEAVVGD 373 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~D 373 (552)
++++||.+. +|..+++ ....++...+..|+.||+.|+.|||++ =|+||||||.||||..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 8888885 234789999999999999999999999 79999999999999877 9999999
Q ss_pred cccceecCCCCCc--eeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCccccccc--chHHHHH
Q 008828 374 FGLAKLLDHCDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKG--AMLDWVK 448 (552)
Q Consensus 374 fg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~--~~~~~~~ 448 (552)
||+++.+...-.. ....++.|..|.|||++.+. .||.+.||||.|||..||+|-.+.|.......... ...+.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999987643222 23456789999999999875 59999999999999999999988876543221111 1112222
Q ss_pred HHhh---hcchhhhccccccCc------------CCH-----------HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 449 KIHQ---EKKLEMLVDKDLKNN------------YDR-----------IELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 449 ~~~~---~~~~~~~~~~~~~~~------------~~~-----------~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
.+.. ........+-.-.++ +.. .-++..++|+.+++++||.+|.|+++++++.
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 2111 000000000000000 000 0123478999999999999999999998754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.30 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=201.7
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC------CceeE
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TERLL 304 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~~~l 304 (552)
+...+.||+|+||.||+|+++ .|+.||||.++........+...+|++++++++|+|||+++++-... ...++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 345678999999999999954 79999999998766666677899999999999999999999986543 46789
Q ss_pred EEeeccCCChhhhhccC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC--CCC--ceEEcccccc
Q 008828 305 VYPYMSNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYY--EAVVGDFGLA 377 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfg~~ 377 (552)
|||||.+|+|...+++. ..+++...+.++.+++.||.|||++ +|+||||||.||++- ++| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999743 4699999999999999999999998 999999999999984 334 4699999999
Q ss_pred eecCCCCCceeecccccccccCchhhc-cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcch
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (552)
+.++.+ .....+.||..|++||++. .+.|+..+|.|||||++|+.+||..||.....+..... ..|..........
T Consensus 172 rel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~-~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE-IMWHIITKKPSGV 248 (732)
T ss_pred ccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch-hhhhhhccCCCce
Confidence 988743 3566778999999999998 58899999999999999999999999975443321111 1222211111111
Q ss_pred hhhcccccc------------CcCCHHHHHHHHHHHHHccCCCCCCCC--CHHHHHH
Q 008828 457 EMLVDKDLK------------NNYDRIELEEMVQVALLCTQYLPSLRP--KMSEVVR 499 (552)
Q Consensus 457 ~~~~~~~~~------------~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~ 499 (552)
.....+..+ ....+.....+..++..++..+|++|. .+.+...
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa 305 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFA 305 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHH
Confidence 111111111 112344456677788888899999998 5444433
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=296.24 Aligned_cols=250 Identities=23% Similarity=0.301 Sum_probs=204.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhcc-ccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv 305 (552)
++|.+.+.||+|+||.||+|... ++..||+|++..... ......+..|..++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999975 689999999865322 122346788999999998 99999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999998887899999999999999999999998 999999999999999999999999999876543221
Q ss_pred -------------------ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHH
Q 008828 386 -------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW 446 (552)
Q Consensus 386 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 446 (552)
.......++..|+|||......++.++||||||++++++++|+.||..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~ 230 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-------YLT 230 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-------HHH
Confidence 112234578899999999888899999999999999999999999874321 000
Q ss_pred HHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 008828 447 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKM----SEVVRM 500 (552)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~ 500 (552)
..... . ....++...++.+.+++.+||+.+|.+||++ ++++.+
T Consensus 231 ~~~~~---------~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 231 FQKIL---------K--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHH---------h--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 01110 0 1111223335779999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=293.93 Aligned_cols=260 Identities=23% Similarity=0.299 Sum_probs=194.5
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhc---cccccceeeeEeecCCc-----
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLA---VHRNLLRLIGFCMTTTE----- 301 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~~~~~~~~~----- 301 (552)
|++.+.||+|+||.||+|..+ ++..||+|+++...... ....+.+|+.++.++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999986 48999999997543322 223466787776655 59999999999988776
Q ss_pred eeEEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 302 RLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
.+++|||+.+ +|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999974 888887653 3589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcc---h
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK---L 456 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ 456 (552)
...... .....++..|+|||.+.+..++.++|||||||++|||++|..||........ ...+......... .
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHhcC
Confidence 643321 1223478899999999999999999999999999999999888864332111 1111111000000 0
Q ss_pred hh------hcccccc---CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 457 EM------LVDKDLK---NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 457 ~~------~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.. ....... ..........+.+++.+||+.||++||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 0000000 01112335778899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=297.11 Aligned_cols=248 Identities=29% Similarity=0.352 Sum_probs=195.7
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.|+..+.||+|+||.||+|+.. ++..+|+|.+..... .....++.+|+.+++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666688999999999999965 578999998864322 2233467889999999999999999999999999999999
Q ss_pred eccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 308 YMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 308 ~~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
|+. |++.+.+. ....+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 996 57777664 345689999999999999999999998 9999999999999999999999999998765432
Q ss_pred eeecccccccccCchhhc---cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 387 VTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
....++..|+|||.+. ...++.++|||||||++|+|++|+.|+..... ...........
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~--------- 230 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNE--------- 230 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-------HHHHHHHhhcC---------
Confidence 2235788999999975 35678899999999999999999999853211 01111111100
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.........+..+.+++.+||+.+|++||++.+++.+...
T Consensus 231 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 0000122344678999999999999999999999977554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=297.89 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=193.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCc------
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE------ 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~------ 301 (552)
++|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+|+.++++++||||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999975 6899999998643322 223356789999999999999999999876543
Q ss_pred --eeEEEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 302 --RLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 302 --~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
.++||||+.+ +|.+.+... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4999999965 787777643 3689999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCc---eeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh-
Q 008828 379 LLDHCDSH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE- 453 (552)
Q Consensus 379 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 453 (552)
........ ......++..|+|||.+.+. .++.++||||||+++|||+||+.||........ ...+......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~----~~~~~~~~~~~ 243 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ----LTLISQLCGSI 243 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCC
Confidence 65432221 11233477889999988664 478899999999999999999998864332111 0111111000
Q ss_pred --cchh-----hhccc-cccCcC---------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 454 --KKLE-----MLVDK-DLKNNY---------DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 454 --~~~~-----~~~~~-~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.... ...+. ...... .......+.+++.+||+.||.+|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 00000 000000 00123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.67 Aligned_cols=251 Identities=26% Similarity=0.355 Sum_probs=190.9
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC-------
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------- 299 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------- 299 (552)
--.+|+..++||+||||.||+++++ ||+.||||++.-.........+.+|+..+++++|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4467788899999999999999987 89999999997654333445688999999999999999998651100
Q ss_pred --------------------------------------------------------------------------------
Q 008828 300 -------------------------------------------------------------------------------- 299 (552)
Q Consensus 300 -------------------------------------------------------------------------------- 299 (552)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CceeEEEeeccCCChhhhhccCCCC-CHHHHHHHHHHHHHHHHHHhhc
Q 008828 300 --------------------------------TERLLVYPYMSNGSVASRLKAKPSL-DWATRKRIALGAARGLLYLHEQ 346 (552)
Q Consensus 300 --------------------------------~~~~lv~e~~~~g~L~~~l~~~~~l-~~~~~~~i~~~ia~~l~~LH~~ 346 (552)
...|+-||||+..++.++++.+... .....++++.+|+.||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0125778888887777777766544 5778899999999999999999
Q ss_pred CCCceEEcCCCCCceeeCCCCceEEcccccceecC-----------------CCCCceeecccccccccCchhhccC---
Q 008828 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-----------------HCDSHVTTAVRGTVGHIAPEYLSTG--- 406 (552)
Q Consensus 347 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~--- 406 (552)
|||||||||.||++++++.|||+|||+++... .......+...||.-|+|||++.+.
T Consensus 717 ---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred ---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999998621 0011123456799999999999765
Q ss_pred CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC--cCCHHHHHHHHHHHHHcc
Q 008828 407 QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN--NYDRIELEEMVQVALLCT 484 (552)
Q Consensus 407 ~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl 484 (552)
.|+.|+||||+|||++||+. ||..... +...+..+-+..+.. .+.......=..+|.+++
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsME---------------Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSME---------------RASILTNLRKGSIPEPADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHH---------------HHHHHHhcccCCCCCCcccccccchHHHHHHHHHh
Confidence 49999999999999999985 5643111 111122222222221 122333455678999999
Q ss_pred CCCCCCCCCHHHHHH
Q 008828 485 QYLPSLRPKMSEVVR 499 (552)
Q Consensus 485 ~~dP~~RPs~~evl~ 499 (552)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999874
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=294.47 Aligned_cols=244 Identities=30% Similarity=0.381 Sum_probs=192.7
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
|...+.||+|+||+||+|+.. +++.|++|.+...... .....+..|+.+++.++|||++++++++......++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999964 6889999998643322 2234678899999999999999999999999999999999
Q ss_pred ccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+. |++.+.+. ....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 57777765 345799999999999999999999998 999999999999999999999999999864321
Q ss_pred eecccccccccCchhhc---cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 388 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
.....|+..|+|||.+. ...++.++|||||||++|||++|..|+..... ........... . +
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~-~-----~-- 238 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQND-S-----P-- 238 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcC-C-----C--
Confidence 12345888999999984 45688899999999999999999999864321 11111111110 0 0
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.......+..+.+++.+||+.+|.+||++.+++.+
T Consensus 239 -~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 -TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111233568999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=301.50 Aligned_cols=267 Identities=22% Similarity=0.259 Sum_probs=197.5
Q ss_pred cCCC-CCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-------------hHHHHHHHHHHHhhccccccceeee
Q 008828 230 SNFS-SKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-------------GEIQFQTEVEMISLAVHRNLLRLIG 294 (552)
Q Consensus 230 ~~~~-~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~~~h~niv~l~~ 294 (552)
++|. +.+.||+|+||+||+|... +++.||||.++...... ....+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 4578999999999999965 68999999986432221 0124678999999999999999999
Q ss_pred EeecCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccc
Q 008828 295 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 374 (552)
Q Consensus 295 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 374 (552)
++...+..++||||+. |+|.+++.....+++.....++.|++.||.|||+. +|+||||+|+||+++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999997 69999998777899999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCC-------------CceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccc
Q 008828 375 GLAKLLDHCD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQK 440 (552)
Q Consensus 375 g~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~ 440 (552)
|++....... ........++..|+|||.+.+. .++.++|||||||++|||+||+.||.........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9997654111 0111223467889999998764 4689999999999999999999999754321111
Q ss_pred cchHHHHHHHhhhcchhh-----------hccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 441 GAMLDWVKKIHQEKKLEM-----------LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
..+............... ....... ......+..+.+++.+||+.+|++|||+.|++.+-
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 001000000000000000 0000000 00112246788999999999999999999999643
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=294.60 Aligned_cols=261 Identities=23% Similarity=0.247 Sum_probs=191.9
Q ss_pred CCeeeeeCceEEEEEEECCCcEEEEEEeccC-ccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCC
Q 008828 235 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 313 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 313 (552)
.+.+|.|+++.||++.. +++.||||+++.. ........+.+|+.+++.++||||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555544 5899999999754 233345578999999999999999999999999999999999999999
Q ss_pred hhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC------
Q 008828 314 VASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS------ 385 (552)
Q Consensus 314 L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~------ 385 (552)
|.+++.. ...+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999874 34689999999999999999999999 999999999999999999999999998865432111
Q ss_pred ceeecccccccccCchhhccC--CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHH----hh-------
Q 008828 386 HVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI----HQ------- 452 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~------- 452 (552)
.......++..|+|||.+... .++.++|||||||++|||++|+.||........ ........ ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM---LLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCccccccCchhhh
Confidence 111233467789999998763 588999999999999999999999974321110 00000000 00
Q ss_pred hcchhh----hccc----cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 453 EKKLEM----LVDK----DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 453 ~~~~~~----~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
...... ..+. ............++.+++.+||+.+|++|||+++++++--
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000000 0000 0111123344578899999999999999999999987443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=297.70 Aligned_cols=267 Identities=21% Similarity=0.284 Sum_probs=199.7
Q ss_pred HHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeec-CCc
Q 008828 225 LQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTE 301 (552)
Q Consensus 225 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~ 301 (552)
+...+++|++.+.||+|+||.||+|... +++.||+|.+..... ......+..|++++..++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446788999999999999999999855 789999998864322 2234567789999999999999999998865 457
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.++++||+ +++|..++... .+++.....++.|++.||.|||+. +|+||||+|+||++++++.++|+|||.+....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 88999998 56888887654 588899999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccch--------HHHHHHHhh
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM--------LDWVKKIHQ 452 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~ 452 (552)
.. .....++..|+|||.+.+ ..++.++|||||||++|+|+||+.||...........+ .+|......
T Consensus 160 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 160 PQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred CC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 21 122347888999998866 56899999999999999999999999654321110000 111111111
Q ss_pred hcchhhhccccccCcCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 453 EKKLEMLVDKDLKNNYD-----RIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
................+ ...+..+.+++.+|++.+|++|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111110000011111 1134788999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.21 Aligned_cols=291 Identities=21% Similarity=0.261 Sum_probs=225.6
Q ss_pred HHHHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecC
Q 008828 223 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT 299 (552)
Q Consensus 223 ~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 299 (552)
.+++...++|.+.++||+|+||.|..++++ +++.||+|++.+... ......|..|-++|...+.+-|+++.-.|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 455566788999999999999999999976 588999999976432 22345699999999999999999999999999
Q ss_pred CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 300 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
.+.|+|||||+||+|..++.....+++..++.++..|+-||.-||+. |+|||||||+|||+|.+|++||+|||.+-.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHh
Confidence 99999999999999999998887899999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeecccccccccCchhhcc-----CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhc
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 454 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 454 (552)
+...+.-.....+|||.|++||++.. +.|+..+|.||+||++|||+.|..||........++.+. ...
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm-------~hk 297 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM-------NHK 297 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh-------chh
Confidence 77655555666779999999999963 578999999999999999999999998543322222221 111
Q ss_pred chhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHhcCCCchhhhHhhhhhhhhccccccccccc
Q 008828 455 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK---MSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSER 531 (552)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (552)
....+.+ ....+++..+||.+.+. +|+.|.. +.++-.|..-. ...|..-. +....-..+++|...
T Consensus 298 ~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~--g~~W~~iR--~~~pP~vPevssd~D 365 (1317)
T KOG0612|consen 298 ESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFE--GIDWDNIR--ESVPPVVPEVSSDDD 365 (1317)
T ss_pred hhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcccc--CCChhhhh--hcCCCCCCcCCCCCc
Confidence 1111110 12245778888888776 6777777 77777654432 22352211 222233456666555
Q ss_pred CCCC
Q 008828 532 YSDL 535 (552)
Q Consensus 532 ~~~~ 535 (552)
-|++
T Consensus 366 TsnF 369 (1317)
T KOG0612|consen 366 TSNF 369 (1317)
T ss_pred cccc
Confidence 5555
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=300.02 Aligned_cols=268 Identities=25% Similarity=0.296 Sum_probs=194.4
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCC------
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ 300 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 300 (552)
.++|.+.+.||+|+||.||+|... +++.+|+|.+......+ ....+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467889999999999999999965 58899999986443222 2335678999999999999999999875443
Q ss_pred --ceeEEEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccc
Q 008828 301 --ERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 377 (552)
Q Consensus 301 --~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 377 (552)
..++|+||+.+ ++...+.. ...+++..+..++.|+++||.|||+. +|+|+||||+||++++++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 45899999975 66666653 45799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCc----------eeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHH
Q 008828 378 KLLDHCDSH----------VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW 446 (552)
Q Consensus 378 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 446 (552)
+........ ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 765432211 11233468889999988654 5889999999999999999999998643322111111100
Q ss_pred HHHHh-----hhcchhhhccccccCcCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 447 VKKIH-----QEKKLEMLVDKDLKNNYD-------RIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 447 ~~~~~-----~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..... .........+.......+ ......+.+++.+|++.+|++|||+.|++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000 000000000000000000 1122678899999999999999999998854
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=290.14 Aligned_cols=244 Identities=20% Similarity=0.276 Sum_probs=195.8
Q ss_pred CeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCCh
Q 008828 236 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 314 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 314 (552)
..||+|+||.||+|..+ ++..||+|.+.... ......+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 57899999999999874 68999999885432 23345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeeccccc
Q 008828 315 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 394 (552)
Q Consensus 315 ~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt 394 (552)
.+++... .+++.....++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++....... .......|+
T Consensus 105 ~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~ 179 (292)
T cd06657 105 TDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGT 179 (292)
T ss_pred HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccccC
Confidence 9987544 589999999999999999999998 99999999999999999999999999987654322 122334588
Q ss_pred ccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHH
Q 008828 395 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE 474 (552)
Q Consensus 395 ~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 474 (552)
..|+|||.+.+..++.++|||||||++|+|++|..||...... ........ .....+. .....+.
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-------~~~~~~~~------~~~~~~~--~~~~~~~ 244 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRD------NLPPKLK--NLHKVSP 244 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh------hCCcccC--CcccCCH
Confidence 9999999998888999999999999999999999998642211 11111110 0011110 0112346
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 475 EMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 475 ~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+.+++.+||+.+|.+||++.+++++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 68899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=287.81 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=195.7
Q ss_pred CCCCCCeeeeeCceEEEEEEECC-CcEEEEEEeccCc----cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
+|.+.+.||+|+||.||++.... +..+++|.++... ......++..|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998653 4456666654321 122334577899999999999999999999999999999
Q ss_pred EeeccCCChhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 306 YPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 306 ~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
|||+++++|.+.+. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999998875 345799999999999999999999998 9999999999999975 569999999987654
Q ss_pred CCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||.... ..........
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~~~--------- 219 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIVE--------- 219 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHc---------
Confidence 322 22233457889999999988889999999999999999999999986321 1111111110
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......+...+.++.+++.+||+.+|++||++.|++++
T Consensus 220 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 -GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 01112234456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=278.66 Aligned_cols=264 Identities=22% Similarity=0.315 Sum_probs=201.6
Q ss_pred CHHHHHHHhcCCCCCCeeeeeCceEEEEEE-ECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeec
Q 008828 221 HFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMT 298 (552)
Q Consensus 221 ~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~ 298 (552)
.|.++.+.|+ ++||+|+|+.|--++ +.+|..+|||++.+. ......++.+|++++.+.+ |+||+.++++|++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 4555555543 689999999999988 678999999999654 3334567889999999985 9999999999999
Q ss_pred CCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC---ceEEcccc
Q 008828 299 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVGDFG 375 (552)
Q Consensus 299 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg 375 (552)
+...|||||.|.||.|..++++...+++.++.++.++||.||.|||.+ ||.||||||+|||-.... -+|||||.
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccc
Confidence 999999999999999999999999999999999999999999999999 999999999999997543 57999998
Q ss_pred cceecCCC------CCceeecccccccccCchhhc-----cCCCCCccchhHHHHHHHHHHhCCCccccCcccc--c-cc
Q 008828 376 LAKLLDHC------DSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTAN--Q-KG 441 (552)
Q Consensus 376 ~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~--~-~~ 441 (552)
+..-+... ......+.+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+||...=..+ . .+
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 87533211 111223456899999999874 3468999999999999999999999997532211 1 11
Q ss_pred chHHHHHHHhhhcchhhhccccccCcCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 442 AMLDWVKKIHQEKKLEMLVDKDLKNNYDR----IELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
....-... .-++.+.+... +++. ..+.+..+++...+..|+.+|.++.+++.
T Consensus 305 e~Cr~CQ~----~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQN----KLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHH----HHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11111111 01111111111 1232 33566788999999999999999998876
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=291.87 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=198.8
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
|+..+.||+|+||.||+|+.. +++.||+|.++.... ......+..|+.+++.++|+|++++++++......++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999976 589999999976432 222346778999999999999999999999999999999999
Q ss_pred cCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 310 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 310 ~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+ ++|.+++... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||.++....... ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 8 5899999765 5799999999999999999999999 999999999999999999999999999986643322 12
Q ss_pred ecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHH--------HHhh----hcc
Q 008828 389 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK--------KIHQ----EKK 455 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~----~~~ 455 (552)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+..... .... ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 223467789999998776 789999999999999999999988864332111000000000 0000 000
Q ss_pred hhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 456 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
............ .+.....+.+++.+||+.+|++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 236 FPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000000000 11124679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.51 Aligned_cols=261 Identities=22% Similarity=0.307 Sum_probs=192.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCC------
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ 300 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 300 (552)
..+|...+.||+|+||.||+|... +|+.||+|.++..... .....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368888999999999999999964 6899999998653222 22345789999999999999999999986542
Q ss_pred ceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 301 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
..++|+||+.. +|..+.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 46899999964 6766553 3589999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchH--------HHHHHHh
Q 008828 381 DHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKKIH 451 (552)
Q Consensus 381 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~ 451 (552)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+. .+.....
T Consensus 168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 168 DAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 321 123457889999999876 468999999999999999999999997532211000000 0000000
Q ss_pred hhcchhhhcc--cc-ccCcC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 452 QEKKLEMLVD--KD-LKNNY---DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 452 ~~~~~~~~~~--~~-~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ........ +. ..... .+.....+.+++.+||+.||++||++.|++.+
T Consensus 244 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 244 D-KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred c-cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00000000 00 00000 01123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=300.65 Aligned_cols=270 Identities=23% Similarity=0.279 Sum_probs=199.5
Q ss_pred HHHHHHHhcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecC
Q 008828 222 FKELQSATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT 299 (552)
Q Consensus 222 ~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 299 (552)
..++...+++|.+.+.||+|+||.||+|.. .+++.||+|+++.... ......+.+|+.++..++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 456667789999999999999999999985 4689999999975322 22344677899999999999999999987643
Q ss_pred ------CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcc
Q 008828 300 ------TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 373 (552)
Q Consensus 300 ------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 373 (552)
...+++++++ +++|.+++... .+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEec
Confidence 3467788876 77898877654 599999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchH--------
Q 008828 374 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML-------- 444 (552)
Q Consensus 374 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~-------- 444 (552)
||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.
T Consensus 164 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 164 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred cccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9998754321 223457889999999866 568899999999999999999999986432211100000
Q ss_pred HHHHHHhhhc--chhhhccccccCcC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 445 DWVKKIHQEK--KLEMLVDKDLKNNY---DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 445 ~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+........ .............+ .......+.+++.+|++.||.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000 00000000000000 00124678999999999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=283.00 Aligned_cols=237 Identities=27% Similarity=0.290 Sum_probs=195.2
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCCh
Q 008828 238 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 314 (552)
Q Consensus 238 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 314 (552)
||+|+||.||++... +++.+|+|.+....... ....+..|+.+++.++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 58999999987543322 345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeeccccc
Q 008828 315 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 394 (552)
Q Consensus 315 ~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt 394 (552)
.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 99998877899999999999999999999998 99999999999999999999999999998654322 122344588
Q ss_pred ccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHH
Q 008828 395 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE 474 (552)
Q Consensus 395 ~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 474 (552)
..|+|||...+...+.++|+||||+++|+|++|..||..... ......... . ...++...+.
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~---------~--~~~~~~~~~~ 218 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILK---------D--PLRFPEFLSP 218 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhc---------C--CCCCCCCCCH
Confidence 899999999888899999999999999999999999964321 111111111 0 0112222357
Q ss_pred HHHHHHHHccCCCCCCCCCHHH
Q 008828 475 EMVQVALLCTQYLPSLRPKMSE 496 (552)
Q Consensus 475 ~l~~li~~cl~~dP~~RPs~~e 496 (552)
.+.+++.+||..||++||++.+
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCccc
Confidence 7899999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=280.55 Aligned_cols=262 Identities=24% Similarity=0.324 Sum_probs=212.3
Q ss_pred HHHHHHHhcCCCCCCeeeeeCceEEEEEEECC------CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeE
Q 008828 222 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295 (552)
Q Consensus 222 ~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~ 295 (552)
.+++.....+++...++-+|.||.||.|.|.+ .+.|-+|.++.....-+...+..|.-++.-..|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34566667788888999999999999997653 456788888876655555678889888888999999999998
Q ss_pred eec-CCceeEEEeeccCCChhhhhc--------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC
Q 008828 296 CMT-TTERLLVYPYMSNGSVASRLK--------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 366 (552)
Q Consensus 296 ~~~-~~~~~lv~e~~~~g~L~~~l~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 366 (552)
+.. ...+++++.++.-|+|..++. ..+.++..+...++.|++.|++|||.+ +|||.||.++|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 865 467889999999999999997 123577888999999999999999999 99999999999999999
Q ss_pred CceEEcccccceecCCCCCcee-ecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchH
Q 008828 367 YEAVVGDFGLAKLLDHCDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAML 444 (552)
Q Consensus 367 ~~~kl~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~ 444 (552)
..+||+|=.+++.+...+.+.- ........||+||.+....|+.++|||||||++|||+| |+.|+..-++.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf------- 505 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF------- 505 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-------
Confidence 9999999999998766665532 33346789999999999999999999999999999998 77776532221
Q ss_pred HHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 445 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.+...+....+-..+.+++++++.+|..||..+|++||+++|+...|.+
T Consensus 506 ----------Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 506 ----------EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ----------HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1111111122222355678999999999999999999999999988875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=297.21 Aligned_cols=262 Identities=21% Similarity=0.257 Sum_probs=192.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC---------
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--------- 299 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--------- 299 (552)
.+|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57888999999999999999964 688999999865433 3445688999999999999999999876543
Q ss_pred -----CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC-CCCceEEcc
Q 008828 300 -----TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGD 373 (552)
Q Consensus 300 -----~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~D 373 (552)
...++||||++ ++|.+.+... .+++..+..++.||+.||.|||+. +|+||||||+||+++ +++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence 34689999997 5888887644 589999999999999999999998 999999999999998 456789999
Q ss_pred cccceecCCCCCc--eeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHH
Q 008828 374 FGLAKLLDHCDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 450 (552)
Q Consensus 374 fg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 450 (552)
||+++........ ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.......... ......
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~---~~~~~~ 235 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ---LILESV 235 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhc
Confidence 9999765422111 1122347889999998754 567889999999999999999999997443211100 000000
Q ss_pred hh--h-------cchhhhcc-ccccC-----cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 451 HQ--E-------KKLEMLVD-KDLKN-----NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 451 ~~--~-------~~~~~~~~-~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.. . ........ ..... ........++.+++.+||+.||++|||+.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00 0 00000000 00000 0011234678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=273.34 Aligned_cols=252 Identities=21% Similarity=0.252 Sum_probs=195.3
Q ss_pred HhcCCCC-CCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecC----C
Q 008828 228 ATSNFSS-KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT----T 300 (552)
Q Consensus 228 ~~~~~~~-~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~----~ 300 (552)
.+++|.+ .++||-|-.|.|-.+..+ +++.+|+|++.+.. ...+|+++.-+. .|||||.+++++.+. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 3456654 368999999999999876 68999999996532 235777775444 699999999998653 4
Q ss_pred ceeEEEeeccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC---CCCceEEcccc
Q 008828 301 ERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFG 375 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg 375 (552)
..++|||.|+||.|++.+++++ .+++.++..|++||+.|+.|||+. +|.||||||+|+|.. .|..+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 5679999999999999998665 599999999999999999999999 999999999999997 46689999999
Q ss_pred cceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcc
Q 008828 376 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455 (552)
Q Consensus 376 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 455 (552)
+|+.-.. .....+.+-|+.|.|||++...+|+...|+||+||++|-|++|.+||...... .+..=++.-...+.
T Consensus 210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~----aispgMk~rI~~gq 283 (400)
T KOG0604|consen 210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKRRIRTGQ 283 (400)
T ss_pred cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc----cCChhHHhHhhccC
Confidence 9986442 22334556899999999999999999999999999999999999999853321 11100010000000
Q ss_pred hhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 456 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. .+..+-....++...++|+.+|..+|++|.|+.|++.+
T Consensus 284 y------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 Y------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred c------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0 01111123456788999999999999999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=253.18 Aligned_cols=264 Identities=20% Similarity=0.273 Sum_probs=198.2
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
|...++||+|.||+||+|+.. +++.||+|+++-....+ .-....+|+-+++.++|.|||+++++...+...-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 445578999999999999954 68999999997544333 3346789999999999999999999999999999999999
Q ss_pred cCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 310 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 310 ~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
.. +|..+..+ ++.++.+..+.++.|+++||.|+|++ ++.|||+||.|.||+.+|+.|++|||+++.++- .....
T Consensus 84 dq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgi-pvrcy 158 (292)
T KOG0662|consen 84 DQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI-PVRCY 158 (292)
T ss_pred hH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCC-ceEee
Confidence 76 77777753 56799999999999999999999999 999999999999999999999999999987653 23344
Q ss_pred ecccccccccCchhhccCC-CCCccchhHHHHHHHHHHhCCCccccCcc-cccccchHHHHHHHhhhcc--hhhhccccc
Q 008828 389 TAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKT-ANQKGAMLDWVKKIHQEKK--LEMLVDKDL 464 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 464 (552)
+....|..|.+|.++.+.. |+...|+||-|||+.|+.....|...+.. .++...+...+.....+.+ +..+.|-..
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 5566899999999998865 88999999999999999875555443332 2211111111111111111 222333222
Q ss_pred cCcCCH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNNYDR---------IELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+.|+. .....=.+++++.+.-+|..|.++++.+++
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 222221 111233678888888899999999988765
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=290.91 Aligned_cols=265 Identities=19% Similarity=0.207 Sum_probs=193.0
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-C--CcEEEEEEeccCccC-chHHHHHHHHHHHhhc-cccccceeeeEeecC----Cc
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-D--GTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT----TE 301 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~----~~ 301 (552)
+|.+.+.||+|+||.||++... . +..||+|.+...... .....+.+|+.++.++ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999965 3 779999998643222 2244678899999988 599999999875432 45
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.++++||+. ++|.+.+.....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 678888886 68999998778899999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCc---eeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccc--------hHHHHHH
Q 008828 382 HCDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA--------MLDWVKK 449 (552)
Q Consensus 382 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~--------~~~~~~~ 449 (552)
..... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........... ...+...
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 32211 1123458899999998766 4689999999999999999999999864331100000 0011111
Q ss_pred Hhhhcc--hhhhccccccCc---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 450 IHQEKK--LEMLVDKDLKNN---YDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 450 ~~~~~~--~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
...... ............ ........+.+++.+|++.+|++|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 000000000000 01112467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=296.12 Aligned_cols=263 Identities=22% Similarity=0.298 Sum_probs=197.4
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCCc----
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE---- 301 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~---- 301 (552)
..++|.+.+.||+|+||.||+|+.. ++..||+|++..... ......+.+|+.+++.++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4568999999999999999999975 588999999864321 2233457789999999999999999998766554
Q ss_pred --eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 302 --RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 302 --~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
.++|+||+ +++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++..
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999998 56998888754 699999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchH--------HHHHHH
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKKI 450 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~--------~~~~~~ 450 (552)
.... .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||...........+. .+....
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 5432 223357889999999865 367899999999999999999999996433211100000 000000
Q ss_pred hhhcchhhhcc---ccccCcC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 451 HQEKKLEMLVD---KDLKNNY---DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 451 ~~~~~~~~~~~---~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+. ....+. ......+ ....+..+.+++.+|++.+|++|||+.||+++
T Consensus 244 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 244 SSES-ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred cchh-HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000 000000 0000001 01125789999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=291.59 Aligned_cols=262 Identities=22% Similarity=0.278 Sum_probs=195.6
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCC-----
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT----- 300 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----- 300 (552)
..++|++.+.||+|+||.||+|... ++..||||+++..... .....+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4567999999999999999999854 6899999998643222 22345789999999999999999999887543
Q ss_pred -ceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 301 -ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 301 -~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999999 6788888764 4699999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccc--------hHHHHHHH
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA--------MLDWVKKI 450 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~--------~~~~~~~~ 450 (552)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........... ...+...+
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 168 TDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 5422 123357889999999876 4588999999999999999999999874322110000 00111111
Q ss_pred hhhcchhhhcc--cccc----CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 451 HQEKKLEMLVD--KDLK----NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 451 ~~~~~~~~~~~--~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
..... ..... +... ..........+.+++.+|++.||++|||+.+++.
T Consensus 244 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 244 QSEDA-KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred cchhH-HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 00000 0000 0001123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.42 Aligned_cols=146 Identities=29% Similarity=0.398 Sum_probs=132.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||+||+|... +++.||||+++...... ....+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888899999999999999976 68999999997543222 2346888999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
||+.+++|.+++.....+++..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998777899999999999999999999998 99999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=274.99 Aligned_cols=249 Identities=25% Similarity=0.305 Sum_probs=192.2
Q ss_pred CCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhh-ccccccceeeeEeecCCceeEEEeeccCC
Q 008828 235 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRNLLRLIGFCMTTTERLLVYPYMSNG 312 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~~~lv~e~~~~g 312 (552)
...||.|+||+|+|-.++ .|+..|||+++.........++..|.+...+ -+.||||+++|.+..++..|+.||.|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 357999999999999876 6999999999877665556678888887554 4799999999999999999999999964
Q ss_pred Chhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 313 SVASRLK-----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 313 ~L~~~l~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
++..+-+ .+..+++...-.|....+.||.||-+.. .|||||+||+|||++..|.+||||||++-.+.. +..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--SiA 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SIA 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--HHH
Confidence 5544332 3456899999999999999999998764 899999999999999999999999999865532 222
Q ss_pred eecccccccccCchhhcc--CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 388 TTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.+.-.|-..|||||.+.. ..|+.++||||+|++|||+.||+.|+..-.. ..+.+......... .+.
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfeql~~Vv~gdpp------~l~ 291 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFEQLCQVVIGDPP------ILL 291 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHHHHHHHHcCCCC------eec
Confidence 233458889999999854 3589999999999999999999999863211 22222222211111 111
Q ss_pred CcC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNY-DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+. .......+..++..|+.+|-.+||...++.++
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111 12345778999999999999999999998764
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=282.30 Aligned_cols=243 Identities=24% Similarity=0.324 Sum_probs=203.6
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCch--HHHHHHHHHHHhhc-cccccceeeeEeecCCceeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~l 304 (552)
..+|....+||+|+||.|-+|.-+ +.+.+|||++++...++. .+.-+.|-.+|+.. +-|.++++..++..-+..|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457888899999999999999865 467899999987654432 22345677777766 46789999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
||||+.||+|-.++++-+.+.++.+..++..||-||-|||++ +|++||||..|||+|.+|++||+|||+++.-- -+
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-FD 503 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc-cC
Confidence 999999999999999999999999999999999999999999 99999999999999999999999999997422 13
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
...+.+++||+.|+|||++...+|...+|.|||||+||||+.|.+||+..+.. +-...+.+..
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~----------------elF~aI~ehn- 566 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----------------ELFQAIMEHN- 566 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHHHHcc-
Confidence 34567789999999999999999999999999999999999999999864321 1112222222
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCC
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPK 493 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs 493 (552)
-.|+...+.+...+....+...|.+|..
T Consensus 567 -vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 -VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 2467777788999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=295.29 Aligned_cols=240 Identities=23% Similarity=0.298 Sum_probs=196.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 306 (552)
+..|.....+|.|+|+.|-.+... +++..++|++.+... +-.+|+.++... +||||+++.+.+.+..+.++||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 567888888999999999998854 688899999976522 123566555544 6999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee-CCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL-DEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|.+.+|-+.+.+...+... ..+..|+.+|+.|+.|||++ |+|||||||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999988887766555 77788999999999999999 99999999999999 58999999999999876643
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
....+-|..|.|||++...+||+++|+||||++||+|++|+.||...... .++...-..
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------------~ei~~~i~~ 528 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------------------IEIHTRIQM 528 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------------------HHHHHhhcC
Confidence 22335688999999999999999999999999999999999999753321 111111112
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+.+....+....+|+..||+.||.+||+|.++..+
T Consensus 529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 22335556889999999999999999999999754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=275.23 Aligned_cols=220 Identities=20% Similarity=0.186 Sum_probs=177.6
Q ss_pred eCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCChhhhhc
Q 008828 241 GGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 319 (552)
Q Consensus 241 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~ 319 (552)
|.+|.||++... +++.||+|.++... .+..|...+....||||+++++++......++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999964 68999999996543 12344444555579999999999999999999999999999999998
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecccccccccC
Q 008828 320 AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 399 (552)
Q Consensus 320 ~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~a 399 (552)
....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 777899999999999999999999998 9999999999999999999999999987655432 122345678999
Q ss_pred chhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHH
Q 008828 400 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQV 479 (552)
Q Consensus 400 PE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 479 (552)
||.+....++.++||||+|+++|||++|+.|+........ ... ....+...+..+.++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------------~~~----~~~~~~~~~~~~~~l 208 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------------THT----TLNIPEWVSEEARSL 208 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------------ccc----ccCCcccCCHHHHHH
Confidence 9999888899999999999999999999887653211000 000 001122234678999
Q ss_pred HHHccCCCCCCCCCHH
Q 008828 480 ALLCTQYLPSLRPKMS 495 (552)
Q Consensus 480 i~~cl~~dP~~RPs~~ 495 (552)
+.+|++.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 9999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=285.81 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=200.8
Q ss_pred CCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc-cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCC
Q 008828 235 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 312 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 312 (552)
.+.||+|.||+||-|+++ +|+.||||++.+.. ...++.++.+|+++|..++||.||.+-..|+..+..++|||.+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 478999999999999975 79999999996543 33455679999999999999999999999999999999999995 4
Q ss_pred Chhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC---CCceEEcccccceecCCCCCce
Q 008828 313 SVASRLK--AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 313 ~L~~~l~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
++.+.+- +.+.+++.....++.||+.||.|||.+ +|+|.||||+|||+.+ .-.+||||||+|++++ ....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--EksF 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--EKSF 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecc--hhhh
Confidence 6666553 456899999999999999999999999 9999999999999974 3579999999999987 3455
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
...+.||+.|+|||+++...|+..-|+||.|||+|--++|.-||..+.. +-+.+... .-... +.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd------IndQIQNA------aFMyP----p~ 786 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED------INDQIQNA------AFMYP----PN 786 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc------hhHHhhcc------ccccC----CC
Confidence 6778899999999999999999999999999999999999999975432 21211110 00111 11
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 468 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
-..+...+..++|...++..-++|-|.++.+.+
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 224455778999999999999999998887654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=278.14 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=199.6
Q ss_pred hcCCCCCCeeeeeCceEEEEEE-ECCCcEEEEEEeccCccCchH------HHHHHHHHHHhhccccccceeeeEee-cCC
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGE------IQFQTEVEMISLAVHRNLLRLIGFCM-TTT 300 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~------~~~~~e~~~l~~~~h~niv~l~~~~~-~~~ 300 (552)
.++|-..++||+|||+.||+|. +...+.||||+-.-...+..+ +...+|..+-+.+.||.||++++++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3556777899999999999998 456889999987544333322 34678999999999999999999986 456
Q ss_pred ceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC---CCCceEEcccccc
Q 008828 301 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLA 377 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~ 377 (552)
.+|-|.|||+|.+|.-+|+....+++.+++.|+.||+.||.||.+. .++|||-||||.|||+. ..|.+||.|||++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 7889999999999999999999999999999999999999999986 67899999999999995 4578999999999
Q ss_pred eecCCCCC------ceeecccccccccCchhhccC----CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHH
Q 008828 378 KLLDHCDS------HVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 447 (552)
Q Consensus 378 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 447 (552)
++++.... ..+....||.+|++||.+.-+ .++.|+||||.|||+|..+.|+.||..... ...++
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs---QQdIL--- 694 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS---QQDIL--- 694 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh---HHHHH---
Confidence 98864322 234556799999999987543 478999999999999999999999974221 01111
Q ss_pred HHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 008828 448 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 498 (552)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 498 (552)
.+..+..... ..-+.-+....+...+|.+||++--++|....++.
T Consensus 695 ----qeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 ----QENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ----hhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111111000 01011123346788999999999999998876665
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=264.95 Aligned_cols=251 Identities=22% Similarity=0.264 Sum_probs=205.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhc-cccccceeeeEeecCCceeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~l 304 (552)
-++|....+||+|+|++|-.++++ +.+.+|+|+++++-..+ ...-.+.|-.+..+. +||.+|.+..+|......++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467889999999999999999965 68899999998653322 233466777777665 69999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|.||+++|+|.-+++....++++.++.+...|.-||.|||+. ||++||||..|||+|..|++||.|+|+++.- -.+
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~-l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-LGP 404 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC-CCC
Confidence 999999999999999989999999999999999999999999 9999999999999999999999999999752 224
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
...+++++||+.|+|||++.+.+|...+|.|++||+++||+.|+.||+.-...+....-.+++.++.-+. .+
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--------qi 476 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--------QI 476 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh--------cc
Confidence 4556788999999999999999999999999999999999999999986443333222223333332221 11
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCC
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPK 493 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs 493 (552)
..++..+.....+++.-+++||++|..
T Consensus 477 --riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 --RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 134444566778899999999999863
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=283.75 Aligned_cols=252 Identities=21% Similarity=0.256 Sum_probs=210.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCC-cEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDG-TVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.+++....||-|+||.|=++..+.. ..+|+|++++....+ +++.+..|-.+|...+.|.||+++--|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 4556667899999999999987643 358999997654433 3445778999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
|-|-||.+...++.++.++..+...++..+.+|++|||++ +||+|||||+|.+++.+|-+||.|||+|+.+..+ .
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--R 574 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC--C
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999999988754 3
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.+-+++||+.|.|||++.+...+.++|.||+|+++|||+||.+||...++......++.= ++ .-
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG---------id-------~i 638 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG---------ID-------KI 638 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh---------hh-------hh
Confidence 455688999999999999999999999999999999999999999865543322222110 00 11
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRMLE 502 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~ 502 (552)
.+|+.......+++++.+..+|.+|.. +.+|-+|--
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 345555677899999999999999986 556655443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=296.96 Aligned_cols=259 Identities=18% Similarity=0.200 Sum_probs=170.3
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-C----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeE------e
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-D----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF------C 296 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~------~ 296 (552)
..++|.+.+.||+|+||.||+|.+. + +..||+|+++.... ...+..+ .+....+.+++.++.. +
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 4578999999999999999999975 4 68999998864321 1111111 1111122222222211 2
Q ss_pred ecCCceeEEEeeccCCChhhhhccCCC--------------------CCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCC
Q 008828 297 MTTTERLLVYPYMSNGSVASRLKAKPS--------------------LDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356 (552)
Q Consensus 297 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl 356 (552)
......++||||+.+++|.+++..... .....+..++.|++.||.|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 355678999999999999998864321 12334567999999999999998 9999999
Q ss_pred CCCceeeCC-CCceEEcccccceecCCCCCceeecccccccccCchhhccC----------------------CCCCccc
Q 008828 357 KAANILLDE-YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG----------------------QSSEKTD 413 (552)
Q Consensus 357 k~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 413 (552)
||+|||++. ++.+||+|||+++.+............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 68999999999986654433444556789999999965322 2345679
Q ss_pred hhHHHHHHHHHHhCCCccccCccc------ccccchHHHHHHHhhhcchhhhccccccCcC--CHHHHHHHHHHHHHccC
Q 008828 414 VFGFGILLLELISGLRALEFGKTA------NQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY--DRIELEEMVQVALLCTQ 485 (552)
Q Consensus 414 vws~Gv~l~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~ 485 (552)
||||||++|||+++..+....... ........|....... ..+.+...+ .........+|+.+|++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999976554311000 0000111221111100 000000000 00012345689999999
Q ss_pred CCCCCCCCHHHHHHH
Q 008828 486 YLPSLRPKMSEVVRM 500 (552)
Q Consensus 486 ~dP~~RPs~~evl~~ 500 (552)
.||++|||++|++++
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=266.02 Aligned_cols=239 Identities=27% Similarity=0.328 Sum_probs=194.4
Q ss_pred CceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCChhhhhcc
Q 008828 242 GFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA 320 (552)
Q Consensus 242 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 320 (552)
+||.||+|+.. +++.+|+|++...........+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999997654433256789999999999999999999999999999999999999999999987
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecccccccccCc
Q 008828 321 KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 400 (552)
Q Consensus 321 ~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aP 400 (552)
...+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|++|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 66699999999999999999999998 99999999999999999999999999998765432 22344578899999
Q ss_pred hhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHH
Q 008828 401 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVA 480 (552)
Q Consensus 401 E~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 480 (552)
|.+....++.++||||||+++|+|++|..|+..... ......+ ..... .. ........+.++.+++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~---~~~~~~~---~~~~~-~~-------~~~~~~~~~~~~~~~i 221 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ---LLELFKK---IGKPK-PP-------FPPPEWKISPEAKDLI 221 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHH---HhccC-CC-------CccccccCCHHHHHHH
Confidence 999988899999999999999999999999864211 1111111 11000 00 0000000346799999
Q ss_pred HHccCCCCCCCCCHHHHHH
Q 008828 481 LLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 481 ~~cl~~dP~~RPs~~evl~ 499 (552)
.+|+..+|++||++.++++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=261.69 Aligned_cols=267 Identities=23% Similarity=0.331 Sum_probs=194.9
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecC--------C
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--------T 300 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--------~ 300 (552)
.|....+||+|.||.||+|+.+ +|+.||+|++--++. .+--....+|+++|..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3455678999999999999965 477889887643222 22223457899999999999999999988643 3
Q ss_pred ceeEEEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 301 ERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
..++||.+|+. +|..++... ..++..++.+++.++..||.|+|.. .|+|||+||.|+||+.++.+||+|||+++.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 47899999987 888888755 5799999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCc---eeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcc
Q 008828 380 LDHCDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455 (552)
Q Consensus 380 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 455 (552)
+...+.. ..+..+.|..|.+||.+.+ .+|+++.|||..|||+.||.||.+-+.......+-..+......+..+-+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 5433221 2344557999999999877 56999999999999999999998777654332221111122222111111
Q ss_pred h--------hhhcccccc-CcCC--HH------HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 456 L--------EMLVDKDLK-NNYD--RI------ELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 456 ~--------~~~~~~~~~-~~~~--~~------~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
. ..+--+.+. ..+. .+ -..+..+|+.+++..||.+|+.+++++.+-
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 0 000000000 0000 00 124678999999999999999999998643
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=271.39 Aligned_cols=263 Identities=20% Similarity=0.262 Sum_probs=197.0
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccc--cc----cceeeeEeecCCc
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH--RN----LLRLIGFCMTTTE 301 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~n----iv~l~~~~~~~~~ 301 (552)
+.+|.+..++|+|.||.|-.+... .+..||||+++.-... .+.-+-|++++.++.+ |+ +|.+.+++.-.++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY--reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY--REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH--hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 678999999999999999999854 4789999999754332 2345578999998842 22 7788888999999
Q ss_pred eeEEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC--------------
Q 008828 302 RLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-------------- 365 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------------- 365 (552)
.|+|+|.+ |-++++++..+ .+++..++..|+.|++++++|||+. +++|.||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999998 45999999864 4789999999999999999999999 9999999999999942
Q ss_pred ------CCceEEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCccccc
Q 008828 366 ------YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 439 (552)
Q Consensus 366 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~ 439 (552)
+..+|++|||.|++-... ....+.|..|.|||++.+-.++..+||||+||||.|+.||...|...+..+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 345899999999875432 2456689999999999999999999999999999999999998875442211
Q ss_pred c-------cchHHHH-H-----HHhhhcch-----------hhhcccccc----CcCCHHHHHHHHHHHHHccCCCCCCC
Q 008828 440 K-------GAMLDWV-K-----KIHQEKKL-----------EMLVDKDLK----NNYDRIELEEMVQVALLCTQYLPSLR 491 (552)
Q Consensus 440 ~-------~~~~~~~-~-----~~~~~~~~-----------~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~R 491 (552)
. +.+...+ . .....+.+ ..+.+.... ......+...+++|+.+|+.+||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 0 0000000 0 00000000 001111000 00123345679999999999999999
Q ss_pred CCHHHHHHHH
Q 008828 492 PKMSEVVRML 501 (552)
Q Consensus 492 Ps~~evl~~L 501 (552)
+|+.|++.+-
T Consensus 398 iTl~EAL~Hp 407 (415)
T KOG0671|consen 398 ITLREALSHP 407 (415)
T ss_pred ccHHHHhcCH
Confidence 9999998753
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=284.92 Aligned_cols=260 Identities=24% Similarity=0.320 Sum_probs=206.7
Q ss_pred HHHHHHHhcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeec-
Q 008828 222 FKELQSATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMT- 298 (552)
Q Consensus 222 ~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~- 298 (552)
++.+...+.-|++.+.||.|.+|.||+++. ++++.+|+|++......+ +++..|..++... .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 334444567788999999999999999995 478999999987655443 3456777887766 69999999999863
Q ss_pred ----CCceeEEEeeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEc
Q 008828 299 ----TTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG 372 (552)
Q Consensus 299 ----~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 372 (552)
+++.|||||||.+|+.-++++. ...+.|+.+.-|+..++.|+.+||.. .++|||||-.|||++.++.||++
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 4688999999999999999874 45799999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCceeecccccccccCchhhccC-----CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHH
Q 008828 373 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 447 (552)
Q Consensus 373 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 447 (552)
|||++..++.. ...+....||+.|||||++... .|+..+|+||+|++..||.-|.+|+....+...
T Consensus 166 DFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-------- 236 (953)
T KOG0587|consen 166 DFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-------- 236 (953)
T ss_pred eeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--------
Confidence 99999877542 2334556799999999998543 467889999999999999999999875433110
Q ss_pred HHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 448 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
+. .+ ...+...-.-+.....++.++|..|+..|-++||++.+++++-.
T Consensus 237 --LF---~I--pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF 284 (953)
T KOG0587|consen 237 --LF---LI--PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF 284 (953)
T ss_pred --hc---cC--CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence 00 00 11111111124556789999999999999999999999987533
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=282.42 Aligned_cols=261 Identities=20% Similarity=0.193 Sum_probs=180.3
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEE-----------------CCCcEEEEEEeccCccCc-------------hHHHHHHH
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYL-----------------QDGTVVAVKRLKDGNAIG-------------GEIQFQTE 277 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~e 277 (552)
..++|.+.++||+|+||+||+|.. .+++.||||+++...... .......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235689999986432110 01123346
Q ss_pred HHHHhhcccccc-----ceeeeEeec--------CCceeEEEeeccCCChhhhhccC-----------------------
Q 008828 278 VEMISLAVHRNL-----LRLIGFCMT--------TTERLLVYPYMSNGSVASRLKAK----------------------- 321 (552)
Q Consensus 278 ~~~l~~~~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~----------------------- 321 (552)
+.++.+++|.++ ++++++|.. ....++||||+++|+|.++++..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766554 677887753 35689999999999999888631
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecccccccccCc
Q 008828 322 -PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 400 (552)
Q Consensus 322 -~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aP 400 (552)
..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1246778899999999999999998 999999999999999999999999999976543222111222357899999
Q ss_pred hhhccCCC----------------------CCccchhHHHHHHHHHHhCCC-ccccCccccc-----ccchHHHHHHHhh
Q 008828 401 EYLSTGQS----------------------SEKTDVFGFGILLLELISGLR-ALEFGKTANQ-----KGAMLDWVKKIHQ 452 (552)
Q Consensus 401 E~~~~~~~----------------------~~~~Dvws~Gv~l~elltg~~-p~~~~~~~~~-----~~~~~~~~~~~~~ 452 (552)
|.+..... ..+.||||+||++|+|++|.. |+........ ......|......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98754321 235799999999999999875 5532111000 0111112111000
Q ss_pred hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHHH
Q 008828 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLP---SLRPKMSEVVRML 501 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~L 501 (552)
. .+- .......+...+++.+++..+| .+|+|++|+++|-
T Consensus 460 ~------~~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 460 K------YDF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred C------CCc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 0 000 0112234678899999999766 6899999999753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-33 Score=242.70 Aligned_cols=201 Identities=24% Similarity=0.318 Sum_probs=167.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhh-ccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++......||+|++|.|-+-++. +|...|+|+++..-......+...|+++..+ ..+|.+|.++|........++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 34445578999999999888854 7999999999876555556677888887654 469999999999999999999999
Q ss_pred eccCCChhhh----hccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 308 YMSNGSVASR----LKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 308 ~~~~g~L~~~----l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
.|+. +|..+ +..+..+++...-+|+..+.+||.|||++. .++|||+||+|||++.+|++|+||||.+-.+.++
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9975 66544 346778999999999999999999999985 8999999999999999999999999999876532
Q ss_pred CCceeecccccccccCchhhcc----CCCCCccchhHHHHHHHHHHhCCCccccCc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELISGLRALEFGK 435 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dvws~Gv~l~elltg~~p~~~~~ 435 (552)
-..+--.|...|||||.+.. ..|+.|+||||+|+++.||.+++.|++...
T Consensus 203 --iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 203 --IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred --hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 11222348889999998853 478999999999999999999999997543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-33 Score=255.90 Aligned_cols=267 Identities=22% Similarity=0.269 Sum_probs=201.0
Q ss_pred CCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCc-cCchHHHHHHHHHHHhhccccccceeeeEeecC-----CceeE
Q 008828 232 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TERLL 304 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~~l 304 (552)
.+..+-||-|+||.||.... ++|+.||+|++..-. .....+++-+|++++..++|.|++..++...-. .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999885 479999999885321 122345688999999999999999998876543 35678
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
++|.|. .+|..++-+...++.+.++-++.||++||.|||+. +|.||||||.|.|++.+..+||||||+++..+..+
T Consensus 135 ~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh
Confidence 999995 48999988888999999999999999999999999 99999999999999999999999999999876655
Q ss_pred CceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHH--------HHhhhcc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK--------KIHQEKK 455 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~ 455 (552)
....+....|..|.|||++++. .|+.+.||||.|||..||+..+..|.......+..-+.+.+. ..-.+.+
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 5444555678999999999885 599999999999999999998888875444333222222221 1111111
Q ss_pred hhhhccccccCcCC--------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 456 LEMLVDKDLKNNYD--------RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 456 ~~~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
...+....-.+.++ .....+...+...++.+||++|.+..+.+.++-
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111111111 112245678888999999999999999987654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-33 Score=286.60 Aligned_cols=242 Identities=26% Similarity=0.325 Sum_probs=186.4
Q ss_pred CCCCeeeeeCceE-EEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEEeecc
Q 008828 233 SSKNLVGKGGFGN-VYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMS 310 (552)
Q Consensus 233 ~~~~~iG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~ 310 (552)
...+++|.|+.|+ ||+|..+ |+.||||++-.+. ....++|++.|+.- .|||||++++.-.+....|+..|.|.
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 3446789999985 7999997 7899999985332 33467899999877 59999999999999999999999996
Q ss_pred CCChhhhhccC-C---CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC---C--CceEEcccccceecC
Q 008828 311 NGSVASRLKAK-P---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---Y--YEAVVGDFGLAKLLD 381 (552)
Q Consensus 311 ~g~L~~~l~~~-~---~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfg~~~~~~ 381 (552)
. +|.+++... . .......+.+..|++.||++||+. +||||||||.||||+. + .+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 999999763 1 111144578899999999999998 9999999999999975 2 578999999999887
Q ss_pred CCCCcee--ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhC-CCccccCcccccccchHHHHHHHhhhcchhh
Q 008828 382 HCDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG-LRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458 (552)
Q Consensus 382 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (552)
.+..... ....||-+|+|||.+....-+.++||||+||++|+.++| .+||......+. .+. .....+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl------~~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NIL------TGNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhh------cCccceee
Confidence 6655433 345699999999999999888999999999999999997 889874211000 000 00000000
Q ss_pred hccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+.+ ... .+..+||.+|++++|..||++.+|+.|
T Consensus 735 -----L~~--~~d--~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 -----LEP--LPD--CEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -----ecc--Cch--HHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 010 011 178899999999999999999999854
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=270.06 Aligned_cols=215 Identities=22% Similarity=0.334 Sum_probs=181.4
Q ss_pred cCCCCCCeeeeeCceEEEEEE-ECCCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.-|..++.||-|+||+|.++. .++...+|.|.+++.... .+...++.|.++|+....+-||+|+-.|.+++..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 346677899999999999998 455778999999754322 23345788999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC-----
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD----- 381 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~----- 381 (552)
+|++||++-.+|-.-+.+.+..++.++..+.+|+++.|.. |+|||||||+|||||.+|++||.|||++.-+.
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999999999998888899999999999999999999999 99999999999999999999999999985321
Q ss_pred ----CCC-----Cc---------------------------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHH
Q 008828 382 ----HCD-----SH---------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 425 (552)
Q Consensus 382 ----~~~-----~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ell 425 (552)
.++ +. .....+||..|+|||++....|+..+|.||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 000 00 001235999999999999999999999999999999999
Q ss_pred hCCCccccCcccccccchHHHH
Q 008828 426 SGLRALEFGKTANQKGAMLDWV 447 (552)
Q Consensus 426 tg~~p~~~~~~~~~~~~~~~~~ 447 (552)
.|+.||-..........+..|-
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~ 887 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWR 887 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehh
Confidence 9999998766655555555553
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=237.69 Aligned_cols=260 Identities=17% Similarity=0.295 Sum_probs=197.0
Q ss_pred hcCCCCCCeeeeeCceEEEEEE-ECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecCC--ceeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTT--ERLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~--~~~l 304 (552)
.++|++.+.+|+|.|+.||.|. ..+.+.++||+++.-. .+.+.+|+.+|..+. ||||+++++...+.. .+.+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 4678888999999999999998 4578899999997543 356889999999997 999999999987754 5679
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC-CCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~ 383 (552)
|+||+.+.+...+- +.++...+..++.+++.||.|+|++ ||+|||+||.|++||. ...++|+|+|+|.++...
T Consensus 113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99999886655444 4588889999999999999999999 9999999999999994 567999999999988654
Q ss_pred CCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCccccccc----------chHHHHHHH--
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKG----------AMLDWVKKI-- 450 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~----------~~~~~~~~~-- 450 (552)
... .-...+..|.-||++..- .|+..-|+|||||++..|+..+.||..+....++- .+..++...
T Consensus 187 ~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 187 KEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred cee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 322 223356678899998764 57888999999999999999999998765432211 011111111
Q ss_pred hhhcchhhhccccccCcC--------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 451 HQEKKLEMLVDKDLKNNY--------DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.-......++....+... ..-..++..+++.+.+..|..+|||++|++.+
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111222222222221111 11123788999999999999999999998754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=236.29 Aligned_cols=211 Identities=35% Similarity=0.507 Sum_probs=185.0
Q ss_pred eeeeCceEEEEEEECC-CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCChhh
Q 008828 238 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS 316 (552)
Q Consensus 238 iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 316 (552)
||+|.+|.||++...+ ++.+++|++...........+.+|+..+..++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999999765433234578899999999999999999999999999999999999999999
Q ss_pred hhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC-CCceEEcccccceecCCCCCceeeccccc
Q 008828 317 RLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDHCDSHVTTAVRGT 394 (552)
Q Consensus 317 ~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt 394 (552)
++... ..+++..+..++.++++++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 99765 5799999999999999999999999 9999999999999999 89999999999986654321 12234478
Q ss_pred ccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHH
Q 008828 395 VGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 473 (552)
Q Consensus 395 ~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 473 (552)
..|++||..... .++.++|+|++|+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 899999999887 888999999999999998
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 474 EEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 474 ~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4578999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=259.19 Aligned_cols=197 Identities=23% Similarity=0.336 Sum_probs=170.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-----hH--HHHHHHHHHHhhcc---ccccceeeeEeec
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GE--IQFQTEVEMISLAV---HRNLLRLIGFCMT 298 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~--~~~~~e~~~l~~~~---h~niv~l~~~~~~ 298 (552)
.+|...+.+|+|+||.|+.|.++ +...|+||.+.++..-. .. -.+-.||++|+.++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45788899999999999999986 46689999997653211 11 12556999999997 9999999999999
Q ss_pred CCceeEEEeec-cCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccc
Q 008828 299 TTERLLVYPYM-SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 377 (552)
Q Consensus 299 ~~~~~lv~e~~-~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 377 (552)
.+.++++||-. ++.+|++++.-++.+++..+.-|++|++.|+++||++ +|||||||-+||.++.+|-+||+|||.+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccch
Confidence 99999999975 5679999999999999999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeecccccccccCchhhccCCC-CCccchhHHHHHHHHHHhCCCccc
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALE 432 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~elltg~~p~~ 432 (552)
.....++ ...+.||..|.|||++.+..| ...-|||++|++||.++....|+.
T Consensus 718 a~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 7665432 345679999999999999887 566799999999999998877764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=234.87 Aligned_cols=256 Identities=18% Similarity=0.275 Sum_probs=194.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeE-eecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGF-CMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~-~~~~~~~~lv~ 306 (552)
+.|.+.+.+|+|.||.+-++.++ ..+.+++|.++.... ...+|.+|...--.+ .|.||+.-+++ |...+.+++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 46888899999999999999987 578899999876432 356788988764444 59999988775 55667788999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC--CCCceEEcccccceecCCCC
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~~ 384 (552)
||++.|+|.+.+... .+-+....+++.|+++|+.|||++ ++||||||.+||||- +..++||||||.++..+.
T Consensus 102 E~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-- 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-- 175 (378)
T ss_pred ccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc--
Confidence 999999999999765 488999999999999999999999 999999999999994 456899999999875432
Q ss_pred CceeecccccccccCchhhccC-----CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
.......+..|.|||..... ...+.+|||.||+++|.++||+.||..... .+...+.|.+...... ..+
T Consensus 176 --tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~--~d~~Y~~~~~w~~rk~--~~~ 249 (378)
T KOG1345|consen 176 --TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI--MDKPYWEWEQWLKRKN--PAL 249 (378)
T ss_pred --eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc--cCchHHHHHHHhcccC--ccC
Confidence 11223356789999987542 347889999999999999999999983322 2333445544433221 111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
.+ . -....+.+..+.++-+..+|++|-...++.++-...+
T Consensus 250 P~-----~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 250 PK-----K-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred ch-----h-hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 11 1 1123467889999999999999977777766655543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=261.25 Aligned_cols=252 Identities=23% Similarity=0.267 Sum_probs=202.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.+|+....+|+|+||.||||+.. .++..|+|+++-... +...-.++|+-+++..+||||+.++|.+...+..++.|||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 57888899999999999999954 689999999976443 3344577899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
|.+|+|.+.-+-.+++++.++..+++..++|++|||++ +-+|||||-.|||+++.|.+|++|||.+..+.. .....
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita-ti~Kr 169 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA-TIAKR 169 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-hhhhh
Confidence 99999999999889999999999999999999999999 899999999999999999999999999876543 22345
Q ss_pred ecccccccccCchhh---ccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 389 TAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~---~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
..+.||+.|||||+. ..+.|..++|||+.|+...|+-.-.+|........ +-.+. ....+++.-.
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--------~l~Lm----TkS~~qpp~l 237 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--------ALFLM----TKSGFQPPTL 237 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--------HHHHh----hccCCCCCcc
Confidence 567799999999986 45679999999999999999977666654322110 00000 0001111111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
. -.....+.+.++++.|+..+|++||+++.+++
T Consensus 238 k-Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 K-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred c-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 0 01223477899999999999999999998876
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=236.93 Aligned_cols=257 Identities=23% Similarity=0.257 Sum_probs=193.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccC-ccCchHHHHHHHHHHHhhccccccceeeeEeecC------Cc
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TE 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~ 301 (552)
.+|.-...+|.|.- .|..|... .++.||+|.+... .......+..+|...+..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888887 56655532 5889999987543 1223345677899999999999999999998643 35
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.++|||+|.. +|...+. -.++-.++..|..|+++|+.|||+. +|+||||||+||++..++.+||.|||+++.-+
T Consensus 96 ~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccC
Confidence 7899999964 8888877 3478899999999999999999999 99999999999999999999999999998544
Q ss_pred CCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcc------
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK------ 455 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 455 (552)
. ....+....|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+... +.+|.+....-+.
T Consensus 170 ~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~------idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 170 T--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH------IDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred c--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH------HHHHHHHHHHhcCCCHHHH
Confidence 3 2445667789999999999998899999999999999999999988874332 2233332111100
Q ss_pred ---------------------hhh-hccccccCc--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 456 ---------------------LEM-LVDKDLKNN--YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 456 ---------------------~~~-~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
..+ +.|...... .++.....+.+++.+||-.+|++|-+++++++|-
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 001 111111110 1122345678999999999999999999999753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=242.24 Aligned_cols=130 Identities=23% Similarity=0.376 Sum_probs=110.0
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-----c---cccceeeeEeec-
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----H---RNLLRLIGFCMT- 298 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----h---~niv~l~~~~~~- 298 (552)
..+|.+.++||-|-|++||++.. .+.+.||+|+.+.... -.+....||.+|++++ | .+||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh--YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH--YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH--HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 36788999999999999999984 5688999999976432 2344678999999884 2 359999999875
Q ss_pred ---CCceeEEEeeccCCChhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee
Q 008828 299 ---TTERLLVYPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 299 ---~~~~~lv~e~~~~g~L~~~l~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 363 (552)
..+.|+|+|++ |.+|..++. ..+.++...+++|+.||+.||.|||.+| +|||.||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45789999999 558888886 3457999999999999999999999999 99999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=233.15 Aligned_cols=199 Identities=29% Similarity=0.425 Sum_probs=173.3
Q ss_pred CCCCCeeeeeCceEEEEEEECC-CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeecc
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 310 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 310 (552)
|...+.||+|++|.||++...+ +..+|+|.+...........+.+|++.+..++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566889999999999999875 889999999754432245578899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceee
Q 008828 311 NGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389 (552)
Q Consensus 311 ~g~L~~~l~~~~~-l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 389 (552)
+++|.+++..... +++.....++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999999987666 89999999999999999999998 9999999999999999999999999999876543311223
Q ss_pred cccccccccCchhh-ccCCCCCccchhHHHHHHHHHHhCCCcccc
Q 008828 390 AVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELISGLRALEF 433 (552)
Q Consensus 390 ~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~elltg~~p~~~ 433 (552)
...++..|++||.. ....++.++|||+||+++++|++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34578899999998 667788899999999999999999999963
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-29 Score=243.92 Aligned_cols=200 Identities=23% Similarity=0.231 Sum_probs=168.1
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc------ccccceeeeEeecC
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV------HRNLLRLIGFCMTT 299 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~------h~niv~l~~~~~~~ 299 (552)
....+|.+....|+|-|++|..|... .|..||||+|.....+ .+.=+.|+++|.+++ .-|+++++-.|...
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 34578888899999999999999854 4789999999765443 223457899999885 45789999999999
Q ss_pred CceeEEEeeccCCChhhhhccC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC-CceEEcccc
Q 008828 300 TERLLVYPYMSNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFG 375 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg 375 (552)
++.|||+|-+. -+|.++|+.. -.|....+..++.|+.-||..|-.. +|+|.||||.||||++. ..+||||||
T Consensus 507 nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCc
Confidence 99999999885 4899999743 3688899999999999999999987 99999999999999965 568999999
Q ss_pred cceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCc
Q 008828 376 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 435 (552)
Q Consensus 376 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~ 435 (552)
.|-...... .+.+..+..|.|||++.+-+|+...|+||.||.||||.||+..|....
T Consensus 583 SA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 583 SASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred ccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 997665332 233445678999999999999999999999999999999999987644
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=235.02 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=197.3
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC----CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecCCc
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTE 301 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~ 301 (552)
...+.|...++||+|.|++||+|... .++.||+|.+..... -.++..|+++|..+. +.||+++.+++...+.
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 34466888999999999999999843 467899999865443 345789999999884 9999999999999999
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC-CCCceEEcccccceec
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLL 380 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~ 380 (552)
..+|+||++.....++... ++...+..++..+..||.++|.+ |||||||||+|+|.+ ..+.-.|.|||++...
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHH
Confidence 9999999999888777763 67889999999999999999999 999999999999998 4577889999998621
Q ss_pred CCC-------------------------------------------CCceeecccccccccCchhhccC-CCCCccchhH
Q 008828 381 DHC-------------------------------------------DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFG 416 (552)
Q Consensus 381 ~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws 416 (552)
+.. .........||++|.|||++... ..+.++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 100 00011234599999999998764 5789999999
Q ss_pred HHHHHHHHHhCCCccccCcccccccchHHHHHHH---------hhhcc---------------------h--hhhccccc
Q 008828 417 FGILLLELISGLRALEFGKTANQKGAMLDWVKKI---------HQEKK---------------------L--EMLVDKDL 464 (552)
Q Consensus 417 ~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~---------------------~--~~~~~~~~ 464 (552)
.|||++-+++++.||......- ..+...+... ...+. + +.+...+.
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~--~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDA--DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred ccceeehhhccccccccCcccc--chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999997543211 1111111000 00000 0 00000000
Q ss_pred ---c-CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 465 ---K-NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 465 ---~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
. .......+..+++++.+|+..+|.+|-|+++++.+---.
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 0 001122235789999999999999999999999876554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=270.35 Aligned_cols=194 Identities=16% Similarity=0.157 Sum_probs=139.4
Q ss_pred ccc-cccceeeeEee-------cCCceeEEEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEc
Q 008828 284 AVH-RNLLRLIGFCM-------TTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354 (552)
Q Consensus 284 ~~h-~niv~l~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 354 (552)
..| +||.++++++. .....+.++||+ +++|.+++.. ...+++.+++.++.||++||.|||++ +|+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 345 58888888772 234567788887 5699999965 45699999999999999999999998 99999
Q ss_pred CCCCCceeeCC-------------------CCceEEcccccceecCCCCC---------------ceeecccccccccCc
Q 008828 355 DVKAANILLDE-------------------YYEAVVGDFGLAKLLDHCDS---------------HVTTAVRGTVGHIAP 400 (552)
Q Consensus 355 dlk~~Nill~~-------------------~~~~kl~Dfg~~~~~~~~~~---------------~~~~~~~gt~~y~aP 400 (552)
||||+||||+. ++.+|++|||+++....... .......||+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 45566777777654221000 001123478889999
Q ss_pred hhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHH
Q 008828 401 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVA 480 (552)
Q Consensus 401 E~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 480 (552)
|++.+..++.++|||||||++|||++|..|+.... ..+..... ....+.. ........+++
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~~~~-----~~~~~~~-----~~~~~~~~~~~ 245 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSSLRH-----RVLPPQI-----LLNWPKEASFC 245 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHHHHH-----hhcChhh-----hhcCHHHHHHH
Confidence 99999999999999999999999999887764211 01111100 0111110 11124457889
Q ss_pred HHccCCCCCCCCCHHHHHHH
Q 008828 481 LLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 481 ~~cl~~dP~~RPs~~evl~~ 500 (552)
.+||+++|.+||++.|++++
T Consensus 246 ~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHhCCCChhhCcChHHHhhc
Confidence 99999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=211.99 Aligned_cols=165 Identities=19% Similarity=0.175 Sum_probs=125.9
Q ss_pred CChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeec
Q 008828 312 GSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 390 (552)
Q Consensus 312 g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 390 (552)
|+|.+++.. +..+++..++.|+.|++.||.|||+. + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 689999976 45699999999999999999999998 5 999999999999999 99998764322
Q ss_pred ccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCH
Q 008828 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 470 (552)
Q Consensus 391 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (552)
..||+.|+|||++.+..++.++|||||||++|||+||+.||...... ......+....... ++. ......
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~-------~~~-~~~~~~ 133 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPAD-------DPR-DRSNLE 133 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccC-------Ccc-ccccHH
Confidence 24889999999999999999999999999999999999998643211 00011111111100 000 001112
Q ss_pred HHHH--HHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 471 IELE--EMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 471 ~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.... .+.+++.+||+.+|++||++.|+++++..
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 2223 69999999999999999999999998875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=210.80 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=192.5
Q ss_pred CCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccC
Q 008828 233 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 233 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
....+|.+...|..|+|+|+ |..+++|+++...... ....|..|.-.|+.+.||||+.++|.|....+..++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34457888999999999998 5566678775433222 234689999999999999999999999999999999999999
Q ss_pred CChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceee
Q 008828 312 GSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389 (552)
Q Consensus 312 g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 389 (552)
|+|+..+++.. ..+..++.+++.++|+|++|||+. .|-|.---|.+..|+||++.+++|+ .+-+++. ....
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfs-----fqe~ 344 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS-----FQEV 344 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceee-----eecc
Confidence 99999998654 467889999999999999999997 4445555799999999999998873 1111111 1111
Q ss_pred cccccccccCchhhccCCC---CCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 390 AVRGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 390 ~~~gt~~y~aPE~~~~~~~---~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
...-.+.||+||.++..+- -.++|+|||++++|||.|...||......+-. ..+.-+.++.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----------------mkialeglrv 408 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----------------MKIALEGLRV 408 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------------hhhhhccccc
Confidence 2235688999999987654 35789999999999999999999754332211 1122334555
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
..++..+..+.+++.-|+..||.+||.++.|+-.|+..
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 66777778999999999999999999999999888763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=216.67 Aligned_cols=176 Identities=20% Similarity=0.228 Sum_probs=134.7
Q ss_pred HHHhcCCCCCCeeeeeCceEEEEEEEC--CCcEEEEEEeccCc----cCchHHHHHHHHHHHhhccccccce-eeeEeec
Q 008828 226 QSATSNFSSKNLVGKGGFGNVYKGYLQ--DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLR-LIGFCMT 298 (552)
Q Consensus 226 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~-l~~~~~~ 298 (552)
.....+|.+.+.||+|+||+||+|.++ +++.||||++.... .......|.+|++++.+++|+|++. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345578999999999999999999865 57888999875331 1112446899999999999999985 4432
Q ss_pred CCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCC-CCCceeeCCCCceEEcccccc
Q 008828 299 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV-KAANILLDEYYEAVVGDFGLA 377 (552)
Q Consensus 299 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~~ 377 (552)
...++||||+++++|... ... . ...++.|+++||.|||+. +|+|||| ||+|||++.++.+||+|||++
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~~---~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RPH---G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Ccc---c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 467999999999999732 211 1 246789999999999998 9999999 999999999999999999999
Q ss_pred eecCCCCCcee-------ecccccccccCchhhccCC------CCCccchh
Q 008828 378 KLLDHCDSHVT-------TAVRGTVGHIAPEYLSTGQ------SSEKTDVF 415 (552)
Q Consensus 378 ~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 415 (552)
+.+........ ....+++.|+|||.+...+ .+..+|-|
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 87654321111 3456888999999986543 23346666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-22 Score=202.32 Aligned_cols=259 Identities=28% Similarity=0.357 Sum_probs=199.0
Q ss_pred CCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCc--hHHHHHHHHHHHhhcccc-ccceeeeEeecCCceeEEEee
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHR-NLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~-niv~l~~~~~~~~~~~lv~e~ 308 (552)
|...+.||.|+||.||++... ..+++|.+....... ....+.+|+.++..+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999977 889999997665544 366799999999999988 799999999777778999999
Q ss_pred ccCCChhhhhccCC---CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC-ceEEcccccceecCCCC
Q 008828 309 MSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 309 ~~~g~L~~~l~~~~---~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~ 384 (552)
+.++++.+.+.... .+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776654 799999999999999999999999 999999999999999988 79999999998654433
Q ss_pred Cc-----eeecccccccccCchhhcc---CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcch
Q 008828 385 SH-----VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456 (552)
Q Consensus 385 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (552)
.. ......|+..|+|||.+.. ..+....|+||+|++++++++|..|+...............+.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---- 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT---- 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC----
Confidence 22 2355679999999999987 57899999999999999999999996543321000011111111100
Q ss_pred hhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 457 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. .................+.+++..|+..+|..|.++.+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000001223578899999999999999999987764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=203.52 Aligned_cols=256 Identities=20% Similarity=0.251 Sum_probs=190.9
Q ss_pred CCCCCCeeeeeCceEEEEEEECCC--cEEEEEEeccCccCchHHHHHHHHHHHhhccc----cccceeeeEe-ecCCcee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQDG--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH----RNLLRLIGFC-MTTTERL 303 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h----~niv~l~~~~-~~~~~~~ 303 (552)
+|.+.+.||+|+||.||.+...+. ..+|+|........... .+..|..++..+.. +++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 789999999999999999996543 57999988654333322 56778888887763 5888999888 4777889
Q ss_pred EEEeeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC-----CceEEccccc
Q 008828 304 LVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-----YEAVVGDFGL 376 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~ 376 (552)
+||+.+ |.+|.++... .+.++..+...|+.|++.+|.+||+. |++||||||.|+++... ..+.|.|||+
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 999988 6699988753 35799999999999999999999999 99999999999999854 4689999999
Q ss_pred ceecC--CCCCc------e-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHH
Q 008828 377 AKLLD--HCDSH------V-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 447 (552)
Q Consensus 377 ~~~~~--~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 447 (552)
++... ..... . .....||..|.++....+.+.+.+.|+||++.++.|++.|..||.......... -+
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~----~~ 249 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS----KF 249 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH----HH
Confidence 98322 11110 1 223559999999999999999999999999999999999999986433211110 01
Q ss_pred HHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 448 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
...... ..... .....+..+.++...+-..+...+|....+...++..
T Consensus 250 ~~~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 250 EKDPRK----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHhhh----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 111100 00100 1112235566666666678999999999998886653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.3e-24 Score=225.69 Aligned_cols=254 Identities=20% Similarity=0.217 Sum_probs=187.4
Q ss_pred CCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc-cCchHH----HHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 233 SSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEI----QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 233 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~----~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
....++|.|++|.|+..... .....+.|...... ....+. .+..|+-+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988777633 33334444332100 111111 2555666677889999988888777766666669
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC-
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS- 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 385 (552)
||+++ +|+..+.....+....+..+++|+..|+.|||+. ||.|||+|++|++++.+|.+||+|||.+........
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 9999998877899999999999999999999999 999999999999999999999999999976543332
Q ss_pred --ceeecccccccccCchhhccCCCCC-ccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 386 --HVTTAVRGTVGHIAPEYLSTGQSSE-KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 386 --~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
......+|+..|+|||++...+|.+ ..||||.|+++..|.+|+.||......+... .. ..........
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~---~~~~~~~~~~ 547 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KT---NNYSDQRNIF 547 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hh---hccccccccc
Confidence 4456678999999999999999865 5799999999999999999998654433221 00 0000000000
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
.-........+.+...++.++++.+|.+|-|+++|++
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0001122344567789999999999999999999974
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=183.61 Aligned_cols=141 Identities=16% Similarity=0.194 Sum_probs=110.9
Q ss_pred CCeeeeeCceEEEEEEECCCcEEEEEEeccCccCc-h-------HHH-----------------HHHHHHHHhhcccccc
Q 008828 235 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-G-------EIQ-----------------FQTEVEMISLAVHRNL 289 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~-------~~~-----------------~~~e~~~l~~~~h~ni 289 (552)
...||+|+||.||+|...+|+.||||+++...... . ... ...|+..+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999998889999999997542211 0 111 2348999999988876
Q ss_pred ceeeeEeecCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceEEcCCCCCceeeCCCCc
Q 008828 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL-HEQCDPKIIHRDVKAANILLDEYYE 368 (552)
Q Consensus 290 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~dlk~~Nill~~~~~ 368 (552)
.....+.. ...++||||++++++.........+++.....++.|++.+|.|+ |+. +|+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCc
Confidence 44333322 23489999999887765544456789999999999999999999 687 999999999999998 478
Q ss_pred eEEcccccceecC
Q 008828 369 AVVGDFGLAKLLD 381 (552)
Q Consensus 369 ~kl~Dfg~~~~~~ 381 (552)
++|+|||++....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-22 Score=212.54 Aligned_cols=253 Identities=23% Similarity=0.260 Sum_probs=189.1
Q ss_pred CCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHH---HHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++...+-+|++.|=+|.+|++++|. |+||++-+....-... +-..|++ ...++|||.+.+.-+-......|+|=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4666788999999999999998777 8899986544332333 3334444 566789999998877777777888989
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee--cCCCCC
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL--LDHCDS 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~--~~~~~~ 385 (552)
|..+ +|++.+..++-+..-+.+.|+.|++.||.-+|.. ||+|||||.+||||+.-.-+.|+||-.-+. +..++.
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9866 9999999988899999999999999999999999 999999999999999988999999986542 333222
Q ss_pred cee----ecccccccccCchhhccC----------C-CCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHH
Q 008828 386 HVT----TAVRGTVGHIAPEYLSTG----------Q-SSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKK 449 (552)
Q Consensus 386 ~~~----~~~~gt~~y~aPE~~~~~----------~-~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 449 (552)
... .+...-..|+|||.+... . .+++-||||+||+++||++ |+++|....- ..+-..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-------~aYr~~ 250 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-------LAYRSG 250 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-------HhHhcc
Confidence 222 122234579999987542 1 4678899999999999988 5777763211 000000
Q ss_pred --HhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCch
Q 008828 450 --IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAE 508 (552)
Q Consensus 450 --~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 508 (552)
...+..++.+-| ..+.+++..|++.||.+|.++++.++.-.+..+++
T Consensus 251 ~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~ 299 (1431)
T KOG1240|consen 251 NADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPE 299 (1431)
T ss_pred CccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhccccHH
Confidence 001111222222 35789999999999999999999999988887775
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.3e-21 Score=176.34 Aligned_cols=142 Identities=18% Similarity=0.163 Sum_probs=113.0
Q ss_pred CCeeeeeCceEEEEEEECCCcEEEEEEeccCccCc--------------------h-----HHHHHHHHHHHhhcccccc
Q 008828 235 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG--------------------G-----EIQFQTEVEMISLAVHRNL 289 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~-----~~~~~~e~~~l~~~~h~ni 289 (552)
...||+|+||.||+|...+|+.||||+++...... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998789999999997542110 0 1124578889999999987
Q ss_pred ceeeeEeecCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEEcCCCCCceeeCCCCc
Q 008828 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYE 368 (552)
Q Consensus 290 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~ 368 (552)
.....+... ..++||||++++++.........++......++.|++.++.++|+ . ||+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCC
Confidence 555444332 358999999988654433334568888999999999999999999 8 999999999999999 899
Q ss_pred eEEcccccceecCC
Q 008828 369 AVVGDFGLAKLLDH 382 (552)
Q Consensus 369 ~kl~Dfg~~~~~~~ 382 (552)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999986653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=181.74 Aligned_cols=173 Identities=10% Similarity=0.056 Sum_probs=134.4
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchH--HH------HHHHHHHHhhccccccceeeeEeecC
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGE--IQ------FQTEVEMISLAVHRNLLRLIGFCMTT 299 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--~~------~~~e~~~l~~~~h~niv~l~~~~~~~ 299 (552)
...+|...+++|.|+||.||.+.. ++..+|+|.++........ .. +.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999765 5778999999755433221 11 67899999999999999998886533
Q ss_pred --------CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEE
Q 008828 300 --------TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV 371 (552)
Q Consensus 300 --------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 371 (552)
...+++|||++|.+|.+... ++. ....+++.++..+|+. |++|||+||+||+++.++ ++|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEE
Confidence 35789999999999977632 332 3456999999999999 999999999999999988 999
Q ss_pred cccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh
Q 008828 372 GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426 (552)
Q Consensus 372 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt 426 (552)
+|||........... ..+.....+..++|+||||+++..+..
T Consensus 176 iDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 176 IDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999988644211100 114445567789999999999876643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-21 Score=196.13 Aligned_cols=214 Identities=23% Similarity=0.372 Sum_probs=163.6
Q ss_pred HhhccccccceeeeEeecCCceeEEEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCce-EEcCCCC
Q 008828 281 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKI-IHRDVKA 358 (552)
Q Consensus 281 l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i-vH~dlk~ 358 (552)
|+.+.|.|+.+++|.+.+....+.|.+||..|+|.+.+.. ...+++.....++++|+.||.|||.. +| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 3567899999999999999999999999999999999975 56799999999999999999999987 55 8999999
Q ss_pred CceeeCCCCceEEcccccceecCCC-CCceeecccccccccCchhhccCC-------CCCccchhHHHHHHHHHHhCCCc
Q 008828 359 ANILLDEYYEAVVGDFGLAKLLDHC-DSHVTTAVRGTVGHIAPEYLSTGQ-------SSEKTDVFGFGILLLELISGLRA 430 (552)
Q Consensus 359 ~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dvws~Gv~l~elltg~~p 430 (552)
+|.++|..+.+||+|||+....... .........-..-|.|||.+.... .+.++||||||++++|+++...|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998876421 111122222456799999997642 46789999999999999999999
Q ss_pred cccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 431 LEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
|...........+..+++. .-...+.+.+... .+..+++..++.+||..+|.+||++++|-..++..
T Consensus 158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9865443332233333222 0111111211111 13335799999999999999999999998776653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-22 Score=204.08 Aligned_cols=234 Identities=23% Similarity=0.233 Sum_probs=189.2
Q ss_pred eeeeCceEEEEEE----ECCCcEEEEEEeccCccCchH-HHHHHHHHHHhhcc-ccccceeeeEeecCCceeEEEeeccC
Q 008828 238 VGKGGFGNVYKGY----LQDGTVVAVKRLKDGNAIGGE-IQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 238 iG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+|+|+||.|+.+. .+.|..+|+|+.++....... .....|..++...+ ||.++++.-.+..+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999765 345788999988654322211 13456778888887 99999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 391 (552)
|.|...+.....+++.....+...+|-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----- 153 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----
Confidence 99999999888899999999999999999999999 9999999999999999999999999999865322221
Q ss_pred cccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHH
Q 008828 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471 (552)
Q Consensus 392 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (552)
+||..|||||++. .....+|.||||++++||+||..||.. +.++.+ ... ...+++.
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~I---------l~~--~~~~p~~ 209 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRI---------LKA--ELEMPRE 209 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHH---------hhh--ccCCchh
Confidence 7999999999998 567789999999999999999999874 111111 111 1235677
Q ss_pred HHHHHHHHHHHccCCCCCCCCCH--HHHHHHHhc
Q 008828 472 ELEEMVQVALLCTQYLPSLRPKM--SEVVRMLEG 503 (552)
Q Consensus 472 ~~~~l~~li~~cl~~dP~~RPs~--~evl~~L~~ 503 (552)
.+..+.+++..++..+|..|--. ..+.+..+.
T Consensus 210 l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h 243 (612)
T KOG0603|consen 210 LSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQH 243 (612)
T ss_pred hhHHHHHHHHHHHhhCHHHHhccCcchhHHHhcc
Confidence 77889999999999999999866 344444443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-21 Score=171.09 Aligned_cols=249 Identities=19% Similarity=0.229 Sum_probs=189.0
Q ss_pred hcCCCCCCeeeeeCceEEEEEE-ECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccc-cccceeeeEeecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-~niv~l~~~~~~~~~~~lv~ 306 (552)
...|.+.+.||+|+||.+|.|. ..+|+.||||+-..... ..++..|..+...+++ ..|..+..+..+.....+||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 4578899999999999999999 56799999998765433 3356788888888874 56777788888889999999
Q ss_pred eeccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC---CCceEEcccccceecCC
Q 008828 307 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 307 e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~ 382 (552)
+.. |-+|.++.. -...++..+++-++-|++.-++|+|.+ +++||||||+|+|..- ...+.++|||+++.+.+
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 998 568888876 345689999999999999999999999 9999999999999974 34678999999987654
Q ss_pred CCCc------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcch
Q 008828 383 CDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456 (552)
Q Consensus 383 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (552)
.... ......||.+|.+--...+.+.+...|+=|+|.+|.++.-|..||.......... +.
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q-------------Ky 233 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ-------------KY 233 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH-------------HH
Confidence 3322 2234569999999888888888999999999999999999999998643322211 11
Q ss_pred hhhccccccC---cCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 008828 457 EMLVDKDLKN---NYDRIELEEMVQVALLCTQYLPSLRPKMSEV 497 (552)
Q Consensus 457 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 497 (552)
+.+....+.. ......+.++.-.+..|-..--++-|...-+
T Consensus 234 EkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 234 EKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred HHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 1111111110 1112234677788888888888888875444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-20 Score=173.98 Aligned_cols=200 Identities=20% Similarity=0.264 Sum_probs=167.8
Q ss_pred cCCCCCCeeeeeCceEEEEEE-ECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e 307 (552)
-.|.+.++||+|.||+.+.|+ +-+++.||||.-..... .-++..|....+.+. .++|-.++-|.....+..||+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 368899999999999999999 45799999998754332 235677888887774 7899998888888888999999
Q ss_pred eccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC-----CCceEEcccccceecC
Q 008828 308 YMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-----YYEAVVGDFGLAKLLD 381 (552)
Q Consensus 308 ~~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~~~~~~ 381 (552)
.+ |-+|.++.. -...++.+++..+|.|++.-++|+|++ .+|+|||||+|+||.. ...+.|+|||+|+.+.
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 98 558887775 345799999999999999999999999 9999999999999974 3457899999999876
Q ss_pred CCCCc------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcc
Q 008828 382 HCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 436 (552)
Q Consensus 382 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~ 436 (552)
+.... ......||.+||+--...+.+.+..-|+=|+|-+..+.+-|..||.....
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 54433 23455699999999999999999999999999999999999999986543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=179.59 Aligned_cols=197 Identities=20% Similarity=0.219 Sum_probs=141.0
Q ss_pred cccccceeeeEeecC---------------------------CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHH
Q 008828 285 VHRNLLRLIGFCMTT---------------------------TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA 337 (552)
Q Consensus 285 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia 337 (552)
+|||||++.++|.+. ...|+||.-.+. +|.+++..+. .+.....-|+.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence 599999999987542 235788887765 8888887654 56677788899999
Q ss_pred HHHHHHhhcCCCceEEcCCCCCceeeC--CCC--ceEEcccccceecCCCCC-----ceeecccccccccCchhhccCC-
Q 008828 338 RGLLYLHEQCDPKIIHRDVKAANILLD--EYY--EAVVGDFGLAKLLDHCDS-----HVTTAVRGTVGHIAPEYLSTGQ- 407 (552)
Q Consensus 338 ~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~- 407 (552)
+|+.|||.+ ||.|||+|++|||+. +|+ ...|+|||++---+..+- .......|...-||||+....+
T Consensus 352 Eav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999 999999999999994 443 467999998753222111 1112334778899999986542
Q ss_pred -----CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHH
Q 008828 408 -----SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALL 482 (552)
Q Consensus 408 -----~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 482 (552)
...|+|.|+.|.+.||+++...||.......- + ..... +...+..+..++..+.+++..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-----~-------~r~Yq----e~qLPalp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-----D-------TRTYQ----ESQLPALPSRVPPVARQLVFD 492 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchhee-----c-------hhhhh----hhhCCCCcccCChHHHHHHHH
Confidence 24699999999999999999999975221100 0 00011 111223345556788999999
Q ss_pred ccCCCCCCCCCHHHHHHHHh
Q 008828 483 CTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 483 cl~~dP~~RPs~~evl~~L~ 502 (552)
.++.||.+|++..-....|+
T Consensus 493 lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HhcCCccccCCccHHHhHHH
Confidence 99999999999876655443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-20 Score=165.56 Aligned_cols=186 Identities=17% Similarity=0.052 Sum_probs=139.6
Q ss_pred CCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCch---HHHHHHHHHHHhhcc-ccccceeeeEeecCCceeEEEee
Q 008828 233 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG---EIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 233 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.+...|++|+||+||.+.. .+.+++.+.+........ ...+.+|+++|.++. |+++.+++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997665 578888887765433211 124789999999995 5889999886 456999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCC-CCCceeeCCCCceEEcccccceecCCCCCc-
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV-KAANILLDEYYEAVVGDFGLAKLLDHCDSH- 386 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 386 (552)
+.|.+|...... ....++.|++.+|.++|+. ||+|||| ||+|||++.++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999888754321 1245788999999999999 9999999 799999999999999999999865432210
Q ss_pred ---e--------eecccccccccCchhhccC-CCC-CccchhHHHHHHHHHHhCCCcccc
Q 008828 387 ---V--------TTAVRGTVGHIAPEYLSTG-QSS-EKTDVFGFGILLLELISGLRALEF 433 (552)
Q Consensus 387 ---~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dvws~Gv~l~elltg~~p~~~ 433 (552)
. ......++.|++|+-..-- ..+ ...+.++-|.-+|.++|++.+...
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0112257778888754322 222 566888999999999999887754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=173.91 Aligned_cols=230 Identities=23% Similarity=0.286 Sum_probs=146.4
Q ss_pred CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhcc----------ccccceeeeEeec
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAV----------HRNLLRLIGFCMT 298 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~----------h~niv~l~~~~~~ 298 (552)
+...+.||.|+++.||.+... +++.+|||++.... .....+++.+|.-....+. |-.++..++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 344578999999999999976 58999999985433 2233456666665444422 2223322222211
Q ss_pred ---------C---C-----ceeEEEeeccCCChhhhhc---cCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEc
Q 008828 299 ---------T---T-----ERLLVYPYMSNGSVASRLK---AKP----SLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354 (552)
Q Consensus 299 ---------~---~-----~~~lv~e~~~~g~L~~~l~---~~~----~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 354 (552)
. . ..+++|+-+. ++|.+.+. ... .+....+..+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 1 1 2357777774 58877754 111 233445667779999999999999 99999
Q ss_pred CCCCCceeeCCCCceEEcccccceecCCCCCceeecccccccccCchhhccC--------CCCCccchhHHHHHHHHHHh
Q 008828 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG--------QSSEKTDVFGFGILLLELIS 426 (552)
Q Consensus 355 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dvws~Gv~l~ellt 426 (552)
||+|+|++++.+|.+.|+||+.....+. .......+..|.+||..... .+|.+.|.|++|+++|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999998765432 12213456789999987442 47889999999999999999
Q ss_pred CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCC
Q 008828 427 GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLR 491 (552)
Q Consensus 427 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 491 (552)
|..||.......... | .+ .... ..++.+..||..+|+.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~----~----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPE----W----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSG----G----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccccc----c----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999998543321110 0 11 1122 566889999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.6e-20 Score=198.21 Aligned_cols=200 Identities=21% Similarity=0.223 Sum_probs=164.0
Q ss_pred HHHHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc---ccccceeeeEeecC
Q 008828 223 KELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLIGFCMTT 299 (552)
Q Consensus 223 ~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~~ 299 (552)
.+.+...+.|.+.+.||+|+||+||+|...+|+.||+|+-+....++-.. -.+++.+++ -+-|..+..+..-.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI----~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI----CLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee----hHHHHHhhchhhhcchHHHHHHHccC
Confidence 34555667788999999999999999998889999999998766654322 112223333 34455666666667
Q ss_pred CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC-------CCCceEEc
Q 008828 300 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-------EYYEAVVG 372 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-------~~~~~kl~ 372 (552)
+.-++|+||.+.|+|.++++..+.++|.....++.|+++.+++||.. +|||+||||+|.||. ++..++|+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 78899999999999999999888999999999999999999999999 999999999999994 34568999
Q ss_pred ccccceecCCC-CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCC
Q 008828 373 DFGLAKLLDHC-DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR 429 (552)
Q Consensus 373 Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~ 429 (552)
|||.+..+.-- +.......++|-.+-.+|...++.++..+|-|.++.+++-|+.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99998654322 2345566778999999999999999999999999999999999954
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.5e-19 Score=163.72 Aligned_cols=138 Identities=17% Similarity=0.210 Sum_probs=106.6
Q ss_pred CCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-----cccccceeeeEeecCC---c-e
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-----VHRNLLRLIGFCMTTT---E-R 302 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-----~h~niv~l~~~~~~~~---~-~ 302 (552)
+...+.||+|+||.||. +.+....+||++..... .....+.+|+.++..+ .||||++++|++.... . .
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34457999999999996 43333347998865332 2345789999999999 5799999999998764 3 3
Q ss_pred eEEEee--ccCCChhhhhccCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCceEEcCCCCCceeeCC----CCceEEcc-c
Q 008828 303 LLVYPY--MSNGSVASRLKAKPSLDWATRKRIALGAARGL-LYLHEQCDPKIIHRDVKAANILLDE----YYEAVVGD-F 374 (552)
Q Consensus 303 ~lv~e~--~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~D-f 374 (552)
.+|+|| +.+|+|.+++... .+++. ..++.|++.++ +|||++ +|+||||||+|||++. ++.++|+| |
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 378999 5579999999764 46655 35678888887 999999 9999999999999974 34899999 5
Q ss_pred ccce
Q 008828 375 GLAK 378 (552)
Q Consensus 375 g~~~ 378 (552)
|...
T Consensus 155 G~~~ 158 (210)
T PRK10345 155 GEST 158 (210)
T ss_pred CCcc
Confidence 5443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=164.36 Aligned_cols=144 Identities=16% Similarity=0.157 Sum_probs=113.8
Q ss_pred cCCCCCCeeeeeCceEEEEEE--ECCCcEEEEEEeccCccC-------------------c----hHHHHHHHHHHHhhc
Q 008828 230 SNFSSKNLVGKGGFGNVYKGY--LQDGTVVAVKRLKDGNAI-------------------G----GEIQFQTEVEMISLA 284 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-------------------~----~~~~~~~e~~~l~~~ 284 (552)
..|.+.+.||+|+||.||+|. ..+|+.||+|+++..... . ....+..|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347788999999999999998 568999999999743210 0 012356899999998
Q ss_pred cccc--cceeeeEeecCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc-eEEcCCCCCce
Q 008828 285 VHRN--LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK-IIHRDVKAANI 361 (552)
Q Consensus 285 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~dlk~~Ni 361 (552)
.+.. +.+++++ ...++||||+++++|.........+.......++.|++.++.+||+. + |+||||||+||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI 180 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI 180 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence 7533 3344443 24589999999988877664445567777889999999999999999 8 99999999999
Q ss_pred eeCCCCceEEcccccceecC
Q 008828 362 LLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 362 ll~~~~~~kl~Dfg~~~~~~ 381 (552)
+++ ++.++|+|||.+...+
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=8e-18 Score=158.28 Aligned_cols=135 Identities=19% Similarity=0.247 Sum_probs=114.3
Q ss_pred CeeeeeCceEEEEEEECCCcEEEEEEeccCccCc-------hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+.||+|++|.||+|.. +|..|++|+........ ....+.+|+.++..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999988 57789999875432211 123577899999999999998888887777888999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
+++++|.+.+..... .+..++.+++.+|.++|+. +++|||++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998865432 8889999999999999999 999999999999999 78999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.3e-18 Score=156.72 Aligned_cols=145 Identities=19% Similarity=0.167 Sum_probs=112.6
Q ss_pred HHHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccC---------------------chHHHHHHHHHHHh
Q 008828 224 ELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI---------------------GGEIQFQTEVEMIS 282 (552)
Q Consensus 224 e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~ 282 (552)
++......|.+.+.||+|+||.||++..++|+.||||+++..... .....+..|+..+.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444447788999999999999999888999999987543210 00113567888888
Q ss_pred hccccc--cceeeeEeecCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCc
Q 008828 283 LAVHRN--LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 360 (552)
Q Consensus 283 ~~~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 360 (552)
.+.|++ +...++ ....++||||+++++|...... .....++.+++.++.++|+. +|+||||||+|
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~N 155 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFN 155 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCccc
Confidence 888774 444443 2456899999999998765431 34567899999999999998 99999999999
Q ss_pred eeeCCCCceEEcccccceecC
Q 008828 361 ILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 361 ill~~~~~~kl~Dfg~~~~~~ 381 (552)
|++++++.++|+|||++....
T Consensus 156 ill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEEcCCCcEEEEECCccccCC
Confidence 999999999999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.6e-18 Score=156.19 Aligned_cols=131 Identities=19% Similarity=0.266 Sum_probs=107.8
Q ss_pred eeeeeCceEEEEEEECCCcEEEEEEeccCccCc-------hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 237 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 237 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
+||+|+||.||+|.+ ++..|++|......... ...++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 47889999865432111 1245778999999999888766666666677789999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 310 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 310 ~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
++++|.+.+..... .++.+++.+|.+||+. +++|||++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988754321 8899999999999999 999999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-18 Score=184.29 Aligned_cols=214 Identities=24% Similarity=0.270 Sum_probs=148.6
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
..+|+.+++|..|+||.||..+++ ..+.+|+|+-++ +. +.+- ++.....|. .|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~l------ilRn--ilt~a~npf---------------vv-- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL------ILRN--ILTFAGNPF---------------VV-- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-ch------hhhc--cccccCCcc---------------ee--
Confidence 367888999999999999999876 467888854322 11 1110 122222222 22
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC---
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD--- 384 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--- 384 (552)
|+-...++.-++++... +.+++|||+. +|+|||+||+|.+|+.-|++|+.|||+++..-...
T Consensus 136 ----gDc~tllk~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhcccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 55566666555555443 7889999999 99999999999999999999999999987431110
Q ss_pred -----------CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh
Q 008828 385 -----------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 453 (552)
Q Consensus 385 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 453 (552)
......++||+.|+|||++....|...+|.|++|+|+||.+-|+.||..+....--+..+ .+
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi-------sd 273 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI-------SD 273 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh-------hh
Confidence 011234579999999999999999999999999999999999999998654422111111 10
Q ss_pred cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 008828 454 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 498 (552)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 498 (552)
. ..+.+-....+.++.+++.+.++.+|..|--....+
T Consensus 274 ~--------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 274 D--------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred h--------ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 0 001111222347789999999999999997544333
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=177.23 Aligned_cols=139 Identities=19% Similarity=0.271 Sum_probs=112.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEE-eccCccC------chHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKR-LKDGNAI------GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~------~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
...|...+.||+|+||+||+|.+.+.. +++|+ +...... ....++.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 445567889999999999999876443 34343 2221111 112458899999999999999988888887788
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
.++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 899999999999998875 4578999999999999999 99999999999999 6789999999999753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.9e-18 Score=170.84 Aligned_cols=168 Identities=24% Similarity=0.331 Sum_probs=129.2
Q ss_pred ceeEEEeeccCCChhhhhccC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccc
Q 008828 301 ERLLVYPYMSNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 377 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 377 (552)
..++.|++|...+|.+++... ...++.....++.|++.|+.| + +.+|+|+||.||++..+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999743 356788899999999999999 5 8999999999999999999999999999
Q ss_pred eecCCCC-----CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhC-CCccccCcccccccchHHHHHHHh
Q 008828 378 KLLDHCD-----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG-LRALEFGKTANQKGAMLDWVKKIH 451 (552)
Q Consensus 378 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 451 (552)
....... ....+...||..||+||.+.+..|+.|+||||+|+|++|+++- ..+++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------------------ 465 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------------------ 465 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------------------
Confidence 8765544 2233455699999999999999999999999999999999971 112210
Q ss_pred hhcchhhhccc----cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 008828 452 QEKKLEMLVDK----DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 498 (552)
Q Consensus 452 ~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 498 (552)
...+.++-|. ....+++ .=..++++++.+.|.+||++.++.
T Consensus 466 -~~t~~d~r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 466 -IATLTDIRDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred -HHhhhhhhcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHh
Confidence 1111222222 2222222 235789999999999999665544
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.1e-16 Score=143.62 Aligned_cols=138 Identities=19% Similarity=0.199 Sum_probs=98.2
Q ss_pred CCeeeeeCceEEEEEEECCCcEEEEEEeccCccCc-hHHH----------------------HHHHHHHHhhccccc--c
Q 008828 235 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GEIQ----------------------FQTEVEMISLAVHRN--L 289 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~----------------------~~~e~~~l~~~~h~n--i 289 (552)
.+.||+|+||+||+|...+++.||||+++...... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999986532211 1111 124555555554332 3
Q ss_pred ceeeeEeecCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEEcCCCCCceeeCCCCc
Q 008828 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYE 368 (552)
Q Consensus 290 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~ 368 (552)
.+.+++ ...++||||++++.+....-...... .....++.+++.++.++|. . +|+||||||+||+++ ++.
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCc
Confidence 344433 34689999999865432111111111 6678999999999999999 7 999999999999999 899
Q ss_pred eEEcccccceecC
Q 008828 369 AVVGDFGLAKLLD 381 (552)
Q Consensus 369 ~kl~Dfg~~~~~~ 381 (552)
++|+|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.5e-15 Score=134.29 Aligned_cols=135 Identities=19% Similarity=0.136 Sum_probs=115.1
Q ss_pred CCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccc--cccceeeeEeecCCceeEEEeeccC
Q 008828 234 SKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH--RNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 234 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++.+++++....+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 34679999999999999864 7899999865432 4568899999999976 5899999988888889999999998
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
+.+... +......++.++++++++||.....+++|+|++|.||++++.+.+++.|||.+..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 6677888999999999999986445799999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.6e-16 Score=170.18 Aligned_cols=113 Identities=35% Similarity=0.612 Sum_probs=99.9
Q ss_pred CCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccccccCCCCccccccccccEEecc
Q 008828 27 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLS 106 (552)
Q Consensus 27 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 106 (552)
.++.|+|++|.++|.+|..+.+|++|+.|+|++|.|+|.+|..++.+++|+.|+|++|+|+|.+|+.+..|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccc------CcccccCCccccCCCCCCCC
Q 008828 107 YNNLSGPVPSFHA------KTFNITGNSLICATGAEEDC 139 (552)
Q Consensus 107 ~N~l~~~~~~~~~------~~~~l~~N~~~c~~~~~~~c 139 (552)
+|+++|.+|..+. ..+++.+|+..|+.+....|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence 9999998887544 36788999999976544444
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=9.3e-16 Score=176.72 Aligned_cols=129 Identities=33% Similarity=0.561 Sum_probs=108.1
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
|++|++|+|++|++++.+|..+..+++|+.|+|++|++.+.+|..+ .+++|+.|+|++|++++.+|..+.++++|+.|+
T Consensus 427 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~ 505 (968)
T PLN00113 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLK 505 (968)
T ss_pred CCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEE
Confidence 4678888888888888888888888888888888888888777755 468888888888888888888888888888888
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccc
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 130 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~ 130 (552)
|++|++.+.+|..+..+++|+.|+|++|.+++.+|..+. +.++|++|.+.
T Consensus 506 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 560 (968)
T PLN00113 506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS 560 (968)
T ss_pred CcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCccc
Confidence 888888888888888888888888888888888877654 67788888875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.1e-17 Score=171.60 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=191.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC--CcEEEEEEeccCc-cCchHHHHHHHHHHHhhcc-ccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD--GTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv 305 (552)
..|...+.||+|.|+.|-...... ...+|+|.+.... ..........|..+-..+. |+|++++++........++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456777889999999998887533 4456666664332 2222334455777766676 99999999999999999999
Q ss_pred EeeccCCChhhhh-ccCC-CCCHHHHHHHHHHHHHHHHHHh-hcCCCceEEcCCCCCceeeCCCC-ceEEcccccceecC
Q 008828 306 YPYMSNGSVASRL-KAKP-SLDWATRKRIALGAARGLLYLH-EQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLD 381 (552)
Q Consensus 306 ~e~~~~g~L~~~l-~~~~-~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~ 381 (552)
++|..++++.+.+ .... ..+......++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999999998 5544 6788889999999999999999 76 999999999999999999 99999999998776
Q ss_pred C--CCCceeecccc-cccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh
Q 008828 382 H--CDSHVTTAVRG-TVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457 (552)
Q Consensus 382 ~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (552)
. +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... ...|.... ..
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--~~~~~~~~---~~-- 249 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--YSSWKSNK---GR-- 249 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--ceeecccc---cc--
Confidence 5 22333445568 9999999999884 4577899999999999999999999865443321 11222111 00
Q ss_pred hhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 458 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
... ...........++..+++..+|..|.+.+++..
T Consensus 250 --~~~----~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 --FTQ----LPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --ccc----CccccCChhhhhcccccccCCchhccccccccc
Confidence 000 111222355778889999999999999888753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.6e-15 Score=140.24 Aligned_cols=136 Identities=18% Similarity=0.185 Sum_probs=105.9
Q ss_pred CCeee-eeCceEEEEEEECCCcEEEEEEeccCcc------------CchHHHHHHHHHHHhhcccccc--ceeeeEeecC
Q 008828 235 KNLVG-KGGFGNVYKGYLQDGTVVAVKRLKDGNA------------IGGEIQFQTEVEMISLAVHRNL--LRLIGFCMTT 299 (552)
Q Consensus 235 ~~~iG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~e~~~l~~~~h~ni--v~l~~~~~~~ 299 (552)
...|| .|+.|+||.+... +..++||++..... ......+.+|+.++..+.|+++ .+.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999876 77889998853211 0122457889999999998885 6777765432
Q ss_pred C----ceeEEEeeccC-CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccc
Q 008828 300 T----ERLLVYPYMSN-GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 374 (552)
Q Consensus 300 ~----~~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 374 (552)
. ..++|||++++ .+|.+++... .++.. .+.+++.+|.+||+. ||+||||||.|||++.++.++|+||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEEC
Confidence 2 23599999997 6888887653 45543 367899999999999 9999999999999999899999999
Q ss_pred cccee
Q 008828 375 GLAKL 379 (552)
Q Consensus 375 g~~~~ 379 (552)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 99875
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-16 Score=135.53 Aligned_cols=130 Identities=25% Similarity=0.378 Sum_probs=111.4
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
|++++.|-||+|+++. +|+.+..|.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. .+|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 4578899999999875 7889999999999999999999 89999999999999999999999 8999999999999999
Q ss_pred ccccccc-CCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccccCC
Q 008828 81 LNNNSLT-GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICAT 133 (552)
Q Consensus 81 l~~N~l~-~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~~ 133 (552)
|..|++. ..+|..|..|+.|+.|+|+.|.+.-.+|+.-. +.+.+..|.++..+
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~lp 166 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSLP 166 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhCc
Confidence 9999885 45788888899999999999999877776432 56667777766543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.8e-14 Score=155.90 Aligned_cols=112 Identities=35% Similarity=0.549 Sum_probs=104.5
Q ss_pred ccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccccc
Q 008828 4 LCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83 (552)
Q Consensus 4 l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 83 (552)
++.|+|++|++.+.+|..++.|++|+.|+|++|.|+|.+|..+.++++|+.|+|++|+++|.+|+.+++|++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 78899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccc-ccccEEeccCCCCCCCCC
Q 008828 84 NSLTGAIPPSLSNM-SQLAFLDLSYNNLSGPVP 115 (552)
Q Consensus 84 N~l~~~~p~~~~~l-~~L~~l~l~~N~l~~~~~ 115 (552)
|+++|.+|..+..+ .++..+++.+|...+..|
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCC
Confidence 99999999988764 467899999998765444
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.4e-15 Score=128.31 Aligned_cols=132 Identities=23% Similarity=0.391 Sum_probs=117.6
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCC-CCCccccCCcccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYL 79 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L 79 (552)
|++|+.|++++|+|+. +|..++.|+.|+.|+++-|++. .+|..|+.++.|+.|||.+|++.. .+|..|..++.|+.|
T Consensus 55 l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral 132 (264)
T KOG0617|consen 55 LKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL 132 (264)
T ss_pred hhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH
Confidence 5789999999999875 8999999999999999999998 999999999999999999999973 489999999999999
Q ss_pred ccccccccCCCCccccccccccEEeccCCCCCCCCCCcc----cCcccccCCccccCCCC
Q 008828 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH----AKTFNITGNSLICATGA 135 (552)
Q Consensus 80 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~----~~~~~l~~N~~~c~~~~ 135 (552)
+|+.|.+. .+|..++++++|+.|.+..|.+-..+-+.- .+.+.+.||.+.-.++.
T Consensus 133 yl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~vlppe 191 (264)
T KOG0617|consen 133 YLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLTVLPPE 191 (264)
T ss_pred HhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceeeecChh
Confidence 99999999 899999999999999999999986544321 17788999998766543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.2e-13 Score=141.03 Aligned_cols=141 Identities=23% Similarity=0.250 Sum_probs=100.2
Q ss_pred CCeeeeeCceEEEEEEECCCcEEEEEEeccCccCc---------------------------------------hHHHHH
Q 008828 235 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG---------------------------------------GEIQFQ 275 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------------~~~~~~ 275 (552)
.+.||.|++|.||+|++++|+.||||+.+...... .+..|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986542100 001244
Q ss_pred HHHHHHhhcc----ccccceeeeEe-ecCCceeEEEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHH-HHHHHhhcCC
Q 008828 276 TEVEMISLAV----HRNLLRLIGFC-MTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAAR-GLLYLHEQCD 348 (552)
Q Consensus 276 ~e~~~l~~~~----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~-~l~~LH~~~~ 348 (552)
+|...+.+++ |.+-+.+-.++ ......++||||++|++|.+..... ... .+..++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC--
Confidence 4555444442 33333333333 2345679999999999998876422 122 24556666666 46788887
Q ss_pred CceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 349 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
|++|+|++|.||+++.++.++++|||++..++
T Consensus 277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997665
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.6e-14 Score=131.52 Aligned_cols=201 Identities=21% Similarity=0.280 Sum_probs=139.5
Q ss_pred HHHHhhccccccceeeeEeecC-----CceeEEEeeccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 008828 278 VEMISLAVHRNLLRLIGFCMTT-----TERLLVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCD 348 (552)
Q Consensus 278 ~~~l~~~~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 348 (552)
+.-+-++.|.|||++..|+.+. ....+++|||..|++..+|+. ...+....-.+|+.||..||.|||+ |+
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 3445566799999999987654 346799999999999999973 3467788888999999999999998 58
Q ss_pred CceEEcCCCCCceeeCCCCceEEcccccceecCC----CCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHH
Q 008828 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH----CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 424 (552)
Q Consensus 349 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el 424 (552)
|+|+|+++..+-|++..++-+||+- +.-..... ..........+-++|.|||+-.....+..+|||+||+-..||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 8999999999999999999999832 11111100 001111222366899999998888888899999999999999
Q ss_pred HhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 425 ISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 425 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..|......+...... +..+....- .+.. ..=..++.+|++..|..||+|++++.+
T Consensus 276 ailEiq~tnseS~~~~------------ee~ia~~i~-~len-------~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEV------------EENIANVII-GLEN-------GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCcceeeh------------hhhhhhhee-eccC-------ccccCcCcccccCCCCCCcchhhhhcC
Confidence 8875432211110000 000000000 0000 111356889999999999999998754
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.8e-15 Score=147.03 Aligned_cols=36 Identities=17% Similarity=0.053 Sum_probs=13.9
Q ss_pred ccEeccCCCCCcccccccccCCCCCcEEecccCccC
Q 008828 4 LCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNIS 39 (552)
Q Consensus 4 l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 39 (552)
|+.|+||+|.|..+.+++++..++|++|+|++|+|+
T Consensus 295 L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~ 330 (873)
T KOG4194|consen 295 LEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT 330 (873)
T ss_pred hhhhccchhhhheeecchhhhcccceeEeccccccc
Confidence 333333333333333333333333333333333333
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1e-14 Score=146.19 Aligned_cols=134 Identities=25% Similarity=0.276 Sum_probs=120.8
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCc---cccCCccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS---TVSHLETLQY 78 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~---~~~~l~~L~~ 78 (552)
.+|+.|+|++|+|+...+.+|..|..|++|+|++|+|...-...|..+++|+.|||++|.|++.+-+ .|..|++|+.
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 5799999999999999999999999999999999999977777899999999999999999976654 4888999999
Q ss_pred cccccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccccCCCC
Q 008828 79 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICATGA 135 (552)
Q Consensus 79 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~~~~ 135 (552)
|+|.+|+|..+.-.+|.++++|++|||.+|.|..+-|+.|. +.+-+..-.++|+|..
T Consensus 397 L~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql 457 (873)
T KOG4194|consen 397 LRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQL 457 (873)
T ss_pred eeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccH
Confidence 99999999944447899999999999999999988888776 6777888889999985
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=8e-13 Score=134.86 Aligned_cols=247 Identities=21% Similarity=0.181 Sum_probs=180.5
Q ss_pred CCCCCCeeee--eCceEEEEEEE---CCCcEEEEEEeccCccC-chHHHHHHHHHHHhhcc-ccccceeeeEeecCCcee
Q 008828 231 NFSSKNLVGK--GGFGNVYKGYL---QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 231 ~~~~~~~iG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~ 303 (552)
.|...+.+|. |.+|.||.+.. .++..+|+|.-+..... .....=.+|+.....++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566788999 99999999986 36788999985432221 11112235565555564 999999888888899999
Q ss_pred EEEeeccCCChhhhhccCCC-CCHHHHHHHHHHHHH----HHHHHhhcCCCceEEcCCCCCceeeCCC-CceEEcccccc
Q 008828 304 LVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAAR----GLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLA 377 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~ 377 (552)
+-+|++. .+|..+...... ++....+.+..+..+ ||.++|+. +++|-|+||.||+...+ ...+++|||+.
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCccee
Confidence 9999986 588888776544 788888999999888 99999999 99999999999999999 88999999999
Q ss_pred eecCCCCCc----eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh
Q 008828 378 KLLDHCDSH----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 453 (552)
Q Consensus 378 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 453 (552)
..+....-. ......|...|++||... +-++...|||++|.+..+-.+|......+.... |..
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-------W~~----- 337 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS-------WSQ----- 337 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC-------ccc-----
Confidence 877654421 122335788899999885 457789999999999999999877766442211 100
Q ss_pred cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 454 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
+.... +..++...-..++...+..+++.+|..|++.+.+..
T Consensus 338 --~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 --LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00000 111122222345556899999999999999888753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.4e-11 Score=127.02 Aligned_cols=233 Identities=18% Similarity=0.203 Sum_probs=154.0
Q ss_pred CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCChhhhhccCCCCCHHHHHH
Q 008828 252 QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR 331 (552)
Q Consensus 252 ~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~ 331 (552)
.++.+|.|...+.... .......+.++.++.++||||++++.........|+|+|-+. -|..++.+. ......-
T Consensus 35 ~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~v~~ 108 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEEVCL 108 (690)
T ss_pred ccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHHHHH
Confidence 4678888888865544 334456788889999999999999999999999999999875 455555543 3566677
Q ss_pred HHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecccccccccCchhhccCCCCCc
Q 008828 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 411 (552)
Q Consensus 332 i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 411 (552)
.+.||+.||.|||+.| +++|++|.-..|+|+..|+.||++|.++........ ......--..|..|+.+.... ..
T Consensus 109 Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cc
Confidence 7899999999999776 899999999999999999999999998764432221 111111223567777654333 45
Q ss_pred cchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCC
Q 008828 412 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLR 491 (552)
Q Consensus 412 ~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 491 (552)
.|.|-|||+++|++.|..+- .......+.+........ ...+...... . ....++++.|....+--|
T Consensus 184 ~D~~~Lg~li~el~ng~~~~--~~~~~~~~~ipk~~~~~~----~k~~~~~~~~------r-~n~~~~~~~~~~~~gff~ 250 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNGSLLT--KTDLSNTGKIPKALIELY----CKKLGATELK------R-PNKLRFILECRLLGGFFR 250 (690)
T ss_pred hhhhhHHHHHHHHhCcccCc--chhhhccCccchhHHHHH----HHHhcccccc------c-cchhhHHHHHHhcccccc
Confidence 79999999999999982221 111111111110000000 0001111110 0 115667777777777777
Q ss_pred CCHHHHHHHHhcCCCch
Q 008828 492 PKMSEVVRMLEGDGLAE 508 (552)
Q Consensus 492 Ps~~evl~~L~~~~~~~ 508 (552)
=.+-+++..|++....+
T Consensus 251 n~fvd~~~fLeel~lks 267 (690)
T KOG1243|consen 251 NDFVDTLLFLEELRLKS 267 (690)
T ss_pred chHHHHHHHHHhcccCc
Confidence 77777777777765444
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.7e-12 Score=134.38 Aligned_cols=142 Identities=20% Similarity=0.199 Sum_probs=94.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC-CcEEEEEEeccCccC--------------------------c-------hH----
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI--------------------------G-------GE---- 271 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--------------------------~-------~~---- 271 (552)
..|+. +-||+|++|+||+|++++ |+.||||+.+..... . -.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999987 999999999754210 0 00
Q ss_pred --HHHHHHHHHHhhcc----ccccceeeeEeec-CCceeEEEeeccCCChhhh--hccCC----CCCHHHHHHHHHHHHH
Q 008828 272 --IQFQTEVEMISLAV----HRNLLRLIGFCMT-TTERLLVYPYMSNGSVASR--LKAKP----SLDWATRKRIALGAAR 338 (552)
Q Consensus 272 --~~~~~e~~~l~~~~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~----~l~~~~~~~i~~~ia~ 338 (552)
..|.+|...+.+++ +.+.+.+-.++.+ ....++||||++|+.+.+. +...+ .+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 12344444444442 3334444444432 4567899999999999764 22222 12222233333333
Q ss_pred HHHHHhhcCCCceEEcCCCCCceeeCCCC----ceEEcccccceecCC
Q 008828 339 GLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAKLLDH 382 (552)
Q Consensus 339 ~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~~~~~~~ 382 (552)
... |++|+|+||.||+++.++ .+++.|||+...++.
T Consensus 277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 334 999999999999999888 999999999987653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.1e-12 Score=114.90 Aligned_cols=129 Identities=19% Similarity=0.141 Sum_probs=96.3
Q ss_pred CeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccc-eeeeEeecCCceeEEEeeccCCCh
Q 008828 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL-RLIGFCMTTTERLLVYPYMSNGSV 314 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L 314 (552)
+.++.|.++.||++... +..|++|....... ....+..|+..+..+.+.+++ +++.+. ....++||||+++.++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 56789999999999876 77899998865432 123467889898888665544 445443 3346899999999877
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 315 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQC--DPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 315 ~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
... ......++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 543 0112346789999999999872 22369999999999999 6789999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.3e-13 Score=139.22 Aligned_cols=128 Identities=30% Similarity=0.373 Sum_probs=69.9
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCC-------------------
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT------------------- 63 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~------------------- 63 (552)
++..|+||+|+|.++.-+-|-+|+.|-.||||+|++. .+|+.+..|..|++|+|++|.|.
T Consensus 127 n~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms 205 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMS 205 (1255)
T ss_pred CcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcc
Confidence 3444455555544433334445555555555555555 45555555555555555555433
Q ss_pred ------CCCCccccCCccccccccccccccCCCCccccccccccEEeccCCCCCCCCCC--cc--cCcccccCCccccC
Q 008828 64 ------GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS--FH--AKTFNITGNSLICA 132 (552)
Q Consensus 64 ------~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~--~~--~~~~~l~~N~~~c~ 132 (552)
..+|.++..|.+|..+|||.|.+. .+|+++-++.+|+.|+||+|+|+...-. .+ .+.+||+.|.+...
T Consensus 206 ~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~L 283 (1255)
T KOG0444|consen 206 NTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVL 283 (1255)
T ss_pred cccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccc
Confidence 124444555566666666666666 6666666666777777777766643221 11 15677777776543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.7e-11 Score=110.27 Aligned_cols=138 Identities=16% Similarity=0.149 Sum_probs=100.1
Q ss_pred CeeeeeCceEEEEEEECC-------CcEEEEEEeccCcc---------------------CchHHHHH----HHHHHHhh
Q 008828 236 NLVGKGGFGNVYKGYLQD-------GTVVAVKRLKDGNA---------------------IGGEIQFQ----TEVEMISL 283 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~---------------------~~~~~~~~----~e~~~l~~ 283 (552)
..||.|.-+.||.|...+ +..+|||+.+.... ......+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998553 47999998742110 01112233 78888888
Q ss_pred ccc--cccceeeeEeecCCceeEEEeeccCCChhh-hhccCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceEEcCCCCC
Q 008828 284 AVH--RNLLRLIGFCMTTTERLLVYPYMSNGSVAS-RLKAKPSLDWATRKRIALGAARGLLYL-HEQCDPKIIHRDVKAA 359 (552)
Q Consensus 284 ~~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~dlk~~ 359 (552)
+.. -++-+++++ ...++||||+.++.+.. .+. ...++......+..+++.+|..| |.. +||||||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 853 355566654 56789999997654422 222 22455566778889999999999 777 9999999999
Q ss_pred ceeeCCCCceEEcccccceecCC
Q 008828 360 NILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 360 Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
||+++ ++.+.|+|||.+...++
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCCC
Confidence 99997 46899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=8e-14 Score=134.08 Aligned_cols=124 Identities=32% Similarity=0.436 Sum_probs=69.7
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCcccc-CCccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS-HLETLQYLR 80 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~ 80 (552)
+.|+.||..+|-+. .+|+.++.|.+|+-|||.+|+|. .+| +|.+|..|+.|+++.|+|+ .+|.... ++++|..||
T Consensus 183 ~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLD 258 (565)
T KOG0472|consen 183 KRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLD 258 (565)
T ss_pred HHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeee
Confidence 34555555555443 35555555555555555555555 555 4555555555556555555 4554433 556666666
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCc---ccCcccccCCccc
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGNSLI 130 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~---~~~~~~l~~N~~~ 130 (552)
|..|++. ..|+.+.-+.+|..||+|+|.|++.++.+ +.+.+.+.||++.
T Consensus 259 LRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 259 LRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred ccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccceeeehhhcCCchH
Confidence 6666666 55666666666666666666666555433 2255555666553
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.3e-13 Score=128.31 Aligned_cols=91 Identities=27% Similarity=0.272 Sum_probs=80.7
Q ss_pred hhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----
Q 008828 45 EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----- 119 (552)
Q Consensus 45 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----- 119 (552)
.|..|++|++|+|++|+|+++-+.+|..+..|++|.|..|+|...-...|.++++|+.|+|.+|+|+...|..|.
T Consensus 269 cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l 348 (498)
T KOG4237|consen 269 CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL 348 (498)
T ss_pred HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccccee
Confidence 477899999999999999988888999999999999999999866667899999999999999999988887665
Q ss_pred CcccccCCccccCCCC
Q 008828 120 KTFNITGNSLICATGA 135 (552)
Q Consensus 120 ~~~~l~~N~~~c~~~~ 135 (552)
..++|-+|++.|.|..
T Consensus 349 ~~l~l~~Np~~CnC~l 364 (498)
T KOG4237|consen 349 STLNLLSNPFNCNCRL 364 (498)
T ss_pred eeeehccCcccCccch
Confidence 6788999999999875
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.5e-13 Score=137.24 Aligned_cols=123 Identities=27% Similarity=0.347 Sum_probs=65.2
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCc-------------
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS------------- 68 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~------------- 68 (552)
.||..+|||.|++. .+|..+-++++|+.|+||+|+|+ .+......+.+|++|+||.|+|+ .+|+
T Consensus 222 ~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~ 298 (1255)
T KOG0444|consen 222 HNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYA 298 (1255)
T ss_pred hhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHh
Confidence 45666666666655 35666666666666666666665 44444444445555555555554 4444
Q ss_pred ------------cccCCccccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCc
Q 008828 69 ------------TVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNS 128 (552)
Q Consensus 69 ------------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~ 128 (552)
.++.|.+|+.+.+++|.+. .+|+.++.|..|+.|.|+.|+|-+.|...+. +.+++..|+
T Consensus 299 n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 299 NNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred ccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCc
Confidence 4445555555555555554 4555555555555555555555543333222 445555554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.6e-12 Score=130.12 Aligned_cols=248 Identities=21% Similarity=0.189 Sum_probs=176.5
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC--CCcEEEEEEeccCccCchH-HHHHHHHHHHhhc-cccccceeeeEeecCCcee
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ--DGTVVAVKRLKDGNAIGGE-IQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~ 303 (552)
-..+|.....||.|.|+.|++...+ ++..+++|.+......... ..-..|+.+...+ .|.++++....+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3467888899999999999997743 6788999988654332221 1223455555544 4888888888777777888
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC-CceEEcccccceecCC
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLDH 382 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~ 382 (552)
+--||++++++.....-...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||.+..+..
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccce
Confidence 9999999999887775555788999999999999999999998 99999999999999986 7889999999864221
Q ss_pred CCCceeecccccccc-cCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 383 CDSHVTTAVRGTVGH-IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
.......++..| .+|+......+..++|+||||.-+.+.++|..--+.... |. .+.
T Consensus 420 ---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---------~~----------~i~- 476 (524)
T KOG0601|consen 420 ---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---------SL----------TIR- 476 (524)
T ss_pred ---ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---------ce----------eee-
Confidence 111111123334 356666677889999999999999999998543321110 00 000
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.......+. ....+..+.+.+...++..||.+.++..+..
T Consensus 477 ~~~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 477 SGDTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cccccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 000011111 2266778888899999999999988866544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=8.3e-11 Score=111.29 Aligned_cols=143 Identities=20% Similarity=0.269 Sum_probs=112.2
Q ss_pred CeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccc--cccceeeeEeecCC---ceeEEEeecc
Q 008828 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH--RNLLRLIGFCMTTT---ERLLVYPYMS 310 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~niv~l~~~~~~~~---~~~lv~e~~~ 310 (552)
+.||.|.++.||++...+|..+++|.............+..|.+++..+.+ ..+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999999877789999998654332234467889999998875 34567777766543 5689999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 008828 311 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC------------------------------------------- 347 (552)
Q Consensus 311 ~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------------- 347 (552)
++++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 84 GRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 9888876643 45788888899999999999998531
Q ss_pred ----------CCceEEcCCCCCceeeCC--CCceEEccccccee
Q 008828 348 ----------DPKIIHRDVKAANILLDE--YYEAVVGDFGLAKL 379 (552)
Q Consensus 348 ----------~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~ 379 (552)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.8e-12 Score=113.57 Aligned_cols=104 Identities=31% Similarity=0.409 Sum_probs=30.7
Q ss_pred cccEeccCCCCCccccccccc-CCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccc-cCCccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIG-NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLR 80 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~ 80 (552)
+++.|+|++|.|+.+ ..++ .+.+|+.|+|++|.|+ .++ .+..+++|+.|+|++|+|+ .+++.+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 356666677666653 2344 4666667777777766 333 3666666777777777766 344333 3466666677
Q ss_pred cccccccCCCC-ccccccccccEEeccCCCCC
Q 008828 81 LNNNSLTGAIP-PSLSNMSQLAFLDLSYNNLS 111 (552)
Q Consensus 81 l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~ 111 (552)
|++|+|...-. ..+..+++|+.|+|.+|+++
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 77766653211 34555666666666666665
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=8.1e-13 Score=139.50 Aligned_cols=125 Identities=31% Similarity=0.444 Sum_probs=110.0
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
+.|..|.|.+|.++...-+.|-+.++|++|+|++|+|.......+.+|..|+.|+||+|+|+ .+|+.+..++.|+.|..
T Consensus 359 ~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 45788999999999887778999999999999999999444456789999999999999999 89999999999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCC-CC----cccCcccccCCcc
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPV-PS----FHAKTFNITGNSL 129 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~-~~----~~~~~~~l~~N~~ 129 (552)
.+|+|. .+| .+..+++|+.+||+.|+|+... |. --.+.+||+||..
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 999999 888 7899999999999999998643 22 2238899999985
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.3e-10 Score=100.51 Aligned_cols=132 Identities=20% Similarity=0.269 Sum_probs=100.7
Q ss_pred CeeeeeCceEEEEEEECCCcEEEEEE-eccCccCchH------HHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 236 NLVGKGGFGNVYKGYLQDGTVVAVKR-LKDGNAIGGE------IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~~~------~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
..+++|+-+.+|.+.+. |..+++|. +++.-..... .+-.+|..++.+++--.|.-..=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36789999999999876 34455553 3332222211 2466789999988766666666677788889999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
++|-.|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888755 255667777778889999 999999999999998765 99999999974
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.4e-12 Score=124.05 Aligned_cols=122 Identities=30% Similarity=0.432 Sum_probs=90.8
Q ss_pred EeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccccccc
Q 008828 6 YRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85 (552)
Q Consensus 6 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 85 (552)
.+.+++|. .+.+|..++.+++|..|+|++|-+- .+|.+++.+..|+.||+|+|+|. .+|..+-.+..|+.+-.++|+
T Consensus 416 ~l~lsnn~-isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nq 492 (565)
T KOG0472|consen 416 DLVLSNNK-ISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQ 492 (565)
T ss_pred HHHhhcCc-cccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccc
Confidence 34455544 4568888888888888888888887 78888888888888888888888 777776666677777777778
Q ss_pred ccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccc
Q 008828 86 LTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLI 130 (552)
Q Consensus 86 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~ 130 (552)
+....|+.+.+|.+|..|||.+|.|..+||..-. +.+.+.||++.
T Consensus 493 i~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 493 IGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 8755566677788888888888888765554322 56777777775
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.5e-12 Score=123.70 Aligned_cols=136 Identities=24% Similarity=0.249 Sum_probs=119.9
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccC-CcCCCCCCccccCCcccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN-NFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l 81 (552)
+-+.|+|..|+|+.+.|..|+.+++|+.|||++|.|+-+-|..|.++.+|..|-+.+ |+|+....+.|.+|.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 457899999999999999999999999999999999988899999999999888777 9999544467999999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCCCCCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATGAEED 138 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~~~~~ 138 (552)
.-|++.-...+.|..|++|..|.+-.|.+..+....+. +.+-++.|++.|+|..+..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wl 209 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWL 209 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchh
Confidence 99999977889999999999999999999865554443 7788999999999877553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.2e-11 Score=132.85 Aligned_cols=250 Identities=17% Similarity=0.186 Sum_probs=174.0
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
..+.+.+.+-+-+|.++.++.+.-. .|...+.|+......+. .......+-.++-..++|-+++..-.+.......|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4456667777888999998877632 24334444433221111 11112223333333445666655444555677889
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC-
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC- 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~- 383 (552)
+++|..+++|...++..+..+.+........+..+++|||.. .+.|+|++|.|.++..++..++.|||........
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccccc
Confidence 999999999999999888888888888888999999999997 7999999999999999999999999843221100
Q ss_pred --------------------C---C------ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccC
Q 008828 384 --------------------D---S------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 434 (552)
Q Consensus 384 --------------------~---~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~ 434 (552)
. . .......||..|.+||...+......+|.|++|+.++|.++|..||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 0 0112345899999999999999999999999999999999999999754
Q ss_pred cccccccchHHHHHHHhhhcchhhhccccc-cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 008828 435 KTANQKGAMLDWVKKIHQEKKLEMLVDKDL-KNNYDRIELEEMVQVALLCTQYLPSLRPKMSE 496 (552)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 496 (552)
..... ++.+..... +...+.....+..+++.+.+..+|.+|-.+.-
T Consensus 1039 tpq~~----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~ 1085 (1205)
T KOG0606|consen 1039 TPQQI----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKG 1085 (1205)
T ss_pred chhhh----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCccc
Confidence 43211 111111111 12233444577888999999999999998873
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.4e-09 Score=108.97 Aligned_cols=217 Identities=15% Similarity=0.171 Sum_probs=153.1
Q ss_pred CceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEee----cCCceeEEEeeccC-CChh
Q 008828 242 GFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM----TTTERLLVYPYMSN-GSVA 315 (552)
Q Consensus 242 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~ 315 (552)
-..+.|++.. .||..|++|+++.......- .-..-+++++++.|+|+|++.+++. .....++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN-KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc-cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3457899985 48999999999543322211 1234577899999999999999876 34567899999876 5676
Q ss_pred hhhc---------------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 316 SRLK---------------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 316 ~~l~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
+.-- ++...++..+|.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 6542 223578899999999999999999999 9999999999999999999999999988766
Q ss_pred CCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 381 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 381 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
...+.. -+.+ -.+-|.=.||.+++.|.||..--..... .....+
T Consensus 444 ~~d~~~---------------~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~--------------~~~s~~---- 487 (655)
T KOG3741|consen 444 QEDPTE---------------PLES---QQQNDLRDLGLLLLALATGTENSNRTDS--------------TQSSHL---- 487 (655)
T ss_pred cCCCCc---------------chhH---HhhhhHHHHHHHHHHHhhcccccccccc--------------hHHHHH----
Confidence 543311 1111 1367888999999999998533211000 000001
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.......+.++.+++.......+++ -+..+++.++-+.
T Consensus 488 -----~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ 525 (655)
T KOG3741|consen 488 -----TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSR 525 (655)
T ss_pred -----HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHH
Confidence 1122334567778888888888876 6788887766553
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.1e-09 Score=92.91 Aligned_cols=142 Identities=18% Similarity=0.211 Sum_probs=104.9
Q ss_pred CCCeeeeeCceEEEEEEECCCcEEEEEEe-ccCccCc------hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 234 SKNLVGKGGFGNVYKGYLQDGTVVAVKRL-KDGNAIG------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 234 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~~------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
...++-+|+-+.|+++.+. |+...||.- .+..... ...+..+|+..+.+++--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999987 677666643 2221111 1235778999998887656655555667777888999
Q ss_pred eeccC-CChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC---ceEEccccccee
Q 008828 307 PYMSN-GSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVGDFGLAKL 379 (552)
Q Consensus 307 e~~~~-g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~~~ 379 (552)
||+++ -++.+++... .....+.....+..|-+.+.-||.. +|+|+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 4777777632 2233334478889999999999999 999999999999997554 458999999863
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.2e-10 Score=85.45 Aligned_cols=61 Identities=33% Similarity=0.361 Sum_probs=39.9
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcC
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFF 62 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 62 (552)
++|++|+|++|+++.+.+..|.++++|++|++++|.|+...|..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4566666666666665556666666666666666666655555666666666666666654
|
... |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.9e-10 Score=102.75 Aligned_cols=115 Identities=30% Similarity=0.401 Sum_probs=37.7
Q ss_pred cCCCCCcccccccccCCCCCcEEecccCccCCCCchhhc-CCCCCCEEEccCCcCCCCCCccccCCcccccccccccccc
Q 008828 9 APSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG-KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT 87 (552)
Q Consensus 9 l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 87 (552)
|..+-|.. . ..+.+...+++|+|++|.|+ .+. .++ .+.+|+.|+|++|.|+ .++ .+..++.|+.|++++|+|+
T Consensus 4 lt~~~i~~-~-~~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 4 LTANMIEQ-I-AQYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp ------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred cccccccc-c-cccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC
Confidence 44444443 2 24566778999999999999 554 465 6899999999999999 454 5888999999999999999
Q ss_pred CCCCccc-cccccccEEeccCCCCCCCCCC-cc-----cCcccccCCccc
Q 008828 88 GAIPPSL-SNMSQLAFLDLSYNNLSGPVPS-FH-----AKTFNITGNSLI 130 (552)
Q Consensus 88 ~~~p~~~-~~l~~L~~l~l~~N~l~~~~~~-~~-----~~~~~l~~N~~~ 130 (552)
.+++.+ ..+++|+.|+|++|+|...-.- .+ .+.++|.+||+.
T Consensus 78 -~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 78 -SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred -ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 555445 4689999999999999864321 11 167889999873
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.6e-10 Score=120.86 Aligned_cols=116 Identities=22% Similarity=0.371 Sum_probs=69.5
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
+|+.|+|++|+|++ +|..+ .++|+.|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|+|+
T Consensus 200 ~L~~L~Ls~N~Lts-LP~~l--~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 200 QITTLILDNNELKS-LPENL--QGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred CCcEEEecCCCCCc-CChhh--ccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 46667777777664 44443 246777777777776 4555443 35667777777766 5565543 366777777
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCCCCcc--cCcccccCCccc
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH--AKTFNITGNSLI 130 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~--~~~~~l~~N~~~ 130 (552)
+|+|+ .+|..+. ++|+.|+|++|+|++.++.+. .+.+++++|.+.
T Consensus 271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp~sL~~L~Ls~N~Lt 317 (754)
T PRK15370 271 HNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHLPSGITHLNVQSNSLT 317 (754)
T ss_pred CCccC-ccccccC--CCCcEEECCCCccccCcccchhhHHHHHhcCCccc
Confidence 77776 4565443 367777777777765443222 145556666554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.1e-10 Score=84.24 Aligned_cols=59 Identities=42% Similarity=0.572 Sum_probs=30.0
Q ss_pred CCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccccccc
Q 008828 27 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85 (552)
Q Consensus 27 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 85 (552)
+|++|+|++|+|+...+..|.++++|++|+|++|.++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45555555555553333445555555555555555554444445555555555555554
|
... |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.7e-10 Score=121.29 Aligned_cols=120 Identities=26% Similarity=0.381 Sum_probs=81.1
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|+.|+|++|++++ +|..+ ..+|+.|+|++|.|. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|
T Consensus 220 ~nL~~L~Ls~N~Lts-LP~~l--~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~L 290 (754)
T PRK15370 220 GNIKTLYANSNQLTS-IPATL--PDTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSV 290 (754)
T ss_pred cCCCEEECCCCcccc-CChhh--hccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEEC
Confidence 478889999988875 56554 347888888888887 6776664 47888888888887 5676553 47788888
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCcc--cCcccccCCccccCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH--AKTFNITGNSLICAT 133 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~--~~~~~l~~N~~~c~~ 133 (552)
++|+|+ .+|..+. ++|+.|++++|+|+..++... .+.+++++|.+.+.+
T Consensus 291 s~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~Lt~LP 341 (754)
T PRK15370 291 YDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETLPPGLKTLEAGENALTSLP 341 (754)
T ss_pred CCCccc-cCcccch--hhHHHHHhcCCccccCCccccccceeccccCCccccCC
Confidence 888877 4555443 356677777777765433222 255666666665543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=9e-09 Score=99.20 Aligned_cols=140 Identities=14% Similarity=0.051 Sum_probs=100.3
Q ss_pred CeeeeeCceEEEEEEECCCcEEEEEEeccCccC----------chHHHHHHHHHHHhhcccccc--ceeeeEeec-----
Q 008828 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI----------GGEIQFQTEVEMISLAVHRNL--LRLIGFCMT----- 298 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~e~~~l~~~~h~ni--v~l~~~~~~----- 298 (552)
+.+-+.....|++..+ +|+.+.||+....... .....+.+|...+.++...+| ..++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445667666 4778999977433211 111236788888888754443 344555543
Q ss_pred CCceeEEEeeccCC-Chhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC-------CCc
Q 008828 299 TTERLLVYPYMSNG-SVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-------YYE 368 (552)
Q Consensus 299 ~~~~~lv~e~~~~g-~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------~~~ 368 (552)
....++|||++++. +|.+++.. ....+...+..++.+++..+.-||.. ||+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 23468999999875 78888753 23456677889999999999999999 9999999999999975 568
Q ss_pred eEEccccccee
Q 008828 369 AVVGDFGLAKL 379 (552)
Q Consensus 369 ~kl~Dfg~~~~ 379 (552)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998863
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.96 E-value=8.3e-11 Score=109.47 Aligned_cols=124 Identities=23% Similarity=0.329 Sum_probs=89.1
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
.|+.||||+|.|+. +..++.-++.++.|++|+|.|. .+-. +..|++|+.||||+|.++ .+...-..|-+.+.|.|+
T Consensus 285 ~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchhh-hhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 47888999988875 5667777888899999999887 4433 888888999999998888 555555566778888888
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCCC-----Cc-ccCcccccCCccccC
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP-----SF-HAKTFNITGNSLICA 132 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-----~~-~~~~~~l~~N~~~c~ 132 (552)
.|.|.. + ..+..+-+|..||+++|+|...-. .+ ..+.+.|.+|++.-.
T Consensus 361 ~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 361 QNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 888873 2 346667778888888888863211 11 125667777777543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=8.2e-10 Score=120.03 Aligned_cols=52 Identities=27% Similarity=0.261 Sum_probs=31.7
Q ss_pred cccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc--CcccccCCcccc
Q 008828 75 TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSLIC 131 (552)
Q Consensus 75 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~--~~~~l~~N~~~c 131 (552)
+|+.|+|++|+|+ .+|.. .++|+.|++++|+|++.+ .... ..+++++|.+.-
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~LssIP-~l~~~L~~L~Ls~NqLt~ 436 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTSLP-MLPSGLLSLSVYRNQLTR 436 (788)
T ss_pred ccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCCCC-cchhhhhhhhhccCcccc
Confidence 5666777777776 34533 246777777777777643 3221 456677776653
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=8.8e-11 Score=124.44 Aligned_cols=106 Identities=26% Similarity=0.401 Sum_probs=95.1
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|+.|+|++|.|.....+.+.++..|++|+||+|+++ .+|..+.+|..|++|...+|++. .+| .+..++.|+.+|
T Consensus 382 ~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lD 458 (1081)
T KOG0618|consen 382 FKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLD 458 (1081)
T ss_pred ccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEe
Confidence 468999999999999877778999999999999999999 89999999999999999999999 888 789999999999
Q ss_pred cccccccCC-CCccccccccccEEeccCCCC
Q 008828 81 LNNNSLTGA-IPPSLSNMSQLAFLDLSYNNL 110 (552)
Q Consensus 81 l~~N~l~~~-~p~~~~~l~~L~~l~l~~N~l 110 (552)
+|.|+|+.. +|..... ++|++|||++|.-
T Consensus 459 lS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 459 LSCNNLSEVTLPEALPS-PNLKYLDLSGNTR 488 (1081)
T ss_pred cccchhhhhhhhhhCCC-cccceeeccCCcc
Confidence 999999733 4544433 8999999999985
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-08 Score=92.97 Aligned_cols=127 Identities=23% Similarity=0.286 Sum_probs=83.3
Q ss_pred EEEEEEECCCcEEEEEEeccCc--------------c-------Cc----hHHHHHHHHHHHhhcccc--ccceeeeEee
Q 008828 245 NVYKGYLQDGTVVAVKRLKDGN--------------A-------IG----GEIQFQTEVEMISLAVHR--NLLRLIGFCM 297 (552)
Q Consensus 245 ~Vy~~~~~~~~~vavK~~~~~~--------------~-------~~----~~~~~~~e~~~l~~~~h~--niv~l~~~~~ 297 (552)
.||.|...+|..+|||+.+... . .. ......+|...|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899999889999999884321 0 00 012467799999988755 45566654
Q ss_pred cCCceeEEEeecc--CCChhhhhccCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCceEEcCCCCCceeeCCCCceEEccc
Q 008828 298 TTTERLLVYPYMS--NGSVASRLKAKPSLDWATRKRIALGAARGLLY-LHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 374 (552)
Q Consensus 298 ~~~~~~lv~e~~~--~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 374 (552)
...++||||++ +..+.. +.... ++......++.+++..+.. +|.. ||+|+||.+.||+++++ .+.|+||
T Consensus 79 --~~~~ivME~I~~~G~~~~~-l~~~~-~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPR-LKDVD-LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp --ETTEEEEE--EETTEEGGC-HHHCG-GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--G
T ss_pred --eCCEEEEEecCCCccchhh-HHhcc-ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEec
Confidence 35689999998 544433 33221 2245567788888886666 4677 99999999999999987 9999999
Q ss_pred ccceecC
Q 008828 375 GLAKLLD 381 (552)
Q Consensus 375 g~~~~~~ 381 (552)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9887544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.7e-08 Score=95.26 Aligned_cols=255 Identities=15% Similarity=0.157 Sum_probs=157.9
Q ss_pred CCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEe------ecCC-ceeE
Q 008828 233 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFC------MTTT-ERLL 304 (552)
Q Consensus 233 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~------~~~~-~~~l 304 (552)
....-||+|+-+.+|-.- .-...+.|+++....... .+.+..|... .||-+..=+.+= -+.. ...+
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQ----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHH----HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 456789999999999642 112234577765432211 1233344433 466544312211 1112 2457
Q ss_pred EEeeccCCC-hhhhh------ccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccc
Q 008828 305 VYPYMSNGS-VASRL------KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 377 (552)
Q Consensus 305 v~e~~~~g~-L~~~l------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 377 (552)
+|..+++.. ...+. ++.+..+|...++.+..+|.+.+.||+. |.+-+|+.++|+|+.+++.+.|.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 777766531 11222 2445689999999999999999999999 9999999999999999999999885544
Q ss_pred eecCCCCCceeecccccccccCchhhc-----cCCCCCccchhHHHHHHHHHHhC-CCccccCcccc-cccchH-HHHHH
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISG-LRALEFGKTAN-QKGAML-DWVKK 449 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~elltg-~~p~~~~~~~~-~~~~~~-~~~~~ 449 (552)
.... ........+|...|.+||.-. +...+...|-|.+||++++++.| ++||..-.... ...... +...
T Consensus 165 qi~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~- 241 (637)
T COG4248 165 QINA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH- 241 (637)
T ss_pred eecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc-
Confidence 3322 333445566899999999764 34567889999999999999887 89987421110 001011 0000
Q ss_pred Hhhhcchhhhcccc--c---cCcC-CHHHHHHHHHHHHHccCCC--CCCCCCHHHHHHHHhc
Q 008828 450 IHQEKKLEMLVDKD--L---KNNY-DRIELEEMVQVALLCTQYL--PSLRPKMSEVVRMLEG 503 (552)
Q Consensus 450 ~~~~~~~~~~~~~~--~---~~~~-~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~ 503 (552)
+.+....+.. + .... -...+..+..+..+|+... +.-|||++..+..|..
T Consensus 242 ----g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 242 ----GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred ----ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 0000001100 0 0011 1223467888999998764 5689999988776654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.6e-10 Score=107.60 Aligned_cols=109 Identities=25% Similarity=0.241 Sum_probs=94.3
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
++.++.|++|+|.|..+ ..+..|.+|+.||||+|.++ .+.++-.+|-++++|.|++|.|. .+ ..+..|-+|..||
T Consensus 306 ~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~L-SGL~KLYSLvnLD 380 (490)
T KOG1259|consen 306 APKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TL-SGLRKLYSLVNLD 380 (490)
T ss_pred ccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hh-hhhHhhhhheecc
Confidence 46799999999999875 34999999999999999999 77777788999999999999998 33 4678889999999
Q ss_pred cccccccCCC-CccccccccccEEeccCCCCCCCC
Q 008828 81 LNNNSLTGAI-PPSLSNMSQLAFLDLSYNNLSGPV 114 (552)
Q Consensus 81 l~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~ 114 (552)
+++|+|...- -..++++|.|+++.|.+|+|.+++
T Consensus 381 l~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 381 LSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred ccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 9999998332 256999999999999999999754
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.7e-09 Score=117.69 Aligned_cols=122 Identities=27% Similarity=0.270 Sum_probs=78.6
Q ss_pred CcccEeccCCCCCccc--ccccccC--------------CCCCcEEecccCccCCCCchhhcC-----------------
Q 008828 2 VLLCYRGAPSQNLSGT--LSSSIGN--------------LTNLQLVLLQNNNISGHIPTEIGK----------------- 48 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~--~p~~~~~--------------l~~L~~L~l~~N~l~~~~p~~~~~----------------- 48 (552)
++|++|+|++|+++++ +|..+.. ..+|+.|+|++|+|+ .+|....+
T Consensus 302 ~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l 380 (788)
T PRK15387 302 PGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPAL 380 (788)
T ss_pred cccceeECCCCccccCCCCcccccccccccCccccccccccccceEecCCCccC-CCCCCCcccceehhhccccccCccc
Confidence 4566666666666663 1111111 136777777777776 34432221
Q ss_pred CCCCCEEEccCCcCCCCCCccccCCccccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc----Ccccc
Q 008828 49 LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNI 124 (552)
Q Consensus 49 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l 124 (552)
..+|+.|+|++|+|+ .+|.. .++|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+.+|..+.. ..++|
T Consensus 381 ~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdL 452 (788)
T PRK15387 381 PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLTRLPESLIHLSSETTVNL 452 (788)
T ss_pred ccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCcccccChHHhhccCCCeEEC
Confidence 136788888888888 46643 357889999999998 56753 34678899999999965433221 67899
Q ss_pred cCCccccC
Q 008828 125 TGNSLICA 132 (552)
Q Consensus 125 ~~N~~~c~ 132 (552)
++|++.+.
T Consensus 453 s~N~Ls~~ 460 (788)
T PRK15387 453 EGNPLSER 460 (788)
T ss_pred CCCCCCch
Confidence 99988643
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.1e-10 Score=115.50 Aligned_cols=121 Identities=31% Similarity=0.493 Sum_probs=62.4
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
.|++|||+.|+++. +|..++.|+ |+.|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++.+.+|+.|++.
T Consensus 122 ~lt~l~ls~NqlS~-lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr 197 (722)
T KOG0532|consen 122 ALTFLDLSSNQLSH-LPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR 197 (722)
T ss_pred HHHHhhhccchhhc-CChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence 45666666666553 444444443 555555566555 55555555555555555555555 455555555555555555
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCcc
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 129 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~ 129 (552)
.|++. .+|..+.. -.|..||+++|+++.+|-.+-. +.+-|.+|++
T Consensus 198 Rn~l~-~lp~El~~-LpLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPL 246 (722)
T KOG0532|consen 198 RNHLE-DLPEELCS-LPLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPL 246 (722)
T ss_pred hhhhh-hCCHHHhC-CceeeeecccCceeecchhhhhhhhheeeeeccCCC
Confidence 55554 34444442 2345555555555543332211 3444555554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.5e-10 Score=93.45 Aligned_cols=125 Identities=21% Similarity=0.272 Sum_probs=100.4
Q ss_pred ccEeccCCCCCcccccc---cccCCCCCcEEecccCccCCCCchhhc-CCCCCCEEEccCCcCCCCCCccccCCcccccc
Q 008828 4 LCYRGAPSQNLSGTLSS---SIGNLTNLQLVLLQNNNISGHIPTEIG-KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79 (552)
Q Consensus 4 l~~L~l~~n~l~~~~p~---~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 79 (552)
+-.|||++|.|-- ++. .+.....|+..+|++|.+. ..|+.|. .++.++.|+|++|.|+ .+|..+..++.|+.|
T Consensus 29 ~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 5578899998653 443 5666778888899999999 5566564 5679999999999999 789999999999999
Q ss_pred ccccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccccC
Q 008828 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICA 132 (552)
Q Consensus 80 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~ 132 (552)
+++.|.|. ..|..+..|.+|..|+..+|.+..++-+.+. ....+.+|++...
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~ 161 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDE 161 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCccccc
Confidence 99999999 8888888899999999999999876665443 3445656655433
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.5e-09 Score=112.76 Aligned_cols=151 Identities=16% Similarity=0.245 Sum_probs=105.7
Q ss_pred HHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC--------ceeecccccccccCchhhc
Q 008828 333 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS--------HVTTAVRGTVGHIAPEYLS 404 (552)
Q Consensus 333 ~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~ 404 (552)
+.+++.|+.|+|... ++||++|.|++|.++..+..||+.|+.+........ .......-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 445569999999864 899999999999999999999999998765433111 1111112446799999999
Q ss_pred cCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHc
Q 008828 405 TGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLC 483 (552)
Q Consensus 405 ~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 483 (552)
....+.++|+||+||++|.+.. |+.-+........ .......+..-...+....+.++.+=+.+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~--------------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS--------------YSFSRNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcch--------------hhhhhcccccccccccccCcHHHHHHHHHH
Confidence 9888999999999999999994 4444433211111 011111111112223455668899999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 008828 484 TQYLPSLRPKMSEVVR 499 (552)
Q Consensus 484 l~~dP~~RPs~~evl~ 499 (552)
+..++.-||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999998887753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.9e-08 Score=91.77 Aligned_cols=138 Identities=21% Similarity=0.192 Sum_probs=97.0
Q ss_pred CCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCcc-----------------C----chHHHHHHHHHHHhhcccc--c
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-----------------I----GGEIQFQTEVEMISLAVHR--N 288 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------~----~~~~~~~~e~~~l~~~~h~--n 288 (552)
..+.+.||-|.-+.||.|...+|..+|||.-+.+.. . -.....++|.+.|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 346689999999999999999999999996532210 0 0112356788888887533 4
Q ss_pred cceeeeEeecCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc
Q 008828 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 368 (552)
Q Consensus 289 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 368 (552)
+.+.+++ +...+||||+++-.|...- ++.+....++..|+.-+.-+-.. ||||+|+.+-||+++++|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCC
Confidence 5555443 5678999999986554332 23344444555555555444455 9999999999999999999
Q ss_pred eEEcccccceecC
Q 008828 369 AVVGDFGLAKLLD 381 (552)
Q Consensus 369 ~kl~Dfg~~~~~~ 381 (552)
+.++||--+....
T Consensus 241 ~~vIDwPQ~v~~~ 253 (304)
T COG0478 241 IVVIDWPQAVPIS 253 (304)
T ss_pred EEEEeCcccccCC
Confidence 9999998775443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.2e-10 Score=112.13 Aligned_cols=111 Identities=23% Similarity=0.211 Sum_probs=68.3
Q ss_pred CcccEeccCCCCCcc------cccccccCCCCCcEEecccCccCCCCchhhcCCCC---CCEEEccCCcCCC----CCCc
Q 008828 2 VLLCYRGAPSQNLSG------TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSK---LLTLDLSNNFFTG----PIPS 68 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~------~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---L~~L~l~~N~l~~----~~p~ 68 (552)
++|++|+++++.+.+ .++..+.++++|+.|+|++|.+.+..+..+..+.+ |+.|++++|++++ .+..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 356777777776652 23345666777777777777776555555555554 7777777777662 1222
Q ss_pred cccCC-ccccccccccccccCC----CCccccccccccEEeccCCCCCC
Q 008828 69 TVSHL-ETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLSG 112 (552)
Q Consensus 69 ~~~~l-~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~ 112 (552)
.+..+ ++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 179 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCch
Confidence 34455 6777777777777632 22344555667777777777764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.77 E-value=2e-08 Score=116.96 Aligned_cols=105 Identities=24% Similarity=0.257 Sum_probs=47.8
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
+|+.|+|++|++.. ++..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..+.++++|+.|+++
T Consensus 612 ~L~~L~L~~s~l~~-L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 612 NLVKLQMQGSKLEK-LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred CCcEEECcCccccc-cccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 34444454444432 344444455555555554432223442 4445555555555544333445455555555555555
Q ss_pred cccccCCCCccccccccccEEeccCCCC
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNL 110 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l 110 (552)
+|...+.+|..+ ++++|+.|++++|..
T Consensus 690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 690 RCENLEILPTGI-NLKSLYRLNLSGCSR 716 (1153)
T ss_pred CCCCcCccCCcC-CCCCCCEEeCCCCCC
Confidence 433222444333 344555555555443
|
syringae 6; Provisional |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.77 E-value=5e-10 Score=112.86 Aligned_cols=124 Identities=25% Similarity=0.354 Sum_probs=90.9
Q ss_pred ccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccccc
Q 008828 4 LCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83 (552)
Q Consensus 4 l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 83 (552)
|..|.|.+|.+. .+|..+.+|..|++|||+.|+++ .+|..++.|+ |+.|.+++|+++ .+|+.++.+..|..||.+.
T Consensus 100 Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~ 175 (722)
T KOG0532|consen 100 LESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSK 175 (722)
T ss_pred HHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhh
Confidence 444555555554 36667777778888888888887 6777776665 777888888887 7777777777888888888
Q ss_pred ccccCCCCccccccccccEEeccCCCCCCCCCCccc---CcccccCCccccC
Q 008828 84 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---KTFNITGNSLICA 132 (552)
Q Consensus 84 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~---~~~~l~~N~~~c~ 132 (552)
|+|. .+|..+..+.+|+.|++..|++...++++.. -.+|++.|++.-.
T Consensus 176 nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis~i 226 (722)
T KOG0532|consen 176 NEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKISYL 226 (722)
T ss_pred hhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCceeec
Confidence 8887 6777777888888888888888876665433 5788888887643
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.1e-08 Score=115.37 Aligned_cols=108 Identities=28% Similarity=0.276 Sum_probs=78.5
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|+.|+|++|...+.+|..+++|++|+.|+|++|..-+.+|..+ ++++|+.|+|++|.....+|.. .++|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 467778888877777778888888888888888764444677655 6788888888887544455543 357778888
Q ss_pred ccccccCCCCccccccccccEEeccC-CCCCCCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSY-NNLSGPV 114 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~-N~l~~~~ 114 (552)
++|.|+ .+|..+..+++|+.|+|++ |+|...+
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~ 886 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVS 886 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCCCCcCccC
Confidence 888887 6777788888888888877 5555533
|
syringae 6; Provisional |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.4e-07 Score=87.88 Aligned_cols=106 Identities=17% Similarity=0.179 Sum_probs=85.3
Q ss_pred HHHHHHHHHHhhccccc--cceeeeEeecCC----ceeEEEeeccC-CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHh
Q 008828 272 IQFQTEVEMISLAVHRN--LLRLIGFCMTTT----ERLLVYPYMSN-GSVASRLKAKPSLDWATRKRIALGAARGLLYLH 344 (552)
Q Consensus 272 ~~~~~e~~~l~~~~h~n--iv~l~~~~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH 344 (552)
....+|...+..+.... ..+.+++..... ..++|+|++++ -+|.+++......+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 35678888877775333 456666665432 34799999987 479998887555778888999999999999999
Q ss_pred hcCCCceEEcCCCCCceeeCCCC---ceEEcccccceec
Q 008828 345 EQCDPKIIHRDVKAANILLDEYY---EAVVGDFGLAKLL 380 (552)
Q Consensus 345 ~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~~~~ 380 (552)
+. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 136 ~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99 999999999999999877 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=6.9e-10 Score=114.65 Aligned_cols=124 Identities=31% Similarity=0.374 Sum_probs=95.6
Q ss_pred ccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCc-cccCCccccccccc
Q 008828 4 LCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS-TVSHLETLQYLRLN 82 (552)
Q Consensus 4 l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~ 82 (552)
|...+.+.|.+.. +..++.-++.|+.|+|++|+++... .+..|++|++|||+.|.|. .+|. ....+. |+.|.|.
T Consensus 166 L~~a~fsyN~L~~-mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLVL-MDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHHh-HHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence 4556777888764 6678888999999999999998543 6888999999999999998 6664 344555 9999999
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCCCC--cc----cCcccccCCccccCCC
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS--FH----AKTFNITGNSLICATG 134 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~--~~----~~~~~l~~N~~~c~~~ 134 (552)
||.++.. ..+.+|.+|..|||+.|-|++-..- ++ ...++|.||++-|.+-
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 9998843 3578889999999999988863221 11 1678999999988753
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.4e-09 Score=106.20 Aligned_cols=128 Identities=23% Similarity=0.334 Sum_probs=90.3
Q ss_pred cccEeccCCCCCcc----cccccccCC-CCCcEEecccCccCCC----CchhhcCCCCCCEEEccCCcCCCC----CCcc
Q 008828 3 LLCYRGAPSQNLSG----TLSSSIGNL-TNLQLVLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IPST 69 (552)
Q Consensus 3 ~l~~L~l~~n~l~~----~~p~~~~~l-~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~ 69 (552)
+|++|++++|++.+ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++..
T Consensus 109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~ 188 (319)
T cd00116 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG 188 (319)
T ss_pred cccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHH
Confidence 48899999988873 233456666 8899999999988842 344566778899999999988742 2334
Q ss_pred ccCCccccccccccccccCC----CCccccccccccEEeccCCCCCCCCCC----------cccCcccccCCccc
Q 008828 70 VSHLETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLSGPVPS----------FHAKTFNITGNSLI 130 (552)
Q Consensus 70 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~~~----------~~~~~~~l~~N~~~ 130 (552)
+..+++|+.|+|++|.+.+. ++..+..+++|+.|++++|++++.... ...+.+++++|.+.
T Consensus 189 l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 45567899999999888633 334566678899999999988752110 12367788888764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.4e-08 Score=105.05 Aligned_cols=103 Identities=33% Similarity=0.496 Sum_probs=63.1
Q ss_pred cccEeccCCCCCcccccccccCCC-CCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLT-NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
.++.|++.+|+++. +|.....++ +|+.|++++|.+. .+|..+.++++|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 117 ~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 117 NLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred ceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 45666666666654 444555553 6666666666666 55555666666666666666666 55555445666666666
Q ss_pred ccccccCCCCccccccccccEEeccCCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNN 109 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~ 109 (552)
++|+++ .+|.....+..|+.|++++|+
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 666666 555544444456666666664
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.4e-08 Score=103.23 Aligned_cols=128 Identities=30% Similarity=0.424 Sum_probs=98.3
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
+|+.|++++|.+.. +|..+..+++|+.|++++|+++ .+|.....+++|+.|++++|+++ .+|..+..+..|+.|.++
T Consensus 141 nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchhh-hhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 78999999999886 5577899999999999999998 77777768899999999999999 778776666778899999
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCCC---Ccc-cCcccccCCccccCCC
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP---SFH-AKTFNITGNSLICATG 134 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~---~~~-~~~~~l~~N~~~c~~~ 134 (552)
+|++. ..+..+..++++..+.+.+|++...+. ... .+.+++++|.+.-.+.
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~~ 272 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISS 272 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccccccc
Confidence 98655 456667777777777788887764211 111 2667777777655443
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.5e-09 Score=86.51 Aligned_cols=110 Identities=21% Similarity=0.212 Sum_probs=91.9
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
.|+..+|++|.+....+..-...+.++.|+|++|+|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|-.|+..
T Consensus 54 el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~ 131 (177)
T KOG4579|consen 54 ELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSP 131 (177)
T ss_pred eEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCC
Confidence 5778899999998755555556679999999999999 89999999999999999999999 789888889999999999
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCCC
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 115 (552)
+|.+. .+|-.+.--+++-..++.++++.+..+
T Consensus 132 ~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 132 ENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred CCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 99998 666554333445567788999987655
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=6e-07 Score=83.13 Aligned_cols=157 Identities=24% Similarity=0.282 Sum_probs=99.4
Q ss_pred cccCHHHHHHHhcCCCCCCeee---eeCceEEEEEEECCCcEEEEEEeccCccCc--------hHHH-------------
Q 008828 218 KRFHFKELQSATSNFSSKNLVG---KGGFGNVYKGYLQDGTVVAVKRLKDGNAIG--------GEIQ------------- 273 (552)
Q Consensus 218 ~~~~~~e~~~~~~~~~~~~~iG---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~------------- 273 (552)
...+.+.+....++..+..+.| .|.-+.||+|...++..+|||+++.....- ...+
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 3445566666666666666555 566668999998889999999986432110 0000
Q ss_pred --HHHHHHHHhhcc--ccccceeeeEeecCCceeEEEeeccCC-ChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 008828 274 --FQTEVEMISLAV--HRNLLRLIGFCMTTTERLLVYPYMSNG-SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 348 (552)
Q Consensus 274 --~~~e~~~l~~~~--h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 348 (552)
..+|+.-|.++. +-.+-+.+++ ....|||||+... .-.-.|..- ++.......+..++++.+.-|-..+
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 123444444432 1222222222 2457999999653 222222222 2333367778888888888887633
Q ss_pred CceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 349 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||+||+.-|||+. ++.+.|+|||-+....+
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 999999999999999 89999999999875543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.2e-06 Score=80.05 Aligned_cols=137 Identities=17% Similarity=0.078 Sum_probs=100.4
Q ss_pred eeeCceEEEEEEECCCcEEEEEEeccCc--c---CchHHHHHHHHHHHhhccccc--cceeeeEeec----CCceeEEEe
Q 008828 239 GKGGFGNVYKGYLQDGTVVAVKRLKDGN--A---IGGEIQFQTEVEMISLAVHRN--LLRLIGFCMT----TTERLLVYP 307 (552)
Q Consensus 239 G~G~~g~Vy~~~~~~~~~vavK~~~~~~--~---~~~~~~~~~e~~~l~~~~h~n--iv~l~~~~~~----~~~~~lv~e 307 (552)
|+||-+-|+....+ |..+-+|+-.... . .-+...|.+|+..+.++..-+ +.++..+... ...-+||+|
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 66888889987776 4468888764110 0 225567999999999886433 4444422211 123579999
Q ss_pred eccC-CChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc--eEEccccccee
Q 008828 308 YMSN-GSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--AVVGDFGLAKL 379 (552)
Q Consensus 308 ~~~~-g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~~~~ 379 (552)
-+.+ -+|.+++... .+.+...+..++.+++..+.-||+. |+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7764 5788887653 3567888899999999999999999 9999999999999986666 99999987753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.2e-07 Score=95.00 Aligned_cols=140 Identities=23% Similarity=0.273 Sum_probs=92.4
Q ss_pred CeeeeeCceEEEEEEECCCcEEEEEEeccCccCc---------------------------------------hHHHHHH
Q 008828 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG---------------------------------------GEIQFQT 276 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------------~~~~~~~ 276 (552)
+-|+.++-|.||+|++++|+.||||+.+.+-... .+-.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999999999999999999875431100 0012344
Q ss_pred HHHHHhhcc----ccccceeeeEee-cCCceeEEEeeccCCChhhhh--ccCCCCCHHHHHHHHHHHHHHH-HHHhhcCC
Q 008828 277 EVEMISLAV----HRNLLRLIGFCM-TTTERLLVYPYMSNGSVASRL--KAKPSLDWATRKRIALGAARGL-LYLHEQCD 348 (552)
Q Consensus 277 e~~~l~~~~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l--~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~ 348 (552)
|..-+.+++ +..-+++=.++. -....+++|||++|..+.+.. +. ..++ +..++..++++. ..+=..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~~d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhc--
Confidence 444444442 222233333333 356789999999998888774 33 3455 333343333332 222223
Q ss_pred CceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 349 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
|+.|.|..|-||+++.++.+.+.|||+...++.
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876653
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=8.6e-08 Score=99.51 Aligned_cols=126 Identities=28% Similarity=0.336 Sum_probs=72.8
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
.+..+++..|.+.. +-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|.|+.. ..+..++.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhhheec
Confidence 34555566666554 2234666667777777777766 3333356666777777777776632 235555666677777
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCCC---Cccc--CcccccCCccccCCC
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP---SFHA--KTFNITGNSLICATG 134 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~---~~~~--~~~~l~~N~~~c~~~ 134 (552)
+|.|+ .+ ..+..+++|+.+++++|.+....+ ..+. +.+.+.+|.+....+
T Consensus 149 ~N~i~-~~-~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~~ 203 (414)
T KOG0531|consen 149 GNLIS-DI-SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIEG 203 (414)
T ss_pred cCcch-hc-cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcccc
Confidence 77666 22 234446666667777776665544 2211 455666666655443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=9.9e-08 Score=99.08 Aligned_cols=129 Identities=24% Similarity=0.251 Sum_probs=96.6
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|+.|++.+|+|..+ ...+..+++|++|+|++|.|+...+ +..++.|+.|++++|.|+ .+ ..+..+++|+.++
T Consensus 94 ~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~-~~-~~~~~l~~L~~l~ 168 (414)
T KOG0531|consen 94 LKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLIS-DI-SGLESLKSLKLLD 168 (414)
T ss_pred ccceeeeeccccchhhc-ccchhhhhcchheeccccccccccc--hhhccchhhheeccCcch-hc-cCCccchhhhccc
Confidence 46788999999998874 3347889999999999999985433 777888999999999998 33 4566788999999
Q ss_pred cccccccCCCCcc-ccccccccEEeccCCCCCCCCCCccc---CcccccCCccccCCCC
Q 008828 81 LNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLSGPVPSFHA---KTFNITGNSLICATGA 135 (552)
Q Consensus 81 l~~N~l~~~~p~~-~~~l~~L~~l~l~~N~l~~~~~~~~~---~~~~l~~N~~~c~~~~ 135 (552)
+++|++.. ++.. ...+.+|+.+++.+|.+...-.--.. ..+++..|.+....+.
T Consensus 169 l~~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~~i~~~~~~~~l~~~~l~~n~i~~~~~l 226 (414)
T KOG0531|consen 169 LSYNRIVD-IENDELSELISLEELDLGGNSIREIEGLDLLKKLVLLSLLDNKISKLEGL 226 (414)
T ss_pred CCcchhhh-hhhhhhhhccchHHHhccCCchhcccchHHHHHHHHhhcccccceeccCc
Confidence 99999984 3332 57788899999999998854332211 3447788877765544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=7.5e-06 Score=77.35 Aligned_cols=132 Identities=14% Similarity=0.107 Sum_probs=84.3
Q ss_pred CeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccc--cceeeeEeecCCceeEEEeeccCCC
Q 008828 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIGFCMTTTERLLVYPYMSNGS 313 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~ 313 (552)
..||+|..+.||+. .+..+++|..+... ......+|.+++..+..-. +.+++++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 24567888876432 2335678999998886433 4677778777777889999999863
Q ss_pred -hhhhhccCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHhhc-CCCceE
Q 008828 314 -VASRLKAKPSLDWATRKRIALGAARG---------------------------------------LLYLHEQ-CDPKII 352 (552)
Q Consensus 314 -L~~~l~~~~~l~~~~~~~i~~~ia~~---------------------------------------l~~LH~~-~~~~iv 352 (552)
+...+. .+......++.++++. ..+|... ..+.++
T Consensus 81 ~~~~~~~----~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 81 SFSRIIS----DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred chhhhhc----CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 211110 0001111111111111 1222211 134578
Q ss_pred EcCCCCCceeeCCCCceEEcccccce
Q 008828 353 HRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 353 H~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
|+|+.|.||++++++ +.++||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.3e-07 Score=97.35 Aligned_cols=181 Identities=19% Similarity=0.165 Sum_probs=132.0
Q ss_pred CeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccc-cceeeeEeecCCceeEEEeeccCC-C
Q 008828 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIGFCMTTTERLLVYPYMSNG-S 313 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-~ 313 (552)
+-.++|+++++||.+--..+....+.+... ....-++++|.+++||| .++.++-+..+...+++++++.++ +
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 456889999999987432333335555332 23456889999999999 777777777788889999999887 2
Q ss_pred hhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeeccc
Q 008828 314 VASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 392 (552)
Q Consensus 314 L~~~l-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 392 (552)
..... .....+...+...+...-+++++++|+. .=+|+| ||+..+ +..+..||+....+.... ......
T Consensus 322 ~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~ 391 (829)
T KOG0576|consen 322 SALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAI 391 (829)
T ss_pred ccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccccCC
Confidence 22221 1222344444555666778899999986 458998 777665 788999999987665432 344566
Q ss_pred ccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccc
Q 008828 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 432 (552)
Q Consensus 393 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~ 432 (552)
+++.|+|||+.....+..+.|+|+.|+-..++.-|.+|-.
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 9999999999999999999999999997777777766643
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.7e-08 Score=102.17 Aligned_cols=106 Identities=25% Similarity=0.262 Sum_probs=87.1
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCch-hhcCCCCCCEEEccCCcCCCCCCccccCCcccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPT-EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 79 (552)
++.|+.|||++|+++..- .+..|++|+.|||++|.+. .+|. ....+. |+.|+|+||-++ .+ ..+.+|.+|+.|
T Consensus 186 l~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~-tL-~gie~LksL~~L 259 (1096)
T KOG1859|consen 186 LPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALT-TL-RGIENLKSLYGL 259 (1096)
T ss_pred HHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHH-hh-hhHHhhhhhhcc
Confidence 356899999999998753 8999999999999999999 5664 233444 999999999998 33 468899999999
Q ss_pred ccccccccCCCC-ccccccccccEEeccCCCCCC
Q 008828 80 RLNNNSLTGAIP-PSLSNMSQLAFLDLSYNNLSG 112 (552)
Q Consensus 80 ~l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~ 112 (552)
||+.|-|++.-. ..+..|..|+.|+|.+|++..
T Consensus 260 DlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 260 DLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred chhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 999999974322 336677889999999999974
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.8e-07 Score=60.49 Aligned_cols=36 Identities=44% Similarity=0.636 Sum_probs=18.4
Q ss_pred CCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCC
Q 008828 27 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT 63 (552)
Q Consensus 27 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 63 (552)
+|++|+|++|+|+ .+|..+++|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555555 34444555555555555555554
|
... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-05 Score=74.19 Aligned_cols=137 Identities=14% Similarity=0.095 Sum_probs=89.0
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHH---------HHHHHHHhhcccc---ccceeeeE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQF---------QTEVEMISLAVHR---NLLRLIGF 295 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------~~e~~~l~~~~h~---niv~l~~~ 295 (552)
...+|...+++-......|.+-..+ |..+++|..+..... .+..| .+.+..+..++.. ..+.++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3466777777777666666665554 789999988754432 22222 2333333333322 22333333
Q ss_pred eec-----CCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceE
Q 008828 296 CMT-----TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 370 (552)
Q Consensus 296 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 370 (552)
... ....+++|||++|..|.+... +++ .++..+++++.-||+. |++|+|..|.|+++++++ ++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EE
Confidence 222 234568999999987765532 222 2456677889999999 999999999999999654 89
Q ss_pred Ecccccce
Q 008828 371 VGDFGLAK 378 (552)
Q Consensus 371 l~Dfg~~~ 378 (552)
+.||+..+
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.4e-05 Score=75.90 Aligned_cols=140 Identities=17% Similarity=0.169 Sum_probs=83.2
Q ss_pred CeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccc--cceeeeEeecC---CceeEEEeecc
Q 008828 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIGFCMTT---TERLLVYPYMS 310 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l~~~~~~~---~~~~lv~e~~~ 310 (552)
+.++.|..+.||+....+ ..+++|..... .....+..|..++..+.... +.+++.++... ...+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 568999999999999887 69999987543 23456778888888875433 45666644332 34689999999
Q ss_pred CCChhh----------------hh---ccC----CCCCHHHH---------HHH------------HHHHHH-HHHHHhh
Q 008828 311 NGSVAS----------------RL---KAK----PSLDWATR---------KRI------------ALGAAR-GLLYLHE 345 (552)
Q Consensus 311 ~g~L~~----------------~l---~~~----~~l~~~~~---------~~i------------~~~ia~-~l~~LH~ 345 (552)
+..+.. .+ +.. ....+... ... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 887776 11 111 11111100 000 111222 2333332
Q ss_pred c----CCCceEEcCCCCCceeeC-CCCceEEccccccee
Q 008828 346 Q----CDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKL 379 (552)
Q Consensus 346 ~----~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~ 379 (552)
. ....++|+|+.|.||+++ +++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1 244799999999999999 666678999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 552 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-130 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-127 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-38 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-12 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-07 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 552 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 0.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-148 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-133 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-78 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-65 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 8e-58 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-56 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-56 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-55 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-54 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-53 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-53 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-52 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 4e-52 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 6e-52 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-51 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-51 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 8e-51 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-40 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 9e-40 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-39 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 5e-38 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 6e-37 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 8e-33 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-21 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 5e-39 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 9e-39 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-38 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 9e-38 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-37 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-37 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-37 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 7e-37 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 8e-37 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-36 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-36 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-36 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-36 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-36 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-35 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-34 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-34 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-32 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-31 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-31 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-28 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-27 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-27 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-24 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-21 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-13 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-36 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-35 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-35 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-34 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-34 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-34 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-34 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 8e-34 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-33 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-33 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-33 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-33 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-33 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-33 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-33 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-33 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-33 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-33 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-33 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 7e-33 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-32 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-32 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-32 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-32 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-32 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 4e-32 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 9e-32 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-31 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-31 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-31 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-31 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-31 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-31 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-31 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-31 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 6e-31 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 8e-31 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 8e-31 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-30 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-30 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 5e-30 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 8e-30 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-29 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-29 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 5e-29 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 6e-29 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 8e-29 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 8e-29 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 8e-29 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-28 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-28 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-28 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 8e-28 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-27 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-27 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 4e-27 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 9e-27 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-26 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-26 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-26 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-24 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-23 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-20 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-20 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-19 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 9e-15 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-13 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-12 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-11 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-10 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-09 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-26 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-26 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-26 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-25 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-24 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 8e-23 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-22 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-22 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-21 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-21 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-20 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-20 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-20 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-19 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-18 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-17 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-12 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-08 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 5e-26 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-26 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 6e-26 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-25 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-25 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 4e-25 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-25 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 8e-25 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-24 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-24 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-24 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-24 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 6e-24 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-23 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-23 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-23 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-21 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-19 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-19 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-19 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-19 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 8e-19 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-18 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-18 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-17 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 8e-10 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-06 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-23 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-23 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-23 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 9e-23 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-19 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-19 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-17 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 8e-17 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-16 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-16 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-14 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-12 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-12 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-11 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-07 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-22 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-22 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-22 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-22 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-21 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 6e-21 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-19 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-21 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-21 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-19 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-19 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-17 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-16 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-15 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-12 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-11 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-11 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-10 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 5e-21 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 7e-21 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-20 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-20 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 8e-20 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 9e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-17 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 8e-17 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-16 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-16 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-16 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-15 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-15 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 8e-14 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-19 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 4e-19 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 5e-19 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 8e-19 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 9e-19 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-18 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-18 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-04 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-18 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-18 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 8e-18 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-17 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-17 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-17 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-17 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 8e-17 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-16 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-14 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-14 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-14 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-12 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-09 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 9e-05 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-17 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-17 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-17 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-15 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-15 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-13 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-13 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 7e-13 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-11 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-08 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-07 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-06 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-04 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 6e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-16 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-08 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 9e-17 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 9e-17 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-16 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-16 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-15 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-14 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-07 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-16 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-16 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-16 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-15 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-15 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-14 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-13 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-13 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-12 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 9e-11 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-16 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-16 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-16 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-16 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-16 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-16 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-16 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 5e-16 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-16 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 8e-15 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-14 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-12 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-11 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-10 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 8e-16 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 9e-16 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-15 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-15 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-15 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-15 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-15 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-15 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-15 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-15 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-15 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-14 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-12 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-10 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-05 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-04 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-15 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-15 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-15 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 3e-15 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-15 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 5e-15 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 6e-15 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 6e-15 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 6e-15 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 8e-15 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-14 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-11 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-11 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-10 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-09 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-14 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-06 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-14 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-14 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 6e-13 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 7e-13 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-12 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-12 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-12 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 5e-12 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-11 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-11 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 9e-08 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-14 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 5e-14 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-14 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 7e-13 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-11 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-11 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-11 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 9e-11 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 7e-10 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-09 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-08 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 9e-06 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-14 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-11 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-11 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 7e-11 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-08 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-07 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 7e-14 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 7e-14 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 8e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 8e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-09 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 9e-14 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 9e-13 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-12 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-11 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 9e-11 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 9e-08 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-13 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-13 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-12 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 8e-12 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-11 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-13 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-13 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-13 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-13 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-13 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-13 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 3e-13 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-13 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-13 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-13 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-13 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 4e-13 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 4e-13 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 4e-13 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-13 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-13 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-13 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-12 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-12 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-11 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-10 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 8e-10 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 5e-13 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 5e-13 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-13 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-12 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-07 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 6e-13 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-13 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-12 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-10 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-10 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-08 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-07 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-07 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-13 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 9e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-11 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-09 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-08 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 7e-13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 7e-13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-12 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-11 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-11 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-11 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 6e-10 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-09 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-08 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 8e-13 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 8e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 9e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-12 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-09 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 7e-08 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-12 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-12 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-12 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-12 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-12 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-12 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-12 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-12 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 8e-12 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-11 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-10 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-09 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-09 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-08 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-12 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-11 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-10 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-10 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-10 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-08 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-08 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 8e-08 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-04 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-12 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-12 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-10 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-09 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-08 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 5e-12 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 6e-12 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 7e-12 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-10 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-10 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 5e-09 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-09 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-09 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-06 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-12 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-11 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 9e-10 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-09 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-06 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 8e-05 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 9e-12 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-11 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-09 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-09 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-08 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-07 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-06 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-11 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-10 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-10 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-09 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-09 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-06 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-06 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-11 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-10 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-10 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-10 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-09 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-08 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-08 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-05 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-05 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-11 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-11 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-09 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-08 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-07 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-05 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-04 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-10 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-10 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-10 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-09 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-08 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-07 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-07 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-10 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-10 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-09 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 5e-08 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 8e-08 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-07 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-07 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-06 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-10 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-09 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 7e-09 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-08 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 7e-07 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-10 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-07 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 6e-07 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-06 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-05 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-10 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 9e-10 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 8e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-08 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-06 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-05 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-09 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-09 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-08 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-08 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-08 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-06 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-09 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-09 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-09 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-07 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-05 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-05 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-09 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-09 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-08 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-07 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-09 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-09 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 6e-09 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-08 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-08 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-07 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-06 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-06 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 8e-09 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 9e-09 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 6e-04 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-08 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-08 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 5e-08 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 8e-08 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 4e-06 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 6e-05 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 6e-05 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-04 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 9e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-04 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 5e-07 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 5e-07 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 9e-07 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-06 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-06 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-04 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-06 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-06 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 8e-06 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 9e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 6e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 4e-05 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 5e-04 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 5e-05 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 6e-05 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 6e-05 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 5e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 6e-04 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 5e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 571 bits (1474), Expect = 0.0
Identities = 227/325 (69%), Positives = 265/325 (81%), Gaps = 5/325 (1%)
Query: 201 FFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVK 260
FFDV + EV LG LKRF +ELQ A+ NFS+KN++G+GGFG VYKG L DGT+VAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 261 RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL-- 318
RLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS L
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 319 --KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 376
+++P LDW R+RIALG+ARGL YLH+ CDPKIIHRDVKAANILLDE +EAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 377 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 436
AKL+D+ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELI+G RA + +
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 437 ANQKGAML-DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMS 495
AN ML DWVK + +EKKLE LVD DL+ NY E+E+++QVALLCTQ P RPKMS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 496 EVVRMLEGDGLAEKWAASQKAEATR 520
EVVRMLEGDGLAE+W QK E R
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFR 325
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 426 bits (1097), Expect = e-148
Identities = 116/313 (37%), Positives = 179/313 (57%), Gaps = 23/313 (7%)
Query: 206 EQRREEVCLGNLKRFHFKELQSATSNFSSK------NLVGKGGFGNVYKGYLQDGTVVAV 259
E + EV F F EL++ T+NF + N +G+GGFG VYKGY+ + T VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 260 KRLKDGNAIG---GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS 316
K+L I + QF E+++++ H NL+ L+GF + LVY YM NGS+
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 317 RL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 373
RL P L W R +IA GAA G+ +LHE IHRD+K+ANILLDE + A + D
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 374 FGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 432
FGLA+ + + +T+ + GT ++APE L G+ + K+D++ FG++LLE+I+GL A++
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 433 FGKTANQKGAMLDWVKKIHQEKK-LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLR 491
+ + +LD ++I E+K +E +DK + N+ D +E M VA C + R
Sbjct: 236 EHR---EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 492 PKMSEVVRMLEGD 504
P + +V ++L+
Sbjct: 292 PDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 389 bits (1001), Expect = e-133
Identities = 112/294 (38%), Positives = 164/294 (55%), Gaps = 10/294 (3%)
Query: 216 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQ 275
R +L+ AT+NF K L+G G FG VYKG L+DG VA+KR ++ G E +F+
Sbjct: 25 ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE-EFE 83
Query: 276 TEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKR 331
TE+E +S H +L+ LIGFC E +L+Y YM NG++ L S+ W R
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTA 390
I +GAARGL YLH + IIHRDVK+ NILLDE + + DFG++K D +H++T
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200
Query: 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 450
V+GT+G+I PEY G+ +EK+DV+ FG++L E++ A+ + +W +
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWAVES 259
Query: 451 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504
H +LE +VD +L + L + A+ C RP M +V+ LE
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 3e-78
Identities = 71/302 (23%), Positives = 116/302 (38%), Gaps = 28/302 (9%)
Query: 224 ELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 283
L + + +G FG V+K L VAVK + Q + EV +
Sbjct: 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPG 74
Query: 284 AVHRNLLRLIGFCM----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 339
H N+L+ IG + L+ + GS++ LK + W IA ARG
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARG 133
Query: 340 LLYLHE-------QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAV 391
L YLHE P I HRD+K+ N+LL A + DFGLA + S T
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193
Query: 392 RGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW 446
GT ++APE L + + D++ G++L EL S A + G +
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD-GPVDEYMLPFEEE 252
Query: 447 VKKIHQEKKLEMLVDKD-----LKNNYDRIE-LEEMVQVALLCTQYLPSLRPKMSEVVRM 500
+ + + ++ +V L++ + + + + + C + R V
Sbjct: 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312
Query: 501 LE 502
+
Sbjct: 313 IT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-65
Identities = 72/318 (22%), Positives = 120/318 (37%), Gaps = 41/318 (12%)
Query: 220 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVE 279
E N L+G+G +G VYKG L D VAVK N F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKN 57
Query: 280 MISLAV--HRNLLRLIGFCMTT-----TERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 332
+ + + H N+ R I E LLV Y NGS+ L + DW + R+
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-LHTSDWVSSCRL 116
Query: 333 ALGAARGLLYLHE------QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--- 383
A RGL YLH P I HRD+ + N+L+ V+ DFGL+ L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 384 ----DSHVTTAVRGTVGHIAPEYL-------STGQSSEKTDVFGFGILLLELISGLRALE 432
+ + + GT+ ++APE L + ++ D++ G++ E+ L
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 433 FGKTANQ-KGAMLDWVKKIHQEKKLEMLVDKD-----LKNNY--DRIELEEMVQVALLCT 484
G++ + + A V + +++LV ++ + + + + + + C
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 485 QYLPSLRPKMSEVVRMLE 502
R +
Sbjct: 297 DQDAEARLTAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 8e-58
Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 33/274 (12%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 296
+G G FG V++ G+ VAVK L + + + F EV ++ H N++ +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 297 MTTTERLLVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
+V Y+S GS+ L A+ LD R +A A+G+ YLH +P I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 413
R++K+ N+L+D+ Y V DFGL++L + + GT +APE L S+EK+D
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 414 VFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 473
V+ FG++L EL + W ++ + + + K R+E+
Sbjct: 222 VYSFGVILWELATL---------------QQPW-GNLNPAQVVAAVGFKCK-----RLEI 260
Query: 474 -----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
++ + C P RP + ++ +L
Sbjct: 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-56
Identities = 69/283 (24%), Positives = 108/283 (38%), Gaps = 34/283 (12%)
Query: 235 KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
++GKG FG K + + G V+ +K L + + F EV+++ H N+L+ I
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-ETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 294 GFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
G + Y+ G++ + W+ R A A G+ YLH II
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NII 130
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-------------TAVRGTVGHIA 399
HRD+ + N L+ E VV DFGLA+L+ + V G +A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 400 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459
PE ++ EK DVF FGI+L E+I + A L+ L+
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-DYLPRTMDFGLN------VRGFLDRY 243
Query: 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ + + C P RP ++ LE
Sbjct: 244 CPPNC--------PPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-56
Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 46/288 (15%)
Query: 235 KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEI------QFQTEVEMISLAVHR 287
+ +GKGGFG V+KG ++D +VVA+K L G++ G +FQ EV ++S H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQ 346
N+++L G +V ++ G + RL + W+ + R+ L A G+ Y+
Sbjct: 84 NIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-N 140
Query: 347 CDPKIIHRDVKAANILLDEYYEAV-----VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 401
+P I+HRD+++ NI L E V DFGL++ H + + G +APE
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPE 196
Query: 402 YLSTGQS--SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459
+ + +EK D + F ++L +++G + + + + M+
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFI-------------NMI 242
Query: 460 VDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
++ L R + + V LC P RP S +V+ L
Sbjct: 243 REEGL-----RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-55
Identities = 70/273 (25%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
VG+G FG V K + VA+K+++ + F E+ +S H N+++L G C+
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIESESERK---AFIVELRQLSRVNHPNIVKLYGACL 71
Query: 298 TT----TERLLVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
E Y GS+ + L + P A L ++G+ YLH
Sbjct: 72 NPVCLVME------YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 351 IIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 409
+IHRD+K N+LL + + DFG A + T +G+ +APE S
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGSNYS 181
Query: 410 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469
EK DVF +GI+L E+I+ R F G + +H + ++ +
Sbjct: 182 EKCDVFSWGIILWEVIT--RRKPF---DEIGGPAFRIMWAVHNGTRPPLIKNLP------ 230
Query: 470 RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ + + C PS RP M E+V+++
Sbjct: 231 ----KPIESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-54
Identities = 68/279 (24%), Positives = 113/279 (40%), Gaps = 38/279 (13%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVHRNLLRLIG 294
+G GGFG VY+ + G VAVK + + E ++ ++ H N++ L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
C+ LV + G + L K + A+ ARG+ YLH++ IIHR
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132
Query: 355 DVKAANILLDEYYEAV--------VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 406
D+K++NIL+ + E + DFGLA+ + G +APE +
Sbjct: 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRAS 189
Query: 407 QSSEKTDVFGFGILLLELISGL---RALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463
S+ +DV+ +G+LL EL++G R ++ A KL + +
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA-----------MNKLALPIPST 238
Query: 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
E ++ C P RP + ++ L
Sbjct: 239 C--------PEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-53
Identities = 75/293 (25%), Positives = 122/293 (41%), Gaps = 34/293 (11%)
Query: 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLI 293
VGKG +G V++G Q G VAVK + E + E E+ + + H N+L I
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFI 68
Query: 294 GFCMTT----TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE---- 345
MT+ T+ L+ Y GS+ L+ +LD + RI L A GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 346 -QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV---TTAVRGTVGHIAPE 401
Q P I HRD+K+ NIL+ + + + D GLA + + + GT ++APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 402 ------YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV-KKIHQEK 454
+ S ++ D++ FG++L E+ R + G + K D V E
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVAR--RMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 455 KLEMLVDKDL-----KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+++ + L + ++ C PS R + + L
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-52
Identities = 68/296 (22%), Positives = 114/296 (38%), Gaps = 40/296 (13%)
Query: 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLI 293
+GKG +G V+ G + G VAVK E + E E+ + H N+L I
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFI 97
Query: 294 GFCM----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE---- 345
+ + T+ L+ Y NGS+ LK +LD + ++A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK-STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 346 -QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV---TTAVRGTVGHIAPE 401
Q P I HRD+K+ NIL+ + + D GLA + V GT ++ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 402 ------YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455
+ QS D++ FG++L E+ + + L + + +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS-----GGIVEEYQLPYHDLVPSDPS 271
Query: 456 LEMLVDKDLKNNY---------DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
E + + L +M ++ C + P+ R V + L
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-52
Identities = 77/275 (28%), Positives = 126/275 (45%), Gaps = 32/275 (11%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 296
+G G FG VYKG G V AVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 297 MTTTERL-LVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
T +L +V + S+ L ++ + IA ARG+ YLH + IIHR
Sbjct: 90 --TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHR 144
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHC-DSHVTTAVRGTVGHIAPEYLSTGQS---SE 410
D+K+ NI L E +GDFGLA SH + G++ +APE + S S
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 411 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 470
++DV+ FGI+L EL++G L + ++++ +EM+ L + +
Sbjct: 205 QSDVYAFGIVLYELMTG---------------QLPYSNINNRDQIIEMVGRGSLSPDLSK 249
Query: 471 IEL---EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ + M ++ C + RP ++ +E
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-52
Identities = 57/279 (20%), Positives = 105/279 (37%), Gaps = 44/279 (15%)
Query: 238 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 296
+ + G ++KG Q G + VK LK + + + F E + + H N+L ++G C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 297 MTTTERLL--VYPYMSNGSVASRL--KAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
+ + +M GS+ + L +D + + AL ARG+ +LH +P I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS---S 409
+ + ++++DE A + + S + +APE L
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPEDTNR 189
Query: 410 EKTDVFGFGILLLELI------SGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463
D++ F +LL EL+ + L +E G +G I
Sbjct: 190 RSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS------------ 237
Query: 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ ++ +C P+ RPK +V +LE
Sbjct: 238 ----------PHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-51
Identities = 66/285 (23%), Positives = 119/285 (41%), Gaps = 41/285 (14%)
Query: 235 KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRL 292
L+GKG FG VY G + + VA++ + +++ F+ EV H N++
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
+G CM+ ++ ++ S + AK LD ++IA +G+ YLH + I
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GI 151
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD----SHVTTAVRGTVGHIAPEYLSTGQ 407
+H+D+K+ N+ D + V+ DFGL + G + H+APE +
Sbjct: 152 LHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 408 S---------SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458
S+ +DVF G + EL + + Q + W
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-----TQPAEAIIWQ----------- 254
Query: 459 LVDKDLKNNYDRIEL-EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ +K N +I + +E+ + L C + RP ++++ MLE
Sbjct: 255 -MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 8e-51
Identities = 66/294 (22%), Positives = 117/294 (39%), Gaps = 36/294 (12%)
Query: 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLI 293
+GKG FG V++G + G VAVK E + E E+ + H N+L I
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102
Query: 294 GFCM----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE---- 345
T T+ LV Y +GS+ L + ++ ++AL A GL +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 346 -QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT---TAVRGTVGHIAPE 401
Q P I HRD+K+ NIL+ + + D GLA D + GT ++APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 402 YL------STGQSSEKTDVFGFGILLLELISGLRALEFGKT-------ANQKGAMLDWVK 448
L +S ++ D++ G++ E+ + ++ ++
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 449 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
K+ E+KL + ++ + ++++ C + R + + L
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 67/276 (24%), Positives = 112/276 (40%), Gaps = 40/276 (14%)
Query: 239 GKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
G+G FG V+ G L+ VAVK ++ + +F E ++ H N++RLIG C
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182
Query: 298 TTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356
+V + G + L+ L T ++ AA G+ YL + IHRD+
Sbjct: 183 QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDL 239
Query: 357 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI-----APEYLSTGQSSEK 411
A N L+ E + DFG+++ D G + + APE L+ G+ S +
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEA--DGVYAA--SGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 412 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 471
+DV+ FGILL E S + + Q + ++ R+
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQ--------------------TREFVEKGG-RL 334
Query: 472 EL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ + ++ C Y P RP S + + L+
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-40
Identities = 37/110 (33%), Positives = 60/110 (54%), Gaps = 3/110 (2%)
Query: 10 PSQNLSGT--LSSSIGNLTNLQ-LVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPI 66
NL + SS+ NL L L + NN+ G IP I KL++L L +++ +G I
Sbjct: 58 SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117
Query: 67 PSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
P +S ++TL L + N+L+G +PPS+S++ L + N +SG +P
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 144 bits (367), Expect = 3e-39
Identities = 36/105 (34%), Positives = 60/105 (57%), Gaps = 1/105 (0%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
NL G + +I LT L + + + N+SG IP + ++ L+TLD S N +G +P ++S
Sbjct: 88 NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLA-FLDLSYNNLSGPVPS 116
L L + + N ++GAIP S + S+L + +S N L+G +P
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-38
Identities = 32/123 (26%), Positives = 49/123 (39%), Gaps = 6/123 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
L+G + + NL NL V L N + G G + L+ N + V
Sbjct: 185 RLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGL 242
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF----HAKTFNITGNS 128
+ L L L NN + G +P L+ + L L++S+NNL G +P N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 129 LIC 131
+C
Sbjct: 303 CLC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 2/105 (1%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
N+SG + + + L + N +SG +P I L L+ + N +G IP +
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 73 LETL-QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
L + ++ N LTG IPP+ +N++ LAF+DLS N L G
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASV 215
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 8e-33
Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 3/107 (2%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISG--HIPTEIGKLSKLLTLDLSN-NFFTGPIPST 69
G L + + + L N+ IP+ + L L L + N GPIP
Sbjct: 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA 96
Query: 70 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
++ L L YL + + +++GAIP LS + L LD SYN LSG +P
Sbjct: 97 IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 27/86 (31%), Positives = 49/86 (56%), Gaps = 3/86 (3%)
Query: 35 NNNISGHIPTEIGKLSKLLTLDLSNNFFTG--PIPSTVSHLETLQYLRL-NNNSLTGAIP 91
N G + + ++ LDLS PIPS++++L L +L + N+L G IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 92 PSLSNMSQLAFLDLSYNNLSGPVPSF 117
P+++ ++QL +L +++ N+SG +P F
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDF 120
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 76/288 (26%), Positives = 120/288 (41%), Gaps = 52/288 (18%)
Query: 236 NLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
++G+G FG VY G L D AVK L IG QF TE ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 292 LIGFCMTTTE-RLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 349
L+G C+ + L+V PYM +G + + ++ + L A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK--- 147
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI-----APEYLS 404
K +HRD+ A N +LDE + V DFGLA+ + + + + T + A E L
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALESLQ 205
Query: 405 TGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEML 459
T + + K+DV+ FG+LL EL++ G
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFD------------------- 240
Query: 460 VDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ L R+ + + +V L C +RP SE+V +
Sbjct: 241 ITVYLLQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-39
Identities = 63/280 (22%), Positives = 117/280 (41%), Gaps = 27/280 (9%)
Query: 239 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
G+G FG V G VAVK LK + + E+E++ H N+++
Sbjct: 30 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYK 89
Query: 294 GFCMTTTER--LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 350
G C L+ ++ +GS+ L K ++ + + A+ +G+ YL + +
Sbjct: 90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---Q 146
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLSTGQ 407
+HRD+ A N+L++ ++ +GDFGL K + D T + APE L +
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAPECLMQSK 205
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467
+DV+ FG+ L EL++ + + + A+ + + + LK
Sbjct: 206 FYIASDVWSFGVTLHELLT------YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259
Query: 468 YDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
R+ +E+ Q+ C ++ PS R ++ E
Sbjct: 260 K-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 64/266 (24%), Positives = 109/266 (40%), Gaps = 33/266 (12%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLRLIG 294
+G+G F VYKG + VA L+D E +F+ E EM+ H N++R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 295 FCMTTTE---RLLVYP-YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
+T + +++ M++G++ + LK + + +GL +LH P
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPP 151
Query: 351 IIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 409
IIHRD+K NI + +V +GD GLA L + AV GT +APE
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEEK-YD 207
Query: 410 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK---LEMLVDKDLKN 466
E DV+ FG+ +LE+ + ++ +++ K + + ++K
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRVTSGVKPASFDKVAIPEVK- 260
Query: 467 NYDRIELEEMVQVALLCTQYLPSLRP 492
+ IE C + R
Sbjct: 261 --EIIE---------GCIRQNKDERY 275
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-38
Identities = 71/289 (24%), Positives = 114/289 (39%), Gaps = 52/289 (17%)
Query: 235 KNLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 290
++GKG FG VY G D A+K L + F E ++ H N+L
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 291 RLIGFCMTTTERLL-VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 348
LIG + + PYM +G + +++ + + L ARG+ YL EQ
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ-- 143
Query: 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI-----APEYL 403
K +HRD+ A N +LDE + V DFGLA+ + + + + + A E L
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHARLPVKWTALESL 200
Query: 404 STGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEM 458
T + + K+DV+ FG+LL EL++ G
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT------RGAPPYRHIDPFD------------------ 236
Query: 459 LVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ L R+ + + QV C + P++RP +V +E
Sbjct: 237 -LTHFLAQGR-RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 68/282 (24%), Positives = 112/282 (39%), Gaps = 33/282 (11%)
Query: 239 GKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
G+G FG V G +VAVK LK ++ E++++ H ++++
Sbjct: 40 GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYK 99
Query: 294 GFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
G C LV Y+ GS+ L + S+ A A G+ YLH Q
Sbjct: 100 GCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHAQ---HY 155
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLST 405
IHRD+ A N+LLD +GDFGLAK + + G APE L
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----APECLKE 211
Query: 406 GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465
+ +DV+ FG+ L EL++ ++ + I Q + + + + L+
Sbjct: 212 YKFYYASDVWSFGVTLYELLT------HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 466 NNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
R+ E+ + C + S RP ++ +L+
Sbjct: 266 RGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 75/288 (26%), Positives = 118/288 (40%), Gaps = 52/288 (18%)
Query: 236 NLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
++G+G FG VY G L D AVK L IG QF TE ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 292 LIGFCMTTTE-RLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 349
L+G C+ + L+V PYM +G + + ++ + L A+G+ +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK--- 211
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI-----APEYLS 404
K +HRD+ A N +LDE + V DFGLA+ + + T + A E L
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMALESLQ 269
Query: 405 TGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEML 459
T + + K+DV+ FG+LL EL++ G
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFD------------------- 304
Query: 460 VDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ L R+ + + +V L C +RP SE+V +
Sbjct: 305 ITVYLLQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 71/299 (23%), Positives = 123/299 (41%), Gaps = 64/299 (21%)
Query: 235 KNLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL 289
++G+G FG+V +G L+ VAVK +K N+ EI+ F +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 290 LRLIGFC-----MTTTERLLVYPYMSNGSVASRLKA------KPSLDWATRKRIALGAAR 338
+RL+G C + +++ P+M G + + L + T + + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 339 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRG 393
G+ YL + +HRD+ A N +L + V DFGL+K + D + V+
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 394 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVK 448
A E L+ + K+DV+ FG+ + E+ + G T N
Sbjct: 216 I----AIESLADRVYTSKSDVWAFGVTMWEIAT------RGMTPYPGVQNH--------- 256
Query: 449 KIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
EM L + + R++ L+E+ ++ C + P RP S + LE
Sbjct: 257 --------EMY--DYLLHGH-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-37
Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 29/281 (10%)
Query: 239 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
GKG FG+V G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 19 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 294 GFCMTTTER--LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 350
G C + R L+ Y+ GS+ L+ K +D + +G+ YL + +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---R 134
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLSTGQ 407
IHRD+ NIL++ +GDFGL K+L D I APE L+ +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 408 SSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466
S +DV+ FG++L EL + ++ + + I + + LKN
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------LIELLKN 247
Query: 467 NYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
N R+ +E+ + C + RP ++ ++
Sbjct: 248 NG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-37
Identities = 56/285 (19%), Positives = 109/285 (38%), Gaps = 55/285 (19%)
Query: 239 GKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
G G FG VYKG VA+K L++ + + E +++ + ++ RL+
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
G C T+ L+ M G + ++ K ++ + A+G+ YL ++ +++
Sbjct: 84 GIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLV 139
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 407
HRD+ A N+L+ + DFGLAKLL + ++ A E +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRI 195
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDK 462
+ ++DV+ +G+ + EL++ FG + +
Sbjct: 196 YTHQSDVWSYGVTVWELMT------FGSKPYDGIPASE-------------------ISS 230
Query: 463 DLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
L+ R+ ++ + C RPK E++
Sbjct: 231 ILEKGE-RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 29/281 (10%)
Query: 239 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
GKG FG+V G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 50 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYK 108
Query: 294 GFCMTTTER--LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 350
G C + R L+ Y+ GS+ L+ K +D + +G+ YL + +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---R 165
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLSTGQ 407
IHRD+ NIL++ +GDFGL K+L D I APE L+ +
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 408 SSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466
S +DV+ FG++L EL + ++ + + I + + LKN
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------LIELLKN 278
Query: 467 NYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
N R+ +E+ + C + RP ++ ++
Sbjct: 279 NG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 69/326 (21%), Positives = 118/326 (36%), Gaps = 66/326 (20%)
Query: 239 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLI 293
GKG FG+V + L+ VAVK LK +I+ F E + H ++ +L+
Sbjct: 32 GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91
Query: 294 GFC------MTTTERLLVYPYMSNGSVASRLKA------KPSLDWATRKRIALGAARGLL 341
G +++ P+M +G + + L A +L T R + A G+
Sbjct: 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVG 396
YL + IHRD+ A N +L E V DFGL++ + D + V+
Sbjct: 152 YLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL-- 206
Query: 397 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIH 451
A E L+ + +DV+ FG+ + E+++ G+T N +
Sbjct: 207 --ALESLADNLYTVHSDVWAFGVTMWEIMT------RGQTPYAGIENAE----------- 247
Query: 452 QEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL 506
+ L R++ EE+ + C P RP + + LE + L
Sbjct: 248 --------IYNYLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE-NIL 297
Query: 507 AEKWAASQKAEATRSRANEFSSSERY 532
S + +
Sbjct: 298 GHLSVLSTSQDPLYINIERAHHHHHH 323
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-36
Identities = 40/105 (38%), Positives = 61/105 (58%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
+G + ++ N + L + L N +SG IP+ +G LSKL L L N G IP + +
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 117
++TL+ L L+ N LTG IP LSN + L ++ LS N L+G +P +
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-36
Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 4/153 (2%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
L G + + + L+ ++L N+++G IP+ + + L + LSNN TG IP +
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS-FHAKTFNITGNSLIC 131
LE L L+L+NNS +G IP L + L +LDL+ N +G +P+ ++ I N +
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI-- 570
Query: 132 ATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPK 164
G M + +
Sbjct: 571 -AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE 602
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 7e-36
Identities = 44/104 (42%), Positives = 63/104 (60%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
LSGT+ SS+G+L+ L+ + L N + G IP E+ + L TL L N TG IPS +S+
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
L ++ L+NN LTG IP + + LA L LS N+ SG +P+
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 44/123 (35%), Positives = 65/123 (52%), Gaps = 4/123 (3%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
G S + N ++ + + N +SG+IP EIG + L L+L +N +G IP V
Sbjct: 619 VYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGD 678
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-KTFNIT---GNS 128
L L L L++N L G IP ++S ++ L +DLS NNLSGP+P +TF N
Sbjct: 679 LRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP 738
Query: 129 LIC 131
+C
Sbjct: 739 GLC 741
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-34
Identities = 30/122 (24%), Positives = 53/122 (43%), Gaps = 5/122 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
G S + L+ + + GH ++ LD+S N +G IP +
Sbjct: 595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAK-----TFNITGN 127
+ L L L +N ++G+IP + ++ L LDLS N L G +P + +++ N
Sbjct: 655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714
Query: 128 SL 129
+L
Sbjct: 715 NL 716
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-34
Identities = 40/106 (37%), Positives = 60/106 (56%), Gaps = 2/106 (1%)
Query: 13 NLSGTLSSSIGN--LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
N SG + ++ LQ + LQNN +G IP + S+L++L LS N+ +G IPS++
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
L L+ L+L N L G IP L + L L L +N+L+G +PS
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-32
Identities = 46/125 (36%), Positives = 63/125 (50%), Gaps = 8/125 (6%)
Query: 13 NLSGTLSSSIGNLT-NLQLVLLQNNNISGHIPTEIGK--LSKLLTLDLSNNFFTGPIPST 69
SG L S+ NL+ +L + L +NN SG I + + + L L L NN FTG IP T
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 70 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAK-----TFNI 124
+S+ L L L+ N L+G IP SL ++S+L L L N L G +P T +
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473
Query: 125 TGNSL 129
N L
Sbjct: 474 DFNDL 478
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 38/107 (35%), Positives = 57/107 (53%), Gaps = 3/107 (2%)
Query: 13 NLSGTLSSSI-GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP-STV 70
+G + + G L + L N+ G +P G S L +L LS+N F+G +P T+
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMS-QLAFLDLSYNNLSGPVPS 116
+ L+ L L+ N +G +P SL+N+S L LDLS NN SGP+
Sbjct: 340 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 386
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-31
Identities = 42/123 (34%), Positives = 62/123 (50%), Gaps = 9/123 (7%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
N S + +G+ + LQ + + N +SG I ++L L++S+N F GPIP
Sbjct: 211 NFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LP 267
Query: 73 LETLQYLRLNNNSLTGAIPPSLS-NMSQLAFLDLSYNNLSGPVPSF-----HAKTFNITG 126
L++LQYL L N TG IP LS L LDLS N+ G VP F ++ ++
Sbjct: 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327
Query: 127 NSL 129
N+
Sbjct: 328 NNF 330
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-28
Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 4/122 (3%)
Query: 7 RGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPI 66
P +SSS+ +LT L+ + L N++I+G + + L +LDLS N +GP+
Sbjct: 58 SSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPV 116
Query: 67 PSTVS--HLETLQYLRLNNNSLTGAIP-PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 123
+ S L++L +++N+L ++ L LDLS N++SG +
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176
Query: 124 IT 125
Sbjct: 177 CG 178
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-27
Identities = 23/106 (21%), Positives = 48/106 (45%), Gaps = 2/106 (1%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNN--NISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
++G I N + N G ++ +LS ++++ + G T
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
+ ++ +L ++ N L+G IP + +M L L+L +N++SG +P
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-27
Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 8/111 (7%)
Query: 13 NLSGTLSS--SIGNLTNLQLVLLQNNNISGHIPTEIG-KLSKLLTLDLSNNFFTGPIPST 69
+LSG +++ S+G+ + L+ + + +N + G KL+ L LDLS N +G
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170
Query: 70 V---SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 117
L++L ++ N ++G + +S L FLD+S NN S +P
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFL 219
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-24
Identities = 19/107 (17%), Positives = 38/107 (35%), Gaps = 6/107 (5%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
+ SG + + +G+ +L + L N +G IP + K S ++ NF G + +
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKN 580
Query: 73 LETLQYLRL--NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 117
+ N G L+ +S +++ G
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-21
Identities = 27/96 (28%), Positives = 44/96 (45%), Gaps = 3/96 (3%)
Query: 23 GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82
+T++ L N + + + L+ L +L LSN+ G + +L L L+
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108
Query: 83 NNSLTGAIPP--SLSNMSQLAFLDLSYNNLSGPVPS 116
NSL+G + SL + S L FL++S N L P
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKV 144
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-13
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 50 SKLLTLDLSNNFFT---GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLS 106
K+ ++DLS+ + S++ L L+ L L+N+ + G++ + L LDLS
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 107 YNNLSGPVPSFHA-------KTFNITGNSL 129
N+LSGPV + + K N++ N+L
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTL 138
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-36
Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 34/283 (12%)
Query: 239 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
GKG FG+V G +VAVK+L+ + FQ E++++ +++
Sbjct: 32 GKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 294 GFCMTTTER--LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 350
G + LV Y+ +G + L+ + LD + + +G+ YL + +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---R 147
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLS 404
+HRD+ A NIL++ + DFGLAKLL + G APE LS
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----APESLS 203
Query: 405 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464
S ++DV+ FG++L EL + + + A + ++ + + L
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFT------YCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 465 KNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ R+ E+ ++ LC P RP S + L+
Sbjct: 258 EEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 61/325 (18%), Positives = 119/325 (36%), Gaps = 56/325 (17%)
Query: 239 GKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
G G FG VYKG VA+K L++ + + E +++ + ++ RL+
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
G C T+ L+ M G + ++ K ++ + A+G+ YL ++ +++
Sbjct: 84 GIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLV 139
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 407
HRD+ A N+L+ + DFGLAKLL + ++ A E +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRI 195
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDK 462
+ ++DV+ +G+ + EL++ FG + +
Sbjct: 196 YTHQSDVWSYGVTVWELMT------FGSKPYDGIPASE-------------------ISS 230
Query: 463 DLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAE 517
L+ R+ ++ + + C RPK E++ +
Sbjct: 231 ILEKGE-RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS-KMARDPQRYLVIQG 288
Query: 518 ATRSRANEFSSSERYSDLTDDSSLL 542
R + S Y L D+ +
Sbjct: 289 DERMHLPSPTDSNFYRALMDEEDMD 313
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 73/280 (26%), Positives = 114/280 (40%), Gaps = 34/280 (12%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+ + +G+G FG V+ G T VA+K LK G F E +++ H L
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKL 241
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQC 347
++L + +V YMS GS+ LK + L +A A G+ Y+
Sbjct: 242 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 299
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
+HRD++AANIL+ E V DFGLA+L++ + + + APE G+
Sbjct: 300 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467
+ K+DV+ FGILL EL + R G + V ++
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------------------VLDQVERG 397
Query: 468 YDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
Y R+ E + + C + P RP + LE
Sbjct: 398 Y-RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-34
Identities = 73/271 (26%), Positives = 111/271 (40%), Gaps = 34/271 (12%)
Query: 239 GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 298
G+G FG V+ G T VA+K LK G F E +++ H L++L +
Sbjct: 276 GQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVV-S 332
Query: 299 TTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356
+V YMS GS+ LK + L +A A G+ Y+ +HRD+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 389
Query: 357 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 416
+AANIL+ E V DFGLA+L++ + + + APE G+ + K+DV+
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 417 FGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL--- 473
FGILL EL + R G + V ++ Y R+
Sbjct: 450 FGILLTELTTKGRVPYPGMVNRE--------------------VLDQVERGY-RMPCPPE 488
Query: 474 --EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
E + + C + P RP + LE
Sbjct: 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 63/285 (22%), Positives = 110/285 (38%), Gaps = 57/285 (20%)
Query: 239 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
G+G FG VY+G + VAVK K + + +F +E ++ H ++++LIG
Sbjct: 21 GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
++ G + L+ K SL T +L + + YL +H
Sbjct: 81 II-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVH 136
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLSTGQ 407
RD+ NIL+ +GDFGL++ ++ D A +PE ++ +
Sbjct: 137 RDIAVRNILVASPECVKLGDFGLSRYIE--DEDYYKASVTRLPIKWM----SPESINFRR 190
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDK 462
+ +DV+ F + + E++S FGK N+ V
Sbjct: 191 FTTASDVWMFAVCMWEILS------FGKQPFFWLENKD-------------------VIG 225
Query: 463 DLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
L+ R+ + + C Y PS RP+ +E+V L
Sbjct: 226 VLEKGD-RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 235 KNLVGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 291
+G G FG+V +G + VA+K LK G + E +++ + ++R
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 350
LIG C +LV G + L + + + + + G+ YL E+
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---N 130
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLS 404
+HRD+ A N+LL + A + DFGL+K L DS+ T G APE ++
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECIN 186
Query: 405 TGQSSEKTDVFGFGILLLELIS 426
+ S ++DV+ +G+ + E +S
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALS 208
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 239 GKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
G G FG V+KG V +K ++D + + I H +++RL+
Sbjct: 22 GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLL 81
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
G C + LV Y+ GS+ ++ + +L + A+G+ YL E ++
Sbjct: 82 GLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMV 137
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 407
HR++ A N+LL + V DFG+A LL D + + ++ A E + G+
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----ALESIHFGK 193
Query: 408 SSEKTDVFGFGILLLELIS 426
+ ++DV+ +G+ + EL++
Sbjct: 194 YTHQSDVWSYGVTVWELMT 212
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-34
Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 57/285 (20%)
Query: 239 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
G+G FG+V++G VA+K K+ + +F E + H ++++LIG
Sbjct: 24 GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 83
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
T ++ + G + S L+ K SLD A+ A + L YL + + +H
Sbjct: 84 VI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVH 139
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLSTGQ 407
RD+ A N+L+ +GDFGL++ ++ DS A +G APE ++ +
Sbjct: 140 RDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWM----APESINFRR 193
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDK 462
+ +DV+ FG+ + E++ G N V
Sbjct: 194 FTSASDVWMFGVCMWEILM------HGVKPFQGVKNND-------------------VIG 228
Query: 463 DLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
++N R+ + + + C Y PS RP+ +E+ L
Sbjct: 229 RIENGE-RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 62/290 (21%), Positives = 124/290 (42%), Gaps = 54/290 (18%)
Query: 239 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G+G FG VY+G + T VA+K + + ++ I+F E ++ +++RL
Sbjct: 34 GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAK-------PSLDWATRKR---IALGAARGLLY 342
+G L++ M+ G + S L++ P L + + +A A G+ Y
Sbjct: 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY 153
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---- 398
L+ K +HRD+ A N ++ E + +GDFG+ + + D +G G +
Sbjct: 154 LNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRW 206
Query: 399 -APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457
+PE L G + +DV+ FG++L E+ + + +Q E
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQP-------------YQGLSNE 247
Query: 458 MLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
++ + ++ + + ++ +C QY P +RP E++ ++
Sbjct: 248 QVLRF-VMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 69/273 (25%), Positives = 124/273 (45%), Gaps = 36/273 (13%)
Query: 239 GKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLIGFC 296
G G +G VY+G + ++ VAVK LK+ +F E M + H NL++L+G C
Sbjct: 229 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIK-HPNLVQLLGVC 285
Query: 297 MTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
++ +M+ G++ L+ + + +A + + YL ++ IHR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHR 342
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 414
++ A N L+ E + V DFGL++L+ + + APE L+ + S K+DV
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 415 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL- 473
+ FG+LL E+ + + G +Q V + L+ +Y R+E
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLSQ--------------------VYELLEKDY-RMERP 441
Query: 474 ----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
E++ ++ C Q+ PS RP +E+ + E
Sbjct: 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 72/304 (23%), Positives = 116/304 (38%), Gaps = 73/304 (24%)
Query: 239 GKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNL 289
G+G FG V VAVK LKD +E+E M + H+N+
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRK-----------RIA 333
+ L+G C ++ Y S G++ A R R
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA--- 390
ARG+ YL Q K IHRD+ A N+L+ E + DFGLA+ +++ D + T
Sbjct: 210 YQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266
Query: 391 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAM 443
V+ APE L + ++DV+ FG+L+ E+ + G + ++
Sbjct: 267 LPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEE--- 313
Query: 444 LDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVV 498
+ K LK + R++ E+ + C +PS RP ++V
Sbjct: 314 ----------------LFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356
Query: 499 RMLE 502
L+
Sbjct: 357 EDLD 360
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 48/287 (16%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
S + +G G FG V+ GY + VA+K +++G E F E E++ H L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKL 65
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 348
++L G C+ LV +M +G ++ L+ + T + L G+ YL E
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-- 123
Query: 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLST 405
+IHRD+ A N L+ E V DFG+ + + T+ GT + +PE S
Sbjct: 124 -CVIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSF 179
Query: 406 GQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLV 460
+ S K+DV+ FG+L+ E+ S GK +N + V
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFS------EGKIPYENRSNSE-------------------V 214
Query: 461 DKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+D+ + R+ + Q+ C + P RP S ++R L
Sbjct: 215 VEDISTGF-RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-33
Identities = 64/285 (22%), Positives = 116/285 (40%), Gaps = 57/285 (20%)
Query: 239 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
G+G FG+V++G VA+K K+ + +F E + H ++++LIG
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 458
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
T ++ + G + S L+ K SLD A+ A + L YL + + +H
Sbjct: 459 VI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVH 514
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA------VRGTVGHIAPEYLSTGQ 407
RD+ A N+L+ +GDFGL++ ++ DS A ++ APE ++ +
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWM----APESINFRR 568
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDK 462
+ +DV+ FG+ + E++ G N V
Sbjct: 569 FTSASDVWMFGVCMWEILM------HGVKPFQGVKNND-------------------VIG 603
Query: 463 DLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
++N R+ + + + C Y PS RP+ +E+ L
Sbjct: 604 RIENGE-RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 72/288 (25%), Positives = 112/288 (38%), Gaps = 54/288 (18%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+GKG FG+V G + G VAVK +K+ F E +++ H NL
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNL 248
Query: 290 LRLIGFCMTTTERLLVY---PYMSNGSVAS--RLKAKPSLDWATRKRIALGAARGLLYLH 344
++L+G E+ +Y YM+ GS+ R + + L + +L + YL
Sbjct: 249 VQLLGVI--VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 404
+HRD+ A N+L+ E A V DFGL K V+ T APE L
Sbjct: 307 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALR 359
Query: 405 TGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEML 459
+ S K+DV+ FGILL E+ S FG+ +
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYS------FGRVPYPRIPLKD------------------- 394
Query: 460 VDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
V ++ Y +++ + V C + RP ++ LE
Sbjct: 395 VVPRVEKGY-KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 70/279 (25%), Positives = 109/279 (39%), Gaps = 44/279 (15%)
Query: 239 GKGGFGNVYKGYLQDG---TVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
G G FG V KGY Q VAVK LK+ N + + E ++ + ++R+IG
Sbjct: 26 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
C +LV G + L+ + + + G+ YL E +HR
Sbjct: 86 IC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHR 141
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLSTGQS 408
D+ A N+LL + A + DFGL+K L +++ G APE ++ +
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APECINYYKF 197
Query: 409 SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468
S K+DV+ FG+L+ E S +G+ + E V L+
Sbjct: 198 SSKSDVWSFGVLMWEAFS------YGQKP--------YRGMKGSE------VTAMLEKGE 237
Query: 469 DRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
R+ EM + LC Y RP + V L
Sbjct: 238 -RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-33
Identities = 64/275 (23%), Positives = 113/275 (41%), Gaps = 36/275 (13%)
Query: 239 GKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295
G G FG+V +G + VA+K LK G + E +++ + ++RLIG
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 296 CMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
C +LV G + L + + + + + G+ YL E+ +HR
Sbjct: 405 C-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHR 460
Query: 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSSEKT 412
++ A N+LL + A + DFGL+K L DS+ T G + APE ++ + S ++
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 520
Query: 413 DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 472
DV+ +G+ + E +S +G+ + K E V ++ R+E
Sbjct: 521 DVWSYGVTMWEALS------YGQKP--------YKKMKGPE------VMAFIEQGK-RME 559
Query: 473 L-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
E+ + C Y RP V + +
Sbjct: 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 52/289 (17%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+ +G G FG V G + VAVK +K+G+ E +F E + + H L
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKL 65
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 348
++ G C +V Y+SNG + + L++ L+ + + G+ +L
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH-- 123
Query: 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYL 403
+ IHRD+ A N L+D V DFG+ + + D +V++ V+ + APE
Sbjct: 124 -QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWS----APEVF 177
Query: 404 STGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEM 458
+ S K+DV+ FGIL+ E+ S GK N +
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFS------LGKMPYDLYTNSE------------------ 213
Query: 459 LVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
V + + R+ + + Q+ C LP RP +++ +E
Sbjct: 214 -VVLKVSQGH-RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 73/295 (24%), Positives = 115/295 (38%), Gaps = 64/295 (21%)
Query: 239 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 39 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKA-------KPSLDWATRKRIALGAARGLLYLHE 345
IG + + R ++ M+ G + S L+ SL +A A G YL E
Sbjct: 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 158
Query: 346 QCDPKIIHRDVKAANILLDEYYEAVV---GDFGLAKLLDHCDSHVTTAVRGTVGHI---- 398
IHRD+ A N LL V GDFG+A+ + +G +
Sbjct: 159 N---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCAMLPVKW 211
Query: 399 -APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQ 452
PE G + KTD + FG+LL E+ S G +NQ+
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS------LGYMPYPSKSNQE------------ 253
Query: 453 EKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
V + + + R++ + ++ C Q+ P RP + ++ +E
Sbjct: 254 -------VLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 80/301 (26%), Positives = 114/301 (37%), Gaps = 59/301 (19%)
Query: 239 GKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQ--FQTEVE-MISLAVHRNLLR 291
G G FG V +G VAVK LK E F EV M SL HRNL+R
Sbjct: 27 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIR 85
Query: 292 LIGFCMTTTERL-LVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 349
L G T + +V GS+ RL+ + T R A+ A G+ YL +
Sbjct: 86 LYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK--- 140
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYL 403
+ IHRD+ A N+LL +GDFGL + L D H APE L
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----APESL 196
Query: 404 STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE--KKLEMLVD 461
T S +D + FG+ L E+ + +G+ W+ + K++
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT------YGQEP--------WIGLNGSQILHKID---- 238
Query: 462 KDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKA 516
K R+ +++ V + C + P RP + L E +A
Sbjct: 239 ---KEGE-RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL-----EAQPTDMRA 289
Query: 517 E 517
E
Sbjct: 290 E 290
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 71/304 (23%), Positives = 119/304 (39%), Gaps = 73/304 (24%)
Query: 239 GKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNL 289
G+G FG V VAVK LKD +E+E M + H+N+
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIA 333
+ L+G C ++ Y S G++ L+A+ + +
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA--- 390
ARG+ YL Q K IHRD+ A N+L+ E + DFGLA+ +++ D + T
Sbjct: 164 YQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 391 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAM 443
V+ APE L + ++DV+ FG+L+ E+ + G + ++
Sbjct: 221 LPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEE--- 267
Query: 444 LDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVV 498
+ K LK + R++ E+ + C +PS RP ++V
Sbjct: 268 ----------------LFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 499 RMLE 502
L+
Sbjct: 311 EDLD 314
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 58/287 (20%), Positives = 111/287 (38%), Gaps = 48/287 (16%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+ + +G G FG V G + VA+K +K+G+ E +F E +++ H L
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKL 81
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 348
++L G C ++ YM+NG + + L+ + + + YL +
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-- 139
Query: 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLST 405
+ +HRD+ A N L+++ V DFGL++ + T+ G+ + PE L
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 406 GQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLV 460
+ S K+D++ FG+L+ E+ S GK N +
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYS------LGKMPYERFTNSE-------------------T 230
Query: 461 DKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ + R+ E++ + C RP ++ +
Sbjct: 231 AEHIAQGL-RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 81/291 (27%), Positives = 126/291 (43%), Gaps = 56/291 (19%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRL 70
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQC 347
+RL T ++ YM NGS+ LK L +A A G+ ++ E+
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA------VRGTVGHIAPE 401
IHRD++AANIL+ + + DFGLA+L++ D+ T ++ T APE
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWT----APE 180
Query: 402 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKL 456
++ G + K+DV+ FGILL E+++ G+ N +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT------HGRIPYPGMTNPE---------------- 218
Query: 457 EMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
V ++L+ Y R+ EE+ Q+ LC + P RP + +LE
Sbjct: 219 ---VIQNLERGY-RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 69/279 (24%), Positives = 120/279 (43%), Gaps = 50/279 (17%)
Query: 239 GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 298
G G FG V+ T VAVK +K G+ F E ++ H L++L T
Sbjct: 197 GAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVV-T 253
Query: 299 TTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356
++ +M+ GS+ LK+ + A G+ ++ ++ IHRD+
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDL 310
Query: 357 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLSTGQSSEKTD 413
+AANIL+ + DFGLA+++ + + TA G I APE ++ G + K+D
Sbjct: 311 RAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 414 VFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468
V+ FGILL+E+++ +G+ +N + V + L+ Y
Sbjct: 368 VWSFGILLMEIVT------YGRIPYPGMSNPE-------------------VIRALERGY 402
Query: 469 DRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
R+ EE+ + + C + P RP + +L+
Sbjct: 403 -RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 71/285 (24%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 239 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
G G G V G L+ VA+K LK G F +E ++ H N++RL G
Sbjct: 58 GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG 117
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
++V YM NGS+ + L+ + G G+ YL + +H
Sbjct: 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVH 174
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 407
RD+ A N+L+D V DFGL+++L D D+ TT +R T APE ++
Sbjct: 175 RDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAIAFRT 230
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDK 462
S +DV+ FG+++ E+++ +G+ N+ V
Sbjct: 231 FSSASDVWSFGVVMWEVLA------YGERPYWNMTNRD-------------------VIS 265
Query: 463 DLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
++ Y R+ + Q+ L C + RP+ S++V +L+
Sbjct: 266 SVEEGY-RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 70/303 (23%), Positives = 124/303 (40%), Gaps = 71/303 (23%)
Query: 235 KNLVGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 290
++++G+G FG V K ++ A+KR+K+ + F E+E + L H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK----------------RIAL 334
L+G C L Y +G++ L+ L+ A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 335 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 394
ARG+ YL ++ + IHRD+ A NIL+ E Y A + DFGL++ + V+ T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 199
Query: 395 VGHI-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAML 444
+G + A E L+ + +DV+ +G+LL E++S G T +
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCAE---- 249
Query: 445 DWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVR 499
+ + L Y R+E +E+ + C + P RP ++++
Sbjct: 250 ---------------LYEKLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293
Query: 500 MLE 502
L
Sbjct: 294 SLN 296
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 70/304 (23%), Positives = 115/304 (37%), Gaps = 73/304 (24%)
Query: 239 GKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 291
G+G FG V + VAVK LK+G +E++ +I + H N++
Sbjct: 36 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 292 LIGFCMTTTE-RLLVYPYMSNGSV-----ASRLKAKPSLDWATRKR-----------IAL 334
L+G C +++ + G++ + R + P +
Sbjct: 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 335 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA---- 390
A+G+ +L + K IHRD+ A NILL E + DFGLA+ + +V
Sbjct: 156 QVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 391 -VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT------ANQKGAM 443
++ APE + + ++DV+ FG+LL E+ S G + +++
Sbjct: 213 PLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEE--- 259
Query: 444 LDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVV 498
+ LK R+ EM Q L C PS RP SE+V
Sbjct: 260 ----------------FCRRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302
Query: 499 RMLE 502
L
Sbjct: 303 EHLG 306
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 73/293 (24%), Positives = 117/293 (39%), Gaps = 64/293 (21%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+GKG FG+V G + G VAVK +K+ F E +++ H NL
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNL 76
Query: 290 LRLIGFCMTTTERLLVY---PYMSNGSVAS--RLKAKPSLDWATRKRIALGAARGLLYLH 344
++L+G E+ +Y YM+ GS+ R + + L + +L + YL
Sbjct: 77 VQLLGVI--VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIA 399
+HRD+ A N+L+ E A V DFGL K ++ T V+ T A
Sbjct: 135 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWT----A 182
Query: 400 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEK 454
PE L + S K+DV+ FGILL E+ S FG+ +
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS------FGRVPYPRIPLKD-------------- 222
Query: 455 KLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
V ++ Y +++ + +V C ++RP ++ LE
Sbjct: 223 -----VVPRVEKGY-KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 73/304 (24%), Positives = 116/304 (38%), Gaps = 73/304 (24%)
Query: 239 GKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNL 289
G+G FG V T VAVK LK +E+E M + H+N+
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRK-----------RIA 333
+ L+G C ++ Y S G++ A R + A
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA--- 390
ARG+ YL + K IHRD+ A N+L+ E + DFGLA+ + H D + T
Sbjct: 198 YQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254
Query: 391 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAM 443
V+ APE L + ++DV+ FG+LL E+ + G + ++
Sbjct: 255 LPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEE--- 301
Query: 444 LDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVV 498
+ K LK + R++ E+ + C +PS RP ++V
Sbjct: 302 ----------------LFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 344
Query: 499 RMLE 502
L+
Sbjct: 345 EDLD 348
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 55/286 (19%)
Query: 239 GKGGFGNVYKGYLQDGTV-----VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
G G FG VYKG L+ + VA+K LK G + F E ++ H N++RL
Sbjct: 53 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLE 112
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
G +++ YM NG++ L+ + G A G+ YL +
Sbjct: 113 GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYV 169
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTA-----VRGTVGHIAPEYLSTG 406
HRD+ A NIL++ V DFGL+++L D ++ TT+ +R T APE +S
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAISYR 225
Query: 407 QSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVD 461
+ + +DV+ FGI++ E+++ +G+ +N + V
Sbjct: 226 KFTSASDVWSFGIVMWEVMT------YGERPYWELSNHE-------------------VM 260
Query: 462 KDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
K + + + R+ + Q+ + C Q + RPK +++V +L+
Sbjct: 261 KAINDGF-RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 73/295 (24%), Positives = 115/295 (38%), Gaps = 64/295 (21%)
Query: 239 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 80 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 139
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKA-------KPSLDWATRKRIALGAARGLLYLHE 345
IG + + R ++ M+ G + S L+ SL +A A G YL E
Sbjct: 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 199
Query: 346 QCDPKIIHRDVKAANILLDEYYEAVV---GDFGLAKLLDHCDSHVTTAVRGTVGHI---- 398
IHRD+ A N LL V GDFG+A+ + +G +
Sbjct: 200 N---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAMLPVKW 252
Query: 399 -APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQ 452
PE G + KTD + FG+LL E+ S G +NQ+
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS------LGYMPYPSKSNQE------------ 294
Query: 453 EKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
V + + + R++ + ++ C Q+ P RP + ++ +E
Sbjct: 295 -------VLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 84/333 (25%), Positives = 139/333 (41%), Gaps = 56/333 (16%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
+N S +VG G FG V G L+ VA+K LK G F E ++
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 286 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLH 344
H N++RL G + ++V YM NGS+ S L+ + G A G+ YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTA-----VRGTVGHI 398
+ +HRD+ A NIL++ V DFGL ++L D ++ TT +R T
Sbjct: 165 DM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT---- 217
Query: 399 APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQE 453
+PE ++ + + +DV+ +GI+L E++S +G+ +NQ
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQD------------- 258
Query: 454 KKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAE 508
V K + Y R+ + Q+ L C Q + RPK ++V +L D L
Sbjct: 259 ------VIKAVDEGY-RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL--DKLIR 309
Query: 509 KWAASQKAEATRSRANEFSSSERYSDLTDDSSL 541
+ + + +R + + D+T +
Sbjct: 310 NPGSLKIITSAAARPSNLLLDQSNVDITTFRTT 342
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 65/295 (22%), Positives = 116/295 (39%), Gaps = 58/295 (19%)
Query: 239 GKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 291
G G FG V + VAVK LK + +E++ M L H N++
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 114
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKAK--------------PSLDWATRKRIALGAA 337
L+G C L++ Y G + + L+ K + + A
Sbjct: 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VR 392
+G+ +L + IHRDV A N+LL + A +GDFGLA+ + + +++ V+
Sbjct: 175 QGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452
APE + + ++DV+ +GILL E+ S G G + ++
Sbjct: 232 WM----APESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYP-GIL------VNS 274
Query: 453 EKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ K +K+ Y ++ + + + C P+ RP ++ L+
Sbjct: 275 K------FYKLVKDGY-QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 71/282 (25%), Positives = 129/282 (45%), Gaps = 54/282 (19%)
Query: 239 GKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
G G +G VY+G + ++ VAVK LK+ +F E ++ H NL++L+G C
Sbjct: 22 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 298 TTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 355
++ +M+ G++ L+ + + +A + + YL ++ IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 356 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQSSE 410
+ A N L+ E + V DFGL++L+ D++ A ++ T APE L+ + S
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWT----APESLAYNKFSI 191
Query: 411 KTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465
K+DV+ FG+LL E+ + +G + + V + L+
Sbjct: 192 KSDVWAFGVLLWEIAT------YGMSPYPGIDLSQ-------------------VYELLE 226
Query: 466 NNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+Y R+E E++ ++ C Q+ PS RP +E+ + E
Sbjct: 227 KDY-RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 60/301 (19%), Positives = 112/301 (37%), Gaps = 70/301 (23%)
Query: 239 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G+ FG VYKG+L VA+K LKD +F+ E + + H N++ L
Sbjct: 18 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCL 77
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKA----------------KPSLDWATRKRIALGA 336
+G +++ Y S+G + L K +L+ +
Sbjct: 78 LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 137
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----V 391
A G+ YL ++H+D+ N+L+ + + D GL + + D + +
Sbjct: 138 AAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 194
Query: 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDW 446
R APE + G+ S +D++ +G++L E+ S +G +NQ
Sbjct: 195 RWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS------YGLQPYCGYSNQD------ 238
Query: 447 VKKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRML 501
V + ++N + + + + C PS RP+ ++ L
Sbjct: 239 -------------VVEMIRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 502 E 502
Sbjct: 285 R 285
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 66/305 (21%), Positives = 108/305 (35%), Gaps = 74/305 (24%)
Query: 239 GKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 291
G G FG V + VAVK LK + +E++ + L H N++
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 292 LIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRKR-------------IA 333
L+G C L++ Y G + R S +
Sbjct: 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA--- 390
A+G+ +L + IHRD+ A NILL + DFGLA+ + + ++V
Sbjct: 152 YQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 391 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT------ANQKGA 442
V+ APE + + ++DV+ +GI L EL S G + + K
Sbjct: 209 LPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS------LGSSPYPGMPVDSK-- 256
Query: 443 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEV 497
K +K + R+ EM + C P RP ++
Sbjct: 257 -----------------FYKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
Query: 498 VRMLE 502
V+++E
Sbjct: 299 VQLIE 303
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 68/301 (22%), Positives = 120/301 (39%), Gaps = 71/301 (23%)
Query: 239 GKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G+G FG V+ +D +VAVK LKD + FQ E E+++ H ++++
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKF 82
Query: 293 IGFCMTTTERLLVYPYMSNGS-----VASRLKAKPSLDWATRKR-----------IALGA 336
G C ++V+ YM +G A A +D R+ IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----V 391
A G++YL Q +HRD+ N L+ +GDFG+++ + D + +
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDW 446
R PE + + + ++DV+ FG++L E+ + +GK +N +
Sbjct: 200 RWM----PPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSNTE------ 243
Query: 447 VKKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRML 501
V + + +E +E+ V L C Q P R + E+ ++L
Sbjct: 244 -------------VIECITQGR-VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289
Query: 502 E 502
Sbjct: 290 H 290
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 15/211 (7%)
Query: 223 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 281
E + + + VG+G FG V++ Q G AVK+ + E+ E+
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK------VRLEVFRVEELVAC 104
Query: 282 SLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 341
+ ++ L G + + GS+ +K L A GL
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE 164
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTA----VRGTVG 396
YLH + +I+H DVKA N+LL + DFG A L + + GT
Sbjct: 165 YLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 397 HIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
H+APE + K D++ ++L +++G
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 57/289 (19%), Positives = 105/289 (36%), Gaps = 59/289 (20%)
Query: 239 GKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 290
G+G F ++KG ++ T V +K L F M+S H++L+
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLV 75
Query: 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 349
G C+ E +LV ++ GS+ + LK K ++ + +A A + +L E
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN--- 132
Query: 350 KIIHRDVKAANILLDEYYEAV--------VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 401
+IH +V A NILL + + D G++ + + + PE
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-KDILQERIPWV----PPE 187
Query: 402 YLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKK 455
+ ++ + TD + FG L E+ S G +Q+
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICS------GGDKPLSALDSQR--------------- 226
Query: 456 LEMLVDKDLKNNY--DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ ++ + + E+ + C Y P RP ++R L
Sbjct: 227 ----KLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 61/300 (20%), Positives = 114/300 (38%), Gaps = 70/300 (23%)
Query: 239 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G+G FG V+ + +VAVK LK+ + FQ E E++++ H++++R
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTMLQHQHIVRF 108
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKR--------------IALGAA 337
G C L+V+ YM +G + L++ P +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 397
G++YL +HRD+ N L+ + +GDFG+++ + D G
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRVGGRTM 221
Query: 398 I-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWV 447
+ PE + + + ++DV+ FG++L E+ + +GK +N +
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT------YGKQPWYQLSNTE------- 268
Query: 448 KKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ +E E+ + C Q P R + +V L+
Sbjct: 269 ------------AIDCITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 64/310 (20%), Positives = 108/310 (34%), Gaps = 79/310 (25%)
Query: 239 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 291
G G FG V VAVK LK+ +E++ M L H N++
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113
Query: 292 LIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRKR--------------- 331
L+G C + L++ Y G + + R K ++
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173
Query: 332 ---IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388
A A+G+ +L + +HRD+ A N+L+ + DFGLA+ + ++V
Sbjct: 174 LLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 230
Query: 389 TA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT------A 437
V+ APE L G + K+DV+ +GILL E+ S G
Sbjct: 231 RGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS------LGVNPYPGIPV 280
Query: 438 NQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRP 492
+ K ++N + +++ EE+ + C + RP
Sbjct: 281 DAN-------------------FYKLIQNGF-KMDQPFYATEEIYIIMQSCWAFDSRKRP 320
Query: 493 KMSEVVRMLE 502
+ L
Sbjct: 321 SFPNLTSFLG 330
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 73/309 (23%), Positives = 120/309 (38%), Gaps = 78/309 (25%)
Query: 239 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G+G FG V K T VAVK LK+ + +E ++ H ++++L
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL 91
Query: 293 IGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRK----------------- 330
G C LL+ Y GS+ SR L +
Sbjct: 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151
Query: 331 --RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388
A ++G+ YL E K++HRD+ A NIL+ E + + DFGL++ + DS+V
Sbjct: 152 LISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208
Query: 389 TA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----AN 438
+ V+ A E L + ++DV+ FG+LL E+++ G
Sbjct: 209 RSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVT------LGGNPYPGIPP 258
Query: 439 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPK 493
+ + LK + R+E EEM ++ L C + P RP
Sbjct: 259 E-----------------RLF--NLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPV 298
Query: 494 MSEVVRMLE 502
+++ + LE
Sbjct: 299 FADISKDLE 307
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
++GKG +G VY G L + +A+K +D E+ + H+N+++ +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ---PLHEEIALHKHLKHKNIVQYL 85
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA---RGLLYLHEQCDPK 350
G + + GS+++ L++K + I GL YLH+ +
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 351 IIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS- 408
I+HRD+K N+L++ Y + + DFG +K L + T GT+ ++APE + G
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRG 201
Query: 409 -SEKTDVFGFGILLLELISG 427
+ D++ G ++E+ +G
Sbjct: 202 YGKAADIWSLGCTIIEMATG 221
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 53/206 (25%), Positives = 78/206 (37%), Gaps = 17/206 (8%)
Query: 230 SNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--- 285
+F + +G G +G V+K +DG + AVKR + + E+ S
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQ 115
Query: 286 HRNLLRLIGFCMTTTERLLVYPYM--SNGSVASRLKAKP-SLDWATRKRIALGAARGLLY 342
H +RL +Y S+ +A SL A L +
Sbjct: 116 HPCCVRLEQAWEEGGI---LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 402
LH Q ++H DVK ANI L +GDFGL L + G ++APE
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPEL 227
Query: 403 LSTGQSSEKTDVFGFGILLLELISGL 428
L G DVF G+ +LE+ +
Sbjct: 228 LQ-GSYGTAADVFSLGLTILEVACNM 252
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 78/309 (25%)
Query: 239 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G+G FG V++ T+VAVK LK+ + + FQ E +++ + N+++L
Sbjct: 56 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKL 115
Query: 293 IGFCMTTTERLLVYPYMSNGS-----VASRLKAKPSLDWATRK----------------- 330
+G C L++ YM+ G + SL +
Sbjct: 116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 175
Query: 331 --RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388
IA A G+ YL E+ K +HRD+ N L+ E + DFGL++ + D
Sbjct: 176 QLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---- 228
Query: 389 TAVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----AN 438
I PE + + + ++DV+ +G++L E+ S +G A+
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS------YGLQPYYGMAH 282
Query: 439 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPK 493
++ V +++ + E+ + LC LP+ RP
Sbjct: 283 EE-------------------VIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPS 322
Query: 494 MSEVVRMLE 502
+ R+L+
Sbjct: 323 FCSIHRILQ 331
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 65/291 (22%), Positives = 124/291 (42%), Gaps = 51/291 (17%)
Query: 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 288
+F L+G GGFG V+K DG +KR+K N + + EV+ ++ H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-----KAEREVKALAKLDHVN 65
Query: 289 LLRLIGFCMTTTERLLVYP----------------YMSNGSVASRLKAKPS--LDWATRK 330
++ G + G++ ++ + LD
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 331 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 390
+ +G+ Y+H + K+I+RD+K +NI L + + +GDFGL L + D T +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-DGKRTRS 181
Query: 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 450
GT+ +++PE +S+ ++ D++ G++L EL+ TA + ++
Sbjct: 182 K-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------CDTAFETSKFFTDLRDG 234
Query: 451 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501
+ + +D+ + + ++Q LL + P RP SE++R L
Sbjct: 235 I------------ISDIFDK-KEKTLLQ-KLLSKK--PEDRPNTSEILRTL 269
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 15/198 (7%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLL 290
+GKGGF ++ V A K L + + E+ + H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVV 78
Query: 291 RLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 349
G + + +V S+ K + +L + G YLH
Sbjct: 79 GFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 134
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 409
++IHRD+K N+ L+E E +GDFGLA +++ GT +IAPE LS S
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHS 193
Query: 410 EKTDVFGFGILLLELISG 427
+ DV+ G ++ L+ G
Sbjct: 194 FEVDVWSIGCIMYTLLVG 211
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 64/200 (32%), Positives = 93/200 (46%), Gaps = 6/200 (3%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 287
F+ +GKG FG V+KG + VVA+K + A Q E+ ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 347
+ + G + T+ ++ Y+ GS L+ P LD I +GL YLH +
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE- 138
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
K IHRD+KAAN+LL E+ E + DFG+A L T V GT +APE +
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 195
Query: 408 SSEKTDVFGFGILLLELISG 427
K D++ GI +EL G
Sbjct: 196 YDSKADIWSLGITAIELARG 215
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 15/198 (7%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLL 290
+GKGGF ++ V A K L + + E+ + H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVV 104
Query: 291 RLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 349
G + + +V S+ K + +L + G YLH
Sbjct: 105 GFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 160
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 409
++IHRD+K N+ L+E E +GDFGLA +++ GT +IAPE LS S
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHS 219
Query: 410 EKTDVFGFGILLLELISG 427
+ DV+ G ++ L+ G
Sbjct: 220 FEVDVWSIGCIMYTLLVG 237
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 58/297 (19%), Positives = 104/297 (35%), Gaps = 49/297 (16%)
Query: 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 288
++F +G+GGFG V++ D A+KR++ N + EV+ ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 289 LLRLIGFCMTTTERLLVYP------------YMSNGSVASRLKAK---PSLDWATRKRIA 333
++R + + P ++ + + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR- 392
L A + +LH + ++HRD+K +NI VGDFGL +D + T
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 393 ----------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA 442
GT +++PE + S K D+F G++L EL+ T ++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFS------TQMERVR 235
Query: 443 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499
L + K Y MVQ P RP+ ++
Sbjct: 236 TL---TDVRNLK-----FPPLFTQKYP--CEYVMVQ---DMLSPSPMERPEAINIIE 279
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 63/295 (21%), Positives = 120/295 (40%), Gaps = 41/295 (13%)
Query: 216 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF 274
+ +F+ ++ + +G+G FG +DG +K + E +
Sbjct: 14 GTENLYFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE 69
Query: 275 -QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--------LD 325
+ EV +++ H N+++ +V Y G + R+ A+ LD
Sbjct: 70 SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129
Query: 326 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385
W + I L L ++H++ KI+HRD+K+ NI L + +GDFG+A++L+
Sbjct: 130 WFVQ--ICLA----LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180
Query: 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 445
+ GT +++PE + K+D++ G +L EL + A F + + K
Sbjct: 181 LARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA--F-EAGSMKNL--- 233
Query: 446 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500
V KI + +Y +L +V L P RP ++ ++
Sbjct: 234 -VLKIISGSF------PPVSLHYSY-DLRSLVS-QLFKRN--PRDRPSVNSILEK 277
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 63/314 (20%), Positives = 121/314 (38%), Gaps = 47/314 (14%)
Query: 205 NEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKD 264
+ + +F+ + +S +G GG V++ + + A+K +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL 62
Query: 265 GNAIGGEIQ-FQTEVEMISLAVHRNL--LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK 321
A + ++ E+ ++ + +RL + +T +V N + S LK K
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK 121
Query: 322 PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAKL 379
S+D RK + +H+ I+H D+K AN L+ + ++ DFG+A
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQ 175
Query: 380 L-DHCDSHVTTAVRGTVGHIAPEYL-----------STGQSSEKTDVFGFGILLLELISG 427
+ S V + GTV ++ PE + S + S K+DV+ G +L + G
Sbjct: 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235
Query: 428 LRALEFGKTANQKGAMLDWVKKIHQEKKLEM--LVDKDLKNNYDRIELEEMVQVALL--C 483
F + NQ + I ++E + +KDL++ +L C
Sbjct: 236 --KTPFQQIINQISKLH---AIIDPNHEIEFPDIPEKDLQD--------------VLKCC 276
Query: 484 TQYLPSLRPKMSEV 497
+ P R + E+
Sbjct: 277 LKRDPKQRISIPEL 290
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 59/305 (19%), Positives = 118/305 (38%), Gaps = 40/305 (13%)
Query: 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAVH 286
+NF + +G+G F VY+ L DG VA+K+++ + + + E++++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 287 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS----------LDWATRKRIALGA 336
N+++ + E +V G ++ +K + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ--LCSA- 148
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 396
L ++H + +++HRD+K AN+ + +GD GL + + + V GT
Sbjct: 149 ---LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 201
Query: 397 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456
+++PE + + K+D++ G LL E+ + K + KKI Q
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLYSLCKKIEQCD-- 254
Query: 457 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKA 516
++Y EL ++V +C P RP ++ V + AS
Sbjct: 255 ---YPPLPSDHYSE-ELRQLVN---MCINPDPEKRPDVTYV---YDVAKRMHACTASSLE 304
Query: 517 EATRS 521
Sbjct: 305 HHHHH 309
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 61/214 (28%), Positives = 89/214 (41%), Gaps = 21/214 (9%)
Query: 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVH 286
++ + ++G G V Y VA+KR L+ E+ E++ +S H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL--KEIQAMSQCHH 72
Query: 287 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR-----IAL---GAAR 338
N++ + E LV +S GSV +K + IA
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 339 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT-VGH 397
GL YLH+ IHRDVKA NILL E + DFG++ L VR T VG
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 398 ---IAPEYLSTGQS-SEKTDVFGFGILLLELISG 427
+APE + + K D++ FGI +EL +G
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 60/201 (29%), Positives = 87/201 (43%), Gaps = 9/201 (4%)
Query: 230 SNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVH 286
+F +GKG FGNVY Q ++A+K L G E Q + EVE+ S H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 287 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 346
N+LRL G+ T L+ Y G+V L+ D A L Y H +
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 406
++IHRD+K N+LL E + DFG + GT+ ++ PE +
Sbjct: 129 ---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLC--GTLDYLPPEMIEGR 182
Query: 407 QSSEKTDVFGFGILLLELISG 427
EK D++ G+L E + G
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVG 203
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 61/281 (21%), Positives = 113/281 (40%), Gaps = 43/281 (15%)
Query: 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL--LRL 292
+G GG V++ + + A+K + A + ++ E+ ++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 293 IGFCMTTTERLLVYPYM--SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
+ +T +Y M N + S LK K S+D RK + +H+
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---G 128
Query: 351 IIHRDVKAANILLDEYYEAVV--GDFGLAKLL-DHCDSHVTTAVRGTVGHIAPEYL---- 403
I+H D+K AN L+ + ++ DFG+A + S V + GTV ++ PE +
Sbjct: 129 IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 404 -------STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456
S + S K+DV+ G +L + G F + NQ KL
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYG--KTPFQQIINQI-------------SKL 230
Query: 457 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEV 497
++D + + + I +++ V C + P R + E+
Sbjct: 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 73/296 (24%), Positives = 120/296 (40%), Gaps = 52/296 (17%)
Query: 227 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLA 284
S ++ +G G +G K DG ++ K L G+ E Q +EV ++
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 285 VHRNLLRLIG-FCMTTTERL-LVYPYMSNGSVASRLKAKPS----------LDWATRKRI 332
H N++R T L +V Y G +AS + L T+ +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ--L 120
Query: 333 ALGAARGLLYLHEQCDP--KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 390
L L H + D ++HRD+K AN+ LD +GDFGLA++L+H S T
Sbjct: 121 TLA----LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF 176
Query: 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 450
V GT +++PE ++ +EK+D++ G LL EL + + F
Sbjct: 177 V-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--F----------------- 216
Query: 451 HQEKKLEMLVDKDLKNNYDRI------ELEEMVQVALLCTQYLPSLRPKMSEVVRM 500
+ L K + + RI EL E++ +L + RP + E++
Sbjct: 217 -TAFSQKELAGKIREGKFRRIPYRYSDELNEIIT-RMLNLK--DYHRPSVEEILEN 268
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 9e-27
Identities = 65/331 (19%), Positives = 125/331 (37%), Gaps = 42/331 (12%)
Query: 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL--LRL 292
+G GG V++ + + A+K + A + ++ E+ ++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
+ +T +V N + S LK K S+D RK + +H+ I+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIV 177
Query: 353 HRDVKAANILLDEYYEAVV--GDFGLAKLL-DHCDSHVTTAVRGTVGHIAPEYLS----- 404
H D+K AN L+ + ++ DFG+A + S V + G V ++ PE +
Sbjct: 178 HSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 405 ------TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458
+ S K+DV+ G +L + G F + NQ + I ++E
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYG--KTPFQQIINQISKLH---AIIDPNHEIEF 289
Query: 459 --LVDKDLKN------NYD---RIELEEMVQVALLCTQYLP--SLRPKMSEVVRMLEGDG 505
+ +KDL++ D RI + E++ + Q P + +E ++ + G
Sbjct: 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQL 349
Query: 506 LAEKWAASQKAEATRSRANEFSSSERYSDLT 536
+ S A + S +
Sbjct: 350 VGLNSPNSILKAAKTLYEHYSGGESHNSSSS 380
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 36/230 (15%)
Query: 229 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 287
S+F ++G+G FG V K D A+K+++ + +EV +++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 288 NLLRLIGFCMTTTERLLVYP-------------YMSNGSVASRLKAKPS-LDWATRKRIA 333
++R + + Y NG++ + ++ R+
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC---------- 383
L Y+H Q IIHRD+K NI +DE +GDFGLAK +
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 384 ----DSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELISGL 428
++T+A+ GT ++A E L TG +EK D++ GI+ E+I
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF 228
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 30/204 (14%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
GKG F VY+ + G VA+K + + Q EV++ H ++L L
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM---VQRVQNEVKIHCQLKHPSILEL 76
Query: 293 IGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYL 343
+ + LV NG + LK + K + AR G+LYL
Sbjct: 77 YN-YFEDSNYVYLVLEMCHNGEMNRYLKNR-------VKPFSENEARHFMHQIITGMLYL 128
Query: 344 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 403
H I+HRD+ +N+LL + DFGLA L T GT +I+PE
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIA 184
Query: 404 STGQSSEKTDVFGFGILLLELISG 427
+ ++DV+ G + L+ G
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIG 208
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 25/126 (19%), Positives = 49/126 (38%), Gaps = 7/126 (5%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 71
+ + L++L+++ + N+ + +I +L L LDLS P+ +
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNIT 125
L +LQ L +++N+ ++ L LD S N++ N+T
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551
Query: 126 GNSLIC 131
N C
Sbjct: 552 QNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 26/123 (21%), Positives = 48/123 (39%), Gaps = 6/123 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
L S S + LQ++ L I LS L TL L+ N S
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL-SGPVPSF-----HAKTFNITG 126
L +LQ L +L + ++ L L++++N + S +P + + + +++
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 127 NSL 129
N +
Sbjct: 159 NKI 161
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 31/126 (24%), Positives = 56/126 (44%), Gaps = 7/126 (5%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPST 69
S N T+SS+ L L+ + Q++N+ + L L+ LD+S+
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 70 VSHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVP-SFHA----KTFN 123
+ L +L+ L++ NS P + + L FLDLS L P +F++ + N
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 124 ITGNSL 129
++ N+
Sbjct: 501 MSHNNF 506
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 25/109 (22%), Positives = 48/109 (44%), Gaps = 5/109 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVS 71
+ + L++LQ ++ N++ IG L L L++++N +P S
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAF----LDLSYNNLSGPVPS 116
+L L++L L++N + L + Q+ LDLS N ++ P
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-20
Identities = 20/101 (19%), Positives = 29/101 (28%), Gaps = 1/101 (0%)
Query: 18 LSSSIGNL-TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 76
NL + + + L N + +L LDLS L L
Sbjct: 19 FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 77 QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 117
L L N + + S +S L L NL+
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 28/109 (25%), Positives = 45/109 (41%), Gaps = 6/109 (5%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNI-SGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 71
NL+ + IG+L L+ + + +N I S +P L+ L LDLS+N + +
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 72 HLETLQY----LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
L + L L+ N + P + + L L L N S V
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMK 218
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-15
Identities = 21/121 (17%), Positives = 38/121 (31%), Gaps = 28/121 (23%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
L ++ +L++LQ++ + +NN L+ L LD S N + H
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 540
Query: 73 LET-LQYLRLNNNSLTG--------------------------AIPPSLSNMSQLAFLDL 105
+ L +L L N A P M + L++
Sbjct: 541 FPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNI 599
Query: 106 S 106
+
Sbjct: 600 T 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 26/142 (18%), Positives = 45/142 (31%), Gaps = 27/142 (19%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--------- 63
+ LTN+ L + I L+L N F
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 64 ----------GPIPSTVSHLETLQYLRLNNNSLT--GAIPPSLSNMSQLAFLDLSYNNLS 111
G + L +L++L L+ N L+ G S + L +LDLS+N +
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 112 GPVPSFHA----KTFNITGNSL 129
+F + + ++L
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNL 408
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 24/136 (17%), Positives = 46/136 (33%), Gaps = 20/136 (14%)
Query: 13 NLSGTLSSSIGNLTNLQLVL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS 68
+ + + L + L+ L N ++ I K +L L L NNF + +
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMK 218
Query: 69 TVSH-LETLQYLRL------NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG----PVPSF 117
T L L+ RL N +L +L + L + L + F
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278
Query: 118 HA----KTFNITGNSL 129
+ +F++ ++
Sbjct: 279 NCLTNVSSFSLVSVTI 294
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 25/121 (20%), Positives = 38/121 (31%), Gaps = 24/121 (19%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQ---NNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 69
NL S++ L NL + + + I L+ + + L +
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF- 300
Query: 70 VSHLETLQYLRLNNNSLT-------------------GAIPPSLSNMSQLAFLDLSYNNL 110
S+ Q+L L N G S ++ L FLDLS N L
Sbjct: 301 -SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL 359
Query: 111 S 111
S
Sbjct: 360 S 360
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 20/115 (17%), Positives = 33/115 (28%), Gaps = 10/115 (8%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPST 69
S N + L + L+NN S ++ I L+ L L F
Sbjct: 185 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 70 V---SHLETLQYLRLNNNSLT------GAIPPSLSNMSQLAFLDLSYNNLSGPVP 115
S LE L L + L I + ++ ++ L +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 16/127 (12%), Positives = 31/127 (24%), Gaps = 12/127 (9%)
Query: 13 NLSGTL-SSSIGNLTNLQLVLLQNNNISGHI---PTEIGKLSKLLTLDLSNN------FF 62
S + + I L L++ L + L L L + ++
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 63 TGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 122
I + L + L + ++ S L+L
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
Query: 123 NITGNSL 129
+T S
Sbjct: 329 RLTFTSN 335
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 43/214 (20%), Positives = 73/214 (34%), Gaps = 19/214 (8%)
Query: 229 TSNFSSKNLVGKG--GFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLA 284
+ ++GKG V G V V+R+ + F Q E+ + L
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 285 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLL 341
H N++ + E +V +M+ GS + D IA G + L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALD 142
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI--- 398
Y+H +HR VKA++IL+ + + + +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 399 ---APEYLSTGQS--SEKTDVFGFGILLLELISG 427
+PE L K+D++ GI EL +G
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 48/234 (20%), Positives = 83/234 (35%), Gaps = 41/234 (17%)
Query: 226 QSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEM 280
S ++++ +G G FG+V+K DG + A+KR K A + Q E+
Sbjct: 3 MGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-NALREV 61
Query: 281 ISLAV---HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA----KPSLDWATRKRIA 333
+ AV H +++R L+ Y + GS+A + A K +
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDE-----------------YYEAVV--GDF 374
L RGL Y+H ++H D+K +NI + + + GD
Sbjct: 122 LQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 375 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISG 427
G + G +A E L + K D+F + ++
Sbjct: 179 GHVTRISS-----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 28/130 (21%), Positives = 52/130 (40%), Gaps = 13/130 (10%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--------G 64
T NL +L V + N +PT + L ++ ++++ N
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295
Query: 65 PIPSTVSHLETLQYLRLNNNSL-TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---- 119
+ E +Q + + N+L T + SL M +L L+ YN L G +P+F +
Sbjct: 296 QALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKL 355
Query: 120 KTFNITGNSL 129
+ N+ N +
Sbjct: 356 ASLNLAYNQI 365
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-25
Identities = 26/131 (19%), Positives = 50/131 (38%), Gaps = 15/131 (11%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNI--------SGHIPTEIGKLSKLLTLDLS-NNFFT 63
L + + L +QL+ + N + K+ + + NN T
Sbjct: 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319
Query: 64 GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKT-- 121
P+ +++ ++ L L N L G P+ + +LA L+L+YN ++ +F T
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 122 ---FNITGNSL 129
+ N L
Sbjct: 379 VENLSFAHNKL 389
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-24
Identities = 23/100 (23%), Positives = 45/100 (45%), Gaps = 4/100 (4%)
Query: 15 SGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE 74
+ + +S+ + L ++ N + G +P G KL +L+L+ N T + E
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 75 TLQYLRLNNNSLTGAIPPSLS--NMSQLAFLDLSYNNLSG 112
++ L +N L IP ++S ++ +D SYN +
Sbjct: 378 QVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGS 416
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-23
Identities = 29/154 (18%), Positives = 51/154 (33%), Gaps = 14/154 (9%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNI-SGHIPTEIGKLSKLLTLDLSNNFFTGPI 66
+ +Q++ + NN+ + + T + K+ KL L+ N G +
Sbjct: 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346
Query: 67 PSTVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLSGPVPSFHA------ 119
P+ L L L N +T IP + Q+ L ++N L F A
Sbjct: 347 PA-FGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVM 404
Query: 120 KTFNITGNSLICATGAEEDCFGTAPMPLSFALNN 153
+ + N + + F P F N
Sbjct: 405 SAIDFSYNEI---GSVDGKNFDPLD-PTPFKGIN 434
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 24/131 (18%), Positives = 47/131 (35%), Gaps = 12/131 (9%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI--GKLSKLLTLDLSNNFFTGPIPS 68
+N + + N L + L+ N ++ + + L L+ +DLS N F+ P+
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPT 530
Query: 69 TVSHLETLQYLRLNN------NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF--HAK 120
+ TL+ + N N P ++ L L + N++ +
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNIS 590
Query: 121 TFNITGNSLIC 131
+I N I
Sbjct: 591 VLDIKDNPNIS 601
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 7e-22
Identities = 24/111 (21%), Positives = 37/111 (33%), Gaps = 10/111 (9%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG------ 64
L + N+ + L NN IS S L +++L N T
Sbjct: 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSL 477
Query: 65 -PIPSTVSHLETLQYLRLNNNSLTGAIPPSL--SNMSQLAFLDLSYNNLSG 112
+ L + L N LT + + + L +DLSYN+ S
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-21
Identities = 23/131 (17%), Positives = 42/131 (32%), Gaps = 20/131 (15%)
Query: 19 SSSIGNLTNLQLVLLQNNNISG-------HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 71
+++ + + N I + K + +++LSNN + S
Sbjct: 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454
Query: 72 HLETLQYLRLNNNSLTG-------AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----- 119
L + L N LT + N L +DL +N L+ F A
Sbjct: 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY 514
Query: 120 -KTFNITGNSL 129
+++ NS
Sbjct: 515 LVGIDLSYNSF 525
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-21
Identities = 19/109 (17%), Positives = 42/109 (38%), Gaps = 10/109 (9%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIP--TEIGKLSKLLTLDLSNNFFTG------ 64
++ ++ G ++ + +N + IP + +S + +D S N
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF 422
Query: 65 -PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
P+ T + + L+NN ++ S S L+ ++L N L+
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-20
Identities = 18/134 (13%), Positives = 39/134 (29%), Gaps = 28/134 (20%)
Query: 11 SQNLSGTLSSSIGNLTNLQ-------------------LVLLQNNNISGHIPTEIGKLSK 51
N +S ++ LT L+ + + L
Sbjct: 191 LSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKD 250
Query: 52 LLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGA--------IPPSLSNMSQLAFL 103
L +++ N +P+ + L +Q + + N ++ +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310
Query: 104 DLSYNNL-SGPVPS 116
+ YNNL + PV +
Sbjct: 311 YIGYNNLKTFPVET 324
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 19/125 (15%), Positives = 39/125 (31%), Gaps = 11/125 (8%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
S ++ S + +NNI+ + + +L+KL + N+ F
Sbjct: 168 SDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA 226
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAK-----TFNIT 125
E +Y + N+ L +++ +P+F N+
Sbjct: 227 WENENSEYAQQYKT-----EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281
Query: 126 GNSLI 130
N I
Sbjct: 282 CNRGI 286
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-20
Identities = 20/112 (17%), Positives = 38/112 (33%), Gaps = 11/112 (9%)
Query: 13 NLSGTLSS-SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN------NFFTGP 65
L+ L L + L N+ S PT+ S L + N N
Sbjct: 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLRE 557
Query: 66 IPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 117
P ++ +L L++ +N + + + ++ LD+ N S+
Sbjct: 558 WPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 14/109 (12%), Positives = 29/109 (26%), Gaps = 13/109 (11%)
Query: 13 NLSG----TLSSSIGNLTNLQ-LVLLQN-----NNISGHIPTEIGKLSKLLTLDLSNNFF 62
+LS + N + L+ + N P I L L + +N
Sbjct: 519 DLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
Query: 63 TGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ + + L + +N + + L Y+
Sbjct: 579 RK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 16/108 (14%), Positives = 33/108 (30%), Gaps = 6/108 (5%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGPI 66
SG + +IG LT L+++ L ++ P I +
Sbjct: 90 GFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTF 149
Query: 67 PSTVSHLET--LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
+ L +N++ +I S + + NN++
Sbjct: 150 VDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 15/102 (14%), Positives = 35/102 (34%), Gaps = 6/102 (5%)
Query: 21 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP----IPSTVSHLETL 76
S+ + + + L+ SG +P IG+L++L L L ++ P +S +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 77 QYLRLNNNSLTGAIPPSLS--NMSQLAFLDLSYNNLSGPVPS 116
+ + + S L ++ + +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 12/113 (10%), Positives = 29/113 (25%), Gaps = 8/113 (7%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
+ + G + N + + + + ++ L L +G +P
Sbjct: 43 NGKNWSQQGFGTQPGANWNFNK----ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVP 98
Query: 68 STVSHLETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
+ L L+ L L ++ P +S +
Sbjct: 99 DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVD 151
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 8/64 (12%), Positives = 23/64 (35%)
Query: 54 TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 113
+ + + +++ + L L +G +P ++ +++L L L +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 114 VPSF 117
F
Sbjct: 121 ERLF 124
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 56/225 (24%), Positives = 87/225 (38%), Gaps = 24/225 (10%)
Query: 223 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 281
+ ++ +G+GGF V L DG A+KR+ E + Q E +M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-EAQREADMH 80
Query: 282 SLAVHRNLLRLIGFCMTTTER----LLVYPYMSNGSVA----SRLKAKPSLDWATRKRIA 333
L H N+LRL+ +C+ L+ P+ G++ L +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR- 392
LG RGL +H HRD+K NILL + + V+ D G A+
Sbjct: 141 LGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 393 -------GTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISG 427
T+ + APE S E+TDV+ G +L ++ G
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 45/215 (20%), Positives = 82/215 (38%), Gaps = 32/215 (14%)
Query: 239 GKGGFGNVYKGYLQDGTVVAVKRLK----------------DGNAIGGEIQFQTEVEMIS 282
+G F + +D A+K+ + + F+ E+++I+
Sbjct: 40 NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 283 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR---- 338
+ L G E ++Y YM N S+ + LD I + +
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 339 ----GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 394
Y+H + + I HRDVK +NIL+D+ + DFG ++ + D + + GT
Sbjct: 159 SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSR-GT 213
Query: 395 VGHIAPEYLST--GQSSEKTDVFGFGILLLELISG 427
+ PE+ S + K D++ GI L +
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 45/306 (14%), Positives = 99/306 (32%), Gaps = 33/306 (10%)
Query: 223 KELQSATSNFSSKNLVGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQT 276
E Q + +L+G+G F VY+ ++ +K K N I Q
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ- 116
Query: 277 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW-----ATRKR 331
+E + ++ ++ + +LV S G++ + + +
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG-----------DFGLAKLL 380
A+ + +H+ +IIH D+K N +L + D G + +
Sbjct: 177 FAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 381 DHC-DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 439
+ TA T G E LS + + D FG + ++ G ++
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-TYMKVKNE-GG 291
Query: 440 KGAMLDWVKKIHQEKKLEMLVDKDLK-NNYDRIELEEMVQVAL---LCTQYLPSLRPKMS 495
+ +++ L + + ++++ L Y +R +
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRN 351
Query: 496 EVVRML 501
++ +L
Sbjct: 352 RLIVLL 357
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 56/194 (28%), Positives = 87/194 (44%), Gaps = 9/194 (4%)
Query: 237 LVGKGGFGNVYKG-YLQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
+GKG FGNVY Q+ ++A+K L G E Q + E+E+ S H N+LR+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
+ L+ + G + L+ D A L Y HE+ K+IH
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIH 137
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 413
RD+K N+L+ E + DFG + H S + GT+ ++ PE + EK D
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVD 194
Query: 414 VFGFGILLLELISG 427
++ G+L E + G
Sbjct: 195 LWCAGVLCYEFLVG 208
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 22/210 (10%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKR-LKDGNAIGGEIQFQTEVE-MISLAVHRN 288
+F K+++G G G + + D VAVKR L + + EV+ + H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPN 79
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQC 347
++R + + + ++ ++ K + + GL +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL- 137
Query: 348 DPKIIHRDVKAANILLDEYYE-----AVVGDFGLAKLLDHCDS--HVTTAVRGTVGHIAP 400
I+HRD+K NIL+ A++ DFGL K L + V GT G IAP
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 401 EYLSTGQS---SEKTDVFGFGILLLELISG 427
E LS + D+F G + +IS
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVH 286
F +G+G +G+VYK + G +VA+K++ + ++Q E+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIKEISIMQQCDS 83
Query: 287 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHE 345
++++ G T+ +V Y GSV+ ++ + L I +GL YLH
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 346 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405
+ IHRD+KA NILL+ A + DFG+A L + T + GT +APE +
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQE 199
Query: 406 GQSSEKTDVFGFGILLLELISG---------LRAL 431
+ D++ GI +E+ G +RA+
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 68/243 (27%), Positives = 110/243 (45%), Gaps = 34/243 (13%)
Query: 215 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ 273
+L L+ F LVG G +G VYKG ++ G + A+K + + G E +
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEE 65
Query: 274 -FQTEVEMIS-LAVHRNLLRLIG-----FCMTTTERL-LVYPYMSNGSVASRLKAKPSLD 325
+ E+ M+ + HRN+ G ++L LV + GSV +K +
Sbjct: 66 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-N 124
Query: 326 WATRKRIAL---GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382
+ IA RGL +LH+ K+IHRD+K N+LL E E + DFG++ LD
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
Query: 383 CDSHVTTAVRGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELISG---------L 428
T + GT +APE ++ ++ + K+D++ GI +E+ G +
Sbjct: 182 TVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240
Query: 429 RAL 431
RAL
Sbjct: 241 RAL 243
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 287
++ +G+G G VY + G VA++++ E+ E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 347
N++ + + E +V Y++ GS+ + +D + + L +LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSN- 135
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
++IHRD+K+ NILL + DFG + S +T V GT +APE ++
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192
Query: 408 SSEKTDVFGFGILLLELISG---------LRAL 431
K D++ GI+ +E+I G LRAL
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 52/191 (27%), Positives = 92/191 (48%), Gaps = 6/191 (3%)
Query: 238 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 296
+G G G V+K + G V+A K + Q E++++ ++ G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 297 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356
+ E + +M GS+ LK + ++++ +GL YL E+ KI+HRDV
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDV 158
Query: 357 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 416
K +NIL++ E + DFG++ L DS + V GT +++PE L S ++D++
Sbjct: 159 KPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSDIWS 215
Query: 417 FGILLLELISG 427
G+ L+E+ G
Sbjct: 216 MGLSLVEMAVG 226
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 16/213 (7%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 287
S +G+G G V G VAVK + E+ EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHF 102
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 347
N++ + + E ++ ++ G++ + L+ + + L YLH Q
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQ- 160
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
+IHRD+K+ +ILL + DFG + + V GT +APE +S
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSL 217
Query: 408 SSEKTDVFGFGILLLELISG---------LRAL 431
+ + D++ GI+++E++ G ++A+
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 47/218 (21%), Positives = 90/218 (41%), Gaps = 25/218 (11%)
Query: 232 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHRN 288
+ +G G FG VYK + G + A K K + + E+E+++ H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHPY 77
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQC 347
+++L+G + ++ + G+V + + L + + L +LH +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK- 136
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
+IIHRD+KA N+L+ + + DFG++ + + GT +APE +
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCET 193
Query: 408 SSE-----KTDVFGFGILLLELISG---------LRAL 431
+ K D++ GI L+E+ +R L
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 231
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 29/232 (12%), Positives = 63/232 (27%), Gaps = 44/232 (18%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVK---------------------------RLKDGNAI 268
++G+ + + G V +K+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 269 GGEIQFQTEVEMISLAVHRNLLRLIGF--CMTTTERLLVYPYMSN------GSVASRLKA 320
++F +++ + ++R+ M R +YP M + + S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 321 KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380
SL R ++ L R L LH ++H ++ +I+LD+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 381 DHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISG 427
A L + D + G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 29/238 (12%), Positives = 67/238 (28%), Gaps = 55/238 (23%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVK---------------------------RLKDGNAI 268
++G+ + + G V +K+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 269 GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ERLLVYPYMSN------GSVASRLKA 320
++F +++ + ++R+ R +YP M + + S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 321 KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380
SL R ++ L R L LH ++H ++ +I+LD+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 381 DHCDSHVTTAVRGTVGHIAPEYLSTGQS-----------SEKTDVFGFGILLLELISG 427
+ G PE + + + D + G+++ +
Sbjct: 257 GA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 41/220 (18%), Positives = 87/220 (39%), Gaps = 23/220 (10%)
Query: 226 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 284
++ + +++G+G NV++G + G + A+K + + + E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 285 VHRNLLRLIGFCMTTTERL--LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA---ARG 339
H+N+++L TT R L+ + GS+ + L+ + + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVTTAVRGTV 395
+ +L E I+HR++K NI+ + + DFG A+ L+ D + GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY-GTE 179
Query: 396 GHIAPEYLSTGQS--------SEKTDVFGFGILLLELISG 427
++ P+ D++ G+ +G
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 67/304 (22%), Positives = 111/304 (36%), Gaps = 53/304 (17%)
Query: 226 QSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLA 284
QS + S+ ++G G G V G VAVKR+ E++ +
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESD 66
Query: 285 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR------ 338
H N++R T + N ++ +++K D + +
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 339 -GLLYLHEQCDPKIIHRDVKAANILLD-------------EYYEAVVGDFGLAKLLDHCD 384
G+ +LH KIIHRD+K NIL+ E ++ DFGL K LD
Sbjct: 126 SGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 385 SHVTTAVR---GTVGHIAPEYLSTGQS-------SEKTDVFGFGILLLELISGLRALEFG 434
S T + GT G APE L + + D+F G + ++S + FG
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-HPFG 241
Query: 435 KTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN-YDRIELEEMVQVALLCTQYLPSLRPK 493
+++ ++ + I +++ L D+ L D I + P RP
Sbjct: 242 DKYSRESNII---RGIFSLDEMKCLHDRSLIAEATDLIS---------QMIDHDPLKRPT 289
Query: 494 MSEV 497
+V
Sbjct: 290 AMKV 293
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 27/122 (22%), Positives = 46/122 (37%), Gaps = 5/122 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
L +++ + L + + N IS P KL L L+L +N + T +
Sbjct: 36 QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGN 127
L L L +NS+ L LDLS+N LS + + + ++ N
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
Query: 128 SL 129
+
Sbjct: 156 KI 157
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-21
Identities = 27/133 (20%), Positives = 48/133 (36%), Gaps = 14/133 (10%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNIS--------GHIPTEIGKLSKLLTLDLSNNFFTG 64
N++ + L L+++ LQ+NN++ G + LS L L+L +N F
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
Query: 65 PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----- 119
L L+ + L N+L +N L L+L N ++
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 120 -KTFNITGNSLIC 131
++ N C
Sbjct: 611 LTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 32/109 (29%), Positives = 44/109 (40%), Gaps = 5/109 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG--KLSKLLTLDLSNNFFTGPIPSTV 70
LS T + L NLQ +LL NN I E+ S L L+LS+N P
Sbjct: 132 GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLS---NMSQLAFLDLSYNNLSGPVPS 116
+ L L LNN L ++ L + + L LS + LS +
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-19
Identities = 26/135 (19%), Positives = 48/135 (35%), Gaps = 18/135 (13%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNF---------FT 63
NL+ + S L L+ L+ NNI + L + L+L +F
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
Query: 64 GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---- 119
+ L+ L++L + +N + G + + L +L LS + S +
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378
Query: 120 -----KTFNITGNSL 129
N+T N +
Sbjct: 379 AHSPLHILNLTKNKI 393
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-19
Identities = 27/110 (24%), Positives = 41/110 (37%), Gaps = 10/110 (9%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISG--HIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
+S + +LQ ++L+ + P+ L L LDLSNN +
Sbjct: 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
Query: 71 SHLETLQYLRLNNNSLT--------GAIPPSLSNMSQLAFLDLSYNNLSG 112
LE L+ L L +N+L G L +S L L+L N
Sbjct: 501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-19
Identities = 20/92 (21%), Positives = 39/92 (42%)
Query: 25 LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 84
TN+ ++ L +N + + S+L +LD+ N + P L L+ L L +N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 85 SLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
L+ + + + L L L N++ +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNN 115
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-19
Identities = 20/104 (19%), Positives = 36/104 (34%), Gaps = 1/104 (0%)
Query: 10 PSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 69
G + L++L ++ L++N L +L +DL N S
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
Query: 70 VSHLETLQYLRLNNNSLTGAIPPSLS-NMSQLAFLDLSYNNLSG 112
++ +L+ L L N +T L LD+ +N
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-18
Identities = 24/105 (22%), Positives = 39/105 (37%), Gaps = 5/105 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG----KLSKLLTLDLSNNFFTGPIPS 68
++ G S+ L NL+ + L N+ S T S L L+L+ N +
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
Query: 69 TVSHLETLQYLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLSG 112
S L L+ L L N + + + + + LSYN
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-18
Identities = 22/114 (19%), Positives = 36/114 (31%), Gaps = 8/114 (7%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLN 82
+ L ++ L N IS L L LDL N + LE + + L+
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-------KTFNITGNSL 129
N S + + L L L L S +++ N++
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-17
Identities = 23/105 (21%), Positives = 43/105 (40%), Gaps = 5/105 (4%)
Query: 13 NLSGTLSSSIG---NLTNLQLVLLQNNNISGHIPTEIG--KLSKLLTLDLSNNFFTGPIP 67
L +L+ + T+++ + L N+ +S T K + L LDLS N
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
+ + L L+Y L N++ SL + + +L+L +
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 20/83 (24%), Positives = 31/83 (37%), Gaps = 8/83 (9%)
Query: 52 LLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
D S+ T +P + + L L +N L + + SQL LD+ +N +S
Sbjct: 6 HEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 112 GPVP-SFHA----KTFNITGNSL 129
P K N+ N L
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNEL 85
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 22/99 (22%), Positives = 33/99 (33%), Gaps = 6/99 (6%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGK-LSKLLTLDLSNNFFTGPIPSTVS 71
NL+ +S N +L+ + LQ N I+ G L LD+ N F S
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAW 630
Query: 72 HLETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLS 106
+ + N L+ PP + D S
Sbjct: 631 FVNWINETHTNIPELSSHYLCNTPPHYHGFP-VRLFDTS 668
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 43/201 (21%), Positives = 73/201 (36%), Gaps = 21/201 (10%)
Query: 237 LVGKGGFGNVYKGY--LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
+ GG G +Y +G V +K L + E + ++ VH +++++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 295 FCMTTTERLLVYPYM-----SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 349
F T Y+ S+ K + A L L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYLHSI--- 201
Query: 350 KIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 408
+++ D+K NI+L E E + + D G ++ + GT G APE +
Sbjct: 202 GLVYNDLKPENIMLTE--EQLKLIDLGAVSRINS-----FGYLYGTPGFQAPE-IVRTGP 253
Query: 409 SEKTDVFGFGILLLELISGLR 429
+ TD++ G L L L
Sbjct: 254 TVATDIYTVGRTLAALTLDLP 274
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 24/241 (9%), Positives = 53/241 (21%), Gaps = 44/241 (18%)
Query: 224 ELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEM 280
L + G V+ ++ A+K + N+ +
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 281 ISLAVHRNLLRLIGFC--------------------------MTTTERLLVYPYM--SNG 312
+ + + LL+ P
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175
Query: 313 SVASRLKAKPS----LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 368
+ S L + R L + ++H N+ +
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGR 232
Query: 369 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELIS 426
++GD A V + E+L ST + + + G+ + +
Sbjct: 233 LMLGDVSAL----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 427 G 427
Sbjct: 289 L 289
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 51/217 (23%), Positives = 85/217 (39%), Gaps = 28/217 (12%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLIG 294
++ +GGF VY+ + G A+KRL N EV M L+ H N+++
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 295 FCMTTTER-------LLVYPYMSNGSVAS---RLKAKPSLDWATRKRIALGAARGLLYLH 344
E L+ + G + +++++ L T +I R + ++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----------VRG 393
Q P IIHRD+K N+LL + DFG A + H + +A
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 394 TVGHIAPEYLSTGQS---SEKTDVFGFGILLLELISG 427
T + PE + + EK D++ G +L L
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-23
Identities = 25/132 (18%), Positives = 44/132 (33%), Gaps = 17/132 (12%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP------- 65
S NL +L V L N +P + L +L +L+++ N
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
Query: 66 --IPSTVSHLETLQYLRLNNNSLTGAIPPS--LSNMSQLAFLDLSYNNLSGPVPSFHA-- 119
+ +Q + N+L P S L M +L LD +N + + +F
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNV 595
Query: 120 --KTFNITGNSL 129
+ N +
Sbjct: 596 KLTDLKLDYNQI 607
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 5e-19
Identities = 22/130 (16%), Positives = 38/130 (29%), Gaps = 28/130 (21%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISG-------------------HIPTEIGKLSK 51
N +S +I LT LQ++ N+ + + L
Sbjct: 433 LTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKD 492
Query: 52 LLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG---------AIPPSLSNMSQLAF 102
L ++L N +P + L LQ L + N + ++
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552
Query: 103 LDLSYNNLSG 112
+ YNNL
Sbjct: 553 FYMGYNNLEE 562
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 5e-19
Identities = 21/130 (16%), Positives = 43/130 (33%), Gaps = 12/130 (9%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI--GKLSKLLTLDLSNNFFTGPIPS 68
+N + N L + L+ N ++ + + L L +D+S N F+ P+
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPT 770
Query: 69 TVSHLETLQYLRL------NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA-K 120
+ L+ + N + P ++ L L + N++
Sbjct: 771 QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLY 830
Query: 121 TFNITGNSLI 130
+I N I
Sbjct: 831 ILDIADNPNI 840
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 22/113 (19%), Positives = 44/113 (38%), Gaps = 5/113 (4%)
Query: 19 SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 78
S+S+ + L L+ +N + H+ G KL L L N + + ++
Sbjct: 566 SASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEG 623
Query: 79 LRLNNNSLTGAIPP--SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSL 129
L ++N L IP + ++ + +D SYN + + + G +
Sbjct: 624 LGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA 675
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 8e-17
Identities = 25/129 (19%), Positives = 45/129 (34%), Gaps = 13/129 (10%)
Query: 10 PSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTE--IGKLSKLLTLDLSNNFFTGPIP 67
+ L+ +Q+ + NN+ P + K+ KL LD +N
Sbjct: 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR--HL 588
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLSGPVPSFHA------K 120
L L+L+ N + IP + Q+ L S+N L F+A
Sbjct: 589 EAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMG 647
Query: 121 TFNITGNSL 129
+ + + N +
Sbjct: 648 SVDFSYNKI 656
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 21/128 (16%), Positives = 40/128 (31%), Gaps = 20/128 (15%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP------- 65
+ + N I+ I I +L+KL + +N+ FT
Sbjct: 412 PEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWE 470
Query: 66 ------------IPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 113
+ S+L+ L + L N +P L ++ +L L+++ N
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 114 VPSFHAKT 121
T
Sbjct: 531 AQLKADWT 538
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 4e-16
Identities = 12/103 (11%), Positives = 34/103 (33%), Gaps = 9/103 (8%)
Query: 17 TLSSSIG-NLTNLQLVLLQNNNISGHIP--TEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 73
+ ++ + +N + IP + + ++D S N + +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 74 ET-----LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ + L+ N + + S ++ + LS N ++
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 18/107 (16%), Positives = 33/107 (30%), Gaps = 9/107 (8%)
Query: 11 SQNLSGTLSSSIGNLTNLQ-LVLLQN-----NNISGHIPTEIGKLSKLLTLDLSNNFFTG 64
S N + + N + L+ + N I PT I L+ L + +N
Sbjct: 761 SYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK 820
Query: 65 PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ + L L + +N S+ + L Y+
Sbjct: 821 -VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 15/101 (14%), Positives = 29/101 (28%), Gaps = 1/101 (0%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
+ N + + L G +P IG+L++L L + T
Sbjct: 310 MWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369
Query: 73 LETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSG 112
T + + L +L DL + ++
Sbjct: 370 ELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR 410
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 16/150 (10%), Positives = 40/150 (26%), Gaps = 31/150 (20%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIP-------------------------TE 45
G + +IG LT L+++ ++ +
Sbjct: 332 GFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMF 391
Query: 46 IGKLSKLLTLDLSNNFFT-----GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQL 100
+ +L DL + PI + N +T I ++ +++L
Sbjct: 392 LDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKL 450
Query: 101 AFLDLSYNNLSGPVPSFHAKTFNITGNSLI 130
+ + + + + + N
Sbjct: 451 QIIYFANSPFTYDNIAVDWEDANSDYAKQY 480
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 10/109 (9%), Positives = 29/109 (26%), Gaps = 1/109 (0%)
Query: 8 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
+ ++ + N + + ++ ++ L L+ G +P
Sbjct: 282 DGKNWRYYSGTINNTIHSLNWNFNK-ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP 340
Query: 68 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
+ L L+ L +S T + + + +
Sbjct: 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 7/76 (9%), Positives = 24/76 (31%)
Query: 54 TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 113
+ + + + + + L L G +P ++ +++L L ++ +
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 114 VPSFHAKTFNITGNSL 129
F + +
Sbjct: 363 GRLFGDEELTPDMSEE 378
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 41/220 (18%), Positives = 87/220 (39%), Gaps = 23/220 (10%)
Query: 226 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 284
++ + +++G+G NV++G + G + A+K + + + E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 285 VHRNLLRLIGFCMTTTERL--LVYPYMSNGSVASRLKAKPSLDWATRK---RIALGAARG 339
H+N+++L TT R L+ + GS+ + L+ + + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVTTAVRGTV 395
+ +L E I+HR++K NI+ + + DFG A+ L+ D + GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY-GTE 179
Query: 396 GHIAPEYLSTGQS--------SEKTDVFGFGILLLELISG 427
++ P+ D++ G+ +G
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 64/219 (29%), Positives = 90/219 (41%), Gaps = 25/219 (11%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAV 285
FS +G G FG VY +++ VVA+K+ + EV +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 286 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLH 344
H N ++ G + LV Y GS + L+ L + GA +GL YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 404
+IHRDVKA NILL E +GDFG A ++ +S V GT +APE +
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 223
Query: 405 TGQSSE---KTDVFGFGILLLELISG---------LRAL 431
+ K DV+ GI +EL + AL
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 6/194 (3%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRLI 293
+G GG VY VA+K + E F+ EV S H+N++ +I
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
LV Y+ +++ +++ L T G+ + H+ +I+H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVH 134
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 413
RD+K NIL+D + DFG+AK L T V GTV + +PE + E TD
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194
Query: 414 VFGFGILLLELISG 427
++ GI+L E++ G
Sbjct: 195 IYSIGIVLYEMLVG 208
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 5e-22
Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 18/210 (8%)
Query: 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+ K +G GGFG V + G VA+K+ + + ++ E++++ H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 290 LRLI------GFCMTTTERLLVYPYMSNGSVASRLKAK---PSLDWATRKRIALGAARGL 340
+ LL Y G + L L + + + L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 341 LYLHEQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGH 397
YLHE +IIHRD+K NI+L + + + D G AK LD T V GT+ +
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTEFV-GTLQY 189
Query: 398 IAPEYLSTGQSSEKTDVFGFGILLLELISG 427
+APE L + + D + FG L E I+G
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITG 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISLAVHRNLL 290
++G GG V+ L+D VAVK L+ D + +F+ E + + H ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYL---RFRREAQNAAALNHPAIV 75
Query: 291 RL--IGFCMTTTERL--LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 346
+ G T L +V Y+ ++ + + + + A + L + H+
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT--AVRGTVGHIAPEYLS 404
IIHRDVK ANI++ V DFG+A+ + + VT AV GT +++PE
Sbjct: 136 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 405 TGQSSEKTDVFGFGILLLELISG 427
++DV+ G +L E+++G
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTG 215
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-21
Identities = 27/125 (21%), Positives = 46/125 (36%), Gaps = 6/125 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 71
N LT+L + + N+ + + + + L LDLS
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITG 126
L LQ L +++N+L + + L+ LD S+N + FN+T
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 127 NSLIC 131
NS+ C
Sbjct: 555 NSVAC 559
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 31/126 (24%), Positives = 50/126 (39%), Gaps = 7/126 (5%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPST 69
S N + +S++ L LQ + Q++ + L KLL LD+S
Sbjct: 384 SFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 70 VSHLETLQYLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFN 123
L +L L++ NS + +N + L FLDLS L F + N
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503
Query: 124 ITGNSL 129
++ N+L
Sbjct: 504 MSHNNL 509
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-19
Identities = 24/123 (19%), Positives = 45/123 (36%), Gaps = 6/123 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
L S S N + LQ + L I L L L L+ N P + S
Sbjct: 43 PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSF-----HAKTFNITG 126
L +L+ L L + + L L++++N + +P++ + +++
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 127 NSL 129
N +
Sbjct: 163 NYI 165
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-17
Identities = 23/100 (23%), Positives = 40/100 (40%)
Query: 12 QNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 71
TLS+ N TNL + L + L +L L++S+N S +
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L +L L + N + + LAF +L+ N+++
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 22/104 (21%), Positives = 45/104 (43%), Gaps = 5/104 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVS 71
+ S LT+L+ ++ ++ IG+L L L++++NF +P+ S
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAF----LDLSYNNLS 111
+L L ++ L+ N + L + + LD+S N +
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID 194
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 22/109 (20%), Positives = 34/109 (31%), Gaps = 5/109 (4%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85
++ + + L N + S+L LDLS L L L L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 86 LTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSL 129
+ P S S ++ L L L+ K N+ N +
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 24/104 (23%), Positives = 41/104 (39%), Gaps = 7/104 (6%)
Query: 13 NLSGTLSSSI--GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
++ +L L+ + L N S I + L L LDLS N + +
Sbjct: 313 SIIRCQLKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSY 370
Query: 71 SHLET--LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
S L T L++L L+ N + + + +L LD ++ L
Sbjct: 371 SDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR 413
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 17/131 (12%), Positives = 38/131 (29%), Gaps = 12/131 (9%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIP-TEIGKLSKLLTLDLSNNFFTGPIPST 69
S N + L + L+ N S +I T + L+ L L F
Sbjct: 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 70 VSHLETLQ--------YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-- 119
+ ++ RL + ++ ++ + L+ ++
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFK 308
Query: 120 -KTFNITGNSL 129
++ +I L
Sbjct: 309 WQSLSIIRCQL 319
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 26/125 (20%), Positives = 46/125 (36%), Gaps = 14/125 (11%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
N L N+ + L +I ++ ++ K K +L + P+
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQLKQ-FPT--LD 326
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA------KTFNIT 125
L L+ L L N + I + L++LDLS N LS S+ + +++
Sbjct: 327 LPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 126 GNSLI 130
N I
Sbjct: 385 FNGAI 389
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 24/135 (17%), Positives = 42/135 (31%), Gaps = 19/135 (14%)
Query: 13 NLSGTLSSSIGNLTNLQLVL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS 68
+ + + L V + N I I + + KL L L NF + I
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMK 222
Query: 69 TV-SHLETLQYLRL------NNNSLTGAIPPSLSNMSQLAF--LDLSYNNLSGPVPSF-- 117
T +L L RL + +L P + + + L+Y N
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFH 282
Query: 118 ---HAKTFNITGNSL 129
+ ++ G S+
Sbjct: 283 CLANVSAMSLAGVSI 297
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 18/202 (8%)
Query: 238 VGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
+G+G +G+V K G ++AVK R ++ +V M + +++ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVM-RSSDCPYIVQFYG 88
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK-----RIALGAARGLLYLHEQCDP 349
+ + M + S K S+ +I L + L +L E
Sbjct: 89 ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL-- 145
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS- 408
KIIHRD+K +NILLD + DFG++ L DS T G ++APE + S
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 409 ---SEKTDVFGFGILLLELISG 427
++DV+ GI L EL +G
Sbjct: 204 QGYDVRSDVWSLGITLYELATG 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 7e-21
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 223 KELQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVK--RLKDGNAIGGEIQFQTEVE 279
+ Q+ ++ + +G G G V+K + + G V+AVK R I +V
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 280 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 339
+ S +++ G +T T+ + M + + + + + ++ + +
Sbjct: 78 LKSHD-CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 399
L YL E+ +IHRDVK +NILLDE + + DFG++ L D G ++A
Sbjct: 137 LYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAAYMA 192
Query: 400 PEYLSTGQSSE-----KTDVFGFGILLLELISG 427
PE + ++ + DV+ GI L+EL +G
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 46/199 (23%), Positives = 82/199 (41%), Gaps = 16/199 (8%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRL- 292
LVG+GG G+VY+ +VA+K + + + + Q E +++ +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 293 -IGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
G +L + ++ +A+ L+ + L I L H
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---G 154
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT--AVRGTVGHIAPEYLSTGQS 408
HRDVK NIL+ A + DFG+A D +T GT+ ++APE S +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 409 SEKTDVFGFGILLLELISG 427
+ + D++ +L E ++G
Sbjct: 213 TYRADIYALTCVLYECLTG 231
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 7e-20
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI--GGEIQFQTE---VEMISL 283
++FS ++G+GGFG VY D G + A+K L GE E + ++S
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 284 AVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 342
++ + + T ++L + M+ G + L A + A GL +
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 402
+H + +++RD+K ANILLDE+ + D GLA H +V GT G++APE
Sbjct: 308 MHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEV 361
Query: 403 LSTGQSSEKT-DVFGFGILLLELISGL 428
L G + + + D F G +L +L+ G
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 8e-20
Identities = 55/239 (23%), Positives = 97/239 (40%), Gaps = 29/239 (12%)
Query: 212 VCLGNLKRFHFKELQSATSNFSSKNL---------VGKGGFGNVYKGY-LQDGTVVAVK- 260
+ L K F F +L + K L +G G G V + + VA++
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRI 167
Query: 261 ------RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 314
+ + +TE+E++ H ++++ F + +V M G +
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL 226
Query: 315 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV---V 371
++ L AT K + YLHE IIHRD+K N+LL E +
Sbjct: 227 FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283
Query: 372 GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELISG 427
DFG +K+L ++ + + GT ++APE L + + + D + G++L +SG
Sbjct: 284 TDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 24/122 (19%), Positives = 43/122 (35%), Gaps = 5/122 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
L +++ L NL + L I +L TL L+ N + +S
Sbjct: 44 VLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG 103
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGN 127
+ L++L ++ L N L L L N++S +P K + N
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 128 SL 129
++
Sbjct: 164 AI 165
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 27/126 (21%), Positives = 53/126 (42%), Gaps = 9/126 (7%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
S++ + LQ + L ++S +P+ + LS L L LS N F + S+
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323
Query: 73 LETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHA-------KTFNI 124
+L +L + N+ + L N+ L LDLS++++ ++ N+
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383
Query: 125 TGNSLI 130
+ N +
Sbjct: 384 SYNEPL 389
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-19
Identities = 30/127 (23%), Positives = 56/127 (44%), Gaps = 9/127 (7%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG---KLSKLLTLDLSNNFFTGPIPST 69
L + L LQ + LQ N+ + L +L L LS +
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA 495
Query: 70 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS-FHA----KTFNI 124
+ L+ + ++ L++N LT + +LS++ + +L+L+ N++S +PS +T N+
Sbjct: 496 FTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINL 554
Query: 125 TGNSLIC 131
N L C
Sbjct: 555 RQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 16/100 (16%), Positives = 33/100 (33%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
+ + + L ++L N + T + L L + + +
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN 127
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
+TL+ L L +N ++ P +L LD N +
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-17
Identities = 21/106 (19%), Positives = 36/106 (33%), Gaps = 3/106 (2%)
Query: 13 NLSGTLSSSIGNLTNLQLVLL--QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
+ + L + + + Q + S L LDL+ + +PS +
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGL 297
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
L TL+ L L+ N S SN L L + N + +
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 21/99 (21%), Positives = 38/99 (38%), Gaps = 1/99 (1%)
Query: 15 SGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHL 73
S + + NL++LQ + L N + +L LDL+ S +L
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424
Query: 74 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
L+ L L+++ L + + L L+L N+
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 18/93 (19%), Positives = 26/93 (27%)
Query: 25 LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 84
+ + + N + T +L L LDL+ T L L L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 85 SLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 117
L +LS L L +S
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIP 124
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 23/103 (22%), Positives = 37/103 (35%), Gaps = 3/103 (2%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFT--GPIPST 69
S N +L + ++ N + T + L L LDLS++
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 70 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
+ +L LQ L L+ N + QL LDL++ L
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 25/101 (24%), Positives = 48/101 (47%), Gaps = 1/101 (0%)
Query: 12 QNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 71
+ ++S+ L L++++L ++S L + +DLS+N T +S
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
HL+ + YL L +N ++ +P L +SQ ++L N L
Sbjct: 522 HLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 23/105 (21%), Positives = 41/105 (39%), Gaps = 3/105 (2%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS-T 69
+ L S + L+ L+ ++L N L L + N + +
Sbjct: 286 TATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
Query: 70 VSHLETLQYLRLNNNSLT--GAIPPSLSNMSQLAFLDLSYNNLSG 112
+ +LE L+ L L+++ + L N+S L L+LSYN
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS 390
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 16/127 (12%), Positives = 34/127 (26%), Gaps = 8/127 (6%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG--KLSKLLTLDLSNNFFTGPIPS 68
+ N + + Q + I + + L + P+
Sbjct: 187 NGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246
Query: 69 TVSHLE--TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTF 122
L +++ + L + + S L LDL+ +LS K
Sbjct: 247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKL 306
Query: 123 NITGNSL 129
++ N
Sbjct: 307 VLSANKF 313
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 43/200 (21%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 238 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLLRLIGF 295
+G+G +G V K ++ G ++AVKR++ + + ++++ + G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 296 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATR----KRIALGAARGLLYLHEQCDPKI 351
+ + M + S+ K +IA+ + L +LH + +
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 131
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS--- 408
IHRDVK +N+L++ + + DFG++ L D G ++APE ++ +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 409 -SEKTDVFGFGILLLELISG 427
S K+D++ GI ++EL
Sbjct: 190 YSVKSDIWSLGITMIELAIL 209
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 15/214 (7%)
Query: 225 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEV 278
+ S + S +G G +G V A+K ++ + EV
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 279 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR 338
++ L H N+++L F LV G + + + + I
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS 147
Query: 339 GLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 395
G+ YLH+ I+HRD+K N+LL ++ + DFGL+ + + + GT
Sbjct: 148 GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTA 202
Query: 396 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR 429
+IAPE L + EK DV+ G++L L++G
Sbjct: 203 YYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 5e-19
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 16/220 (7%)
Query: 219 RFHFKELQSAT-SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI--GGEIQF 274
++ + E Q F ++G+GGFG V+ ++ G + A K+L G
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 275 QTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWA-TRKRI 332
E ++++ R ++ L + T L LV M+ G + + + R
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 333 ALGAAR---GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389
A+ GL +LH++ II+RD+K N+LLD+ + D GLA L +
Sbjct: 292 IFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
Query: 390 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 428
GT G +APE L G+ + + D F G+ L E+I+
Sbjct: 349 YA-GTPGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-19
Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 16/213 (7%)
Query: 225 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGE--IQFQTE 277
+Q +T+ FS + ++GKG FG V G AVK + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 278 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA 337
V+++ H N+++L F LV + G + + ++ RI
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 394
G+ Y+H+ KI+HRD+K N+LL + + DFGL+ + S GT
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGT 191
Query: 395 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
+IAPE L G EK DV+ G++L L+SG
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 224 ELQSAT-SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI--GGEIQFQTEVE 279
E Q T + F ++GKGGFG V ++ G + A K+L+ GE E +
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 280 MISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR 338
++ R ++ L + T + L LV M+ G + + R AA
Sbjct: 237 ILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEARAVFYAAE 294
Query: 339 ---GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 395
GL LH + +I++RD+K NILLD++ + D GLA + + GTV
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGRVGTV 349
Query: 396 GHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 428
G++APE + + + D + G LL E+I+G
Sbjct: 350 GYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 38/173 (21%), Positives = 69/173 (39%), Gaps = 33/173 (19%)
Query: 339 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR------ 392
+ +LH + ++HRD+K +NI VGDFGL +D + T
Sbjct: 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 393 -----GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 447
GT +++PE + S K D+F G++L EL+ T ++ ++ V
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF------STQMERVRIITDV 286
Query: 448 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500
+ + Y + MVQ +L P+ RP+ ++++
Sbjct: 287 RNLK--------FPLLFTQKYP--QEHMMVQ-DMLSPS--PTERPEATDIIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 17/71 (23%), Positives = 33/71 (46%), Gaps = 1/71 (1%)
Query: 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 288
++F +G+GGFG V++ D A+KR++ N + EV+ ++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 289 LLRLIGFCMTT 299
++R + T
Sbjct: 66 IVRYFNAWLET 76
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 49/222 (22%), Positives = 86/222 (38%), Gaps = 25/222 (11%)
Query: 226 QSATSNFSSK----NLVGKGGFGNVYKG-YLQDGTVVAVK--------RLKDGNAIGGEI 272
+T F ++G+G V + + AVK
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 273 QFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR 331
EV+ + ++ H N+++L T T LV+ M G + L K +L ++
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391
I + LH+ I+HRD+K NILLD+ + DFG + LD +
Sbjct: 129 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVC 184
Query: 392 RGTVGHIAPEYLSTGQSSEKT------DVFGFGILLLELISG 427
GT ++APE + + D++ G+++ L++G
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISL----AVH 286
L+GKGGFG V+ G+ L D VA+K R+ + + + EV ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 287 RNLLRLIGFCMTTTERLLVYPYMSNGS-VASRLKAKPSLDWATRKRIALGAARGLLYLHE 345
++RL+ + T +LV + + K L + + + H
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157
Query: 346 QCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 404
+ ++HRD+K NIL+D + DFG LL D T GT + PE++S
Sbjct: 158 R---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFD-GTRVYSPPEWIS 211
Query: 405 TGQ-SSEKTDVFGFGILLLELISG 427
Q + V+ GILL +++ G
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCG 235
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 47/202 (23%), Positives = 84/202 (41%), Gaps = 17/202 (8%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHR--N 288
L+G GGFG+VY G + D VA+K R+ D + + EV ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 289 LLRLIGFCMTTTERLLVYPYMSN-GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 347
++RL+ + +L+ + + + +L + + + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC- 168
Query: 348 DPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 406
++HRD+K NIL+D + + DFG LL D+ T GT + PE++
Sbjct: 169 --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFD-GTRVYSPPEWIRYH 223
Query: 407 Q-SSEKTDVFGFGILLLELISG 427
+ V+ GILL +++ G
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCG 245
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 11/217 (5%)
Query: 216 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ- 273
+ R + + ++ ++GKG FG V K AVK + +A +
Sbjct: 8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67
Query: 274 FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIA 333
EVE++ H N+++L ++ +V + G + + + RI
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTA 390
G+ Y+H+ I+HRD+K NILL ++ + + DFGL+ ++ +
Sbjct: 128 KQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDR 183
Query: 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
+ GT +IAPE L G EK DV+ G++L L+SG
Sbjct: 184 I-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 49/223 (21%), Positives = 86/223 (38%), Gaps = 26/223 (11%)
Query: 225 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLK------------DGNA 267
++ +G G +G V + A+K +K + N
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 268 IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWA 327
+ E+ ++ H N+++L LV + G + ++ + D
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 328 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCD 384
I G+ YLH+ I+HRD+K NILL + + DFGL+ D
Sbjct: 147 DAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-D 202
Query: 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
+ + GT +IAPE L + +EK DV+ G+++ L+ G
Sbjct: 203 YKLRDRL-GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 45/216 (20%), Positives = 81/216 (37%), Gaps = 19/216 (8%)
Query: 222 FKELQSATSNFSS----KNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT 276
++L + F+ K +G G + + AVK + E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----- 64
Query: 277 EVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 335
E+E ++ H N++ L +V M G + ++ + +
Sbjct: 65 EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT 124
Query: 336 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVTTAV 391
+ + YLH Q ++HRD+K +NIL + + DFG AK L + + T
Sbjct: 125 ITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 392 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
T +APE L D++ G+LL +++G
Sbjct: 182 -YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 23/92 (25%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+++ +LT L+++ + +N IS + + LS+L +L L+NN + L L L
Sbjct: 259 NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L+ N +T P L+++S++ D + +
Sbjct: 317 FLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 26/93 (27%), Positives = 45/93 (48%), Gaps = 4/93 (4%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
S + NL+ L + + N IS + L+KL L++ +N + S +++L L L
Sbjct: 237 SPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSL 292
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
LNNN L + ++ L L LS N+++
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 26/97 (26%), Positives = 46/97 (47%), Gaps = 6/97 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ + N+T L + + NN I+ P + LS+L L++ N + + V L L+ L
Sbjct: 215 TPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKML 270
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
+ +N ++ L+N+SQL L L+ N L
Sbjct: 271 NVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 24/102 (23%), Positives = 46/102 (45%), Gaps = 6/102 (5%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
N + + S + N+T L + + + + T I L+ L +L L+ N P +
Sbjct: 140 GANHNLSDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--L 195
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
+ L +L Y N +T P ++NM++L L + N ++
Sbjct: 196 ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 19/93 (20%), Positives = 41/93 (44%), Gaps = 5/93 (5%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
S + NLT + + L N+ + + ++ L L ++ + P +++L L L
Sbjct: 126 SPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
LN N + P L++++ L + N ++
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 7e-14
Identities = 25/115 (21%), Positives = 50/115 (43%), Gaps = 11/115 (9%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ L ++ +++ ++ I I L+ L L+L+ N T P +S+L L L
Sbjct: 38 VTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNL 93
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLI 130
+ N +T +L N++ L L L+ +N+S + + N+ N +
Sbjct: 94 YIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHNL 145
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 20/96 (20%), Positives = 39/96 (40%), Gaps = 6/96 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+L +LQ +++ + +L + L ++ + +L L+YL
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQG--IEYLTNLEYL 71
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115
LN N +T P LSN+ +L L + N ++
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA 105
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 14/91 (15%), Positives = 31/91 (34%), Gaps = 9/91 (9%)
Query: 25 LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 84
L + N I L++ + L T + LE++ L +
Sbjct: 2 AATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54
Query: 85 SLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115
+ + ++ L +L+L+ N ++ P
Sbjct: 55 KVAS--IQGIEYLTNLEYLNLNGNQITDISP 83
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 9e-05
Identities = 16/48 (33%), Positives = 23/48 (47%), Gaps = 2/48 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNN 60
L IG LTNL + L N+I+ P + LSK+ + D +N
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 13/218 (5%)
Query: 215 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ 273
+ +F+ + ++ ++GKG FG V K AVK + +A +
Sbjct: 9 SGRENLYFQG--TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 274 -FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 332
EVE++ H N+++L ++ +V + G + + + RI
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI 126
Query: 333 ALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTT 389
G+ Y+H+ I+HRD+K NILL ++ + + DFGL+ ++ +
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKD 182
Query: 390 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
+ GT +IAPE L G EK DV+ G++L L+SG
Sbjct: 183 RI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 56/247 (22%), Positives = 87/247 (35%), Gaps = 59/247 (23%)
Query: 235 KNLVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRN 288
K +G+G +G V Q + A+K +++ N E + +TEV ++ H N
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE-RIKTEVRLMKKLHHPN 89
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG------------- 335
+ RL LV G + +L +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 336 --------------------AAR-------GLLYLHEQCDPKIIHRDVKAANILL--DEY 366
+ L YLH Q I HRD+K N L ++
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKS 206
Query: 367 YEAVVGDFGLAKLLDHCDSH----VTTAVRGTVGHIAPEYLSTGQSS--EKTDVFGFGIL 420
+E + DFGL+K ++ +TT GT +APE L+T S K D + G+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 421 LLELISG 427
L L+ G
Sbjct: 266 LHLLLMG 272
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 29/115 (25%), Positives = 47/115 (40%), Gaps = 6/115 (5%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPST 69
S N T+SS+ L L+ + Q++N+ + L L+ LD+S+
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 70 VSHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 123
+ L +L+ L++ NS P + + L FLDLS L FN
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE----QLSPTAFN 491
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 21/105 (20%), Positives = 40/105 (38%), Gaps = 2/105 (1%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-S 71
+ G S S T+L+ + L N + + + L +L LD ++ +V
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
L L YL +++ A + +S L L ++ N+
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 26/123 (21%), Positives = 48/123 (39%), Gaps = 6/123 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
L S S + LQ++ L I LS L TL L+ N S
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL-SGPVPSF-----HAKTFNITG 126
L +LQ L +L + ++ L L++++N + S +P + + + +++
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 127 NSL 129
N +
Sbjct: 159 NKI 161
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 20/100 (20%), Positives = 40/100 (40%), Gaps = 1/100 (1%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 71
+ + L++L+++ + N+ + +I +L L LDLS P+ +
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L +LQ L + +N L ++ L + L N
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 18/86 (20%), Positives = 27/86 (31%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85
+ + + L N + +L LDLS L L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 86 LTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ + S +S L L NL+
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLA 113
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 24/104 (23%), Positives = 47/104 (45%), Gaps = 5/104 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT-GPIPSTVS 71
+ + L++LQ ++ N++ IG L L L++++N +P S
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAF----LDLSYNNLS 111
+L L++L L++N + L + Q+ LDLS N ++
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 23/90 (25%), Positives = 41/90 (45%), Gaps = 5/90 (5%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--GPIPSTVSHLETLQYLRL 81
L +L+ + +N + +E+ L L LDLS N + G + +L+YL L
Sbjct: 323 KLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ N + + + + QL LD ++NL
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 409
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 24/112 (21%), Positives = 43/112 (38%), Gaps = 14/112 (12%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
+L+LV + KL L L ++N L +L++L L+
Sbjct: 305 GWQHLELVNCKFGQFPTL------KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSR 356
Query: 84 NSLT--GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 129
N L+ G S + L +LDLS+N + +F + + ++L
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 408
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 25/100 (25%), Positives = 38/100 (38%), Gaps = 7/100 (7%)
Query: 12 QNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 71
+ LTN+ L + I + + L+L N F P+
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK-DFSYNFGWQHLELVNCKFGQ-FPT--L 322
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L++L+ L +N A S ++ L FLDLS N LS
Sbjct: 323 KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLS 360
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 22/110 (20%), Positives = 37/110 (33%), Gaps = 12/110 (10%)
Query: 13 NLSGTLSSSIGNLTNLQLVL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS 68
+ + + L + L+ L N ++ I K +L L L NNF + +
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMK 218
Query: 69 TV-SHLETLQYLRL------NNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
T L L+ RL N +L +L + L + L
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 18/111 (16%), Positives = 32/111 (28%), Gaps = 10/111 (9%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIP-TEIGKLSKLLTLDL------SNNFFT 63
S N + L + L+NN S ++ T I L+ L L +
Sbjct: 185 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 64 GPIPSTVSHLETLQYLRLNNNSLTG---AIPPSLSNMSQLAFLDLSYNNLS 111
S + L L L I + ++ ++ L +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 229 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVK-------RLKDGNAIGGEIQFQTEVE- 279
+ K+++G+G V + + G AVK RL + E
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 280 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 339
+ +A H +++ LI +++ LV+ M G + L K +L + I
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 399
+ +LH I+HRD+K NILLD+ + + DFG + L+ + GT G++A
Sbjct: 213 VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELC-GTPGYLA 267
Query: 400 PEYLSTGQS------SEKTDVFGFGILLLELISG 427
PE L ++ D++ G++L L++G
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-17
Identities = 18/92 (19%), Positives = 44/92 (47%), Gaps = 1/92 (1%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ I L+NL+ + + +++ + L+ L LD+S++ I + ++ L + +
Sbjct: 82 NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L+ N I P L + +L L++ ++ +
Sbjct: 142 DLSYNGAITDIMP-LKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-16
Identities = 19/91 (20%), Positives = 41/91 (45%), Gaps = 2/91 (2%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ I N++ + + N + + I LS L L + T +S L +L L
Sbjct: 60 TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 110
+++++ +I ++ + ++ +DLSYN
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 20/100 (20%), Positives = 43/100 (43%), Gaps = 3/100 (3%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
+++ ++ LT+L L+ + ++ I T+I L K+ ++DLS N I +
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKT 157
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
L L+ L + + + + + +L L + G
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-13
Identities = 24/115 (20%), Positives = 51/115 (44%), Gaps = 9/115 (7%)
Query: 21 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80
+ + +L + L N N++ + T I + L ++N T + +S L L+ LR
Sbjct: 39 TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLR 94
Query: 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 130
+ +T P+LS ++ L LD+S++ + + + +++ N I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-08
Identities = 15/93 (16%), Positives = 34/93 (36%), Gaps = 7/93 (7%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
LL ++ + +++ L + L+N T + + ++ L +NN
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 84 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
T P +S +S L L + +++
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIP 106
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 52/251 (20%), Positives = 99/251 (39%), Gaps = 39/251 (15%)
Query: 203 DVNEQRREEVCLGNLKRF-----HFKELQSATSNFSSKNLVGKGGFGNVY----KGYLQD 253
+ + RRE+ L L+ K+++ +F ++G+G FG V K
Sbjct: 42 NNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---A 98
Query: 254 GTVVAVKRLKDGNAIG-GEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMS 310
V A+K L + E F+ E +++ + + L + L LV Y
Sbjct: 99 DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYV 157
Query: 311 NG---SVASRLKAKPSLDWATRKR-----IALGAARGLLYLHEQCDPKIIHRDVKAANIL 362
G ++ S+ + + + A R + + + +H+ +HRD+K NIL
Sbjct: 158 GGDLLTLLSKFEDRLPEEMA---RFYLAEMVIA----IDSVHQL---HYVHRDIKPDNIL 207
Query: 363 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-----DVFGF 417
+D + DFG L + ++ GT +I+PE L + + D +
Sbjct: 208 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267
Query: 418 GILLLELISGL 428
G+ + E++ G
Sbjct: 268 GVCMYEMLYGE 278
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 9e-17
Identities = 71/289 (24%), Positives = 108/289 (37%), Gaps = 67/289 (23%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVK-------------------------RLKDGNAIGGEI 272
GKG +G V Y D T A+K G
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 273 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRK 330
Q E+ ++ H N+++L+ E L V+ ++ G V ++ T K
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---------MEVPTLK 132
Query: 331 RIALGAAR--------GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382
++ AR G+ YLH Q KIIHRD+K +N+L+ E + DFG++
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 383 CDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISG--------LRAL 431
D+ ++ V GT +APE LS + S + DV+ G+ L + G + L
Sbjct: 190 SDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 432 EFGKTANQKGAMLDWVKKIHQEKKL--EMLVDKDLKNNYDRIELEEMVQ 478
K +Q D K L ML KN RI + E+
Sbjct: 249 -HSKIKSQALEFPDQPDIAEDLKDLITRMLD----KNPESRIVVPEIKL 292
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 16/102 (15%), Positives = 37/102 (36%), Gaps = 2/102 (1%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN-NFFTGPIPST 69
+ L +I +L L+ + L+ + P G + L L L + + +P
Sbjct: 214 RNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLD 272
Query: 70 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ L L+ L L +P ++ + + + + +
Sbjct: 273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 3/101 (2%)
Query: 17 TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 76
+L +SI NL NL+ + ++N+ +S + I L KL LDL P L
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255
Query: 77 QYLRL-NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
+ L L + ++L +P + ++QL LDL +PS
Sbjct: 256 KRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 24/117 (20%), Positives = 52/117 (44%), Gaps = 15/117 (12%)
Query: 13 NLSG----TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGK---------LSKLLTLDLSN 59
L+ L +SI +L L+ + ++ +P + L L +L L
Sbjct: 133 TLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW 192
Query: 60 NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
+P+++++L+ L+ L++ N+ L+ A+ P++ ++ +L LDL P
Sbjct: 193 TGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPP 247
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 23/134 (17%), Positives = 48/134 (35%), Gaps = 19/134 (14%)
Query: 13 NLSG----TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS 68
L L++LQ + + + +P + + + L TL L+ N +P+
Sbjct: 87 ELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPA 144
Query: 69 TVSHLETLQYLRLNNNSLTGAIPPSLSN---------MSQLAFLDLSYNNLSGPVPSFHA 119
+++ L L+ L + +P L++ + L L L + + S
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIAN 204
Query: 120 ----KTFNITGNSL 129
K+ I + L
Sbjct: 205 LQNLKSLKIRNSPL 218
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 7e-07
Identities = 10/117 (8%), Positives = 26/117 (22%), Gaps = 22/117 (18%)
Query: 16 GTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS------- 68
G+ + + + + Q + + + + D + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 69 --------------TVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ L L + L P +S L + + L
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 45/200 (22%), Positives = 81/200 (40%), Gaps = 13/200 (6%)
Query: 233 SSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 290
+G+G F K + AVK + E Q E+ + H N++
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIV 69
Query: 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
+L LV ++ G + R+K K I + ++H+
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---G 126
Query: 351 IIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
++HRD+K N+L ++ E + DFG A+L + + T T+ + APE L+
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNG 185
Query: 408 SSEKTDVFGFGILLLELISG 427
E D++ G++L ++SG
Sbjct: 186 YDESCDLWSLGVILYTMLSG 205
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 287
F ++G G F V+ G + A+K +K + + + E+ ++ H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHE 66
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLH 344
N++ L +TT LV +S G + R+ + D + + L A + YLH
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA---VKYLH 123
Query: 345 EQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 401
E I+HRD+K N+L +E + ++ DFGL+K+ + ++TA GT G++APE
Sbjct: 124 EN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMSTAC-GTPGYVAPE 177
Query: 402 YLSTGQSSEKTDVFGFGILLLELISG 427
L+ S+ D + G++ L+ G
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 28/113 (24%), Positives = 45/113 (39%), Gaps = 9/113 (7%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
S + LT L + L N + + I L L L L N + P VS L LQ L
Sbjct: 281 SPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAK---TFNITGNSL 129
NN ++ SL+N++ + +L +N +S P + + +
Sbjct: 337 FFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAW 387
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ L NL + NN ++ P + L+KL+ + ++NN P +++L L L
Sbjct: 62 DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115
L NN +T P L N++ L L+LS N +S
Sbjct: 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
S + LTNL+ ++ NN IS P +G L+ L L L+ N T++ L L L
Sbjct: 193 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDL 248
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
L NN ++ P LS +++L L L N +S
Sbjct: 249 DLANNQISNLAP--LSGLTKLTELKLGANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 25/93 (26%), Positives = 45/93 (48%), Gaps = 7/93 (7%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ NLTNL + L +N IS + + L+ L L N T P +++L TL+ L
Sbjct: 128 DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQV-TDLKP--LANLTTLERL 182
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
+++N ++ L+ ++ L L + N +S
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISD 213
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 24/99 (24%), Positives = 42/99 (42%), Gaps = 6/99 (6%)
Query: 17 TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 76
T + S +L + + I + L+ L ++ SNN T P + +L L
Sbjct: 37 TDTVSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKL 92
Query: 77 QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115
+ +NNN + P L+N++ L L L N ++ P
Sbjct: 93 VDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 19/96 (19%), Positives = 37/96 (38%), Gaps = 6/96 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ L +L N++ + L ++ TL V +L L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115
+NN LT P L N+++L + ++ N ++ P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 20/94 (21%), Positives = 44/94 (46%), Gaps = 4/94 (4%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
SS+ NLTN+ + +N IS P + L+++ L L++ +T + +++ +
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 113
+ +L P ++S+ D+++N S
Sbjct: 405 KNVTGALI--APATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 12/86 (13%), Positives = 31/86 (36%), Gaps = 6/86 (6%)
Query: 30 LVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGA 89
+ Q+ I+ L++ + L T + + L+ + L+ + +
Sbjct: 6 ATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-- 59
Query: 90 IPPSLSNMSQLAFLDLSYNNLSGPVP 115
+ ++ L ++ S N L+ P
Sbjct: 60 SIDGVEYLNNLTQINFSNNQLTDITP 85
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 49/218 (22%), Positives = 89/218 (40%), Gaps = 14/218 (6%)
Query: 218 KRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT 276
R + + F K +G G FG+V+ G +K + + Q +
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA 69
Query: 277 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 336
E+E++ H N++++ +V G + R+ + + A +
Sbjct: 70 EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129
Query: 337 AR----GLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTT 389
+ L Y H Q ++H+D+K NIL + + DFGLA+L D H T
Sbjct: 130 MKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTN 185
Query: 390 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
A GT ++APE + K D++ G+++ L++G
Sbjct: 186 AA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 50/230 (21%), Positives = 89/230 (38%), Gaps = 20/230 (8%)
Query: 210 EEVCLGNLKRFHFKELQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKD 264
+ K+++ + ++ + +G G FG V++ G A K +
Sbjct: 133 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192
Query: 265 GNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS- 323
+ E + E++ +S+ H L+ L E +++Y +MS G + ++ + +
Sbjct: 193 PHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 251
Query: 324 ---LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAK 378
+ R GL ++HE +H D+K NI+ + DFGL
Sbjct: 252 MSEDEAVEYMRQVCK---GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
Query: 379 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 428
LD V GT APE TD++ G+L L+SGL
Sbjct: 306 HLDP-KQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVK---RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
L+G+G +G V + + AVK + K GE + E++++ H+N+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 293 --IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLY 342
+ + + +V Y G + LD KR + A GL Y
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGM--QEM-----LDSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--DSHVTTAVRGTVGHIAP 400
LH Q I+H+D+K N+LL + G+A+ L D T+ +G+ P
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPP 180
Query: 401 EYLSTGQ--SSEKTDVFGFGILLLELISG 427
E + S K D++ G+ L + +G
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 49/203 (24%), Positives = 82/203 (40%), Gaps = 21/203 (10%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G G F V K G A K + + + + EV ++ +H N++ L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLHEQCDP 349
T+ +L+ +S G + L K SL + + + L G+ YLH +
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNYLHTK--- 134
Query: 350 KIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405
KI H D+K NI+L + DFGLA ++ GT +APE ++
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-GVEFKNIF-GTPEFVAPEIVNY 192
Query: 406 GQSSEKTDVFGFGILLLELISGL 428
+ D++ G++ L+SG
Sbjct: 193 EPLGLEADMWSIGVITYILLSGA 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 47/224 (20%), Positives = 89/224 (39%), Gaps = 26/224 (11%)
Query: 219 RFHFKELQSATSNFS-----SKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI 272
F+ + + SK ++G G G V + + + G A+K L D E+
Sbjct: 13 EVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV 72
Query: 273 QFQTEVEMISLAVHRNLLRLIGFCMTTTER----LLVYPYMSNGSVASRLKAKPSLDWAT 328
+ +++ ++ L++ M G + SR++ + +
Sbjct: 73 DH-----HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE 127
Query: 329 RK--RIALGAARGLLYLHEQCDPKIIHRDVKAANILL-DEYYEAVV--GDFGLAKLLDHC 383
R+ I + +LH I HRDVK N+L + +AV+ DFG AK
Sbjct: 128 REAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-- 182
Query: 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
+ + T T ++APE L + + D++ G+++ L+ G
Sbjct: 183 QNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 20/203 (9%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVK-------RLKDGNAIGGEIQFQTEVEMISLAVHRNLL 290
G G G V + + VA+K + + +TE+E++ H ++
Sbjct: 19 GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78
Query: 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
++ F + +V M G + ++ L AT K + YLHE
Sbjct: 79 KIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---G 134
Query: 351 IIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
IIHRD+K N+LL E + DFG +K+L ++ + + GT ++APE L +
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVG 192
Query: 408 S---SEKTDVFGFGILLLELISG 427
+ + D + G++L +SG
Sbjct: 193 TAGYNRAVDCWSLGVILFICLSG 215
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 45/211 (21%), Positives = 87/211 (41%), Gaps = 19/211 (9%)
Query: 229 TSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 282
+ F+ + +GKG F V + + G A + + Q + E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 283 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARG 339
L H N++RL L++ ++ G + + A+ D + + L A
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA--- 122
Query: 340 LLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 396
+L+ H+ ++HR++K N+LL + + DFGLA ++ GT G
Sbjct: 123 VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPG 178
Query: 397 HIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
+++PE L + D++ G++L L+ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 55/253 (21%), Positives = 93/253 (36%), Gaps = 41/253 (16%)
Query: 203 DVNEQRREEVCLGNLKRF-----HFKELQSATSNFSSKNLVGKGGFGNVY----KGYLQD 253
+E +++ L+ KE++ +F ++G+G F V K
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---T 85
Query: 254 GTVVAVKRLKDGNAIG-GEI-QFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMS 310
G V A+K + + + GE+ F+ E +++ R + +L F L LV Y
Sbjct: 86 GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYV 144
Query: 311 NGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQCDPKIIHRDVKAANIL 362
G + + L +RI AR + +H +HRD+K NIL
Sbjct: 145 GGDLLTLLSKF-------GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNIL 194
Query: 363 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG------ 416
LD + DFG L + + GT +++PE L T +G
Sbjct: 195 LDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254
Query: 417 -FGILLLELISGL 428
G+ E+ G
Sbjct: 255 ALGVFAYEMFYGQ 267
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 18/94 (19%), Positives = 40/94 (42%), Gaps = 2/94 (2%)
Query: 18 LSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 77
+ N ++ + ++++ + + + LDLS N + + ++ L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 78 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L L++N L L ++S L LDL+ N +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 27/114 (23%), Positives = 46/114 (40%), Gaps = 7/114 (6%)
Query: 21 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYL 79
S + + L NN I+ + G S++ LDL N + +TL++L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 129
L N + + + ++L LDLS N L+ P F + ++ N L
Sbjct: 175 NLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 7/99 (7%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
+L L+S + N++ + L N +S ++ +KL L+LS+N + +
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LES 78
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L TL+ L LNNN + L + L + NN+S
Sbjct: 79 LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 20/92 (21%), Positives = 39/92 (42%), Gaps = 8/92 (8%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ +L+ L+ + L NN + E+ + TL +NN + + S + + +
Sbjct: 74 LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR-VSC--SRGQGKKNI 125
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L NN +T S++ +LDL N +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 15/111 (13%), Positives = 33/111 (29%), Gaps = 4/111 (3%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
L+ + L +N ++ + E + + + L NN I + + L++ L
Sbjct: 189 VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRG 246
Query: 84 NSLTGAIPPSL-SNMSQLAFLDLSYN-NLSGPVPSFHAKTFNITGNSLICA 132
N S ++ + L+G + C
Sbjct: 247 NGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 15/92 (16%), Positives = 35/92 (38%), Gaps = 5/92 (5%)
Query: 42 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA 101
I ++ ++++ + S ++ L L+ N L+ L+ ++L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 102 FLDLSYNNLSGPVPSFHA----KTFNITGNSL 129
L+LS N L + +T ++ N +
Sbjct: 62 LLNLSSNVLYE-TLDLESLSTLRTLDLNNNYV 92
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 8e-16
Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 14/208 (6%)
Query: 229 TSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 282
++ FS +GKG F V + G A K + + Q + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 283 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 342
H N++RL + LV+ ++ G + + A+ A + Y
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIA 399
H I+HR++K N+LL + + DFGLA ++ DS GT G+++
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYLS 175
Query: 400 PEYLSTGQSSEKTDVFGFGILLLELISG 427
PE L S+ D++ G++L L+ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 45/214 (21%), Positives = 80/214 (37%), Gaps = 25/214 (11%)
Query: 227 SATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQT 276
S + + N +G+G +G V A K ++D + +
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF------KQ 55
Query: 277 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 336
E+E++ H N++RL T+ LV + G + R+ K + RI
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 393
+ Y H+ + HRD+K N L + DFGLA + G
Sbjct: 116 LSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVG 170
Query: 394 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
T +++P+ L G + D + G+++ L+ G
Sbjct: 171 TPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 20/222 (9%)
Query: 218 KRFHFKELQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI 272
K++ + ++ + +G G FG V++ G V K + +
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY- 93
Query: 273 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL----DWAT 328
+ E+ +++ H L+ L E +L+ ++S G + R+ A+ +
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 329 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL--DEYYEAVVGDFGLAKLLDHCDSH 386
R A GL ++HE I+H D+K NI+ + + DFGLA L+ D
Sbjct: 154 YMRQACE---GLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEI 206
Query: 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 428
V T APE + TD++ G+L L+SGL
Sbjct: 207 VKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 24/203 (11%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295
+G+G +G V VAVK + A+ + E+ + + H N+++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 296 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQC 347
+ L Y S G + R++ + A+ G++YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPD--------IGMPEPDAQRFFHQLMAGVVYLHGI- 124
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--DSHVTTAVRGTVGHIAPEYLS- 404
I HRD+K N+LLDE + DFGLA + + + + GT+ ++APE L
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKR 181
Query: 405 TGQSSEKTDVFGFGILLLELISG 427
+E DV+ GI+L +++G
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 20/215 (9%)
Query: 225 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEV 278
+ +A++ FS +GKG F V + G A K + + Q + E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 279 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALG 335
+ H N++RL + LV+ ++ G + + A+ D + + L
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139
Query: 336 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA---VVGDFGLAKLLDHCDSHVTTAVR 392
+ + Y H I+HR++K N+LL + + DFGLA ++ DS
Sbjct: 140 S---IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFA 191
Query: 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
GT G+++PE L S+ D++ G++L L+ G
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 18/202 (8%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
GKG F V + + G AVK + + E + E + + H +++ L
Sbjct: 33 GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE-DLKREASICHMLKHPHIVEL 91
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL----YLHEQCD 348
+ + +V+ +M + + + + + +A R +L Y H+
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-- 149
Query: 349 PKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405
IIHRDVK +LL + +G FG+A L V GT +APE +
Sbjct: 150 -NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKR 207
Query: 406 GQSSEKTDVFGFGILLLELISG 427
+ DV+G G++L L+SG
Sbjct: 208 EPYGKPVDVWGCGVILFILLSG 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 49/203 (24%), Positives = 82/203 (40%), Gaps = 21/203 (10%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G G F V K G A K + + + + EV ++ +H N++ L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLHEQCDP 349
T+ +L+ +S G + L K SL + + + L G+ YLH +
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNYLHTK--- 134
Query: 350 KIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405
KI H D+K NI+L + DFGLA ++ GT +APE ++
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-GVEFKNIF-GTPEFVAPEIVNY 192
Query: 406 GQSSEKTDVFGFGILLLELISGL 428
+ D++ G++ L+SG
Sbjct: 193 EPLGLEADMWSIGVITYILLSGA 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 49/203 (24%), Positives = 81/203 (39%), Gaps = 21/203 (10%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G G F V K G A K RL + + EV ++ H N++ L
Sbjct: 14 GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLHEQCDP 349
T+ +L+ +S G + L K SL + + L G+ YLH +
Sbjct: 74 HDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSK--- 127
Query: 350 KIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405
+I H D+K NI+L + DFG+A ++ + GT +APE ++
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNIF-GTPEFVAPEIVNY 185
Query: 406 GQSSEKTDVFGFGILLLELISGL 428
+ D++ G++ L+SG
Sbjct: 186 EPLGLEADMWSIGVITYILLSGA 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 51/223 (22%), Positives = 84/223 (37%), Gaps = 27/223 (12%)
Query: 227 SATSNFS-----SKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVE- 279
S + F ++++G+G V L AVK ++ + EVE
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFREVEM 63
Query: 280 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 339
+ HRN+L LI F LV+ M GS+ S + + + + A
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123
Query: 340 LLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHV-------TT 389
L +LH + I HRD+K NIL ++ + DF L + T
Sbjct: 124 LDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 390 AVRGTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELISG 427
G+ ++APE + D++ G++L L+SG
Sbjct: 181 PC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 18/94 (19%), Positives = 40/94 (42%), Gaps = 2/94 (2%)
Query: 18 LSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 77
+ N ++ + ++++ + + + LDLS N + + ++ L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 78 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L L++N L L ++S L LDL+ N +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 37/212 (17%), Positives = 69/212 (32%), Gaps = 10/212 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 71
++ G + +Q + L+ N I + L L+L NF + V
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV 189
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGN 127
L+ L L++N L + P + + + ++ L N L + + F++ GN
Sbjct: 190 -FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGN 247
Query: 128 SLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFG 187
C T D F + A + L + C L
Sbjct: 248 GFHCGT--LRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305
Query: 188 FLLWWRQRHNQQIFFDVNEQRREEVCLGNLKR 219
L+ +++ + + +E R E N R
Sbjct: 306 RLIALKRKEHALLSGQGSETERLECERENQAR 337
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 8e-14
Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 7/99 (7%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
+L L+S + N++ + L N +S ++ +KL L+LS+N + +
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LES 78
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L TL+ L LNNN + L + L + NN+S
Sbjct: 79 LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 20/92 (21%), Positives = 39/92 (42%), Gaps = 8/92 (8%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ +L+ L+ + L NN + E+ + TL +NN + + S + + +
Sbjct: 74 LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR-VSC--SRGQGKKNI 125
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L NN +T S++ +LDL N +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 15/92 (16%), Positives = 35/92 (38%), Gaps = 5/92 (5%)
Query: 42 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA 101
I ++ ++++ + S ++ L L+ N L+ L+ ++L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 102 FLDLSYNNLSGPVPSFHA----KTFNITGNSL 129
L+LS N L + +T ++ N +
Sbjct: 62 LLNLSSNVLYE-TLDLESLSTLRTLDLNNNYV 92
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 9/97 (9%), Positives = 22/97 (22%), Gaps = 4/97 (4%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
L+ Q + + E ++ +D + I + L
Sbjct: 311 KRKEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKK 369
Query: 84 NSLTGAIPPSLSNMSQL---AFLDLSYNNLSGPVPSF 117
+L + ++L + L
Sbjct: 370 KALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQ 406
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 18/169 (10%), Positives = 37/169 (21%), Gaps = 4/169 (2%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
+ + L N + + I + +TL+ + +
Sbjct: 321 QGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGR 380
Query: 71 SHLETLQYLRLNNNSLTG--AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNS 128
L S + L + Y + S
Sbjct: 381 RAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMY 440
Query: 129 LICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLG 177
T E+ L+ + + S + + + L S LG
Sbjct: 441 QHKETQLAEENA--RLKKLNGEADLALASANATLQELVVREQNLASQLG 487
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIG-GEIQF-QTEVEMISLAVH 286
+F +GKG FG V D + A+K + + E++ E++++ H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 287 RNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRK----RIALGAARGLL 341
L+ L + E + +V + G + L+ T K + + L
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA----LD 129
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 401
YL Q +IIHRD+K NILLDE+ + DF +A +L T + GT ++APE
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITTMAGTKPYMAPE 184
Query: 402 YLSTGQSSEKT---DVFGFGILLLELISGLR 429
S+ + + + D + G+ EL+ G R
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 53/250 (21%), Positives = 92/250 (36%), Gaps = 40/250 (16%)
Query: 203 DVNEQRREEVCLGNLKRF-----HFKELQSATSNFSSKNLVGKGGFGNVY----KGYLQD 253
D R+ + L R+ ++L+ ++ ++G+G FG V K
Sbjct: 37 DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---T 93
Query: 254 GTVVAVKRLKDGNAIG-GEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMS 310
V A+K L I + F E ++++ A +++L + L +V YM
Sbjct: 94 RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMP 152
Query: 311 NGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQCDPKIIHRDVKAANIL 362
G + + + + AR L +H IHRDVK N+L
Sbjct: 153 GGDLVNLMS---------NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNML 200
Query: 363 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK----TDVFGFG 418
LD+ + DFG ++ GT +I+PE L + D + G
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 260
Query: 419 ILLLELISGL 428
+ L E++ G
Sbjct: 261 VFLYEMLVGD 270
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 47/200 (23%), Positives = 81/200 (40%), Gaps = 17/200 (8%)
Query: 239 GKGGFGNVYKG-YLQDGTVVAVK-----RLKDGNAIGGEI--QFQTEVEMISLAVHRNLL 290
G G FG V+ + V VK ++ + I + E+ ++S H N++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 291 RLIGFCMTTTERLLVYPYMSNGS-VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 349
+++ LV +G + + + P LD I + YL +
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK--- 149
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 409
IIHRD+K NI++ E + + DFG A L+ T GT+ + APE L G
Sbjct: 150 DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYTFC-GTIEYCAPEVLM-GNPY 206
Query: 410 E--KTDVFGFGILLLELISG 427
+ +++ G+ L L+
Sbjct: 207 RGPELEMWSLGVTLYTLVFE 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 230 SNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAI-GGEIQF-QTEVEMISLAVH 286
+F ++G+G F V L A+K L+ + I ++ + E +++S H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 287 RNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR------- 338
++L F E+L Y NG + ++ R
Sbjct: 90 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKI--------GSFDETCTRFYTAEIV 140
Query: 339 -GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTVG 396
L YLH + IIHRD+K NILL+E + DFG AK+L GT
Sbjct: 141 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 397 HIAPEYLSTGQSSEKTDVFGFGILLLELISGL 428
+++PE L+ + + +D++ G ++ +L++GL
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 16/205 (7%)
Query: 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
S ++G G FG V+K G +A K +K E + + E+ +++ H NL
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANL 148
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS----LDWATRKRIALGAARGLLYLHE 345
++L + + +LV Y+ G + R+ + LD + G+ ++H+
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQ 205
Query: 346 QCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 403
I+H D+K NIL + DFGLA+ + GT +APE +
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-REKLKVNF-GTPEFLAPEVV 260
Query: 404 STGQSSEKTDVFGFGILLLELISGL 428
+ S TD++ G++ L+SGL
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGL 285
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 50/197 (25%), Positives = 81/197 (41%), Gaps = 18/197 (9%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
GKG F V + G VA+K +L + + EV ++ + H N+++L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS----LQKLFREVRIMKILNHPNIVKL 79
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 352
T L+ Y S G V L A + + + Y H++ I+
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IV 136
Query: 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 410
HRD+KA N+LLD + DFG + + G + APE G+ +
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFC-GAPPYAAPELFQ-GKKYDGP 193
Query: 411 KTDVFGFGILLLELISG 427
+ DV+ G++L L+SG
Sbjct: 194 EVDVWSLGVILYTLVSG 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 40/175 (22%), Positives = 67/175 (38%), Gaps = 25/175 (14%)
Query: 219 RFHFKELQSATS--NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG----- 270
SATS + +G+G +G VYK VA+KR++ + G
Sbjct: 21 SMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA 80
Query: 271 --EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWAT 328
E+ E++ HRN++ L L++ Y N + + P +
Sbjct: 81 IREVSLLKELQ------HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRV 133
Query: 329 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG-----DFGLAK 378
K G+ + H + + +HRD+K N+LL + DFGLA+
Sbjct: 134 IKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 49/203 (24%), Positives = 78/203 (38%), Gaps = 21/203 (10%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G G F V K G A K R K + EV ++ H N++ L
Sbjct: 20 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLHEQCDP 349
T+ +L+ ++ G + L K SL + + L + YLH
Sbjct: 80 HEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG---VYYLHSL--- 133
Query: 350 KIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405
+I H D+K NI+L + DFGLA +D + GT +APE ++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIF-GTPEFVAPEIVNY 191
Query: 406 GQSSEKTDVFGFGILLLELISGL 428
+ D++ G++ L+SG
Sbjct: 192 EPLGLEADMWSIGVITYILLSGA 214
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 24/203 (11%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295
+G+G +G V VAVK + A+ + E+ + + H N+++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 296 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQC 347
+ L Y S G + R+ + A+ G++YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI--------EPDIGMPEPDAQRFFHQLMAGVVYLHGI- 124
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--DSHVTTAVRGTVGHIAPEYLS- 404
I HRD+K N+LLDE + DFGLA + + + + GT+ ++APE L
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKR 181
Query: 405 TGQSSEKTDVFGFGILLLELISG 427
+E DV+ GI+L +++G
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 8e-15
Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 19/167 (11%)
Query: 227 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISL- 283
ATS + +G G +G VYK G VA+K ++ N GG + V ++L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 284 -----AVHRNLLRLIGFCMTTTERL-----LVYPYMSN--GSVASRLKAKPSLDWATRKR 331
H N++RL+ C T+ LV+ ++ + + P L T K
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP-PPGLPAETIKD 124
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378
+ RGL +LH I+HRD+K NIL+ + DFGLA+
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 32/122 (26%), Positives = 53/122 (43%), Gaps = 15/122 (12%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
L NL+ + L NI +P + L L L++S N F P + L +L+ L + N
Sbjct: 194 GLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251
Query: 84 NSLTGAIPP-SLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICATGAEE 137
+ ++ I + ++ L L+L++NNLS P F ++ N C
Sbjct: 252 SQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC------ 304
Query: 138 DC 139
DC
Sbjct: 305 DC 306
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82
+L +L+++ L N+I I L+ L TL+L +N+ T +L L+ L L
Sbjct: 97 HLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155
Query: 83 NNSLTGAIPP-SLSNMSQLAFLDLSYNN 109
NN + +IP + + + L LDL
Sbjct: 156 NNPIE-SIPSYAFNRVPSLMRLDLGELK 182
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 24/87 (27%), Positives = 34/87 (39%), Gaps = 2/87 (2%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85
+N + + L NNI L L L L N + L +L L L +N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 86 LTGAIPP-SLSNMSQLAFLDLSYNNLS 111
LT IP + +S+L L L N +
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIE 160
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 24/97 (24%), Positives = 40/97 (41%), Gaps = 6/97 (6%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL- 81
L +L + L +N ++ IP+ LSKL L L NN + + +L L L
Sbjct: 121 GLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLG 179
Query: 82 NNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSF 117
L I + + L +L+L N+ +P+
Sbjct: 180 ELKKLE-YISEGAFEGLFNLKYLNLGMCNIKD-MPNL 214
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 22/86 (25%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 27 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 86
V+ +S +P I S L+L N T HL L+ L+L NS+
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 87 TGAIPP-SLSNMSQLAFLDLSYNNLS 111
I + + ++ L L+L N L+
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT 136
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 16/69 (23%), Positives = 32/69 (46%), Gaps = 2/69 (2%)
Query: 19 SSSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 77
S L++L+ + + N+ +S I L+ L+ L+L++N + + L L
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV 293
Query: 78 YLRLNNNSL 86
L L++N
Sbjct: 294 ELHLHHNPW 302
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 75.7 bits (185), Expect = 2e-14
Identities = 61/365 (16%), Positives = 105/365 (28%), Gaps = 99/365 (27%)
Query: 193 RQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLV--GKGGFGNVYKGY 250
R ++ Q+F N R + L++ EL+ A KN++ G G G K
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYL--KLRQ-ALLELRPA------KNVLIDGVLGSG---K-- 163
Query: 251 LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-----LV 305
T VA+ + + ++ ++L C + L L+
Sbjct: 164 ----TWVALDVCLS---YKVQCKMDFKIFWLNL----------KNCNSPETVLEMLQKLL 206
Query: 306 YPYMSNGSVASRLKAKPSL---DWATRKRIALGA---ARGLLYLHEQCDPKIIHRDVKAA 359
Y N + S + L R L + LL L + K A
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW----NA- 261
Query: 360 NILLDEYYEAVVGDFGLAKLLDHC-------DSHVTTAVRG-TVGHIAPEYLSTGQSSEK 411
F L C VT + T HI+ ++ S + ++
Sbjct: 262 --------------FNL-----SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302
Query: 412 T-DVFG--FGI--------------LLLELISGLRALEFGKTANQ-KGAMLDWVKKIHQE 453
+ L +I + T + K D + I E
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLTTNPRRLSII-AESIRDGLATWDNWKHVNCDKLTTI-IE 360
Query: 454 KKLEMLVDKDLKNNYDRIE-LEEMVQV--ALLCTQYLPSLRPKMSEVVRMLEGDGLAEKW 510
L +L + + +DR+ + LL + ++ + VV L L EK
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 511 AASQK 515
Sbjct: 421 PKEST 425
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 2e-06
Identities = 71/521 (13%), Positives = 151/521 (28%), Gaps = 149/521 (28%)
Query: 21 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80
++ N + + VL + I S D S+N I S + L L +
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRS-----DHSSNIKL-RIHSIQAELRRLLKSK 241
Query: 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLIC----ATGAE 136
N L + L N+ + ++N K T + A
Sbjct: 242 PYENCLL--V---LLNVQNAKAWN-AFN--------LSCKILLTTRFKQVTDFLSAATTT 287
Query: 137 EDCFGTAPMPLS-------FA--LNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFG 187
M L+ L+ P P + L++ I+ I
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI------IAESIRDG- 340
Query: 188 FLLW--WRQRHNQQIFFDVNEQRREEVCLGNLK----RFHFKELQSATSNFSSKNLVGKG 241
W W+ + ++ E L L+ R F L
Sbjct: 341 LATWDNWKHVNCDKL------TTIIESSLNVLEPAEYRKMFDRL---------------- 378
Query: 242 GFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301
++ F I + L LI F + ++
Sbjct: 379 -------------------------SV-----FPPSAH-IPTIL----LSLIWFDVIKSD 403
Query: 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAAN 360
++V + S+ + + + + K+ + A +
Sbjct: 404 VMVVVNKLHKYSLVEK-------QP----------KESTISIPSIYLELKVKLENEYALH 446
Query: 361 ILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-LSTGQSSEKTDVFGFGI 419
+ ++Y + + D + + HI + L + E+ + F +
Sbjct: 447 RSIVDHYNIPKTFDSDDLIPPYLDQYFYS-------HIG--HHLKNIEHPERMTL--FRM 495
Query: 420 LLLEL--ISG-LRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEM 476
+ L+ + +R N G++L+ ++++ K + D D Y+R+ + +
Sbjct: 496 VFLDFRFLEQKIRHD--STAWNASGSILNTLQQLKFYKP--YICDND--PKYERL-VNAI 548
Query: 477 VQVALLCTQYLPSLRPKMSEVVR---MLEGDGLAEKWAASQ 514
+ + L + K ++++R M E + + E+ A Q
Sbjct: 549 LDFLPKIEENL--ICSKYTDLLRIALMAEDEAIFEE-AHKQ 586
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 46/199 (23%), Positives = 84/199 (42%), Gaps = 20/199 (10%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
G G G V + + + A+K L+D E++ + +++R++
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDVYE 125
Query: 298 TTTER----LLVYPYMSNGSVASRLKAKPSLDWATRK--RIALGAARGLLYLHEQCDPKI 351
L+V + G + SR++ + + R+ I + YLH I
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NI 182
Query: 352 IHRDVKAANILL-DEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 408
HRDVK N+L + A++ DFG AK +S +TT T ++APE L +
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLGPEKY 240
Query: 409 SEKTDVFGFGILLLELISG 427
+ D++ G+++ L+ G
Sbjct: 241 DKSCDMWSLGVIMYILLCG 259
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 31/134 (23%), Positives = 56/134 (41%), Gaps = 15/134 (11%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPSTVS 71
T++ + NL + + + N++ +P + L L L+LS N + S +
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLH 269
Query: 72 HLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNIT 125
L LQ ++L L + P + ++ L L++S N L+ FH+ +T +
Sbjct: 270 ELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILD 328
Query: 126 GNSLICATGAEEDC 139
N L C DC
Sbjct: 329 SNPLAC------DC 336
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 27/90 (30%), Positives = 42/90 (46%), Gaps = 4/90 (4%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82
NL NL+ + L++N + IP + LS L LD+S N + L L+ L +
Sbjct: 78 NLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136
Query: 83 NNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 111
+N L I + S ++ L L L NL+
Sbjct: 137 DNDLV-YISHRAFSGLNSLEQLTLEKCNLT 165
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 26/101 (25%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 71
NL+ + ++ +L L ++ L++ NI+ I +L +L L++S+ + +
Sbjct: 163 NLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCL 221
Query: 72 HLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 111
+ L L + + +LT A+P ++ ++ L FL+LSYN +S
Sbjct: 222 YGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 20/89 (22%), Positives = 39/89 (43%), Gaps = 2/89 (2%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82
L +L+ + L+ N++ IPTE L L+ L L + + L L+ L ++
Sbjct: 150 GLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208
Query: 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ + P+ L L +++ NL+
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLT 237
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 18/100 (18%), Positives = 37/100 (37%), Gaps = 6/100 (6%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
L L+++ + + + L +L +++ T V HL L++L L+
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSY 257
Query: 84 NSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 122
N ++ I L + +L + L L+ F
Sbjct: 258 NPIS-TIEGSMLHELLRLQEIQLVGGQLA----VVEPYAF 292
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 18/101 (17%), Positives = 36/101 (35%), Gaps = 4/101 (3%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 71
+ + +L+ + L N +S + L L TL L +N +
Sbjct: 43 RIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFT 101
Query: 72 HLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 111
L L L ++ N + + ++ L L++ N+L
Sbjct: 102 GLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV 141
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 24/90 (26%), Positives = 43/90 (47%), Gaps = 4/90 (4%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82
L+NL + + N I + + L L +L++ +N S L +L+ L L
Sbjct: 102 GLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLE 160
Query: 83 NNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 111
+LT +IP +LS++ L L L + N++
Sbjct: 161 KCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 26/108 (24%), Positives = 47/108 (43%), Gaps = 4/108 (3%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
+L NL+ + + +N++ +I L+ L L L T IP+ SHL L LRL
Sbjct: 126 DLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRL 183
Query: 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSL 129
+ ++ S + +L L++S+ + N+T S+
Sbjct: 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSI 231
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 25/87 (28%), Positives = 38/87 (43%), Gaps = 2/87 (2%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85
T +L+ L N I E L L+L+ N + P ++L L+ L L +N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 86 LTGAIPP-SLSNMSQLAFLDLSYNNLS 111
L IP + +S L LD+S N +
Sbjct: 92 LK-LIPLGVFTGLSNLTKLDISENKIV 117
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 21/84 (25%), Positives = 33/84 (39%), Gaps = 5/84 (5%)
Query: 29 QLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG 88
+ VL +P I ++ LDL N + L+ L LN N ++
Sbjct: 14 RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS- 69
Query: 89 AIPP-SLSNMSQLAFLDLSYNNLS 111
A+ P + +N+ L L L N L
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLK 93
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 226 QSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG-------EIQFQTEV 278
Q + VG+G +G VYK G +VA+KR++ G EI E+
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 279 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAA 337
H N++ LI + LV+ +M + L + L + K
Sbjct: 77 H------HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378
RG+ + H+ +I+HRD+K N+L++ + DFGLA+
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 23/203 (11%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVE-MISLAVHRNLLRLIGF 295
G+G F V + G A K LK E+ + ++ L
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 296 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR-------GLLYLHEQCD 348
T+E +L+ Y + G + S + + + R G+ YLH+
Sbjct: 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSEND-----VIRLIKQILEGVYYLHQN-- 150
Query: 349 PKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405
I+H D+K NILL + + DFG+++ + H + + GT ++APE L+
Sbjct: 151 -NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH-ACELREIM-GTPEYLAPEILNY 207
Query: 406 GQSSEKTDVFGFGILLLELISGL 428
+ TD++ GI+ L++
Sbjct: 208 DPITTATDMWNIGIIAYMLLTHT 230
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 6e-14
Identities = 34/126 (26%), Positives = 48/126 (38%), Gaps = 9/126 (7%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 71
+ +SS L LQL+ L + I E L L LDL ++ P
Sbjct: 35 YIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94
Query: 72 HLETLQYLRLNNNSLTGAIPPS--LSNMSQLAFLDLSYNNLS--GPVPSFHA----KTFN 123
L L LRL L+ A+ N+ L LDLS N + PSF K+ +
Sbjct: 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154
Query: 124 ITGNSL 129
+ N +
Sbjct: 155 FSSNQI 160
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 7e-13
Identities = 27/120 (22%), Positives = 47/120 (39%), Gaps = 9/120 (7%)
Query: 19 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-----SH 72
+ + +LQ+++L N S + + L L L N + +
Sbjct: 419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEG 478
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---KTFNITGNSL 129
L LQ L LN+N L P S+++ L L L+ N L+ + + +I+ N L
Sbjct: 479 LSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQL 538
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 20/90 (22%), Positives = 35/90 (38%), Gaps = 3/90 (3%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLN 82
L + +LL N I + L +L L+L + + I +L L+ L L
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 83 NNSLTGAIPPS-LSNMSQLAFLDLSYNNLS 111
++ + + P + L L L + LS
Sbjct: 82 SSKIY-FLHPDAFQGLFHLFELRLYFCGLS 110
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 21/117 (17%), Positives = 41/117 (35%), Gaps = 6/117 (5%)
Query: 13 NLSGTLSSSIGNLTNLQLVL--LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
N+ ++ L + L + + L L L+L+ N
Sbjct: 251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAF 310
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
L+ LQ L L+ N L + + ++A++DL N+++ +TF
Sbjct: 311 YGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA----IIQDQTFKFLEK 363
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 23/111 (20%), Positives = 38/111 (34%), Gaps = 18/111 (16%)
Query: 29 QLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG 88
++ + N++ +P L+ L LS N+ S+ LE LQ L L +
Sbjct: 7 RIAFYRFCNLT-QVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 89 AIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF---------NITGNSL 129
I + N+ L LDL + + H F + L
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIY----FLHPDAFQGLFHLFELRLYFCGL 109
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 32/133 (24%), Positives = 51/133 (38%), Gaps = 13/133 (9%)
Query: 10 PSQNLSGTLSSSIGNLT-NLQLVLLQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTG-PI 66
P LSG ++ + L+ L N + I + ++ L L L+ N F+
Sbjct: 384 PDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSG 443
Query: 67 PSTVSHLETLQYLRLNNNSLTGAIPPSL-----SNMSQLAFLDLSYNNLSG-PVPSFHA- 119
T S +L+ L L N L A L +S L L L++N L+ P F
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL 503
Query: 120 ---KTFNITGNSL 129
+ ++ N L
Sbjct: 504 TALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 25/116 (21%), Positives = 42/116 (36%), Gaps = 9/116 (7%)
Query: 19 SSSIGNLTNLQLVLLQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE--T 75
NL L + L N I ++ GKL+ L ++D S+N + L+ T
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175
Query: 76 LQYLRLNNNSLTGAIPPSLSNMSQ------LAFLDLSYNNLSGPVPSFHAKTFNIT 125
L + L NSL + L LD+S N + + + + +
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 19/114 (16%), Positives = 45/114 (39%), Gaps = 7/114 (6%)
Query: 23 GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE--TLQYLR 80
GN + + +N IS + ++ + P +T + L ++++L
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272
Query: 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSL 129
L++ + + L L+L+YN ++ +F+ + N++ N L
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 30/214 (14%), Positives = 72/214 (33%), Gaps = 13/214 (6%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 71
+ L++LQ++ L +N ++ +P + L+ L L L++N T +
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTV-LSHN-D 523
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLIC 131
L+ L ++ N L P+ L+ LD+++N + N I
Sbjct: 524 LPANLEILDISRNQLLA---PNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIA 580
Query: 132 ATGAEEDCFGTAPMPLS----FALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFG 187
G D + P S F+L+ + + + + + + L+ +
Sbjct: 581 --GPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTV 638
Query: 188 FLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFH 221
+ + + + ++ ++
Sbjct: 639 TKFRGFCFICYKTAQRLVFKDHPQGTEPDMYKYD 672
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 20/114 (17%), Positives = 34/114 (29%), Gaps = 20/114 (17%)
Query: 18 LSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS--KLLTLDLSNNFFTGPIPSTVSHLE- 74
L S G L +L+ + +N I E+ L L L+ N +
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 75 -----TLQYLRLNNNSLTGAIP------------PSLSNMSQLAFLDLSYNNLS 111
L+ L ++ N T I SL + ++N+
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 32/122 (26%), Positives = 53/122 (43%), Gaps = 15/122 (12%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
L+NL+ + L N+ IP + L KL LDLS N + P + L LQ L +
Sbjct: 183 GLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240
Query: 84 NSLTGAIPP-SLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICATGAEE 137
+ + I + N+ L ++L++NNL+ P F + ++ N C
Sbjct: 241 SQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC------ 293
Query: 138 DC 139
+C
Sbjct: 294 NC 295
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82
+L +L+++ L N+I I L+ L TL+L +N T +L L+ L L
Sbjct: 86 HLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR 144
Query: 83 NNSLTGAIPPSL-SNMSQLAFLDLSYNN 109
NN + +IP + + L LDL
Sbjct: 145 NNPIE-SIPSYAFNRIPSLRRLDLGELK 171
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 30/113 (26%), Positives = 49/113 (43%), Gaps = 10/113 (8%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL- 81
L NL + L +N ++ IP LSKL L L NN + + +L+ L L
Sbjct: 110 GLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLG 168
Query: 82 NNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 129
L+ I + +S L +L+L+ NL +P+ +++GN L
Sbjct: 169 ELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHL 219
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 26/87 (29%), Positives = 34/87 (39%), Gaps = 2/87 (2%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85
TN +L+ L N I L L L LS N + L L L L +N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 86 LTGAIPP-SLSNMSQLAFLDLSYNNLS 111
LT IP + +S+L L L N +
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPIE 149
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 20/97 (20%), Positives = 38/97 (39%), Gaps = 9/97 (9%)
Query: 27 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 86
V+ N+ +P I + L+L N ++ HL L+ L+L+ N +
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 87 TGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 122
I + + ++ L L+L N L+ + F
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNRLT----TIPNGAF 132
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 15/69 (21%), Positives = 29/69 (42%), Gaps = 2/69 (2%)
Query: 19 SSSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 77
S L +LQ + + + I I L L+ ++L++N T + L L+
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLE 282
Query: 78 YLRLNNNSL 86
+ L++N
Sbjct: 283 RIHLHHNPW 291
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 7e-14
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 230 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
S F ++G+G FG V+ + A+K LK ++ + V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT-----LKVRDRVRTKM--- 75
Query: 286 HRNLLRLIG--------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKR----- 331
R++L + + T +L L+ ++ G + +RL + +
Sbjct: 76 ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-EEDVKFYLAE 134
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391
+AL L +LH II+RD+K NILLDE + DFGL+K +
Sbjct: 135 LALA----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSF 186
Query: 392 RGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 428
GTV ++APE + + ++ D + FG+L+ E+++G
Sbjct: 187 CGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 225 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRL---KDGNAIGGEIQFQT 276
S S + +G+G VY+ A+K L D + +T
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV------RT 97
Query: 277 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIA 333
E+ ++ H N+++L T TE LV ++ G + R+ K D A +
Sbjct: 98 EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTA 390
L A + YLHE I+HRD+K N+L + DFGL+K+++H + T
Sbjct: 158 LEA---VAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-QVLMKTV 210
Query: 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
GT G+ APE L + D++ GI+ L+ G
Sbjct: 211 C-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 8e-14
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 230 SNFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
++F+ ++GKG FG V KG + AVK LK I + +VE V
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDD-----DVE--CTMV 390
Query: 286 HRNLLRLIG---------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALG 335
+ +L L G C T +RL V Y++ G + ++ A
Sbjct: 391 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 450
Query: 336 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 395
A GL +L + II+RD+K N++LD + DFG+ K + D T GT
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTP 506
Query: 396 GHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 428
+IAPE + Q K+ D + FG+LL E+++G
Sbjct: 507 DYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 49/183 (26%), Positives = 75/183 (40%), Gaps = 41/183 (22%)
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTA 390
+ A+G+ +L + K IHRD+ A NILL E + DFGLA+ + +V
Sbjct: 198 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT------ANQKGAML 444
R + +APE + + ++DV+ FG+LL E+ S G + +++
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEE---- 304
Query: 445 DWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVR 499
+ LK R+ EM Q L C PS RP SE+V
Sbjct: 305 ---------------FCRRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 348
Query: 500 MLE 502
L
Sbjct: 349 HLG 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 32/156 (20%), Positives = 58/156 (37%), Gaps = 15/156 (9%)
Query: 239 GKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 291
G+G FG V + VAVK LK+G +E++ +I + H N++
Sbjct: 31 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90
Query: 292 LIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
L+G C L+V + G++++ L++K R +G + +
Sbjct: 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-------RNEFVPYKTKGARFRQGKDYVG 143
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386
I D+K + + F K L +
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 25/116 (21%), Positives = 49/116 (42%), Gaps = 9/116 (7%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82
L++L+++ + N+ + +I +L L LDLS P+ + L +LQ L ++
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 207
Query: 83 NNSLTGAIPPS-LSNMSQLAFLDLSYNNLSG-PVPSFHA-----KTFNITGNSLIC 131
+N+ ++ ++ L LD S N++ N+T N C
Sbjct: 208 HNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 27/104 (25%), Positives = 47/104 (45%), Gaps = 4/104 (3%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPST 69
S N T+SS+ L L+ + Q++N+ + L L+ LD+S+ +
Sbjct: 86 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNG 144
Query: 70 V-SHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 111
+ + L +L+ L++ NS P + + L FLDLS L
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 23/91 (25%), Positives = 42/91 (46%), Gaps = 4/91 (4%)
Query: 24 NLTNLQLVLLQNNNIS-GHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81
LT L + L +N +S ++ + L LDLS N + S LE L++L
Sbjct: 50 KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDF 108
Query: 82 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 111
+++L S+ ++ L +LD+S+ +
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 139
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 17/95 (17%), Positives = 34/95 (35%), Gaps = 4/95 (4%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLN 82
T+L+ + L N + + + L +L LD ++ S L L YL ++
Sbjct: 76 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 134
Query: 83 NNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPS 116
+ + +S L L ++ N+
Sbjct: 135 HTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLP 168
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 21/88 (23%), Positives = 41/88 (46%), Gaps = 3/88 (3%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--GPIPSTVSHLETLQYLRLNN 83
++ + L++N + KL++L L LS+N + G + +L+YL L+
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 84 NSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
N + + + + QL LD ++NL
Sbjct: 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLK 114
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 21/87 (24%), Positives = 36/87 (41%), Gaps = 5/87 (5%)
Query: 27 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 86
+ + + ++ +PT I S L+L +N L L L L++N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 87 T--GAIPPSLSNMSQLAFLDLSYNNLS 111
+ G S + L +LDLS+N +
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI 91
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 10/204 (4%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 288
+ F L+GKG FG V + G A+K LK + + T E L R+
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 289 --LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 345
L L + T +RL V Y + G + L + + L YLH
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 346 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405
+ + +++RD+K N++LD+ + DFGL K D GT ++APE L
Sbjct: 267 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVL-E 322
Query: 406 GQSSEKT-DVFGFGILLLELISGL 428
+ D +G G+++ E++ G
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 30/123 (24%), Positives = 48/123 (39%), Gaps = 15/123 (12%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82
L LQ + LQ+N + +P + L L L L N + L +L L L+
Sbjct: 127 GLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 83 NNSLTGAIPP-SLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICATGAE 136
N + + P + ++ +L L L NNLS P + + + N +C
Sbjct: 186 QNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC----- 239
Query: 137 EDC 139
DC
Sbjct: 240 -DC 241
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 5/91 (5%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
L L+ + L +N + L +L TL L + + L LQYL L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYL 136
Query: 82 NNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 111
+N+L A+P + ++ L L L N +S
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS 166
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 25/102 (24%), Positives = 41/102 (40%), Gaps = 5/102 (4%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV- 70
+S ++S NL ++ L +N ++ I L+ L LDLS+N +
Sbjct: 43 RISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATF 101
Query: 71 SHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 111
L L L L+ L + P ++ L +L L N L
Sbjct: 102 HGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 19/87 (21%), Positives = 32/87 (36%), Gaps = 1/87 (1%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85
Q + L N IS L L L +N + + L L+ L L++N+
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 86 LTGAIPPS-LSNMSQLAFLDLSYNNLS 111
++ P+ + +L L L L
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 230 SNFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
+F ++GKG FG V +K A+K LK + + T VE L++
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 286 HRN---LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 341
L + T E L V Y++ G + +++ D + A GL
Sbjct: 74 AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 401
+LH + I++RD+K NILLD+ + DFG+ K + T GT +IAPE
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIAPE 188
Query: 402 YLSTGQSSEKT-DVFGFGILLLELISGL 428
L GQ + D + FG+LL E++ G
Sbjct: 189 IL-LGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 41/212 (19%), Positives = 82/212 (38%), Gaps = 25/212 (11%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVK----RLKDGNAIGGEIQFQTEVEMISL 283
+ +G+G FG V++ K + D + + E+ ++++
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV------KKEISILNI 57
Query: 284 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR----G 339
A HRN+L L + E ++++ ++S + R+ + +R +
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEA 114
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGH 397
L +LH I H D++ NI+ + + +FG A+ L + +
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLLF-TAPEY 169
Query: 398 IAPEYLSTGQSSEKTDVFGFGILLLELISGLR 429
APE S TD++ G L+ L+SG+
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 22/167 (13%)
Query: 224 ELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG----------EI 272
+++S + + +G+G F VYK +VA+K++K G+ EI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 273 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKR 331
+ E+ H N++ L+ + LV+ +M + +K L + K
Sbjct: 64 KLLQELS------HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKA 116
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378
L +GL YLH+ I+HRD+K N+LLDE + DFGLAK
Sbjct: 117 YMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 230 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
NF ++GKG FG V K G + AVK LK + + T E L++
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 286 HRN---LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--- 338
RN L +L C T +RL V +++ G + ++ R AA
Sbjct: 80 ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF---DEARARFYAAEIIS 135
Query: 339 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 398
L++LH++ II+RD+K N+LLD + DFG+ K C+ T GT +I
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYI 191
Query: 399 APEYLSTGQSSEKT-DVFGFGILLLELISGL 428
APE L D + G+LL E++ G
Sbjct: 192 APEIL-QEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 222 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKR-LKDGNAIGGEIQFQTEVEM 280
K + +++ ++G G FG V++ L + VA+K+ L+D E+Q V+
Sbjct: 32 GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK- 90
Query: 281 ISLAVHRNLLRLIGFCMTTTERL------LVYPYMS---NGSVASRLKAKPSLDWATRKR 331
H N++ L F + ++ LV Y+ + K K ++ K
Sbjct: 91 -----HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTA 390
R L Y+H I HRD+K N+LLD + + DFG AK+L + +V+
Sbjct: 146 YMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202
Query: 391 V----RGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISG 427
R APE + + + D++ G ++ EL+ G
Sbjct: 203 CSRYYR------APELIFGATNYTTNIDIWSTGCVMAELMQG 238
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 9/151 (5%)
Query: 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVHR 287
+ + LVG+G +G V K G +VA+K+ + + ++ E++++ H
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM-VKKIAMREIKLLKQLRHE 84
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQ 346
NL+ L+ C LV+ ++ + ++ L+ P+ LD+ ++ G+ + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLA 377
IIHRD+K NIL+ + + DFG A
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMIS 282
+ +G+G +G V+K + +VA+KR++ + G EI E++
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--- 59
Query: 283 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLL 341
H+N++RL + + LV+ + + + LD K +GL
Sbjct: 60 ---HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSH--VTTAVRGTVG 396
+ H + ++HRD+K N+L++ E + +FGLA+ C S VT R
Sbjct: 116 FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR---- 168
Query: 397 HIAPEYL--STGQSSEKTDVFGFGILLLELISGLRAL 431
P+ L + S+ D++ G + EL + R L
Sbjct: 169 --PPDVLFGAKLYSTS-IDMWSAGCIFAELANAGRPL 202
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 57/224 (25%), Positives = 92/224 (41%), Gaps = 43/224 (19%)
Query: 230 SNFSSKNLVGKGGFGNVY---KGYLQD-GTVVAVKRL-KDGNAIGGEIQFQTEVEMISLA 284
NF ++G G +G V+ K D G + A+K L K + T E
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE----- 108
Query: 285 VHRNLLRLIG---------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIAL 334
R +L I + T +L L+ Y++ G + + L R+R
Sbjct: 109 --RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--------QRERFTE 158
Query: 335 GAAR--------GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386
+ L +LH+ II+RD+K NILLD V+ DFGL+K ++
Sbjct: 159 HEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDV--FGFGILLLELISGL 428
GT+ ++AP+ + G S V + G+L+ EL++G
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 21/166 (12%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVH 286
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------H 106
Query: 287 RNLLRLIGFCMTTTERL------LVYPYMS---NGSVASRLKAKPSLDWATRKRIALGAA 337
N++RL F ++ E+ LV Y+ +AK +L K
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDH 382
R L Y+H I HRD+K N+LLD + + DFG AK L
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 31/204 (15%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G G FG V G G VAVK +++ + +G + + E++ + L H ++++L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG---KIKREIQNLKLFRHPHIIKL 76
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLH 344
T T+ +V Y+S G + + R+ AR + Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYI--------CKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 404
++HRD+K N+LLD + A + DFGL+ ++ + T+ G+ + APE +S
Sbjct: 129 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPEVIS 183
Query: 405 -TGQSSEKTDVFGFGILLLELISG 427
+ + D++ G++L L+ G
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCG 207
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 40/168 (23%), Positives = 72/168 (42%), Gaps = 23/168 (13%)
Query: 227 SATSNFSSKNLVGKGGFGNVYKG--YLQDGTVVAVKRLKDGNAIGG-------EIQFQTE 277
A + +G+G +G V+K G VA+KR++ G E+
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV--- 64
Query: 278 VEMISLAVHRNLLRLIGFCMTTTERL-----LVYPYMSN--GSVASRLKAKPSLDWATRK 330
+ + H N++RL C + LV+ ++ + ++ +P + T K
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIK 123
Query: 331 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378
+ RGL +LH +++HRD+K NIL+ + + DFGLA+
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 230 SNFSSKNLVGKGGFGNVY---KGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
F ++GKGG+G V+ K + G + A+K LK + + +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV----RNAKDTA--HTKA 70
Query: 286 HRNLLRLIG--------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKR----- 331
RN+L + + T +L L+ Y+S G + +L+ +
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM-EDTACFYLAE 129
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391
I++ L +LH++ II+RD+K NI+L+ + DFGL K D VT
Sbjct: 130 ISMA----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTF 181
Query: 392 RGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 428
GT+ ++APE L + D + G L+ ++++G
Sbjct: 182 CGTIEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 230 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
S+F ++GKG FG V K + AVK L+ + + + E L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 286 HRN---LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKR-----IALGA 336
+ L+ L F T ++L V Y++ G + L+ + R R IA
Sbjct: 95 NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFL-EPRARFYAAEIASA- 151
Query: 337 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 396
L YLH I++RD+K NILLD V+ DFGL K + + T+ GT
Sbjct: 152 ---LGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPE 204
Query: 397 HIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 428
++APE L Q ++T D + G +L E++ GL
Sbjct: 205 YLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 46/222 (20%)
Query: 230 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
+F ++G+G + V K + A+K +K E + E
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTE------ 59
Query: 286 HRNLLRLIG---------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALG 335
+++ C T RL V Y++ G + ++ ++++
Sbjct: 60 -KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ--------RQRKLPEE 110
Query: 336 AAR--------GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387
AR L YLHE+ II+RD+K N+LLD + D+G+ K
Sbjct: 111 HARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDT 166
Query: 388 TTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 428
T+ GT +IAPE L G+ + D + G+L+ E+++G
Sbjct: 167 TSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 46/166 (27%), Positives = 72/166 (43%), Gaps = 29/166 (17%)
Query: 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMI 281
S + +G+G FG V+K + G VA+K++ N G EI+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-- 74
Query: 282 SLAVHRNLLRLIGFCMTTTERL--------LVYPYMSN--GSVASRLKAKPSLDWATRKR 331
H N++ LI C T LV+ + + + S + K + KR
Sbjct: 75 ----HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKR 128
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 377
+ GL Y+H KI+HRD+KAAN+L+ + DFGLA
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 20/89 (22%), Positives = 37/89 (41%), Gaps = 5/89 (5%)
Query: 23 GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82
+ L+ + + NN + + + L LDLS+N + + L+ L L+
Sbjct: 269 VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLD 326
Query: 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+NS+ + S L L LS+N+
Sbjct: 327 HNSIV-TLKL--STHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 21/103 (20%), Positives = 42/103 (40%), Gaps = 4/103 (3%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPST 69
Q L N ++V +N+ + +P + ++ L+L++
Sbjct: 30 MQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYA 88
Query: 70 VSHLETLQYLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLS 111
++ T+Q L + N++ +PP N+ L L L N+LS
Sbjct: 89 FAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 20/95 (21%), Positives = 36/95 (37%), Gaps = 4/95 (4%)
Query: 19 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 77
+ + +Q + + N I ++P + + L L L N + + L
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 144
Query: 78 YLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLS 111
L ++NN+L I + L L LS N L+
Sbjct: 145 TLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 24/115 (20%), Positives = 45/115 (39%), Gaps = 9/115 (7%)
Query: 13 NLSGTLSSSI--GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
+ S + + L ++ LQ+NN++ + L+ +DLS N +
Sbjct: 211 DASHNSINVVRGPVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPF 268
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNIT 125
++ L+ L ++NN L A+ + L LDLS+N+L
Sbjct: 269 VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL----HVERNQPQFD 318
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 21/99 (21%), Positives = 42/99 (42%), Gaps = 5/99 (5%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
N+S L S++ ++ + +N+I+ + + +L L L +N T + + +
Sbjct: 192 NVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLLN 246
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L + L+ N L + M +L L +S N L
Sbjct: 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 22/91 (24%), Positives = 36/91 (39%), Gaps = 10/91 (10%)
Query: 21 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80
+ + +L + N + + + + LD S+N + V L L+
Sbjct: 181 DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINV-VRGPV--NVELTILK 232
Query: 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L +N+LT L N L +DLSYN L
Sbjct: 233 LQHNNLTD--TAWLLNYPGLVEVDLSYNELE 261
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 14/107 (13%), Positives = 34/107 (31%), Gaps = 2/107 (1%)
Query: 6 YRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP 65
Y P Q + S++ V + + E L+ + N+
Sbjct: 1 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 60
Query: 66 IPSTVSHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 111
+ + ++ L LN+ + I + + + L + +N +
Sbjct: 61 PAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 106
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 5e-13
Identities = 39/156 (25%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISL 283
+ +G+G +G VYK G A+K+++ G EI E++
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK---- 58
Query: 284 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLY 342
H N+++L T +LV+ ++ + L L+ T K L G+ Y
Sbjct: 59 --HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378
H++ +++HRD+K N+L++ E + DFGLA+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 5e-13
Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 20/158 (12%)
Query: 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMIS 282
NF +G+G +G VYK G VVA+K+++ G EI E+
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--- 60
Query: 283 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--LDWATRKRIALGAARGL 340
H N+++L+ T + LV+ ++ + + A + K +GL
Sbjct: 61 ---HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 341 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378
+ H +++HRD+K N+L++ + DFGLA+
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 24/99 (24%), Positives = 39/99 (39%), Gaps = 7/99 (7%)
Query: 25 LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS----HLETLQYLR 80
L+++ + + ++ L TLDLS+N G + TLQ L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 81 LNNN---SLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
L N + +G + QL LDLS+N+L +
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 23/103 (22%), Positives = 36/103 (34%), Gaps = 6/103 (5%)
Query: 12 QNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV 70
+ SG S+ LQ + L +N++ S+L +L+LS
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP 273
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 113
+ L L L+ N L PS + Q+ L L N
Sbjct: 274 AKLSV---LDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 23/111 (20%), Positives = 36/111 (32%), Gaps = 4/111 (3%)
Query: 23 GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET---LQYL 79
G + L+ + T+I K L L + I + LQ L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS-GPVPSFHAKTFNITGNSL 129
L N +TG PP L + L+ N+S ++ A+ L
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGL 151
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 22/126 (17%), Positives = 43/126 (34%), Gaps = 20/126 (15%)
Query: 17 TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS-------------KLLTLDLSNNFFT 63
+ N+ + + + P G+ + L+L+N +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 64 GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 123
+P HLE+ L + NSLT +P ++ L + + LS P +
Sbjct: 85 -SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLL--EYLG 137
Query: 124 ITGNSL 129
++ N L
Sbjct: 138 VSNNQL 143
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 24/116 (20%), Positives = 39/116 (33%), Gaps = 21/116 (18%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPT---------------EIGKLSKLLTL 55
S N L +L +L + +S P E+ S L +
Sbjct: 99 SCNSLTELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKII 158
Query: 56 DLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
D+ NN +P +L+++ NN L P L N+ L + N+L
Sbjct: 159 DVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 208
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 26/120 (21%), Positives = 40/120 (33%), Gaps = 12/120 (10%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
N L +L + NN + +P E+ L L + NN +P
Sbjct: 161 DNNSLKKLPDLPPSLEFIAA---GNNQLE-ELP-ELQNLPFLTAIYADNNSLKK-LPD-- 212
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHAKTFNITGNSL 129
+L+ + NN L P L N+ L + N L P + N+ N L
Sbjct: 213 -LPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYL 269
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 23/101 (22%), Positives = 40/101 (39%), Gaps = 13/101 (12%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
+ +L +L +L N+++ +P L LL + + + P
Sbjct: 79 NNLGLSSLPELPPHLESLVA---SCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-- 132
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L+YL ++NN L P L N S L +D+ N+L
Sbjct: 133 -----LEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK 166
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 19/104 (18%), Positives = 35/104 (33%), Gaps = 18/104 (17%)
Query: 21 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL------- 73
+ T LQ L ++N++ +P E + + + + P
Sbjct: 6 RNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSR 64
Query: 74 ------ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L LNN L+ ++P + L L S N+L+
Sbjct: 65 LRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT 104
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 24/114 (21%), Positives = 37/114 (32%), Gaps = 21/114 (18%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIP------------TEI-GKLSKLLTLDL 57
N L +LT L + + +S P + L L++
Sbjct: 265 RDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNV 324
Query: 58 SNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
SNN +P+ L+ L + N L +P N L L + YN L
Sbjct: 325 SNNKLIE-LPAL---PPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 15/101 (14%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
NL TL +L L + ++N ++ +P L+ L + + +
Sbjct: 245 DNNLLKTLPDLPPSLEALNV---RDNYLT-DLPELPQSLTFLDVSENIFSGLS------- 293
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L YL ++N + ++ + L L++S N L
Sbjct: 294 ELPPNLYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 17/116 (14%), Positives = 35/116 (30%), Gaps = 22/116 (18%)
Query: 11 SQNLSGTLSSSIGNLTNL---------------QLVLLQNNNISGHIPTEIGKLSKLLTL 55
S N + NL L + L+ N+ +P L +L
Sbjct: 345 SFNHLAEVPELPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQL--- 401
Query: 56 DLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ N P E+++ LR+N+ + + +L +++
Sbjct: 402 HVETNPLRE-FPDI---PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 21/127 (16%), Positives = 36/127 (28%), Gaps = 28/127 (22%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
S N L + L L N+++ +P L +L + N P
Sbjct: 325 SNNKLIELPALPPRLERLIA---SFNHLA-EVPELPQNLKQL---HVEYNPLRE-FPDIP 376
Query: 71 SHLET----------------LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPV 114
+E L+ L + N L P + + L ++ + P
Sbjct: 377 ESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPY 432
Query: 115 PSFHAKT 121
H T
Sbjct: 433 EFAHETT 439
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 28/130 (21%), Positives = 47/130 (36%), Gaps = 12/130 (9%)
Query: 11 SQN-LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGK-LSKLLTLDLSNNFFT---GP 65
Q L LS+ L ++ + ++N+ + +P + L L LDLS N
Sbjct: 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLK 352
Query: 66 IPSTVSHLETLQYLRLNNNSLT--GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---- 119
+ +LQ L L+ N L L + L LD+S N S
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKM 412
Query: 120 KTFNITGNSL 129
+ N++ +
Sbjct: 413 RFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 28/126 (22%), Positives = 44/126 (34%), Gaps = 14/126 (11%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
S+N + S ++ + L + I + T I L LD+SNN S
Sbjct: 395 SRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD----SFS 447
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNIT 125
L LQ L ++ N L +P + S L + +S N L + +
Sbjct: 448 LFLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLH 505
Query: 126 GNSLIC 131
N C
Sbjct: 506 TNPWDC 511
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 25/106 (23%), Positives = 44/106 (41%), Gaps = 3/106 (2%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 71
++ + NLQ+++L+++ I+ I + L L LDLS+N + S
Sbjct: 37 KITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFG 95
Query: 72 HLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLSGPVPS 116
L +L+YL L N SL N++ L L + +
Sbjct: 96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 20/116 (17%), Positives = 42/116 (36%), Gaps = 1/116 (0%)
Query: 17 TLSSSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPSTVSHLET 75
++S NLTNLQ + + N I L+ L L++ ++ +
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 76 LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLIC 131
+ +L L+ + + +S + +L+L NL+ S + +
Sbjct: 174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 18/89 (20%), Positives = 36/89 (40%)
Query: 23 GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82
G ++ + L N I+ ++ + L L L ++ L +L++L L+
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82
Query: 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+N L+ +S L +L+L N
Sbjct: 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 21/93 (22%), Positives = 36/93 (38%), Gaps = 6/93 (6%)
Query: 24 NLTNLQLVLLQNNNIS---GHIPTEIGKLSKLLTLDLSNNFFT--GPIPSTVSHLETLQY 78
+L +L+ + L N + G L TL LS N + L+ L
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391
Query: 79 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L ++ N+ +P S ++ FL+LS +
Sbjct: 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 14/100 (14%), Positives = 33/100 (33%)
Query: 12 QNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 71
+ + + T L + + + L + + + + S
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
LE ++ + + N+ + ++ L FLDLS N +
Sbjct: 308 LLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 13/100 (13%), Positives = 33/100 (33%)
Query: 12 QNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 71
+ S LT+L + ++ ++ + + + + L L + +
Sbjct: 134 ETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFAD 193
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L +++YL L + +L L + + S
Sbjct: 194 ILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 25/165 (15%)
Query: 227 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK----DG---NAIGGEIQFQTEV 278
S++S F +G G + VYKG G VA+K +K +G AI EI E+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKEL 60
Query: 279 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN------GSVASRLKAKPSLDWATRKRI 332
+ H N++RL T + LV+ +M N S + L+ K
Sbjct: 61 K------HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRG-LELNLVKYF 113
Query: 333 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 377
+GL + HE KI+HRD+K N+L+++ + +GDFGLA
Sbjct: 114 QWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 20/93 (21%), Positives = 37/93 (39%), Gaps = 5/93 (5%)
Query: 19 SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 78
+ L+ + + NN + + + L LDLS+N + + L+
Sbjct: 271 YHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLEN 328
Query: 79 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L L++NS+ + S L L LS+N+
Sbjct: 329 LYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 21/103 (20%), Positives = 42/103 (40%), Gaps = 4/103 (3%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPST 69
Q L N ++V +N+ + +P + ++ L+L++
Sbjct: 36 MQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYA 94
Query: 70 VSHLETLQYLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLS 111
++ T+Q L + N++ +PP N+ L L L N+LS
Sbjct: 95 FAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 136
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 23/106 (21%), Positives = 41/106 (38%), Gaps = 8/106 (7%)
Query: 19 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 77
++ + + ++L+ L + I I T + L + N P ++ L
Sbjct: 68 AALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 126
Query: 78 YLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLSGPVPSFHAKTF 122
L L N L+ ++P + N +L L +S NNL TF
Sbjct: 127 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE----RIEDDTF 167
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 20/95 (21%), Positives = 36/95 (37%), Gaps = 4/95 (4%)
Query: 19 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 77
+ + +Q + + N I ++P + + L L L N + + L
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150
Query: 78 YLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLS 111
L ++NN+L I + L L LS N L+
Sbjct: 151 TLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 21/99 (21%), Positives = 42/99 (42%), Gaps = 5/99 (5%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
N+S L S++ ++ + +N+I+ + + +L L L +N T + + +
Sbjct: 198 NVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLLN 252
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L + L+ N L + M +L L +S N L
Sbjct: 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 22/91 (24%), Positives = 36/91 (39%), Gaps = 10/91 (10%)
Query: 21 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80
+ + +L + N + + + + LD S+N + V L L+
Sbjct: 187 DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINV-VRGPV--NVELTILK 238
Query: 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L +N+LT L N L +DLSYN L
Sbjct: 239 LQHNNLTD--TAWLLNYPGLVEVDLSYNELE 267
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 14/107 (13%), Positives = 34/107 (31%), Gaps = 2/107 (1%)
Query: 6 YRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP 65
Y P Q + S++ V + + E L+ + N+
Sbjct: 7 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 66
Query: 66 IPSTVSHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 111
+ + ++ L LN+ + I + + + L + +N +
Sbjct: 67 PAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 112
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 20/99 (20%), Positives = 42/99 (42%), Gaps = 5/99 (5%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
S N L+ + L+++ L +N++ H+ + +L L L +N +
Sbjct: 286 SNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-- 341
Query: 71 SHLETLQYLRLNNNSLTG-AIPPSLSNMSQLAFLDLSYN 108
S TL+ L L++N ++ N+++ A D +
Sbjct: 342 STHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 37/144 (25%), Positives = 62/144 (43%), Gaps = 9/144 (6%)
Query: 238 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVHRNLLRLIG 294
+G+G +G V+K G +VA+K+ + I+ E+ M+ H NL+ L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV-IKKIALREIRMLKQLKHPNLVNLLE 69
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIH 353
LV+ Y + +V L + K I + + + H+ IH
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIH 125
Query: 354 RDVKAANILLDEYYEAVVGDFGLA 377
RDVK NIL+ ++ + DFG A
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFA 149
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 53/256 (20%), Positives = 94/256 (36%), Gaps = 46/256 (17%)
Query: 196 HNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVY----KGYL 251
N + EE N + +F ++G+G + V K
Sbjct: 18 ENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKK-- 75
Query: 252 QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG---------FCMTTTER 302
+ A++ +K E + E +++ C T R
Sbjct: 76 -TDRIYAMRVVKKELVNDDEDIDWVQTE-------KHVFEQASNHPFLVGLHSCFQTESR 127
Query: 303 L-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQCDPKIIH 353
L V Y++ G + ++ ++++ AR L YLHE+ II+
Sbjct: 128 LFFVIEYVNGGDLMFHMQ--------RQRKLPEEHARFYSAEISLALNYLHER---GIIY 176
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT- 412
RD+K N+LLD + D+G+ K T+ GT +IAPE L G+ +
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEIL-RGEDYGFSV 234
Query: 413 DVFGFGILLLELISGL 428
D + G+L+ E+++G
Sbjct: 235 DWWALGVLMFEMMAGR 250
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 10/102 (9%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
LTNL +LL +N+++ I +E + L LDLS+N + + S L+ L+ L L
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLL 119
Query: 82 NNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 122
NN + + + +M+QL L LS N +S F +
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS----RFPVELI 156
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 29/129 (22%), Positives = 49/129 (37%), Gaps = 22/129 (17%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
+ NL+ + L +N++ + + L L L L NN + + LQ L L
Sbjct: 86 PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYL 143
Query: 82 NNNSLTGAIPP----SLSNMSQLAFLDLSYNNLS-------GPVPSFHAKTFNITGNSLI 130
+ N ++ P + + +L LDLS N L +P++ + N L
Sbjct: 144 SQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
Query: 131 CATGAEEDC 139
C DC
Sbjct: 203 C------DC 205
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 26/102 (25%), Positives = 44/102 (43%), Gaps = 11/102 (10%)
Query: 26 TNLQLVLLQNNNISGHIPTEI--GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLN 82
+ L+ L +NN+S + E +L+ L +L LS+N I S + L+YL L+
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLS 96
Query: 83 NNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 123
+N L + S++ L L L N++ F
Sbjct: 97 SNHLH-TLDEFLFSDLQALEVLLLYNNHIV----VVDRNAFE 133
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 21/98 (21%), Positives = 38/98 (38%), Gaps = 10/98 (10%)
Query: 27 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNS 85
++ + ++P + + LDLS+N + + L L L L++N
Sbjct: 19 ASNILSCSKQQLP-NVPQSLPSYTA--LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH 75
Query: 86 LTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 122
L I + + L +LDLS N+L + F
Sbjct: 76 LN-FISSEAFVPVPNLRYLDLSSNHLH----TLDEFLF 108
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 55/201 (27%), Positives = 80/201 (39%), Gaps = 27/201 (13%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
G G FG +VAVK ++ G AI +Q E+ H N++R +
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIVRFKEVIL 86
Query: 298 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQCDP 349
T T ++ Y S G + R+ R + AR G+ Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERI--------CNAGRFSEDEARFFFQQLLSGVSYCHSM--- 135
Query: 350 KIIHRDVKAANILLDEYYEAV--VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS-TG 406
+I HRD+K N LLD + DFG +K S + V GT +IAPE L
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTV-GTPAYIAPEVLLRQE 193
Query: 407 QSSEKTDVFGFGILLLELISG 427
+ DV+ G+ L ++ G
Sbjct: 194 YDGKIADVWSCGVTLYVMLVG 214
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 231 NFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLK----DG---NAIGGEIQFQTEVEMIS 282
+ + +G+G + VYKG +VA+K ++ +G AI E+ +++
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLK--- 58
Query: 283 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLL 341
H N++ L T LV+ Y+ + L + ++ K RGL
Sbjct: 59 ---HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378
Y H Q K++HRD+K N+L++E E + DFGLA+
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 12/203 (5%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI-GGEIQ-FQTEVEMISLAVH 286
F +G G FG V ++ G A+K L + +I+ E ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 287 RNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 345
L++L F L +V Y++ G + S L+ + A YLH
Sbjct: 101 PFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 346 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405
+I+RD+K N+L+D+ V DFG AK + T + GT +APE + +
Sbjct: 160 L---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILS 212
Query: 406 GQSSEKTDVFGFGILLLELISGL 428
++ D + G+L+ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGY 235
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 28/220 (12%)
Query: 226 QSATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISL 283
+ F + + G+G FG V G + G VA+K+ ++D E+Q ++ +++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAV 75
Query: 284 AVHRNLLRLIGFCMTTTER-------LLVYPYMS---NGSVASRLKAKPSLDWATRKRIA 333
H N+++L + T ER +V Y+ + + + + + K
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLDHCDSHVTTAV- 391
R + LH + HRD+K N+L++E + DFG AK L + +V
Sbjct: 136 FQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS 194
Query: 392 ---RGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISG 427
R APE + Q + D++ G + E++ G
Sbjct: 195 RYYR------APELIFGNQHYTTAVDIWSVGCIFAEMMLG 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 27/212 (12%)
Query: 230 SNFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
++F L+GKG FG V K G A+K L+ I + T E L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 286 HRN--LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKR-----IALGAA 337
R+ L L + T +RL V Y + G + L + R R I
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFT-EERARFYGAEIVSA-- 117
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 397
L YLH + +++RD+K N++LD+ + DFGL K D GT +
Sbjct: 118 --LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEY 171
Query: 398 IAPEYLSTGQSSEKT-DVFGFGILLLELISGL 428
+APE L + D +G G+++ E++ G
Sbjct: 172 LAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 230 SNFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
++F+ ++GKG FG V KG + AVK LK I + T VE LA+
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 286 HRN---LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 341
L +L C T +RL V Y++ G + ++ A A GL
Sbjct: 77 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 342 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 401
+L + II+RD+K N++LD + DFG+ K + D T GT +IAPE
Sbjct: 136 FLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPE 191
Query: 402 YLSTGQSSEKT-DVFGFGILLLELISGL 428
+ Q K+ D + FG+LL E+++G
Sbjct: 192 II-AYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 26/89 (29%), Positives = 40/89 (44%), Gaps = 5/89 (5%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
+ L + + + NI+ IP G L L L N T +++ L L L L+
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225
Query: 84 NSLTGAIPP-SLSNMSQLAFLDLSYNNLS 111
NS++ A+ SL+N L L L+ N L
Sbjct: 226 NSIS-AVDNGSLANTPHLRELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 3/90 (3%)
Query: 23 GNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81
G +L + L N I+ + L+ L L LS N + ++++ L+ L L
Sbjct: 189 GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247
Query: 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
NNN L +P L++ + + L NN+S
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 20/94 (21%), Positives = 39/94 (41%), Gaps = 7/94 (7%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
L NL + L N+IS + L L L+NN +P ++ + +Q + L+N
Sbjct: 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHN 272
Query: 84 NSLTG------AIPPSLSNMSQLAFLDLSYNNLS 111
N+++ P + + + + L N +
Sbjct: 273 NNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 29/95 (30%), Positives = 44/95 (46%), Gaps = 7/95 (7%)
Query: 19 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 77
NL NL ++L NN IS I L KL L LS N +P + +TLQ
Sbjct: 69 DGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQ 124
Query: 78 YLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 111
LR++ N +T + + ++Q+ ++L N L
Sbjct: 125 ELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK 158
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 18/90 (20%), Positives = 37/90 (41%), Gaps = 5/90 (5%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
L L+ + L N + +P ++ L L + N T S + L + + L
Sbjct: 98 PLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 154
Query: 84 NSLT-GAIPP-SLSNMSQLAFLDLSYNNLS 111
N L I + M +L+++ ++ N++
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT 184
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 24/86 (27%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85
+ L+ LQNN I+ + L L TL L NN + P + L L+ L L+ N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 86 LTGAIPPSLSNMSQLAFLDLSYNNLS 111
L +P + L L + N ++
Sbjct: 112 LK-ELPEKMP--KTLQELRVHENEIT 134
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 17/93 (18%), Positives = 33/93 (35%), Gaps = 9/93 (9%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG------PIPSTVSHLETLQ 77
N +L+ + L NN + +P + + + L NN + P + +
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 296
Query: 78 YLRLNNNSLT-GAIPPSL-SNMSQLAFLDLSYN 108
+ L +N + I PS + A + L
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 3/85 (3%)
Query: 27 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 86
+L++V + + +P ++ LDL NN T +L+ L L L NN +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 87 TGAIPPSLSNMSQLAFLDLSYNNLS 111
+ P + + + +L L LS N L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK 113
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 32/121 (26%), Positives = 50/121 (41%), Gaps = 6/121 (4%)
Query: 13 NLSGTLSSSI--GNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPST 69
+S + I L + L +N I I E + SKL L L +N +
Sbjct: 178 RISEAKLTGIPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGS 236
Query: 70 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHAKTFNITGNS 128
+S L TL+ L L+NN L+ +P L ++ L + L NN++ V F F +
Sbjct: 237 LSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAY 295
Query: 129 L 129
Sbjct: 296 Y 296
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 24/95 (25%), Positives = 41/95 (43%), Gaps = 7/95 (7%)
Query: 19 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 77
L +L ++L NN IS I + L KL L +S N IP + +L
Sbjct: 71 KDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLV 126
Query: 78 YLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 111
LR+++N + +P S + + +++ N L
Sbjct: 127 ELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 25/102 (24%), Positives = 40/102 (39%), Gaps = 10/102 (9%)
Query: 24 NLTNLQLVLLQNNNI-SGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82
L N+ + + N + + KL L +S TG IP + ETL L L+
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETLNELHLD 201
Query: 83 NNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 123
+N + AI L S+L L L +N + + +
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIR----MIENGSLS 238
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 11/96 (11%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82
+ L + L +N I I L L L L NN + +P+ + L+ LQ + L+
Sbjct: 215 RYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLH 272
Query: 83 NNSLTGAIPPS-------LSNMSQLAFLDLSYNNLS 111
N++T + + + + L N +
Sbjct: 273 TNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 22/87 (25%), Positives = 32/87 (36%), Gaps = 7/87 (8%)
Query: 27 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNS 85
L + + ++ IP ++ L L L +N I L L L +N
Sbjct: 173 KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQ 228
Query: 86 LTGAIPP-SLSNMSQLAFLDLSYNNLS 111
+ I SLS + L L L N LS
Sbjct: 229 IR-MIENGSLSFLPTLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 28/86 (32%), Positives = 38/86 (44%), Gaps = 3/86 (3%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85
+ L+ LQNN+IS + L L L L NN + S L LQ L ++ N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 86 LTGAIPPSLSNMSQLAFLDLSYNNLS 111
L IPP+L S L L + N +
Sbjct: 114 LV-EIPPNLP--SSLVELRIHDNRIR 136
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 16/93 (17%), Positives = 31/93 (33%), Gaps = 9/93 (9%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET------LQ 77
L L+ + L NN +S +P + L L + L N T + +
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN 297
Query: 78 YLRLNNNSLT-GAIPPSL-SNMSQLAFLDLSYN 108
+ L NN + + P+ ++ +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 23/86 (26%), Positives = 38/86 (44%), Gaps = 5/86 (5%)
Query: 27 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 86
+L++V + + +P EI LDL NN + L+ L L L NN +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 87 TGAIPP-SLSNMSQLAFLDLSYNNLS 111
+ I + S + +L L +S N+L
Sbjct: 91 S-KIHEKAFSPLRKLQKLYISKNHLV 115
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 16/85 (18%), Positives = 30/85 (35%), Gaps = 14/85 (16%)
Query: 13 NLSG----TLSSSIGNLTNLQLVLLQNNNISGHIPTEI-------GKLSKLLTLDLSNNF 61
+L + + + +L LQ+V L NNI+ + K + + L NN
Sbjct: 247 HLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNP 305
Query: 62 FTGPI--PSTVSHLETLQYLRLNNN 84
P+T + ++ N
Sbjct: 306 VPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 41/176 (23%), Positives = 68/176 (38%), Gaps = 30/176 (17%)
Query: 238 VGKGGFGNVYKG---YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
VG+G +G+VYK +D A+K+++ G + E+ ++ H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELKHPNVISLQK 85
Query: 295 FCMTTTERL--LVYPYMS--------NGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 344
++ +R L++ Y + K L K + G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLA-------KLLDHCDSHVTT 389
++HRD+K ANIL+ + D G A K L D V T
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 30/91 (32%), Positives = 41/91 (45%), Gaps = 5/91 (5%)
Query: 23 GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
G L L + L +N + +P L L LD+S N T +P L LQ L L
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYL 131
Query: 82 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 111
N L +PP L + +L L L+ NNL+
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLT 161
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 6/103 (5%)
Query: 11 SQNLSGTLSSSI-GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 69
S+NL T S + T L + L ++ + + G L L TLDLS+N +P
Sbjct: 39 SENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQS-LPLL 95
Query: 70 VSHLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 111
L L L ++ N LT ++P + +L L L N L
Sbjct: 96 GQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK 137
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 25/98 (25%), Positives = 42/98 (42%), Gaps = 6/98 (6%)
Query: 17 TLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLE 74
+L L L ++ + N ++ +P L +L L L N +P + +
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTP 148
Query: 75 TLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 111
L+ L L NN+LT +P L + + L L L N+L
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 19/86 (22%), Positives = 36/86 (41%), Gaps = 3/86 (3%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85
+ ++ L N + + ++L L+L T + L L L L++N
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQ 88
Query: 86 LTGAIPPSLSNMSQLAFLDLSYNNLS 111
L ++P + L LD+S+N L+
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLT 113
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 28/87 (32%), Positives = 38/87 (43%), Gaps = 5/87 (5%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
L LQ + L+ N + +P + KL L L+NN T +P+ + + LE L L L
Sbjct: 122 GLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLL 179
Query: 82 NNNSLTGAIPPSLSNMSQLAFLDLSYN 108
NSL IP L F L N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 23/196 (11%), Positives = 51/196 (26%), Gaps = 40/196 (20%)
Query: 237 LVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLR 291
G ++ D VA+ + + ++ + +S + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
++ T L+V ++ GS+ PS A R A H +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAHRA---GV 150
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 411
+ + + + V+ + ++ +
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPD--ANPQ 182
Query: 412 TDVFGFGILLLELISG 427
D+ G G L L+
Sbjct: 183 DDIRGIGASLYALLVN 198
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G G FG V G G VAVK +++ + +G + + E++ + L H ++++L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG---KIRREIQNLKLFRHPHIIKL 81
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLH 344
T ++ +V Y+S G + + R+ +R G+ Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYI--------CKNGRLDEKESRRLFQQILSGVDYCH 133
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 404
++HRD+K N+LLD + A + DFGL+ ++ + T+ G+ + APE +S
Sbjct: 134 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPEVIS 188
Query: 405 -TGQSSEKTDVFGFGILLLELISG 427
+ + D++ G++L L+ G
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCG 212
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 25/101 (24%), Positives = 41/101 (40%), Gaps = 12/101 (11%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
N +L + L L + N ++ +P +L +L +S N T +P
Sbjct: 209 YNNRLTSLPALPSGLKELIV---SGNRLT-SLPVLPSELKEL---MVSGNRLTS-LPML- 259
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L L + N LT +P SL ++S ++L N LS
Sbjct: 260 --PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 19/101 (18%), Positives = 32/101 (31%), Gaps = 15/101 (14%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
N +L + L L+ + N ++ +P L +L
Sbjct: 69 PDNNLTSLPALPPELRTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-- 122
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L L + N LT ++P L L +S N L+
Sbjct: 123 -----LCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLA 154
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 14/87 (16%), Positives = 36/87 (41%), Gaps = 8/87 (9%)
Query: 25 LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 84
++ + + ++ +P + + TL + +N T +P+ L+ L ++ N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPA---LPPELRTLEVSGN 91
Query: 85 SLTGAIPPSLSNMSQLAFLDLSYNNLS 111
LT ++P + +L+ +L
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLP 117
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 25/117 (21%), Positives = 39/117 (33%), Gaps = 27/117 (23%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISG----------------HIPTEIGKLSKLLT 54
S N +L L L + ++ +P L +
Sbjct: 89 SGNQLTSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQE--- 145
Query: 55 LDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L +S+N +P+ S L L NN LT ++P S L L +S N L+
Sbjct: 146 LSVSDNQLAS-LPALPSE---LCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 11/100 (11%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
S N +L L L + N ++ +P L L + N T +P ++
Sbjct: 229 SGNRLTSLPVLPSELKELMV---SGNRLT-SLPMLPSGLLSL---SVYRNQLTR-LPESL 280
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 110
HL + + L N L+ +L + ++ +
Sbjct: 281 IHLSSETTVNLEGNPLS---ERTLQALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 24/101 (23%), Positives = 38/101 (37%), Gaps = 15/101 (14%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
N +L L L + +N ++ +P +L KL NN T +P
Sbjct: 129 FGNQLTSLPVLPPGLQELSV---SDNQLA-SLPALPSELCKL---WAYNNQLTS-LPML- 179
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
LQ L +++N L ++P S L L N L+
Sbjct: 180 --PSGLQELSVSDNQLA-SLPTLPSE---LYKLWAYNNRLT 214
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 12/91 (13%), Positives = 27/91 (29%), Gaps = 4/91 (4%)
Query: 17 TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 76
+L L +L + N ++ +P + LS T++L N + + + +
Sbjct: 255 SLPMLPSGLLSLSV---YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310
Query: 77 QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY 107
A + L +
Sbjct: 311 PGYSGPIIRFDMAGASAPRETRALHLAAADW 341
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 35/176 (19%), Positives = 58/176 (32%), Gaps = 15/176 (8%)
Query: 19 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETL 76
+S L +LQ + ++ I LS L+ L L N F + + + L L
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-LETGAFNGLANL 105
Query: 77 QYLRLNNNSLTGAIPP--SLSNMSQLAFLDLSYNNLS--GPVPSFHA----KTFNITGNS 128
+ L L +L GA+ ++ L L L NN+ P F ++T N
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165
Query: 129 LICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLIL 184
+ E+ L S + M + G+ S+ L
Sbjct: 166 VKS---ICEEDLLNFQGKHFTLLRLSSITLQD-MNEYWLGWEKCGNPFKNTSITTL 217
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 33/117 (28%), Positives = 51/117 (43%), Gaps = 11/117 (9%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
+ T+L+ + L N I+ I L+ LL L+LS NF I S + +L+ L+ L L
Sbjct: 297 HFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDL 354
Query: 82 NNNSLTGAIPP-SLSNMSQLAFLDLSYNNL-SGPVPSFHA----KTFNITGNSLICA 132
+ N + A+ S + L L L N L S P F + + N C+
Sbjct: 355 SYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 410
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 21/91 (23%), Positives = 36/91 (39%), Gaps = 3/91 (3%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 84
++ V L N+I+ T +L L L + I + L +L L+L+ N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 85 SLTGAIPPS-LSNMSQLAFLDLSYNNLSGPV 114
+ + ++ L L L+ NL G V
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAV 119
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 23/100 (23%), Positives = 40/100 (40%), Gaps = 10/100 (10%)
Query: 26 TNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNN 83
+ ++ L + I + + + L L L+ N I L L L L+
Sbjct: 275 SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQ 332
Query: 84 NSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 122
N L +I N+ +L LDLSYN++ + ++F
Sbjct: 333 NFLG-SIDSRMFENLDKLEVLDLSYNHIR----ALGDQSF 367
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 21/78 (26%), Positives = 33/78 (42%), Gaps = 3/78 (3%)
Query: 11 SQNLSGTLSSSI-GNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPS 68
SQN G++ S + NL L+++ L N+I + + L L L L N
Sbjct: 331 SQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDG 389
Query: 69 TVSHLETLQYLRLNNNSL 86
L +LQ + L+ N
Sbjct: 390 IFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 22/118 (18%), Positives = 44/118 (37%), Gaps = 17/118 (14%)
Query: 10 PSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKL---SKLLTLDLSNNF----- 61
L + T++ + L N + +K+ +L LSN++
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 62 -----FTGPIPSTVSHLET--LQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 111
F P T LE ++ L+ + + A+ S+ S+ + L L L+ N ++
Sbjct: 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN 312
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 9e-12
Identities = 26/92 (28%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ + NLT + + L N + + I L + TLDL++ T P ++ L LQ L
Sbjct: 79 APLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVL 134
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L+ N +T I P L+ ++ L +L + +S
Sbjct: 135 YLDLNQITN-ISP-LAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 24/92 (26%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ L NL + L++N I+ + + L+K+ L+LS N S ++ L++++ L
Sbjct: 57 EGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK--NVSAIAGLQSIKTL 112
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L + +T P L+ +S L L L N ++
Sbjct: 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 17/92 (18%), Positives = 40/92 (43%), Gaps = 6/92 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ +L + + ++ I + L+ L+ L+L +N T P + +L + L
Sbjct: 35 VTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L+ N L + ++ + + LDL+ ++
Sbjct: 91 ELSGNPLKN-VSA-IAGLQSIKTLDLTSTQIT 120
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 22/88 (25%), Positives = 36/88 (40%), Gaps = 6/88 (6%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
L N + +N++ L + TL T V +L L L L +
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 84 NSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
N +T + P L N++++ L+LS N L
Sbjct: 73 NQITD-LAP-LKNLTKITELELSGNPLK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 23/113 (20%), Positives = 43/113 (38%), Gaps = 7/113 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ + NL+ L + +N IS I + L L+ + L NN + P +++ L +
Sbjct: 167 TPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTF---NITGNSL 129
L N ++T +N+ + P T+ N+T N
Sbjct: 223 TLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLT 275
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 23/94 (24%), Positives = 41/94 (43%), Gaps = 4/94 (4%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
S + +L NL V L+NN IS P + S L + L+N T ++L +
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV 246
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 113
+ + + P ++S+ A +L++N S
Sbjct: 247 KGPSGAPI--APATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 14/80 (17%), Positives = 30/80 (37%), Gaps = 6/80 (7%)
Query: 32 LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 91
+ Q I+ P L+ + + + T T + L+ + L +T I
Sbjct: 3 ITQPTAINVIFP--DPALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TIE 57
Query: 92 PSLSNMSQLAFLDLSYNNLS 111
+ ++ L L+L N ++
Sbjct: 58 G-VQYLNNLIGLELKDNQIT 76
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 28/106 (26%), Positives = 49/106 (46%), Gaps = 8/106 (7%)
Query: 11 SQN-LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG---KLSKLLTLDLSNNFFTGPI 66
S N L+ T+ + G+LT L+ ++LQ N + + ++ L LD+S N +
Sbjct: 332 SNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDE 390
Query: 67 PSTV-SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
S ++L L +++N LT I L ++ LDL N +
Sbjct: 391 KKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 24/115 (20%), Positives = 48/115 (41%), Gaps = 9/115 (7%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82
+ +LQ + + N++S LL+L++S+N T I ++ L L+
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR--CLPPRIKVLDLH 429
Query: 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICA 132
+N + +IP + + L L+++ N L P F + + N C+
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 483
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
+S +S I +L+ L+++++ +N I + +L LDLS+N I
Sbjct: 32 YISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISC--HP 88
Query: 73 LETLQYLRLNNNSLTGAIPPS--LSNMSQLAFLDLSYNNLS 111
L++L L+ N+ A+P NMSQL FL LS +L
Sbjct: 89 TVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLE 128
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 36/221 (16%), Positives = 65/221 (29%), Gaps = 11/221 (4%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85
++ + N IS ++I LSKL L +S+N S + L+YL L++N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 86 LTGAIPPSLSNMSQLAFLDLSYNNLS--GPVPSFHA----KTFNITGNSLICATGAEEDC 139
L N L LDLS+N F K ++ L ++
Sbjct: 81 LVKISCHPTVN---LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 140 FGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGF--LLWWRQRHN 197
+ + L P G+ +L + IL + +
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 198 QQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLV 238
+ + D + L + + +
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 27/116 (23%), Positives = 39/116 (33%), Gaps = 4/116 (3%)
Query: 4 LCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT 63
L S S +N+ + + K+S L LD SNN T
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337
Query: 64 GPIPSTVSHLETLQYLRLNNNSLTGAIPPS---LSNMSQLAFLDLSYNNLSGPVPS 116
+ HL L+ L L N L + + M L LD+S N++S
Sbjct: 338 DTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 19/123 (15%), Positives = 34/123 (27%), Gaps = 11/123 (8%)
Query: 12 QNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 71
+ SI N+ + ++ + SG L L + ++ F P
Sbjct: 244 VWHTTVWYFSISNVKLQGQLDFRDFDYSGT------SLKALSIHQVVSDVFGFPQSYIYE 297
Query: 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL-SGPVPSFHA----KTFNITG 126
+ + S +S LD S N L + +T +
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 127 NSL 129
N L
Sbjct: 358 NQL 360
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 36/215 (16%)
Query: 230 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVE------ 279
+F +G G FG V+ + +G A+K LK + +VE
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKE-----IVVRLKQVEHTNDER 57
Query: 280 -MISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRK----RIA 333
M+S+ H ++R+ +++ ++ Y+ G + S L+ K +
Sbjct: 58 LMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 393
L L YLH + II+RD+K NILLD+ + DFG AK + VT + G
Sbjct: 117 LA----LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCG 165
Query: 394 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 428
T +IAPE +ST ++ D + FGIL+ E+++G
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 25/93 (26%), Positives = 40/93 (43%), Gaps = 4/93 (4%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ L + + L +N + +P + L L L S+N + V++L LQ L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQEL 513
Query: 80 RLNNNSLTG-AIPPSLSNMSQLAFLDLSYNNLS 111
L NN L A L + +L L+L N+L
Sbjct: 514 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 18/78 (23%), Positives = 30/78 (38%), Gaps = 3/78 (3%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPST 69
S N L ++ L L+++ +N + ++ + L +L L L NN
Sbjct: 471 SHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQP 528
Query: 70 VSHLETLQYLRLNNNSLT 87
+ L L L NSL
Sbjct: 529 LVSCPRLVLLNLQGNSLC 546
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 25/99 (25%), Positives = 47/99 (47%), Gaps = 8/99 (8%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
+ T + S L L + N++I+ T I KL+ L L ++N T + +S
Sbjct: 29 EMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITT-LD--LSQ 83
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L YL ++N LT + ++ +++L +L+ N L+
Sbjct: 84 NTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 25/91 (27%), Positives = 39/91 (42%), Gaps = 8/91 (8%)
Query: 21 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80
+ + T L + N ++ ++L TLD S N T VS + L L
Sbjct: 143 DVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLN 197
Query: 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ N++T + L+ QL FLD S N L+
Sbjct: 198 CDTNNIT-KLD--LNQNIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 23/119 (19%), Positives = 43/119 (36%), Gaps = 11/119 (9%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
+ T L + N I+ + + + L L+ N T ++
Sbjct: 157 LNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKL---DLNQ 210
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA-KTFNITGNSL 129
L +L ++N LT I ++ ++QL + D S N L+ V + T + L
Sbjct: 211 NIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDL 266
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 26/112 (23%), Positives = 44/112 (39%), Gaps = 12/112 (10%)
Query: 21 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80
+ TNL + +N ++ ++ + L+KL L+ N T VS L YL
Sbjct: 80 DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLN 133
Query: 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---KTFNITGNSL 129
N+LT +S+ +QL LD N + T + + N +
Sbjct: 134 CARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKI 182
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 22/99 (22%), Positives = 37/99 (37%), Gaps = 6/99 (6%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
+ T I N QL+ Q ++ ++L LD T + +S
Sbjct: 260 HCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQ 316
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L YL LNN LT + +S+ ++L L ++
Sbjct: 317 NPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 22/105 (20%), Positives = 37/105 (35%), Gaps = 7/105 (6%)
Query: 27 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 86
N + + +L+ L +LD N+ T + + L L L +N++
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNI 76
Query: 87 TGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA-KTFNITGNSL 129
T + LS + L +L N L+ V N N L
Sbjct: 77 T-TLD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKL 118
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 19/90 (21%), Positives = 32/90 (35%), Gaps = 9/90 (10%)
Query: 21 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80
+ L + +N ++ I + L++L D S N T + VS L L L
Sbjct: 207 DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLH 260
Query: 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 110
L I L++ +QL +
Sbjct: 261 CIQTDLL-EID--LTHNTQLIYFQAEGCRK 287
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 16/99 (16%), Positives = 34/99 (34%), Gaps = 5/99 (5%)
Query: 21 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80
+ + T L+ + N +I +GK+ L + T+++ +
Sbjct: 334 DVSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVS 391
Query: 81 LNNNSLTG---AIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
+ G I P + A +++ NLS P+
Sbjct: 392 PDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 14/83 (16%), Positives = 29/83 (34%), Gaps = 7/83 (8%)
Query: 29 QLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG 88
L Q + + P + + + + L TL L +N+S+T
Sbjct: 2 TLKAGQTQSFNDWFPDD--NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITD 56
Query: 89 AIPPSLSNMSQLAFLDLSYNNLS 111
+ ++ L L + NN++
Sbjct: 57 M--TGIEKLTGLTKLICTSNNIT 77
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 27/105 (25%), Positives = 47/105 (44%), Gaps = 11/105 (10%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLN 82
L++LQ ++ N++ IG L L L++++N +P S+L L++L L+
Sbjct: 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 83 NNSLTGAIPP----SLSNMSQLAF-LDLSYNNLSGPVPSFHAKTF 122
+N + +I L M L LDLS N ++ F
Sbjct: 158 SNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN----FIQPGAF 197
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 6/91 (6%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
+ LQ++ L I I LS L TL L+ N + S L +LQ L
Sbjct: 50 SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVA 107
Query: 82 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 111
+L ++ ++ L L++++N +
Sbjct: 108 VETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 26/91 (28%), Positives = 39/91 (42%), Gaps = 9/91 (9%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKL----LTLDLSNNFFTGPIPSTVSHLETLQY 78
NLTNL+ + L +N I I L ++ L+LDLS N I L+
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKE 204
Query: 79 LRLNNNSLTGAIPP-SLSNMSQLAFLDLSYN 108
L L+ N L ++P ++ L + L N
Sbjct: 205 LALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 25/98 (25%), Positives = 39/98 (39%), Gaps = 6/98 (6%)
Query: 19 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 77
+ IG+L L+ + + +N I E L+ L LDLS+N + + L +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 78 Y----LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L L+ N + I P +L L L N L
Sbjct: 177 LLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK 213
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 17/71 (23%), Positives = 26/71 (36%), Gaps = 4/71 (5%)
Query: 42 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQL 100
IP + LDLS N + LQ L L+ + I ++S L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 101 AFLDLSYNNLS 111
+ L L+ N +
Sbjct: 79 STLILTGNPIQ 89
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 18/74 (24%), Positives = 28/74 (37%), Gaps = 2/74 (2%)
Query: 12 QNLSGTLSSSIGNLTNLQLVL-LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
Q++ T + + L L L L N ++ I K +L L L N
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIF 220
Query: 71 SHLETLQYLRLNNN 84
L +LQ + L+ N
Sbjct: 221 DRLTSLQKIWLHTN 234
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
SS+ +L L+ + L++N IS I + L +L +L L NN T + +S L L L
Sbjct: 103 SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTL 158
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L +N ++ I P L+ +++L L LS N++S
Sbjct: 159 SLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 4e-10
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 10/94 (10%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP--STVSHLETLQ 77
I L N+ + L N ++ I + L L L L N I S++ L+ L+
Sbjct: 59 QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDEN----KIKDLSSLKDLKKLK 112
Query: 78 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L L +N ++ I L ++ QL L L N ++
Sbjct: 113 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT 144
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ NL NL + L N I + + + L KL +L L +N + + + HL L+ L
Sbjct: 81 KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS--DINGLVHLPQLESL 136
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L NN +T LS +++L L L N +S
Sbjct: 137 YLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 21/92 (22%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ L ++ ++ N++I + I L + L L+ N T I +++L+ L +L
Sbjct: 37 VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTD-I-KPLTNLKNLGWL 92
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L+ N + + L ++ +L L L +N +S
Sbjct: 93 FLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 4/104 (3%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ + LT L + L++N IS I + L+KL L LS N + ++ L+ L L
Sbjct: 147 TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVL 202
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 123
L + SN+ + + +L P +
Sbjct: 203 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 246
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 19/90 (21%), Positives = 36/90 (40%), Gaps = 10/90 (11%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--GPIPSTVSHLETLQYLRL 81
L+ +++ + +L+ + + +N+ I +L + L L
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGI----QYLPNVTKLFL 72
Query: 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
N N LT I P L+N+ L +L L N +
Sbjct: 73 NGNKLTD-IKP-LTNLKNLGWLFLDENKIK 100
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 18/92 (19%), Positives = 35/92 (38%), Gaps = 4/92 (4%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ LT LQ + L N+IS + L L L+L + + S+L +
Sbjct: 169 VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ + SL P +S+ ++ ++
Sbjct: 227 KNTDGSLV--TPEIISDDGDYEKPNVKWHLPE 256
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 34/205 (16%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 292
G+G FG V + VA+K LK + + + E+ + L H ++++L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM---RVEREISYLKLLRHPHIIKL 74
Query: 293 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLH 344
T T+ ++V Y + G + + +KR+ R + Y H
Sbjct: 75 YDVITTPTDIVMVIEY-AGGELFDYI--------VEKKRMTEDEGRRFFQQIICAIEYCH 125
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 404
KI+HRD+K N+LLD+ + DFGL+ ++ + + T+ G+ + APE ++
Sbjct: 126 RH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTSC-GSPNYAAPEVIN 180
Query: 405 TGQSSE--KTDVFGFGILLLELISG 427
G+ + DV+ GI+L ++ G
Sbjct: 181 -GKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
SS+ +L L+ + L++N IS I + L +L +L L NN T + +S L L L
Sbjct: 106 SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTL 161
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L +N ++ I P L+ +++L L LS N++S
Sbjct: 162 SLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 24/94 (25%), Positives = 41/94 (43%), Gaps = 10/94 (10%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP--STVSHLETLQ 77
I L N+ + L N ++ I + L L L L N + S++ L+ L+
Sbjct: 62 QGIQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDEN----KVKDLSSLKDLKKLK 115
Query: 78 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L L +N ++ I L ++ QL L L N ++
Sbjct: 116 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 21/92 (22%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ L ++ ++ N++I + I L + L L+ N T P +++L+ L +L
Sbjct: 40 VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWL 95
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L+ N + + L ++ +L L L +N +S
Sbjct: 96 FLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 4/104 (3%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ + LT L + L++N IS I + L+KL L LS N + ++ L+ L L
Sbjct: 150 TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVL 205
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 123
L + SN+ + + +L P +
Sbjct: 206 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 249
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 18/92 (19%), Positives = 36/92 (39%), Gaps = 4/92 (4%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+ LT LQ + L N+IS + + L L L+L + + S+L +
Sbjct: 172 VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ + SL P +S+ ++ ++
Sbjct: 230 KNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 19/92 (20%), Positives = 38/92 (41%), Gaps = 6/92 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
S L+ +++ + +L+ + + +N+ + + +L + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-V-QGIQYLPNVTKL 73
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
LN N LT I P L+N+ L +L L N +
Sbjct: 74 FLNGNKLT-DIKP-LANLKNLGWLFLDENKVK 103
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 11/80 (13%), Positives = 29/80 (36%), Gaps = 6/80 (7%)
Query: 32 LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 91
+ I ++ + +L T T + L ++ + NN+ + ++
Sbjct: 8 ITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ 62
Query: 92 PSLSNMSQLAFLDLSYNNLS 111
+ + + L L+ N L+
Sbjct: 63 G-IQYLPNVTKLFLNGNKLT 81
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 2e-10
Identities = 20/104 (19%), Positives = 36/104 (34%), Gaps = 13/104 (12%)
Query: 42 IPTEIGKLSKLLTLDLSNNFFTGPIPS-TVSHLETLQYLRLNNNSLTGAIPP-SLSNMSQ 99
+ L L + N + + L L+ L + + L + P + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 100 LAFLDLSYNNLS----GPVPSFHAKTFNITGNSLICATGAEEDC 139
L+ L+LS+N L V + ++GN L C C
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC------SC 119
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 1e-09
Identities = 19/92 (20%), Positives = 32/92 (34%), Gaps = 2/92 (2%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 78
+ NL + ++N H+ + L +L L + + P L
Sbjct: 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84
Query: 79 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 110
L L+ N+L ++ L L LS N L
Sbjct: 85 LNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 4e-06
Identities = 18/79 (22%), Positives = 31/79 (39%), Gaps = 4/79 (5%)
Query: 11 SQNLSGTL-SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPS 68
+Q L + L L+ + + + + + + +L L+LS N
Sbjct: 40 NQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALESLSWK 98
Query: 69 TVSHLETLQYLRLNNNSLT 87
TV L +LQ L L+ N L
Sbjct: 99 TVQGL-SLQELVLSGNPLH 116
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 33/153 (21%), Positives = 58/153 (37%), Gaps = 24/153 (15%)
Query: 239 GKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297
G G G V + + + A+K L+D E++ + +++R++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDVYE 81
Query: 298 TTTER----LLVYPYMSNGSVASRLKAKPSLDWATRK-----RIALGAARGLLYLHEQCD 348
L+V + G + SR++ + + R+ + A + YLH
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA---IQYLHSI-- 136
Query: 349 PKIIHRDVKAANILL---DEYYEAVVGDFGLAK 378
I HRDVK N+L + DFG AK
Sbjct: 137 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 51/236 (21%), Positives = 92/236 (38%), Gaps = 39/236 (16%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQT---------EV 278
S ++ + + G +G V G +G VA+KR+ + + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 279 EMISLAVHRNLLRLIG-FCMTTTERL----LVYPYMS---NGSVASRLKAKPSLDWATRK 330
+++ H N+L L F + LV M + + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ---RIVISPQHIQ 137
Query: 331 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 390
GL LHE ++HRD+ NILL + + + DF LA+ D++ T
Sbjct: 138 YFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTA-DANKTHY 193
Query: 391 V-----RGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 439
V R APE + ++ D++ G ++ E+ + +AL G NQ
Sbjct: 194 VTHRWYR------APELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYNQ 242
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
LT L+L+ L +N + +P I +L L TL +++N +P V L L LRL
Sbjct: 59 RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRL 116
Query: 82 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 111
+ N L ++PP + ++++L +L L YN L
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ 146
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 24/88 (27%), Positives = 43/88 (48%), Gaps = 4/88 (4%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 84
+ + + LQ+N +S +L+KL L L++N +P+ + L+ L+ L + +N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDN 95
Query: 85 SLTGAIPPSL-SNMSQLAFLDLSYNNLS 111
L A+P + + LA L L N L
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK 122
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 25/91 (27%), Positives = 39/91 (42%), Gaps = 6/91 (6%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
L NL+ + + +N + +P + +L L L L N +P V L L YL L
Sbjct: 83 ELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSL 140
Query: 82 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 111
N L ++P + ++ L L L N L
Sbjct: 141 GYNELQ-SLPKGVFDKLTSLKELRLYNNQLK 170
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 28/91 (30%), Positives = 40/91 (43%), Gaps = 6/91 (6%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
L NL + L N + +P + L+KL L L N +P V L +L+ LRL
Sbjct: 107 QLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRL 164
Query: 82 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 111
NN L +P +++L L L N L
Sbjct: 165 YNNQLK-RVPEGAFDKLTELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 25/87 (28%), Positives = 39/87 (44%), Gaps = 4/87 (4%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
+LT L + L N + +P + KL+ L L L NN +P L L+ L+L
Sbjct: 131 SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKL 188
Query: 82 NNNSLTGAIPPSLSNMSQLAFLDLSYN 108
+NN L + ++ +L L L N
Sbjct: 189 DNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 22/106 (20%), Positives = 44/106 (41%), Gaps = 8/106 (7%)
Query: 11 SQN-LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT----GP 65
+QN + ++ L LQ ++LQ N + + + +L+ +
Sbjct: 361 TQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHA 419
Query: 66 IPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
T + E++ L L++N LTG++ L ++ LDL N +
Sbjct: 420 YDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM 463
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 22/100 (22%), Positives = 49/100 (49%), Gaps = 5/100 (5%)
Query: 12 QNLSGTLSSSIGNLTNLQLVLLQNNNI-SGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
+N + N+++L+ + + N++ S +L L+LS+N TG + +
Sbjct: 390 KNFFKV-ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 110
++ L L+NN + +IP ++++ L L+++ N L
Sbjct: 449 P--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 24/97 (24%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 15 SGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLT-LDLSNNFFTGPIPSTVSHL 73
S + ++ ++ L +N ++G + L + LDL NN IP V+HL
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFR---CLPPKVKVLDLHNNRIMS-IPKDVTHL 472
Query: 74 ETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNN 109
+ LQ L + +N L ++P ++ L ++ L N
Sbjct: 473 QALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 19/72 (26%), Positives = 35/72 (48%), Gaps = 4/72 (5%)
Query: 41 HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQ 99
H+P ++ + L LS N + +S L L+ LRL++N + ++ +
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 100 LAFLDLSYNNLS 111
L +LD+S+N L
Sbjct: 102 LEYLDVSHNRLQ 113
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 24/148 (16%), Positives = 43/148 (29%), Gaps = 13/148 (8%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIG-----KLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 78
++ + + N I+ I E L L+ + N F + S +
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 79 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICAT 133
L+ + + S FL+ + N + +T + N L
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL---K 390
Query: 134 GAEEDCFGTAPMPLSFALNNSPNSKPSG 161
+ T M L+ S NS S
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSH 418
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 52/243 (21%), Positives = 93/243 (38%), Gaps = 38/243 (15%)
Query: 218 KRFHFKELQSAT----SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI 272
+F+ E+ +T + + +G G G V Y VA+K+L
Sbjct: 46 NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------- 97
Query: 273 QFQT---------EVEMISLAVHRNLLRLI------GFCMTTTERLLVYPYMSNGSVASR 317
FQ E+ ++ H+N++ L+ + LV M + +
Sbjct: 98 PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQ 155
Query: 318 LKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 377
+ LD + G+ +LH IIHRD+K +NI++ + DFGLA
Sbjct: 156 VIQME-LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
Query: 378 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK-T 436
+ S + T T + APE + E D++ G ++ E++ + L G+
Sbjct: 212 RTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDY 268
Query: 437 ANQ 439
+Q
Sbjct: 269 IDQ 271
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 9e-10
Identities = 33/210 (15%), Positives = 55/210 (26%), Gaps = 48/210 (22%)
Query: 228 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRL-------------KDGNAIGGEIQF 274
T +G+G FG V++ D T VA+K + K I EI
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 275 QTEVEMISLAV---HRNLLRLIGFCM-----------------------------TTTER 302
E+ ++S V + L ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 362
L + G + AT K I L + HRD+ N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVL 194
Query: 363 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 392
L + + K + ++
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 53/231 (22%), Positives = 87/231 (37%), Gaps = 40/231 (17%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 278
+ + +G G G V Y VA+K+L FQ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75
Query: 279 EMISLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKA--KPSLDWATR 329
++ H+N++ L+ T + L +V M + L + LD
Sbjct: 76 VLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMD-----ANLCQVIQMELDHERM 129
Query: 330 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389
+ G+ +LH IIHRD+K +NI++ + DFGLA+ S + T
Sbjct: 130 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMT 184
Query: 390 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 439
T + APE + E D++ G ++ E+I G L G +Q
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQ 234
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 24/94 (25%), Positives = 43/94 (45%), Gaps = 11/94 (11%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE--TLQ 77
+ + TNL+ + L +N IS + + + L+KL L ++ N + ++ + L
Sbjct: 57 AGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRN----RL-KNLNGIPSACLS 109
Query: 78 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L L+NN L SL ++ L L + N L
Sbjct: 110 RLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 16/92 (17%), Positives = 39/92 (42%), Gaps = 6/92 (6%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
L N L +++ + + +LS + + N+ + + L+ L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKEL 68
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L++N ++ + P L ++++L L ++ N L
Sbjct: 69 HLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 18/101 (17%), Positives = 39/101 (38%), Gaps = 8/101 (7%)
Query: 13 NLSGTLSSSIGNLTNLQLVLL--QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
+++ ++ + + L L NN + + L L L + NN +
Sbjct: 91 SVNRNRLKNLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKS--IVML 146
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L L+ L L+ N +T L+ + ++ ++DL+
Sbjct: 147 GFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 20/90 (22%), Positives = 39/90 (43%), Gaps = 7/90 (7%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
S+ +L NL+++ ++NN + I +G LSKL LDL N T ++ L+ + ++
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWI 177
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNN 109
L + +L + +
Sbjct: 178 DLTGQKCV---NEPVKYQPELYITNTVKDP 204
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 14/92 (15%), Positives = 32/92 (34%), Gaps = 4/92 (4%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
+G L+ L+++ L N I+ + + +L K+ +DL+ L +
Sbjct: 144 VMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTV 201
Query: 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ + P +SN + +
Sbjct: 202 KDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 21/122 (17%), Positives = 42/122 (34%), Gaps = 16/122 (13%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS--------HLE 74
++ N+ ++L + S + L+L + S +S
Sbjct: 196 SIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF 254
Query: 75 TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSL 129
T + +++ + SL + L+ +S L L+ S N L P F + + N
Sbjct: 255 TFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
Query: 130 IC 131
C
Sbjct: 314 DC 315
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 23/88 (26%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 84
++ + L NN I+ +++ + L L L++N I S L +L++L L+ N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYN 110
Query: 85 SLTGAIPPSL-SNMSQLAFLDLSYNNLS 111
L+ + S +S L FL+L N
Sbjct: 111 YLS-NLSSSWFKPLSSLTFLNLLGNPYK 137
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 16/92 (17%), Positives = 38/92 (41%), Gaps = 3/92 (3%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82
+LT LQ++ + N + I + L+ L L++ + P ++ ++ + +L L+
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 83 NNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGP 113
+ + S + L+L +L
Sbjct: 207 MKQHI-LLLEIFVDVTSSVECLELRDTDLDTF 237
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 23/97 (23%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
NLQ ++L +N I+ I + L L LDLS N+ + + S+ L +L +L L
Sbjct: 74 RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNL 131
Query: 82 NNNSLTGAIPPS--LSNMSQLAFLDLSYNNLSGPVPS 116
N + + S++++L L + + +
Sbjct: 132 LGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 13/103 (12%), Positives = 35/103 (33%), Gaps = 8/103 (7%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
LT L+ + + +++ + P + + + L L + V +++ L L +
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231
Query: 84 NSLTG----AIPP----SLSNMSQLAFLDLSYNNLSGPVPSFH 118
L + SL + ++ +L + +
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLN 274
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 27/71 (38%), Positives = 36/71 (50%), Gaps = 4/71 (5%)
Query: 42 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP-SLSNMSQL 100
IP+ + + +LDLSNN T S + LQ L L +N + I S S++ L
Sbjct: 46 IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102
Query: 101 AFLDLSYNNLS 111
LDLSYN LS
Sbjct: 103 EHLDLSYNYLS 113
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 49/235 (20%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 278
+ S VG G +G+V + G VA+K+L FQ+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74
Query: 279 EMISLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKR 331
++ H N++ L+ T L LV P+M + + K S + +
Sbjct: 75 LLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEE--KIQY 130
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391
+ +GL Y+H ++HRD+K N+ ++E E + DFGLA+ H D+ +T V
Sbjct: 131 LVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYV 184
Query: 392 -----RGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 439
R APE LS ++ D++ G ++ E+++G + L GK +Q
Sbjct: 185 VTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQ 232
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 18/103 (17%), Positives = 39/103 (37%), Gaps = 7/103 (6%)
Query: 19 SSSIGNLTNLQ-LVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLET 75
S + NL N+ + + + + + + LSK+ +++ N I L
Sbjct: 48 SHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPL 106
Query: 76 LQYLRLNNNSLTGAIPP--SLSNMSQLAFLDLSYNNLSGPVPS 116
L++L + N L P + + L+++ N +P
Sbjct: 107 LKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 16/90 (17%), Positives = 33/90 (36%), Gaps = 4/90 (4%)
Query: 25 LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL-N 82
+ Q + L ++ L + + +S + + S +L + ++ + N
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 83 NNSLTGAIPPS-LSNMSQLAFLDLSYNNLS 111
+LT I P L + L FL + L
Sbjct: 90 TRNLT-YIDPDALKELPLLKFLGIFNTGLK 118
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 21/96 (21%), Positives = 40/96 (41%), Gaps = 5/96 (5%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEI--GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 77
+ + + ++ + +N IP G ++ LTL L NN FT + + L
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLD 182
Query: 78 YLRLNNNSLTGAIPP-SLSNM-SQLAFLDLSYNNLS 111
+ LN N I + + S + LD+S +++
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 19/91 (20%), Positives = 37/91 (40%), Gaps = 6/91 (6%)
Query: 19 SSSIGNLTNLQLVL-LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLET- 75
++ L N L L L NN + + +KL + L+ N + I + +
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 76 LQYLRLNNNSLTGAIPP-SLSNMSQLAFLDL 105
L ++ S+T A+P L ++ +L +
Sbjct: 207 PSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 26/117 (22%), Positives = 46/117 (39%), Gaps = 11/117 (9%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
L L+ + NN I+ I S + + L++N + + LE+L+ L L
Sbjct: 55 KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLML 112
Query: 82 NNNSLTGAIPP-SLSNMSQLAFLDLSYNNL-SGPVPSFHA----KTFNITGNSLICA 132
+N +T + S +S + L L N + + +F T N+ N C
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 13/84 (15%)
Query: 41 HIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLNNNSLTGAIPP-SLSNMS 98
HIP L L+NN FT L L+ + +NN +T I + S
Sbjct: 29 HIPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 99 QLAFLDLSYNNLSGPVPSFHAKTF 122
+ + L+ N L + K F
Sbjct: 82 GVNEILLTSNRLE----NVQHKMF 101
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 27/101 (26%), Positives = 43/101 (42%), Gaps = 15/101 (14%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
+QN +L +L L +N +S +P L LD+ NN T +P
Sbjct: 88 TQNALISLPELPASLEYLD---ACDNRLS-TLPELPASLKH---LDVDNNQLTM-LPELP 139
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ LE Y+ +NN LT +P ++ L L + N L+
Sbjct: 140 ALLE---YINADNNQLT-MLPELPTS---LEVLSVRNNQLT 173
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 27/101 (26%), Positives = 41/101 (40%), Gaps = 15/101 (14%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
N TL +L +L + NN ++ +P L + + NN T +P
Sbjct: 108 CDNRLSTLPELPASLKHLDV---DNNQLT-MLPELPALLEYI---NADNNQLTM-LPELP 159
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+ LE L + NN LT +P + L LD+S N L
Sbjct: 160 TSLEVL---SVRNNQLT-FLPELPES---LEALDVSTNLLE 193
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 19/117 (16%), Positives = 36/117 (30%), Gaps = 7/117 (5%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPI 66
S NL +L + + + + N I+ HIP I L T+ L +N + I
Sbjct: 188 STNLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRI 246
Query: 67 PSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 123
++S + + N D S ++ ++
Sbjct: 247 RESLSQQTAQPDYHGPRIYFS--MSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWH 301
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 18/101 (17%), Positives = 43/101 (42%), Gaps = 14/101 (13%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
++ +L ++ + ++ + N + +P L L D +N + +P
Sbjct: 67 NRLNLSSLPDNLP--PQITVLEITQNALI-SLPELPASLEYL---DACDNRLST-LPEL- 118
Query: 71 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
+L++L ++NN LT +P + L +++ N L+
Sbjct: 119 --PASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLT 153
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 30/117 (25%), Positives = 49/117 (41%), Gaps = 11/117 (9%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
L+ + L NN IS + + L L +L L N T +P ++ L +LQ L L
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLL 111
Query: 82 NNNSLTGAIPP-SLSNMSQLAFLDLSYNNL-SGPVPSFHA----KTFNITGNSLICA 132
N N + + + ++ L L L N L + +F +T ++ N IC
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 24/88 (27%), Positives = 37/88 (42%), Gaps = 4/88 (4%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 84
+ + L+ N I P KL +DLSNN + + L +L L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGN 90
Query: 85 SLTGAIPPSL-SNMSQLAFLDLSYNNLS 111
+T +P SL + L L L+ N ++
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKIN 117
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 45/254 (17%), Positives = 87/254 (34%), Gaps = 68/254 (26%)
Query: 225 LQSATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQT---EVEM 280
L++++ +S +G G FG V + + + G A+K++ + E+++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL--------QDPRYKNRELDI 53
Query: 281 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA---- 336
+ + H N+++L+ + TT + P + K + +
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 337 -------------------------------------ARGLLYLHEQCDPKIIHRDVKAA 359
R + ++H I HRD+K
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQ 170
Query: 360 NILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAV----RGTVGHIAPE-YLSTGQSSEKTD 413
N+L++ + + DFG AK L + V R APE L + + D
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSID 224
Query: 414 VFGFGILLLELISG 427
++ G + ELI G
Sbjct: 225 LWSIGCVFGELILG 238
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 19/89 (21%), Positives = 36/89 (40%), Gaps = 4/89 (4%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSN-NFFTGPIPSTVSHLETLQYLRL 81
+L+ + + N++ I ++ L KL + + N P +L LQYL +
Sbjct: 52 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 111
Query: 82 NNNSLTGAIPP-SLSNMSQLAFLDLSYNN 109
+N + +P + Q LD+ N
Sbjct: 112 SNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 18/89 (20%), Positives = 32/89 (35%), Gaps = 4/89 (4%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL-NN 83
N + + L +++S N I + V S+L L +R+
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 84 NSLTGAIPPS-LSNMSQLAFLDLSYNNLS 111
N+L I P N+ L +L +S +
Sbjct: 90 NNLL-YINPEAFQNLPNLQYLLISNTGIK 117
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 20/86 (23%), Positives = 34/86 (39%), Gaps = 8/86 (9%)
Query: 25 LTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLN 82
+L L NNN+ +P ++ S + LD+S +PS +L+ L+
Sbjct: 177 TQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTY 234
Query: 83 NNSLTGAIPPSLSNMSQLAFLDLSYN 108
N P+L + L L+Y
Sbjct: 235 NLKKL----PTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 25/108 (23%), Positives = 37/108 (34%), Gaps = 9/108 (8%)
Query: 24 NLTNLQ-LVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81
NL L + + + NN+ +I E L L L +SN H L +
Sbjct: 77 NLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 135
Query: 82 NNNSLTGAIPP-SLSNMS-QLAFLDLSYNNLSGPVPSFHAKTFNITGN 127
+N I S +S + L L+ N + H FN T
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQ----EIHNSAFNGTQL 179
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 5/93 (5%)
Query: 22 IGNLTNLQLVLLQNNNISGHIPTEI--GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79
I +L + L + N NI I G + + L L+ N S + + +
Sbjct: 125 IHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELN 183
Query: 80 RLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 111
+NN+L +P S LD+S +
Sbjct: 184 LSDNNNLE-ELPNDVFHGASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 14/85 (16%), Positives = 33/85 (38%), Gaps = 6/85 (7%)
Query: 27 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNS 85
+ ++ L Q + ++ IP+++ + L I S L+ + ++ N
Sbjct: 10 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQND 65
Query: 86 LTGAIPPS-LSNMSQLAFLDLSYNN 109
+ I SN+ +L + + N
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKAN 90
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 46/222 (20%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 278
+ + VG G +G V + G VA+K+L FQ+ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75
Query: 279 EMISLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKR 331
++ H N++ L+ T E L LV P+M G+ +L L +
Sbjct: 76 RLLKHMRHENVIGLLD-VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQF 132
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391
+ +GL Y+H IIHRD+K N+ ++E E + DFGLA+ DS +T V
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYV 186
Query: 392 -----RGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELISG 427
R APE L+ + ++ D++ G ++ E+I+G
Sbjct: 187 VTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 56.5 bits (135), Expect = 9e-09
Identities = 20/121 (16%), Positives = 39/121 (32%), Gaps = 13/121 (10%)
Query: 4 LCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI------GKLSKLLTLDL 57
+ G P + L S + NL L L + + + L L +
Sbjct: 200 IISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGI 259
Query: 58 SNNFFTGPIPSTVSH---LETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLSYNNL 110
+ + L L+ + ++ LT + + + L F+++ YN L
Sbjct: 260 VDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
Query: 111 S 111
S
Sbjct: 320 S 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 41.5 bits (96), Expect = 6e-04
Identities = 13/82 (15%), Positives = 31/82 (37%), Gaps = 7/82 (8%)
Query: 23 GNLTNLQLVLLQNNNISGHIPTEIGK---LSKLLTLDLSNNFFTG----PIPSTVSHLET 75
NL+ + + + + + L +L T+D+S T + V ++
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308
Query: 76 LQYLRLNNNSLTGAIPPSLSNM 97
L+++ + N L+ + L
Sbjct: 309 LKFINMKYNYLSDEMKKELQKS 330
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 37/202 (18%), Positives = 76/202 (37%), Gaps = 35/202 (17%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---EVEMISLA 284
+ ++L+G G +G+V + Y + VVA+K++ I + E+ +++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRL 109
Query: 285 VHRNLLRLIGFCMTTTERL-----LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA-- 337
H ++++++ + +V S K R + L
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-----SDFKK------LFRTPVYLTELHI 158
Query: 338 --------RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389
G+ Y+H I+HRD+K AN L+++ V DFGLA+ +D+ ++ +
Sbjct: 159 KTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 390 AVRGTVGHIAPEYLSTGQSSEK 411
+ K
Sbjct: 216 LPISPREDDMNLVTFPHTKNLK 237
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 51/244 (20%), Positives = 91/244 (37%), Gaps = 26/244 (10%)
Query: 200 IFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVA 258
++ DVN R E + ++ +G+G + V++ + + V
Sbjct: 10 VYTDVNTHRPREYWDYESHVVEW----GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVV 65
Query: 259 VKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER--LLVYPYMSNGSV 314
VK LK I EI+ + +L N++ L R LV+ +++N
Sbjct: 66 VKILKPVKKKKIKREIKI-----LENLRGGPNIITLADIVKDPVSRTPALVFEHVNN--- 117
Query: 315 ASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVG 372
+ K +L + + L Y H I+HRDVK N+++D E+ + +
Sbjct: 118 -TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLI 173
Query: 373 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRAL 431
D+GLA+ + V + PE L Q D++ G +L +I
Sbjct: 174 DWGLAEFYHPGQEY-NVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
Query: 432 EFGK 435
G
Sbjct: 232 FHGH 235
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 38/230 (16%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 278
+ + + VG G +G+V + + G VAVK+L FQ+ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79
Query: 279 EMISLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKR 331
++ H N++ L+ T L LV M + + +K + L +
Sbjct: 80 RLLKHMKHENVIGLLD-VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQF 136
Query: 332 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 391
+ RGL Y+H IIHRD+K +N+ ++E E + DFGLA+ H +T V
Sbjct: 137 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYV 190
Query: 392 RGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 439
T + APE L+ ++ D++ G ++ EL++G R L G +Q
Sbjct: 191 -ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQ 238
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 8e-08
Identities = 48/223 (21%), Positives = 92/223 (41%), Gaps = 44/223 (19%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 278
+++ + +G+G +G V Y + VA+K++ F+ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---------FEHQTYCQRTLREI 76
Query: 279 EMISLAVHRNLLRLIG-FCMTTTERL----LVYPYMSNGSVASRLKAKPSLDWATRKRIA 333
+++ H N++ + T E++ +V M + +L L
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICYFL 134
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH------- 386
RGL Y+H ++HRD+K +N+LL+ + + DFGLA++ D H
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 387 -VTTAVRGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELISG 427
T R APE L++ ++ D++ G +L E++S
Sbjct: 192 VATRWYR------APEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 53/246 (21%), Positives = 94/246 (38%), Gaps = 57/246 (23%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 278
S + +G GG G V+ VA+K+ I E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK----------IVLTDPQSVKHALREI 59
Query: 279 EMISLAVHRNLLRLI----------GFCMTTTERL----LVYPYMSNGSVASRLKAKPSL 324
++I H N++++ + + L +V YM + + + + L
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPL 117
Query: 325 DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHC 383
+ RGL Y+H ++HRD+K AN+ ++ E +GDFGLA+++D
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174
Query: 384 DSH--------VTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFG 434
SH VT R +P LS ++ D++ G + E+++G + L G
Sbjct: 175 YSHKGHLSEGLVTKWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAG 227
Query: 435 K-TANQ 439
Q
Sbjct: 228 AHELEQ 233
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 31/158 (19%), Positives = 49/158 (31%), Gaps = 39/158 (24%)
Query: 25 LTNLQLVLLQNNNIS----GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL------- 73
L Q+V L + ++ I + + L L+L +N V +
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG---DVGVHCVLQGLQTP 83
Query: 74 -ETLQYLRLNNNSLT----GAIPPSLSNMSQLAFLDLSYNNLSGPV----------PSFH 118
+Q L L N LT G + +L + L L LS N L P
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 119 AKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPN 156
+ + S + A E L+ L P+
Sbjct: 144 LEKLQLEYCS-LSAASCEP---------LASVLRAKPD 171
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 22/116 (18%), Positives = 41/116 (35%), Gaps = 22/116 (18%)
Query: 12 QNLSGTLSSSIGNLTNLQLVLLQNNNIS----GHIPTEIGKLSKLLTLDLSNNFFTGPIP 67
+ L + + L L QN ++ G + + + L L L LS+N
Sbjct: 74 HCVLQGLQTPSCKIQKLSL---QNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG---D 127
Query: 68 STVSHLE--------TLQYLRLNNNSLT----GAIPPSLSNMSQLAFLDLSYNNLS 111
+ + L L+ L+L SL+ + L L +S N+++
Sbjct: 128 AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 21/113 (18%), Positives = 37/113 (32%), Gaps = 16/113 (14%)
Query: 12 QNLSGTLSSSIGNLTNLQLVLLQNNNIS----GHIPTEIGKLSKLLTLDLSNNFFTGP-- 65
+ L L S L L+L ++ ++ + + + L L L +N
Sbjct: 188 RVLCQGLKDSPCQLEALKL---ESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244
Query: 66 ---IPSTVSHLETLQYLRLNNNSLT----GAIPPSLSNMSQLAFLDLSYNNLS 111
P + L+ L + +T G + L L L L+ N L
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 18/104 (17%), Positives = 37/104 (35%), Gaps = 19/104 (18%)
Query: 24 NLTNLQLVLLQNNNIS----GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL------ 73
L+ + L+ ++S + + + L +SNN + V L
Sbjct: 140 PQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN---EAGVRVLCQGLKD 196
Query: 74 --ETLQYLRLNNNSLT----GAIPPSLSNMSQLAFLDLSYNNLS 111
L+ L+L + +T + +++ + L L L N L
Sbjct: 197 SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 16/67 (23%), Positives = 27/67 (40%), Gaps = 5/67 (7%)
Query: 50 SKLLTLDLSNNFFTGP-IPSTVSHLETLQYLRLNNNSLT----GAIPPSLSNMSQLAFLD 104
+ +LD+ + + L+ Q +RL++ LT I +L LA L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 105 LSYNNLS 111
L N L
Sbjct: 63 LRSNELG 69
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 49/249 (19%), Positives = 87/249 (34%), Gaps = 69/249 (27%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 278
N+ K+L+G+G +G VY Y VA+K++ F+ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--------MFEDLIDCKRILREI 76
Query: 279 EMISLAVHRNLLRLIGFCMTTTERL-----LVYPYMSNGSVASRLKAKPSLDWATRKRIA 333
+++ ++RL + +V S LK + I
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKK------LFKTPIF 125
Query: 334 LGAA----------RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383
L G ++HE IIHRD+K AN LL++ V DFGLA+ ++
Sbjct: 126 LTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
Query: 384 DSHVTTAVRGTVGHI---------------------APEYLSTGQS-SEKTDVFGFGILL 421
APE + ++ ++ D++ G +
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242
Query: 422 LELISGLRA 430
EL++ L++
Sbjct: 243 AELLNMLQS 251
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 27/102 (26%), Positives = 40/102 (39%), Gaps = 9/102 (8%)
Query: 13 NLSGTLSSSIGNL----TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS 68
+L G I NL + +N I + L +L TL ++NN
Sbjct: 25 DLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEG 82
Query: 69 TVSHLETLQYLRLNNNSLT--GAIPPSLSNMSQLAFLDLSYN 108
L L L L NNSL G + P L+++ L +L + N
Sbjct: 83 LDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 19/93 (20%), Positives = 34/93 (36%), Gaps = 3/93 (3%)
Query: 19 SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 78
++ N + + L+ I I L + +D S+N + L L+
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKT 68
Query: 79 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L +NNN + + L L L+ N+L
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 19/94 (20%), Positives = 42/94 (44%), Gaps = 5/94 (5%)
Query: 18 LSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 77
+ +++ L + + L NNI I + + + L L L N I + + +TL+
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK-IENLDAVADTLE 96
Query: 78 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L ++ N + ++ + + L L +S N ++
Sbjct: 97 ELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 19/94 (20%), Positives = 31/94 (32%), Gaps = 11/94 (11%)
Query: 21 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80
++L I + + L L LS N +S L ++ LR
Sbjct: 21 VATEAEKVEL-HGMIPPIE-KMDATLSTLKACKHLALSTNNIE-----KISSLSGMENLR 73
Query: 81 ---LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L N + I + L L +SYN ++
Sbjct: 74 ILSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-07
Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 3/99 (3%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
S++ G L L+ + N ++ I + KL+KL L+LS+N +G +
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLA 84
Query: 71 SHLETLQYLRLNNNSLTG-AIPPSLSNMSQLAFLDLSYN 108
L +L L+ N + + L + L LDL
Sbjct: 85 EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-07
Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 4/88 (4%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
++ L L ++N + + +L L N T + + L L+ L L++
Sbjct: 18 DVKELVLDNSRSNEGK--LEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELSD 73
Query: 84 NSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
N ++G + L L+LS N +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 23/81 (28%), Positives = 36/81 (44%), Gaps = 8/81 (9%)
Query: 13 NLSGTLSSSIGNL---TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 69
+ +SI NL L+ + L +N +SG + K L L+LS N ST
Sbjct: 48 STINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LST 105
Query: 70 VSHLETLQYLR---LNNNSLT 87
+ L+ L+ L+ L N +T
Sbjct: 106 IEPLKKLENLKSLDLFNCEVT 126
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 4/87 (4%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 84
+ + + LQ+ ++ L+KL L+L N + + V L L L L NN
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANN 93
Query: 85 SLTGAIPPSL-SNMSQLAFLDLSYNNL 110
L ++P + +++QL L L N L
Sbjct: 94 QLA-SLPLGVFDHLTQLDKLYLGGNQL 119
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 6/91 (6%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
LT L + L N + + + L++L TL L+NN +P V HL L L L
Sbjct: 57 GLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYL 114
Query: 82 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 111
N L ++P + +++L L L+ N L
Sbjct: 115 GGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 5/88 (5%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
+LT L + L N + +P+ + +L+KL L L+ N IP+ L LQ L L
Sbjct: 105 HLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSL 162
Query: 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNN 109
+ N L + + +L + L + N
Sbjct: 163 STNQLQSVPHGAFDRLGKLQTITL-FGN 189
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 45/226 (19%), Positives = 85/226 (37%), Gaps = 55/226 (24%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-----------A 284
+G G F V+ + + T VA+K ++ + E++++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 285 VHRNLLRLIGF-----------CMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRI 332
++L+L+ M E L + ++ + + + L + K+I
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVF-EVL----GENLLALIKKYEHRGIPLIYV--KQI 136
Query: 333 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDE------YYEAVVGDFGLAKLLDHCDSH 386
+ GL Y+H +C IIH D+K N+L++ + + D G A D H
Sbjct: 137 SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---H 191
Query: 387 VTTAV-----RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
T ++ R +PE L D++ L+ ELI+G
Sbjct: 192 YTNSIQTREYR------SPEVLLGAPWGCGADIWSTACLIFELITG 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 17/114 (14%)
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 397
R + LH +IHRD+K +N+L++ + V DFGLA+++D + + G
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE-SAADNSEPTGQQSG 178
Query: 398 I----------APEY-LSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 439
+ APE L++ + S DV+ G +L EL R + G+ +Q
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRDYRHQ 231
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 9e-07
Identities = 24/87 (27%), Positives = 39/87 (44%), Gaps = 3/87 (3%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85
++ + L N + +P E+ L +DLSNN + + S++ L L L+ N
Sbjct: 31 RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 86 LTGAIPPSL-SNMSQLAFLDLSYNNLS 111
L IPP + L L L N++S
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 24/71 (33%), Positives = 37/71 (52%), Gaps = 9/71 (12%)
Query: 42 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQL 100
IP ++ +L L N FT +P +S+ + L + L+NN ++ + SNM+QL
Sbjct: 29 IPRDVTEL------YLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80
Query: 101 AFLDLSYNNLS 111
L LSYN L
Sbjct: 81 LTLILSYNRLR 91
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 22/83 (26%), Positives = 32/83 (38%), Gaps = 2/83 (2%)
Query: 29 QLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG 88
+LVL + G I + L L L N S + L L+ L L+ N + G
Sbjct: 28 ELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFG 85
Query: 89 AIPPSLSNMSQLAFLDLSYNNLS 111
+ + L L+LS N L
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 5/100 (5%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
++ G + NL+ + L N + + + KL KL L+LS N G +
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLA 91
Query: 71 SHLETLQYLRLNNNSLT--GAIPPSLSNMSQLAFLDLSYN 108
L L +L L+ N L + P L + L LDL
Sbjct: 92 EKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 24/81 (29%), Positives = 35/81 (43%), Gaps = 8/81 (9%)
Query: 13 NLSGTLSSSIGNL---TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 69
+L S+ NL L+ + L N I G + KL L L+LS N ST
Sbjct: 55 SLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--IST 112
Query: 70 VSHLETLQYLR---LNNNSLT 87
+ L+ L+ L+ L N +T
Sbjct: 113 LEPLKKLECLKSLDLFNCEVT 133
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 25/99 (25%), Positives = 46/99 (46%), Gaps = 12/99 (12%)
Query: 17 TLSSSIGNLTNLQLVLLQNNNISGHIPTEIG---KLSKLLTLDLSNNFFTGPIPSTV-SH 72
I L N++ + L N + +I +L+ L L L+ N +P+ V
Sbjct: 54 KSVQGIQYLPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQS-LPNGVFDK 107
Query: 73 LETLQYLRLNNNSLTGAIPPSLSN-MSQLAFLDLSYNNL 110
L L+ L L N L ++P + + ++ L +L+L++N L
Sbjct: 108 LTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQL 145
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 31/90 (34%), Positives = 44/90 (48%), Gaps = 6/90 (6%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
LTNL ++L N + +P + KL+ L L L N +P V L L YL L
Sbjct: 83 ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNL 140
Query: 82 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNL 110
+N L ++P + ++ L LDLSYN L
Sbjct: 141 AHNQLQ-SLPKGVFDKLTNLTELDLSYNQL 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 25 LTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLN 82
LTNL+ ++L N + +P + KL+ L L+L++N +P V L L L L+
Sbjct: 108 LTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLS 165
Query: 83 NNSLTGAIPPSL-SNMSQLAFLDLSYNNL 110
N L ++P + ++QL L L N L
Sbjct: 166 YNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 39/167 (23%), Positives = 59/167 (35%), Gaps = 34/167 (20%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG----EIQFQTEV---EMISLAVHRN 288
+G GGFG +Y + A +K G E++F V + I + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 289 LLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDW---ATRK-------RIA 333
L +G T + Y +M V RL L ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFM----VMERLG--IDLQKISGQNGTFKKSTVLQLG 157
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAK 378
+ L Y+HE +H D+KAAN+LL V D+GL+
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 42/192 (21%), Positives = 76/192 (39%), Gaps = 20/192 (10%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKD--GNAIGG-----EIQFQTEVEM 280
+ +GKG +G V+K + G VVAVK++ D N+ EI +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMI-----L 62
Query: 281 ISLAVHRNLLRLIGFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR 338
L+ H N++ L+ +R LV+ YM + + L+ ++ + +
Sbjct: 63 TELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQLIK 120
Query: 339 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 398
+ YLH ++HRD+K +NILL+ V DFGL++ + +
Sbjct: 121 VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 399 APEYLSTGQSSE 410
++
Sbjct: 178 ENFDDDQPILTD 189
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 47/216 (21%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVH-----RNL 289
++GKG FG V K Y + VA+K +++ Q E+ ++ L N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 290 LRLIGF-------CMTTTERLL--VYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARG 339
+ ++ CMT E L +Y + K + SL RK A +
Sbjct: 162 IHMLENFTFRNHICMTF-ELLSMNLYELIKKN------KFQGFSLP-LVRK-FAHSILQC 212
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV--VGDFGLAKLLDHCDSHVTTAV-----R 392
L LH+ +IIH D+K NILL + + V DFG + V T + R
Sbjct: 213 LDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQSRFYR 266
Query: 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 428
APE + + D++ G +L EL++G
Sbjct: 267 ------APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 36/170 (21%), Positives = 62/170 (36%), Gaps = 37/170 (21%)
Query: 237 LVGKGGFGNVYKGYLQDGT------VVAVKRLKDGNA-IGGEIQFQTEV---EMISLAVH 286
+G+GGFG +Y + VK N + E++F E I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 287 RNLLRLIGFCM-----TTTERLLVYPYMSNGSVASRLKAKPSL----DWATRK------- 330
L+ +G + Y +M + R L + ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFG--SDLQKIYEANAKRFSRKTVL 155
Query: 331 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAK 378
+++L L Y+HE +H D+KA+N+LL+ V D+GLA
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 26/87 (29%), Positives = 37/87 (42%), Gaps = 4/87 (4%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 84
TN Q++ L +N I+ P L L L L +N +P V L L L L N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTN 98
Query: 85 SLTGAIPPSL-SNMSQLAFLDLSYNNL 110
LT +P ++ + L L + N L
Sbjct: 99 QLT-VLPSAVFDRLVHLKELFMCCNKL 124
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 22/86 (25%), Positives = 38/86 (44%), Gaps = 4/86 (4%)
Query: 25 LTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
LT L ++ L N ++ +P+ + +L L L + N T +P + L L +L L+
Sbjct: 87 LTQLTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQ 144
Query: 84 NSLTGAIPPSLSNMSQLAFLDLSYNN 109
N L + +S L L + N
Sbjct: 145 NQLKSIPHGAFDRLSSLTHAYL-FGN 169
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 23/87 (26%), Positives = 40/87 (45%), Gaps = 4/87 (4%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 84
+ L+ N++ +L+ L L L N +P+ V + L +L YL L+ N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTN 86
Query: 85 SLTGAIPPSL-SNMSQLAFLDLSYNNL 110
L ++P + ++QL L L+ N L
Sbjct: 87 QLQ-SLPNGVFDKLTQLKELALNTNQL 112
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 6/90 (6%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
LT+L + L N + +P + KL+ L L+LS N +P+ V L L+ L L
Sbjct: 50 ELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELAL 107
Query: 82 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNL 110
N N L ++P + ++QL L L N L
Sbjct: 108 NTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 17/116 (14%), Positives = 33/116 (28%), Gaps = 22/116 (18%)
Query: 18 LSSSIGNLTNLQLVLLQNNNIS-------------GHIPTEIGKLSKLLTLDLSNNFFTG 64
L + T L+ + L NN + + + L ++ N
Sbjct: 114 LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173
Query: 65 P----IPSTVSHLETLQYLRLNNNSLT-----GAIPPSLSNMSQLAFLDLSYNNLS 111
T L +++ N + + L+ +L LDL N +
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 21/112 (18%), Positives = 39/112 (34%), Gaps = 18/112 (16%)
Query: 18 LSSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNF---FTGPIPSTV 70
+ + + +++ ++L N I + I L + S+ F IP +
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 71 SHL-------ETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLSYNNLS 111
L L +RL++N+ + LS + L L L N L
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 135
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 27/170 (15%), Positives = 51/170 (30%), Gaps = 39/170 (22%)
Query: 238 VGKGGFGNVYKGY---------LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHR 287
+ G +Y+ ++K + E F Q + + + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGS-----VASRLKAKPSL----DWATRK-------- 330
L + T + + V L SL D + +
Sbjct: 110 KLYSTPLLAIPT-----CMGFGVHQDKYRFLVLPSLG--RSLQSALDVSPKHVLSERSVL 162
Query: 331 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAK 378
++A L +LHE +H +V A NI +D ++ V +G A
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 24/87 (27%), Positives = 39/87 (44%), Gaps = 4/87 (4%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 84
++ + L++N + KL++L L LS N +P V L L L L+ N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHEN 86
Query: 85 SLTGAIPPSL-SNMSQLAFLDLSYNNL 110
L ++P + ++QL L L N L
Sbjct: 87 KLQ-SLPNGVFDKLTQLKELALDTNQL 112
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 20/85 (23%), Positives = 27/85 (31%), Gaps = 13/85 (15%)
Query: 41 HIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIPPSL-SNMS 98
IP +L L++N + L L L L N LT I P+ S
Sbjct: 26 DIPLHTTEL------LLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78
Query: 99 QLAFLDLSYNNLSGPVPSFHAKTFN 123
+ L L N + K F
Sbjct: 79 HIQELQLGENKIK----EISNKMFL 99
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 22/89 (24%), Positives = 40/89 (44%), Gaps = 7/89 (7%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 81
L +L + L+ N ++G I S + L L N I + + L L+ L L
Sbjct: 52 RLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNL 109
Query: 82 NNNSLTGAIPP-SLSNMSQLAFLDLSYNN 109
+N ++ + P S +++ L L+L +N
Sbjct: 110 YDNQIS-CVMPGSFEHLNSLTSLNL-ASN 136
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 20/116 (17%), Positives = 47/116 (40%), Gaps = 19/116 (16%)
Query: 12 QNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKL-----SKLLTLDLSNNFFTGP- 65
L+ L+S ++T+L L N + E+ + + +++L+L N GP
Sbjct: 185 AELAKFLASIPASVTSLDL---SANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241
Query: 66 ---IPSTVSHLETLQYLRLNNNSLTG-------AIPPSLSNMSQLAFLDLSYNNLS 111
+ L+ LQ + L+ + + A+ + N+ ++ +D + +
Sbjct: 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 552 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.79 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.76 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.76 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.76 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.75 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.75 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.72 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.72 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.71 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.71 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.71 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.71 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.7 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.69 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.69 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.69 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.68 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.68 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.66 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.66 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.66 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.65 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.65 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.65 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.65 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.64 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.64 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.64 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.63 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.62 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.61 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.61 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.6 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.6 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.59 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.59 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.59 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.59 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.58 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.58 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.58 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.58 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.57 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.57 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.57 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.57 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.57 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.57 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.56 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.56 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.56 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.55 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.55 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.55 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.55 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.55 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.54 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.54 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.54 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.54 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.54 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.53 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.53 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.52 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.52 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.52 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.52 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.52 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.52 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.51 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.51 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.51 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.51 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.51 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.51 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.5 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.5 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.49 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.49 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.49 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.49 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.48 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.48 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.47 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.46 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.46 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.46 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.45 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.45 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.43 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.42 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.41 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.39 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.37 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.36 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.36 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.34 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.33 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.33 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.32 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.32 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.26 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.24 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.23 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.21 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.21 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.21 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.21 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.19 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.03 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.02 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.91 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.89 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.86 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.85 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.83 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.72 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.64 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.57 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.55 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.49 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.39 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.31 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.29 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.28 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.24 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.24 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.23 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.2 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.15 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.07 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.03 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.81 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.76 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.76 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.75 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.74 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.45 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.4 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.39 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.39 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.37 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.36 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.33 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.28 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.27 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.27 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.24 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.13 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.04 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.03 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.03 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.94 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.93 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.58 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.03 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.94 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 95.33 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 95.29 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.0 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.4 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.06 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 88.5 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 86.8 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.54 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.76 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 80.3 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-57 Score=446.44 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=210.0
Q ss_pred CCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
++++.+.||+|+||+||+|.+. +++.||||+++........++|.+|+.++++++|||||+++|+|...+..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3456688999999999999863 4678999999866555556789999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc
Q 008828 305 VYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 368 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 368 (552)
|||||++|+|.+++... ..++|..+..|+.|||+||+|||++ +||||||||+|||++++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 99999999999999532 3589999999999999999999999 9999999999999999999
Q ss_pred eEEcccccceecCCCCC-ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHH
Q 008828 369 AVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDW 446 (552)
Q Consensus 369 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 446 (552)
+||+|||+++.....+. .......||+.|||||++.++.|+.++|||||||++|||+| |+.||..... .+.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-------~~~ 256 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDV 256 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------HHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------HHH
Confidence 99999999987643322 22344569999999999999999999999999999999999 8999864321 111
Q ss_pred HHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 447 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
+..+... ...+.+..++..+.+|+.+||+.||++||||.||+++|+.
T Consensus 257 ~~~i~~~----------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 257 VEMIRNR----------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHHHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHcC----------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 2222111 1112334456789999999999999999999999999986
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-57 Score=441.99 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=208.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
++|.+.+.||+|+||+||+|++. ++..||||+++... ....++|.+|++++++++|||||+++|+|.+.+..+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 45777889999999999999864 47889999997543 234567999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceE
Q 008828 304 LVYPYMSNGSVASRLKAK-------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 370 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~-------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 370 (552)
+|||||++|+|.++++.. ..++|..+..|+.|||+||.|||++ +|+||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 999999999999999643 3699999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHH
Q 008828 371 VGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK 448 (552)
Q Consensus 371 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 448 (552)
|+|||+++.....+... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .+.+.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~~ 241 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVIE 241 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH
Confidence 99999998765433222 233469999999999999999999999999999999999 8999974321 11122
Q ss_pred HHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 449 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.+.... ....+..+++++.+|+.+||+.||++||||+||.+.|+.
T Consensus 242 ~i~~~~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 242 CITQGR----------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHcCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 221111 112233455789999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=443.07 Aligned_cols=254 Identities=25% Similarity=0.406 Sum_probs=203.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
++|.+.+.||+|+||+||+|+++ +++.||||+++... ....++|.+|++++++++|||||+++|+|.+....+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35666789999999999999864 47899999997543 334567999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc
Q 008828 304 LVYPYMSNGSVASRLKAK---------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 368 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 368 (552)
+|||||++|+|.++++.. .+++|.++..|+.|||+||+|||++ +||||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 999999999999998642 3699999999999999999999998 9999999999999999999
Q ss_pred eEEcccccceecCCCCC-ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHH
Q 008828 369 AVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDW 446 (552)
Q Consensus 369 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 446 (552)
+||+|||+++.....+. .......||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .+.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~ 269 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------TEA 269 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------HHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------HHH
Confidence 99999999987654332 23344669999999999999999999999999999999999 8999974321 111
Q ss_pred HHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 447 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
+..+.... ....+..+++++.+|+.+||+.||++||||+||+++|+..
T Consensus 270 ~~~i~~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 270 IDCITQGR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHHHHTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHcCC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 12221111 1122334557899999999999999999999999999863
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=433.58 Aligned_cols=257 Identities=28% Similarity=0.405 Sum_probs=202.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.+++.+.+.||+|+||+||+|++++ .||||+++..... .....|.+|+.++++++|||||+++|++.. +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4567788999999999999999753 5999999754322 334579999999999999999999999864 56899999
Q ss_pred eccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC-C
Q 008828 308 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-S 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 385 (552)
||++|+|.++++. ...++|..+..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+...... .
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999999999964 45799999999999999999999998 99999999999999999999999999998765332 2
Q ss_pred ceeecccccccccCchhhcc---CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 386 HVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.......||+.|||||++.+ +.|+.++|||||||++|||+||+.||...... ..+....... ...+
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~~~~~~~~~~----~~~p 257 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------DQIIFMVGRG----YASP 257 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHTT----CCCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcC----CCCC
Confidence 23445679999999999964 46899999999999999999999999743221 1111111111 1111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.+ ...+..++..+.+|+.+||+.||++||||.||+++|+.
T Consensus 258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 12233455789999999999999999999999998875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-55 Score=439.21 Aligned_cols=265 Identities=26% Similarity=0.378 Sum_probs=216.8
Q ss_pred cCHHHHHHHhcCCCCCCeeeeeCceEEEEEEECC------CcEEEEEEeccCccCchHHHHHHHHHHHhhccc-ccccee
Q 008828 220 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRL 292 (552)
Q Consensus 220 ~~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-~niv~l 292 (552)
+..++++...++|++.+.||+|+||+||+|.+.. ++.||||+++..........|.+|+.++.++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445566667889999999999999999998642 358999999876555556679999999999965 899999
Q ss_pred eeEeecC-CceeEEEeeccCCChhhhhcc----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcC
Q 008828 293 IGFCMTT-TERLLVYPYMSNGSVASRLKA----------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 355 (552)
Q Consensus 293 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~d 355 (552)
+|+|... ...++|||||++|+|.++++. ...+++..+..|+.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 568999999999999999964 23589999999999999999999999 999999
Q ss_pred CCCCceeeCCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCcccc
Q 008828 356 VKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEF 433 (552)
Q Consensus 356 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~ 433 (552)
|||+|||+++++.+||+|||+|+.+...... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999977544333 3345679999999999999999999999999999999998 8999974
Q ss_pred CcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 434 GKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.... . .....+... .....+..+++++.+++.+||+.||++|||+.||+++|+.
T Consensus 291 ~~~~---~---~~~~~i~~g----------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 291 VKID---E---EFCRRLKEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CCCS---H---HHHHHHHHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHH---H---HHHHHHHcC----------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 3221 0 111111111 1112233345789999999999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=435.07 Aligned_cols=250 Identities=21% Similarity=0.289 Sum_probs=203.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+.++++++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57889999999999999999975 6999999999754332 234578999999999999999999999999999999999
Q ss_pred eccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 308 YMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||++|+|.+++... ..+++..++.|+.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.+... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence 99999999999643 4679999999999999999999999 9999999999999999999999999999876421 1
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||..... .+.+..+.....
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~---------- 242 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-------KNLVLKIISGSF---------- 242 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCC----------
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCCC----------
Confidence 223456799999999999999999999999999999999999999974322 122222221110
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122334779999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=428.37 Aligned_cols=250 Identities=22% Similarity=0.206 Sum_probs=205.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+.|...+.||+|+||+||+|+.+ +|+.||||+++.... ..+|+.+++.++|||||++++++.+.+..++||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45677789999999999999975 689999999975432 24799999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC-ceEEcccccceecCCCCCc-
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCDSH- 386 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~- 386 (552)
|++|+|.++++..+.+++..+..|+.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+.+......
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999999888899999999999999999999999 999999999999999987 6999999999977543221
Q ss_pred ---eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 387 ---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 387 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
.....+||+.|||||++.+..|+.++|||||||++|||+||+.||....... +.. .+.....
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~---~i~~~~~-------- 273 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP----LCL---KIASEPP-------- 273 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC----CHH---HHHHSCC--------
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----HHH---HHHcCCC--------
Confidence 1234579999999999999999999999999999999999999997533211 111 1111110
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.....+...+..+.+++.+||+.||++|||+.|++++|..
T Consensus 274 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 0011233345789999999999999999999999998764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-55 Score=427.41 Aligned_cols=248 Identities=21% Similarity=0.282 Sum_probs=210.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. .......+.+|++++++++|||||++++++.+.+..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46889999999999999999975 68999999996432 2233557899999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC-
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS- 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 385 (552)
||+++|+|.+++...+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999999888899999999999999999999999 999999999999999999999999999998754332
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||..... ......+....
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~----------- 250 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------GLIFAKIIKLE----------- 250 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTC-----------
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCC-----------
Confidence 234567899999999999999999999999999999999999999974322 11111211110
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 498 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 498 (552)
..++...++++.+|+.+||+.||++|||++|++
T Consensus 251 ~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 012223346789999999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-54 Score=426.10 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=208.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+.|+..+.||+|+||+||+|+.+ +|+.||||+++.... .....+.+|+.+++.++|||||++++++.+.+..|+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 45888899999999999999975 699999999965432 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
|++|+|.+++... .+++..+..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+.... ...
T Consensus 153 ~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 227 (346)
T 4fih_A 153 LEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 227 (346)
T ss_dssp CTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred CCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccc
Confidence 9999999999764 599999999999999999999999 99999999999999999999999999999775432 234
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
...+||+.|||||++.+..|+.++|||||||++|||+||+.||..... ...+..+... ..+.+ ..
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~------~~~~~--~~ 292 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDN------LPPRL--KN 292 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHS------SCCCC--SC
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcC------CCCCC--Cc
Confidence 456799999999999999999999999999999999999999974321 1111111111 01111 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....++++.+|+.+||+.||++|||+.|++++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22334788999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=420.66 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=199.0
Q ss_pred CCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeec----CCceeEEE
Q 008828 233 SSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTERLLVY 306 (552)
Q Consensus 233 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~~lv~ 306 (552)
...+.||+|+||+||+|.+. ++..||+|++...... .....|.+|+.++++++|||||++++++.. ....++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999975 5889999999754332 234569999999999999999999999865 34578999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC-CCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|||++|+|.+++.....+++..+..|+.||+.||+|||++ .++|+||||||+|||++ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 9999999999999888899999999999999999999998 12399999999999998 489999999999986432
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......+||+.|||||++.+ .|+.++|||||||++|||+||+.||..... .......+..... .
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~~i~~~~~---------~ 248 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVK---------P 248 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCC---------C
T ss_pred CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHHHHHHcCCC---------C
Confidence 23445679999999998864 699999999999999999999999964221 1111111111100 0
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..++...++++.+|+.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112223578999999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=413.13 Aligned_cols=247 Identities=20% Similarity=0.310 Sum_probs=194.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ......+.+|+++++.++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999964 699999999975432 223457899999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+ +|+|.+++...+.+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+..... .
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--N 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC--C
Confidence 999 689999998888999999999999999999999999 9999999999999999999999999999876532 2
Q ss_pred eeecccccccccCchhhccCCC-CCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.....+||+.|||||++.+..+ +.++||||+||++|||+||+.||..... ......+....
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-------~~~~~~i~~~~----------- 228 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-------PVLFKNISNGV----------- 228 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTC-----------
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCC-----------
Confidence 3345679999999999998876 5799999999999999999999974321 12222221111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..++...++++.+++.+||+.||++|||++|++++
T Consensus 229 ~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01222334778999999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=421.79 Aligned_cols=266 Identities=23% Similarity=0.324 Sum_probs=200.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCC----ceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT----ERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----~~~lv 305 (552)
++|.+.+.||+|+||+||+|++. |+.||||+++.... ....+..|+..+.+++|||||+++|+|...+ ..++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 34667789999999999999985 89999999964321 1222345666667889999999999998654 57899
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ-----CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
||||++|+|.++++.. .++|+.+.+++.|+|+||+|||++ ..++|+||||||+|||++.++++||+|||+++..
T Consensus 80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999999999865 599999999999999999999976 2458999999999999999999999999999877
Q ss_pred CCCCCce---eecccccccccCchhhccC------CCCCccchhHHHHHHHHHHhCCCccccCccccc-------ccchH
Q 008828 381 DHCDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELISGLRALEFGKTANQ-------KGAML 444 (552)
Q Consensus 381 ~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~-------~~~~~ 444 (552)
....... .....||+.|||||++.+. .++.++|||||||++|||+||+.|+........ .....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 5443322 2345699999999999764 467899999999999999999888754322110 00011
Q ss_pred HHHHHHhhhcchhhhccccccCc-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 445 DWVKKIHQEKKLEMLVDKDLKNN-YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
..+...... ...++.+... .....+..+.+|+.+||+.||++||||.||++.|+.
T Consensus 239 ~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 239 EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111111111 1112222111 123456789999999999999999999999999976
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=427.02 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=208.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+.|+..+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+.+|+.++|||||++++++...+..|+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 56888999999999999999975 699999999975432 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
|++|+|.+++... .+++..+..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+.... ...
T Consensus 230 ~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 304 (423)
T 4fie_A 230 LEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 304 (423)
T ss_dssp CTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCB
T ss_pred CCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccc
Confidence 9999999999765 599999999999999999999999 99999999999999999999999999998775432 234
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ...+..+... ..+.+ ..
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~------~~~~~--~~ 369 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDN------LPPRL--KN 369 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHS------CCCCC--SC
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcC------CCCCC--cc
Confidence 556799999999999999999999999999999999999999974321 1111111111 11111 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+.++.+|+.+||+.||++|||+.|++++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 12234778999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-54 Score=420.47 Aligned_cols=249 Identities=23% Similarity=0.294 Sum_probs=199.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC----CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
++|++.+.||+|+||+||+|+.. +++.||||+++.... .....++.+|++++++++|||||++++++.+.+..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56899999999999999999852 478999999975432 1223468899999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
||||+++|+|.+++...+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 999999999999999888899999999999999999999999 99999999999999999999999999998654322
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||..... .+....+... .
T Consensus 181 -~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~---------~- 242 (304)
T 3ubd_A 181 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-------KETMTMILKA---------K- 242 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHC---------C-
T ss_pred -ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-------HHHHHHHHcC---------C-
Confidence 223456799999999999999999999999999999999999999974322 1111221111 0
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKM-----SEVVRM 500 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 500 (552)
..++...++++.+|+.+||+.||++|||+ +|++++
T Consensus 243 -~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 243 -LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 11223345778999999999999999985 566543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-52 Score=415.60 Aligned_cols=311 Identities=71% Similarity=1.124 Sum_probs=262.8
Q ss_pred hhhhhhcCCccccCHHHHHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcccc
Q 008828 208 RREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 287 (552)
Q Consensus 208 ~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ 287 (552)
.......+.++.+++.++....++|.+.+.||+|+||+||+|...+++.||||+++..........+.+|+.++..++||
T Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ 87 (326)
T 3uim_A 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 87 (326)
T ss_dssp -------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCT
T ss_pred cCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCC
Confidence 33444556788899999999999999999999999999999998889999999997655444445789999999999999
Q ss_pred ccceeeeEeecCCceeEEEeeccCCChhhhhccC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee
Q 008828 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 288 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 363 (552)
||+++++++......++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+.++|+||||||+|||+
T Consensus 88 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~ 167 (326)
T 3uim_A 88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 167 (326)
T ss_dssp TBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred CccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence 9999999999999999999999999999999753 349999999999999999999999877799999999999999
Q ss_pred CCCCceEEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccc-cccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN-QKGA 442 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~-~~~~ 442 (552)
+.++.+||+|||+++..............||+.|+|||.+.+..++.++|||||||++|||+||+.||....... ....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 168 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 999999999999999876555555566679999999999999999999999999999999999999997433222 2334
Q ss_pred hHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCchhhhHhhhhhh
Q 008828 443 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEA 518 (552)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 518 (552)
..+|+...........+.+......+....+..+.+++.+||+.||.+|||+.||+++|++....+.|...++.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~ 323 (326)
T 3uim_A 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEM 323 (326)
T ss_dssp HHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-------
T ss_pred HHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHHHh
Confidence 5578877777778888888888888899999999999999999999999999999999999998888876555443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=408.08 Aligned_cols=249 Identities=20% Similarity=0.305 Sum_probs=189.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCC--------
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-------- 300 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-------- 300 (552)
++|++.+.||+|+||+||+|+.+ +|+.||||+++..........+.+|+.++++++|||||++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888899999999999999975 689999999976544444567899999999999999999999987544
Q ss_pred ----ceeEEEeeccCCChhhhhccCCC---CCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcc
Q 008828 301 ----ERLLVYPYMSNGSVASRLKAKPS---LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 373 (552)
Q Consensus 301 ----~~~lv~e~~~~g~L~~~l~~~~~---l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 373 (552)
..++|||||++|+|.+++..... .++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999986544 45567889999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCc-----------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccc
Q 008828 374 FGLAKLLDHCDSH-----------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA 442 (552)
Q Consensus 374 fg~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~ 442 (552)
||+|+.+...... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~------ 232 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME------ 232 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH------
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH------
Confidence 9999876543221 1234569999999999999999999999999999999996 6642110
Q ss_pred hHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 443 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+.... .... +.......+.+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~---------~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 233 RVRTLTDVR---------NLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHHH---------TTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHh---------cCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001111111 1000 01112233567889999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=406.40 Aligned_cols=263 Identities=18% Similarity=0.261 Sum_probs=203.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeec------CCc
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT------TTE 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~------~~~ 301 (552)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+.+|+.++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57889999999999999999975 6999999999754332 234568899999999999999999998764 356
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.|+|||||+ |+|.+++...+.+++..+..|+.||+.||.|||++ +||||||||+|||++.++.+||+|||+++.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 799999996 68999999888999999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC---CceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh
Q 008828 382 HCD---SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457 (552)
Q Consensus 382 ~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (552)
... .......+||+.|+|||++.+. .++.++||||+||++|||+||+.||...........+. .........
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~----~~~g~p~~~ 285 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM----MVLGTPSPA 285 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH----HHHCCCCGG
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHH----HhcCCCChH
Confidence 322 2233456799999999998875 56999999999999999999999997543211111010 000000000
Q ss_pred h-----------h---ccccccCc---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 M-----------L---VDKDLKNN---YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 ~-----------~---~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. . ..+..... ..+..+.++.+|+.+||+.||++|||+.|+++|
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0 00000000 001124678999999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=394.49 Aligned_cols=199 Identities=25% Similarity=0.386 Sum_probs=171.3
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC----CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCce
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 302 (552)
..++|++.+.||+|+||+||+|+.+ +++.||+|.+.... ...++.+|++++..+ +||||+++++++...+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 3578999999999999999999853 46789999986543 245678999999988 699999999999999999
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC-CceEEcccccceecC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLD 381 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~ 381 (552)
++||||+++|+|.++++ .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 99999999999999984 589999999999999999999999 99999999999999876 799999999998654
Q ss_pred CCCC---------------------------ceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCcccc
Q 008828 382 HCDS---------------------------HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEF 433 (552)
Q Consensus 382 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~ 433 (552)
.... ......+||+.|+|||++.+. .|+.++||||+||++|||+||+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 3221 112345699999999999875 589999999999999999999999975
Q ss_pred Cc
Q 008828 434 GK 435 (552)
Q Consensus 434 ~~ 435 (552)
+.
T Consensus 250 ~~ 251 (361)
T 4f9c_A 250 AS 251 (361)
T ss_dssp CS
T ss_pred CC
Confidence 43
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=380.92 Aligned_cols=279 Identities=39% Similarity=0.678 Sum_probs=238.1
Q ss_pred cCHHHHHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC
Q 008828 220 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT 299 (552)
Q Consensus 220 ~~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 299 (552)
+.+.++...+++|+..+.||+|+||+||+|.+++++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34445556778999999999999999999998889999999986543 33456789999999999999999999999999
Q ss_pred CceeEEEeeccCCChhhhhccC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccc
Q 008828 300 TERLLVYPYMSNGSVASRLKAK----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 375 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 375 (552)
+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999644 2589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCC-CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhc
Q 008828 376 LAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 454 (552)
Q Consensus 376 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 454 (552)
+++...... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||...... .......|........
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNNG 263 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS-SCCCHHHHTHHHHTTT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH-HHHHHHHHhhhccccc
Confidence 998654322 22233455899999999999999999999999999999999999999754432 2233445665555566
Q ss_pred chhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 455 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.+...+++.+........+..+.+++.+||+.||++|||+.|++++|+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 6677777777777788899999999999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=406.27 Aligned_cols=251 Identities=24% Similarity=0.271 Sum_probs=202.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHH---HHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTE---VEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e---~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
++|++.++||+|+||+||+|+.+ +|+.||||++++... ......+.+| +.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57899999999999999999975 699999999964321 1122233344 55667778999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
+||||++||+|.+++...+.+++..+..|+.||+.||.|||++ +||||||||+|||++.+|++||+|||+|+.+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999999999999888899999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
. ....+||+.|||||++.. ..|+.++||||+||++|||+||+.||........ ......... .
T Consensus 346 ~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~----~~i~~~i~~---------~ 409 (689)
T 3v5w_A 346 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLT---------M 409 (689)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH----HHHHHHHHH---------C
T ss_pred C---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHhhcC---------C
Confidence 2 345679999999999975 5799999999999999999999999974322111 111111110 0
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRML 501 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L 501 (552)
...++...+.++.+|+.+||+.||.+|++ ++||.+|-
T Consensus 410 --~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 410 --AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred --CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 01123334577899999999999999998 67776543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=407.89 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=208.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|++.+.||+|+||+||+|..+ +|+.||+|+++.... .....+.+|+.+|+.++|||||++++++.+....++||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 57899999999999999999975 699999999975432 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC--CceEEcccccceecCCCCC
Q 008828 309 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY--YEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 309 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~~~~~~~~~~ 385 (552)
|++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 999999999864 45799999999999999999999999 99999999999999854 89999999999987643
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||...... ..+..+.... ..+.
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------~~~~~i~~~~-------~~~~ 376 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCD-------WNMD 376 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTC-------CCCC
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHhCC-------CCCC
Confidence 3344567999999999999999999999999999999999999999743221 1111111110 0011
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.......+.++.+|+.+||+.||++|||+.|+++|
T Consensus 377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112234678999999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=355.11 Aligned_cols=280 Identities=40% Similarity=0.675 Sum_probs=230.7
Q ss_pred CccccCHHHHHHHhcCCCCC------CeeeeeCceEEEEEEECCCcEEEEEEeccCcc---CchHHHHHHHHHHHhhccc
Q 008828 216 NLKRFHFKELQSATSNFSSK------NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVH 286 (552)
Q Consensus 216 ~~~~~~~~e~~~~~~~~~~~------~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h 286 (552)
....|++.++..++++|... +.||+|+||.||+|.. +++.||||++..... ......+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45778999999999999877 8999999999999987 588999999965322 2234578999999999999
Q ss_pred cccceeeeEeecCCceeEEEeeccCCChhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee
Q 008828 287 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK---AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 287 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 363 (552)
|||+++++++...+..++||||+++|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999986 345699999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA 442 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~ 442 (552)
+.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|+|+||+.||....... .
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~ 242 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ---L 242 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS---B
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH---H
Confidence 99999999999999876543222 2334569999999998864 58899999999999999999999997543322 2
Q ss_pred hHHHHHHHhh-hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 443 MLDWVKKIHQ-EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 443 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
...+...... ...+...+++.+ ...+...+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2233333222 222344444433 345677788999999999999999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=375.19 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=209.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC--------CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCC
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTT 300 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~ 300 (552)
++|.+.+.||+|+||+||+|... ++..||||+++..........+.+|+.++..+ +||||+++++++...+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 56888899999999999999852 35679999997654444456799999999999 8999999999999999
Q ss_pred ceeEEEeeccCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC
Q 008828 301 ERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 364 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 364 (552)
..++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence 999999999999999999753 2489999999999999999999999 999999999999999
Q ss_pred CCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccc
Q 008828 365 EYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGA 442 (552)
Q Consensus 365 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~ 442 (552)
.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... .
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~----~ 313 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----E 313 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----G
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----H
Confidence 9999999999999876543322 2233457889999999999999999999999999999999 99998643211 1
Q ss_pred hHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 443 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
. ....... .....+..++..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 314 ~---~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 314 L---FKLLKEG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp H---HHHHHTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H---HHHHhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 1111111 1112223345789999999999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=364.38 Aligned_cols=257 Identities=28% Similarity=0.391 Sum_probs=202.8
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
....+|++.+.||+|+||+||+|.. +++.||||++...... .....+.+|+.++++++||||+++++++......++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456788899999999999999987 4889999999754432 2335688999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCC---CCHHHHHHHHHHHHHHHHHHhhcCCCc--eEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 306 YPYMSNGSVASRLKAKPS---LDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~---l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
|||+++|+|.+++..... +++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999986543 99999999999999999999998 8 999999999999999999999999999754
Q ss_pred CCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 381 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 381 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
.... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... .........
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------~~~~~~~~~------- 254 (309)
T 3p86_A 190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-------QVVAAVGFK------- 254 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHHHHS-------
T ss_pred cccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhc-------
Confidence 4321 2233456999999999999999999999999999999999999999743221 111111000
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
......+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 255 --~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 255 --CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp --CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011122333447799999999999999999999999999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=357.67 Aligned_cols=251 Identities=19% Similarity=0.282 Sum_probs=208.1
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|.+.+.||+|+||+||+|.. .+++.||||++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 35799999999999999999996 4689999999965433 334568899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
|+++|+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++........ .
T Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (297)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence 99999999999765 599999999999999999999999 999999999999999999999999999987654332 2
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
.....||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ........... + ...
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~------~--~~~ 237 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGT------P--ELQ 237 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCS------C--CCS
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC------C--CCC
Confidence 34456999999999999999999999999999999999999999643221 11111111100 0 011
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 468 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+...+..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 122334678999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=367.29 Aligned_cols=255 Identities=26% Similarity=0.391 Sum_probs=208.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC----CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
.+|.+.+.||+|+||+||+|.+. .+..||||+++..........+.+|+.++..++||||+++++++......++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46778899999999999999974 35569999998655444556799999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999999644 5799999999999999999999999 99999999999999999999999999998765433
Q ss_pred Cc--eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 385 SH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 385 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... .........
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------~~~~~~~~~-------- 270 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-------DVISSVEEG-------- 270 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHHHTT--------
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHcC--------
Confidence 22 2223346788999999999999999999999999999999 99998643211 111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.....+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 271 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 271 --YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11112233457899999999999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=359.75 Aligned_cols=269 Identities=17% Similarity=0.211 Sum_probs=215.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCC--ceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~--~~~lv~ 306 (552)
++|.+.+.||+|+||+||+|... +++.||||+++..........+.+|+++++.++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888899999999999999976 589999999976554455667889999999999999999999988665 679999
Q ss_pred eeccCCChhhhhccCC---CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee----CCCCceEEccccccee
Q 008828 307 PYMSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVVGDFGLAKL 379 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~---~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~~~~ 379 (552)
||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997543 399999999999999999999999 99999999999999 7888899999999987
Q ss_pred cCCCCCceeecccccccccCchhhc--------cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHh
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLS--------TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 451 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 451 (552)
...... .....||..|+|||++. +..++.++|||||||++|||+||+.||.......... ..+....
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~ 240 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK---EVMYKII 240 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH---HHHHHHH
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH---HHHHHHh
Confidence 654332 23456999999999986 5678999999999999999999999997543322221 1122221
Q ss_pred hhcc---hhhhc-----------cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 008828 452 QEKK---LEMLV-----------DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL 506 (552)
Q Consensus 452 ~~~~---~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 506 (552)
.... ...+. +..............+.+++.+||+.||++|||++|++++..+...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 1111 00000 0011224557788899999999999999999999999999997544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=363.49 Aligned_cols=256 Identities=27% Similarity=0.411 Sum_probs=208.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|.+.+.||+|+||+||+|... +++.||+|.+.... ......+.+|+.++..++||||+++++++......++||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 46788899999999999999975 68999999885432 23455789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999986 56799999999999999999999999 99999999999999999999999999998764332211
Q ss_pred -------------eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhc
Q 008828 388 -------------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 454 (552)
Q Consensus 388 -------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 454 (552)
.....||+.|+|||.+.+..++.++|||||||++|||++|..|+.............
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~---------- 235 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN---------- 235 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC----------
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh----------
Confidence 114569999999999999999999999999999999999999887533221111000
Q ss_pred chhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 455 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.....+.. .+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 236 -~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 236 -VRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp -HHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -hhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00001111 1122235689999999999999999999999998864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=367.37 Aligned_cols=249 Identities=21% Similarity=0.298 Sum_probs=208.2
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
..+|.+.+.||+|+||.||+|.. .+|+.||||++...... .....+.+|+.+++.++||||+++++++......++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999997 57999999999654322 23456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-- 168 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--
Confidence 9999999999998778899999999999999999999999 99999999999999999999999999998665332
Q ss_pred eeecccccccccCchhhccCCCC-CccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......||+.|+|||++.+..++ .++|||||||++|||+||+.||..... .......... ..
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~---------~~- 231 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------KELRERVLRG---------KY- 231 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHC---------CC-
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhC---------CC-
Confidence 23456799999999999988875 799999999999999999999974321 1111111111 00
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+...+.++.+++.+||+.||.+|||++|++++
T Consensus 232 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 -RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122234678999999999999999999999865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=353.73 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=212.3
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.++|.+.+.||+|+||.||+|..+++..||+|+++.... ...++.+|+.++..++||||+++++++......++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 356888899999999999999999888999999975432 245688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999999754 4599999999999999999999999 99999999999999999999999999998776544333
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... .......... ..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~----------~~ 224 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------EVVLKVSQGH----------RL 224 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTTC----------CC
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-------HHHHHHHcCC----------CC
Confidence 444457788999999999899999999999999999999 99998643221 1111111110 01
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
..+...+..+.+++.+||+.||++|||+.|++++|+...
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111223467899999999999999999999999999753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=372.75 Aligned_cols=255 Identities=28% Similarity=0.408 Sum_probs=199.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC----CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
.+|.+.+.||+|+||.||+|+.. ++..||||+++..........|.+|+.++.+++||||+++++++......++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57899999999999999999864 57789999997654444456799999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999999999764 4799999999999999999999999 99999999999999999999999999998765432
Q ss_pred Cce--eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 385 SHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 385 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .........
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-------~~~~~~i~~--------- 265 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-------QDVIKAVDE--------- 265 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-------HHHHHHHHT---------
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHc---------
Confidence 221 122235778999999999999999999999999999998 9999864321 111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
......+...+..+.+++.+||+.||++||++.|+++.|+..
T Consensus 266 -~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 266 -GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 111112223457899999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=376.55 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=209.2
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
..++|.+.+.||+|+||.||+|.+. +++.||||+++..........|.+|+.+++.++||||+++++++......++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3457888899999999999999986 789999999976543333456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999999754 4699999999999999999999999 999999999999999999999999999986543211
Q ss_pred cee-ecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 386 HVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 386 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
... ....++..|+|||.+.+..++.++|||||||++|||+| |..||...... ........ .
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~----------~ 331 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEK----------G 331 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHT----------T
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHc----------C
Confidence 111 11235778999999999999999999999999999999 99888643211 11111111 1
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.....+..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 1112233345789999999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=374.10 Aligned_cols=265 Identities=26% Similarity=0.391 Sum_probs=214.0
Q ss_pred cCHHHHHHHhcCCCCCCeeeeeCceEEEEEEE------CCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-ccccccee
Q 008828 220 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRL 292 (552)
Q Consensus 220 ~~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l 292 (552)
+...+++...++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34455666678899999999999999999984 246799999997655444556799999999999 79999999
Q ss_pred eeEeecCCc-eeEEEeeccCCChhhhhccCCC------------------------------------------------
Q 008828 293 IGFCMTTTE-RLLVYPYMSNGSVASRLKAKPS------------------------------------------------ 323 (552)
Q Consensus 293 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------ 323 (552)
++++...+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999975432
Q ss_pred ------------------CCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 324 ------------------LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 324 ------------------l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 89999999999999999999999 999999999999999999999999999986643332
Q ss_pred -ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 386 -HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 386 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... ....... ..
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~-~~--------- 312 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLK-EG--------- 312 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHH-HT---------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHH-cC---------
Confidence 23344568999999999999999999999999999999999 999996432211 1111111 11
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.....+...+.++.+++.+||+.||++|||+.|++++|+.
T Consensus 313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 0111222234679999999999999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=364.43 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=204.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|++.+.||+|+||+||+|... +++.||||++...........+.+|+.+++.++||||+++++++......++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888999999999999999976 78999999997554444445688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC-ce
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 387 (552)
+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 99999999999888899999999999999999999999 999999999999999999999999999986543221 22
Q ss_pred eecccccccccCchhhccCCC-CCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 388 TTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....||+.|+|||++.+..+ +.++|||||||++|||+||+.||........ ....|. ... ...
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~----~~~---------~~~ 228 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWK----EKK---------TYL 228 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHHH----TTC---------TTS
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHh----ccc---------ccC
Confidence 334569999999999988775 7899999999999999999999975332111 011111 000 000
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......+..+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011234678899999999999999999999865
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=380.08 Aligned_cols=265 Identities=18% Similarity=0.195 Sum_probs=213.3
Q ss_pred HHHHHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeec
Q 008828 222 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 298 (552)
Q Consensus 222 ~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 298 (552)
+.++....++|++.+.||+|+||+||+|+.+ +++.||+|+++.... ......+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4555566789999999999999999999976 478999999964221 1122348899999999999999999999999
Q ss_pred CCceeEEEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccc
Q 008828 299 TTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 377 (552)
Q Consensus 299 ~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 377 (552)
....++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 9999999999999999999986 56899999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeecccccccccCchhhc-----cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
+..............||+.|+|||++. ...++.++|||||||++|||+||+.||....... ....+..
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~ 295 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMN 295 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHT
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-------HHHhhhh
Confidence 877654444445567999999999997 4578999999999999999999999997533211 1111111
Q ss_pred hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHh
Q 008828 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSL--RPKMSEVVRMLE 502 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~ 502 (552)
... ....+. .....+.++.+++.+||..+|++ ||+++|++++--
T Consensus 296 ~~~--~~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 296 HKE--RFQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp HHH--HCCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred ccc--cccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 000 000011 11113467899999999999888 999999987543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=355.04 Aligned_cols=252 Identities=28% Similarity=0.448 Sum_probs=209.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
++|++.+.||+|+||+||+|...+++.||+|+++.... ...++.+|+.++.+++||||+++++++......++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 56888899999999999999998899999999975432 3457899999999999999999999999999999999999
Q ss_pred cCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 310 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 310 ~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 99999999964 45699999999999999999999999 999999999999999999999999999986643322223
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
....+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||..... .......... ....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-------~~~~~~~~~~----------~~~~ 227 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTG----------FRLY 227 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTT----------CCCC
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhcC----------ccCC
Confidence 33457788999999999999999999999999999999 8999864322 1111111111 1111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 468 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 122234779999999999999999999999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=364.51 Aligned_cols=254 Identities=22% Similarity=0.246 Sum_probs=208.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-----hHHHHHHHHHHHhhccccccceeeeEeecCCce
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 302 (552)
.++|.+.+.||+|+||+||+|..+ +|+.||+|+++...... ....+.+|+.++..++||||+++++++......
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 357888999999999999999976 68999999997543321 245789999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC----ceEEcccccce
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAK 378 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~~~ 378 (552)
++||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999998888899999999999999999999999 999999999999998877 79999999998
Q ss_pred ecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhh
Q 008828 379 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458 (552)
Q Consensus 379 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (552)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+.... .
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-------~~~~~~i~~~~---~ 235 (361)
T 2yab_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANITAVS---Y 235 (361)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTC---C
T ss_pred EcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcC---C
Confidence 765432 23445699999999999999999999999999999999999999974321 11111111110 0
Q ss_pred hccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 459 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 459 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
-.++... ...+..+.+++.+||+.||++|||+.|++++-
T Consensus 236 ~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 236 DFDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred CCCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0011111 12246789999999999999999999998643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=357.30 Aligned_cols=260 Identities=23% Similarity=0.279 Sum_probs=207.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||.||+|... +++.||+|.+....... ....+.+|+.++..++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 57888999999999999999965 68999999986543322 2356889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 9999999999998878899999999999999999999999 9999999999999999999999999999876543333
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... .......... . +....
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~-~-----~~~~~ 234 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDS-V-----PNVTT 234 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSC-C-----CCHHH
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhcc-C-----CCcch
Confidence 344556999999999999999999999999999999999999999753221 1111111110 0 00001
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCC
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRP-KMSEVVRMLEGDG 505 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~ 505 (552)
......+..+.+++.+||+.||++|| +++++.+.|+...
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 11222347799999999999999999 8999999998743
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=362.97 Aligned_cols=251 Identities=23% Similarity=0.246 Sum_probs=209.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||+||+|..+ +|+.||+|+++... .......+.+|+.++..++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888899999999999999976 68999999997532 2233456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|..++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~ 160 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC-CC
Confidence 9999999999998877899999999999999999999999 9999999999999999999999999999854322 22
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... . .
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~---------~--~ 222 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILME---------E--I 222 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHC---------C--C
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-------HHHHHHHHcC---------C--C
Confidence 33456799999999999999999999999999999999999999974321 1111111111 0 1
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRMLE 502 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 502 (552)
.++...+.++.+++.+||+.||++|| +++|++++--
T Consensus 223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 12223447789999999999999999 8999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=353.19 Aligned_cols=262 Identities=19% Similarity=0.258 Sum_probs=213.1
Q ss_pred cccCHHHHHHHhcC----------CCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccc
Q 008828 218 KRFHFKELQSATSN----------FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH 286 (552)
Q Consensus 218 ~~~~~~e~~~~~~~----------~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h 286 (552)
..++++++..+++. |...+.||+|+||.||+|... +|+.||||++..... .....+.+|+.+++.++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCC
Confidence 35677777777654 566678999999999999976 799999999975432 335568899999999999
Q ss_pred cccceeeeEeecCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC
Q 008828 287 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 366 (552)
Q Consensus 287 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 366 (552)
|||+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 99999999999999999999999999999998754 699999999999999999999999 99999999999999999
Q ss_pred CceEEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHH
Q 008828 367 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW 446 (552)
Q Consensus 367 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 446 (552)
+.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ...
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-------~~~ 249 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQA 249 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHH
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHH
Confidence 9999999999987654322 23445699999999999999999999999999999999999999974321 111
Q ss_pred HHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 447 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....... ..+.+. .....+..+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~------~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 MKRLRDS------PPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHS------SCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhcC------CCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 111110 111234678999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=363.90 Aligned_cols=266 Identities=27% Similarity=0.327 Sum_probs=206.0
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCc----eeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE----RLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~----~~l 304 (552)
.++|++.+.||+|+||+||+|... ++.||||+++... .....+..|+.++..++||||+++++++..... .++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 357888999999999999999886 7999999996432 223356678888999999999999999987543 699
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcC-------CCceEEcCCCCCceeeCCCCceEEcccccc
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-------DPKIIHRDVKAANILLDEYYEAVVGDFGLA 377 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 377 (552)
||||+++|+|.+++... .+++..+..++.|++.||.|||+.+ .++|+||||||+|||++.++.+||+|||++
T Consensus 100 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 99999999999999765 4999999999999999999999752 348999999999999999999999999999
Q ss_pred eecCCCCCc-eeecccccccccCchhhccC-----CCCCccchhHHHHHHHHHHhCCCccccCccccccc---------c
Q 008828 378 KLLDHCDSH-VTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKG---------A 442 (552)
Q Consensus 378 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~---------~ 442 (552)
+........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.......... .
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 876543322 22335699999999999863 45678899999999999999999997543221110 0
Q ss_pred hHHHHHHHhhhcchhhhccccccCc-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 443 MLDWVKKIHQEKKLEMLVDKDLKNN-YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
...+....... ...+.+... .....+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 259 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 259 LEDMQEVVVHK-----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp HHHHHHHHTTS-----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhhhhhhhhcc-----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11111111110 011111111 123456779999999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=355.23 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=207.6
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.++|.+.+.||+|+||+||+|.+.++..||+|+++.... ...++.+|+.++..++||||+++++++......++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 457888899999999999999999888999999975432 245788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 999999999975 45799999999999999999999999 99999999999999999999999999998664332222
Q ss_pred eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... ......... ...
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~----------~~~ 240 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQG----------LRL 240 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTT----------CCC
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-------HHHHHHhcc----------cCC
Confidence 233447788999999999999999999999999999998 99998743221 111111111 111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
..+...+..+.+++.+||+.||++|||+.|++++|++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1122234679999999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=358.77 Aligned_cols=257 Identities=27% Similarity=0.378 Sum_probs=211.3
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEE------CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
..++|.+.+.||+|+||.||+|.. .++..||||+++..........+.+|+.+++.++||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 346788889999999999999986 24578999999765544445678999999999999999999999999999
Q ss_pred eeEEEeeccCCChhhhhccCC------------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCC
Q 008828 302 RLLVYPYMSNGSVASRLKAKP------------------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVK 357 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~------------------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 357 (552)
.++||||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 999999999999999997543 389999999999999999999999 99999999
Q ss_pred CCceeeCCCCceEEcccccceecCCCCCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCc
Q 008828 358 AANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 435 (552)
Q Consensus 358 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~ 435 (552)
|+||+++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998765433322 223447889999999999999999999999999999999 999986432
Q ss_pred ccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 436 TANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.. ..... .... .....+...++.+.+++.+||+.||++|||+.|++++|+..
T Consensus 258 ~~----~~~~~---~~~~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 PE----RLFNL---LKTG----------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GG----GHHHH---HHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HHHHH---hhcC----------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 21 11111 1110 11112233457899999999999999999999999999863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=368.70 Aligned_cols=256 Identities=29% Similarity=0.392 Sum_probs=210.7
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC--------CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecC
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 299 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~ 299 (552)
.++|.+.+.||+|+||+||+|... ++..||||+++..........+.+|++++.++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357888899999999999999852 24579999997665444556789999999999 899999999999999
Q ss_pred CceeEEEeeccCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee
Q 008828 300 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 363 (552)
+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 9999999999999999999754 3599999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccccceecCCCCC-ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCccccccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG 441 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~ 441 (552)
+.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||+| |..||.....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~----- 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 9999999999999987654332 22333457889999999999999999999999999999999 9999864321
Q ss_pred chHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 442 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
........... ....+...+.++.+++.+||+.||++|||+.|++++|+..
T Consensus 300 --~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 300 --EELFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp --HHHHHHHHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHHcCC----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111111111 1111222347799999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=361.02 Aligned_cols=254 Identities=23% Similarity=0.396 Sum_probs=200.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCc----EEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
++|++.+.||+|+||+||+|.+. +++ .||+|.++..........+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46888899999999999999964 344 468888865554455667999999999999999999999998754 789
Q ss_pred EEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
|+||+.+|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 9999999999999975 45799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 384 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 384 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
... ......+|..|+|||.+.+..++.++|||||||++|||+| |+.||....... .... +.
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~-------------~~ 233 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSI-------------LE 233 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHH-------------HH
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----HHHH-------------HH
Confidence 322 2233447889999999999999999999999999999999 999997432211 1111 11
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.......+...+..+.+++.+||+.||++|||+.|++++|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111112233446799999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=357.70 Aligned_cols=263 Identities=21% Similarity=0.253 Sum_probs=201.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|++.+.||+|+||+||+|...+++.||+|+++...... ....+.+|+.+++.++||||+++++++......++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 36788899999999999999999889999999997543322 34568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 308 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 308 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
|+++ +|.+.+.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 9985 77777764 44699999999999999999999999 999999999999999999999999999987653322
Q ss_pred eeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh---h----
Q 008828 387 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE---M---- 458 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~---- 458 (552)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ........ ...... .
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~-~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSIL-GTPNPREWPQVQEL 250 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHH-CCCCTTTSGGGTTS
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHH-CCCChHHhhhhhcc
Confidence 2334468999999999876 5689999999999999999999999975433211 11111111 000000 0
Q ss_pred ---------hccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 ---------LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
................++.+++.+||+.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000000111234678999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=362.25 Aligned_cols=259 Identities=26% Similarity=0.373 Sum_probs=209.1
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEE------CCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecC
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 299 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~ 299 (552)
...++|.+.+.||+|+||.||+|.. .++..||||+++..........+.+|+.++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457888999999999999999996 245689999997654444456789999999999 899999999999999
Q ss_pred CceeEEEeeccCCChhhhhccCC-----------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCC
Q 008828 300 TERLLVYPYMSNGSVASRLKAKP-----------------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~~-----------------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl 356 (552)
+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 99999999999999999997542 379999999999999999999999 9999999
Q ss_pred CCCceeeCCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccC
Q 008828 357 KAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 434 (552)
Q Consensus 357 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~ 434 (552)
||+|||++.++.+||+|||++......... ......||+.|+|||.+.+..++.++|||||||++|||+| |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999866543322 2334557889999999999999999999999999999998 99999743
Q ss_pred cccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 435 KTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.... .+...... ......+...+..+.+++.+||+.||.+|||+.|++++|+..
T Consensus 279 ~~~~-------~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 279 PVDA-------NFYKLIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp CCSH-------HHHHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcHH-------HHHHHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 2211 01111111 111112223357899999999999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=353.13 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=197.1
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECC----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
.++|++.+.||+|+||+||+|.... +..||+|.++..........+.+|+.++..++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4578888999999999999999642 45799999876544444567899999999999999999999984 567889
Q ss_pred EEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999999999754 3799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.........+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... ... .......
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~----~~~---~~i~~~~-------- 234 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVI---GRIENGE-------- 234 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHH---HHHHTTC--------
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH----HHH---HHHHcCC--------
Confidence 3333334457789999999999999999999999999999997 88898743221 111 1111110
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
....+...+..+.+++.+||+.||++|||+.|++++|+..
T Consensus 235 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 235 --RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0112233457799999999999999999999999999873
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=379.06 Aligned_cols=258 Identities=23% Similarity=0.380 Sum_probs=212.0
Q ss_pred HHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 225 LQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 225 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
++...++|.+.+.||+|+||+||+|.++++..||||+++... .....|.+|+.++++++||||+++++++. ....++
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 344556788889999999999999999888999999997543 23567999999999999999999999986 567899
Q ss_pred EEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 305 VYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999999999743 3689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
..........++..|+|||.+....++.++|||||||++|||+| |+.||..... .+....+...
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~-------- 401 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PEVIRALERG-------- 401 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHHT--------
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcC--------
Confidence 22122223346789999999999999999999999999999999 9999964321 1111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
.....+..++..+.+++.+||+.||++|||+.+|++.|++..
T Consensus 402 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 402 --YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 111122334578999999999999999999999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=358.01 Aligned_cols=254 Identities=20% Similarity=0.256 Sum_probs=208.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-----hHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
++|.+.+.||+|+||.||+|... +|+.||+|+++...... ....+.+|+.++..++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45888899999999999999976 68999999997543221 3457899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC----ceEEccccccee
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAKL 379 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~~~~ 379 (552)
+||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999998888899999999999999999999999 999999999999999887 899999999987
Q ss_pred cCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...........
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~~----- 233 (326)
T 2y0a_A 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANVSAVN----- 233 (326)
T ss_dssp CCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHTC-----
T ss_pred CCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-------HHHHHHHHhcC-----
Confidence 65332 22345699999999999999999999999999999999999999964321 11111111100
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
...........+..+.+++.+||+.||++|||+.|++++--
T Consensus 234 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 234 --YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp --CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred --CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00000001112467899999999999999999999998543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=364.70 Aligned_cols=252 Identities=22% Similarity=0.272 Sum_probs=202.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhc-cccccceeeeEeecCCceeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~l 304 (552)
.++|++.+.||+|+||+||+|+.+ +++.||+|+++..... .....+..|..++.++ +||||+++++++......++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357888999999999999999976 5789999999754322 2234578899998877 89999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
||||+++|+|..++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.... .
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-P 206 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-T
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc-C
Confidence 999999999999998878899999999999999999999999 999999999999999999999999999985322 2
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccc-cchHHHHHHHhhhcchhhhcccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK-GAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....++....... .
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------~ 278 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------Q 278 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--------C
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--------c
Confidence 22344567999999999999999999999999999999999999999743221111 11111111111111 1
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKM 494 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 494 (552)
..++...+.++.+++.+||+.||++||++
T Consensus 279 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 --IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11233345778999999999999999996
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=363.58 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=211.5
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
..++|.+.+.||+|+||.||+|... +++.||||+++..........+.+|+.++..++||||+++++++.....
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4567889999999999999999974 3488999999865544445679999999999999999999999999999
Q ss_pred eeEEEeeccCCChhhhhccC------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCC
Q 008828 302 RLLVYPYMSNGSVASRLKAK------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVK 357 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 357 (552)
.++||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 99999999999999998752 5699999999999999999999999 99999999
Q ss_pred CCceeeCCCCceEEcccccceecCCCCC-ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCc
Q 008828 358 AANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 435 (552)
Q Consensus 358 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~ 435 (552)
|+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||+| |..||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999976543221 12233458899999999999999999999999999999999 999986432
Q ss_pred ccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 436 TANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
. .......... .. ...+...+..+.+++.+||+.||++|||+.+++++|+...
T Consensus 282 ~-------~~~~~~~~~~-~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 282 H-------EEVIYYVRDG-NI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp H-------HHHHHHHHTT-CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred h-------HHHHHHHhCC-Cc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 1 1111111111 10 1122234467999999999999999999999999999753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=379.49 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=213.8
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEECC-CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
...+|.+.+.||+|+||.||+|.++. +..||||+++.... ....|.+|+.++.+++||||+++++++......++||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 44668888999999999999999874 88999999975432 3567999999999999999999999999999999999
Q ss_pred eeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 307 PYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 307 e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999974 34699999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
........++..|+|||.+....++.++|||||||++|||+| |+.||...... ..... +. ..
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----~~~~~---~~----------~~ 435 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYEL---LE----------KD 435 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHH---HH----------TT
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHH---HH----------cC
Confidence 222333446789999999999999999999999999999999 88888643221 11111 11 11
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCc
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLA 507 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 507 (552)
.....+..++..+.+++.+||+.||++|||+.++++.|+.....
T Consensus 436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 11122334457899999999999999999999999999986433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=365.26 Aligned_cols=252 Identities=26% Similarity=0.335 Sum_probs=203.3
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhc-cccccceeeeEeecCCcee
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~ 303 (552)
..++|++.+.||+|+||+||+|+.+ +++.||||+++... .......+..|..++..+ +||||+++++++......+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3468899999999999999999975 58999999997532 122344678899999987 6999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
+||||+++|+|..++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999999999998878899999999999999999999999 9999999999999999999999999999854322
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+... .
T Consensus 178 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~---------~ 240 (353)
T 3txo_A 178 -GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILND---------E 240 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC---------C
T ss_pred -CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC---------C
Confidence 22344567999999999999999999999999999999999999999743221 111111111 1
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKM------SEVVRML 501 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~L 501 (552)
..++...+..+.+++.+||+.||++||++ .|++++-
T Consensus 241 --~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 241 --VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred --CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 11222344778999999999999999998 7776543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=356.38 Aligned_cols=252 Identities=19% Similarity=0.233 Sum_probs=206.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|.+.+.||+|+||+||+|... +++.||+|.++... .....+.+|+.++..++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 357888999999999999999976 58899999996432 234568899999999999999999999999999999999
Q ss_pred eccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC--CCceEEcccccceecCCCC
Q 008828 308 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--YYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 308 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~ 384 (552)
|+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999999765 4799999999999999999999999 9999999999999997 7899999999998775432
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ............ ..+...
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~---~~~~~~ 226 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAEY---TFDEEA 226 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCC---CCCHHH
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHHcCCC---CCChhh
Confidence 33445699999999999988899999999999999999999999974322 111111111110 000000
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
. ...+.++.+++.+||+.||++|||+.|++++-
T Consensus 227 ~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 227 F----KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp H----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred h----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 1 11246789999999999999999999999743
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=356.59 Aligned_cols=256 Identities=27% Similarity=0.388 Sum_probs=210.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE------CCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCc
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~ 301 (552)
.++|.+.+.||+|+||.||+|.. .+++.||+|+++..........+.+|+.++.++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46788889999999999999985 246799999997655444456799999999999 89999999999999999
Q ss_pred eeEEEeeccCCChhhhhccCC------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee
Q 008828 302 RLLVYPYMSNGSVASRLKAKP------------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~------------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 363 (552)
.++||||+++|+|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 999999999999999997543 489999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCccccccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG 441 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~ 441 (552)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 255 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--- 255 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh---
Confidence 99999999999999876544332 2234457889999999999999999999999999999999 999986432211
Q ss_pred chHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 442 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
. ....... ......+...+..+.+++.+||+.||.+|||+.|++++|+.
T Consensus 256 ---~-~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 256 ---K-FYKMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp ---H-HHHHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---H-HHHHhcc---------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 0 1111111 01111122234779999999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=368.93 Aligned_cols=255 Identities=27% Similarity=0.381 Sum_probs=207.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
++|.+.+.||+|+||+||+|.+. ++..||||+++..........+.+|+.++..++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56788899999999999999953 467899999976544445567889999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC---ceEEcc
Q 008828 304 LVYPYMSNGSVASRLKAK-------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVGD 373 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~-------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~D 373 (552)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999999642 3589999999999999999999999 999999999999999554 599999
Q ss_pred cccceecCCCC-CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHh
Q 008828 374 FGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIH 451 (552)
Q Consensus 374 fg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 451 (552)
||+++...... ........||+.|+|||.+.+..++.++|||||||++|||+| |..||..... ........
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-------~~~~~~i~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLEFVT 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH
Confidence 99997542211 122234558899999999999999999999999999999998 9999864321 11111111
Q ss_pred hhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 452 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
... ....+...+..+.+++.+||+.||++|||+.||+++|+..
T Consensus 301 ~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 1111223346789999999999999999999999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=351.54 Aligned_cols=259 Identities=27% Similarity=0.385 Sum_probs=201.2
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhh--ccccccceeeeEeecC----Cce
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLIGFCMTT----TER 302 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~h~niv~l~~~~~~~----~~~ 302 (552)
.++|.+.+.||+|+||+||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 45788999999999999999998 5899999998643 23455667777665 7899999999986543 457
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCceEEcCCCCCceeeCCCCceEEccc
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH--------EQCDPKIIHRDVKAANILLDEYYEAVVGDF 374 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 374 (552)
++||||+++|+|.++++.. .+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHhhc-ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence 8999999999999999654 6999999999999999999999 76 9999999999999999999999999
Q ss_pred ccceecCCCCCce---eecccccccccCchhhccC------CCCCccchhHHHHHHHHHHhC----------CCccccCc
Q 008828 375 GLAKLLDHCDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELISG----------LRALEFGK 435 (552)
Q Consensus 375 g~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~elltg----------~~p~~~~~ 435 (552)
|+++......... .....||+.|+|||.+.+. .++.++|||||||++|||+|| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9998765433322 2234699999999999876 455799999999999999999 67765432
Q ss_pred ccccccchHHHHHHHhhhcchhhhcccccc-CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 436 TANQKGAMLDWVKKIHQEKKLEMLVDKDLK-NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
..... ............ ..+... .......+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 238 ~~~~~--~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 238 PNDPS--FEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CSSCC--HHHHHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcc--hhhhhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 21111 111111111111 011111 11234567889999999999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=369.90 Aligned_cols=266 Identities=20% Similarity=0.216 Sum_probs=213.2
Q ss_pred HHHHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecC
Q 008828 223 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT 299 (552)
Q Consensus 223 ~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 299 (552)
.++....++|.+.+.||+|+||+||+|+.+ +++.||+|+++.... ......+.+|+.++..++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455688999999999999999999976 588999999964221 12233578999999999999999999999999
Q ss_pred CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 300 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
...++||||+++|+|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 9999999999999999999764 599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeecccccccccCchhhccCC----CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcc
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 455 (552)
............+||+.|+|||++.+.. ++.++|||||||++|||+||+.||...... .....+.....
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~ 290 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNHKN 290 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHH
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------hHHHHHHhccc
Confidence 7644433344667999999999998765 789999999999999999999999743221 11111111100
Q ss_pred hhhhccccccCcCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHhcCCC
Q 008828 456 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSL--RPKMSEVVRMLEGDGL 506 (552)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~~~~~ 506 (552)
. +..+ .....+.++.+++.+||+.+|.+ ||+++||+++---...
T Consensus 291 ~--~~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 291 S--LTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp H--CCCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred c--ccCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 0 0000 00122477899999999999998 9999999987654433
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=354.77 Aligned_cols=247 Identities=27% Similarity=0.346 Sum_probs=207.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||+||+|+.. +|+.||+|+++... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888899999999999999975 68999999997532 1223456788999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 9999999999999888899999999999999999999999 9999999999999999999999999999876432
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... ..
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~---------~~-- 220 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNA---------EL-- 220 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHC---------CC--
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhC---------CC--
Confidence 2345699999999999999999999999999999999999999974321 1111111111 10
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRML 501 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 501 (552)
.++...+.++.+++.+||+.||++|| +++|++++-
T Consensus 221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 12223347789999999999999999 888888653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=356.24 Aligned_cols=263 Identities=23% Similarity=0.338 Sum_probs=190.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|++.+.||+|+||+||+|... +++.||+|+++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999965 6899999999765444444578899999999999999999999999999999999
Q ss_pred eccCCChhhhhccC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 308 YMSNGSVASRLKAK------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 308 ~~~~g~L~~~l~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
|++ |+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5999888632 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhc---chh
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK---KLE 457 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 457 (552)
.... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ...+....... ...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ----LKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCTTTCG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCChhHhh
Confidence 3222 22344689999999999764 689999999999999999999999975432111 11111100000 000
Q ss_pred h---h--ccccc------------cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 M---L--VDKDL------------KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 ~---~--~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. . ..+.. ........+.++.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0 00000 000011234679999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=350.75 Aligned_cols=264 Identities=19% Similarity=0.255 Sum_probs=202.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|++.+.||+|+||+||+|... +++.||+|+++...... ....+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999975 68999999997544332 34568899999999999999999999999999999999
Q ss_pred eccCCChhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 308 YMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 308 ~~~~g~L~~~l-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
|+++ ++.+.+ .....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-R 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-S
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-c
Confidence 9986 555544 4467899999999999999999999999 99999999999999999999999999998765322 2
Q ss_pred eeecccccccccCchhhccCC-CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh--cc---hhhhc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE--KK---LEMLV 460 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~ 460 (552)
......||..|+|||.+.+.. ++.++|||||||++|||+||..|+........ ............ .. .....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhcccc
Confidence 234456899999999998766 89999999999999999999888754322111 011111111000 00 00000
Q ss_pred c---------ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 461 D---------KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 461 ~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+ ...........+..+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000011122345778999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=356.90 Aligned_cols=249 Identities=20% Similarity=0.309 Sum_probs=198.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCC--------
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-------- 300 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-------- 300 (552)
++|++.+.||+|+||.||+|+.. +++.||||+++..........+.+|+.++++++||||+++++++....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 56888899999999999999986 799999999976554455667999999999999999999999986543
Q ss_pred -------------------------------------------------ceeEEEeeccCCChhhhhccCC---CCCHHH
Q 008828 301 -------------------------------------------------ERLLVYPYMSNGSVASRLKAKP---SLDWAT 328 (552)
Q Consensus 301 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~---~l~~~~ 328 (552)
..++||||+++|+|.+++.... ..++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 2789999999999999997654 356667
Q ss_pred HHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC-----------ceeecccccccc
Q 008828 329 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-----------HVTTAVRGTVGH 397 (552)
Q Consensus 329 ~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~gt~~y 397 (552)
++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 899999999999999999 999999999999999999999999999987754321 122334699999
Q ss_pred cCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHH
Q 008828 398 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMV 477 (552)
Q Consensus 398 ~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 477 (552)
+|||.+.+..++.++|||||||++|||++|..|+... ........ .. ..+.........+.
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---------~~~~~~~~---------~~-~~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---------VRIITDVR---------NL-KFPLLFTQKYPQEH 303 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---------HHHHHHHH---------TT-CCCHHHHHHCHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---------HHHHHHhh---------cc-CCCcccccCChhHH
Confidence 9999999999999999999999999999987665310 00000000 00 00111223346779
Q ss_pred HHHHHccCCCCCCCCCHHHHHHH
Q 008828 478 QVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 478 ~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+++.+||+.||++|||+.|++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=361.98 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=211.4
Q ss_pred HHHHhcCCCCCCeeeeeCceEEEEEEECC------CcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEee
Q 008828 225 LQSATSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCM 297 (552)
Q Consensus 225 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 297 (552)
++...++|.+.+.||+|+||.||+|.... ...||+|.++..........+.+|+.++..+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34455788999999999999999999642 2479999997655444556789999999999 8999999999999
Q ss_pred cCCceeEEEeeccCCChhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee
Q 008828 298 TTTERLLVYPYMSNGSVASRLKA--------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 298 ~~~~~~lv~e~~~~g~L~~~l~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 363 (552)
..+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 99999999999999999999863 34689999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCccccccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG 441 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~ 441 (552)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||.......
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--- 274 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--- 274 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---
Confidence 99999999999999866433322 2234457889999999999999999999999999999999 888886432211
Q ss_pred chHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 442 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
......... .....+...+..+.+++.+||+.||.+|||+.|++++|+..
T Consensus 275 ----~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 275 ----KFYKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ----HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111111111 11111222347789999999999999999999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=351.85 Aligned_cols=263 Identities=21% Similarity=0.302 Sum_probs=200.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|.+.+.||+|+||+||+|...+++.||+|+++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468888999999999999999988999999999654322 2235688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+++ +|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-cc
Confidence 985 89888875 36799999999999999999999999 99999999999999999999999999998664322 12
Q ss_pred eecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh--cc---hhh--h
Q 008828 388 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE--KK---LEM--L 459 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~---~~~--~ 459 (552)
.....||+.|+|||.+.+. .++.++|||||||++|||+||+.||........ ........... .. ... .
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhcccc
Confidence 2334589999999999764 589999999999999999999999975332111 11111110000 00 000 0
Q ss_pred ccccc-------cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 460 VDKDL-------KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 460 ~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.++.. ...+....+..+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 001112234778999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=359.52 Aligned_cols=247 Identities=20% Similarity=0.285 Sum_probs=204.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.+|.+.+.||+|+||+||+|.. .+++.||+|++.... .......+.+|+.+++.++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5688899999999999999997 478999999986432 1122346889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+ +|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 999 689999998777899999999999999999999999 99999999999999999999999999998665322
Q ss_pred eeecccccccccCchhhccCCC-CCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.......... .+... .
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~i~~~--~ 224 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------KVNSC--V 224 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------CCCSS--C
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------HHHcC--C
Confidence 2334569999999999988776 789999999999999999999997533221110 00000 0
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11222334778999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.40 Aligned_cols=253 Identities=20% Similarity=0.270 Sum_probs=207.4
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.++|.+.+.||+|+||.||+|..+ +++.||+|+++..... .....+.+|+.++..++||||+++++++......++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457889999999999999999975 6899999999754332 23456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC---CceEEcccccceecCCC
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY---YEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~~~~~~ 383 (552)
||+++|+|.+.+.....+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++......
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999998888899999999999999999999999 99999999999999865 45999999999876532
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.... . +
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~i~~~~-~----~-- 248 (362)
T 2bdw_A 185 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGA-Y----D-- 248 (362)
T ss_dssp C--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTC-C----C--
T ss_pred c--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCC-C----C--
Confidence 2 23345699999999999999999999999999999999999999974321 11111111110 0 0
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.........+.++.+++.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000111234678999999999999999999999865
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=350.91 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=197.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-------------------------chHHHHHHHHHHHhh
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-------------------------GGEIQFQTEVEMISL 283 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~~ 283 (552)
++|.+.+.||+|+||.||+|... +++.||||+++..... .....+.+|+.+++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888999999999999999965 6889999999654321 113468899999999
Q ss_pred ccccccceeeeEeec--CCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCce
Q 008828 284 AVHRNLLRLIGFCMT--TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 361 (552)
Q Consensus 284 ~~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni 361 (552)
++||||+++++++.. ....++||||+++|+|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL 168 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence 999999999999986 5678999999999999887654 4699999999999999999999999 999999999999
Q ss_pred eeCCCCceEEcccccceecCCCCCceeecccccccccCchhhccCC---CCCccchhHHHHHHHHHHhCCCccccCcccc
Q 008828 362 LLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISGLRALEFGKTAN 438 (552)
Q Consensus 362 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~ 438 (552)
|++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-- 245 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI-- 245 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred EECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH--
Confidence 999999999999999987654322 234456999999999998765 37889999999999999999999964321
Q ss_pred cccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 439 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+....... . .........+..+.+++.+||+.||++|||+.|++++
T Consensus 246 -----~~~~~~~~~~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 -----MCLHSKIKSQ-A--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp -----HHHHHHHHHC-C--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred -----HHHHHHHhcc-c--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1111111111 0 0000011234678999999999999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=363.05 Aligned_cols=250 Identities=24% Similarity=0.295 Sum_probs=206.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||.||+|... +++.||+|+++... .......+.+|+.++..++||||+++++++......++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888899999999999999975 58899999996432 2233457889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+.+|+|..++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--T 169 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--C
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC--C
Confidence 9999999999999888899999999999999999999999 9999999999999999999999999999876532 2
Q ss_pred eeecccccccccCchhhcc---CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 387 VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
......||+.|+|||++.. ..++.++|||||||++|||+||+.||....... ...........
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~~~~~~~~---------- 235 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----SKEIVHTFETT---------- 235 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC----HHHHHHHHHHC----------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc----HHHHHHHHhhc----------
Confidence 3345679999999999974 458999999999999999999999997432211 11111111100
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPK-MSEVVR 499 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 499 (552)
...++...+..+.+++.+||+.||++||+ +.++.+
T Consensus 236 -~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 -VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01122334578999999999999999998 777765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=373.62 Aligned_cols=256 Identities=27% Similarity=0.371 Sum_probs=205.8
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
...++|.+.+.||+|+||.||+|.++++..||||+++.... ....|.+|+.++++++||||+++++++.. ...++||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 34567888899999999999999998888899999975432 34578999999999999999999999876 6789999
Q ss_pred eeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 307 PYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 307 e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999974 35699999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
........++..|+|||.+....++.++|||||||++|||+| |+.||..... .+........
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~---------- 397 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERG---------- 397 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTT----------
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcC----------
Confidence 233334457889999999999999999999999999999999 8999864321 1111111111
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
.....+..++..+.+++.+||+.||++|||+.++++.|+...
T Consensus 398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 111223344578999999999999999999999999999753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=367.59 Aligned_cols=255 Identities=19% Similarity=0.243 Sum_probs=207.2
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
..++|.+.+.||+|+||+||+|... +|+.||+|++...... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3467889999999999999999864 6899999999754322 2345688999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC---CCCceEEcccccceecCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~ 382 (552)
|||+++|+|.+.+.....+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999999999998888899999999999999999999999 999999999999998 568899999999987654
Q ss_pred CCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ......+.... . +
T Consensus 166 ~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~-~----~- 231 (444)
T 3soa_A 166 EQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-------HRLYQQIKAGA-Y----D- 231 (444)
T ss_dssp TCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTC-C----C-
T ss_pred CCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhCC-C----C-
Confidence 322 23345699999999999999999999999999999999999999964321 11111111110 0 0
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.........+.++.+++.+||+.||++|||+.|++++
T Consensus 232 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 -FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0011112234678999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=345.17 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=195.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccC---chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI---GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||.||+|.+. ++.||||+++..... .....+.+|+.+++.++||||+++++++......++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 56888899999999999999976 889999998754322 22456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC--------CCceEEcccccce
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--------YYEAVVGDFGLAK 378 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--------~~~~kl~Dfg~~~ 378 (552)
||+++++|.+++.. ..+++..+..++.|++.||.|||++...+|+||||||+||+++. ++.+||+|||+++
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 86 EFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp ECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 99999999999864 46999999999999999999999981112999999999999986 7789999999998
Q ss_pred ecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhh
Q 008828 379 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458 (552)
Q Consensus 379 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (552)
...... .....||+.|+|||.+.+..++.++||||||+++|+|+||+.||...... ......
T Consensus 165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~-------- 226 (271)
T 3dtc_A 165 EWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-------AVAYGV-------- 226 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHH--------
T ss_pred cccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHhh--------
Confidence 654322 22346899999999999999999999999999999999999999743211 001111
Q ss_pred hccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 459 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 459 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.........+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus 227 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 227 -AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11111112233345789999999999999999999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=370.06 Aligned_cols=248 Identities=28% Similarity=0.388 Sum_probs=204.9
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCC-ceeEEE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-ERLLVY 306 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-~~~lv~ 306 (552)
..++|.+.+.||+|+||.||+|.+. ++.||||+++... ....|.+|+.++++++||||+++++++.... ..++||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 3467888899999999999999986 7899999997643 3457899999999999999999999987765 789999
Q ss_pred eeccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 307 PYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 9999999999997543 479999999999999999999999 9999999999999999999999999999854322
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
.....++..|+|||.+.+..++.++|||||||++|||+| |+.||...... .. ...+...
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~---~~~i~~~---------- 402 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DV---VPRVEKG---------- 402 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT----TH---HHHHHTT----------
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HH---HHHHHcC----------
Confidence 122347889999999999999999999999999999999 99998743221 11 1111111
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.....+..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus 403 ~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1112233445789999999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=349.51 Aligned_cols=253 Identities=28% Similarity=0.448 Sum_probs=208.7
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
..++|.+.+.||+|+||.||+|...++..||+|.++.... ....+.+|++++..++||||+++++++. .+..++|||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 3467888999999999999999998888999999975432 3457899999999999999999999986 456899999
Q ss_pred eccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 308 YMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999997543 699999999999999999999999 999999999999999999999999999987764333
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
.......++..|+|||.+.+..++.++||||||+++|||+| |+.||..... .......... .
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~----------~ 227 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERG----------Y 227 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTT----------C
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------HHHHHHHhcc----------c
Confidence 33334457789999999998999999999999999999999 8888864321 1111111111 0
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 111122334789999999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=358.38 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=203.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcE----EEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTV----VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
++|.+.+.||+|+||+||+|.+. +++. ||+|.+...........+.+|+.++..++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46788899999999999999964 3443 88888865443334456778999999999999999999986 566889
Q ss_pred EEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
||||+.+|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999999764 5799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 384 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 384 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
... ......||..|+|||.+.+..++.++|||||||++|||+| |+.||...... .... .....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~---~~~~~-------- 233 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----EVPD---LLEKG-------- 233 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT----HHHH---HHHTT--------
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH----HHHH---HHHcC--------
Confidence 322 2344568889999999999999999999999999999999 99999753221 1111 11111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
.....+...+..+.+++.+||+.||++|||+.|++++|+...
T Consensus 234 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 234 --ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp --CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred --CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011112223356889999999999999999999999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=355.57 Aligned_cols=251 Identities=23% Similarity=0.273 Sum_probs=202.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 305 (552)
++|.+.+.||+|+||.||+|+.+ +++.||+|+++...... ....+.+|..++.++ +||||+++++++......++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888899999999999999976 58899999997654322 234578899999887 899999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|||+++|+|.+++.....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~- 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence 99999999999998777899999999999999999999999 99999999999999999999999999998543222
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccc-cchHHHHHHHhhhcchhhhccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK-GAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+....... .
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--------~- 235 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------Q- 235 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--------C-
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--------C-
Confidence 2334567999999999999999999999999999999999999999743221111 01111111111111 1
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKM 494 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 494 (552)
..++...+..+.+++.+||+.||++||++
T Consensus 236 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 -IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11223345778999999999999999996
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=356.12 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=209.6
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC--------CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecC
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 299 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~ 299 (552)
.++|.+.+.||+|+||+||+|... ++..||+|+++..........+.+|+.++.++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467888999999999999999863 46789999997655444456789999999999 899999999999999
Q ss_pred CceeEEEeeccCCChhhhhccCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee
Q 008828 300 TERLLVYPYMSNGSVASRLKAKP----------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 363 (552)
+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 99999999999999999997543 389999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCccccccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG 441 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~ 441 (552)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----- 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence 99999999999999876543322 1223347889999999999999999999999999999999 9999864321
Q ss_pred chHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 442 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
........... ....+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 266 --~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 266 --EELFKLLKEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp --HHHHHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHhcCC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111110 1112223346799999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=351.01 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=203.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-----CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC--Cce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 302 (552)
++|++.+.||+|+||+||+|++ .+++.||||+++... ......+.+|+.++..++||||+++++++... ...
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 5688889999999999999984 258899999997543 23345789999999999999999999998653 558
Q ss_pred eEEEeeccCCChhhhhccCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 303 LLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 99999999999999997643 599999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh------
Q 008828 382 HCDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE------ 453 (552)
Q Consensus 382 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 453 (552)
..... ......++..|+|||.+.+..++.++||||||+++|||+||..|+...... +.......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQGQMI 237 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--------HHHHHCTTCCTHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--------HHhhhcCccccchh
Confidence 43221 223344778899999999999999999999999999999999888642210 00000000
Q ss_pred -cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 454 -KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 454 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
...............+..++.++.+++.+||+.||++|||+.|+++.|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 00011111111122233445789999999999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=357.62 Aligned_cols=248 Identities=20% Similarity=0.237 Sum_probs=208.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||.||+|+.. +|+.||+|+++... .......+.+|+.++..++||||+++++++......++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56888899999999999999975 68999999996532 1233456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 9999999999998877899999999999999999999999 9999999999999999999999999999876532
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... . .
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~---------~--~ 255 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSG---------K--V 255 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHC---------C--C
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-------HHHHHHHHcC---------C--C
Confidence 2345699999999999999999999999999999999999999974321 1111111111 0 0
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRMLE 502 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~ 502 (552)
.++...+..+.+++.+||+.||++||+ ++|++++--
T Consensus 256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 122233477899999999999999998 888876543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=346.14 Aligned_cols=252 Identities=28% Similarity=0.430 Sum_probs=209.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
++|.+.+.||+|+||.||+|...+++.||+|+++.... ....+.+|+.++..++||||+++++++......++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 56788899999999999999998889999999976433 2457899999999999999999999999999999999999
Q ss_pred cCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 310 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 310 ~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999999754 5689999999999999999999999 999999999999999999999999999986543222222
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
....++..|+|||.+.+..++.++||||||+++|||+| |+.||..... ........... ...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~i~~~~----------~~~ 225 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGF----------RLY 225 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTC----------CCC
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-------HHHHHHHhcCC----------cCC
Confidence 33447788999999999999999999999999999999 8988864321 11111111110 011
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 468 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 122234778999999999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=369.59 Aligned_cols=265 Identities=22% Similarity=0.223 Sum_probs=210.7
Q ss_pred CHHHHHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEee
Q 008828 221 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCM 297 (552)
Q Consensus 221 ~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~ 297 (552)
.+++.....++|++.+.||+|+||+||+|+.+ +|+.||+|++++... ......+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555556788999999999999999999975 689999999964321 112335789999999999999999999999
Q ss_pred cCCceeEEEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccc
Q 008828 298 TTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 376 (552)
Q Consensus 298 ~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 376 (552)
+.+..++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999999764 4799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeecccccccccCchhhc-------cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHH
Q 008828 377 AKLLDHCDSHVTTAVRGTVGHIAPEYLS-------TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 449 (552)
Q Consensus 377 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 449 (552)
++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~ 281 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-------ETYGK 281 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-------HHHHH
Confidence 9877654433344567999999999997 356899999999999999999999999753321 11111
Q ss_pred HhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHHHh
Q 008828 450 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLR---PKMSEVVRMLE 502 (552)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~L~ 502 (552)
+..... ....+ ......+.++.+++.+||. +|++| |+++|++++--
T Consensus 282 i~~~~~--~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 282 IVHYKE--HLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp HHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred HHhccc--CcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 111000 00001 1112234789999999999 99998 58999986543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=355.65 Aligned_cols=266 Identities=25% Similarity=0.353 Sum_probs=209.0
Q ss_pred CCCCCeeeeeCceEEEEEEEC-----CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC--CceeE
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLL 304 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~l 304 (552)
|.+.+.||+|+||+||++.+. +++.||||+++..........+.+|+.+++.++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998753 58899999998654444456789999999999999999999999874 56789
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
||||+++|+|.+++.... +++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 113 v~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 999999999999997654 99999999999999999999999 99999999999999999999999999998876543
Q ss_pred Cc--eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 385 SH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 385 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.. ......+|..|+|||.+.+..++.++||||||+++|||+||+.||......... ...+................
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE--LIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--HHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh--hhcccccchhHHHHHHHHhc
Confidence 32 223345788899999999999999999999999999999999998742211000 00000000000111112222
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
......+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 22222334455789999999999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=358.94 Aligned_cols=253 Identities=22% Similarity=0.294 Sum_probs=200.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccc--cccceeeeEeecCCceeEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVH--RNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h--~niv~l~~~~~~~~~~~lv 305 (552)
.++|.+.+.||+|+||.||+|...+++.||||++....... ....+.+|+.++..++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45688899999999999999999889999999997543322 33568899999999976 9999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|| +.+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.......
T Consensus 88 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred Ee-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 99 55789999999888999999999999999999999999 999999999999997 67899999999987654322
Q ss_pred c-eeecccccccccCchhhcc-----------CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh
Q 008828 386 H-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 453 (552)
Q Consensus 386 ~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 453 (552)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~------- 229 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISK------- 229 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHH-------
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh------HHHH-------
Confidence 2 2334569999999999865 6789999999999999999999999963211 0111
Q ss_pred cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 454 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
...+.++.....++...+..+.+++.+||+.||++|||+.|++++.
T Consensus 230 --~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 230 --LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp --HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1112222222223333346789999999999999999999998753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=360.67 Aligned_cols=251 Identities=25% Similarity=0.326 Sum_probs=206.4
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhc-cccccceeeeEeecCCce
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 302 (552)
...++|.+.+.||+|+||.||+|+.+ +++.||+|+++.... ......+..|..++..+ +||||+++++++......
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45578999999999999999999976 589999999975421 22345677899998876 899999999999999999
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999998877899999999999999999999999 999999999999999999999999999985432
Q ss_pred CCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 171 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~-------- 234 (345)
T 1xjd_A 171 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDN-------- 234 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC--------
T ss_pred CC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHhCC--------
Confidence 22 223456799999999999999999999999999999999999999974321 11111111110
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMS-EVVR 499 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 499 (552)
..++...+.++.+++.+||+.||++||++. |+.+
T Consensus 235 ---~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 ---PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 112223347789999999999999999997 6654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=347.82 Aligned_cols=255 Identities=22% Similarity=0.374 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECC----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
.++|.+.+.||+|+||+||+|.+.+ +..||+|.++..........+.+|+.+++.++||||+++++++.. +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678888999999999999998643 346999999765444456679999999999999999999999765 45789
Q ss_pred EEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 9999999999999975 44699999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.........+++.|+|||.+.+..++.++||||||+++|||+| |+.||....... ... ......
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----~~~---~~~~~~-------- 231 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIG---VLEKGD-------- 231 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG----HHH---HHHHTC--------
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH----HHH---HHhcCC--------
Confidence 3333344557889999999999999999999999999999998 999997432211 111 111110
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
....+...++.+.+++.+||+.||++|||+.|++++|+..
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 232 --RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0111222346799999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=355.00 Aligned_cols=265 Identities=26% Similarity=0.379 Sum_probs=213.5
Q ss_pred CHHHHHHHhcCCCCCCeeeeeCceEEEEEEE------CCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceee
Q 008828 221 HFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLI 293 (552)
Q Consensus 221 ~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~ 293 (552)
...++....++|.+.+.||+|+||+||+|.. .+++.||||+++..........+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444455567899999999999999999984 246899999997655444456789999999999 799999999
Q ss_pred eEeecCC-ceeEEEeeccCCChhhhhccCCC----------------CCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCC
Q 008828 294 GFCMTTT-ERLLVYPYMSNGSVASRLKAKPS----------------LDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 356 (552)
Q Consensus 294 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl 356 (552)
+++...+ ..++||||+++|+|.+++..... +++..+..++.|++.||.|||+. +|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence 9988755 48999999999999999976543 89999999999999999999999 9999999
Q ss_pred CCCceeeCCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccC
Q 008828 357 KAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 434 (552)
Q Consensus 357 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~ 434 (552)
||+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999999999999999999876543332 2334558899999999999999999999999999999998 99998643
Q ss_pred cccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 435 KTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.... .......... ....+...+..+.+++.+||+.||.+|||+.|++++|+..
T Consensus 255 ~~~~------~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 255 KIDE------EFCRRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCSH------HHHHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhH------HHHHHhccCc----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2211 1111111110 0111222346789999999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.36 Aligned_cols=253 Identities=23% Similarity=0.254 Sum_probs=196.6
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|.+.+.||+|+||+||+|+.. +++.||||++...... ...+.+|+.+++.++||||+++++++......++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 357888999999999999999976 6899999999754432 3467899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc--eEEcccccceecCCCCC
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--AVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~~~~~~~~~~ 385 (552)
|+++|+|.+++...+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++.....
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 999999999998777899999999999999999999999 9999999999999987765 999999999743321
Q ss_pred ceeecccccccccCchhhccCCCCCc-cchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEK-TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
.......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ....+...... ..
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~~~~~~---------~~ 239 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRKTIQRILSV---------KY 239 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHHHHHHHHTT---------CC
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhcC---------CC
Confidence 22234569999999999988887665 8999999999999999999975332211 11111111111 11
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
........+..+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000011123678999999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=352.93 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=184.4
Q ss_pred CCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecCCceeEEEeeccCC
Q 008828 235 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYMSNG 312 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~~g 312 (552)
.+.||+|+||+||+|... +++.||||++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999975 6899999999643 2456788999999997 999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC---ceEEcccccceecCCCCCceee
Q 008828 313 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVGDFGLAKLLDHCDSHVTT 389 (552)
Q Consensus 313 ~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~ 389 (552)
+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+++...... ....
T Consensus 92 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 167 (325)
T 3kn6_A 92 ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLK 167 (325)
T ss_dssp BHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccc
Confidence 9999999888999999999999999999999999 999999999999998665 89999999998765432 2233
Q ss_pred cccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCC
Q 008828 390 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469 (552)
Q Consensus 390 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (552)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||........................ .......
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-------~~~~~~~ 240 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-------SFEGEAW 240 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-------CCCSHHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-------CCCcccc
Confidence 456899999999999999999999999999999999999999754432222222222222221110 0001111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 470 RIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 470 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+.++.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 2235789999999999999999999999854
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=351.62 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=213.8
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
...++|.+.+.||+|+||+||+|.+. ++..||+|.++... .....+.+|+.+++.++||||+++++++......++|
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 34567888899999999999999976 48899999997532 3456789999999999999999999999999999999
Q ss_pred EeeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 306 YPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999999975 34599999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....... ... ... .
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----~~~---~~~----------~ 227 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYE---LLE----------K 227 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHH---HHH----------T
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH---HHh----------c
Confidence 4444455567889999999999999999999999999999999 888886432211 111 111 1
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
......+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 228 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 111122233447899999999999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=350.63 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=196.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCCce----
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER---- 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~---- 302 (552)
++|.+.+.||+|+||.||+|.. .+++.||||+++...... ....+.+|+.++..++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5788899999999999999996 578999999997653322 234688999999999999999999998765543
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||||+++|+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 99999999999999998777899999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCc--eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 383 CDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 383 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
.... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... .............
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~--- 238 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIP--- 238 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCC---
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCCCCC---
Confidence 3222 223456899999999999999999999999999999999999999643221 1111111111000
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
+ .......+.++.+++.+||+.||++||++.++++
T Consensus 239 -~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 239 -P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp -H---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred -c---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0 0001113467899999999999999998877764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=351.26 Aligned_cols=245 Identities=25% Similarity=0.286 Sum_probs=193.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||+||+|... +++.||||++....... ....+..|+..+..+ +||||+++++++......++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56888899999999999999976 79999999986543222 233455566555555 8999999999999999999999
Q ss_pred eeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+ +++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-- 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-- 210 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC--
Confidence 999 6688888764 45699999999999999999999999 9999999999999999999999999999876532
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.......||+.|+|||++.+ .++.++|||||||++|||++|..++..... | ..... ....
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~-~~~~~---------~~~~ 270 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------W-QQLRQ---------GYLP 270 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------H-HHHTT---------TCCC
T ss_pred CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------H-HHHhc---------cCCC
Confidence 22334559999999998875 799999999999999999999777653211 1 01110 0011
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..++...+..+.+++.+||+.||++|||+.|++++
T Consensus 271 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11111234779999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=357.08 Aligned_cols=251 Identities=22% Similarity=0.272 Sum_probs=192.3
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|.+.+.||+|+||+||+|... +++.||||+++... ....+.+|+.++..++||||+++++++......++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 457888899999999999999976 57899999997543 23467889999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC---CCceEEcccccceecCCCC
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~~~ 384 (552)
|+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 999999999998888899999999999999999999999 9999999999999975 899999999999866432
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ........... ..
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~-------~~ 270 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEY-------YF 270 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCC-------CC
T ss_pred -cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCC-------cc
Confidence 22334569999999999999999999999999999999999999996432210 01111111100 00
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
........+..+.+++.+||+.||++|||+.|++++
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111112334678999999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=353.74 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=206.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-----CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC--Cce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 302 (552)
+.|++.+.||+|+||.||+|.+ .+++.||+|+++..........+.+|+.++..++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3477889999999999999984 368899999998655445566799999999999999999999999876 668
Q ss_pred eEEEeeccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 303 LLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
++||||+++|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence 99999999999999995 456799999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCc--eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCccc-------cccc-chHHHHHHHh
Q 008828 382 HCDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTA-------NQKG-AMLDWVKKIH 451 (552)
Q Consensus 382 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~-------~~~~-~~~~~~~~~~ 451 (552)
..... ......||..|+|||.+.+..++.++||||||+++|||+||+.|+...... .... ........
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 255 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT-- 255 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH--
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH--
Confidence 54332 223455888899999999999999999999999999999999886532110 0000 00011111
Q ss_pred hhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 452 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.........+...++.+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 256 --------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 --------LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp --------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred --------HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 11111112233445789999999999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=344.44 Aligned_cols=249 Identities=21% Similarity=0.307 Sum_probs=203.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecC--CceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv~ 306 (552)
++|.+.+.||+|+||+||+|.++ ++.||||+++..... .....+.+|+.++++++||||+++++++... ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888899999999999999986 889999999765322 2345689999999999999999999999887 7789999
Q ss_pred eeccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 307 PYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
||+++|+|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999998654 589999999999999999999998 7 99999999999999999999999998754322
Q ss_pred CCCceeecccccccccCchhhccCCCCC---ccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQSSE---KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
....||+.|+|||.+.+..++. ++|||||||++|||+||+.||...... .......
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~-------- 224 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKVA-------- 224 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHHH--------
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHHH--------
Confidence 2235899999999998765544 799999999999999999999743211 1111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
........+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 225 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 225 -LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp -HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11111222333457799999999999999999999999999863
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=354.15 Aligned_cols=252 Identities=23% Similarity=0.267 Sum_probs=198.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE----CCCcEEEEEEeccCcc---CchHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
.++|++.+.||+|+||.||+|+. .+++.||+|+++.... ......+.+|+.++..++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788899999999999999997 4689999999976432 1223457889999999999999999999999999
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.++||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999999999998777899999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+...
T Consensus 173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~-------- 236 (327)
T 3a62_A 173 HDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-------KKTIDKILKC-------- 236 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHT--------
T ss_pred cCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhC--------
Confidence 222 223445699999999999999999999999999999999999999974322 1111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRMLE 502 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 502 (552)
. ..++...+..+.+++.+||+.||++|| ++.|++++--
T Consensus 237 -~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 237 -K--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp -C--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred -C--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 0 112223347789999999999999999 7778877544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=361.53 Aligned_cols=267 Identities=18% Similarity=0.212 Sum_probs=213.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCC--ceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~--~~~lv~ 306 (552)
++|.+.+.||+|+||+||+|... +++.||||+++..........+.+|+++++.++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56888899999999999999976 589999999976554445667889999999999999999999988765 679999
Q ss_pred eeccCCChhhhhccCC---CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee----CCCCceEEccccccee
Q 008828 307 PYMSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVVGDFGLAKL 379 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~---~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~~~~ 379 (552)
||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997533 399999999999999999999999 99999999999999 7888899999999987
Q ss_pred cCCCCCceeecccccccccCchhhcc--------CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHh
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLST--------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 451 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 451 (552)
..... ......||..|+|||++.. ..++.++|||||||++|||+||+.||......... ...+....
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~---~~~~~~~~ 240 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYKII 240 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC---HHHHHHHH
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch---HHHHHHHh
Confidence 65322 2234569999999999875 56788999999999999999999999753332221 12222221
Q ss_pred hhcchhh---h---c--------cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 452 QEKKLEM---L---V--------DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 452 ~~~~~~~---~---~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
....... + . +..............+.+++.+||+.||++||++.|+++.+++.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 1111000 0 0 00112234577888999999999999999999999999888763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=356.67 Aligned_cols=251 Identities=23% Similarity=0.278 Sum_probs=206.3
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhc-cccccceeeeEeecCCcee
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~ 303 (552)
..++|.+.+.||+|+||+||+|..+ +++.||+|+++... .......+..|..++..+ +||||+++++++...+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3467889999999999999999986 47899999997542 122345678899999887 7999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
+||||+++|+|.+++.....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999999999998777899999999999999999999999 9999999999999999999999999999854322
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... .
T Consensus 175 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~---------~ 237 (353)
T 2i0e_A 175 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEH---------N 237 (353)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHC---------C
T ss_pred -CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhC---------C
Confidence 2233456799999999999999999999999999999999999999974321 1111111111 1
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRM 500 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 500 (552)
..++...+.++.+++.+||+.||++||+ ++|++++
T Consensus 238 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1122334578999999999999999995 4677654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=356.11 Aligned_cols=267 Identities=22% Similarity=0.379 Sum_probs=215.6
Q ss_pred cCHHHHHHHhcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceee
Q 008828 220 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293 (552)
Q Consensus 220 ~~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~ 293 (552)
+..++++...++|.+.+.||+|+||.||+|... +++.||+|.++..........+.+|+.++..++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344555566788999999999999999999864 36789999997655444455789999999999999999999
Q ss_pred eEeecCCceeEEEeeccCCChhhhhccC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee
Q 008828 294 GFCMTTTERLLVYPYMSNGSVASRLKAK----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 294 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 363 (552)
+++......++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 9999999999999999999999998632 4579999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCccccccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG 441 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~ 441 (552)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||.....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 246 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----- 246 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----
Confidence 99999999999999865432211 1122346889999999999999999999999999999999 8888864321
Q ss_pred chHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 008828 442 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL 506 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 506 (552)
........... . ...+...+..+.+++.+||+.||++|||+.|++++|+....
T Consensus 247 --~~~~~~~~~~~-~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 --EQVLRFVMEGG-L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --HHHHHHHHTTC-C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HHHHHHHHcCC-c---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111111111 0 11122334779999999999999999999999999998543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=353.38 Aligned_cols=258 Identities=26% Similarity=0.366 Sum_probs=193.3
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEECC-C---cEEEEEEeccCc-cCchHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQD-G---TVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
...++|.+.+.||+|+||+||+|.... + ..||||+++... .......+.+|+.++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345679999999999999999999653 3 279999997543 22345679999999999999999999999987765
Q ss_pred e------eEEEeeccCCChhhhhccC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCce
Q 008828 302 R------LLVYPYMSNGSVASRLKAK------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 369 (552)
Q Consensus 302 ~------~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 369 (552)
. ++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 5 8999999999999998532 2699999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHH
Q 008828 370 VVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWV 447 (552)
Q Consensus 370 kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 447 (552)
||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||+| |+.||....... . .
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~---~ 249 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----I---Y 249 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----H---H
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH----H---H
Confidence 99999999866433221 2223447789999999999999999999999999999999 899887432211 1 1
Q ss_pred HHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 448 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
....... ....+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 250 ~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 250 NYLIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HHHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111 1112223447799999999999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=361.76 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=200.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccC-chHHHHHHHHHHHhhcc--ccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV--HRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~--h~niv~l~~~~~~~~~~~lv~ 306 (552)
.+|.+.+.||+|+||+||+|...+++.||||++...... .....+.+|+.++..++ ||||+++++++......++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888999999999654322 23457899999999996 599999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
| +.+++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++........
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 56789999999888899999999999999999999999 999999999999996 589999999999876533222
Q ss_pred -eeecccccccccCchhhcc-----------CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhc
Q 008828 387 -VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 454 (552)
Q Consensus 387 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 454 (552)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~------- 277 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKL------- 277 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHH-------
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH------HHHHH-------
Confidence 2344569999999999875 4689999999999999999999999964221 11111
Q ss_pred chhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 455 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
..+.+......++...+..+.+++.+||+.||++|||+.|++++-
T Consensus 278 --~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 278 --HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp --HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 112222222222222246789999999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=357.47 Aligned_cols=251 Identities=22% Similarity=0.278 Sum_probs=206.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|.+.+.||+|+||+||+|... +++.||+|++..... .....+.+|+.++..++||||+++++++......++||||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 57889999999999999999975 689999999965432 2344688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC--CCceEEcccccceecCCCCC
Q 008828 309 MSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--YYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 309 ~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~ 385 (552)
+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 9999999999754 4799999999999999999999999 9999999999999974 5789999999998775432
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ...+........ ..+
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~i~~~~~---~~~---- 270 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKRCDW---EFD---- 270 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHCCC---CCC----
T ss_pred -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC---CCC----
Confidence 23344699999999999999999999999999999999999999974321 111111111100 011
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.......+.++.+++.+||+.||++|||+.|++++
T Consensus 271 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11112234678999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=349.14 Aligned_cols=256 Identities=18% Similarity=0.181 Sum_probs=206.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|.+.+.||+|+||+||+|.. .+++.||||++..... ...+.+|+.++..+ +||||+++++++......++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 5788899999999999999996 4789999999865432 23578999999999 89999999999999999999999
Q ss_pred eccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc-----eEEcccccceecC
Q 008828 308 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE-----AVVGDFGLAKLLD 381 (552)
Q Consensus 308 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~~~~~~ 381 (552)
|+ +++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 8999999975 46799999999999999999999999 9999999999999998887 9999999998765
Q ss_pred CCCCc------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcc
Q 008828 382 HCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455 (552)
Q Consensus 382 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 455 (552)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .............
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~----~~~~~~~i~~~~~ 237 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT----LKERYQKIGDTKR 237 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS----HHHHHHHHHHHHH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc----HHHHHHHHHhhhc
Confidence 43321 1235569999999999999999999999999999999999999997543211 1111111111000
Q ss_pred hhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 456 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.. ....+. ...+ ++.+++.+||+.||.+||++.++.+.|++
T Consensus 238 -~~-~~~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 238 -AT-PIEVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp -HS-CHHHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred -cC-CHHHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 00 000000 1122 79999999999999999999999998874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=344.60 Aligned_cols=254 Identities=25% Similarity=0.351 Sum_probs=207.0
Q ss_pred cCCCCCC-eeeeeCceEEEEEEEC---CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKN-LVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~-~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
++|.+.+ .||+|+||.||+|... ++..||+|+++..........+.+|+.++..++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999853 57889999998654444556799999999999999999999999 45678999
Q ss_pred EeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 999999999999864 45699999999999999999999999 99999999999999999999999999998775433
Q ss_pred Cce--eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 385 SHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 385 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... .........
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~i~~~-------- 229 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQG-------- 229 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTT--------
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHhcC--------
Confidence 322 123346889999999998899999999999999999999 99999643221 111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.....+...+..+.+++.+||+.||++||++.+++++|+..
T Consensus 230 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 230 --KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11122333457899999999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=353.39 Aligned_cols=254 Identities=23% Similarity=0.392 Sum_probs=200.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCc----EEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
++|.+.+.||+|+||+||+|.+. +++ .||+|.++..........+.+|+.++..++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57888899999999999999964 344 358888766555556678999999999999999999999998754 789
Q ss_pred EEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
|+||+.+|+|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 9999999999999975 45799999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 384 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 384 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
... ......+|..|+|||.+.+..++.++|||||||++|||+| |+.||....... .... . .
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~---~----------~ 233 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSI---L----------E 233 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHH---H----------H
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHH---H----------H
Confidence 222 2233447889999999999999999999999999999999 999997432211 1111 1 1
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.......+...+..+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 234 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 234 KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111112233446799999999999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=342.97 Aligned_cols=251 Identities=29% Similarity=0.500 Sum_probs=202.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchH------HHHHHHHHHHhhccccccceeeeEeecCCce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGE------IQFQTEVEMISLAVHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~------~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 302 (552)
++|.+.+.||+|+||+||+|... +++.||+|++......... ..+.+|+.++..++||||+++++++....
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 57888899999999999999974 7899999999654332221 56889999999999999999999986554
Q ss_pred eEEEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEEcCCCCCceeeCCCCc-----eEEccc
Q 008828 303 LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDEYYE-----AVVGDF 374 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~-----~kl~Df 374 (552)
++||||+++|+|.+.+.. ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 799999999999888764 45799999999999999999999998 8 999999999999988776 999999
Q ss_pred ccceecCCCCCceeecccccccccCchhhc--cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh
Q 008828 375 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLS--TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 375 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
|+++.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||...... ...+......
T Consensus 174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~ 244 (287)
T 4f0f_A 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-----KIKFINMIRE 244 (287)
T ss_dssp TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-----HHHHHHHHHH
T ss_pred Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-----HHHHHHHHhc
Confidence 99975432 234456999999999984 456789999999999999999999999743221 1111111111
Q ss_pred hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.......+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 245 ---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 ---------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ---------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111222233445789999999999999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=353.90 Aligned_cols=252 Identities=21% Similarity=0.256 Sum_probs=202.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc----cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
++|++.+.||+|+||+||+|... +++.||||+++... .......+.+|+.++..++||||+++++++......++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888899999999999999975 68999999986321 11235678999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc---eEEcccccc
Q 008828 305 VYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGLA 377 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~ 377 (552)
||||+++|+|.+.+.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999887753 34589999999999999999999999 9999999999999986554 999999999
Q ss_pred eecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (552)
+...... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||..... .......... .
T Consensus 181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~~~-~- 249 (351)
T 3c0i_A 181 IQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIKGK-Y- 249 (351)
T ss_dssp EECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHHTC-C-
T ss_pred eEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHcCC-C-
Confidence 8765432 223345699999999999999999999999999999999999999974211 1111111110 0
Q ss_pred hhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+.... ..+..+.+++.+||+.||++|||+.|++++
T Consensus 250 -~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 -KMNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp -CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -CCCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000011 124678999999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=342.16 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=207.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|++.+.||+|+||.||+|... +++.||+|++...........+.+|+.++..++||||+++++++......++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 56888899999999999999976 68999999997655445566789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC-ce
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 387 (552)
+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........ ..
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99999999998888899999999999999999999999 999999999999999999999999999986543221 12
Q ss_pred eecccccccccCchhhccCCC-CCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 388 TTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....||..|+|||.+.+..+ +.++||||||+++|||+||+.||........ ....|. ..... .
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~----~~~~~---~------ 228 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWK----EKKTY---L------ 228 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHH----TTCTT---S------
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhh----hcccc---c------
Confidence 234568999999999987765 7899999999999999999999975332111 011111 10000 0
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......+..+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0011234678899999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=341.35 Aligned_cols=259 Identities=17% Similarity=0.187 Sum_probs=207.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+.++..+ +|+|++++++++......++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 35788899999999999999996 5789999999865432 23477899999998 7999999999999999999999
Q ss_pred eeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc-----eEEcccccceec
Q 008828 307 PYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE-----AVVGDFGLAKLL 380 (552)
Q Consensus 307 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~~~~~ 380 (552)
||+ +++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++. +||+|||+++..
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999 99999999854 4699999999999999999999999 9999999999999987776 999999999876
Q ss_pred CCCCCc------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhc
Q 008828 381 DHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 454 (552)
Q Consensus 381 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 454 (552)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ....+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~ 240 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIGEKKQST 240 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHHHHHHHHHS
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH-HHHHHHhhccCc
Confidence 543321 2244569999999999999999999999999999999999999997543221111 111111111001
Q ss_pred chhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 455 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.... . ....+..+.+++.+||+.||++||++++|++.|+..
T Consensus 241 ~~~~-----~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 241 PLRE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHHH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHHH-----H----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 1111 1 112247799999999999999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=347.87 Aligned_cols=255 Identities=26% Similarity=0.339 Sum_probs=205.4
Q ss_pred hcCCCCCC-eeeeeCceEEEEEEEC---CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 229 TSNFSSKN-LVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 229 ~~~~~~~~-~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
.++|.+.+ .||+|+||+||+|.+. +++.||||+++...... ....+.+|+.++..++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 9999999999999642 46889999997543322 245789999999999999999999999 567789
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
+||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 9999999999999999888899999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCcee--ecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 384 DSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 384 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
..... ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... .........
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~------- 236 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKG------- 236 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTT-------
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcC-------
Confidence 33222 22346788999999999899999999999999999999 99998743221 111111111
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.....+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 237 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 237 ---ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01112233457899999999999999999999999999873
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=369.07 Aligned_cols=253 Identities=23% Similarity=0.229 Sum_probs=199.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
.++|++.+.||+|+||.||+|... +|+.||||+++... .......+.+|+.++..++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 356888999999999999999965 68999999997532 222334678899999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|||+++|+|.+++.....+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD- 302 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC-
Confidence 9999999999999887889999999999999999999998 7 9999999999999999999999999999754322
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~---------~- 365 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILME---------E- 365 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHC---------C-
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHHhC---------C-
Confidence 2233446799999999999999999999999999999999999999964322 1111111111 0
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhc
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRMLEG 503 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~ 503 (552)
..++...+.++.+++.+||+.||++|| +++|++++---
T Consensus 366 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f 408 (446)
T 4ejn_A 366 -IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408 (446)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred -CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence 112223347789999999999999999 99999875443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=351.89 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=201.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC-----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
++|...+.||+|+||+||+|.... +..||||+++..........+.+|+.++..++||||+++++++......++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456677899999999999998642 246999999765444445578999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999754 5799999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCc--eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 384 DSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 384 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
... ......+|..|+|||.+.+..++.++|||||||++|||+| |+.||..... ...........
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~~~~~~~------ 267 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGF------ 267 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTC------
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHCCC------
Confidence 221 1222346788999999999999999999999999999999 9999864321 11111111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
....+...+..+.+++.+||+.||++||++.+++++|+..
T Consensus 268 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 268 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp ----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111223347799999999999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=366.31 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=207.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.+|.+.+.||+|+||.||+|... +|+.||||+++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888899999999999999976 799999999964321 223456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-- 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 170 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence 9999999999999888899999999999999999999999 99999999999999999999999999998765432
Q ss_pred eeecccccccccCchhhccCCC-CCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ......+... ..
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~---------~~- 233 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------PTLFKKICDG---------IF- 233 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-------HHHHHHHHTT---------CC-
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcC---------Cc-
Confidence 2334569999999999988765 6899999999999999999999974322 1111111111 00
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+...+.++.+++.+||+.||++|||+.|++++
T Consensus 234 -~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 -YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1112234678999999999999999999999873
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=347.90 Aligned_cols=267 Identities=20% Similarity=0.229 Sum_probs=202.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|.+.+.||+|+||+||+|... +|+.||+|++....... ....+.+|+.++.+++||||+++++++......++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888899999999999999976 58999999986544322 23468899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
|+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 158 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y 158 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence 999999999998888899999999999999999999999 999999999999999999999999999987653222 2
Q ss_pred eecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHH--------HHHHHhhhcchhh
Q 008828 388 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--------WVKKIHQEKKLEM 458 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 458 (552)
.....||..|+|||.+.+ ..++.++|||||||++|+|+||+.||...........+.. +............
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 334568999999999976 6689999999999999999999999975432211100000 0000000000000
Q ss_pred hccccccCcC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 LVDKDLKNNY-----DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+...... ....+..+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 01234678999999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.49 Aligned_cols=253 Identities=20% Similarity=0.273 Sum_probs=206.6
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.++|.+.+.||+|+||.||+|... +++.||+|++...... .....+.+|+.++..++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 367889999999999999999975 5899999999754322 23456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc---eEEcccccceecCCC
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGLAKLLDHC 383 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~~~~~~~ 383 (552)
||+++|+|.+.+.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999999998778899999999999999999999999 9999999999999986655 999999999876533
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... .......... . .
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~-~----~-- 225 (284)
T 3kk8_A 162 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGA-Y----D-- 225 (284)
T ss_dssp C--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTC-C----C--
T ss_pred c--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-------HHHHHHHhcc-c----c--
Confidence 2 223456999999999999999999999999999999999999999643221 1111111110 0 0
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.........+..+.+++.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000111234678999999999999999999999863
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=344.87 Aligned_cols=254 Identities=28% Similarity=0.373 Sum_probs=203.3
Q ss_pred CCCCCCeeeeeCceEEEEEEECC----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCce-eEE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER-LLV 305 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~-~lv 305 (552)
.|...+.||+|+||+||+|.+.+ +..||+|.++..........+.+|+.+++.++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34556899999999999998532 2379999997655444556789999999999999999999999876655 899
Q ss_pred EeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|||+.+|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999976 45789999999999999999999999 99999999999999999999999999997654321
Q ss_pred ---CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 385 ---SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 385 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
........++..|+|||.+.+..++.++||||||+++|+|+||..|+........ ... ......
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~---~~~~~~------- 245 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTH---FLAQGR------- 245 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHH---HHHTTC-------
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHH---HhhcCC-------
Confidence 1122344588999999999999999999999999999999997666543222111 111 111110
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 246 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 246 ---RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111122234679999999999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=344.08 Aligned_cols=255 Identities=22% Similarity=0.243 Sum_probs=208.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-----hHHHHHHHHHHHhhccccccceeeeEeecCCce
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 302 (552)
.++|.+.+.||+|+||.||+|... +|+.||+|+++...... ....+.+|+.++..++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999976 68999999997543222 245789999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC----ceEEcccccce
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAK 378 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~~~ 378 (552)
++||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999998888899999999999999999999999 999999999999999888 79999999998
Q ss_pred ecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhh
Q 008828 379 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458 (552)
Q Consensus 379 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (552)
...... ......||+.|+|||.+.+..++.++|||||||++|+|+||+.||..... ........... .
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~---~ 235 (321)
T 2a2a_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANITSVS---Y 235 (321)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTC---C
T ss_pred ecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcc---c
Confidence 765432 22345699999999999999999999999999999999999999964321 11111111100 0
Q ss_pred hccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 459 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 459 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
..++... ...+..+.+++.+||+.||++|||+.|++++--
T Consensus 236 ~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 236 DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 0001111 112367899999999999999999999997543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=358.78 Aligned_cols=253 Identities=25% Similarity=0.275 Sum_probs=199.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHH-HhhccccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEM-ISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
++|++.+.||+|+||+||+|+.+ +++.||+|+++..... .....+..|..+ ++.++||||+++++++...+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46888899999999999999976 5889999999754322 223346667766 5678999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|||+++|+|.+++.....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~- 193 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN- 193 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence 99999999999998877899999999999999999999999 99999999999999999999999999998643222
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.. ..+
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~---------~~~- 256 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILN---------KPL- 256 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-------HHHHHHHH---------SCC-
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHh---------ccc-
Confidence 2334567999999999999999999999999999999999999999743221 11111111 110
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.++...+..+.+++.+||+.||++||++.+.++.+..+
T Consensus 257 -~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 257 -QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp -CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 11222346789999999999999999986555555544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=356.16 Aligned_cols=264 Identities=17% Similarity=0.174 Sum_probs=202.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECC------CcEEEEEEeccCccCc-h---------HHHHHHHHHHHhhcccccccee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIG-G---------EIQFQTEVEMISLAVHRNLLRL 292 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-~---------~~~~~~e~~~l~~~~h~niv~l 292 (552)
.++|.+.+.||+|+||+||+|.+.+ ++.||||++....... . ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578889999999999999999764 4789999986543110 0 0123345556677789999999
Q ss_pred eeEeecC----CceeEEEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC--C
Q 008828 293 IGFCMTT----TERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--E 365 (552)
Q Consensus 293 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~ 365 (552)
++++... ...++||||+ +++|.+++... ..+++..+..|+.||+.||.|||+. +|+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCC
Confidence 9998765 4579999999 99999999765 6799999999999999999999999 999999999999999 8
Q ss_pred CCceEEcccccceecCCCCCc------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCccccc
Q 008828 366 YYEAVVGDFGLAKLLDHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 439 (552)
Q Consensus 366 ~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~ 439 (552)
++.+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~-- 267 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD-- 267 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC--
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC--
Confidence 899999999999876432211 113345999999999999999999999999999999999999999742211
Q ss_pred ccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 440 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.....+.... ....+..+.+..+.. ...+.++.+++..||+.+|++||++.++++.|+.
T Consensus 268 -~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 268 -PKYVRDSKIR-YRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp -HHHHHHHHHH-HHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred -HHHHHHHHHH-hhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 1111111111 112233333333221 1123679999999999999999999999998875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=357.52 Aligned_cols=269 Identities=19% Similarity=0.226 Sum_probs=203.8
Q ss_pred hcCCCCCCeeeee--CceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 229 TSNFSSKNLVGKG--GFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
..+|++.+.||+| +||+||+|+.. +++.||||+++...... ....+.+|+.+++.++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578889999999 99999999976 69999999997544322 23468889999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 305 VYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999754 6799999999999999999999999 999999999999999999999999999865422
Q ss_pred CCC------ceeecccccccccCchhhcc--CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchH-HHHHHHhh-
Q 008828 383 CDS------HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML-DWVKKIHQ- 452 (552)
Q Consensus 383 ~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~- 452 (552)
... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||............. ........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 111 11122368999999999987 578999999999999999999999997533211100000 00000000
Q ss_pred -----------------hcchhhhcc---------ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 453 -----------------EKKLEMLVD---------KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 453 -----------------~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......... ......+....+..+.+|+.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000000 000011223345779999999999999999999999865
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=354.33 Aligned_cols=272 Identities=24% Similarity=0.309 Sum_probs=210.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-----CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEee--cCCce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM--TTTER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~--~~~~~ 302 (552)
++|++.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|++++.+++||||+++++++. .....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 5688889999999999999984 358899999997543 233456899999999999999999999887 45568
Q ss_pred eEEEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 303 LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 899999999999999975 45699999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCc--eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 382 HCDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 382 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
..... ......||..|+|||.+.+..++.++|||||||++|+|++|+.||........... .+.............
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM--GCERDVPALSRLLEL 256 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC--C----CCHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc--ccccccccHHHHHHH
Confidence 43332 22334578889999999999999999999999999999999999864322100000 000000000011111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCc
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLA 507 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 507 (552)
.........+...+..+.+++.+||+.||++|||+.|++++|+.....
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 112222223344557899999999999999999999999999986443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=339.53 Aligned_cols=250 Identities=21% Similarity=0.282 Sum_probs=199.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|.+.+.||+|+||+||+|... ++..||+|++...........+.+|+++++.++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888899999999999999975 68899999997665555567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee---CCCCceEEcccccceecC
Q 008828 309 MSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 309 ~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~ 381 (552)
+++|+|.+.+.. ...+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999998853 46799999999999999999999999 99999999999999 456889999999998654
Q ss_pred CCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
... ......||..|+|||.+. ..++.++|||||||++|||++|+.||...... ..........
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~------- 241 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-------EVQQKATYKE------- 241 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC-------
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-------HHHhhhccCC-------
Confidence 322 233456899999999985 57899999999999999999999999743211 1111111000
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..... .....++.+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 242 PNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 000123678899999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=342.79 Aligned_cols=260 Identities=18% Similarity=0.176 Sum_probs=202.0
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
.++|.+.+.||+|+||.||+|... +++.||+|+++...... ....+.+|+.++..++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467889999999999999999975 68899999997543322 235688999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999999998877899999999999999999999999 999999999999999999999999999986654333
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.......|+..|+|||.+.+..++.++||||||+++|||+||+.||...... .+....... ... .
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~----~~~---~ 254 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHINQA----IPR---P 254 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHHSC----CCC---G
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhccC----CCC---c
Confidence 3334456899999999999999999999999999999999999999743211 111111100 000 0
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCCC
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRP-KMSEVVRMLEGDGL 506 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~ 506 (552)
...+...+..+.+++.+||+.||++|| +++++++.|+....
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 111223346789999999999999999 99999999997533
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=378.03 Aligned_cols=246 Identities=25% Similarity=0.360 Sum_probs=199.9
Q ss_pred eeeeeCceEEEEEEEC---CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCC
Q 008828 237 LVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 313 (552)
Q Consensus 237 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 313 (552)
.||+|+||.||+|.+. ++..||||+++..........|.+|+.++.+++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 4668999999876555556789999999999999999999999976 56899999999999
Q ss_pred hhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee--ec
Q 008828 314 VASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TA 390 (552)
Q Consensus 314 L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~~ 390 (552)
|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.......... ..
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 9999974 45699999999999999999999999 999999999999999999999999999987643332221 22
Q ss_pred ccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCC
Q 008828 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469 (552)
Q Consensus 391 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (552)
..+++.|+|||++.+..++.++|||||||++|||+| |+.||...... +....+... .....+
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~----------~~~~~p 561 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQG----------KRMECP 561 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-------HHHHHHHTT----------CCCCCC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcC----------CCCCCC
Confidence 335689999999999999999999999999999998 99999743221 111111111 111223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 470 RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 470 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
..++..+.+++.+||+.||++||++.+|++.|+.
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 3455789999999999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=342.97 Aligned_cols=248 Identities=28% Similarity=0.402 Sum_probs=203.2
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
.++|.+.+.||+|+||+||+|... ++..||+|++..... ......+.+|+.+++.++||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 356888899999999999999975 577999999864321 12245688999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence 99999999999998877899999999999999999999998 9999999999999999999999999998654322
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......||..|+|||.+.+..++.++||||||+++|+|++|+.||..... .......... .
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~-----------~ 223 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRV-----------E 223 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHT-----------C
T ss_pred -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-------HHHHHHHHhC-----------C
Confidence 22345689999999999999999999999999999999999999974321 1111111110 0
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..++...+..+.+++.+||+.||++|||+.|++++
T Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11222234678999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=353.10 Aligned_cols=259 Identities=22% Similarity=0.232 Sum_probs=201.8
Q ss_pred HHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc----cCchHHHHHHHHHHHhhccccccceeeeEeecC
Q 008828 225 LQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT 299 (552)
Q Consensus 225 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 299 (552)
+....++|.+.+.||+|+||+||+|... ++..||+|+++... .......+.+|+.++..++||||+++++++...
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3455678999999999999999999975 68899999986432 233456789999999999999999999999999
Q ss_pred CceeEEEeeccCCChhhhhcc----------------------------------------CCCCCHHHHHHHHHHHHHH
Q 008828 300 TERLLVYPYMSNGSVASRLKA----------------------------------------KPSLDWATRKRIALGAARG 339 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~----------------------------------------~~~l~~~~~~~i~~~ia~~ 339 (552)
...++||||+++|+|.+++.. ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999998852 1123677888999999999
Q ss_pred HHHHhhcCCCceEEcCCCCCceeeCCCC--ceEEcccccceecCCCCC---ceeecccccccccCchhhcc--CCCCCcc
Q 008828 340 LLYLHEQCDPKIIHRDVKAANILLDEYY--EAVVGDFGLAKLLDHCDS---HVTTAVRGTVGHIAPEYLST--GQSSEKT 412 (552)
Q Consensus 340 l~~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 412 (552)
|.|||+. +|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998766 899999999986543221 12344569999999999975 6789999
Q ss_pred chhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCC
Q 008828 413 DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRP 492 (552)
Q Consensus 413 Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 492 (552)
|||||||++|||++|+.||...... +........... .........+..+.+++.+||+.||++||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA-------DTISQVLNKKLC-------FENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC-------TTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcccc-------cCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999999643221 111111111100 00011112346789999999999999999
Q ss_pred CHHHHHHH
Q 008828 493 KMSEVVRM 500 (552)
Q Consensus 493 s~~evl~~ 500 (552)
|+.|++++
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=357.72 Aligned_cols=258 Identities=22% Similarity=0.273 Sum_probs=207.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEE----CCCcEEEEEEeccCcc---CchHHHHHHHHHHHhhc-cccccceeeeEeecCCc
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~ 301 (552)
++|.+.+.||+|+||+||+|+. .+++.||||+++.... ......+.+|+.++..+ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5688899999999999999997 3689999999975321 12234567899999999 59999999999999999
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.++||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 999999999999999998777899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeecccccccccCchhhcc--CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
...........||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...........
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~------ 281 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRILKS------ 281 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHHHHHC------
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch---HHHHHHHHhcc------
Confidence 433333445679999999999986 3478999999999999999999999975432211 11111111110
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhcC
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRMLEGD 504 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~~ 504 (552)
...++...+..+.+++.+||+.||++|| +++|++++..-.
T Consensus 282 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 282 -----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred -----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 1112233446789999999999999999 999999876653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=357.50 Aligned_cols=253 Identities=30% Similarity=0.440 Sum_probs=193.5
Q ss_pred CCCCCCeeeeeCceEEEEEEEC--C--CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeec-CCceeEE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ--D--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTERLLV 305 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~~lv 305 (552)
.|.+.+.||+|+||+||+|.+. + +..||+|.++.........+|.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556689999999999999864 2 246899999765544556679999999999999999999998764 4578999
Q ss_pred EeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999754 4689999999999999999999999 99999999999999999999999999998654322
Q ss_pred Cc---eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 385 SH---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 385 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
.. ......+|+.|+|||.+.+..++.++|||||||++|||+| |.+||...... .... ......
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~----~~~~---~~~~~~------ 313 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITV---YLLQGR------ 313 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS----CHHH---HHHTTC------
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH----HHHH---HHHcCC------
Confidence 11 1233457889999999999999999999999999999999 56666532211 1111 111111
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 314 ----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 314 ----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 001122234679999999999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=370.25 Aligned_cols=254 Identities=24% Similarity=0.302 Sum_probs=208.2
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++..++||||+++++++......++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 466888899999999999999975 69999999996432 122345688999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 306 YPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
|||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999987543 499999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... .. .
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~---i~-~---------- 403 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---VK-E---------- 403 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH---HH-H----------
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH---hh-c----------
Confidence 2 233457999999999999989999999999999999999999999754321111111111 11 0
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRML 501 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 501 (552)
....++...+.++.+++.+||+.||++|| ++.|++++-
T Consensus 404 ~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 01112233447899999999999999999 778887653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=350.53 Aligned_cols=244 Identities=21% Similarity=0.287 Sum_probs=205.1
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-------hHHHHHHHHHHHhhccccccceeeeEeecCC
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTT 300 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 300 (552)
.++|.+.+.||+|+||+||+|... +++.||||+++...... ....+.+|+.++..++||||+++++++....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 467899999999999999999964 68999999997543211 2235678999999999999999999999999
Q ss_pred ceeEEEeeccCC-ChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 301 ERLLVYPYMSNG-SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 301 ~~~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
..++||||+.+| +|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999777 9999999888899999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeecccccccccCchhhccCCC-CCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhh
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (552)
...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 180 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------------- 236 (335)
T 3dls_A 180 LERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------------- 236 (335)
T ss_dssp CCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------------
T ss_pred CCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------------
Confidence 754332 234569999999999988876 88999999999999999999999632110
Q ss_pred hccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 459 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 459 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
...... .+...+.++.+++.+||+.||++|||+.|++++-
T Consensus 237 -~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 237 -VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp -TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred -HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 000000 0111346789999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=376.54 Aligned_cols=258 Identities=27% Similarity=0.369 Sum_probs=211.1
Q ss_pred HHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 225 LQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 225 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
++...++|.+.+.||+|+||.||+|.++++..||||+++.... ....|.+|+.++++++||||+++++++.. ...++
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 3344567888899999999999999998888999999976442 34579999999999999999999999876 67899
Q ss_pred EEeeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 305 VYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
||||+++|+|.+++.. ...+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999999974 35699999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
..........++..|+|||.+....++.++|||||||++|||+| |+.||..... .+....+...
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~~~~i~~~-------- 480 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERG-------- 480 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHHHHHHHTT--------
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcC--------
Confidence 21112223346789999999999999999999999999999999 8988864321 1111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
.....+..++..+.+++.+||+.||++|||+.+|++.|+...
T Consensus 481 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 481 --YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111122334578999999999999999999999999999753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=349.43 Aligned_cols=264 Identities=25% Similarity=0.301 Sum_probs=199.1
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCcc----CchHHHHHHHHHHHhhcc---ccccceeeeEeecC
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA----IGGEIQFQTEVEMISLAV---HRNLLRLIGFCMTT 299 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~~ 299 (552)
..++|++.+.||+|+||+||+|.. .+++.||||+++.... ......+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999996 4689999999964321 112235677888877665 99999999999875
Q ss_pred C-----ceeEEEeeccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEc
Q 008828 300 T-----ERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG 372 (552)
Q Consensus 300 ~-----~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 372 (552)
. ..++||||+. |+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5 4789999997 59999997654 399999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh
Q 008828 373 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 373 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ..........
T Consensus 163 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~ 237 (308)
T 3g33_A 163 DFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGL 237 (308)
T ss_dssp SCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred eCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCC
Confidence 99999865432 223455689999999999999999999999999999999999999975332111 1111111100
Q ss_pred ---hcchhhh--cccccc-------CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 453 ---EKKLEML--VDKDLK-------NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 453 ---~~~~~~~--~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....... ...... .......++.+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000000 000000 00011234678999999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=343.88 Aligned_cols=255 Identities=30% Similarity=0.428 Sum_probs=200.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEee-cCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM-TTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~-~~~~~~l 304 (552)
.+|.+.+.||+|+||+||+|...+ +..||+|.++..........+.+|+.++++++||||+++++++. .....++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457788999999999999998642 23689999976554445567899999999999999999999865 4567899
Q ss_pred EEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999975 45689999999999999999999999 9999999999999999999999999999866432
Q ss_pred CC---ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 384 DS---HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 384 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+....... ... .......
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~---~~~~~~~------ 249 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DIT---VYLLQGR------ 249 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THH---HHHHTTC------
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHH---HHHhcCC------
Confidence 21 12233457889999999999999999999999999999999554443222111 111 1111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 250 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 250 ----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011112234679999999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=352.22 Aligned_cols=266 Identities=18% Similarity=0.185 Sum_probs=200.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC----CCcEEEEEEeccCccCc----------hHHHHHHHHHHHhhccccccceeeeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIG----------GEIQFQTEVEMISLAVHRNLLRLIGF 295 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~~~h~niv~l~~~ 295 (552)
++|.+.+.||+|+||+||+|... ++..||+|++....... ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888899999999999999975 57889999987543210 11236678888899999999999999
Q ss_pred eec----CCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC--ce
Q 008828 296 CMT----TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY--EA 369 (552)
Q Consensus 296 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~--~~ 369 (552)
+.. ....++||||+ +++|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcE
Confidence 987 67889999999 999999998777899999999999999999999999 999999999999999877 99
Q ss_pred EEcccccceecCCCCCc------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccch
Q 008828 370 VVGDFGLAKLLDHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 443 (552)
Q Consensus 370 kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~ 443 (552)
||+|||+++.+...... ......||..|+|||.+.+..++.++|||||||++|||+||+.||........ .
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~ 269 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV---A 269 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH---H
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH---H
Confidence 99999999876432111 11344699999999999999999999999999999999999999963211100 0
Q ss_pred HHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 008828 444 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL 506 (552)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 506 (552)
........... .......... ....+..+.+++.+||+.||++|||+.+|++.|+....
T Consensus 270 ~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 VQTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111110000 0000000000 00233679999999999999999999999999998654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=345.34 Aligned_cols=250 Identities=27% Similarity=0.402 Sum_probs=196.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
++|++.+.||+|+||+||+|.+. ++.||+|.+... .....+.+|+.++++++||||+++++++. +..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 46778899999999999999986 789999999643 23557899999999999999999999887 4589999999
Q ss_pred cCCChhhhhccCC---CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc-eEEcccccceecCCCCC
Q 008828 310 SNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE-AVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 310 ~~g~L~~~l~~~~---~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfg~~~~~~~~~~ 385 (552)
++|+|.+++.... .+++..++.++.|+++||.|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 9999999997654 4789999999999999999999932239999999999999998886 799999999755422
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.....||..|+|||.+.+..++.++|||||||++|||+||+.||...... ............ .
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~----------~ 222 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-----AFRIMWAVHNGT----------R 222 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-----HHHHHHHHHTTC----------C
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-----HHHHHHHHhcCC----------C
Confidence 22345899999999999999999999999999999999999999743211 111111111110 1
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.......+..+.+++.+||+.||++|||+.|++++|+..
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111222346789999999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=353.86 Aligned_cols=251 Identities=20% Similarity=0.263 Sum_probs=192.4
Q ss_pred cCCCCC-CeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHh-hccccccceeeeEeec----CCce
Q 008828 230 SNFSSK-NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLLRLIGFCMT----TTER 302 (552)
Q Consensus 230 ~~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~~~h~niv~l~~~~~~----~~~~ 302 (552)
++|.+. +.||+|+||+||+|... +++.||||+++.. ..+.+|+.++. ..+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 345554 68999999999999975 6899999999632 34667888874 4589999999998865 5668
Q ss_pred eEEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC---CCceEEcccccc
Q 008828 303 LLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLA 377 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~ 377 (552)
++||||+++|+|.+++... ..+++..+..|+.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999999764 3599999999999999999999999 9999999999999997 789999999999
Q ss_pred eecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (552)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...............+.. . ..
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~---~-~~- 284 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---G-QY- 284 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH---T-CC-
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc---C-cc-
Confidence 8654322 233456899999999999999999999999999999999999999754332211111111110 0 00
Q ss_pred hhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 458 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
..........+.++.+++.+||+.||++|||+.|++++-
T Consensus 285 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 285 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred -----cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 000001122346789999999999999999999999753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=349.85 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=202.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcE--EEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTV--VAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 305 (552)
++|.+.+.||+|+||.||+|... ++.. ||+|.++..........+.+|+.++.++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888899999999999999965 4554 4999997654444556789999999999 899999999999999999999
Q ss_pred EeeccCCChhhhhccCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCce
Q 008828 306 YPYMSNGSVASRLKAKP----------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 369 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 369 (552)
|||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997543 799999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHH
Q 008828 370 VVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK 448 (552)
Q Consensus 370 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 448 (552)
||+|||+++..... .......++..|+|||.+.+..++.++|||||||++|||+| |+.||..... .....
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYE 252 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------HHHHH
Confidence 99999999743211 11223347889999999999899999999999999999998 9999964321 11111
Q ss_pred HHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 449 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
..... .....+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus 253 ~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 253 KLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp HGGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhhcC----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11111 1111222334779999999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.03 Aligned_cols=266 Identities=26% Similarity=0.353 Sum_probs=201.2
Q ss_pred HHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhh--ccccccceeeeEeecC---
Q 008828 225 LQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLIGFCMTT--- 299 (552)
Q Consensus 225 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~h~niv~l~~~~~~~--- 299 (552)
-....++|.+.+.||+|+||.||+|... ++.||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3445578999999999999999999986 8999999985432 3344556666554 4899999999999877
Q ss_pred -CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCceEEcCCCCCceeeCCCCceEEcc
Q 008828 300 -TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-----DPKIIHRDVKAANILLDEYYEAVVGD 373 (552)
Q Consensus 300 -~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~D 373 (552)
...++||||+++|+|.+++... .+++..++.++.|++.||.|||+.+ .++|+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 6789999999999999999765 5999999999999999999999752 34899999999999999999999999
Q ss_pred cccceecCCCCCce---eecccccccccCchhhccCCCCCc------cchhHHHHHHHHHHhCC----------CccccC
Q 008828 374 FGLAKLLDHCDSHV---TTAVRGTVGHIAPEYLSTGQSSEK------TDVFGFGILLLELISGL----------RALEFG 434 (552)
Q Consensus 374 fg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dvws~Gv~l~elltg~----------~p~~~~ 434 (552)
||+++......... .....||+.|+|||.+.+..++.+ +|||||||++|||+||. .||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99998764433221 124469999999999988776665 99999999999999994 444322
Q ss_pred cccccccchHHHHHHHhhhcchhhhccccccCc-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 435 KTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN-YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
..... ............. ..+..... ....++..+.+++.+||+.||++|||+.|++++|+.
T Consensus 266 ~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 266 VPSDP---SYEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp SCSSC---CHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCC---chhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 11111 1111111111110 11111111 123567889999999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=340.47 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=195.6
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
..++|.+.+.||+|+||+||+|... ..||+|+++..... .....+.+|+.+++.++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3467889999999999999999865 35999999754432 2345689999999999999999999965 456689999
Q ss_pred eeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC-
Q 008828 307 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD- 384 (552)
Q Consensus 307 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 384 (552)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 99999999999963 45799999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeecccccccccCchhhc---cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 385 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
........||+.|+|||.+. +..++.++||||||+++|||++|+.||....... ....... .... .
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~-~~~~----~ 244 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVG-RGSL----S 244 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHH-HTSC----C
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhc-cccc----C
Confidence 22233456999999999986 5678899999999999999999999997432211 1111111 1111 1
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
+.. ......++..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 245 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 110 1112234578999999999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.49 Aligned_cols=274 Identities=20% Similarity=0.260 Sum_probs=208.8
Q ss_pred ccccCHHHHHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-----ccccc
Q 008828 217 LKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----HRNLL 290 (552)
Q Consensus 217 ~~~~~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----h~niv 290 (552)
...+.+++.+...++|.+.+.||+|+||+||+|... +++.||||+++... .....+..|+.++..++ ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 345555665666789999999999999999999974 68999999996422 22345778999998886 99999
Q ss_pred eeeeEeecCCceeEEEeeccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC---
Q 008828 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--- 365 (552)
Q Consensus 291 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--- 365 (552)
++++++...+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence 9999999999999999999 899999997543 599999999999999999999999 9999999999999975
Q ss_pred ----------------------CCceEEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHH
Q 008828 366 ----------------------YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 423 (552)
Q Consensus 366 ----------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~e 423 (552)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 789999999999865432 234568999999999999999999999999999999
Q ss_pred HHhCCCccccCcccccccchH--------HHHHHHhhhcchhhhccccccCc--------------------CCHHHHHH
Q 008828 424 LISGLRALEFGKTANQKGAML--------DWVKKIHQEKKLEMLVDKDLKNN--------------------YDRIELEE 475 (552)
Q Consensus 424 lltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~ 475 (552)
|+||+.||...........+. .+..................... +.....+.
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 999999997533211100000 00000000000000000000000 00011266
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 476 MVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 476 l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+.+++.+||+.||++|||+.|++++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcC
Confidence 8899999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=337.66 Aligned_cols=246 Identities=19% Similarity=0.257 Sum_probs=204.1
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|.+.+.||+|+||+||+|... ++..||+|++..... .....+.+|+.++..++||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 356888999999999999999976 477999999975433 335678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee---CCCCceEEcccccceecCCCC
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 999999999998878899999999999999999999999 99999999999999 788999999999998765332
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
......||+.|+|||.+.+. ++.++||||||+++|||+||+.||...... ..........
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~---------- 223 (277)
T 3f3z_A 164 --MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-------EVMLKIREGT---------- 223 (277)
T ss_dssp --CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC----------
T ss_pred --chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCC----------
Confidence 23345699999999998654 899999999999999999999999743221 1111111110
Q ss_pred cCcCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 465 KNNYDR----IELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 465 ~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
...+. ..+..+.+++.+||+.||++|||+.|+++
T Consensus 224 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 -FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111 12467899999999999999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=339.17 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=184.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.++..++||||+++++++......++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4688889999999999999997 4789999999964321 122456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999764 5799999999999999999999999 999999999999999999999999999987653222
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......||+.|+|||.+.+..++.++||||||+++|||+||+.||......... ..+.....
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------------~~~~~~~~- 229 (278)
T 3cok_A 168 -KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------------NKVVLADY- 229 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCSSCC-
T ss_pred -cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------------HHHhhccc-
Confidence 223356899999999999989999999999999999999999999753321110 00000000
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+...+.++.+++.+||+.||++|||+.+++++
T Consensus 230 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 -EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1122234678999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=339.61 Aligned_cols=252 Identities=21% Similarity=0.252 Sum_probs=203.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-----chHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
++|.+.+.||+|+||.||+|... +++.||+|+++..... .....+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888899999999999999976 6899999999754322 13567899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC----ceEEccccccee
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAKL 379 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~~~~ 379 (552)
+||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999998777899999999999999999999999 999999999999999877 899999999987
Q ss_pred cCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
..... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ........... ..
T Consensus 162 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~---~~ 229 (283)
T 3bhy_A 162 IEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-------QETLTNISAVN---YD 229 (283)
T ss_dssp CC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTC---CC
T ss_pred ccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-------HHHHHHhHhcc---cC
Confidence 65322 22344589999999999999999999999999999999999999974321 11111111100 00
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..... ....+..+.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 230 FDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred Ccchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 00001 11124678999999999999999999999873
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.45 Aligned_cols=252 Identities=20% Similarity=0.289 Sum_probs=202.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.++|++.+.||+|+||+||+|..+ +++.||+|+++.... ...+|++++.++ +||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 456888999999999999999976 688999999975432 234678888777 7999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC----CceEEcccccceecCC
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY----YEAVVGDFGLAKLLDH 382 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~~~~ 382 (552)
||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||+.++ +.+||+|||+++....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999999999998888899999999999999999999999 99999999999998533 3599999999987654
Q ss_pred CCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.... .
T Consensus 173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~i~~~~-~------ 240 (342)
T 2qr7_A 173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD----TPEEILARIGSGK-F------ 240 (342)
T ss_dssp TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS----CHHHHHHHHHHCC-C------
T ss_pred CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC----CHHHHHHHHccCC-c------
Confidence 332 233456899999999998888999999999999999999999999743211 1112222221111 0
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.....+....+..+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111222345778999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=358.80 Aligned_cols=267 Identities=22% Similarity=0.341 Sum_probs=192.0
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhcc-ccccceeeeEeecCC--ce
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTT--ER 302 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~--~~ 302 (552)
..++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3568999999999999999999965 689999999865422 223446788999999997 999999999997544 68
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||||++ |+|..++... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEecccC-cCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 99999997 5899888764 699999999999999999999999 999999999999999999999999999986532
Q ss_pred CC--------------------CceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCccccccc
Q 008828 383 CD--------------------SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG 441 (552)
Q Consensus 383 ~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~ 441 (552)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 11 112234579999999999986 678999999999999999999999997543221111
Q ss_pred chHHHHHHHhhhcchhhhc------------------cccccCcC------------CHHHHHHHHHHHHHccCCCCCCC
Q 008828 442 AMLDWVKKIHQEKKLEMLV------------------DKDLKNNY------------DRIELEEMVQVALLCTQYLPSLR 491 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~------------~~~~~~~l~~li~~cl~~dP~~R 491 (552)
.+...+. ......+..+. .......+ ....+.++.+|+.+||+.||++|
T Consensus 242 ~i~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 242 RIIGVID-FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHC-CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHhcC-CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 1100000 00000000000 00000000 00224678999999999999999
Q ss_pred CCHHHHHHH
Q 008828 492 PKMSEVVRM 500 (552)
Q Consensus 492 Ps~~evl~~ 500 (552)
||+.|++++
T Consensus 321 ~t~~e~l~H 329 (388)
T 3oz6_A 321 ISANDALKH 329 (388)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhCC
Confidence 999999876
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=341.82 Aligned_cols=250 Identities=28% Similarity=0.377 Sum_probs=208.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+.|.+.+.||+|+||.||+|... +++.||+|+++..........+.+|+.++..++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 46888899999999999999864 68999999997665555567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........ ..
T Consensus 102 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 176 (303)
T 3a7i_A 102 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 176 (303)
T ss_dssp CTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CB
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-cc
Confidence 999999999875 4699999999999999999999999 999999999999999999999999999987654321 22
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
....||..|+|||.+.+..++.++||||||+++|+|++|+.||..... .......... ..+.+
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~------~~~~~---- 239 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPKN------NPPTL---- 239 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHS------CCCCC----
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-------HHHHHHhhcC------CCCCC----
Confidence 345689999999999999999999999999999999999999864321 1111111110 01111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
+...+..+.+++.+||+.||++|||+.|++++.
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 222346789999999999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=350.94 Aligned_cols=247 Identities=30% Similarity=0.386 Sum_probs=200.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
+.|...+.||+|+||+||+|.. .+++.||||++....... ....+.+|+.++..++||||+++++++......++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3477788999999999999996 478999999997543222 2346889999999999999999999999999999999
Q ss_pred eeccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+. |+|.+.+. ....+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 57877775 456799999999999999999999999 9999999999999999999999999999865432
Q ss_pred ceeecccccccccCchhhc---cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 386 HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
....||+.|+|||++. ...++.++|||||||++|||+||+.||..... ...+....... .+
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~~~~~~~~~~~------~~ 271 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNE------SP 271 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSC------CC
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcC------CC
Confidence 2346999999999985 56789999999999999999999999864321 11111111111 01
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
.. .....+..+.+++.+||+.||++|||+.+++++.
T Consensus 272 ~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 272 AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11 1122346789999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=333.92 Aligned_cols=258 Identities=20% Similarity=0.240 Sum_probs=205.4
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEe-ecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC-MTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~-~~~~~~~lv~ 306 (552)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+.++..++|++++..++++ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46788999999999999999996 5789999999865432 23578999999999998877766665 5566779999
Q ss_pred eeccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee---CCCCceEEcccccceecCC
Q 008828 307 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 307 e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~ 382 (552)
||+ +++|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999 899999997 455799999999999999999999999 99999999999999 4889999999999987654
Q ss_pred CCCc------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcch
Q 008828 383 CDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456 (552)
Q Consensus 383 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (552)
.... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.................... ....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-HSCH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc-CCch
Confidence 4321 12345699999999999999999999999999999999999999985433222222211111111 0000
Q ss_pred hhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 457 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
. .+. ...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 240 ~-----~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 240 E-----VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp H-----HHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred H-----HHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 0 011 1123679999999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=334.37 Aligned_cols=260 Identities=20% Similarity=0.229 Sum_probs=202.9
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEe-ecCCceeEE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC-MTTTERLLV 305 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~-~~~~~~~lv 305 (552)
..++|.+.+.||+|+||+||+|.. .+++.||||++...... ..+.+|+.++..++|++++..++++ ......++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 357899999999999999999996 57899999987544322 2477899999999988877777665 566778999
Q ss_pred EeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee---CCCCceEEcccccceecC
Q 008828 306 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~ 381 (552)
|||+ +|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 8999999973 45799999999999999999999999 99999999999999 788999999999998765
Q ss_pred CCCCc------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcc
Q 008828 382 HCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455 (552)
Q Consensus 382 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 455 (552)
..... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.................... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-HSC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-cch
Confidence 43321 22345699999999999999999999999999999999999999975443322222211111111 000
Q ss_pred hhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 456 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
... ... ..+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 239 ~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 IEV-----LCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHH-----HTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhh-----hhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 000 011 1236799999999999999999999999999863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=351.88 Aligned_cols=246 Identities=24% Similarity=0.277 Sum_probs=196.0
Q ss_pred CCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccCCC
Q 008828 235 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 313 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 313 (552)
.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|+.++.+++||||+++++++...+..++||||+++|+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 468999999999999964 689999999975432 334578999999999999999999999999999999999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee--CCCCceEEcccccceecCCCCCceeec
Q 008828 314 VASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL--DEYYEAVVGDFGLAKLLDHCDSHVTTA 390 (552)
Q Consensus 314 L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 390 (552)
|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++...... ....
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKV 247 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cccc
Confidence 99988643 4699999999999999999999999 99999999999999 577899999999998765432 2233
Q ss_pred ccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCH
Q 008828 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 470 (552)
Q Consensus 391 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (552)
..||+.|+|||++.+..++.++|||||||++|||+||+.||...... ..+..+..... ........
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~-------~~~~~~~~ 313 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNNILACRW-------DLEDEEFQ 313 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCC-------CSCSGGGT
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccC-------CCChhhhc
Confidence 46999999999999999999999999999999999999999753221 11111111110 00000111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 471 IELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 471 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+.++.+++.+||+.||++|||+.|++++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 234678999999999999999999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=344.44 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=202.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC-C-------cEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD-G-------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
++|.+.+.||+|+||+||+|.... + ..||+|++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 567888999999999999998653 3 479999996543 2345578999999999999999999999999999
Q ss_pred eeEEEeeccCCChhhhhccCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc--------eEEc
Q 008828 302 RLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--------AVVG 372 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~ 372 (552)
.++||||+++|+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999999999986554 99999999999999999999999 9999999999999998887 9999
Q ss_pred ccccceecCCCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHh
Q 008828 373 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 451 (552)
Q Consensus 373 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 451 (552)
|||++..... .....||..|+|||.+.+ ..++.++|||||||++|||+||..|+...... ........
T Consensus 164 Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~------~~~~~~~~ 232 (289)
T 4fvq_A 164 DPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS------QRKLQFYE 232 (289)
T ss_dssp CCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHH
T ss_pred cCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch------HHHHHHhh
Confidence 9999865432 223458899999999987 67999999999999999999976555432211 01111111
Q ss_pred hhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCch
Q 008828 452 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAE 508 (552)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 508 (552)
... . .+...+..+.+++.+||+.||++|||+.|++++|+....+.
T Consensus 233 ~~~--------~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 233 DRH--------Q----LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp TTC--------C----CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ccC--------C----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 000 0 11111356889999999999999999999999999865443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=357.43 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=195.4
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-------CchHHHHHHHHHHHhhccccccceeeeEeec
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-------IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 298 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 298 (552)
...++|.+.+.||+|+||+||+|... +++.||||++..... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34578999999999999999999975 589999999965321 111234789999999999999999999975
Q ss_pred CCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC---CceEEcccc
Q 008828 299 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY---YEAVVGDFG 375 (552)
Q Consensus 299 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg 375 (552)
....++||||+++|+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence 455799999999999999998888899999999999999999999999 99999999999999754 459999999
Q ss_pred cceecCCCCCceeecccccccccCchhhcc---CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh
Q 008828 376 LAKLLDHCDSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 376 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||....... .....+.
T Consensus 288 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~~~i~---- 358 (419)
T 3i6u_A 288 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQIT---- 358 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC---CHHHHHH----
T ss_pred cceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH---HHHHHHh----
Confidence 99876532 23344669999999999864 578899999999999999999999997432211 1111111
Q ss_pred hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
..... ..+... ...+..+.+++.+||+.||++|||+.|++++-
T Consensus 359 ~~~~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 359 SGKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp TTCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred cCCCC--CCchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 00000 000000 11246789999999999999999999999754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=375.25 Aligned_cols=247 Identities=27% Similarity=0.354 Sum_probs=200.0
Q ss_pred CeeeeeCceEEEEEEEC---CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||+||+|.+. .++.||||+++..... .....+.+|+.++.+++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 4678999999764332 234679999999999999999999999964 568899999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc--eee
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--VTT 389 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~ 389 (552)
|+|.+++.....+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999999888899999999999999999999999 9999999999999999999999999999876543322 223
Q ss_pred cccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 390 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 390 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
...+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+... .....
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~----------~~~~~ 593 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKG----------ERMGC 593 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTT----------CCCCC
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcC----------CCCCC
Confidence 3346789999999999999999999999999999998 99999743221 111111111 11122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
+..++.++.+++.+||+.||++||++.+|++.|++
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 33445789999999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=343.82 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=196.1
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC----CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
...++|.+.+.||+|+||.||+|... ++..||+|+++..... .....+.+|+.++.+++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567888999999999999999864 3458999999754332 234568899999999999999999999987653
Q ss_pred -----eeEEEeeccCCChhhhhc------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceE
Q 008828 302 -----RLLVYPYMSNGSVASRLK------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 370 (552)
Q Consensus 302 -----~~lv~e~~~~g~L~~~l~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 370 (552)
.++||||+++|+|.+++. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 489999999999999983 345799999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHH
Q 008828 371 VGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK 448 (552)
Q Consensus 371 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 448 (552)
|+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |..||...... ... .
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~---~ 260 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH----EMY---D 260 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHH---H
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH----HHH---H
Confidence 9999999866433221 2233457889999999999999999999999999999999 88888643221 111 1
Q ss_pred HHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 449 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
...... ....+...+..+.+++.+||+.||++|||+.+++++|+.
T Consensus 261 ~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 261 YLLHGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp HHHTTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHcCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111110 111222334779999999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=347.70 Aligned_cols=255 Identities=27% Similarity=0.386 Sum_probs=203.6
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE------CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCce
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 302 (552)
.++|.+.+.||+|+||.||+|.+ .++..||||++..........++.+|+.++..++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788999999999999999984 247789999997554444556789999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhccC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC---CCceEEc
Q 008828 303 LLVYPYMSNGSVASRLKAK-------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVG 372 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~-------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 372 (552)
++||||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999754 3589999999999999999999999 9999999999999994 4569999
Q ss_pred ccccceecCCCCC-ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHH
Q 008828 373 DFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKI 450 (552)
Q Consensus 373 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 450 (552)
|||++........ .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||..... .......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLEFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-------HHHHHHH
Confidence 9999975533221 12234457899999999999999999999999999999998 8888864321 1111111
Q ss_pred hhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 451 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.... ....+...+..+.+++.+||+.||.+|||+.|++++|+.
T Consensus 259 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 259 TSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcCC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 1111 111122334678999999999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=360.76 Aligned_cols=264 Identities=18% Similarity=0.231 Sum_probs=196.1
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecC------C
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------T 300 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~ 300 (552)
.++|++.+.||+|+||+||+|... +++.||||++..... .....++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 367888999999999999999965 689999999975422 22345688999999999999999999998654 3
Q ss_pred ceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 301 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 56999999976 46666654 489999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHH--------H-----
Q 008828 381 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW--------V----- 447 (552)
Q Consensus 381 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~--------~----- 447 (552)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... .
T Consensus 215 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 215 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp --C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred CCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 532 2334567999999999999999999999999999999999999999754321111000000 0
Q ss_pred --HHHhhh------cchhhhccccccC---cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 448 --KKIHQE------KKLEMLVDKDLKN---NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 448 --~~~~~~------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...... ..........+.. ........++.+|+.+||+.||++|||++|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000000000000 0112235789999999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=344.05 Aligned_cols=261 Identities=21% Similarity=0.266 Sum_probs=205.5
Q ss_pred HHHHHHHhcCCCCC-CeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhcc-ccccceeeeEee
Q 008828 222 FKELQSATSNFSSK-NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV-HRNLLRLIGFCM 297 (552)
Q Consensus 222 ~~e~~~~~~~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~-h~niv~l~~~~~ 297 (552)
+...+...+.|.+. +.||+|+||+||+|... +++.||+|+++..... .....+.+|+.++..+. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34444555667766 89999999999999976 6899999999754322 23557889999999884 699999999999
Q ss_pred cCCceeEEEeeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC---CCceEEc
Q 008828 298 TTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVG 372 (552)
Q Consensus 298 ~~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 372 (552)
.....++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999999999864 36799999999999999999999999 9999999999999997 7899999
Q ss_pred ccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh
Q 008828 373 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 373 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ........
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~ 247 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------ETYLNISQ 247 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHHHh
Confidence 999998765322 223456999999999999999999999999999999999999999643221 11111110
Q ss_pred hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
. ............+..+.+++.+||+.||++|||++|++++-
T Consensus 248 ~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 248 V-------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp T-------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred c-------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 0 00111111223346789999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=339.24 Aligned_cols=244 Identities=24% Similarity=0.369 Sum_probs=199.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 305 (552)
.++|.+.+.||+|+||+||+|... +++.||+|+++.... ......+.+|+..+..+ +||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457888999999999999999976 799999999975432 23455688899999988 899999999999999999999
Q ss_pred EeeccCCChhhhhccC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC----------------
Q 008828 306 YPYMSNGSVASRLKAK----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---------------- 365 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---------------- 365 (552)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999753 6799999999999999999999999 9999999999999984
Q ss_pred ---CCceEEcccccceecCCCCCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCccccccc
Q 008828 366 ---YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKG 441 (552)
Q Consensus 366 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~ 441 (552)
...+||+|||.+....... ...||..|+|||.+.+. .++.++|||||||++|+|++|.+++.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence 4479999999998765432 23489999999999876 567899999999999999999877642211
Q ss_pred chHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 442 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+ ..... ... ...+...+..+.+++.+||+.||++|||+.|++++
T Consensus 237 ----~-~~~~~-~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 ----W-HEIRQ-GRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ----H-HHHHT-TCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----H-HHHHc-CCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0 11111 111 11222234779999999999999999999999865
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=350.47 Aligned_cols=264 Identities=19% Similarity=0.253 Sum_probs=195.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.++|.+.+.||+|+||+||+|... +++.||||+++...... ....+.+|+.+++.++||||+++++++......++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 357888999999999999999965 68999999997543322 2345779999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee-----CCCCceEEcccccceecC
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL-----DEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill-----~~~~~~kl~Dfg~~~~~~ 381 (552)
||++ |+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9998 49999999888899999999999999999999999 99999999999999 455669999999998765
Q ss_pred CCCCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh--cchhh
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE--KKLEM 458 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 458 (552)
.... ......||..|+|||++.+. .++.++|||||||++|||++|+.||........ ........... .....
T Consensus 189 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 189 IPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ---LFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSTT
T ss_pred Cccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH---HHHHHHHhCCCchhhhhh
Confidence 3222 23344589999999999875 489999999999999999999999975332111 11111110000 00000
Q ss_pred h-------------ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 L-------------VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ....+........+.++.+++.+||+.||++|||+.|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 00000000011134678999999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=352.52 Aligned_cols=263 Identities=21% Similarity=0.292 Sum_probs=195.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|.+.+.||+|+||+||+|... +++.||+|+++..........+.+|+.++..++||||+++++++......++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999976 68999999997544332223456799999999999999999999999999999999
Q ss_pred ccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
++ |+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cc
Confidence 97 5888888754 4699999999999999999999999 99999999999999999999999999998654322 22
Q ss_pred eecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcc---hhhhcc--
Q 008828 388 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK---LEMLVD-- 461 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-- 461 (552)
.....||..|+|||.+.+ ..++.++|||||||++|||+||+.||........ ...+........ ......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ----LHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCTTTSTTGGGCH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHhchhhhcch
Confidence 234468999999999876 5689999999999999999999999975432111 111111100000 000000
Q ss_pred -------ccccC----cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 462 -------KDLKN----NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 462 -------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
+.... ......+.++.+++.+||+.||++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 00000 00112346789999999999999999999998743
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=343.08 Aligned_cols=267 Identities=23% Similarity=0.307 Sum_probs=208.4
Q ss_pred HHHHHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhh--ccccccceeeeEeecC
Q 008828 222 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLIGFCMTT 299 (552)
Q Consensus 222 ~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~h~niv~l~~~~~~~ 299 (552)
+.--....++|.+.+.||+|+||+||+|... ++.||||+++.. ....+.+|.+++.. ++||||+++++++...
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3333455678999999999999999999985 899999999643 24467788888877 7899999999999877
Q ss_pred C----ceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCceEEcCCCCCceeeCCCC
Q 008828 300 T----ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH--------EQCDPKIIHRDVKAANILLDEYY 367 (552)
Q Consensus 300 ~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~dlk~~Nill~~~~ 367 (552)
. ..++||||+++|+|.+++... .+++..++.++.|++.||.||| +. +|+||||||+|||++.++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence 6 789999999999999999764 5999999999999999999999 66 999999999999999999
Q ss_pred ceEEcccccceecCCCCCc---eeecccccccccCchhhccCC------CCCccchhHHHHHHHHHHhC----------C
Q 008828 368 EAVVGDFGLAKLLDHCDSH---VTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELISG----------L 428 (552)
Q Consensus 368 ~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dvws~Gv~l~elltg----------~ 428 (552)
.+||+|||++......... ......||+.|+|||.+.+.. ++.++|||||||++|||+|| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999876544332 123446999999999997763 34689999999999999999 5
Q ss_pred CccccCcccccccchHHHHHHHhhhcchhhhccccccCc-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 429 RALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN-YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 429 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.||....... .....+....... ...+.+... .....+..+.+++.+||+.||++|||+.||+++|+..
T Consensus 265 ~p~~~~~~~~--~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 265 LPYYDLVPSD--PSVEEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CTTTTTSCSS--CCHHHHHHHHTTS-----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCccccCcCc--ccHHHHHHHHHHH-----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 5665322211 1111222211111 111111111 1235678899999999999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=356.06 Aligned_cols=266 Identities=21% Similarity=0.281 Sum_probs=205.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|.+.+.||+|+||+||+|... ++..||+|+++..........+.+|+.++..++||||+++++++......++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56888899999999999999976 68999999997654444456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++|+|.+++.....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 187 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 187 (360)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C-
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---cc
Confidence 999999999988778999999999999999999999832 7999999999999999999999999998754321 22
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccch---------------------HHHH
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM---------------------LDWV 447 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~---------------------~~~~ 447 (552)
....||+.|+|||++.+..++.++|||||||++|||+||+.||............ ..+.
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 3346899999999999999999999999999999999999999753321100000 0000
Q ss_pred -HHHhhhcc----hhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 448 -KKIHQEKK----LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 448 -~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
........ ...+.............+.++.+++.+||+.||++|||+.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000 000000000001111234679999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=343.97 Aligned_cols=261 Identities=20% Similarity=0.231 Sum_probs=198.8
Q ss_pred cCCCC-CCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEE
Q 008828 230 SNFSS-KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~-~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 306 (552)
+.|.+ .+.||+|+||+||+|... +++.||||+++... ......+.+|+.++.++ +||||+++++++...+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 45776 478999999999999954 68999999997543 23455788999999884 7999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc---eEEcccccceecCCC
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGLAKLLDHC 383 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~~~~~~~ 383 (552)
||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 9999999999998877899999999999999999999999 9999999999999998776 999999998765322
Q ss_pred CC------ceeecccccccccCchhhcc-----CCCCCccchhHHHHHHHHHHhCCCccccCcccccccch----HHHHH
Q 008828 384 DS------HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM----LDWVK 448 (552)
Q Consensus 384 ~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~----~~~~~ 448 (552)
.. .......||..|+|||.+.. ..++.++|||||||++|||+||+.||............ .....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11223459999999999975 56889999999999999999999999754332211000 00000
Q ss_pred HHhhhcchhhhccccccCcCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 449 KIHQEKKLEMLVDKDLKNNYDR----IELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
.. ...+..... .++. ..+..+.+++.+||+.||++|||+.|++++-
T Consensus 248 ~~-----~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 248 ML-----FESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HH-----HHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HH-----HHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 00 000000000 1111 1246789999999999999999999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=337.66 Aligned_cols=247 Identities=24% Similarity=0.374 Sum_probs=205.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.++..++||||+++++++......++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888899999999999999976 57899999996432 1223456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-- 168 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence 9999999999998777899999999999999999999999 99999999999999999999999999997654322
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ......... +.
T Consensus 169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~-------~~---- 229 (284)
T 2vgo_A 169 -RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------ETHRRIVNV-------DL---- 229 (284)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTT-------CC----
T ss_pred -cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-------HHHHHHhcc-------cc----
Confidence 23456899999999999999999999999999999999999999743211 111111110 01
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.++...+..+.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1222334678999999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=338.67 Aligned_cols=247 Identities=28% Similarity=0.396 Sum_probs=197.3
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC-CceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-TERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-~~~~lv~e 307 (552)
.++|++.+.||+|+||+||+|... |+.||||+++... ....+.+|+.++.+++||||+++++++... ...++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 356888899999999999999875 8899999997543 345788999999999999999999997654 47899999
Q ss_pred eccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 308 YMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999997543 389999999999999999999999 9999999999999999999999999999755422
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
.....++..|+|||.+.+..++.++||||||+++|||+| |+.||...... +........ .
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~~~~~~~~~----------~ 231 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEKG----------Y 231 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------GHHHHHTTT----------C
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhcC----------C
Confidence 122347889999999999999999999999999999998 99998643211 111111111 1
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 111223345789999999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=346.08 Aligned_cols=248 Identities=16% Similarity=0.191 Sum_probs=201.8
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEE------ECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc---ccccceeeeEee
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLIGFCM 297 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~ 297 (552)
...++|.+.+.||+|+||+||+|. ..+++.||||+++... ...+..|+.++..++ |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 345678888999999999999994 4468899999996532 345777888877776 999999999999
Q ss_pred cCCceeEEEeeccCCChhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC-------
Q 008828 298 TTTERLLVYPYMSNGSVASRLK-----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE------- 365 (552)
Q Consensus 298 ~~~~~~lv~e~~~~g~L~~~l~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~------- 365 (552)
..+..++||||+++|+|.+++. ....+++..++.|+.||+.||+|||+. +|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 9999999999999999999997 356799999999999999999999998 9999999999999998
Q ss_pred ----CCceEEcccccceecCCC-CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccc
Q 008828 366 ----YYEAVVGDFGLAKLLDHC-DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK 440 (552)
Q Consensus 366 ----~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~ 440 (552)
++.+||+|||+++.+... .........||..|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 899999999999865422 23344556799999999999999999999999999999999999999864322110
Q ss_pred cchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhc
Q 008828 441 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLR-PKMSEVVRMLEG 503 (552)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~ 503 (552)
.. ...+.. ++ ..+.+.+++..|++.+|.+| |+++++.+.|+.
T Consensus 294 --------------~~----~~~~~~-~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 294 --------------KP----EGLFRR-LP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp --------------EE----CSCCTT-CS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred --------------ee----chhccc-cC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 00 111111 11 24667889999999999998 567777777765
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=346.25 Aligned_cols=257 Identities=20% Similarity=0.296 Sum_probs=206.7
Q ss_pred HHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-------hHHHHHHHHHHHhhc-cccccceeeeE
Q 008828 225 LQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLA-VHRNLLRLIGF 295 (552)
Q Consensus 225 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~~-~h~niv~l~~~ 295 (552)
.....++|.+.+.||+|+||.||+|... +|+.||||+++...... ....+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445577999999999999999999985 69999999996543211 133578899999998 79999999999
Q ss_pred eecCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccc
Q 008828 296 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 375 (552)
Q Consensus 296 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 375 (552)
+......++||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecC
Confidence 999999999999999999999998777899999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeecccccccccCchhhcc------CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHH
Q 008828 376 LAKLLDHCDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 449 (552)
Q Consensus 376 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 449 (552)
++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ......
T Consensus 246 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~~~~~ 316 (365)
T 2y7j_A 246 FSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-------ILMLRM 316 (365)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH
T ss_pred cccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------HHHHHH
Confidence 998765432 2334569999999999864 3588999999999999999999999964321 111111
Q ss_pred HhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 450 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..... .. ....... ..+..+.+++.+||+.||++|||+.|++++
T Consensus 317 i~~~~-~~--~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 317 IMEGQ-YQ--FSSPEWD----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHTC-CC--CCHHHHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhCC-CC--CCCcccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11110 00 0000001 123678999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=337.72 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=199.3
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeec----CCceeE
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTERLL 304 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~~l 304 (552)
.|.+.+.||+|+||+||+|... ++..||+|.+...... .....+.+|+.+++.++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3667788999999999999975 6889999999754322 234568899999999999999999998865 345789
Q ss_pred EEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEEcCCCCCceeeC-CCCceEEcccccceecC
Q 008828 305 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLD-EYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~ 381 (552)
||||+++|+|.+++.....+++..+..++.|++.||.|||+. + |+||||||+||+++ .++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999998877899999999999999999999998 7 99999999999998 78999999999997544
Q ss_pred CCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
.. ......||+.|+|||.+. +.++.++|||||||++|+|+||+.||..... .............
T Consensus 184 ~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~------ 247 (290)
T 1t4h_A 184 AS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVK------ 247 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCC------
T ss_pred cc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc------HHHHHHHHhccCC------
Confidence 32 233456999999999886 4699999999999999999999999964222 1111111111110
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+...+..+.+++.+||+.||++|||+.|++++
T Consensus 248 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 248 ---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 011111223678999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=342.08 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=203.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEee--cCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCM--TTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~--~~~~~~lv 305 (552)
++|++.+.||+|+||.||+|... +++.||+|.+...... .....+.+|+.+++.++||||+++++++. .....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 57888899999999999999975 6899999999754322 23456889999999999999999999875 35678999
Q ss_pred EeeccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCc-----eEEcCCCCCceeeCCCCceEEccccc
Q 008828 306 YPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPK-----IIHRDVKAANILLDEYYEAVVGDFGL 376 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfg~ 376 (552)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999864 34599999999999999999999998 7 99999999999999999999999999
Q ss_pred ceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcch
Q 008828 377 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456 (552)
Q Consensus 377 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (552)
++...... .......|+..|+|||.+.+..++.++||||||+++|+|+||+.||..... ......+... ..
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~-~~ 233 (279)
T 2w5a_A 163 ARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREG-KF 233 (279)
T ss_dssp HHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHT-CC
T ss_pred heeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------HHHHHHHhhc-cc
Confidence 98664322 122334689999999999999999999999999999999999999874321 1111111111 11
Q ss_pred hhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 457 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
...+...+..+.+++.+||+.||++|||+.|+++++...
T Consensus 234 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 234 ---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 111223347799999999999999999999999887653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=343.75 Aligned_cols=260 Identities=24% Similarity=0.304 Sum_probs=203.0
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEee----cCCcee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM----TTTERL 303 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~----~~~~~~ 303 (552)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++. .....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 35788899999999999999997 578999999986532 233457889999999999999999999987 344778
Q ss_pred EEEeeccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 304 LVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999998864 56799999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCc--------eeecccccccccCchhhccCC---CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHH
Q 008828 380 LDHCDSH--------VTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK 448 (552)
Q Consensus 380 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 448 (552)
....... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||....... ......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~-- 259 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG--DSVALA-- 259 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT--SCHHHH--
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc--chhhHH--
Confidence 4321110 012234799999999987654 6899999999999999999999986321110 001100
Q ss_pred HHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCc
Q 008828 449 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLA 507 (552)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 507 (552)
.. ...........+..+.+++.+||+.||.+|||+.|++++|+....+
T Consensus 260 -~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 260 -VQ----------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp -HH----------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred -hh----------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 00 0011111122346799999999999999999999999999986433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=363.12 Aligned_cols=252 Identities=23% Similarity=0.296 Sum_probs=205.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|...+.||+|+||.||+|+.+ +|+.||+|+++.... ......+..|+.++..++||||+++++++......++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999975 699999999964321 223456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 307 PYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 307 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999864 34699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ...........
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~---~~~~~~~i~~~--------- 408 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRVLEQ--------- 408 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC---HHHHHHHHHHC---------
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh---HHHHHHHHhhc---------
Confidence 322 23345799999999999999999999999999999999999999975432111 11111111111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKM-----SEVVR 499 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 499 (552)
. ..++...+..+.+++.+||+.||++||++ .++++
T Consensus 409 ~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 409 A--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred c--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0 11223345788999999999999999976 55654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=338.97 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=207.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||.||+|... +++.||+|++...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56888899999999999999976 5889999998654322 23456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 9999999999998777899999999999999999999999 999999999999999999999999999987653222
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......||..|+|||.+.+..++.++||||||+++|+|+||+.||...... ......... . .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~---------~--~ 232 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKKN---------E--Y 232 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTT---------C--C
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhhc---------c--C
Confidence 233456899999999999989999999999999999999999999743211 111111110 0 0
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+...+..+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1122234678999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=335.92 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=202.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeec---------
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--------- 298 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--------- 298 (552)
..+|++.+.||+|+||.||+|... +++.||+|+++... ..+.+|+.++..++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 456888999999999999999986 78999999997542 246789999999999999999998754
Q ss_pred -------CCceeEEEeeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCce
Q 008828 299 -------TTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 369 (552)
Q Consensus 299 -------~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 369 (552)
....++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 3457899999999999999964 35799999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHH
Q 008828 370 VVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 449 (552)
Q Consensus 370 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 449 (552)
||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.... .+...
T Consensus 162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~~~ 230 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------KFFTD 230 (284)
T ss_dssp EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------HHHHH
T ss_pred EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---------HHHHH
Confidence 999999998765432 2233458999999999999999999999999999999999988875210 11111
Q ss_pred HhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 450 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
. ....+.. ..+..+.+++.+||+.||++|||+.|++++|+..
T Consensus 231 ~---------~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 231 L---------RDGIISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp H---------HTTCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred h---------hcccccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 1111111 2235688999999999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=340.48 Aligned_cols=257 Identities=22% Similarity=0.339 Sum_probs=197.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.+|.+.+.||+|+||.||+|.. .+|+.||+|+++..... .....+.+|+.++..++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688889999999999999996 47899999999753322 23456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 307 PYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 307 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999998863 56799999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ............. . +
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~-~-----~ 256 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCD-Y-----P 256 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHHHHHTTC-S-----C
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHHHhhccc-C-----C
Confidence 222 22334589999999999999999999999999999999999999864321 1112222221111 0 0
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.. .....+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 257 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 257 PL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00 1122346799999999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=347.25 Aligned_cols=266 Identities=26% Similarity=0.392 Sum_probs=197.7
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHH--HhhccccccceeeeEeec-----CCc
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEM--ISLAVHRNLLRLIGFCMT-----TTE 301 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~~~h~niv~l~~~~~~-----~~~ 301 (552)
.++|.+.+.||+|+||+||+|.. +++.||||+++... ...+..|.++ +..++||||+++++++.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 35788889999999999999987 58999999996432 2334444444 456899999999986532 235
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCceEEcCCCCCceeeCCCCceEEcccc
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC------DPKIIHRDVKAANILLDEYYEAVVGDFG 375 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivH~dlk~~Nill~~~~~~kl~Dfg 375 (552)
.++||||+++|+|.+++.... .++..+..++.||+.||.|||+.+ .++|+||||||+|||++.++.+||+|||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 689999999999999997654 589999999999999999999863 3389999999999999999999999999
Q ss_pred cceecCCCCC-------ceeecccccccccCchhhcc-------CCCCCccchhHHHHHHHHHHhCCCccccCccccccc
Q 008828 376 LAKLLDHCDS-------HVTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG 441 (552)
Q Consensus 376 ~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~ 441 (552)
+++.+..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.|+..........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9987653221 12234469999999999976 356779999999999999999988876543322211
Q ss_pred chH----------HHHHHHhhhcchhhhccccccCc--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 442 AML----------DWVKKIHQEKKLEMLVDKDLKNN--YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 442 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
... ........... ..+.+... .....+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 111 00111100000 01111111 1234567899999999999999999999999999873
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=352.10 Aligned_cols=200 Identities=25% Similarity=0.332 Sum_probs=168.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecC-----Cc
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TE 301 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~ 301 (552)
.++|.+.+.||+|+||+||+|... +++.||||+++..... ....++.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 357889999999999999999975 5889999999754322 2345788999999999999999999998766 56
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.++||||+. |+|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 899999996 59999999888899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc---------------------eeecccccccccCchhh-ccCCCCCccchhHHHHHHHHHHhCCCccc
Q 008828 382 HCDSH---------------------VTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELISGLRALE 432 (552)
Q Consensus 382 ~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~elltg~~p~~ 432 (552)
..... ......||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 33211 12456799999999986 55679999999999999999998655543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.27 Aligned_cols=194 Identities=23% Similarity=0.354 Sum_probs=155.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecC-----Cce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~ 302 (552)
++|.+.+.||+|+||+||+|+.. +++.||||++...... ....++.+|+.++..++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57899999999999999999965 6899999999654322 2345788999999999999999999998543 568
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||||+. |+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 99999985 69999998888899999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC--------------------------ceeecccccccccCchhh-ccCCCCCccchhHHHHHHHHHHhC
Q 008828 383 CDS--------------------------HVTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELISG 427 (552)
Q Consensus 383 ~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~elltg 427 (552)
... .......||+.|+|||++ ....++.++|||||||++|||+||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 211 122345689999999986 456799999999999999999994
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=357.37 Aligned_cols=241 Identities=12% Similarity=0.097 Sum_probs=190.1
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCc--cCchHHHHHHHHH---HHhhccccccceee-------eE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGN--AIGGEIQFQTEVE---MISLAVHRNLLRLI-------GF 295 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~---~l~~~~h~niv~l~-------~~ 295 (552)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++... .......+.+|+. .++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999996 469999999997432 2234567889994 55566899999998 55
Q ss_pred eecCC-----------------ceeEEEeeccCCChhhhhccCCCCC-------HHHHHHHHHHHHHHHHHHhhcCCCce
Q 008828 296 CMTTT-----------------ERLLVYPYMSNGSVASRLKAKPSLD-------WATRKRIALGAARGLLYLHEQCDPKI 351 (552)
Q Consensus 296 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~l~-------~~~~~~i~~~ia~~l~~LH~~~~~~i 351 (552)
+...+ ..++||||+ +|+|.+++.....++ +..+..|+.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 689999997544344 488889999999999999999 99
Q ss_pred EEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecccccccccCchhhccC-----------CCCCccchhHHHHH
Q 008828 352 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGIL 420 (552)
Q Consensus 352 vH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dvws~Gv~ 420 (552)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 3344567 999999999887 89999999999999
Q ss_pred HHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 421 LLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 421 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+|||+||+.||........ ...+... .. ..+..+.+++.+||+.||++|||+.|++++
T Consensus 303 l~elltg~~Pf~~~~~~~~----------------~~~~~~~--~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG----------------SEWIFRS--CK----NIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC------CC----------------SGGGGSS--CC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCcccccccc----------------hhhhhhh--cc----CCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999964332111 1111110 01 123678999999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=344.31 Aligned_cols=267 Identities=22% Similarity=0.317 Sum_probs=202.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|.+.+.||+|+||.||+|... +++.||||++....... ....+.+|+.++..++||||+++++++......++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46888899999999999999976 58999999986543322 23457899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
|+++++|..++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 180 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 180 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cc
Confidence 999999999887777899999999999999999999999 99999999999999999999999999998654322 22
Q ss_pred eecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchH--------HHHHHHhhhcchhh
Q 008828 388 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKKIHQEKKLEM 458 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 458 (552)
.....||..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+. .+............
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 3345689999999999875 78999999999999999999999997543221110000 00000011111111
Q ss_pred hccccccCcC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 LVDKDLKNNY-----DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+...... .+..++.+.+++.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111111111 11235789999999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=345.73 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=206.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||.||++... +++.||+|++...... .....+.+|+.++..++||||+++++++...+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 56778899999999999999976 5789999998654322 23456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 9999999999998777899999999999999999999999 999999999999999999999999999987653222
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......||..|+|||.+.+..++.++|||||||++|||++|+.||..... ........... .
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~-------~---- 258 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYLRIKKNE-------Y---- 258 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTC-------C----
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-------HHHHHHHhcCC-------C----
Confidence 23345689999999999999999999999999999999999999974321 11111111110 0
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+......+.+++.+||+.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112233678999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=347.88 Aligned_cols=257 Identities=17% Similarity=0.196 Sum_probs=202.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC---------CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccce---------
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD---------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR--------- 291 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~--------- 291 (552)
++|.+.+.||+|+||.||+|.... ++.||+|++... ..+.+|+.++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 578889999999999999999763 789999999653 25779999999999999998
Q ss_pred ------eeeEeec-CCceeEEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCcee
Q 008828 292 ------LIGFCMT-TTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 362 (552)
Q Consensus 292 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 362 (552)
+++++.. ....++||||+ +|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 5677765 67889999999 99999999865 6899999999999999999999999 9999999999999
Q ss_pred eCCCC--ceEEcccccceecCCCCCc------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccC
Q 008828 363 LDEYY--EAVVGDFGLAKLLDHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 434 (552)
Q Consensus 363 l~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~ 434 (552)
++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999866432211 123346999999999999999999999999999999999999999753
Q ss_pred cccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 435 KTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.... ..+......... ....+.+.... ....+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 272 ~~~~--~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 272 LPNT--EDIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp TTCH--HHHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CcCH--HHHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 3111 111111111111 11111111100 01123779999999999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=363.04 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=206.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||+||+|... +++.||||++..... ......+.+|+.++++++||||+++++++......++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888899999999999999976 789999999965432 234567899999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee---CCCCceEEcccccceecCCC
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~ 383 (552)
||+.+|+|.+.+.....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 9999999999998888899999999999999999999999 99999999999999 56789999999999876543
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
. ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ...+..+......
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~------- 245 (484)
T 3nyv_A 183 K--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-------YDILKKVEKGKYT------- 245 (484)
T ss_dssp C--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC-------
T ss_pred c--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCC-------
Confidence 2 2334569999999999866 699999999999999999999999974322 1111111111100
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.........+..+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0000112234678999999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.83 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=202.3
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC------------chHHHHHHHHHHHhhccccccceeeeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI------------GGEIQFQTEVEMISLAVHRNLLRLIGF 295 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~~~h~niv~l~~~ 295 (552)
.++|.+.+.||+|+||+||+|... +++.||+|+++..... .....+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467888999999999999999975 5789999999754321 234568899999999999999999999
Q ss_pred eecCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC---ceEEc
Q 008828 296 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVG 372 (552)
Q Consensus 296 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~ 372 (552)
+......++||||+++|+|.+.+.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999998777899999999999999999999999 999999999999999775 69999
Q ss_pred ccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh
Q 008828 373 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 373 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
|||+++...... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||..... ......+..
T Consensus 192 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~ 261 (504)
T 3q5i_A 192 DFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-------QDIIKKVEK 261 (504)
T ss_dssp CCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH
T ss_pred ECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHc
Confidence 999998765432 233456999999999986 5689999999999999999999999974322 111122111
Q ss_pred hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.... .+.... ...+.++.+++.+||+.||.+|||+.|++++
T Consensus 262 ~~~~---~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 262 GKYY---FDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCC---CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCC---CCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1100 000000 1123678999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=334.86 Aligned_cols=248 Identities=22% Similarity=0.339 Sum_probs=197.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||.||+|... +++.||||+++... .......+.+|+.+++.++||||+++++++......++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888899999999999999976 68999999996432 2223457889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 9999999999998777899999999999999999999999 99999999999999999999999999998664322
Q ss_pred eeecccccccccCchhhccCCC-CCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ...........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~----------- 227 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PTLFKKIRGGV----------- 227 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-----------
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhcCc-----------
Confidence 2234468999999999988765 6899999999999999999999964321 11111111110
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+...+..+.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01122234678999999999999999999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=343.37 Aligned_cols=261 Identities=27% Similarity=0.371 Sum_probs=187.0
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
...++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.++..++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999854 68999999997554444455788999999999999999999999999999999
Q ss_pred EeeccCCChhhhhcc--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccc
Q 008828 306 YPYMSNGSVASRLKA--------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 377 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 377 (552)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999863 45699999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCC----ceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh
Q 008828 378 KLLDHCDS----HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 378 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
........ .......||+.|+|||.+.+ ..++.++||||||+++|||+||+.||....... . .......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~--~~~~~~~ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK----V--LMLTLQN 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----H--HHHHHTS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh----H--HHHHhcc
Confidence 76543221 12234568999999999876 568999999999999999999999997533211 0 0011110
Q ss_pred hc-ch-hhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 453 EK-KL-EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 453 ~~-~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.. .. ....+.... ...+..+.+++.+||+.||.+|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPSLETGVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCCTTC-----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCccccccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 00 001111111 1233678999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=361.01 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=200.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|.+.+.||+|+||+||+|... ++..||+|+++.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46888899999999999999976 688999999975432 2234578899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC---CCceEEcccccceecCCCC
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~~~ 384 (552)
|+++|+|.+.+.....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 999999999998777899999999999999999999999 9999999999999976 4559999999998765432
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
......||+.|+|||++. ..++.++|||||||++|+|++|+.||..... ............ ..+...
T Consensus 194 --~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~---~~~~~~ 260 (494)
T 3lij_A 194 --KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-------QEILRKVEKGKY---TFDSPE 260 (494)
T ss_dssp --CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCC---CCCSGG
T ss_pred --cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC---CCCchh
Confidence 233456999999999986 5699999999999999999999999974322 111122111110 001111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ...+..+.+++.+||+.||.+|||+.|++++
T Consensus 261 ~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 261 W----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp G----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred c----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1 1234678999999999999999999999853
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=350.74 Aligned_cols=274 Identities=19% Similarity=0.223 Sum_probs=200.3
Q ss_pred HHHHHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCc----------hHHHHHHHHHHHhhccccccce
Q 008828 222 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG----------GEIQFQTEVEMISLAVHRNLLR 291 (552)
Q Consensus 222 ~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~~~h~niv~ 291 (552)
..++....++|.+.+.||+|+||.||+|...+|+.||||++....... ....+.+|+.++.+++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 467778889999999999999999999998889999999996432211 1256899999999999999999
Q ss_pred eeeEeec-----CCceeEEEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC
Q 008828 292 LIGFCMT-----TTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE 365 (552)
Q Consensus 292 l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~ 365 (552)
+++++.. ....++||||+. |+|.+.+.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcC
Confidence 9999854 335799999998 578777764 34799999999999999999999999 9999999999999999
Q ss_pred CCceEEcccccceecCCCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchH
Q 008828 366 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML 444 (552)
Q Consensus 366 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~ 444 (552)
++.+||+|||+++..... .......||..|+|||.+.+ ..++.++|||||||++|+|+||+.||...........+.
T Consensus 170 ~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 170 NNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999999754322 22334568999999999877 678999999999999999999999997543211110000
Q ss_pred HHHHHH-------hhhcchhhhcccccc-------CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 445 DWVKKI-------HQEKKLEMLVDKDLK-------NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 445 ~~~~~~-------~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
...... ............... .......+..+.+++.+||+.||++|||+.|++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 000000 000000000000000 001122346789999999999999999999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=373.46 Aligned_cols=251 Identities=23% Similarity=0.280 Sum_probs=207.6
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhc-cccccceeeeEeecCCcee
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~ 303 (552)
..++|++.+.||+|+||+||+|... +++.||||+++... .......+..|..++..+ +||+|+++++++...+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4567889999999999999999975 58899999997532 122344677899999877 7999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
+||||+++|+|..++.....+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 9999999999999999877899999999999999999999999 9999999999999999999999999999864332
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+. ...
T Consensus 496 ~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~---------~~~ 558 (674)
T 3pfq_A 496 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIM---------EHN 558 (674)
T ss_dssp T-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHH---------SSC
T ss_pred C-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-------HHHHHHHH---------hCC
Confidence 2 234456799999999999999999999999999999999999999975322 11111111 111
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKM-----SEVVRM 500 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 500 (552)
..++...+.++.+|+.+||+.||++||++ +||+++
T Consensus 559 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 559 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred --CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 12233445789999999999999999998 666643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=347.94 Aligned_cols=262 Identities=22% Similarity=0.287 Sum_probs=196.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCC------c
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------E 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------~ 301 (552)
++|.+.+.||+|+||.||+|... +|+.||||++...... ....++.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 56888899999999999999974 6899999999654322 22456889999999999999999999987653 4
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 59999999 7899999876 4699999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHH--------HHHHHhh
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--------WVKKIHQ 452 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~ 452 (552)
.. .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||...........+.. +...+..
T Consensus 180 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 180 SE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp SS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 32 234568999999999987 6799999999999999999999999975432111000000 0000000
Q ss_pred h---c---chhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 453 E---K---KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 453 ~---~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
. . .+.......+ .......+..+.+++.+||+.||++|||+.|++++-
T Consensus 256 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp HHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 0 0 0000000000 011122347789999999999999999999999853
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=340.76 Aligned_cols=265 Identities=23% Similarity=0.348 Sum_probs=206.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-----CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCC--ce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~--~~ 302 (552)
++|.+.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 5678889999999999999984 368899999997542 334457899999999999999999999987654 67
Q ss_pred eEEEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 303 LLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 8999999999999999764 4699999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCce--eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccc----cccchHHHHHHHhhhcc
Q 008828 382 HCDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN----QKGAMLDWVKKIHQEKK 455 (552)
Q Consensus 382 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~ 455 (552)
...... .....++..|+|||.+.+..++.++||||||+++|||+||..|+....... .......+.. ..
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 271 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV-----FH 271 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH-----HH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH-----HH
Confidence 433321 123347788999999999899999999999999999999998886321100 0000000000 00
Q ss_pred hhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 456 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
+...+........+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011111111112233345789999999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=347.79 Aligned_cols=251 Identities=24% Similarity=0.287 Sum_probs=184.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEee--------c
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCM--------T 298 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~--------~ 298 (552)
..+|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++.++. ||||+++++++. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 357888899999999999999975 68999999985543 233456889999999996 999999999984 3
Q ss_pred CCceeEEEeeccCCChhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEEcCCCCCceeeCCCCceEEcc
Q 008828 299 TTERLLVYPYMSNGSVASRLKA---KPSLDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDEYYEAVVGD 373 (552)
Q Consensus 299 ~~~~~lv~e~~~~g~L~~~l~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~D 373 (552)
....++||||+. |+|.+++.. ...+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 344789999996 699888763 55799999999999999999999998 7 99999999999999999999999
Q ss_pred cccceecCCCCCce-----------eecccccccccCchhh---ccCCCCCccchhHHHHHHHHHHhCCCccccCccccc
Q 008828 374 FGLAKLLDHCDSHV-----------TTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 439 (552)
Q Consensus 374 fg~~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~ 439 (552)
||+++......... .....||+.|+|||.+ .+..++.++|||||||++|||+||+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 99998765432211 1134589999999998 56678999999999999999999999996432110
Q ss_pred ccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 440 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
+.............+..+.+++.+||+.||++|||+.|++++|+..
T Consensus 261 -------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 261 -------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000000001111224578999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=339.17 Aligned_cols=257 Identities=17% Similarity=0.246 Sum_probs=200.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeec--CCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMT--TTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~--~~~~~lv 305 (552)
++|++.+.||+|+||+||+|.. .+++.||||+++... ...+.+|+.++..++ ||||+++++++.. ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 5688889999999999999986 468999999996432 456889999999997 9999999999987 5678999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC-ceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~ 384 (552)
|||+++++|.+++. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+++......
T Consensus 112 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999885 389999999999999999999999 999999999999999776 89999999998765432
Q ss_pred CceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhc---------
Q 008828 385 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK--------- 454 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 454 (552)
. .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+...........
T Consensus 186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHHTT
T ss_pred c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHHHhcCCchhhhHHHHhc
Confidence 2 234468999999999987 6789999999999999999999999964332111 0111111000000
Q ss_pred -----chhhhcc--------ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 455 -----KLEMLVD--------KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 455 -----~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....... ...........+.++.+++.+||+.||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 000011112235789999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=356.72 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=203.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc-cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|.+.+.||+|+||+||+|... +++.||||+++... .......+.+|+.++.+++||||+++++++......++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 56888999999999999999975 68999999996432 22335678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC---CCCceEEcccccceecCCCC
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|+.+|+|.+.+.....+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++......
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 999999999998777899999999999999999999999 999999999999995 56689999999998664322
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......+...... .+
T Consensus 179 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~---~~--- 242 (486)
T 3mwu_A 179 --KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYA---FD--- 242 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCC---SC---
T ss_pred --ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC---CC---
Confidence 2334569999999999875 599999999999999999999999974321 1111221111100 00
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.......+..+.+++.+||+.||++|||+.|++++
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 -LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00112234678999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=339.05 Aligned_cols=255 Identities=29% Similarity=0.369 Sum_probs=196.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC--CCc--EEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ--DGT--VVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
++|++.+.||+|+||+||+|.+. +++ .||||+++.... ......+.+|+.++..++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56888899999999999999863 233 689999875432 233457899999999999999999999998754 88
Q ss_pred EEEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 304 LVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999998753 5699999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCce--eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 383 CDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 383 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
..... .....+|..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ...........
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~----- 241 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKEG----- 241 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTSC-----
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-------HHHHHHHHccC-----
Confidence 43321 223457889999999999889999999999999999999 9999864321 11111111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.....+...+..+.+++.+||+.||++|||+.+++++|+..
T Consensus 242 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 242 ----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 11111223447799999999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=344.77 Aligned_cols=266 Identities=23% Similarity=0.280 Sum_probs=198.7
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc----hHHHHHHHHHHHhhccccccceeeeEeecCCce
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 302 (552)
..++|.+.+.||+|+||.||+|... +|+.||||+++...... ....+.+|+.++..++||||+++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4568999999999999999999975 58999999997532211 123678999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 303 LLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
++||||+++ +|..++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999999986 888887654 4699999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
... .......||+.|+|||.+.+. .++.++|||||||++|||++|..||........ +........ ........
T Consensus 164 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~-~~~~~~~~ 238 (346)
T 1ua2_A 164 SPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLG-TPTEEQWP 238 (346)
T ss_dssp SCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHC-CCCTTTSS
T ss_pred CCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcC-CCChhhhh
Confidence 322 223345689999999999764 589999999999999999999998865332111 111111110 00000000
Q ss_pred ------cc---cccCcC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 461 ------DK---DLKNNY-----DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 461 ------~~---~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
+. ...... ....+..+.+++.+||+.||++|||+.|++++--
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 00 000000 1223478999999999999999999999997643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=336.46 Aligned_cols=251 Identities=20% Similarity=0.249 Sum_probs=186.1
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHH-HHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.++|++.+.||+|+||+||+|... +++.||+|+++.........+ +.++...++.++||||+++++++...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 457888999999999999999974 789999999976533333333 444555578889999999999999999999999
Q ss_pred eeccCCChhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 307 PYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 307 e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
||+++ +|.+++. ....+++..+..++.|++.||.|||+++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99974 8877664 4568999999999999999999999853 899999999999999999999999999986643
Q ss_pred CCCceeecccccccccCchhh----ccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhh
Q 008828 383 CDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (552)
.. ......||+.|+|||.+ .+..++.++|||||||++|||+||+.||...... ...+.......
T Consensus 163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~---- 230 (290)
T 3fme_A 163 DV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP------FQQLKQVVEEP---- 230 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH------HHHHHHHHHSC----
T ss_pred cc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch------HHHHHHHhccC----
Confidence 22 22334599999999996 5567899999999999999999999999642211 11111111111
Q ss_pred hccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 459 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 459 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
.........+..+.+++.+||+.||++|||+.|+++
T Consensus 231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 -----SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 001111223467899999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=338.46 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=204.4
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|.+.+.||+|+||+||+|... +|+.||+|+++.... .....+.+|+.++..++||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 356888899999999999999975 689999999975432 223468899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee---CCCCceEEcccccceecCCCC
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 999999999998777899999999999999999999999 99999999999999 78899999999999754322
Q ss_pred CceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccc
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (552)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.... . ..
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~-~------~~ 226 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-------SKLFEKIKEGY-Y------EF 226 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHCC-C------CC
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCC-C------CC
Confidence 22334589999999999999999999999999999999999999964321 11111111110 0 00
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 465 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
........+..+.+++.+||+.||++|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111122334779999999999999999999999873
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=338.30 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=198.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-------CchHHHHHHHHHHHhhccccccceeeeEeecCC
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-------IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT 300 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 300 (552)
.++|.+.+.||+|+||.||+|... +++.||||+++.... ......+.+|+.++..++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457889999999999999999975 588999999964321 112235889999999999999999999987654
Q ss_pred ceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc---eEEcccccc
Q 008828 301 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGLA 377 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~ 377 (552)
.++||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 899999999999999998888899999999999999999999999 9999999999999987654 999999999
Q ss_pred eecCCCCCceeecccccccccCchhhc---cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhc
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 454 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 454 (552)
+..... .......||..|+|||++. ...++.++|||||||++|+|++|+.||....... .....+.. .
T Consensus 165 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~----~ 235 (322)
T 2ycf_A 165 KILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQITS----G 235 (322)
T ss_dssp EECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---CHHHHHHH----T
T ss_pred eecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---HHHHHHHh----C
Confidence 876432 2223456899999999974 4678999999999999999999999997433211 11111111 0
Q ss_pred chhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 455 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
... ..+... ...+..+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~--~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 236 KYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccc--cCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 000 000011 1124678999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=332.37 Aligned_cols=250 Identities=21% Similarity=0.303 Sum_probs=198.0
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
+|....+||+|+||.||+|... +++.||||.++... ......+.+|+.++..++||||+++++++...+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455569999999999999964 68899999997543 233456889999999999999999999999999999999999
Q ss_pred cCCChhhhhccC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC-CCceEEcccccceecCCCCC
Q 008828 310 SNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 310 ~~g~L~~~l~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~ 385 (552)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999999754 3567899999999999999999999 9999999999999987 89999999999987653221
Q ss_pred ceeecccccccccCchhhccCC--CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
......||..|+|||.+.+.. ++.++||||||+++|+|+||+.||....... ........ . .
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~-~---------~ 242 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGM-F---------K 242 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHH-H---------C
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhcc-c---------c
Confidence 223456899999999997654 8899999999999999999999996422110 00000000 0 0
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.....+...+..+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1112223344778999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=351.21 Aligned_cols=261 Identities=20% Similarity=0.284 Sum_probs=196.1
Q ss_pred HHHhcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC-----
Q 008828 226 QSATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT----- 299 (552)
Q Consensus 226 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~----- 299 (552)
+...++|.+.+.||+|+||+||+|.. .+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 34567899999999999999999996 47899999998654322 23799999999999999999998543
Q ss_pred ---------------------------------CceeEEEeeccCCChhhhhc----cCCCCCHHHHHHHHHHHHHHHHH
Q 008828 300 ---------------------------------TERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLY 342 (552)
Q Consensus 300 ---------------------------------~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~ia~~l~~ 342 (552)
...++||||+++ +|.+.+. ....+++..+..++.||++||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 337899999984 7766664 45689999999999999999999
Q ss_pred HhhcCCCceEEcCCCCCceeeC-CCCceEEcccccceecCCCCCceeecccccccccCchhhccC-CCCCccchhHHHHH
Q 008828 343 LHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGIL 420 (552)
Q Consensus 343 LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~ 420 (552)
||+. +|+||||||+|||++ .++.+||+|||+++...... ......||..|+|||.+.+. .++.++|||||||+
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 999999999999998 68999999999998765332 22344689999999998775 48999999999999
Q ss_pred HHHHHhCCCccccCcccccccchHHHHHHHhhh---------cchhh-----hccccccCcCCHHHHHHHHHHHHHccCC
Q 008828 421 LLELISGLRALEFGKTANQKGAMLDWVKKIHQE---------KKLEM-----LVDKDLKNNYDRIELEEMVQVALLCTQY 486 (552)
Q Consensus 421 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~ 486 (552)
+|||++|+.||........ +...+...... ..... +........++...+..+.+++.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999975432211 11111110000 00000 0001111112233457799999999999
Q ss_pred CCCCCCCHHHHHHH
Q 008828 487 LPSLRPKMSEVVRM 500 (552)
Q Consensus 487 dP~~RPs~~evl~~ 500 (552)
||++|||+.|++++
T Consensus 309 dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 309 EPDLRINPYEAMAH 322 (383)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=344.18 Aligned_cols=259 Identities=20% Similarity=0.300 Sum_probs=205.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCch----------------HHHHHHHHHHHhhcccccccee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG----------------EIQFQTEVEMISLAVHRNLLRL 292 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------~~~~~~e~~~l~~~~h~niv~l 292 (552)
.++|.+.+.||+|+||.||+|.. +++.||||++........ ...+.+|+.++..++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788899999999999999999 899999999964322111 1678999999999999999999
Q ss_pred eeEeecCCceeEEEeeccCCChhhh------hcc--CCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEEcCCCCCceee
Q 008828 293 IGFCMTTTERLLVYPYMSNGSVASR------LKA--KPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILL 363 (552)
Q Consensus 293 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~--~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill 363 (552)
++++...+..++||||+++|+|.++ +.. ...+++..+..++.|++.||.|||+ . +|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999998 665 5689999999999999999999998 8 99999999999999
Q ss_pred CCCCceEEcccccceecCCCCCceeecccccccccCchhhccC-CCCC-ccchhHHHHHHHHHHhCCCccccCccccccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSE-KTDVFGFGILLLELISGLRALEFGKTANQKG 441 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~ 441 (552)
+.++.+||+|||.+...... ......||..|+|||.+.+. .++. ++|||||||++|||++|+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 99999999999999876432 33445699999999999887 6666 999999999999999999999753321
Q ss_pred chHHHHHHHhhhcchhhhcc------c---cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 442 AMLDWVKKIHQEKKLEMLVD------K---DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~------~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
.......... ......+ + ..........+..+.+++.+||+.||.+|||+.|++++-
T Consensus 259 --~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 259 --VELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp --HHHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred --HHHHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 1111111111 0000000 0 000000123457889999999999999999999999743
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=344.50 Aligned_cols=263 Identities=23% Similarity=0.326 Sum_probs=199.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecC--------
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTT-------- 299 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-------- 299 (552)
++|.+.+.||+|+||+||+|.. .+|+.||+|++....... ....+.+|+.++..++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5688899999999999999997 478999999986543322 344678999999999999999999998763
Q ss_pred CceeEEEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 300 TERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
...++||||+++ +|.+.+.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 467899999986 66666654 45799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC---ceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhc
Q 008828 379 LLDHCDS---HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 454 (552)
Q Consensus 379 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 454 (552)
....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...+.......
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~ 248 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ----LALISQLCGSI 248 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCC
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCC
Confidence 7653221 22234568999999999876 4589999999999999999999999975332111 11111111000
Q ss_pred c---hhhhccccc----------cCcCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 455 K---LEMLVDKDL----------KNNYDR-----IELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 455 ~---~~~~~~~~~----------~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ......... ...... ...+.+.+++.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 000000000 000000 013568899999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=346.66 Aligned_cols=268 Identities=21% Similarity=0.263 Sum_probs=202.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC-----Cce
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TER 302 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~ 302 (552)
..+|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.++..++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457899999999999999999965 68899999997544434446788999999999999999999998755 367
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||||+. |+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 89999997 5999988764 599999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCce--eecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh------
Q 008828 383 CDSHV--TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE------ 453 (552)
Q Consensus 383 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 453 (552)
..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+.........+
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 22211 234569999999998754 458999999999999999999999997543322111111000000000
Q ss_pred -----cchhhhcccccc--CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 454 -----KKLEMLVDKDLK--NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 454 -----~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
............ .......+..+.+++.+||+.||++|||+.|++++-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 000000000000 000112346789999999999999999999998653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=348.82 Aligned_cols=254 Identities=10% Similarity=0.004 Sum_probs=182.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--chHHHHHHHHHHHhhc--cccccceee-------eEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA--VHRNLLRLI-------GFC 296 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~--~h~niv~l~-------~~~ 296 (552)
..+|...+.||+|+||+||+|.+. +++.||||+++..... .....+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888899999999999999975 7899999999865432 2334577885555444 699988755 343
Q ss_pred ecC-----------------CceeEEEeeccCCChhhhhcc-CCCCCHHHH------HHHHHHHHHHHHHHhhcCCCceE
Q 008828 297 MTT-----------------TERLLVYPYMSNGSVASRLKA-KPSLDWATR------KRIALGAARGLLYLHEQCDPKII 352 (552)
Q Consensus 297 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~iv 352 (552)
... ...++||||++ |+|.+++.. ...+.+..+ ..++.||+.||+|||++ +|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 322 23799999999 899999975 334566666 78889999999999999 999
Q ss_pred EcCCCCCceeeCCCCceEEcccccceecCCCCCceeecccccccccCchhhcc--CCCCCccchhHHHHHHHHHHhCCCc
Q 008828 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRA 430 (552)
Q Consensus 353 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~elltg~~p 430 (552)
||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999986642 2224457799999999987 6799999999999999999999999
Q ss_pred cccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 431 LEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
|.......... . .....................+..+.+++.+||+.||++|||+.|+++
T Consensus 293 f~~~~~~~~~~-~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGS-W--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTC-C--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccc-h--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 97543211100 0 000000000111111111234578999999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=342.78 Aligned_cols=260 Identities=26% Similarity=0.363 Sum_probs=199.2
Q ss_pred ccCHHHHHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEe
Q 008828 219 RFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFC 296 (552)
Q Consensus 219 ~~~~~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~ 296 (552)
.+.+.++....++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.++.++ +||||+++++++
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 3444445556788999999999999999999974 68999999996543 2345688999999998 799999999998
Q ss_pred ec------CCceeEEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc
Q 008828 297 MT------TTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 368 (552)
Q Consensus 297 ~~------~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 368 (552)
.. ....++||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence 76 45789999999999999999753 5799999999999999999999999 9999999999999999999
Q ss_pred eEEcccccceecCCCCCceeecccccccccCchhhc-----cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccch
Q 008828 369 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 443 (552)
Q Consensus 369 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~ 443 (552)
+||+|||++........ ......||..|+|||.+. ...++.++|||||||++|+|+||+.||......
T Consensus 168 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------ 240 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------ 240 (326)
T ss_dssp EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------
T ss_pred EEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------
Confidence 99999999986543221 223446899999999997 567899999999999999999999999643211
Q ss_pred HHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 444 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......... . .+.. .....+..+.+++.+||+.||++|||+.|++++
T Consensus 241 -~~~~~~~~~-~-----~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 241 -RALFLIPRN-P-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp -HHHHHHHHS-C-----CCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHHHhhcC-c-----cccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111110 0 0111 111224678999999999999999999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=335.48 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=201.0
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
..++|++.+.||+|+||.||+|... +|+.||+|.++... ....+.+|+.++..++||||+++++++......++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 4567899999999999999999976 58999999997543 2356889999999999999999999999999999999
Q ss_pred eeccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+++|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999999986 456799999999999999999999999 999999999999999999999999999987653222
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......||..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......... .+..
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~------~~~~- 245 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-------RAIFMIPTNP------PPTF- 245 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSC------CCCC-
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCC------Cccc-
Confidence 223446899999999999999999999999999999999999999743211 1111111000 0000
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1112234678999999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=370.68 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=205.4
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEECC----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCce
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 302 (552)
...++|.+.+.||+|+||+||+|.+.. +..||+|.++..........+.+|+.+++.++||||+++++++. .+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 344668888999999999999999742 46799999876544444567999999999999999999999985 4568
Q ss_pred eEEEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 303 LLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999999754 4799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
...........+|+.|+|||.+.+..++.++|||||||++|||++ |..||..... .+.........
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-------~~~~~~i~~~~------ 609 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENGE------ 609 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHHTC------
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHcCC------
Confidence 443333334457889999999999999999999999999999997 8889864321 11111111111
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
....+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 610 ----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 610 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112233457899999999999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=333.33 Aligned_cols=253 Identities=22% Similarity=0.260 Sum_probs=204.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC--------chHHHHHHHHHHHhhcc-ccccceeeeEeec
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--------GGEIQFQTEVEMISLAV-HRNLLRLIGFCMT 298 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~ 298 (552)
.++|.+.+.||+|+||.||+|... +++.||||+++..... .....+.+|+.++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888999999999999999975 6899999999654211 11345789999999995 9999999999999
Q ss_pred CCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 299 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 299 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
....++||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchh
Confidence 999999999999999999998877899999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeecccccccccCchhhc------cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh
Q 008828 379 LLDHCDSHVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 379 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
...... ......|+..|+|||.+. ...++.++||||||+++|+|++|+.||..... .........
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~ 243 (298)
T 1phk_A 173 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMIMS 243 (298)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH
T ss_pred hcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-------HHHHHHHhc
Confidence 765432 223456899999999985 45688999999999999999999999964321 111111111
Q ss_pred hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
... ..........+..+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 244 GNY-------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp TCC-------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCc-------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 100 00001112234679999999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=336.98 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=200.7
Q ss_pred HHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccC-chHHHHHHHHHHHhhcc--ccccceeeeEeecCCce
Q 008828 226 QSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV--HRNLLRLIGFCMTTTER 302 (552)
Q Consensus 226 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~--h~niv~l~~~~~~~~~~ 302 (552)
....++|.+.+.||+|+||.||+|...+++.||||++...... .....+.+|+.++..++ ||||+++++++......
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3345678899999999999999999888999999999654322 23457889999999997 59999999999999999
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||| +.+++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||+++ +.+||+|||+++....
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 99999 56789999999888899999999999999999999999 9999999999999965 8999999999987643
Q ss_pred CCCc-eeecccccccccCchhhcc-----------CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHH
Q 008828 383 CDSH-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 450 (552)
Q Consensus 383 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 450 (552)
.... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ....+.
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~-- 250 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLH-- 250 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHH--
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH------HHHHHH--
Confidence 3222 2234568999999999875 4688899999999999999999999964221 011111
Q ss_pred hhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 451 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
.+.+......++...+..+.+++.+||+.||++|||+.|++++-
T Consensus 251 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 251 -------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp -------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 11122222222222346789999999999999999999998643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=346.72 Aligned_cols=259 Identities=19% Similarity=0.226 Sum_probs=204.4
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccc-cccceeeeEeecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-~niv~l~~~~~~~~~~~lv~ 306 (552)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... .++..|+.++..++| +++..+..++......++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 36789999999999999999996 46899999988654332 347789999999986 55666666777788889999
Q ss_pred eeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee---CCCCceEEcccccceecCC
Q 008828 307 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 307 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~ 382 (552)
||+ +++|.+++.. ...+++..++.|+.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999 8999999974 55799999999999999999999999 99999999999999 6889999999999987654
Q ss_pred CCCc------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcch
Q 008828 383 CDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456 (552)
Q Consensus 383 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (552)
.... ......||..|+|||.+.+..++.++|||||||++|||++|+.||...........+... .........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i-~~~~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI-SEKKVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH-HHHHHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH-hhccccccH
Confidence 3322 122556999999999999999999999999999999999999999753322111111111 111111111
Q ss_pred hhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 457 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
..+ .. ..+.++.+++.+||+.+|++||++.+|++.|+..
T Consensus 238 ~~l-----~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EAL-----CR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHH-----HT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHH-----hc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111 11 1236799999999999999999999999988764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=350.18 Aligned_cols=258 Identities=21% Similarity=0.317 Sum_probs=194.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCc------ee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE------RL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~------~~ 303 (552)
.+|.+.+.||+|+||+||+|+..++..||+|++...... ..+|+.+++.++||||+++++++..... .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 458888999999999999999877777999988643322 2369999999999999999999865433 77
Q ss_pred EEEeeccCCChhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC-CCCceEEccccccee
Q 008828 304 LVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKL 379 (552)
Q Consensus 304 lv~e~~~~g~L~~~l---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~ 379 (552)
+||||++++.+.... .....+++..+..++.||++||.|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999999875433322 2356799999999999999999999999 999999999999999 799999999999987
Q ss_pred cCCCCCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh------
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ------ 452 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 452 (552)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +...++....
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ---LVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHH
Confidence 643322 2345689999999998765 589999999999999999999999975432211 1111111000
Q ss_pred ----h----cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 453 ----E----KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 453 ----~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. .....+........+....+.++.+++.+||+.||++|||+.|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 00000000000111122244789999999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.03 Aligned_cols=264 Identities=20% Similarity=0.233 Sum_probs=193.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCC------c
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------E 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------~ 301 (552)
++|.+.+.||+|+||.||+|... +++.||||++...... .....+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 57888999999999999999965 6889999999754322 23456889999999999999999999987654 6
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.++||||+++ +|.+.+.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred eEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 7999999975 78888763 489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccch--------HHH-------
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM--------LDW------- 446 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~--------~~~------- 446 (552)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+ ..+
T Consensus 179 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 179 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred cc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 32 2233456999999999999999999999999999999999999999754321100000 000
Q ss_pred HHHHhhh------cchhhhccccccC---cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 447 VKKIHQE------KKLEMLVDKDLKN---NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 447 ~~~~~~~------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
+...... ............+ ......+..+.+++.+||+.||++|||++|++++-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 0000000 0000000000000 01123467899999999999999999999998753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=351.61 Aligned_cols=196 Identities=22% Similarity=0.277 Sum_probs=170.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhc------cccccceeeeEeecCCce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA------VHRNLLRLIGFCMTTTER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~------~h~niv~l~~~~~~~~~~ 302 (552)
.+|++.+.||+|+||+||+|... +++.||||+++... ....++.+|+.++..+ .|+||+++++++......
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 56888999999999999999865 58999999997532 2234577888888776 577999999999999999
Q ss_pred eEEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc--eEEcccccce
Q 008828 303 LLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--AVVGDFGLAK 378 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~~~ 378 (552)
++||||+. ++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+|||++.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 6899988754 3599999999999999999999999 9999999999999999887 9999999997
Q ss_pred ecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCc
Q 008828 379 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 435 (552)
Q Consensus 379 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~ 435 (552)
..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 65432 223568999999999999999999999999999999999999997543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=344.73 Aligned_cols=264 Identities=20% Similarity=0.263 Sum_probs=200.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC-----Cce
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TER 302 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~ 302 (552)
.++|.+.+.||+|+||.||+|... +|+.||||+++..........+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 367888999999999999999976 68999999997544333455688999999999999999999988754 678
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||||+. |+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEeccC-ccHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 99999997 5899988764 699999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCc---------eeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh
Q 008828 383 CDSH---------VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 383 ~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
.... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~ 240 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ----LLLIFGIIG 240 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHhC
Confidence 2211 1123468999999998765 6789999999999999999999999975432110 000000000
Q ss_pred hc----ch--------hhhccc------cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 453 EK----KL--------EMLVDK------DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 453 ~~----~~--------~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
.. .. .+.... ..........+..+.+++.+||+.||++|||+.|++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 00 00 000000 000000112346789999999999999999999998743
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.72 Aligned_cols=262 Identities=19% Similarity=0.238 Sum_probs=200.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc--------ccccceeeeEee---
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--------HRNLLRLIGFCM--- 297 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~--------h~niv~l~~~~~--- 297 (552)
++|.+.+.||+|+||+||+|+.. +++.||||+++... .....+.+|+.++..++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 67889999999999999999864 68899999996432 23456889999999886 788999999987
Q ss_pred -cCCceeEEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC-------
Q 008828 298 -TTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY------- 367 (552)
Q Consensus 298 -~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~------- 367 (552)
.....++||||+ ++++.+.+... ..+++..++.++.||+.||.|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 556789999999 55666665432 56999999999999999999999864 899999999999999775
Q ss_pred ------------------------------------------ceEEcccccceecCCCCCceeecccccccccCchhhcc
Q 008828 368 ------------------------------------------EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405 (552)
Q Consensus 368 ------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 405 (552)
.+||+|||+++..... .....||..|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999876432 233468999999999999
Q ss_pred CCCCCccchhHHHHHHHHHHhCCCccccCcccccccch--HHHHHHHhhhcc---------hhhhcccc-----------
Q 008828 406 GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM--LDWVKKIHQEKK---------LEMLVDKD----------- 463 (552)
Q Consensus 406 ~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~---------~~~~~~~~----------- 463 (552)
..++.++|||||||++|||+||+.||............ ...+........ ........
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 99999999999999999999999999754332211110 011111100000 00000000
Q ss_pred --------ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 464 --------LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 464 --------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
-....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0012356677889999999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=340.81 Aligned_cols=261 Identities=23% Similarity=0.375 Sum_probs=202.3
Q ss_pred HHHHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 223 KELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 223 ~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
+++....++|.+.+.||+|+||.||+|..++ .||+|+++.... ......+.+|+.++.+++||||+++++++.....
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3334456788999999999999999999864 499999875432 2223457789999999999999999999999999
Q ss_pred eeEEEeeccCCChhhhhccCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 302 RLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++ ++.+||+|||+++..
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999998654 799999999999999999999999 999999999999998 689999999998754
Q ss_pred CCCC----CceeecccccccccCchhhcc---------CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHH
Q 008828 381 DHCD----SHVTTAVRGTVGHIAPEYLST---------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 447 (552)
Q Consensus 381 ~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 447 (552)
.... ........||..|+|||.+.. ..++.++|||||||++|||+||+.||...... ...
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~ 252 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-------AII 252 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-------HHH
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHH
Confidence 3211 112233458999999999874 45789999999999999999999999743211 111
Q ss_pred HHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 008828 448 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG 505 (552)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 505 (552)
...... ..+... ....+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 253 ~~~~~~------~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 253 WQMGTG------MKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HHHHTT------CCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred HHhccC------CCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 111111 111111 1112356899999999999999999999999999854
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=328.64 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=198.6
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc---cCchHHHHHHHHHHHhhccccccceeeeEee--cCCce
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN---AIGGEIQFQTEVEMISLAVHRNLLRLIGFCM--TTTER 302 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~--~~~~~ 302 (552)
.++|.+.+.||+|+||.||+|... +++.||+|+++... .......+.+|+.++..++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999974 68899999997532 1234567899999999999999999999984 45578
Q ss_pred eEEEeeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 303 LLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
++||||++++ |.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 6666653 45799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-CceeecccccccccCchhhccCC--CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh
Q 008828 381 DHCD-SHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457 (552)
Q Consensus 381 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (552)
.... ........||..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ......+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~--- 229 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YKLFENIGKGS--- 229 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCC---
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HHHHHHHhcCC---
Confidence 5322 22334456999999999997654 37899999999999999999999974321 11111111110
Q ss_pred hhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ..+...+..+.+++.+||+.||++|||+.|++++
T Consensus 230 ----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 ----Y----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----C----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----C----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 1122234678999999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.42 Aligned_cols=253 Identities=20% Similarity=0.270 Sum_probs=199.0
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++..++||||+++++++......++|||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 357888999999999999999986 58999999996543 2345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 308 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 308 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...... ..
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 172 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ 172 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 9999999998864 56799999999999999999999999 9999999999999999999999999987532110 11
Q ss_pred eeecccccccccCchhhc-----cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 387 VTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
......||..|+|||.+. ...++.++||||||+++|+|++|+.||..... ............ ..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-~~--- 241 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSDP-PT--- 241 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCC-CC---
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-------HHHHHHHhccCC-cc---
Confidence 122345899999999984 56789999999999999999999999874321 111111111110 00
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
...+...+..+.+++.+||+.||++|||+.|++++-
T Consensus 242 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 242 ----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp ----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred ----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 011222346789999999999999999999998753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=341.41 Aligned_cols=270 Identities=21% Similarity=0.266 Sum_probs=190.4
Q ss_pred HHHHHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCc
Q 008828 223 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 223 ~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 301 (552)
.+.....++|.+.+.||+|+||+||+|... +++.||||++...... ...+.+++..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 344566789999999999999999999975 6899999998654322 2346678888888999999999999865433
Q ss_pred -------eeEEEeeccCCChhhh----hccCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCceEEcCCCCCceeeCC-CC
Q 008828 302 -------RLLVYPYMSNGSVASR----LKAKPSLDWATRKRIALGAARGLLYLH--EQCDPKIIHRDVKAANILLDE-YY 367 (552)
Q Consensus 302 -------~~lv~e~~~~g~L~~~----l~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~ivH~dlk~~Nill~~-~~ 367 (552)
.++||||++++ |... ......+++..+..++.|++.||.||| +. +|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 78999999874 4433 345667999999999999999999999 77 9999999999999996 89
Q ss_pred ceEEcccccceecCCCCCceeecccccccccCchhhccCC-CCCccchhHHHHHHHHHHhCCCccccCcccccccchHH-
Q 008828 368 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD- 445 (552)
Q Consensus 368 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~- 445 (552)
.+||+|||+++...... ......||..|+|||++.+.. ++.++|||||||++|||+||+.||...........+..
T Consensus 170 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 99999999998765332 233456899999999987654 89999999999999999999999975432111110000
Q ss_pred -------HHHHHhhhcchhhhccc------cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 446 -------WVKKIHQEKKLEMLVDK------DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 446 -------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+..............+. ..........+.++.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000000000 00011112245789999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=337.18 Aligned_cols=264 Identities=23% Similarity=0.329 Sum_probs=200.4
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEE--CCCcEEEEEEeccCccC-chHHHHHHHHHHHhhc---cccccceeeeEee----
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYL--QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA---VHRNLLRLIGFCM---- 297 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~---~h~niv~l~~~~~---- 297 (552)
+.++|.+.+.||+|+||.||+|.. .+++.||+|+++..... .....+.+|+.++..+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456899999999999999999997 36889999999643322 1223466788777766 7999999999987
Q ss_pred -cCCceeEEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccc
Q 008828 298 -TTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 374 (552)
Q Consensus 298 -~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 374 (552)
.....++||||+. |+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence 4567899999998 6999998753 3599999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh--
Q 008828 375 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ-- 452 (552)
Q Consensus 375 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 452 (552)
|+++..... .......||..|+|||.+.+..++.++|||||||++|||+||+.||........ ....+.....
T Consensus 165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~ 239 (326)
T 1blx_A 165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG 239 (326)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCC
Confidence 999765422 122345689999999999999999999999999999999999999975432111 0011111000
Q ss_pred -hcchhhh------cc---ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 453 -EKKLEML------VD---KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 453 -~~~~~~~------~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....... .. ......+....+..+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 00 000011122334778999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=349.68 Aligned_cols=256 Identities=24% Similarity=0.317 Sum_probs=193.0
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC------Ccee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TERL 303 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~~~ 303 (552)
+|...+.||+|+||+||+|++. +|+.||||++..... .+.+|+++++.++||||+++++++... ...+
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 5778899999999999999985 589999999865432 234799999999999999999988542 2356
Q ss_pred EEEeeccCCChhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC-CceEEcccccce
Q 008828 304 LVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAK 378 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~ 378 (552)
+||||+++ ++.+.+. ....+++..+..++.||++||.|||+. +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 6665553 456799999999999999999999998 99999999999999955 678999999998
Q ss_pred ecCCCCCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh----
Q 008828 379 LLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE---- 453 (552)
Q Consensus 379 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 453 (552)
....... .....||..|+|||++.+. .++.++|||||||++|||++|+.||....... .+...++.....
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence 7653322 2345689999999999765 79999999999999999999999997543211 111111111000
Q ss_pred -----cchhhhcccccc-----CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 454 -----KKLEMLVDKDLK-----NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 454 -----~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
........+.+. ..+....+.++.+|+.+||+.||++|||+.|++++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000000001100 00122334789999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=340.59 Aligned_cols=262 Identities=22% Similarity=0.260 Sum_probs=183.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecC------Cc
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TE 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~ 301 (552)
++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 67888999999999999999964 689999999965432 22345688999999999999999999998654 56
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 79999999 6799988876 4699999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh-
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML- 459 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 459 (552)
.. .....||..|+|||++.+ ..++.++|||||||++|||+||+.||...........+...+.. ........+
T Consensus 184 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~-p~~~~~~~~~ 258 (367)
T 2fst_X 184 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT-PGAELLKKIS 258 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS-CCHHHHTTCC
T ss_pred cc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CCHHHHHHhh
Confidence 21 234568999999999987 67899999999999999999999999754321111000000000 000000000
Q ss_pred -------cc---ccccCc---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 460 -------VD---KDLKNN---YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 460 -------~~---~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
.. ...... .....+..+.+|+.+||+.||++|||+.|++++-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 00 000000 0011246789999999999999999999999753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=334.28 Aligned_cols=257 Identities=19% Similarity=0.267 Sum_probs=201.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-C-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccc------cceeeeEeecCCc
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-Q-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN------LLRLIGFCMTTTE 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n------iv~l~~~~~~~~~ 301 (552)
++|.+.+.||+|+||+||+|.. . +++.||||+++... .....+.+|+.++..++|++ ++++++++...+.
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 5788899999999999999986 3 68899999996432 23456889999999888765 9999999999999
Q ss_pred eeEEEeeccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC--------------
Q 008828 302 RLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-------------- 365 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------------- 365 (552)
.++||||+ +++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 889999997654 689999999999999999999999 9999999999999987
Q ss_pred -----CCceEEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccc
Q 008828 366 -----YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK 440 (552)
Q Consensus 366 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~ 440 (552)
++.+||+|||+++..... .....||..|+|||.+.+..++.++|||||||++|||+||+.||........
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH- 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH-
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-
Confidence 678999999999865432 2334689999999999999999999999999999999999999975432111
Q ss_pred cchHHHHHHHhhhcc-----------------------------hhhhcccc-ccCcCCHHHHHHHHHHHHHccCCCCCC
Q 008828 441 GAMLDWVKKIHQEKK-----------------------------LEMLVDKD-LKNNYDRIELEEMVQVALLCTQYLPSL 490 (552)
Q Consensus 441 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~ 490 (552)
...+........ ......+. -........++.+.+++.+||+.||++
T Consensus 243 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 243 ---LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp ---HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred ---HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 011111000000 00000000 001113345688999999999999999
Q ss_pred CCCHHHHHHH
Q 008828 491 RPKMSEVVRM 500 (552)
Q Consensus 491 RPs~~evl~~ 500 (552)
|||+.|++++
T Consensus 320 Rpt~~ell~h 329 (339)
T 1z57_A 320 RITLREALKH 329 (339)
T ss_dssp SCCHHHHTTS
T ss_pred ccCHHHHhcC
Confidence 9999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=328.38 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=203.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++++++||||+++++++......++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 467899999999999999999976 689999999965432 234567889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC---CceEEcccccceecCCC
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY---YEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~~~~~~ 383 (552)
||+++++|.+.+.....+++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999999999988777899999999999999999999999 99999999999999754 47999999999865432
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
. ......||..|+|||.+.+ .++.++||||||+++|+|++|+.||..... ............ . .+..
T Consensus 178 ~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-~--~~~~ 244 (287)
T 2wei_A 178 T--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKY-A--FDLP 244 (287)
T ss_dssp S--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC-C--CCSG
T ss_pred C--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCC-C--CCch
Confidence 2 2233458999999999865 489999999999999999999999974321 111111111110 0 0000
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ....+..+.+++.+||+.||++|||+.|++++
T Consensus 245 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 245 Q----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp G----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h----hhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 11224678999999999999999999999873
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=335.72 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=179.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHH-HHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|...+.||+|+||.||+|... +|+.||||+++.........++..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 67888999999999999999975 689999999976543333445566666 6777899999999999999999999999
Q ss_pred eccCCChhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 308 YMSNGSVASRLKA-----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 308 ~~~~g~L~~~l~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
|+++ +|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9985 78777752 567999999999999999999999852 899999999999999999999999999986643
Q ss_pred CCCceeecccccccccCchhh----ccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhh
Q 008828 383 CDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (552)
.. ......||..|+|||.+ .+..++.++|||||||++|||++|+.||........ .+. ....
T Consensus 179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~------~~~~ 244 (327)
T 3aln_A 179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLT------QVVK 244 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------C------CCCC
T ss_pred cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------HHH------HHhc
Confidence 22 22333589999999998 456789999999999999999999999974321100 000 0000
Q ss_pred hccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+.+........+..+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 000111111112234779999999999999999999999763
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=342.12 Aligned_cols=264 Identities=20% Similarity=0.264 Sum_probs=182.5
Q ss_pred CCC-CCeeeeeCceEEEEEEEC---CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEee--cCCceeEE
Q 008828 232 FSS-KNLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM--TTTERLLV 305 (552)
Q Consensus 232 ~~~-~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~--~~~~~~lv 305 (552)
|.+ .++||+|+||+||+|+++ +++.||||++..... ...+.+|+.+++.++||||+++++++. .....++|
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 554 568999999999999975 578999999975432 236789999999999999999999995 46778999
Q ss_pred EeeccCCChhhhhcc---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee----CCCCceEEc
Q 008828 306 YPYMSNGSVASRLKA---------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVVG 372 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~ 372 (552)
|||+.+ +|.+++.. ...+++..++.|+.||+.||.|||+. +|+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999974 78777742 12599999999999999999999999 99999999999999 678999999
Q ss_pred ccccceecCCCCC--ceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccc--cchHHHH
Q 008828 373 DFGLAKLLDHCDS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQK--GAMLDWV 447 (552)
Q Consensus 373 Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~--~~~~~~~ 447 (552)
|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||......... ....+.+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987653221 223445689999999999874 5899999999999999999999999754321100 0000111
Q ss_pred HHHhhh---c---chhhh------------ccccccCcCC---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 448 KKIHQE---K---KLEML------------VDKDLKNNYD---------RIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 448 ~~~~~~---~---~~~~~------------~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+... . ....+ .......... ......+.+|+.+||+.||.+|||++|++++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111000 0 00000 0000000000 0013568899999999999999999999975
Q ss_pred Hh
Q 008828 501 LE 502 (552)
Q Consensus 501 L~ 502 (552)
--
T Consensus 335 p~ 336 (405)
T 3rgf_A 335 PY 336 (405)
T ss_dssp GG
T ss_pred hh
Confidence 43
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=335.33 Aligned_cols=259 Identities=19% Similarity=0.249 Sum_probs=196.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCce-----
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER----- 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~----- 302 (552)
++|.+.+.||+|+||+||+|... +|+.||||+++...... ....+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 57888899999999999999965 68999999997543322 245688999999999999999999999877654
Q ss_pred -eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 303 -LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 303 -~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
++||||+. |+|.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 122 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 588888754 499999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh--hc----
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ--EK---- 454 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~---- 454 (552)
.. .....||+.|+|||.+.+ ..++.++|||||||++|+|+||+.||......... ......... ..
T Consensus 196 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 196 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGTEFVQK 268 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCHHHHTT
T ss_pred cC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCcHHHHHH
Confidence 22 234568999999999987 68999999999999999999999999753321110 010000000 00
Q ss_pred --------chhhhccccccCc---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 455 --------KLEMLVDKDLKNN---YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 455 --------~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
....+. ...... .....+..+.+++.+||+.||++|||+.|++++--
T Consensus 269 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 269 LNDKAAKSYIQSLP-QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp CSCHHHHHHHHHSC-CCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hhhhhhhhhhhccC-CCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 000000 000000 01123478999999999999999999999987533
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=327.57 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=193.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeec---------
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--------- 298 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--------- 298 (552)
.++|++.+.||+|+||.||+|... +++.||||+++... .....+.+|+.++..++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 456888899999999999999975 78999999996422 234568899999999999999999998864
Q ss_pred ----CCceeEEEeeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcc
Q 008828 299 ----TTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 373 (552)
Q Consensus 299 ----~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 373 (552)
....++||||+++|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 34678999999999999999743 4688899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCC-------------CceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCccccc
Q 008828 374 FGLAKLLDHCD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQ 439 (552)
Q Consensus 374 fg~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~ 439 (552)
||++....... ........||..|+|||.+.+. .++.++|||||||++|||++ |+.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~--- 233 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME--- 233 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH---
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh---
Confidence 99998654221 1122344589999999999864 78999999999999999998 4432110
Q ss_pred ccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 440 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
.......... ........++...+..+.+++.+||+.||.+|||+.|++++-
T Consensus 234 ---~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 234 ---RVNILKKLRS-------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp ---HHHHHHHHHS-------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred ---HHHHHHhccc-------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 0111111111 011122223344457789999999999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.74 Aligned_cols=199 Identities=25% Similarity=0.311 Sum_probs=169.4
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-cc-----ccceeeeEeecCC
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HR-----NLLRLIGFCMTTT 300 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~-----niv~l~~~~~~~~ 300 (552)
..++|.+.+.||+|+||+||+|... +++.||||+++... ....++..|+.++..++ |+ +|+++++++....
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 3568999999999999999999975 68899999997432 22345777888888775 44 4999999999999
Q ss_pred ceeEEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC--CCCceEEccccc
Q 008828 301 ERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYYEAVVGDFGL 376 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~ 376 (552)
..++||||+. |+|.+++... ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999996 5999998754 4699999999999999999999952 22899999999999995 578899999999
Q ss_pred ceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccC
Q 008828 377 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 434 (552)
Q Consensus 377 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~ 434 (552)
++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9876432 23356899999999999999999999999999999999999999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=328.03 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=194.9
Q ss_pred HHHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-----hHHHHHHHHHHHhhc----cccccceeeeE
Q 008828 226 QSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLA----VHRNLLRLIGF 295 (552)
Q Consensus 226 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~----~h~niv~l~~~ 295 (552)
+...++|.+.+.||+|+||.||+|... +++.||||+++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344578999999999999999999864 68899999996543221 223456789998888 89999999999
Q ss_pred eecCCceeEEEee-ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC-CCCceEEcc
Q 008828 296 CMTTTERLLVYPY-MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGD 373 (552)
Q Consensus 296 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~D 373 (552)
+...+..++|+|| +.+++|.+++.....+++..++.++.||+.||.|||+. +|+||||||+||+++ .++.+||+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999999 78999999998877899999999999999999999999 999999999999999 889999999
Q ss_pred cccceecCCCCCceeecccccccccCchhhccCCCC-CccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh
Q 008828 374 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452 (552)
Q Consensus 374 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 452 (552)
||+++...... .....||..|+|||++.+..+. .++|||||||++|||++|+.||..... ...
T Consensus 184 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------------~~~ 247 (312)
T 2iwi_A 184 FGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------------ILE 247 (312)
T ss_dssp CSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHH
T ss_pred cchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------------Hhh
Confidence 99998765422 2345589999999999877764 589999999999999999999863210 000
Q ss_pred hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.. ..++...+..+.+++.+||+.||++|||+.|++++--
T Consensus 248 ---------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 248 ---------AE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp ---------TC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred ---------hc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00 0112223467899999999999999999999997543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=332.39 Aligned_cols=259 Identities=19% Similarity=0.257 Sum_probs=196.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCCc------
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE------ 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~------ 301 (552)
++|.+.+.||+|+||.||+|... +|+.||||++....... ....+.+|+.++..++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888899999999999999975 68999999997543222 24568899999999999999999999987654
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.++||||+. |+|.+++.. .+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999997 588888754 499999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh--hcchhh
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ--EKKLEM 458 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 458 (552)
.. .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +......... ......
T Consensus 178 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 178 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHHHTT
T ss_pred CC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHH
Confidence 22 234468999999999987 6789999999999999999999999975432111 0000000000 000000
Q ss_pred h-----------cccccc---CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 459 L-----------VDKDLK---NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 459 ~-----------~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
+ ...... .......+..+.+++.+||+.||++|||+.|++++-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 0 000000 111223457899999999999999999999998653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=330.14 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=201.6
Q ss_pred HhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-----hHHHHHHHHHHHhhcc--ccccceeeeEeecC
Q 008828 228 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAV--HRNLLRLIGFCMTT 299 (552)
Q Consensus 228 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~--h~niv~l~~~~~~~ 299 (552)
..++|.+.+.||+|+||.||+|... +++.||||+++...... ....+.+|+.++.+++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 4567889999999999999999864 68999999997543221 2234668999999986 59999999999999
Q ss_pred CceeEEEeeccC-CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC-CCCceEEcccccc
Q 008828 300 TERLLVYPYMSN-GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLA 377 (552)
Q Consensus 300 ~~~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~ 377 (552)
+..++|||++.+ ++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++ +++.+||+|||++
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999976 89999998878899999999999999999999999 999999999999999 7899999999999
Q ss_pred eecCCCCCceeecccccccccCchhhccCCC-CCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcch
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (552)
+..... ......||..|+|||++.+..+ +.++|||||||++|||+||+.||..... .... .
T Consensus 198 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------~~~~-~- 259 (320)
T 3a99_A 198 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRG-Q- 259 (320)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHC-C-
T ss_pred cccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------hhcc-c-
Confidence 876532 2234569999999999987775 6889999999999999999999963210 0000 0
Q ss_pred hhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 457 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
.. ++...+.++.+++.+||+.||++|||+.|++++-
T Consensus 260 -----~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 260 -----VF----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp -----CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred -----cc----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 00 1112236789999999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=330.44 Aligned_cols=251 Identities=20% Similarity=0.247 Sum_probs=173.0
Q ss_pred hcCCCCC-CeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeec----CCce
Q 008828 229 TSNFSSK-NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTER 302 (552)
Q Consensus 229 ~~~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~ 302 (552)
.++|.+. ++||+|+||+||+|... +++.||||++.... ....+....+..+.||||+++++++.. ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 3577774 47999999999999976 68999999996432 112223334566789999999999876 4457
Q ss_pred eEEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC---CCceEEcccccc
Q 008828 303 LLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLA 377 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~ 377 (552)
++||||+++|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 8999999999999999755 3699999999999999999999999 9999999999999986 456999999999
Q ss_pred eecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (552)
+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............. .... .
T Consensus 179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~-~--- 248 (336)
T 3fhr_A 179 KETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR---RIRL-G--- 248 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH---hhhc-c---
Confidence 865432 22345589999999999888899999999999999999999999974332111000000 0000 0
Q ss_pred hhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
............+..+.+++.+||+.||++|||+.|++++
T Consensus 249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000111112234778999999999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=333.69 Aligned_cols=262 Identities=19% Similarity=0.261 Sum_probs=198.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-----------ccccceeeeEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----------HRNLLRLIGFCM 297 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----------h~niv~l~~~~~ 297 (552)
.+|.+.+.||+|+||+||+|.. .+++.||||+++... .....+.+|+.++.+++ ||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 5788899999999999999996 468999999996432 22446788999988876 899999999987
Q ss_pred cCC----ceeEEEeeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC------C
Q 008828 298 TTT----ERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD------E 365 (552)
Q Consensus 298 ~~~----~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~------~ 365 (552)
... ..++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+++ +|+||||||+|||++ .
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 654 688999999 8899999875 346999999999999999999999853 899999999999994 4
Q ss_pred CCceEEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccc---
Q 008828 366 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA--- 442 (552)
Q Consensus 366 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~--- 442 (552)
.+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...........
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 458999999999876432 2234689999999999999999999999999999999999999975432111100
Q ss_pred hHHHHHHHhh--------hcchhhhcc----------c---------cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 008828 443 MLDWVKKIHQ--------EKKLEMLVD----------K---------DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMS 495 (552)
Q Consensus 443 ~~~~~~~~~~--------~~~~~~~~~----------~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 495 (552)
+......... .......+. . .-...++...+.++.+++.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 0011100000 000000000 0 001134567788999999999999999999999
Q ss_pred HHHHH
Q 008828 496 EVVRM 500 (552)
Q Consensus 496 evl~~ 500 (552)
|++++
T Consensus 330 ell~h 334 (373)
T 1q8y_A 330 GLVNH 334 (373)
T ss_dssp HHHTC
T ss_pred HHhhC
Confidence 99874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=341.48 Aligned_cols=249 Identities=24% Similarity=0.271 Sum_probs=187.6
Q ss_pred CCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEEeecc
Q 008828 232 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMS 310 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~ 310 (552)
|...+.||+|+||+||.+...+|+.||||++.... ...+.+|+.++.++ +||||+++++++......++||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 44567899999999987766779999999986432 34577899999876 89999999999999999999999996
Q ss_pred CCChhhhhccCCCC-------CHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC-------------CceE
Q 008828 311 NGSVASRLKAKPSL-------DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-------------YEAV 370 (552)
Q Consensus 311 ~g~L~~~l~~~~~l-------~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-------------~~~k 370 (552)
|+|.+++...... ++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999999755322 3334678999999999999999 99999999999999754 5899
Q ss_pred EcccccceecCCCCCc---eeecccccccccCchhhcc-------CCCCCccchhHHHHHHHHHHh-CCCccccCccccc
Q 008828 371 VGDFGLAKLLDHCDSH---VTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQ 439 (552)
Q Consensus 371 l~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~ 439 (552)
|+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 9999999877643322 1234569999999999976 578999999999999999999 899986422110
Q ss_pred ccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 008828 440 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501 (552)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 501 (552)
....... .. .+..........+.++.+++.+||+.||++|||+.|++++-
T Consensus 248 ----~~i~~~~---~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 248 ----SNIIRGI---FS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp ----HHHHHTC---CC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred ----HHHhcCC---CC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 0111000 00 01111122456678899999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=329.69 Aligned_cols=257 Identities=18% Similarity=0.247 Sum_probs=198.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CC-cEEEEEEeccCccCchHHHHHHHHHHHhhccccc------cceeeeEeecCCc
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DG-TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN------LLRLIGFCMTTTE 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n------iv~l~~~~~~~~~ 301 (552)
++|.+.+.||+|+||+||+|... ++ +.||+|+++... .....+.+|+.++..++|++ ++.+.+++.....
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 57888999999999999999975 34 789999996432 23456888999999998776 8999999999999
Q ss_pred eeEEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee----------------
Q 008828 302 RLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---------------- 363 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---------------- 363 (552)
.++||||+ ++++.+.+... ..+++..+..++.||+.||.|||++ +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 56777776543 4799999999999999999999999 99999999999999
Q ss_pred ---CCCCceEEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccc
Q 008828 364 ---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK 440 (552)
Q Consensus 364 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~ 440 (552)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH- 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 56789999999999865432 2335699999999999999999999999999999999999999975332111
Q ss_pred cchHHHHHHHhhhcc---h--------------------------hhhccc-cccCcCCHHHHHHHHHHHHHccCCCCCC
Q 008828 441 GAMLDWVKKIHQEKK---L--------------------------EMLVDK-DLKNNYDRIELEEMVQVALLCTQYLPSL 490 (552)
Q Consensus 441 ~~~~~~~~~~~~~~~---~--------------------------~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~ 490 (552)
...+........ . .....+ .............+.+++.+||+.||++
T Consensus 248 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 248 ---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp ---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred ---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 111111100000 0 000000 0000112344578999999999999999
Q ss_pred CCCHHHHHHH
Q 008828 491 RPKMSEVVRM 500 (552)
Q Consensus 491 RPs~~evl~~ 500 (552)
|||+.|++++
T Consensus 325 Rpt~~e~l~h 334 (355)
T 2eu9_A 325 RITLAEALLH 334 (355)
T ss_dssp SCCHHHHTTS
T ss_pred CcCHHHHhcC
Confidence 9999999854
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=331.87 Aligned_cols=262 Identities=21% Similarity=0.263 Sum_probs=191.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEee-----------
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM----------- 297 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~----------- 297 (552)
++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 57888899999999999999976 48999999986543 233457889999999999999999999874
Q ss_pred ---cCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC-CCCceEEcc
Q 008828 298 ---TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGD 373 (552)
Q Consensus 298 ---~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~D 373 (552)
.....++||||++ |+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++ +++.+||+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3456789999998 699999875 4699999999999999999999999 999999999999997 577999999
Q ss_pred cccceecCCCCC--ceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHH
Q 008828 374 FGLAKLLDHCDS--HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 450 (552)
Q Consensus 374 fg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 450 (552)
||+++....... .......+|..|+|||.+.+ ..++.++|||||||++|||+||+.||......... .......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~~ 241 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLILESI 241 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHS
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhc
Confidence 999987643211 12233457899999998866 67899999999999999999999999754321110 0000000
Q ss_pred hh--hcchhh-------hcccccc------CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 451 HQ--EKKLEM-------LVDKDLK------NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 451 ~~--~~~~~~-------~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.. .....+ ....... .......+..+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00 000000 0000000 00111234779999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=322.92 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=179.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHH-HHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|.+.+.||+|+||.||+|... +|+.||||+++.........+ +.++..++..++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 56788899999999999999975 689999999976543333333 4445556778899999999999999999999999
Q ss_pred eccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 308 YMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 308 ~~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|+ ++.+..+.. ....+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 99 445555443 25679999999999999999999998 5 89999999999999999999999999997654322
Q ss_pred ceeecccccccccCchhhc-----cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 386 HVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
......||+.|+|||.+. ...++.++|||||||++|||+||+.||..... .............
T Consensus 180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~----- 247 (318)
T 2dyl_A 180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT------DFEVLTKVLQEEP----- 247 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHHSCC-----
T ss_pred -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc------cHHHHHHHhccCC-----
Confidence 223445899999999994 45689999999999999999999999974221 1111111111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+... .....+..+.+++.+||+.||.+|||+.|++++
T Consensus 248 -~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 248 -PLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -CCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -CCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000 011133678999999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=354.08 Aligned_cols=258 Identities=24% Similarity=0.331 Sum_probs=199.2
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeec------CCc
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT------TTE 301 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~------~~~ 301 (552)
..+|.+.+.||+|+||+||+|... +|+.||||+++..........+.+|+.++..++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 367999999999999999999974 6899999999765444445678999999999999999999999765 667
Q ss_pred eeEEEeeccCCChhhhhccCC---CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc---eEEcccc
Q 008828 302 RLLVYPYMSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFG 375 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg 375 (552)
.++||||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999997543 699999999999999999999999 9999999999999997664 9999999
Q ss_pred cceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcc
Q 008828 376 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455 (552)
Q Consensus 376 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 455 (552)
++....... ......||..|+|||.+.+..++.++|||||||++|+|+||..||....... .|.........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~------~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV------QWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH------HSSTTCC----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh------hhhhhhhcccc
Confidence 998765432 2334569999999999999999999999999999999999999997532111 11110000000
Q ss_pred hhhhcc----------c--cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 008828 456 LEMLVD----------K--DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEV 497 (552)
Q Consensus 456 ~~~~~~----------~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 497 (552)
...... . ..........+..+.+++.+||+.||++|||+.|+
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000000 0 01122345567889999999999999999999774
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=334.88 Aligned_cols=248 Identities=23% Similarity=0.280 Sum_probs=187.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.+|...+.||+|+||+||.....+++.||||++..... ..+.+|+.++..+ +||||+++++++......++||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 45778889999999997655566799999999965332 2345899999988 799999999999999999999999
Q ss_pred ccCCChhhhhccCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC-----CCceEEcccccceecCC
Q 008828 309 MSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-----YYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 309 ~~~g~L~~~l~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~~~~~~~ 382 (552)
+. |+|.+++.... ...+..+..++.||+.||.|||+. +|+||||||+|||++. ...+||+|||+++....
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 96 59999987543 466667789999999999999999 9999999999999953 34688999999987653
Q ss_pred CCC--ceeecccccccccCchhhc---cCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcch
Q 008828 383 CDS--HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKL 456 (552)
Q Consensus 383 ~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (552)
... .......||+.|+|||++. ...++.++|||||||++|||+| |..||..... ............
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~~~ 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--------RQANILLGACSL 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--------HHHHHHTTCCCC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--------HHHHHHhccCCc
Confidence 322 2234456999999999997 4567889999999999999999 8888853211 001111110000
Q ss_pred hhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 457 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. . ..........+.+++.+||+.||++|||+.|++++
T Consensus 248 ~-----~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 D-----C--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp T-----T--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c-----c--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0 0 01122345668899999999999999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.54 Aligned_cols=238 Identities=22% Similarity=0.291 Sum_probs=192.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC--CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCc-----e
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ--DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE-----R 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~-----~ 302 (552)
++|.+.+.||+|+||+||+|... +++.||||++...........+.+|+.++..++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57888999999999999999975 5899999999754433445578899999999999999999999987665 6
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||||+++++|.+++.. .+++..+..|+.||+.||.|||++ +|+||||||+|||++.+ .+||+|||+++....
T Consensus 160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 999999999999988765 699999999999999999999999 99999999999999985 899999999987653
Q ss_pred CCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 383 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 383 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
. ....||+.|+|||++.+.. +.++|||||||++|+|++|..|+....... +.
T Consensus 234 ~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------------~~-- 285 (681)
T 2pzi_A 234 F-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------LP-- 285 (681)
T ss_dssp C-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------------CC--
T ss_pred C-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------------cc--
Confidence 2 3346999999999997754 889999999999999999988876321100 00
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHhc
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPK-MSEVVRMLEG 503 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~ 503 (552)
...........+.+++.+||+.||++||+ ++++.+.|..
T Consensus 286 --~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 --EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp --TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00001122367899999999999999996 4555555543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=307.64 Aligned_cols=230 Identities=12% Similarity=0.032 Sum_probs=182.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|.+.+.||+|+||.||+|... +++.||||+++...... ....+.+|+..+..++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 46888899999999999999976 48999999997654332 2357889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++++|.+++... .....+..|+.|++.||.|||++ +|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999654 46667899999999999999999 99999999999999999999997443
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
|++ .++.++|||||||++|||+||+.||............. ........ ...
T Consensus 175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---------~~~~~~~~--~~~ 226 (286)
T 3uqc_A 175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---------RDTAGQPI--EPA 226 (286)
T ss_dssp ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---------BCTTSCBC--CHH
T ss_pred ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---------HHhccCCC--Chh
Confidence 333 36789999999999999999999998543321100000 00000000 000
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
......+..+.+++.+||+.||++| |+.|+++.|+..
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0112234678999999999999999 999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=319.59 Aligned_cols=243 Identities=13% Similarity=0.149 Sum_probs=185.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCcc-------CchHHHHHHHHHHHhhcc---------ccccceee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-------IGGEIQFQTEVEMISLAV---------HRNLLRLI 293 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~~~---------h~niv~l~ 293 (552)
++|.+.+.||+|+||+||+|+. +|+.||||+++.... ......+.+|+.+++.++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 5678889999999999999998 689999999975432 222357889999988886 66666665
Q ss_pred eE-----------------eec-------------CCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHH
Q 008828 294 GF-----------------CMT-------------TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 343 (552)
Q Consensus 294 ~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~L 343 (552)
++ +.. ....++||||+++|++.+.+.. ..+++..+..++.||+.||.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Confidence 54 332 6788999999999987777754 5689999999999999999999
Q ss_pred h-hcCCCceEEcCCCCCceeeCCCC--------------------ceEEcccccceecCCCCCceeecccccccccCchh
Q 008828 344 H-EQCDPKIIHRDVKAANILLDEYY--------------------EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 402 (552)
Q Consensus 344 H-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~ 402 (552)
| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||+
T Consensus 178 H~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 178 EASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGG
T ss_pred HHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhh
Confidence 9 88 999999999999999887 8999999999876532 2369999999999
Q ss_pred hccCCCCCccchhHHHHH-HHHHHhCCCccccCcccccccchHHHHHHHhhhcchhh-hccccccCcCCHHHHHHHHHHH
Q 008828 403 LSTGQSSEKTDVFGFGIL-LLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM-LVDKDLKNNYDRIELEEMVQVA 480 (552)
Q Consensus 403 ~~~~~~~~~~Dvws~Gv~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li 480 (552)
+.+.. +.++||||+|++ .+++++|..||.. ..|....... .... ..............+.++.+|+
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~----------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN----------VLWLHYLTDK-MLKQMTFKTKCNTPAMKQIKRKIQEFH 316 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH----------HHHHHHHHHH-HHHTCCCSSCCCSHHHHHHHHHHHHHH
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcc----------hhhhhHHHHh-hhhhhccCcccchhhhhhcCHHHHHHH
Confidence 98766 889999998777 7788889888852 1122111110 0000 0111111222345778999999
Q ss_pred HHccCCCCCCCCCHHHHH-HH
Q 008828 481 LLCTQYLPSLRPKMSEVV-RM 500 (552)
Q Consensus 481 ~~cl~~dP~~RPs~~evl-~~ 500 (552)
.+||+.| |++|++ ++
T Consensus 317 ~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 317 RTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHGGGSS-----SHHHHHHHC
T ss_pred HHHhccC-----CHHHHHhcC
Confidence 9999976 899988 54
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=305.59 Aligned_cols=225 Identities=19% Similarity=0.270 Sum_probs=176.9
Q ss_pred cCCCCC-CeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHH-hhccccccceeeeEeec----CCce
Q 008828 230 SNFSSK-NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLLRLIGFCMT----TTER 302 (552)
Q Consensus 230 ~~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~~~h~niv~l~~~~~~----~~~~ 302 (552)
++|.+. +.||+|+||.||+|... +++.||+|+++.. ..+.+|+.++ +..+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456655 78999999999999974 6899999999642 3466888887 56689999999999876 6678
Q ss_pred eEEEeeccCCChhhhhccCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC---CCceEEcccccc
Q 008828 303 LLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLA 377 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~ 377 (552)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999997643 699999999999999999999999 9999999999999998 789999999998
Q ss_pred eecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (552)
.... +..++.++|||||||++|||+||+.||.......... ....
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------------~~~~ 212 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------GMKT 212 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------------CSCC
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------------HHHH
Confidence 7543 1345679999999999999999999996432211000 0000
Q ss_pred hhccccccCcCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 MLVDKDLKNNYD----RIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 ~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+.... ...+ ...+.++.+++.+||+.||++|||+.|++++
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 0111 1234779999999999999999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=328.09 Aligned_cols=240 Identities=15% Similarity=0.111 Sum_probs=179.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccc-ccccee---------eeE-
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVH-RNLLRL---------IGF- 295 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h-~niv~l---------~~~- 295 (552)
..|...++||+|+||+||+|.+. +|+.||||+++...... ....+.+|+.++..++| +|...+ ...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45667789999999999999954 69999999997433222 24568899999998876 221111 111
Q ss_pred -----------eec-----CCceeEEEeeccCCChhhhhc-------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceE
Q 008828 296 -----------CMT-----TTERLLVYPYMSNGSVASRLK-------AKPSLDWATRKRIALGAARGLLYLHEQCDPKII 352 (552)
Q Consensus 296 -----------~~~-----~~~~~lv~e~~~~g~L~~~l~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 352 (552)
+.. ....+++|+++ +++|.+++. ....+++..+..++.||++||.|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111 12346667665 579998884 134588889999999999999999999 999
Q ss_pred EcCCCCCceeeCCCCceEEcccccceecCCCCCceeecccccccccCchhh----------ccCCCCCccchhHHHHHHH
Q 008828 353 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL----------STGQSSEKTDVFGFGILLL 422 (552)
Q Consensus 353 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dvws~Gv~l~ 422 (552)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999865422 344567 999999999 5556889999999999999
Q ss_pred HHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 423 ELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 423 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
||+||+.||........ ...++... .. .++.+.+++.+||+.||++||++.|++++
T Consensus 309 elltg~~Pf~~~~~~~~----------------~~~~~~~~--~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG----------------SEWIFRSC--KN----IPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHSSCCCCTTGGGSC----------------SGGGGSSC--CC----CCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHCCCCCCCcchhhh----------------HHHHHhhc--cc----CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999975332111 11111110 11 23679999999999999999999988753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=283.36 Aligned_cols=186 Identities=15% Similarity=0.057 Sum_probs=132.9
Q ss_pred eeeeCceEEEEEE-ECCCcEEEEEEeccCccC---------chHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEEE
Q 008828 238 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI---------GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 238 iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 306 (552)
.+.|++|.+..++ .--|+.+|+|++...... ....+|.+|+++|+++ .|+||+++++++.+....||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666555544 224889999999654211 1234699999999999 6999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||++|++|.+++...++++.. +|+.||+.||+|+|++ |||||||||+|||+++++.+||+|||+++...... .
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~ 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-S 394 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC----C
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC-c
Confidence 999999999999988888765 5889999999999999 99999999999999999999999999998765432 2
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCcc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRAL 431 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~ 431 (552)
.....+||+.|+|||++.+ .+..++|+||+|++++++.+|..++
T Consensus 395 ~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 3345679999999999865 5677899999999998887765554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=253.57 Aligned_cols=185 Identities=16% Similarity=0.190 Sum_probs=145.5
Q ss_pred CCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCc-------hHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 233 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 233 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
...+.||+|+||+||+|.. .++.+++|......... ...++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 47888999875432211 123588999999999999999777777778888999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|||+++|+|.+++.. +..++.|+++||.|||++ +|+||||||+|||++. .+||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999999999976 568999999999999999 9999999999999999 999999999998754322
Q ss_pred ce------eecccccccccCchhhcc--CCCCCccchhHHHHHHHHHHhCCCcc
Q 008828 386 HV------TTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRAL 431 (552)
Q Consensus 386 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~elltg~~p~ 431 (552)
.. .....||+.|+|||++.. ..|+..+|+||..+-..+-+.++.++
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 235679999999999987 56888899999988888877765544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=212.15 Aligned_cols=153 Identities=14% Similarity=0.072 Sum_probs=122.2
Q ss_pred HHHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccC-----------------chHHHHHHHHHHHhhccc
Q 008828 224 ELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-----------------GGEIQFQTEVEMISLAVH 286 (552)
Q Consensus 224 e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~~~h 286 (552)
.+......|.+.+.||+|+||.||+|...+|+.||+|+++..... .....+.+|+.++..++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 344445567777999999999999999977999999999643211 12346889999999998
Q ss_pred cccceeeeEeecCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCC
Q 008828 287 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 366 (552)
Q Consensus 287 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 366 (552)
| +++.+++. .+..++||||+++|+|.+ +.. .....++.|++.||.|||+. +|+||||||+|||++ +
T Consensus 163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-T
T ss_pred -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-C
Confidence 5 66666543 356799999999999998 432 23557999999999999999 999999999999999 9
Q ss_pred CceEEcccccceecCCCCCceeecccccccccCchhhcc
Q 008828 367 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405 (552)
Q Consensus 367 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 405 (552)
+.+||+|||+++. +..|.|||++..
T Consensus 229 ~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 229 EGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp TEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred CcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 9999999999963 345788998753
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=4.9e-20 Score=173.08 Aligned_cols=134 Identities=22% Similarity=0.227 Sum_probs=123.2
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|+.|+|++|+|+++.+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|+.|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 47899999999999988889999999999999999999888999999999999999999999655566899999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATGA 135 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~~ 135 (552)
++|+|++..|..|..+++|+.|+|++|+|++.++..+. +.++|++|++.|.|..
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l 170 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL 170 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence 99999988899999999999999999999998887554 6889999999998764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.7e-20 Score=176.56 Aligned_cols=138 Identities=17% Similarity=0.172 Sum_probs=107.6
Q ss_pred CCCCCeeeeeCceEEEEEEE-CCCcE--EEEEEeccCccC-----------------------chHHHHHHHHHHHhhcc
Q 008828 232 FSSKNLVGKGGFGNVYKGYL-QDGTV--VAVKRLKDGNAI-----------------------GGEIQFQTEVEMISLAV 285 (552)
Q Consensus 232 ~~~~~~iG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~~~ 285 (552)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+|+..+..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 67888 999997543111 00125788999999999
Q ss_pred cccc--ceeeeEeecCCceeEEEeeccC-C----ChhhhhccCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCceEEcCCC
Q 008828 286 HRNL--LRLIGFCMTTTERLLVYPYMSN-G----SVASRLKAKPSLDWATRKRIALGAARGLLYLH-EQCDPKIIHRDVK 357 (552)
Q Consensus 286 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~dlk 357 (552)
|+++ ..++++ ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| +. +|+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCC
Confidence 8864 334432 367899999942 4 55555432 235578899999999999999 88 99999999
Q ss_pred CCceeeCCCCceEEcccccceecC
Q 008828 358 AANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 358 ~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
|+|||++. .++|+|||++....
T Consensus 199 p~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEETT
T ss_pred HHHEEEcC--cEEEEECcccccCC
Confidence 99999998 99999999997653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.5e-19 Score=169.33 Aligned_cols=132 Identities=20% Similarity=0.217 Sum_probs=120.6
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|++++..|..|.++++|++|+|++|+|+...+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 57999999999999998999999999999999999998666677899999999999999999766677899999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 134 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~ 134 (552)
++|+|+ .+|..+..+++|+.|+|++|+|++.++..+. +.++|++|++.|.|.
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 999999 8899999999999999999999988776544 788999999999874
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=2e-19 Score=168.91 Aligned_cols=134 Identities=19% Similarity=0.183 Sum_probs=122.0
Q ss_pred CcccEeccCCCCCccccc-ccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLS-SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+.+++|+|++|++++..| ..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 32 ~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 111 (220)
T 2v70_A 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLM 111 (220)
T ss_dssp TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEE
T ss_pred CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEE
Confidence 357899999999998755 4689999999999999999988788999999999999999999977777899999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATGA 135 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~~ 135 (552)
|++|+|++..|..|..+++|+.|+|++|+|++.+|..+. +.++|++|++.|.|..
T Consensus 112 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 112 LRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp CTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred CCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 999999988899999999999999999999998887655 6789999999998764
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.79 E-value=6.4e-19 Score=169.08 Aligned_cols=113 Identities=23% Similarity=0.206 Sum_probs=57.3
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
+|+.|+|++|++++..+..|+++++|++|+|++|.|++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 34555555555555444455555555555555555554444445555555555555555554333444555555555555
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCCC
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 115 (552)
+|+|++..+..|..+++|+.|+|++|+|++.++
T Consensus 116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 148 (251)
T 3m19_A 116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA 148 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CCcCCCcChhHhccCCcccEEECcCCcCCccCH
Confidence 555553333344445555555555555554444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.7e-18 Score=166.81 Aligned_cols=132 Identities=22% Similarity=0.235 Sum_probs=66.9
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|++++..+..|+++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 34555555555555444444555555555555555555444444455555555555555555443444455555555555
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICAT 133 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~ 133 (552)
++|+|++..+..+..+++|+.|+|++|++++.++..+. +.+++++|++.|.+
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 221 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 221 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccC
Confidence 55555544444445555555555555555554443322 44555555555443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.6e-18 Score=158.92 Aligned_cols=133 Identities=22% Similarity=0.233 Sum_probs=119.3
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|++++..+..|+.+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 57999999999999887778999999999999999999766667899999999999999999666667899999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 134 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~ 134 (552)
++|+|++..+..+..+++|+.|+|++|+|++.++..+. +.+++++|++.|.+.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 99999977777789999999999999999988876544 788999999998765
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.9e-18 Score=167.11 Aligned_cols=132 Identities=22% Similarity=0.200 Sum_probs=81.6
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|+++. +|..+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 77 ~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 155 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (290)
T ss_dssp TTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CcCCEEECCCCcCCc-CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence 455666666666553 4556666666666666666666555556666666666666666666544455666666666666
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccccCCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICATG 134 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~~~ 134 (552)
++|+|++..+..|..+++|+.|+|++|+|+..++..+. +.++|++|++.|.|+
T Consensus 156 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 156 ANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCc
Confidence 66666644444556666666666666666654444332 456667777766653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.4e-18 Score=164.49 Aligned_cols=130 Identities=22% Similarity=0.234 Sum_probs=83.3
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|+|++|+++++.+..|.++++|++|+|++|++++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+
T Consensus 60 l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 139 (270)
T 2o6q_A 60 LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139 (270)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence 35677777777777665555566677777777777777655555566667777777777776655555566666666666
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccc
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 130 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~ 130 (552)
|++|+|++..+..|..+++|+.|+|++|++++.++..+. +.++|++|.+.
T Consensus 140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (270)
T 2o6q_A 140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCC
Confidence 666666644444566666666666666666665554332 45566666554
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-18 Score=193.50 Aligned_cols=115 Identities=35% Similarity=0.573 Sum_probs=77.4
Q ss_pred CCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccccccCCCCccccccccccEEe
Q 008828 25 LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLD 104 (552)
Q Consensus 25 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 104 (552)
+++|+.|||++|+++|.+|..|+++++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|+.|+
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 45566666666666666676777777777777777777777777777777777777777777777777777777777777
Q ss_pred ccCCCCCCCCCCccc----CcccccCCccccCCCCCCCCC
Q 008828 105 LSYNNLSGPVPSFHA----KTFNITGNSLICATGAEEDCF 140 (552)
Q Consensus 105 l~~N~l~~~~~~~~~----~~~~l~~N~~~c~~~~~~~c~ 140 (552)
|++|+|+|.+|.... ...++.||+..|+.+.. .|.
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~ 749 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCD 749 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCC
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCC
Confidence 777777776665321 34556677777776544 553
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-17 Score=153.66 Aligned_cols=127 Identities=23% Similarity=0.312 Sum_probs=114.1
Q ss_pred cEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccc
Q 008828 5 CYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 84 (552)
Q Consensus 5 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 84 (552)
+++++++|+++. +|..+ .++|++|+|++|.|+ .+|..|.++++|+.|+|++|.|++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~~-ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKV-LPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSS-CCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCc-CCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 678999999886 66655 479999999999998 78899999999999999999999877788999999999999999
Q ss_pred cccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCCC
Q 008828 85 SLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATGA 135 (552)
Q Consensus 85 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~~ 135 (552)
+|++..|..|..+++|+.|+|++|+|++.++..+. +.++|++|++.|+|..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence 99988888999999999999999999988876554 7889999999998764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=5.8e-18 Score=155.36 Aligned_cols=127 Identities=22% Similarity=0.331 Sum_probs=76.8
Q ss_pred cEeccCCCCCcccccccccCCCCCcEEecccCccCCCCch-hhcCCCCCCEEEccCCcCCCCCCccccCCcccccccccc
Q 008828 5 CYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPT-EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83 (552)
Q Consensus 5 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 83 (552)
++|++++|+++. +|..+. .+|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~~-ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCc-CccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 456666666643 444442 2666666666666644443 356666666666666666655566666666666666666
Q ss_pred ccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCC
Q 008828 84 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 134 (552)
Q Consensus 84 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~ 134 (552)
|+|++..|..|..+++|+.|+|++|+|++.+|..+. +.++|++|++.|.+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 666655555566666666666666666665554433 455666666666654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=4.3e-18 Score=166.52 Aligned_cols=132 Identities=22% Similarity=0.223 Sum_probs=62.5
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
+|++|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|+
T Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 185 (285)
T 1ozn_A 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185 (285)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECC
Confidence 44444444444444444444444444444444444443333334444444455555444443333334444555555555
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCC
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 134 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~ 134 (552)
+|++++..|..+..+++|+.|+|++|++++.++..+. +.+++++|++.|.+.
T Consensus 186 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred CCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 5555444444555555555555555555544433221 445555555555443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=8.8e-18 Score=154.13 Aligned_cols=131 Identities=20% Similarity=0.248 Sum_probs=114.6
Q ss_pred cccEeccCCCCCcccccc-cccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSS-SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
+|++|+|++|++++..+. .|+.+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 789999999999987665 5999999999999999999888999999999999999999999888888999999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccccCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICAT 133 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~~ 133 (552)
++|+|++..|..+..+++|+.|+|++|++++..+-.+. +...+.++...|..
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~ 165 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCC
Confidence 99999999999999999999999999999987663222 23345555555654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.72 E-value=2.5e-17 Score=157.91 Aligned_cols=132 Identities=23% Similarity=0.287 Sum_probs=114.3
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 57899999999999998888899999999999999999977777888999999999999999966666688899999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
|++|+|++..+..|..+++|+.|+|++|+|++.++..+. +.++|++|++.|.
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 999999976666888999999999999999988776544 6788999999886
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.72 E-value=4.7e-18 Score=172.16 Aligned_cols=133 Identities=21% Similarity=0.162 Sum_probs=67.5
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus 64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 143 (361)
T 2xot_A 64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYL 143 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEEC
Confidence 44555555555555544445555555555555555555444444555555555555555555444455555555555555
Q ss_pred ccccccCCCCccc---cccccccEEeccCCCCCCCCCCccc-------CcccccCCccccCCC
Q 008828 82 NNNSLTGAIPPSL---SNMSQLAFLDLSYNNLSGPVPSFHA-------KTFNITGNSLICATG 134 (552)
Q Consensus 82 ~~N~l~~~~p~~~---~~l~~L~~l~l~~N~l~~~~~~~~~-------~~~~l~~N~~~c~~~ 134 (552)
++|+|++..+..| ..+++|+.|+|++|+|++.++..+. +.++|++|++.|+|.
T Consensus 144 ~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 144 SQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 5555553222222 3455555555555555544432211 345666666666543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=5.6e-18 Score=169.53 Aligned_cols=144 Identities=13% Similarity=0.110 Sum_probs=100.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccC-------------chHHHHHHHHHHHhhccccccceeeeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-------------GGEIQFQTEVEMISLAVHRNLLRLIGF 295 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~~~h~niv~l~~~ 295 (552)
..-|.+...||+|+||.||+|...+|+.||||+++..... ........+..+.....|+|+.+++..
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 3448889999999999999999989999999998632110 001112222222223334444433322
Q ss_pred eec------CCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC--
Q 008828 296 CMT------TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-- 367 (552)
Q Consensus 296 ~~~------~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-- 367 (552)
... ....++||||+++++|..+... +....++.|++.+|.|||+. |||||||||.|||+++++
T Consensus 174 gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 174 GFPVPEPIAQSRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp TCSCCCEEEEETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECS
T ss_pred CCCCCeeeeccCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCc
Confidence 111 1234799999999888765432 23467889999999999998 999999999999998776
Q ss_pred --------ceEEcccccceecC
Q 008828 368 --------EAVVGDFGLAKLLD 381 (552)
Q Consensus 368 --------~~kl~Dfg~~~~~~ 381 (552)
.+.|+||+-+....
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETT
T ss_pred ccccccccceEEEEeCCcccCC
Confidence 38999999876544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.71 E-value=5.6e-18 Score=168.06 Aligned_cols=132 Identities=27% Similarity=0.448 Sum_probs=74.3
Q ss_pred CCcccEeccCCCCCcccccccccCCC-CCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCcc----------
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLT-NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST---------- 69 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---------- 69 (552)
|++|++|+|++|.+++.+|..+..++ +|++|+|++|++++.+|..|.+++ |+.|+|++|.+++..|..
T Consensus 148 l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 226 (313)
T 1ogq_A 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKI 226 (313)
T ss_dssp CTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEE
T ss_pred CCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEE
Confidence 35666666666666666666666665 666666666666555555554444 444444444444444444
Q ss_pred -------------ccCCccccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccccC
Q 008828 70 -------------VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICA 132 (552)
Q Consensus 70 -------------~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~ 132 (552)
+..+++|+.|+|++|+|++.+|..+..+++|+.|+|++|+|++.+|.... +.+++++|+..|+
T Consensus 227 ~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp ECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES
T ss_pred ECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccC
Confidence 44455555555555555555555555556666666666666555554311 4555666665555
Q ss_pred C
Q 008828 133 T 133 (552)
Q Consensus 133 ~ 133 (552)
.
T Consensus 307 ~ 307 (313)
T 1ogq_A 307 S 307 (313)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.5e-18 Score=181.01 Aligned_cols=30 Identities=20% Similarity=-0.003 Sum_probs=25.8
Q ss_pred HHHHHHHHHHHhhccccccceeeeEeecCC
Q 008828 271 EIQFQTEVEMISLAVHRNLLRLIGFCMTTT 300 (552)
Q Consensus 271 ~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 300 (552)
..+|..|++++.+++|+|+|+++|||....
T Consensus 323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 323 SETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred HHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 557999999999999999999999997654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.9e-17 Score=155.32 Aligned_cols=115 Identities=18% Similarity=0.198 Sum_probs=109.1
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|+|++|+++++.+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 57899999999999998888999999999999999999988888899999999999999999988899999999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 115 (552)
|++|+|++..|..|..+++|+.|+|++|++.+..+
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99999998889999999999999999999998765
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.4e-17 Score=164.68 Aligned_cols=133 Identities=20% Similarity=0.284 Sum_probs=76.2
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCC-CCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
++|++|+|++|.+.+..+..|..+++|++|+|++|.+++ .+|..|.++++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 126 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 205 (306)
T 2z66_A 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205 (306)
T ss_dssp TTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEE
Confidence 455555555555555555555556666666666666554 3455555666666666666666654455566666666666
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc------CcccccCCccccCCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLICATG 134 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~------~~~~l~~N~~~c~~~ 134 (552)
|++|++++..+..+..+++|+.|+|++|++++.+|..+. +.++|++|++.|.|.
T Consensus 206 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred CCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 666666544444555566666666666666655443322 445566666665543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2e-17 Score=172.98 Aligned_cols=133 Identities=21% Similarity=0.234 Sum_probs=124.6
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..|.++++|+.|+|++|.+++..|..|..+++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 57999999999999999999999999999999999999888999999999999999999999777889999999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 134 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~ 134 (552)
++|++++..|..|..+++|+.|+|++|+|++.++..+. +.+++++|++.|.++
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 99999988899999999999999999999998876643 789999999999876
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.69 E-value=6.4e-18 Score=167.65 Aligned_cols=129 Identities=30% Similarity=0.501 Sum_probs=114.3
Q ss_pred CcccEeccCCCCCcc--cccccccCCCCCcEEeccc-CccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccc
Q 008828 2 VLLCYRGAPSQNLSG--TLSSSIGNLTNLQLVLLQN-NNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 78 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~--~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 78 (552)
.+|+.|+|++|++.+ .+|..|+++++|++|+|++ |.+.+.+|..|.++++|++|+|++|.+++.+|..|..+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 468899999999998 8899999999999999995 9999899999999999999999999998889999999999999
Q ss_pred cccccccccCCCCccccccccccEEeccCCCCCCCCCCccc------CcccccCCccc
Q 008828 79 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLI 130 (552)
Q Consensus 79 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~------~~~~l~~N~~~ 130 (552)
|+|++|+|++.+|..+..+++|+.|+|++|++++.+|..+. +.+++++|.+.
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~ 187 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeee
Confidence 99999999988999999999999999999999877765432 66788888875
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.4e-16 Score=154.51 Aligned_cols=132 Identities=24% Similarity=0.285 Sum_probs=114.4
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|+.|+|++|++++..+..|.++++|++|+|++|.|+...+..|.++++|++|+|++|++++..+..|..+++|+.|+|
T Consensus 37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 46899999999999877778999999999999999999666666788999999999999999666677899999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICAT 133 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~ 133 (552)
++|++++..+..|..+++|+.|+|++|.|++.++..+. +.+++++|.+...+
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 99999977778889999999999999999987776543 67889999886544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3.4e-17 Score=182.38 Aligned_cols=83 Identities=30% Similarity=0.557 Sum_probs=60.6
Q ss_pred CCCCCEEEccCCcCCCCCCccccCCccccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----Cccc
Q 008828 49 LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFN 123 (552)
Q Consensus 49 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~ 123 (552)
+++|+.|||++|+++|.+|..|+++++|+.|+|++|+++|.+|..+..+++|+.|||++|+++|.+|..+. +.++
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 35566777777777777777777777777777777777777777777777777777777777777776544 5677
Q ss_pred ccCCcccc
Q 008828 124 ITGNSLIC 131 (552)
Q Consensus 124 l~~N~~~c 131 (552)
+++|++..
T Consensus 711 ls~N~l~g 718 (768)
T 3rgz_A 711 LSNNNLSG 718 (768)
T ss_dssp CCSSEEEE
T ss_pred CcCCcccc
Confidence 77777653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2e-16 Score=153.50 Aligned_cols=130 Identities=25% Similarity=0.326 Sum_probs=99.6
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|+|++|++++. ..++.+++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|+.|+
T Consensus 62 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 46788888888887763 3677888888888888888866666678888888888888888866666678888888888
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
|++|+|++..+..+..+++|+.|+|++|+|++.++..+. +.+++++|.+...
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSV 196 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCcc
Confidence 888888866666677888888888888888877765533 6777888877543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.68 E-value=9.1e-17 Score=150.72 Aligned_cols=115 Identities=18% Similarity=0.152 Sum_probs=106.6
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 55 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 134 (220)
T 2v9t_B 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence 57899999999999999999999999999999999999966666689999999999999999988889999999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 115 (552)
|++|+|++..+..|..+++|+.|+|++|++.....
T Consensus 135 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 99999998777889999999999999999987544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-16 Score=155.45 Aligned_cols=130 Identities=20% Similarity=0.221 Sum_probs=101.5
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|.+++..+..+..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 130 (276)
T 2z62_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (276)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEE
Confidence 46788888888888887777888888888888888888877777888888888888888888866665788888888888
Q ss_pred cccccccCC-CCccccccccccEEeccCCCCCCCCCCccc-----C----cccccCCccc
Q 008828 81 LNNNSLTGA-IPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----K----TFNITGNSLI 130 (552)
Q Consensus 81 l~~N~l~~~-~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~----~~~l~~N~~~ 130 (552)
|++|++++. +|..+..+++|+.|+|++|++++.++..+. + .+++++|.+.
T Consensus 131 l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~ 190 (276)
T 2z62_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190 (276)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCC
T ss_pred CcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCccc
Confidence 888888753 578888888888888888888876654332 1 4556666554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.3e-16 Score=141.61 Aligned_cols=128 Identities=20% Similarity=0.215 Sum_probs=103.0
Q ss_pred ccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccccc
Q 008828 4 LCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83 (552)
Q Consensus 4 l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 83 (552)
.+.+++++|+++. +|..+ .++|+.|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 4678888888876 45444 47889999999999866666778899999999999999866666678899999999999
Q ss_pred ccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCC
Q 008828 84 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 134 (552)
Q Consensus 84 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~ 134 (552)
|+|++..+..+..+++|+.|+|++|+|++.++..+. +.++|++|++.|.++
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 999876667788889999999999999887776543 678888998887653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.9e-16 Score=153.79 Aligned_cols=127 Identities=23% Similarity=0.205 Sum_probs=82.7
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|+.|+|++|++++..+..|.++++|+.|+|++|.|++ ++. ...+++|+.|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccC-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 357777777777777777777777777777777777763 332 256666666666666666 55666666666666666
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCcccc
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLIC 131 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c 131 (552)
++|+|++..|..|..+++|+.|+|++|+|++.++..+. +.++|++|.+..
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 162 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc
Confidence 66666655555666666666666666666665554432 456666666553
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=6.6e-17 Score=144.87 Aligned_cols=129 Identities=21% Similarity=0.182 Sum_probs=111.9
Q ss_pred CcccEeccCCCCCc-ccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 2 VLLCYRGAPSQNLS-GTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 2 ~~l~~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
++|+.|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..+.++++|+.|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 67999999999998 67888899999999999999999965 7799999999999999999977888888899999999
Q ss_pred cccccccCCC-CccccccccccEEeccCCCCCCCCC---Cccc-----CcccccCCccccC
Q 008828 81 LNNNSLTGAI-PPSLSNMSQLAFLDLSYNNLSGPVP---SFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~~---~~~~-----~~~~l~~N~~~c~ 132 (552)
|++|+|++.. +..+..+++|+.|++++|++++.++ ..+. +.+++++|.+.-.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 9999999542 2789999999999999999998776 2222 6778888876544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.5e-16 Score=153.93 Aligned_cols=131 Identities=21% Similarity=0.209 Sum_probs=108.7
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCc-CCCCCCccccCCccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNF-FTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~ 80 (552)
++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|. +....|..|..+++|+.|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 468889999999888777788888999999999998887778888888999999999987 7755577888888999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
|++|++++..|..+..+++|+.|+|++|++++.++..+. +.+++++|.+...
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 168 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccccc
Confidence 999998877788888888899999999988887766443 6788888877643
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-16 Score=165.14 Aligned_cols=132 Identities=22% Similarity=0.246 Sum_probs=102.3
Q ss_pred CcccEeccCCCCCcc-cccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 2 VLLCYRGAPSQNLSG-TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
++|++|+|++|+..+ +.+..|.++++|++|+|++|.|+ .+| .+.++++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 160 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 237 (440)
T 3zyj_A 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237 (440)
T ss_dssp TTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEE
Confidence 344444444422222 22235667777777777788777 555 377888888888888888877788899999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATGA 135 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~~ 135 (552)
|++|+|++..+..|..+++|+.|+|++|+|++.++..+. +.++|++|++.|+|..
T Consensus 238 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred CCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence 999999988888899999999999999999988877654 6789999999998864
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1e-16 Score=174.46 Aligned_cols=135 Identities=20% Similarity=0.288 Sum_probs=123.5
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCcc-CCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNI-SGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l-~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 79 (552)
+++++.++++.|++.+..+..+..+++|+.|+|++|.+ .+.+|..|..+++|+.|+|++|+|++..|..|.++++|+.|
T Consensus 444 l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 444 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 46789999999999999999999999999999999975 44578889999999999999999998889999999999999
Q ss_pred ccccccccCCCCccccccccccEEeccCCCCCCCCCCccc------CcccccCCccccCCCC
Q 008828 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLICATGA 135 (552)
Q Consensus 80 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~------~~~~l~~N~~~c~~~~ 135 (552)
+|++|+|++..|..|..+++|+.|+|++|+|++.+|..+. +.++|++|++.|+|..
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 9999999988888999999999999999999999887653 5789999999999874
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.2e-16 Score=144.86 Aligned_cols=113 Identities=24% Similarity=0.262 Sum_probs=104.1
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|+++. +|..|.++++|+.|+|++|.|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus 31 ~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 31 RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 479999999999985 7789999999999999999999888888999999999999999999888888999999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 115 (552)
++|+|++..+..|..+++|+.|+|++|++.+...
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 110 HGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 9999996666779999999999999999987554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.4e-16 Score=142.54 Aligned_cols=115 Identities=22% Similarity=0.185 Sum_probs=104.4
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|++++..+..|+.+++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 57999999999999887788999999999999999999776777899999999999999999776677899999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~ 116 (552)
++|+|++..+..+..+++|+.|+|++|++.+.+|.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 99999966666678999999999999999987763
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.5e-16 Score=161.02 Aligned_cols=131 Identities=25% Similarity=0.201 Sum_probs=117.2
Q ss_pred CcccEeccCCCCCccccccccc-CCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIG-NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+.++.|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+
T Consensus 39 ~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 118 (361)
T 2xot_A 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL 118 (361)
T ss_dssp TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEE
Confidence 3588999999999998888887 999999999999999977778899999999999999999976677899999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCcc--------cCcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH--------AKTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~--------~~~~~l~~N~~~c~ 132 (552)
|++|+|++..|..|..+++|+.|+|++|+|++.++..+ .+.++|++|.+...
T Consensus 119 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 119 LYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred CCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 99999998888999999999999999999998777654 16789999988643
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.8e-16 Score=144.45 Aligned_cols=128 Identities=20% Similarity=0.195 Sum_probs=112.0
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 57899999999999987777889999999999999999977677789999999999999999976666789999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCcccCcccccCCccc
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLI 130 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~l~~N~~~ 130 (552)
|++|+|++..+..+..+++|+.|+|++|++.+..|.+ +.+++..|.+.
T Consensus 131 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l--~~L~~~~n~~~ 178 (208)
T 2o6s_A 131 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGI--RYLSEWINKHS 178 (208)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTTT--HHHHHHHHHCT
T ss_pred CCCCccceeCHHHhccCCCccEEEecCCCeecCCCCH--HHHHHHHHhCC
Confidence 9999999777777999999999999999999877643 45555566554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=9.1e-17 Score=174.27 Aligned_cols=135 Identities=21% Similarity=0.248 Sum_probs=108.9
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCC-CCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 79 (552)
+++|++|++++|.+++..|..|+++++|++|+|++|.+++ .+|..|.++++|+.|+|++|++++..|..|..+++|+.|
T Consensus 423 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 502 (606)
T 3vq2_A 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502 (606)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEE
Confidence 4678888888888888788888888888888888888886 367778888888888888888887777888888888888
Q ss_pred ccccccccCCCCccccccccccEEeccCCCCCCCCCCcc-----cCcccccCCccccCCCC
Q 008828 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH-----AKTFNITGNSLICATGA 135 (552)
Q Consensus 80 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~-----~~~~~l~~N~~~c~~~~ 135 (552)
+|++|++++..|..+..+++|+.|+|++|+|+..++.+. .+.+++++|++.|.|+.
T Consensus 503 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp ECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred ECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 888888887778888888888888888888886554421 25678888888888764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.7e-16 Score=172.73 Aligned_cols=131 Identities=19% Similarity=0.148 Sum_probs=116.5
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
+++++|||++|+|+++.+..|.++++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..+..|.+|++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 36899999999999988889999999999999999999777888999999999999999999666677999999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCC-CCCccc-----CcccccCCccccC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP-VPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~-~~~~~~-----~~~~l~~N~~~c~ 132 (552)
++|+|++..+..|..+++|+.|+|++|.+++. .|..+. +.+++++|.+...
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 188 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 188 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccc
Confidence 99999977777899999999999999999874 354433 7889999988654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.7e-16 Score=158.36 Aligned_cols=127 Identities=21% Similarity=0.314 Sum_probs=104.5
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcC---------CCCCCEEEccCCcCCCCCCcccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGK---------LSKLLTLDLSNNFFTGPIPSTVS 71 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~---------l~~L~~L~l~~N~l~~~~p~~~~ 71 (552)
|++|++|+|++|+++ .+|..|+++++|++|+|++|.+.+.+|..+.. +++|+.|+|++|+++ .+|..++
T Consensus 126 l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~ 203 (328)
T 4fcg_A 126 FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA 203 (328)
T ss_dssp GTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGG
T ss_pred cCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhc
Confidence 467889999999888 57888888999999999988887788877654 888888888888888 7888888
Q ss_pred CCccccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccc
Q 008828 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 130 (552)
Q Consensus 72 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~ 130 (552)
.+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++.+.+|..+. +.+++++|.+.
T Consensus 204 ~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 266 (328)
T 4fcg_A 204 NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266 (328)
T ss_dssp GCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTC
T ss_pred CCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCch
Confidence 8888888888888888 4666788888888888888888888777654 67788887654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.5e-16 Score=147.70 Aligned_cols=114 Identities=21% Similarity=0.188 Sum_probs=105.8
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
|++|++|+|++|++.++.+..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|+ .+|..+..+++|+.|+
T Consensus 63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 141 (229)
T 3e6j_A 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEE
T ss_pred ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEE
Confidence 578999999999998877788999999999999999999777777899999999999999999 8899999999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 115 (552)
|++|+|++..+..|..+++|+.|+|++|++.+..+
T Consensus 142 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 99999997767789999999999999999998776
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.2e-16 Score=163.64 Aligned_cols=113 Identities=24% Similarity=0.330 Sum_probs=95.1
Q ss_pred cccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccccccCCCCccccccccc
Q 008828 21 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQL 100 (552)
Q Consensus 21 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 100 (552)
.|.++++|++|+|++|+|+ .+| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..|..|..+++|
T Consensus 191 ~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 268 (452)
T 3zyi_A 191 AFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268 (452)
T ss_dssp TTTTCTTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred hccCCCCCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCC
Confidence 4667777777777778777 344 47788888888888888887778889999999999999999998888889999999
Q ss_pred cEEeccCCCCCCCCCCccc-----CcccccCCccccCCCC
Q 008828 101 AFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATGA 135 (552)
Q Consensus 101 ~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~~ 135 (552)
+.|+|++|+|++.++..+. +.++|++|++.|+|..
T Consensus 269 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 269 VELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred CEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 9999999999988877654 6789999999999874
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1e-16 Score=180.40 Aligned_cols=132 Identities=27% Similarity=0.324 Sum_probs=89.9
Q ss_pred CcccEeccCCCCCcccccc-cccCCCCCcEEecccCccC-----CCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcc
Q 008828 2 VLLCYRGAPSQNLSGTLSS-SIGNLTNLQLVLLQNNNIS-----GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET 75 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~-~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 75 (552)
++|++|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|+|++..|..|..+++
T Consensus 426 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 505 (844)
T 3j0a_A 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505 (844)
T ss_dssp TTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCS
T ss_pred CccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhh
Confidence 4566666666666553332 3445666666666666665 233445667777777777777777666666777777
Q ss_pred ccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc--CcccccCCccccCCCC
Q 008828 76 LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSLICATGA 135 (552)
Q Consensus 76 L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~--~~~~l~~N~~~c~~~~ 135 (552)
|+.|+|++|+|++..|..+. ++|+.|+|++|+|++.+|..+. +.+++++|++.|.|..
T Consensus 506 L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 506 LRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp CSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred hheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 77777777777755555544 6777777777777777776654 6789999999998864
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.4e-16 Score=156.21 Aligned_cols=129 Identities=20% Similarity=0.235 Sum_probs=110.3
Q ss_pred CCcccEeccCCCCCcccccccccC---------CCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCcccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGN---------LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 71 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~---------l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 71 (552)
|++|++|+|++|++.+.+|..+.. +++|++|+|++|+|+ .+|..+.++++|+.|+|++|+++ .+|..+.
T Consensus 149 l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~ 226 (328)
T 4fcg_A 149 LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226 (328)
T ss_dssp CTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGG
T ss_pred CcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhc
Confidence 578899999998888888877654 899999999999998 78888999999999999999998 5677788
Q ss_pred CCccccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCcccc
Q 008828 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLIC 131 (552)
Q Consensus 72 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c 131 (552)
.+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++.+.+|..+. +.++|++|++..
T Consensus 227 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp GCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred cCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 899999999999998888898899999999999999988888886554 678888887653
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.63 E-value=8.9e-16 Score=137.72 Aligned_cols=111 Identities=24% Similarity=0.281 Sum_probs=99.7
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
+.+.|++++|+++. +|..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 10 ~~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 35789999999987 67666 4899999999999998889999999999999999999997767778999999999999
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCCCC
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~ 116 (552)
+|+|++..+..|..+++|+.|+|++|++++.++.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 9999977777899999999999999999987763
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.6e-16 Score=139.27 Aligned_cols=112 Identities=20% Similarity=0.217 Sum_probs=101.9
Q ss_pred CcccEeccCCCCCc-ccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 2 VLLCYRGAPSQNLS-GTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 2 ~~l~~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
++|+.|++++|+++ +.+|..++.+++|++|+|++|.+++. ..+.++++|++|+|++|.+++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 57999999999998 67888999999999999999999965 7799999999999999999977888888899999999
Q ss_pred cccccccCC-CCccccccccccEEeccCCCCCCCCC
Q 008828 81 LNNNSLTGA-IPPSLSNMSQLAFLDLSYNNLSGPVP 115 (552)
Q Consensus 81 l~~N~l~~~-~p~~~~~l~~L~~l~l~~N~l~~~~~ 115 (552)
+++|++++. .+..+..+++|+.|++++|++++.++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 999999953 34789999999999999999998766
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=8.3e-16 Score=149.49 Aligned_cols=130 Identities=19% Similarity=0.151 Sum_probs=116.5
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|+.|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 36999999999999988889999999999999999999777778999999999999999999777788999999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCC-CCCccc-----CcccccCCcccc
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP-VPSFHA-----KTFNITGNSLIC 131 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~-~~~~~~-----~~~~l~~N~~~c 131 (552)
++|++.+..+..+..+++|+.|+|++|.+++. .|..+. +.+++++|.+..
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~ 163 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCc
Confidence 99999977777899999999999999999974 365544 788999998754
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=4.7e-16 Score=168.67 Aligned_cols=133 Identities=24% Similarity=0.285 Sum_probs=104.8
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCC---CchhhcCCCCCCEEEccCCcCCCCCCccccCCcccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGH---IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 77 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~---~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 77 (552)
+++|++|+|++|.+.+..|..|+.+++|++|+|++|.+++. .+..+.++++|+.|+|++|++++..|..|..+++|+
T Consensus 424 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 503 (606)
T 3t6q_A 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN 503 (606)
T ss_dssp CTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred cccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCC
Confidence 45677778888877777777777888888888888887752 235677788888888888888877777888888888
Q ss_pred ccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCC
Q 008828 78 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 134 (552)
Q Consensus 78 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~ 134 (552)
.|+|++|++++..|..+..+++| .|+|++|++++.+|..+. +.+++++|++.|.|+
T Consensus 504 ~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 504 HVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp EEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred EEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 88888888887888888888888 888888888887776543 678888999888765
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=6.6e-16 Score=152.57 Aligned_cols=131 Identities=22% Similarity=0.314 Sum_probs=99.5
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCc-hhhcCCCCCCEEEccCCcCCCCCCccccCCcccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIP-TEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 79 (552)
+++|++|+|++|.+.+ +|..+..+++|++|+|++|.+++..+ ..+.++++|++|+|++|.+.+..|..+..+++|+.|
T Consensus 77 ~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 155 (306)
T 2z66_A 77 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 155 (306)
T ss_dssp CSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred ccccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence 4678888888888775 66668888888888888888875444 467788888888888888877777777888888888
Q ss_pred ccccccccC-CCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccC
Q 008828 80 RLNNNSLTG-AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 80 ~l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
+|++|.+.+ .+|..+..+++|+.|+|++|++++.+|..+. +.+++++|.+...
T Consensus 156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 214 (306)
T 2z66_A 156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 214 (306)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBC
T ss_pred ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCcc
Confidence 888888875 4677788888888888888888877665543 5677778877544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=6.6e-16 Score=166.11 Aligned_cols=133 Identities=20% Similarity=0.252 Sum_probs=91.4
Q ss_pred CcccEeccCCCCCccccc-ccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCC-CCCCccccCCcccccc
Q 008828 2 VLLCYRGAPSQNLSGTLS-SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT-GPIPSTVSHLETLQYL 79 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L 79 (552)
++|++|++++|.+.+..| ..+.++++|++|+|++|.+++..|..|.++++|+.|+|++|.++ +.+|..+..+++|+.|
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 456666666666665544 35666677777777777776666666777777777777777775 4566677777777777
Q ss_pred ccccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCC
Q 008828 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 134 (552)
Q Consensus 80 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~ 134 (552)
+|++|++++..|..+..+++|+.|+|++|++++.++..+. +.+++++|++.|.++
T Consensus 476 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 7777777766677777777777777777777776665443 566777777777654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.2e-15 Score=135.57 Aligned_cols=110 Identities=23% Similarity=0.249 Sum_probs=97.1
Q ss_pred ccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccccc
Q 008828 4 LCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83 (552)
Q Consensus 4 l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 83 (552)
-+.+++++|++.. +|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 3689999999975 676663 8999999999999988899999999999999999999966556689999999999999
Q ss_pred ccccCCCCccccccccccEEeccCCCCCCCCCC
Q 008828 84 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116 (552)
Q Consensus 84 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~ 116 (552)
|+|++..+..|..+++|+.|+|++|++...++.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~ 123 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECRD 123 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccccccc
Confidence 999966666799999999999999999977653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.6e-15 Score=162.42 Aligned_cols=130 Identities=18% Similarity=0.105 Sum_probs=86.9
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
|++|++|+|++|.+++..|..|+.+++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|+++++|+.|+
T Consensus 74 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 35677777777777776666777777777777777777766666667777777777777777744444456777777777
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc--CcccccCCccc
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSLI 130 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~--~~~~l~~N~~~ 130 (552)
|++|.|++..|..|..+++|+.|+|++|.|++.+...+. ..+++++|.+.
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCS
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccc
Confidence 777777766666677777777777777777765443333 45555555543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.6e-15 Score=166.76 Aligned_cols=135 Identities=20% Similarity=0.219 Sum_probs=104.0
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCc--------hhhcCCCCCCEEEccCCcCCCCCCccccC
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIP--------TEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 72 (552)
+++|++|+|++|+++++.+..|.++++|++|+|++|++++..+ ..|.++++|+.|+|++|+++...+..|.+
T Consensus 479 l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~ 558 (680)
T 1ziw_A 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred CCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccc
Confidence 3567888888888887777778888888888888888874311 23677888888888888888433446888
Q ss_pred CccccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc------CcccccCCccccCCCC
Q 008828 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLICATGA 135 (552)
Q Consensus 73 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~------~~~~l~~N~~~c~~~~ 135 (552)
+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++..+. +.+++++|++.|.|..
T Consensus 559 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred ccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 88888888888888866666778888888899999888887775432 6788999999998764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.5e-15 Score=159.75 Aligned_cols=132 Identities=21% Similarity=0.163 Sum_probs=102.4
Q ss_pred ccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccccc
Q 008828 4 LCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83 (552)
Q Consensus 4 l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 83 (552)
|++|+|++|++.+.+|..+....+|+.|+|++|+|++..+..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++
T Consensus 202 L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 281 (477)
T 2id5_A 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG 281 (477)
T ss_dssp CCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCS
T ss_pred cceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCC
Confidence 33333333333333333333334566666667778744446788999999999999999977777899999999999999
Q ss_pred ccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCCC
Q 008828 84 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATGA 135 (552)
Q Consensus 84 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~~ 135 (552)
|++++..|..|..+++|+.|+|++|+|++.++..+. +.++|++|++.|.|..
T Consensus 282 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~ 338 (477)
T 2id5_A 282 GQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL 338 (477)
T ss_dssp SCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred CccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch
Confidence 999988899999999999999999999988876654 7889999999998754
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.2e-15 Score=152.04 Aligned_cols=111 Identities=17% Similarity=0.125 Sum_probs=52.3
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|.+++..+..|+.+++|++|+|++|.+++..|..|.++++|++|+|++|+++...+..|..+++|+.|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 34445555555444444444444555555555555554444444444555555555555544222222344445555555
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 112 (552)
++|++++..|..+..+++|+.|++++|++++
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence 5555444444444444455555555554444
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.1e-15 Score=158.64 Aligned_cols=131 Identities=15% Similarity=0.132 Sum_probs=110.7
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|+.|+|++|++++..|..|.++++|++|+|++|.|++..|..|.++++|++|+|++|++++..+..|.++++|+.|+|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 46889999999999888888999999999999999999877888999999999999999998555566888999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
++|++.+..|..|..+++|+.|+|++|.+++..+..+. +.++|++|.+...
T Consensus 112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 167 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI 167 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC
T ss_pred CCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc
Confidence 99999888888888899999999999998877765544 6778888876543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=3.9e-15 Score=161.42 Aligned_cols=130 Identities=18% Similarity=0.146 Sum_probs=95.6
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|++++..+..|+++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 45777788888777777777777888888888888777666777777778888888888777666777777777888888
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCC-CCCCccc-----CcccccCCcccc
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA-----KTFNITGNSLIC 131 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~-~~~~~~~-----~~~~l~~N~~~c 131 (552)
++|++++..+..+..+++|+.|+|++|.+++ .+|..+. +.+++++|.+..
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~ 167 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee
Confidence 7777776665677777777777777777775 3354433 566777776654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.3e-15 Score=160.13 Aligned_cols=109 Identities=25% Similarity=0.302 Sum_probs=72.9
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCC--CCchhhcCCCCCCEEEccCCcCCCCCCcc-ccCCcccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISG--HIPTEIGKLSKLLTLDLSNNFFTGPIPST-VSHLETLQ 77 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~ 77 (552)
+++|++|+|++|++++..|..++++++|++|+|++|++++ .+|..+.++++|+.|+|++|.+++.+|.. +..+++|+
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 4678888888888888778888888888888888888875 45567778888888888888887645543 55555555
Q ss_pred ccccccccccCCCCccccccccccEEeccCCCCC
Q 008828 78 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111 (552)
Q Consensus 78 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 111 (552)
.|+|++|++++..|..+. ++|+.|+|++|+|+
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCccc
Confidence 555555555444433332 34444444444444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.5e-15 Score=139.78 Aligned_cols=127 Identities=21% Similarity=0.282 Sum_probs=103.0
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
|++|++|++++|++.. +| .+..+++|++|++++|.++ .+ ..+.++++|++|+|++|++++..|..++.+++|+.|+
T Consensus 43 l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 3578899999999885 55 6888999999999999776 33 4688899999999999999876788888999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCC-CCCCCCCcc----cCcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNN-LSGPVPSFH----AKTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~-l~~~~~~~~----~~~~~l~~N~~~c~ 132 (552)
|++|++++..|..+..+++|+.|+|++|+ ++.. |.+. .+.+++++|.+...
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~~l~~l~~L~~L~l~~n~i~~~ 174 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY 174 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-GGGGGCSSCCEEECTTBCCCCC
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-HhhcCCCCCCEEECCCCCCcCh
Confidence 99999987778888899999999999998 6654 3321 16788888887543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.58 E-value=8e-16 Score=169.40 Aligned_cols=127 Identities=25% Similarity=0.337 Sum_probs=111.6
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|+.|+|++|.+.. +|..+.++++|++|+|++|.|+ .+|..|.+|++|+.|+|++|+|+ .+|..|+.|++|+.|+
T Consensus 223 l~~L~~L~Ls~n~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 299 (727)
T 4b8c_D 223 DQLWHALDLSNLQIFN-ISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY 299 (727)
T ss_dssp CCCCCEEECTTSCCSC-CCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEE
T ss_pred CCCCcEEECCCCCCCC-CChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEE
Confidence 4678999999999884 7777779999999999999999 88999999999999999999999 7899999999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc------CcccccCCcccc
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLIC 131 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~------~~~~l~~N~~~c 131 (552)
|++|.|+ .+|..|..|++|+.|+|++|+|++.+|..+. ..++|++|.+..
T Consensus 300 L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~ 355 (727)
T 4b8c_D 300 FFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEI 355 (727)
T ss_dssp CCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred CCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccC
Confidence 9999998 7888899999999999999999998887654 236788887753
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=3.6e-15 Score=155.77 Aligned_cols=116 Identities=21% Similarity=0.158 Sum_probs=109.6
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 298 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 377 (455)
T 3v47_A 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELA 377 (455)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEE
Confidence 57899999999999999899999999999999999999988899999999999999999999988899999999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~ 116 (552)
|++|+|++..+..+..+++|+.|+|++|++++.+|.
T Consensus 378 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 378 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 999999977677789999999999999999998884
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.57 E-value=1.8e-15 Score=143.73 Aligned_cols=129 Identities=17% Similarity=0.202 Sum_probs=107.3
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCc-cCCCCchhhcCCCCCCEEEccC-CcCCCCCCccccCCcccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNN-ISGHIPTEIGKLSKLLTLDLSN-NFFTGPIPSTVSHLETLQYL 79 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L 79 (552)
++|++|+|++|+++++.+..|+++++|++|+|++|+ +++..+..|.++++|+.|+|++ |++++..+..|.++++|+.|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 368899999999998777789999999999999997 8866666889999999999998 99986666778899999999
Q ss_pred ccccccccCCCCcccccccccc---EEeccCC-CCCCCCCCccc-----C-cccccCCccccC
Q 008828 80 RLNNNSLTGAIPPSLSNMSQLA---FLDLSYN-NLSGPVPSFHA-----K-TFNITGNSLICA 132 (552)
Q Consensus 80 ~l~~N~l~~~~p~~~~~l~~L~---~l~l~~N-~l~~~~~~~~~-----~-~~~l~~N~~~c~ 132 (552)
+|++|++++ +|. +..+++|+ .|++++| .+++.++..+. + .+++++|.+...
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i 171 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSV 171 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEE
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCccc
Confidence 999999985 676 78888887 9999999 88877776544 4 778888877533
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.2e-15 Score=134.87 Aligned_cols=112 Identities=26% Similarity=0.267 Sum_probs=100.7
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCC--ccccCCccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP--STVSHLETLQY 78 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~ 78 (552)
+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|+.|+|++|.+++ +| ..+..+++|+.
T Consensus 48 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~ 124 (168)
T 2ell_A 48 FVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKS 124 (168)
T ss_dssp GGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCE
T ss_pred CCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCE
Confidence 46899999999999986 789999999999999999997789888889999999999999995 44 68999999999
Q ss_pred cccccccccCCCC---ccccccccccEEeccCCCCCCCCC
Q 008828 79 LRLNNNSLTGAIP---PSLSNMSQLAFLDLSYNNLSGPVP 115 (552)
Q Consensus 79 L~l~~N~l~~~~p---~~~~~l~~L~~l~l~~N~l~~~~~ 115 (552)
|+|++|.+++..+ ..+..+++|+.|++++|.+...+.
T Consensus 125 L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 164 (168)
T 2ell_A 125 LDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPD 164 (168)
T ss_dssp EECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCS
T ss_pred EEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhccc
Confidence 9999999995554 489999999999999999986554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.57 E-value=4.8e-15 Score=154.73 Aligned_cols=131 Identities=21% Similarity=0.174 Sum_probs=111.1
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|+++++.|..|.++++|+.|+|++|.|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 46899999999999988999999999999999999999888889999999999999999999666667999999999999
Q ss_pred ccccccCCCCccccccccccEEeccCC-CCCCCCCCccc-----CcccccCCccccC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYN-NLSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N-~l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
++|+|++..+..|..+++|+.|+|++| .+...++..+. +.++|++|.+...
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 999999666678889999999999984 44444443333 6788888887654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=3e-15 Score=151.00 Aligned_cols=131 Identities=20% Similarity=0.212 Sum_probs=107.0
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|++++..+..|.++++|+.|+|++|.|++..|..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 46899999999999877778999999999999999999777888999999999999999999544444888999999999
Q ss_pred ccccccCCCC-ccccccccccEEeccCC-CCCCCCCCccc-----CcccccCCccccC
Q 008828 82 NNNSLTGAIP-PSLSNMSQLAFLDLSYN-NLSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 82 ~~N~l~~~~p-~~~~~l~~L~~l~l~~N-~l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
++|++++..+ ..+..+++|+.|++++| .++..++..+. +.+++++|.+...
T Consensus 132 ~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 189 (353)
T 2z80_A 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSY 189 (353)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred CCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCcc
Confidence 9999984433 47888999999999998 46666555544 6788888877543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.57 E-value=2.4e-15 Score=142.97 Aligned_cols=130 Identities=16% Similarity=0.157 Sum_probs=113.0
Q ss_pred CCcccEeccCCCC-CcccccccccCCCCCcEEeccc-CccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccc-
Q 008828 1 MVLLCYRGAPSQN-LSGTLSSSIGNLTNLQLVLLQN-NNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ- 77 (552)
Q Consensus 1 l~~l~~L~l~~n~-l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~- 77 (552)
+++|++|+|++|+ ++++.+..|.++++|++|+|++ |+|++..+..|.++++|+.|+|++|++++ +|. |..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 5789999999997 8887777999999999999999 99997777789999999999999999995 776 88888888
Q ss_pred --ccccccc-cccCCCCcccccccccc-EEeccCCCCCCCCCCccc----CcccccCCc-cccC
Q 008828 78 --YLRLNNN-SLTGAIPPSLSNMSQLA-FLDLSYNNLSGPVPSFHA----KTFNITGNS-LICA 132 (552)
Q Consensus 78 --~L~l~~N-~l~~~~p~~~~~l~~L~-~l~l~~N~l~~~~~~~~~----~~~~l~~N~-~~c~ 132 (552)
.|++++| ++++..+..|..+++|+ .|++++|.++..++..+. +.+++++|+ +...
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i 195 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVI 195 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEE
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccC
Confidence 9999999 99977677899999999 999999999966655443 678899995 6543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.57 E-value=3.9e-15 Score=159.89 Aligned_cols=133 Identities=21% Similarity=0.299 Sum_probs=86.7
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCC--CchhhcCCCCCCEEEccCCcCCCCCCcc-ccCCcccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGH--IPTEIGKLSKLLTLDLSNNFFTGPIPST-VSHLETLQ 77 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~ 77 (552)
+++|++|+|++|++++..|..++++++|++|+|++|++++. +|..|.++++|+.|+|++|++++.+|.. +..+++|+
T Consensus 352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 46788888888888888888888888888888888888853 2456788888888888888888645543 55555555
Q ss_pred ccccccccccC---------------------CCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCcccc
Q 008828 78 YLRLNNNSLTG---------------------AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLIC 131 (552)
Q Consensus 78 ~L~l~~N~l~~---------------------~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c 131 (552)
.|+|++|+|++ .+|..+..+++|+.|+|++|+|++.++..+. +.+++++|++.|
T Consensus 432 ~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c 511 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 511 (562)
T ss_dssp EEECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCC
T ss_pred EEECCCCCCCcchhhhhcCcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCC
Confidence 55555554443 3444444555566666666666544443222 445566666655
Q ss_pred CC
Q 008828 132 AT 133 (552)
Q Consensus 132 ~~ 133 (552)
.|
T Consensus 512 ~c 513 (562)
T 3a79_B 512 TC 513 (562)
T ss_dssp CH
T ss_pred Cc
Confidence 54
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=8.7e-15 Score=146.12 Aligned_cols=129 Identities=20% Similarity=0.246 Sum_probs=81.0
Q ss_pred CCcccEeccCCCCCcc--cccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccc
Q 008828 1 MVLLCYRGAPSQNLSG--TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 78 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 78 (552)
+++|++|+|++|.+.. ..+..|.++++|++|++++|.++ .+|..+. ++|+.|+|++|++++..|..|..+++|+.
T Consensus 144 l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 220 (330)
T 1xku_A 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAK 220 (330)
T ss_dssp CTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCE
T ss_pred CccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCE
Confidence 4677888888887753 56667777777777777777776 4554443 56666666666666555566666666666
Q ss_pred cccccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccccC
Q 008828 79 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICA 132 (552)
Q Consensus 79 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~ 132 (552)
|+|++|++++..+..+..+++|+.|+|++|+|+..+..+.. +.+++++|.+...
T Consensus 221 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~~ 278 (330)
T 1xku_A 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 278 (330)
T ss_dssp EECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred EECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCcc
Confidence 66666666655555666666666666666666643332211 4566666665443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.4e-15 Score=149.35 Aligned_cols=128 Identities=19% Similarity=0.212 Sum_probs=92.3
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhc-CCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG-KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
++|++|+|++|++++..+..++.+++|++|+|++|.+++..+..+. ++++|+.|+|++|.+++. |. ...+++|+.|+
T Consensus 120 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~ 197 (317)
T 3o53_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLD 197 (317)
T ss_dssp SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEE
T ss_pred CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEE
Confidence 5677777777777776677777788888888888888766666653 678888888888888743 32 33477888888
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~ 132 (552)
|++|+|++ +|..+..+++|+.|+|++|+|++.++.+.. +.+++++|++.|+
T Consensus 198 Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 198 LSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp CCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHH
T ss_pred CCCCcCCc-chhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCc
Confidence 88888884 455577788888888888888865443211 6778888888765
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=5.6e-15 Score=160.17 Aligned_cols=131 Identities=18% Similarity=0.089 Sum_probs=115.5
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
+++++|+|++|+++++.|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 36899999999999988999999999999999999999888999999999999999999999888889999999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCC-CCccc----CcccccCCccccC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPV-PSFHA----KTFNITGNSLICA 132 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~-~~~~~----~~~~l~~N~~~c~ 132 (552)
++|++++..|..+..+++|+.|+|++|++++.. |.... +.+++++|.+...
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 168 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEE
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccccc
Confidence 999999766788999999999999999999853 44332 7788889887643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-14 Score=160.08 Aligned_cols=131 Identities=21% Similarity=0.177 Sum_probs=110.8
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|++++..+..|+++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 46889999999999887788999999999999999999888888999999999999999998554457889999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
++|++++..|..|..+++|++|+|++|.+++.+|..+. +.+++++|.+...
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 160 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCB
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccccc
Confidence 99999877778889999999999999999888776543 6778888876543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.55 E-value=5.4e-15 Score=136.04 Aligned_cols=125 Identities=14% Similarity=0.219 Sum_probs=107.0
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|++++|.++. ++.+..+++|++|+|++|.+++..|..|.++++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 65 l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 65 AHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp CTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 5789999999997764 34799999999999999999987888999999999999999999977788899999999999
Q ss_pred ccccc-ccCCCCccccccccccEEeccCCCCCCCCCCc-c--cCcccccCCcc
Q 008828 81 LNNNS-LTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF-H--AKTFNITGNSL 129 (552)
Q Consensus 81 l~~N~-l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~-~--~~~~~l~~N~~ 129 (552)
|++|+ +. .+| .+..+++|+.|++++|++++..+-. + .+.+++++|++
T Consensus 143 L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 143 LSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp CCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC--
T ss_pred ccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCccc
Confidence 99998 66 666 6899999999999999999854211 1 17889999986
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.3e-15 Score=165.88 Aligned_cols=130 Identities=22% Similarity=0.321 Sum_probs=114.8
Q ss_pred CCcccEeccCCCCCccc-----------------cccccc--CCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCc
Q 008828 1 MVLLCYRGAPSQNLSGT-----------------LSSSIG--NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNF 61 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 61 (552)
|++|++|+|++|++++. +|..++ ++++|++|+|++|.+.+.+|..|+++++|+.|+|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 57899999999999986 899988 99999999999999999999999999999999999998
Q ss_pred -CCC-CCCccccCC------ccccccccccccccCCCCc--cccccccccEEeccCCCCCCCCCCccc-----CcccccC
Q 008828 62 -FTG-PIPSTVSHL------ETLQYLRLNNNSLTGAIPP--SLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITG 126 (552)
Q Consensus 62 -l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~ 126 (552)
++| .+|..++.+ ++|+.|+|++|+++ .+|. .+..+++|+.|+|++|+++|.+| .+. +.+++++
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCC
Confidence 887 788888776 89999999999999 8888 89999999999999999997777 333 7788888
Q ss_pred CccccC
Q 008828 127 NSLICA 132 (552)
Q Consensus 127 N~~~c~ 132 (552)
|.+...
T Consensus 363 N~l~~l 368 (636)
T 4eco_A 363 NQITEI 368 (636)
T ss_dssp SEEEEC
T ss_pred Cccccc
Confidence 887633
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.2e-14 Score=151.23 Aligned_cols=131 Identities=21% Similarity=0.147 Sum_probs=103.5
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++++.|+|++|+++++.+..|.++++|++|+|++|.|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 46788999999988888888899999999999999998777788888999999999999988655567888899999999
Q ss_pred ccccccCCCCccccccccccEEeccCCC-CCCCCCCccc-----CcccccCCccccC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNN-LSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~-l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
++|+|++..+..|..+++|+.|+|++|+ +...++..+. +.++|++|.+...
T Consensus 144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 200 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI 200 (440)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC
T ss_pred CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc
Confidence 9998886666678888888888888844 4433333332 6677788777644
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.55 E-value=6.1e-15 Score=150.87 Aligned_cols=132 Identities=15% Similarity=0.129 Sum_probs=117.1
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|++++|.+....+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|+.|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 46899999999999887666789999999999999999977778999999999999999999988888899999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
|++|+++...+..|..+++|+.|++++|++++.++..+. +.+++++|.+...
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence 999999955445579999999999999999998876554 7889999987643
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.54 E-value=7.4e-15 Score=158.79 Aligned_cols=132 Identities=15% Similarity=0.129 Sum_probs=119.1
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++++.|++++|.+..+.+..|..+++|++|+|++|.|++..|..|.++++|+.|+|++|.+++..|..|+++++|+.|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 36789999999999987777899999999999999999988888999999999999999999988888899999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
|++|.|++..+..|..+++|+.|+|++|.|++.+|..+. +.+++++|.+...
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 186 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 186 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence 999999966666689999999999999999998887654 7889999988654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.7e-15 Score=148.41 Aligned_cols=130 Identities=18% Similarity=0.116 Sum_probs=76.4
Q ss_pred CCcccEeccCCCCCccccc----ccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCC--C--CccccC
Q 008828 1 MVLLCYRGAPSQNLSGTLS----SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP--I--PSTVSH 72 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~--p~~~~~ 72 (552)
+++|++|+|++|.+++..+ ..+..+++|++|+|++|+|++..|..|.++++|++|+|++|++.+. + +..+..
T Consensus 116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 195 (310)
T 4glp_A 116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK 195 (310)
T ss_dssp CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence 3566777777777666433 3345666777777777777666666666777777777777766531 1 122355
Q ss_pred CccccccccccccccCCCCc----cccccccccEEeccCCCCCCCCCCcc--------cCcccccCCcccc
Q 008828 73 LETLQYLRLNNNSLTGAIPP----SLSNMSQLAFLDLSYNNLSGPVPSFH--------AKTFNITGNSLIC 131 (552)
Q Consensus 73 l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~l~l~~N~l~~~~~~~~--------~~~~~l~~N~~~c 131 (552)
+++|++|+|++|+|+ .++. .+..+++|+.|+|++|+|++..|..+ .+.++|++|.+..
T Consensus 196 l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~ 265 (310)
T 4glp_A 196 FPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ 265 (310)
T ss_dssp SCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS
T ss_pred CCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc
Confidence 666666666666665 3332 23455666666666666666533221 1455666666653
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=2.6e-15 Score=135.53 Aligned_cols=125 Identities=18% Similarity=0.148 Sum_probs=101.3
Q ss_pred CCcccEeccCCCCCcccccccccCCC-CCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLT-NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 79 (552)
+++|+.|+|++|+++.. |. +..+. +|++|+|++|.|++. ..|.++++|++|+|++|+|++..+..+..+++|+.|
T Consensus 18 ~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 36799999999999864 54 55554 999999999999964 579999999999999999995444445899999999
Q ss_pred ccccccccCCCCc--cccccccccEEeccCCCCCCCCCC---ccc-----CcccccCCccc
Q 008828 80 RLNNNSLTGAIPP--SLSNMSQLAFLDLSYNNLSGPVPS---FHA-----KTFNITGNSLI 130 (552)
Q Consensus 80 ~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~~~~~~---~~~-----~~~~l~~N~~~ 130 (552)
+|++|+|. .+|. .+..+++|+.|++++|+++..++. .+. +.+++++|...
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999997 6666 789999999999999999865442 121 66777777653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.54 E-value=3.4e-15 Score=147.92 Aligned_cols=129 Identities=22% Similarity=0.187 Sum_probs=80.4
Q ss_pred CCcccEeccCCCCCcccccccccCC-----CCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCC--CCccc--c
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNL-----TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP--IPSTV--S 71 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~--~ 71 (552)
+++|++|+|++|++++. |..++.+ ++|++|+|++|+|++..|..|.++++|+.|+|++|++.+. .|..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 35677777777777765 6666655 6777777777777766666777777777777777776543 22233 6
Q ss_pred CCccccccccccccccCC--CC-ccccccccccEEeccCCCCCCCCC-Ccc-----cCcccccCCccc
Q 008828 72 HLETLQYLRLNNNSLTGA--IP-PSLSNMSQLAFLDLSYNNLSGPVP-SFH-----AKTFNITGNSLI 130 (552)
Q Consensus 72 ~l~~L~~L~l~~N~l~~~--~p-~~~~~l~~L~~l~l~~N~l~~~~~-~~~-----~~~~~l~~N~~~ 130 (552)
.+++|+.|+|++|+|++. ++ ..+..+++|+.|+|++|+|++.+| ..+ .+.++|++|.+.
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence 667777777777776621 11 223455667777777777766553 111 156666676665
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=5.3e-15 Score=149.17 Aligned_cols=121 Identities=21% Similarity=0.213 Sum_probs=77.8
Q ss_pred cEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccc
Q 008828 5 CYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 84 (552)
Q Consensus 5 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 84 (552)
...++++|+++. +|..+. ++|++|+|++|.|++..+..|.++++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus 34 ~~c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (353)
T 2z80_A 34 GICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110 (353)
T ss_dssp SEEECCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred eEeeCCCCCccc-cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCC
Confidence 345666676665 454442 46777777777777555556777777777777777777655666777777777777777
Q ss_pred cccCCCCccccccccccEEeccCCCCCCCCC-Cccc-----CcccccCCc
Q 008828 85 SLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP-SFHA-----KTFNITGNS 128 (552)
Q Consensus 85 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~-----~~~~l~~N~ 128 (552)
+|++..+..+..+++|+.|+|++|++++.++ ..+. +.+++++|.
T Consensus 111 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~ 160 (353)
T 2z80_A 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160 (353)
T ss_dssp CCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred cCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCc
Confidence 7774434446677777777777777775544 2222 556666663
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.54 E-value=1.7e-14 Score=129.28 Aligned_cols=105 Identities=25% Similarity=0.255 Sum_probs=94.2
Q ss_pred CCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccccccCCCCccccccccccEEecc
Q 008828 27 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLS 106 (552)
Q Consensus 27 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 106 (552)
..+.|++++|.|+ .+|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 4689999999999 6887664 899999999999998888899999999999999999997777778999999999999
Q ss_pred CCCCCCCCCCccc-----CcccccCCccccCCC
Q 008828 107 YNNLSGPVPSFHA-----KTFNITGNSLICATG 134 (552)
Q Consensus 107 ~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~ 134 (552)
+|+|++.++..+. +.++|++|++.|.+.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999998887554 789999999999874
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.54 E-value=8.8e-16 Score=152.15 Aligned_cols=131 Identities=18% Similarity=0.212 Sum_probs=106.2
Q ss_pred CCcccEeccCCCCCcccccccc--cCCCCCcEEecccCccCCCCchhhcCC-----CCCCEEEccCCcCCCCCCccccCC
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSI--GNLTNLQLVLLQNNNISGHIPTEIGKL-----SKLLTLDLSNNFFTGPIPSTVSHL 73 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~--~~l~~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~l 73 (552)
+++|++|+|++|++++.+|..+ +.+++|++|+|++|++++. |..+.++ ++|++|+|++|++++..|..|+.+
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 4688999999999998888876 8899999999999999966 8878777 899999999999997777889999
Q ss_pred ccccccccccccccCC--CCccc--cccccccEEeccCCCCCCCC--C-Cc-----ccCcccccCCccccC
Q 008828 74 ETLQYLRLNNNSLTGA--IPPSL--SNMSQLAFLDLSYNNLSGPV--P-SF-----HAKTFNITGNSLICA 132 (552)
Q Consensus 74 ~~L~~L~l~~N~l~~~--~p~~~--~~l~~L~~l~l~~N~l~~~~--~-~~-----~~~~~~l~~N~~~c~ 132 (552)
++|+.|+|++|++.+. +|..+ ..+++|+.|+|++|+|++.+ + .. ..+.+++++|.+...
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 243 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDA 243 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSS
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcc
Confidence 9999999999998754 23334 78899999999999998432 1 21 237889999987653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=8.9e-15 Score=156.25 Aligned_cols=109 Identities=24% Similarity=0.260 Sum_probs=99.2
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
.|+.|+|++|+|++ +|. |+++++|+.|+|++|.|+ .+|..|+++++|+.|+|++|+|++ +| .++.|++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 57899999999988 565 999999999999999999 889999999999999999999995 67 89999999999999
Q ss_pred cccccCCC-CccccccccccEEeccCCCCCCCCCC
Q 008828 83 NNSLTGAI-PPSLSNMSQLAFLDLSYNNLSGPVPS 116 (552)
Q Consensus 83 ~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~~~ 116 (552)
+|+|++.. |..+..+++|+.|+|++|+|++.+|.
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 99999776 89999999999999999999987764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.53 E-value=3e-14 Score=142.37 Aligned_cols=127 Identities=20% Similarity=0.257 Sum_probs=96.5
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+++ .+|..+. ++|++|++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 46788888888888777778888888888888888888777788888888888888888888 5666554 68888888
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCC--CCCCccc----CcccccCCcccc
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG--PVPSFHA----KTFNITGNSLIC 131 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~~~~~~----~~~~l~~N~~~c 131 (552)
++|++.+..+..|..+++|+.|++++|.++. ..+..+. +.+++++|.+..
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG 186 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSS
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCc
Confidence 8888886656668888888888888888853 4444332 567777777654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.2e-14 Score=156.09 Aligned_cols=103 Identities=21% Similarity=0.297 Sum_probs=56.3
Q ss_pred CCcEEecccCccCCCCchhhc--CCCCCCEEEccCCcCCCCCCccccCCcccccccc------ccccccCCCCccccccc
Q 008828 27 NLQLVLLQNNNISGHIPTEIG--KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL------NNNSLTGAIPPSLSNMS 98 (552)
Q Consensus 27 ~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l------~~N~l~~~~p~~~~~l~ 98 (552)
+|+.|+|++|+|+ .+|..+. ++++|+.|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|..+..++
T Consensus 489 ~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~ 566 (636)
T 4eco_A 489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566 (636)
T ss_dssp GCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCS
T ss_pred CccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCC
Confidence 5555555555555 4555554 55566666666666554 5555555556666655 34455555555555556
Q ss_pred cccEEeccCCCCCCCCCCccc---CcccccCCccccC
Q 008828 99 QLAFLDLSYNNLSGPVPSFHA---KTFNITGNSLICA 132 (552)
Q Consensus 99 ~L~~l~l~~N~l~~~~~~~~~---~~~~l~~N~~~c~ 132 (552)
+|+.|+|++|+|+. +|..+. +.+++++|++.|.
T Consensus 567 ~L~~L~Ls~N~l~~-ip~~~~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 567 SLTQLQIGSNDIRK-VNEKITPNISVLDIKDNPNISI 602 (636)
T ss_dssp SCCEEECCSSCCCB-CCSCCCTTCCEEECCSCTTCEE
T ss_pred CCCEEECCCCcCCc-cCHhHhCcCCEEECcCCCCccc
Confidence 66666666666632 332221 4555566655543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.52 E-value=3.3e-14 Score=139.24 Aligned_cols=121 Identities=26% Similarity=0.373 Sum_probs=66.8
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|++++..+ +.++++|++|+|++|.+++ +| .+.++++|+.|+|++|++++ + ..+..+++|+.|+|
T Consensus 68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence 455666666666555333 5566666666666666653 22 25556666666666666653 2 34555666666666
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCcccc
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLIC 131 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c 131 (552)
++|++++. ..+..+++|+.|+|++|++++.++ +.. +.+++++|.+..
T Consensus 142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB
T ss_pred cCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCC
Confidence 66666533 345556666666666666665443 111 455566665543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=8.6e-15 Score=156.71 Aligned_cols=129 Identities=20% Similarity=0.194 Sum_probs=98.5
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 46888888888888877788888888888888888888777778888888888888888888666666888888888888
Q ss_pred ccccccCC-CCccccccccccEEeccCCCCCC-CCCCccc-----CcccccCCccc
Q 008828 82 NNNSLTGA-IPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA-----KTFNITGNSLI 130 (552)
Q Consensus 82 ~~N~l~~~-~p~~~~~l~~L~~l~l~~N~l~~-~~~~~~~-----~~~~l~~N~~~ 130 (552)
++|++++. .|..+..+++|+.|++++|.+.+ .++..+. +.+++++|.+.
T Consensus 106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 88888753 46678888888888888887433 3333333 56677777664
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.52 E-value=7.3e-15 Score=128.63 Aligned_cols=105 Identities=24% Similarity=0.265 Sum_probs=94.6
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCC-CCccccCCcccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP-IPSTVSHLETLQYL 79 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L 79 (552)
+++|++|+|++|++++. ..++++++|++|+|++|.+++.+|..+.++++|+.|+|++|.+++. .+..+..+++|+.|
T Consensus 41 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L 118 (149)
T 2je0_A 41 FEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118 (149)
T ss_dssp CTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEE
T ss_pred cCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEE
Confidence 57899999999999986 7899999999999999999977999888999999999999999953 33789999999999
Q ss_pred ccccccccCCCC---ccccccccccEEeccC
Q 008828 80 RLNNNSLTGAIP---PSLSNMSQLAFLDLSY 107 (552)
Q Consensus 80 ~l~~N~l~~~~p---~~~~~l~~L~~l~l~~ 107 (552)
++++|++++..+ ..+..+++|+.|++++
T Consensus 119 ~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 119 DLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred eCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999996655 5799999999999874
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.6e-14 Score=162.57 Aligned_cols=129 Identities=23% Similarity=0.176 Sum_probs=84.3
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCC-chhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHI-PTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
++|++|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++..|..|.++++|+.|+
T Consensus 24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 103 (844)
T 3j0a_A 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103 (844)
T ss_dssp TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence 46777777777777766677777777777777777444344 56677777777777777777766666677777777777
Q ss_pred cccccccCCCCcc--ccccccccEEeccCCCCCCCCCC-ccc-----CcccccCCccc
Q 008828 81 LNNNSLTGAIPPS--LSNMSQLAFLDLSYNNLSGPVPS-FHA-----KTFNITGNSLI 130 (552)
Q Consensus 81 l~~N~l~~~~p~~--~~~l~~L~~l~l~~N~l~~~~~~-~~~-----~~~~l~~N~~~ 130 (552)
|++|.+++.+|.. +..+++|+.|+|++|.+++..+. .+. +.++|++|.+.
T Consensus 104 Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~ 161 (844)
T 3j0a_A 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161 (844)
T ss_dssp CTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred CcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence 7777776555443 66677777777777777665432 222 55566666553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.4e-14 Score=153.85 Aligned_cols=131 Identities=19% Similarity=0.148 Sum_probs=100.1
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 35788888888888877778888888888888888888766777888888888888888888666677888888888888
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCC-CCCccc-----CcccccCCccccC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP-VPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~-~~~~~~-----~~~~l~~N~~~c~ 132 (552)
++|++++..+..+..+++|++|++++|.+++. .|..+. +.+++++|.+...
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~ 164 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEE
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcccee
Confidence 88888855555678888888888888888763 354433 6677777776543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.7e-14 Score=153.37 Aligned_cols=127 Identities=19% Similarity=0.203 Sum_probs=74.0
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCC--CCCccccCCccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG--PIPSTVSHLETLQYLR 80 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~ 80 (552)
+|+.|++++|++.... .+..+++|++|+|++|++++.+|..+.++++|+.|+|++|++++ .+|..+..+++|+.|+
T Consensus 303 ~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~ 380 (520)
T 2z7x_B 303 NIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380 (520)
T ss_dssp CCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEE
T ss_pred ceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEE
Confidence 4666666666654422 12456666666666666665566666666666666666666664 2344566666666666
Q ss_pred cccccccCCCCc-cccccccccEEeccCCCCCCCCCCcc---cCcccccCCcccc
Q 008828 81 LNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFH---AKTFNITGNSLIC 131 (552)
Q Consensus 81 l~~N~l~~~~p~-~~~~l~~L~~l~l~~N~l~~~~~~~~---~~~~~l~~N~~~c 131 (552)
|++|++++.+|. .+..+++|+.|+|++|++++..|..+ .+.+++++|.+..
T Consensus 381 Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~~ 435 (520)
T 2z7x_B 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKS 435 (520)
T ss_dssp CCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCCC
T ss_pred CCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhcccCCEEECCCCcccc
Confidence 666666653443 35556666666666666655444332 2556666666553
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.6e-14 Score=137.70 Aligned_cols=122 Identities=24% Similarity=0.346 Sum_probs=85.6
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
|++|++|++++|+++. +| .++.+++|+.|+|++|+|++ ++. +.++++|+.|+|++|++++ +|.. .. ++|+.|+
T Consensus 40 l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~ 112 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLF 112 (263)
T ss_dssp HTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEE
T ss_pred cCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEE
Confidence 3578888888888776 44 67788888888888888884 444 7888888888888888874 4432 22 7777777
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCcc----cCcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH----AKTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~----~~~~~l~~N~~~c~ 132 (552)
|++|+|++ ++ .+..+++|+.|+|++|+|++.+ .+. .+.+++++|.+...
T Consensus 113 L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 113 LDNNELRD-TD-SLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEECTTSCCCBC
T ss_pred ccCCccCC-Ch-hhcCcccccEEECCCCcCCCCh-HHccCCCCCEEECCCCcCcch
Confidence 77777774 33 4777777777777777777653 221 15667777776554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.51 E-value=3.9e-14 Score=127.39 Aligned_cols=104 Identities=29% Similarity=0.314 Sum_probs=92.6
Q ss_pred CcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccccccCCCCccccccccccEEeccC
Q 008828 28 LQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY 107 (552)
Q Consensus 28 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 107 (552)
-+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 478999999998 7887765 8999999999999988888999999999999999999976666789999999999999
Q ss_pred CCCCCCCCCccc-----CcccccCCccccCCC
Q 008828 108 NNLSGPVPSFHA-----KTFNITGNSLICATG 134 (552)
Q Consensus 108 N~l~~~~~~~~~-----~~~~l~~N~~~c~~~ 134 (552)
|+|++.++..+. +.++|++|++.|.+.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 999988876544 788999999998764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=3.8e-14 Score=141.44 Aligned_cols=130 Identities=22% Similarity=0.288 Sum_probs=114.1
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCC--CCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISG--HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 79 (552)
++|++|++++|.+++..+..|.++++|+.|+|++|.++. ..+..|.++++|+.|++++|.++ .+|..+. ++|+.|
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L 197 (330)
T 1xku_A 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTEL 197 (330)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEE
T ss_pred ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEE
Confidence 579999999999999888889999999999999999963 67888999999999999999999 5776654 799999
Q ss_pred ccccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCC
Q 008828 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 134 (552)
Q Consensus 80 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~ 134 (552)
+|++|++++..|..+..+++|+.|+|++|.+++.++..+. +.+++++|.+...+.
T Consensus 198 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~ 257 (330)
T 1xku_A 198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG 257 (330)
T ss_dssp ECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCT
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCCh
Confidence 9999999988888999999999999999999987775543 788999999875543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.7e-14 Score=142.71 Aligned_cols=131 Identities=20% Similarity=0.175 Sum_probs=107.6
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCC--C--chhhcCCCCCCEEEccCCcCCCCCCc----cccC
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGH--I--PTEIGKLSKLLTLDLSNNFFTGPIPS----TVSH 72 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~--p~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~ 72 (552)
+++|++|+|++|++.+..|..|+.+++|++|+|++|++.+. + +..+.++++|++|+|++|+++ .++. .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 46899999999999998889999999999999999998642 2 223468999999999999997 4444 2567
Q ss_pred CccccccccccccccCCCCcccccc---ccccEEeccCCCCCCCCCCccc--CcccccCCccccC
Q 008828 73 LETLQYLRLNNNSLTGAIPPSLSNM---SQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSLICA 132 (552)
Q Consensus 73 l~~L~~L~l~~N~l~~~~p~~~~~l---~~L~~l~l~~N~l~~~~~~~~~--~~~~l~~N~~~c~ 132 (552)
+++|++|+|++|+|++..|..+..+ ++|+.|+|++|+|+..+..... +.++|++|.+...
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~L~~L~Ls~N~l~~~ 287 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLPAKLRVLDLSSNRLNRA 287 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCCSCCSCEECCSCCCCSC
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhcCCCCEEECCCCcCCCC
Confidence 8999999999999998778777777 6999999999999965444432 7889999988754
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.6e-14 Score=154.62 Aligned_cols=129 Identities=19% Similarity=0.172 Sum_probs=112.2
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCC-CCCccccCCcccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYL 79 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L 79 (552)
|++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++ ..|..++++++|+.|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 5789999999999999888999999999999999999998777789999999999999999986 356789999999999
Q ss_pred ccccccccCCCC-ccccccccccEEeccCCCCCCCCCCccc-----CcccccCCcc
Q 008828 80 RLNNNSLTGAIP-PSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSL 129 (552)
Q Consensus 80 ~l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~ 129 (552)
++++|++.+.+| ..+..+++|+.|++++|.+++..|..+. +.+++++|.+
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~ 184 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBS
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcc
Confidence 999999544554 6899999999999999999987776554 4556666654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.51 E-value=5.7e-14 Score=140.34 Aligned_cols=124 Identities=23% Similarity=0.259 Sum_probs=57.5
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccC--CCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNIS--GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+|++|++++|++.+..+..|.++++|+.|+|++|.++ +..|..|..+ +|+.|++++|+++ .+|..+. ++|+.|+
T Consensus 124 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-~l~~~~~--~~L~~L~ 199 (332)
T 2ft3_A 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLP--ETLNELH 199 (332)
T ss_dssp TCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-SCCSSSC--SSCSCCB
T ss_pred cCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-ccCcccc--CCCCEEE
Confidence 3444444444444444444555555555555555553 1333334333 3333333333222 1222111 3455555
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccc
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 130 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~ 130 (552)
|++|++++..+..+..+++|+.|+|++|++++.++..+. +.+++++|.+.
T Consensus 200 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 254 (332)
T 2ft3_A 200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254 (332)
T ss_dssp CCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe
Confidence 555555544445555555555555555555555443322 44555555554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.50 E-value=7.2e-15 Score=163.55 Aligned_cols=128 Identities=20% Similarity=0.270 Sum_probs=104.2
Q ss_pred CCcccEeccCCCCCcc-----------------ccccccc--CCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCc
Q 008828 1 MVLLCYRGAPSQNLSG-----------------TLSSSIG--NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNF 61 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~-----------------~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 61 (552)
|++|++|+|++|++++ .+|..++ ++++|++|+|++|.+.+.+|..|.++++|+.|+|++|+
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 5788899999999888 3788877 89999999999998888889889999999999999997
Q ss_pred -CCC-CCCccccCCc-------cccccccccccccCCCCc--cccccccccEEeccCCCCCCCCCCccc----CcccccC
Q 008828 62 -FTG-PIPSTVSHLE-------TLQYLRLNNNSLTGAIPP--SLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITG 126 (552)
Q Consensus 62 -l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~ 126 (552)
+++ .+|..++.++ +|+.|+|++|+|+ .+|. .+..+++|+.|+|++|+|+ .+|.+.. +.++|++
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDY 604 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCS
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcC
Confidence 887 6777666555 8888888888888 7787 7888888888888888888 4553221 6778888
Q ss_pred Cccc
Q 008828 127 NSLI 130 (552)
Q Consensus 127 N~~~ 130 (552)
|.+.
T Consensus 605 N~l~ 608 (876)
T 4ecn_A 605 NQIE 608 (876)
T ss_dssp SCCS
T ss_pred Cccc
Confidence 8776
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.50 E-value=8.6e-15 Score=154.01 Aligned_cols=129 Identities=22% Similarity=0.213 Sum_probs=88.0
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCc-------------
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS------------- 68 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~------------- 68 (552)
++|++|+|++|++++..|..|+.+++|++|+|++|.|++..| |.++++|+.|+|++|.|++..+.
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l 111 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI 111 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcC
Confidence 478999999999998888889999999999999999986555 77888887777777766532110
Q ss_pred ---cccCCccccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc------CcccccCCccccC
Q 008828 69 ---TVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLICA 132 (552)
Q Consensus 69 ---~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~------~~~~l~~N~~~c~ 132 (552)
....+++|+.|+|++|.|++..|..+..+++|+.|+|++|.|++.+|..+. +.++|++|.+...
T Consensus 112 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 112 SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp CCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 011245566666666666666666666666777777777777665444321 4556666665433
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.49 E-value=3e-14 Score=143.28 Aligned_cols=127 Identities=18% Similarity=0.144 Sum_probs=103.9
Q ss_pred cEeccCCC-CCcccccccccCCCCCcEEeccc-CccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 5 CYRGAPSQ-NLSGTLSSSIGNLTNLQLVLLQN-NNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 5 ~~L~l~~n-~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
..++++++ +|++ +|. |..+++|+.|+|++ |.|++..+..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35788888 7876 777 99999999999996 99998877899999999999999999998888899999999999999
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCCCCc-cc-----CcccccCCccccCCC
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF-HA-----KTFNITGNSLICATG 134 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~-~~-----~~~~l~~N~~~c~~~ 134 (552)
+|+|++..+..+..++ |+.|+|++|+|.....-. +. ....+..+.+.|..+
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~ 145 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ 145 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCC
Confidence 9999966666666665 999999999999765421 11 233344566667644
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.49 E-value=3.3e-14 Score=140.43 Aligned_cols=125 Identities=23% Similarity=0.339 Sum_probs=95.2
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|+|++|.+++. + .+..+++|++|+|++|++++ ++. +.++++|+.|+|++|.+++. +. +..+++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~ 157 (308)
T 1h6u_A 84 LTKITELELSGNPLKNV-S-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLS 157 (308)
T ss_dssp CCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEE
T ss_pred CCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEE
Confidence 56788899999888774 3 68888888888888888884 443 88888888888888888843 33 77888888888
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCc---ccCcccccCCccccCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGNSLICAT 133 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~---~~~~~~l~~N~~~c~~ 133 (552)
|++|++++ ++. +..+++|+.|+|++|++++.++-. ..+.+++++|.+....
T Consensus 158 l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 158 IGNAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp CCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCG
T ss_pred ccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCccc
Confidence 88888884 443 788888888888888888765411 1167788888776554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.49 E-value=5.2e-14 Score=151.11 Aligned_cols=130 Identities=16% Similarity=0.186 Sum_probs=110.2
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCC--CCccccCCcccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP--IPSTVSHLETLQYL 79 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L 79 (552)
.+|++|++++|.+.... ..+.+++|++|+|++|++++.+|..+.++++|+.|+|++|++++. +|..+..+++|+.|
T Consensus 331 ~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L 408 (562)
T 3a79_B 331 MNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETL 408 (562)
T ss_dssp CCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEE
T ss_pred CcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEE
Confidence 36999999999986532 237899999999999999988999999999999999999999953 24678999999999
Q ss_pred ccccccccCCCCc-cccccccccEEeccCCCCCCCCCCcc---cCcccccCCccccCC
Q 008828 80 RLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFH---AKTFNITGNSLICAT 133 (552)
Q Consensus 80 ~l~~N~l~~~~p~-~~~~l~~L~~l~l~~N~l~~~~~~~~---~~~~~l~~N~~~c~~ 133 (552)
+|++|++++.+|. .+..+++|+.|+|++|++++..|..+ .+.++|++|.+...+
T Consensus 409 ~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip 466 (562)
T 3a79_B 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIP 466 (562)
T ss_dssp ECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCC
T ss_pred ECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhcCcCCEEECCCCcCcccC
Confidence 9999999975664 58889999999999999987766554 378899999887544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.49 E-value=8.3e-14 Score=137.54 Aligned_cols=104 Identities=23% Similarity=0.396 Sum_probs=53.8
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
+|++|++++|++.. +| .+..+++|+.|+|++|.+++ ++. +.++++|+.|+|++|++++ ++ .+..+++|+.|+|+
T Consensus 42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLT 115 (308)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECT
T ss_pred CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECC
Confidence 45555555555554 22 35555555555555555552 332 5555555555555555552 22 35555555555555
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCC
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPV 114 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 114 (552)
+|++++ ++. +..+++|+.|+|++|.+++.+
T Consensus 116 ~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~ 145 (308)
T 1h6u_A 116 STQITD-VTP-LAGLSNLQVLYLDLNQITNIS 145 (308)
T ss_dssp TSCCCC-CGG-GTTCTTCCEEECCSSCCCCCG
T ss_pred CCCCCC-chh-hcCCCCCCEEECCCCccCcCc
Confidence 555553 222 555555555555555555433
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.48 E-value=5.8e-14 Score=137.49 Aligned_cols=123 Identities=25% Similarity=0.345 Sum_probs=106.0
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
|++|++|+|++|.+++. | .+..+++|++|+|++|+|++ + ..+.++++|+.|+|++|++++. ..+..+++|+.|+
T Consensus 89 l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 162 (291)
T 1h6t_A 89 LKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLS 162 (291)
T ss_dssp CTTCCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred CCCCCEEECCCCcCCCC-h-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEE
Confidence 57899999999999873 3 49999999999999999995 4 4699999999999999999954 6799999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~ 132 (552)
|++|+|++..| +..+++|+.|+|++|+|++.+ .+.. +.+++++|++.+.
T Consensus 163 L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 163 LEDNQISDIVP--LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEEEEEEECC
T ss_pred ccCCccccchh--hcCCCccCEEECCCCcCCCCh-hhccCCCCCEEECcCCcccCC
Confidence 99999996544 999999999999999999753 3221 7889999988653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.48 E-value=1e-13 Score=154.34 Aligned_cols=124 Identities=19% Similarity=0.207 Sum_probs=70.9
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCC--------CCCCEEEccCCcCCCCCCcccc--C
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKL--------SKLLTLDLSNNFFTGPIPSTVS--H 72 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l--------~~L~~L~l~~N~l~~~~p~~~~--~ 72 (552)
+|+.|+|++|+++.+.+..+..+++|+.|+|++|+|+ .+|..+... ++|+.|+|++|+|+ .+|..+. .
T Consensus 674 ~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~ 751 (876)
T 4ecn_A 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATT 751 (876)
T ss_dssp CEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTT
T ss_pred CcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhcc
Confidence 5666666666666432233345666666666666666 444433322 25666666666666 5555554 5
Q ss_pred CccccccccccccccCCCCccccccccccEEeccC------CCCCCCCCCccc-----CcccccCCcc
Q 008828 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY------NNLSGPVPSFHA-----KTFNITGNSL 129 (552)
Q Consensus 73 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~------N~l~~~~~~~~~-----~~~~l~~N~~ 129 (552)
+++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..+. +.++|++|.+
T Consensus 752 l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L 818 (876)
T 4ecn_A 752 LPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818 (876)
T ss_dssp CTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred CCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC
Confidence 6666666666666664 555566666666666644 555555554432 4556666655
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.47 E-value=3.1e-14 Score=128.45 Aligned_cols=106 Identities=21% Similarity=0.206 Sum_probs=95.3
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCc--cccCCcccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS--TVSHLETLQYL 79 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L 79 (552)
++|++|+|++|++++. ..|+.+++|++|+|++|+|++..+..|.++++|+.|+|++|+++ .+|. .+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 4899999999999986 68999999999999999999665566699999999999999997 6776 78999999999
Q ss_pred ccccccccCCCCcc----ccccccccEEeccCCCCC
Q 008828 80 RLNNNSLTGAIPPS----LSNMSQLAFLDLSYNNLS 111 (552)
Q Consensus 80 ~l~~N~l~~~~p~~----~~~l~~L~~l~l~~N~l~ 111 (552)
++++|.+. .+|.. +..+++|+.||+++|.+.
T Consensus 119 ~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 119 CILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp ECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999999 56664 899999999999999875
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.3e-13 Score=132.91 Aligned_cols=123 Identities=24% Similarity=0.307 Sum_probs=97.2
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|+|++|++++..+ +.++++|++|+|++|+|++ +|. +.. ++|+.|+|++|++++ ++ .+..+++|+.|+
T Consensus 62 l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILS 134 (263)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEE
Confidence 4688999999999888554 8899999999999999984 554 333 889999999999984 43 588899999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccccCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICAT 133 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~~ 133 (552)
|++|+|++ ++ .+..+++|+.|+|++|++++. +.+.. +.+++++|++.+.+
T Consensus 135 Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 135 IRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp CTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECCC
T ss_pred CCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCCc
Confidence 99999985 44 688889999999999999876 22211 67888888887653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.46 E-value=6.8e-14 Score=154.07 Aligned_cols=124 Identities=23% Similarity=0.244 Sum_probs=95.8
Q ss_pred ccEeccCCCCCcc---------cccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCc
Q 008828 4 LCYRGAPSQNLSG---------TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE 74 (552)
Q Consensus 4 l~~L~l~~n~l~~---------~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 74 (552)
|..|+|+.|.|.+ ..|..|..+++|+.|+|++|.|. .+|..+.++++|+.|+|++|.|+ .+|..|++|+
T Consensus 193 l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 270 (727)
T 4b8c_D 193 LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLS 270 (727)
T ss_dssp -----------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGT
T ss_pred hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCC
Confidence 3455555555544 34778999999999999999999 78888889999999999999999 8999999999
Q ss_pred cccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCcccc
Q 008828 75 TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLIC 131 (552)
Q Consensus 75 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c 131 (552)
+|+.|+|++|+|+ .+|..|..|++|+.|+|++|.|+.++.. +. +.++|++|++..
T Consensus 271 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~L~~N~l~~ 330 (727)
T 4b8c_D 271 NLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWE-FGNLCNLQFLGVEGNPLEK 330 (727)
T ss_dssp TCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSS-TTSCTTCCCEECTTSCCCS
T ss_pred CCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChh-hhcCCCccEEeCCCCccCC
Confidence 9999999999999 8899999999999999999999865544 33 788999999864
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1.5e-13 Score=147.60 Aligned_cols=123 Identities=27% Similarity=0.354 Sum_probs=76.2
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
|++|+.|+|++|++.+..| +..|++|+.|+|++|.|++ +| .+.++++|+.|+|++|+|++ + ..+..|++|+.|+
T Consensus 64 l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~ 137 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 137 (605)
T ss_dssp CTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEE
T ss_pred CCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEE
Confidence 4566677777776666443 6666677777777776663 33 46666677777777776663 2 3466666677777
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCc---ccCcccccCCcccc
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGNSLIC 131 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~---~~~~~~l~~N~~~c 131 (552)
|++|+|++. ..+..|++|+.|+|++|.|++.+|-. ..+.++|++|.+..
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~ 189 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD 189 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCC
Confidence 777766643 45666667777777777776655411 01556666666543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.2e-13 Score=138.84 Aligned_cols=124 Identities=25% Similarity=0.354 Sum_probs=77.1
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|++++|.+.+..+ +..+++|+.|+|++|.+++ ++. +.++++|+.|+|++|.+++ + ..+..+++|+.|+
T Consensus 198 l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~ 271 (347)
T 4fmz_A 198 LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLN 271 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEE
T ss_pred CCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEE
Confidence 3566677777776665443 6666777777777777763 333 6666777777777776663 2 3466666777777
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
+++|++++. ..+..+++|+.|++++|++++..+..+. +.+++++|++...
T Consensus 272 l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 272 VGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred ccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence 777766643 3466666677777777766655544322 5566666666544
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.8e-14 Score=142.95 Aligned_cols=129 Identities=22% Similarity=0.213 Sum_probs=93.0
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCc-------------
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS------------- 68 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~------------- 68 (552)
++|++|+|++|++++..|..|.++++|++|+|++|.+++..+ |.++++|++|+|++|++++..+.
T Consensus 34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l 111 (317)
T 3o53_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI 111 (317)
T ss_dssp GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCC
T ss_pred CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCcc
Confidence 578899999999998888889999999999999999885544 88888888888888877632100
Q ss_pred ---cccCCccccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc------CcccccCCccccC
Q 008828 69 ---TVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLICA 132 (552)
Q Consensus 69 ---~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~------~~~~l~~N~~~c~ 132 (552)
....+++|+.|+|++|++++..+..+..+++|+.|+|++|.+++..+..+. +.++|++|.+...
T Consensus 112 ~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 184 (317)
T 3o53_A 112 SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (317)
T ss_dssp SEEEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc
Confidence 012245677777777777766666777777888888888887765544321 5667777776544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.43 E-value=2.4e-13 Score=146.07 Aligned_cols=123 Identities=26% Similarity=0.357 Sum_probs=106.5
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
|++|+.|+|++|.+.+ +| .+..|++|+.|+|++|.|++ ++ .+.+|++|+.|+|++|+|++. ..+..|++|+.|+
T Consensus 86 l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~ 159 (605)
T 1m9s_A 86 LKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLS 159 (605)
T ss_dssp CTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEE
T ss_pred CCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEE
Confidence 5789999999999987 33 79999999999999999995 44 599999999999999999954 6799999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCcc----cCcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH----AKTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~----~~~~~l~~N~~~c~ 132 (552)
|++|+|++..| +..+++|+.|+|++|+|++. +.+. .+.++|++|++...
T Consensus 160 Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 160 LEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECC
T ss_pred CcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCC
Confidence 99999996655 89999999999999999975 3322 27889999988654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.42 E-value=1.5e-15 Score=139.99 Aligned_cols=127 Identities=20% Similarity=0.278 Sum_probs=110.5
Q ss_pred CcccEeccCCCCCcccccc------cccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcc
Q 008828 2 VLLCYRGAPSQNLSGTLSS------SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET 75 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 75 (552)
.+++.++++.+.+.+..|. .|+.+++|++|+|++|.|++ +| .+.++++|+.|+|++|.++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 5688889999999988777 89999999999999999995 77 8999999999999999999 78888888899
Q ss_pred ccccccccccccCCCCccccccccccEEeccCCCCCCCCC-Ccc-----cCcccccCCccccCC
Q 008828 76 LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP-SFH-----AKTFNITGNSLICAT 133 (552)
Q Consensus 76 L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~-----~~~~~l~~N~~~c~~ 133 (552)
|+.|+|++|+|++ +| .+..+++|+.|+|++|++++.++ ..+ .+.+++++|++.|.+
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 156 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccc
Confidence 9999999999995 55 68899999999999999997443 111 278899999987653
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.41 E-value=2e-13 Score=137.25 Aligned_cols=104 Identities=17% Similarity=0.227 Sum_probs=94.7
Q ss_pred cEEecccC-ccCCCCchhhcCCCCCCEEEccC-CcCCCCCCccccCCccccccccccccccCCCCccccccccccEEecc
Q 008828 29 QLVLLQNN-NISGHIPTEIGKLSKLLTLDLSN-NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLS 106 (552)
Q Consensus 29 ~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 106 (552)
..+++++| .|+ .+|. |..+++|+.|+|++ |+|++..+..|.+|++|+.|+|++|+|++..|..|..|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 45799998 998 6888 99999999999996 99997777889999999999999999999889999999999999999
Q ss_pred CCCCCCCCCCccc----CcccccCCccccCCC
Q 008828 107 YNNLSGPVPSFHA----KTFNITGNSLICATG 134 (552)
Q Consensus 107 ~N~l~~~~~~~~~----~~~~l~~N~~~c~~~ 134 (552)
+|+|++.++..+. +.++|.+|++.|.|.
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCCCc
Confidence 9999998877654 788999999999986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.39 E-value=6.1e-13 Score=139.29 Aligned_cols=122 Identities=25% Similarity=0.318 Sum_probs=75.8
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|++++|.+.+..+ +..+++|+.|+|++|.+++. +. +..+++|+.|+|++|++++..| +..+++|+.|+
T Consensus 242 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 315 (466)
T 1o6v_A 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-SP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLT 315 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEE
T ss_pred CCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcc-cc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEE
Confidence 4567777777777776544 66777777777777777643 33 6667777777777777764332 56666677777
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCcc----cCcccccCCcccc
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH----AKTFNITGNSLIC 131 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~----~~~~~l~~N~~~c 131 (552)
|++|++++..| +..+++|+.|++++|++++. +.+. .+.+++++|.+..
T Consensus 316 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~ 367 (466)
T 1o6v_A 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISD 367 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCB
T ss_pred CcCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCccCc
Confidence 77776665443 55666666666666666654 2111 1455666665543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.5e-12 Score=138.49 Aligned_cols=114 Identities=23% Similarity=0.288 Sum_probs=72.0
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|+|+. +| +.+++|+.|+|++|+|++ +|. |.+ +|+.|+|++|+|++ +|. .+++|+.|+|
T Consensus 80 ~~L~~L~Ls~N~l~~-ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 80 PQITVLEITQNALIS-LP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TTCSEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCCCcc-cc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 457777777777764 55 446777777777777774 555 544 77777777777774 554 4566777777
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc--CcccccCCccccC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSLICA 132 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~--~~~~l~~N~~~c~ 132 (552)
++|+|++ +|. .+++|+.|+|++|+|++.++ +.. +.++|++|.+...
T Consensus 148 s~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l~~~L~~L~Ls~N~L~~l 195 (571)
T 3cvr_A 148 DNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-LPESLEALDVSTNLLESL 195 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC-CCTTCCEEECCSSCCSSC
T ss_pred CCCccCc-CCC---cCCCcCEEECCCCCCCCcch-hhCCCCEEECcCCCCCch
Confidence 7777764 454 45666677777777666333 211 5566666666543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.36 E-value=9.8e-13 Score=132.07 Aligned_cols=122 Identities=19% Similarity=0.354 Sum_probs=89.6
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|+|++|.+++ ++. +..+++|+.|+
T Consensus 176 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~ 249 (347)
T 4fmz_A 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLE 249 (347)
T ss_dssp CTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEE
T ss_pred CCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEE
Confidence 4678888888888876443 7788888888888888874433 7788888888888888884 343 77888888888
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCcc----cCcccccCCcccc
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH----AKTFNITGNSLIC 131 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~----~~~~~l~~N~~~c 131 (552)
+++|.+++ + +.+..+++|+.|++++|++++. +.+. .+.+++++|.+..
T Consensus 250 l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~ 301 (347)
T 4fmz_A 250 IGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGN 301 (347)
T ss_dssp CCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCG
T ss_pred CCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCC
Confidence 88888874 3 4577788888888888888865 3221 1677888887653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.5e-12 Score=136.29 Aligned_cols=124 Identities=29% Similarity=0.382 Sum_probs=100.2
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|+.|++++|++++. +.+..+++|+.|++++|.+++..| +.++++|+.|+|++|.+++. +. +..+++|+.|+
T Consensus 220 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~ 293 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-SP-LAGLTALTNLE 293 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEE
T ss_pred cCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcc-cc-ccCCCccCeEE
Confidence 46889999999998874 468889999999999999985544 88899999999999999854 33 88889999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCcc---cCcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH---AKTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~---~~~~~l~~N~~~c~ 132 (552)
|++|++++..| +..+++|+.|+|++|++++.+|-.. .+.+++++|.+...
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc
Confidence 99999986443 7888999999999999988766221 17788888887665
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.34 E-value=3.2e-12 Score=133.21 Aligned_cols=118 Identities=23% Similarity=0.319 Sum_probs=95.4
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
|++|++|+|++|++++. | .++.+++|++|+|++|.|++ +| ++++++|++|+|++|++++ +| ++.+++|+.|+
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~ 112 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLN 112 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEE
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEE
Confidence 46789999999999874 5 68899999999999999985 45 8889999999999999985 44 88899999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc--CcccccCCcc
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSL 129 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~--~~~~l~~N~~ 129 (552)
|++|++++ +| +..+++|+.|++++|+|++..-.... +.+++++|..
T Consensus 113 L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l~l~~l~~L~~L~l~~n~~ 160 (457)
T 3bz5_A 113 CDTNKLTK-LD--VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKK 160 (457)
T ss_dssp CCSSCCSC-CC--CTTCTTCCEEECTTSCCSCCCCTTCTTCCEEECTTCSC
T ss_pred CCCCcCCe-ec--CCCCCcCCEEECCCCccceeccccCCcCCEEECCCCCc
Confidence 99999985 44 88889999999999999885322111 5677777743
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.9e-12 Score=138.26 Aligned_cols=102 Identities=18% Similarity=0.227 Sum_probs=90.9
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCC-CccccCCcccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPI-PSTVSHLETLQYL 79 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L 79 (552)
|++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .|+++++|+.|+|++|+|++.. |..|+.|++|+.|
T Consensus 462 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred cccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 578999999999999 588999999999999999999995 77 8999999999999999999776 9999999999999
Q ss_pred ccccccccCCCCcc---ccccccccEEec
Q 008828 80 RLNNNSLTGAIPPS---LSNMSQLAFLDL 105 (552)
Q Consensus 80 ~l~~N~l~~~~p~~---~~~l~~L~~l~l 105 (552)
+|++|+|++..|.. +..+++|+.|++
T Consensus 539 ~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 539 NLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp ECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred EecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999999665532 344789999875
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.33 E-value=2.7e-12 Score=136.56 Aligned_cols=117 Identities=26% Similarity=0.291 Sum_probs=89.1
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|+|++|+|++ +|. |.+ +|+.|+|++|.|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+
T Consensus 99 l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~ 166 (571)
T 3cvr_A 99 PASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLS 166 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred cCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEE
Confidence 4678999999999888 666 655 89999999999885 665 67888888888888884 665 567888888
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc---------CcccccCCccccCCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---------KTFNITGNSLICATG 134 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~---------~~~~l~~N~~~c~~~ 134 (552)
|++|+|++ +|. |. ++|+.|+|++|+|+..++ +.. +.++|++|.+...+.
T Consensus 167 Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~~L~~~~~~L~~L~Ls~N~l~~lp~ 224 (571)
T 3cvr_A 167 VRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPVRNHHSEETEIFFRCRENRITHIPE 224 (571)
T ss_dssp CCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC--------CCEEEECCSSCCCCCCG
T ss_pred CCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHHhhhcccccceEEecCCCcceecCH
Confidence 88888885 666 55 788888888888885444 221 456788888775543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.5e-12 Score=131.03 Aligned_cols=103 Identities=17% Similarity=0.125 Sum_probs=48.9
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCc-hhhcCCCCCCE-EEccCCcCCCCCCccccCCccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIP-TEIGKLSKLLT-LDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~-L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
++++|+|++|+|+.+.+..|++|++|++|+|++|++.+.+| ..|.++++|+. +++++|+|++..|..|..+++|+.|+
T Consensus 31 ~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~ 110 (350)
T 4ay9_X 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 110 (350)
T ss_dssp TCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEE
T ss_pred CCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccc
Confidence 44555555555554433445555555555555555443333 23444554443 33444555544444455555555555
Q ss_pred cccccccCCCCccccccccccEEec
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDL 105 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l 105 (552)
+++|+|.+..+..+....++..|++
T Consensus 111 l~~n~l~~~~~~~~~~~~~l~~l~l 135 (350)
T 4ay9_X 111 ISNTGIKHLPDVHKIHSLQKVLLDI 135 (350)
T ss_dssp EEEECCSSCCCCTTCCBSSCEEEEE
T ss_pred ccccccccCCchhhcccchhhhhhh
Confidence 5555555333333434444444444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.32 E-value=8.1e-15 Score=134.98 Aligned_cols=111 Identities=23% Similarity=0.217 Sum_probs=98.9
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|+|++|++++ +| .+..+++|++|+|++|.|+ .+|..+..+++|+.|+|++|++++ +| .+..+++|+.|+
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 5789999999999998 66 8999999999999999999 788888889999999999999995 56 688999999999
Q ss_pred cccccccCCCC-ccccccccccEEeccCCCCCCCCCC
Q 008828 81 LNNNSLTGAIP-PSLSNMSQLAFLDLSYNNLSGPVPS 116 (552)
Q Consensus 81 l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~~~ 116 (552)
|++|+|++..+ ..+..+++|+.|++++|++++.+|.
T Consensus 122 l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 99999994332 4788999999999999999887654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.29 E-value=1e-11 Score=129.39 Aligned_cols=121 Identities=26% Similarity=0.255 Sum_probs=92.3
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|++++|++++. + ++++++|++|++++|...+.+ .+.++++|+.|+|++|++++ +| +..+++|+.|+
T Consensus 126 l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~ 197 (457)
T 3bz5_A 126 NPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLN 197 (457)
T ss_dssp CTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEE
T ss_pred CCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEE
Confidence 56889999999999884 3 788888888888888555455 37788888888888888885 55 77888888888
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc--CcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~--~~~~l~~N~~~c~ 132 (552)
+++|++++. .+..+++|+.|++++|+|++.+...+. +.+++++|.+...
T Consensus 198 l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip~~~l~~L~~L~l~~N~l~~~ 248 (457)
T 3bz5_A 198 CDTNNITKL---DLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLTEL 248 (457)
T ss_dssp CCSSCCSCC---CCTTCTTCSEEECCSSCCSCCCCTTCTTCSEEECCSSCCSCC
T ss_pred CcCCcCCee---ccccCCCCCEEECcCCcccccCccccCCCCEEEeeCCcCCCc
Confidence 888888854 377788888888888888875321111 6778888877654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=1.5e-11 Score=118.38 Aligned_cols=145 Identities=13% Similarity=0.070 Sum_probs=112.6
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecCCceeEE
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv 305 (552)
....+|.+...+|.|+.+.||++... ++.+++|+...... .....+.+|+.++..+. +..+.++++++...+..++|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34456777778888888999999765 68999999865321 11235788999998884 67788999999888889999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-------------------------------------- 347 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------- 347 (552)
|||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999877642 12234578899999999999810
Q ss_pred ------------------CCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 348 ------------------DPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 348 ------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1469999999999999876566799999875
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.26 E-value=2.2e-11 Score=126.71 Aligned_cols=116 Identities=25% Similarity=0.340 Sum_probs=66.1
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
+|++|+|++|++++ +| .|+++++|++|++++|++++ +|..+ ++|++|+|++|++++ +| .++.+++|+.|+++
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 56666666666665 44 46666666666666666663 44322 356666666666663 44 46666666666666
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCcccc
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLIC 131 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c 131 (552)
+|++++ +|... ++|+.|++++|.++. +|.+.. +.+++++|.+..
T Consensus 204 ~N~l~~-l~~~~---~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~ 251 (454)
T 1jl5_A 204 NNSLKK-LPDLP---LSLESIVAGNNILEE-LPELQNLPFLTTIYADNNLLKT 251 (454)
T ss_dssp SSCCSS-CCCCC---TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSS
T ss_pred CCcCCc-CCCCc---CcccEEECcCCcCCc-ccccCCCCCCCEEECCCCcCCc
Confidence 666663 33322 356666666666663 333211 566777777654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.24 E-value=3.7e-13 Score=134.47 Aligned_cols=129 Identities=19% Similarity=0.221 Sum_probs=93.4
Q ss_pred CCcccEeccCCCCCccc-ccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCC-cCCCC-CCccccCCcccc
Q 008828 1 MVLLCYRGAPSQNLSGT-LSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNN-FFTGP-IPSTVSHLETLQ 77 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~ 77 (552)
+++|++|+|++|++++. +|..+..+++|++|+|++|.+++..+..+.++++|++|+|++| .+++. ++..+..+++|+
T Consensus 92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 46788888888887765 7777888888888888888887777777888888888888888 56642 555577788888
Q ss_pred ccccccc-cccCC-CCccccccc-cccEEeccCC--CCC-CCCCCcc-----cCcccccCCcc
Q 008828 78 YLRLNNN-SLTGA-IPPSLSNMS-QLAFLDLSYN--NLS-GPVPSFH-----AKTFNITGNSL 129 (552)
Q Consensus 78 ~L~l~~N-~l~~~-~p~~~~~l~-~L~~l~l~~N--~l~-~~~~~~~-----~~~~~l~~N~~ 129 (552)
.|+|++| .+++. ++..+..++ +|+.|+|++| .++ +.++..+ .+.+++++|.+
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~ 234 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 234 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc
Confidence 8888888 77743 466677777 8888888888 344 2222221 26677777763
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.23 E-value=8.6e-13 Score=133.41 Aligned_cols=108 Identities=18% Similarity=0.238 Sum_probs=52.7
Q ss_pred ccEeccCCCCCccccc----ccccCCC-CCcEEecccCccCCCCchhhcCC-----CCCCEEEccCCcCCCCCCcccc--
Q 008828 4 LCYRGAPSQNLSGTLS----SSIGNLT-NLQLVLLQNNNISGHIPTEIGKL-----SKLLTLDLSNNFFTGPIPSTVS-- 71 (552)
Q Consensus 4 l~~L~l~~n~l~~~~p----~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~-- 71 (552)
|++|+|++|++++..+ ..|..++ +|++|+|++|.|++..+..|..+ ++|+.|+|++|.+++..+..+.
T Consensus 24 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 103 (362)
T 3goz_A 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103 (362)
T ss_dssp CCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred ceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHH
Confidence 5555555555555444 4445555 55555555555554444444443 5555555555555543333222
Q ss_pred --CC-ccccccccccccccCCCCccccc-----cccccEEeccCCCCC
Q 008828 72 --HL-ETLQYLRLNNNSLTGAIPPSLSN-----MSQLAFLDLSYNNLS 111 (552)
Q Consensus 72 --~l-~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~l~l~~N~l~ 111 (552)
.+ ++|+.|+|++|+|++..+..+.. .++|+.|+|++|.|+
T Consensus 104 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 151 (362)
T 3goz_A 104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151 (362)
T ss_dssp HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence 22 45555555555555433332222 135555555555555
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.6e-11 Score=130.52 Aligned_cols=52 Identities=27% Similarity=0.265 Sum_probs=28.1
Q ss_pred ccccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc--CcccccCCccc
Q 008828 74 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSLI 130 (552)
Q Consensus 74 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~--~~~~l~~N~~~ 130 (552)
++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+..++ ... +.++|++|.+.
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~-~~~~L~~L~Ls~N~L~ 274 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM-LPSGLLSLSVYRNQLT 274 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC-CCTTCCEEECCSSCCC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc-ccccCcEEeCCCCCCC
Confidence 455666666666663 44 234556666666666664433 211 45566666554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.8e-12 Score=129.64 Aligned_cols=125 Identities=18% Similarity=0.169 Sum_probs=107.1
Q ss_pred EeccCCCCCcccccccccCCCCCcEEecccCccCCCCc----hhhcCCC-CCCEEEccCCcCCCCCCccccCC-----cc
Q 008828 6 YRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIP----TEIGKLS-KLLTLDLSNNFFTGPIPSTVSHL-----ET 75 (552)
Q Consensus 6 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p----~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l-----~~ 75 (552)
++.|+.|++++.+|..+...++|++|+|++|.|++..+ ..|.+++ +|+.|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 67899999999999888888889999999999997766 7888999 99999999999997777777765 99
Q ss_pred ccccccccccccCCCCcccccc-----ccccEEeccCCCCCCCCCCc----------ccCcccccCCccc
Q 008828 76 LQYLRLNNNSLTGAIPPSLSNM-----SQLAFLDLSYNNLSGPVPSF----------HAKTFNITGNSLI 130 (552)
Q Consensus 76 L~~L~l~~N~l~~~~p~~~~~l-----~~L~~l~l~~N~l~~~~~~~----------~~~~~~l~~N~~~ 130 (552)
|+.|+|++|+|++..+..+... ++|+.|+|++|+|++..+.. ..+.++|++|.+.
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 151 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence 9999999999997776655444 89999999999999876532 3377899999875
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.21 E-value=1.1e-12 Score=133.81 Aligned_cols=111 Identities=20% Similarity=0.269 Sum_probs=69.2
Q ss_pred CCcccEeccCCCCCcc----cccccccCCCCCcEEecccCccCCCCchhhc----CC---------CCCCEEEccCCcCC
Q 008828 1 MVLLCYRGAPSQNLSG----TLSSSIGNLTNLQLVLLQNNNISGHIPTEIG----KL---------SKLLTLDLSNNFFT 63 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~l---------~~L~~L~l~~N~l~ 63 (552)
+++|++|+|++|.+.+ .+|..+.++++|+.|+|++|.|++..+..+. .+ ++|++|+|++|+++
T Consensus 93 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~ 172 (386)
T 2ca6_A 93 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172 (386)
T ss_dssp CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred CCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCC
Confidence 3667777777777776 4666777777777777777777533232232 33 67777777777765
Q ss_pred -CCCC---ccccCCcccccccccccccc--C---CCCccccccccccEEeccCCCCC
Q 008828 64 -GPIP---STVSHLETLQYLRLNNNSLT--G---AIPPSLSNMSQLAFLDLSYNNLS 111 (552)
Q Consensus 64 -~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~l~l~~N~l~ 111 (552)
+.+| ..+..+++|+.|+|++|+|+ | ..|..+..+++|+.|+|++|.|+
T Consensus 173 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~ 229 (386)
T 2ca6_A 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229 (386)
T ss_dssp GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred cHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCC
Confidence 2333 24555666667777766665 2 23335666666666666666664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=1.7e-11 Score=117.55 Aligned_cols=137 Identities=15% Similarity=0.073 Sum_probs=101.0
Q ss_pred CCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccc--cceeeeEeecCCceeEEEee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l~~~~~~~~~~~lv~e~ 308 (552)
++.+..+.+.|..+.||++...+|+.+++|+..... ...+..|+.+++.+.+.+ +.+++++....+..++||||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344333334566699999987778889999976431 234678999998886544 45688888877788999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC----------------------------------------- 347 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----------------------------------------- 347 (552)
++|.++. ... .+ ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 97 VPGQDLL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp CSSEETT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cCCcccC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 9998884 211 12 3367788888888888742
Q ss_pred --------------CCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 348 --------------DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 348 --------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
...++|+|++|.||+++++..+.|+|||.+..
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998753
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.21 E-value=3.8e-13 Score=137.31 Aligned_cols=130 Identities=16% Similarity=0.186 Sum_probs=101.6
Q ss_pred CCcccEeccCCC---CCcccccccc-------cCCCCCcEEecccCccCC----CCchhhcCCCCCCEEEccCCcCCCCC
Q 008828 1 MVLLCYRGAPSQ---NLSGTLSSSI-------GNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGPI 66 (552)
Q Consensus 1 l~~l~~L~l~~n---~l~~~~p~~~-------~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~ 66 (552)
+++|++|+|++| ++++.+|..+ ..+++|++|+|++|.|++ .+|..+.++++|+.|+|++|.+++..
T Consensus 59 ~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~ 138 (386)
T 2ca6_A 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQA 138 (386)
T ss_dssp CTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHH
T ss_pred CCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHH
Confidence 578999999996 4455566555 789999999999999996 47888999999999999999997443
Q ss_pred Cccc----cCC---------cccccccccccccc-CCCC---ccccccccccEEeccCCCCC--C---CCC-C----ccc
Q 008828 67 PSTV----SHL---------ETLQYLRLNNNSLT-GAIP---PSLSNMSQLAFLDLSYNNLS--G---PVP-S----FHA 119 (552)
Q Consensus 67 p~~~----~~l---------~~L~~L~l~~N~l~-~~~p---~~~~~l~~L~~l~l~~N~l~--~---~~~-~----~~~ 119 (552)
+..+ ..+ ++|+.|+|++|+|+ +.+| ..+..+++|+.|+|++|.|+ + ..+ . ...
T Consensus 139 ~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L 218 (386)
T 2ca6_A 139 GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTC
T ss_pred HHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCc
Confidence 3333 334 89999999999997 4445 46778899999999999998 2 222 1 122
Q ss_pred CcccccCCccc
Q 008828 120 KTFNITGNSLI 130 (552)
Q Consensus 120 ~~~~l~~N~~~ 130 (552)
+.++|++|.+.
T Consensus 219 ~~L~Ls~n~l~ 229 (386)
T 2ca6_A 219 KVLDLQDNTFT 229 (386)
T ss_dssp CEEECCSSCCH
T ss_pred cEEECcCCCCC
Confidence 78899999873
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.21 E-value=2.7e-13 Score=135.47 Aligned_cols=126 Identities=21% Similarity=0.216 Sum_probs=101.0
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCC-CchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGH-IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
++++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+.++++|+.|+|++|.+++..|..++.+++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 5688999999998886554 56789999999999998855 778888999999999999998877778888899999999
Q ss_pred cccc-cccCC-CCccccccccccEEeccCC-CCCCC-CCCc------ccCcccccCCc
Q 008828 81 LNNN-SLTGA-IPPSLSNMSQLAFLDLSYN-NLSGP-VPSF------HAKTFNITGNS 128 (552)
Q Consensus 81 l~~N-~l~~~-~p~~~~~l~~L~~l~l~~N-~l~~~-~~~~------~~~~~~l~~N~ 128 (552)
|++| .+++. ++..+..+++|+.|+|++| .+++. ++.. ..+.+++++|.
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~ 206 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 206 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCc
Confidence 9999 67642 5667888899999999999 88753 2221 23677888884
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.19 E-value=7e-11 Score=122.94 Aligned_cols=97 Identities=24% Similarity=0.321 Sum_probs=55.3
Q ss_pred CCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccccccCCCCccccccccccEEec
Q 008828 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDL 105 (552)
Q Consensus 26 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 105 (552)
++|++|+|++|++++ +| .|.++++|++|++++|++++ +|..+ ++|+.|++++|++++ +| .+..+++|+.|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 456666666666653 55 36666666666666666663 44432 356666666666663 44 4666666666666
Q ss_pred cCCCCCCCCCCc-ccCcccccCCccc
Q 008828 106 SYNNLSGPVPSF-HAKTFNITGNSLI 130 (552)
Q Consensus 106 ~~N~l~~~~~~~-~~~~~~l~~N~~~ 130 (552)
++|.+++.+... ..+.+++++|.+.
T Consensus 203 ~~N~l~~l~~~~~~L~~L~l~~n~l~ 228 (454)
T 1jl5_A 203 DNNSLKKLPDLPLSLESIVAGNNILE 228 (454)
T ss_dssp CSSCCSSCCCCCTTCCEEECCSSCCS
T ss_pred CCCcCCcCCCCcCcccEEECcCCcCC
Confidence 666666532211 1255666666554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.18 E-value=7.1e-11 Score=127.07 Aligned_cols=53 Identities=23% Similarity=0.311 Sum_probs=28.7
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCC
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT 63 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 63 (552)
+|++|+|++|++++ +|. .+++|++|+|++|+|+ .+|. .+++|++|+|++|.++
T Consensus 62 ~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~ 114 (622)
T 3g06_A 62 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT 114 (622)
T ss_dssp TCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC
T ss_pred CCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC
Confidence 45666666666554 332 3555666666666655 3443 4455555555555555
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.13 E-value=2.5e-10 Score=115.07 Aligned_cols=142 Identities=13% Similarity=0.179 Sum_probs=106.5
Q ss_pred CCeeeeeCceEEEEEEECCCcEEEEEEec--cCccCchHHHHHHHHHHHhhcc--ccccceeeeEeecC---CceeEEEe
Q 008828 235 KNLVGKGGFGNVYKGYLQDGTVVAVKRLK--DGNAIGGEIQFQTEVEMISLAV--HRNLLRLIGFCMTT---TERLLVYP 307 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~~~--h~niv~l~~~~~~~---~~~~lv~e 307 (552)
.+.++.|.++.||+....+ ..+++|+.. ..........+.+|+.+++.+. +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4578899999999988764 678888876 3332222345778999998886 45578889888766 45899999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC---------------------------------------- 347 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------- 347 (552)
|++|..+.+... ..++...+..++.++++.|..||+..
T Consensus 122 ~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 122 FVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp CCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred ecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 999987754222 24788889999999999999999731
Q ss_pred ---------------CCceEEcCCCCCceeeCCCCc--eEEccccccee
Q 008828 348 ---------------DPKIIHRDVKAANILLDEYYE--AVVGDFGLAKL 379 (552)
Q Consensus 348 ---------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~~~~ 379 (552)
.+.++|||+++.||+++.++. +.|.||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999999864
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.06 E-value=1.9e-10 Score=115.53 Aligned_cols=132 Identities=22% Similarity=0.137 Sum_probs=90.8
Q ss_pred CCcccEeccCCCCCccccc-ccccCCCCCcE-EecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCc----
Q 008828 1 MVLLCYRGAPSQNLSGTLS-SSIGNLTNLQL-VLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE---- 74 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p-~~~~~l~~L~~-L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~---- 74 (552)
|++|++|+|++|++.+.+| ..|.++++|.+ +++++|+|+...|..|.++++|++|++++|++++..+..+....
T Consensus 53 l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~ 132 (350)
T 4ay9_X 53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 132 (350)
T ss_dssp CTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEE
T ss_pred CCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhh
Confidence 5789999999999877655 57889988775 66778999977788899999999999999998854443333222
Q ss_pred ----------------------cccccccccccccCCCCccccccccccEEeccC-CCCCCCCCCccc-----CcccccC
Q 008828 75 ----------------------TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY-NNLSGPVPSFHA-----KTFNITG 126 (552)
Q Consensus 75 ----------------------~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~-N~l~~~~~~~~~-----~~~~l~~ 126 (552)
.|+.|+|++|+|+ .+|.......+|+.|++++ |.++.++++.+. +.+++++
T Consensus 133 l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~ 211 (350)
T 4ay9_X 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISR 211 (350)
T ss_dssp EEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTT
T ss_pred hhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCC
Confidence 3455666666666 3444333445666666653 555555444443 5677777
Q ss_pred CccccCC
Q 008828 127 NSLICAT 133 (552)
Q Consensus 127 N~~~c~~ 133 (552)
|.+...+
T Consensus 212 N~l~~lp 218 (350)
T 4ay9_X 212 TRIHSLP 218 (350)
T ss_dssp SCCCCCC
T ss_pred CCcCccC
Confidence 7776543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.03 E-value=3.5e-10 Score=111.19 Aligned_cols=187 Identities=19% Similarity=0.183 Sum_probs=123.3
Q ss_pred CCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccc--cceeeeEeecCC---ceeEEEee
Q 008828 235 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRN--LLRLIGFCMTTT---ERLLVYPY 308 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~n--iv~l~~~~~~~~---~~~lv~e~ 308 (552)
.+.++.|.+..||+.. ..+++|+.... .....+.+|..++..+. +.. +.+++....... ..++||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4578999999999863 56888886432 23456889999998873 333 334555443333 34789999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhc------------------------------------------
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ------------------------------------------ 346 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------------ 346 (552)
++|.++..... ..++..++..++.++++.+..||+.
T Consensus 98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99988765433 2477888888999999999999861
Q ss_pred -------------CCCceEEcCCCCCceeeCC--CCceEEcccccceecCCCCCce---e----------eccccccccc
Q 008828 347 -------------CDPKIIHRDVKAANILLDE--YYEAVVGDFGLAKLLDHCDSHV---T----------TAVRGTVGHI 398 (552)
Q Consensus 347 -------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~---~----------~~~~gt~~y~ 398 (552)
..+.++|+|++|.||++++ ...+.|.||+.+..-+...... . .......++.
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 1245899999999999998 4567899999987533210000 0 0000111122
Q ss_pred C-chhhccCCCCCccchhHHHHHHHHHHhCCCccc
Q 008828 399 A-PEYLSTGQSSEKTDVFGFGILLLELISGLRALE 432 (552)
Q Consensus 399 a-PE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~ 432 (552)
. |+..... ....+.|++|.++|.+.+|..++.
T Consensus 256 ~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence 2 2222111 223689999999999999977664
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.02 E-value=3.9e-12 Score=132.82 Aligned_cols=130 Identities=15% Similarity=0.082 Sum_probs=89.3
Q ss_pred CCcccEeccCCCCCcccc-----cccccCCCCCcEEecccCccCCC----CchhhcCCCCCCEEEccCCcCCCCCCcccc
Q 008828 1 MVLLCYRGAPSQNLSGTL-----SSSIGNLTNLQLVLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 71 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~-----p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 71 (552)
+++|++|+|++|.+.+.. +..+..+++|+.|+|++|.++.. ++..+.++++|+.|+|++|.+++..+..+.
T Consensus 226 ~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~ 305 (461)
T 1z7x_W 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC 305 (461)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred CCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHH
Confidence 467888888888877642 22334678888888888888743 567777788888888888887643333332
Q ss_pred C-----CccccccccccccccCC----CCccccccccccEEeccCCCCCCCCCC----------cccCcccccCCccc
Q 008828 72 H-----LETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLSGPVPS----------FHAKTFNITGNSLI 130 (552)
Q Consensus 72 ~-----l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~~~----------~~~~~~~l~~N~~~ 130 (552)
. .++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++..+. ...+.+++++|.+.
T Consensus 306 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred HHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 2 25788888888887754 455566678888888888887654321 12366777777664
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.91 E-value=4.4e-11 Score=124.82 Aligned_cols=130 Identities=18% Similarity=0.129 Sum_probs=102.2
Q ss_pred CCcccEeccCCCCCccc----ccccccCCCCCcEEecccCccCCCCchhhcC-----CCCCCEEEccCCcCCCC----CC
Q 008828 1 MVLLCYRGAPSQNLSGT----LSSSIGNLTNLQLVLLQNNNISGHIPTEIGK-----LSKLLTLDLSNNFFTGP----IP 67 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~----~p 67 (552)
+++|++|+|++|+++.. ++..+.++++|+.|+|++|.+++..+..+.. .++|+.|+|++|.+++. ++
T Consensus 255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 334 (461)
T 1z7x_W 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334 (461)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence 46899999999999875 6778888999999999999997544444433 37999999999999854 45
Q ss_pred ccccCCccccccccccccccCCCCccccc-----cccccEEeccCCCCCC----CCCCcc-----cCcccccCCccc
Q 008828 68 STVSHLETLQYLRLNNNSLTGAIPPSLSN-----MSQLAFLDLSYNNLSG----PVPSFH-----AKTFNITGNSLI 130 (552)
Q Consensus 68 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~l~l~~N~l~~----~~~~~~-----~~~~~l~~N~~~ 130 (552)
..+..+++|+.|+|++|++.+..+..+.. +++|+.|+|++|++++ .++..+ .+.+++++|++.
T Consensus 335 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred HHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 56777899999999999998654444443 6799999999999985 334322 278899999875
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.89 E-value=2.8e-11 Score=122.38 Aligned_cols=129 Identities=19% Similarity=0.150 Sum_probs=73.5
Q ss_pred CcccEeccCCCCCcccccccc-cCCCCCcEEecccCccCCCCchhh-----cCCCCCCEEEccCCcCCCC----CCcccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSI-GNLTNLQLVLLQNNNISGHIPTEI-----GKLSKLLTLDLSNNFFTGP----IPSTVS 71 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~~----~p~~~~ 71 (552)
++|+.|+|++|.++......+ ..+++|+.|+|++|.|+..-...+ ...++|+.|+|++|.|+.. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 356666666666654322222 234566677777776653322222 2356777777777776521 233345
Q ss_pred CCccccccccccccccCC----CCccccccccccEEeccCCCCCCCCCC---------cccCcccccCCccc
Q 008828 72 HLETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLSGPVPS---------FHAKTFNITGNSLI 130 (552)
Q Consensus 72 ~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~~~---------~~~~~~~l~~N~~~ 130 (552)
.+++|++|+|++|.|... ++..+..+++|+.|+|++|.|+..... ...+.++|++|.+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence 567777777777777632 234455666777777777777642211 11256777777653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.86 E-value=2.5e-09 Score=106.35 Aligned_cols=101 Identities=14% Similarity=0.062 Sum_probs=56.4
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCC-EEEccCCcCCCCCCccccCCccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLL-TLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
++|+.|+|++|+++.+.+..|.++++|+.|+|.+| ++.+-+..|.+|++|+ .|+|++ .++...+.+|.+|++|+.|+
T Consensus 226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 45556666655555555555666666666666555 4434444555566665 666655 44433344555666666666
Q ss_pred cccccccCCCCccccccccccEEe
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLD 104 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~ 104 (552)
+++|++...-+.+|.++++|+.|+
T Consensus 304 l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 304 ATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp ECSSCCCEECTTTTCTTCCCCEEE
T ss_pred eCCCccCccchhhhcCCcchhhhc
Confidence 655555544445555555555554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.85 E-value=4.1e-09 Score=104.72 Aligned_cols=129 Identities=17% Similarity=0.173 Sum_probs=100.3
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhc---------------------------------
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG--------------------------------- 47 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--------------------------------- 47 (552)
|++|+.|+|++ +++.+.+..|.+|++|+.|+|++|.+....+..|.
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 57899999999 88887788899999999999999976311111100
Q ss_pred ---------------------------------------------CCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 48 ---------------------------------------------KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 48 ---------------------------------------------~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
.+++|+.|+|++|+++...+..|.+|++|+.|+|+
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~ 258 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP 258 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence 27899999999999995555679999999999999
Q ss_pred cccccCCCCcccccccccc-EEeccCCCCCCCCCCccc-----CcccccCCccccC
Q 008828 83 NNSLTGAIPPSLSNMSQLA-FLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~-~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
+| +...-+.+|.+|++|+ .|++.+ .++.+.+..|. +.+++.+|.+...
T Consensus 259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I 312 (329)
T 3sb4_A 259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTL 312 (329)
T ss_dssp TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEE
T ss_pred cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCcc
Confidence 98 7756678899999999 999988 77777666665 5667778877554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.83 E-value=1.5e-10 Score=116.88 Aligned_cols=113 Identities=15% Similarity=0.186 Sum_probs=90.2
Q ss_pred CcccEeccCCCCCcccccccc-----cCCCCCcEEecccCccCC----CCchhhcCCCCCCEEEccCCcCCCC----CCc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSI-----GNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGP----IPS 68 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~ 68 (552)
++|+.|+|++|+++......+ ...++|+.|+|++|.|+. .++..+..+++|++|+|++|.|+.. ++.
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence 478999999999987554444 357899999999999974 2455667899999999999998742 245
Q ss_pred cccCCccccccccccccccCC----CCccccccccccEEeccCCCCCCCC
Q 008828 69 TVSHLETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLSGPV 114 (552)
Q Consensus 69 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~ 114 (552)
.+..+++|+.|+|++|.|+.. ++..+..+++|+.|+|++|.|+...
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g 255 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEG 255 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHH
T ss_pred HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHH
Confidence 567788999999999999843 3445566789999999999998543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.72 E-value=2.2e-09 Score=102.22 Aligned_cols=40 Identities=28% Similarity=0.353 Sum_probs=18.5
Q ss_pred CCCCCcEEecccCccCC--CCchhhcCCCCCCEEEccCCcCC
Q 008828 24 NLTNLQLVLLQNNNISG--HIPTEIGKLSKLLTLDLSNNFFT 63 (552)
Q Consensus 24 ~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~ 63 (552)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|+
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~ 209 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 209 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCC
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccC
Confidence 34445555555555443 22233444445555555555544
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.64 E-value=2.1e-09 Score=97.26 Aligned_cols=110 Identities=14% Similarity=0.171 Sum_probs=60.7
Q ss_pred CcccEeccCCC-CCccc----ccccccCCCCCcEEecccCccCCC----CchhhcCCCCCCEEEccCCcCCCC----CCc
Q 008828 2 VLLCYRGAPSQ-NLSGT----LSSSIGNLTNLQLVLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IPS 68 (552)
Q Consensus 2 ~~l~~L~l~~n-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~ 68 (552)
++|++|+|++| .+... +...+...++|++|+|++|.|+.. +...+...++|++|+|++|.|... +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 45666666666 65532 233455566666666666666521 233344456666666666666522 233
Q ss_pred cccCCcccccccc--ccccccCC----CCccccccccccEEeccCCCCC
Q 008828 69 TVSHLETLQYLRL--NNNSLTGA----IPPSLSNMSQLAFLDLSYNNLS 111 (552)
Q Consensus 69 ~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~ 111 (552)
.+...++|+.|+| ++|.|... +...+...++|+.|+|++|.+.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4455566666666 55666532 2233444456666666666553
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.55 E-value=2.7e-08 Score=94.66 Aligned_cols=78 Identities=22% Similarity=0.249 Sum_probs=61.7
Q ss_pred CCcccEeccCCCCCcc--cccccccCCCCCcEEecccCccCCCCchhhcCCC--CCCEEEccCCcCCCCCCc-------c
Q 008828 1 MVLLCYRGAPSQNLSG--TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS--KLLTLDLSNNFFTGPIPS-------T 69 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~-------~ 69 (552)
+++|+.|+|++|+|++ .+|..++.+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|+ .
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~i 246 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAI 246 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHH
Confidence 5789999999999998 3457788999999999999999964 3455555 999999999999876663 2
Q ss_pred ccCCccccccc
Q 008828 70 VSHLETLQYLR 80 (552)
Q Consensus 70 ~~~l~~L~~L~ 80 (552)
+..+++|+.||
T Consensus 247 l~~~P~L~~LD 257 (267)
T 3rw6_A 247 RERFPKLLRLD 257 (267)
T ss_dssp HHHCTTCCEES
T ss_pred HHHCcccCeEC
Confidence 44566666655
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.49 E-value=2.6e-08 Score=107.25 Aligned_cols=103 Identities=10% Similarity=0.059 Sum_probs=64.3
Q ss_pred ccEeccCCCCC-cc-cccccccCCCCCcEEecccCccCCC----CchhhcCCCCCCEEEccCCcCCCC----CCccccCC
Q 008828 4 LCYRGAPSQNL-SG-TLSSSIGNLTNLQLVLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IPSTVSHL 73 (552)
Q Consensus 4 l~~L~l~~n~l-~~-~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l 73 (552)
|++|+|++|.- +. .++..+.++++|++|+|++|.+++. ++..+.++++|+.|+|++|.+++. ++..+.++
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~ 219 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence 77777777651 11 1222334677777777777777654 334455677777777777777632 22334566
Q ss_pred ccccccccccccccCCCCccccccccccEEeccC
Q 008828 74 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY 107 (552)
Q Consensus 74 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 107 (552)
++|+.|+|++|.+.+ +|..+..+++|+.|++++
T Consensus 220 ~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 220 RSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp TTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 777777777777763 556666667777777764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.3e-07 Score=99.82 Aligned_cols=126 Identities=11% Similarity=0.042 Sum_probs=90.1
Q ss_pred CCcccEeccCCCCCccc----ccccccCCCCCcEEecccCccCC----CCchhhcCCCCCCEEEccCCcCCCCCCccccC
Q 008828 1 MVLLCYRGAPSQNLSGT----LSSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 72 (552)
+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++ .++..+.++++|+.|+|++|.+.+ +|..+..
T Consensus 163 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~ 241 (592)
T 3ogk_B 163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKA 241 (592)
T ss_dssp CTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHH
T ss_pred CCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhh
Confidence 57899999999988765 44556788999999999999973 344556788999999999999884 6777888
Q ss_pred Ccccccccccccccc---CCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCc
Q 008828 73 LETLQYLRLNNNSLT---GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNS 128 (552)
Q Consensus 73 l~~L~~L~l~~N~l~---~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~ 128 (552)
+++|+.|+++++... +..+..+..+++|+.|+++++... .+|..+. +.++|++|.
T Consensus 242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~ 304 (592)
T 3ogk_B 242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYAL 304 (592)
T ss_dssp CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCC
T ss_pred hhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCc
Confidence 888888888754322 233455666777777777775433 2333322 566777765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=3.5e-06 Score=82.49 Aligned_cols=135 Identities=18% Similarity=0.179 Sum_probs=94.8
Q ss_pred CeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcccc---ccceeeeEee-cCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR---NLLRLIGFCM-TTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 311 (552)
+.++.|....||+. +..+++|+... ......+..|..++..+.+. .+.+++.++. ..+..++||||++|
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 56788888899987 56788887532 12345688999999988642 2456666664 44567899999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhc---------------------------------------------
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ--------------------------------------------- 346 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~--------------------------------------------- 346 (552)
..+..... ..++......++.++++.|..||+.
T Consensus 98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 87765321 1245555666666666666666642
Q ss_pred ------------CCCceEEcCCCCCceeeCC---CCc-eEEccccccee
Q 008828 347 ------------CDPKIIHRDVKAANILLDE---YYE-AVVGDFGLAKL 379 (552)
Q Consensus 347 ------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfg~~~~ 379 (552)
..+.++|+|+++.||+++. ++. +.|.||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999997 455 47999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.6e-06 Score=86.87 Aligned_cols=144 Identities=12% Similarity=0.146 Sum_probs=89.6
Q ss_pred Cee-eeeCceEEEEEEEC-------CCcEEEEEEeccCcc--CchHHHHHHHHHHHhhccc---cccceeeeEeecC---
Q 008828 236 NLV-GKGGFGNVYKGYLQ-------DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVH---RNLLRLIGFCMTT--- 299 (552)
Q Consensus 236 ~~i-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h---~niv~l~~~~~~~--- 299 (552)
+.| +.|....+|+.... +++.+++|+...... ......+..|..++..+.. -.+.++++++...
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999988764 267888998754320 1011346788888887753 2466788887655
Q ss_pred CceeEEEeeccCCChhhhhccC------CCCCHHHHHHHHHHHHHHH---------------------------------
Q 008828 300 TERLLVYPYMSNGSVASRLKAK------PSLDWATRKRIALGAARGL--------------------------------- 340 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~~ia~~l--------------------------------- 340 (552)
...++||||++|..+.+.+... ..++...+..++.++++.|
T Consensus 106 g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWV 185 (357)
T ss_dssp SSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHHH
T ss_pred CCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHHH
Confidence 3568999999987765421000 0122222222333333333
Q ss_pred ---------------------HHHhhcC-------CCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 341 ---------------------LYLHEQC-------DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 341 ---------------------~~LH~~~-------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
.+|.+.. .+.++|+|+.+.||+++++..+.|.||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 186 RSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 3332211 35799999999999999654578999998863
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=5.6e-06 Score=79.35 Aligned_cols=135 Identities=19% Similarity=0.141 Sum_probs=96.4
Q ss_pred eeeeeCce-EEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecCCceeEEEeeccCCC
Q 008828 237 LVGKGGFG-NVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYMSNGS 313 (552)
Q Consensus 237 ~iG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~~g~ 313 (552)
.+..|..| .||+.... ++..+++|+-... ....+..|...++.+. +--+-++++++.+.+..++|||++++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 45556655 68987754 4678999986532 2446778999888774 2235678888888899999999999988
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------------
Q 008828 314 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQC---------------------------------------------- 347 (552)
Q Consensus 314 L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------------- 347 (552)
+.+..... ......++.+++..|..||+..
T Consensus 107 ~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 107 AFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 76654321 2234456666777777777421
Q ss_pred ---------CCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 348 ---------DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 348 ---------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
.+.++|+|+.+.||++++++.+-|.||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999877777999998853
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.28 E-value=1.2e-08 Score=109.85 Aligned_cols=110 Identities=18% Similarity=0.217 Sum_probs=55.8
Q ss_pred CCcccEecc---------CCCCCccccccccc-CCCCCcEEecccCccCCCCchhhc-CCCCCCEEEcc--C----CcCC
Q 008828 1 MVLLCYRGA---------PSQNLSGTLSSSIG-NLTNLQLVLLQNNNISGHIPTEIG-KLSKLLTLDLS--N----NFFT 63 (552)
Q Consensus 1 l~~l~~L~l---------~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~--~----N~l~ 63 (552)
+++|++|+| +.+.+++.....+. .+++|+.|+++.|.+++.....+. ++++|+.|+|+ + |.++
T Consensus 337 ~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~ 416 (594)
T 2p1m_B 337 CKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT 416 (594)
T ss_dssp CTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT
T ss_pred CCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc
Confidence 456777766 23444433222332 366667776666666644444443 46667777766 3 4444
Q ss_pred CCCCc------cccCCccccccccccccccCCCCccccc-cccccEEeccCCCCCC
Q 008828 64 GPIPS------TVSHLETLQYLRLNNNSLTGAIPPSLSN-MSQLAFLDLSYNNLSG 112 (552)
Q Consensus 64 ~~~p~------~~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~l~l~~N~l~~ 112 (552)
. .|. .+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++
T Consensus 417 ~-~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~ 470 (594)
T 2p1m_B 417 L-EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSD 470 (594)
T ss_dssp C-CCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSH
T ss_pred C-CchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcH
Confidence 2 111 134455666666654 343322233333 5556666666665543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.24 E-value=9.4e-08 Score=95.71 Aligned_cols=126 Identities=18% Similarity=0.154 Sum_probs=82.3
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhc--CCCCCCEEEccC--CcCCCC-----CCccc-
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG--KLSKLLTLDLSN--NFFTGP-----IPSTV- 70 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~l~~--N~l~~~-----~p~~~- 70 (552)
+++|+.|+|++|.-.. ++. +. +++|+.|+|..|.++......+. ++++|+.|+|+. |...+. +...+
T Consensus 171 ~P~L~~L~L~g~~~l~-l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNLS-IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp CTTCCEEEEECCBTCB-CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred CCCCcEEEEeCCCCce-ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 4789999998873222 333 43 88999999998888643333443 789999999864 222111 11122
Q ss_pred -cCCccccccccccccccCCCCcccc---ccccccEEeccCCCCCCCC----CC-----cccCcccccCCcc
Q 008828 71 -SHLETLQYLRLNNNSLTGAIPPSLS---NMSQLAFLDLSYNNLSGPV----PS-----FHAKTFNITGNSL 129 (552)
Q Consensus 71 -~~l~~L~~L~l~~N~l~~~~p~~~~---~l~~L~~l~l~~N~l~~~~----~~-----~~~~~~~l~~N~~ 129 (552)
..+++|+.|+|.+|.+.+..+..+. .+++|+.|+|+.|.|.+.. +. ...+.++|++|.+
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 2478999999999988743333332 5789999999999987631 11 1236778887765
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.24 E-value=1.3e-06 Score=88.82 Aligned_cols=124 Identities=14% Similarity=0.086 Sum_probs=94.7
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCC-----CCCCccccCCcc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT-----GPIPSTVSHLET 75 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~ 75 (552)
+++|+.|+|..| ++.+-...|.+ .+|+.+.|. |.++..-+..|.+|++|+.++|.+|.+. ...+..|.+|++
T Consensus 225 ~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~ 301 (401)
T 4fdw_A 225 TSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPK 301 (401)
T ss_dssp CTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTT
T ss_pred CCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCcc
Confidence 467899999874 77777778888 789999994 5566566778999999999999998875 344567899999
Q ss_pred ccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCcc
Q 008828 76 LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 129 (552)
Q Consensus 76 L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~ 129 (552)
|+.++|.+ .++..-..+|.+|++|+.|+|.+| ++.+....|. +.+.+.+|.+
T Consensus 302 L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~~L~~l~l~~n~~ 357 (401)
T 4fdw_A 302 LARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNTGIKEVKVEGTTP 357 (401)
T ss_dssp CCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSSCCCEEEECCSSC
T ss_pred CCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCCCCCEEEEcCCCC
Confidence 99999984 577566678999999999999655 6655555554 4566666644
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.23 E-value=4.4e-08 Score=88.54 Aligned_cols=112 Identities=18% Similarity=0.168 Sum_probs=83.7
Q ss_pred ccccccCCCCCcEEecccC-ccCCC----CchhhcCCCCCCEEEccCCcCCCC----CCccccCCccccccccccccccC
Q 008828 18 LSSSIGNLTNLQLVLLQNN-NISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IPSTVSHLETLQYLRLNNNSLTG 88 (552)
Q Consensus 18 ~p~~~~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 88 (552)
+...+...++|++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|..
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3445778999999999999 88732 455677789999999999999732 22345556899999999999984
Q ss_pred C----CCccccccccccEEec--cCCCCCCCCCCc---------ccCcccccCCcc
Q 008828 89 A----IPPSLSNMSQLAFLDL--SYNNLSGPVPSF---------HAKTFNITGNSL 129 (552)
Q Consensus 89 ~----~p~~~~~l~~L~~l~l--~~N~l~~~~~~~---------~~~~~~l~~N~~ 129 (552)
. +...+...++|+.|+| ++|.|....... ..+.++|++|.+
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 3 4566777889999999 889997532211 126677777765
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.20 E-value=2.5e-06 Score=86.79 Aligned_cols=121 Identities=15% Similarity=0.094 Sum_probs=94.9
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|+.+.|.. +++.+....|.++++|+.|+|..| ++..-...|.+ .+|+.+.|. |.++..-+..|.+|++|+.+++
T Consensus 203 ~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l 278 (401)
T 4fdw_A 203 AGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTT 278 (401)
T ss_dssp CCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEE
T ss_pred cccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEe
Confidence 5788999985 488888889999999999999986 55455667777 899999994 5566455678999999999999
Q ss_pred cccccc-----CCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCC
Q 008828 82 NNNSLT-----GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGN 127 (552)
Q Consensus 82 ~~N~l~-----~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N 127 (552)
.+|.+. ...+.+|..|++|+.++|. |.++.+....|. +.+.|..|
T Consensus 279 ~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 279 YGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp ESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred CCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence 998775 3556789999999999999 457766665554 44555443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.15 E-value=3.1e-07 Score=98.77 Aligned_cols=87 Identities=18% Similarity=0.184 Sum_probs=49.5
Q ss_pred cCCCCCcEEecccCccCCCCchhhc-CCCCCCEEEccCC-cCCCC-CCccccCCccccccccccccccCCCCcccc----
Q 008828 23 GNLTNLQLVLLQNNNISGHIPTEIG-KLSKLLTLDLSNN-FFTGP-IPSTVSHLETLQYLRLNNNSLTGAIPPSLS---- 95 (552)
Q Consensus 23 ~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~---- 95 (552)
..+++|+.|+|++|.+++..+..+. ++++|+.|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence 4566666777776666655444454 4666777777666 33311 223334566666666666666544333332
Q ss_pred ccccccEEeccCCC
Q 008828 96 NMSQLAFLDLSYNN 109 (552)
Q Consensus 96 ~l~~L~~l~l~~N~ 109 (552)
.+++|+.|++++|.
T Consensus 182 ~~~~L~~L~l~~~~ 195 (594)
T 2p1m_B 182 TYTSLVSLNISCLA 195 (594)
T ss_dssp TCCCCCEEECTTCC
T ss_pred cCCcCcEEEecccC
Confidence 44566666666665
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.07 E-value=4.7e-07 Score=90.62 Aligned_cols=128 Identities=14% Similarity=0.108 Sum_probs=84.3
Q ss_pred CCcccEeccCCCCCc---------ccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCcccc
Q 008828 1 MVLLCYRGAPSQNLS---------GTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 71 (552)
Q Consensus 1 l~~l~~L~l~~n~l~---------~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 71 (552)
+++|+.|.+.++... +.+...+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.+.......+.
T Consensus 138 l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~ 214 (362)
T 2ra8_A 138 FAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDIL 214 (362)
T ss_dssp HTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHH
T ss_pred cchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHH
Confidence 368899988765431 124456678899999999988422 2343 4 389999999999987633222333
Q ss_pred --CCcccccccccc--ccccCC-----CCccc--cccccccEEeccCCCCCCCCCC--------cccCcccccCCcccc
Q 008828 72 --HLETLQYLRLNN--NSLTGA-----IPPSL--SNMSQLAFLDLSYNNLSGPVPS--------FHAKTFNITGNSLIC 131 (552)
Q Consensus 72 --~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~l~l~~N~l~~~~~~--------~~~~~~~l~~N~~~c 131 (552)
.+++|+.|+|+. |...+. +...+ ..+++|+.|+|++|.+.+..+. ...+.++|+.|.+..
T Consensus 215 ~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp HSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred HccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 689999999863 332211 11122 2578999999999998742211 123788999887643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=2.5e-05 Score=79.44 Aligned_cols=76 Identities=14% Similarity=0.051 Sum_probs=49.2
Q ss_pred CCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc------CchHHHHHHHHHHHhhccc--cc-cceeeeEeecCCceeE
Q 008828 235 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA------IGGEIQFQTEVEMISLAVH--RN-LLRLIGFCMTTTERLL 304 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~~~h--~n-iv~l~~~~~~~~~~~l 304 (552)
.+.||.|.++.||++... +++.++||....... .....++..|.+++..+.. +. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357899999999999754 468899998653221 1123356778888887642 33 3455554 3455789
Q ss_pred EEeeccCC
Q 008828 305 VYPYMSNG 312 (552)
Q Consensus 305 v~e~~~~g 312 (552)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=4.3e-05 Score=75.74 Aligned_cols=136 Identities=17% Similarity=0.230 Sum_probs=78.3
Q ss_pred eeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcccc--ccceeee------EeecCCceeEEEee
Q 008828 237 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR--NLLRLIG------FCMTTTERLLVYPY 308 (552)
Q Consensus 237 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~--niv~l~~------~~~~~~~~~lv~e~ 308 (552)
.|+.|..+.||+....+| .+++|+.... ...+..|..++..+... .+.+++. +....+..+++|+|
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 456677889999987655 5889988642 12334455555554321 2333333 11235667899999
Q ss_pred ccCCChh-----------h---hhc---c-C--C--------CCCHHHH-------------------------------
Q 008828 309 MSNGSVA-----------S---RLK---A-K--P--------SLDWATR------------------------------- 329 (552)
Q Consensus 309 ~~~g~L~-----------~---~l~---~-~--~--------~l~~~~~------------------------------- 329 (552)
++|..+. . .++ . . + .-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 0 111 0 0 0 0122211
Q ss_pred HHHHHHHHHHHHHHhh----------cCCCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 330 KRIALGAARGLLYLHE----------QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 330 ~~i~~~ia~~l~~LH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
..+..++..++.+|+. ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666663 124589999999999999888899999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00012 Score=71.34 Aligned_cols=135 Identities=16% Similarity=0.152 Sum_probs=89.8
Q ss_pred CCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc---ccccceeeeEeecCCceeEEEeeccC
Q 008828 235 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
.+.|+.|.+..+|+.... +..+++|+.... ....+..|...|+.+. ...+.++++++...+..++||||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 357899999999998864 678888987532 2446788999888774 25677888888878889999999998
Q ss_pred CChhh--------h---hcc--C-CC-------------------CCHHHHH---HHHH----------------HHHHH
Q 008828 312 GSVAS--------R---LKA--K-PS-------------------LDWATRK---RIAL----------------GAARG 339 (552)
Q Consensus 312 g~L~~--------~---l~~--~-~~-------------------l~~~~~~---~i~~----------------~ia~~ 339 (552)
..+.. . ++. . .. -+|.... ++.. .++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76421 1 111 1 00 1343321 1111 11111
Q ss_pred -HHHHhh-cCCCceEEcCCCCCceeeCCCCceEEcccc
Q 008828 340 -LLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFG 375 (552)
Q Consensus 340 -l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 375 (552)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223421 2356899999999999999887 8888974
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.76 E-value=3.2e-06 Score=74.55 Aligned_cols=92 Identities=14% Similarity=0.079 Sum_probs=64.5
Q ss_pred ccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCc-CCCCCCccccCC----cccccccccccc-ccCCCC
Q 008828 18 LSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNF-FTGPIPSTVSHL----ETLQYLRLNNNS-LTGAIP 91 (552)
Q Consensus 18 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p 91 (552)
+|.....--+|+.|||+++.|+..--..+.++++|+.|+|+++. ++..--..++.+ ++|++|+|++|. |+..--
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl 132 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI 132 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence 44433333479999999998875444557789999999999985 653222234443 479999999975 764333
Q ss_pred ccccccccccEEeccCCC
Q 008828 92 PSLSNMSQLAFLDLSYNN 109 (552)
Q Consensus 92 ~~~~~l~~L~~l~l~~N~ 109 (552)
..+..+++|+.|+|++++
T Consensus 133 ~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 133 IALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHGGGCTTCCEEEEESCT
T ss_pred HHHhcCCCCCEEECCCCC
Confidence 457788999999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00021 Score=69.05 Aligned_cols=79 Identities=19% Similarity=0.223 Sum_probs=55.4
Q ss_pred CCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcccc---ccceeeeEeecCCceeEEEe
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR---NLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~---niv~l~~~~~~~~~~~lv~e 307 (552)
.....+.+|.|..+.||+....||+.|++|+...... .....|..|...|+.+.-. -+.+++++. ..++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 3444567899999999999999999999998754332 2233577899988877421 244555542 3578999
Q ss_pred eccCCCh
Q 008828 308 YMSNGSV 314 (552)
Q Consensus 308 ~~~~g~L 314 (552)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9886543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.75 E-value=3.6e-06 Score=74.27 Aligned_cols=83 Identities=14% Similarity=0.151 Sum_probs=57.8
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCc-cCCCCchhhcCC----CCCCEEEccCCc-CCCCCCccccCCccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNN-ISGHIPTEIGKL----SKLLTLDLSNNF-FTGPIPSTVSHLETL 76 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~L 76 (552)
+|+.|||+++.++..--..+..+++|+.|+|++|. |+..--..++.+ ++|+.|+|++|. ++..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 47888888888776655667888888888888884 653222334443 368888888874 663222346678888
Q ss_pred ccccccccc
Q 008828 77 QYLRLNNNS 85 (552)
Q Consensus 77 ~~L~l~~N~ 85 (552)
+.|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 888888875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00019 Score=73.48 Aligned_cols=78 Identities=12% Similarity=0.037 Sum_probs=46.4
Q ss_pred CCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeecc-cccccccCchhhccCC---CCCccchhHHHHHHHH
Q 008828 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV-RGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLE 423 (552)
Q Consensus 348 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~e 423 (552)
.+.++|+|+++.|||++.++ +++.||+.+..-... ....... .-...|++|+...... .....++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34899999999999999876 999999988743210 0000000 0113466666553211 1122445577777777
Q ss_pred HHhC
Q 008828 424 LISG 427 (552)
Q Consensus 424 lltg 427 (552)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7665
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.46 E-value=1.6e-05 Score=71.43 Aligned_cols=85 Identities=15% Similarity=0.159 Sum_probs=35.7
Q ss_pred CCCCCcEEecccC-ccCC----CCchhhcCCCCCCEEEccCCcCCCC----CCccccCCccccccccccccccCC----C
Q 008828 24 NLTNLQLVLLQNN-NISG----HIPTEIGKLSKLLTLDLSNNFFTGP----IPSTVSHLETLQYLRLNNNSLTGA----I 90 (552)
Q Consensus 24 ~l~~L~~L~l~~N-~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~ 90 (552)
+-+.|++|+|++| .|.. .+-+.+..-+.|+.|+|++|+|... +-+.+..-+.|+.|+|++|.|... +
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 3445555555543 4431 1223333444555555555555411 111122234555555555555421 1
Q ss_pred CccccccccccEEeccCC
Q 008828 91 PPSLSNMSQLAFLDLSYN 108 (552)
Q Consensus 91 p~~~~~l~~L~~l~l~~N 108 (552)
.+.+..-+.|+.|+|++|
T Consensus 119 a~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHTTTTCCCSEEECCCC
T ss_pred HHHHhhCCceeEEECCCC
Confidence 122333344555555543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00056 Score=67.05 Aligned_cols=155 Identities=9% Similarity=0.050 Sum_probs=85.3
Q ss_pred cCHHHHHHHhcCCCCC-----CeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccc--ccee
Q 008828 220 FHFKELQSATSNFSSK-----NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRL 292 (552)
Q Consensus 220 ~~~~e~~~~~~~~~~~-----~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l 292 (552)
++.+++...-..|... +.|+.|....+|+....+| .+++|+...... ...+..|..++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcc
Confidence 3444555554556542 3456688889999987755 678898865211 224556777776664222 2333
Q ss_pred eeE------eecCCceeEEEeeccCCChhh--------------hhcc---C-C-C----C---CHHHHHH---------
Q 008828 293 IGF------CMTTTERLLVYPYMSNGSVAS--------------RLKA---K-P-S----L---DWATRKR--------- 331 (552)
Q Consensus 293 ~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~---~-~-~----l---~~~~~~~--------- 331 (552)
+.. ....+..+++++|++|..+.. .++. . . + . .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 112355689999998765321 0110 0 0 0 1 1221100
Q ss_pred ---HHHHHHHHHHHHhhc----CCCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 332 ---IALGAARGLLYLHEQ----CDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 332 ---i~~~ia~~l~~LH~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
+...+...+.+++.. ...+++|+|+.+.|||++++..+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001234455555532 23479999999999999987666899999875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00076 Score=65.46 Aligned_cols=71 Identities=11% Similarity=0.083 Sum_probs=44.6
Q ss_pred CCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccc-eeeeEeecCCceeEEEeec-cCC
Q 008828 235 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL-RLIGFCMTTTERLLVYPYM-SNG 312 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv-~l~~~~~~~~~~~lv~e~~-~~g 312 (552)
.+.|+.|....+|+. ..+++|+....... ......|..++..+....+. +++++ ..+.-++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 577888999999998 56888887643211 11234677777766533333 55554 344467899999 554
Q ss_pred Ch
Q 008828 313 SV 314 (552)
Q Consensus 313 ~L 314 (552)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 43
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00032 Score=70.99 Aligned_cols=85 Identities=13% Similarity=0.146 Sum_probs=41.3
Q ss_pred cccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccccccCCCCccccccc
Q 008828 19 SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMS 98 (552)
Q Consensus 19 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 98 (552)
...|.++.+|+.+.+.++..+ .-...|.++++|+.+.+. +.++......|.+|.+|+.++|.+| ++..-..+|.+|+
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 344555555555555544433 334445555555555554 2333222334555555555555433 3323334555555
Q ss_pred cccEEecc
Q 008828 99 QLAFLDLS 106 (552)
Q Consensus 99 ~L~~l~l~ 106 (552)
+|+.+.+.
T Consensus 335 ~L~~i~ip 342 (394)
T 4gt6_A 335 QLERIAIP 342 (394)
T ss_dssp TCCEEEEC
T ss_pred CCCEEEEC
Confidence 55555554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00016 Score=73.30 Aligned_cols=86 Identities=12% Similarity=0.064 Sum_probs=65.7
Q ss_pred ccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccccccCCCCcccccccc
Q 008828 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQ 99 (552)
Q Consensus 20 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 99 (552)
..|..+.+|+.+.+.++ ++..-...|.++++|+.++|.++ ++..-..+|.+|++|+.++|..| ++..-..+|.+|++
T Consensus 291 ~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~ 367 (394)
T 4fs7_A 291 KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCIN 367 (394)
T ss_dssp TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTT
T ss_pred ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCC
Confidence 46778888999888766 55455667888899999998755 66344567888899999988776 66455678888889
Q ss_pred ccEEeccCC
Q 008828 100 LAFLDLSYN 108 (552)
Q Consensus 100 L~~l~l~~N 108 (552)
|+.+++..|
T Consensus 368 L~~i~lp~~ 376 (394)
T 4fs7_A 368 LKKVELPKR 376 (394)
T ss_dssp CCEEEEEGG
T ss_pred CCEEEECCC
Confidence 998888654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00021 Score=71.85 Aligned_cols=114 Identities=12% Similarity=0.042 Sum_probs=74.5
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|+.+.+..+ +..+....|.++.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ +.......|.+|++|+.+.+
T Consensus 217 ~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 217 KNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEE
T ss_pred cccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccc
Confidence 34556666543 45555567777888888888766 44345566777888888887654 44233456777888888888
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA 119 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~ 119 (552)
.+|.++..-..+|.+|.+|+.+.|..+ ++.+....|.
T Consensus 294 ~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~ 330 (379)
T 4h09_A 294 DNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFK 330 (379)
T ss_dssp CCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT
T ss_pred cccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhh
Confidence 777777455567777888888877654 5544444444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00027 Score=59.23 Aligned_cols=37 Identities=24% Similarity=0.257 Sum_probs=18.1
Q ss_pred CCCEEEccCCcCCCCCCccccCCcccccccccccccc
Q 008828 51 KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT 87 (552)
Q Consensus 51 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 87 (552)
+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555555555333333445555555555555443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0002 Score=72.53 Aligned_cols=106 Identities=15% Similarity=0.149 Sum_probs=83.4
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|+.+.+.++- ..+....|.++++|+.+.+. +.++..-...|.++++|+.++|..| ++..-..+|.+|.+|+.+.
T Consensus 264 c~~L~~i~lp~~~-~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ 340 (394)
T 4gt6_A 264 CAYLASVKMPDSV-VSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIA 340 (394)
T ss_dssp CSSCCEEECCTTC-CEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred cccccEEeccccc-ceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEE
Confidence 3567888887653 45666789999999999997 4565455678999999999999876 5534556799999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 110 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l 110 (552)
|.++ ++..-..+|.+|++|+.+++.+|..
T Consensus 341 ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 341 IPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp ECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred ECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 9755 6645567899999999999988754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00081 Score=66.29 Aligned_cols=32 Identities=41% Similarity=0.375 Sum_probs=27.8
Q ss_pred CCceEEcCCCCCceeeCCC----CceEEccccccee
Q 008828 348 DPKIIHRDVKAANILLDEY----YEAVVGDFGLAKL 379 (552)
Q Consensus 348 ~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~ 379 (552)
.+.++|||+.+.||+++.+ +.+.|.||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999875 6789999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0012 Score=67.64 Aligned_cols=72 Identities=15% Similarity=0.178 Sum_probs=48.8
Q ss_pred CeeeeeCceEEEEEEECC--------CcEEEEEEeccCccCchHHHHHHHHHHHhhcccccc-ceeeeEeecCCceeEEE
Q 008828 236 NLVGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLIGFCMTTTERLLVY 306 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~ 306 (552)
+.|+.|....||+....+ +..+++|+.... .....+..|..++..+...++ .++++.+.+ .+|+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 467788889999998753 478999988432 111345578888887754444 566766542 3899
Q ss_pred eeccCCCh
Q 008828 307 PYMSNGSV 314 (552)
Q Consensus 307 e~~~~g~L 314 (552)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0022 Score=62.96 Aligned_cols=138 Identities=14% Similarity=0.127 Sum_probs=79.9
Q ss_pred eeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccc--cceeeeE-----eecCCceeEEEeec
Q 008828 237 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIGF-----CMTTTERLLVYPYM 309 (552)
Q Consensus 237 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l~~~-----~~~~~~~~lv~e~~ 309 (552)
.++ |....||+....+|+.+++|+...... ....+..|..++..+.... +.+++.. ....+..+++|+|+
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 466 888899998877787899999864321 2345667888777764222 3444433 11234567899999
Q ss_pred cCCChhh-----------h---hc----cC-----CCCCHHHH----HHH---------------HHHHHHHHHHHhhc-
Q 008828 310 SNGSVAS-----------R---LK----AK-----PSLDWATR----KRI---------------ALGAARGLLYLHEQ- 346 (552)
Q Consensus 310 ~~g~L~~-----------~---l~----~~-----~~l~~~~~----~~i---------------~~~ia~~l~~LH~~- 346 (552)
+|..+.. . ++ .. ...++... ..+ ...+...+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8754321 0 11 00 11222211 001 11111223333221
Q ss_pred ---CCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 347 ---CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 347 ---~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
....++|+|+++.||+++ + .+.|.||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999998753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0004 Score=58.22 Aligned_cols=59 Identities=22% Similarity=0.219 Sum_probs=46.4
Q ss_pred CEEEccCCcCC-CCCCccccCCccccccccccccccCCCCccccccccccEEeccCCCCCCC
Q 008828 53 LTLDLSNNFFT-GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 113 (552)
Q Consensus 53 ~~L~l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 113 (552)
..++.++++|+ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|++...
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~Cd 70 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCD 70 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeecc
Confidence 47888888886 34665543 4799999999999966667788999999998888887653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0026 Score=63.69 Aligned_cols=138 Identities=16% Similarity=0.160 Sum_probs=82.0
Q ss_pred CeeeeeCceEEEEEEEC--------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccc-cceeeeEeecCCceeEEE
Q 008828 236 NLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n-iv~l~~~~~~~~~~~lv~ 306 (552)
+.+..|-...+|+.... +++.+++|+.... ......+.+|..+++.+...+ ..++++++.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 45666888889998864 2478999986332 123445668999988775323 3466666543 3999
Q ss_pred eeccCCChhhh--------------h---ccC-----CCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 008828 307 PYMSNGSVASR--------------L---KAK-----PSLD--WATRKRIALGAAR-------------------GLLYL 343 (552)
Q Consensus 307 e~~~~g~L~~~--------------l---~~~-----~~l~--~~~~~~i~~~ia~-------------------~l~~L 343 (552)
||++|.+|... | +.- .... +.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99987554311 0 111 1112 3455555544322 22333
Q ss_pred hh----c-CCCceEEcCCCCCceeeCCC----CceEEccccccee
Q 008828 344 HE----Q-CDPKIIHRDVKAANILLDEY----YEAVVGDFGLAKL 379 (552)
Q Consensus 344 H~----~-~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~ 379 (552)
.+ . ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 1 23468999999999999876 7899999998853
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0014 Score=65.86 Aligned_cols=101 Identities=15% Similarity=0.066 Sum_probs=46.5
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
+|+.+.+..+ ++.+-...|.++.+|+.+.+..+ +...-...|.++++|+.+.+.+|.++..-...|.+|.+|+.+.|.
T Consensus 241 ~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 241 ALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp SCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECC
T ss_pred cceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcC
Confidence 3444444433 34433444555555555555433 322333345555555555555555542333345555555555554
Q ss_pred cccccCCCCccccccccccEEecc
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLS 106 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~ 106 (552)
++ ++..-..+|.+|++|+.+.+.
T Consensus 319 ~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 319 TA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp TT-CCEECTTTTTTCTTCCCCCCC
T ss_pred cc-ccEEHHHHhhCCCCCCEEEEC
Confidence 33 332223445555555555443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0022 Score=57.86 Aligned_cols=98 Identities=15% Similarity=0.117 Sum_probs=63.7
Q ss_pred CChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceeec
Q 008828 312 GSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 390 (552)
Q Consensus 312 g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 390 (552)
-+|.++|+ .+.+++++++|.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------------
Confidence 37888887 456899999999999999998776211111 1233456889999999988753 1110
Q ss_pred ccccccccCchhhccCCCCCccchhHHHHHHHHHHh
Q 008828 391 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 426 (552)
Q Consensus 391 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt 426 (552)
.....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1223466888763 345678889999999998875
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00056 Score=69.22 Aligned_cols=111 Identities=12% Similarity=-0.006 Sum_probs=87.3
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
.+|+.+.+..+. ..+....|.++..|+.+.+..+.+. ...|.++.+|+.+.+.++ ++..-..+|.+|++|+.++|
T Consensus 253 ~~l~~~~~~~~~-~~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~l 327 (394)
T 4fs7_A 253 TDLESISIQNNK-LRIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDL 327 (394)
T ss_dssp SSCCEEEECCTT-CEECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECC
T ss_pred ccceeEEcCCCc-ceeeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEe
Confidence 567778887764 4567778999999999999887654 356889999999999876 55345567999999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA 119 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~ 119 (552)
.++ ++..-..+|.+|++|+.+++..| ++.+....|.
T Consensus 328 p~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~ 363 (394)
T 4fs7_A 328 PYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQ 363 (394)
T ss_dssp CTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBT
T ss_pred CCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhh
Confidence 755 76455678999999999999877 7655555555
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0029 Score=63.32 Aligned_cols=73 Identities=10% Similarity=0.055 Sum_probs=43.8
Q ss_pred CeeeeeCceEEEEEEECC---------CcEEEEEEeccCccCchHHHHHHHHHHHhhcccccc-ceeeeEeecCCceeEE
Q 008828 236 NLVGKGGFGNVYKGYLQD---------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLIGFCMTTTERLLV 305 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv 305 (552)
+.++.|....+|+....+ +..+++|+...... .......|..++..+...++ .++++.. .-++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 456778888999998754 26888888754321 11123577888877754343 3666554 23789
Q ss_pred EeeccCCCh
Q 008828 306 YPYMSNGSV 314 (552)
Q Consensus 306 ~e~~~~g~L 314 (552)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0046 Score=63.57 Aligned_cols=73 Identities=10% Similarity=0.079 Sum_probs=46.8
Q ss_pred CeeeeeCceEEEEEEECC-CcEEEEEEeccCccCchHHHHHHHHHHHhhcccccc-ceeeeEeecCCceeEEEeeccCCC
Q 008828 236 NLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLIGFCMTTTERLLVYPYMSNGS 313 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~ 313 (552)
+.|+.|-...+|+....+ +..+++|+..... ........|..++..+...++ .++++.+. -.+||||+++.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIINREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCcc
Confidence 467888889999998765 4788899874322 111122478888887764444 46677663 235999998754
Q ss_pred h
Q 008828 314 V 314 (552)
Q Consensus 314 L 314 (552)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.02 Score=56.40 Aligned_cols=32 Identities=22% Similarity=0.295 Sum_probs=28.1
Q ss_pred CCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 348 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
...++|+|+.+.||+++.++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34799999999999999888899999987764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.42 E-value=0.00056 Score=61.39 Aligned_cols=108 Identities=16% Similarity=0.165 Sum_probs=64.9
Q ss_pred CcccEeccCCC-CCccc----ccccccCCCCCcEEecccCccCC----CCchhhcCCCCCCEEEccCCcCCCC----CCc
Q 008828 2 VLLCYRGAPSQ-NLSGT----LSSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGP----IPS 68 (552)
Q Consensus 2 ~~l~~L~l~~n-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~ 68 (552)
+.|+.|+|++| +|... +-..+..-++|+.|+|++|.|.. .+.+.+..-+.|+.|+|++|.|... +-+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 35778888875 55432 33456666778888888888862 2344455567788888888887622 112
Q ss_pred cccCCccccccccccccc---cCC----CCccccccccccEEeccCCC
Q 008828 69 TVSHLETLQYLRLNNNSL---TGA----IPPSLSNMSQLAFLDLSYNN 109 (552)
Q Consensus 69 ~~~~l~~L~~L~l~~N~l---~~~----~p~~~~~l~~L~~l~l~~N~ 109 (552)
.+..-+.|+.|+|++|.. ... +...+..-+.|+.|+++.|.
T Consensus 121 aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 344446688888876533 211 22334444567777766543
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.94 E-value=0.0064 Score=39.30 Aligned_cols=31 Identities=29% Similarity=0.472 Sum_probs=21.2
Q ss_pred eeeehhhhHHHHHHHHHHHHhhhhhcccccc
Q 008828 169 ALALGSSLGCISLLILGFGFLLWWRQRHNQQ 199 (552)
Q Consensus 169 ~i~v~~~~~~v~l~il~~~~~~~~r~~~~~~ 199 (552)
.++.+++.|+++++++++++++++|+|+.++
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~ 42 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHIVR 42 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHhhc
Confidence 4556666667777777777777777776543
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.33 E-value=0.0072 Score=38.95 Aligned_cols=31 Identities=26% Similarity=0.470 Sum_probs=20.3
Q ss_pred eeeehhhhHHHHHHHHHHHHhhhhhcccccc
Q 008828 169 ALALGSSLGCISLLILGFGFLLWWRQRHNQQ 199 (552)
Q Consensus 169 ~i~v~~~~~~v~l~il~~~~~~~~r~~~~~~ 199 (552)
.++.+++.|+++++++++.+++|||+|+.++
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 3555566667776777777777777776553
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=95.29 E-value=0.0082 Score=38.59 Aligned_cols=30 Identities=17% Similarity=0.427 Sum_probs=19.9
Q ss_pred eeeehhhhHHHHHHHHHHHHhhhhhccccc
Q 008828 169 ALALGSSLGCISLLILGFGFLLWWRQRHNQ 198 (552)
Q Consensus 169 ~i~v~~~~~~v~l~il~~~~~~~~r~~~~~ 198 (552)
..+++.++|+++++++++++++|+|||+.+
T Consensus 12 ~~Ia~~vVGvll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 12 TSIISAVVGILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred cchHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence 345566666666667777777777777654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.00 E-value=0.075 Score=53.81 Aligned_cols=137 Identities=9% Similarity=0.083 Sum_probs=81.8
Q ss_pred CeeeeeCceEEEEEEECC--------CcEEEEEEeccCccCchHHHHHHHHHHHhhccccc-cceeeeEeecCCceeEEE
Q 008828 236 NLVGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n-iv~l~~~~~~~~~~~lv~ 306 (552)
+.+..|-...+|+....+ +..+++|+..... .......+|..+++.+...+ ..++++.+. -++||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 456668888999998753 5789999874432 11122357888887775333 345555432 37899
Q ss_pred eeccCCChhh-------h-------h---c---c---------C-CCCCHHHHHHHHHHH-------------------H
Q 008828 307 PYMSNGSVAS-------R-------L---K---A---------K-PSLDWATRKRIALGA-------------------A 337 (552)
Q Consensus 307 e~~~~g~L~~-------~-------l---~---~---------~-~~l~~~~~~~i~~~i-------------------a 337 (552)
||++|.+|.. . + + . . .+.-+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865421 0 0 0 0 0 111234444443322 1
Q ss_pred HHHHHHhh---------------------cCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 338 RGLLYLHE---------------------QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 338 ~~l~~LH~---------------------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
..+.+|.+ .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11236899999999999 8888999999998853
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.40 E-value=1 Score=45.06 Aligned_cols=30 Identities=30% Similarity=0.427 Sum_probs=25.2
Q ss_pred ceEEcCCCCCceee------CCCCceEEccccccee
Q 008828 350 KIIHRDVKAANILL------DEYYEAVVGDFGLAKL 379 (552)
Q Consensus 350 ~ivH~dlk~~Nill------~~~~~~kl~Dfg~~~~ 379 (552)
.++|+|+.+.|||+ +++..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567899999998853
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.06 E-value=0.78 Score=41.27 Aligned_cols=116 Identities=10% Similarity=0.057 Sum_probs=78.8
Q ss_pred cccccceeeeEeecCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC
Q 008828 285 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 364 (552)
Q Consensus 285 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 364 (552)
.||+.+.. .+-...+...+.++.-+.+.=+..++ .++...+++++.+|+....+++.. +|--|.|+|++++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEc
Confidence 48888765 45555666666666544222222232 478899999999999988777654 7889999999999
Q ss_pred CCCceEEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccc
Q 008828 365 EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 432 (552)
Q Consensus 365 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~ 432 (552)
.++.+++.-.|+...+.+.. .+...=.-.+=+++..+++++..|+
T Consensus 114 ~~~~p~i~~RGik~~l~P~~-----------------------~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 114 RDGLPIAKTRGLQNVVDPLP-----------------------VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TTSCEEESCCEETTTBSCCC-----------------------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCCCEEEEEccCccCCCCCC-----------------------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999998887754332110 1111113356778888999988886
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.50 E-value=0.14 Score=32.74 Aligned_cols=28 Identities=29% Similarity=0.383 Sum_probs=14.0
Q ss_pred eeeeehhhhHHHHHHHHHHHHhhhhhcc
Q 008828 168 IALALGSSLGCISLLILGFGFLLWWRQR 195 (552)
Q Consensus 168 ~~i~v~~~~~~v~l~il~~~~~~~~r~~ 195 (552)
..++.+++.|+++++++.+.++++|||+
T Consensus 13 ~~I~~~vv~Gv~ll~~iv~~~~~~~rRr 40 (41)
T 2k9y_A 13 LAVIGGVAVGVVLLLVLAGVGFFIHRRR 40 (41)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHSSSSSC
T ss_pred EEEEeehhHHHHHHHHHHHHheeEeeec
Confidence 3445555555555442444445555543
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=86.80 E-value=0.083 Score=32.02 Aligned_cols=26 Identities=19% Similarity=0.323 Sum_probs=15.8
Q ss_pred eehhhhHHHHHHHHHHHHhhhhhccc
Q 008828 171 ALGSSLGCISLLILGFGFLLWWRQRH 196 (552)
Q Consensus 171 ~v~~~~~~v~l~il~~~~~~~~r~~~ 196 (552)
+.+.++|++++++++.++.+++|||+
T Consensus 10 IaagVvglll~vii~l~~~~~iRRr~ 35 (35)
T 1iij_A 10 IIATVVGVLLFLILVVVVGILIKRRR 35 (35)
T ss_dssp HHHHHHHHHHHHHHTTTTTHHHHHCC
T ss_pred eHHHHHHHHHHHHHHHHhheEEeecC
Confidence 33444555556666677777777664
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.54 E-value=2 Score=38.66 Aligned_cols=115 Identities=14% Similarity=0.064 Sum_probs=77.3
Q ss_pred cccccceeeeEeecCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCceEEcCCCCCceee
Q 008828 285 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL-YLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 285 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~~~ivH~dlk~~Nill 363 (552)
.||++ -..+-...+...+.++.-+++.=...+ ..++...+++++.+|+.... +++.. +|--|.|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceEEE
Confidence 47877 444446667777777665443333333 24788999999999988777 66654 788999999999
Q ss_pred CCCCceEEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 432 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~ 432 (552)
+.++.+++.-.|+-..+.+.. +.+|- =.-.+=+++..++.++..|+
T Consensus 118 ~~~~~p~i~hRGi~~~lpP~e-------------~~ee~----------fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 118 NRALEPFFLHVGVKESLPPDE-------------WDDER----------LLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CTTCCEEESCCEETTTBSSCS-------------CCHHH----------HHHHHHHHHHHHTTCSSCHH
T ss_pred eCCCcEEEEEcCCcccCCCCC-------------CCHHH----------HHHHHHHHHHHHHcCCCCHH
Confidence 999999998888754332111 11111 12346677888888877775
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.76 E-value=0.14 Score=52.57 Aligned_cols=61 Identities=7% Similarity=-0.014 Sum_probs=17.9
Q ss_pred CCCeeeeeCceEEEEEEECC-CcEEEE------EEeccCccC-chHHHHHHHHHHHhhccccccceeeeEee
Q 008828 234 SKNLVGKGGFGNVYKGYLQD-GTVVAV------KRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCM 297 (552)
Q Consensus 234 ~~~~iG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~ 297 (552)
+.+.|| ||.||+|.+.. ..+||+ |..+..... +....|.+|..++...+|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 446676 99999999864 467888 766543322 22345788888888889999999988754
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=80.30 E-value=1 Score=28.07 Aligned_cols=24 Identities=13% Similarity=-0.038 Sum_probs=10.1
Q ss_pred eehhhhHHHHHHH-HHHHHhhhhhc
Q 008828 171 ALGSSLGCISLLI-LGFGFLLWWRQ 194 (552)
Q Consensus 171 ~v~~~~~~v~l~i-l~~~~~~~~r~ 194 (552)
+.+++++.++.++ +++..+++|||
T Consensus 13 IAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 13 IVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred eeeeehHHHHHHHHHHHHHHHHeec
Confidence 3455555544332 22333444444
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 552 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-66 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.002 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.004 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 8e-66
Identities = 73/275 (26%), Positives = 120/275 (43%), Gaps = 24/275 (8%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRL 70
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--LDWATRKRIALGAARGLLYLHEQC 347
+RL T ++ YM NGS+ LK L +A A G+ ++ E+
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
IHRD++AANIL+ + + DFGLA+L++ + + + APE ++ G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467
+ K+DV+ FGILL E+++ G+ + ++ + + ++
Sbjct: 187 FTIKSDVWSFGILLTEIVTH------GRIPYPGMTNPEVIQNLERGYRMVR--------- 231
Query: 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
EE+ Q+ LC + P RP + +LE
Sbjct: 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 7e-64
Identities = 72/279 (25%), Positives = 120/279 (43%), Gaps = 24/279 (8%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRN 288
+ +G G FG VYKG VAVK L ++Q F+ EV ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQC 347
+L +G+ T + +V + S+ L + + IA A+G+ YLH +
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTG 406
IIHRD+K+ NI L E +GDFGLA + SH + G++ +APE +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 407 QS---SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463
S ++DV+ FGI+L EL++G N + ++ V + + L +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSKVRSN- 237
Query: 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ M ++ C + RP +++ +E
Sbjct: 238 --------CPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-63
Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 22/274 (8%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
S + +G G FG V+ GY + VA+K +++G E F E E++ H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKL 62
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL-DWATRKRIALGAARGLLYLHEQCD 348
++L G C+ LV+ +M +G ++ L+ + L T + L G+ YL E C
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 408
+IHRD+ A N L+ E V DFG+ + + +T + V +PE S +
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 409 SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468
S K+DV+ FG+L+ E+ S GK + + + V+ I +L
Sbjct: 180 SSKSDVWSFGVLMWEVFSE------GKIPYENRSNSEVVEDISTGFRLY----------K 223
Query: 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
R+ + Q+ C + P RP S ++R L
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (522), Expect = 2e-62
Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 37/301 (12%)
Query: 220 FHFKELQSATSNFSSK---------NLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGN 266
F F++ A F+ + ++G G FG V G+L + VA+K LK G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 267 AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-PSLD 325
F +E ++ H N++ L G +T +++ +M NGS+ S L+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 326 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385
+ G A G+ YL + +HRD+ A NIL++ V DFGL++ L+ S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 386 HVTT----AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG 441
T + + APE + + + +DV+ +GI++ E++S +G+
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS------YGERPYWDM 237
Query: 442 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 501
D + I Q+ +L +D + Q+ L C Q + RPK ++V L
Sbjct: 238 TNQDVINAIEQDYRLPPPMD----------CPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 502 E 502
+
Sbjct: 288 D 288
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 4e-61
Identities = 65/282 (23%), Positives = 123/282 (43%), Gaps = 27/282 (9%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGT-----VVAVKRLKDGNAIGGEIQFQTEVEMISLA 284
S + + ++G G FG VYKG L+ + VA+K LK G + F E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 285 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASR-LKAKPSLDWATRKRIALGAARGLLYL 343
H N++RL G +++ YM NG++ + + G A G+ YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 344 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPE 401
+HRD+ A NIL++ V DFGL+++L D ++ T+ + + APE
Sbjct: 127 AN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 402 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461
+S + + +DV+ FGI++ E+++ + + ++ ++
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----------------NHEVMKAIN 227
Query: 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503
+ + Q+ + C Q + RPK +++V +L+
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-60
Identities = 55/274 (20%), Positives = 110/274 (40%), Gaps = 22/274 (8%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+ + +G G FG V G + VA+K +K+G+ E +F E +++ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKL 61
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCD 348
++L G C ++ YM+NG + + L+ + + + YL +
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 120
Query: 349 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 408
+HRD+ A N L+++ V DFGL++ + + + + V PE L +
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 409 SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468
S K+D++ FG+L+ E+ S + T ++ + + L+
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRLYR 222
Query: 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ E++ + C RP ++ +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-60
Identities = 78/281 (27%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH 286
+F ++G+G FG VY G L D AVK L IG QF TE ++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 287 RNLLRLIGFCMTT-TERLLVYPYMSNGSVAS-RLKAKPSLDWATRKRIALGAARGLLYLH 344
N+L L+G C+ + L+V PYM +G + + + L A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---K 144
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD---SHVTTAVRGTVGHIAPE 401
K +HRD+ A N +LDE + V DFGLA+ + + H T + V +A E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 402 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461
L T + + K+DV+ FG+LL EL++ G D + Q ++L
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTR------GAPPYPDVNTFDITVYLLQGRRLL---- 254
Query: 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ + +V L C +RP SE+V +
Sbjct: 255 ------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 1e-60
Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 27/287 (9%)
Query: 223 KELQSATSNFSSKNLV-GKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEV 278
K+L N ++ G G FG+V +G + VA+K LK G + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 279 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAA 337
+++ + ++RLIG C +LV G + L K + + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 338 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTV 395
G+ YL E+ +HRD+ A N+LL + A + DFGL+K L DS+ T +A + +
Sbjct: 120 MGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 396 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455
APE ++ + S ++DV+ +G+ + E +S +G+ +K + + I Q K+
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALS------YGQKPYKKMKGPEVMAFIEQGKR 230
Query: 456 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+E + E+ + C Y RP V + +
Sbjct: 231 MECPPECP----------PELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-60
Identities = 71/275 (25%), Positives = 114/275 (41%), Gaps = 24/275 (8%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+ + +G+G FG V+ G T VA+K LK G F E +++ H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKL 74
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQC 347
++L + +V YMS GS+ LK + L +A A G+ Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
+HRD++AANIL+ E V DFGLA+L++ + + + APE G+
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467
+ K+DV+ FGILL EL + R G +++ V++ +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMV----------------NREVLDQVERGYRMP 234
Query: 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
E + + C + P RP + LE
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (505), Expect = 5e-60
Identities = 68/313 (21%), Positives = 127/313 (40%), Gaps = 50/313 (15%)
Query: 221 HFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQF 274
L+ +N +G+G FG V++ + T+VAVK LK+ + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 275 QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK--------------- 319
Q E +++ + N+++L+G C L++ YM+ G + L+
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 320 ---------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 370
P L A + IA A G+ YL E+ K +HRD+ N L+ E
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 371 VGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR 429
+ DFGL++ + D + + PE + + + ++DV+ +G++L E+ S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 430 ALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPS 489
+G E+ + + D ++ + E+ + LC LP+
Sbjct: 241 QPYYGMA---------------HEEVIYYVRDGNILACPENCP-LELYNLMRLCWSKLPA 284
Query: 490 LRPKMSEVVRMLE 502
RP + R+L+
Sbjct: 285 DRPSFCSIHRILQ 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 7e-60
Identities = 66/290 (22%), Positives = 111/290 (38%), Gaps = 26/290 (8%)
Query: 235 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
+ +GKG FG V++G G VAVK + E+ + H N+L I
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIA 64
Query: 295 FCM----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC--- 347
T T+ LV Y +GS+ L + ++AL A GL +LH +
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 348 --DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV---TTAVRGTVGHIAPEY 402
P I HRD+K+ NIL+ + + D GLA D + GT ++APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 403 LST------GQSSEKTDVFGFGILLLELISGLR---ALEFGKTANQKGAMLDWVKKIHQE 453
L +S ++ D++ G++ E+ E + D + ++
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 454 KKLEMLVDKDLKNNYDRIE-LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
E + ++ N + E L M ++ C + R + + L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (500), Expect = 2e-59
Identities = 69/288 (23%), Positives = 128/288 (44%), Gaps = 24/288 (8%)
Query: 218 KRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQT 276
++ + + ++ + K+ +G G +G VY+G + VAVK LK+ E F
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62
Query: 277 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL--KAKPSLDWATRKRIAL 334
E ++ H NL++L+G C ++ +M+ G++ L + + +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 335 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 394
+ + YL + IHRD+ A N L+ E + V DFGL++L+ +
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 395 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 454
+ APE L+ + S K+DV+ FG+LL E+ + + G +Q
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------- 224
Query: 455 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ L++KD + E++ ++ C Q+ PS RP +E+ + E
Sbjct: 225 -VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-58
Identities = 68/301 (22%), Positives = 117/301 (38%), Gaps = 44/301 (14%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS- 282
+ S +G G FG V + VAVK LK + +E++++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 283 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK------------------PSL 324
L H N++ L+G C L++ Y G + + L+ K +L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 325 DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384
D + A+G+ +L + IHRD+ A NILL + DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 385 SH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 443
++ V R V +APE + + ++DV+ +GI L EL S + G
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-------- 251
Query: 444 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503
+ K ++ + + EM + C P RP ++V+++E
Sbjct: 252 -------PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 504 D 504
Sbjct: 305 Q 305
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 5e-58
Identities = 59/302 (19%), Positives = 113/302 (37%), Gaps = 32/302 (10%)
Query: 225 LQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 283
++ +F + +G G G V+K G V+A K + Q E++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 284 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 343
++ G + E + +M GS+ LK + ++++ +GL YL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 344 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 403
E+ KI+HRDVK +NIL++ E + DFG++ L + + GT +++PE L
Sbjct: 121 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERL 175
Query: 404 STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463
S ++D++ G+ L+E+ G + + V+ E
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 464 LKNNYDRIELEEMVQVALL--------------------------CTQYLPSLRPKMSEV 497
++Y M LL C P+ R + ++
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 498 VR 499
+
Sbjct: 296 MV 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 5e-58
Identities = 68/273 (24%), Positives = 109/273 (39%), Gaps = 26/273 (9%)
Query: 236 NLVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLR 291
+G G FG V KGY Q VAVK LK+ + E ++ + ++R
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 292 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
+IG C + +LV G + L+ + + + G+ YL E
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 128
Query: 352 IHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQSS 409
+HRD+ A N+LL + A + DFGL+K L D T + V APE ++ + S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 410 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469
K+DV+ FG+L+ E S + G ++ + +++K +
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGERMGCP 232
Query: 470 RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
EM + LC Y RP + V L
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 6e-58
Identities = 71/293 (24%), Positives = 126/293 (43%), Gaps = 41/293 (13%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAV 285
++ ++++G+G FG V K ++ A+KR+K+ + F E+E++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 286 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----------------AKPSLDWATR 329
H N++ L+G C L Y +G++ L+ +L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 330 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389
A ARG+ YL + + IHRD+ A NIL+ E Y A + DFGL++ T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 184
Query: 390 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 449
R V +A E L+ + +DV+ +G+LL E++S G T + +K
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEK 238
Query: 450 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ Q +LE ++ D +E+ + C + P RP ++++ L
Sbjct: 239 LPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-57
Identities = 72/276 (26%), Positives = 115/276 (41%), Gaps = 30/276 (10%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+GKG FG+V G G VAVK +K+ F E +++ H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNL 62
Query: 290 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQ 346
++L+G + L +V YM+ GS+ L+++ L + +L + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 406
+HRD+ A N+L+ E A V DFGL K S + V APE L
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREK 175
Query: 407 QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466
+ S K+DV+ FGILL E+ S G+ + + D V ++ + K++
Sbjct: 176 KFSTKSDVWSFGILLWEIYSF------GRVPYPRIPLKDVVPRVEKGYKMDAPDGCP--- 226
Query: 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ +V C ++RP ++ LE
Sbjct: 227 -------PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-57
Identities = 67/304 (22%), Positives = 112/304 (36%), Gaps = 49/304 (16%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMIS- 282
N ++G G FG V VAVK LK+ +E++M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 283 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--------------------- 321
L H N++ L+G C + L++ Y G + + L++K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 322 --PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379
L + A A+G+ +L + +HRD+ A N+L+ + DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 380 LDHCDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN 438
+ ++V R V +APE L G + K+DV+ +GILL E+ S G +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 439 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 498
L+ K + EE+ + C + RP +
Sbjct: 274 A---------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 499 RMLE 502
L
Sbjct: 319 SFLG 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-56
Identities = 64/269 (23%), Positives = 114/269 (42%), Gaps = 27/269 (10%)
Query: 238 VGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGF 295
+G+G F VYKG + VA L+D E Q F+ E EM+ H N++R
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 296 CMTTTER----LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 351
+T + +LV M++G++ + LK + + +GL +LH + P I
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPI 135
Query: 352 IHRDVKAANILL-DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 410
IHRD+K NI + +GD GLA L + AV GT +APE + E
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYE-EKYDE 191
Query: 411 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 470
DV+ FG+ +LE+ + + + + + + ++D+
Sbjct: 192 SVDVYAFGMCMLEMATSEYP---------------YSECQNAAQIYRRVTSGVKPASFDK 236
Query: 471 IELEEMVQVALLCTQYLPSLRPKMSEVVR 499
+ + E+ ++ C + R + +++
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-54
Identities = 68/283 (24%), Positives = 116/283 (40%), Gaps = 28/283 (9%)
Query: 227 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLA 284
S ++ +G G +G K DG ++ K L G+ E Q +EV ++
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 285 VHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRL----KAKPSLDWATRKRIALGAAR 338
H N++R + T L V Y G +AS + K + LD R+
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 339 GLLYLHEQ--CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 396
L H + ++HRD+K AN+ LD +GDFGLA++L+H D+ A GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPY 179
Query: 397 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456
+++PE ++ +EK+D++ G LL EL + + + KI + K
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCA-------LMPPFTAFSQKELAGKIREGKFR 232
Query: 457 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499
+ Y +E+ ++ RP + E++
Sbjct: 233 R------IPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 3e-54
Identities = 61/278 (21%), Positives = 119/278 (42%), Gaps = 25/278 (8%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 285
+G+G FG+V++G VA+K K+ + +F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 286 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLH 344
H ++++LIG T ++ + G + S L+ + SLD A+ A + L YL
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 404
+ + +HRD+ A N+L+ +GDFGL++ ++ + + + + +APE ++
Sbjct: 126 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 405 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 464
+ + +DV+ FG+ + E++ G Q D + +I ++L M +
Sbjct: 183 FRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIENGERLPMPPNCP- 235
Query: 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ + C Y PS RP+ +E+ L
Sbjct: 236 ---------PTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 6e-54
Identities = 62/318 (19%), Positives = 132/318 (41%), Gaps = 26/318 (8%)
Query: 230 SNFSSKNLVGKGGFGNVYKG-YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVEMISLA 284
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 285 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 344
+ ++ RL+G C+T+T +L+ + + K ++ + A+G+ YL
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYL 403
++ +++HRD+ A N+L+ + DFGLAKLL + + + + +A E +
Sbjct: 129 DR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 404 STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463
+ ++DV+ +G+ + EL++ G A++ + +++K
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILEKG 229
Query: 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRA 523
+ I ++ + + C RPK E++ + R
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS-KMARDPQRYLVIQGDERMHL 288
Query: 524 NEFSSSERYSDLTDDSSL 541
+ S Y L D+ +
Sbjct: 289 PSPTDSNFYRALMDEEDM 306
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 3e-53
Identities = 58/272 (21%), Positives = 111/272 (40%), Gaps = 21/272 (7%)
Query: 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
++ +G+G +G V VAVK + A+ + E+ + + H N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 349
++ G + L Y S G + R++ + +R G++YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ- 407
I HRD+K N+LLDE + DFGLA + + + + + GT+ ++APE L +
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467
+E DV+ GI+L +++G L + + ++ DW +K + +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEKKTYLNPWKKID------- 233
Query: 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499
+ + PS R + ++ +
Sbjct: 234 ------SAPLALLHKILVENPSARITIPDIKK 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-52
Identities = 74/273 (27%), Positives = 113/273 (41%), Gaps = 27/273 (9%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVH 286
+F +GKG FGNVY Q ++A+K L G E Q + EVE+ S H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 287 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 346
N+LRL G+ T L+ Y G+V L+ D A L Y H +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 406
++IHRD+K N+LL E + DFG + H S T + GT+ ++ PE +
Sbjct: 126 ---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGR 179
Query: 407 QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466
EK D++ G+L E + G E AN + ++ E V + ++
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRV--EFTFPDFVTEGARD 233
Query: 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499
+ ++ PS RP + EV+
Sbjct: 234 ------------LISRLLKHNPSQRPMLREVLE 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 5e-52
Identities = 62/292 (21%), Positives = 124/292 (42%), Gaps = 36/292 (12%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 283
+ +G+G FG VY+G + T VA+K + + ++ I+F E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 284 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----------AKPSLDWATRKRIA 333
+++RL+G L++ M+ G + S L+ + ++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 334 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVR 392
A G+ YL+ K +HRD+ A N ++ E + +GDFG+ + + D
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452
V ++PE L G + +DV+ FG++L E+ + G +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---------------N 241
Query: 453 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504
E+ L +++ L + D + + ++ +C QY P +RP E++ ++ +
Sbjct: 242 EQVLRFVMEGGLLDKPDNC-PDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (450), Expect = 8e-52
Identities = 71/277 (25%), Positives = 102/277 (36%), Gaps = 30/277 (10%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAV 285
FS +G G FG VY +++ VVA+K++ E EV +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 286 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 345
H N ++ G + LV Y + K L + GA +GL YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 346 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 405
+IHRDVKA NILL E +GDFG A ++ +S V GT +APE +
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILA 185
Query: 406 ---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462
GQ K DV+ GI +EL L ++ L +
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLF----------------NMNAMSALYHIAQN 229
Query: 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499
+ E C Q +P RP +++
Sbjct: 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-51
Identities = 75/299 (25%), Positives = 109/299 (36%), Gaps = 40/299 (13%)
Query: 213 CLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNAI 268
CL K E +G G FG V +G VAVK LK
Sbjct: 3 CLIGEKDLRLLEK------------LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 50
Query: 269 GGEI--QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASR-LKAKPSLD 325
E F EV + HRNL+RL G +T + +V GS+ R K +
Sbjct: 51 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL 109
Query: 326 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385
T R A+ A G+ YL + IHRD+ A N+LL +GDFGL + L D
Sbjct: 110 LGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166
Query: 386 H--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 443
H + + APE L T S +D + FG+ L E+ + + G
Sbjct: 167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------- 219
Query: 444 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
+ L + + + +++ V + C + P RP + L
Sbjct: 220 --------GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-49
Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 43/298 (14%)
Query: 230 SNFSSKNLVGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 283
+G+G FG V + VAVK LK+G +E++++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 284 AVHR-NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLK----------------AKPSLD 325
H N++ L+G C L ++ + G++++ L+ K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 326 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385
+ A+G+ +L + K IHRD+ A NILL E + DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 386 HV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML 444
+V R + +APE + + ++DV+ FG+LL E+ S + G ++
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 244
Query: 445 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
++ +++ + ++ EM Q L C PS RP SE+V L
Sbjct: 245 EFCRRLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-48
Identities = 72/299 (24%), Positives = 117/299 (39%), Gaps = 45/299 (15%)
Query: 230 SNFSSKNLVGKGGFGNVYKGYL--------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 281
+G+G FG V T VAVK LK +E+EM+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 282 S-LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS----------------L 324
+ H+N++ L+G C ++ Y S G++ L+A+ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 325 DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384
A ARG+ YL K IHRD+ A N+L+ E + DFGLA+ + H D
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 385 SHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 443
+ T R V +APE L + ++DV+ FG+LL E+ + + G +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245
Query: 444 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
K + + +++ E+ + C +PS RP ++V L+
Sbjct: 246 --LFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 4e-48
Identities = 53/271 (19%), Positives = 106/271 (39%), Gaps = 27/271 (9%)
Query: 236 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 294
+G G FG VYK + + A K + + E + E+++++ H N+++L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLD 76
Query: 295 FCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
++ + + G+V + + + + L + + + L YLH+ KIIH
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIH 133
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS----- 408
RD+KA NIL + + DFG++ + + GT +APE + S
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 192
Query: 409 SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468
K DV+ GI L+E+ + + + + + KI + + +
Sbjct: 193 DYKADVWSLGITLIEMAE-------IEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS--- 242
Query: 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499
C + R S++++
Sbjct: 243 -----SNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 6e-47
Identities = 54/272 (19%), Positives = 104/272 (38%), Gaps = 22/272 (8%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 287
++ +G+G G VY + G VA++++ E E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNP 77
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 347
N++ + + E +V Y++ GS+ + + + +D + + L +LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN- 135
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
++IHRD+K+ NILL + DFG + S +T V GT +APE ++
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467
K D++ GI+ +E+I G + L + I E+ + L
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG-EPPYLNENP------LRALYLIATNGTPELQNPEKLS-- 243
Query: 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499
C R E+++
Sbjct: 244 ------AIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 160 bits (405), Expect = 5e-45
Identities = 68/353 (19%), Positives = 124/353 (35%), Gaps = 38/353 (10%)
Query: 192 WRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY- 250
W+Q + Q + E + + V L + E +G G FG V++
Sbjct: 9 WKQYYPQPV-----EIKHDHV----LDHYDIHEE------------LGTGAFGVVHRVTE 47
Query: 251 LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 310
G A K + + E + E++ +S+ H L+ L E +++Y +MS
Sbjct: 48 RATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106
Query: 311 NGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL--DEYY 367
G + ++ + +GL ++HE +H D+K NI+
Sbjct: 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSN 163
Query: 368 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
E + DFGL LD S T GT APE TD++ G+L L+SG
Sbjct: 164 ELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221
Query: 428 LRALEFGKTANQKGAMLDWVKKIHQE------KKLEMLVDKDL-KNNYDRIELEEMVQVA 480
L + + + + + K L + R+ + + ++
Sbjct: 222 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281
Query: 481 LLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYS 533
L P ++ D + K+ A + R + +SS ++
Sbjct: 282 WLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHR 334
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-44
Identities = 56/278 (20%), Positives = 101/278 (36%), Gaps = 29/278 (10%)
Query: 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHR 287
+F ++G+G F V L A+K L+ + I E +++S H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 347
++L + Y NG + ++ S D + L YLH +
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTG 406
IIHRD+K NILL+E + DFG AK+L + GT +++PE L+
Sbjct: 129 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 407 QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466
+ + +D++ G ++ +L++G + ++ K +K
Sbjct: 186 SACKSSDLWALGCIIYQLVAG--------------------LPPFRAGNEYLIFQKIIKL 225
Query: 467 NYDRIE--LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
YD E + + + R E+
Sbjct: 226 EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 6e-43
Identities = 58/282 (20%), Positives = 108/282 (38%), Gaps = 23/282 (8%)
Query: 222 FKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEM 280
+K+ + + ++++G G F V + +VA+K + G E + E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 281 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 340
+ H N++ L + L+ +S G + R+ K R+ +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 120
Query: 341 LYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 397
YLH+ I+HRD+K N+L DE + ++ DFGL+K+ D V + GT G+
Sbjct: 121 KYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGY 175
Query: 398 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457
+APE L+ S+ D + G++ L+ G A Q K E
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL----------FEQILKAE 225
Query: 458 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499
D ++ + + P R + ++
Sbjct: 226 YEFDSPYWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (390), Expect = 7e-43
Identities = 57/267 (21%), Positives = 101/267 (37%), Gaps = 24/267 (8%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295
+G G FG V++ G V K + + + E+ +++ H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDA 94
Query: 296 CMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
E +L+ ++S G + R+ A+ + A A GL ++HE I+H
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHL 151
Query: 355 DVKAANILLDEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 412
D+K NI+ + + V DFGLA L+ + T APE + T
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 413 DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 472
D++ G+L L+SGL D ++ + K+ + D+D ++
Sbjct: 210 DMWAIGVLGYVLLSGLSPFA----------GEDDLETLQNVKRCDWEFDEDAFSSVS--- 256
Query: 473 LEEMVQVALLCTQYLPSLRPKMSEVVR 499
E Q P R + + +
Sbjct: 257 -PEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (381), Expect = 3e-42
Identities = 56/285 (19%), Positives = 104/285 (36%), Gaps = 39/285 (13%)
Query: 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI--------GGEIQFQTEVE-M 280
N+ K ++G+G V + AVK + EV+ +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 281 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 340
++ H N+++L T T LV+ M G + L K +L ++I +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 341 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 400
LH+ I+HRD+K NILLD+ + DFG + LD V GT ++AP
Sbjct: 124 CALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPSYLAP 178
Query: 401 EYLSTGQS------SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 454
E + + ++ D++ G+++ L++G + + Q
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-SPPFWHR---------------KQML 222
Query: 455 KLEMLVDKDLKNNYDRIEL--EEMVQVALLCTQYLPSLRPKMSEV 497
L M++ + + + + + + P R E
Sbjct: 223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (385), Expect = 4e-42
Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAV-- 285
+FS ++G+GGFG VY G + A+K L GE E M+SL
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 286 -HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 344
++ + T + + M+ G + L A + A GL ++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 345 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 404
+ +++RD+K ANILLDE+ + D GLA H + GT G++APE L
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQ 178
Query: 405 TGQS-SEKTDVFGFGILLLELISG 427
G + D F G +L +L+ G
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRG 202
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-40
Identities = 60/294 (20%), Positives = 107/294 (36%), Gaps = 26/294 (8%)
Query: 225 LQSATSNFSSKNLVGKGGFGNVYKGY--LQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMI 281
L A + +G+G +G V+K G VA+KR++ G + EV ++
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 282 SLAV---HRNLLRLIGFCMTTTERLLVYPYMSNGSVAS------RLKAKPSLDWATRKRI 332
H N++RL C + + V +P + T K +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 333 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 392
RGL +LH +++HRD+K NIL+ + + DFGLA++ + + V
Sbjct: 122 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VV 176
Query: 393 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML-------- 444
T+ + APE L + D++ G + E+ +Q G +L
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 445 -DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEV 497
DW + + ++ + E + L C + P+ R
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 146 bits (368), Expect = 2e-40
Identities = 56/276 (20%), Positives = 106/276 (38%), Gaps = 27/276 (9%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLLRLI 293
++G GG V+ L+ VAVK L+ A +F+ E + + H ++ +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 294 GFCMTTTERL----LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 349
T +V Y+ ++ + + + + A + L + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN--- 130
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV--TTAVRGTVGHIAPEYLSTGQ 407
IIHRDVK ANI++ V DFG+A+ + + V T AV GT +++PE
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467
++DV+ G +L E+++G + + + ++ + L
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIPPSARHEGLS-- 242
Query: 468 YDRIELEEMVQVALLCTQYLPSLRPK-MSEVVRMLE 502
++ V L P R + +E+ L
Sbjct: 243 ------ADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 2e-40
Identities = 50/278 (17%), Positives = 87/278 (31%), Gaps = 29/278 (10%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295
+G G FG++Y G + G VA+K Q E ++ + + I +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 296 CMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
C + +V + T +A + Y+H + IHR
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHR 127
Query: 355 DVKAANIL---LDEYYEAVVGDFGLAKLLDHCDSHV------TTAVRGTVGHIAPEYLST 405
DVK N L + + DFGLAK +H + GT + +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 406 GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM-LVDKDL 464
+ S + D+ G +L+ G Q +K + + +M + L
Sbjct: 188 IEQSRRDDLESLGYVLMYFN-------LGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 465 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
Y E C +P S + ++
Sbjct: 241 CKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 8/201 (3%)
Query: 231 NFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAV-H 286
+F ++GKG FG V+ + + A+K LK + + E ++SLA H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 287 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 346
L + T V Y++ G + +++ D + A GL +LH +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 406
I++RD+K NILLD+ + DFG+ K D+ T GT +IAPE L
Sbjct: 123 ---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 407 QSSEKTDVFGFGILLLELISG 427
+ + D + FG+LL E++ G
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIG 199
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (368), Expect = 2e-40
Identities = 49/281 (17%), Positives = 105/281 (37%), Gaps = 15/281 (5%)
Query: 231 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNL 289
+ +G+G +G VYK G A+K+++ + G E+ ++ H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 290 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 349
++L T +LV+ ++ + L+ T K L G+ Y H++
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--- 119
Query: 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 409
+++HRD+K N+L++ E + DFGLA+ T + + + + S
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 410 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 469
D++ G + E+++G A+Q + + + + + N+
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 470 RIEL-----------EEMVQVALLCTQYLPSLRPKMSEVVR 499
E E + + + P+ R + +
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-39
Identities = 52/292 (17%), Positives = 110/292 (37%), Gaps = 25/292 (8%)
Query: 229 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 287
+++ + +G+G +G V Y + VA+K++ + E++++ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 288 NLLRLIGFCMTTTERLLVYPYM----SNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 343
N++ + T + Y+ + LK + L RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 344 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPE 401
H ++HRD+K +N+LL+ + + DFGLA++ DH + T T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 402 YLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460
+ + ++ D++ G +L E++S +Q +L + QE ++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 461 DKDLKNNYDRIEL-------------EEMVQVALLCTQYLPSLRPKMSEVVR 499
K + + + + P R ++ + +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-39
Identities = 49/267 (18%), Positives = 93/267 (34%), Gaps = 25/267 (9%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295
+G+G FG V++ K +K ++ + E+ ++++A HRN+L L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHES 69
Query: 296 CMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
+ E ++++ ++S + R+ L+ L +LH I H
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHF 126
Query: 355 DVKAANILLDEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 412
D++ NI+ + + +FG A+ L D+ + APE S T
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVSTAT 184
Query: 413 DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 472
D++ G L+ L+SG+ I E D++
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQI----------IENIMNAEYTFDEEAFKEIS--- 231
Query: 473 LEEMVQVALLCTQYLPSLRPKMSEVVR 499
E + R SE ++
Sbjct: 232 -IEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 142 bits (359), Expect = 3e-39
Identities = 44/279 (15%), Positives = 88/279 (31%), Gaps = 29/279 (10%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL-RLIG 294
+G+G FG +++G L + VA+K + Q + E L + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 295 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354
F +LV + T A + +HE+ +++R
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYR 125
Query: 355 DVKAANILLDEYYEAVVG-----DFGLAKLLD------HCDSHVTTAVRGTVGHIAPEYL 403
D+K N L+ DFG+ K H + GT +++
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 404 STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463
+ S + D+ G + + + G + K A ++I ++K+ L ++
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN----KQKYERIGEKKQSTPL--RE 239
Query: 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502
L + EE + P + +
Sbjct: 240 LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 7e-39
Identities = 68/281 (24%), Positives = 117/281 (41%), Gaps = 20/281 (7%)
Query: 236 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLL 290
+ +G+G F VYK +VA+K++K G+ G E++++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
L+ + LV+ +M L + K L +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--- 120
Query: 351 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-S 409
I+HRD+K N+LLDE + DFGLAK + T V T + APE L +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMYG 179
Query: 410 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM--LVDKDLKNN 467
D++ G +L EL+ + L +Q + + + +E+ +M L D +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 468 YDRIELEEMVQVA------LL--CTQYLPSLRPKMSEVVRM 500
+ I L + A L+ + P R ++ ++M
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (359), Expect = 7e-39
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVH 286
+F +G G FG V+ +G A+K LK + + E M+S+ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 287 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 346
++R+ G + ++ Y+ G + S L+ K A L YLH +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 347 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 406
II+RD+K NILLD+ + DFG AK + VT + GT +IAPE +ST
Sbjct: 124 D---IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTK 176
Query: 407 QSSEKTDVFGFGILLLELISG 427
++ D + FGIL+ E+++G
Sbjct: 177 PYNKSIDWWSFGILIYEMLAG 197
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-38
Identities = 54/281 (19%), Positives = 102/281 (36%), Gaps = 17/281 (6%)
Query: 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 288
NF +G+G +G VYK G VVA+K+++ D G E+ ++ H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGSVAS-RLKAKPSLDWATRKRIALGAARGLLYLHEQC 347
+++L+ T + LV+ ++ A + K +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
++HRD+K N+L++ + DFGLA+ T V L
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 408 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467
S D++ G + E+++ +Q + + + + D K +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 468 YDRIELEEMVQV---------ALL--CTQYLPSLRPKMSEV 497
+ + ++ +V +LL Y P+ R
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 7e-37
Identities = 52/273 (19%), Positives = 103/273 (37%), Gaps = 30/273 (10%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295
++G G G V + + + A+K L+D E++ + +++R++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDV 73
Query: 296 CMTTTER----LLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDP 349
L+V + G + SR++ + + I + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--- 130
Query: 350 KIIHRDVKAANILLDEYYE---AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 406
I HRDVK N+L + DFG AK +S T T ++APE L
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 188
Query: 407 QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466
+ + D++ G+++ L+ G +N A+ +K + + E + +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFY----SNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499
+ EE+ + + P+ R ++E +
Sbjct: 245 S------EEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 60/289 (20%), Positives = 107/289 (37%), Gaps = 31/289 (10%)
Query: 231 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 289
+++ ++G G FG VY+ L G +VA+K++ + E++++ H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75
Query: 290 LRLIGFCMTTTER------LLVYPYMSNG---SVASRLKAKPSLDWATRKRIALGAARGL 340
+RL F ++ E+ LV Y+ +AK +L K R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 341 LYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 399
Y+H I HRD+K N+LLD + + DFG AK L + +V+ +
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191
Query: 400 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD-----------WVK 448
+ DV+ G +L EL+ G +Q ++ +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 449 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEV 497
+ E K + + E + + +Y P+ R E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 6e-36
Identities = 56/274 (20%), Positives = 101/274 (36%), Gaps = 41/274 (14%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISL--AVHRN 288
L+G GGFG+VY G + D VA+K ++ D + + EV ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 289 LLRLIGFCMTTTERLLVYPYMSNGS-VASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 347
++RL+ + +L+ + + + +L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC- 129
Query: 348 DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 406
++HRD+K NIL+D E + DFG LL V T GT + PE++
Sbjct: 130 --GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRYH 184
Query: 407 Q-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465
+ V+ GILL +++ G F + + +++ E + L+
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIRGQVFFRQRVSSE--CQHLIRW--- 237
Query: 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499
C PS RP E+
Sbjct: 238 -----------------CLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-35
Identities = 48/278 (17%), Positives = 94/278 (33%), Gaps = 17/278 (6%)
Query: 236 NLVGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLI 293
+G+G +G V+K + +VA+KR++ D + G E+ ++ H+N++RL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 294 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 353
+ + LV+ + LD K + L L ++H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL---FQLLKGLGFCHSRNVLH 124
Query: 354 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 413
RD+K N+L++ E + +FGLA+ + V S D
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 414 VFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 473
++ G + EL + R L G + + + + E++ + Y
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244
Query: 474 ------------EEMVQVALLCTQYLPSLRPKMSEVVR 499
+ + P R E ++
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-34
Identities = 56/273 (20%), Positives = 96/273 (35%), Gaps = 29/273 (10%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI-----QFQTEVEMISLAVHRNLL 290
+G G F V K G A K +K + EV ++ H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 291 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 350
L T+ +L+ ++ G + L K SL G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--- 133
Query: 351 IIHRDVKAANILLDEY----YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 406
I H D+K NI+L + + DFGLA +D + + GT +APE ++
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEFVAPEIVNYE 191
Query: 407 QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466
+ D++ G++ L+SG + G T + L V ++ E + E +
Sbjct: 192 PLGLEADMWSIGVITYILLSG-ASPFLGDTKQE---TLANVSAVNYEFEDEYFSNTS--- 244
Query: 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499
P R + + ++
Sbjct: 245 -------ALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 48/200 (24%), Positives = 76/200 (38%), Gaps = 7/200 (3%)
Query: 231 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAVHR 287
+F L+GKG FG V G A+K L+ I + TE ++ H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 288 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 347
L L T V Y + G + L + + A + L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG---AEIVSALEYLH 122
Query: 348 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 407
+++RD+K N++LD+ + DFGL K D GT ++APE L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 408 SSEKTDVFGFGILLLELISG 427
D +G G+++ E++ G
Sbjct: 182 YGRAVDWWGLGVVMYEMMCG 201
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 6e-34
Identities = 63/304 (20%), Positives = 117/304 (38%), Gaps = 35/304 (11%)
Query: 220 FHFKELQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQ 273
F+ +E+ + VG G +G V + G VA+K+L + + +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 274 FQTEVEMISLAVHRNLLRLIGFCMT------TTERLLVYPYMSNGSVASRLKAKPSLDWA 327
E+ ++ H N++ L+ T+ LV P+M G+ +L L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGED 121
Query: 328 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387
+ + +GL Y+H IIHRD+K N+ ++E E + DFGLA+ DS +
Sbjct: 122 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM 175
Query: 388 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 447
T V L+ + ++ D++ G ++ E+I+G + L G + + V
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLDQLKEIMKV 234
Query: 448 KKIHQEKKLEMLVDKDLKN------NYDRIELEEMVQ------VALL--CTQYLPSLRPK 493
+ ++ L + KN ++ + ++ V LL R
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294
Query: 494 MSEV 497
E
Sbjct: 295 AGEA 298
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-33
Identities = 62/300 (20%), Positives = 112/300 (37%), Gaps = 39/300 (13%)
Query: 230 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHR 287
S + +G+G FG V+K + G VA+K++ N G I E++++ L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 288 NLLRLIGFCMTTTER--------LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 339
N++ LI C T LV+ + + + KR+ G
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS---HVTTAVRGTVG 396
L + KI+HRD+KAAN+L+ + DFGLA+ + + T T+
Sbjct: 130 L---YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 397 HIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455
+ PE L + D++G G ++ E+ + + G T L + ++
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQH---QLALISQLCGSIT 242
Query: 456 LEMLVDKDLKNNYDRIEL------------------EEMVQVALLCTQYLPSLRPKMSEV 497
E+ + D Y+++EL + + P+ R +
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (315), Expect = 2e-32
Identities = 51/232 (21%), Positives = 92/232 (39%), Gaps = 16/232 (6%)
Query: 205 NEQRREEVCLGNLKRFHFKELQSATSNFSSKN------LVGKGGFGNVYKGY-LQDGTVV 257
+EQ + L K K+ ++ + N + + +G G FG V + G
Sbjct: 10 SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 258 AVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVA 315
A+K L + + E ++ L++L + +V Y++ G +
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 316 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 375
S L+ + A YLH +I+RD+K N+L+D+ V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 376 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
AK T + GT +APE + + ++ D + G+L+ E+ +G
Sbjct: 187 FAK---RVKGRTWT-LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (305), Expect = 3e-31
Identities = 59/333 (17%), Positives = 116/333 (34%), Gaps = 58/333 (17%)
Query: 199 QIFFDVNEQRREE--------VCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY 250
+++ DVN R E V GN + +G+G + V++
Sbjct: 8 RVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRK------------LGRGKYSEVFEAI 55
Query: 251 -LQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERL--LVY 306
+ + V VK LK + + + E++ + +L N++ L R LV+
Sbjct: 56 NITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111
Query: 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-E 365
+++N + +L + + L Y H I+HRDVK N+++D E
Sbjct: 112 EHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHE 165
Query: 366 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLEL 424
+ + + D+GLA+ + + PE L Q D++ G +L +
Sbjct: 166 HRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 223
Query: 425 ISGLRALEFGKTANQKGAML----------DWVKKIHQE--KKLEMLVDKDLKNNYDRIE 472
I G + + D++ K + E + ++ + + ++R
Sbjct: 224 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 283
Query: 473 LEEMVQVA------LL--CTQYLPSLRPKMSEV 497
E + L +Y R E
Sbjct: 284 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 5e-30
Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 20/237 (8%)
Query: 201 FFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL----QDGTV 256
V + R G+ ++ + NF ++G G +G V+ G +
Sbjct: 2 LLTVKHELRTANLTGHAEKVGIE-------NFELLKVLGTGAYGKVFLVRKISGHDTGKL 54
Query: 257 VAVKRLKDGNAIGGEI---QFQTEVEMIS-LAVHRNLLRLIGFCMTTTERLLVYPYMSNG 312
A+K LK + +TE +++ + L+ L T T+ L+ Y++ G
Sbjct: 55 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 114
Query: 313 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG 372
+ + L + + + +L L II+RD+K NILLD V+
Sbjct: 115 ELFTHLSQRERFTE---HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 171
Query: 373 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS--SEKTDVFGFGILLLELISG 427
DFGL+K ++ GT+ ++AP+ + G S + D + G+L+ EL++G
Sbjct: 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-27
Identities = 59/303 (19%), Positives = 118/303 (38%), Gaps = 33/303 (10%)
Query: 220 FHFKELQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQ 273
F+ +EL + + VG G +G+V + + G VAVK+L + +I +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 274 FQTEVEMISLAVHRNLLRLIGFCMTTT-----ERLLVYPYMSNGSVASRLKAKPSLDWAT 328
E+ ++ H N++ L+ + + ++ + + +K + L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDH 122
Query: 329 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388
+ + RGL Y+H IIHRD+K +N+ ++E E + DFGLA H D +T
Sbjct: 123 VQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMT 176
Query: 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK 448
V L+ ++ D++ G ++ EL++G R L G + ++ +
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQLKLILRLV 235
Query: 449 KIHQEKKLEMLVDKDLKN------NYDRIELEEMVQVA------LL--CTQYLPSLRPKM 494
+ L+ + + +N ++ + A LL R
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 495 SEV 497
++
Sbjct: 296 AQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 2e-26
Identities = 45/221 (20%), Positives = 78/221 (35%), Gaps = 22/221 (9%)
Query: 221 HFKELQSATSNFSSKN------LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI- 272
F ++ S F+ +G G G V Y VA+K+L
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 273 QFQTEVEMISLAVHRNLLRLIGFCMTT------TERLLVYPYMSNGSVASRLKAKPSLDW 326
+ E+ ++ H+N++ L+ + LV M
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---H 118
Query: 327 ATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386
+ G+ +LH IIHRD+K +NI++ + DFGLA+ S
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSF 173
Query: 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 427
+ T T + APE + E D++ G ++ E++
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 101 bits (251), Expect = 6e-24
Identities = 42/235 (17%), Positives = 81/235 (34%), Gaps = 24/235 (10%)
Query: 237 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 295
+G G F V+ + + T VA+K ++ + E++++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 296 CMTTTERLLVY----------------PYMSNGSVASRLKAKPSLDWATRKRIALGAARG 339
+LL + N + + K+I+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 340 LLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLDHCDSHVTTA-VRGTVGH 397
L Y+H +C IIH D+K N+L++ + +A L + C T +
Sbjct: 138 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 398 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 452
+PE L D++ L+ ELI+G L + D + +I +
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.9 bits (230), Expect = 2e-22
Identities = 23/160 (14%), Positives = 48/160 (30%), Gaps = 24/160 (15%)
Query: 236 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA---------IGGEIQFQTEVEMISLAVH 286
L+G+G V+ Y + VK K G+ G++ F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 287 RNLLRLIGFCMTTT----ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 342
R L +L G + ++ + + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAK 118
Query: 343 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382
+ + I+H D+ N+L+ E + DF + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGE 154
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.9 bits (180), Expect = 8e-15
Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
NL NL + L NNIS P + L+KL L +NN + S++++L + +L +
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGH 360
Query: 84 NSLTGAIPPSLSNMSQLAFLDLSYN 108
N ++ P L+N++++ L L+
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.7 bits (164), Expect = 7e-13
Identities = 30/116 (25%), Positives = 44/116 (37%), Gaps = 24/116 (20%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIP--------------------TEIGKLSKLLTLDLSN 59
+ + LT L + L N IS P + I L L L L
Sbjct: 257 APLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF 316
Query: 60 NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115
N + P VS L LQ L NN ++ SL+N++ + +L +N +S P
Sbjct: 317 NNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.1 bits (152), Expect = 3e-11
Identities = 33/134 (24%), Positives = 55/134 (41%), Gaps = 29/134 (21%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP------------ 67
++ +LTNL + L NN IS P + L+KL L L N + P
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292
Query: 68 --------STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA 119
S +S+L+ L YL L N+++ P +S++++L L + N +S S
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLAN 349
Query: 120 ----KTFNITGNSL 129
+ N +
Sbjct: 350 LTNINWLSAGHNQI 363
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 5e-07
Identities = 30/127 (23%), Positives = 47/127 (37%), Gaps = 27/127 (21%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85
TNL + L N + + L+ L LDL+NN + P +S L L L+L N
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274
Query: 86 LTGAIP--------------------PSLSNMSQLAFLDLSYNNLSGPVPSFHA---KTF 122
++ P +SN+ L +L L +NN+S P +
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRL 334
Query: 123 NITGNSL 129
N +
Sbjct: 335 FFANNKV 341
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 10/67 (14%), Positives = 27/67 (40%), Gaps = 4/67 (5%)
Query: 49 LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 108
L++ + L T + + + L+ + L+ + + + ++ L ++ S N
Sbjct: 21 LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 76
Query: 109 NLSGPVP 115
L+ P
Sbjct: 77 QLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 21/74 (28%), Positives = 36/74 (48%), Gaps = 8/74 (10%)
Query: 12 QNLSGTLS-SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
N++ T+S + + +T LQ L +I G + L+ L ++ SNN T P +
Sbjct: 32 TNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP--L 84
Query: 71 SHLETLQYLRLNNN 84
+L L + +NNN
Sbjct: 85 KNLTKLVDILMNNN 98
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.9 bits (172), Expect = 4e-14
Identities = 22/71 (30%), Positives = 35/71 (49%), Gaps = 2/71 (2%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL-NNN 84
NL + L+NN I G +P + +L L +L++S N G IP +L+ NN
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302
Query: 85 SLTGAIPPSLS 95
L G+ P+ +
Sbjct: 303 CLCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.8 bits (151), Expect = 2e-11
Identities = 16/55 (29%), Positives = 25/55 (45%), Gaps = 4/55 (7%)
Query: 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF----HAKTFNITGNSLIC 131
L NN + G +P L+ + L L++S+NNL G +P N +C
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.8 bits (143), Expect = 2e-10
Identities = 16/58 (27%), Positives = 26/58 (44%), Gaps = 3/58 (5%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--GPIPS 68
+ GTL + L L + + NN+ G IP + G L + +NN P+P+
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.5 bits (106), Expect = 8e-06
Identities = 35/117 (29%), Positives = 60/117 (51%), Gaps = 3/117 (2%)
Query: 10 PSQNLSG--TLSSSIGNLTNLQLVLLQNN-NISGHIPTEIGKLSKLLTLDLSNNFFTGPI 66
NL + SS+ NL L + + N+ G IP I KL++L L +++ +G I
Sbjct: 58 SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117
Query: 67 PSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 123
P +S ++TL L + N+L+G +PPS+S++ L + N +SG +P +
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.5 bits (93), Expect = 4e-04
Identities = 35/116 (30%), Positives = 53/116 (45%), Gaps = 6/116 (5%)
Query: 19 SSSIGNLTNLQLVLLQNNNISG--HIPTEIGKLSKLLTLDLSNN-FFTGPIPSTVSHLET 75
+ + NL L N+ IP+ + L L L + GPIP ++ L
Sbjct: 46 DTQTYRVNNLDL---SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ 102
Query: 76 LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLIC 131
L YL + + +++GAIP LS + L LD SYN LSG +P + N+ G +
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 38.2 bits (87), Expect = 0.002
Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 3/111 (2%)
Query: 56 DLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGA--IPPSLSNMSQLAFLDLSYN-NLSG 112
D N + G + T + + L L+ +L IP SL+N+ L FL + NL G
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91
Query: 113 PVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMP 163
P+P AK + + + + + L+ S N+ +P
Sbjct: 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 60.1 bits (144), Expect = 2e-10
Identities = 33/177 (18%), Positives = 61/177 (34%), Gaps = 3/177 (1%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 85
+ L+ LQNN I+ + L L TL L NN + P + L L+ L L+ N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 86 LTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNIT-GNSLICATGAEEDCFGTAP 144
L + +L + + V + + + G + + ++G E F
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 145 MPLSFAL-NNSPNSKPSGMPKG-QKIALALGSSLGCISLLILGFGFLLWWRQRHNQQ 199
+ + + + P G+P ++ L + + G L N
Sbjct: 151 KLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.3 bits (124), Expect = 6e-08
Identities = 28/133 (21%), Positives = 51/133 (38%), Gaps = 7/133 (5%)
Query: 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNN 60
+++ G SG + + + L + + + NI+ IP + L L L N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 181
Query: 61 FFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA- 119
T +++ L L L L+ NS++ SL+N L L L+ N L
Sbjct: 182 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH 241
Query: 120 ---KTFNITGNSL 129
+ + N++
Sbjct: 242 KYIQVVYLHNNNI 254
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.3 bits (124), Expect = 6e-08
Identities = 22/106 (20%), Positives = 35/106 (33%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 72
++ NL NL ++L NN IS P L KL L LS N
Sbjct: 42 KITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKT 101
Query: 73 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH 118
L+ L+ + ++ L+ M + + +F
Sbjct: 102 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.0 bits (123), Expect = 7e-08
Identities = 29/121 (23%), Positives = 51/121 (42%), Gaps = 4/121 (3%)
Query: 12 QNLSGTLSSSI--GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 69
++ T ++I G +L + L N I+ + L+ L L LS N + +
Sbjct: 155 IRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 214
Query: 70 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHAKTFNITGNS 128
+++ L+ L LNNN L +P L++ + + L NN+S F +N S
Sbjct: 215 LANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS 273
Query: 129 L 129
Sbjct: 274 Y 274
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 20/130 (15%), Positives = 39/130 (30%), Gaps = 26/130 (20%)
Query: 12 QNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKL------------------- 52
+S + L L+ + L N + L +L
Sbjct: 65 NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN 124
Query: 53 ----LTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 108
+ L + +G ++ L Y+R+ + ++T IP L L L L N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 181
Query: 109 NLSGPVPSFH 118
++ +
Sbjct: 182 KITKVDAASL 191
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (135), Expect = 2e-09
Identities = 22/133 (16%), Positives = 42/133 (31%), Gaps = 28/133 (21%)
Query: 4 LCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS------------- 50
L + +S + L +L +LL N ++ P L
Sbjct: 155 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214
Query: 51 -----------KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQ 99
L L L++N + + LQ R +++ + ++P L+
Sbjct: 215 ALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRD- 272
Query: 100 LAFLDLSYNNLSG 112
L+ N+L G
Sbjct: 273 --LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 9e-08
Identities = 29/134 (21%), Positives = 45/134 (33%), Gaps = 4/134 (2%)
Query: 4 LCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT 63
L Y L + +L NL + L N IS L L L L N
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 64 GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF----HA 119
P L L L L N+L+ +L+ + L +L L+ N +
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWL 250
Query: 120 KTFNITGNSLICAT 133
+ F + + + C+
Sbjct: 251 QKFRGSSSEVPCSL 264
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 3e-05
Identities = 27/144 (18%), Positives = 44/144 (30%), Gaps = 25/144 (17%)
Query: 13 NLSGTLSSSIGNLTNLQLVLLQNNNISGHI-------------------------PTEIG 47
+S ++S NL ++ L +N ++ P
Sbjct: 43 RISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
Query: 48 KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY 107
L +L TL L P L LQYL L +N+L + ++ L L L
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162
Query: 108 NNLSGPVPSFHAKTFNITGNSLIC 131
N +S ++ L
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQ 186
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (131), Expect = 9e-09
Identities = 16/83 (19%), Positives = 29/83 (34%), Gaps = 5/83 (6%)
Query: 52 LLTLDLSNNFFT-GPIPSTVSHLETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLS 106
+ +LD+ + + L+ Q +RL++ LT I +L LA L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 107 YNNLSGPVPSFHAKTFNITGNSL 129
N L + +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 5e-08
Identities = 16/91 (17%), Positives = 30/91 (32%), Gaps = 5/91 (5%)
Query: 27 NLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTG----PIPSTVSHLETLQYLRL 81
++Q + +Q +S E+ L + + L + T I S + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
+N L + Q + +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 3e-07
Identities = 17/77 (22%), Positives = 27/77 (35%), Gaps = 9/77 (11%)
Query: 50 SKLLTLDLSNNFFTG----PIPSTVSHLETLQYLRLNNNSLTGAIPPSLS-----NMSQL 100
S L L L++ + + +T+ +L+ L L+NN L A L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 101 AFLDLSYNNLSGPVPSF 117
L L S +
Sbjct: 429 EQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 1e-06
Identities = 14/85 (16%), Positives = 30/85 (35%), Gaps = 9/85 (10%)
Query: 24 NLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS-----HLE 74
+ L+++ L + ++S + + L LDLSNN +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 75 TLQYLRLNNNSLTGAIPPSLSNMSQ 99
L+ L L + + + L + +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 2e-05
Identities = 13/75 (17%), Positives = 31/75 (41%), Gaps = 11/75 (14%)
Query: 18 LSSSIGNLTNLQLVLLQNNNISGHIPTEIGK-----LSKLLTLDLSNNFFTGPIPSTVSH 72
L++++ +L+ + L NN + ++ + L L L + +++ +
Sbjct: 389 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME----- 443
Query: 73 LETLQYLRLNNNSLT 87
+ LQ L + SL
Sbjct: 444 -DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 4e-05
Identities = 16/84 (19%), Positives = 28/84 (33%), Gaps = 10/84 (11%)
Query: 11 SQNLSGT-LSSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGP 65
+ LS + + L Q+V L + ++ I + + L L+L +N
Sbjct: 11 CEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDV 70
Query: 66 IPSTVSHL-----ETLQYLRLNNN 84
V +Q L L N
Sbjct: 71 GVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.9 bits (121), Expect = 1e-08
Identities = 24/97 (24%), Positives = 36/97 (37%), Gaps = 4/97 (4%)
Query: 17 TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 76
T+ + L + + L +N + P + L L L S+N L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLP--RL 67
Query: 77 QYLRLNNNSLTG-AIPPSLSNMSQLAFLDLSYNNLSG 112
Q L L NN L A L + +L L+L N+L
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 2e-04
Identities = 16/84 (19%), Positives = 27/84 (32%), Gaps = 2/84 (2%)
Query: 77 QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAE 136
+ L L + LT + L + + LDLS+N L P+ A + A
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 137 EDCFGTAPMPLSFALNNSPNSKPS 160
+ + NN +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAA 82
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 9e-04
Identities = 18/79 (22%), Positives = 33/79 (41%), Gaps = 6/79 (7%)
Query: 54 TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN---L 110
L L++ T + + L + +L L++N L +PP+L+ + L L S N +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV 58
Query: 111 SGPVPSFHAKTFNITGNSL 129
G + + N L
Sbjct: 59 DGVANLPRLQELLLCNNRL 77
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 4e-08
Identities = 21/80 (26%), Positives = 29/80 (36%), Gaps = 8/80 (10%)
Query: 33 LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 92
N S I + L L++SNN +P+ LE L + N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPE 321
Query: 93 SLSNMSQLAFLDLSYNNLSG 112
N L L + YN L
Sbjct: 322 LPQN---LKQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 7e-08
Identities = 15/77 (19%), Positives = 29/77 (37%), Gaps = 9/77 (11%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
+L+ + + NN + +P +L + L S N +P + L+ L +
Sbjct: 282 LPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLAE-VP---ELPQNLKQLHVEY 333
Query: 84 NSLTGAIPPSLSNMSQL 100
N L P ++ L
Sbjct: 334 NPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 2e-06
Identities = 15/73 (20%), Positives = 26/73 (35%), Gaps = 11/73 (15%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 70
S N L + L L N+++ +P L L + N P
Sbjct: 292 SNNKLIELPALPPRLERLI---ASFNHLA-EVPELPQNLK---QLHVEYNPLRE-FP--- 340
Query: 71 SHLETLQYLRLNN 83
E+++ LR+N+
Sbjct: 341 DIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.003
Identities = 16/69 (23%), Positives = 28/69 (40%), Gaps = 5/69 (7%)
Query: 50 SKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN 109
+ L+L+N + +P HL + L + NSLT +P ++ L + +
Sbjct: 38 RQAHELELNNLGLSS-LPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 110 LSGPVPSFH 118
LS P
Sbjct: 93 LSDLPPLLE 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 1e-07
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 4/96 (4%)
Query: 13 NLSGT--LSSSIGNLTNLQLVLLQ-NNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPS 68
+L+G G L + ++ + + E ++ +DLSN+ +
Sbjct: 6 DLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHG 65
Query: 69 TVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLD 104
+S LQ L L L+ I +L+ S L L+
Sbjct: 66 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 21/93 (22%), Positives = 35/93 (37%), Gaps = 4/93 (4%)
Query: 5 CYRGAPSQNLSGTLSSSIGNLTNLQ-LVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT 63
+ S L L LQ L L + +I E+G++ L TL +
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238
Query: 64 GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSN 96
G + E L +L++N + T P++ N
Sbjct: 239 GTLQLL---KEALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 4e-04
Identities = 9/59 (15%), Positives = 21/59 (35%), Gaps = 2/59 (3%)
Query: 54 TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 112
TLDL+ + + + R + + + S ++ +DLS + +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEV 60
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (85), Expect = 0.003
Identities = 14/70 (20%), Positives = 28/70 (40%), Gaps = 1/70 (1%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTGPIPST 69
++ + + +Q + L N+ I + + + SKL L L + PI +T
Sbjct: 31 PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90
Query: 70 VSHLETLQYL 79
++ L L
Sbjct: 91 LAKNSNLVRL 100
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 1e-07
Identities = 17/105 (16%), Positives = 38/105 (36%), Gaps = 12/105 (11%)
Query: 33 LQNNNISGHIPTEIGK------LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 86
L + I+ +PT I + ++ + +L T + T + L ++ + NN+ +
Sbjct: 3 LGSETIT--VPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDI 58
Query: 87 TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLIC 131
+ + + L L+ N L+ P + K
Sbjct: 59 KSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENK 101
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 2e-05
Identities = 13/85 (15%), Positives = 31/85 (36%), Gaps = 10/85 (11%)
Query: 10 PSQNLSGTLSSSIG------NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT 63
P + + T+ + I L+ +++ + +L+ + + +N+
Sbjct: 2 PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 59
Query: 64 GPIPSTVSHLETLQYLRLNNNSLTG 88
+ +L + L LN N LT
Sbjct: 60 SVQG--IQYLPNVTKLFLNGNKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.5 bits (83), Expect = 0.004
Identities = 12/40 (30%), Positives = 18/40 (45%), Gaps = 2/40 (5%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN 59
+ LT LQ + L N+IS + L L L+L +
Sbjct: 172 VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 5e-07
Identities = 16/62 (25%), Positives = 28/62 (45%), Gaps = 4/62 (6%)
Query: 22 IGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81
+ NL+ L + +N IS P + L L+ + L NN + P +++ L + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 82 NN 83
N
Sbjct: 225 TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 3e-06
Identities = 19/61 (31%), Positives = 30/61 (49%), Gaps = 4/61 (6%)
Query: 46 IGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDL 105
+ LSKL TL +N + P ++ L L + L NN ++ P L+N S L + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 106 S 106
+
Sbjct: 225 T 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 3e-05
Identities = 15/40 (37%), Positives = 21/40 (52%), Gaps = 2/40 (5%)
Query: 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN 59
S + +L NL V L+NN IS P + S L + L+N
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 5e-05
Identities = 13/77 (16%), Positives = 28/77 (36%), Gaps = 6/77 (7%)
Query: 34 QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS 93
Q I+ P L+ + + + T + T + L+ + L +T
Sbjct: 5 QPTAINVIFPDP--ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EG 58
Query: 94 LSNMSQLAFLDLSYNNL 110
+ ++ L L+L N +
Sbjct: 59 VQYLNNLIGLELKDNQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 13/63 (20%), Positives = 22/63 (34%), Gaps = 4/63 (6%)
Query: 24 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 83
L N + +N++ + L + TL T V +L L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 84 NSL 86
N +
Sbjct: 73 NQI 75
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 5e-07
Identities = 13/65 (20%), Positives = 26/65 (40%), Gaps = 3/65 (4%)
Query: 45 EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLD 104
E+ K++ L ++ T +P + + L L+ N L +L ++L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 105 LSYNN 109
L
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 3e-05
Identities = 14/53 (26%), Positives = 19/53 (35%), Gaps = 1/53 (1%)
Query: 34 QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 86
NNN++ + L L TL L N IP L + L+ N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 5e-04
Identities = 15/62 (24%), Positives = 23/62 (37%), Gaps = 1/62 (1%)
Query: 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNN 60
L + NL+ + + L NL +LLQ N++ IP L L N
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
Query: 61 FF 62
+
Sbjct: 206 PW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 8/52 (15%), Positives = 19/52 (36%), Gaps = 3/52 (5%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFF 62
+NL+ L + + ++ L N + + ++L L+L
Sbjct: 19 KRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.0 bits (84), Expect = 0.004
Identities = 14/57 (24%), Positives = 22/57 (38%), Gaps = 3/57 (5%)
Query: 69 TVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNIT 125
VS + + + + +LT A+PP L L LS N L + +T
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLT 58
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.3 bits (108), Expect = 2e-06
Identities = 20/106 (18%), Positives = 38/106 (35%), Gaps = 4/106 (3%)
Query: 5 CYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG 64
+ + L L+ + L +N IS +P L+ L +L+L++N F
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 65 PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 110
E L+ LN + P + ++ DL ++
Sbjct: 141 -NCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQ---IKDLPHSEF 182
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (104), Expect = 5e-06
Identities = 22/103 (21%), Positives = 36/103 (34%), Gaps = 9/103 (8%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGH--IPTEIGKLSKLLTLDLSNNFFTGPIPS 68
+++ TL N+ L + L NN + + + + K L L+LS N
Sbjct: 50 RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSEREL 109
Query: 69 TVSHLETLQYLRLNNNSLTGAIPPS-------LSNMSQLAFLD 104
L+ L L+ NSL+ +L LD
Sbjct: 110 DKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 1e-04
Identities = 24/101 (23%), Positives = 41/101 (40%), Gaps = 4/101 (3%)
Query: 20 SSIGNLTNLQL--VLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG--PIPSTVSHLET 75
S +L + VL + ++++ + + +LL+L+LSNN + S V
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPN 92
Query: 76 LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116
L+ L L+ N L +L L L N+LS
Sbjct: 93 LKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 1e-05
Identities = 19/93 (20%), Positives = 33/93 (35%), Gaps = 3/93 (3%)
Query: 19 SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 78
++ N + + L+ I I L + +D S+N L L+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67
Query: 79 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
L +NNN + + L L L+ N+L
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.1 bits (82), Expect = 0.004
Identities = 10/58 (17%), Positives = 20/58 (34%), Gaps = 7/58 (12%)
Query: 53 LTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 110
LT +L + ++ + L L + I + + Q +D S N +
Sbjct: 3 LTAELIEQ------AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (103), Expect = 1e-05
Identities = 11/60 (18%), Positives = 22/60 (36%), Gaps = 4/60 (6%)
Query: 34 QNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 92
+NN +P ++ S + LD+S + +L+ L+ N +P
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.002
Identities = 8/54 (14%), Positives = 13/54 (24%), Gaps = 2/54 (3%)
Query: 58 SNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111
NN L ++ + L N+ +L NL
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (83), Expect = 0.004
Identities = 5/40 (12%), Positives = 10/40 (25%)
Query: 21 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNN 60
+ ++ + I + L KL N
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 5e-05
Identities = 11/79 (13%), Positives = 30/79 (37%), Gaps = 6/79 (7%)
Query: 34 QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS 93
Q+ I+ L++ + L T + + + L+ + L+ + +
Sbjct: 4 QDTPINQIFTDT--ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DG 57
Query: 94 LSNMSQLAFLDLSYNNLSG 112
+ ++ L ++ S N L+
Sbjct: 58 VEYLNNLTQINFSNNQLTD 76
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 1e-04
Identities = 18/111 (16%), Positives = 34/111 (30%), Gaps = 6/111 (5%)
Query: 26 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 84
+ + + L L + N + L L+ L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 85 SLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP----SFHAKTFNITGNSLIC 131
L P + +L+ L+LS+N L + ++GN L C
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 4e-04
Identities = 21/133 (15%), Positives = 40/133 (30%), Gaps = 8/133 (6%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPST 69
+++ + + NL + ++N H+ L +L L + + P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 70 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTF------N 123
L L L+ N+L ++ L L LS N L + +
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGG 134
Query: 124 ITGNSLICATGAE 136
+ L C
Sbjct: 135 VPEQKLQCHGQGP 147
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 8e-04
Identities = 8/65 (12%), Positives = 25/65 (38%), Gaps = 4/65 (6%)
Query: 50 SKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDL 105
K L LD + + + ++++ + L+ N++ + ++++ L +
Sbjct: 7 GKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 106 SYNNL 110
S
Sbjct: 67 SDIFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.001
Identities = 11/80 (13%), Positives = 24/80 (30%), Gaps = 4/80 (5%)
Query: 11 SQNLSGTLSSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGPI 66
+ ++ + + +++ ++L N I + I L + S+ F
Sbjct: 16 TTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVK 75
Query: 67 PSTVSHLETLQYLRLNNNSL 86
L L L L
Sbjct: 76 DEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.002
Identities = 14/45 (31%), Positives = 18/45 (40%), Gaps = 5/45 (11%)
Query: 72 HLETLQYLRLNNNSLTGAIPPSL-----SNMSQLAFLDLSYNNLS 111
LQ LRL N + +L M L FL+L+ N S
Sbjct: 271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 552 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.69 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.68 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.65 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.63 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.59 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.55 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.53 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.53 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.47 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.47 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.42 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.4 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.36 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.36 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.32 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.27 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.26 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.22 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.19 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.15 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.13 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.01 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.85 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.75 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.53 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.52 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.47 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.44 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.43 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.4 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.28 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.06 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.99 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.99 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.95 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.78 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.43 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.33 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.26 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.57 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.54 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.83 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=418.89 Aligned_cols=253 Identities=27% Similarity=0.425 Sum_probs=200.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
++|++.+.||+|+||+||+|++.+++.||||+++... ....+|.+|++++++++|||||+++|+|...+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 4678889999999999999999888999999997543 23457999999999999999999999999999999999999
Q ss_pred cCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 310 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 310 ~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
++|+|.+++... ..+++..+..|+.|||+||.|||++ +|+||||||+|||+++++.+||+|||+++..........
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999988644 5789999999999999999999999 999999999999999999999999999987755444444
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
....||+.|+|||++.+..++.++|||||||++|||+|+..|+..... ........... .....
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~i~~~----------~~~~~ 223 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTG----------FRLYK 223 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHHHHHT----------CCCCC
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHHHHHHhc----------CCCCC
Confidence 456689999999999999999999999999999999996555442211 11112221111 11112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
+..+++++.+++.+||+.||++||||+||+++|++
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 23345789999999999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=419.27 Aligned_cols=252 Identities=22% Similarity=0.325 Sum_probs=205.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|++.+.||+|+||+||+|+.+ +|+.||||+++.....+....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46888999999999999999975 68999999997654444445689999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC-ce
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 387 (552)
+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+....... ..
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 99999999999888899999999999999999999999 999999999999999999999999999987653322 22
Q ss_pred eecccccccccCchhhccCCC-CCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 388 TTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....||+.|+|||++.+..+ +.++|||||||++|||+||+.||....... ..+ ....... ...
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----~~~-~~~~~~~---------~~~ 226 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEY-SDWKEKK---------TYL 226 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-----HHH-HHHHTTC---------TTS
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-----HHH-HHHhcCC---------CCC
Confidence 345679999999999988876 678999999999999999999997533211 111 1111100 000
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
......+.++.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111223467889999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-54 Score=423.85 Aligned_cols=257 Identities=26% Similarity=0.387 Sum_probs=215.6
Q ss_pred HHhcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 227 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 227 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
...++|++.+.||+|+||+||+|.++ +++.||||+++... ...++|.+|++++++++|||||+++|+|.+.+..++|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 34567888899999999999999976 58899999997543 2355799999999999999999999999999999999
Q ss_pred EeeccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 306 YPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
|||+++|+|.+++.. ...+++..+..|+.|||+||.|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999999864 35799999999999999999999999 9999999999999999999999999999877655
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
.........|++.|+|||++.+..++.++|||||||++|||+||..|+...... ..... .+...
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~----------~i~~~ 232 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYE----------LLEKD 232 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHH----------HHHTT
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH------HHHHH----------HHhcC
Confidence 444455556899999999999999999999999999999999987777543221 11111 11112
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.....+...++++.+|+.+||+.||++|||+.||++.|+..
T Consensus 233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22233344557899999999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=419.90 Aligned_cols=253 Identities=29% Similarity=0.444 Sum_probs=209.0
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.++|++.+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+.++++++|||||+++|++.. +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 45788889999999999999999988999999997543 234579999999999999999999998754 567899999
Q ss_pred ccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++|+|.+++... ..+++..+..|+.|||+||.|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999999977633 3699999999999999999999999 9999999999999999999999999999987654444
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......||+.|+|||++.++.++.++|||||||++|||+||..|+...... .+....+... ...
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~------~~~~~~i~~~----------~~~ 229 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERG----------YRM 229 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTT----------CCC
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhc----------CCC
Confidence 445567899999999999999999999999999999999976665432211 1111111111 111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
..+...++++.+++.+||+.||++||||+||++.|++
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1223345779999999999999999999999999885
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=408.53 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=214.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
++|+..+.||+|+||+||+|++++++.||||+++.... ...+|.+|+.++++++||||++++|+|.+.+..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 67899999999999999999999888999999976433 3457999999999999999999999999999999999999
Q ss_pred cCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 310 SNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 310 ~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
++|+|..++. ....+++..+.+++.|+|+||.|||++ +|+||||||+|||+++++.+||+|||+++..........
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 9999999865 445799999999999999999999999 999999999999999999999999999987765444444
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCc
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 467 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (552)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +....+... ....
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-------~~~~~i~~~----------~~~~ 221 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQG----------LRLY 221 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHHHTT----------CCCC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-------HHHHHHHhC----------CCCC
Confidence 45679999999999999999999999999999999998 78888643221 111111111 1112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 468 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 468 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.+...++++.+++.+||+.||++|||++|++++|.+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 233344789999999999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-54 Score=421.59 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=199.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC-C---cEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD-G---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 305 (552)
++|++.++||+|+||+||+|.++. + ..||||.+.........+.|.+|+.++++++|||||+++|++...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 345567899999999999999752 2 368999987655544556799999999999999999999999999999999
Q ss_pred EeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 384 (552)
|||+++|+|.+++.. .+.+++.++..|+.|||+||.|||++ +|+||||||+|||++.++++||+|||+++.+....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 999999999998875 45799999999999999999999999 99999999999999999999999999998765432
Q ss_pred Cce----eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 385 SHV----TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 385 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||..... .+.+..+...
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-------~~~~~~i~~~------ 249 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-------QDVINAIEQD------ 249 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTT------
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcC------
Confidence 221 122457899999999999999999999999999999998 8999864321 1112222111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.....+...+..+.+++.+||+.||++|||+.||++.|+.
T Consensus 250 ----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 250 ----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1112233445789999999999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-54 Score=415.82 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=202.2
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|.+.+.||+|+||+||+|+++ ..||||+++.... ......|.+|+.++++++|||||+++|++.. +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467899999999999999999875 3599999975432 3345679999999999999999999998754 56899999
Q ss_pred eccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC-
Q 008828 308 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS- 385 (552)
Q Consensus 308 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 385 (552)
|+++|+|.+++.. ...+++..+..|+.|||+||+|||++ +||||||||+|||++.++.+||+|||+++.......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9999999999964 45799999999999999999999999 999999999999999999999999999987654322
Q ss_pred ceeecccccccccCchhhcc---CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 386 HVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.......||+.|+|||++.+ ..|+.++|||||||++|||+||+.||...... ..+....... ...+
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~----~~~p 229 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIFMVGRG----YLSP 229 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHHT----SCCC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcC----CCCC
Confidence 23345679999999999964 35899999999999999999999999743221 1111111111 0111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.+ ...+..+++++.+++.+||+.||++|||++||+++|+.
T Consensus 230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 11223345789999999999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=409.07 Aligned_cols=247 Identities=28% Similarity=0.407 Sum_probs=208.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||+||+|+.+ +++.||+|+++... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999975 68999999986432 2233557889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 9999999999998878899999999999999999999999 9999999999999999999999999999866432
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ........... .
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~-----------~ 221 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVE-----------F 221 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTC-----------C
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC-----------C
Confidence 23445799999999999999999999999999999999999999964321 11111111110 1
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.++...++++.+++.+||+.||++|||++|++++
T Consensus 222 ~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1223345788999999999999999999999863
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-53 Score=410.93 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=202.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCC-----cEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
+.|+..++||+|+||+||+|.+++. ..||||+++.........+|.+|+.++++++|||||+++|++......++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577788999999999999997532 47999999765544455679999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
||||+.+|++.+.+.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999999988764 46799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc--eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 384 DSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 384 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
... ......||+.|+|||++.+..++.++|||||||++|||+||..|+...... ......+.
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------~~~~~~i~---------- 227 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAIN---------- 227 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHH----------
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH------HHHHHHHh----------
Confidence 322 223456899999999999999999999999999999999977776543221 11111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.......+...+..+.+|+.+||+.||++||||.||++.|+.
T Consensus 228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 112222333455789999999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=408.24 Aligned_cols=250 Identities=19% Similarity=0.275 Sum_probs=208.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|++.+.||+|+||+||+|... +|+.||||+++.... ...+.+.+|+.++++++|||||++++++...+..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 46999999999999999999964 699999999975433 2345789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+++|+|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++.+.... ...
T Consensus 99 ~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 173 (293)
T d1yhwa1 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (293)
T ss_dssp CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred cCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence 9999999988764 699999999999999999999999 99999999999999999999999999999775433 233
Q ss_pred ecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 389 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ..+........ .....
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~~~--------~~~~~ 238 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGT--------PELQN 238 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCS--------CCCSS
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCCC--------CCCCC
Confidence 4556999999999999999999999999999999999999999643211 11111111110 00111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+...+.++.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22334779999999999999999999999754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=410.50 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=207.2
Q ss_pred CCCCCCe-eeeeCceEEEEEEEC---CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 231 NFSSKNL-VGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 231 ~~~~~~~-iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
+|.+.+. ||+|+||+||+|.++ ++..||||+++.........+|.+|++++++++|||||+++|++.. +..++||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 4555564 999999999999864 3557999999766544556679999999999999999999999865 5688999
Q ss_pred eeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+++|+|.+++.. ...+++..+..++.|||.||.|||++ +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 99999999998764 46799999999999999999999999 999999999999999999999999999998765433
Q ss_pred ce--eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 386 HV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 386 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.. .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +....+...
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------~~~~~i~~~--------- 228 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQG--------- 228 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTT---------
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcC---------
Confidence 22 234458999999999999999999999999999999998 89999743221 111112111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.....+...+.++.+|+.+||+.||++||||.+|.+.|+.
T Consensus 229 -~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 229 -KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1112233445789999999999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-53 Score=418.16 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=206.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECC-C-----cEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCc
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQD-G-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~ 301 (552)
.++|++.+.||+|+||+||+|++.. + ..||+|.+...........+.+|+.++.++ +|||||+++|++...+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3678889999999999999999642 2 369999997655444556789999999988 89999999999999999
Q ss_pred eeEEEeeccCCChhhhhccC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCC
Q 008828 302 RLLVYPYMSNGSVASRLKAK-----------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKA 358 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~-----------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~ 358 (552)
.++||||+++|+|.++++.. ..+++..++.|+.||++||+|||++ +|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 99999999999999999643 2489999999999999999999999 999999999
Q ss_pred CceeeCCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcc
Q 008828 359 ANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKT 436 (552)
Q Consensus 359 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~ 436 (552)
+|||++.++.+||+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543332 3344568999999999999999999999999999999998 8999864322
Q ss_pred cccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 008828 437 ANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 502 (552)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 502 (552)
.. .+. .. +........+...++++.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~~---~~~----~~---------~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DA---NFY----KL---------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SH---HHH----HH---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH---HHH----HH---------HhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 10 111 11 1111122233344578999999999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=409.34 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=194.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeec--CCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~~lv 305 (552)
++|++.+.||+|+||+||+|+.+ +|+.||||.++.....+ ....+.+|++++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56888999999999999999975 68999999997654322 34468899999999999999999999865 3557899
Q ss_pred EeeccCCChhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 306 YPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQC--DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 306 ~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
|||+++|+|.+++. ....+++..++.++.||+.||.|||++. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999885 3567999999999999999999999871 12499999999999999999999999999987
Q ss_pred cCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
+.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+....+.. ...
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~~~~~~i~~-~~~--- 231 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIRE-GKF--- 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHH-TCC---
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------HHHHHHHHc-CCC---
Confidence 65432 233456799999999999999999999999999999999999999964321 111111111 111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...+...++++.+++.+||+.||++|||+.|++++
T Consensus 232 ------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11222334679999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=421.58 Aligned_cols=266 Identities=21% Similarity=0.274 Sum_probs=208.7
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++.........++.+|+.++++++|||||++++++.+..+.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467899999999999999999975 6899999999765544555679999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
|+++|+|.+++...+.+++..+..++.|++.||.|||+ + +|+||||||+|||++.++++||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 99999999999887789999999999999999999997 5 8999999999999999999999999999865421
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHH------------------
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK------------------ 448 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~------------------ 448 (552)
......||+.|+|||++.+..|+.++||||+||++|||+||+.||.................
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 22345799999999999999999999999999999999999999975432111000000000
Q ss_pred HH----hhhcc----hhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 449 KI----HQEKK----LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 449 ~~----~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.. ..... ...+.............+.++.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00 00000 000000000000011124678999999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=405.34 Aligned_cols=247 Identities=27% Similarity=0.348 Sum_probs=201.2
Q ss_pred CeeeeeCceEEEEEEECC---CcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeeccC
Q 008828 236 NLVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 311 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 311 (552)
+.||+|+||+||+|.+++ ++.||||+++..... ....+|.+|+.++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 468999999754332 234579999999999999999999999865 467899999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee--e
Q 008828 312 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--T 389 (552)
Q Consensus 312 g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~ 389 (552)
|+|.+++.....+++..+..|+.|||.||.|||++ +|+||||||+|||++.++.+||+|||+++.+........ .
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999999888999999999999999999999999 999999999999999999999999999997754433322 3
Q ss_pred cccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccccccCcC
Q 008828 390 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 468 (552)
Q Consensus 390 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (552)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... .+....+... .....
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~~~~~~i~~~----------~~~~~ 231 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKG----------ERMGC 231 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTT----------CCCCC
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------HHHHHHHHcC----------CCCCC
Confidence 3568999999999999999999999999999999998 8999874321 1111111111 11223
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 469 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 469 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
+..++.++.+|+.+||+.||++|||+.+|.+.|+.
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 33445789999999999999999999999998875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=408.31 Aligned_cols=253 Identities=28% Similarity=0.392 Sum_probs=203.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
.++|++.+.||+|+||+||+|++++++.||||+++.... ..+.|.+|+.++++++|||||+++|++. .+..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 457889999999999999999998888999999975432 3467999999999999999999999985 4568899999
Q ss_pred ccCCChhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++|+|..++.. ...++|..+..|+.|||.||+|||++ +|+||||||+|||+++++++||+|||+++........
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999988863 35699999999999999999999999 9999999999999999999999999999877544444
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
......||+.|+|||++..+.++.++|||||||++|||+||..|+...... .+.+..+... ...
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~~~~~~i~~~----------~~~ 233 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERG----------YRM 233 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTT----------CCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------HHHHHHHHhc----------CCC
Confidence 445566999999999999999999999999999999999987776543221 1112221111 112
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
..+...++++.+++.+||+.||++|||+++|+++|+.
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 2333445789999999999999999999999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=401.75 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=198.1
Q ss_pred CCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeec----CCceeEEE
Q 008828 233 SSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTERLLVY 306 (552)
Q Consensus 233 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~~lv~ 306 (552)
...+.||+|+||+||+|... +++.||+|.+...... .....|.+|++++++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999975 6889999999754332 234568999999999999999999999864 34578999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC-CCCceEEcccccceecCCCCC
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
||+++|+|.+++.....+++..+..++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 167 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC---
Confidence 9999999999998888899999999999999999999998 12299999999999997 578999999999986443
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.......||+.|+|||++.+ .++.++|||||||++|||+||+.||...... ......+..... ..
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~-----~~--- 232 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVK-----PA--- 232 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCC-----CG---
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCC-----Cc---
Confidence 22345679999999999865 6999999999999999999999999642211 111111111100 01
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.++...++++.+++.+||+.||++|||++|++++
T Consensus 233 -~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 -SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1112223568999999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-52 Score=412.34 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=193.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+.|++.+.||+|+||+||+|..+ +++.||||++...........+.+|+.+++.++|||||++++++.+.+..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56888999999999999999975 68999999997655444455688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC---CCCceEEcccccceecCCCCC
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||+. +++.+||+|||+++......
T Consensus 89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~- 164 (307)
T d1a06a_ 89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS- 164 (307)
T ss_dssp CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence 99999999999888999999999999999999999999 999999999999995 57899999999998665322
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......||+.|+|||++.+..|+.++|||||||++|||+||+.||...... .....+.... ....
T Consensus 165 -~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~-------~~~~ 229 (307)
T d1a06a_ 165 -VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------KLFEQILKAE-------YEFD 229 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHTTC-------CCCC
T ss_pred -eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHhccC-------CCCC
Confidence 234466999999999999999999999999999999999999999743221 1111111110 0111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.......++++.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11222344778999999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=406.22 Aligned_cols=251 Identities=20% Similarity=0.265 Sum_probs=204.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
+.|++.+.||+|+||+||+|+.. +++.||||+++... ......+.+|++++++++|||||++++++.+.+..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 35788899999999999999975 68999999997543 33445788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 309 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 309 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999999998764 56799999999999999999999999 99999999999999999999999999997653211 12
Q ss_pred eecccccccccCchhhc-----cCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 388 TTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.....||+.|+|||++. ...|+.++|||||||++|||+||+.||....... . +........ +
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----~---~~~i~~~~~------~ 233 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----V---LLKIAKSEP------P 233 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----H---HHHHHHSCC------C
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH----H---HHHHHcCCC------C
Confidence 23456999999999984 4568999999999999999999999997533211 1 111111110 0
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
....+...++++.+++.+||+.||++|||+.|++++
T Consensus 234 --~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 234 --TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011122345789999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=407.94 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=206.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||+||+|... +|+.||||+++... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46889999999999999999975 68999999996432 2233457899999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC-
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS- 385 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 385 (552)
||+++|+|.+++...+.+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999999888899999999999999999999999 999999999999999999999999999998754332
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+... .
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~---------~-- 226 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQKIIKL---------E-- 226 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTT---------C--
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-------HHHHHHHHcC---------C--
Confidence 233456799999999999999999999999999999999999999974321 1111111111 0
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 499 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 499 (552)
..++...++++.+|+.+||+.||++|||++|++.
T Consensus 227 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1122233477899999999999999999999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-52 Score=408.72 Aligned_cols=247 Identities=28% Similarity=0.356 Sum_probs=204.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
+.|+..+.||+|+||+||+|+.. +++.||||+++...... ....+.+|+.++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34788899999999999999964 68899999997554332 2346889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
|||.+|+|..++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 9999999988887778899999999999999999999999 999999999999999999999999999986543
Q ss_pred eeecccccccccCchhhcc---CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccc
Q 008828 387 VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 463 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (552)
.....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||..... ...+....... .+.
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~~~~i~~~~------~~~ 233 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNE------SPA 233 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSC------CCC
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCC------CCC
Confidence 233569999999999864 4689999999999999999999999964321 11111111111 011
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 464 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 464 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+ .+...++.+.+++.+||+.||++|||+.|++++
T Consensus 234 ~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 234 L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp C---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1 112234679999999999999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.8e-52 Score=407.09 Aligned_cols=260 Identities=25% Similarity=0.379 Sum_probs=211.4
Q ss_pred HHHHhcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeec
Q 008828 225 LQSATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 298 (552)
Q Consensus 225 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 298 (552)
++...++|++.+.||+|+||+||+|+++ +++.||||+++.........+|.+|+.++++++||||+++++++..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3445578999999999999999999864 3578999999765544455679999999999999999999999999
Q ss_pred CCceeEEEeeccCCChhhhhccC------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEc
Q 008828 299 TTERLLVYPYMSNGSVASRLKAK------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 354 (552)
Q Consensus 299 ~~~~~lv~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 354 (552)
....+++|||+++|+|.+++... ..+++..+..|+.|+|.||+|||++ +||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence 99999999999999999998532 2489999999999999999999999 99999
Q ss_pred CCCCCceeeCCCCceEEcccccceecCCCCC-ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCC-ccc
Q 008828 355 DVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR-ALE 432 (552)
Q Consensus 355 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~-p~~ 432 (552)
||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|.. ||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999999986643322 23344568899999999999999999999999999999999964 554
Q ss_pred cCcccccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 433 FGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.... .+....+... . ....+...+.++.+|+.+||+.||++||||.||+++|+..
T Consensus 245 ~~~~-------~e~~~~v~~~-~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 245 GMAH-------EEVIYYVRDG-N---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TSCH-------HHHHHHHHTT-C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCH-------HHHHHHHHcC-C---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 3211 1111111111 1 1122333446799999999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-52 Score=401.53 Aligned_cols=254 Identities=23% Similarity=0.364 Sum_probs=197.7
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECC----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
.++|++.+.||+|+||+||+|++.. +..||||.++..........|.+|+.++++++||||++++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578888999999999999998642 45789999876554444567999999999999999999999986 467899
Q ss_pred EEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
||||+++|+|.+++.. ...+++..+..++.||++||.|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 9999999999998764 45799999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
.........||+.|+|||.+.+..++.++|||||||++|||+| |.+||...... .+.. .+....
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~----~~~~---~i~~~~-------- 226 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIG---RIENGE-------- 226 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHH---HHHTTC--------
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH----HHHH---HHHcCC--------
Confidence 4444555668999999999999999999999999999999998 88888643321 1111 111111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....+...++.+.+|+.+||+.||++|||+.||+++|+.
T Consensus 227 --~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 227 --RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 112233445789999999999999999999999999985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=394.10 Aligned_cols=252 Identities=20% Similarity=0.261 Sum_probs=207.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-----chHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
++|++.+.||+|+||+||+|+.+ +|+.||||+++..... ...+.+.+|+.++++++|||||++++++.+....+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56889999999999999999975 6899999999643221 23457999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC----ceEEccccccee
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAKL 379 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~~~~ 379 (552)
+||||+++|+|.+++...+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999998878899999999999999999999999 999999999999999776 499999999987
Q ss_pred cCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+....+....
T Consensus 167 ~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~----- 232 (293)
T d1jksa_ 167 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANVSAVN----- 232 (293)
T ss_dssp CTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTC-----
T ss_pred cCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcC-----
Confidence 75432 23445699999999999999999999999999999999999999974321 11111111110
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
...........+..+.+++.+||+.||++|||++|++++
T Consensus 233 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 --YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp --CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000111234678999999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.3e-51 Score=406.36 Aligned_cols=251 Identities=20% Similarity=0.270 Sum_probs=207.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 47889999999999999999975 689999999965432 3345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC--CCCceEEcccccceecCCCCC
Q 008828 309 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 309 ~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
+++|+|.+++. ....+++..+..|+.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 99999999985 455799999999999999999999999 999999999999996 4688999999999877643
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+.+..+..... ...
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~-------~~~ 245 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDW-------NMD 245 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCC-------CSC
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC-------CCC
Confidence 233456799999999999999999999999999999999999999964321 111222211110 001
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.......++++.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112234678999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=401.58 Aligned_cols=253 Identities=23% Similarity=0.394 Sum_probs=201.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCc----EEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 304 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 304 (552)
++|++.++||+|+||+||+|.+. +|+ .||+|.++........++|.+|+.++++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999965 343 68999987655555567899999999999999999999999864 5678
Q ss_pred EEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 305 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 305 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
++||+.+|+|.+.+.. ...+++..+..++.|||.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 8899999999988764 45799999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcc
Q 008828 384 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 461 (552)
Q Consensus 384 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (552)
... ......||+.|+|||++.++.++.++|||||||++|||+| |..||...... .+...+ .
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~----~~~~~i---~---------- 227 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSIL---E---------- 227 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG----GHHHHH---H----------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH----HHHHHH---H----------
Confidence 333 2334468999999999999999999999999999999999 67777643211 111111 1
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 462 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 462 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.......+..+++.+.+++.+||+.||++|||+.|++++|+.
T Consensus 228 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 111122233445789999999999999999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.7e-50 Score=403.31 Aligned_cols=251 Identities=21% Similarity=0.284 Sum_probs=208.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|+.++++++|||||++++++.+....++||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46889999999999999999974 699999999975432 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC--CCCceEEcccccceecCCCCC
Q 008828 309 MSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 309 ~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
+++|+|.+.+... ..+++..++.|+.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.+....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999999887654 4799999999999999999999999 999999999999998 67899999999999876432
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ...+..+.... ....
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~-------~~~~ 248 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKRCD-------WEFD 248 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHCC-------CCCC
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC-------CCCC
Confidence 33445699999999999999999999999999999999999999974322 11111111110 0111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.......+.++.+|+.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11222344778999999999999999999999885
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-51 Score=390.67 Aligned_cols=246 Identities=28% Similarity=0.395 Sum_probs=196.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC-CceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-TERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-~~~~lv~e~ 308 (552)
++|++.+.||+|+||.||+|.++ |+.||||+++... ..+.|.+|++++++++||||++++|+|.+. +..++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 45677889999999999999986 7899999997543 345789999999999999999999998654 567999999
Q ss_pred ccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 309 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 309 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
+++|+|.+++... ..+++..++.|+.|||.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999999643 3589999999999999999999999 9999999999999999999999999999865432
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.....+|..|+|||++.+..++.++|||||||++|||+| |+.|+...... .+..+ +. ....
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~----~~~~~---i~----------~~~~ 218 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPR---VE----------KGYK 218 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHH---HT----------TTCC
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH----HHHHH---HH----------cCCC
Confidence 223458899999999999999999999999999999999 67766532211 11111 11 1122
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
...+...++++.+++.+||+.||++||||.|++++|+.
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 23333445789999999999999999999999999976
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-50 Score=399.07 Aligned_cols=246 Identities=26% Similarity=0.341 Sum_probs=208.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||+||+|+.+ +|+.||||+++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999999999999975 68999999996432 2233557889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|..++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 9999999999999888999999999999999999999999 9999999999999999999999999999876532
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....||+.|+|||++.+..|+.++|||||||++|||+||+.||..... ......+... . .
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~---------~--~ 218 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNA---------E--L 218 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHC---------C--C
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------HHHHHHHHcC---------C--C
Confidence 2346799999999999999999999999999999999999999974322 1111111111 0 1
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 500 (552)
.++...++++.+++.+||+.||.+|| |++|++++
T Consensus 219 ~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 12223346789999999999999996 89999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=400.83 Aligned_cols=249 Identities=23% Similarity=0.253 Sum_probs=209.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||+||+|+.+ +|+.||||++++.. .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56888999999999999999974 79999999997532 2234567889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+++|+|.+++.....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~ 160 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC-c
Confidence 9999999999999888899999999999999999999999 99999999999999999999999999998664322 2
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....+||+.|+|||++.+..|+.++||||+||++|||+||+.||..... .......... . .
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-------~~~~~~i~~~---------~--~ 222 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILME---------E--I 222 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHC---------C--C
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-------HHHHHHHhcC---------C--C
Confidence 34456799999999999999999999999999999999999999975332 1111111111 0 1
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 500 (552)
.++...+.++.+|+.+||+.||++||+ +.|+++|
T Consensus 223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 123334567899999999999999995 7888764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=399.23 Aligned_cols=261 Identities=26% Similarity=0.362 Sum_probs=198.9
Q ss_pred HHHHHhcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEe
Q 008828 224 ELQSATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFC 296 (552)
Q Consensus 224 e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~ 296 (552)
+++...++|++.+.||+|+||+||+|.+. +++.||||+++..........+.+|...+.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 33344567899999999999999999863 24689999997655545556788888888776 689999999998
Q ss_pred ecC-CceeEEEeeccCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCC
Q 008828 297 MTT-TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAA 359 (552)
Q Consensus 297 ~~~-~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~ 359 (552)
... ...++||||+++|+|.++++.. ..+++..+..++.|||+||.|||++ +|+||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence 765 4678999999999999998632 3489999999999999999999999 9999999999
Q ss_pred ceeeCCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCC-ccccCccc
Q 008828 360 NILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR-ALEFGKTA 437 (552)
Q Consensus 360 Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~-p~~~~~~~ 437 (552)
|||+++++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||.. ||......
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876543332 2344569999999999999999999999999999999999754 55432211
Q ss_pred ccccchHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 438 NQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
........ .+ .....+...++++.+++.+||+.||++|||+.|++++|+.
T Consensus 244 ------~~~~~~~~-~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 244 ------EEFCRRLK-EG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp ------HHHHHHHH-HT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------HHHHHHHh-cC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 01111111 11 1112223344779999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=399.05 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=202.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC-Cc--EEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD-GT--VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 305 (552)
++|++.+.||+|+||+||+|++++ +. .||||+++........+.|.+|+++++++ +|||||+++|++...+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567888999999999999999753 44 57888886554444566799999999998 799999999999999999999
Q ss_pred EeeccCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCce
Q 008828 306 YPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 369 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 369 (552)
|||+++|+|.++++.. ..+++..+..++.|||.||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999998643 5799999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCc-cccCcccccccchHHHHH
Q 008828 370 VVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRA-LEFGKTANQKGAMLDWVK 448 (552)
Q Consensus 370 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p-~~~~~~~~~~~~~~~~~~ 448 (552)
||+|||+++...... ......||..|+|||.+....++.++|||||||++|||++|..| |..... .+...
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-------~~~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYE 237 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-------HHHHH
Confidence 999999998654221 22234589999999999999999999999999999999998654 532211 11111
Q ss_pred HHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 449 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
.+.. ......+...++++.+|+.+||+.||++||||+||+++|+..
T Consensus 238 ~i~~----------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 238 KLPQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HGGG----------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHh----------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111 111223334457899999999999999999999999998863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=390.41 Aligned_cols=254 Identities=28% Similarity=0.362 Sum_probs=196.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEECC----CcEEEEEEeccCcc--CchHHHHHHHHHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
++|++.+.||+|+||+||+|++.. ...||||+++.... ....++|.+|+.++++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568888999999999999998642 23789999875432 2234579999999999999999999999975 4678
Q ss_pred EEEeeccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 304 LVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
+||||+++|++.+.+.. ...+++..+..++.|||.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 99999999999988764 45699999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCce--eecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 383 CDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 383 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
..... .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||..... .+.+..+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-------~~~~~~i~~~------ 230 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKE------ 230 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTS------
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-------HHHHHHHHhC------
Confidence 43322 233458889999999999999999999999999999998 8999864221 1111111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
....+.+...+..+.+++.+||+.||++|||+.||.+.|++
T Consensus 231 ---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 231 ---GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ---CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11122233344779999999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=392.33 Aligned_cols=251 Identities=30% Similarity=0.437 Sum_probs=202.7
Q ss_pred CCeeeeeCceEEEEEEECC----CcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeec-CCceeEEEeec
Q 008828 235 KNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTERLLVYPYM 309 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~~lv~e~~ 309 (552)
.++||+|+||+||+|.+.+ ...||||+++.........+|.+|++++++++||||++++|++.. ....++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999999753 236899999765444455679999999999999999999999875 45789999999
Q ss_pred cCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc--
Q 008828 310 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-- 386 (552)
Q Consensus 310 ~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 386 (552)
++|+|.+++... ..+++..+..++.|+|+||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999988744 4678899999999999999999999 9999999999999999999999999999876543322
Q ss_pred -eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 387 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 387 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .++...+.....
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~------~~~~~~i~~g~~---------- 252 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR---------- 252 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCC----------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH------HHHHHHHHcCCC----------
Confidence 223346899999999999999999999999999999999988887643221 111111111111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
...+...++++.+++.+||+.||++||||.||+++|+..
T Consensus 253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112223347799999999999999999999999999763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=395.23 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=211.3
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecCCc
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 301 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~ 301 (552)
.++|++.+.||+|+||.||+|++. +++.||||+++..........|.+|+.+++.+ +|||||+++|+|.....
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 467888899999999999999852 46789999998665555566799999999998 69999999999999999
Q ss_pred eeEEEeeccCCChhhhhccCC------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee
Q 008828 302 RLLVYPYMSNGSVASRLKAKP------------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~------------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 363 (552)
.++||||+++|+|.++++... .+++..+..++.|||+||+|||++ +|+||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999986432 589999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA 442 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~ 442 (552)
+.++.+|++|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+|+..|+...... ...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~--~~~ 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--DSK 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--SHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 99999999999999977654333 334567999999999999999999999999999999999955554432211 111
Q ss_pred hHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 443 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
+.. ++........+...+.++.+|+.+||+.||++||||.||+++|++
T Consensus 257 ~~~-------------~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 257 FYK-------------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHH-------------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH-------------HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111 111112222233345789999999999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-49 Score=384.96 Aligned_cols=252 Identities=22% Similarity=0.263 Sum_probs=206.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--------hHHHHHHHHHHHhhcc-ccccceeeeEeecC
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--------GEIQFQTEVEMISLAV-HRNLLRLIGFCMTT 299 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~ 299 (552)
++|++.+.||+|+||+||+|+.. +|+.||||+++...... ....+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57889999999999999999974 68999999996543221 1235889999999997 99999999999999
Q ss_pred CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 300 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
+..++||||+++|+|.+++...+.+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999998888899999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCceeecccccccccCchhhcc------CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhh
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 453 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 453 (552)
..... ......||..|+|||.+.+ ..++.++||||+||++|||+||+.||...... .....+...
T Consensus 160 ~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------~~~~~i~~~ 230 (277)
T d1phka_ 160 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMIMSG 230 (277)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHT
T ss_pred ccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------HHHHHHHhC
Confidence 75432 2344669999999999864 34688999999999999999999999753221 111111111
Q ss_pred cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 454 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. . ..........++++.+++.+||+.||++|||++||+++
T Consensus 231 ~-~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 N-Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp C-C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred C-C------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 0 01111112344789999999999999999999999764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=391.57 Aligned_cols=255 Identities=29% Similarity=0.394 Sum_probs=203.8
Q ss_pred hcCCCCCCeeeeeCceEEEEEEECC--------CcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeecC
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 299 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~ 299 (552)
.++|.+.+.||+|+||.||+|+... +..||||+++..........+.+|...+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578888999999999999998532 3479999998765544556788899888888 799999999999999
Q ss_pred CceeEEEeeccCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceee
Q 008828 300 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 363 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 363 (552)
...++||||+++|+|.+++... ..+++..++.++.|||.||.|||+. +||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 9999999999999999999643 3589999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccccceecCCCCCc-eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHh-CCCccccCccccccc
Q 008828 364 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG 441 (552)
Q Consensus 364 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~ellt-g~~p~~~~~~~~~~~ 441 (552)
+.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||+| |..||.....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~----- 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-----
Confidence 99999999999999876543322 2344568999999999999999999999999999999998 6777753221
Q ss_pred chHHHHHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 442 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
......+.. ......+...++++.+|+.+||+.||++|||+.||++.|+.
T Consensus 244 --~~~~~~i~~----------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 244 --EELFKLLKE----------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp --HHHHHHHHT----------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHHHHc----------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 111111111 11122233344779999999999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.5e-49 Score=380.93 Aligned_cols=257 Identities=21% Similarity=0.255 Sum_probs=202.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc--hHHHHHHHHHHHhhccccccceeeeEeecCC----ce
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTT----ER 302 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----~~ 302 (552)
++|++.+.||+|+||+||+|... +|+.||||+++.....+ ....|.+|+.+++.++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 56889999999999999999964 79999999997654332 2346899999999999999999999987654 37
Q ss_pred eEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCC
Q 008828 303 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 382 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 382 (552)
++||||+++|+|.+++...+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++..+|+|||.+.....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcc
Confidence 89999999999999998888899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCC--ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhc
Q 008828 383 CDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 460 (552)
Q Consensus 383 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (552)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..............
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVREDPIP--- 233 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCCCCC---
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-------HHHHHHHHhcCCCC---
Confidence 222 233455699999999999999999999999999999999999999974322 11111111111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 008828 461 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRP-KMSEVVRMLEG 503 (552)
Q Consensus 461 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~ 503 (552)
........++++.+++.+||+.||++|| |++++++.|..
T Consensus 234 ----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 ----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0011122347789999999999999999 89999887764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-50 Score=393.68 Aligned_cols=260 Identities=22% Similarity=0.377 Sum_probs=211.4
Q ss_pred HHHHhcCCCCCCeeeeeCceEEEEEEEC------CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeec
Q 008828 225 LQSATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 298 (552)
Q Consensus 225 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 298 (552)
++...++|++.+.||+|+||+||+|.+. +++.||||+++..........|.+|+.++++++||||++++|++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3344567888899999999999999863 3578999999765544455579999999999999999999999999
Q ss_pred CCceeEEEeeccCCChhhhhcc----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCc
Q 008828 299 TTERLLVYPYMSNGSVASRLKA----------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 368 (552)
Q Consensus 299 ~~~~~lv~e~~~~g~L~~~l~~----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 368 (552)
....++||||+++|+|.+++.. ...+++..+..++.|+|+||.|||++ +|+||||||+|||++++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence 9999999999999999998852 13579999999999999999999999 9999999999999999999
Q ss_pred eEEcccccceecCCCCCce-eecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCC-CccccCcccccccchHHH
Q 008828 369 AVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL-RALEFGKTANQKGAMLDW 446 (552)
Q Consensus 369 ~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~-~p~~~~~~~~~~~~~~~~ 446 (552)
+||+|||+++......... .....||+.|+|||.+.+..++.++|||||||++|||+||+ .|+.... ...+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-------~~~~ 244 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQV 244 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------HHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-------HHHH
Confidence 9999999998764433222 23345899999999999999999999999999999999996 4553221 1122
Q ss_pred HHHHhhhcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 008828 447 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 504 (552)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 504 (552)
...+.... ....+...+..+.+++.+||+.+|++||||.||+++|+..
T Consensus 245 ~~~i~~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 245 LRFVMEGG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHhCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 22222111 1112233447899999999999999999999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-49 Score=395.68 Aligned_cols=246 Identities=21% Similarity=0.252 Sum_probs=207.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 306 (552)
++|++.+.||+|+||+||+|+.+ +|+.||||+++... .......+.+|+.+++.++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46889999999999999999975 69999999996432 2233456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 307 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 307 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
||+.+|+|..++...+.+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 9999999999998878899999999999999999999999 9999999999999999999999999999977532
Q ss_pred eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccccccC
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 466 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (552)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+.... .
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~-----------~ 255 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGK-----------V 255 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-----------C
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-------HHHHHHHhcCC-----------C
Confidence 2345699999999999999999999999999999999999999974321 11111111110 0
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008828 467 NYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM 500 (552)
Q Consensus 467 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 500 (552)
..+...+.++.+++.+||+.||.+|+ |++|+++|
T Consensus 256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 11223347789999999999999994 89998864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-49 Score=388.30 Aligned_cols=250 Identities=19% Similarity=0.239 Sum_probs=205.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|.+.+.||+|+||+||+|... +++.||||+++... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 57889999999999999999975 68899999997543 2344688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC--CCceEEcccccceecCCCCC
Q 008828 309 MSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--YYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 309 ~~~g~L~~~l~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~ 385 (552)
+++|+|.+++...+ .+++.++..|+.||+.||.|||++ +|+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 99999999998654 799999999999999999999999 9999999999999984 458999999999876533
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.......+|+.|+|||.+.+..++.++||||+||++|+|++|+.||...... +....+..... ..+....
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-------~~~~~i~~~~~---~~~~~~~ 227 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEY---TFDEEAF 227 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCC---CCCHHHH
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC---CCChhhc
Confidence 2334456899999999999999999999999999999999999999753321 11111111100 0011111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ..+.++.+++.+||+.||++|||+.|++++
T Consensus 228 ~----~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 228 K----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 124678999999999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.2e-49 Score=395.03 Aligned_cols=250 Identities=24% Similarity=0.295 Sum_probs=201.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCcc--CchHHHHHHH---HHHHhhccccccceeeeEeecCCcee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTE---VEMISLAVHRNLLRLIGFCMTTTERL 303 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e---~~~l~~~~h~niv~l~~~~~~~~~~~ 303 (552)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ......+.+| +.+++.++|||||++++++...+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57888999999999999999975 699999999854321 1122234444 66677778999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
+||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999999998888899999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc
Q 008828 384 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 462 (552)
Q Consensus 384 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (552)
. .....||+.|+|||++.. ..|+.++|||||||++|||+||+.||........ .. +... ....
T Consensus 161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~-~~~~--------~~~~ 224 (364)
T d1omwa3 161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HE-IDRM--------TLTM 224 (364)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH----HH-HHHH--------SSSC
T ss_pred c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH----HH-HHHh--------cccC
Confidence 2 234569999999999975 5689999999999999999999999975332111 11 1100 0000
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 008828 463 DLKNNYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRM 500 (552)
Q Consensus 463 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 500 (552)
....+...++++.+++.+||+.||++||| ++|++++
T Consensus 225 --~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 --AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 01112233467899999999999999999 6888764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=388.38 Aligned_cols=266 Identities=23% Similarity=0.327 Sum_probs=199.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCC----ceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT----ERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----~~~lv 305 (552)
++|.+.+.||+|+||+||+|+++ |+.||||+++.... ....+..|+..+.+++||||++++|++...+ ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35667789999999999999974 88999999964321 1112334555556789999999999998654 57899
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-----DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
|||+++|+|.++++.. .++|..+..++.|+|.||.|||+.. .++|+||||||+||||+.++.+||+|||+++..
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 9999999999999865 5999999999999999999999731 349999999999999999999999999999877
Q ss_pred CCCCCc---eeecccccccccCchhhccCC------CCCccchhHHHHHHHHHHhCCCccccCcccccc-------cchH
Q 008828 381 DHCDSH---VTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELISGLRALEFGKTANQK-------GAML 444 (552)
Q Consensus 381 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~-------~~~~ 444 (552)
...... ......||+.|+|||++.... ++.++|||||||++|||+||..|+......... ....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 543322 223456999999999987643 577999999999999999998887543221110 0111
Q ss_pred HHHHHHhhhcchhhhccccccCcC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 445 DWVKKIHQEKKLEMLVDKDLKNNY-DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
.......... ..++.+.... .......+.+++.+||+.||++|||+.||+++|+.
T Consensus 239 ~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 239 EEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 2222211111 1112221111 23455779999999999999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=392.22 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=204.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCc--cCchHHHHHHHHHHHh-hccccccceeeeEeecCCceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS-LAVHRNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~~~h~niv~l~~~~~~~~~~~lv 305 (552)
++|.+.+.||+|+||+||+|+.. +++.||||+++... .......+..|..++. .++||||+++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 47888999999999999999975 68999999996432 1223345667777665 68999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 385 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 385 (552)
|||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 99999999999999888899999999999999999999999 99999999999999999999999999998655332
Q ss_pred ceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhcccccc
Q 008828 386 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 465 (552)
Q Consensus 386 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (552)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ......... .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~-------~---- 219 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMD-------N---- 219 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC-------C----
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC-------C----
Confidence 2334457999999999999999999999999999999999999999743221 111111111 0
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 008828 466 NNYDRIELEEMVQVALLCTQYLPSLRPKMS-EVVR 499 (552)
Q Consensus 466 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 499 (552)
..++...+.++.+|+.+||+.||++|||+. |+++
T Consensus 220 ~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 112233457799999999999999999995 6754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=387.05 Aligned_cols=258 Identities=24% Similarity=0.270 Sum_probs=198.1
Q ss_pred CCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc----hHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEeec
Q 008828 235 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 309 (552)
Q Consensus 235 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 309 (552)
.++||+|+||+||+|+.+ +|+.||||+++...... ....+.+|+.++++++|||||++++++...+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999965 68999999996543221 1246889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCceee
Q 008828 310 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 389 (552)
Q Consensus 310 ~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 389 (552)
.++++..+......+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~ 158 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT 158 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-ccc
Confidence 9988888887778899999999999999999999999 999999999999999999999999999986654322 233
Q ss_pred cccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhhccc------
Q 008828 390 AVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK------ 462 (552)
Q Consensus 390 ~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 462 (552)
...||+.|+|||++... .++.++|||||||++|||+||..||......+. ...+.............+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~----l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ----LTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH----HHHHHHhcCCCChhhccchhccchh
Confidence 45699999999998754 579999999999999999999999875332111 1111111000000000000
Q ss_pred ---cccCcCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 463 ---DLKNNYD-----RIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 463 ---~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
......+ ...++++.+|+.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000001 1224679999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=386.73 Aligned_cols=248 Identities=21% Similarity=0.250 Sum_probs=197.6
Q ss_pred cCCCCC-CeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhc-cccccceeeeEeec----CCce
Q 008828 230 SNFSSK-NLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMT----TTER 302 (552)
Q Consensus 230 ~~~~~~-~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~----~~~~ 302 (552)
++|.+. ++||+|+||+||+|+. .+++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ ....
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 567765 4699999999999997 46899999999642 3567899886654 89999999999865 3568
Q ss_pred eEEEeeccCCChhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC---CCceEEcccccc
Q 008828 303 LLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLA 377 (552)
Q Consensus 303 ~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~ 377 (552)
++|||||++|+|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999753 4699999999999999999999999 9999999999999985 567999999999
Q ss_pred eecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh
Q 008828 378 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457 (552)
Q Consensus 378 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (552)
+...... ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.......... .+. .
T Consensus 162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~----~~~--------~ 227 (335)
T d2ozaa1 162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----GMK--------T 227 (335)
T ss_dssp EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------------
T ss_pred eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH----HHH--------H
Confidence 8765433 2344569999999999999999999999999999999999999997543211110 000 0
Q ss_pred hhccccc--cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 MLVDKDL--KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.+..... ........++++.+|+.+||+.||++|||+.|++++
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0111111 111112345789999999999999999999999884
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=375.25 Aligned_cols=241 Identities=23% Similarity=0.351 Sum_probs=199.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-----hHHHHHHHHHHHhhcc--ccccceeeeEeecCCc
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAV--HRNLLRLIGFCMTTTE 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~--h~niv~l~~~~~~~~~ 301 (552)
++|++.+.||+|+||+||+|+.. +|+.||||+++...... ...++.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57889999999999999999975 68999999996532211 1234678999999886 8999999999999999
Q ss_pred eeEEEeeccC-CChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC-CCceEEccccccee
Q 008828 302 RLLVYPYMSN-GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKL 379 (552)
Q Consensus 302 ~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~ 379 (552)
.++||||+.+ +++.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999976 68888888778899999999999999999999999 9999999999999985 57999999999987
Q ss_pred cCCCCCceeecccccccccCchhhccCCC-CCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhh
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 458 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (552)
.... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||..... .....
T Consensus 161 ~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~~---- 220 (273)
T d1xwsa_ 161 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQ---- 220 (273)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCC----
T ss_pred cccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------Hhhcc----
Confidence 5432 2345679999999999988775 5778999999999999999999963210 00000
Q ss_pred hccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 459 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 459 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.. ++...++++.+++.+||+.||++|||++|++++
T Consensus 221 ---~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 ---VF----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---cC----CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01 111234678999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.4e-48 Score=379.08 Aligned_cols=264 Identities=20% Similarity=0.269 Sum_probs=204.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCcc-CchHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEee
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 308 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 308 (552)
++|++.+.||+|+||+||+|+.++|+.||||+++.... .....++.+|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 47888999999999999999999999999999965432 22345789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCcee
Q 008828 309 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 388 (552)
Q Consensus 309 ~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 388 (552)
+.++.+..+......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+....... ...
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc-ccc
Confidence 99888888888788899999999999999999999999 99999999999999999999999999998765322 223
Q ss_pred ecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh---h-----cchhhh
Q 008828 389 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ---E-----KKLEML 459 (552)
Q Consensus 389 ~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~ 459 (552)
....|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+. +......... . ......
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCChhhccchhhhhhc
Confidence 344589999999998764 569999999999999999999999974332111 1110000000 0 000000
Q ss_pred ------ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 460 ------VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 460 ------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..+..........+..+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000011122234678999999999999999999999854
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=380.14 Aligned_cols=264 Identities=21% Similarity=0.271 Sum_probs=199.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ....++.+|++++++++||||+++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4788899999999999999997 46899999999654322 224578999999999999999999999999999999999
Q ss_pred eccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCc
Q 008828 308 YMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 386 (552)
Q Consensus 308 ~~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 386 (552)
|+.++.+..... ....+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 997654443333 345799999999999999999999999 99999999999999999999999999998765322 2
Q ss_pred eeecccccccccCchhhccCC-CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhh--hcchhhhc-cc
Q 008828 387 VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ--EKKLEMLV-DK 462 (552)
Q Consensus 387 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-~~ 462 (552)
......||+.|+|||.+.... ++.++|||||||++|+|++|+.||........ +......... +....... .+
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGST
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHHHHHhcCCCchhhcccccccc
Confidence 233456999999999987765 58899999999999999999999975332110 1111110000 00000000 00
Q ss_pred cccCc-----------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 463 DLKNN-----------YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 463 ~~~~~-----------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
..... .....+.++.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 011224678999999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=378.56 Aligned_cols=267 Identities=23% Similarity=0.320 Sum_probs=197.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-C-CcEEEEEEeccCccCc-hHHHHHHHHHHHhhc---cccccceeeeEeec----
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-D-GTVVAVKRLKDGNAIG-GEIQFQTEVEMISLA---VHRNLLRLIGFCMT---- 298 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~~~~~~---- 298 (552)
.++|++.+.||+|+||+||+|+.. + ++.||||+++...... ....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 4 6789999996533222 223466788777665 79999999999853
Q ss_pred -CCceeEEEeeccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccc
Q 008828 299 -TTERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 376 (552)
Q Consensus 299 -~~~~~lv~e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 376 (552)
....+++|||+++|++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence 346789999999887754443 455799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcch
Q 008828 377 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 456 (552)
Q Consensus 377 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (552)
++.... ........||+.|+|||++.+..|+.++||||+||++|||+||+.||...........+.............
T Consensus 163 ~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 163 ARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 976542 223345669999999999999999999999999999999999999997543211100000000000000000
Q ss_pred h------hhcc---ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 457 E------MLVD---KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 457 ~------~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. .... ......+....++.+.+|+.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000 000011122234678899999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=362.66 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=198.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeec--------C
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT--------T 299 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--------~ 299 (552)
++|++.+.||+|+||+||+|+.. +|+.||||++...... ....++.+|+.+++.++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 57888999999999999999974 7999999998654332 234568899999999999999999998865 3
Q ss_pred CceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 300 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 300 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
...++||||+.++.+.........+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeee
Confidence 45789999999888877777777899999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---eeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcc
Q 008828 380 LDHCDSH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 455 (552)
Q Consensus 380 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 455 (552)
....... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... ....+........
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~ 242 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLALISQLCGSIT 242 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCC
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH----HHHHHHHhcCCCC
Confidence 6533221 22334699999999998765 68999999999999999999999996432211 1111111110000
Q ss_pred ---hhhhcccc--------ccCcCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 456 ---LEMLVDKD--------LKNNYD-------RIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 456 ---~~~~~~~~--------~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
........ ...... ....+.+.+|+.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000000 000000 0113567899999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=369.88 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=193.7
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecC------Ccee
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TERL 303 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~~~ 303 (552)
+|+..++||+|+||+||+|+.. +|+.||||+++..... +.+|++++++++||||+++++++... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 4677789999999999999975 6999999999754322 24799999999999999999998543 3468
Q ss_pred EEEeeccCCChhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC-ceEEccccccee
Q 008828 304 LVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKL 379 (552)
Q Consensus 304 lv~e~~~~g~L~~~l---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~ 379 (552)
+||||+++|.+.... .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999999876433332 3566799999999999999999999998 999999999999999775 899999999987
Q ss_pred cCCCCCceeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchH--------HHHHHH
Q 008828 380 LDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKKI 450 (552)
Q Consensus 380 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~--------~~~~~~ 450 (552)
..... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||...........+. .+....
T Consensus 173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 65432 2334569999999998875 568999999999999999999999997543221110000 011110
Q ss_pred hhh---cchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 451 HQE---KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 451 ~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
... ...................++++.+|+.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00000000000111122345678999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=366.56 Aligned_cols=264 Identities=19% Similarity=0.237 Sum_probs=197.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEE-CCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccceeeeEeecCC----cee
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT----ERL 303 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----~~~ 303 (552)
+.+|++.+.||+|+||+||+|+. .+|+.||||+++.........++.+|+.++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35688899999999999999986 4799999999976544444557899999999999999999999987653 335
Q ss_pred EEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCC
Q 008828 304 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 304 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 383 (552)
++++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 566777799999999765 599999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCc--eeecccccccccCchhhcc-CCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh---
Q 008828 384 DSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE--- 457 (552)
Q Consensus 384 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 457 (552)
... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||.......... ...... ......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~---~~~~~~-~~~~~~~~~ 238 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN---HILGIL-GSPSQEDLN 238 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHH-CSCCHHHHH
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH---HHhhhc-cCCChhhhh
Confidence 221 2234569999999999854 567899999999999999999999997543211100 000000 000000
Q ss_pred --------h--hcccccc-Cc---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 458 --------M--LVDKDLK-NN---YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 458 --------~--~~~~~~~-~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ...+... .. .....+.++.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000 00 001123578999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=368.02 Aligned_cols=254 Identities=22% Similarity=0.290 Sum_probs=205.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC----CCcEEEEEEeccCcc---CchHHHHHHHHHHHhhccc-cccceeeeEeecCCc
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVH-RNLLRLIGFCMTTTE 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h-~niv~l~~~~~~~~~ 301 (552)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ......+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56889999999999999999852 478999999864321 1223457899999999977 899999999999999
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.+++|||+.+|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 999999999999999999888899999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCceeecccccccccCchhhccC--CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchhhh
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 459 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (552)
...........|++.|+|||.+.+. .++.++|||||||++|||+||+.||......... ..........
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~~~------ 251 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKS------ 251 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHC------
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcccC------
Confidence 5444444556799999999999765 4688999999999999999999999754332211 1111111100
Q ss_pred ccccccCcCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 008828 460 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRM 500 (552)
Q Consensus 460 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 500 (552)
...++...+.++.+++.+||++||++||| ++|++++
T Consensus 252 -----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 -----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 11123334578999999999999999995 7888753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=359.22 Aligned_cols=264 Identities=20% Similarity=0.250 Sum_probs=207.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 307 (552)
++|++.+.||+|+||+||+|+.. +++.||||+++..... ....++.+|+.+++.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 46888999999999999999974 7899999999754433 345678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecCCCCCce
Q 008828 308 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 387 (552)
Q Consensus 308 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 387 (552)
++.++++..++...+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++....... .
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-C
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-c
Confidence 999999999888888999999999999999999999999 999999999999999999999999999987654322 2
Q ss_pred eecccccccccCchhhccCC-CCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhc---c---hhhhc
Q 008828 388 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK---K---LEMLV 460 (552)
Q Consensus 388 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~ 460 (552)
.....++..|+|||.+.... ++.++|||||||++|||++|+.||..+...... ..-+....... . .....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ---LKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH---HHHHHHHHCCCCTTTCTTGGGST
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH---HHHHHhhcCCCChhhhhhhhhcc
Confidence 33345788999999987765 689999999999999999999998643321110 11111110000 0 00000
Q ss_pred c---------ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 461 D---------KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 461 ~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
+ ..............+.+|+.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000011122334678999999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-44 Score=353.88 Aligned_cols=257 Identities=19% Similarity=0.196 Sum_probs=196.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhcccccccee-eeEeecCCceeEEEe
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL-IGFCMTTTERLLVYP 307 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l-~~~~~~~~~~~lv~e 307 (552)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ..++..|+++++.++|+|++.. .++....+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 46889999999999999999964 689999999865432 2347789999999987775555 555567778889999
Q ss_pred eccCCChhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeC---CCCceEEcccccceecCCC
Q 008828 308 YMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHC 383 (552)
Q Consensus 308 ~~~~g~L~~~l-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~~ 383 (552)
|+.+ ++...+ .....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+++.+...
T Consensus 84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9954 555555 4566899999999999999999999999 999999999999986 4567999999999987543
Q ss_pred CCc------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhcchh
Q 008828 384 DSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 457 (552)
Q Consensus 384 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (552)
... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||..............+..... ....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~- 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPI- 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-HSCH-
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-CCCh-
Confidence 322 22345699999999999999999999999999999999999999975433222211111111100 0000
Q ss_pred hhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 458 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
+.+. ...++++.+++.+||+.+|++||++.++.+.|+.
T Consensus 238 ----~~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 238 ----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp ----HHHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred ----hHhc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1111 1233678999999999999999999999887775
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-45 Score=364.55 Aligned_cols=262 Identities=23% Similarity=0.294 Sum_probs=193.5
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCc-hHHHHHHHHHHHhhccccccceeeeEeecCC------
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ 300 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 300 (552)
.++|++.+.||+|+||+||+|... +|+.||||+++...... ....+.+|++++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 357888999999999999999975 69999999997543322 3446889999999999999999999997654
Q ss_pred ceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceec
Q 008828 301 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 380 (552)
Q Consensus 301 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 380 (552)
+.++||||+ +++|..+.+. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceecc
Confidence 468999999 5577776654 4699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchH--------HHHHHHh
Q 008828 381 DHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKKIH 451 (552)
Q Consensus 381 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~ 451 (552)
... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||............. .+.....
T Consensus 172 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 172 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred CCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 532 2345699999999998764 56899999999999999999999997543211100000 0000000
Q ss_pred h------hcchhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 452 Q------EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 452 ~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
. ...........+ ........+.+.+|+.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000000000000 01112234678899999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-44 Score=360.56 Aligned_cols=259 Identities=17% Similarity=0.245 Sum_probs=198.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecC--CceeEE
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTT--TERLLV 305 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~--~~~~lv 305 (552)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ..++.+|++++..+. ||||+++++++... ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 57999999999999999999974 68999999996432 457889999999995 99999999998744 568899
Q ss_pred EeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCC-ceEEcccccceecCCCC
Q 008828 306 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCD 384 (552)
Q Consensus 306 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~ 384 (552)
|||+.+|+|.... +.+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++......
T Consensus 111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999999998765 3599999999999999999999999 999999999999998654 69999999998765432
Q ss_pred CceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCccccccc-chH---------HHHHHHhhh
Q 008828 385 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKG-AML---------DWVKKIHQE 453 (552)
Q Consensus 385 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~-~~~---------~~~~~~~~~ 453 (552)
......+|..|+|||.+.+. .++.++||||+||++|||++|+.||.......... .+. .|.......
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 23445689999999998775 47999999999999999999999997544321110 000 011100000
Q ss_pred --cchhhhcccc--------ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 454 --KKLEMLVDKD--------LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 454 --~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
.......... .........++++.+|+.+||+.||++|||++|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000 0011112234678999999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-43 Score=347.22 Aligned_cols=258 Identities=17% Similarity=0.202 Sum_probs=203.9
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhccc-cccceeeeEeecCCceeEEE
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLIGFCMTTTERLLVY 306 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-~niv~l~~~~~~~~~~~lv~ 306 (552)
.++|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.+|++.+..+.| +|++.+++++......++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 357889999999999999999965 6899999998654332 346788888888865 89999999999999999999
Q ss_pred eeccCCChhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCC-----CCceEEcccccceec
Q 008828 307 PYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-----YYEAVVGDFGLAKLL 380 (552)
Q Consensus 307 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~~~~~ 380 (552)
||+ +|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++..
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999 67999888754 4799999999999999999999999 9999999999999974 578999999999976
Q ss_pred CCCCCc------eeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHHHhhhc
Q 008828 381 DHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 454 (552)
Q Consensus 381 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 454 (552)
...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........... ...+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~-~~~i~~~~~~~ 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKKQST 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH-HHHHHHHHHHS
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH-HHHHHhccCCC
Confidence 543221 23345699999999999999999999999999999999999999975433222111 11111111111
Q ss_pred chhhhccccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 008828 455 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 503 (552)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 503 (552)
...+ +... .++++.+++..|+..+|++||+++.+.+.|++
T Consensus 236 ~~~~-----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChHH-----hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111 1112 23678999999999999999999988877764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=359.75 Aligned_cols=263 Identities=19% Similarity=0.225 Sum_probs=190.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeec------CCc
Q 008828 230 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT------TTE 301 (552)
Q Consensus 230 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~------~~~ 301 (552)
++|++.+.||+|+||+||+|++. +|+.||||+++..... ....++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56888999999999999999975 6999999999754332 233468899999999999999999999864 367
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.++||||+.++. .+.+. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~l-~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANL-CQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEH-HHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchHH-HHhhh--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence 899999997654 44443 3589999999999999999999999 99999999999999999999999999988654
Q ss_pred CCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccchH---------------HH
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML---------------DW 446 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~---------------~~ 446 (552)
.. .......||..|+|||++.+..++.++||||+||++|||++|+.||...........+. ..
T Consensus 171 ~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 171 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred cc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 32 23345569999999999999999999999999999999999999997443211100000 00
Q ss_pred HHHHhhhc------chhhhccccccC---cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 447 VKKIHQEK------KLEMLVDKDLKN---NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 447 ~~~~~~~~------~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
........ ............ ......+.++.+|+.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 000111111111 1123456789999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-43 Score=350.86 Aligned_cols=264 Identities=20% Similarity=0.246 Sum_probs=195.4
Q ss_pred hcCCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccC-chHHHHHHHHHHHhhccccccceeeeEeecC-----Cc
Q 008828 229 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TE 301 (552)
Q Consensus 229 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~ 301 (552)
.++|++.+.||+|+||+||+|+.. +|+.||||+++..... ....++.+|+.++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 457999999999999999999964 7999999999754322 2344688999999999999999999998643 34
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccccceecC
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 381 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 381 (552)
.+++++|+.+|+|.+++..+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhcccc-cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence 57778888999999999654 699999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCceeecccccccccCchhhccC-CCCCccchhHHHHHHHHHHhCCCccccCcccccccchHHHHHH----Hhh---h
Q 008828 382 HCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK----IHQ---E 453 (552)
Q Consensus 382 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~---~ 453 (552)
. ......||..|+|||...+. .++.++|||||||++|+|++|+.||...........+...... ... .
T Consensus 173 ~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 173 D----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp G----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred c----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 2 23345689999999987765 4689999999999999999999999754321111000000000 000 0
Q ss_pred cchhhhcc---ccccCc---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008828 454 KKLEMLVD---KDLKNN---YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 500 (552)
Q Consensus 454 ~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 500 (552)
........ ...... .....+..+.+|+.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000 000000 001124678999999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-38 Score=322.30 Aligned_cols=261 Identities=20% Similarity=0.218 Sum_probs=188.2
Q ss_pred CCCCCCeeeeeCceEEEEEEEC-CCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-----------ccccceeeeEeec
Q 008828 231 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----------HRNLLRLIGFCMT 298 (552)
Q Consensus 231 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----------h~niv~l~~~~~~ 298 (552)
+|++.+.||+|+||+||+|+.. +|+.||||+++.... ....+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4889999999999999999974 799999999975432 2345778888887765 5789999988764
Q ss_pred C--CceeEEEeeccCCChhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceEEcCCCCCceeeCCCC-----
Q 008828 299 T--TERLLVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYY----- 367 (552)
Q Consensus 299 ~--~~~~lv~e~~~~g~L~~~l---~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~----- 367 (552)
. ...+++++++..+...... .....+++..+..++.||+.||.|||+ . +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence 3 4556667666554432222 245578999999999999999999998 5 899999999999998654
Q ss_pred -ceEEcccccceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHHHHHHhCCCccccCcccccccc---h
Q 008828 368 -EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA---M 443 (552)
Q Consensus 368 -~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~elltg~~p~~~~~~~~~~~~---~ 443 (552)
.++++|||.+...... .....||+.|+|||.+....++.++||||+||++++|++|+.||........... +
T Consensus 169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 3899999999865422 2345699999999999999999999999999999999999999975332111111 1
Q ss_pred HHHHHHHh--------hhcchhhhccc-------------------cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 008828 444 LDWVKKIH--------QEKKLEMLVDK-------------------DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSE 496 (552)
Q Consensus 444 ~~~~~~~~--------~~~~~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 496 (552)
...+..+. .........+. ..........+.++.+|+.+||+.||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 11111100 00000000000 0011234567789999999999999999999999
Q ss_pred HHHH
Q 008828 497 VVRM 500 (552)
Q Consensus 497 vl~~ 500 (552)
++++
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.5e-24 Score=195.59 Aligned_cols=170 Identities=13% Similarity=0.101 Sum_probs=121.1
Q ss_pred CCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccC-----------------chHHHHHHHHHHHhhccccccceeeeE
Q 008828 233 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-----------------GGEIQFQTEVEMISLAVHRNLLRLIGF 295 (552)
Q Consensus 233 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~~~h~niv~l~~~ 295 (552)
.+.+.||+|+||+||+|...+|+.||||+++..... ........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356799999999999999989999999987532110 001234567888889999999988766
Q ss_pred eecCCceeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEEcCCCCCceeeCCCCceEEcccc
Q 008828 296 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 375 (552)
Q Consensus 296 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 375 (552)
. ..+++|||++++.+.. ++......++.|++.++.|||++ +|+||||||+|||++++ .++|+|||
T Consensus 83 ~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCT
T ss_pred c----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECC
Confidence 3 3479999998765532 44556778999999999999999 99999999999999965 58999999
Q ss_pred cceecCCCCCceeecccccccccCchhhccCCCCCccchhHHHHHH
Q 008828 376 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 421 (552)
Q Consensus 376 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l 421 (552)
.|....+...... ...+...+ .+.+ .+.|..++|+||..--+
T Consensus 148 ~a~~~~~~~~~~~--l~rd~~~~-~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWREI--LERDVRNI-ITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHHHH--HHHHHHHH-HHHH-HHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcHHH--HHHHHHHH-HHHH-cCCCCCcccHHHHHHHH
Confidence 9976543221100 00000000 1111 35678899999975433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=1.7e-18 Score=156.64 Aligned_cols=125 Identities=22% Similarity=0.334 Sum_probs=59.1
Q ss_pred EeccCCCCCcccccccccCCCCCcEEecccCccCCCC-chhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccc
Q 008828 6 YRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHI-PTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 84 (552)
Q Consensus 6 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 84 (552)
.++.++++++. +|..+ .+++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|+.|+|++|
T Consensus 12 ~v~Cs~~~L~~-iP~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLKE-IPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCSS-CCSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcCc-cCCCC--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 44445555443 33333 234555555555554322 333444555555555555555444444445555555555555
Q ss_pred cccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCC
Q 008828 85 SLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICAT 133 (552)
Q Consensus 85 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~ 133 (552)
+|++..|..|.++++|+.|+|++|+|+++++..|. +.++|++|++.|.+
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 55544444455555555555555555544444332 34445555554443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=9.3e-18 Score=151.74 Aligned_cols=133 Identities=19% Similarity=0.240 Sum_probs=116.7
Q ss_pred CcccEeccCCCCCccc-ccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 2 VLLCYRGAPSQNLSGT-LSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++++|+|++|+|++. .+..|.++++|+.|+|++|.+....+..|..+++|+.|+|++|+|++..|..|.++++|+.|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 4789999999999874 466889999999999999999989999999999999999999999977788899999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccccCCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICATG 134 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~~~ 134 (552)
|++|+|++..|+.|..+++|+.|+|++|++.+.....+. +...+..|.+.|..+
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence 999999988888999999999999999999876543322 455677788877643
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=5.8e-17 Score=154.45 Aligned_cols=132 Identities=22% Similarity=0.203 Sum_probs=83.1
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
+|++|+|++|+++. .+..+.++++|+.|++++|.+.+..+..+..+.+|+.|++++|.++...+..+..+++|+.|+++
T Consensus 78 ~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~ 156 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156 (266)
T ss_dssp TCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred cccccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccc
Confidence 33444444443332 23334444444444444444443334444445555555555666664445556678888888888
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccccCCCC
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICATGA 135 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~~~~ 135 (552)
+|+|++..+..|..+++|+.|+|++|+|+.+++.++. +.++|++|++.|+|..
T Consensus 157 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 157 NNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred cccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcch
Confidence 9988877777788888999999999999865555443 6788999999888653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=3.2e-17 Score=157.92 Aligned_cols=135 Identities=22% Similarity=0.223 Sum_probs=123.8
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
|++|++|+|++|.+....+..+..+++|+.+++++|.|++..+..|.++++|+.|+|++|+|++..+..|.++++|+.++
T Consensus 104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence 57899999999999888888899999999999999999977778899999999999999999977788899999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccCCCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATGA 135 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~~~~ 135 (552)
+++|++++..|..|..+++|+.|++++|++++.++..+. +.++|++|++.|.|+.
T Consensus 184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred hhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence 999999988899999999999999999999998876654 7889999999998754
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.65 E-value=4.9e-17 Score=158.90 Aligned_cols=64 Identities=28% Similarity=0.470 Sum_probs=45.0
Q ss_pred CCccccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccccCCCC
Q 008828 72 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICATGA 135 (552)
Q Consensus 72 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~~~~ 135 (552)
.+++|+.|+|++|+|+|.+|..|.++++|+.|+|++|+|+|.+|.... +.+++++|+..|+.+.
T Consensus 242 ~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl 309 (313)
T d1ogqa_ 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred cccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC
Confidence 355666777777777777777777777777777777777776665421 5667777777776543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.63 E-value=3.3e-16 Score=130.22 Aligned_cols=104 Identities=24% Similarity=0.285 Sum_probs=91.9
Q ss_pred cEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccc
Q 008828 5 CYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 84 (552)
Q Consensus 5 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 84 (552)
++|+|++|+++.. + .++.+++|++|++++|+|+ .+|..|+.+++|+.|++++|.|+ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 5799999999864 4 5899999999999999998 78888999999999999999999 455 5899999999999999
Q ss_pred cccCCCC-ccccccccccEEeccCCCCCCC
Q 008828 85 SLTGAIP-PSLSNMSQLAFLDLSYNNLSGP 113 (552)
Q Consensus 85 ~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~ 113 (552)
+|+.... ..+..+++|+.|++++|+++..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 9994432 5688999999999999999853
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.59 E-value=2.8e-16 Score=153.45 Aligned_cols=128 Identities=30% Similarity=0.508 Sum_probs=117.0
Q ss_pred cccEeccCCCCCcc--cccccccCCCCCcEEeccc-CccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccc
Q 008828 3 LLCYRGAPSQNLSG--TLSSSIGNLTNLQLVLLQN-NNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 79 (552)
Q Consensus 3 ~l~~L~l~~n~l~~--~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 79 (552)
+++.|+|++|++.+ .+|..+++|++|++|+|++ |.++|.+|..|++|++|++|+|++|++.+..|..+..+..|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 58999999999998 4789999999999999997 89999999999999999999999999998888889999999999
Q ss_pred ccccccccCCCCccccccccccEEeccCCCCCCCCCCccc------CcccccCCccc
Q 008828 80 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLI 130 (552)
Q Consensus 80 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~------~~~~l~~N~~~ 130 (552)
++++|.+.+.+|..+..+++|+.+++++|.+++.+|..+. ..+++++|.+.
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~ 187 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEE
T ss_pred ccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999988887544 45567777664
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=1.2e-14 Score=138.03 Aligned_cols=128 Identities=23% Similarity=0.200 Sum_probs=102.2
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|++|+|++|+|+++.+..|.++++|++|+|++|+|+ .+| .++.+++|+.|+|++|+++ ..+..+..+++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 46899999999999877788999999999999999998 555 3678999999999999998 56777888888888888
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----CcccccCCccccC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
++|.+.+..+..+..+.+|..|++++|.++..++..+. +.+++++|.+...
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhccccccccccc
Confidence 88888866666777777777777777777766655443 5567777766544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=2.8e-15 Score=130.86 Aligned_cols=106 Identities=20% Similarity=0.168 Sum_probs=65.6
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
+|+.|+|++|+|+.+ +..+..+++|+.|+|++|+|+ .++ .|..+++|+.|+|++|+++...+..+..+++|+.|+|+
T Consensus 19 ~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 19 RDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp SCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred cCcEEECCCCCCCcc-CccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 466677777766653 445566666777777777766 333 36666677777777777663333334556667777777
Q ss_pred cccccCCCC--ccccccccccEEeccCCCCCC
Q 008828 83 NNSLTGAIP--PSLSNMSQLAFLDLSYNNLSG 112 (552)
Q Consensus 83 ~N~l~~~~p--~~~~~l~~L~~l~l~~N~l~~ 112 (552)
+|+|+ .++ ..+..+++|+.|++++|+++.
T Consensus 96 ~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 96 NNSLV-ELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp SCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ccccc-ccccccccccccccchhhcCCCcccc
Confidence 77666 333 345666667777777666654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=2.1e-15 Score=145.00 Aligned_cols=132 Identities=22% Similarity=0.238 Sum_probs=117.4
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|+.+++++|+++++.+..|..+++|+.|+|++|+|++..+..|.++++|+.|++++|++++..|..|..+++|++|+
T Consensus 128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence 35789999999999998888999999999999999999988888999999999999999999988899999999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCc----ccCcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF----HAKTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~----~~~~~~l~~N~~~c~ 132 (552)
+++|++.+..|..|..+++|+.|+|++|++.+..+.. +.+.+....+.+.|.
T Consensus 208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~ 263 (284)
T d1ozna_ 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263 (284)
T ss_dssp CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred ccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeC
Confidence 9999999888889999999999999999999876532 224555666777775
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=4e-14 Score=117.40 Aligned_cols=102 Identities=25% Similarity=0.384 Sum_probs=87.1
Q ss_pred cEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccccccCCCCccccccccccEEeccCC
Q 008828 29 QLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 108 (552)
Q Consensus 29 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 108 (552)
++|+|++|+|+ .++. +.++++|++|+|++|+|+ .+|..++.+++|+.|++++|+|+ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 58999999999 6664 899999999999999999 78888999999999999999999 455 5899999999999999
Q ss_pred CCCCCCC-Cccc-----CcccccCCccccCCCC
Q 008828 109 NLSGPVP-SFHA-----KTFNITGNSLICATGA 135 (552)
Q Consensus 109 ~l~~~~~-~~~~-----~~~~l~~N~~~c~~~~ 135 (552)
+|+..+. ..+. +.+++++|++...++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~ 108 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 108 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccH
Confidence 9997653 2222 6789999998765543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=5.3e-14 Score=121.75 Aligned_cols=109 Identities=17% Similarity=0.076 Sum_probs=85.6
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccC-ccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNN-NISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
..+.++.+++++.. .|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|+.|+|
T Consensus 9 ~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 35667888888775 6777888899999999765 588666677888999999999999998666777888999999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 113 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 113 (552)
++|+|+ .+|.......+|+.|+|++|++...
T Consensus 88 s~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~ 118 (156)
T d2ifga3 88 SFNALE-SLSWKTVQGLSLQELVLSGNPLHCS 118 (156)
T ss_dssp CSSCCS-CCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred cCCCCc-ccChhhhccccccccccCCCcccCC
Confidence 999998 4544433445788899988888643
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.47 E-value=7.2e-14 Score=135.45 Aligned_cols=129 Identities=22% Similarity=0.259 Sum_probs=112.7
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|++++|++.. +|..+ +++|+.|++++|.+++..+..|.+++.++.|++++|.+++..+..+.++++|++|+
T Consensus 149 l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~ 225 (305)
T d1xkua_ 149 MKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 225 (305)
T ss_dssp CTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred ccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeee
Confidence 4679999999999886 45443 78999999999999989999999999999999999999987788899999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCccc-----------CcccccCCccccCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----------KTFNITGNSLICAT 133 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----------~~~~l~~N~~~c~~ 133 (552)
|++|+|+ .+|.+|..+++|+.|+|++|+|+.+....|. +.++|++|++.+.+
T Consensus 226 L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~ 288 (305)
T d1xkua_ 226 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288 (305)
T ss_dssp CCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGG
T ss_pred ccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCc
Confidence 9999999 6788999999999999999999976554332 57889999987643
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=6.9e-14 Score=121.01 Aligned_cols=112 Identities=16% Similarity=0.153 Sum_probs=97.8
Q ss_pred cCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCC-cCCCCCCccccCCccccccccccccccCCCCcccccccccc
Q 008828 23 GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNN-FFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA 101 (552)
Q Consensus 23 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 101 (552)
..+...+.++.+++.+. ..|..+..+++|+.|+|++| .|+...+..|.++++|+.|+|++|+|+...|.+|..+++|+
T Consensus 5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~ 83 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (156)
T ss_dssp SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence 34556778999999998 67888999999999999876 48855567799999999999999999977788999999999
Q ss_pred EEeccCCCCCCCCCCccc----CcccccCCccccCCCC
Q 008828 102 FLDLSYNNLSGPVPSFHA----KTFNITGNSLICATGA 135 (552)
Q Consensus 102 ~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~~~~ 135 (552)
.|+|++|+|+..++..+. ..++|++|++.|.|..
T Consensus 84 ~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~ 121 (156)
T d2ifga3 84 RLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121 (156)
T ss_dssp EEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGG
T ss_pred ceeccCCCCcccChhhhccccccccccCCCcccCCchH
Confidence 999999999988877665 6899999999998864
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=7.1e-14 Score=121.73 Aligned_cols=110 Identities=19% Similarity=0.108 Sum_probs=91.6
Q ss_pred ccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccccccccCCCCcccccccc
Q 008828 20 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQ 99 (552)
Q Consensus 20 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 99 (552)
..+.++.+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .|..+++|+.|+|++|+|+...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 34778899999999999999 66877788999999999999999 554 5899999999999999999655556778999
Q ss_pred ccEEeccCCCCCCCCC-Ccc-----cCcccccCCccccC
Q 008828 100 LAFLDLSYNNLSGPVP-SFH-----AKTFNITGNSLICA 132 (552)
Q Consensus 100 L~~l~l~~N~l~~~~~-~~~-----~~~~~l~~N~~~c~ 132 (552)
|+.|+|++|+|+.... ..+ .+.+++++|++...
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~ 127 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred cccceeccccccccccccccccccccchhhcCCCccccc
Confidence 9999999999986432 122 27788999987543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.40 E-value=6.1e-13 Score=120.22 Aligned_cols=121 Identities=25% Similarity=0.355 Sum_probs=77.3
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
.+|++|++++|++... +.++.+++|++|+|++|+|++ +++ +.++++|+.|++++|.+. .++ .+.++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCCc--cccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-ccccccccccccc
Confidence 4677777777777653 246777777777777777774 332 777777777777777776 333 3667777777777
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCcccc
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLIC 131 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c 131 (552)
++|.+... ..+..+++|+.|++++|++... +.+.. +.+++.+|.+..
T Consensus 114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 114 FNNQITDI--DPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp CSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCC
T ss_pred cccccccc--cccchhhhhHHhhhhhhhhccc-ccccccccccccccccccccC
Confidence 77766632 2356667777777777776643 22211 556666666543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.36 E-value=7.4e-13 Score=128.14 Aligned_cols=110 Identities=19% Similarity=0.174 Sum_probs=99.3
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|+.|++++|.+++..+..|.+++.++.|++++|.+++..+..|.++++|+.|+|++|+|+ .+|.+|..+++|+.|+
T Consensus 170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~ 248 (305)
T d1xkua_ 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248 (305)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEE
Confidence 368999999999999999999999999999999999999888889999999999999999999 7788999999999999
Q ss_pred cccccccCCCCc------cccccccccEEeccCCCCC
Q 008828 81 LNNNSLTGAIPP------SLSNMSQLAFLDLSYNNLS 111 (552)
Q Consensus 81 l~~N~l~~~~p~------~~~~l~~L~~l~l~~N~l~ 111 (552)
|++|+|+..-.. .+..+++|+.|+|++|+++
T Consensus 249 Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 999999954332 3445678999999999986
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.36 E-value=1.3e-12 Score=118.97 Aligned_cols=101 Identities=24% Similarity=0.324 Sum_probs=52.0
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
+|++|++++|.+++.. .+..+++|++|+|++|+|++ ++ .++++++|+.|++++|+++ .+| .+..+++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccccccc
Confidence 4555666666555432 25555666666666666653 32 2455566666666666655 233 35555555555555
Q ss_pred cccccCCCCccccccccccEEeccCCCCC
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLS 111 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 111 (552)
+|.+. .++ .+..+++|+.+++++|.++
T Consensus 121 ~~~~~-~~~-~l~~l~~l~~l~~~~n~l~ 147 (210)
T d1h6ta2 121 HNGIS-DIN-GLVHLPQLESLYLGNNKIT 147 (210)
T ss_dssp TSCCC-CCG-GGGGCTTCCEEECCSSCCC
T ss_pred ccccc-ccc-ccccccccccccccccccc
Confidence 55554 222 2444444444444444444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.32 E-value=1.9e-12 Score=116.81 Aligned_cols=123 Identities=27% Similarity=0.377 Sum_probs=100.1
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
|++|++|+|++|++++..| ++++++|++|++++|.+. .++ .+.++++|+.|++++|.+... ..+..+++|+.|+
T Consensus 61 l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~ 134 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLE 134 (199)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred CCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhh
Confidence 5789999999999987544 899999999999999998 555 388999999999999998843 3578899999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCc---ccCcccccCCcccc
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGNSLIC 131 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~---~~~~~~l~~N~~~c 131 (552)
+++|++. .++ .+..+++|+.|++++|++++..+-. ..+.+++++|++.-
T Consensus 135 l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 135 LSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred hhhhhhc-ccc-cccccccccccccccccccCCccccCCCCCCEEECCCCCCCC
Confidence 9999988 444 5888899999999999998764311 11788899998753
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.27 E-value=4.6e-12 Score=115.29 Aligned_cols=124 Identities=27% Similarity=0.362 Sum_probs=102.8
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
|++|++|+|++|++++.. .++++++|++|++++|+|+ .+| .+.++++|+.|++++|.+. .+ ..+..+++|+.++
T Consensus 67 l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~ 140 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLY 140 (210)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEE
T ss_pred CCCCCEEeCCCccccCcc--ccccCcccccccccccccc-ccc-ccccccccccccccccccc-cc-ccccccccccccc
Confidence 578999999999998854 3789999999999999998 455 5889999999999999987 33 4688899999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCc---ccCcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~---~~~~~~l~~N~~~c~ 132 (552)
+++|.+++ . ..+..+++|+.+++++|++++..+-. ..+.++|++|.+...
T Consensus 141 ~~~n~l~~-~-~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~~l 193 (210)
T d1h6ta2 141 LGNNKITD-I-TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL 193 (210)
T ss_dssp CCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC
T ss_pred cccccccc-c-ccccccccccccccccccccccccccCCCCCCEEECCCCCCCCC
Confidence 99999984 3 45778999999999999999765411 127889999987643
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.26 E-value=3.3e-14 Score=128.32 Aligned_cols=123 Identities=18% Similarity=0.256 Sum_probs=95.7
Q ss_pred ccEeccCCC--CCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 4 LCYRGAPSQ--NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 4 l~~L~l~~n--~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++.+++.++ .+. .++.+++.|++|+.|+|++|+|+ .++ .+.++++|+.|+|++|+|+ .+|..+..+++|+.|++
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence 344555543 232 36678999999999999999998 555 4889999999999999998 67766666788999999
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCC-Ccc-----cCcccccCCccccC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP-SFH-----AKTFNITGNSLICA 132 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~-----~~~~~l~~N~~~c~ 132 (552)
++|+|+. + +.+..+++|+.|+|++|+|+.... ..+ .+.++|++|++.+.
T Consensus 101 ~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 101 SYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp SEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred ccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccccC
Confidence 9999994 4 358889999999999999986432 111 27889999987643
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.22 E-value=1.1e-11 Score=123.58 Aligned_cols=125 Identities=27% Similarity=0.308 Sum_probs=77.9
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCC---------------
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPI--------------- 66 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--------------- 66 (552)
++|+.|++++|.++.. +.+..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..
T Consensus 219 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~ 294 (384)
T d2omza2 219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294 (384)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCS
T ss_pred CCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccc
Confidence 4566666666666542 245566666666666666653222 555566666666665555321
Q ss_pred -----CccccCCccccccccccccccCCCCccccccccccEEeccCCCCCCCCCCccc----CcccccCCccccCC
Q 008828 67 -----PSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICAT 133 (552)
Q Consensus 67 -----p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~l~~N~~~c~~ 133 (552)
...+..+++++.|++++|+|++. + .+..+++|+.|++++|+|++. +.+.. +.+++++|++....
T Consensus 295 n~l~~~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~l-~~l~~l~~L~~L~l~~N~l~~l~ 367 (384)
T d2omza2 295 NQLEDISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSDV-SSLANLTNINWLSAGHNQISDLT 367 (384)
T ss_dssp SCCSCCGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECCSSCCCBCG
T ss_pred cccccccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCCC-hhHcCCCCCCEEECCCCcCCCCh
Confidence 12355667888888888888854 3 377888888888888888764 32211 67788888876543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.19 E-value=1.7e-13 Score=123.54 Aligned_cols=110 Identities=24% Similarity=0.228 Sum_probs=94.1
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
|++|++|+|++|+|+.+ + .|+.|++|+.|+|++|.|+ .+|..+..+++|+.|++++|+++ .+ ..+..+++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l-~~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CH-HHHHHHHHSSEEE
T ss_pred ccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccc-cc-ccccccccccccc
Confidence 57899999999999874 3 5999999999999999998 67776777789999999999999 44 3588899999999
Q ss_pred cccccccCCCC--ccccccccccEEeccCCCCCCCCCC
Q 008828 81 LNNNSLTGAIP--PSLSNMSQLAFLDLSYNNLSGPVPS 116 (552)
Q Consensus 81 l~~N~l~~~~p--~~~~~l~~L~~l~l~~N~l~~~~~~ 116 (552)
|++|+|+ .++ ..+..+++|+.|+|++|++....+.
T Consensus 122 L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 122 MSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp ESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred cccchhc-cccccccccCCCccceeecCCCccccCccc
Confidence 9999998 444 4688999999999999998765443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.15 E-value=6.8e-11 Score=108.80 Aligned_cols=79 Identities=22% Similarity=0.328 Sum_probs=44.7
Q ss_pred CcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCcccccccc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 81 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 81 (552)
++|+.|++.+|+|+.. +.+.++++|++|+|++|+|++..| +.++++|+.|++++|.++ .++ .+..+++|+.+++
T Consensus 41 ~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l 114 (227)
T d1h6ua2 41 DGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDL 114 (227)
T ss_dssp HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEEC
T ss_pred CCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-ccccccccccccc
Confidence 4566666666666653 246666666666666666663322 566666666666666555 222 3444555555555
Q ss_pred ccccc
Q 008828 82 NNNSL 86 (552)
Q Consensus 82 ~~N~l 86 (552)
++|.+
T Consensus 115 ~~~~~ 119 (227)
T d1h6ua2 115 TSTQI 119 (227)
T ss_dssp TTSCC
T ss_pred ccccc
Confidence 54443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.13 E-value=3.2e-11 Score=120.03 Aligned_cols=119 Identities=24% Similarity=0.326 Sum_probs=98.8
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|++++|.+++.. .+..++.++.+++++|.+++ + ..+..+++++.|+|++|++++. + .+..+++|+.|+
T Consensus 262 ~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~ 335 (384)
T d2omza2 262 LTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLF 335 (384)
T ss_dssp CTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEE
T ss_pred cccCCEeeccCcccCCCC--cccccccccccccccccccc-c-cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEE
Confidence 467889999999888754 38889999999999999984 3 3588999999999999999954 3 388999999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCc---ccCcccccCC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGN 127 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~---~~~~~~l~~N 127 (552)
|++|+|+ .++ .+..+++|+.|+|++|+|++.+|-. ..+.++|++|
T Consensus 336 L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 336 FANNKVS-DVS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 9999998 455 6899999999999999999876521 1167788777
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.01 E-value=2.3e-10 Score=106.15 Aligned_cols=108 Identities=16% Similarity=0.168 Sum_probs=70.2
Q ss_pred cEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCC-ccccCCcccccccccc
Q 008828 5 CYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP-STVSHLETLQYLRLNN 83 (552)
Q Consensus 5 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~ 83 (552)
+.++.++++++. +|..+ .+++++|+|++|+|+...+..|.++++|++|+|++|.+...++ ..|.+++.++.|.+..
T Consensus 11 ~~i~c~~~~l~~-iP~~l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCSS-CCSCS--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCCC-cCCCC--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 455666666663 55444 2567777777777774444467777777777777777664433 3566777777776653
Q ss_pred -ccccCCCCccccccccccEEeccCCCCCCCCC
Q 008828 84 -NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115 (552)
Q Consensus 84 -N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 115 (552)
|.+....+..|..+++|+.|++++|.+...++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~ 120 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 120 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCC
T ss_pred cccccccccccccccccccccccchhhhccccc
Confidence 56665666667777777777777777765443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.97 E-value=6.3e-10 Score=102.13 Aligned_cols=124 Identities=23% Similarity=0.295 Sum_probs=84.0
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|++++|.++.. +.+..+++|+.|++++|.+.+.. .+...+.+..+.++++.+... ..+..+++|+.|+
T Consensus 84 l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~ 157 (227)
T d1h6ua2 84 LTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLS 157 (227)
T ss_dssp CCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEE
T ss_pred ccccccccccccccccc--ccccccccccccccccccccccc--hhccccchhhhhchhhhhchh--hhhcccccccccc
Confidence 46889999999988763 35888999999999999887432 356667777777777776632 2356667777777
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCCc---ccCcccccCCccccC
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGNSLICA 132 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~---~~~~~~l~~N~~~c~ 132 (552)
+++|.+.+. + .+..+++|+.|+|++|++++.++-. ..+.++|++|++...
T Consensus 158 l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 158 IGNAQVSDL-T-PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp CCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBC
T ss_pred ccccccccc-h-hhcccccceecccCCCccCCChhhcCCCCCCEEECcCCcCCCC
Confidence 777777632 2 2667777777777777776543210 115667777766543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.85 E-value=7e-09 Score=101.14 Aligned_cols=100 Identities=24% Similarity=0.287 Sum_probs=83.2
Q ss_pred cccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccccc
Q 008828 3 LLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 82 (552)
Q Consensus 3 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 82 (552)
++++|||++|+++. +|+ .+++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++.- .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp~---~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPE---LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCS---CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCCC-CCC---CCCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 68999999999986 674 3678999999999999 77865 468999999999998 55532 2469999999
Q ss_pred cccccCCCCccccccccccEEeccCCCCCCCCCC
Q 008828 83 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 116 (552)
Q Consensus 83 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~ 116 (552)
+|.|. .+|. +..+++|+.|++++|.++..+..
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~ 138 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL 138 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC
T ss_pred ccccc-cccc-hhhhccceeeccccccccccccc
Confidence 99999 6675 67899999999999999865543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.75 E-value=6.7e-09 Score=95.96 Aligned_cols=131 Identities=22% Similarity=0.116 Sum_probs=76.3
Q ss_pred CCcccEeccC-CCCCcccccccccCCCCCcEEecccCccCCCCch-hhcCCCCCCEEEccCCcCCCCCCccccCCc-ccc
Q 008828 1 MVLLCYRGAP-SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPT-EIGKLSKLLTLDLSNNFFTGPIPSTVSHLE-TLQ 77 (552)
Q Consensus 1 l~~l~~L~l~-~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~ 77 (552)
++++.+|.+. .|++....+..|.++++|+.|++++|.+....+. .+..+..|..+..+++.+....+..|..++ .++
T Consensus 77 l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~ 156 (242)
T d1xwdc1 77 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESV 156 (242)
T ss_dssp CTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCE
T ss_pred ccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccce
Confidence 3566777765 4677777777888888888888888888733221 233455555555666666644444455543 566
Q ss_pred ccccccccccCCCCccccccccccE-EeccCCCCCCCCCCccc-----CcccccCCccccC
Q 008828 78 YLRLNNNSLTGAIPPSLSNMSQLAF-LDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 132 (552)
Q Consensus 78 ~L~l~~N~l~~~~p~~~~~l~~L~~-l~l~~N~l~~~~~~~~~-----~~~~l~~N~~~c~ 132 (552)
.|++++|+++. ++......+++.. +++++|+|+.+++..+. +.+++++|++...
T Consensus 157 ~L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l 216 (242)
T d1xwdc1 157 ILWLNKNGIQE-IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216 (242)
T ss_dssp EEECCSSCCCE-ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCC
T ss_pred eeecccccccc-cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCcc
Confidence 66666666663 3333333344433 34566666655444333 5566666665533
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=2.5e-09 Score=92.32 Aligned_cols=107 Identities=19% Similarity=0.074 Sum_probs=71.3
Q ss_pred ccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCC--CccccCCcccccccc
Q 008828 4 LCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPI--PSTVSHLETLQYLRL 81 (552)
Q Consensus 4 l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--p~~~~~l~~L~~L~l 81 (552)
.+.|+++++... ..+..+..+..|+..+|.+. .++..+.++++|++|+|++|+|+..- +..+..+++|+.|+|
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 455677665422 23555566666666666665 55656667888999999999888432 234567888888899
Q ss_pred ccccccCCCCccccccccccEEeccCCCCCCCCC
Q 008828 82 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 115 (552)
Q Consensus 82 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 115 (552)
++|+|+...+-.+....+|+.|++++|+++....
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred ccCccccchhhhhhhccccceeecCCCCcCcCcc
Confidence 9988884333233344568888888888876544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.52 E-value=1.9e-07 Score=90.52 Aligned_cols=116 Identities=24% Similarity=0.273 Sum_probs=82.1
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccCccCCCCchhhcCCCCCCEEEccCCcCCCCCCccccCCccccccc
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 80 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 80 (552)
+++|++|+|++|+|+. +|.. +.+|+.|++++|+++ .++. + .+.|++|+|++|.++ .+|. ++.+++|+.|+
T Consensus 57 ~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 57 PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIID 126 (353)
T ss_dssp CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCcc-cccc---hhhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cccc-hhhhccceeec
Confidence 3689999999999985 6754 568999999999998 5553 2 146999999999999 6775 68899999999
Q ss_pred cccccccCCCCccccccccccEEeccCCCCCCCCCC---cccCcccccCCccc
Q 008828 81 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS---FHAKTFNITGNSLI 130 (552)
Q Consensus 81 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~---~~~~~~~l~~N~~~ 130 (552)
+++|.+. ..+.. ...+..+.+..+.......- ...+.+.+.+|.+.
T Consensus 127 l~~~~~~-~~~~~---~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 127 VDNNSLK-KLPDL---PPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp CCSSCCS-CCCCC---CTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCS
T ss_pred ccccccc-ccccc---cccccchhhccccccccccccccccceeccccccccc
Confidence 9999998 44433 34555666666555432211 11144556665543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.47 E-value=2e-08 Score=86.44 Aligned_cols=91 Identities=25% Similarity=0.199 Sum_probs=69.2
Q ss_pred cccccccCCCCCcEEecccCccCCCC--chhhcCCCCCCEEEccCCcCCCCCCc-cccCCccccccccccccccCCCCc-
Q 008828 17 TLSSSIGNLTNLQLVLLQNNNISGHI--PTEIGKLSKLLTLDLSNNFFTGPIPS-TVSHLETLQYLRLNNNSLTGAIPP- 92 (552)
Q Consensus 17 ~~p~~~~~l~~L~~L~l~~N~l~~~~--p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~- 92 (552)
.++..+..+++|++|+|++|+|+..- +..+..+++|+.|+|++|+++ .+++ .+.....|+.|++++|.+......
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~ 134 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQ 134 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSH
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccc
Confidence 34445578999999999999999542 455778999999999999999 4443 334456799999999999865543
Q ss_pred ------cccccccccEEeccCCCC
Q 008828 93 ------SLSNMSQLAFLDLSYNNL 110 (552)
Q Consensus 93 ------~~~~l~~L~~l~l~~N~l 110 (552)
.+..+|+|+.|| ++.+
T Consensus 135 ~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 135 STYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHHHHHTTSTTCCEET--TEEC
T ss_pred hhHHHHHHHHCCCCCEEC--cCCC
Confidence 266789999886 5544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=3.2e-09 Score=107.46 Aligned_cols=111 Identities=23% Similarity=0.251 Sum_probs=87.1
Q ss_pred CcccEeccCCCCCcccc-cccccCCCCCcEEecccCccCC----CCchhhcCCCCCCEEEccCCcCCCC----CCcccc-
Q 008828 2 VLLCYRGAPSQNLSGTL-SSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGP----IPSTVS- 71 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~- 71 (552)
.+|+.|||+.|++++.. ..-+..+++|+.|+|++|.|+. .+...+..+++|+.|||++|.|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 47899999999998742 4456778999999999999872 3455678999999999999998621 122222
Q ss_pred CCccccccccccccccCC----CCccccccccccEEeccCCCCCC
Q 008828 72 HLETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLSG 112 (552)
Q Consensus 72 ~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~ 112 (552)
...+|+.|+|++|+|+.. ++..+..+++|+.|+|++|.++.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 235799999999999743 45667888999999999999874
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=3.9e-08 Score=93.07 Aligned_cols=127 Identities=21% Similarity=0.177 Sum_probs=78.9
Q ss_pred CCcccEeccCCCCCcccccccccCCCCCcEEecccC-ccCCC-CchhhcCCCCCCEEEccCC-cCCC-------------
Q 008828 1 MVLLCYRGAPSQNLSGTLSSSIGNLTNLQLVLLQNN-NISGH-IPTEIGKLSKLLTLDLSNN-FFTG------------- 64 (552)
Q Consensus 1 l~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~------------- 64 (552)
+++|++|+|++|.++...+..++.+++|+.|+|+++ .++.. +...+.++++|+.|+|+++ .++.
T Consensus 70 c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~ 149 (284)
T d2astb2 70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 149 (284)
T ss_dssp BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred CCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccc
Confidence 356777777777777666667777777777777773 45421 1222345667777777663 2220
Q ss_pred ---------------C-CCccccCCccccccccccc-cccCCCCccccccccccEEeccCC-CCCCCCCCccc-----Cc
Q 008828 65 ---------------P-IPSTVSHLETLQYLRLNNN-SLTGAIPPSLSNMSQLAFLDLSYN-NLSGPVPSFHA-----KT 121 (552)
Q Consensus 65 ---------------~-~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~l~l~~N-~l~~~~~~~~~-----~~ 121 (552)
. +...+.++++|++|+|++| .+++.....+.++++|++|+|++| .+++.....+. +.
T Consensus 150 L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~ 229 (284)
T d2astb2 150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229 (284)
T ss_dssp CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred cchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCE
Confidence 0 0001134788999999886 477666777888999999999984 56543322222 45
Q ss_pred ccccCC
Q 008828 122 FNITGN 127 (552)
Q Consensus 122 ~~l~~N 127 (552)
+++.++
T Consensus 230 L~l~~~ 235 (284)
T d2astb2 230 LQVFGI 235 (284)
T ss_dssp EECTTS
T ss_pred EeeeCC
Confidence 566554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.40 E-value=1.5e-08 Score=98.80 Aligned_cols=128 Identities=16% Similarity=0.159 Sum_probs=67.6
Q ss_pred CcccEeccCCCCCccc----ccccccCCCCCcEEecccCccCCCCc-------------hhhcCCCCCCEEEccCCcCCC
Q 008828 2 VLLCYRGAPSQNLSGT----LSSSIGNLTNLQLVLLQNNNISGHIP-------------TEIGKLSKLLTLDLSNNFFTG 64 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p-------------~~~~~l~~L~~L~l~~N~l~~ 64 (552)
++|+.|+|++|.+... +...+..+++|+.|++++|.++..-. ......+.|+.|++++|.++.
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 4566666666666543 22334455666666666665531000 001234455555555555441
Q ss_pred C----CCccccCCccccccccccccccCC-----CCccccccccccEEeccCCCCCCCC--------CC-cccCcccccC
Q 008828 65 P----IPSTVSHLETLQYLRLNNNSLTGA-----IPPSLSNMSQLAFLDLSYNNLSGPV--------PS-FHAKTFNITG 126 (552)
Q Consensus 65 ~----~p~~~~~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~l~l~~N~l~~~~--------~~-~~~~~~~l~~ 126 (552)
. +...+..++.|+.|+|++|+|... +...+..+++|+.|+|++|.++... .. ...+.++|++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence 1 111233456777777777776521 2344666677777788777764321 01 1125667777
Q ss_pred Ccc
Q 008828 127 NSL 129 (552)
Q Consensus 127 N~~ 129 (552)
|.+
T Consensus 253 n~i 255 (344)
T d2ca6a1 253 CLL 255 (344)
T ss_dssp CCC
T ss_pred Ccc
Confidence 765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=9.5e-07 Score=82.03 Aligned_cols=149 Identities=13% Similarity=0.063 Sum_probs=98.7
Q ss_pred HHHHHHhcCCCCCCeeeeeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcc-ccccceeeeEeecCCc
Q 008828 223 KELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTE 301 (552)
Q Consensus 223 ~e~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~ 301 (552)
.++...-..|...+..+.++.+.||+...+ ++.+++|+....... ....+.+|...+..+. +--+-+++.+....+.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 344555556665555444555789988654 566778877543221 2224667888877663 3235677888888888
Q ss_pred eeEEEeeccCCChhhhhccCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 008828 302 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC---------------------------------- 347 (552)
Q Consensus 302 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------- 347 (552)
.++||+++++.++.+..... .....++.++++.+..||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999999998776544321 123345556666666666421
Q ss_pred ----------------------CCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 348 ----------------------DPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 348 ----------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
.+.++|+|+.|.||++++++.+-|.||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987667799999885
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.28 E-value=4e-08 Score=95.78 Aligned_cols=129 Identities=20% Similarity=0.190 Sum_probs=92.2
Q ss_pred CcccEeccCCCCCccc----ccccccCCCCCcEEecccCccCCC-----CchhhcCCCCCCEEEccCCcCCCC----CCc
Q 008828 2 VLLCYRGAPSQNLSGT----LSSSIGNLTNLQLVLLQNNNISGH-----IPTEIGKLSKLLTLDLSNNFFTGP----IPS 68 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~----~p~ 68 (552)
+.|+.|++++|++... +...+..+++|+.|+|++|.|+.. +...+..+++|+.|+|++|.++.. +..
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 4688999999988743 334567788999999999998731 334567889999999999987622 334
Q ss_pred cccCCccccccccccccccCCCC----ccccc--cccccEEeccCCCCCCCCC----C------cccCcccccCCccc
Q 008828 69 TVSHLETLQYLRLNNNSLTGAIP----PSLSN--MSQLAFLDLSYNNLSGPVP----S------FHAKTFNITGNSLI 130 (552)
Q Consensus 69 ~~~~l~~L~~L~l~~N~l~~~~p----~~~~~--l~~L~~l~l~~N~l~~~~~----~------~~~~~~~l~~N~~~ 130 (552)
.+..+++|++|+|++|.|++.-. ..+.. .+.|+.|++++|+|+.... . ...+.++|++|.+.
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred cccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 56788999999999999874322 22332 3568999999999864210 0 12367889998874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.06 E-value=1e-05 Score=74.35 Aligned_cols=130 Identities=18% Similarity=0.112 Sum_probs=85.4
Q ss_pred eeeeCc-eEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcccc--ccceeeeEeecCCceeEEEeeccCCCh
Q 008828 238 VGKGGF-GNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR--NLLRLIGFCMTTTERLLVYPYMSNGSV 314 (552)
Q Consensus 238 iG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L 314 (552)
+..|.. +.||+...+++..+++|....... ..+..|...++.+... -+.+++++..+.+..++||+++++.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344543 689999988888899998754432 2356777777766432 356678888888889999999988665
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------------
Q 008828 315 ASRLKAKPSLDWATRKRIALGAARGLLYLHE------------------------------------------------- 345 (552)
Q Consensus 315 ~~~l~~~~~l~~~~~~~i~~~ia~~l~~LH~------------------------------------------------- 345 (552)
.+.. .. ....+.++++.|.-||+
T Consensus 94 ~~~~-----~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 94 LSSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp TTSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred cccc-----cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHH
Confidence 4321 11 11112233333333332
Q ss_pred --c----CCCceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 346 --Q----CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 346 --~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
. ..+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 112489999999999999877678999998753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.99 E-value=6.9e-07 Score=76.93 Aligned_cols=107 Identities=16% Similarity=0.157 Sum_probs=62.2
Q ss_pred CcccEeccCCC-CCccc----ccccccCCCCCcEEecccCccCC----CCchhhcCCCCCCEEEccCCcCCCC----CCc
Q 008828 2 VLLCYRGAPSQ-NLSGT----LSSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGP----IPS 68 (552)
Q Consensus 2 ~~l~~L~l~~n-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~ 68 (552)
++|+.|+|+++ .+... +-..+...++|+.|+|++|.+.. .+...+...+.|+.|+|++|.++.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 56777777764 34432 22345666777777777777762 2333455567777777777777632 112
Q ss_pred cccCCccccccccccccccCC-------CCccccccccccEEeccCC
Q 008828 69 TVSHLETLQYLRLNNNSLTGA-------IPPSLSNMSQLAFLDLSYN 108 (552)
Q Consensus 69 ~~~~l~~L~~L~l~~N~l~~~-------~p~~~~~l~~L~~l~l~~N 108 (552)
.+...++|++|+|++|.+... +...+...++|+.|+++.+
T Consensus 95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 345556677777777765421 2233444456666666554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.99 E-value=1.9e-06 Score=81.01 Aligned_cols=108 Identities=16% Similarity=0.142 Sum_probs=81.9
Q ss_pred CCcccEeccCCCC-Cccc-ccccccC-CCCCcEEecccC--ccCCC-CchhhcCCCCCCEEEccCC-cCCCCCCccccCC
Q 008828 1 MVLLCYRGAPSQN-LSGT-LSSSIGN-LTNLQLVLLQNN--NISGH-IPTEIGKLSKLLTLDLSNN-FFTGPIPSTVSHL 73 (552)
Q Consensus 1 l~~l~~L~l~~n~-l~~~-~p~~~~~-l~~L~~L~l~~N--~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l 73 (552)
+++|++|+|++|. ++.. +...+.. .++|+.|+++++ .++.. +...+.++++|+.|+|++| .+++.....+..+
T Consensus 120 ~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~ 199 (284)
T d2astb2 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL 199 (284)
T ss_dssp CTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGC
T ss_pred HHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhccc
Confidence 5789999999964 4432 2233433 578999999975 34421 3334467999999999996 5776666778899
Q ss_pred cccccccccc-ccccCCCCccccccccccEEeccCC
Q 008828 74 ETLQYLRLNN-NSLTGAIPPSLSNMSQLAFLDLSYN 108 (552)
Q Consensus 74 ~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~l~l~~N 108 (552)
++|++|+|++ +.+++.....+.++++|+.|+++++
T Consensus 200 ~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 200 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 9999999999 4677665667889999999999987
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.95 E-value=3.4e-07 Score=92.07 Aligned_cols=129 Identities=16% Similarity=0.112 Sum_probs=89.3
Q ss_pred CcccEeccCCCCCcccccccc-----cCCCCCcEEecccCccCCCC----chhhcCCCCCCEEEccCCcCCCC----CCc
Q 008828 2 VLLCYRGAPSQNLSGTLSSSI-----GNLTNLQLVLLQNNNISGHI----PTEIGKLSKLLTLDLSNNFFTGP----IPS 68 (552)
Q Consensus 2 ~~l~~L~l~~n~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~~~----p~~~~~l~~L~~L~l~~N~l~~~----~p~ 68 (552)
+.++.+++++|.+.......+ .....|+.+++++|.++... ...+...++|++|+|++|+++.. ++.
T Consensus 283 ~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~ 362 (460)
T d1z7xw1 283 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhh
Confidence 568899999999875322222 24568999999999987543 23345667899999999998632 223
Q ss_pred ccc-CCccccccccccccccCC----CCccccccccccEEeccCCCCCCCCC----------CcccCcccccCCccc
Q 008828 69 TVS-HLETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLSGPVP----------SFHAKTFNITGNSLI 130 (552)
Q Consensus 69 ~~~-~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~~----------~~~~~~~~l~~N~~~ 130 (552)
.+. ..+.|+.|+|++|+|+.. +++.+..+++|++|+|++|+|+.... ....+.+++.+|.+.
T Consensus 363 ~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred hhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence 332 456799999999999732 44556777899999999999974221 112356777777653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.78 E-value=5.4e-05 Score=74.25 Aligned_cols=76 Identities=16% Similarity=0.078 Sum_probs=47.3
Q ss_pred CeeeeeCceEEEEEEECC-CcEEEEEEeccC------ccCchHHHHHHHHHHHhhcc-c--cccceeeeEeecCCceeEE
Q 008828 236 NLVGKGGFGNVYKGYLQD-GTVVAVKRLKDG------NAIGGEIQFQTEVEMISLAV-H--RNLLRLIGFCMTTTERLLV 305 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~~~e~~~l~~~~-h--~niv~l~~~~~~~~~~~lv 305 (552)
+.||.|....||+....+ ++.++||.-... .......+...|.+.+..+. + ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 678999965321 11112234556777776653 2 335555554 45567899
Q ss_pred EeeccCCC
Q 008828 306 YPYMSNGS 313 (552)
Q Consensus 306 ~e~~~~g~ 313 (552)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.43 E-value=8e-06 Score=69.92 Aligned_cols=109 Identities=13% Similarity=0.142 Sum_probs=70.9
Q ss_pred CcccEeccCC-CCCccc----ccccccCCCCCcEEecccCccCCC----CchhhcCCCCCCEEEccCCcCCCC----CCc
Q 008828 2 VLLCYRGAPS-QNLSGT----LSSSIGNLTNLQLVLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IPS 68 (552)
Q Consensus 2 ~~l~~L~l~~-n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~ 68 (552)
++|++|+|++ ++++.. +-..+...++|++|+|++|.++.. +-..+...+.|+.|++++|.+... +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 5788888887 445432 234556788888888888888632 233455678888888888887622 123
Q ss_pred cccCCcccccc--ccccccccC----CCCccccccccccEEeccCCCC
Q 008828 69 TVSHLETLQYL--RLNNNSLTG----AIPPSLSNMSQLAFLDLSYNNL 110 (552)
Q Consensus 69 ~~~~l~~L~~L--~l~~N~l~~----~~p~~~~~l~~L~~l~l~~N~l 110 (552)
.+...++|+.+ ++++|.+.. .+...+...++|+.|+++.|..
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 45566777764 445666652 2344566677888888876543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.33 E-value=2e-05 Score=67.40 Aligned_cols=90 Identities=16% Similarity=0.141 Sum_probs=66.7
Q ss_pred cCCCCCcEEecccC-ccCCC----CchhhcCCCCCCEEEccCCcCCCC----CCccccCCccccccccccccccCC----
Q 008828 23 GNLTNLQLVLLQNN-NISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IPSTVSHLETLQYLRLNNNSLTGA---- 89 (552)
Q Consensus 23 ~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~---- 89 (552)
.+.++|++|+|+++ .++.. +-..+...+.|+.|+|++|.+... +...+...+.|+.|+|++|.|...
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 46789999999974 56522 333566788999999999998732 222345568999999999998732
Q ss_pred CCccccccccccEEeccCCCCCC
Q 008828 90 IPPSLSNMSQLAFLDLSYNNLSG 112 (552)
Q Consensus 90 ~p~~~~~l~~L~~l~l~~N~l~~ 112 (552)
+-.++...++|+.|+|++|.+..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~ 114 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSV 114 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCC
Confidence 22446667889999999997764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.26 E-value=0.00053 Score=65.03 Aligned_cols=133 Identities=16% Similarity=0.138 Sum_probs=77.0
Q ss_pred ceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhcccccc--ceeee-----EeecCCceeEEEeeccCCChh
Q 008828 243 FGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL--LRLIG-----FCMTTTERLLVYPYMSNGSVA 315 (552)
Q Consensus 243 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~g~L~ 315 (552)
--.||++..++|+.+++|+.+.+.. ...++..|.+.+..+....+ +..+. ........+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 3489999999999999999875432 24567788888777653322 11111 123345677889998764321
Q ss_pred h-----------hh---c----c-----CCCCCH-------------------HHHHHHHHHHHHHHHHHh----hcCCC
Q 008828 316 S-----------RL---K----A-----KPSLDW-------------------ATRKRIALGAARGLLYLH----EQCDP 349 (552)
Q Consensus 316 ~-----------~l---~----~-----~~~l~~-------------------~~~~~i~~~ia~~l~~LH----~~~~~ 349 (552)
. .+ + . ....++ ..+..+...+.+.+..+. +....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 00 0 0 011111 111122222223333332 22345
Q ss_pred ceEEcCCCCCceeeCCCCceEEccccccee
Q 008828 350 KIIHRDVKAANILLDEYYEAVVGDFGLAKL 379 (552)
Q Consensus 350 ~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 379 (552)
+++|+|+.+.|||++++ ..+.||+.+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 79999999999999753 45889998853
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.57 E-value=0.0073 Score=58.51 Aligned_cols=72 Identities=15% Similarity=0.165 Sum_probs=48.0
Q ss_pred CeeeeeCceEEEEEEECCC--------cEEEEEEeccCccCchHHHHHHHHHHHhhcccccc-ceeeeEeecCCceeEEE
Q 008828 236 NLVGKGGFGNVYKGYLQDG--------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLIGFCMTTTERLLVY 306 (552)
Q Consensus 236 ~~iG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~ 306 (552)
+.|+.|-.=.+|+....++ ..|.+++.- .. .......+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4677788889999986542 456676654 21 223355678888887753344 477777643 6899
Q ss_pred eeccCCCh
Q 008828 307 PYMSNGSV 314 (552)
Q Consensus 307 e~~~~g~L 314 (552)
||+++..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.54 E-value=0.02 Score=53.34 Aligned_cols=154 Identities=9% Similarity=-0.011 Sum_probs=80.7
Q ss_pred CHHHHHHHhcCCCCCCeee-----eeCceEEEEEEECCCcEEEEEEeccCccCchHHHHHHHHHHHhhccccccc--eee
Q 008828 221 HFKELQSATSNFSSKNLVG-----KGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL--RLI 293 (552)
Q Consensus 221 ~~~e~~~~~~~~~~~~~iG-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv--~l~ 293 (552)
+.+|++....+|.+.++.. .|---+.|+...++| .+++|+....... ..+..|++++..+...++. ..+
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCH---HHHHHHHHHHHhhhhccccccccc
Confidence 4567777778888766554 455567899988765 4899988653222 2344566666665432221 111
Q ss_pred e------EeecCCceeEEEeeccCCChhhhh--------------c---cC----C--CC------------------CH
Q 008828 294 G------FCMTTTERLLVYPYMSNGSVASRL--------------K---AK----P--SL------------------DW 326 (552)
Q Consensus 294 ~------~~~~~~~~~lv~e~~~~g~L~~~l--------------~---~~----~--~l------------------~~ 326 (552)
- +.........++.+..+......- + .. . .. ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 111233445666666553321100 0 00 0 00 00
Q ss_pred HHHHHHHHHHHHHHHHHhh-cCCCceEEcCCCCCceeeCCCCceEEcccccce
Q 008828 327 ATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 378 (552)
Q Consensus 327 ~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 378 (552)
......+..+...+...+. ....++||+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111222222222222221 234589999999999999988777899999885
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.83 E-value=0.00027 Score=59.98 Aligned_cols=95 Identities=20% Similarity=0.231 Sum_probs=65.3
Q ss_pred cccccccCCCCCcEEeccc-CccCCC----CchhhcCCCCCCEEEccCCcCCCCCC----ccccCCcccccccccccccc
Q 008828 17 TLSSSIGNLTNLQLVLLQN-NNISGH----IPTEIGKLSKLLTLDLSNNFFTGPIP----STVSHLETLQYLRLNNNSLT 87 (552)
Q Consensus 17 ~~p~~~~~l~~L~~L~l~~-N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~ 87 (552)
.+.....+.++|++|+|++ |.|+.. +-..+...++|+.|+|++|.++...- ..+...++|+.|++++|.+.
T Consensus 8 ~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 8 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 3444556789999999998 567622 23345678999999999999873211 23455688999999999886
Q ss_pred CC----CCccccccccccEEec--cCCCCC
Q 008828 88 GA----IPPSLSNMSQLAFLDL--SYNNLS 111 (552)
Q Consensus 88 ~~----~p~~~~~l~~L~~l~l--~~N~l~ 111 (552)
.. +...+...++|+.++| ++|.+.
T Consensus 88 ~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 88 GSGILALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred chhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence 22 2355667788886555 456664
|